PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Tedesco, M; La Sala, G; Barbagallo, F; De Felici, M; Farini, D				Tedesco, Marianna; La Sala, Gina; Barbagallo, Federica; De Felici, Massimo; Farini, Donatella			STRA8 Shuttles between Nucleus and Cytoplasm and Displays Transcriptional Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID GENE-8 STRA8; RETINOIC ACID; GERM-CELLS; EXPORT SIGNALS; NUCLEOCYTOPLASMIC TRANSPORT; SUBCELLULAR-DISTRIBUTION; EMBRYONAL CARCINOMA; MEIOTIC INITIATION; STEM-CELLS; MOUSE	Stra8 (stimulated by retinoic acid 8) encodes a protein crucial for mammalian germ cells entering into premeiotic stages. Here, to elucidate the still unknown STRA8 molecular functions, we studied the cellular localization of the protein in several cell types, including premeiotic mouse germ cells and stem cell lines. We reported distinct STRA8 localization in germ and stem cell types and a heterogeneous protein distribution in the cytoplasm and nucleus of such cells suggesting that the protein can shuttle between these two compartments. Moreover, we identified specific protein motifs determining its nuclear import/export. Furthermore, we demonstrated that in transfected cell lines the nuclear import of STRA8 is an active process depending on an N-terminal basic nuclear localization signal. Moreover, its nuclear export is mainly mediated by the Exportin1 (XPO1) recognition of a nuclear export signal. Significantly, we also demonstrated that STRA8 associates with DNA and possesses transcriptional activity. These observations strongly suggest that STRA8 can exert important functions in the nucleus rather than in the cytoplasm as believed previously, likely depending on the cell type and regulated by its nuclear-cytoplasmic shuttling.	[Tedesco, Marianna; La Sala, Gina; Barbagallo, Federica; De Felici, Massimo; Farini, Donatella] Univ Roma Tor Vergata, Dept Publ Hlth & Cell Biol, I-00173 Rome, Italy	University of Rome Tor Vergata	Farini, D (corresponding author), Univ Roma Tor Vergata, Dept Publ Hlth & Cell Biol, Via Montpellier 1, I-00173 Rome, Italy.	donatella.farini@uniroma2.it	Barbagallo, Federica/AAD-4903-2022; De Felici, Massimo/J-4845-2018; Barbagallo, Federica/K-1185-2018; LA SALA, GINA/AAF-5414-2021	Barbagallo, Federica/0000-0002-2972-370X; Barbagallo, Federica/0000-0002-2972-370X; LA SALA, GINA/0000-0002-1907-5948; FARINI, DONATELLA/0000-0002-1991-3956; De Felici, Massimo/0000-0001-8479-8264	Italian Ministry of Work and Welfare [1650];  [YFP-XPO1]	Italian Ministry of Work and Welfare; 	This work was supported by Italian Ministry of Work and Welfare Grant 1650.; We are grateful to Dr. Rodriguez for the generous gift of YFP-XPO1; to Prof. C. Sette and Dr. A. Di Florio for fruitful discussions; to Dr. S. Di Siena and Dr. F. Barrios for the spermatogonial cell preparation; to Mr. G. Bonelli for the images preparation; and to Dr. I. Moscatelli for critical reading of the paper.	Anderson EL, 2008, P NATL ACAD SCI USA, V105, P14976, DOI [10.1073/pnas.0807297105, 10.1038/s41598-019-45839-z]; Askjaer P, 1998, J BIOL CHEM, V273, P33414, DOI 10.1074/jbc.273.50.33414; Baltus AE, 2006, NAT GENET, V38, P1430, DOI 10.1038/ng1919; Birbach A, 2004, J CELL SCI, V117, P3615, DOI 10.1242/jcs.01224; Black BE, 2001, CURR BIOL, V11, P1749, DOI 10.1016/S0960-9822(01)00537-1; BOUILLET P, 1995, DEV BIOL, V170, P420, DOI 10.1006/dbio.1995.1226; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; Di Agostino S, 2004, MOL BIOL CELL, V15, P1224, DOI 10.1091/mbc.E03-09-0638; FISCHER U, 1994, EMBO J, V13, P4105, DOI 10.1002/j.1460-2075.1994.tb06728.x; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Gama-Carvalho M, 2001, FEBS LETT, V498, P157, DOI 10.1016/S0014-5793(01)02487-5; Giuili G, 2002, EMBO REP, V3, P753, DOI 10.1093/embo-reports/kvf149; HILSCHER B, 1974, CELL TISSUE RES, V154, P443, DOI 10.1007/BF00219667; HOFMANN MC, 1992, EXP CELL RES, V201, P417, DOI 10.1016/0014-4827(92)90291-F; Hogarth CA, 2007, DEV DYNAM, V236, P2311, DOI 10.1002/dvdy.21238; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hutten S, 2007, TRENDS CELL BIOL, V17, P193, DOI 10.1016/j.tcb.2007.02.003; Jans DA, 1996, PHYSIOL REV, V76, P651, DOI 10.1152/physrev.1996.76.3.651; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Kurooka H, 2005, J BIOL CHEM, V280, P4313, DOI 10.1074/jbc.M412614200; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Li C, 2007, MOL CELL BIOL, V27, P1296, DOI 10.1128/MCB.00336-06; Mark M, 2008, J CELL SCI, V121, P3233, DOI 10.1242/jcs.035071; Menke DB, 2003, DEV BIOL, V262, P303, DOI 10.1016/S0012-1606(03)00391-9; Norton JD, 2000, J CELL SCI, V113, P3897; OuladAbdelghani M, 1996, J CELL BIOL, V135, P469, DOI 10.1083/jcb.135.2.469; Pellegrini M, 2003, J CELL SCI, V116, P3363, DOI 10.1242/jcs.00650; PESCE M, 1995, DEV BIOL, V170, P722, DOI 10.1006/dbio.1995.1250; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; ROSSI P, 1993, DEV BIOL, V155, P68, DOI 10.1006/dbio.1993.1007; Soprano DR, 2007, VITAM HORM, V75, P69, DOI 10.1016/S0083-6729(06)75003-8; SPEED RM, 1982, CHROMOSOMA, V85, P427, DOI 10.1007/BF00330366; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Taagepera S, 1998, P NATL ACAD SCI USA, V95, P7457, DOI 10.1073/pnas.95.13.7457; Toyooka Y, 2000, MECH DEVELOP, V93, P139, DOI 10.1016/S0925-4773(00)00283-5; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Yamaguchi YL, 2006, DEV BIOL, V297, P350, DOI 10.1016/j.ydbio.2006.04.465; Yasuhara N, 2007, NAT CELL BIOL, V9, P72, DOI 10.1038/ncb1521; Zhou Q, 2008, BIOL REPROD, V79, P35, DOI 10.1095/biolreprod.107.066795; Zhou Q, 2008, BIOL REPROD, V78, P537, DOI 10.1095/biolreprod.107.064337	44	65	70	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35781	35793		10.1074/jbc.M109.056481	http://dx.doi.org/10.1074/jbc.M109.056481			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19805549	hybrid, Green Published			2022-12-27	WOS:000272645600055
J	Vince, JE; Pantaki, D; Feltham, R; Mace, PD; Cordier, SM; Schmukle, AC; Davidson, AJ; Callus, BA; Wong, WWL; Gentle, IE; Carter, H; Lee, EF; Walczak, H; Day, CL; Vaux, DL; Silke, J				Vince, James E.; Pantaki, Delara; Feltham, Rebecca; Mace, Peter D.; Cordier, Stephanie M.; Schmukle, Anna C.; Davidson, Angelina J.; Callus, Bernard A.; Wong, Wendy Wei-Lynn; Gentle, Ian E.; Carter, Holly; Lee, Erinna F.; Walczak, Henning; Day, Catherine L.; Vaux, David L.; Silke, John			TRAF2 Must Bind to Cellular Inhibitors of Apoptosis for Tumor Necrosis Factor (TNF) to Efficiently Activate NF-kappa B and to Prevent TNF-induced Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-ASSOCIATED FACTOR-2; ALPHA-DEPENDENT APOPTOSIS; SIGNALING COMPLEX; MULTIPLE-MYELOMA; STRUCTURAL BASIS; UBIQUITINATION; PROTEIN; CIAP1; DEGRADATION; SURVIVAL	Tumor necrosis factor (TNF) receptor-associated factor-2 (TRAF2) binds to cIAP1 and cIAP2 (cIAP1/2) and recruits them to the cytoplasmic domain of several members of the TNF receptor (TNFR) superfamily, including the TNF-TNFR1 ligand-receptor complex. Here, we define a cIAP1/2-interacting motif (CIM) within the TRAF-N domain of TRAF2, and we use TRAF2 CIM mutants to determine the role of TRAF2 and cIAP1/2 individually, and the TRAF2-cIAP1/2 interaction, in TNFR1-dependent signaling. We show that both the TRAF2 RING domain and the TRAF2 CIM are required to regulate NF-kappa B-inducing kinase stability and suppress constitutive noncanonical NF-kappa B activation. Conversely, following TNFR1 stimulation, cells bearing a CIM-mutated TRAF2 showed reduced canonical NF-kappa B activation and TNF-induced RIPK1 ubiquitylation. Remarkably, the RING domain of TRAF2 was dispensable for these functions. However, like the TRAF2 CIM, the RING domain of TRAF2 was required for protection against TNF-induced apoptosis. These results show that TRAF2 has anti-apoptotic signaling roles in addition to promoting NF-kappa B signaling and that efficient activation of NF-kappa B by TNFR1 requires the recruitment of cIAP1/2 by TRAF2.	[Vince, James E.; Pantaki, Delara; Feltham, Rebecca; Davidson, Angelina J.; Callus, Bernard A.; Wong, Wendy Wei-Lynn; Gentle, Ian E.; Carter, Holly; Vaux, David L.; Silke, John] La Trobe Univ, Dept Biochem, Melbourne, Vic 3086, Australia; [Mace, Peter D.; Day, Catherine L.] Univ Otago, Dept Biochem, Dunedin 9054, New Zealand; [Cordier, Stephanie M.; Schmukle, Anna C.; Walczak, Henning] Univ London Imperial Coll Sci Technol & Med, Div Med, Tumour Immunol Unit, Dept Immunol,Hammersmith Hosp, London W12 0NN, England; [Lee, Erinna F.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia	La Trobe University; University of Otago; Imperial College London; Walter & Eliza Hall Institute	Silke, J (corresponding author), La Trobe Univ, Dept Biochem, Kingsbury Dr, Melbourne, Vic 3086, Australia.	j.silke@latrobe.edu.au	Lee, Erinna/N-1523-2015; Walczak, Henning/AAV-2214-2020; Wong, W. Wei-Lynn/A-6851-2015; Gentle, Ian/X-2888-2019; Vaux, David L/C-7249-2013; Silke, John/B-7622-2008	Lee, Erinna/0000-0003-1255-9808; Walczak, Henning/0000-0002-6312-4591; Wong, W. Wei-Lynn/0000-0003-3155-1211; Gentle, Ian/0000-0002-6707-7809; Vaux, David L/0000-0003-2703-1651; Silke, John/0000-0002-7611-5774; Mace, Peter/0000-0003-2175-9537; Day, Catherine/0000-0003-1571-4367; Anderton, Holly/0000-0003-3913-9686; Feltham, Rebecca/0000-0001-8376-6869	Human Frontiers science program; University of Otago; The Cancer Council Victoria; Leukemia and Lymphoma Society; National Health and Medical Research Council [461221, 433013, 541901, 541902]	Human Frontiers science program(Human Frontier Science Program); University of Otago; The Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Supported by a Human Frontiers science program fellowship.; Recipient of a health sciences career development award (University of Otago).; Supported by The Cancer Council Victoria.; Australian Fellow, funded by the Leukemia and Lymphoma Society and National Health and Medical Research Council Grant 461221.; Supported by National Health and Medical Research Council Grants 433013, 541901, and 541902.	Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Arch RH, 2000, BIOCHEM BIOPH RES CO, V272, P936, DOI 10.1006/bbrc.2000.2873; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Brown KD, 2001, J EXP MED, V193, P943, DOI 10.1084/jem.193.8.943; Callus BA, 2008, CELL DEATH DIFFER, V15, P213, DOI 10.1038/sj.cdd.4402245; Chan FKM, 2000, EUR J IMMUNOL, V30, P652; Dai ZY, 2003, HUM MOL GENET, V12, P791, DOI 10.1093/hmg/ddg083; Duckett CS, 1997, GENE DEV, V11, P2810, DOI 10.1101/gad.11.21.2810; Dupoux A, 2009, BLOOD, V113, P175, DOI 10.1182/blood-2008-02-137919; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Fotin-Mleczek M, 2002, J CELL SCI, V115, P2757; Gaither A, 2007, CANCER RES, V67, P11493, DOI 10.1158/0008-5472.CAN-07-5173; Gardam S, 2008, IMMUNITY, V28, P391, DOI 10.1016/j.immuni.2008.01.009; Grech AP, 2004, IMMUNITY, V21, P629, DOI 10.1016/j.immuni.2004.09.011; Guiet C, 2002, CELL DEATH DIFFER, V9, P138, DOI 10.1038/sj/cdd/4400947; Hostager BS, 2000, J BIOL CHEM, V275, P15392, DOI 10.1074/jbc.M909520199; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Hughes MA, 2009, MOL CELL, V35, P265, DOI 10.1016/j.molcel.2009.06.012; Imoto I, 2002, CANCER RES, V62, P4860; Imoto I, 2001, CANCER RES, V61, P6629; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Lee SY, 1997, IMMUNITY, V7, P703, DOI 10.1016/S1074-7613(00)80390-8; Lee TH, 2004, J BIOL CHEM, V279, P33185, DOI 10.1074/jbc.M404206200; Li HX, 2006, J BIOL CHEM, V281, P13636, DOI 10.1074/jbc.M600620200; Li L, 2004, SCIENCE, V305, P1471, DOI 10.1126/science.1098231; LI L, 2008, BIOCHIM BIOPHYS ACTA, V8, P8; Li S, 2009, MOL CELL, V33, P30, DOI 10.1016/j.molcel.2008.11.023; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; Mahoney DJ, 2008, P NATL ACAD SCI USA, V105, P11778, DOI 10.1073/pnas.0711122105; Nakajima A, 2006, EMBO J, V25, P5549, DOI 10.1038/sj.emboj.7601423; Nguyen LT, 1999, IMMUNITY, V11, P379, DOI 10.1016/S1074-7613(00)80113-2; Park YC, 1999, NATURE, V398, P533, DOI 10.1038/19110; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Pineda G, 2007, ADV EXP MED BIOL, V597, P80; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; Samuel T, 2006, J BIOL CHEM, V281, P1080, DOI 10.1074/jbc.M509381200; Shi CS, 2003, J BIOL CHEM, V278, P15429, DOI 10.1074/jbc.M211796200; Silke J, 2005, P NATL ACAD SCI USA, V102, P16182, DOI 10.1073/pnas.0502828102; SILKE J, 2009, CELL DEATH IN PRESS; Tada K, 2001, J BIOL CHEM, V276, P36530, DOI 10.1074/jbc.M104837200; Tanimoto T, 2005, CANCER LETT, V224, P141, DOI 10.1016/j.canlet.2004.11.049; Uren AG, 1996, P NATL ACAD SCI USA, V93, P4974, DOI 10.1073/pnas.93.10.4974; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Varfolomeev E, 2006, J BIOL CHEM, V281, P29022, DOI 10.1074/jbc.M605116200; Vaux DL, 2005, NAT REV MOL CELL BIO, V6, P287, DOI 10.1038/nrm1621; Vince JE, 2008, J CELL BIOL, V182, P171, DOI 10.1083/jcb.200801010; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Wu CJ, 2005, EMBO J, V24, P1886, DOI 10.1038/sj.emboj.7600649; Ye H, 1999, MOL CELL, V4, P321, DOI 10.1016/S1097-2765(00)80334-2; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhao YG, 2007, J BIOL CHEM, V282, P7777, DOI 10.1074/jbc.M609146200	59	173	184	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35906	35915		10.1074/jbc.M109.072256	http://dx.doi.org/10.1074/jbc.M109.072256			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19815541	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000272645600066
J	Gupta, M; Sajid, A; Arora, G; Tandon, V; Singh, Y				Gupta, Meetu; Sajid, Andaleeb; Arora, Gunjan; Tandon, Vibha; Singh, Yogendra			Forkhead-associated Domain-containing Protein Rv0019c and Polyketide-associated Protein PapA5, from Substrates of Serine/Threonine Protein Kinase PknB to Interacting Proteins of Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FHA DOMAIN; BINDING DOMAIN; PSEUDOMONAS-AERUGINOSA; CRYSTAL-STRUCTURE; ABC TRANSPORTER; PHOSPHORYLATION; ACTIVATION; SECRETION; EMBR; ACETYLTRANSFERASE	Mycobacterium tuberculosis profoundly exploits protein phosphorylation events carried out by serine/threonine protein kinases (STPKs) for its survival and pathogenicity. Forkhead-associated domains (FHA), the phosphorylation-responsive modules, have emerged as prominent players in STPK mediated signaling. In this study, we demonstrate the association of the previously uncharacterized FHA domain-containing protein Rv0019c with cognate STPK PknB. The consequent phosphorylation of Rv0019c is shown to be dependent on the conserved residues in the Rv0019c FHA domain and activation loop of PknB. Furthermore, by creating deletion mutants we identify Thr(36) as the primary phosphorylation site in Rv0019c. During purification of Rv0019c from Escherichia coli, the E. coli protein chloramphenicol acetyltransferase (CAT) specifically and reproducibly copurifies with Rv0019c in a FHA domain-dependent manner. On the basis of structural similarity of E. coli CAT with M. tuberculosis PapA5, a protein involved in phthiocerol dimycocerosate biosynthesis, PapA5 is identified as an interaction partner of Rv0019c. The interaction studies on PapA5, purified as an unphosphorylated protein from E. coli, with Rv0019c deletion mutants reveal that the residues N-terminal to the functional FHA domain of Rv0019c are critical for formation of the Rv0019c-PapA5 complex and thus constitute a previously unidentified phosphoindependent binding motif. Finally, PapA5 is shown to be phosphorylated on threonine residue(s) by PknB, whereas serine/threonine phosphatase Mstp completely reverses the phosphorylation. Thus, our data provides initial clues for a possible regulation of PapA5 and hence the phthiocerol dimycocerosate biosynthesis by PknB, either by direct phosphorylation of PapA5 or indirectly through Rv0019c.	[Sajid, Andaleeb; Singh, Yogendra] CSIR, Inst Genom & Integrat Biol, Delhi 110007, India; [Gupta, Meetu; Tandon, Vibha] Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Delhi 110007, India; [Tandon, Vibha] Univ Delhi, Dept Chem, Delhi 110007, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); University of Delhi; University of Delhi	Singh, Y (corresponding author), Mall Rd, Delhi 110007, India.	ysingh@igib.res.in	Sajid, Andaleeb/AAI-2960-2020; Arora, Gunjan/AAL-3448-2020	Sajid, Andaleeb/0000-0001-6248-4985; Arora, Gunjan/0000-0003-0575-6205	Council of Scientific and Industrial Research [NWP-0038]	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Council of Scientific and Industrial Research Grant NWP-0038.	Alderwick LJ, 2006, P NATL ACAD SCI USA, V103, P2558, DOI 10.1073/pnas.0507766103; Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; Boitel B, 2003, MOL MICROBIOL, V49, P1493, DOI 10.1046/j.1365-2958.2003.03657.x; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Buglino J, 2004, J BIOL CHEM, V279, P30634, DOI 10.1074/jbc.M404011200; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Curry JM, 2005, INFECT IMMUN, V73, P4471, DOI 10.1128/IAI.73.8.4471-4477.2005; Duran R, 2005, BIOCHEM BIOPH RES CO, V333, P858, DOI 10.1016/j.bbrc.2005.05.173; Durocher D, 2002, FEBS LETT, V513, P58, DOI 10.1016/S0014-5793(01)03294-X; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; England P, 2009, FEBS LETT, V583, P301, DOI 10.1016/j.febslet.2008.12.036; Ganguly S, 2001, P NATL ACAD SCI USA, V98, P8083, DOI 10.1073/pnas.141118798; Grundner C, 2005, PROTEIN SCI, V14, P1918, DOI 10.1110/ps.051413405; Hammet A, 2000, FEBS LETT, V471, P141, DOI 10.1016/S0014-5793(00)01392-2; Hammet A, 2003, IUBMB LIFE, V55, P23, DOI 10.1080/1521654031000070636; HOFMANN K, 1995, TRENDS BIOCHEM SCI, V20, P347, DOI 10.1016/S0968-0004(00)89072-6; Hsu FS, 2009, MOL MICROBIOL, V72, P1111, DOI 10.1111/j.1365-2958.2009.06701.x; Jelsbak L, 2005, P NATL ACAD SCI USA, V102, P3010, DOI 10.1073/pnas.0409371102; Johnson DL, 2008, J BACTERIOL, V190, P2972, DOI 10.1128/JB.01997-07; Johnson DL, 2007, J BACTERIOL, V189, P7549, DOI 10.1128/JB.00893-07; Kennelly PJ, 1996, J BACTERIOL, V178, P4759, DOI 10.1128/jb.178.16.4759-4764.1996; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; Leonard CJ, 1998, GENOME RES, V8, P1038, DOI 10.1101/gr.8.10.1038; LESLIE AGW, 1988, P NATL ACAD SCI USA, V85, P4133, DOI 10.1073/pnas.85.12.4133; Li HY, 2004, J MOL BIOL, V335, P371, DOI 10.1016/j.jmb.2003.10.032; Li J, 2000, J CELL SCI, V113, P4143; Li J, 1999, P NATL ACAD SCI USA, V96, P7821, DOI 10.1073/pnas.96.14.7821; Li JJ, 2002, MOL CELL, V9, P1045, DOI 10.1016/S1097-2765(02)00527-0; Liao H, 1999, J MOL BIOL, V294, P1041, DOI 10.1006/jmbi.1999.3313; Lu YB, 1996, P NATL ACAD SCI USA, V93, P12902, DOI 10.1073/pnas.93.23.12902; Mahajan A, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.151re12; Molle V, 2004, FEMS MICROBIOL LETT, V234, P215, DOI 10.1016/j.femsle.2004.03.033; Molle V, 2003, BIOCHEMISTRY-US, V42, P15300, DOI 10.1021/bi035150b; Molle V, 2008, BIOCHEM J, V410, P309, DOI 10.1042/BJ20071384; Mougous JD, 2007, NAT CELL BIOL, V9, P797, DOI 10.1038/ncb1605; MUNOZDORADO J, 1991, CELL, V67, P995, DOI 10.1016/0092-8674(91)90372-6; Nott TJ, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000212; O'Hare HM, 2008, MOL MICROBIOL, V70, P1408, DOI 10.1111/j.1365-2958.2008.06489.x; Obsil T, 2001, CELL, V105, P257, DOI 10.1016/S0092-8674(01)00316-6; Onwueme KC, 2004, P NATL ACAD SCI USA, V101, P4608, DOI 10.1073/pnas.0306928101; Pallen M, 2002, TRENDS MICROBIOL, V10, P556, DOI 10.1016/S0966-842X(02)02476-9; Papavinasasundaram KG, 2005, J BACTERIOL, V187, P5751, DOI 10.1128/JB.187.16.5751-5760.2005; Sharma K, 2006, J BACTERIOL, V188, P2936, DOI 10.1128/JB.188.8.2936-2944.2006; Trivedi OA, 2005, MOL CELL, V17, P631, DOI 10.1016/j.molcel.2005.02.009; Villarino A, 2005, J MOL BIOL, V350, P953, DOI 10.1016/j.jmb.2005.05.049; WANG JYJ, 1978, J BIOL CHEM, V253, P7605; Wehenkel A, 2008, BBA-PROTEINS PROTEOM, V1784, P193, DOI 10.1016/j.bbapap.2007.08.006; Yaffe MB, 2004, ANNU REV BIOPH BIOM, V33, P225, DOI 10.1146/annurev.biophys.33.110502.133346; Young TA, 2003, NAT STRUCT BIOL, V10, P168, DOI 10.1038/nsb897	49	45	51	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34723	34734		10.1074/jbc.M109.058834	http://dx.doi.org/10.1074/jbc.M109.058834			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19826007	hybrid, Green Published			2022-12-27	WOS:000272439600028
J	Gross, SA; Guzman, GA; Wissenbach, U; Philipp, SE; Zhu, MX; Bruns, D; Cavalie, A				Gross, Stefan Alfred; Guzman, Gustavo Adolfo; Wissenbach, Ulrich; Philipp, Stephan Ernst; Zhu, Michael Xi; Bruns, Dieter; Cavalie, Adolfo			TRPC5 Is a Ca2+-activated Channel Functionally Coupled to Ca2+-selective Ion Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATION CHANNELS; CA2+ MICRODOMAINS; CELL; ENTRY; STIM1; ORAI1; MODULATION; ACTIVATION; EXOCYTOSIS; INHIBITION	TRPC5 forms non-selective cation channels. Here we studied the role of internal Ca2+ in the activation of murine TRPC5 heterologously expressed in human embryonic kidney cells. Cell dialysis with various Ca2+ concentrations (Ca-i(2+)) revealed a dose-dependent activation of TRPC5 channels by internal Ca2+ with EC50 of 635.1 and 358.2 nM at negative and positive membrane potentials, respectively. Stepwise increases of Ca-i(2+) induced by photolysis of caged Ca2+ showed that the Ca2+ activation of TRPC5 channels follows a rapid exponential time course with a time constant of 8.6 +/- 0.2 ms at Ca-i(2+) below 10 mu M, suggesting that the action of internal Ca2+ is a primary mechanism in the activation of TRPC5 channels. A second slow activation phase with a time to peak of 1.4 +/- 0.1 s was also observed at Ca-i(2+) above 10 mu M. In support of a Ca2+-activation mechanism, the thapsigargin-induced release of Ca2+ from internal stores activated TRPC5 channels transiently, and the subsequent Ca2+ entry produced a sustained TRPC5 activation, which in turn supported a long-lasting membrane depolarization. By co-expressing STIM1 plus ORAI1 or the alpha C-1 and beta(2) subunits of L-type Ca2+ channels, we found that Ca2+ entry through either calcium-release-activated-calcium or voltage-dependent Ca2+ channels is sufficient for TRPC5 channel activation. The Ca2+ entry activated TRPC5 channels under buffering of internal Ca2+ with EGTA but not with BAPTA. Our data support the hypothesis that TRPC5 forms Ca2+-activated cation channels that are functionally coupled to Ca2+-selective ion channels through local Ca2+ increases beneath the plasma membrane.	[Cavalie, Adolfo] Univ Saarland, Inst Expt & Klin Pharmakol & Toxikol, D-66421 Homburg, Germany; [Guzman, Gustavo Adolfo; Bruns, Dieter] Univ Saarland, Inst Physiol, D-66421 Homburg, Germany; [Zhu, Michael Xi] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA; [Zhu, Michael Xi] Ohio State Univ, Ctr Mol Neurobiol, Columbus, OH 43210 USA	Saarland University; Saarland University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Cavalie, A (corresponding author), Univ Saarland, Inst Expt & Klin Pharmakol & Toxikol, Campus Homburg,Bldg 46, D-66421 Homburg, Germany.	ptacav@uks.eu	Philipp, Stephan/AAR-7519-2020	Philipp, Stephan/0000-0003-1959-9167	Deutsche Forschungsgemeinschaft; National Institutes of Health; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042183, P30NS045758, R21NS056942] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Deutsche Forschungsgemeinschaft to D.B. and A.C.). This work was also supported, in whole or in part, by the National Institutes of Health and by the American Heart Association (to M.X.Z.).	Abramowitz J, 2009, FASEB J, V23, P297, DOI 10.1096/fj.08-119495; Aneiros E, 2005, J IMMUNOL, V174, P119, DOI 10.4049/jimmunol.174.1.119; Baxter DF, 2002, J BIOMOL SCREEN, V7, P79, DOI 10.1177/108705710200700110; Beech D. J., 2007, V179, P109; Berkefeld H, 2006, SCIENCE, V314, P615, DOI 10.1126/science.1132915; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Blair NT, 2009, J GEN PHYSIOL, V133, P525, DOI 10.1085/jgp.200810153; Borisovska M, 2005, EMBO J, V24, P2114, DOI 10.1038/sj.emboj.7600696; Chaudhuri P, 2008, MOL BIOL CELL, V19, P3203, DOI 10.1091/mbc.E07-08-0765; COLQUHOUN D, 1981, NATURE, V294, P752, DOI 10.1038/294752a0; Dattilo M, 2008, MOL PHARMACOL, V73, P42, DOI 10.1124/mol.107.040899; DeHaven WI, 2009, J PHYSIOL-LONDON, V587, P2275, DOI 10.1113/jphysiol.2009.170431; Dietrich A, 2005, PFLUG ARCH EUR J PHY, V451, P72, DOI 10.1007/s00424-005-1460-0; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Flemming PK, 2006, J BIOL CHEM, V281, P4977, DOI 10.1074/jbc.M510301200; Gomis A, 2008, J PHYSIOL-LONDON, V586, P5633, DOI 10.1113/jphysiol.2008.161257; Greka A, 2003, NAT NEUROSCI, V6, P837, DOI 10.1038/nn1092; Gross SA, 2007, J BIOL CHEM, V282, P19375, DOI 10.1074/jbc.M701962200; Hui H, 2006, J PHYSIOL-LONDON, V572, P165, DOI 10.1113/jphysiol.2005.102889; Jung S, 2003, J BIOL CHEM, V278, P3562, DOI 10.1074/jbc.M211484200; Kinoshita-Kawada M, 2005, PFLUG ARCH EUR J PHY, V450, P345, DOI 10.1007/s00424-005-1419-1; Klingauf J, 1997, BIOPHYS J, V72, P674, DOI 10.1016/S0006-3495(97)78704-6; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Liao YY, 2009, P NATL ACAD SCI USA, V106, P3202, DOI 10.1073/pnas.0813346106; Ma HT, 2008, J IMMUNOL, V180, P2233, DOI 10.4049/jimmunol.180.4.2233; MUALLEM S, 1995, J CELL BIOL, V128, P589, DOI 10.1083/jcb.128.4.589; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Obukhov AG, 2008, J CELL PHYSIOL, V216, P162, DOI 10.1002/jcp.21388; Okada T, 1998, J BIOL CHEM, V273, P10279, DOI 10.1074/jbc.273.17.10279; Ordaz B, 2005, J BIOL CHEM, V280, P30788, DOI 10.1074/jbc.M504745200; Parekh AB, 2008, J PHYSIOL-LONDON, V586, P3043, DOI 10.1113/jphysiol.2008.153460; Philipp S, 1998, EMBO J, V17, P4274, DOI 10.1093/emboj/17.15.4274; Plant TD, 2005, N-S ARCH PHARMACOL, V371, P266, DOI 10.1007/s00210-005-1055-5; Riccio A, 2009, CELL, V137, P761, DOI 10.1016/j.cell.2009.03.039; Schaefer M, 2000, J BIOL CHEM, V275, P17517, DOI 10.1074/jbc.275.23.17517; Semtner M, 2007, J BIOL CHEM, V282, P33868, DOI 10.1074/jbc.M702577200; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Trebak M., 2007, V179, P593; Trebak M, 2009, PFLUG ARCH EUR J PHY, V457, P757, DOI 10.1007/s00424-008-0550-1; Ullrich ND, 2005, CELL CALCIUM, V37, P267, DOI 10.1016/j.ceca.2004.11.001; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Xu SZ, 2008, NATURE, V451, P69, DOI 10.1038/nature06414; Yoshida T, 2006, NAT CHEM BIOL, V2, P596, DOI 10.1038/nchembio821; Yuan JP, 2007, NAT CELL BIOL, V9, P636, DOI 10.1038/ncb1590; Zeng FN, 2004, J PHYSIOL-LONDON, V559, P739, DOI 10.1113/jphysiol.2004.065391; Zhu MH, 2005, AM J PHYSIOL-CELL PH, V289, pC591, DOI 10.1152/ajpcell.00440.2004; Zhu MX, 2005, PFLUG ARCH EUR J PHY, V451, P105, DOI 10.1007/s00424-005-1427-1	47	78	79	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34423	34432		10.1074/jbc.M109.018192	http://dx.doi.org/10.1074/jbc.M109.018192			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19815560	Green Published, hybrid			2022-12-27	WOS:000272165200072
J	Yea, K; Kim, J; Yoon, JH; Kwon, T; Kim, JH; Lee, BD; Lee, HJ; Lee, SJ; Kim, JI; Lee, TG; Baek, MC; Park, HS; Park, KS; Ohba, M; Suh, PG; Ryu, SH				Yea, Kyungmoo; Kim, Jaeyoon; Yoon, Jong Hyuk; Kwon, Taewan; Kim, Jong Hyun; Lee, Byoung Dae; Lee, Hae-Jeong; Lee, Seung Jae; Kim, Jong-In; Lee, Taehoon G.; Baek, Moon-Chang; Park, Ho Seon; Park, Kyong Soo; Ohba, Motoi; Suh, Pann-Ghill; Ryu, Sung Ho			Lysophosphatidylcholine Activates Adipocyte Glucose Uptake and Lowers Blood Glucose Levels in Murine Models of Diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; SKELETAL-MUSCLE; GLUT4 TRANSLOCATION; INSULIN; TRANSPORT; EXERCISE; ACID; IDENTIFICATION; KERATINOCYTES; INCREASES	Glucose homeostasis is maintained by the orchestration of peripheral glucose utilization and hepatic glucose production, mainly by insulin. In this study, we found by utilizing a combined parallel chromatography mass profiling approach that lysophosphatidylcholine (LPC) regulates glucose levels. LPC was found to stimulate glucose uptake in 3T3-L1 adipocytes dose- and time-dependently, and this activity was found to be sensitive to variations in acyl chain lengths and to polar head group types in LPC. Treatment with LPC resulted in a significant increase in the level of GLUT4 at the plasma membranes of 3T3-L1 adipocytes. Moreover, LPC did not affect IRS-1 and AKT2 phosphorylations, and LPC-induced glucose uptake was not influenced by pretreatment with the PI 3-kinase inhibitor LY294002. However, glucose uptake stimulation by LPC was abrogated both by rottlerin (a protein kinase C delta inhibitor) and by the adenoviral expression of dominant negative protein kinase C delta. In line with its determined cellular functions, LPC was found to lower blood glucose levels in normal mice. Furthermore, LPC improved blood glucose levels in mouse models of type 1 and 2 diabetes. These results suggest that an understanding of the mode of action of LPC may provide a new perspective of glucose homeostasis.	[Yea, Kyungmoo; Kim, Jaeyoon; Yoon, Jong Hyuk; Kwon, Taewan; Kim, Jong Hyun; Lee, Byoung Dae; Suh, Pann-Ghill; Ryu, Sung Ho] Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang 790784, South Korea; [Lee, Hae-Jeong; Lee, Seung Jae; Kim, Jong-In] Pohang Univ Sci & Technol, Peptide Lib Support Facil, Postech Biotech Ctr, Pohang 790784, South Korea; [Lee, Taehoon G.] Sigmol Incorp, Pohang 790834, South Korea; [Baek, Moon-Chang] Kyungpook Natl Univ, Dept Mol Med, Sch Med, Taegu 700721, South Korea; [Park, Ho Seon; Park, Kyong Soo] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 110744, South Korea; [Ohba, Motoi] Showa Univ, Inst Mol Oncol, Tokyo 1428555, Japan	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Kyungpook National University; Seoul National University (SNU); Showa University	Ryu, SH (corresponding author), Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang 790784, South Korea.	sungho@postech.ac.kr	Suh, Pann-Ghill/F-3610-2010; Park, Kyong Soo/C-2265-2008	Park, Kyong Soo/0000-0003-3597-342X; Ryu, Sung Ho/0000-0003-0913-3048; Park, Ho Seon/0000-0003-1200-4626	Korean Ministry of Education and Science [FPR08B1-160]; Korean Ministry of Science and Technology/Korean Science and Engineering Foundation	Korean Ministry of Education and Science(Ministry of Education (MOE), Republic of Korea); Korean Ministry of Science and Technology/Korean Science and Engineering Foundation(Korea Science and Engineering FoundationMinistry of Science & Technology (MOST), Republic of Korea)	This work was supported by Grant FPR08B1-160 from the 21C Frontier Functional Proteomics project of the Korean Ministry of Education and Science and by a grant from the Korean Ministry of Science and Technology/Korean Science and Engineering Foundation to the Korean National Core Research Center for Systems Bio-Dynamics.	An SZ, 1998, J BIOL CHEM, V273, P7906, DOI 10.1074/jbc.273.14.7906; Baek MC, 2006, PROTEOMICS, V6, P1741, DOI 10.1002/pmic.200500511; Bandoh K, 1999, J BIOL CHEM, V274, P27776, DOI 10.1074/jbc.274.39.27776; Bandyopadhyay G, 1997, J BIOL CHEM, V272, P2551; Braiman L, 1999, MOL ENDOCRINOL, V13, P2002, DOI 10.1210/me.13.12.2002; Chaudhuri P, 2005, CIRC RES, V97, P674, DOI 10.1161/01.RES.0000184667.82354.b1; Chiasson JL, 2004, DIABETES, V53, pS34, DOI 10.2337/diabetes.53.suppl_3.S34; Contos JJA, 2000, MOL PHARMACOL, V58, P1188, DOI 10.1124/mol.58.6.1188; Croset M, 2000, BIOCHEM J, V345, P61, DOI 10.1042/0264-6021:3450061; Elmendorf JS, 2002, J MEMBRANE BIOL, V190, P167, DOI 10.1007/s00232-002-1035-3; Goetzl EJ, 1998, FASEB J, V12, P1589, DOI 10.1096/fasebj.12.15.1589; Hespel P, 1996, DIABETES, V45, pS99, DOI 10.2337/diab.45.1.S99; Hutchinson DS, 2006, DIABETES, V55, P682, DOI 10.2337/diabetes.55.03.06.db05-0901; Ishibashi KI, 2000, ENDOCRINOLOGY, V141, P4623, DOI 10.1210/en.141.12.4623; Kemppainen J, 2002, J PHYSIOL-LONDON, V542, P403, DOI 10.1113/jphysiol.2002.018135; Kishi K, 1998, DIABETES, V47, P550, DOI 10.2337/diabetes.47.4.550; Li LW, 1999, MOL CELL BIOL, V19, P8547; Moller DE, 2001, NATURE, V414, P821, DOI 10.1038/414821a; Murugesan G, 2003, J MOL CELL CARDIOL, V35, P1375, DOI 10.1016/j.yjmcc.2003.08.004; Ohba M, 1998, MOL CELL BIOL, V18, P5199, DOI 10.1128/MCB.18.9.5199; Perrini S, 2004, DIABETES, V53, P41, DOI 10.2337/diabetes.53.1.41; Richter EA, 2001, J PHYSIOL-LONDON, V535, P313, DOI 10.1111/j.1469-7793.2001.t01-2-00313.x; Ryder JW, 2001, ACTA PHYSIOL SCAND, V171, P249, DOI 10.1046/j.1365-201x.2001.00827.x; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Soga T, 2005, BIOCHEM BIOPH RES CO, V326, P744, DOI 10.1016/j.bbrc.2004.11.120; Sugo T, 2006, BIOCHEM BIOPH RES CO, V341, P1078, DOI 10.1016/j.bbrc.2006.01.069; Tanishita T, 1997, J BIOCHEM, V122, P90; van Meeteren LA, 2007, PROG LIPID RES, V46, P145, DOI 10.1016/j.plipres.2007.02.001; VANDENBERGHE N, 1994, MOL CELL BIOL, V14, P2372, DOI 10.1128/MCB.14.4.2372; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Wang L, 2005, MOL BIOL CELL, V16, P2234, DOI 10.1091/mbc.E04-12-1044; Xing FY, 2009, J CELL MOL MED, V13, P1136, DOI 10.1111/j.1582-4934.2008.00394.x; XU Y, 1995, BIOCHEM J, V309, P933, DOI 10.1042/bj3090933; Xu Y, 2002, BBA-MOL CELL BIOL L, V1582, P81, DOI 10.1016/S1388-1981(02)00140-3; Yea K, 2008, J MOL MED-JMM, V86, P211, DOI 10.1007/s00109-007-0269-z	35	97	102	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33833	33840		10.1074/jbc.M109.024869	http://dx.doi.org/10.1074/jbc.M109.024869			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19815546	Green Published, hybrid			2022-12-27	WOS:000272165200015
J	Kanekiyo, T; Bu, GJ				Kanekiyo, Takahisa; Bu, Guojun			Receptor-associated Protein Interacts with Amyloid-beta Peptide and Promotes Its Cellular Uptake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRECURSOR PROTEIN; HEPARAN-SULFATE; LDL-RECEPTOR; ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; ALPHA-2-MACROGLOBULIN RECEPTOR; LIPOPROTEIN RECEPTORS; MOLECULAR CHAPERONE; TRANSGENIC MICE; TERMINAL DOMAIN	Brain amyloid-beta (A beta) peptide accumulation and aggregation are critical events in the pathogenesis of Alzheimer disease. Increasing evidence has demonstrated that LRP1 is involved in Alzheimer disease pathogenesis. The physiological ligands of LRP1, including apoE, play significant roles in the cellular clearance of A beta. The receptor-associated protein (RAP) is a specialized chaperone for members of the low density lipoprotein receptor family. RAP shares structural and receptor-binding properties with apoE. Here, we show that RAP binds to both A beta 40 and A beta 42 in a concentration-dependent manner and forms complexes with them. Fluorescence-activated cell sorter analysis showed that RAP significantly enhances the cellular internalization of A beta in different cell types, including brain vascular smooth muscle, neuroblastoma, glioblastoma, and Chinese hamster ovary cells. This effect of RAP was confirmed by fluorescence microscopy and enzyme-linked immunosorbent assay. RAP binds to both LRP1 and heparin; however, the ability of RAP to enhance A beta cellular uptake was blocked by heparin and heparinase treatment but not by LRP1 deficiency. Furthermore, the effects of RAP were significantly decreased in heparan sulfate proteoglycan-deficient Chinese hamster ovary cells. Our findings reveal that RAP is a novel A beta-binding protein that promotes cellular internalization of A beta.	[Kanekiyo, Takahisa; Bu, Guojun] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Bu, Guojun] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Bu, Guojun] Xiamen Univ, Inst Biomed Res, Xiamen 361005, Peoples R China	Washington University (WUSTL); Washington University (WUSTL); Xiamen University	Bu, GJ (corresponding author), Washington Univ, Sch Med, Dept Pediat, Campus Box 8208,660 S Euclid Ave, St Louis, MO 63110 USA.	bu@wustl.edu			National Institutes of Health [AG027924, AG031784]; Alzheimer's Association; Uehara Memorial Foundation; American Health Assistance Foundation; American Heart Association; NATIONAL INSTITUTE ON AGING [P01AG030128, R01AG027924, R01AG031784] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); Uehara Memorial Foundation(Uehara Memorial Foundation); American Health Assistance Foundation(BrightFocus Foundation); American Heart Association(American Heart Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG027924 and AG031784 (to G.B.). This work was also supported by a Zenith Fellows award from the Alzheimer's Association (to G. B.) and by fellowships from the Uehara Memorial Foundation, the American Health Assistance Foundation, and the American Heart Association (to T.K.).	ASHCOM JD, 1990, J CELL BIOL, V110, P1041, DOI 10.1083/jcb.110.4.1041; Avirutnan P, 2007, PLOS PATHOG, V3, P1798, DOI 10.1371/journal.ppat.0030183; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Broekelmann TJ, 2005, J BIOL CHEM, V280, P40939, DOI 10.1074/jbc.M507309200; Bu GJ, 1997, J CELL SCI, V110, P65; BU GJ, 1995, EMBO J, V14, P2269, DOI 10.1002/j.1460-2075.1995.tb07221.x; Bu GJ, 1996, J BIOL CHEM, V271, P22218, DOI 10.1074/jbc.271.36.22218; BU GJ, 1994, J BIOL CHEM, V269, P29874; Bu GJ, 2000, TRENDS CARDIOVAS MED, V10, P148, DOI 10.1016/S1050-1738(00)00045-1; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Bu GJ, 2006, ANN NY ACAD SCI, V1086, P35, DOI 10.1196/annals.1377.005; Cam JA, 2005, J BIOL CHEM, V280, P15464, DOI 10.1074/jbc.M500613200; Cam JA, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-8; Carey DJ, 1997, BIOCHEM J, V327, P1; Cole SL, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-22; Cuitino L, 2005, TRAFFIC, V6, P820, DOI 10.1111/j.1600-0854.2005.00320.x; Deane R, 2004, NEURON, V43, P333, DOI 10.1016/j.neuron.2004.07.017; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Fuentealba RA, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-14; Greenfield JP, 1999, P NATL ACAD SCI USA, V96, P742, DOI 10.1073/pnas.96.2.742; Hatters DM, 2006, TRENDS BIOCHEM SCI, V31, P445, DOI 10.1016/j.tibs.2006.06.008; IADONATO SP, 1993, BIOCHEM J, V296, P867, DOI 10.1042/bj2960867; Ida N, 1996, FEBS LETT, V394, P174, DOI 10.1016/0014-5793(96)00948-9; Jaeger S, 2008, CURR ALZHEIMER RES, V5, P15; Kanekiyo T, 2009, FUTUR NEUROL, V4, P55, DOI 10.2217/14796708.4.1.55; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Kudva YC, 1997, FEBS LETT, V416, P117, DOI 10.1016/S0014-5793(97)01180-0; Lee D, 2007, PROTEIN SCI, V16, P1628, DOI 10.1110/ps.072865407; Lee SJ, 1998, NAT MED, V4, P730, DOI 10.1038/nm0698-730; LEVINE H, 1995, NEUROBIOL AGING, V16, P755, DOI 10.1016/0197-4580(95)00052-G; Li YH, 2005, J CELL SCI, V118, P5305, DOI 10.1242/jcs.02651; Li YH, 2003, FEBS LETT, V555, P346, DOI 10.1016/S0014-5793(03)01272-9; Libeu CP, 2001, J BIOL CHEM, V276, P39138, DOI 10.1074/jbc.M104746200; Marzolo MP, 2009, SEMIN CELL DEV BIOL, V20, P191, DOI 10.1016/j.semcdb.2008.10.005; Melman L, 2001, J BIOL CHEM, V276, P29338, DOI 10.1074/jbc.M103717200; Nielsen PR, 1997, P NATL ACAD SCI USA, V94, P7521, DOI 10.1073/pnas.94.14.7521; O'Callaghan P, 2008, BRAIN PATHOL, V18, P548, DOI 10.1111/j.1750-3639.2008.00152.x; Obermoeller LM, 1997, J BIOL CHEM, V272, P10761; Pandey P, 2008, GENES BRAIN BEHAV, V7, P943, DOI 10.1111/j.1601-183X.2008.00436.x; Pietrzik CU, 2002, EMBO J, V21, P5691, DOI 10.1093/emboj/cdf568; Poon GMK, 2007, BIOCHEM SOC T, V35, P788, DOI 10.1042/BST0350788; Qiu ZH, 1999, J NEUROCHEM, V73, P1393, DOI 10.1046/j.1471-4159.1999.0731393.x; Raman B, 2005, BIOCHEM J, V392, P573, DOI 10.1042/BJ20050339; Reblin T, 1997, J LIPID RES, V38, P2103; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Skidmore MA, 2008, CONNECT TISSUE RES, V49, P140, DOI 10.1080/03008200802148595; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; Takayama Y, 2005, J BIOL CHEM, V280, P18504, DOI 10.1074/jbc.M410265200; Ulery PG, 2000, J BIOL CHEM, V275, P7410, DOI 10.1074/jbc.275.10.7410; Urmoneit B, 1997, LAB INVEST, V77, P157; Van Uden E, 2002, J NEUROSCI, V22, P9298; WARSHAWSKY I, 1993, J BIOL CHEM, V268, P22046; WARSHAWSKY I, 1993, J CLIN INVEST, V92, P937, DOI 10.1172/JCI116669; WILLNOW TE, 1994, SCIENCE, V264, P1471, DOI 10.1126/science.7515194; WILLNOW TE, 1994, METHOD CELL BIOL, V43, P305; WILSON C, 1991, SCIENCE, V252, P1817, DOI 10.1126/science.2063194; Wu YB, 2004, J BIOMOL NMR, V29, P271, DOI 10.1023/B:JNMR.0000032507.96325.6d; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838; Xu GL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003159; Yamauchi Y, 2008, BIOCHEMISTRY-US, V47, P6702, DOI 10.1021/bi8003999; Zerbinatti CV, 2004, P NATL ACAD SCI USA, V101, P1075, DOI 10.1073/pnas.0305803101; Zheng H, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-5; Zlokovic BV, 2005, TRENDS NEUROSCI, V28, P202, DOI 10.1016/j.tins.2005.02.001	64	38	41	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33352	33359		10.1074/jbc.M109.015032	http://dx.doi.org/10.1074/jbc.M109.015032			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19826010	hybrid, Green Published			2022-12-27	WOS:000272028500040
J	Kunzelmann, S; Webb, MR				Kunzelmann, Simone; Webb, Martin R.			A Biosensor for Fluorescent Determination of ADP with High Time Resolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRANDED-DNA TRANSLOCATION; PROKARYOTIC ACTIN HOMOLOG; PHOSPHATE-BINDING PROTEIN; IRON-SULFUR CLUSTERS; DYNAMIC INSTABILITY; PCRA HELICASE; REAL-TIME; SEGREGATION; KINASE; MECHANISM	Nearly every cellular process requires the presence of ATP. This is reflected in the vast number of enzymes like kinases or ATP hydrolases, both of which cleave the terminal phosphate from ATP, thereby releasing ADP. Despite the fact that ATP hydrolysis is one of the most fundamental reactions in biological systems, there are only a few methods available for direct measurements of enzymatic-driven ATP conversion. Here we describe the development of a reagentless biosensor for ADP, the common product of all ATPases and kinases, which allows the real-time detection of ADP, produced enzymatically. The biosensor is derived from a bacterial actin homologue, ParM, as protein framework. A single fluorophore (a diethylaminocoumarin), attached to ParM at the edge of the nucleotide binding site, couples ADP binding to a > 3.5-fold increase in fluorescence intensity. The labeled ParM variant has high affinity for ADP (0.46 mu M) and a fast signal response, controlled by the rate of ADP binding to the sensor (0.65 mu M(-1)s(-1)). Amino acids in the active site were mutated to reduce ATP affinity and achieve a > 400-fold discrimination against triphosphate binding. A further mutation ensured that the final sensor did not form filaments and, as a consequence, has extremely low ATPase activity. The broad applicability of N-[2-(1-maleimidyl)ethyl]-7-diethylaminocoumarin-3-carboxamide (MDCC)-ParM as a sensitive probe for ADP is demonstrated in real-time kinetic assays on two different ATPases and a protein kinase.	[Kunzelmann, Simone; Webb, Martin R.] MRC Natl Inst Med Res, London NW7 1AA, England	MRC National Institute for Medical Research	Webb, MR (corresponding author), MRC Natl Inst Med Res, Ridgeway,Mill Hill, London NW7 1AA, England.	mwebb@nimr.mrc.ac.uk		Webb, Martin/0000-0002-0134-9621	Medical Research Council Technology; Medical Research Council, United Kingdom; MRC [MC_U117512742] Funding Source: UKRI; Medical Research Council [MC_U117512742] Funding Source: researchfish	Medical Research Council Technology(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Medical Research Council Technology and by Medical Research Council, United Kingdom. A patent application has been made by the Medical Research Council on part of this work.	Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; Brune M, 1998, BIOCHEMISTRY-US, V37, P10370, DOI 10.1021/bi9804277; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; Brune M, 2001, BIOCHEMISTRY-US, V40, P5087, DOI 10.1021/bi002484h; Charter NW, 2006, J BIOMOL SCREEN, V11, P390, DOI 10.1177/1087057106286829; Dattelbaum JD, 2001, ANAL BIOCHEM, V291, P89, DOI 10.1006/abio.2001.4998; De Lorimier RM, 2002, PROTEIN SCI, V11, P2655, DOI 10.1110/ps.021860; Dillingham MS, 2000, BIOCHEMISTRY-US, V39, P205, DOI 10.1021/bi992105o; Dillingham MS, 2002, BIOCHEMISTRY-US, V41, P643, DOI 10.1021/bi011137k; Ebersbach G, 2005, ANNU REV GENET, V39, P453, DOI 10.1146/annurev.genet.38.072902.091252; Eccleston JF, 2006, J BIOL CHEM, V281, P8371, DOI 10.1074/jbc.M513455200; Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; GILARDI G, 1994, ANAL CHEM, V66, P3840, DOI 10.1021/ac00093a047; Hong L, 2009, ANAL BIOCHEM, V391, P31, DOI 10.1016/j.ab.2009.04.033; IORDANESCU S, 1989, J BACTERIOL, V171, P4501, DOI 10.1128/JB.171.8.4501-4503.1989; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kleman-Leyer KM, 2009, ASSAY DRUG DEV TECHN, V7, P56, DOI 10.1089/adt.2008.175; Lara B, 2005, MOL MICROBIOL, V55, P699, DOI 10.1111/j.1365-2958.2004.04432.x; Leatherbarrow R.J., 2001, GRAFIT VERSION 5; Lowery RG, 2006, EXPERT OPIN THER TAR, V10, P179, DOI 10.1517/14728222.10.1.179; Moller-Jensen J, 2002, EMBO J, V21, P3119, DOI 10.1093/emboj/cdf320; Nott TJ, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000212; Okoh MP, 2006, BIOCHEMISTRY-US, V45, P14764, DOI 10.1021/bi060960j; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Petrovic A, 2008, PROTEIN SCI, V17, P1264, DOI 10.1110/ps.034652.108; Popp D, 2008, EMBO J, V27, P570, DOI 10.1038/sj.emboj.7601978; Roeben A, 2006, J MOL BIOL, V358, P145, DOI 10.1016/j.jmb.2006.01.096; Salins LLE, 2001, ANAL BIOCHEM, V294, P19, DOI 10.1006/abio.2001.5131; Salje J, 2008, EMBO J, V27, P2230, DOI 10.1038/emboj.2008.152; Srinivasan J, 2004, CHEM BIOL, V11, P499, DOI 10.1016/j.chembiol.2004.03.014; Takahashi Y, 2002, J BIOL CHEM, V277, P28380, DOI 10.1074/jbc.C200365200; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; van den Ent F, 2002, EMBO J, V21, P6935, DOI 10.1093/emboj/cdf672; Villarino A, 2005, J MOL BIOL, V350, P953, DOI 10.1016/j.jmb.2005.05.049; West TG, 2009, BIOPHYS J, V96, P3281, DOI 10.1016/j.bpj.2009.01.016	36	38	38	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33130	33138		10.1074/jbc.M109.047118	http://dx.doi.org/10.1074/jbc.M109.047118			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801632	Green Published, hybrid			2022-12-27	WOS:000272028500017
J	Roth, HM; Tessmer, I; Van Houten, B; Kisker, C				Roth, Heide M.; Tessmer, Ingrid; Van Houten, Bennett; Kisker, Caroline			Bax1 Is a Novel Endonuclease IMPLICATIONS FOR ARCHAEAL NUCLEOTIDE EXCISION REPAIR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-SPECIFICITY; RESTRICTION ENZYMES; STRUCTURAL BASIS; DNA-REPLICATION; TFIIH; TRANSCRIPTION; MECHANISMS; ARGONAUTE; MUTATIONS; NUCLEASES	The helicases XPB and XPD are part of the TFIIH complex, which mediates transcription initiation as well as eukaryotic nucleotide excision repair (NER). Although there is no TFIIH complex present in archaea, most species contain both XPB and XPD and serve as a model for their eukaryotic homologs. Recently, a novel binding partner for XPB, Bax1 (binds archeal XPB), was identified in archaea. To gain insights into its role in NER, Bax1 from Thermoplasma acidophilum was characterized. We identified Bax1 as a novel Mg2+-dependent structure-specific endonuclease recognizing DNA containing a 3' overhang. Incision assays conducted with DNA substrates providing different lengths of the 3' overhang indicate that Bax1 specifically incises DNA in the single-stranded region of the 3' overhang 4-6 nucleotides to the single-stranded DNA/double-stranded DNA junction and thus is a structure-specific and not a sequence-specific endonuclease. In contrast, no incision was detected in the presence of a 5' overhang, double-stranded DNA, or DNA containing few unpaired nucleotides forming a bubble. Several Bax1 variants were generated based on multiple sequence alignments and examined with respect to their ability to perform the incision reaction. Residues Glu-124, Asp-132, Tyr-152, and Glu-155 show a dramatic reduction in incision activity, indicating a pivotal role in catalysis. Interestingly, Bax1 does not exhibit any incision activity in the presence of XPB, thus suggesting a role in NER in which the endonuclease activity is tightly regulated until the damage has been recognized and verified prior to the incision event.	[Roth, Heide M.; Tessmer, Ingrid; Kisker, Caroline] Rudolf Virchow Ctr Environm Biomed, D-97080 Wurzburg, Germany; [Van Houten, Bennett] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kisker, C (corresponding author), Rudolf Virchow Ctr Environm Biomed, Josef Schneider Str 2 D15, D-97080 Wurzburg, Germany.	caroline.kisker@virchow.uni-wuerzburg.de	Van Houten, Bennett/K-2284-2019; Tessmer, Ingrid/O-2810-2013; Kisker, Caroline/T-1724-2019	Kisker, Caroline/0000-0002-0216-6026; Resch, Heide Marie/0000-0001-9635-6340; Tessmer, Ingrid/0000-0002-8353-6315	Deutsche Forschungsgemeinschaft [KI-562/2-1, FZ-82]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants KI-562/2-1 and Forschungszentrum FZ-82 (to C.K.).	Araujo SJ, 2000, GENE DEV, V14, P349; Chapados BR, 2004, CELL, V116, P39, DOI 10.1016/S0092-8674(03)01036-5; Coin F, 2007, MOL CELL, V26, P245, DOI 10.1016/j.molcel.2007.03.009; de Laat WL, 1998, J BIOL CHEM, V273, P7835, DOI 10.1074/jbc.273.14.7835; Desai NA, 2003, FEMS MICROBIOL REV, V26, P457, DOI 10.1016/S0168-6445(02)00129-8; Fan L, 2006, MOL CELL, V22, P27, DOI 10.1016/j.molcel.2006.02.017; Fan L, 2008, CELL, V133, P789, DOI 10.1016/j.cell.2008.04.030; Gillet LCJ, 2006, CHEM REV, V106, P253, DOI 10.1021/cr040483f; HARRINGTON JJ, 1994, EMBO J, V13, P1235, DOI 10.1002/j.1460-2075.1994.tb06373.x; Hwang JR, 1996, J BIOL CHEM, V271, P15898, DOI 10.1074/jbc.271.27.15898; Karakas E, 2007, EMBO J, V26, P613, DOI 10.1038/sj.emboj.7601497; Kelman Z, 2005, CURR OPIN MICROBIOL, V8, P669, DOI 10.1016/j.mib.2005.10.001; Kinch LN, 2005, NUCLEIC ACIDS RES, V33, P3598, DOI 10.1093/nar/gki676; Komori K, 2002, GENES GENET SYST, V77, P227, DOI 10.1266/ggs.77.227; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu H, 2008, CELL, V133, P801, DOI 10.1016/j.cell.2008.04.029; Lovell S, 2002, NAT STRUCT BIOL, V9, P278, DOI 10.1038/nsb778; Moolenaar GF, 2002, P NATL ACAD SCI USA, V99, P1467, DOI 10.1073/pnas.032584099; Nishino T, 2006, CURR OPIN STRUC BIOL, V16, P60, DOI 10.1016/j.sbi.2006.01.009; Nishino T, 2003, STRUCTURE, V11, P445, DOI 10.1016/S0969-2126(03)00046-7; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; ODONOVAN A, 1994, NATURE, V371, P432, DOI 10.1038/371432a0; Ogrunc M, 1998, J BACTERIOL, V180, P5796; Richards JD, 2008, J MOL BIOL, V376, P634, DOI 10.1016/j.jmb.2007.12.019; Roberts RJ, 2003, NUCLEIC ACIDS RES, V31, P1805, DOI 10.1093/nar/gkg274; Ruepp A, 2000, NATURE, V407, P508, DOI 10.1038/35035069; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; SANCAR A, 1994, SCIENCE, V266, P1954, DOI 10.1126/science.7801120; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Truglio JJ, 2005, EMBO J, V24, P885, DOI 10.1038/sj.emboj.7600568; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Wolski SC, 2008, PLOS BIOL, V6, P1332, DOI 10.1371/journal.pbio.0060149	35	11	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32272	32278		10.1074/jbc.M109.055913	http://dx.doi.org/10.1074/jbc.M109.055913			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19759013	Green Published, hybrid			2022-12-27	WOS:000272028400008
J	Ahn, SY; Eraly, SA; Tsigelny, I; Nigam, SK				Ahn, Sun-Young; Eraly, Satish A.; Tsigelny, Igor; Nigam, Sanjay K.			Interaction of Organic Cations with Organic Anion Transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASOLATERAL MEMBRANE; FAMILY; SYSTEMS; IDENTIFICATION; LOCALIZATION; SUBSTANCES; VERAPAMIL; SLC22A8; KIDNEY; OAT3	Studies of the organic anion transporters (Oats) have focused mainly on their interactions with organic anionic substrates. However, as suggested when Oat1 was originally identified as NKT (Lopez-Nieto, C. E., You, G., Bush, K. T., Barros, E. J., Beier, D. R., and Nigam, S. K. (1997) J. Biol. Chem. 272, 6471-6478), since the Oats share close homology with organic cation transporters (Octs), it is possible that Oats interact with cations as well. We now show that mouse Oat1 (mOat1) and mOat3 and, to a lesser degree, mOat6 bind a number of "prototypical" Oct substrates, including 1-methyl-4-phenylpyridinium. In addition to oocyte expression assays, we have tested binding of organic cations to Oat1 and Oat3 in ex vivo assays by analyzing interactions in kidney organ cultures deficient in Oat1 and Oat3. We also demonstrate that mOat3 transports organic cations such as 1-methyl-4-phenylpyridinium and cimetidine. A pharmacophore based on the binding affinities of the tested organic cations for Oat3 was generated. Using this pharmacophore, we screened a chemical library and were able to identify novel cationic compounds that bound to Oat1 and Oat3. These compounds bound Oat3 with an affinity higher than the highest affinity compounds in the original set of prototypical Oct substrates. Thus, whereas Oat1, Oat3, and Oat6 appear to function largely in organic anion transport, they also bind and transport some organic cations. These findings could be of clinical significance, since drugs and metabolites that under normal physiological conditions do not bind to the Oats may undergo changes in charge and become Oat substrates during pathologic conditions wherein significant variations in body fluid pH occur.	[Ahn, Sun-Young; Nigam, Sanjay K.] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA; [Eraly, Satish A.; Nigam, Sanjay K.] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; [Nigam, Sanjay K.] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Tsigelny, Igor] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; [Tsigelny, Igor] Univ Calif San Diego, Sch Med, San Diego Supercomp Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Nigam, SK (corresponding author), Univ Calif San Diego, Sch Med, Dept Pediat, 9500 Gilman Dr, La Jolla, CA 92093 USA.	snigam@ucsd.edu		Ahn, Sun-Young/0000-0001-5571-6901	National Institutes of Health [AI057695, DK079784, NS062156, DK064839, DK075486]; Coplon award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK064839, R03DK075486, R01DK079784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062156] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Coplon award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI057695, DK079784, and NS062156 (to S. K. N.) and DK064839 and DK075486. This work was also supported by a Coplon award (to S. A. E.).	Ahn SY, 2009, MOL PHARMACOL, V76, P481, DOI 10.1124/mol.109.056564; Barnum D, 1996, J CHEM INF COMP SCI, V36, P563, DOI 10.1021/ci950273r; Clement OO, 2000, IUL BIOTECH, V2, P69; DANTZLER WH, 1984, AM J PHYSIOL, V246, pF188, DOI 10.1152/ajprenal.1984.246.2.F188; Eraly SA, 2006, J BIOL CHEM, V281, P5072, DOI 10.1074/jbc.M508050200; JENSEN RE, 1988, J PHARMACOL EXP THER, V244, P543; Kaler G, 2007, J BIOL CHEM, V282, P23841, DOI 10.1074/jbc.M703467200; Kaler G, 2006, BIOCHEM BIOPH RES CO, V351, P872, DOI 10.1016/j.bbrc.2006.10.136; Karbach U, 2000, AM J PHYSIOL-RENAL, V279, pF679, DOI 10.1152/ajprenal.2000.279.4.F679; Koepsell H, 2004, REV PHYSIOL BIOCH P, V150, P36, DOI 10.1007/s10254-003-0017-x; LopezNieto CE, 1997, J BIOL CHEM, V272, P6471, DOI 10.1074/jbc.272.10.6471; Monte JC, 2004, BIOCHEM BIOPH RES CO, V323, P429, DOI 10.1016/j.bbrc.2004.08.112; Motohashi H, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134866; RUSSELL MAH, 1980, BMJ-BRIT MED J, V280, P972, DOI 10.1136/bmj.280.6219.972; SOKOL PP, 1989, J PHARMACOL EXP THER, V251, P937; Sugawara-Yokoo M, 2000, HISTOCHEM CELL BIOL, V114, P175; Sweet DH, 2003, AM J PHYSIOL-RENAL, V284, pF763, DOI 10.1152/ajprenal.00405.2002; Sweet DH, 2002, J BIOL CHEM, V277, P26934, DOI 10.1074/jbc.M203803200; Sweet DH, 1997, J BIOL CHEM, V272, P30088, DOI 10.1074/jbc.272.48.30088; Truong DM, 2008, J BIOL CHEM, V283, P8654, DOI 10.1074/jbc.M708615200; ULLRICH KJ, 1993, PFLUG ARCH EUR J PHY, V425, P300, DOI 10.1007/BF00374180; ULLRICH KJ, 1993, PFLUG ARCH EUR J PHY, V425, P280, DOI 10.1007/BF00374179; Vallon V, 2008, J AM SOC NEPHROL, V19, P1732, DOI 10.1681/ASN.2008020180; Vallon V, 2008, AM J PHYSIOL-RENAL, V294, pF867, DOI 10.1152/ajprenal.00528.2007; Wright SH, 2005, TOXICOL APPL PHARM, V204, P309, DOI 10.1016/j.taap.2004.10.021; Wu W, 2009, PHYSIOL GENOMICS, V38, P116, DOI 10.1152/physiolgenomics.90309.2008	26	50	52	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31422	31430		10.1074/jbc.M109.024489	http://dx.doi.org/10.1074/jbc.M109.024489			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19737926	Green Published, hybrid			2022-12-27	WOS:000271378400067
J	Oka, M; Sumita, N; Sakaguchi, M; Iwasaki, T; Bito, T; Kageshita, T; Sato, K; Fukami, Y; Nishigori, C				Oka, Masahiro; Sumita, Naoko; Sakaguchi, Masanobu; Iwasaki, Tetsushi; Bito, Toshinori; Kageshita, Toshiro; Sato, Ken-ichi; Fukami, Yasuo; Nishigori, Chikako			12-O-Tetradecanoylphorbol-13-acetate Inhibits Melanoma Growth by Inactivation of STAT3 through Protein Kinase C-activated Tyrosine Phosphatase(s)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NORMAL HUMAN MELANOCYTES; PHOSPHOLIPASE D1; TARGETING STAT3; CELLS; SRC; PHOSPHORYLATION; 21ST-CENTURY	The growth of most melanoma cells in vitro is inhibited by the tumor-promoting phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA). In this study, the involvement of the signal transducer and activator of transcription 3 (STAT3) in the TPA-induced growth inhibition of melanoma cells was examined. The in vitro growth and DNA synthesis of five melanoma cell lines, whose STAT3 was activated (phosphorylated), was inhibited by TPA, whereas that of WM35 and WM39 cells, whose STAT3 activity was at negligible levels, was considerably slow and not affected by TPA. Blockade of STAT3 activity by small interfering RNAs suppressed the growth of WM1205Lu cells containing constitutively activated STAT3. Treatment of WM1205Lu cells with TPA decreased both the phosphorylated STAT3 and the DNA-binding activity of STAT3. Pretreatment of WM1205Lu cells with either a protein-tyrosine phosphatase inhibitor or a protein kinase C (PKC) inhibitor prevented the inhibitory effects of TPA on the level of phosphorylated STAT3. The five melanoma cell lines containing phosphorylated STAT3 commonly expressed PKC alpha, PKC delta, and PKC epsilon. Introduction of the dominant negative mutant of one of these PKC isoforms into WM1205Lu cells inhibited the TPA-induced dephosphorylation of STAT3. A Src inhibitor attenuated the STAT3 phosphorylation in WM1205Lu cells. These results indicate that constitutively activated STAT3 is positively regulated by c-Src and negatively regulated by a PKC-activated tyrosine phosphatase(s) in melanoma cells. Because TPA did not affect c-Src activity, we conclude that the growth inhibitory effect of TPA on melanoma cells is mediated through inactivation of STAT3 by a PKC-activated tyrosine phosphatase(s).	[Oka, Masahiro; Sumita, Naoko; Sakaguchi, Masanobu; Bito, Toshinori; Nishigori, Chikako] Kobe Univ, Grad Sch Med, Div Dermatol, Dept Internal Related,Chuo Ku, Kobe, Hyogo 6500017, Japan; [Iwasaki, Tetsushi; Fukami, Yasuo] Kobe Univ, Org Adv Sci & Technol, Res Ctr Environm Gen, Nada Ku, Kobe, Hyogo 6578501, Japan; [Kageshita, Toshiro] Kumamoto Univ, Grad Sch Med Sci, Dept Dermatol, Kumamoto 8608556, Japan; [Sato, Ken-ichi] Kyoto Sangyo Univ, Fac Engn, Dept Biotechnol, Kita Ku, Kyoto 6038555, Japan	Kobe University; Kobe University; Kumamoto University; Kyoto Sangyo University	Oka, M (corresponding author), Kobe Univ, Grad Sch Med, Div Dermatol, Dept Internal Related,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	oka@med.kobe-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan;  [19591305]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This work was supported in part by Research Grant 19591305 (to M. O.) and the Global Center of Excellence Program "Global Center for Education and Research in Integrative Membrane Biology" (to M. S.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; ARITA Y, 1994, INT J CANCER, V56, P229, DOI 10.1002/ijc.2910560215; BECKER D, 1990, ONCOGENE, V5, P1133; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Bromberg J, 2001, METHOD ENZYMOL, V333, P138; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; BROOKS G, 1990, PIGM CELL RES, V3, P98, DOI 10.1111/j.1600-0749.1990.tb00328.x; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Fecher LA, 2007, J CLIN ONCOL, V25, P1606, DOI 10.1200/JCO.2006.06.0442; HALABAN R, 1986, J INVEST DERMATOL, V87, P95, DOI 10.1111/1523-1747.ep12523594; Han JM, 2002, MOL BIOL CELL, V13, P3976, DOI 10.1091/mbc.E02-02-0100; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hocker TL, 2008, J INVEST DERMATOL, V128, P2575, DOI 10.1038/jid.2008.226; HORVATH CM, 1995, GENE DEV, V9, P984, DOI 10.1101/gad.9.8.984; Hsu MY, 1999, HUMAN CELL CULTURE, V1, P259; Jing N, 2005, ANTI-CANCER DRUG, V16, P601, DOI 10.1097/00001813-200507000-00002; KANEGAE Y, 1995, NUCLEIC ACIDS RES, V23, P3816, DOI 10.1093/nar/23.19.3816; Kortylewski M, 2005, CANCER METAST REV, V24, P315, DOI 10.1007/s10555-005-1580-1; Kortylewski M, 1999, ONCOGENE, V18, P3742, DOI 10.1038/sj.onc.1202708; Kreis S, 2007, MOL CANCER RES, V5, P1331, DOI 10.1158/1541-7786.MCR-07-0317; Kubo M, 2003, NAT IMMUNOL, V4, P1169, DOI 10.1038/ni1012; Lacreusette A, 2007, ONCOGENE, V26, P881, DOI 10.1038/sj.onc.1209844; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Markovic SN, 2007, MAYO CLIN PROC, V82, P364; Messina Jane L, 2008, Cancer Control, V15, P196; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Niu G, 2002, ONCOGENE, V21, P7001, DOI 10.1038/sj.onc.1205859; Niu GL, 1999, CANCER RES, V59, P5059; Oka M, 2002, BIOCHEM BIOPH RES CO, V294, P1109, DOI 10.1016/S0006-291X(02)00614-9; Oka M, 2005, CANCER METAST REV, V24, P287, DOI 10.1007/s10555-005-1578-8; Oka M, 1996, J CELL PHYSIOL, V167, P406, DOI 10.1002/(SICI)1097-4652(199606)167:3<406::AID-JCP4>3.3.CO;2-A; Oka M, 2003, FEBS LETT, V554, P179, DOI 10.1016/S0014-5793(03)01158-X; OKA M, 1995, J INVEST DERMATOL, V105, P567, DOI 10.1111/1523-1747.ep12323485; Sasse J, 1997, MOL CELL BIOL, V17, P4677, DOI 10.1128/MCB.17.8.4677; Smalley KSM, 2005, ANN NY ACAD SCI, V1059, P16, DOI 10.1196/annals.1339.005; Thompson JE, 2002, BIOORG MED CHEM LETT, V12, P1219, DOI 10.1016/S0960-894X(02)00106-3; Turkson J, 2000, ONCOGENE, V19, P6613, DOI 10.1038/sj.onc.1204086; Xi SC, 2005, ONCOGENE, V24, P970, DOI 10.1038/sj.onc.1208316; Yamamoto N, 2006, J CELL SCI, V119, P4623, DOI 10.1242/jcs.03236; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	44	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30416	30423		10.1074/jbc.M109.001073	http://dx.doi.org/10.1074/jbc.M109.001073			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19755418	Green Published, hybrid			2022-12-27	WOS:000271090000044
J	Garza, RM; Tran, PN; Hampton, RY				Garza, Renee M.; Tran, Peter N.; Hampton, Randolph Y.			Geranylgeranyl Pyrophosphate Is a Potent Regulator of HRD-dependent 3-Hydroxy-3-methylglutaryl-CoA Reductase Degradation in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HMG-COA REDUCTASE; UBIQUITIN-MEDIATED REGULATION; RAB ESCORT PROTEIN; ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; DIPHOSPHATE SYNTHASE; MEMBRANE-PROTEIN; IN-VITRO; PRENYLTRANSFERASES; INSIG	3-Hydroxy-3-methylglutaryl (HMG)-CoA reductase (HMGR), the rate-limiting enzymes of sterol synthesis, undergoes feed-back-regulated endoplasmic reticulum degradation in both mammals and yeast. The yeast Hmg2p isozyme is subject to ubiquitin-mediated endoplasmic reticulum degradation by the HRD pathway. We had previously shown that alterations in cellular levels of the 15-carbon sterol pathway intermediate farnesyl pyrophosphate (FPP) cause increased Hmg2p ubiquitination and degradation. We now present evidence that the FPP-derived, 20-carbon molecule geranylgeranyl pyrophosphate (GGPP) is a potent endogenous regulator of Hmg2p degradation. This work was launched by the unexpected observation that GGPP addition directly to living yeast cultures caused high potency and specific stimulation of Hmg2p degradation. This effect of GGPP was not recapitulated by FPP, GGOH, or related isoprenoids. GGPP-caused Hmg2p degradation met all the criteria for the previously characterized endogenous signal. The action of added GGPP did not require production of endogenous sterol molecules, indicating that it did not act by causing the build-up of an endogenous pathway signal. Manipulation of endogenous GGPP by several means showed that naturally made GGPP controls Hmg2p stability. Analysis of the action of GGPP indicated that the molecule works upstream of retrotranslocation and can directly alter the structure of Hmg2p. We propose that GGPP is the FPP-derived regulator of Hmg2p ubiquitination. Intriguingly, the sterol-dependent degradation of mammalian HMGR is similarly stimulated by the addition of GGOH to intact cells, implying that a dependence on 20-carbon geranylgeranyl signals may be a common conserved feature of HMGR regulation that may lead to highly specific therapeutic approaches for modulation of HMGR.	[Garza, Renee M.; Tran, Peter N.; Hampton, Randolph Y.] Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Hampton, RY (corresponding author), Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	rhampton@ucsd.edu			National Institutes of Health [5 R01 DK051996-15]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051996] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant 5 R01 DK051996-15 (to R. Y. H.). This work was also supported by a minority supplement associated with the same grant (to R. M. G.).	Bauer BE, 1996, MOL BIOL CELL, V7, P1521, DOI 10.1091/mbc.7.10.1521; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; BERGSTROM JD, 1993, P NATL ACAD SCI USA, V90, P80, DOI 10.1073/pnas.90.1.80; Casey PJ, 1996, J BIOL CHEM, V271, P5289, DOI 10.1074/jbc.271.10.5289; Cronin SR, 1999, METHOD ENZYMOL, V302, P58, DOI 10.1016/S0076-6879(99)02010-8; Cronin SR, 2000, J CELL BIOL, V148, P915, DOI 10.1083/jcb.148.5.915; Flury I, 2005, EMBO J, V24, P3917, DOI 10.1038/sj.emboj.7600855; Gardner R, 1998, MOL BIOL CELL, V9, P2611, DOI 10.1091/mbc.9.9.2611; Gardner RG, 1999, EMBO J, V18, P5994, DOI 10.1093/emboj/18.21.5994; Gardner RG, 1999, J BIOL CHEM, V274, P31671, DOI 10.1074/jbc.274.44.31671; Gardner RG, 2001, J BIOL CHEM, V276, P8681, DOI 10.1074/jbc.M007888200; Garza RM, 2009, J BIOL CHEM, V284, P14710, DOI 10.1074/jbc.M809607200; Guo RT, 2007, P NATL ACAD SCI USA, V104, P10022, DOI 10.1073/pnas.0702254104; Hampton RY, 2009, CHEM REV, V109, P1561, DOI 10.1021/cr800544v; Hampton RY, 1997, P NATL ACAD SCI USA, V94, P12944, DOI 10.1073/pnas.94.24.12944; HAMPTON RY, 1994, J CELL BIOL, V125, P299, DOI 10.1083/jcb.125.2.299; JIANG Y, 1995, J BIOL CHEM, V270, P21793, DOI 10.1074/jbc.270.37.21793; Lange BM, 2000, P NATL ACAD SCI USA, V97, P13172, DOI 10.1073/pnas.240454797; Miaczynska M, 2001, YEAST, V18, P697, DOI 10.1002/yea.719; Muramatsu M, 2008, APPL MICROBIOL BIOT, V80, P589, DOI 10.1007/s00253-008-1578-z; Sever N, 2003, J BIOL CHEM, V278, P52479, DOI 10.1074/jbc.M310053200; Shearer AG, 2004, J BIOL CHEM, V279, P188, DOI 10.1074/jbc.M307734200; Shearer AG, 2005, EMBO J, V24, P149, DOI 10.1038/sj.emboj.7600498; Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001; Spang A, 1998, J CELL BIOL, V143, P589, DOI 10.1083/jcb.143.3.589; SWERDLOW PS, 1986, ANAL BIOCHEM, V156, P147, DOI 10.1016/0003-2697(86)90166-1; TRUEBLOOD CE, 1993, MOL CELL BIOL, V13, P4260, DOI 10.1128/MCB.13.7.4260; Ye YF, 2007, MOL BIOL CELL, V18, P3568, DOI 10.1091/mbc.e07-02-0112	28	39	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35368	35380		10.1074/jbc.M109.023994	http://dx.doi.org/10.1074/jbc.M109.023994			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19776008	Green Published, hybrid			2022-12-27	WOS:000272645600013
J	Jordanova, R; Groves, MR; Kostova, E; Woltersdorf, C; Liebau, E; Tucker, PA				Jordanova, Rositsa; Groves, Matthew R.; Kostova, Elena; Woltersdorf, Christian; Liebau, Eva; Tucker, Paul A.			Fatty Acid- and Retinoid-binding Proteins Have Distinct Binding Pockets for the Two Types of Cargo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAENORHABDITIS-ELEGANS; FAR PROTEINS; ASCARIS-SUUM; NEMATODES; RECEPTOR; PHOSPHORYLATION; POLYPROTEIN; SECRETION; SYSTEM; DOMAIN	Parasitic nematodes cause serious diseases in humans, animals, and plants. They have limited lipid metabolism and are reliant on lipid-binding proteins to acquire these metabolites from their hosts. Several structurally novel families of lipid-binding proteins in nematodes have been described, including the fatty acid- and retinoid-binding protein family (FAR). In Caenorhabditis elegans, used as a model for studying parasitic nematodes, eight C. elegans FAR proteins have been described. The crystal structure of C. elegans FAR-7 is the first structure of a FAR protein, and it exhibits a novel fold. It differs radically from the mammalian fatty acid- binding proteins and has two ligand binding pockets joined by a surface groove. The first can accommodate the aliphatic chain of fatty acids, whereas the second can accommodate the bulkier retinoids. In addition to demonstrating lipid binding by fluorescence spectroscopy, we present evidence that retinol binding is positively regulated by casein kinase II phosphorylation at a conserved site near the bottom of the second pocket. far-7::GFP (green fluorescent protein) expression shows that it is localized in the head hypodermal syncytia and the excretory cell but that this localization changes under starvation conditions. In conclusion, our study provides the basic structural and functional information for investigation of inhibitors of lipid binding by FAR proteins.	European Mol Biol Lab, Hamburg Outstn, D-22603 Hamburg, Germany; [Woltersdorf, Christian; Liebau, Eva] Univ Munster, Inst Anim Physiol, D-48143 Munster, Germany	European Molecular Biology Laboratory (EMBL); University of Munster		tucker@embl-hamburg.de		Kostova, Elena/0000-0002-8116-727X; Groves, Matthew/0000-0001-9859-5177	Marie Curie Intra-European [MEIF-CT-2006-025860]	Marie Curie Intra-European(European Commission)	This work was supported by Marie Curie Intra-European Fellowship Contract MEIF-CT-2006-025860 (to R. J.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barrett J, 2001, PERSPECTIVES ON HELMINTHOLOGY, P309; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; BOURGUET W, 1995, NATURE, V375, P377, DOI 10.1038/375377a0; BRENNER S, 1974, GENETICS, V77, P71; Buechner M, 2002, TRENDS CELL BIOL, V12, P479, DOI 10.1016/S0962-8924(02)02364-4; BUELT MK, 1991, J BIOL CHEM, V266, P12266; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Garofalo A, 2003, MED MICROBIOL IMMUN, V192, P47, DOI 10.1007/s00430-002-0158-6; Garofalo A, 2003, J BIOL CHEM, V278, P8065, DOI 10.1074/jbc.M206278200; Garofalo A, 2002, MOL BIOCHEM PARASIT, V122, P161, DOI 10.1016/S0166-6851(02)00097-X; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GRANATO M, 1994, NUCLEIC ACIDS RES, V22, P1762, DOI 10.1093/nar/22.9.1762; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Jordanova R, 2005, J BIOL CHEM, V280, P41429, DOI 10.1074/jbc.M504474200; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kennedy MW, 1997, J BIOL CHEM, V272, P29442, DOI 10.1074/jbc.272.47.29442; KENNEDY MW, 1995, BIOCHEMISTRY-US, V34, P6700, DOI 10.1021/bi00020a015; LEHRER SS, 1971, BIOCHEMISTRY-US, V10, P3254, DOI 10.1021/bi00793a015; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; McDermott L, 1999, MOL CELL BIOCHEM, V192, P69, DOI 10.1023/A:1006822321081; MEENAN N, 2004, THESIS U GLASGOW GLA; Meenan NAG, 2005, J BIOMOL NMR, V32, P176, DOI 10.1007/s10858-005-6070-9; Mueller-Dieckmann J, 2006, ACTA CRYSTALLOGR D, V62, P1446, DOI 10.1107/S0907444906038121; NIELSEN SU, 1993, J LIPID RES, V34, P1355; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Plenefisch J, 2000, MOL BIOCHEM PARASIT, V105, P223, DOI 10.1016/S0166-6851(99)00179-6; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; PRINSEN CFM, 1994, BBA-LIPID LIPID MET, V1215, P103, DOI 10.1016/0005-2760(94)90097-3; Prior A, 2001, BIOCHEM J, V356, P387, DOI 10.1042/0264-6021:3560387; SAMBROOK J, 1989, MOL CLONING LAB MANU, pB20; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Solovyova AS, 2003, EUR BIOPHYS J BIOPHY, V32, P465, DOI 10.1007/s00249-003-0297-8; Taubert S, 2006, GENE DEV, V20, P1137, DOI 10.1101/gad.1395406; Tendler M, 1996, P NATL ACAD SCI USA, V93, P269, DOI 10.1073/pnas.93.1.269; Tendler M, 2008, ACTA TROP, V108, P263, DOI 10.1016/j.actatropica.2008.09.002; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P6970, DOI 10.1073/pnas.0602178103; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Van Gilst MR, 2005, P NATL ACAD SCI USA, V102, P13496, DOI 10.1073/pnas.0506234102; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; WILKINSON TCI, 1986, BIOCHEM J, V238, P419, DOI 10.1042/bj2380419; Zimmerman AW, 2002, CELL MOL LIFE SCI, V59, P1096, DOI 10.1007/s00018-002-8490-y	51	30	31	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35818	35826		10.1074/jbc.M109.022731	http://dx.doi.org/10.1074/jbc.M109.022731			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19828452	Green Published, hybrid			2022-12-27	WOS:000272645600058
J	Thompson, SM; Fernig, DG; Jesudason, EC; Losty, PD; van de Westerlo, EMA; van Kuppevelt, TH; Turnbull, JE				Thompson, Sophie M.; Fernig, David G.; Jesudason, Edwin C.; Losty, Paul D.; van de Westerlo, Els M. A.; van Kuppevelt, Toin H.; Turnbull, Jeremy E.			Heparan Sulfate Phage Display Antibodies Identify Distinct Epitopes with Complex Binding Characteristics INSIGHTS INTO PROTEIN BINDING SPECIFICITIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; IDURONATE 2-SULFATE RESIDUES; MONOCLONAL-ANTIBODY; KERATAN SULFATE; SUBSTITUTION PATTERN; SEQUENCE-ANALYSIS; ANTITHROMBIN-III; SKELETAL-MUSCLE; IDENTIFICATION; DOMAINS	Heparan sulfate (HS) binds and modulates the transport and activity of a large repertoire of regulatory proteins. The HS phage display antibodies are powerful tools for the analysis of native HS structure in situ; however, their epitopes are not well defined. Analysis of the binding specificities of a set of HS antibodies by competitive binding assays with well defined chemically modified heparins demonstrates that O-sulfates are essential for binding; however, increasing sulfation does not necessarily correlate with increased antibody reactivity. IC50 values for competition with double modified heparins were not predictable from IC50 values with corresponding singly modified heparins. Binding assays and immunohistochemistry revealed that individual antibodies recognize distinct epitopes and that these are not single linear sequences but families of structurally similar motifs in which subtle variations in sulfation and conformation modify the affinity of interaction. Modeling of the antibodies demonstrates that they possess highly basic CDR3 and surrounding surfaces, presenting a number of possible orientations for HS binding. Unexpectedly, there are significant differences between the existence of epitopes in tissue sections and observed in vitro in dot blotted tissue extracts, demonstrating that in vitro specificity does not necessarily correlate with specificity in situ/vivo. The epitopes are therefore more complex than previously considered. Overall, these data have significance for structure-activity relationships of HS, because the model of one antibody recognizing multiple HS structures and the influence of other in situ HS-binding proteins on epitope availability are likely to reflect the selectivity of many HS-protein interactions in vivo.	[Thompson, Sophie M.; Fernig, David G.; Turnbull, Jeremy E.] Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England; [Jesudason, Edwin C.; Losty, Paul D.] Royal Liverpool Childrens Hosp, Div Child Hlth, Sch Reprod & Dev Med, Liverpool L12 2AP, Merseyside, England; [van de Westerlo, Els M. A.; van Kuppevelt, Toin H.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Matrix Biochem, NL-6500 HB Nijmegen, Netherlands	University of Liverpool; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; University of Liverpool; Radboud University Nijmegen	Turnbull, JE (corresponding author), Univ Liverpool, Sch Biol Sci, Crown St, Liverpool L69 7ZB, Merseyside, England.	turnbull@liverpool.ac.uk	Fernig, David G/A-3590-2008; van Kuppevelt, A.H.M.S.M./L-4463-2015	Fernig, David G/0000-0003-4875-4293; 	Human Frontiers Science Program; Birth Defects Foundation; Biotechnology and Biological Sciences Research Council (United Kingdom); North West Cancer Research Fund	Human Frontiers Science Program(Human Frontier Science Program); Birth Defects Foundation; Biotechnology and Biological Sciences Research Council (United Kingdom)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); North West Cancer Research Fund	This work was supported by the Human Frontiers Science Program, the Birth Defects Foundation, the Biotechnology and Biological Sciences Research Council (United Kingdom), and the North West Cancer Research Fund.	Allen BL, 2003, J CELL BIOL, V163, P637, DOI 10.1083/jcb.200307053; ATHA DH, 1984, P NATL ACAD SCI-BIOL, V81, P1030, DOI 10.1073/pnas.81.4.1030; Bernsen MR, 2003, CANCER IMMUNOL IMMUN, V52, P780, DOI 10.1007/s00262-003-0421-8; CATERSON B, 1983, J BIOL CHEM, V258, P8848; Chen J, 2007, CHEM BIOL, V14, P986, DOI 10.1016/j.chembiol.2007.07.015; Couchman J R, 1984, Prog Clin Biol Res, V151, P31; COUCHMAN JR, 1984, NATURE, V307, P650, DOI 10.1038/307650a0; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; Dennissen MABA, 2002, J BIOL CHEM, V277, P10982, DOI 10.1074/jbc.M104852200; Drummond KJ, 2001, PROTEOMICS, V1, P304, DOI 10.1002/1615-9861(200102)1:2<304::AID-PROT304>3.0.CO;2-B; FERRO DR, 1990, CARBOHYD RES, V195, P157, DOI 10.1016/0008-6215(90)84164-P; Gallagher JT, 2006, BIOCHEM SOC T, V34, P438, DOI 10.1042/BST0340438; Guerrini M, 2008, J BIOL CHEM, V283, P26662, DOI 10.1074/jbc.M801102200; Guerrini M, 2006, BIOCHEM J, V399, P191, DOI 10.1042/BJ20060656; Guimond SE, 1999, CURR BIOL, V9, P1343, DOI 10.1016/S0960-9822(00)80060-3; Hjelm R, 2007, BIOCHEMISTRY-US, V46, P3378, DOI 10.1021/bi6024929; HOVINGH P, 1986, BIOCHEM J, V237, P573, DOI 10.1042/bj2370573; Hricovini M, 2001, BIOCHEM J, V359, P265, DOI 10.1042/0264-6021:3590265; Jenniskens GJ, 2006, J CELL PHYSIOL, V206, P283, DOI 10.1002/jcp.20450; Jenniskens GJ, 2000, J NEUROSCI, V20, P4099; Jenniskens GJ, 2002, DEV DYNAM, V225, P70, DOI 10.1002/dvdy.10138; KOZACK RE, 1995, BIOPHYS J, V68, P807, DOI 10.1016/S0006-3495(95)80257-2; Kreuger J, 2001, J BIOL CHEM, V276, P30744, DOI 10.1074/jbc.M102628200; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; KURE S, 1986, J IMMUNOL, V137, P3900; Kurup S, 2007, J BIOL CHEM, V282, P21032, DOI 10.1074/jbc.M702073200; Lensen JFM, 2005, J AM SOC NEPHROL, V16, P1279, DOI 10.1681/ASN.2004050413; LINDAHL U, 1979, P NATL ACAD SCI USA, V76, P3198, DOI 10.1073/pnas.76.7.3198; LINDBLOM A, 1990, GLYCOCONJUGATE J, V7, P545, DOI 10.1007/BF01189076; Lookene A, 1996, BIOCHEMISTRY-US, V35, P12155, DOI 10.1021/bi960008e; LYON M, 1987, BIOCHEM J, V242, P493, DOI 10.1042/bj2420493; LYON M, 1994, J BIOL CHEM, V269, P11208; MEHMET H, 1986, EUR J BIOCHEM, V157, P385, DOI 10.1111/j.1432-1033.1986.tb09680.x; Merry CLR, 1999, J BIOL CHEM, V274, P18455, DOI 10.1074/jbc.274.26.18455; MULLOY B, 1993, BIOCHEM J, V293, P849, DOI 10.1042/bj2930849; Mulloy B, 2000, GLYCOBIOLOGY, V10, P1147, DOI 10.1093/glycob/10.11.1147; Murphy KJ, 2004, J BIOL CHEM, V279, P27239, DOI 10.1074/jbc.M401774200; OLSON ST, 1991, J BIOL CHEM, V266, P6342; Ori A, 2008, FRONT BIOSCI-LANDMRK, V13, P4309, DOI 10.2741/3007; PETITOU M, 1988, EUR J BIOCHEM, V176, P637, DOI 10.1111/j.1432-1033.1988.tb14324.x; Powell AK, 2004, GLYCOBIOLOGY, V14, p17R, DOI 10.1093/glycob/cwh051; Powell Andrew K., 2009, V534, P313, DOI 10.1007/978-1-59745-022-5_22; Rahmoune H, 1998, J BIOL CHEM, V273, P7303, DOI 10.1074/jbc.273.13.7303; Rudd TR, 2007, GLYCOBIOLOGY, V17, P983, DOI 10.1093/glycob/cwm062; RUDLAND PS, 1993, J HISTOCHEM CYTOCHEM, V41, P887, DOI 10.1177/41.6.7686196; Shriver Z, 2000, P NATL ACAD SCI USA, V97, P10359, DOI 10.1073/pnas.97.19.10359; SMITS NC, 2004, AM J PHYSIOL-LUNG C, V30, pL166; SORRELL JM, 1990, J HISTOCHEM CYTOCHEM, V38, P393, DOI 10.1177/38.3.1689338; SORRELL JM, 1988, CELL TISSUE RES, V252, P523, DOI 10.1007/BF00216639; SORRELL JM, 1988, J IMMUNOL, V140, P4263; ten Dam GB, 2006, J BIOL CHEM, V281, P4654, DOI 10.1074/jbc.M506357200; ten Dam GB, 2003, J HISTOCHEM CYTOCHEM, V51, P727; THOMPSON LD, 1994, BIOCHEMISTRY-US, V33, P3831, DOI 10.1021/bi00179a006; Thompson SM, 2007, PEDIATR SURG INT, V23, P411, DOI 10.1007/s00383-006-1864-8; Toida T, 1997, BIOCHEM J, V322, P499, DOI 10.1042/bj3220499; TURNBULL JE, 1990, BIOCHEM J, V265, P715, DOI 10.1042/bj2650715; TURNBULL JE, 1991, BIOCHEM J, V277, P297, DOI 10.1042/bj2770297; Turnbull JE, 1999, P NATL ACAD SCI USA, V96, P2698, DOI 10.1073/pnas.96.6.2698; TURNBULL JE, 1991, BIOCHEM J, V273, P553, DOI 10.1042/bj2730553; van de Westerlo EMA, 2002, BLOOD, V99, P2427, DOI 10.1182/blood.V99.7.2427; van Kuppevelt TH, 1998, J BIOL CHEM, V273, P12960, DOI 10.1074/jbc.273.21.12960; VANDENBORN J, 1992, KIDNEY INT, V41, P115, DOI 10.1038/ki.1992.15; VANDENBORN J, 1991, LAB INVEST, V65, P287; Venkataraman G, 1999, SCIENCE, V286, P537, DOI 10.1126/science.286.5439.537; Yates EA, 2000, CARBOHYD RES, V329, P239, DOI 10.1016/S0008-6215(00)00144-0; Yates EA, 1996, CARBOHYD RES, V294, P15; Yates EA, 2004, J MED CHEM, V47, P277, DOI 10.1021/jm0309755	67	32	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35621	35631		10.1074/jbc.M109.009712	http://dx.doi.org/10.1074/jbc.M109.009712			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19837661	Green Published, hybrid			2022-12-27	WOS:000272645600040
J	Dolovcak, S; Waldrop, SL; Fitz, JG; Kilic, G				Dolovcak, Svjetlana; Waldrop, Shar L.; Fitz, J. Gregory; Kilic, Gordan			5-Nitro-2-(3-phenylpropylamino)benzoic Acid (NPPB) Stimulates Cellular ATP Release through Exocytosis of ATP-enriched Vesicles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERLEUKIN-1-BETA RELEASE; VOLUME REGULATION; MEMBRANE; CHANNELS; CONDUCTANCE; PANNEXIN-1; PATHWAY; CELLS; LINE; CONTRIBUTES	Cells release ATP in response to physiologic stimuli. Extracellular ATP regulates a broad range of important cellular functions by activation of the purinergic receptors in the plasma membrane. The purpose of these studies was to assess the role of vesicular exocytosis in cellular ATP release. FM1-43 fluorescence was used to measure exocytosis and bioluminescence to measure ATP release in HTC rat hepatoma and Mz-Cha-1 human cholangiocarcinoma cells. Exposure to a Cl- channel inhibitor 5-nitro-2-(3-phenylpropylamino)benzoic acid (NPPB) (50-300 mu M) stimulated a 5-100-fold increase in extracellular ATP levels within minutes of the exposure. This rapid response was not a result of changes in cell viability or Cl- channel activity. NPPB also potently stimulated ATP release in HEK293 cells and HEK293 cells expressing a rat P2X7 receptor indicating that P2X7 receptors are not involved in stimulation of ATP release by NPPB. In all cells studied, NPPB rapidly stimulated vesicular exocytosis that persisted many minutes after the exposure. The kinetics of NPPB-evoked exocytosis and ATP release were similar. Furthermore, the magnitudes of NPPB-evoked exocytosis and ATP release were correlated (correlation coefficient 0.77), indicating that NPPB may stimulate exocytosis of a pool of ATP-enriched vesicles. These findings provide further support for the concept that vesicular exocytosis plays an important role in cellular ATP release and suggest that NPPB can be used as a biochemical tool to specifically stimulate ATP release through exocytic mechanisms.	[Dolovcak, Svjetlana; Waldrop, Shar L.; Fitz, J. Gregory; Kilic, Gordan] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Kilic, G (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	gordan.kilic@utsouthwestern.edu		Dolovcak, Svjetlana/0000-0002-5227-7525	National Institutes of Health [DK43278, DK46082]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046082, R37DK046082, R01DK043278] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK43278 and DK46082.	Adinolfi E, 2003, J BIOL CHEM, V278, P37344, DOI 10.1074/jbc.M301508200; Arcuino G, 2002, P NATL ACAD SCI USA, V99, P9840, DOI 10.1073/pnas.152588599; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Bell PD, 2003, P NATL ACAD SCI USA, V100, P4322, DOI 10.1073/pnas.0736323100; Bodily K, 1997, HEPATOLOGY, V25, P403; Bodin P, 2001, J CARDIOVASC PHARM, V38, P900, DOI 10.1097/00005344-200112000-00012; Boudreault F, 2004, J PHYSIOL-LONDON, V561, P499, DOI 10.1113/jphysiol.2004.072306; BREUER W, 1989, BIOCHEM BIOPH RES CO, V163, P398, DOI 10.1016/0006-291X(89)92149-9; Burnstock G, 2006, PHARMACOL REV, V58, P58, DOI 10.1124/pr.58.1.5; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; Coco S, 2003, J BIOL CHEM, V278, P1354, DOI 10.1074/jbc.M209454200; Cotrina ML, 1998, P NATL ACAD SCI USA, V95, P15735, DOI 10.1073/pnas.95.26.15735; Doctor RB, 2002, AM J PHYSIOL-CELL PH, V282, pC1042, DOI 10.1152/ajpcell.00367.2001; Donnelly-Roberts DL, 2007, BRIT J PHARMACOL, V151, P571, DOI 10.1038/sj.bjp.0707265; Feranchak AP, 1999, J BIOL CHEM, V274, P30979, DOI 10.1074/jbc.274.43.30979; Feranchak AP, 2000, J HEPATOL, V33, P174, DOI 10.1016/S0168-8278(00)80357-8; Feranchak AP, 1998, J BIOL CHEM, V273, P14906, DOI 10.1074/jbc.273.24.14906; Hazama A, 1999, J GEN PHYSIOL, V114, P525, DOI 10.1085/jgp.114.4.525; He ML, 2003, AM J PHYSIOL-CELL PH, V285, pC467, DOI 10.1152/ajpcell.00042.2003; Hisadome K, 2002, J GEN PHYSIOL, V119, P511, DOI 10.1085/jgp.20028540; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; Kilic G, 2002, BIOPHYS J, V83, P849, DOI 10.1016/S0006-3495(02)75213-2; Kilic G, 2001, J BIOL CHEM, V276, P26762, DOI 10.1074/jbc.M100992200; Kochukov MY, 2004, AM J PHYSIOL-CELL PH, V287, pC992, DOI 10.1152/ajpcell.00538.2003; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; Mitchell CH, 1998, P NATL ACAD SCI USA, V95, P7174, DOI 10.1073/pnas.95.12.7174; Okada SF, 2004, J GEN PHYSIOL, V124, P513, DOI 10.1085/jgp.200409154; Orriss IR, 2009, J CELL PHYSIOL, V220, P155, DOI 10.1002/jcp.21745; Pankratov Y, 2006, PFLUG ARCH EUR J PHY, V452, P589, DOI 10.1007/s00424-006-0061-x; Pelegrin P, 2007, J BIOL CHEM, V282, P2386, DOI 10.1074/jbc.M610351200; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Pelegrin P, 2009, PURINERG SIGNAL, V5, P129, DOI 10.1007/s11302-009-9141-7; Pellegatti P, 2005, MOL BIOL CELL, V16, P3659, DOI 10.1091/mbc.E05-03-0222; Qiu F, 2009, AM J PHYSIOL-CELL PH, V296, pC250, DOI 10.1152/ajpcell.00433.2008; Qu Y, 2009, PURINERG SIGNAL, V5, P163, DOI 10.1007/s11302-009-9132-8; Ransford GA, 2009, AM J RESP CELL MOL, V41, P525, DOI 10.1165/rcmb.2008-0367OC; Roman RM, 1997, J BIOL CHEM, V272, P21970, DOI 10.1074/jbc.272.35.21970; Roman RM, 1999, AM J PHYSIOL-GASTR L, V276, pG1391, DOI 10.1152/ajpgi.1999.276.6.G1391; Roman RM, 1996, AM J PHYSIOL-GASTR L, V271, pG239, DOI 10.1152/ajpgi.1996.271.2.G239; Sabirov Ravshan Z, 2005, Purinergic Signal, V1, P311, DOI 10.1007/s11302-005-1557-0; Sabirov RZ, 2001, J GEN PHYSIOL, V118, P251, DOI 10.1085/jgp.118.3.251; Sauer H, 2000, AM J PHYSIOL-CELL PH, V279, pC295, DOI 10.1152/ajpcell.2000.279.2.C295; Sim JA, 2004, J NEUROSCI, V24, P6307, DOI 10.1523/JNEUROSCI.1469-04.2004; Smith CB, 1996, NATURE, V380, P531, DOI 10.1038/380531a0; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Suadicani SO, 2006, J NEUROSCI, V26, P1378, DOI 10.1523/JNEUROSCI.3902-05.2006; Suadicani SO, 2009, ASN NEURO, V1, DOI 10.1042/AN20090001; Taylor AL, 1998, AM J PHYSIOL-CELL PH, V275, pC1391, DOI 10.1152/ajpcell.1998.275.5.C1391; Woo K, 2008, J PHYSIOL-LONDON, V586, P2779, DOI 10.1113/jphysiol.2008.153015; Yan ZH, 2008, J GEN PHYSIOL, V132, P563, DOI 10.1085/jgp.200810059	50	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33894	33903		10.1074/jbc.M109.046193	http://dx.doi.org/10.1074/jbc.M109.046193			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19808682	hybrid, Green Published			2022-12-27	WOS:000272165200022
J	Eriksson, HM; Wessman, P; Ge, CR; Edwards, K; Wieslander, A				Eriksson, Hanna M.; Wessman, Per; Ge, Changrong; Edwards, Katarina; Wieslander, Ake			Massive Formation of Intracellular Membrane Vesicles in Escherichia coli by a Monotopic Membrane-bound Lipid Glycosyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS SPORULATION; OUTER-MEMBRANE; ACHOLEPLASMA-LAIDLAWII; CRYSTAL-STRUCTURE; INNER-MEMBRANE; 1,2-DIACYLGLYCEROL 3-GLUCOSYLTRANSFERASE; ENDOPLASMIC-RETICULUM; PROTEIN COMPLEXES; MOLECULAR SHAPE; ANIONIC LIPIDS	The morphology and curvature of biological bilayers are determined by the packing shapes and interactions of their participant molecules. Bacteria, except photosynthetic groups, usually lack intracellular membrane organelles. Strong overexpression in Escherichia coli of a foreign monotopic glycosyltransferase (named monoglycosyldiacylglycerol synthase), synthesizing a nonbilayer-prone glucolipid, induced massive formation of membrane vesicles in the cytoplasm. Vesicle assemblies were visualized in cytoplasmic zones by fluorescence microscopy. These have a very low buoyant density, substantially different from inner membranes, with a lipid content of >= 60% (w/w). Cryo-transmission electron microscopy revealed cells to be filled with membrane vesicles of various sizes and shapes, which when released were mostly spherical (diameter approximate to 100 nm). The protein repertoire was similar in vesicle and inner membranes and dominated by the glycosyltransferase. Membrane polar lipid composition was similar too, including the foreign glucolipid. A related glycosyltransferase and an inactive monoglycosyldiacylglycerol synthase mutant also yielded membrane vesicles, but without glucolipid synthesis, strongly indicating that vesiculation is induced by the protein itself. The high capacity for membrane vesicle formation seems inherent in the glycosyltransferase structure, and it depends on the following: (i) lateral expansion of the inner monolayer by interface binding of many molecules; (ii) membrane expansion through stimulation of phospholipid synthesis, by electrostatic binding and sequestration of anionic lipids; (iii) bilayer bending by the packing shape of excess nonbilayer-prone phospholipid or glucolipid; and (iv) potentially also the shape or penetration profile of the glycosyltransferase binding surface. These features seem to apply to several other proteins able to achieve an analogous membrane expansion.	[Eriksson, Hanna M.; Ge, Changrong; Wieslander, Ake] Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, SE-10691 Stockholm, Sweden; [Wessman, Per; Edwards, Katarina] Uppsala Univ, Dept Phys & Analyt Chem, SE-75123 Uppsala, Sweden	Stockholm University; Uppsala University	Wieslander, A (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, SE-10691 Stockholm, Sweden.	ake@dbb.su.se	Edwards, Katarina/AAR-7679-2021; Edwards, Katarina/A-1159-2012	Edwards, Katarina/0000-0003-0674-2219; Edwards, Katarina/0000-0003-0674-2219	Swedish Research Council; European Commission; Marie-Curie Action BIOCONTROL	Swedish Research Council(Swedish Research CouncilEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Marie-Curie Action BIOCONTROL(European Commission)	This work was supported in part by grants from the Swedish Research Council (to angstrom.W. and K. E.) and by the European Commission 6th Framework Programme, Marie-Curie Action BIOCONTROL (to angstrom.W.).	ALLISON DP, 1971, J BACTERIOL, V108, P1390, DOI 10.1128/JB.108.3.1390-1401.1971; Almgren M, 2000, COLLOID SURFACE A, V174, P3, DOI 10.1016/S0927-7757(00)00516-1; Arechaga I, 2000, FEBS LETT, V482, P215, DOI 10.1016/S0014-5793(00)02054-8; ARMOUR GA, 1990, FASEB J, V4, P1488, DOI 10.1096/fasebj.4.5.2407591; Balali-Mood K, 2009, BIOCHEMISTRY-US, V48, P2135, DOI 10.1021/bi8017398; Bendezu FO, 2008, J BACTERIOL, V190, P1792, DOI 10.1128/JB.01322-07; Berg S, 2001, J BIOL CHEM, V276, P22056, DOI 10.1074/jbc.M102576200; Campelo F, 2008, BIOPHYS J, V95, P2325, DOI 10.1529/biophysj.108.133173; CHRISTIANSSON A, 1985, J CELL BIOL, V101, P1455, DOI 10.1083/jcb.101.4.1455; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; DECOCK H, 1989, BIOCHIM BIOPHYS ACTA, V985, P313, DOI 10.1016/0005-2736(89)90418-5; Domanov YA, 2006, BIOPHYS J, V91, P4427, DOI 10.1529/biophysj.106.091702; Drin G, 2008, SCIENCE, V320, P670, DOI 10.1126/science.1155821; Dupuy AD, 2008, P NATL ACAD SCI USA, V105, P2848, DOI 10.1073/pnas.0712379105; Edman M, 2003, J BIOL CHEM, V278, P8420, DOI 10.1074/jbc.M211492200; Epand RF, 2007, J MOL BIOL, V365, P968, DOI 10.1016/j.jmb.2006.10.028; Epand RM, 2008, J AM CHEM SOC, V130, P14346, DOI 10.1021/ja8062327; Eriksson HM, 2009, PROTEIN EXPRES PURIF, V66, P143, DOI 10.1016/j.pep.2009.03.008; GEORGIEV A, 2008, THESIS STOCKHOLM U S; Guerin ME, 2007, J BIOL CHEM, V282, P20705, DOI 10.1074/jbc.M702087200; Ha S, 2000, PROTEIN SCI, V9, P1045, DOI 10.1110/ps.9.6.1045; He J, 2009, PROTEINS, V76, P852, DOI 10.1002/prot.22392; Herskovits AA, 2002, J CELL BIOL, V159, P403, DOI 10.1083/jcb.200204144; Hu JJ, 2008, SCIENCE, V319, P1247, DOI 10.1126/science.1153634; Huang KC, 2006, PLOS COMPUT BIOL, V2, P1357, DOI 10.1371/journal.pcbi.0020151; JACKSON BJ, 1986, J BIOL CHEM, V261, P3464; KARLSSON OP, 1994, J BIOL CHEM, V269, P23484; Kawai C, 2009, BIOCHEMISTRY-US, V48, P8335, DOI 10.1021/bi9006463; Kim AC, 2008, J MOL BIOL, V376, P352, DOI 10.1016/j.jmb.2007.11.080; Kim JY, 2008, J MOL BIOL, V380, P51, DOI 10.1016/j.jmb.2008.03.076; Kol S, 2008, J BIOL CHEM, V283, P31269, DOI 10.1074/jbc.R800029200; Laan EVDD, 2003, J BACTERIOL, V185, P3773, DOI 10.1128/JB.185.3773.3779.2003; Lamaziere A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000201; LETELLIER L, 1977, P NATL ACAD SCI USA, V74, P452, DOI 10.1073/pnas.74.2.452; Li L, 2003, BIOCHEMISTRY-US, V42, P9677, DOI 10.1021/bi034360l; Liberton M, 2006, PROTOPLASMA, V227, P129, DOI 10.1007/s00709-006-0145-7; Lind J, 2007, BIOCHEMISTRY-US, V46, P5664, DOI 10.1021/bi700042x; Linde K, 2004, FEBS LETT, V575, P77, DOI 10.1016/j.febslet.2004.08.038; Lingwood D, 2009, J BIOL CHEM, V284, P12041, DOI 10.1074/jbc.M900220200; Marius P, 2008, BIOPHYS J, V94, P1689, DOI 10.1529/biophysj.107.117507; Martinez-Fleites C, 2006, CHEM BIOL, V13, P1143, DOI 10.1016/j.chembiol.2006.09.005; Mashburn-Warren L, 2008, GEOBIOLOGY, V6, P214, DOI 10.1111/j.1472-4669.2008.00157.x; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; McNaughton BR, 2009, P NATL ACAD SCI USA, V106, P6111, DOI 10.1073/pnas.0807883106; Morein S, 1996, J BIOL CHEM, V271, P6801, DOI 10.1074/jbc.271.12.6801; Mukhopadhyay R, 2008, BIOPHYS J, V95, P1034, DOI 10.1529/biophysj.107.126920; Nevo R, 2007, EMBO J, V26, P1467, DOI 10.1038/sj.emboj.7601594; Nieboer M, 1996, EUR J BIOCHEM, V241, P691, DOI 10.1111/j.1432-1033.1996.00691.x; OSBORN MJ, 1972, J BIOL CHEM, V247, P3962; Palsdottir H, 2004, BBA-BIOMEMBRANES, V1666, P2, DOI 10.1016/j.bbamem.2004.06.012; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; Pogliano J, 1999, MOL MICROBIOL, V31, P1149, DOI 10.1046/j.1365-2958.1999.01255.x; Price CE, 2008, J BIOL CHEM, V283, P26921, DOI 10.1074/jbc.M804490200; Reinbothe C, 1999, NATURE, V397, P80, DOI 10.1038/16283; Ren G, 2006, MICROBIOL MOL BIOL R, V70, P37, DOI 10.1128/MMBR.70.1.37-120.2006; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; Ruiz N, 2008, P NATL ACAD SCI USA, V105, P5537, DOI 10.1073/pnas.0801196105; SELSTAM E, 1998, LIPIDS PHOTOSYNTHESI, P209; Sener MK, 2007, P NATL ACAD SCI USA, V104, P15723, DOI 10.1073/pnas.0706861104; Sharp MD, 1999, P NATL ACAD SCI USA, V96, P14553, DOI 10.1073/pnas.96.25.14553; SHEETZ MP, 1974, P NATL ACAD SCI USA, V71, P4457, DOI 10.1073/pnas.71.11.4457; Sturgis JN, 2009, BIOCHEMISTRY-US, V48, P3679, DOI 10.1021/bi900045x; SUPPLY P, 1993, J BIOL CHEM, V268, P19744; Svetina S, 2001, CELL MOL BIOL LETT, V6, P305; VANWEEGHEL RP, 1990, P NATL ACAD SCI USA, V87, P2613, DOI 10.1073/pnas.87.7.2613; VERGERES G, 1993, J CELL SCI, V106, P249; Vonck J, 2009, BBA-MOL CELL RES, V1793, P117, DOI 10.1016/j.bbamcr.2008.05.019; VONMEYENBURG K, 1984, EMBO J, V3, P1791, DOI 10.1002/j.1460-2075.1984.tb02047.x; Wan SZ, 2009, J COMPUT CHEM, V30, P1038, DOI 10.1002/jcc.21130; Weber S, 1996, VIRUS GENES, V12, P5, DOI 10.1007/BF00369995; WEIGAND RA, 1970, J BACTERIOL, V102, P240, DOI 10.1128/JB.102.1.240-249.1970; WEINER JH, 1984, J BACTERIOL, V158, P590, DOI 10.1128/JB.158.2.590-596.1984; WIESLANDER A, 1980, BIOCHEMISTRY-US, V19, P3650, DOI 10.1021/bi00557a002; Wikstrom M, 2009, J BIOL CHEM, V284, P954, DOI 10.1074/jbc.M804482200; WILKISON WO, 1986, J BIOL CHEM, V261, P9951; Yeh JI, 2008, P NATL ACAD SCI USA, V105, P3280, DOI 10.1073/pnas.0712331105; Zhang YM, 2008, J LIPID RES, V49, P1867, DOI 10.1194/jlr.R800005-JLR200; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	79	35	36	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33904	33914		10.1074/jbc.M109.021618	http://dx.doi.org/10.1074/jbc.M109.021618			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19767390	Green Published, hybrid			2022-12-27	WOS:000272165200023
J	Wang, F; Mei, ZQ; Qi, YT; Yan, CY; Xiang, SH; Zhou, ZY; Hu, Q; Wang, JW; Shi, YG				Wang, Feng; Mei, Ziqing; Qi, Yutao; Yan, Chuangye; Xiang, Siheng; Zhou, Zhiyuan; Hu, Qi; Wang, Jiawei; Shi, Yigong			Crystal Structure of the MecA Degradation Tag	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADAPTER PROTEIN; COMPETENCE; CLPC; PROTEOLYSIS; SOFTWARE	MecA is an adaptor protein that regulates the assembly and activity of the ATP-dependent ClpCP protease in Bacillus subtilis. MecA contains two domains. Although the amino-terminal domain of MecA recruits substrate proteins such as ComK and ComS, the carboxyl-terminal domain (residues 121-218) has dual roles in the regulation and function of ClpCP protease. MecA-(121-218) facilitates the assembly of ClpCP oligomer, which is required for the protease activity of ClpCP. This domain was identified to be a non-recycling degradation tag that targets heterologous fusion proteins to the ClpCP protease for degradation. To elucidate the mechanism of MecA, we determined the crystal structure of MecA-(121-218) at 2.2 angstrom resolution, which reveals a previously uncharacterized alpha/beta fold. Structure-guided mutagenesis allows identification of surface residues that are essential for the function of MecA. We also solved the structure of a carboxyl-terminal domain of YpbH, a paralogue of MecA in B. subtilis, at 2.4 angstrom resolution. Despite low sequence identity, the two structures share essentially the same fold. The presence of MecA homologues in other bacterial species suggests conservation of a large family of unique degradation tags.	[Wang, Jiawei; Shi, Yigong] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Wang, Feng; Mei, Ziqing; Qi, Yutao; Xiang, Siheng; Zhou, Zhiyuan; Shi, Yigong] Tsinghua Univ, Prot Sci Lab, Minist Educ, Sch Life Sci, Beijing 100084, Peoples R China; [Yan, Chuangye; Hu, Qi; Wang, Jiawei] Tsinghua Univ, State Key Lab Biomembrane, Struct Biol Ctr, Sch Life Sci, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University	Wang, JW (corresponding author), Tsinghua Univ, Sch Med, Rm C327,Med Sci Bldg, Beijing 100084, Peoples R China.	jwwang@tsinghua.edu.cn; shi-lab@tsinghua.edu.cn	Wang, Feng/AAC-6221-2022; Wang, Jiawei/D-1144-2010; Yan, Chuangye/AAJ-5832-2021; Xiang, Siheng/A-5063-2010	Wang, Feng/0000-0002-9403-4337; Wang, Jiawei/0000-0001-9893-8539; Yan, Chuangye/0000-0001-9338-8048; Shi, Yigong/0000-0003-2030-168X; Xiang, Siheng/0000-0003-4475-5707	Ministry of Science and Technology [2009CB918801]; Tsinghua University 985 Phase II; National Natural Science Foundation of China [30888001]; Beijing Municipal Commissions of Education and Science and Technology	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Tsinghua University 985 Phase II; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Commissions of Education and Science and Technology	This work was supported by grants from the Ministry of Science and Technology (Grant 2009CB918801), Tsinghua University 985 Phase II funds, Project 30888001 supported by the National Natural Science Foundation of China, and Beijing Municipal Commissions of Education and Science and Technology.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Kirstein J, 2006, EMBO J, V25, P1481, DOI 10.1038/sj.emboj.7601042; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Mei ZQ, 2009, J BIOL CHEM, V284, P34366, DOI 10.1074/jbc.M109.053017; Nakano S, 2002, J BACTERIOL, V184, P3664, DOI 10.1128/JB.184.13.3664-3670.2002; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Persuh M, 1999, MOL MICROBIOL, V33, P886, DOI 10.1046/j.1365-2958.1999.01544.x; Persuh M, 2002, J BACTERIOL, V184, P2310, DOI 10.1128/JB.184.8.2310-2313.2002; Prepiak P, 2007, MOL CELL, V26, P639, DOI 10.1016/j.molcel.2007.05.011; Razeto A, 2007, STRUCTURE, V15, P683, DOI 10.1016/j.str.2007.04.009; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Schlothauer T, 2003, P NATL ACAD SCI USA, V100, P2306, DOI 10.1073/pnas.0535717100; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Turgay K, 1997, GENE DEV, V11, P119, DOI 10.1101/gad.11.1.119; Turgay K, 1998, EMBO J, V17, P6730; VIJAYKUMAR S, 1985, P NATL ACAD SCI USA, V82, P3582, DOI 10.1073/pnas.82.11.3582; Yan N, 2004, NAT STRUCT MOL BIOL, V11, P420, DOI 10.1038/nsmb764; Zolkiewski M, 2006, MOL MICROBIOL, V61, P1094, DOI 10.1111/j.1365-2958.2006.05309.x	23	10	11	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34376	34381		10.1074/jbc.M109.053033	http://dx.doi.org/10.1074/jbc.M109.053033			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19801546	Green Published, hybrid			2022-12-27	WOS:000272165200067
J	Aviv, V; Meivar-Levy, I; Rachmut, IH; Rubinek, T; Mor, E; Ferber, S				Aviv, Vered; Meivar-Levy, Irit; Rachmut, Itzhak H.; Rubinek, Tamar; Mor, Eytan; Ferber, Sarah			Exendin-4 Promotes Liver Cell Proliferation and Enhances the PDX-1-induced Liver to Pancreas Transdifferentiation Process	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCAGON-LIKE PEPTIDE-1; INSULIN-PRODUCING CELLS; EMBRYONIC STEM-CELLS; BETA-CELL; GENE-THERAPY; ISLET; GLP-1; EXPRESSION; DIFFERENTIATION; TRANSCRIPTION	Over the last few years, evidence has accumulated revealing the unexpected potential of committed mammalian cells to convert to a different phenotype via a process called transdifferentiation or adult cell reprogramming. These findings may have major practical implications because this process may facilitate the generation of functional autologous tissues that can be used for replacing malfunctioning organs. An instructive role for transcription factors in diverting the developmental fate of cells in adult tissues has been demonstrated when adult human liver cells were induced to transdifferentiate to the pancreatic endocrine lineage upon ectopic expression of the pancreatic master regulator PDX-1 (pancreatic and duodenal homeobox gene 1). Since organogenesis and lineage commitment are affected also by developmental signals generated in response to environmental triggers, we have now analyzed whether the hormone GLP-1 (glucogen-like peptide-1) documented to play a role in pancreatic beta cell differentiation, maturation, and survival, can also increase the efficiency of liver to pancreas transdifferentiation. We demonstrate that the GLP-1R agonist, exendin-4, significantly improves the efficiency of PDX-1-mediated transdifferentiation. Exendin-4 affects the transdifferentiation process at two distinct steps; it increases the proliferation of liver cells predisposed to transdifferentiated in response to PDX-1 and promotes the maturation of transdifferentiated cells along the pancreatic lineage. Liver cell reprogramming toward the pancreatic beta cell lineage has been suggested as a strategy for functional replacement of the ablated insulin-producing cells in diabetics. Understanding the cellular and molecular basis of the transdifferentiation process will allow us to increase the efficiency of the reprogramming process and optimize its therapeutic merit.	[Aviv, Vered; Meivar-Levy, Irit; Rachmut, Itzhak H.; Ferber, Sarah] Chaim Sheba Med Ctr, Endocrine Inst, IL-52621 Tel Hashomer, Israel; [Aviv, Vered; Ferber, Sarah] Tel Aviv Univ, Sackler Sch Med, Dept Human Genet & Mol Med, IL-69978 Tel Aviv, Israel; [Rachmut, Itzhak H.] Bar Ilan Univ, IL-52900 Ramat Gan, Israel; [Rubinek, Tamar] Chaim Sheba Med Ctr, Inst Oncol, IL-52621 Tel Hashomer, Israel; [Mor, Eytan] Rabin Med Ctr, IL-49100 Petah Tiqwa, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Bar Ilan University; Chaim Sheba Medical Center; Rabin Medical Center	Ferber, S (corresponding author), Chaim Sheba Med Ctr, Endocrine Inst, IL-52621 Tel Hashomer, Israel.	sferber@sheba.health.gov.il		Ferber, Sarah/0000-0003-2764-2786	Juvenile Diabetes Research Foundation [1-2006-221]; Israel Science Foundation [ISF-99-05]; EFSD-Lilly award; Legacy Heritage Fund of New York	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Israel Science Foundation(Israel Science Foundation); EFSD-Lilly award; Legacy Heritage Fund of New York	This work was supported in part by Juvenile Diabetes Research Foundation Grant 1-2006-221, Israel Science Foundation Grant ISF-99-05, and EFSD-Lilly award 2005 (all to S. F.) and by the Legacy Heritage Fund of New York (to V. A.).	Ahren B, 2004, HORM METAB RES, V36, P842, DOI 10.1055/s-2004-826173; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Bai L, 2005, J ENDOCRINOL, V186, P343, DOI 10.1677/joe.1.06078; Ber I, 2003, J BIOL CHEM, V278, P31950, DOI 10.1074/jbc.M303127200; Brubaker PL, 2002, RECEPTOR CHANNEL, V8, P179, DOI 10.1080/1060682020005155; Buteau J, 2008, DIABETES METAB, V34, pS73, DOI 10.1016/S1262-3636(08)73398-6; Chakrabarti SK, 2003, J BIOL CHEM, V278, P23617, DOI 10.1074/jbc.M303423200; Doyle ME, 2007, PHARMACOL THERAPEUT, V113, P546, DOI 10.1016/j.pharmthera.2006.11.007; Drucker DJ, 2003, ENDOCRINOLOGY, V144, P5145, DOI 10.1210/en.2003-1147; Ferber S, 2000, NAT MED, V6, P568, DOI 10.1038/75050; Francis J, 2005, J BIOL CHEM, V280, P36244, DOI 10.1074/jbc.M505741200; Francis J, 2006, MOL ENDOCRINOL, V20, P3133, DOI 10.1210/me.2006-0126; Hardikar AA, 2002, ENDOCRINOLOGY, V143, P3505, DOI 10.1210/en.2001-211344; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hui HX, 2001, DIABETES, V50, P785, DOI 10.2337/diabetes.50.4.785; Kaneto H, 2005, J BIOL CHEM, V280, P15047, DOI 10.1074/jbc.M412013200; Korner M, 2007, J NUCL MED, V48, P736, DOI 10.2967/jnumed.106.038679; Kojima H, 2003, NAT MED, V9, P596, DOI 10.1038/nm867; Li WC, 2005, J CELL MOL MED, V9, P569, DOI 10.1111/j.1582-4934.2005.tb00489.x; Li WC, 2005, MECH DEVELOP, V122, P835, DOI 10.1016/j.mod.2005.01.001; Meivar-Levy I, 2003, TRENDS ENDOCRIN MET, V14, P460, DOI 10.1016/j.tem.2003.10.006; Meivar-Levy I, 2007, HEPATOLOGY, V46, P898, DOI 10.1002/hep.21766; Meivar-Levy I, 2006, ISR MED ASSOC J, V8, P430; Samson SL, 2006, TRENDS ENDOCRIN MET, V17, P92, DOI 10.1016/j.tem.2006.02.002; Sapir T, 2005, P NATL ACAD SCI USA, V102, P7964, DOI 10.1073/pnas.0405277102; Shternhall-Ron K, 2007, J AUTOIMMUN, V28, P134, DOI 10.1016/j.jaut.2007.02.010; Tang DQ, 2006, LAB INVEST, V86, P829, DOI 10.1038/labinvest.3700434; VILLANUEVAPENACARRILLO ML, 1995, J ENDOCRINOL, V146, P183, DOI 10.1677/joe.0.1460183; Wang AY, 2007, MOL THER, V15, P255, DOI 10.1038/sj.mt.6300032; Yue FM, 2006, TISSUE ENG, V12, P2105, DOI 10.1089/ten.2006.12.2105; Zalzman M, 2005, DIABETES, V54, P2568, DOI 10.2337/diabetes.54.9.2568	31	70	76	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33509	33520		10.1074/jbc.M109.017608	http://dx.doi.org/10.1074/jbc.M109.017608			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19755420	hybrid, Green Published			2022-12-27	WOS:000272028500057
J	Gao, XL; Patel, TB				Gao, Xianlong; Patel, Tarun B.			Regulation of Protein Kinase A Activity by p90 Ribosomal S6 Kinase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOCRINE OVERACTIVITY; SPOTTY PIGMENTATION; CARNEY COMPLEX; CELL-SURVIVAL; ACTIVATION; SIGNAL; PHOSPHORYLATION; RSK; BAD; DOMAIN	Previously, we reported that the catalytic subunit of cAMP-dependent protein kinase (PKAc) binds to the active p90 ribosomal S6 kinase 1 (RSK1) (Chaturvedi, D., Poppleton, H. M., Stringfield, T., Barbier, A., and Patel, T. B. (2006) Mol. Cell. Biol. 26, 4586-4600). Herein, by overexpressing hemagglutinin-tagged RSK1 fragments in HeLa cells we have identified the region of RSK1 that is responsible for the interaction with PKAc. PKAc bound to the last 13 amino acids of RSK1, which overlaps the Erk1/2 docking site. This interaction between PKAc and RSK1 required the phosphorylation of Ser-732 in the C terminus of RSK1. Depending upon its phosphorylation status, RSK1 switched interactions between Erk1/2 and PKAc. In addition, a peptide corresponding to the last 13 amino acids of RSK1 with substitution of Ser-732 with Glu (peptide E), but not Ala (peptide A), decreased interactions between endogenous active RSK1 and PKAc. RSK1 attenuated the ability of cAMP to activate PKA in vitro and this modulation was abrogated by peptide E, but not by peptide A. Similarly, in intact cells, cAMP-mediated phosphorylation of Bcl-xL/Bcl-2-associated death promoter on Ser-115, the PKA site, was reduced when RSK1 was activated by epidermal growth factor, and this effect was blocked by peptide E, but not by peptide A. These findings demonstrate that interactions between endogenous RSK1 and PKAc in intact cells regulate the ability of cAMP to activate PKA and identify a novel mechanism by which PKA activity is regulated by the Erk1/2 pathway.	[Gao, Xianlong; Patel, Tarun B.] Loyola Univ, Stritch Sch Med, Dept Pharmacol & Expt Therapeut, Maywood, IL 60153 USA	Loyola University Chicago	Patel, TB (corresponding author), Loyola Univ, Stritch Sch Med, Dept Pharmacol & Expt Therapeut, Maywood, IL 60153 USA.	tpatel7@lumc.edu			National Institutes of Health [GM079226]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079226] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM079226.	Boikos SA, 2007, CURR OPIN ONCOL, V19, P24, DOI 10.1097/CCO.0b013e32801195eb; CARNEY JA, 1995, SEMIN DERMATOL, V14, P90, DOI 10.1016/S1085-5629(05)80003-3; CARNEY JA, 1986, MAYO CLIN PROC, V61, P165, DOI 10.1016/S0025-6196(12)61843-6; Carriere A, 2008, FRONT BIOSCI-LANDMRK, V13, P4258, DOI 10.2741/3003; Chaturvedi D, 2006, MOL CELL BIOL, V26, P4586, DOI 10.1128/MCB.01422-05; Chaturvedi D, 2009, J BIOL CHEM, V284, P23670, DOI 10.1074/jbc.M109.032813; DOSKELAND SO, 1993, BIOCHIM BIOPHYS ACTA, V1178, P249, DOI 10.1016/0167-4889(93)90201-Y; Dummler BA, 2005, J BIOL CHEM, V280, P13304, DOI 10.1074/jbc.M408194200; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; Hauge C, 2006, J CELL SCI, V119, P3021, DOI 10.1242/jcs.02950; HIRATA Y, 1993, J BIOL CHEM, V268, P24808; Jacquot S, 1998, AM J HUM GENET, V63, P1631, DOI 10.1086/302153; Jensen CJ, 1999, J BIOL CHEM, V274, P27168, DOI 10.1074/jbc.274.38.27168; Kohler K, 2004, J CELL BIOL, V165, P175, DOI 10.1083/jcb.200312118; Lizcano JM, 2000, BIOCHEM J, V349, P547, DOI 10.1042/bj3490547; Malakhova M, 2008, NAT STRUCT MOL BIOL, V15, P112, DOI 10.1038/nsmb1347; Myers AP, 2004, MOL CELL BIOL, V24, P4255, DOI 10.1128/MCB.24.10.4255-4266.2004; Richards SA, 1999, CURR BIOL, V9, P810, DOI 10.1016/S0960-9822(99)80364-9; Robinson-White AJ, 2006, CANCER RES, V66, P10603, DOI 10.1158/0008-5472.CAN-06-2200; Roux PP, 2003, MOL CELL BIOL, V23, P4796, DOI 10.1128/MCB.23.14.4796-4804.2003; Shimamura A, 2000, CURR BIOL, V10, P127, DOI 10.1016/S0960-9822(00)00310-9; Silverman E, 2004, MOL CELL BIOL, V24, P10573, DOI 10.1128/MCB.24.24.10573-10583.2004; Skalhegg Bjorn S., 1997, Frontiers in Bioscience (online), V2, pD331; Smith JA, 1999, J BIOL CHEM, V274, P2893, DOI 10.1074/jbc.274.5.2893; Tan Y, 1999, J BIOL CHEM, V274, P34859, DOI 10.1074/jbc.274.49.34859; Thomas GM, 2005, P NATL ACAD SCI USA, V102, P15006, DOI 10.1073/pnas.0507476102; Virdee K, 2000, CURR BIOL, V10, P1151, DOI 10.1016/S0960-9822(00)00702-8; Wingate AD, 2006, BIOCHEM J, V393, P715, DOI 10.1042/BJ20050967; Wu JM, 2002, J BIOL CHEM, V277, P42669, DOI 10.1074/jbc.M205501200; Xing J, 1998, MOL CELL BIOL, V18, P1946, DOI 10.1128/MCB.18.4.1946; Yusta B, 2002, J BIOL CHEM, V277, P24896, DOI 10.1074/jbc.M201358200; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6	32	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33070	33078		10.1074/jbc.M109.058453	http://dx.doi.org/10.1074/jbc.M109.058453			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19808666	Green Published, hybrid			2022-12-27	WOS:000272028500010
J	Jackson, EK; Ren, J; Mi, ZC				Jackson, Edwin K.; Ren, Jin; Mi, Zaichuan			Extracellular 2 ',3 '-cAMP Is a Source of Adenosine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2',3'-CYCLIC NUCLEOTIDE 3'-PHOSPHODIESTERASE; SPONTANEOUSLY HYPERTENSIVE-RATS; MUSCLE-CELL GROWTH; MAJOR RNASE TYPES; CYCLIC-AMP; CATALYTIC-PROPERTIES; ECTO-NUCLEOTIDASES; RENAL PHYSIOLOGY; BRAIN-TISSUE; PATHWAY	We discovered that renal injury releases 2',3'-cAMP (positional isomer of 3',5'-cAMP) into the interstitium. This finding motivated a novel hypothesis: renal injury leads to activation of an extracellular 2',3'-cAMP-adenosine pathway (i.e. metabolism of extracellular 2',3'-cAMP to 3'-AMP and 2'-AMP, which are metabolized to adenosine, a retaliatory metabolite). In isolated rat kidneys, arterial infusions of 2',3'-cAMP (30 mu mol/liter) increased the mean venous secretion of 3'-AMP (3,400-fold), 2'-AMP (26,000-fold), adenosine (53-fold), and inosine (adenosine metabolite, 30-fold). Renal injury with metabolic inhibitors increased the mean secretion of 2',3'-cAMP (29-fold), 3'-AMP (16-fold), 2'-AMP (10-fold), adenosine (4.2-fold), and inosine (6.1-fold) while slightly increasing 5'-AMP (2.4-fold). Arterial infusions of 2'-AMP and 3'-AMP increased secretion of adenosine and inosine similar to that achieved by 5'-AMP. Renal artery infusions of 2',3'-cAMP in vivo increased urinary excretion of 2'-AMP, 3'-AMP and adenosine, and infusions of 2'-AMP and 3'-AMP increased urinary excretion of adenosine as efficiently as 5'-AMP. The implications are that 1) in intact organs, 2'-AMP and 3'-AMP are converted to adenosine as efficiently as 5'-AMP (previously considered the most important adenosine precursor) and 2) because 2',3'-cAMP opens mitochondrial permeability transition pores, a pro-apoptotic/pronecrotic process, conversion of 2',3'-cAMP to adenosine by the extracellular 2',3'-cAMP-adenosine pathway would protect tissues by reducing a pro-death factor (2',3'-cAMP) while increasing a retaliatory metabolite (adenosine).	[Jackson, Edwin K.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15219 USA; [Jackson, Edwin K.; Ren, Jin; Mi, Zaichuan] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15219 USA; [Jackson, Edwin K.; Ren, Jin; Mi, Zaichuan] Univ Pittsburgh, Sch Med, Ctr Clin Pharmacol, Pittsburgh, PA 15219 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Jackson, EK (corresponding author), 100 Technol Dr,Ste 450, Pittsburgh, PA 15219 USA.	edj@pitt.edu		Jackson, Edwin/0000-0002-8101-6009	National Institutes of Health [DK068575, DK077777, HL069846]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068575, R01DK077777] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK068575, DK077777, and HL069846.	Akahane M, 2001, J RECONSTR MICROSURG, V17, P203, DOI 10.1055/s-2001-14352; Akahane M, 2001, J ORTHOP RES, V19, P559, DOI 10.1016/S0736-0266(00)00062-0; Alberts B, 1989, MOL BIOL CELL, P481; Almeida A, 2004, ANAL BIOCHEM, V328, P101, DOI 10.1016/j.ab.2004.02.004; Atkinson B, 2006, BLOOD CELL MOL DIS, V36, P217, DOI 10.1016/j.bcmd.2005.12.025; Azarashvili T, 2009, AM J PHYSIOL-CELL PH, V296, pC1428, DOI 10.1152/ajpcell.00006.2009; Borst P, 2007, PFLUG ARCH EUR J PHY, V453, P661, DOI 10.1007/s00424-006-0054-9; Catts VS, 2005, MOL BRAIN RES, V138, P164, DOI 10.1016/j.molbrainres.2005.04.017; Chevyreva I, 2008, EXP MOL PATHOL, V84, P71, DOI 10.1016/j.yexmp.2007.08.019; Chiavegatti T, 2008, BRIT J PHARMACOL, V153, P1331, DOI 10.1038/sj.bjp.0707648; Deeley RG, 2006, PHYSIOL REV, V86, P849, DOI 10.1152/physrev.00035.2005; Dubey RK, 2000, HYPERTENSION, V35, P262, DOI 10.1161/01.HYP.35.1.262; Dubey RK, 2001, HYPERTENSION, V37, P1095, DOI 10.1161/01.HYP.37.4.1095; Dubey RK, 1998, HYPERTENSION, V31, P296, DOI 10.1161/01.HYP.31.1.296; Dubey RK, 1996, HYPERTENSION, V28, P765, DOI 10.1161/01.HYP.28.5.765; Dubey RK, 2000, HYPERTENSION, V36, P337, DOI 10.1161/01.HYP.36.3.337; DUBEY RK, 1997, HYPERTENSION, V30, P506; Gao LP, 2003, J PHARMACOL EXP THER, V305, P581, DOI 10.1124/jpet.102.047647; Giron MC, 2008, GASTROENTEROLOGY, V134, P1116, DOI 10.1053/j.gastro.2008.01.030; Hong KW, 1999, AM J PHYSIOL-HEART C, V276, pH376, DOI 10.1152/ajpheart.1999.276.2.H376; Jackson EK, 2008, J PHARMACOL EXP THER, V325, P210, DOI 10.1124/jpet.107.134445; Jackson EK, 2007, J PHARMACOL EXP THER, V321, P810, DOI 10.1124/jpet.106.119057; Jackson EK, 2007, J PHARMACOL EXP THER, V321, P799, DOI 10.1124/jpet.106.119164; Jackson EK, 2009, HYPERTENSION, V54, P270, DOI 10.1161/HYPERTENSIONAHA.109.130542; Jackson EK, 2006, J PHARMACOL EXP THER, V317, P1219, DOI 10.1124/jpet.106.101360; Jackson EK, 2007, J PHARMACOL EXP THER, V320, P117, DOI 10.1124/jpet.106.112748; JACKSON EK, 1991, ANNU REV PHARMACOL, V31, P1; Jackson EK, 2001, AM J PHYSIOL-RENAL, V281, pF597, DOI 10.1152/ajprenal.2001.281.4.F597; Jackson EK, 1997, J PHARMACOL EXP THER, V283, P177; Jackson EK, 2000, J PHARMACOL EXP THER, V295, P23; Jackson EK, 2003, J PHARMACOL EXP THER, V307, P888, DOI 10.1124/jpet.103.057166; Jackson EK, 2004, ANNU REV PHYSIOL, V66, P571, DOI 10.1146/annurev.physiol.66.032102.111604; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kruh GD, 2001, J BIOENERG BIOMEMBR, V33, P493, DOI 10.1023/A:1012827221844; Linden J, 2001, ANNU REV PHARMACOL, V41, P775, DOI 10.1146/annurev.pharmtox.41.1.775; MI Z, 1994, LIFE SCI, V54, P277; Mi ZC, 1998, J PHARMACOL EXP THER, V287, P926; MI ZC, 1995, J PHARMACOL EXP THER, V273, P728; Muller G, 2008, BIOCHEMISTRY-US, V47, P1259, DOI 10.1021/bi701413t; Ren J, 2008, J PHARMACOL EXP THER, V325, P920, DOI 10.1124/jpet.108.137752; Ren J, 2009, J PHARMACOL EXP THER, V328, P855, DOI 10.1124/jpet.108.146712; Sorrentino S, 1998, CELL MOL LIFE SCI, V54, P785, DOI 10.1007/s000180050207; Sorrentino S, 1997, FEBS LETT, V404, P1, DOI 10.1016/S0014-5793(97)00086-0; THOMPSON JE, 1994, BIOCHEMISTRY-US, V33, P7408, DOI 10.1021/bi00189a047; VOGEL US, 1988, J NEUROCHEM, V50, P1667, DOI 10.1111/j.1471-4159.1988.tb02461.x; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Zimmermann H, 1999, PROG BRAIN RES, V120, P371; Zimmermann Herbert, 2006, Novartis Found Symp, V276, P113	48	75	76	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33097	33106		10.1074/jbc.M109.053876	http://dx.doi.org/10.1074/jbc.M109.053876			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801686	Green Published, hybrid			2022-12-27	WOS:000272028500013
J	Shi, I; Hallwyl, SCL; Seong, C; Mortensen, U; Rothstein, R; Sung, P				Shi, Idina; Hallwyl, Swee C. L.; Seong, Changhyun; Mortensen, Uffe; Rothstein, Rodney; Sung, Patrick			Role of the Rad52 Amino-terminal DNA Binding Activity in DNA Strand Capture in Homologous Recombination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATOR FUNCTION; REPAIR; BREAK; PROTEIN; GENES; IDENTIFICATION	Saccharomyces cerevisiae Rad52 protein promotes homologous recombination by nucleating the Rad51 recombinase onto replication protein A-coated single-stranded DNA strands and also by directly annealing such strands. We show that the purified rad52-R70A mutant protein, with a compromised amino-terminal DNA binding domain, is capable of Rad51 delivery to DNA but is deficient in DNA annealing. Results from chromatin immunoprecipitation experiments find that rad52-R70A associates with DNA double-strand breaks and promotes recruitment of Rad51 as efficiently as wild-type Rad52. Analysis of gene conversion intermediates reveals that rad52-R70A cells can mediate DNA strand invasion but are unable to complete the recombination event. These results provide evidence that DNA binding by the evolutionarily conserved amino terminus of Rad52 is needed for the capture of the second DNA end during homologous recombination.	[Shi, Idina; Seong, Changhyun; Sung, Patrick] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Hallwyl, Swee C. L.; Mortensen, Uffe] Tech Univ Denmark, Ctr Microbial Biotechnol, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Rothstein, Rodney] Columbia Univ, Med Ctr, Dept Genet & Dev, New York, NY 10032 USA; [Seong, Changhyun] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Yale University; Technical University of Denmark; Columbia University; Harvard University; Harvard Medical School	Sung, P (corresponding author), Yale Univ, Sch Med, Dept Mol Biophys & Biochem, 333 Cedar St,SHM-C130, New Haven, CT 06520 USA.	Patrick.Sung@yale.edu	Classen, Scott/AAY-8176-2020; Mortensen, Uffe/AAQ-1150-2021	Rothstein, Rodney/0000-0002-4107-9654	National Institutes of Health [PO1CA92584, ES07061, ES10252, and GM50237]; Danish Research Council for Technology and Production Sciences; Technical University of Denmark; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050237, R37GM050237] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Research Council for Technology and Production Sciences; Technical University of Denmark; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1CA92584, ES07061, ES10252, and GM50237. This work was also supported by the Danish Research Council for Technology and Production Sciences (to U. M.) and the Technical University of Denmark (to S. C. L. H.).	BENDIXEN C, 1994, GENOMICS, V23, P300, DOI 10.1006/geno.1994.1503; BEZZUBOVA OY, 1993, NUCLEIC ACIDS RES, V21, P5945, DOI 10.1093/nar/21.25.5945; Cortes-Ledesma F, 2004, GENETICS, V168, P553, DOI 10.1534/genetics.104.030551; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Kagawa W, 2002, MOL CELL, V10, P359, DOI 10.1016/S1097-2765(02)00587-7; Krejci L, 2002, J BIOL CHEM, V277, P40132, DOI 10.1074/jbc.M206511200; Lao JP, 2008, MOL CELL, V29, P517, DOI 10.1016/j.molcel.2007.12.014; Lettier G, 2006, PLOS GENET, V2, P1773, DOI 10.1371/journal.pgen.0020194; MILNE GT, 1993, GENE DEV, V7, P1755, DOI 10.1101/gad.7.9.1755; Moore JK, 1996, MOL CELL BIOL, V16, P2164, DOI 10.1128/mcb.16.5.2164; Mortensen UH, 2002, GENETICS, V161, P549; Mortensen UH, 1996, P NATL ACAD SCI USA, V93, P10729, DOI 10.1073/pnas.93.20.10729; MURIS DFR, 1994, MUTAT RES-DNA REPAIR, V315, P295, DOI 10.1016/0921-8777(94)90040-X; Nimonkar AV, 2009, P NATL ACAD SCI USA, V106, P3077, DOI 10.1073/pnas.0813247106; OGAWA T, 1995, ADV BIOPHYS, V31, P93, DOI 10.1016/0065-227X(95)99385-3; OSTERMANN K, 1993, NUCLEIC ACIDS RES, V21, P5940, DOI 10.1093/nar/21.25.5940; Pierce AJ, 2001, TRENDS CELL BIOL, V11, pS52, DOI 10.1016/S0962-8924(01)02149-3; Raynard S, 2008, GENE DEV, V22, P2903, DOI 10.1101/gad.1742408; Seong C, 2008, J BIOL CHEM, V283, P12166, DOI 10.1074/jbc.M800763200; Seong C, 2009, J BIOL CHEM, V284, P24363, DOI 10.1074/jbc.M109.032953; SHERMAN F, 1991, GETTING STARTED YEAS, P1; Shinohara A, 1998, GENES CELLS, V3, P145, DOI 10.1046/j.1365-2443.1998.00176.x; Song BW, 2000, J BIOL CHEM, V275, P15895, DOI 10.1074/jbc.M910244199; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Sugawara N, 2006, METHOD ENZYMOL, V408, P416, DOI 10.1016/S0076-6879(06)08026-8; Sugiyama T, 2006, EMBO J, V25, P5539, DOI 10.1038/sj.emboj.7601412; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Trujillo KM, 2001, J BIOL CHEM, V276, P35458, DOI 10.1074/jbc.M105482200; Van Komen S, 2006, METHOD ENZYMOL, V408, P445, DOI 10.1016/S0076-6879(06)08028-1; WHITE CI, 1990, EMBO J, V9, P663, DOI 10.1002/j.1460-2075.1990.tb08158.x; Wolner B, 2003, MOL CELL, V12, P221, DOI 10.1016/S1097-2765(03)00242-9; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4	34	36	38	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33275	33284		10.1074/jbc.M109.057752	http://dx.doi.org/10.1074/jbc.M109.057752			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19812039	Green Published, hybrid			2022-12-27	WOS:000272028500032
J	Oya, H; Yokoyama, A; Yamaoka, I; Fujiki, R; Yonezawa, M; Youn, MY; Takada, I; Kato, S; Kitagawa, H				Oya, Hiroyuki; Yokoyama, Atsushi; Yamaoka, Ikuko; Fujiki, Ryoji; Yonezawa, Masayoshi; Youn, Min-Young; Takada, Ichiro; Kato, Shigeaki; Kitagawa, Hirochika			Phosphorylation of Williams Syndrome Transcription Factor by MAPK Induces a Switching between Two Distinct Chromatin Remodeling Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-D-RECEPTOR; ACTIVATED PROTEIN-KINASE; NUCLEAR RECEPTOR; SIGNALING PATHWAYS; ESTROGEN-RECEPTOR; GENE-REGULATION; PPAR-GAMMA; HEART; GROWTH; BETA	Changes in the environment of a cell precipitate extracellular signals and sequential cascades of protein modification and elicit nuclear transcriptional responses. However, the functional links between intracellular signaling-dependent gene regulation and epigenetic regulation by chromatin-modifying proteins within the nucleus are largely unknown. Here, we describe novel epigenetic regulation by MAPK cascades that modulate formation of an ATP dependent chromatin remodeling complex, WINAC (WSTF Including Nucleosome Assembly Complex), an SWI/SNF-type complex containing Williams syndrome transcription factor (WSTF). WSTF, a specific component of two chromatin remodeling complexes (SWI/SNF-type WINAC and ISWI-type WICH), was phosphorylated by the stimulation of MAPK cascades in vitro and in vivo. Ser-158 residue in the WAC (WSTF/Acf1/cbpq46) domain, located close to the N terminus of WSTF, was identified as a major phosphorylation target. Using biochemical analysis of a WSTF mutant (WSTF-S158A) stably expressing cell line, the phosphorylation of this residue (Ser-158) was found to be essential for maintaining the association between WSTF and core BAF complex components, thereby maintaining the ATPase activity of WINAC. WINAC-dependent transcriptional regulation of vitamin D receptor was consequently impaired by this WSTF mutation, but the recovery from DNA damage mediated by WICH was not impaired. Our results suggest that WSTF serves as a nuclear sensor of the extracellular signals to fine-tune the chromatin remodeling activity of WINAC. WINAC mediates a previously unknown MAPK-dependent step in epigenetic regulation, and this MAPK-dependent switching mechanism between the two functionally distinct WSTF-containing complexes might underlie the diverse functions of WSTF in various nuclear events.	[Oya, Hiroyuki; Yokoyama, Atsushi; Fujiki, Ryoji; Yonezawa, Masayoshi; Youn, Min-Young; Takada, Ichiro; Kato, Shigeaki; Kitagawa, Hirochika] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan; [Yokoyama, Atsushi; Yamaoka, Ikuko; Fujiki, Ryoji; Kato, Shigeaki] ERATO, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Kato, S (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan.	uskato@mail.ecc.u-tokyo.ac.jp; hirokita-tky@umin.ac.jp	Yokoyama, Atsushi/W-3519-2019	Yokoyama, Atsushi/0000-0003-2842-4334	Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant from the Encouraging Development of Strategic Research Centers, Special Coordination Funds for Promoting Science and Technology, Ministry of Education, Culture, Sports, Science and Technology, Japan (to H. K. and S. K.).	Ashwell JD, 2006, NAT REV IMMUNOL, V6, P532, DOI 10.1038/nri1865; Belandia B, 2003, CELL, V114, P277, DOI 10.1016/S0092-8674(03)00599-3; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bogoyevitch MA, 1996, INT J BIOCHEM CELL B, V28, P1, DOI 10.1016/1357-2725(95)00142-5; Bouillon R, 2008, ENDOCR REV, V29, P726, DOI 10.1210/er.2008-0004; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; de la Serna IL, 2006, NAT REV GENET, V7, P461, DOI 10.1038/nrg1882; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; duband-Goulet I, 2004, METHODS, V33, P12, DOI 10.1016/j.ymeth.2003.10.015; Emerson BM, 2002, CELL, V109, P267, DOI 10.1016/S0092-8674(02)00740-7; Freedman LP, 1999, CELL, V97, P5, DOI 10.1016/S0092-8674(00)80708-4; Fujiki R, 2005, EMBO J, V24, P3881, DOI 10.1038/sj.emboj.7600853; Fujiki R, 2009, NATURE, V459, P455, DOI 10.1038/nature07954; Igarashi M, 2007, MOL CELL BIOL, V27, P7947, DOI 10.1128/MCB.00813-07; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; Jurutka P W, 2001, Rev Endocr Metab Disord, V2, P203, DOI 10.1023/A:1010062929140; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; KIM M, 2009, NATURE IN PRESS; Kim MS, 2007, MOL CELL ENDOCRINOL, V265, P168, DOI 10.1016/j.mce.2006.12.014; Kishimoto M, 2006, ENDOCR J, V53, P157, DOI 10.1507/endocrj.53.157; Kitagawa H, 2003, CELL, V113, P905, DOI 10.1016/S0092-8674(03)00436-7; Kondoh K, 2005, CHROMOSOMA, V114, P86, DOI 10.1007/s00412-005-0341-9; Kouzu-Fujita M, 2009, MOL CELL BIOL, V29, P83, DOI 10.1128/MCB.00884-08; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li J, 1997, P NATL ACAD SCI USA, V94, P502, DOI 10.1073/pnas.94.2.502; Li QP, 2007, J BIOL CHEM, V282, P1544, DOI 10.1074/jbc.M604052200; Lickert H, 2004, NATURE, V432, P107, DOI 10.1038/nature03071; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Murayama A, 1998, BIOCHEM BIOPH RES CO, V249, P11, DOI 10.1006/bbrc.1998.9098; Nakamura T, 2007, J CLIN INVEST, V117, P2123, DOI 10.1172/JCI30756; Narayanan R, 2004, J BIOL CHEM, V279, P47298, DOI 10.1074/jbc.M404101200; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Nott A, 2008, NATURE, V455, P411, DOI 10.1038/nature07238; Oishi H, 2006, J BIOL CHEM, V281, P20, DOI 10.1074/jbc.M510157200; Okada M, 2008, EMBO REP, V9, P563, DOI 10.1038/embor.2008.55; Olson EN, 2003, GENE DEV, V17, P1937, DOI 10.1101/gad.1110103; Osley MA, 2006, TRENDS GENET, V22, P671, DOI 10.1016/j.tig.2006.09.007; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Poot RA, 2004, NAT CELL BIOL, V6, P1236, DOI 10.1038/ncb1196; Ravingerova T, 2003, MOL CELL BIOCHEM, V247, P127, DOI 10.1023/A:1024119224033; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Rottbauer W, 2002, CELL, V111, P661, DOI 10.1016/S0092-8674(02)01112-1; Sif S, 1998, GENE DEV, V12, P2842, DOI 10.1101/gad.12.18.2842; Sif S, 2004, J CELL BIOCHEM, V91, P1087, DOI 10.1002/jcb.20005; Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378; Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647; Takeuchi JK, 2007, P NATL ACAD SCI USA, V104, P846, DOI 10.1073/pnas.0608118104; Takeuchi JK, 2009, NATURE, V459, P708, DOI 10.1038/nature08039; Takezawa S, 2007, EMBO J, V26, P764, DOI 10.1038/sj.emboj.7601548; Tidyman William E., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000902; Trotter Kevin W, 2008, Nucl Recept Signal, V6, pe004, DOI 10.1621/nrs.06004; Turjanski AG, 2007, ONCOGENE, V26, P3240, DOI 10.1038/sj.onc.1210415; Uchida T, 2007, J BIOL CHEM, V282, P2707, DOI 10.1074/jbc.M610482200; Wang Z, 2004, GENE DEV, V18, P3106, DOI 10.1101/gad.1238104; Xiao A, 2009, NATURE, V457, P57, DOI 10.1038/nature07668; Yanagisawa J, 2002, MOL CELL, V9, P553, DOI 10.1016/S1097-2765(02)00478-1; Yanagisawa J, 1999, SCIENCE, V283, P1317, DOI 10.1126/science.283.5406.1317; Yang SH, 2003, GENE, V320, P3, DOI 10.1016/S0378-1119(03)00816-3; Yang SH, 2004, MOL CELL, V13, P611, DOI 10.1016/S1097-2765(04)00060-7; Yokoyama A, 2008, MOL CELL BIOL, V28, P3995, DOI 10.1128/MCB.02030-07; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139; Yoshimura K, 2009, P NATL ACAD SCI USA, V106, P9280, DOI 10.1073/pnas.0901184106	63	21	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32472	32482		10.1074/jbc.M109.009738	http://dx.doi.org/10.1074/jbc.M109.009738			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19776015	hybrid, Green Published			2022-12-27	WOS:000272028400030
J	Fuson, KL; Zheng, MZ; Craxton, M; Pataer, A; Ramesh, R; Chada, S; Sutton, RB				Fuson, Kerry L.; Zheng, Mingzhong; Craxton, Molly; Pataer, Abujiang; Ramesh, Rajagopal; Chada, Sunil; Sutton, R. Bryan			Structural Mapping of Post-translational Modifications in Human Interleukin-24 ROLE OF N-LINKED GLYCOSYLATION AND DISULFIDE BONDS IN SECRETION AND ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIATION-ASSOCIATED GENE-7; MELANOMA-DIFFERENTIATION; IL-20 RECEPTOR; CRYSTAL-STRUCTURE; BYSTANDER ACTIVITY; ANTITUMOR-ACTIVITY; CANCER; MDA-7/IL-24; PROTEIN; CELLS	Human interleukin-24 (IL-24) is unique among the IL-10 superfamily as there is considerable evidence that it possesses multiple anti-cancer properties, including direct tumor cell cytotoxicity, helper T cell (TH1) immune stimulation, and anti-angiogenic activities. The primary sequence of human IL-24 differs from homologous cytokines, because it possesses three consensus N-linked glycosylation sites and the potential for a single disulfide bond. To address the significance of these modifications in human IL-24, we analyzed the relationship between post-translational modifications and the cytokine activity of the human IL-24 protein. In contrast to related interleukins, we identified a relationship between net glycosylation, protein solubility, and cytokine activity. In addition, abrogation of the two cysteine residues by mutagenesis dramatically altered the ability of IL-24 to secrete from host cells and resulted in the concomitant loss of IL-24 activity. We conclude that, unlike other IL-10 family members, human IL-24 must be glycosylated to maintain solubility and bioavailability. Further, a single, unique disulfide bond is required for secretion and activity. These structure-function relationships show that, although IL-24 is a member of the IL-19 subfamily of IL-10-like cytokines by sequence similarity, its surface properties and its distinctive disulfide arrangement make it unique. These observations could explain the novel biological activities measured of this cytokine. Understanding the structural basis of IL-24 activity will be important in the interpretation of the function of this cytokine and in the development of scale-up strategies for biophysical and clinical applications.	[Fuson, Kerry L.; Sutton, R. Bryan] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys, Lubbock, TX 79430 USA; [Zheng, Mingzhong] Introgen Therapeut Inc, Dept Clin Res & Dev, Introgen Res Inst, Houston, TX 77030 USA; [Craxton, Molly] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Pataer, Abujiang; Ramesh, Rajagopal] Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA; [Chada, Sunil] Intrexon Corp, Blacksburg, VA 24060 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; MRC Laboratory Molecular Biology; University of Texas System; UTMD Anderson Cancer Center	Sutton, RB (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys, 3601 4th St,Mailstop 6551, Lubbock, TX 79430 USA.	roger.b.sutton@ttuhsc.edu			Melanoma Research Foundation; University of Texas M. D. Anderson SPORE in Melanoma developmental award [CA093459]; NATIONAL CANCER INSTITUTE [P50CA093459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008280] Funding Source: NIH RePORTER	Melanoma Research Foundation; University of Texas M. D. Anderson SPORE in Melanoma developmental award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the Melanoma Research Foundation and a University of Texas M. D. Anderson SPORE in Melanoma developmental award (CA093459).	BEINTEMA JJ, 1986, J MOL EVOL, V24, P118, DOI 10.1007/BF02099959; Caudell EG, 2002, J IMMUNOL, V168, P6041, DOI 10.4049/jimmunol.168.12.6041; Chada S, 2005, MOL THER, V11, P724, DOI 10.1016/j.ymthe.2004.12.021; Chada S, 2004, MOL THER, V10, P1085, DOI 10.1016/j.ymthe.2004.08.020; Chang CS, 2003, J BIOL CHEM, V278, P3308, DOI 10.1074/jbc.M208602200; Commins S, 2008, J ALLERGY CLIN IMMUN, V121, P1108, DOI 10.1016/j.jaci.2008.02.026; DeLano W.L, PYMOL MOL GRAPHICS S; Dumoutier L, 2001, J IMMUNOL, V167, P3545, DOI 10.4049/jimmunol.167.7.3545; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Gopalan B, 2008, CANCER GENE THER, V15, P1, DOI 10.1038/sj.cgt.7701095; Inoue S, 2006, CURR GENE THER, V6, P73, DOI 10.2174/156652306775515574; Jiang HP, 1995, ONCOGENE, V11, P2477; Jones BC, 2002, P NATL ACAD SCI USA, V99, P9404, DOI 10.1073/pnas.152147499; Kreis S, 2008, J CELL MOL MED, V12, P2505, DOI 10.1111/j.1582-4934.2008.00372.x; Kreis S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001300; Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x; Mumm JB, 2006, J INTERF CYTOK RES, V26, P877, DOI 10.1089/jir.2006.26.877; Nagem RAP, 2002, STRUCTURE, V10, P1051, DOI 10.1016/S0969-2126(02)00797-9; Neto MDO, 2008, BIOPHYS J, V94, P1754, DOI 10.1529/biophysj.107.112664; NG DTW, 1990, MOL CELL BIOL, V10, P1989, DOI 10.1128/MCB.10.5.1989; Poindexter NJ, 2005, J LEUKOCYTE BIOL, V78, P745, DOI 10.1189/jlb.0205116; Ramesh R, 2003, CANCER RES, V63, P5105; ROBERTS PC, 1993, J VIROL, V67, P3048, DOI 10.1128/JVI.67.6.3048-3060.1993; Runkel L, 1998, PHARM RES-DORDR, V15, P641, DOI 10.1023/A:1011974512425; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sauane M, 2004, ONCOGENE, V23, P7679, DOI 10.1038/sj.onc.1207958; Sauane M, 2006, CANCER RES, V66, P11869, DOI 10.1158/0008-5472.CAN-06-1887; THORNTON JM, 1981, J MOL BIOL, V151, P261, DOI 10.1016/0022-2836(81)90515-5; Tong AW, 2005, MOL THER, V11, P160, DOI 10.1016/j.ymthe.2004.09.021; Wang M, 2002, J BIOL CHEM, V277, P7341, DOI 10.1074/jbc.M106043200; WINDSOR WT, 1993, BIOCHEMISTRY-US, V32, P8807, DOI 10.1021/bi00085a011; Wong Emily Sw, 2006, Immunome Res, V2, P4, DOI 10.1186/1745-7580-2-4; Xu T, 2005, ACTA CRYSTALLOGR D, V61, P942, DOI 10.1107/S0907444905009601; Zdanov A, 2004, CURR PHARM DESIGN, V10, P3873, DOI 10.2174/1381612043382602; Zdanov A, 2006, VITAM HORM, V74, P61, DOI 10.1016/S0083-6729(06)74003-1; Zheng MZ, 2007, CANCER IMMUNOL IMMUN, V56, P205, DOI 10.1007/s00262-006-0175-1	36	27	28	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30526	30533		10.1074/jbc.M109.036061	http://dx.doi.org/10.1074/jbc.M109.036061			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19734147	hybrid, Green Published			2022-12-27	WOS:000271090000055
J	Bulfer, SL; Scott, EM; Couture, JF; Pillus, L; Trievel, RC				Bulfer, Stacie L.; Scott, Erin M.; Couture, Jean-Francois; Pillus, Lorraine; Trievel, Raymond C.			Crystal Structure and Functional Analysis of Homocitrate Synthase, an Essential Enzyme in Lysine Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-AMINOADIPATE PATHWAY; CITRATE SYNTHASE; TERNARY COMPLEX; ACTIVE-SITE; MECHANISM; REFINEMENT; COENZYME; OXALOACETATE; PURIFICATION; PROTEINS	Homocitrate synthase (HCS) catalyzes the first and committed step in lysine biosynthesis in many fungi and certain Archaea and is a potential target for antifungal drugs. Here we report the crystal structure of the HCS apoenzyme from Schizosaccharomyces pombe and two distinct structures of the enzyme in complex with the substrate 2-oxoglutarate (2-OG). The structures reveal that HCS forms an intertwined homodimer stabilized by domain-swapping between the N- and C-terminal domains of each monomer. The N- terminal catalytic domain is composed of a TIM barrel fold in which 2-OG binds via hydrogen bonds and coordination to the active site divalent metal ion, whereas the C-terminal domain is composed of mixed alpha/beta topology. In the structures of the HCS apoenzyme and one of the 2-OG binary complexes, a lid motif from the C-terminal domain occludes the entrance to the active site of the neighboring monomer, whereas in the second 2-OG complex the lid is disordered, suggesting that it regulates substrate access to the active site through its apparent flexibility. Mutations of the active site residues involved in 2-OG binding or implicated in acid-base catalysis impair or abolish activity in vitro and in vivo. Together, these results yield new insights into the structure and catalytic mechanism of HCSs and furnish a platform for developing HCS-selective inhibitors.	[Trievel, Raymond C.] Univ Michigan, Dept Biol Chem, Sch Med, Ann Arbor, MI 48109 USA; [Scott, Erin M.; Pillus, Lorraine] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Scott, Erin M.; Pillus, Lorraine] Univ Calif San Diego, UCSD Moores Canc Ctr, La Jolla, CA 92093 USA	University of Michigan System; University of Michigan; University of California System; University of California San Diego; University of California System; University of California San Diego	Trievel, RC (corresponding author), Univ Michigan, Dept Biol Chem, Sch Med, 1150 W Med Ctr Dr,5301 MSRB 3, Ann Arbor, MI 48109 USA.	rtrievel@umich.edu			National Institutes of Health [GM056469, GM073839, 5T32GM008353-18, T32GM007240, Y1-CO-1020 (NCI), Y1-GM-1104 (NIGMS)]; University of Michigan Biomedical Research Council; University of Michigan Rackham Graduate School; Canadian Institutes of Health; United States Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; Michigan Economic Development Corp.; Michigan Technology Tri- Corridor [085P1000817]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056469, T32GM008353, R01GM073839, T32GM007240] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Biomedical Research Council(University of Michigan System); University of Michigan Rackham Graduate School(University of Michigan System); Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); United States Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); Michigan Economic Development Corp.; Michigan Technology Tri- Corridor; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM056469 (to L.P.) and GM073839 (R.C.T.). This work was also supported by a University of Michigan Biomedical Research Council pilot grant (to R.C.T.).; Supported by National Institutes of Health Cellular Biotechnology Training Program 5T32GM008353-18 and by a predoctoral fellowship and a graduate student research grant from the University of Michigan Rackham Graduate School.; Supported in part by National Institutes of Health Cell, Molecular, and Genetics Training Grant T32GM007240.; Supported by a Canadian Institutes of Health Research postdoctoral fellowship.; We thank J. Woodward at the Sanger Institute for providing the genomic clone of lys4<SUP>+</SUP> and J. Aris for supplying the yeast HCS antibody. We also thank E. Townsend and C. Burbank for assistance in protein purification and preparing site-directed mutants, respectively. In addition, we acknowledge S. Anderson and R. Sanishvili for assistance in x-ray data collection, T. Huston for performing the inductively coupled plasma mass spectrometry analysis, and A. Gafni and E. Lee for use of the CD spectropolarimeter. We kindly thank T. Baker and N. Koon for furnishing the coordinates of the alpha-IPMS.AcCoA.2-OIV model and P. O'Brien and P. Del Rizzo for reading the manuscript and providing useful comments. Use of the Advanced Photon Source was supported by the United States Department of Energy, Basic Energy Sciences, Office of Science under Contract DE-AC02-06CH11357. General Medicine and Cancer Institutes Collaborative Access Team was funded in whole or in part with National Institutes of Health Grants Y1-CO-1020 (NCI) and Y1-GM-1104 (NIGMS). Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corp. and the Michigan Technology Tri- Corridor for support of this research program (Grant 085P1000817).	Amberg DC., 2005, METHODS YEAST GENETI; Andi B, 2005, J BIOL CHEM, V280, P31624, DOI 10.1074/jbc.M502846200; Andi B, 2004, BIOCHEMISTRY-US, V43, P11790, DOI 10.1021/bi048766p; Anstrom DM, 2003, PROTEIN SCI, V12, P1822, DOI 10.1110/ps.03174303; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Collazo E, 2005, ANAL BIOCHEM, V342, P86, DOI 10.1016/j.ab.2005.04.007; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fu ZJ, 2006, J BIOL CHEM, V281, P7526, DOI 10.1074/jbc.M506880200; GARRAD RC, 1992, J BACTERIOL, V174, P7379, DOI 10.1128/jb.174.22.7379-7384.1992; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Howard BR, 2000, BIOCHEMISTRY-US, V39, P3156, DOI 10.1021/bi992519h; JAKLITSCH WM, 1990, BIOCHEM J, V269, P247, DOI 10.1042/bj2690247; KARPUSAS M, 1990, BIOCHEMISTRY-US, V29, P2213, DOI 10.1021/bi00461a002; Koon N, 2004, P NATL ACAD SCI USA, V101, P8295, DOI 10.1073/pnas.0400820101; Kosuge T, 1998, FEMS MICROBIOL LETT, V169, P361, DOI 10.1016/S0378-1097(98)00502-3; Liu YS, 2002, PROTEIN SCI, V11, P371, DOI 10.1110/ps.36602; Manjasetty BA, 2003, P NATL ACAD SCI USA, V100, P6992, DOI 10.1073/pnas.1236794100; Mowat CG, 2001, BIOCHEMISTRY-US, V40, P12292, DOI 10.1021/bi011360h; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Qian JH, 2008, BIOCHEMISTRY-US, V47, P6851, DOI 10.1021/bi800087k; Qian JH, 2006, BIOCHEMISTRY-US, V45, P12136, DOI 10.1021/bi060889h; REMINGTON S, 1982, J MOL BIOL, V158, P111, DOI 10.1016/0022-2836(82)90452-1; Schlippe YVG, 2005, ARCH BIOCHEM BIOPHYS, V433, P266, DOI 10.1016/j.abb.2004.09.018; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Trievel RC, 2000, ANAL BIOCHEM, V287, P319, DOI 10.1006/abio.2000.4855; TUCCI AF, 1972, ARCH BIOCHEM BIOPHYS, V153, P742, DOI 10.1016/0003-9861(72)90393-1; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VOGEL HJ, 1960, BIOCHIM BIOPHYS ACTA, V41, P172, DOI 10.1016/0006-3002(60)90392-9; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Walsh T J, 1999, Transpl Infect Dis, V1, P247, DOI 10.1034/j.1399-3062.1999.010404.x; WIEGAND G, 1984, J MOL BIOL, V174, P205, DOI 10.1016/0022-2836(84)90373-5; WIEGAND G, 1986, ANNU REV BIOPHYS BIO, V15, P97; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Wulandari AP, 2002, FEBS LETT, V522, P35, DOI 10.1016/S0014-5793(02)02877-6; Xu HY, 2006, CELL BIOCHEM BIOPHYS, V46, P43, DOI 10.1385/CBB:46:1:43	39	27	27	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35769	35780		10.1074/jbc.M109.046821	http://dx.doi.org/10.1074/jbc.M109.046821			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19776021	Green Published, hybrid			2022-12-27	WOS:000272645600054
J	Heyes, DJ; Levy, C; Lafite, P; Roberts, IS; Goldrick, M; Stachulski, AV; Rossington, SB; Stanford, D; Rigby, SEJ; Scrutton, NS; Leys, D				Heyes, Derren J.; Levy, Colin; Lafite, Pierre; Roberts, Ian S.; Goldrick, Marie; Stachulski, Andrew V.; Rossington, Steven B.; Stanford, Deborah; Rigby, Stephen E. J.; Scrutton, Nigel S.; Leys, David			Structure-based Mechanism of CMP-2-keto-3-deoxymanno-octulonic Acid Synthetase CONVERGENT EVOLUTION OF A SUGAR-ACTIVATING ENZYME WITH DNA/RNA POLYMERASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CTP-CMP-3-DEOXY-D-MANNO-OCTULOSONATE CYTIDYLYLTRANSFERASE; 3-DEOXY-D-MANNO-2-OCTULOSONIC ACID; LIPOPOLYSACCHARIDE; COMPLEXES; MODEL; KDO	The enzyme CMP-Kdo synthetase (KdsB) catalyzes the addition of 2-keto-3-deoxymanno-octulonic acid (Kdo) to CTP to form CMP-Kdo, a key reaction in the biosynthesis of lipopolysaccharide. The reaction catalyzed by KdsB and the related CMP-acylneuraminate synthase is unique among the sugar-activating enzymes in that the respective sugars are directly coupled to a cytosine monophosphate. Using inhibition studies, in combination with isothermal calorimetry, we show the substrate analogue 2 beta-deoxy-Kdo to be a potent competitive inhibitor. The ligand-free Escherichia coli KdsB and ternary complex KdsB-CTP-2 beta-deoxy-Kdo crystal structures reveal that Kdo binding leads to active site closure and repositioning of the CTP phosphates and associated Mg2+ ion (Mg-B). Both ligands occupy conformations compatible with an S(n)2-type attack on the alpha-phosphate by the Kdo 2-hydroxyl group. Based on strong similarity with DNA/RNA polymerases, both in terms of overall chemistry catalyzed as well as active site configuration, we postulate a second Mg2+ ion (Mg-A) is bound by the catalytically competent KdsB-CTP-Kdo ternary complex. Modeling of this complex reveals the Mg-A coordinated to the conserved Asp(100) and Asp(235) in addition to the CTP alpha-phosphate and both the Kdo carboxylic and 2-hydroxyl groups. EPR measurements on the Mn2+-substituted ternary complex support this model. We propose the KdsB/CNS sugar-activating enzymes catalyze the formation of activated sugars, such as the abundant CMP-5-N-acetylneuraminic acid, by recruitment of two Mg2+ to the active site. Although each metal ion assists in correct positioning of the substrates and activation of the alpha-phosphate, Mg-A is responsible for activation of the sugar-hydroxyl group.	[Heyes, Derren J.; Levy, Colin; Lafite, Pierre; Rigby, Stephen E. J.; Scrutton, Nigel S.; Leys, David] Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, Manchester M1 7DN, Lancs, England; [Roberts, Ian S.; Goldrick, Marie; Stanford, Deborah] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Stachulski, Andrew V.; Rossington, Steven B.] Univ Liverpool, Dept Chem, Liverpool L69 7ZD, Merseyside, England	University of Manchester; University of Manchester; University of Liverpool	Scrutton, NS (corresponding author), Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, 131 Princess St, Manchester M1 7DN, Lancs, England.	nigel.scrutton@manchester.ac.uk; david.leys@manchester.ac.uk	Lafite, Pierre/F-6806-2011	Lafite, Pierre/0000-0003-1637-4966; Heyes, Derren/0000-0002-7453-1571	Biotechnology and Biological Sciences Research Council, United Kingdom; BBSRC [BB/E013007/1, BB/D01963X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D01963X/1, BB/E013007/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council, United Kingdom.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BRADE H, 1984, CARBOHYD RES, V134, P157, DOI 10.1016/0008-6215(84)85030-2; Bravo IG, 2004, TRENDS MICROBIOL, V12, P120, DOI 10.1016/j.tim.2004.01.004; CLAESSON A, 1987, BIOCHEM BIOPH RES CO, V143, P1063, DOI 10.1016/0006-291X(87)90360-3; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; CORNFORTH JW, 1958, BIOCHEM J, V68, P57, DOI 10.1042/bj0680057; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GOLDMAN R, 1987, NATURE, V329, P162, DOI 10.1038/329162a0; GOLDMAN RC, 1986, J BIOL CHEM, V261, P5831; GOLDMAN RC, 1985, J BACTERIOL, V163, P256, DOI 10.1128/JB.163.1.256-261.1985; HAMMOND SM, 1987, NATURE, V327, P730, DOI 10.1038/327730a0; HERSHBERGER C, 1968, J BIOL CHEM, V243, P1585; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; Jelakovic S, 2002, BIOCHEMISTRY-US, V41, P1174, DOI 10.1021/bi0119060; Jelakovic S, 2001, J MOL BIOL, V312, P143, DOI 10.1006/jmbi.2001.4948; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KEAN E L, 1991, Glycobiology, V1, P441, DOI 10.1093/glycob/1.5.441; KOHLBRENNER WE, 1985, J BIOL CHEM, V260, P4695; Krapp S, 2003, J MOL BIOL, V334, P625, DOI 10.1016/j.jmb.2003.09.080; LUTHMAN K, 1987, J ORG CHEM, V52, P3777, DOI 10.1021/jo00226a010; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mosimann SC, 2001, J BIOL CHEM, V276, P8190, DOI 10.1074/jbc.M007235200; Munster AK, 1998, P NATL ACAD SCI USA, V95, P9140, DOI 10.1073/pnas.95.16.9140; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Nudler E, 2009, ANNU REV BIOCHEM, V78, P335, DOI 10.1146/annurev.biochem.76.052705.164655; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; RAY PH, 1981, J BACTERIOL, V145, P1273, DOI 10.1128/JB.145.3.1273-1280.1981; Reed G. H., 1984, BIOL MAGN RESON, P73; Rothwell PJ, 2005, ADV PROTEIN CHEM, V71, P401, DOI 10.1016/S0065-3233(04)71011-6; SHIRAI R, 1989, TETRAHEDRON LETT, V30, P2263, DOI 10.1016/S0040-4039(00)99665-5; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005	36	28	29	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35514	35523		10.1074/jbc.M109.056630	http://dx.doi.org/10.1074/jbc.M109.056630			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19815542	Green Published, hybrid			2022-12-27	WOS:000272645600028
J	Sowd, G; Wang, H; Pretto, D; Chazin, WJ; Opresko, PL				Sowd, Gregory; Wang, Hong; Pretto, Dalyir; Chazin, Walter J.; Opresko, Patricia L.			Replication Protein A Stimulates the Werner Syndrome Protein Branch Migration Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND-ANNEALING ACTIVITIES; ROTHMUND-THOMSON-SYNDROME; DNA-UNWINDING ACTIVITY; MOBILE D-LOOPS; HOMOLOGOUS RECOMBINATION; SYNDROME HELICASE; RECQ HELICASES; SUBSTRATE-SPECIFICITY; PHYSICAL INTERACTION; MAMMALIAN TELOMERES	Loss of the RecQ DNA helicase WRN protein causes Werner syndrome, in which patients exhibit features of premature aging and increased cancer. WRN deficiency induces cellular defects in DNA replication, mitotic homologous recombination (HR), and telomere stability. In addition to DNA unwinding activity, WRN also possesses exonuclease, strand annealing, and branch migration activities. The single strand binding proteins replication protein A (RPA) and telomere-specific POT1 specifically stimulate WRN DNA unwinding activity. To determine whether RPA and POT1 also modulate WRN branch migration activity, we examined biologically relevant mobile D-loops that mimic structures in HR strand invasion and at telomere ends. Both RPA and POT1 block WRN exonuclease digestion of the invading strand by loading on the strand. However, only RPA robustly stimulates WRN branch migration activity and increases the percentage of D-loops that are disrupted. Our results are consistent with cellular data that support RPA enhancement of branch migration during HR repair and, conversely, POT1 limitation of inappropriate recombination and branch migration at telomeric ends. This is, to our knowledge, the first evidence that RPA can stimulate branch migration activity.	[Sowd, Gregory; Opresko, Patricia L.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Environm & Occupat Hlth, Pittsburgh, PA 15219 USA; [Wang, Hong] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA; [Wang, Hong] Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Pittsburgh, PA 15213 USA; [Pretto, Dalyir; Chazin, Walter J.] Vanderbilt Univ, Struct Biol Ctr, Dept Biochem, Nashville, TN 37232 USA; [Pretto, Dalyir; Chazin, Walter J.] Vanderbilt Univ, Struct Biol Ctr, Dept Chem, Nashville, TN 37232 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Vanderbilt University; Vanderbilt University	Opresko, PL (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Environm & Occupat Hlth, Pittsburgh, PA 15219 USA.	plo4@pitt.edu	Wang, Hong/F-3164-2014; Classen, Scott/AAY-8176-2020	Wang, Hong/0000-0003-0165-3559; Opresko, Patricia/0000-0002-6470-2189	National Institutes of Health [ES0515052, GM065484, CA092584, K99ES016758-01]; Ellison Medical Foundation; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R00ES016758, K99ES016758, R01ES015052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065484] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES0515052 ( to P.L.O.), GM065484 and CA092584 ( to W.J.C.), and K99ES016758-01 ( to H. W.). This work was also supported by a grant from the Ellison Medical Foundation ( to P.L.O.).	Bachrati CZ, 2006, METHOD ENZYMOL, V409, P86, DOI 10.1016/S0076-6879(05)09005-1; Bachrati CZ, 2006, NUCLEIC ACIDS RES, V34, P2269, DOI 10.1093/nar/gkl258; Bachrati CZ, 2003, BIOCHEM J, V374, P577, DOI 10.1042/BJ20030491; Bai YL, 2003, HUM GENET, V113, P337, DOI 10.1007/s00439-003-0972-y; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Brosh RM, 2000, J BIOL CHEM, V275, P23500, DOI 10.1074/jbc.M001557200; Brosh RM, 2002, J BIOL CHEM, V277, P23236, DOI 10.1074/jbc.M111446200; Brosh RM, 1999, J BIOL CHEM, V274, P18341, DOI 10.1074/jbc.274.26.18341; Brosh RM, 2007, NUCLEIC ACIDS RES, V35, P7527, DOI 10.1093/nar/gkm1008; Bugreev DV, 2008, J BIOL CHEM, V283, P20231, DOI 10.1074/jbc.M801582200; Bugreev DV, 2007, NAT STRUCT MOL BIOL, V14, P746, DOI 10.1038/nsmb1268; Constantinou A, 2000, EMBO REP, V1, P80, DOI 10.1093/embo-reports/kvd004; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; Cui S, 2003, J BIOL CHEM, V278, P1424, DOI 10.1074/jbc.M209407200; Cui S, 2004, NUCLEIC ACIDS RES, V32, P2158, DOI 10.1093/nar/gkh540; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Dhillon KK, 2007, AGING CELL, V6, P53, DOI 10.1111/j.1474-9726.2006.00260.x; Doherty KM, 2005, J BIOL CHEM, V280, P29494, DOI 10.1074/jbc.M500653200; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Franchitto A, 2008, J CELL BIOL, V183, P241, DOI 10.1083/jcb.200803173; Gao H, 2007, NAT STRUCT MOL BIOL, V14, P208, DOI 10.1038/nsmb1205; Garcia PL, 2004, EMBO J, V23, P2882, DOI 10.1038/sj.emboj.7600301; Gari K, 2008, P NATL ACAD SCI USA, V105, P16107, DOI 10.1073/pnas.0804777105; Gilson E, 2007, NAT REV MOL CELL BIO, V8, P825, DOI 10.1038/nrm2259; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Heller RC, 2006, NAT REV MOL CELL BIO, V7, P932, DOI 10.1038/nrm2058; Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044; Hu Y, 2007, GENE DEV, V21, P3073, DOI 10.1101/gad.1609107; Huang SR, 1998, NAT GENET, V20, P114, DOI 10.1038/2410; Jiang XH, 2006, EMBO J, V25, P5516, DOI 10.1038/sj.emboj.7601432; Kamath-Loeb AS, 1998, J BIOL CHEM, V273, P34145, DOI 10.1074/jbc.273.51.34145; Kitao S, 1999, NAT GENET, V22, P82, DOI 10.1038/8788; Kudlow BA, 2007, NAT REV MOL CELL BIO, V8, P394, DOI 10.1038/nrm2161; Laud PR, 2005, GENE DEV, V19, P2560, DOI 10.1101/gad.1321305; Lei M, 2004, NAT STRUCT MOL BIOL, V11, P1223, DOI 10.1038/nsmb867; Li BM, 2008, MOL CELL BIOL, V28, P1892, DOI 10.1128/MCB.01364-07; Liu D, 2004, J BIOL CHEM, V279, P51338, DOI 10.1074/jbc.M409293200; Loayza D, 2004, J BIOL CHEM, V279, P13241, DOI 10.1074/jbc.M312309200; Machwe A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-6; Machwe A, 2002, J BIOL CHEM, V277, P4492, DOI 10.1074/jbc.M108880200; Machwe A, 2007, NUCLEIC ACIDS RES, V35, P5729, DOI 10.1093/nar/gkm561; McIlwraith MJ, 2005, MOL CELL, V20, P783, DOI 10.1016/j.molcel.2005.10.001; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; Opresko PL, 2007, MECH AGEING DEV, V128, P423, DOI 10.1016/j.mad.2007.05.009; Opresko PL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004825; Opresko PL, 2004, MOL CELL, V14, P763, DOI 10.1016/j.molcel.2004.05.023; Opresko PL, 2005, J BIOL CHEM, V280, P32069, DOI 10.1074/jbc.M505211200; Opresko PL, 2001, J BIOL CHEM, V276, P44677, DOI 10.1074/jbc.M107548200; Pirzio LM, 2008, J CELL BIOL, V180, P305, DOI 10.1083/jcb.200705126; Popuri V, 2008, J BIOL CHEM, V283, P17766, DOI 10.1074/jbc.M709749200; Saintigny Y, 2002, MOL CELL BIOL, V22, P6971, DOI 10.1128/MCB.22.20.6971-6978.2002; Sakaguchi K, 2009, FEBS J, V276, P943, DOI 10.1111/j.1742-4658.2008.06841.x; Sakamoto S, 2001, GENES CELLS, V6, P421, DOI 10.1046/j.1365-2443.2001.00433.x; Sharma S, 2005, J BIOL CHEM, V280, P28072, DOI 10.1074/jbc.M500264200; Sharma S, 2007, MOL CELL BIOL, V27, P1784, DOI 10.1128/MCB.01620-06; Shen JC, 2003, MECH AGEING DEV, V124, P921, DOI 10.1016/S0047-6374(03)00164-7; Sidorova JM, 2008, CELL CYCLE, V7, P796, DOI 10.4161/cc.7.6.5566; Siitonen HA, 2003, HUM MOL GENET, V12, P2837, DOI 10.1093/hmg/ddg306; Sowd G, 2008, NUCLEIC ACIDS RES, V36, P4242, DOI 10.1093/nar/gkn385; Stauffer ME, 2004, J BIOL CHEM, V279, P25638, DOI 10.1074/jbc.M400029200; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Tarsounas M, 2005, CELL CYCLE, V4, P672, DOI 10.4161/cc.4.5.1689; Wan M, 2009, J BIOL CHEM, V284, P26725, DOI 10.1074/jbc.M109.021105; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Wang RC, 2004, CELL, V119, P355, DOI 10.1016/j.cell.2004.10.011; Wang X, 2008, MOL CELL, V31, P463, DOI 10.1016/j.molcel.2008.05.028; Wu L, 2006, ANNU REV GENET, V40, P279, DOI 10.1146/annurev.genet.40.110405.090636; Xu XH, 2009, EMBO J, V28, P568, DOI 10.1038/emboj.2009.13; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258	71	21	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34682	34691		10.1074/jbc.M109.049031	http://dx.doi.org/10.1074/jbc.M109.049031			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19812417	Green Published, hybrid			2022-12-27	WOS:000272439600024
J	Davidson, RE; Chesters, CJ; Reid, JD				Davidson, Ruth E.; Chesters, Christopher J.; Reid, James D.			Metal Ion Selectivity and Substrate Inhibition in the Metal Ion Chelation Catalyzed by Human Ferrochelatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPECIFICITY CONSTANTS; N-METHYLPROTOPORPHYRIN; 2-SUBSTRATE ENZYMES; ZINC PROTOPORPHYRIN; HEME-BIOSYNTHESIS; BACILLUS-SUBTILIS; PRODUCT RELEASE; TERMINAL ENZYME; ACTIVE-SITE; BINDING	Protoporphyrin IX ferrochelatase (EC 4.99.1.1) catalyzes the terminal step in the heme biosynthetic pathway, the insertion of ferrous iron into protoporphyrin IX. Ferrochelatase shows specificity, in vitro, for multiple metal ion substrates and exhibits substrate inhibition in the case of zinc, copper, cobalt, and nickel. Zinc is the most biologically significant of these; when iron is depleted, zinc porphyrins are formed physiologically. Examining the k(cat)/K-m(app) ratios for zinc and iron reveals that, in vitro, zinc is the preferred substrate at all concentrations of porphyrin. This is not the observed biological specificity, where zinc porphyrins are abnormal; these data argue for the existence of a specific iron delivery mechanism in vivo. We demonstrate that zinc acts as an uncompetitive substrate inhibitor, suggesting that ferrochelatase acts via an ordered pathway. Steady-state characterization demonstrates that the apparent k(cat) depends on zinc and shows substrate inhibition. Although porphyrin substrate is not inhibitory, zinc inhibition is enhanced by increasing porphyrin concentration. This indicates that zinc inhibits by binding to an enzyme-product complex (EZnDIX) and is likely to be the second substrate in an ordered mechanism. Our analysis shows that substrate inhibition by zinc is not a mechanism that can promote specificity for iron over zinc, but is instead one that will reduce the production of all metalloporphyrins in the presence of high concentrations of zinc.	Univ Sheffield, Dept Chem, Sheffield S3 7HF, S Yorkshire, England; [Chesters, Christopher J.] Univ Manchester, Sch Chem, Manchester M1 7DN, Lancs, England	University of Sheffield; University of Manchester		j.reid@sheffield.ac.uk		Reid, James/0000-0003-4921-1047	Biotechnology and Biological Sciences Research Council, United Kingdom	Biotechnology and Biological Sciences Research Council, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council, United Kingdom.	ABBAS A, 1993, J BIOL CHEM, V268, P8541; Al-Karadaghi S, 2006, TRENDS BIOCHEM SCI, V31, P135, DOI 10.1016/j.tibs.2006.01.001; Al-Karadaghi S, 1997, STRUCTURE, V5, P1501, DOI 10.1016/S0969-2126(97)00299-2; BARNSLEY EA, 1993, BIOCHEM J, V291, P323; Burden AE, 1999, BBA-PROTEIN STRUCT M, V1435, P191, DOI 10.1016/S0167-4838(99)00196-X; COOK PF, 2007, ENZYME KINETICS MECH, P175; CORNISHBOWDEN A, 1984, J THEOR BIOL, V108, P451, DOI 10.1016/S0022-5193(84)80045-4; CORNISHBOWDEN A, 1993, BIOCHEM J, V291, P323; DAILEY HA, 1983, J BIOL CHEM, V258, P1453; DAILEY HA, 2003, PORPHYRIN HDB, P87; ENGEL PC, 1992, BIOCHEM J, V284, P604, DOI 10.1042/bj2840604; ENGEL PC, 1993, BIOCHEM J, V291, P324, DOI 10.1042/bj2910324; Falk JE, 1964, PORPHYRINS METALLOPO, P236; Fersht AR., 1977, ENZYME STRUCTURE MEC; Franco R, 2001, BIOCHEM J, V356, P217, DOI 10.1042/0264-6021:3560217; GOLDIN BR, 1969, BIOCHIM BIOPHYS ACTA, V171, P321, DOI 10.1016/0005-2744(69)90165-X; Hansen SH, 2006, NEW ASTRON, V11, P333, DOI 10.1016/j.newast.2005.09.001; HANSSON M, 1994, EUR J BIOCHEM, V220, P201, DOI 10.1111/j.1432-1033.1994.tb18615.x; Hoggins M, 2007, BIOCHEMISTRY-US, V46, P8121, DOI 10.1021/bi602418e; Hunter GA, 2008, J BIOL CHEM, V283, P23685, DOI 10.1074/jbc.M803372200; Karlberg T, 2002, BIOCHEMISTRY-US, V41, P13499, DOI 10.1021/bi0260785; Karlberg T, 2008, J MOL BIOL, V378, P1074, DOI 10.1016/j.jmb.2008.03.040; LAMOLA AA, 1974, SCIENCE, V186, P936, DOI 10.1126/science.186.4167.936; LAMOLA AA, 1975, CLIN CHEM, V21, P93; Lange H, 1999, J BIOL CHEM, V274, P18989, DOI 10.1074/jbc.274.27.18989; Lecerof D, 2003, J BIOL INORG CHEM, V8, P452, DOI 10.1007/s00775-002-0436-1; Lecerof D, 2000, J MOL BIOL, V297, P221, DOI 10.1006/jmbi.2000.3569; Medlock A, 2007, P NATL ACAD SCI USA, V104, P1789, DOI 10.1073/pnas.0606144104; Medlock AE, 2007, J MOL BIOL, V373, P1006, DOI 10.1016/j.jmb.2007.08.040; Medlock AE, 2009, J MOL BIOL, V393, P308, DOI 10.1016/j.jmb.2009.08.042; PORRA RJ, 1967, BIOCHEM J, V104, P321, DOI 10.1042/bj1040321; Sellers VM, 2001, BIOCHEMISTRY-US, V40, P9821, DOI 10.1021/bi010012c; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Shi Z, 2006, BIOCHEM J, V399, P21, DOI 10.1042/BJ20060753; Wu CK, 2001, NAT STRUCT BIOL, V8, P156, DOI 10.1038/84152; [No title captured]	36	18	18	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33795	33799		10.1074/jbc.M109.030205	http://dx.doi.org/10.1074/jbc.M109.030205			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19767646	hybrid, Green Published			2022-12-27	WOS:000272165200010
J	Li, HT; Kundu, TK; Zweier, JL				Li, Haitao; Kundu, Tapan Kumar; Zweier, Jay L.			Characterization of the Magnitude and Mechanism of Aldehyde Oxidase-mediated Nitric Oxide Production from Nitrite	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEHYDROGENASE XANTHINE-OXIDASE; FREE-RADICAL GENERATION; BIOLOGICAL TISSUES; MYOCARDIAL-INFARCTION; POSTISCHEMIC HEART; SYNTHASE ACTIVITY; RELAXING FACTOR; ANOXIC TISSUES; CDNA CLONING; REDUCTASE	Aldehyde oxidase (AO) is a cytosolic enzyme with an important role in drug and xenobiotic metabolism. Although AO has structural similarity to bacterial nitrite reductases, it is unknown whether AO-catalyzed nitrite reduction can be an important source of NO. The mechanism, magnitude, and quantitative importance of AO-mediated nitrite reduction in tissues have not been reported. To investigate this pathway and its quantitative importance, EPR spectroscopy, chemiluminescence NO analyzer, and immunoassays of cGMP formation were performed. The kinetics and magnitude of AO-dependent NO formation were characterized. In the presence of typical aldehyde substrates or NADH, AO reduced nitrite to NO. Kinetics of AO-catalyzed nitrite reduction followed Michaelis-Menten kinetics under anaerobic conditions. Under physiological conditions, nitrite levels are far below its measured Km value in the presence of either the flavin site electron donor NADH or molybdenum site aldehyde electron donors. Under aerobic conditions with the FAD site-binding substrate, NADH, AO-mediated NO production was largely maintained, although with aldehyde substrates oxygen-dependent inhibition was seen. Oxygen tension, substrate, and pH levels were important regulators of AO-catalyzed NO generation. From kinetic data, it was determined that during ischemia hepatic, pulmonary, or myocardial AO and nitrite levels were sufficient to result in NO generation comparable to or exceeding maximal production by constitutive NO synthases. Thus, AO-catalyzed nitrite reduction can be an important source of NO generation, and its NO production will be further increased by therapeutic administration of nitrite.	Ohio State Univ, Coll Med, Davis Heart & Lung Res Inst, Ctr Biomed EPR Spect & Imaging, Columbus, OH 43210 USA; Ohio State Univ, Coll Med, Div Cardiovasc Med, Dept Internal Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Li, HT (corresponding author), 110 G Davis Heart & Lung Res Inst,473 W 12th Ave, Columbus, OH 43210 USA.	haitao.li@osumc.edu; jay.zweier@osumc.edu			National Institutes of Health [HL63744, HL65608, HL38324]; Ohio Valley Affiliate of the American Heart Association [BGIA-0565249B]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063744, R29HL038324, R01HL038324, P01HL065608] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio Valley Affiliate of the American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL63744, HL65608, and HL38324 ( to J.L.Z.). This work was also supported by the Ohio Valley Affiliate of the American Heart Association Grant BGIA-0565249B ( to H.L.).	ANDO H, 1993, CLIN CARDIOL, V16, P443, DOI 10.1002/clc.4960160514; AZNAR J, 1983, J CLIN PATHOL, V36, P712, DOI 10.1136/jcp.36.6.712; Baker JE, 2007, J MOL CELL CARDIOL, V43, P437, DOI 10.1016/j.yjmcc.2007.07.057; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Beedham C, 1987, Prog Med Chem, V24, P85, DOI 10.1016/S0079-6468(08)70420-X; BEEDHAM C, 1987, EUR J DRUG METAB PH, V12, P303, DOI 10.1007/BF03189918; BREDT DS, 1992, NEURON, V8, P3, DOI 10.1016/0896-6273(92)90104-L; BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; Calzi ML, 1995, J BIOL CHEM, V270, P31037, DOI 10.1074/jbc.270.52.31037; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; FURCHGOTT RF, 1989, FASEB J, V3, P2007, DOI 10.1096/fasebj.3.9.2545495; Giraldez RR, 1998, ANAL BIOCHEM, V261, P29, DOI 10.1006/abio.1998.2721; Gladwin MT, 2005, AM J RESP CELL MOL, V32, P363, DOI 10.1165/rcmb.F294; Huang Z, 2005, J CLIN INVEST, V115, P2099, DOI 10.1172/JCI24650; IGNARRO LJ, 1987, CIRC RES, V60, P82, DOI 10.1161/01.RES.60.1.82; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; KRENITSKY TA, 1972, ARCH BIOCHEM BIOPHYS, V150, P585, DOI 10.1016/0003-9861(72)90078-1; Kundu TK, 2007, ARCH BIOCHEM BIOPHYS, V460, P113, DOI 10.1016/j.abb.2006.12.032; LANCASTER JR, 1992, J BIOL CHEM, V267, P10994; Li HT, 2008, J BIOL CHEM, V283, P17855, DOI 10.1074/jbc.M801785200; Li HT, 2004, J BIOL CHEM, V279, P16939, DOI 10.1074/jbc.M314336200; Li HT, 2005, J BIOL CHEM, V280, P16594, DOI 10.1074/jbc.M411905200; Li HT, 2003, BIOCHEMISTRY-US, V42, P1150, DOI 10.1021/bi026385a; Li HT, 2001, J BIOL CHEM, V276, P24482, DOI 10.1074/jbc.M011648200; MARLETTA MA, 1988, BIOCHEMISTRY-US, V27, P8706, DOI 10.1021/bi00424a003; Millar TM, 1998, FEBS LETT, V427, P225, DOI 10.1016/S0014-5793(98)00430-X; MIRA L, 1995, ARCH BIOCHEM BIOPHYS, V318, P53, DOI 10.1006/abbi.1995.1203; MONCADA S, 1991, PHARMACOL REV, V43, P109; Moriwaki Y, 1996, HISTOCHEM CELL BIOL, V105, P71, DOI 10.1007/BF01450880; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Samouilov A, 1998, ANAL BIOCHEM, V258, P322, DOI 10.1006/abio.1998.2609; Samouilov A, 1998, ARCH BIOCHEM BIOPHYS, V357, P1, DOI 10.1006/abbi.1998.0785; Sarnesto A, 1996, LAB INVEST, V74, P48; SHINOBU LA, 1984, ACTA PHARMACOL TOX, V54, P189; Shiva S, 2007, CIRC RES, V100, P654, DOI 10.1161/01.RES.0000260171.52224.6b; TISCHLER ME, 1977, ARCH BIOCHEM BIOPHYS, V184, P222, DOI 10.1016/0003-9861(77)90346-0; van Faassen EE, 2009, MED RES REV, V29, P683, DOI 10.1002/med.20151; Wang PH, 1996, J BIOL CHEM, V271, P29223, DOI 10.1074/jbc.271.46.29223; Webb A, 2004, P NATL ACAD SCI USA, V101, P13683, DOI 10.1073/pnas.0402927101; Williamson J R, 1979, Methods Enzymol, V55, P200; WITTENBERG JB, 1956, J BIOL CHEM, V219, P39; WRIGHT RM, 1993, P NATL ACAD SCI USA, V90, P10690, DOI 10.1073/pnas.90.22.10690; XIA Y, 1995, J BIOL CHEM, V270, P18797, DOI 10.1074/jbc.270.32.18797; YOSHIHARA S, 1985, ARCH BIOCHEM BIOPHYS, V242, P213, DOI 10.1016/0003-9861(85)90495-3; Zhang Z, 1998, BIOCHEM BIOPH RES CO, V249, P767, DOI 10.1006/bbrc.1998.9226; ZWEIER JL, 1995, NAT MED, V1, P804, DOI 10.1038/nm0895-804; Zweier JL, 1999, BBA-BIOENERGETICS, V1411, P250, DOI 10.1016/S0005-2728(99)00018-3; ZWEIER JL, 1995, J BIOL CHEM, V270, P304, DOI 10.1074/jbc.270.1.304	49	98	101	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33850	33858		10.1074/jbc.M109.019125	http://dx.doi.org/10.1074/jbc.M109.019125			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19801639	Green Published, hybrid			2022-12-27	WOS:000272165200017
J	Xue, WF; Hellewell, AL; Gosal, WS; Homans, SW; Hewitt, EW; Radford, SE				Xue, Wei-Feng; Hellewell, Andrew L.; Gosal, Walraj S.; Homans, Steve W.; Hewitt, Eric W.; Radford, Sheena E.			Fibril Fragmentation Enhances Amyloid Cytotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGGREGATION; BETA(2)-MICROGLOBULIN; OLIGOMERS; BRAIN; BETA-2-MICROGLOBULIN; MECHANISM; TOXICITY; PEPTIDE; GROWTH; PATHOGENESIS	Fibrils associated with amyloid disease are molecular assemblies of key biological importance, yet how cells respond to the presence of amyloid remains unclear. Cellular responses may not only depend on the chemical composition or molecular properties of the amyloid fibrils, but their physical attributes such as length, width, or surface area may also play important roles. Here, we report a systematic investigation of the effect of fragmentation on the structural and biological properties of amyloid fibrils. In addition to the expected relationship between fragmentation and the ability to seed, we show a striking finding that fibril length correlates with the ability to disrupt membranes and to reduce cell viability. Thus, despite otherwise unchanged molecular architecture, shorter fibrillar samples show enhanced cytotoxic potential than their longer counterparts. The results highlight the importance of fibril length in amyloid disease, with fragmentation not only providing a mechanism by which fibril load can be rapidly increased but also creating fibrillar species of different dimensions that can endow new or enhanced biological properties such as amyloid cytotoxicity.	[Xue, Wei-Feng; Hellewell, Andrew L.; Gosal, Walraj S.; Homans, Steve W.; Hewitt, Eric W.; Radford, Sheena E.] Univ Leeds, Astbury Ctr Struct Mol Biol, Inst Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Radford, SE (corresponding author), Univ Leeds, Astbury Ctr Struct Mol Biol, Inst Mol & Cellular Biol, Garstang Bldg, Leeds LS2 9JT, W Yorkshire, England.	s.e.radford@leeds.ac.uk	Xue, Wei-Feng/C-6038-2013; Gosal, Walraj/J-5260-2012	Gosal, Walraj/0000-0003-3396-1505; Hellewell, Andrew/0000-0002-7803-2884; Xue, Wei-Feng/0000-0002-6504-0404; Hewitt, Eric/0000-0002-6238-6303; Radford, Sheena/0000-0002-3079-8039	Wellcome Trust [075675]; Biotechnology and Biological Sciences Research Council [BB/526502/1]	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Wellcome Trust (Grant 075675) and Biotechnology and Biological Sciences Research Council (Grant BB/526502/1)	Campbell A, 2001, MED HYPOTHESES, V56, P388, DOI 10.1054/mehy.2000.1212; Cappai R, 2005, FASEB J, V19, P1377, DOI 10.1096/fj.04-3437fje; Carulla N, 2005, NATURE, V436, P554, DOI 10.1038/nature03986; Cedervall T, 2007, P NATL ACAD SCI USA, V104, P2050, DOI 10.1073/pnas.0608582104; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321; Colvin VL, 2003, NAT BIOTECHNOL, V21, P1166, DOI 10.1038/nbt875; Devanathan S, 2006, FEBS J, V273, P1389, DOI 10.1111/j.1742-4658.2006.05162.x; Engel MFM, 2008, P NATL ACAD SCI USA, V105, P6033, DOI 10.1073/pnas.0708354105; Fabian H, 2008, BIOCHEMISTRY-US, V47, P6895, DOI 10.1021/bi800279y; Ferrone F, 1999, METHOD ENZYMOL, V309, P256; Friedman R, 2009, J MOL BIOL, V387, P407, DOI 10.1016/j.jmb.2008.12.036; Gharibyan AL, 2007, J MOL BIOL, V365, P1337, DOI 10.1016/j.jmb.2006.10.101; Giorgetti S, 2009, NEPHROL DIAL TRANSPL, V24, P1176, DOI 10.1093/ndt/gfn623; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; Gosal WS, 2005, J MOL BIOL, V351, P850, DOI 10.1016/j.jmb.2005.06.040; Hirakura Y, 2001, AMYLOID, V8, P94, DOI 10.3109/13506120109007350; Jahn TR, 2008, J BIOL CHEM, V283, P17279, DOI 10.1074/jbc.M710351200; Kad NM, 2001, J MOL BIOL, V313, P559, DOI 10.1006/jmbi.2001.5071; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Knight JD, 2004, J MOL BIOL, V341, P1175, DOI 10.1016/j.jmb.2004.06.086; Lee HG, 2004, J ALZHEIMERS DIS, V6, P137; Lee S, 2007, PROTEIN SCI, V16, P723, DOI 10.1110/ps.062514807; Lee YH, 2009, J BIOL CHEM, V284, P2169, DOI 10.1074/jbc.M806939200; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Linse S, 2007, P NATL ACAD SCI USA, V104, P8691, DOI 10.1073/pnas.0701250104; Lynch I., 2006, DETECTING CRYPTIC EP, V2006, DOI [10.1126/stke.3272006pe14, DOI 10.1126/STKE.3272006PE14]; Martins IC, 2008, EMBO J, V27, P224, DOI 10.1038/sj.emboj.7601953; Meinhardt J, 2009, J MOL BIOL, V386, P869, DOI 10.1016/j.jmb.2008.11.005; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Morten IJ, 2007, J BIOL CHEM, V282, P29691, DOI 10.1074/jbc.M705004200; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; Paravastu AK, 2009, P NATL ACAD SCI USA, V106, P7443, DOI 10.1073/pnas.0812033106; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Pieri L, 2006, J BIOL CHEM, V281, P15337, DOI 10.1074/jbc.M511647200; PRESS WH, 2002, NUMERICAL RECIPES C, P666; Reixach N, 2004, P NATL ACAD SCI USA, V101, P2817, DOI 10.1073/pnas.0400062101; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Smith AM, 2006, J MOL BIOL, V364, P9, DOI 10.1016/j.jmb.2006.08.081; Smith DP, 2003, J MOL BIOL, V330, P943, DOI 10.1016/S0022-2836(03)00687-9; Smith JF, 2006, P NATL ACAD SCI USA, V103, P15806, DOI 10.1073/pnas.0604035103; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; van der Wel PCA, 2007, J AM CHEM SOC, V129, P5117, DOI 10.1021/ja068633m; Xue WF, 2008, P NATL ACAD SCI USA, V105, P8926, DOI 10.1073/pnas.0711664105; Xue WF, 2009, PROTEIN ENG DES SEL, V22, P489, DOI 10.1093/protein/gzp026	48	283	288	0	63	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34272	34282		10.1074/jbc.M109.049809	http://dx.doi.org/10.1074/jbc.M109.049809			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19808677	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000272165200058
J	Chang, CW; Tsai, WH; Chuang, WJ; Lin, YS; Wu, JJ; Liu, CC; Tsai, PJ; Lin, MT				Chang, Chia-Wen; Tsai, Wan-Hua; Chuang, Woei-Jer; Lin, Yee-Shin; Wu, Jiunn-Jong; Liu, Ching-Chuan; Tsai, Pei-Jane; Lin, Ming T.			Procaspase 8 and Bax Are Up-regulated by Distinct Pathways in Streptococcal Pyrogenic Exotoxin B-induced Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-INDUCED APOPTOSIS; SHOCK-LIKE SYNDROME; PROTEIN-KINASE; INTERFERON-GAMMA; GENE-EXPRESSION; DEPENDENT PATHWAY; A549 CELLS; TOXIN-A; ACTIVATION; INDUCTION	We have previously identified integrin alpha(v)beta(3) and Fas as receptors for the streptococcal pyrogenic exotoxin B (SPE B), and G308S, a mutant of SPE B that binds to Fas only. In the current study we found that after binding to alpha(v)beta(3), SPE B stimulated the tyrosine phosphorylation of JAK2 and STAT1. STAT1 tyrosine phosphorylation was inhibited by a JAK2 inhibitor, AG490, short interfering RNA(siRNA) silencing of JAK2, and anti-alpha(v)beta(3) antibody. AG490 also decreased the binding of tyrosine-phosphorylated STAT1 to the procaspase 8 promoter, decreasing procaspase 8 expression, suggesting that SPE B up-regulates procaspase 8 expression via the JAK2/STAT1 pathway. Alternatively, both SPEB and G308S increased STAT1 phosphorylation at serine 727, which was inhibited by anti-Fas antibody, a p38 inhibitor, SB203580, and siRNA silencing of p38. In addition, SPE B and G308S increased binding of serine-phosphorylated STAT1 to the Bax promoter and Bax expression, which was decreased by SB203580. SPE B and G308S-stimulated Bax expression was also inhibited by anti-Fas antibody. These findings suggest that Fas mediate SPE B-induced Bax expression through p38. Silencing of JAK2 or p38 by siRNA blocked procaspase 8 expression, whereas only p38 siRNA decreased Bax expression. Furthermore, JAK2 inhibition and p38 inhibition reduced SPE B-induced apoptosis, but only p38 inhibition blocked G308S-induced apoptosis.	[Lin, Ming T.] Tzu Chi Univ, Sch Med, Inst Med Sci, Hualien 97004, Taiwan; [Chang, Chia-Wen; Tsai, Wan-Hua; Chuang, Woei-Jer; Lin, Yee-Shin; Wu, Jiunn-Jong] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 701, Taiwan; [Chang, Chia-Wen; Tsai, Wan-Hua; Chuang, Woei-Jer] Natl Cheng Kung Univ, Coll Med, Dept Biochem, Tainan 701, Taiwan; [Lin, Yee-Shin] Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan 701, Taiwan; [Wu, Jiunn-Jong; Tsai, Pei-Jane] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan 701, Taiwan; [Liu, Ching-Chuan] Natl Cheng Kung Univ, Coll Med, Dept Pediat, Tainan 701, Taiwan; [Tsai, Pei-Jane] Natl Lab Anim Ctr, Natl Appl Res Labs, Taipei 115, Taiwan	Tzu Chi University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Applied Research Laboratories - Taiwan	Lin, MT (corresponding author), Tzu Chi Univ, Sch Med, Inst Med Sci, Hualien 97004, Taiwan.	lin1223@mail.tcu.edu	Wu, Jiunn-Jong/E-6075-2011; Tsai, Pei-Jane/G-3563-2011		National Health Research Institute [NHRI-EX 96-9027SP]; National Science Council, Taiwan [NSC96-2745B-320-003-URD]	National Health Research Institute(National Health Research Institutes - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by National Health Research Institute Grant NHRI-EX 96-9027SP and the National Science Council Grant NSC96-2745B-320-003-URD, Taiwan.	Aiyar A, 1996, Methods Mol Biol, V57, P177; Battle T. E., 2002, Current Molecular Medicine (Hilversum), V2, P381, DOI 10.2174/1566524023362456; Bentley CC, 2005, CELL MICROBIOL, V7, P945, DOI 10.1111/j.1462-5822.2005.00525.x; Brizzi MF, 1999, MOL BIOL CELL, V10, P3463, DOI 10.1091/mbc.10.10.3463; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Chang CW, 2007, J BIOMED SCI, V14, P419, DOI 10.1007/s11373-007-9154-6; CHAUSSEE MS, 1993, INFECT IMMUN, V61, P3719, DOI 10.1128/IAI.61.9.3719-3723.1993; Chen CY, 2003, J BIOL CHEM, V278, P17336, DOI 10.1074/jbc.M209038200; Dai CH, 1999, BLOOD, V93, P3309, DOI 10.1182/blood.V93.10.3309.410k04_3309_3316; De Zutter GS, 2001, P NATL ACAD SCI USA, V98, P6168, DOI 10.1073/pnas.111027698; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; Fu XY, 1999, CELL DEATH DIFFER, V6, P1201, DOI 10.1038/sj.cdd.4400613; HAUSER AR, 1990, J BACTERIOL, V172, P4536, DOI 10.1128/jb.172.8.4536-4542.1990; Holmstrom TH, 1999, MOL CELL BIOL, V19, P5991; Huang YQ, 2000, J BIOL CHEM, V275, P6462, DOI 10.1074/jbc.275.9.6462; IHLE JN, 1995, TRENDS GENET, V11, P69, DOI 10.1016/S0168-9525(00)89000-9; Ihle JN, 2001, CURR OPIN CELL BIOL, V13, P211, DOI 10.1016/S0955-0674(00)00199-X; Kim H, 2005, GASTROENTEROLOGY, V129, P1875, DOI 10.1053/j.gastro.2005.09.011; Kim JM, 1998, J CLIN INVEST, V102, P1815, DOI 10.1172/JCI2466; Kumar A, 1997, SCIENCE, V278, P1630, DOI 10.1126/science.278.5343.1630; Kuo CF, 1998, INFECT IMMUN, V66, P3931, DOI 10.1128/IAI.66.8.3931-3935.1998; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Medan D, 2002, J CELL PHYSIOL, V191, P320, DOI 10.1002/jcp.10105; Meistey N, 2007, EUR J CANCER, V43, P1833, DOI 10.1016/j.ejca.2007.05.028; Minami M, 1996, P NATL ACAD SCI USA, V93, P3963, DOI 10.1073/pnas.93.9.3963; MUSSER JM, 1991, P NATL ACAD SCI USA, V88, P2668, DOI 10.1073/pnas.88.7.2668; Ossina NK, 1997, J BIOL CHEM, V272, P16351, DOI 10.1074/jbc.272.26.16351; Porras A, 2004, MOL BIOL CELL, V15, P922, DOI 10.1091/mbc.E03-08-0592; Refaeli Y, 2002, J EXP MED, V196, P999, DOI 10.1084/JEM.20020666; Sarkar D, 2002, P NATL ACAD SCI USA, V99, P10054, DOI 10.1073/pnas.152327199; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; Schlievert PM, 1996, J LAB CLIN MED, V127, P13, DOI 10.1016/S0022-2143(96)90161-4; Stephanou A, 2000, J BIOL CHEM, V275, P10002, DOI 10.1074/jbc.275.14.10002; STEVENS DL, 1989, NEW ENGL J MED, V321, P1, DOI 10.1056/NEJM198907063210101; Thornborrow EC, 2001, J BIOL CHEM, V276, P15598, DOI 10.1074/jbc.M011643200; Timmer AM, 2009, J BIOL CHEM, V284, P862, DOI 10.1074/jbc.M804632200; Townsend PA, 2004, J BIOL CHEM, V279, P5811, DOI 10.1074/jbc.M302637200; Tsai WH, 2008, INFECT IMMUN, V76, P1349, DOI 10.1128/IAI.01162-07; Tsai WH, 2004, INFECT IMMUN, V72, P7055, DOI 10.1128/IAI.72.12.7055-7062.2004; Wang HY, 2007, APOPTOSIS, V12, P535, DOI 10.1007/s10495-006-0008-x; Wang YB, 1998, J BIOL CHEM, V273, P2161, DOI 10.1074/jbc.273.4.2161; Zhuang SG, 2000, J BIOL CHEM, V275, P25939, DOI 10.1074/jbc.M001185200	42	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33195	33205		10.1074/jbc.M109.020586	http://dx.doi.org/10.1074/jbc.M109.020586			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801665	Green Published, hybrid			2022-12-27	WOS:000272028500024
J	Pillai, BK; Jasuja, R; Simard, JR; Hamilton, JA				Pillai, Biju K.; Jasuja, Ravi; Simard, Jeffrey R.; Hamilton, James A.			Fast Diffusion of Very Long Chain Saturated Fatty Acids across a Bilayer Membrane and Their Rapid Extraction by Cyclodextrins IMPLICATIONS FOR ADRENOLEUKODYSTROPHY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-LINKED ADRENOLEUKODYSTROPHY; FAST FLIP-FLOP; CELLULAR CHOLESTEROL; MODEL MEMBRANES; BETA-OXIDATION; SERUM-ALBUMIN; LORENZOS OIL; PHOSPHOLIPID-MEMBRANES; PEROXISOMAL DISORDERS; FLUORESCENT-PROBE	Abnormalities in the transport of saturated very long chain fatty acids (LCFA; >C18:0) contribute to their toxic levels in peroxisomal disorders of fatty acid metabolism, such as adrenoleukodystrophy and adrenomyeloneuropathy. We previously showed that VLCFA desorb much slower than normal dietary fatty acids from both albumin and protein-free lipid bilayers. The important step of transbilayer movement (flip-flop) was not measured directly as a consequence of this very slow desorption from donors, and the extremely low aqueous solubility of VLCFA precludes addition of unbound VLCFA to lipid membranes. We have overcome these limitations using methyl-beta-cyclodextrin to solubilize VLCFA for rapid delivery to "acceptor" phosphatidylcholine vesicles (small and large unilamellar) and to cells. VLCFA binding was monitored in real time with the fluorescent probe fluorescein-labeled phosphatidylethanolamine in the outer membrane leaflet, and entrapped pyranine was used to detect flip-flop across the membrane. The upper limit of the rate of flip-flop across the membrane was independent of temperature and media viscosity and was similar for model raft and non-raft membranes as well as living cells. We further showed that cyclodextrins can extract VLCFA rapidly (within seconds) from vesicles and cells, which have implications for the mechanism and potential alternative approaches to treat adrenoleukodystrophy. Because VLCFA diffuse through the lipid bilayer, proteins may not be required for their transport across the peroxisomal membrane.	[Pillai, Biju K.; Simard, Jeffrey R.; Hamilton, James A.] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA; [Jasuja, Ravi] Boston Univ, Sch Med, Sect Endocrinol Diabet & Nutr, Boston, MA 02118 USA; [Simard, Jeffrey R.] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA; [Hamilton, James A.] Boston Univ, Dept Biomed Engn, Boston, MA 02118 USA	Boston University; Boston University; Boston University; Boston University	Hamilton, JA (corresponding author), Boston Univ, Sch Med, Dept Physiol & Biophys, 715 Albany St, Boston, MA 02118 USA.	jhamilt@bu.edu		Hamilton, James/0000-0002-4747-7071	National Institutes of Health [NHLBI 2P01 HL26335-21]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL026335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant NHLBI 2P01 HL26335-21.	Asawakarn T, 2001, J BIOL CHEM, V276, P38457, DOI 10.1074/jbc.M103269200; Bondar OP, 1999, BIOPHYS J, V76, P956, DOI 10.1016/S0006-3495(99)77259-0; BOYLAN JG, 1992, BIOCHEMISTRY-US, V31, P557, DOI 10.1021/bi00117a037; Brunaldi K, 2010, J LIPID RES, V51, P120, DOI [10.1194/M900200-JLR200, 10.1194/jlr.M900200-JLR200]; Camargo F, 2001, LIFE SCI, V70, P131, DOI 10.1016/S0024-3205(01)01384-4; CARTIER N, 1995, P NATL ACAD SCI USA, V92, P1674, DOI 10.1073/pnas.92.5.1674; Choi JK, 2002, J LIPID RES, V43, P1000, DOI 10.1194/jlr.M200041-JLR200; Corzo D, 2002, AM J HUM GENET, V70, P1520, DOI 10.1086/340849; Covey SD, 2007, BIOCHEM BIOPH RES CO, V355, P67, DOI 10.1016/j.bbrc.2007.01.135; Deon M, 2008, METAB BRAIN DIS, V23, P43, DOI 10.1007/s11011-007-9079-9; DiBiase A, 1997, NEUROCHEM RES, V22, P327, DOI 10.1023/A:1022451108063; Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0; Eichler FS, 2008, ANN NEUROL, V63, P729, DOI 10.1002/ana.21391; Frank PG, 2002, BIOCHEMISTRY-US, V41, P11931, DOI 10.1021/bi0257078; Grkovic Sanja, 2007, Med Pregl, V60, P401; Hamilton JA, 2003, CURR OPIN LIPIDOL, V14, P263, DOI 10.1097/00041433-200306000-00006; Hamilton JA, 2007, J MOL NEUROSCI, V33, P12, DOI 10.1007/s12031-007-0050-3; Hein S, 2008, HUM MOL GENET, V17, P1750, DOI 10.1093/hmg/ddn066; Heinzer AK, 2003, HUM MOL GENET, V12, P1145, DOI 10.1093/hmg/ddg126; Hettema EH, 2000, BBA-MOL CELL BIOL L, V1486, P18, DOI 10.1016/S1388-1981(00)00045-7; HO JK, 1995, J CLIN INVEST, V96, P1455, DOI 10.1172/JCI118182; Kamp F, 2003, J BIOL CHEM, V278, P7988, DOI 10.1074/jbc.M206648200; KAMP F, 1995, BIOCHEMISTRY-US, V34, P11928, DOI 10.1021/bi00037a034; KAMP F, 1992, P NATL ACAD SCI USA, V89, P11367, DOI 10.1073/pnas.89.23.11367; Kemp S, 2005, MOL GENET METAB, V84, P144, DOI 10.1016/j.ymgme.2004.09.015; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Kleinfeld AM, 1997, BIOCHEMISTRY-US, V36, P14146, DOI 10.1021/bi971440e; Klymchenko AS, 2004, BIOPHYS J, V86, P2929, DOI 10.1016/S0006-3495(04)74344-1; Krasnowska EK, 1998, BIOPHYS J, V74, P1984, DOI 10.1016/S0006-3495(98)77905-6; Krasnowska EK, 2001, BBA-BIOMEMBRANES, V1511, P330, DOI 10.1016/S0005-2736(01)00286-3; Kritharides L, 1996, J BIOL CHEM, V271, P27450, DOI 10.1074/jbc.271.44.27450; Liu B, 2009, P NATL ACAD SCI USA, V106, P2377, DOI 10.1073/pnas.0810895106; MACGREGOR RB, 1986, NATURE, V319, P70, DOI 10.1038/319070a0; MASSEY JB, 1985, BIOCHEMISTRY-US, V24, P6973, DOI 10.1021/bi00345a033; Meshulam T, 2006, BIOCHEMISTRY-US, V45, P2882, DOI 10.1021/bi051999b; Moser HW, 2007, J MOL NEUROSCI, V33, P105, DOI 10.1007/s12031-007-0041-4; MOSER HW, 1995, ANNU REV NUTR, V15, P379, DOI 10.1146/annurev.nu.15.070195.002115; Moser HW, 1996, LIPIDS, V31, pS141, DOI 10.1007/BF02637066; MOSER HW, 1995, J NEUROPATH EXP NEUR, V54, P740, DOI 10.1097/00005072-199509000-00017; OROSZ DE, 1993, ANAL BIOCHEM, V210, P7, DOI 10.1006/abio.1993.1143; PoggiTravert F, 1995, J INHERIT METAB DIS, V18, P1, DOI 10.1007/BF00711425; Putzel GG, 2009, BIOPHYS J, V96, P4935, DOI 10.1016/j.bpj.2009.04.019; Rawicz W, 2008, BIOPHYS J, V94, P4725, DOI 10.1529/biophysj.107.121731; Rawyler A, 1996, BBA-BIOMEMBRANES, V1278, P89, DOI 10.1016/0005-2736(95)00190-5; Simard JR, 2008, BIOCHEMISTRY-US, V47, P9081, DOI 10.1021/bi800697q; Simard JR, 2008, BIOPHYS J, V94, P4493, DOI 10.1529/biophysj.107.121186; SIMARD JR, 2009, J LIPID RES, DOI DOI 10.1194/JLR.M900251-JLR200; SINGH H, 1987, ARCH BIOCHEM BIOPHYS, V257, P302, DOI 10.1016/0003-9861(87)90570-4; SINGH H, 1987, ARCH BIOCHEM BIOPHYS, V259, P382, DOI 10.1016/0003-9861(87)90504-2; SINGH H, 1987, ARCH BIOCHEM BIOPHYS, V254, P526, DOI 10.1016/0003-9861(87)90133-0; Steinberg S., 2008, CURR PROTOC HUM GENE; Tamai N, 2008, COLLOID SURFACE B, V65, P213, DOI 10.1016/j.colsurfb.2008.04.004; THEDA C, 1992, J NEUROL SCI, V110, P195, DOI 10.1016/0022-510X(92)90028-J; van Geel BM, 1999, J NEUROL NEUROSUR PS, V67, P290, DOI 10.1136/jnnp.67.3.290; van Roermund CWT, 2008, FASEB J, V22, P4201, DOI 10.1096/fj.08-110866; VEERKAMP JH, 1995, PROG LIPID RES, V34, P17, DOI 10.1016/0163-7827(94)00005-7; WALL J, 1995, MOL MEMBR BIOL, V12, P183, DOI 10.3109/09687689509027506; WEBER G, 1979, BIOCHEMISTRY-US, V18, P3075, DOI 10.1021/bi00581a025; WHITCOMB RW, 1988, J CLIN INVEST, V81, P185, DOI 10.1172/JCI113292; Wilson-Ashworth HA, 2006, BIOPHYS J, V91, P4091, DOI 10.1529/biophysj.106.090860; Yancey PG, 1996, J BIOL CHEM, V271, P16026, DOI 10.1074/jbc.271.27.16026; Zhang FL, 1996, BIOCHEMISTRY-US, V35, P16055, DOI 10.1021/bi961685b	62	18	21	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33296	33304		10.1074/jbc.M109.043737	http://dx.doi.org/10.1074/jbc.M109.043737			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801636	Green Published, hybrid			2022-12-27	WOS:000272028500034
J	Tiedemann, K; Hussein, O; Sadvakassova, G; Guo, YB; Siegel, PM; Komarova, SV				Tiedemann, Kerstin; Hussein, Osama; Sadvakassova, Gulzhakhan; Guo, Yubin; Siegel, Peter M.; Komarova, Svetlana V.			Breast Cancer-derived Factors Stimulate Osteoclastogenesis through the Ca2+/Protein Kinase C and Transforming Growth Factor-beta/MAPK Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY-TUMOR GROWTH; FACTOR-KAPPA-B; TGF-BETA; PROSTATE-CANCER; DEPENDENT MECHANISM; RECEPTOR ACTIVATOR; BONE METASTASIS; GIANT-CELLS; RANK LIGAND; IN-VITRO	Breast cancer commonly metastasizes to bone where its growth depends on the action of bone-resorbing osteoclasts. We have previously shown that breast cancer cells secrete factors able to directly stimulate osteoclastogenesis from receptor activator of nuclear factor kappa B ligand (RANKL)-primed precursors and that transforming growth factor-beta (TGF beta) plays a permissive role in this process. Now, we evaluate the signaling events triggered in osteoclast precursors by soluble factors produced by MDA-MB-231-human breast carcinoma cells. In mouse bone marrow cultures and RAW 264.7 murine monocytic cells, MDA-MB-231-derived factors increased osteoclast number, size, and nucleation. These factors failed to induce Smad2 phosphorylation, and short interfering RNAs against Smad4 did not affect their ability to induce osteoclastogenesis. In contrast, MDA-MB-231 factors induced phosphorylation of p38 and ERK1/2, and pharmacological inhibitors against p38 (SB203580) and MEK1/2(PD98059) impeded the osteoclastogenic effects of cancer-derived factors. Neutralizing antibodies against TGF beta attenuated p38 activation, whereas activation of ERK1/2 was shortened in duration, but not decreased in amplitude. ERK1/2 phosphorylation induced by cancer-derived factors was blocked by MEK1/2 inhibitor, but not by Ras (manumycin A) or Raf (GW5074) inhibitors. Inhibition of protein kinase C alpha using Go6976 prevented both ERK1/2 phosphorylation and osteoclast formation in response to MDA-MB-231-derived factors. Using microspectrofluorimetry of fura-2-AM-loaded osteoclast precursors, we have found that cancer-derived factors, similar to RANKL, induced sustained oscillations in cytosolic free calcium. The calcium chelator BAPTA prevented calcium elevations and osteoclast formation in response to MDA-MB-231-derived factors. Thus, we have shown that breast cancer-derived factors induce osteoclastogenesis through the activation of calcium/protein kinase C alpha and TGF beta-dependent ERK1/2 and p38 signaling pathways.	[Tiedemann, Kerstin; Hussein, Osama; Sadvakassova, Gulzhakhan; Guo, Yubin; Komarova, Svetlana V.] McGill Univ, Fac Dent, Montreal, PQ H3A 2B2, Canada; [Siegel, Peter M.] McGill Univ, Goodman Canc Ctr, Montreal, PQ H3A 2B2, Canada; [Siegel, Peter M.] McGill Univ, Dept Biochem, Montreal, PQ H3A 2B2, Canada; [Siegel, Peter M.; Komarova, Svetlana V.] McGill Univ, Dept Med, Montreal, PQ H3A 2B2, Canada	McGill University; McGill University; McGill University; McGill University	Komarova, SV (corresponding author), McGill Univ, Fac Dent, 740 Dr Penfield Ave, Montreal, PQ H3A 1A4, Canada.	svetlana.komarova@mcgill.ca	Hussein, Osama/AAA-2620-2019; Tiedemann, one/A-9739-2016	Hussein, Osama/0000-0002-9563-0528; 	Government of Quebec; Lloyd-Carr Harris Fellowship; McGill University	Government of Quebec; Lloyd-Carr Harris Fellowship; McGill University	Supported by Government of Quebec's Merit Doctoral Research Scholarship Program, by Lloyd-Carr Harris Fellowship, and by McGill University.	Akchurin T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002104; Armstrong S, 2009, J CELL SCI, V122, P136, DOI 10.1242/jcs.031534; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Bandyopadhyay A, 2006, CANCER RES, V66, P6714, DOI 10.1158/0008-5472.CAN-05-3565; Barrett JM, 2006, PROSTATE, V66, P632, DOI 10.1002/pros.20370; Besse A, 2007, J BIOL CHEM, V282, P3918, DOI 10.1074/jbc.M608867200; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Chow JYC, 2008, AM J PHYSIOL-GASTR L, V294, pG899, DOI 10.1152/ajpgi.00411.2007; Coleman RE, 2006, CLIN CANCER RES, V12, p6243S, DOI 10.1158/1078-0432.CCR-06-0931; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Dehvari N, 2008, NEUROSCI LETT, V436, P77, DOI 10.1016/j.neulet.2008.02.063; Ehata S, 2007, CANCER SCI, V98, P127, DOI 10.1111/j.1349-7006.2006.00357.x; Fili S, 2009, CANCER LETT, V283, P10, DOI 10.1016/j.canlet.2009.01.011; Futakuchi M, 2009, CANCER SCI, V100, P71, DOI 10.1111/j.1349-7006.2008.01012.x; Galliher-Beckley AJ, 2008, CARCINOGENESIS, V29, P244, DOI 10.1093/carcin/bgm245; Gingery A, 2003, J CELL BIOCHEM, V89, P165, DOI 10.1002/jcb.10503; Guise Theresa A., 2000, Cancer, V88, P2892, DOI 10.1002/1097-0142(20000615)88:12+<2892::AID-CNCR2>3.0.CO;2-Y; Guo YB, 2008, BONE, V43, P386, DOI 10.1016/j.bone.2008.03.026; Hotokezaka H, 2002, J BIOL CHEM, V277, P47366, DOI 10.1074/jbc.M208284200; Huang H, 2006, CELL DEATH DIFFER, V13, P1879, DOI 10.1038/sj.cdd.4401882; Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200; Ishii M, 2008, MOD RHEUMATOL, V18, P220, DOI 10.1007/s10165-008-0051-2; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kalikin LM, 2003, CANCER BIOL THER, V2, P656; KAYE M, 1985, KIDNEY INT, V27, P574, DOI 10.1038/ki.1985.49; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Komarova SV, 2003, CALCIFIED TISSUE INT, V73, P265, DOI 10.1007/s00223-002-1051-4; Komarova SV, 2003, J BIOL CHEM, V278, P8286, DOI 10.1074/jbc.M206421200; KRISHNAMURTHY GT, 1977, JAMA-J AM MED ASSOC, V237, P2504, DOI 10.1001/jama.237.23.2504; Kukita T, 2004, J EXP MED, V200, P941, DOI 10.1084/jem.20040518; Lee MK, 2007, EMBO J, V26, P3957, DOI 10.1038/sj.emboj.7601818; Lee SE, 2001, J BIOL CHEM, V276, P49343, DOI 10.1074/jbc.M103642200; Lee SW, 2003, BONE, V32, P217, DOI 10.1016/S8756-3282(02)00976-6; Lee ZH, 2003, BIOCHEM BIOPH RES CO, V305, P211, DOI 10.1016/S0006-291X(03)00695-8; Lees RL, 2001, BONE, V28, P187, DOI 10.1016/S8756-3282(00)00433-6; MAKRIS GP, 1982, ARCH ORAL BIOL, V27, P965, DOI 10.1016/0003-9969(82)90104-2; Manolson MF, 2003, J BIOL CHEM, V278, P49271, DOI 10.1074/jbc.M309914200; Mourskaia AA, 2009, ONCOGENE, V28, P1005, DOI 10.1038/onc.2008.454; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Mundy GR, 1997, CANCER-AM CANCER SOC, V80, P1546, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1546::AID-CNCR4>3.3.CO;2-R; Nakamura H, 2003, J BONE MINER RES, V18, P1198, DOI 10.1359/jbmr.2003.18.7.1198; Nishihara M, 2007, INT IMMUNOL, V19, P695, DOI 10.1093/intimm/dxm045; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; Oyajobi BO, 2003, CANCER-AM CANCER SOC, V97, P813, DOI 10.1002/cncr.11133; Pereverzev A, 2008, BONE, V42, P150, DOI 10.1016/j.bone.2007.08.044; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Roodman GD, 2008, CANCER TREAT REV, V34, P92, DOI 10.1016/j.ctrv.2007.09.002; Rucci N, 2005, J CELL SCI, V118, P3263, DOI 10.1242/jcs.02436; Schneider A, 2005, ENDOCRINOLOGY, V146, P1727, DOI 10.1210/en.2004-1211; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shinohara M, 2008, CELL, V132, P794, DOI 10.1016/j.cell.2007.12.037; Siclari VA, 2006, CANCER METAST REV, V25, P621, DOI 10.1007/s10555-006-9023-1; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Trebec DP, 2007, J CELL BIOCHEM, V101, P205, DOI 10.1002/jcb.21171; van der Westhuizen ET, 2007, MOL PHARMACOL, V71, P1618, DOI 10.1124/mol.106.032763; Vignery A, 2005, J EXP MED, V202, P337, DOI 10.1084/jem.20051123; Wu WS, 2006, CANCER LETT, V239, P27, DOI 10.1016/j.canlet.2005.07.034; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	61	33	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33662	33670		10.1074/jbc.M109.010785	http://dx.doi.org/10.1074/jbc.M109.010785			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801662	hybrid, Green Published			2022-12-27	WOS:000272028500070
J	Halskau, O; Ying, M; Baumann, A; Kleppe, R; Rodriguez-Larrea, D; Almas, B; Haavik, J; Martinez, A				Halskau, Oyvind, Jr.; Ying, Ming; Baumann, Anne; Kleppe, Rune; Rodriguez-Larrea, David; Almas, Bjorg; Haavik, Jan; Martinez, Aurora			Three-way Interaction between 14-3-3 Proteins, the N-terminal Region of Tyrosine Hydroxylase, and Negatively Charged Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE-PLASMON RESONANCE; ADRENAL CHROMAFFIN CELLS; SUBCELLULAR-LOCALIZATION; PHOSPHOLIPID BICELLES; AMPHITROPIC PROTEINS; ALPHA-LACTALBUMIN; REGULATORY DOMAIN; STRUCTURAL BASIS; SENSOR CHIP; BINDING	Tyrosine hydroxylase (TH), the rate-limiting enzyme in the synthesis of catecholamines, is activated by phosphorylation-dependent binding to 14-3-3 proteins. The N-terminal domain of TH is also involved in interaction with lipid membranes. We investigated the binding of the N-terminal domain to its different partners, both in the unphosphorylated (TH-(1-43)) and Ser(19)-phosphorylated (THp-(1-43)) states by surface plasmon resonance. THp-(1-43) showed high affinity for 14-3-3 proteins (K-d similar to 0.5 mu M for 14-3-3 gamma and -zeta and 7 mu M for 14-3-3 eta). The domains also bind to negatively charged membranes with intermediate affinity (concentration at half-maximal binding S-0.5 = 25-58 mu M (TH-(1-43)) and S-0.5 = 135-475 mu M (THp-(1-43)), depending on phospholipid composition) and concomitant formation of helical structure. 14-3-3 gamma showed a preferential binding to membranes, compared with 14-3-3 zeta, both in chromaffin granules and with liposomes at neutral pH. The affinity of 14-3-3 gamma for negatively charged membranes (S-0.5 = 1-9 mu M) is much higher than the affinity of TH for the same membranes, compatible with the formation of a ternary complex between Ser(19)-phosphorylated TH, 14-3-3 gamma, and membranes. Our results shed light on interaction mechanisms that might be relevant for the modulation of the distribution of TH in the cytoplasm and membrane fractions and regulation of L-DOPA and dopamine synthesis.	[Halskau, Oyvind, Jr.; Ying, Ming; Baumann, Anne; Kleppe, Rune; Haavik, Jan; Martinez, Aurora] Univ Bergen, Dept Biomed, N-5009 Bergen, Norway; [Almas, Bjorg] Haukeland Hosp, Hormone Lab, N-5021 Bergen, Norway; [Rodriguez-Larrea, David] Univ Granada, Fac Ciencias, Dept Quim Fis, E-18071 Granada, Spain	University of Bergen; University of Bergen; Haukeland University Hospital; University of Granada	Martinez, A (corresponding author), Univ Bergen, Dept Biomed, Jonas Lies Vei 91, N-5009 Bergen, Norway.	aurora.martinez@biomed.uib.no	Haavik, Jan/ABE-1535-2020; Martinez, Aurora/M-3088-2019; Haavik, Jan/AAI-3974-2020; Rodriguez-Larrea, David/ABH-3171-2020	Martinez, Aurora/0000-0003-1643-6506; Haavik, Jan/0000-0001-7865-2808; Rodriguez-Larrea, David/0000-0002-5580-7413; Halskau, Oyvind/0000-0003-2517-1060; Kleppe, Rune/0000-0002-6086-755X	Norwegian Cancer Society; Research Council of Norway; Helse-Vest	Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway(Research Council of Norway); Helse-Vest	This work was supported by grants from the Norwegian Cancer Society, the Research Council of Norway, and Helse-Vest.	Agasoster AV, 2003, J BIOL CHEM, V278, P21790, DOI 10.1074/jbc.M211466200; Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Benzinger A, 2005, MOL CELL PROTEOMICS, V4, P785, DOI 10.1074/mcp.M500021-MCP200; Besenicar M, 2006, CHEM PHYS LIPIDS, V141, P169, DOI 10.1016/j.chemphyslip.2006.02.010; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; BRIDGES D, 2005, SCI STKE, pRE10, DOI DOI 10.1126/STKE.2962005RE10; BURN P, 1988, TRENDS BIOCHEM SCI, V13, P79, DOI 10.1016/0968-0004(88)90043-6; Bustos DM, 2006, PROTEINS, V63, P35, DOI 10.1002/prot.20888; Chen R, 2003, J BIOMED SCI, V10, P774, DOI 10.1159/000073965; Cho WW, 2001, ANAL BIOCHEM, V296, P153, DOI 10.1006/abio.2001.5225; Clokie SJ, 2005, FEBS J, V272, P3767, DOI 10.1111/j.1742-4658.2005.04765.x; Cooper MA, 2000, ANAL BIOCHEM, V277, P196, DOI 10.1006/abio.1999.4389; Dunkley PR, 2004, J NEUROCHEM, V91, P1025, DOI 10.1111/j.1471-4159.2004.02797.x; Erb EM, 2000, ANAL BIOCHEM, V280, P29, DOI 10.1006/abio.1999.4469; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; Ginovart N, 1996, BRAIN RES, V719, P45, DOI 10.1016/0006-8993(96)00075-3; Glomm WR, 2007, J PHYS CHEM B, V111, P14329, DOI 10.1021/jp074839d; Glover KJ, 2001, BIOPHYS J, V81, P2163, DOI 10.1016/S0006-3495(01)75864-X; HAAVIK J, 1991, EUR J BIOCHEM, V199, P371, DOI 10.1111/j.1432-1033.1991.tb16133.x; HAAVIK J, 1980, J CHROMATOGR, V198, P511, DOI 10.1016/S0021-9673(00)80522-1; Halskau O, 2002, J MOL BIOL, V321, P99, DOI 10.1016/S0022-2836(02)00565-X; Hekman M, 2006, J BIOL CHEM, V281, P17321, DOI 10.1074/jbc.M600292200; Hermeking H, 2003, NAT REV CANCER, V3, P931, DOI 10.1038/nrc1230; Honing S, 2005, MOL CELL, V18, P519, DOI 10.1016/j.molcel.2005.04.019; Hurley JH, 2006, BBA-MOL CELL BIOL L, V1761, P805, DOI 10.1016/j.bbalip.2006.02.020; ICHIMURA T, 1987, FEBS LETT, V219, P79, DOI 10.1016/0014-5793(87)81194-8; Itagaki C, 1999, BIOCHEMISTRY-US, V38, P15673, DOI 10.1021/bi9914255; Johnson JE, 1999, MOL MEMBR BIOL, V16, P217, DOI 10.1080/096876899294544; Johnson JE, 2003, J BIOL CHEM, V278, P514, DOI 10.1074/jbc.M206072200; JONES DHA, 1995, J MOL BIOL, V245, P375, DOI 10.1006/jmbi.1994.0031; Kaufman S, 1995, Adv Enzymol Relat Areas Mol Biol, V70, P103; Kleppe R, 2001, J NEUROCHEM, V77, P1097, DOI 10.1046/j.1471-4159.2001.00318.x; Kokkinou I, 2009, BLOOD CELL MOL DIS, V42, P92, DOI 10.1016/j.bcmd.2008.10.010; KUCZENSKI RT, 1972, J BIOL CHEM, V247, P3114; KUHN DM, 1990, J BIOL CHEM, V265, P5780; Li ZG, 2008, P NATL ACAD SCI USA, V105, P162, DOI 10.1073/pnas.0710905105; Liang XB, 2008, J BIOL CHEM, V283, P27418, DOI 10.1074/jbc.M803687200; MARTIN H, 1994, J NEUROCHEM, V63, P2259; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; MAYER LD, 1985, BIOCHIM BIOPHYS ACTA, V817, P193, DOI 10.1016/0005-2736(85)90084-7; MCGEER EG, 1971, J NEUROCHEM, V18, P1647, DOI 10.1111/j.1471-4159.1971.tb03738.x; Meier S, 2006, J CHROMATOGR A, V1104, P291, DOI 10.1016/j.chroma.2005.11.045; Moreira JMA, 2008, MOL CELL PROTEOMICS, V7, P1225, DOI 10.1074/mcp.M700439-MCP200; MORGAN A, 1992, NATURE, V355, P833, DOI 10.1038/355833a0; MORITA K, 1994, NEUROCHEM INT, V25, P403, DOI 10.1016/0197-0186(94)90015-9; MORITA K, 1987, J BIOL CHEM, V262, P5654; Murphy KL, 2008, J BIOL CHEM, V283, P13216, DOI 10.1074/jbc.M706749200; Muslin AJ, 2000, CELL SIGNAL, V12, P703, DOI 10.1016/S0898-6568(00)00131-5; Ober RJ, 1999, ANAL BIOCHEM, V271, P70, DOI 10.1006/abio.1999.4129; Obsil T, 2001, CELL, V105, P257, DOI 10.1016/S0092-8674(01)00316-6; Obsilova V, 2008, BIOCHEMISTRY-US, V47, P1768, DOI 10.1021/bi7019468; Ottmann C, 2007, EMBO J, V26, P902, DOI 10.1038/sj.emboj.7601530; Poulikakos P, 2001, NEUROCHEM RES, V26, P479, DOI 10.1023/A:1010952610387; Rosenquist M, 2000, J MOL EVOL, V51, P446, DOI 10.1007/s002390010107; ROTH D, 1994, BIOCHEM J, V301, P305, DOI 10.1042/bj3010305; Schindler CK, 2006, J NEUROCHEM, V99, P561, DOI 10.1111/j.1471-4159.2006.04153.x; Strochlic L, 2004, P NATL ACAD SCI USA, V101, P18189, DOI 10.1073/pnas.0406905102; SUTHERLAND C, 1993, EUR J BIOCHEM, V217, P715, DOI 10.1111/j.1432-1033.1993.tb18297.x; TERLAND O, 1980, BIOCHIM BIOPHYS ACTA, V597, P318, DOI 10.1016/0005-2736(80)90109-1; Thorolfsson M, 2002, FEBS LETT, V519, P221, DOI 10.1016/S0014-5793(02)02745-X; Toska K, 2002, J NEUROCHEM, V83, P775, DOI 10.1046/j.1471-4159.2002.01172.x; TREIMAN M, 1983, J NEUROCHEM, V40, P661, DOI 10.1111/j.1471-4159.1983.tb08031.x; VANDERGOOT FG, 1991, NATURE, V354, P408, DOI 10.1038/354408a0; VAZ WLC, 1978, EUR J BIOCHEM, V83, P299, DOI 10.1111/j.1432-1033.1978.tb12094.x; Vold RR, 1997, J BIOMOL NMR, V9, P329, DOI 10.1023/A:1018643312309; VULLIET PR, 1984, J BIOL CHEM, V259, P3680; WEISSMANN D, 1989, J NEUROCHEM, V53, P793, DOI 10.1111/j.1471-4159.1989.tb11775.x; WESTHEAD EW, 1987, ANN NY ACAD SCI, V493, P92, DOI 10.1111/j.1749-6632.1987.tb27186.x; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Winge I, 2008, BIOCHEM J, V410, P195, DOI 10.1042/BJ20071033; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103	74	37	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32758	32769		10.1074/jbc.M109.027706	http://dx.doi.org/10.1074/jbc.M109.027706			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19801645	hybrid, Green Published			2022-12-27	WOS:000272028400061
J	Martin, S; Okano, S; Kistler, C; Fernandez-Rojo, MA; Hill, MM; Parton, RG				Martin, Sally; Okano, Satomi; Kistler, Carol; Fernandez-Rojo, Manuel A.; Hill, Michelle M.; Parton, Robert G.			Spatiotemporal Regulation of Early Lipolytic Signaling in Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-SENSITIVE LIPASE; KINASE ANCHORING PROTEINS; LIPID DROPLETS; 3T3-L1 ADIPOCYTES; PHOSPHORYLATION; IDENTIFICATION; TRANSLOCATION; STIMULATION; INSULIN; MECHANISM	Hormone-sensitive lipase (HSL) is a key enzyme regulating the acute activation of lipolysis. HSL functionality is controlled by multiple phosphorylation events, which regulate its association with the surface of lipid droplets (LDs). We determined the progression and stability of HSL phosphorylation on individual serine residues both spatially and temporally in adipocytes using phospho-specific antibodies. Within seconds of beta-adrenergic receptor activation, HSL was phosphorylated on Ser-660, the phosphorylated form appearing in the peripheral cytosol prior to rapid translocation to, and stable association with, LDs. In contrast, phosphorylation of HSL on Ser-563 was delayed, the phosphorylated protein was predominantly detected on LDs, and mutation of the Ser-659/Ser-660 site to Ala significantly reduced subsequent phosphorylation on Ser-563. Phosphorylation of HSL on Ser-565 was observed in control cells; the phosphorylated protein was translocated to LDs with similar kinetics to total HSL, and the degree of phosphorylation was inversely related to phospho-HSLSer-563. These results describe the remarkably rapid, sequential phosphorylation of specific serine residues in HSL at spatially distinct intracellular locales, providing new insight into the complex regulation of lipolysis.	[Martin, Sally; Okano, Satomi; Kistler, Carol; Fernandez-Rojo, Manuel A.; Hill, Michelle M.; Parton, Robert G.] Univ Queensland, Mol Cell Biol Div, Inst Mol Biosci, Brisbane, Qld 4072, Australia	University of Queensland	Martin, S (corresponding author), Univ Queensland, Mol Cell Biol Div, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	s.martin@uq.edu.au	Parton, Robert G/C-5673-2009; Hill, Michelle Mei Chih/G-4417-2010; Okano, Satomi/AAX-9546-2021; Martin, Sally/A-7150-2010	Parton, Robert G/0000-0002-7494-5248; Hill, Michelle Mei Chih/0000-0003-1134-0951; Okano, Satomi/0000-0003-4913-9612; Martin, Sally/0000-0001-9294-5404	National Health and Medical Research Council of Australia; Diabetes Australia Research Trust	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Diabetes Australia Research Trust	This work was supported by grants from the National Health and Medical Research Council of Australia (to R. G. P. and S. M.) and the Diabetes Australia Research Trust (to S. M.).	Anthonsen MW, 1998, J BIOL CHEM, V273, P215, DOI 10.1074/jbc.273.1.215; Beene DL, 2007, CURR OPIN CELL BIOL, V19, P192, DOI 10.1016/j.ceb.2007.02.011; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Brasaemle DL, 2000, BBA-MOL CELL BIOL L, V1483, P251, DOI 10.1016/S1388-1981(99)00179-1; Bridges D, 2006, BIOCHEM BIOPH RES CO, V346, P351, DOI 10.1016/j.bbrc.2006.05.138; Collins S, 2004, MOL ENDOCRINOL, V18, P2123, DOI 10.1210/me.2004-0193; Diviani D, 2008, CURR OPIN PHARMACOL, V8, P166, DOI 10.1016/j.coph.2007.11.001; EGAN JJ, 1992, P NATL ACAD SCI USA, V89, P8537, DOI 10.1073/pnas.89.18.8537; GARTON AJ, 1988, FEBS LETT, V229, P68, DOI 10.1016/0014-5793(88)80799-3; GARTON AJ, 1989, EUR J BIOCHEM, V179, P249, DOI 10.1111/j.1432-1033.1989.tb14548.x; Greenberg AS, 2001, J BIOL CHEM, V276, P45456, DOI 10.1074/jbc.M104436200; Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387; Harmer SC, 2008, J ENDOCRINOL, V196, P149, DOI 10.1677/JOE-07-0391; Langin D, 2006, PHARMACOL RES, V53, P482, DOI 10.1016/j.phrs.2006.03.009; Londos C, 1999, SEMIN CELL DEV BIOL, V10, P51, DOI 10.1006/scdb.1998.0275; Londos C, 1999, ANN NY ACAD SCI, V892, P155, DOI 10.1111/j.1749-6632.1999.tb07794.x; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Martin S, 2005, J BIOL CHEM, V280, P42325, DOI 10.1074/jbc.M506651200; Martin S, 2008, METHOD ENZYMOL, V438, P109, DOI 10.1016/S0076-6879(07)38008-7; Murphy DJ, 2001, PROG LIPID RES, V40, P325, DOI 10.1016/S0163-7827(01)00013-3; Shen WJ, 2000, BIOCHEMISTRY-US, V39, P2392, DOI 10.1021/bi992283h; STRALFORS P, 1984, P NATL ACAD SCI-BIOL, V81, P3317, DOI 10.1073/pnas.81.11.3317; STRALFORS P, 1989, EUR J BIOCHEM, V182, P379, DOI 10.1111/j.1432-1033.1989.tb14842.x; Su CL, 2003, J BIOL CHEM, V278, P43615, DOI 10.1074/jbc.M301809200; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Zechner R, 2009, J LIPID RES, V50, P3, DOI 10.1194/jlr.R800031-JLR200; Zhang J, 2005, NATURE, V437, P569, DOI 10.1038/nature04140	28	30	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					32097	32107		10.1074/jbc.M109.002675	http://dx.doi.org/10.1074/jbc.M109.002675			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19755426	Green Published, hybrid			2022-12-27	WOS:000271572700064
J	Duan, L; Chen, GS; Virmani, S; Ying, GG; Raja, SM; Chung, BM; Rainey, MA; Dimri, M; Ortega-Cava, CF; Zhao, XS; Clubb, RJ; Tu, C; Reddi, AL; Naramura, M; Band, V; Band, H				Duan, Lei; Chen, Gengsheng; Virmani, Sumeet; Ying, GuoGuang; Raja, Srikumar M.; Chung, Byung Min; Rainey, Mark A.; Dimri, Manjari; Ortega-Cava, Cesar F.; Zhao, Xiangshan; Clubb, Robert J.; Tu, Chun; Reddi, Alagarsamy L.; Naramura, Mayumi; Band, Vimla; Band, Hamid			Distinct Roles for Rho Versus Rac/Cdc42 GTPases Downstream of Vav2 in Regulating Mammary Epithelial Acinar Architecture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CELL ADHESION; GROWTH-FACTOR RECEPTORS; BASEMENT-MEMBRANE CULTURES; GTP-BINDING PROTEIN; HUMAN BREAST-CANCER; RAC1 SMALL GTPASES; MDCK CELLS; BRANCHING MORPHOGENESIS; NUCLEAR-ORGANIZATION; SIGNALING PATHWAYS	Non-malignant mammary epithelial cells (MECs) undergo acinar morphogenesis in three-dimensional Matrigel culture, a trait that is lost upon oncogenic transformation. Rho GTPases are thought to play important roles in regulating epithelial cell-cell junctions, but their contributions to acinar morphogenesis remain unclear. Here we report that the activity of Rho GTPases is down-regulated in non-malignant MECs in three-dimensional culture with particular suppression of Rac1 and Cdc42. Inducible expression of a constitutively active form of Vav2, a Rho GTPase guanine nucleotide exchange factor activated by receptor tyrosine kinases, in three-dimensional MEC culture activated Rac1 and Cdc42; Vav2 induction from early stages of culture impaired acinar morphogenesis, and induction in preformed acini disrupted the pre-established acinar architecture and led to cellular outgrowths. Knockdown studies demonstrated that Rac1 and Cdc42 mediate the constitutively active Vav2 phenotype, whereas in contrast, RhoA knockdown intensified the Vav2-induced disruption of acini, leading to more aggressive cell outgrowth and branching morphogenesis. These results indicate that RhoA plays an antagonistic role to Rac1/Cdc42 in the control of mammary epithelial acinar morphogenesis.	[Duan, Lei; Raja, Srikumar M.; Chung, Byung Min; Rainey, Mark A.; Ortega-Cava, Cesar F.; Clubb, Robert J.; Tu, Chun; Naramura, Mayumi; Band, Vimla; Band, Hamid] Univ Nebraska, Med Ctr, Eppley Inst Canc & Allied Dis, Omaha, NE 68198 USA; [Zhao, Xiangshan; Band, Vimla; Band, Hamid] Univ Nebraska, Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA; [Naramura, Mayumi; Band, Hamid] Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, Coll Med, Omaha, NE 68198 USA; [Band, Vimla; Band, Hamid] Univ Nebraska, Med Ctr, Eppley Canc Ctr, Omaha, NE 68198 USA; [Duan, Lei; Chen, Gengsheng; Virmani, Sumeet; Ying, GuoGuang; Raja, Srikumar M.; Chung, Byung Min; Rainey, Mark A.; Dimri, Manjari; Ortega-Cava, Cesar F.; Zhao, Xiangshan; Clubb, Robert J.; Tu, Chun; Reddi, Alagarsamy L.; Naramura, Mayumi; Band, Vimla; Band, Hamid] Northwestern Univ, Feinberg Sch Med, Dept Med, NorthShore Univ HealthSyst, Evanston, IL 60201 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; NorthShore University Health System; Northwestern University; Feinberg School of Medicine	Duan, L (corresponding author), Rush Univ, Dept Radiat Oncol, Med Ctr, 1750 W Harrison St,Jelke Bldg Rm 1306A, Chicago, IL 60612 USA.	lei_duan@rush.edu; vband@unmc.edu; hband@unmc.edu	Chung, Byung Min/H-6219-2019	Chung, Byung Min/0000-0003-1262-5107; Naramura, Mayumi/0000-0003-3658-0767	National Institutes of Health [CA105489, CA87986, CA99900, CA99163, CA116552, CA94143, CA96844]; Department of Defense Breast Cancer Research [W81XVVH-08-10617, W81XWH-05-1-0231, DAMD17-02-1-0508, W81XWH-07-1-0351]; Jean Ruggles-Romoser Chair of Cancer Research; Duckworth Family Chair of Breast Cancer Research; Nebraska Department of Health and Human Services [LB506]; University of Nebraska Medical Center-Eppley Cancer Center; NATIONAL CANCER INSTITUTE [R01CA087986, P30CA036727, R01CA099900, R01CA096844, R01CA094143, R01CA105489, R01CA116552, R01CA099163] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research(United States Department of Defense); Jean Ruggles-Romoser Chair of Cancer Research; Duckworth Family Chair of Breast Cancer Research; Nebraska Department of Health and Human Services; University of Nebraska Medical Center-Eppley Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA105489, CA87986, CA99900, CA99163, and CA116552 (to H.B.) and CA94143 and CA96844 (to V.B.). This work was also supported by Department of Defense Breast Cancer Research Grants W81XVVH-08-10617 (to H.B.), W81XWH-05-1-0231 (to V.B.), DAMD17-02-1-0508 (to V.B.), and W81XWH-07-1-0351 (to V.B.); the Jean Ruggles-Romoser Chair of Cancer Research (to H.B.); the Duckworth Family Chair of Breast Cancer Research (to V.B.); Nebraska Department of Health and Human Services Grant LB506 (to S.M.R.); and a Pilot Project grant from the University of Nebraska Medical Center-Eppley Cancer Center (to M.N.).	Abe K, 2000, J BIOL CHEM, V275, P10141, DOI 10.1074/jbc.275.14.10141; Adam L, 2001, J BIOL CHEM, V276, P28443, DOI 10.1074/jbc.M009769200; Ansquer Y, 2005, ANTICANCER RES, V25, P4535; Aranda V, 2006, NAT CELL BIOL, V8, P1235, DOI 10.1038/ncb1485; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; BAND V, 1989, P NATL ACAD SCI USA, V86, P1249, DOI 10.1073/pnas.86.4.1249; BARCELLOSHOFF MH, 1989, DEVELOPMENT, V105, P223; Bissell MJ, 1999, CANCER RES, V59, p1763S; Bissell MJ, 1999, CANCER RES, V59, p1757S; Braga VMM, 1997, J CELL BIOL, V137, P1421, DOI 10.1083/jcb.137.6.1421; Braga VMM, 2000, MOL BIOL CELL, V11, P3703, DOI 10.1091/mbc.11.11.3703; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dimri M, 2007, CANCER RES, V67, P4164, DOI 10.1158/0008-5472.CAN-06-2580; Ewald AJ, 2008, DEV CELL, V14, P570, DOI 10.1016/j.devcel.2008.03.003; Fernandez-Zapico ME, 2005, CANCER CELL, V7, P39, DOI 10.1016/j.ccr.2004.11.024; FLIER JS, 1989, NEW ENGL J MED, V321, P1383, DOI 10.1056/NEJM198911163212007; Fritz G, 2002, BRIT J CANCER, V87, P635, DOI 10.1038/sj.bjc.6600510; Fujita Y., 2005, NOVART FDN SYMP, V269; Fujita Y., 2005, NOVART FDN SYMP, V269, P223; Fujita Yasuyuki, 2005, Novartis Found Symp, V269, P144; Hornstein I, 2004, CELL SIGNAL, V16, P1, DOI 10.1016/S0898-6568(03)00110-4; Jou TS, 1998, J CELL BIOL, V142, P101, DOI 10.1083/jcb.142.1.101; Jou TS, 1998, J CELL BIOL, V142, P85, DOI 10.1083/jcb.142.1.85; Kamei T, 1999, ONCOGENE, V18, P6776, DOI 10.1038/sj.onc.1203114; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; KHAZAIE K, 1993, CANCER METAST REV, V12, P255, DOI 10.1007/BF00665957; Liu BP, 2000, MOL CELL BIOL, V20, P7160, DOI 10.1128/MCB.20.19.7160-7169.2000; Liu H, 2005, CELL CYCLE, V4, P646, DOI 10.4161/cc.4.5.1674; Liu H, 2004, J CELL BIOL, V164, P603, DOI 10.1083/jcb.200306090; Livasy CA, 2006, MODERN PATHOL, V19, P264, DOI 10.1038/modpathol.3800528; Magkou C, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2103; Malliri A, 2004, J BIOL CHEM, V279, P30092, DOI 10.1074/jbc.M401192200; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Miao H, 2003, J CELL BIOL, V162, P1281, DOI 10.1083/jcb.200304018; Mostov K, 2003, NAT CELL BIOL, V5, P287, DOI 10.1038/ncb0403-287; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; O'Brien LE, 2001, NAT CELL BIOL, V3, P831, DOI 10.1038/ncb0901-831; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Pandey A, 2000, P NATL ACAD SCI USA, V97, P179, DOI 10.1073/pnas.97.1.179; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Patton S, 1995, BBA-REV BIOMEMBRANES, V1241, P407, DOI 10.1016/0304-4157(95)00014-3; RAJKUMAR T, 1994, BREAST CANCER RES TR, V29, P3, DOI 10.1007/BF00666177; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; RIDLEY AJ, 1995, MOL CELL BIOL, V15, P1110; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Schiller MR, 2006, CELL SIGNAL, V18, P1834, DOI 10.1016/j.cellsig.2006.01.022; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Shaw KRM, 2004, J MAMMARY GLAND BIOL, V9, P297, DOI 10.1007/s10911-004-1402-z; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; TAKAISHI K, 1994, ONCOGENE, V9, P273; Takaishi K, 1997, J CELL BIOL, V139, P1047, DOI 10.1083/jcb.139.4.1047; Tamas P, 2003, J BIOL CHEM, V278, P5163, DOI 10.1074/jbc.M207555200; Van Aelst L, 2002, GENE DEV, V16, P1032, DOI 10.1101/gad.978802; Wang F, 1998, P NATL ACAD SCI USA, V95, P14821, DOI 10.1073/pnas.95.25.14821; Weaver VM, 1996, BIOCHEM CELL BIOL, V74, P833, DOI 10.1139/o96-089; WEAVER VM, 1995, SEMIN CANCER BIOL, V6, P175, DOI 10.1006/scbi.1995.0021; Wodarz A, 2007, NAT CELL BIOL, V9, P1016, DOI 10.1038/ncb433; Yahara I, 1996, CELL STRUCT FUNCT, V21, P421, DOI 10.1247/csf.21.421	64	22	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1555	1568		10.1074/jbc.M109.057976	http://dx.doi.org/10.1074/jbc.M109.057976			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19826000	hybrid, Green Published			2022-12-27	WOS:000273258200074
J	Cayli, S; Klug, J; Chapiro, J; Frohlich, S; Krasteva, G; Orel, L; Meinhardt, A				Cayli, Sevil; Klug, Joerg; Chapiro, Julius; Froehlich, Suada; Krasteva, Gabriela; Orel, Lukas; Meinhardt, Andreas			COP9 Signalosome Interacts ATP-dependently with p97/Valosin-containing Protein (VCP) and Controls the Ubiquitination Status of Proteins Bound to p97/VCP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIGRATION INHIBITORY FACTOR; AAA-ATPASE; DEUBIQUITINATING ENZYME; DNA-DAMAGE; CELL-CYCLE; MPN DOMAIN; P97; BINDING; DEGRADATION; COMPLEX	Ubiquitinated proteins can alternatively be delivered directly to the proteasome or via p97/VCP (valosin-containing protein). Whereas the proteasome degrades ubiquitinated proteins, the homohexameric ATPase p97/VCP seems to control the ubiquitination status of recruited substrates. The COP9 signalosome (CSN) is also involved in the ubiquitin/proteasome system (UPS) as exemplified by regulating the neddylation of ubiquitin E3 ligases. Here, we show that p97/VCP colocalizes and directly interacts with subunit 5 of the CSN (CSN5) in vivo and is associated with the entire CSN complex in an ATP-dependent manner. Furthermore, we provide evidence that the CSN and in particular the isopeptidase activity of its subunit CSN5 as well as the associated deubiquitinase USP15 are required for proper processing of polyubiquitinated substrates bound to p97/VCP. Moreover, we show that in addition to NEDD8, CSN5 binds to oligoubiquitin chains in vitro. Therefore, CSN and p97/VCP could form an ATP-dependent complex that resembles the 19 S proteasome regulatory particle and serves as a key mediator between ubiquitination and degradation pathways.	[Cayli, Sevil; Klug, Joerg; Chapiro, Julius; Froehlich, Suada; Meinhardt, Andreas] Univ Giessen, Dept Anat & Cell Biol, Reprod Biol Unit, D-35385 Giessen, Germany; [Krasteva, Gabriela] Univ Giessen, Dept Anat & Cell Biol, Unit Cardiopulm Neurobiol, D-35385 Giessen, Germany; [Orel, Lukas] Med Univ Vienna, Ctr Biomol Med & Pharmacol, A-1090 Vienna, Austria	Justus Liebig University Giessen; Justus Liebig University Giessen; Medical University of Vienna	Meinhardt, A (corresponding author), Univ Giessen, Dept Anat & Cell Biol, Reprod Biol Unit, Aulweg 123, D-35385 Giessen, Germany.	andreas.meinhardt@anatomie.med.uni-giessen.de	Meinhardt, Andreas/B-3688-2009; Cayli, Sevil/V-2342-2019; Krasteva-Christ, Gabriela/K-7253-2015; Krasteva-Christ, Gabriela/CAI-9036-2022	Krasteva-Christ, Gabriela/0000-0002-0113-521X; Krasteva-Christ, Gabriela/0000-0002-0113-521X; Cayli, Sevil/0000-0003-2465-5389	University Medical Center Giessen and Marburg	University Medical Center Giessen and Marburg	This work was supported in part by a research grant from the University Medical Center Giessen and Marburg (to A. M.).	Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Allen MD, 2006, J BIOL CHEM, V281, P25502, DOI 10.1074/jbc.M601173200; Alves BSC, 2006, BIOCHEM BIOPH RES CO, V347, P608, DOI 10.1016/j.bbrc.2006.06.133; Ambroggio XI, 2004, PLOS BIOL, V2, P113, DOI 10.1371/journal.pbio.0020002; Bellare P, 2006, RNA, V12, P292, DOI 10.1261/rna.2152306; Beuron F, 2006, EMBO J, V25, P1967, DOI 10.1038/sj.emboj.7601055; Bruderer RM, 2004, J BIOL CHEM, V279, P49609, DOI 10.1074/jbc.M408695200; Burger-Kentischer A, 2005, FEBS LETT, V579, P1693, DOI 10.1016/j.febslet.2005.01.080; Chamovitz DA, 2009, EMBO REP, V10, P352, DOI 10.1038/embor.2009.33; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; Dreveny I, 2004, BIOCHEM SOC T, V32, P715, DOI 10.1042/BST0320715; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; Filip AM, 2009, J BIOL CHEM, V284, P7977, DOI 10.1074/jbc.M808620200; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hetfeld BKJ, 2005, METHOD ENZYMOL, V398, P481, DOI 10.1016/S0076-6879(05)98039-7; Hetfeld BKJ, 2005, CURR BIOL, V15, P1217, DOI 10.1016/j.cub.2005.05.059; Huang XH, 2005, FEBS J, V272, P3909, DOI 10.1111/j.1742-4658.2005.04807.x; Indig FE, 2004, J STRUCT BIOL, V146, P251, DOI 10.1016/j.jsb.2003.11.009; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Kern M, 2009, BIOCHEM BIOPH RES CO, V380, P303, DOI 10.1016/j.bbrc.2009.01.076; Kim BC, 2004, MOL CELL BIOL, V24, P2251, DOI 10.1128/MCB.24.6.2251-2262.2004; Kleemann R, 2000, NATURE, V408, P211, DOI 10.1038/35041591; Konig P, 2006, LAB INVEST, V86, P853, DOI 10.1038/labinvest.3700443; McCullough J, 2004, J CELL BIOL, V166, P487, DOI 10.1083/jcb.200401141; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Nemajerova A, 2007, CELL CYCLE, V6, P1030, DOI 10.4161/cc.6.9.4163; Niepmann M, 2006, ELECTROPHORESIS, V27, P3949, DOI 10.1002/elps.200600172; Oh W, 2006, J BIOL CHEM, V281, P17457, DOI 10.1074/jbc.M601857200; Peth Andreas, 2007, BMC Biochemistry, V8, P27, DOI 10.1186/1471-2091-8-27; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Pye VE, 2006, J STRUCT BIOL, V156, P12, DOI 10.1016/j.jsb.2006.03.003; Sambrook SJ, 2001, MOL CLONING LAB MANU; Schuberth C, 2008, CELL MOL LIFE SCI, V65, P2360, DOI 10.1007/s00018-008-8072-8; Schweitzer K, 2007, EMBO J, V26, P1532, DOI 10.1038/sj.emboj.7601600; Stoeckelhuber M, 2006, HISTOCHEM CELL BIOL, V126, P103, DOI 10.1007/s00418-005-0137-2; Suh MH, 2005, ANAL BIOCHEM, V343, P166, DOI 10.1016/j.ab.2005.05.016; Tresaugues Lionel, 2004, Journal of Structural and Functional Genomics, V5, P195, DOI 10.1023/B:JSFG.0000029017.46332.e3; Tsuge T, 2001, J MOL BIOL, V305, P1, DOI 10.1006/jmbi.2000.4288; Uchiyama K, 2002, J CELL BIOL, V159, P855, DOI 10.1083/jcb.200208112; Wang Q, 2003, BIOCHEM BIOPH RES CO, V300, P253, DOI 10.1016/S0006-291X(02)02840-1; Wang YZ, 2004, J CELL BIOL, V164, P973, DOI 10.1083/jcb.200401010; Wei N, 2003, ANNU REV CELL DEV BI, V19, P261, DOI 10.1146/annurev.cellbio.19.111301.112449; Wei N, 2008, TRENDS BIOCHEM SCI, V33, P592, DOI 10.1016/j.tibs.2008.09.004; Zhao G, 2007, P NATL ACAD SCI USA, V104, P8785, DOI 10.1073/pnas.0702966104	47	21	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34944	34953		10.1074/jbc.M109.037952	http://dx.doi.org/10.1074/jbc.M109.037952			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19826004	Green Published, hybrid			2022-12-27	WOS:000272439600050
J	Enomoto, M; Goto, H; Tomono, Y; Kasahara, K; Tsujimura, K; Kiyono, T; Inagaki, M				Enomoto, Masato; Goto, Hidemasa; Tomono, Yasuko; Kasahara, Kousuke; Tsujimura, Kunio; Kiyono, Tohru; Inagaki, Masaki			Novel Positive Feedback Loop between Cdk1 and Chk1 in the Nucleus during G2/M Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE; CHECKPOINT PATHWAYS; PHOSPHORYLATION; KINASE; REPLICATION; ACTIVATION; BINDING; MITOSIS; SITE	Chk1, one of the critical transducers in DNA damage/replication checkpoints, prevents entry into mitosis through inhibition of Cdk1 activity. However, it has remained unclear how this inhibition is cancelled at the G(2)/M transition. We reported recently that Chk1 is phosphorylated at Ser(286) and Ser(301) by Cdk1 during mitosis. Here, we show that mitotic Chk1 phosphorylation is accompanied by Chk1 translocation from the nucleus to the cytoplasm in prophase. This translocation advanced in accordance with prophase progression and was regulated by Crm-1-dependent nuclear export. Exogenous Chk1 mutated at Ser(286) and Ser(301) to Ala (S286A/S301A) was observed mainly in the nuclei of prophase cells, although such nuclear accumulation was hardly observed in wild-type Chk1. Induction of S286A/S301A resulted in the delay of mitotic entry. Biochemical analyses using immunoprecipitated cyclin B-1-Cdk1 complexes revealed S286A/S301A expression to block the adequate activation of Cdk1. In support of this, S286A/S301A expression retained Wee1 at higher levels and Cdk1-induced phosphorylation of cyclin B-1 and vimentin at lower levels. A kinase-dead version of S286A/S301A also localized predominantly in the nucleus but lost the ability to delay mitotic entry. These results indicate that Chk1 phosphorylation by Cdk1 participates in cytoplasmic sequestration of Chk1 activity, which releases Cdk1 inhibition in the nucleus and promotes mitotic entry.	[Goto, Hidemasa; Inagaki, Masaki] Aichi Canc Ctr, Div Biochem, Res Inst, Chikusa Ku, Aichi 4648681, Japan; [Enomoto, Masato; Goto, Hidemasa; Inagaki, Masaki] Nagoya Univ, Grad Sch Med, Dept Cellular Oncol, Aichi 4668550, Japan; [Tomono, Yasuko] Shigei Med Res Inst, Div Mol & Cell Biol, Okayama 7010202, Japan; [Tsujimura, Kunio] Hamamatsu Univ Sch Med, Dept Infect Dis, Hamamatsu, Shizuoka 4313192, Japan; [Kiyono, Tohru] Natl Canc Ctr, Res Inst, Div Virol, Chuo Ku, Tokyo 1040045, Japan	Aichi Cancer Center; Nagoya University; Hamamatsu University School of Medicine; National Cancer Center - Japan	Goto, H (corresponding author), Aichi Canc Ctr, Div Biochem, Res Inst, Chikusa Ku, 1-1 Kanokoden, Aichi 4648681, Japan.	hgoto@aichi-cc.jp; minagaki@aichi-cc.jp	Inagaki, Masaki/B-9920-2016; Kiyono, Tohru/H-5834-2011	Goto, Hidemasa/0000-0002-6796-4467	Japan Society for the Promotion of Science; Ministry of Education, Science, Technology, Sports, and Culture of Japan; Ministry of Health and Welfare of Japan; Uehara Memorial Foundation; Naito Foundation; Takeda Science Foundation; Princess Takamatsu Cancer Research Fund; Grants-in-Aid for Scientific Research [19057010] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, Technology, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Princess Takamatsu Cancer Research Fund; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for scientific research from the Japan Society for the Promotion of Science and from the Ministry of Education, Science, Technology, Sports, and Culture of Japan, a grant-in-aid for the Third Term Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health and Welfare of Japan, the Uehara Memorial Foundation, the Naito Foundation, the Takeda Science Foundation, and a research grant from the Princess Takamatsu Cancer Research Fund.	Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Goto H, 1999, J BIOL CHEM, V274, P25543, DOI 10.1074/jbc.274.36.25543; Goto H, 2007, NAT PROTOC, V2, P2574, DOI 10.1038/nprot.2007.374; Graves PR, 2000, J BIOL CHEM, V275, P5600, DOI 10.1074/jbc.275.8.5600; Guttinger S, 2009, NAT REV MOL CELL BIO, V10, P178, DOI 10.1038/nrm2641; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Ikegami Y, 2008, BIOCHEM BIOPH RES CO, V377, P1227, DOI 10.1016/j.bbrc.2008.10.119; Jackman M, 2003, NAT CELL BIOL, V5, P143, DOI 10.1038/ncb918; Jiang KC, 2003, J BIOL CHEM, V278, P25207, DOI 10.1074/jbc.M300070200; Kramer A, 2004, NAT CELL BIOL, V6, P884, DOI 10.1038/ncb1165; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Niida H, 2007, MOL CELL BIOL, V27, P2572, DOI 10.1128/MCB.01611-06; Rhind N, 2000, J CELL SCI, V113, P3889; Shimada M, 2008, CELL, V132, P221, DOI 10.1016/j.cell.2007.12.013; Shiromizu T, 2006, GENES CELLS, V11, P477, DOI 10.1111/j.1365-2443.2006.00955.x; Sorensen CS, 2003, CANCER CELL, V3, P247, DOI 10.1016/S1535-6108(03)00048-5; Tibelius A, 2009, J CELL BIOL, V185, P1149, DOI 10.1083/jcb.200810159; TSUJIMURA K, 1994, J BIOL CHEM, V269, P31097; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	23	55	55	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34223	34230		10.1074/jbc.C109.051540	http://dx.doi.org/10.1074/jbc.C109.051540			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19837665	Green Published, hybrid			2022-12-27	WOS:000272165200054
J	Han, YH; Garron, ML; Kim, HY; Kim, WS; Zhang, ZQ; Ryu, KS; Shaya, D; Xiao, ZP; Cheong, C; Kim, YS; Linhardt, RJ; Jeon, YH; Cygler, M				Han, Young-Hyun; Garron, Marie-Line; Kim, Hye-Yeon; Kim, Wan-Seok; Zhang, Zhenqing; Ryu, Kyeong-Seok; Shaya, David; Xiao, Zhongping; Cheong, Chaejoon; Kim, Yeong Shik; Linhardt, Robert J.; Jeon, Young Ho; Cygler, Miroslaw			Structural Snapshots of Heparin Depolymerization by Heparin Lyase I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLAVOBACTERIUM-HEPARINUM; ENZYME; ALGINATE; OLIGOSACCHARIDES; CRYSTALLOGRAPHY; PURIFICATION; ELIMINATION; DEGRADATION; HYDROLASES; DISTORTION	Heparin lyase I (heparinase I) specifically depolymerizes heparin, cleaving the glycosidic linkage next to iduronic acid. Here, we show the crystal structures of heparinase I from Bacteroides thetaiotaomicron at various stages of the reaction with heparin oligosaccharides before and just after cleavage and product disaccharide. The heparinase I structure is comprised of a beta-jelly-roll domain harboring a long and deep substrate binding groove and an unusual thumb-resembling extension. This thumb, decorated with many basic residues, is of particular importance in activity especially on short heparin oligosaccharides. Unexpected structural similarity of the active site to that of heparinase II with an (alpha/alpha)(6) fold is observed. Mutational studies and kinetic analysis of this enzyme provide insights into the catalytic mechanism, the substrate recognition, and processivity.	[Cheong, Chaejoon; Jeon, Young Ho] Korea Basic Sci Inst, Magnet Resonance Team, Ochang 363883, Chungbuk, South Korea; [Garron, Marie-Line; Shaya, David; Cygler, Miroslaw] McGill Univ, Dept Biochem, Montreal, PQ H3A 2T5, Canada; [Kim, Wan-Seok; Kim, Yeong Shik] Seoul Natl Univ, Coll Pharm, Inst Nat Prod Res, Seoul 151742, South Korea; [Zhang, Zhenqing; Xiao, Zhongping; Linhardt, Robert J.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Chem & Chem Biol, Troy, NY 12180 USA; [Zhang, Zhenqing; Xiao, Zhongping; Linhardt, Robert J.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Biol, Troy, NY 12180 USA; [Zhang, Zhenqing; Xiao, Zhongping; Linhardt, Robert J.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Chem & Biol Engn, Troy, NY 12180 USA; [Cygler, Miroslaw] Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada; [Han, Young-Hyun] Chungbuk Natl Univ, Coll Nat Sci, Dept Biochem, Cheongju 361763, South Korea; [Jeon, Young Ho] Univ Sci & Technol, Dept Bioanalyt Sci, Taejon 305333, South Korea	Korea Basic Science Institute (KBSI); McGill University; Seoul National University (SNU); Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; National Research Council Canada; Chungbuk National University	Jeon, YH (corresponding author), Korea Basic Sci Inst, Magnet Resonance Team, Ochang 363883, Chungbuk, South Korea.	yhjeon@kbsi.re.kr; mirek@bri.nrc.ca	Jeon, Young Ho/F-4483-2011; Cheong, Chaejoon/GWC-3135-2022	Garron, Marie-Line/0000-0001-5846-1246	National Institutes of Health [GM38060, HL62244]; Top-brand Research Program [T29220]; 21C Frontier Microbial Genomics and Applications Center program; Canadian Institutes of Health Research [MOP-48370]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038060] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Top-brand Research Program; 21C Frontier Microbial Genomics and Applications Center program(Ministry of Education, Science & Technology (MEST), Republic of Korea); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM38060 and HL62244 (to R. J. L.). This work was also supported by the Top-brand Research Program (T29220, Korea Basic Science Institute) (to Y. H. J.), the 21C Frontier Microbial Genomics and Applications Center program (to Y. H. J.), and the Canadian Institutes of Health Research Grant MOP-48370 (to M. C.).	Andreeva A, 2004, NUCLEIC ACIDS RES, V32, pD226, DOI 10.1093/nar/gkh039; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; CASU B, 1985, ADV CARBOHYD CHEM BI, V43, P51, DOI 10.1016/S0065-2318(08)60067-0; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; DeLano WL, 2004, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ERNST S, 1995, CRIT REV BIOCHEM MOL, V30, P387, DOI 10.3109/10409239509083490; GACESA P, 1987, FEBS LETT, V212, P199, DOI 10.1016/0014-5793(87)81344-3; GERLT JA, 1992, J AM CHEM SOC, V114, P5928, DOI 10.1021/ja00041a004; Godavarti R, 1996, BIOCHEM BIOPH RES CO, V229, P770, DOI 10.1006/bbrc.1996.1879; Guerrini M, 2008, NAT BIOTECHNOL, V26, P669, DOI 10.1038/nbt1407; Imberty A, 2007, CARBOHYD RES, V342, P430, DOI 10.1016/j.carres.2006.12.019; Kato-Toma Y, 2003, BIOCHEM J, V371, P175, DOI 10.1042/BJ20021447; KUROKI R, 1993, SCIENCE, V262, P2030, DOI 10.1126/science.8266098; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li SL, 2000, EMBO J, V19, P1228, DOI 10.1093/emboj/19.6.1228; Linhardt RJ, 2006, ADV PHARMACOL, V53, P187, DOI 10.1016/S1054-3589(05)53009-6; LOHSE DL, 1992, J BIOL CHEM, V267, P24347; Michel G, 2004, J BIOL CHEM, V279, P32882, DOI 10.1074/jbc.M403421200; Money VA, 2006, ANGEW CHEM INT EDIT, V45, P5136, DOI 10.1002/anie.200600802; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ogura K, 2008, J MOL BIOL, V380, P373, DOI 10.1016/j.jmb.2008.05.008; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rice LM, 2000, ACTA CRYSTALLOGR D, V56, P1413, DOI 10.1107/S0907444900010039; Rigden DJ, 2006, J MOL BIOL, V358, P1165, DOI 10.1016/j.jmb.2006.02.066; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shaya D, 2006, J BIOL CHEM, V281, P15525, DOI 10.1074/jbc.M512055200; Strynadka N C, 1996, EXS, V75, P185; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2001, ACTA CRYSTALLOGR D, V57, P1763, DOI 10.1107/S0907444901013749; Yamasaki M, 2005, J MOL BIOL, V352, P11, DOI 10.1016/j.jmb.2005.06.075; YANG VC, 1985, J BIOL CHEM, V260, P1849; Yip VL, 2006, CURR OPIN CHEM BIOL, V10, P147, DOI 10.1016/j.cbpa.2006.02.005	37	45	50	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34019	34027		10.1074/jbc.M109.025338	http://dx.doi.org/10.1074/jbc.M109.025338			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19801541	Green Published, hybrid			2022-12-27	WOS:000272165200034
J	Majeau, N; Fromentin, R; Savard, C; Duval, M; Tremblay, MJ; Leclerc, D				Majeau, Nathalie; Fromentin, Remi; Savard, Christian; Duval, Marie; Tremblay, Michel J.; Leclerc, Denis			Palmitoylation of Hepatitis C Virus Core Protein Is Important for Virion Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DETERGENT-RESISTANT MEMBRANES; LIPID DROPLET; INTRAMEMBRANE PROTEOLYSIS; SUBCELLULAR-LOCALIZATION; YEAST; REPLICATION; INFECTION; PARTICLES; DOMAIN; CELLS	Hepatitis C virus core protein is the viral nucleocapsid of hepatitis C virus. Interaction of core with cellular membranes like endoplasmic reticulum (ER) and lipid droplets (LD) appears to be involved in viral assembly. However, how these interactions with different cellular membranes are regulated is not well understood. In this study, we investigated how palmitoylation, a post-translational protein modification, can modulate the targeting of core to cellular membranes. We show that core is palmitoylated at cysteine 172, which is adjacent to the transmembrane domain at the C-terminal end of core. Site-specific mutagenesis of residue Cys(172) showed that palmitoylation is not involved in the maturation process carried out by the signal peptide peptidase or in the targeting of core to LD. However, palmitoylation was shown to be important for core association with smooth ER membranes and ER closely surrounding LDs. Finally, we demonstrate that mutation of residue Cys(172) in the J6/JFH1 virus genome clearly impairs virion production.	[Majeau, Nathalie; Fromentin, Remi; Savard, Christian; Duval, Marie; Tremblay, Michel J.; Leclerc, Denis] Univ Laval, Infect Dis Res Ctr, CHUL, Quebec City, PQ G1V 4G2, Canada	Laval University	Leclerc, D (corresponding author), Univ Laval, Infect Dis Res Ctr, CHUL, 2705 Blvd Laurier, Quebec City, PQ G1V 4G2, Canada.	denis.leclerc@crchul.ulaval.ca	Leclerc, Denis/AAG-6112-2019; Majeau, Nathalie/AAU-1964-2021; Leclerc, Denis/P-1604-2019		Canadian Institutes of Health Research of Canada; Reseau Sida et Maladies Infectueuses of the Fonds de la Recherche en Sante du Quebec	Canadian Institutes of Health Research of Canada(Canadian Institutes of Health Research (CIHR)); Reseau Sida et Maladies Infectueuses of the Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by grants from the Canadian Institutes of Health Research of Canada and the Reseau Sida et Maladies Infectueuses of the Fonds de la Recherche en Sante du Quebec.	Abid K, 2005, J HEPATOL, V42, P744, DOI 10.1016/j.jhep.2004.12.034; Aizaki H, 2004, VIROLOGY, V324, P450, DOI 10.1016/j.virol.2004.03.034; Aizaki H, 2008, J VIROL, V82, P5715, DOI 10.1128/JVI.02530-07; Baekkeskov S, 2009, MOL MEMBR BIOL, V26, P42, DOI 10.1080/09687680802680108; Bartenschlager R, 2000, J GEN VIROL, V81, P1631, DOI 10.1099/0022-1317-81-7-1631; Boscarino JA, 2008, J VIROL, V82, P2989, DOI 10.1128/JVI.01906-07; Boulant S, 2008, TRAFFIC, V9, P1268, DOI 10.1111/j.1600-0854.2008.00767.x; Boulant S, 2006, J BIOL CHEM, V281, P22236, DOI 10.1074/jbc.M601031200; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Charollais J, 2009, MOL MEMBR BIOL, V26, P55, DOI 10.1080/09687680802620369; Chen BJ, 2005, J VIROL, V79, P13673, DOI 10.1128/JVI.79.21.13673-13684.2005; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Falcon V, 1999, TISSUE CELL, V31, P117, DOI 10.1054/tice.1999.0032; GRAKOUI A, 1993, J VIROL, V67, P1385, DOI 10.1128/JVI.67.3.1385-1395.1993; Greaves J, 2009, MOL BIOL CELL, V20, P1845, DOI 10.1091/mbc.E08-09-0944; Greaves J, 2009, MOL MEMBR BIOL, V26, P67, DOI 10.1080/09687680802620351; Hirschman JE, 1999, MOL CELL BIOL, V19, P7705; Hope RG, 2000, J GEN VIROL, V81, P1913, DOI 10.1099/0022-1317-81-8-1913; Hourioux C, 2007, GUT, V56, P1302, DOI 10.1136/gut.2006.108647; Hourioux C, 2007, CELL MICROBIOL, V9, P1014, DOI 10.1111/j.1462-5822.2006.00848.x; Irshad M, 2008, INT REV IMMUNOL, V27, P497, DOI 10.1080/08830180802432178; JACK EM, 1990, CARCINOGENESIS, V11, P1531, DOI 10.1093/carcin/11.9.1531; Kato T, 2003, J MED VIROL, V69, P357, DOI 10.1002/jmv.10297; Kunkel M, 2001, J VIROL, V75, P2119, DOI 10.1128/JVI.75.5.2119-2129.2001; Li H, 2007, J VIROL, V81, P12899, DOI 10.1128/JVI.01280-07; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Linder ME, 2004, J CELL SCI, V117, P521, DOI 10.1242/jcs.00989; Lingwood D, 2007, NAT PROTOC, V2, P2159, DOI 10.1038/nprot.2007.294; LO SY, 1995, VIROLOGY, V213, P455, DOI 10.1006/viro.1995.0018; Majeau N, 2005, J GEN VIROL, V86, P3055, DOI 10.1099/vir.0.81174-0; Majeau N, 2004, J GEN VIROL, V85, P971, DOI 10.1099/vir.0.79775-0; Majeau N, 2007, BIOCHEM CELL BIOL, V85, P78, DOI 10.1139/O06-195; Matto M, 2004, J VIROL, V78, P12047, DOI 10.1128/JVI.78.21.12047-12053.2004; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Mitaku S, 2002, BIOINFORMATICS, V18, P608, DOI 10.1093/bioinformatics/18.4.608; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Nadolski MJ, 2007, FEBS J, V274, P5202, DOI 10.1111/j.1742-4658.2007.06056.x; Negro F, 2006, WORLD J GASTROENTERO, V12, P6756, DOI 10.3748/wjg.v12.i42.6756; Ogino T, 2004, J VIROL, V78, P11766, DOI 10.1128/JVI.78.21.11766-11777.2004; Okamoto K, 2004, J VIROL, V78, P6370, DOI 10.1128/JVI.78.12.6370-6380.2004; Okamoto K, 2008, J VIROL, V82, P8349, DOI 10.1128/JVI.00306-08; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Roingeard P, 2008, HISTOCHEM CELL BIOL, V130, P561, DOI 10.1007/s00418-008-0447-2; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Rousso I, 2000, P NATL ACAD SCI USA, V97, P13523, DOI 10.1073/pnas.240459697; Schmidt M, 2002, J CELL SCI, V115, P293; Shavinskaya A, 2007, J BIOL CHEM, V282, P37158, DOI 10.1074/jbc.M707329200; Shi ST, 2003, J VIROL, V77, P4160, DOI 10.1128/JVI.77.7.4160-4168.2003; Suzuki R, 2005, J VIROL, V79, P1271, DOI 10.1128/JVI.79.2.1271-1281.2005; SUZUKI R, 1995, J GEN VIROL, V76, P53, DOI 10.1099/0022-1317-76-1-53; Tscherne DM, 2006, J VIROL, V80, P1734, DOI 10.1128/JVI.80.4.1734-1741.2006; Tsutsumi R, 2008, PFLUG ARCH EUR J PHY, V456, P1199, DOI 10.1007/s00424-008-0465-x; Vzorov AN, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-94; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; Yu GY, 2006, J VIROL, V80, P6013, DOI 10.1128/JVI.00053-06; Zweytick D, 2000, BBA-REV BIOMEMBRANES, V1469, P101, DOI 10.1016/S0005-2736(00)00294-7	57	38	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33915	33925		10.1074/jbc.M109.018549	http://dx.doi.org/10.1074/jbc.M109.018549			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19783655	Green Published, hybrid			2022-12-27	WOS:000272165200024
J	Sarajarvi, T; Haapasalo, A; Viswanathan, J; Makinen, P; Laitinen, M; Soininen, H; Hiltunen, M				Sarajarvi, Timo; Haapasalo, Annakaisa; Viswanathan, Jayashree; Makinen, Petra; Laitinen, Marjo; Soininen, Hilkka; Hiltunen, Mikko			Down-regulation of Seladin-1 Increases BACE1 Levels and Activity through Enhanced GGA3 Depletion during Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-SECRETASE ACTIVITY; STRESS-INDUCED APOPTOSIS; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; A-BETA; CHOLESTEROL-BIOSYNTHESIS; CEREBRAL-ISCHEMIA; GENE-EXPRESSION; GENERATION; NEURODEGENERATION	Seladin-1 is a neuroprotective protein selectively down-regulated in brain regions affected in Alzheimer disease (AD). Seladin-1 protects cells against beta-amyloid (A beta) peptide 42- and oxidative stress-induced apoptosis activated by caspase-3, a key mediator of apoptosis. Here, we have employed RNA interference to assess the molecular effects of seladin-1 down-regulation on the beta-secretase (BACE1) function and beta-amyloid precursor protein (APP) processing in SH-SY5Y human neuroblastoma cells in both normal and apoptotic conditions. Our results show that similar to 60% reduction in seladin-1 protein levels, resembling the decrease observed in AD brain, did not significantly affect APP processing or A beta secretion in normal growth conditions. However, under apoptosis, seladin-1 small interfering RNA (siRNA)-transfected cells showed increased caspase-3 activity on average by 2-fold when compared with control siRNA-transfected cells. Increased caspase-3 activity coincided with a significant depletion of the BACE1-sorting protein, GGA3 (Golgi-localized gamma-ear-containing ADP-ribosylation factor-binding protein), and subsequently augmented BACE1 protein levels and activity. Augmented BACE1 activity in turn correlated with the enhanced beta-amyloidogenic processing of APP and ultimately increased A beta production. These adverse changes associated with decreased cell viability in seladin-1 siRNA-transfected cells under apoptosis. No changes in GGA3 or BACE1 levels were found after seladin-1 knockdown in normal growth conditions. Collectively, our results suggest that under stress conditions, reduced seladin-1 expression results in enhanced GGA3 depletion, which further leads to augmented post-translational stabilization of BACE1 and increased beta-amyloidogenic processing of APP. These mechanistic findings related to seladin-1 down-regulation are important in the context of AD as the oxidative stress-induced apoptosis plays a key role in the disease pathogenesis.	[Hiltunen, Mikko] Univ Kuopio, Dept Neurol, FIN-70211 Kuopio, Finland; Kuopio Univ Hosp, FIN-70211 Kuopio, Finland	University of Eastern Finland; Kuopio University Hospital	Hiltunen, M (corresponding author), Univ Kuopio, Dept Neurol, POB 1627, FIN-70211 Kuopio, Finland.	mikko.hiltunen@uku.fi	Sarajärvi, Timo/AAN-3855-2021	Sarajärvi, Timo/0000-0001-8710-1282; Haapasalo, Annakaisa/0000-0003-0959-2957; Chadchankar, Jayashree/0000-0002-0189-569X	Academy of Finland, EVO [5772708]; Nordic Centre of Excellence in Neurodegeneration	Academy of Finland, EVO(Academy of Finland); Nordic Centre of Excellence in Neurodegeneration	This work was supported by the Health Research Council of the Academy of Finland, EVO Grant 5772708 of Kuopio University Hospital, and the Nordic Centre of Excellence in Neurodegeneration.	Abad-Rodriguez J, 2004, J CELL BIOL, V167, P953, DOI 10.1083/jcb.200404149; Bertram L, 2004, HUM MOL GENET, V13, pR135, DOI 10.1093/hmg/ddh077; Blasko I, 2004, J NEURAL TRANSM, V111, P523, DOI 10.1007/s00702-003-0095-6; Crameri A, 2006, EMBO J, V25, P432, DOI 10.1038/sj.emboj.7600938; Di Stasi D, 2005, INT J CANCER, V115, P224, DOI 10.1002/ijc.20885; Fernandez A, 2009, J NEUROSCI, V29, P6394, DOI 10.1523/JNEUROSCI.4909-08.2009; Greeve I, 2000, J NEUROSCI, V20, P7345; Guglielmotto M, 2009, J NEUROCHEM, V108, P1045, DOI 10.1111/j.1471-4159.2008.05858.x; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hiltunen M, 2009, NEUROBIOL DIS, V35, P103, DOI 10.1016/j.nbd.2009.04.009; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Iivonen S, 2002, NEUROSCIENCE, V113, P301, DOI 10.1016/S0306-4522(02)00180-X; Koh YH, 2005, J BIOL CHEM, V280, P32499, DOI 10.1074/jbc.M506199200; Kuehnle K, 2008, MOL CELL BIOL, V28, P539, DOI 10.1128/MCB.00584-07; Lamsa R, 2007, AM J MED GENET B, V144B, P906, DOI 10.1002/ajmg.b.30532; Lu X, 2008, ENDOCRINOLOGY, V149, P3267, DOI 10.1210/en.2008-0024; Luciani P, 2005, J CLIN ENDOCR METAB, V90, P6156, DOI 10.1210/jc.2005-0633; O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047; Rockenstein E, 2005, J BIOL CHEM, V280, P32957, DOI 10.1074/jbc.M507016200; Small SA, 2008, NEURON, V60, P534, DOI 10.1016/j.neuron.2008.11.007; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Tong Y, 2005, J NEURAL TRANSM, V112, P455, DOI 10.1007/s00702-004-0255-3; Vetrivel KS, 2009, J BIOL CHEM, V284, P3793, DOI 10.1074/jbc.M808920200; Waterham HR, 2001, AM J HUM GENET, V69, P685, DOI 10.1086/323473; Wen Y, 2004, BRAIN RES, V1009, P1, DOI 10.1016/j.brainres.2003.09.086; Wu CW, 2004, NATURE, V432, P640, DOI 10.1038/nature03173	26	53	54	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34433	34443		10.1074/jbc.M109.036202	http://dx.doi.org/10.1074/jbc.M109.036202			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19815556	hybrid, Green Published			2022-12-27	WOS:000272165200073
J	Bibby, RA; Tang, C; Faisal, A; Drosopoulos, K; Lubbe, S; Houlston, R; Bayliss, R; Linardopoulos, S				Bibby, Rachel Ann; Tang, Chan; Faisal, Amir; Drosopoulos, Konstantinos; Lubbe, Steven; Houlston, Richard; Bayliss, Richard; Linardopoulos, Spiros			A Cancer-associated Aurora A Mutant Is Mislocalized and Misregulated Due to Loss of Interaction with TPX2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; CELL-DIVISION; CENTROSOME AMPLIFICATION; CHROMOSOME SEGREGATION; SUSCEPTIBILITY GENE; A KINASE; ACTIVATION; SPINDLE; FAMILY; PHOSPHORYLATION	Mutations in protein kinases can drive cancer through alterations of the kinase activity or by uncoupling kinase activity from regulation. Changes to protein expression in Aurora A, a mitotic Ser/Thr kinase, are associated with the development of several human cancers, but the effects of somatic cancer-associated mutations have not been determined. In this study we show that Aurora A kinase activity is altered in different ways in three somatic cancer-associated mutations located within the catalytic domain; Aurora A(V174M) shows constitutively increased kinase activity, Aurora A(S155R) activity is decreased primarily due to misregulation, and Aurora A(S361*) activity is ablated due to loss of structural integrity. These alterations suggest vastly different mechanisms for the role of these three mutations in human cancer. We have further characterized the Aurora A(S155R) mutant protein, found that its reduced cellular activity and mislocalization are due to loss of interaction with TPX2, and deciphered the structural basis of the disruption at 2.5 angstrom resolution. Previous studies have shown that disruption of the Aurora A/TPX2 interaction results in defective spindles that generate chromosomal abnormalities. In a panel of 40 samples from microsatellite instability-positive colon cancer patients, we found one example in which the tumor contained only Aurora A(S155R), whereas the normal tissue contained only wild-type Aurora A. We propose that the S155R mutation is an example of a somatic mutation associated with this tumor type, albeit at modest frequency, that could promote aneuploidy through the loss of regulated interactions between Aurora A and its protein partners.	[Bibby, Rachel Ann; Bayliss, Richard] Chester Beatty Labs, Inst Canc Res, Sect Struct Biol, London SW3 6JB, England; [Tang, Chan; Drosopoulos, Konstantinos; Linardopoulos, Spiros] Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Faisal, Amir; Linardopoulos, Spiros] Inst Canc Res, Canc Res UK Ctr Canc Therapeut, Sutton SM2 5NG, Surrey, England; [Lubbe, Steven; Houlston, Richard] Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK; Cancer Research UK; University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK	Bayliss, R (corresponding author), Chester Beatty Labs, Inst Canc Res, Sect Struct Biol, 237 Fulham Rd, London SW3 6JB, England.	richard.bayliss@icr.ac.uk; linardopoulos@icr.ac.uk	Lubbe, Steven/L-8261-2013; Faisal, Amir/AAE-8992-2020	Lubbe, Steven/0000-0002-7103-6671; Houlston, Richard/0000-0002-5268-0242; Linardopoulos, Spiros/0000-0002-6600-400X; Faisal, Amir/0000-0002-7376-8286; Bayliss, Richard/0000-0003-0604-2773	Royal Society University Research Fellowship; Institute of Cancer Research Studentship; Cancer Research UK [C309/A8274]; Breakthrough Breast Cancer	Royal Society University Research Fellowship(Royal Society of London); Institute of Cancer Research Studentship; Cancer Research UK(Cancer Research UK); Breakthrough Breast Cancer	This work was supported by a Royal Society University Research Fellowship and an Institute of Cancer Research Studentship ( to R. A. B.) and Cancer Research UK Grant C309/A8274 and a grant from Breakthrough Breast Cancer ( to S. L.).	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Barros TP, 2005, J CELL BIOL, V170, P1039, DOI 10.1083/jcb.200504097; Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; Bird AW, 2008, J CELL BIOL, V182, P289, DOI 10.1083/jcb.200802005; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Bischoff JR, 1999, TRENDS CELL BIOL, V9, P454, DOI 10.1016/S0962-8924(99)01658-X; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ewart-Toland A, 2005, CARCINOGENESIS, V26, P1368, DOI 10.1093/carcin/bgi085; Ewart-Toland A, 2003, NAT GENET, V34, P403, DOI 10.1038/ng1220; Eyers PA, 2003, CURR BIOL, V13, P691, DOI 10.1016/S0960-9822(03)00166-0; Giet R, 1999, J CELL SCI, V112, P3591; Giet R, 1999, J BIOL CHEM, V274, P15005, DOI 10.1074/jbc.274.21.15005; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Gritsko TM, 2003, CLIN CANCER RES, V9, P1420; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Honda K, 2000, ONCOGENE, V19, P2812, DOI 10.1038/sj.onc.1203609; KALLIONIEMI A, 1994, P NATL ACAD SCI USA, V91, P2156, DOI 10.1073/pnas.91.6.2156; Katayama H, 2004, NAT GENET, V36, P55, DOI 10.1038/ng1279; Katayama H, 2001, J BIOL CHEM, V276, P46219, DOI 10.1074/jbc.M107540200; Kimura M, 1999, J BIOL CHEM, V274, P7334, DOI 10.1074/jbc.274.11.7334; Kinoshita K, 2005, J CELL BIOL, V170, P1047, DOI 10.1083/jcb.200503023; Kufer TA, 2002, J CELL BIOL, V158, P617, DOI 10.1083/jcb.200204155; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Liu Q, 2004, J BIOL CHEM, V279, P18210, DOI 10.1074/jbc.M400678200; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Mao JH, 2007, CANCER CELL, V11, P161, DOI 10.1016/j.ccr.2006.11.025; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meraldi P, 2004, CURR OPIN GENET DEV, V14, P29, DOI 10.1016/j.gde.2003.11.006; Meraldi P, 2002, EMBO J, V21, P483, DOI 10.1093/emboj/21.4.483; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Ozlu N, 2005, DEV CELL, V9, P237, DOI 10.1016/j.devcel.2005.07.002; Peset I, 2005, J CELL BIOL, V170, P1057, DOI 10.1083/jcb.200504037; Pugacheva EN, 2005, NAT CELL BIOL, V7, P937, DOI 10.1038/ncb1309; Reichardt W, 2003, ONCOL REP, V10, P1275; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; Stewart S, 2005, MOL CELL BIOL, V25, P10516, DOI 10.1128/MCB.25.23.10516-10527.2005; Tanaka T, 1999, CANCER RES, V59, P2041; Terada Y, 2003, J CELL BIOL, V162, P757, DOI 10.1083/jcb.200305048; Torkamani A, 2008, CANCER RES, V68, P1675, DOI 10.1158/0008-5472.CAN-07-5283; Toyooka S, 2003, HUM MUTAT, V21, P229, DOI 10.1002/humu.10177; Tsai MY, 2003, NAT CELL BIOL, V5, P242, DOI 10.1038/ncb936; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496; ZHUO S, 1993, J BIOL CHEM, V268, P17754	46	35	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33177	33184		10.1074/jbc.M109.032722	http://dx.doi.org/10.1074/jbc.M109.032722			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801554	Green Published, hybrid			2022-12-27	WOS:000272028500022
J	Costanzo, G; Pino, S; Ciciriello, F; Di Mauro, E				Costanzo, Giovanna; Pino, Samanta; Ciciriello, Fabiana; Di Mauro, Ernesto			Generation of Long RNA Chains in Water	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TEMPLATE-DIRECTED LIGATION; INFORMATIONAL POLYMERS; AQUEOUS-SOLUTION; DIFFERENTIAL STABILITY; TEMPERATURE-DEPENDENCE; POLYRIBOADENYLIC ACID; PREBIOTIC CHEMISTRY; PHOSPHATE MINERALS; ORIGIN; FORMAMIDE	The synthesis of RNA chains from 3',5'-cAMP and 3',5'-cGMP was observed. The RNA chains formed in water, at moderate temperatures (40-90 degrees C), in the absence of enzymes or inorganic catalysts. As determined by RNase analyses, the bonds formed were canonical 3',5'-phosphodiester bonds. The polymerizations are based on two reactions not previously described: 1) oligomerization of 3',5'-cGMP to similar to 25-nucleotide-long RNA molecules, and of 3',5'-cAMP to 4- to 8-nucleotide-long molecules. Oligonucleotide A molecules were further extended by reciprocal terminal ligation to yield RNA molecules up to > 120 nucleotides long and 2) chain extension by terminal ligation of newly polymerized products of 3',5'-cGMP on preformed oligonucleotides. The enzyme- and template-independent synthesis of long oligomers in water from prebiotically affordable precursors approaches the concept of spontaneous generation of (pre)genetic information.	[Di Mauro, Ernesto] Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, Fdn Ist Pasteur Fdn Cenci Bolognett, I-00185 Rome, Italy; [Costanzo, Giovanna] CNR, Ist Biol & Patol Mol, I-00185 Rome, Italy	Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR)	Di Mauro, E (corresponding author), Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, Fdn Ist Pasteur Fdn Cenci Bolognett, Ple Aldo Moro 5, I-00185 Rome, Italy.	Ernesto.dimauro@uniroma1.it	Ciciriello, Fabiana/AAA-8065-2020	Ciciriello, Fabiana/0000-0003-1493-9767	Italian Space Agency; MoMa project; Agenzia Spaziale Italiana-Istituto Nazionale di Astrofisica, Italy [I/015/07/0]	Italian Space Agency(Agenzia Spaziale Italiana (ASI)); MoMa project; Agenzia Spaziale Italiana-Istituto Nazionale di Astrofisica, Italy(Istituto Nazionale Astrofisica (INAF))	This work was supported by the Italian Space Agency, the MoMa project, and Agenzia Spaziale Italiana-Istituto Nazionale di Astrofisica ( Grant I/015/07/0, Esplorazione del Sistema Solare) Italy.	Alberty RA, 2006, BIOPHYS CHEM, V121, P157, DOI 10.1016/j.bpc.2006.01.004; BECK A, 1965, P NATL ACAD SCI USA, V54, P664, DOI 10.1073/pnas.54.3.664; BERNAL JD, 1949, P PHYS SOC LOND A, V62, P537, DOI 10.1088/0370-1298/62/9/301; BRAHMS J, 1966, J MOL BIOL, V15, P467, DOI 10.1016/S0022-2836(66)80122-5; BRAHMS J, 1967, J MOL BIOL, V25, P481, DOI 10.1016/0022-2836(67)90200-8; CAIRNSSMITH AG, 1966, J THEOR BIOL, V10, P53, DOI 10.1016/0022-5193(66)90178-0; Ciciriello F, 2008, BIOCHEMISTRY-US, V47, P2732, DOI 10.1021/bi7021014; Ciciriello F, 2007, ASTROBIOLOGY, V7, P616, DOI 10.1089/ast.2006.0044; Costanzo G, 2007, J BIOL CHEM, V282, P16729, DOI 10.1074/jbc.M611346200; DARWIN F, 1988, LIFE LETT C DARWIN, V3, P18; DAVIS RC, 1968, BIOPOLYMERS, V6, P223, DOI 10.1002/bip.1968.360060206; EUN HM, 1996, ENZYMOLOGY PRIMER RE, P647; FERRIS JP, 1993, J AM CHEM SOC, V115, P12270, DOI 10.1021/ja00079a006; Ferris JP, 2004, ADV SPACE RES, V33, P100, DOI 10.1016/j.asr.2003.02.010; FINCH JT, 1969, J MOL BIOL, V46, P597, DOI 10.1016/0022-2836(69)90201-0; FRECHET D, 1979, NUCLEIC ACIDS RES, V7, P1981, DOI 10.1093/nar/7.7.1981; Gao K, 2000, ORIGINS LIFE EVOL B, V30, P45, DOI 10.1023/A:1006683507864; HOLCOMB DN, 1965, BIOPOLYMERS, V3, P121, DOI 10.1002/bip.360030203; Huang WH, 2003, CHEM COMMUN, P1458, DOI 10.1039/b303134a; Joyce GF, 2004, ANNU REV BIOCHEM, V73, P791, DOI 10.1146/annurev.biochem.73.011303.073717; Kanavarioti A, 2001, ASTROBIOLOGY, V1, P271, DOI 10.1089/15311070152757465; KANG H, 1992, BIOPOLYMERS, V32, P1351, DOI 10.1002/bip.360321009; KAWAMURA K, 1994, J AM CHEM SOC, V116, P7564, DOI 10.1021/ja00096a013; LOHRMANN R, 1977, J MOL EVOL, V10, P137, DOI 10.1007/BF01751807; LUTAY AV, 2006, BIOGEOSCI DISCUSS, V3, P1; Mansy SS, 2008, NATURE, V454, P122, DOI 10.1038/nature07018; MILLER SL, 1964, NATURE, V204, P1248, DOI 10.1038/2041248a0; Monnard PA, 2003, J AM CHEM SOC, V125, P13734, DOI 10.1021/ja036465h; NORBERG J, 1995, J AM CHEM SOC, V117, P10832, DOI 10.1021/ja00149a006; NORBERG J, 1995, J PHYS CHEM-US, V99, P13056, DOI 10.1021/j100035a002; OLSON WK, 1975, NUCLEIC ACIDS RES, V2, P2055, DOI 10.1093/nar/2.11.2055; Orgel LE, 2004, CRIT REV BIOCHEM MOL, V39, P99, DOI 10.1080/10409230490460765; Orgel LE, 1998, TRENDS BIOCHEM SCI, V23, P491, DOI 10.1016/S0968-0004(98)01300-0; Pino S, 2008, J BIOL CHEM, V283, P36494, DOI 10.1074/jbc.M805333200; Powner MW, 2009, NATURE, V459, P239, DOI 10.1038/nature08013; Rajamani S, 2008, ORIGINS LIFE EVOL B, V38, P57, DOI 10.1007/s11084-007-9113-2; RENZ M, 1971, BIOCHIM BIOPHYS ACTA, V240; Rohatgi R, 1996, J AM CHEM SOC, V118, P3340, DOI 10.1021/ja9537134; Saladino R, 2006, J BIOL CHEM, V281, P5790, DOI 10.1074/jbc.M512545200; Saladino R, 2005, J BIOL CHEM, V280, P35658, DOI 10.1074/jbc.M504537200; Saladino R, 2003, CHEMBIOCHEM, V4, P514, DOI 10.1002/cbic.200300567; Saladino R, 2007, CHEM BIODIVERS, V4, P694, DOI 10.1002/cbdv.200790059; Saladino R, 2006, CHEMBIOCHEM, V7, P1707, DOI 10.1002/cbic.200600139; Saladino R, 2009, RES MICROBIOL, V160, P441, DOI 10.1016/j.resmic.2009.06.001; Saladino R, 2008, J AM CHEM SOC, V130, P15512, DOI 10.1021/ja804782e; Sawai H, 2006, CHEMBIOCHEM, V7, P605, DOI 10.1002/cbic.200500291; Sawai H, 1998, NUCLEIC ACIDS RES, V26, P2995, DOI 10.1093/nar/26.12.2995; SCHWARTZ A, 1968, NATURE, V218, P443, DOI 10.1038/218443a0; SMITH M, 1960, J AM CHEM SOC, V83, P698; STEINMAN G, 1964, P NATL ACAD SCI USA, V52, P27, DOI 10.1073/pnas.52.1.27; Steyaert J, 1997, EUR J BIOCHEM, V247, P1, DOI 10.1111/j.1432-1033.1997.t01-1-00001.x; USHER DA, 1976, SCIENCE, V192, P53, DOI 10.1126/science.1257755; VANHOLDE K, 1980, ORIGINS LIFE EVOL B, P31; VERLANDER MS, 1973, J MOL EVOL, V2, P303, DOI 10.1007/BF01654098	55	87	90	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33206	33216		10.1074/jbc.M109.041905	http://dx.doi.org/10.1074/jbc.M109.041905			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801553	hybrid, Green Published			2022-12-27	WOS:000272028500025
J	Sharma, V; Heriot, W; Trisler, K; Smider, V				Sharma, Vikram; Heriot, William; Trisler, Kirk; Smider, Vaughn			A Human Germ Line Antibody Light Chain with Hydrolytic Properties Associated with Multimerization Status	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; BENCE-JONES PROTEINS; CATALYTIC ANTIBODIES; HEMOPHILIA-A; FACTOR-VIII; EVOLUTION; AFFINITY; AUTOANTIBODIES; DECOMPOSITION; DEGRADATION	Antibodies with nucleophilic or catalytic properties often have these characteristics encoded in their germ line genes. Because hydrolytic activity has been reported to be associated with light chain V regions, we have begun an analysis of germ line light chain proteins that could be the basis for affinity maturation into hydrolytic or other reactive antibodies. We produced the germ line A18b light chain and characterized its hydrolytic, nucleophilic, and tertiary structural activities. This light chain was purified to > 99% purity and found to hydrolyze aminomethylcoumarin-peptide and larger protein substrates and bind a fluorophosphonate probe. Mutation of putative catalytic residues only resulted in loss of activity of a tetrameric but not dimeric form of the light chain. These biochemical properties provide a framework for understanding the structure-function relationships of germ line antibodies.	[Sharma, Vikram; Heriot, William; Trisler, Kirk; Smider, Vaughn] Integrigen Inc, Novato, CA 94949 USA		Smider, V (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd,SR202, La Jolla, CA 92037 USA.	vvsmider@scripps.edu		Smider, Vaughn/0000-0003-3488-6383				ALLEN D, 1988, EMBO J, V7, P1995, DOI 10.1002/j.1460-2075.1988.tb03038.x; Belogurov AA, 2008, J IMMUNOL, V180, P1258, DOI 10.4049/jimmunol.180.2.1258; GAO QS, 1994, J BIOL CHEM, V269, P32389; GAO QS, 1995, J MOL BIOL, V253, P658, DOI 10.1006/jmbi.1995.0580; Gololobov G, 1999, MOL IMMUNOL, V36, P1215, DOI 10.1016/S0161-5890(99)00141-8; Hifumi E, 2002, J IMMUNOL METHODS, V269, P283, DOI 10.1016/S0022-1759(02)00242-9; Hifumi E, 1999, J BIOSCI BIOENG, V88, P323, DOI 10.1016/S1389-1723(00)80018-3; Hifumi E, 2000, APPL BIOCHEM BIOTECH, V83, P209, DOI 10.1385/ABAB:83:1-3:209; Huang DB, 1996, P NATL ACAD SCI USA, V93, P7017, DOI 10.1073/pnas.93.14.7017; KOCKS C, 1988, P NATL ACAD SCI USA, V85, P8206, DOI 10.1073/pnas.85.21.8206; Lacroix-Desmazes S, 2006, IMMUNOL LETT, V103, P3, DOI 10.1016/j.imlet.2005.10.007; Lacroix-Desmazes S, 2005, P NATL ACAD SCI USA, V102, P4109, DOI 10.1073/pnas.0500586102; Lacroix-Desmazes S, 2002, NEW ENGL J MED, V346, P662, DOI 10.1056/NEJMoa011979; Lacroix-Desmazes S, 1999, NAT MED, V5, P1044, DOI 10.1038/12483; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Matsuura K, 2006, BIOL CHEM, V387, P543, DOI 10.1515/BC.2006.070; Mitsuda Y, 2005, IMMUNOL LETT, V96, P63, DOI 10.1016/j.imlet.2004.07.018; Nevinsky GA, 2003, J CELL MOL MED, V7, P265, DOI 10.1111/j.1582-4934.2003.tb00227.x; Patten PA, 1996, SCIENCE, V271, P1086, DOI 10.1126/science.271.5252.1086; PAUL S, 1995, J BIOL CHEM, V270, P15257, DOI 10.1074/jbc.270.25.15257; PAUL S, 1989, SCIENCE, V244, P1158, DOI 10.1126/science.2727702; Planque S, 2004, J BIOL CHEM, V279, P14024, DOI 10.1074/jbc.M312152200; Ponomarenko NA, 2006, P NATL ACAD SCI USA, V103, P281, DOI 10.1073/pnas.0509849103; Reshetnyak AV, 2007, J AM CHEM SOC, V129, P16175, DOI 10.1021/ja076528m; Romesberg FE, 1998, SCIENCE, V279, P1929, DOI 10.1126/science.279.5358.1929; Sambrook J., 2002, MOL CLONING LAB MANU; SCHULTZ PG, 1995, SCIENCE, V269, P1835, DOI 10.1126/science.7569920; Sethi DK, 2006, IMMUNITY, V24, P429, DOI 10.1016/j.immuni.2006.02.010; Smider V, 1997, Semin Immunol, V9, P189, DOI 10.1006/smim.1997.0070; Sreedharan SK, 1996, BIOCHEM J, V316, P777, DOI 10.1042/bj3160777; STEVENS FJ, 1980, P NATL ACAD SCI-BIOL, V77, P1144, DOI 10.1073/pnas.77.2.1144; SUN M, 1994, J IMMUNOL, V153, P5121; Sun M, 1997, J MOL BIOL, V271, P374, DOI 10.1006/jmbi.1997.1196; Trisler K, 2007, J BIOL CHEM, V282, P26344, DOI 10.1074/jbc.M704675200; Wedemayer GJ, 1997, SCIENCE, V276, P1665, DOI 10.1126/science.276.5319.1665; Yin J, 2003, J MOL BIOL, V330, P651, DOI 10.1016/S0022-2836(03)00631-4; Zhu XY, 2004, J MOL BIOL, V343, P1269, DOI 10.1016/j.jmb.2004.08.102; Zimmermann J, 2006, P NATL ACAD SCI USA, V103, P13722, DOI 10.1073/pnas.0603282103	38	16	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33079	33087		10.1074/jbc.M109.036087	http://dx.doi.org/10.1074/jbc.M109.036087			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801545	hybrid, Green Published			2022-12-27	WOS:000272028500011
J	Torres-Bacete, J; Sinha, PK; Castro-Guerrero, N; Matsuno-Yagi, A; Yagi, T				Torres-Bacete, Jesus; Sinha, Prem Kumar; Castro-Guerrero, Norma; Matsuno-Yagi, Akemi; Yagi, Takao			Features of Subunit NuoM (ND4) in Escherichia coli NDH-1 TOPOLOGY AND IMPLICATION OF CONSERVED GLU(144) FOR COUPLING SITE 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-QUINONE OXIDOREDUCTASE; RESPIRATORY COMPLEX-I; MEMBRANE DOMAIN; UBIQUINONE OXIDOREDUCTASE; PARACOCCUS-DENITRIFICANS; PERIPHERAL SUBUNITS; ACIDIC RESIDUES; SUBMITOCHONDRIAL PARTICLES; FUNCTIONAL-ANALYSIS; HYDROPHILIC DOMAIN	The bacterial H+-pumping NADH-quinone oxidoreductase (NDH-1) is an L-shaped membrane-bound enzymatic complex. Escherichia coli NDH-1 is composed of 13 subunits (NuoA-N). NuoM (ND4) subunit is one of the hydrophobic subunits that constitute the membrane arm of NDH-1 and was predicted to bear 14 helices. We attempted to clarify the membrane topology of NuoM by the introduction of histidine tags into different positions by chromosomal site-directed mutagenesis. From the data, we propose a topology model containing 12 helices (helices I-IX and XII-XIV) located in transmembrane position and two (helices X and XI) present in the cytoplasm. We reported previously that residue Glu(144) of NuoM was located in the membrane (helix V) and was essential for the energy-coupling activities of NDH-1 (Torres-Bacete, J., Nakamaru-Ogiso, E., Matsuno-Yagi, A., and Yagi, T. (2007) J. Biol. Chem. 282, 36914-36922). Using mutant E144A, we studied the effect of shifting the glutamate residue to all sites within helix V and three sites each in helix IV and VI on the function of NDH-1. Twenty double site-directed mutants including the mutation E144A were constructed and characterized. None of the mutants showed alteration in the detectable levels of expressed NuoM or on the NDH-1 assembly. In addition, most of the double mutants did not restore the energy transducing NDH-1 activities. Only two mutants E144A/F140E and E144A/L147E, one helix turn downstream and upstream restored the energy transducing activities of NDH-1. Based on these results, a role of Glu(144) for proton translocation has been discussed.	[Torres-Bacete, Jesus; Sinha, Prem Kumar; Castro-Guerrero, Norma; Matsuno-Yagi, Akemi; Yagi, Takao] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Scripps Research Institute	Yagi, T (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, MEM256,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	yagi@scripps.edu		Torres, Jesus/0000-0003-3410-6930	National Institutes of Health [R01GM033712]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033712] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM033712 ( to T. Y. and A. M.- Y.).	Amarneh B, 2003, BIOCHEMISTRY-US, V42, P4800, DOI 10.1021/bi0340346; Amarneh B, 2006, BBA-BIOENERGETICS, V1757, P1557, DOI 10.1016/j.bbabio.2006.08.003; Arkin IT, 2007, SCIENCE, V317, P799, DOI 10.1126/science.1142824; Baranova EA, 2007, J STRUCT BIOL, V159, P238, DOI 10.1016/j.jsb.2007.01.009; Baranova EA, 2007, J MOL BIOL, V366, P140, DOI 10.1016/j.jmb.2006.11.026; Bertsova YV, 2004, FEBS LETT, V563, P207, DOI 10.1016/S0014-5793(04)00312-6; Caputo GA, 2004, BIOCHEMISTRY-US, V43, P8794, DOI 10.1021/bi049696p; Caputo GA, 2003, BIOCHEMISTRY-US, V42, P3275, DOI 10.1021/bi026697d; Carroll J, 2003, MOL CELL PROTEOMICS, V2, P117, DOI 10.1074/mcp.M300014-MCP200; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; CHOMYN A, 1986, SCIENCE, V234, P614, DOI 10.1126/science.3764430; CHOMYN A, 1985, NATURE, V314, P591; COPELAND RA, 1989, ANNU REV PHYS CHEM, V40, P671; Dioumaev AK, 1998, BIOCHEMISTRY-US, V37, P2496, DOI 10.1021/bi971842m; Euro L, 2008, BBA-BIOENERGETICS, V1777, P1166, DOI 10.1016/j.bbabio.2008.06.001; Friedrich T, 1998, BBA-BIOENERGETICS, V1364, P134, DOI 10.1016/S0005-2728(98)00024-3; Friedrich T, 2001, J BIOENERG BIOMEMBR, V33, P169, DOI 10.1023/A:1010722717257; Friedrich T, 2000, FEBS LETT, V479, P1, DOI 10.1016/S0014-5793(00)01867-6; Galkin AS, 1999, FEBS LETT, V451, P157, DOI 10.1016/S0014-5793(99)00575-X; Ghelli A, 1997, J BIOCHEM, V121, P746; Gong X, 2003, J BIOL CHEM, V278, P25731, DOI 10.1074/jbc.M302361200; Guenebaut V, 1998, J MOL BIOL, V276, P105, DOI 10.1006/jmbi.1997.1518; Hedderich R, 2004, J BIOENERG BIOMEMBR, V36, P65, DOI 10.1023/B:JOBB.0000019599.43969.33; Hinchliffe P, 2005, SCIENCE, V309, P771, DOI 10.1126/science.1113988; INOUE H, 1995, FEBS LETT, V363, P264, DOI 10.1016/0014-5793(95)00331-3; Kajiyama Y, 2009, MICROBIOL-SGM, V155, P2137, DOI 10.1099/mic.0.025205-0; Kao MC, 2005, BIOCHEMISTRY-US, V44, P9545, DOI 10.1021/bi050708w; Kao MC, 2005, BIOCHEMISTRY-US, V44, P3562, DOI 10.1021/bi0476477; Kao MC, 2004, J BIOL CHEM, V279, P32360, DOI 10.1074/jbc.M403885200; Kao MC, 2003, BIOCHEMISTRY-US, V42, P4534, DOI 10.1021/bi034166z; Kervinen M, 2004, BIOCHEMISTRY-US, V43, P773, DOI 10.1021/bi0355903; Kosono S, 2006, BBA-BIOMEMBRANES, V1758, P627, DOI 10.1016/j.bbamem.2006.04.012; Krishnakumar SS, 2007, J MOL BIOL, V374, P1251, DOI 10.1016/j.jmb.2007.10.032; Langemeyer L, 2007, BBA-BIOENERGETICS, V1767, P998, DOI 10.1016/j.bbabio.2007.05.007; LEWIS MJ, 1990, J BIOL CHEM, V265, P10541; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; Mathiesen C, 2002, BBA-BIOENERGETICS, V1556, P121, DOI 10.1016/S0005-2728(02)00343-2; Mathiesen C, 2003, FEBS LETT, V549, P7, DOI 10.1016/S0014-5793(03)00767-1; MATSUSHITA K, 1987, BIOCHEMISTRY-US, V26, P7732, DOI 10.1021/bi00398a029; MILLER MJ, 1990, P NATL ACAD SCI USA, V87, P4900, DOI 10.1073/pnas.87.13.4900; Murtazina R, 2001, EUR J BIOCHEM, V268, P4674, DOI 10.1046/j.1432-1327.2001.02391.x; Nakamaru-Ogiso E, 2005, J BIOL CHEM, V280, P301, DOI 10.1074/jbc.M410377200; Nakamaru-Ogiso E, 2003, FEBS LETT, V549, P43, DOI 10.1016/S0014-5793(03)00766-X; Nakamaru-Ogiso E, 2003, BIOCHEMISTRY-US, V42, P746, DOI 10.1021/bi0269660; NEWTON G, 1991, MOL MICROBIOL, V5, P2511, DOI 10.1111/j.1365-2958.1991.tb02097.x; Padan E, 2008, TRENDS BIOCHEM SCI, V33, P435, DOI 10.1016/j.tibs.2008.06.007; Patsi J, 2008, BIOCHEM J, V409, P129, DOI 10.1042/BJ20070866; Satoh T, 1996, BBA-BIOENERGETICS, V1273, P21, DOI 10.1016/0005-2728(95)00131-X; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Sazanov LA, 2000, BIOCHEMISTRY-US, V39, P7229, DOI 10.1021/bi000335t; Sazanov LA, 2007, BIOCHEMISTRY-US, V46, P2275, DOI 10.1021/bi602508x; Sinha PK, 2009, J BIOL CHEM, V284, P9814, DOI 10.1074/jbc.M809468200; Slepkov ER, 2007, BIOCHEM J, V401, P623, DOI 10.1042/BJ20061062; Steuber J, 2001, BBA-BIOENERGETICS, V1505, P45, DOI 10.1016/S0005-2728(00)00276-0; Steuber J, 2003, J BIOL CHEM, V278, P26817, DOI 10.1074/jbc.M301682200; Steuber J, 2000, MOL MICROBIOL, V35, P428, DOI 10.1046/j.1365-2958.2000.01712.x; Stolpe S, 2004, J BIOL CHEM, V279, P18377, DOI 10.1074/jbc.M311242200; Takano S, 1996, BIOCHEMISTRY-US, V35, P9120, DOI 10.1021/bi9605853; Torres-Bacete J, 2007, J BIOL CHEM, V282, P36914, DOI 10.1074/jbc.M707855200; YAGI T, 1986, ARCH BIOCHEM BIOPHYS, V250, P302, DOI 10.1016/0003-9861(86)90731-9; Yagi T, 2003, BIOCHEMISTRY-US, V42, P2266, DOI 10.1021/bi027158b; Yagi T, 1998, BBA-BIOENERGETICS, V1364, P125, DOI 10.1016/S0005-2728(98)00023-1; YAGI T, 2004, RESP ARCHAEA BACTERI, P15; Yano T, 1999, J BIOL CHEM, V274, P28606, DOI 10.1074/jbc.274.40.28606	64	28	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33062	33069		10.1074/jbc.M109.059154	http://dx.doi.org/10.1074/jbc.M109.059154			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19815558	Green Published, hybrid			2022-12-27	WOS:000272028500009
J	Holm, L; Moody, P; Howarth, M				Holm, Lotta; Moody, Paul; Howarth, Mark			Electrophilic Affibodies Forming Covalent Bonds to Protein Targets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIBODY FRAGMENTS; CANCER-DETECTION; PHAGE-DISPLAY; AFFINITY; ANTIGEN; LIGAND; SITE; SENSITIVITY; COMPLEXES; MOLECULES	Antibody affinity limits sensitivity of detection in many areas of biology and medicine. High affinity usually depends on achieving the optimal combination of the natural 20 amino acids in the antibody binding site. Here, we investigate the effect on recognition of protein targets of placing an unnatural electrophile adjacent to the target binding site. We positioned a weak electrophile, acrylamide, near the binding site between an affibody, a non-immunoglobulin binding scaffold, and its protein target. The proximity between cysteine, lysine, or histidine on the target protein drove covalent bond formation to the electrophile on the affibody. Covalent bonds did not form to a non-interacting point mutant of the target, and there was minimal cross-reactivity with serum, cell lysate, or when imaging at the cell surface. Electrophilic affibodies showed more stable protein imaging at the surface of mammalian cells, and the sensitivity of protein detection in an immunoassay improved by two orders of magnitude. Thus electrophilic affibodies combined good specificity with improved detection of protein targets.	[Holm, Lotta; Moody, Paul; Howarth, Mark] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Oxford	Howarth, M (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	mark.howarth@bioch.ox.ac.uk		Moody, Paul/0000-0002-0191-2912	Biotechnology and Biological Sciences Research Council; Engineering and Physical Sciences Research Council; Medical Research Council; Ministry of Defence through the Bionanotechnology Interdisciplinary Research Centre; Oxford University Department of Biochemistry; Worcester College, Oxford	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ministry of Defence through the Bionanotechnology Interdisciplinary Research Centre; Oxford University Department of Biochemistry; Worcester College, Oxford	This work was supported by the Biotechnology and Biological Sciences Research Council, Engineering and Physical Sciences Research Council, Medical Research Council, and Ministry of Defence through the Bionanotechnology Interdisciplinary Research Centre, by the Oxford University Department of Biochemistry, and by Worcester College, Oxford.	AHMED AK, 1975, J BIOL CHEM, V250, P8477; ALBERINI CM, 1990, NATURE, V347, P485, DOI 10.1038/347485a0; Allain JP, 2003, TRANSFUS CLIN BIOL, V10, P1, DOI 10.1016/S1246-7820(02)00276-8; Barbas CF, 1997, SCIENCE, V278, P2085, DOI 10.1126/science.278.5346.2085; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Boder ET, 2000, P NATL ACAD SCI USA, V97, P10701, DOI 10.1073/pnas.170297297; Cheng MMC, 2006, CURR OPIN CHEM BIOL, V10, P11, DOI 10.1016/j.cbpa.2006.01.006; Chmura AJ, 2001, P NATL ACAD SCI USA, V98, P8480, DOI 10.1073/pnas.151260298; Cohen MS, 2005, SCIENCE, V308, P1318, DOI 10.1126/science1108367; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; Eklund M, 2002, PROTEINS, V48, P454, DOI 10.1002/prot.10169; Erlanson DA, 2000, P NATL ACAD SCI USA, V97, P9367, DOI 10.1073/pnas.97.17.9367; Evans MJ, 2005, NAT BIOTECHNOL, V23, P1303, DOI 10.1038/nbt1149; FLEET GWJ, 1972, BIOCHEM J, V128, P499, DOI 10.1042/bj1280499; FOOTE J, 1995, P NATL ACAD SCI USA, V92, P1254, DOI 10.1073/pnas.92.5.1254; Fry DW, 1998, P NATL ACAD SCI USA, V95, P12022, DOI 10.1073/pnas.95.20.12022; Fukuchi S, 2001, J MOL BIOL, V309, P835, DOI 10.1006/jmbi.2001.4718; Gama Lucio, 2002, Methods Mol Biol, V182, P77; Georganopoulou DG, 2005, P NATL ACAD SCI USA, V102, P2273, DOI 10.1073/pnas.0409336102; Griffiths AD, 1998, CURR OPIN BIOTECH, V9, P102, DOI 10.1016/S0958-1669(98)80092-X; Hober S, 2007, J CHROMATOGR B, V848, P40, DOI 10.1016/j.jchromb.2006.09.030; Hogbom M, 2003, P NATL ACAD SCI USA, V100, P3191, DOI 10.1073/pnas.0436100100; Houk KN, 2003, ANGEW CHEM INT EDIT, V42, P4872, DOI 10.1002/anie.200200565; Howarth M, 2008, NAT PROTOC, V3, P534, DOI 10.1038/nprot.2008.20; JACKSON TM, 1986, J IMMUNOL METHODS, V87, P13, DOI 10.1016/0022-1759(86)90338-8; JI LL, 1993, J APPL PHYSIOL, V74, P788, DOI 10.1152/jappl.1993.74.2.788; Jung YW, 2009, ANAL CHEM, V81, P936, DOI 10.1021/ac8014565; Lendel C, 2004, PROTEIN SCI, V13, P2078, DOI 10.1110/ps.04728604; Levitsky K, 2005, CHEMBIOCHEM, V6, P890, DOI 10.1002/cbic.200400383; Li XY, 2004, ANGEW CHEM INT EDIT, V43, P4848, DOI 10.1002/anie.200400656; Lipovsek D, 2004, J IMMUNOL METHODS, V290, P51, DOI 10.1016/j.jim.2004.04.008; LoPachin RM, 2008, TOXICOL SCI, V104, P235, DOI 10.1093/toxsci/kfm301; Maynard JA, 2002, NAT BIOTECHNOL, V20, P597, DOI 10.1038/nbt0602-597; Nam JM, 2004, J AM CHEM SOC, V126, P5932, DOI 10.1021/ja049384+; Nishiyama Y, 2007, J BIOL CHEM, V282, P31250, DOI 10.1074/jbc.M706471200; Orlova A, 2007, CANCER BIOTHER RADIO, V22, P573, DOI 10.1089/cbr.2006.004-U; Parekh DJ, 2007, J UROLOGY, V178, P2252, DOI 10.1016/j.juro.2007.08.055; Platani M, 2002, NAT CELL BIOL, V4, P502, DOI 10.1038/ncb809; Qiu J, 2009, CLIN LAB MED, V29, P31, DOI 10.1016/j.cll.2009.01.002; Schmidt B, 2006, BIOCHEMISTRY-US, V45, P7429, DOI 10.1021/bi0603064; Schwesinger F, 2000, P NATL ACAD SCI USA, V97, P9972, DOI 10.1073/pnas.97.18.9972; Trisler K, 2007, J BIOL CHEM, V282, P26344, DOI 10.1074/jbc.M704675200; Tsukiji S, 2009, NAT CHEM BIOL, V5, P341, DOI 10.1038/nchembio.157; Wahlberg E, 2003, P NATL ACAD SCI USA, V100, P3185, DOI 10.1073/pnas.0436086100; Way JC, 2000, CURR OPIN CHEM BIOL, V4, P40, DOI 10.1016/S1367-5931(99)00049-6; Weisman LE, 2009, CURR OPIN MOL THER, V11, P208; Zheng GF, 2005, NAT BIOTECHNOL, V23, P1294, DOI 10.1038/nbt1138	47	24	31	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32906	32913		10.1074/jbc.M109.034322	http://dx.doi.org/10.1074/jbc.M109.034322			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19759009	Green Published, hybrid			2022-12-27	WOS:000272028400074
J	Sager, C; Terhag, J; Kott, S; Hollmann, M				Sager, Charlotte; Terhag, Jan; Kott, Sabine; Hollmann, Michael			C-terminal Domains of Transmembrane alpha-Amino-3-hydroxy-5-methyl-4-isoxazole Propionate (AMPA) Receptor Regulatory Proteins Not Only Facilitate Trafficking but Are Major Modulators of AMPA Receptor Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTAMATE-RECEPTOR; STARGAZIN; SUBUNITS; MUTATION; DESENSITIZATION; ISOFORM; PSD-95; FAMILY; BLOCK	alpha-Amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)type glutamate receptors are essential players in fast synaptic transmission in the vertebrate central nervous system. Their synaptic delivery and localization as well as their electrophysiological properties are regulated by transmembrane AMPA receptor regulatory proteins (TARPs). However, the exact mechanisms of how the four originally designated TARPs (gamma 2, gamma 3, gamma 4, and gamma 8) modulate AMPA receptor function remain largely unknown. Previous studies suggested the C-terminal domain (CTD) of gamma 2 to mediate increased trafficking and reduced desensitization of AMPA receptors. As it remained unclear whether these findings extend to other TARPs, we set out to investigate and compare the role of the CTDs of the four original TARPs in AMPA receptor modulation. To address this issue, we replaced the TARP CTDs with the CTD of the homologous subunit gamma 1, a voltage-dependent calcium channel subunit expressed in skeletal muscle that lacks TARP properties. We analyzed the impact of the resulting chimeras on GluR1 functional properties in Xenopus oocytes and HEK293 cells. Interestingly, the CTDs of all TARPs not only modulate the extent and kinetics of desensitization but also modulate agonist potencies of AMPA receptors. Furthermore, the CTDs are required for TARP-induced modulation of AMPA receptor gating, including conversion of antagonists to partial agonists and constitutive channel openings. Strikingly, we found a special role of the cytoplasmic tail of gamma 4, suggesting that the underlying mechanisms of modulation of AMPA receptor function are different among the TARPs. We propose that the intracellularly located CTD is the origin of TARP-specific functional modulation and not merely a facilitator of trafficking.	[Sager, Charlotte; Terhag, Jan] Ruhr Univ Bochum, Ruhr Univ Res Sch, D-44780 Bochum, Germany; [Terhag, Jan] Deutsch Forsch Gemeinschaft, D-44780 Bochum, Germany; [Sager, Charlotte; Terhag, Jan; Kott, Sabine; Hollmann, Michael] Ruhr Univ Bochum, Dept Biochem Receptor Biochem 1, D-44780 Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Hollmann, M (corresponding author), Ruhr Univ Bochum, Dept Biochem 1, Bldg NC,Rm 6-171,Univ Str 150, D-44780 Bochum, Germany.	Michael.Hollmann@rub.de			Deutsche Forschungsgemeinschaft [HO 1118/11-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant HO 1118/11-1.	Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Bedoukian MA, 2008, J BIOL CHEM, V283, P1597, DOI 10.1074/jbc.M708141200; Brorson JR, 2004, J NEUROSCI, V24, P3461, DOI 10.1523/JNEUROSCI.5023-03.2004; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Cho CH, 2007, NEURON, V55, P890, DOI 10.1016/j.neuron.2007.08.024; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Chu PJ, 2001, GENE, V280, P37, DOI 10.1016/S0378-1119(01)00738-7; Cokic B, 2008, NEUROPHARMACOLOGY, V54, P1062, DOI 10.1016/j.neuropharm.2008.02.012; Hollmann M, 1999, HANDB EXP PHARM, V141, P3; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HONORE T, 1988, SCIENCE, V241, P701, DOI 10.1126/science.2899909; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Kato AS, 2008, NEURON, V59, P986, DOI 10.1016/j.neuron.2008.07.034; Kato AS, 2007, J NEUROSCI, V27, P4969, DOI 10.1523/JNEUROSCI.5561-06.2007; Korber C, 2007, J NEUROSCI, V27, P8442, DOI 10.1523/JNEUROSCI.0424-07.2007; Kohda K, 2000, NAT NEUROSCI, V3, P315, DOI 10.1038/73877; Kott S, 2009, NEUROSCIENCE, V158, P78, DOI 10.1016/j.neuroscience.2007.12.047; Kott S, 2007, J NEUROSCI, V27, P3780, DOI 10.1523/JNEUROSCI.4185-06.2007; Lee J, 2004, BIOTECHNIQUES, V36, P398, DOI 10.2144/04363BM04; Mansour M, 2001, NEURON, V32, P841, DOI 10.1016/S0896-6273(01)00520-7; Menuz K, 2007, SCIENCE, V318, P815, DOI 10.1126/science.1146317; Milstein AD, 2007, NEURON, V55, P905, DOI 10.1016/j.neuron.2007.08.022; Nakagawa T, 2005, NATURE, V433, P545, DOI 10.1038/nature03328; Nicoll RA, 2006, SCIENCE, V311, P1253, DOI 10.1126/science.1123339; Priel A, 2005, J NEUROSCI, V25, P2682, DOI 10.1523/JNEUROSCI.4834-04.2005; Robert A, 2005, J NEUROSCI, V25, P3752, DOI 10.1523/JNEUROSCI.0188-05.2005; Robert A, 2001, J NEUROSCI, V21, P5574, DOI 10.1523/JNEUROSCI.21-15-05574.2001; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Sager C, 2009, NEUROSCIENCE, V158, P45, DOI 10.1016/j.neuroscience.2007.12.046; Schmid SM, 2007, J NEUROSCI, V27, P12230, DOI 10.1523/JNEUROSCI.3175-07.2007; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Soto D, 2007, NAT NEUROSCI, V10, P1260, DOI 10.1038/nn1966; Strutz-Seebohm N, 2006, PFLUG ARCH EUR J PHY, V452, P276, DOI 10.1007/s00424-005-0032-7; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Taverna F, 2000, J BIOL CHEM, V275, P8475, DOI 10.1074/jbc.275.12.8475; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; Tomita S, 2007, NEUROPHARMACOLOGY, V52, P87, DOI 10.1016/j.neuropharm.2006.07.012; Turetsky D, 2005, J NEUROSCI, V25, P7438, DOI 10.1523/JNEUROSCI.1108-05.2005; Vandenberghe W, 2005, P NATL ACAD SCI USA, V102, P485, DOI 10.1073/pnas.0408269102; Villmann C, 1997, J NEUROSCI, V17, P7634, DOI 10.1523/jneurosci.17-20-07634.1997; Villmann C, 1999, EUR J NEUROSCI, V11, P1765, DOI 10.1046/j.1460-9568.1999.00594.x; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Yamazaki M, 2004, NEUROSCI RES, V50, P369, DOI 10.1016/j.neures.2004.10.002; Yelshansky MV, 2004, J NEUROSCI, V24, P4728, DOI 10.1523/JNEUROSCI.0757-04.2004; Ziff EB, 2007, NEURON, V53, P627, DOI 10.1016/j.neuron.2007.02.006	47	13	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32413	32424		10.1074/jbc.M109.039891	http://dx.doi.org/10.1074/jbc.M109.039891			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19773551	Green Published, hybrid			2022-12-27	WOS:000272028400024
J	Valliere-Douglass, JF; Kodama, P; Mujacic, M; Brady, LJ; Wang, W; Wallace, A; Yan, BX; Reddy, P; Treuheit, MJ; Balland, A				Valliere-Douglass, John F.; Kodama, Paul; Mujacic, Mirna; Brady, Lowell J.; Wang, Wes; Wallace, Alison; Yan, Boxu; Reddy, Pranhitha; Treuheit, Michael J.; Balland, Alain			Asparagine-linked Oligosaccharides Present on a Non-consensus Amino Acid Sequence in the C(H)1 Domain of Human Antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTTRANSLATIONAL N-GLYCOSYLATION; VARIABLE REGION GLYCOSYLATION; X-SER/THR SEQUON; MASS-SPECTROMETRY; ENDOPLASMIC-RETICULUM; PROTEIN-C; MS MS; OLIGOSACCHARYLTRANSFERASE; PEPTIDES; IDENTIFICATION	We report that N-linked oligosaccharide structures can be present on an asparagine residue not adhering to the consensus site motif NX(S/T), where X is not proline, described in the literature. We have observed oligosaccharides on a non-consensus asparaginyl residue in the C(H)1 constant domain of IgG1 and IgG2 antibodies. The initial findings were obtained from characterization of charge variant populations evident in a recombinant human antibody of the IgG2 subclass. HPLC-MS results indicated that cation-exchange chromatography acidic variant populations were enriched in antibody with a second glycosylation site, in addition to the well documented canonical glycosylation site located in the C(H)2 domain. Subsequent tryptic and chymotryptic peptide map data indicated that the second glycosylation site was associated with the amino acid sequence TVSWN(162)SGAL in the C(H)1 domain of the antibody. This highly atypical modification is present at levels of 0.5-2.0% on most of the recombinant antibodies that have been tested and has also been observed in IgG1 antibodies derived from human donors. Site-directed mutagenesis of the C(H)1 domain sequence in a recombinant human IgG1 antibody resulted in an increase in non-consensus glycosylation to 3.15%, a greater than 4-fold increase over the level observed in the wild type, by changing the -1 and +1 amino acids relative to the asparagine residue at position 162. We believe that further understanding of the phenomenon of non-consensus glycosylation can be used to gain fundamental insights into the fidelity of the cellular glycosylation machinery.	[Valliere-Douglass, John F.; Kodama, Paul; Mujacic, Mirna; Brady, Lowell J.; Wang, Wes; Wallace, Alison; Yan, Boxu; Reddy, Pranhitha; Treuheit, Michael J.; Balland, Alain] Amgen Inc, Dept Proc & Prod Dev, Seattle, WA 98119 USA	Amgen	Balland, A (corresponding author), Amgen Inc, 1201 Amgen Ct, W Seattle, WA 98119 USA.	ballanda@amgen.com	Valliere-Douglass, John F/F-1618-2013					Angel PM, 2007, RAPID COMMUN MASS SP, V21, P674, DOI 10.1002/rcm.2874; BAUSE E, 1982, BIOCHEM J, V203, P761, DOI 10.1042/bj2030761; BAUSE E, 1979, FEBS LETT, V108, P341, DOI 10.1016/0014-5793(79)80559-1; BAUSE E, 1981, BIOCHEM J, V195, P639, DOI 10.1042/bj1950639; Bause E, 1995, BIOCHEM J, V312, P979, DOI 10.1042/bj3120979; Bolt G, 2005, GLYCOBIOLOGY, V15, P541, DOI 10.1093/glycob/cwi032; Breuer W, 2001, FEBS LETT, V501, P106, DOI 10.1016/S0014-5793(01)02641-2; BREUER W, 1995, EUR J BIOCHEM, V228, P689, DOI 10.1111/j.1432-1033.1995.0689m.x; Chalkley RJ, 2001, J AM SOC MASS SPECTR, V12, P1106, DOI 10.1016/S1044-0305(01)00295-1; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; GONZALEZ J, 1992, ANAL BIOCHEM, V205, P151, DOI 10.1016/0003-2697(92)90592-U; GRINNELL BW, 1991, J BIOL CHEM, V266, P9778; Holland M, 2006, BBA-GEN SUBJECTS, V1760, P669, DOI 10.1016/j.bbagen.2005.11.021; HUDDLESTON MJ, 1993, ANAL CHEM, V65, P877, DOI 10.1021/ac00055a009; IMPERIALI B, 1991, BIOCHEMISTRY-US, V30, P4374, DOI 10.1021/bi00232a002; IMPERIALI B, 1994, J AM CHEM SOC, V116, P8424, DOI 10.1021/ja00097a083; IMPERIALI B, 1992, J AM CHEM SOC, V114, P7944, DOI 10.1021/ja00046a069; IMPERIALI B, 1992, J AM CHEM SOC, V114, P7942, DOI 10.1021/ja00046a068; IVANCIC MM, 2007, 55 ASMS C MASS SPECT; Jefferis R, 2009, NAT REV DRUG DISCOV, V8, P226, DOI 10.1038/nrd2804; Kabat EA, 1991, SEQUENCES PROTEINS I; KASTURI L, 1995, J BIOL CHEM, V270, P14756, DOI 10.1074/jbc.270.24.14756; Marshall R D, 1974, Biochem Soc Symp, P17; MCGINNES LW, 1994, VIROLOGY, V200, P470, DOI 10.1006/viro.1994.1210; Mellquist JL, 1998, BIOCHEMISTRY-US, V37, P6833, DOI 10.1021/bi972217k; Michels DA, 2007, ANAL CHEM, V79, P5963, DOI 10.1021/ac0705521; Mimura Y, 2007, J IMMUNOL METHODS, V326, P116, DOI 10.1016/j.jim.2007.07.014; Petrescu AJ, 2004, GLYCOBIOLOGY, V14, P103, DOI 10.1093/glycob/cwh008; Qu ZX, 1997, GLYCOBIOLOGY, V7, P803, DOI 10.1093/glycob/7.6.803; Qu ZX, 1998, J IMMUNOL METHODS, V213, P131, DOI 10.1016/S0022-1759(97)00192-0; Rapoport TA, 1996, ANNU REV BIOCHEM, V65, P271; Ren D, 2007, J CHROMATOGR A, V1175, P63, DOI 10.1016/j.chroma.2007.10.005; ROTHMAN JE, 1977, NATURE, V269, P775, DOI 10.1038/269775a0; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Sheeley DM, 1997, ANAL BIOCHEM, V247, P102, DOI 10.1006/abio.1997.2036; SHIBUYA N, 1987, J BIOL CHEM, V262, P1596; Shukla AA, 2007, J CHROMATOGR B, V848, P28, DOI 10.1016/j.jchromb.2006.09.026; Silberstein S, 1996, FASEB J, V10, P849, DOI 10.1096/fasebj.10.8.8666161; STENFLO J, 1982, J BIOL CHEM, V257, P2180; TITANI K, 1986, BIOCHEMISTRY-US, V25, P3171, DOI 10.1021/bi00359a015; Toyoda T, 2002, J BIOCHEM, V131, P511, DOI 10.1093/oxfordjournals.jbchem.a003128; Toyoda T, 2000, J BIOCHEM-TOKYO, V128, P731, DOI 10.1093/oxfordjournals.jbchem.a022809; Valliere-Douglass JF, 2009, GLYCOBIOLOGY, V19, P144, DOI 10.1093/glycob/cwn116; WRIGHT A, 1991, EMBO J, V10, P2717, DOI 10.1002/j.1460-2075.1991.tb07819.x; WRIGHT A, 1993, SPRINGER SEMIN IMMUN, V15, P259	46	49	52	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32493	32506		10.1074/jbc.M109.014803	http://dx.doi.org/10.1074/jbc.M109.014803			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19767389	hybrid, Green Published			2022-12-27	WOS:000272028400032
J	Zhu, ZQC; Gupta, KK; Slabbekoorn, AR; Paulson, BA; Folker, ES; Goodson, HV				Zhu, Zhiqing C.; Gupta, Kamlesh K.; Slabbekoorn, Aranda R.; Paulson, Benjamin A.; Folker, Eric S.; Goodson, Holly V.			Interactions between EB1 and Microtubules DRAMATIC EFFECT OF AFFINITY TAGS AND EVIDENCE FOR COOPERATIVE BEHAVIOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLUS-END-TRACKING; ALPHA-BETA-TUBULIN; HEXAHISTIDINE-TAG; STRUCTURAL BASIS; PROTEINS; DYNAMICS; BINDING; POLYMERIZATION; CLIP-170; P150(GLUED)	Plus end tracking proteins (+TIPs) are a unique group of microtubule binding proteins that dynamically track microtubule (MT) plus ends. EB1 is a highly conserved +TIP with a fundamental role in MT dynamics, but it remains poorly understood in part because reported EB1 activities have differed considerably. One reason for this inconsistency could be the variable presence of affinity tags used for EB1 purification. To address this question and establish the activity of native EB1, we have measured the MT binding and tubulin polymerization activities of untagged EB1 and EB1 fragments and compared them with those of His-tagged EB1 proteins. We found that N-terminal His tags directly influence the interaction between EB1 and MTs, significantly increasing both affinity and activity, and that small amounts of His-tagged proteins act synergistically with larger amounts of untagged proteins. Moreover, the binding ratio between EB1 and tubulin can exceed 1:1, and EB1-MT binding curves do not fit simple binding models. These observations demonstrate that EB1 binding is not limited to the MT seam, and they suggest that EB1 binds cooperatively to MTs. Finally, we found that removal of tubulin C-terminal tails significantly reduces EB1 binding, indicating that EB1-tubulin interactions are mediated in part by the same tubulin acidic tails utilized by other MAPs. These binding relationships are important for helping to elucidate the complex of proteins at the MT tip.	[Zhu, Zhiqing C.; Gupta, Kamlesh K.; Slabbekoorn, Aranda R.; Paulson, Benjamin A.; Goodson, Holly V.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Folker, Eric S.] Columbia Univ, Dept Anat & Cell Biol, New York, NY 11032 USA	University of Notre Dame; Columbia University	Goodson, HV (corresponding author), Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA.	hgoodson@nd.edu	Goodson, Holly/AAE-6079-2022	Goodson, Holly/0000-0001-7942-8349; Folker, Eric/0000-0003-1619-7330	National Institutes of Health [R01 GM065420]; Notre Dame Grace Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065420] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Notre Dame Grace Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM065420 (to H. V. G.). This work was also supported by a Notre Dame Grace Fellowship (to Z. Z.).	Akhmanova A, 2005, CURR OPIN CELL BIOL, V17, P47, DOI 10.1016/j.ceb.2004.11.001; Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Akhmanova A, 2009, TRAFFIC, V10, P268, DOI 10.1111/j.1600-0854.2008.00869.x; Al-Bassam J, 2002, J CELL BIOL, V157, P1187, DOI 10.1083/jcb.200201048; Amor-Mahjoub M, 2006, J CHROMATOGR B, V844, P328, DOI 10.1016/j.jchromb.2006.07.031; ANDERSEN SSL, 1994, J CELL BIOL, V127, P1289, DOI 10.1083/jcb.127.5.1289; Caviston JP, 2006, TRENDS CELL BIOL, V16, P530, DOI 10.1016/j.tcb.2006.08.002; Chant A, 2005, PROTEIN EXPRES PURIF, V39, P152, DOI 10.1016/j.pep.2004.10.017; des Georges A, 2008, NAT STRUCT MOL BIOL, V15, P1102, DOI 10.1038/nsmb.1482; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Devred F, 2004, BIOCHEMISTRY-US, V43, P10520, DOI 10.1021/bi0493160; Dixit R, 2009, P NATL ACAD SCI USA, V106, P492, DOI 10.1073/pnas.0807614106; Folker ES, 2005, MOL BIOL CELL, V16, P5373, DOI 10.1091/mbc.E04-12-1106; Galjart N, 2003, CURR OPIN CELL BIOL, V15, P48, DOI 10.1016/S0955-0674(02)00007-8; Gardner MK, 2008, CURR OPIN CELL BIOL, V20, P64, DOI 10.1016/j.ceb.2007.12.003; GASKIN F, 1974, J MOL BIOL, V89, P737, DOI 10.1016/0022-2836(74)90048-5; Glotzer M, 2009, NAT REV MOL CELL BIO, V10, P9, DOI 10.1038/nrm2609; Goel A, 2000, BBA-GEN SUBJECTS, V1523, P13, DOI 10.1016/S0304-4165(00)00086-6; Gupta KK, 2009, J BIOL CHEM, V284, P6735, DOI 10.1074/jbc.M807675200; Hayashi I, 2005, MOL CELL, V19, P449, DOI 10.1016/j.molcel.2005.06.034; Hayashi I, 2003, J BIOL CHEM, V278, P36430, DOI 10.1074/jbc.M305773200; Honnappa S, 2005, EMBO J, V24, P261, DOI 10.1038/sj.emboj.7600529; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; Junker M, 2006, P NATL ACAD SCI USA, V103, P4918, DOI 10.1073/pnas.0507923103; Kline-Smith SL, 2004, MOL CELL, V15, P317, DOI 10.1016/j.molcel.2004.07.012; Lakamper S, 2006, J MUSCLE RES CELL M, V27, P161, DOI 10.1007/s10974-005-9052-3; Lansbergen G, 2006, TRAFFIC, V7, P499, DOI 10.1111/j.1600-0854.2006.00400.x; Li R, 2008, NAT REV MOL CELL BIO, V9, P860, DOI 10.1038/nrm2522; Ligon LA, 2006, FEBS LETT, V580, P1327, DOI 10.1016/j.febslet.2006.01.050; Ligon LA, 2003, MOL BIOL CELL, V14, P1405, DOI 10.1091/mbc.E02-03-0155; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Manna T, 2008, BIOCHEMISTRY-US, V47, P779, DOI 10.1021/bi701912g; Morrison EE, 2007, CELL MOL LIFE SCI, V64, P307, DOI 10.1007/s00018-007-6360-3; Musch A, 2004, TRAFFIC, V5, P1, DOI 10.1046/j.1600-0854.2003.00149.x; Nakamura M, 2001, CURR BIOL, V11, P1062, DOI 10.1016/S0960-9822(01)00297-4; Nieba L, 1997, ANAL BIOCHEM, V252, P217, DOI 10.1006/abio.1997.2326; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Paborsky LR, 1996, ANAL BIOCHEM, V234, P60, DOI 10.1006/abio.1996.0050; Panda D, 1996, J BIOL CHEM, V271, P29807, DOI 10.1074/jbc.271.47.29807; Peris L, 2006, J CELL BIOL, V174, P839, DOI 10.1083/jcb.200512058; Renn JP, 2008, BIOPOLYMERS, V89, P420, DOI 10.1002/bip.20924; Sandblad L, 2006, CELL, V127, P1415, DOI 10.1016/j.cell.2006.11.025; SAOUDI Y, 1995, J CELL SCI, V108, P357; Skiniotis G, 2004, EMBO J, V23, P989, DOI 10.1038/sj.emboj.7600118; Slep KC, 2005, J CELL BIOL, V168, P587, DOI 10.1083/jcb.200410114; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; Spittle C, 2000, J BIOL CHEM, V275, P20748, DOI 10.1074/jbc.M002597200; Tirnauer JS, 2002, MOL BIOL CELL, V13, P3614, DOI 10.1091/mbc.E02-04-0210; Vaughan KT, 2005, J CELL BIOL, V171, P197, DOI 10.1083/jcb.200509150; Vitre B, 2008, NAT CELL BIOL, V10, P415, DOI 10.1038/ncb1703; Zhu H, 2009, MOL CELLS, V27, P1, DOI 10.1007/s10059-009-0014-2; Zhukovsky EA, 2004, NATURE, V427, P413, DOI 10.1038/427413a	54	39	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32651	32661		10.1074/jbc.M109.013466	http://dx.doi.org/10.1074/jbc.M109.013466			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19778897	Green Published, hybrid			2022-12-27	WOS:000272028400048
J	Baud'huin, M; Duplomb, L; Teletchea, S; Charrier, C; Maillasson, M; Fouassier, M; Heymann, D				Baud'huin, Marc; Duplomb, Laurence; Teletchea, Stephane; Charrier, Celine; Maillasson, Mike; Fouassier, Marc; Heymann, Dominique			Factor VIII-von Willebrand Factor Complex Inhibits Osteoclastogenesis and Controls Cell Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B LIGAND; RECEPTOR ACTIVATOR; CRYSTAL-STRUCTURE; HEMOPHILIC ARTHROPATHY; A1 DOMAIN; BONE MASS; IN-VIVO; OSTEOPROTEGERIN; DISEASE; TRAIL	Factor VIII-von Willebrand factor (FVIII.vWF) complex, a molecule involved in coagulation, can be physically associated with osteoprotegerin (OPG). OPG is an anti-osteoclastic protein and a soluble receptor for the proapoptotic protein TRAIL (tumor necrosis factor-related apoptosis-inducing ligand), suggesting a potential role of FVIII.vWF complex in bone and cancer biology. We, thus, assessed the effects of FVIII.vWF complex on osteoclastogenesis and cell survival. We first evidenced that FVIII.vWF complex inhibited RANKL-induced osteoclastogenesis and enhanced the inhibitory effect of OPG. Interestingly, we revealed by surface plasmon resonance that FVIII.vWF complex bound to RANKL, whereas recombinant FVIII and vWF did not. By modeling, we showed that the OPG binding domain to the A1 domain of vWF was closely located and partially overlapped to its binding site to RANKL. Then, we demonstrated that FVIII.vWF complex cancelled the inhibitory activity of OPG on TRAIL-induced apoptosis and characterized interactions between these molecules. The present work evidenced a direct activity of FVIII.vWF complex on osteoclasts and on induced cell apoptosis, pointing out its potential involvement in physiological bone remodeling or in bone damages associated with severe hemophilia and cancer development.	[Heymann, Dominique] Nantes Atlantique Univ, Univ Nantes, INSERM,U957, Lab Physiopathol Resorpt Osseuse & Therapie Tumeu, F-44035 Nantes, France; [Baud'huin, Marc; Duplomb, Laurence; Teletchea, Stephane; Charrier, Celine; Heymann, Dominique] Univ Nantes, EA3822, F-44035 Nantes, France; [Maillasson, Mike] INSERM, U892, F-44035 Nantes, France; [Maillasson, Mike] IFR26 Ouest Genopole, F-44035 Nantes, France; [Fouassier, Marc] CHU Nantes, Hotel Dieu, Hematol Lab, Ctr Reg Traitement Hemophilie, F-44035 Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes	Heymann, D (corresponding author), 1 Rue Gaston Veil, F-44035 Nantes 1, France.	dominique.heymann@univ-nantes.fr	Téletchéa, Stéphane/B-1082-2009; Téletchéa, Stéphane/N-8897-2019; Baud'huin, Marc/K-8519-2015; Heymann, Dominique/AAC-6014-2019; Charrier, Céline/K-9198-2015	Téletchéa, Stéphane/0000-0002-2402-028X; Téletchéa, Stéphane/0000-0002-2402-028X; Heymann, Dominique/0000-0001-7777-0669; Duplomb, Laurence/0000-0002-5715-3759; Baud'huin, Marc/0000-0002-3357-329X	Region des Pays de la Loire; ANR 2007 INSERM Pathophysiology [R07196NS]	Region des Pays de la Loire(Region Pays de la Loire); ANR 2007 INSERM Pathophysiology(French National Research Agency (ANR))	This work was supported in part by the Region des Pays de la Loire (Program "Ciblage Moleculaire et Applications Therapeutique") and by the ANR 2007 INSERM Pathophysiology of Human Diseases Project R07196NS.	Adachi T, 2006, BIOCHEM BIOPH RES CO, V339, P1178, DOI 10.1016/j.bbrc.2005.11.126; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Astermark J, 1999, BRIT J HAEMATOL, V105, P1109, DOI 10.1046/j.1365-2141.1999.01463.x; Baud'huin M, 2007, CELL MOL LIFE SCI, V64, P2334, DOI 10.1007/s00018-007-7104-0; Bilora F, 2006, CLIN APPL THROMB-HEM, V12, P193, DOI 10.1177/107602960601200207; Bolon B, 2002, CELL MOL LIFE SCI, V59, P1569, DOI 10.1007/s00018-002-8530-7; Bolton-Maggs PHB, 2003, LANCET, V361, P1801, DOI 10.1016/S0140-6736(03)13405-8; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Burgess TL, 1999, J CELL BIOL, V145, P527, DOI 10.1083/jcb.145.3.527; Cheng X, 2004, J BIOL CHEM, V279, P8269, DOI 10.1074/jbc.M309690200; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Degli-Esposti M, 1999, J LEUKOCYTE BIOL, V65, P535, DOI 10.1002/jlb.65.5.535; DEPALMA AF, 1956, ARCH SURG-CHICAGO, V72, P247; Dogan Mutlu, 2005, Support Cancer Ther, V3, P28, DOI 10.3816/SCT.2005.n.022; Dumas JJ, 2004, J BIOL CHEM, V279, P23327, DOI 10.1074/jbc.M401659200; Duplomb L, 2008, ENDOCRINOLOGY, V149, P3688, DOI 10.1210/en.2007-1719; Emery JG, 1998, J BIOL CHEM, V273, P14363, DOI 10.1074/jbc.273.23.14363; Franchini M, 2008, CRIT REV ONCOL HEMAT, V66, P194, DOI 10.1016/j.critrevonc.2007.12.004; Fukuda K, 2002, STRUCTURE, V10, P943, DOI 10.1016/S0969-2126(02)00787-6; Ho-Tin-Noe B, 2008, CANCER RES, V68, P6851, DOI 10.1158/0008-5472.CAN-08-0718; Hollestelle MJ, 2001, THROMB HAEMOSTASIS, V86, P855, DOI 10.1055/s-0037-1616143; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ito S, 2002, J BIOL CHEM, V277, P6631, DOI 10.1074/jbc.M106525200; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kearns AE, 2008, ENDOCR REV, V29, P155, DOI 10.1210/er.2007-0014; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kovacs CS, 2008, TRANSFUS APHER SCI, V38, P33, DOI 10.1016/j.transci.2007.12.003; Lafeber FPJG, 2008, HAEMOPHILIA, V14, P3, DOI 10.1111/j.1365-2516.2008.01732.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LOLLAR P, 1988, J BIOL CHEM, V263, P10451; Maita N, 2003, J BIOL CHEM, V278, P37777, DOI 10.1074/jbc.M305566200; Manco-Johnson MJ, 2007, NEW ENGL J MED, V357, P535, DOI 10.1056/NEJMoa067659; Meeks SL, 2008, BLOOD, V112, P1151, DOI 10.1182/blood-2008-01-132639; Mongkolsapaya J, 1999, NAT STRUCT BIOL, V6, P1048; Nichols WL, 2008, HAEMOPHILIA, V14, P171, DOI 10.1111/j.1365-2516.2007.01643.x; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Pawlinski R, 2008, SEMIN THROMB HEMOST, V34, P182, DOI 10.1055/s-2008-1079258; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Sadler JE, 2005, ANNU REV MED, V56, P173, DOI 10.1146/annurev.med.56.082103.104713; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shahbazi S, 2007, J THROMB HAEMOST, V5, P1956, DOI 10.1111/j.1538-7836.2007.02681.x; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Suva LJ, 2008, AM J PATHOL, V172, P430, DOI 10.2353/ajpath.2008.070417; Theoleyre S, 2004, CYTOKINE GROWTH F R, V15, P457, DOI 10.1016/j.cytogfr.2004.06.004; Tsuda E, 1997, BIOCHEM BIOPH RES CO, V234, P137, DOI 10.1006/bbrc.1997.6603; Valentino LA, 2007, HAEMOPHILIA, V13, P10, DOI 10.1111/j.1365-2516.2007.01534.x; van Durme CMPG, 2008, NETH J MED, V66, P286; Wallny TA, 2007, HAEMOPHILIA, V13, P79, DOI 10.1111/j.1365-2516.2006.01405.x; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Zannettino ACW, 2005, J CELL PHYSIOL, V204, P714, DOI 10.1002/jcp.20354	51	48	53	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31704	31713		10.1074/jbc.M109.030312	http://dx.doi.org/10.1074/jbc.M109.030312			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19758994	Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000271572700025
J	Charrin, S; Yalaoui, S; Bartosch, B; Cocquerel, L; Franetich, JF; Boucheix, C; Mazier, D; Rubinstein, E; Silvie, O				Charrin, Stephanie; Yalaoui, Samir; Bartosch, Birke; Cocquerel, Laurence; Franetich, Jean-Francois; Boucheix, Claude; Mazier, Dominique; Rubinstein, Eric; Silvie, Olivier			The Ig Domain Protein CD9P-1 Down-regulates CD81 Ability to Support Plasmodium yoelii Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATITIS-C-VIRUS; RADIXIN-MOESIN PROTEINS; TETRASPANIN WEB; SCAVENGER RECEPTOR; MEMBRANE-PROTEINS; MALARIA PARASITE; LIVER STAGE; CELL ENTRY; MAJOR CD9; HOST-CELL	Invasion of hepatocytes by Plasmodium sporozoites is a prerequisite for establishment of a malaria natural infection. The molecular mechanisms underlying sporozoite invasion are largely unknown. We have previously reported that CD81 is required on hepatocytes for infection by Plasmodium falciparum and Plasmodium yoelii sporozoites. CD81 belongs to the tetraspanin superfamily of transmembrane proteins. By interacting with each other and with other transmembrane proteins, tetraspanins may play a role in the lateral organization of membrane proteins. In this study, we investigated the role of the two major molecular partners of CD81 in hepatocytic cells, CD9P-1/EWI-F and EWI-2, two transmembrane proteins belonging to a novel subfamily of immunoglobulin proteins. We show that CD9P-1 silencing increases the host cell susceptibility to P. yoelii sporozoite infection, whereas EWI-2 knock-down has no effect. Conversely, overexpression of CD9P-1 but not EWI-2 partially inhibits infection. Using CD81 and CD9P-1 chimeric molecules, we demonstrate the role of transmembrane regions in CD81-CD9P-1 interactions. Importantly, a CD9P-1 chimera that no longer associates with CD81 does not affect infection. Based on these data, we conclude that CD9P-1 acts as a negative regulator of P. yoelii infection by interacting with CD81 and regulating its function.	[Boucheix, Claude; Rubinstein, Eric] Univ Paris Sud, INSERM, U602, F-94807 Villejuif, France; [Charrin, Stephanie; Boucheix, Claude; Rubinstein, Eric] Inst Andre Lwoff, F-94807 Villejuif, France; [Yalaoui, Samir; Franetich, Jean-Francois; Mazier, Dominique; Silvie, Olivier] Univ Paris 06, INSERM, U945, F-75013 Paris, France; [Bartosch, Birke] Univ Lyon 1, F-69007 Lyon, France; INSERM, U758, IFR128, F-69007 Lyon, France; [Cocquerel, Laurence] Univ Lille Nord France, Inst Pasteur, CNRS, Inst Biol Lille,UMR8161, F-59021 Lille, France; [Mazier, Dominique] Grp Hosp Pitie Salpetriere, AP HP, Serv Parasitol Mycol, F-75013 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Rubinstein, E (corresponding author), Hop Paul Brousse, INSERM, U602, 14 Av Paul Vaillant Couturier, F-94807 Villejuif, France.	eric.rubinstein@inserm.fr; silvie@mpiib-berlin.mpg.de	Franetich, Jean-François/GZA-9674-2022; Rubinstein, Eric/B-4650-2019; Silvie, Olivier/AAF-5437-2021; Silvie, Olivier/K-7290-2017; Cocquerel, Laurence/P-1951-2016; CHARRIN, Stephanie/B-2892-2019; Bartosch, Birke/I-7255-2018	Rubinstein, Eric/0000-0001-7623-9665; Silvie, Olivier/0000-0002-0525-6940; Silvie, Olivier/0000-0002-0525-6940; Cocquerel, Laurence/0000-0002-2136-5178; Bartosch, Birke/0000-0001-6354-4660; Boucheix, Claude/0000-0003-4184-7008; Charrin, Stephanie/0000-0002-4942-3990	Association Nouvelle Recherche Biomedicale-Vaincre le Cancer; Association pour la Recherche sur le Cancer; Agence Nationale de Recherche sur le Sida et les Hepatites virales (ANRS); Agence Nationale de la Recherche (ANR); European Union FP5 [QLK2-CT-2002-00774]	Association Nouvelle Recherche Biomedicale-Vaincre le Cancer; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Agence Nationale de Recherche sur le Sida et les Hepatites virales (ANRS)(ANRSFrench National Research Agency (ANR)); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); European Union FP5(European Commission)	This work was supported in part by grants from the Association Nouvelle Recherche Biomedicale-Vaincre le Cancer, the Association pour la Recherche sur le Cancer, the Agence Nationale de Recherche sur le Sida et les Hepatites virales (ANRS), the Agence Nationale de la Recherche (ANR), and by European Union FP5 Contract Number QLK2-CT-2002-00774.	Barreiro O, 2008, J CELL BIOL, V183, P527, DOI 10.1083/jcb.200805076; Bartosch B, 2006, VIROLOGY, V348, P1, DOI 10.1016/j.virol.2005.12.027; Bartosch B, 2003, J BIOL CHEM, V278, P41624, DOI 10.1074/jbc.M305289200; Berditchevski F, 2001, J BIOL CHEM, V276, P41165, DOI 10.1074/jbc.M104041200; Charrin S, 2006, FRONT BIOSCI-LANDMRK, V11, P1987, DOI 10.2741/1940; Charrin S, 2003, BIOCHEM J, V373, P409, DOI 10.1042/BJ20030343; Charrin S, 2001, J BIOL CHEM, V276, P14329, DOI 10.1074/jbc.M011297200; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; Cocquerel L, 2006, J GEN VIROL, V87, P1075, DOI 10.1099/vir.0.81646-0; Coppi A, 2007, CELL HOST MICROBE, V2, P316, DOI 10.1016/j.chom.2007.10.002; Curran AR, 2003, CURR OPIN STRUC BIOL, V13, P412, DOI 10.1016/S0959-440X(03)00102-7; Espenel C, 2008, J CELL BIOL, V182, P765, DOI 10.1083/jcb.200803010; Frevert U, 2004, TRENDS PARASITOL, V20, P417, DOI 10.1016/j.pt.2004.07.007; Gonzalez V, 2009, CELL HOST MICROBE, V5, P259, DOI 10.1016/j.chom.2009.01.011; Guinovart C, 2006, CURR MOL MED, V6, P137, DOI 10.2174/156652406776055131; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Ishino T, 2005, MOL MICROBIOL, V58, P1264, DOI 10.1111/j.1365-2958.2005.04801.x; Kazarov AR, 2002, J CELL BIOL, V158, P1299, DOI 10.1083/jcb.200204056; Kleiger G, 2002, BIOCHEMISTRY-US, V41, P5990, DOI 10.1021/bi0200763; Labaied M, 2007, INFECT IMMUN, V75, P3758, DOI 10.1128/IAI.00225-07; Levy S, 2005, NAT REV IMMUNOL, V5, P136, DOI 10.1038/nri1548; Min GW, 2006, J CELL BIOL, V173, P975, DOI 10.1083/jcb.200602086; Mota MM, 2000, EXP PARASITOL, V96, P257, DOI 10.1006/expr.2000.4570; Pradel G, 2002, MOL MICROBIOL, V45, P637, DOI 10.1046/j.1365-2958.2002.03057.x; Prudencio M, 2006, NAT REV MICROBIOL, V4, P849, DOI 10.1038/nrmicro1529; Rocha-Perugini V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001866; Rodrigues CD, 2008, CELL HOST MICROBE, V4, P271, DOI 10.1016/j.chom.2008.07.012; Sala-Valdes M, 2006, J BIOL CHEM, V281, P19665, DOI 10.1074/jbc.M602116200; Seigneuret M, 2006, BIOPHYS J, V90, P212, DOI 10.1529/biophysj.105.069666; Serru V, 1999, BIOCHEM J, V340, P103, DOI 10.1042/0264-6021:3400103; Silvie O, 2003, NAT MED, V9, P93, DOI 10.1038/nm808; Silvie O, 2008, CURR OPIN MICROBIOL, V11, P352, DOI 10.1016/j.mib.2008.06.005; Silvie O, 2007, INT J PARASITOL, V37, P173, DOI 10.1016/j.ijpara.2006.10.005; Silvie O, 2006, CELL MICROBIOL, V8, P1134, DOI 10.1111/j.1462-5822.2006.00697.x; Silvie O, 2006, J CELL SCI, V119, P1992, DOI 10.1242/jcs.02911; SONEOKA Y, 1995, NUCLEIC ACIDS RES, V23, P628, DOI 10.1093/nar/23.4.628; Stipp CS, 2001, J BIOL CHEM, V276, P40545, DOI 10.1074/jbc.M107338200; Stipp CS, 2001, J BIOL CHEM, V276, P4853, DOI 10.1074/jbc.M009859200; van Schaijk BCL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003549; Yalaoui S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000010; Yalaoui S, 2008, CELL HOST MICROBE, V4, P283, DOI 10.1016/j.chom.2008.07.013; Yang XH, 2006, J BIOL CHEM, V281, P12976, DOI 10.1074/jbc.M510617200	42	14	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31572	31578		10.1074/jbc.M109.057927	http://dx.doi.org/10.1074/jbc.M109.057927			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19762465	Green Published, hybrid			2022-12-27	WOS:000271572700011
J	de Keyzer, J; Steel, GJ; Hale, SJ; Humphries, D; Stirling, CJ				de Keyzer, Jeanine; Steel, Gregor J.; Hale, Sarah J.; Humphries, Daniel; Stirling, Colin J.			Nucleotide Binding by Lhs1p Is Essential for Its Nucleotide Exchange Activity and for Function in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST ENDOPLASMIC-RETICULUM; SHOCK COGNATE PROTEIN; SACCHAROMYCES-CEREVISIAE; MOLECULAR CHAPERONE; CONFORMATIONAL-CHANGE; HSP110 CHAPERONES; HSP70 CHAPERONES; STRUCTURAL BASIS; ATPASE FRAGMENT; TRANSLOCATION	Protein translocation and folding in the endoplasmic reticulum of Saccharomyces cerevisiae involves two distinct Hsp70 chaperones, Lhs1p and Kar2p. Both proteins have the characteristic domain structure of the Hsp70 family consisting of a conserved N-terminal nucleotide binding domain and a C-terminal substrate binding domain. Kar2p is a canonical Hsp70 whose substrate binding activity is regulated by cochaperones that promote either ATP hydrolysis or nucleotide exchange. Lhs1p is a member of the Grp170/Lhs1p subfamily of Hsp70s and was previously shown to function as a nucleotide exchange factor (NEF) for Kar2p. Here we show that in addition to this NEF activity, Lhs1p can function as a holdase that prevents protein aggregation in vitro. Analysis of the nucleotide requirement of these functions demonstrates that nucleotide binding to Lhs1p stimulates the interaction with Kar2p and is essential for NEF activity. In contrast, Lhs1p holdase activity is nucleotide-independent and unaffected by mutations that interfere with ATP binding and NEF activity. In vivo, these mutants show severe protein translocation defects and are unable to support growth despite the presence of a second Kar2p-specific NEF, Sil1p. Thus, Lhs1p-dependent nucleotide exchange activity is vital for ER protein biogenesis in vivo.	[de Keyzer, Jeanine; Steel, Gregor J.; Hale, Sarah J.; Humphries, Daniel; Stirling, Colin J.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Stirling, CJ (corresponding author), Univ Manchester, Fac Life Sci, A4040 Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	colin.stirling@manchester.ac.uk			The Wellcome Trust	The Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by The Wellcome Trust.	Andreasson C, 2008, J BIOL CHEM, V283, P8877, DOI 10.1074/jbc.M710063200; Baxter BK, 1996, MOL CELL BIOL, V16, P6444; CHAPPELL TG, 1987, J BIOL CHEM, V262, P746; Conz C, 2007, J BIOL CHEM, V282, P33977, DOI 10.1074/jbc.M706737200; Corsi AK, 1997, J CELL BIOL, V137, P1483, DOI 10.1083/jcb.137.7.1483; Craven RA, 1996, EMBO J, V15, P2640, DOI 10.1002/j.1460-2075.1996.tb00624.x; Craven RA, 1997, TRENDS CELL BIOL, V7, P277, DOI 10.1016/S0962-8924(97)01079-9; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Dragovic Z, 2006, EMBO J, V25, P2519, DOI 10.1038/sj.emboj.7601138; Easton DP, 2000, CELL STRESS CHAPERON, V5, P276, DOI 10.1379/1466-1268(2000)005<0276:THAGSP>2.0.CO;2; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; FLAHERTY KM, 1994, J BIOL CHEM, V269, P12899; FULLERTON DM, 2004, THESIS U MANCHESTER; GAO BC, 1994, BIOCHEMISTRY-US, V33, P2048, DOI 10.1021/bi00174a010; Hamilton TG, 1996, J BIOL CHEM, V271, P30610, DOI 10.1074/jbc.271.48.30610; Huang P, 2005, NAT STRUCT MOL BIOL, V12, P497, DOI 10.1038/nsmb942; Kabani M, 2000, MOL CELL BIOL, V20, P6923, DOI 10.1128/MCB.20.18.6923-6934.2000; Kabani M, 2003, MOL BIOL CELL, V14, P3437, DOI 10.1091/mbc.E02-12-0847; KASSENBROCK CK, 1989, EMBO J, V8, P1461, DOI 10.1002/j.1460-2075.1989.tb03529.x; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; Liu QL, 2007, CELL, V131, P106, DOI 10.1016/j.cell.2007.08.039; McClellan AJ, 1998, MOL BIOL CELL, V9, P3533, DOI 10.1091/mbc.9.12.3533; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; Oh HJ, 1999, J BIOL CHEM, V274, P15712, DOI 10.1074/jbc.274.22.15712; Park J, 2003, BIOCHEMISTRY-US, V42, P14893, DOI 10.1021/bi030122e; Polier S, 2008, CELL, V133, P1068, DOI 10.1016/j.cell.2008.05.022; Raviol H, 2006, FEBS LETT, V580, P168, DOI 10.1016/j.febslet.2005.11.069; Raviol H, 2006, EMBO J, V25, P2510, DOI 10.1038/sj.emboj.7601139; Saris N, 1997, J CELL BIOL, V137, P813, DOI 10.1083/jcb.137.4.813; SCHMID D, 1994, SCIENCE, V263, P971, DOI 10.1126/science.8310296; Schuermann JP, 2008, MOL CELL, V31, P232, DOI 10.1016/j.molcel.2008.05.006; Shaner L, 2005, J BIOL CHEM, V280, P41262, DOI 10.1074/jbc.M503614200; SIKORSKI RS, 1989, GENETICS, V122, P19; SIMONS JF, 1995, J CELL BIOL, V130, P41, DOI 10.1083/jcb.130.1.41; Steel GJ, 2004, SCIENCE, V303, P98, DOI 10.1126/science.1092287; SZABO A, 1994, P NATL ACAD SCI USA, V91, P10345, DOI 10.1073/pnas.91.22.10345; Theyssen H, 1996, J MOL BIOL, V263, P657, DOI 10.1006/jmbi.1996.0606; Tyson JR, 2000, EMBO J, V19, P6440, DOI 10.1093/emboj/19.23.6440; VOGEL JP, 1990, J CELL BIOL, V110, P1885, DOI 10.1083/jcb.110.6.1885; WEI JY, 1995, J BIOL CHEM, V270, P26677, DOI 10.1074/jbc.270.44.26677; Weitzmann A, 2006, FEBS LETT, V580, P5237, DOI 10.1016/j.febslet.2006.08.055; Wilkinson BM, 2000, J BIOL CHEM, V275, P521, DOI 10.1074/jbc.275.1.521	42	29	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31564	31571		10.1074/jbc.M109.055160	http://dx.doi.org/10.1074/jbc.M109.055160			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19759005	Green Published, hybrid			2022-12-27	WOS:000271572700010
J	Jost, R; Berkowitz, O; Shaw, J; Masle, J				Jost, Ricarda; Berkowitz, Oliver; Shaw, John; Masle, Josette			Biochemical Characterization of Two Wheat Phosphoethanolamine N-Methyltransferase Isoforms with Different Sensitivities to Inhibition by Phosphatidic Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOSYL-L-METHIONINE; ARABIDOPSIS PHOSPHOLIPASE-D; PHOSPHATIDYLCHOLINE BIOSYNTHESIS; PLASMODIUM-FALCIPARUM; CHOLINE SYNTHESIS; SALT STRESS; PHOSPHOCHOLINE BIOSYNTHESIS; CAENORHABDITIS-ELEGANS; KINETIC-ANALYSIS; LOW-TEMPERATURE	In plants the triple methylation of phosphoethanolamine to phosphocholine catalyzed by phosphoethanolamine N-methyltransferase (PEAMT) is considered a rate-limiting step in the de novo synthesis of phosphatidylcholine. Besides being a major membrane phospholipid, phosphatidylcholine can be hydrolyzed into choline and phosphatidic acid. Phosphatidic acid is widely recognized as a second messenger in stress signaling, and choline can be oxidized within the chloroplast to yield the putative osmoprotectant glycine betaine. Here we describe the cloning and biochemical characterization of a second wheat PEAMT isoform that has a four times higher specific activity than the previously described WPEAMT/TaPEAMT1 enzyme and is less sensitive to product inhibition by S-adenosyl homocysteine, but more sensitive to inhibition by phosphocholine. Both enzymes follow a sequential random Bi Bi mechanism and show mixed-type product inhibition patterns with partial inhibition for TaPEAMT1 and a strong non-competitive component for TaPEAMT2. An induction of TaPEAMT protein expression and activity is observed after cold exposure, ahead of an increase in gene expression. Our results demonstrate direct repression of in vitro enzymatic activities by phosphatidic acid for both enzymes, with TaPEAMT1 being more sensitive than TaPEAMT2 in the physiological concentration range. Other lipid ligands identified in protein-lipid overlays are phosphoinositide mono-as well as some di-phosphates and cardiolipin. These results provide new insights into the complex regulatory circuits of phospholipid biosynthesis in plants and underline the importance of head group biosynthesis in adaptive stress responses.	[Jost, Ricarda; Berkowitz, Oliver; Shaw, John; Masle, Josette] Australian Natl Univ, Environm Biol Grp, Res Sch Biol Sci, Canberra, ACT 0200, Australia	Australian National University	Masle, J (corresponding author), Australian Natl Univ, Environm Biol Grp, Res Sch Biol Sci, GPO Box 475, Canberra, ACT 0200, Australia.	josette.masle@anu.edu.au	Berkowitz, Oliver/A-7854-2008; Jost, Ricarda/B-1254-2011; Berkowitz, Oliver/AAE-7979-2019	Berkowitz, Oliver/0000-0002-7671-6983; Jost, Ricarda/0000-0002-3819-6358; Berkowitz, Oliver/0000-0002-7671-6983	Australian National University; Grains Research and Development Corporation	Australian National University(Australian National University); Grains Research and Development Corporation(Grains R&D Corp)	This work was supported by the Australian National University and the Grains Research and Development Corporation.	Allard F, 1998, PLANT CELL PHYSIOL, V39, P1194, DOI 10.1093/oxfordjournals.pcp.a029320; Ashraf M, 2007, ENVIRON EXP BOT, V59, P206, DOI 10.1016/j.envexpbot.2005.12.006; Bargmann BOR, 2009, PLANT CELL PHYSIOL, V50, P78, DOI 10.1093/pcp/pcn173; Berkowitz O, 2008, PLANT CELL, V20, P3430, DOI 10.1105/tpc.108.061010; Bolognese CP, 2000, PLANT PHYSIOL, V124, P1800, DOI 10.1104/pp.124.4.1800; Brendza KM, 2007, BIOCHEM J, V404, P439, DOI 10.1042/BJ20061815; Charron JBF, 2002, PLANT PHYSIOL, V129, P363, DOI 10.1104/pp.001776; Chen THH, 2008, TRENDS PLANT SCI, V13, P499, DOI 10.1016/j.tplants.2008.06.007; Chen Z, 2007, J EXP BOT, V58, P4245, DOI 10.1093/jxb/erm284; Corvera S, 1999, CURR OPIN CELL BIOL, V11, P460, DOI 10.1016/S0955-0674(99)80066-0; Cruz-Ramirez A, 2004, PLANT CELL, V16, P2020, DOI 10.1105/tpc.103.018648; DOWLER S, 2002, SCI STKE, pPL6, DOI DOI 10.1126/STKE.2002.129.PL6; Droppa M, 1995, PHOTOSYNTH RES, V46, P287, DOI 10.1007/BF00020442; HANSON AD, 1983, PLANT PHYSIOL, V71, P692, DOI 10.1104/pp.71.3.692; Hayden CA, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-32; HENDERSON PJF, 1993, ENZYME ASSAYS PRACTI, P276; HITZ WD, 1981, PLANT PHYSIOL, V68, P814, DOI 10.1104/pp.68.4.814; Hoagland DR, 1941, SOIL SCI, V51, P431, DOI 10.1097/00010694-194106000-00002; HORVATH I, 1979, PHYSIOL PLANTARUM, V45, P57, DOI 10.1111/j.1399-3054.1979.tb01663.x; Inatsugi R, 2002, PLANT CELL PHYSIOL, V43, P1342, DOI 10.1093/pcp/pcf169; JONES RGW, 1981, PHYSL BIOCH DROUGHT, P172; Jost R, 2007, BIOTECHNIQUES, V43, P206, DOI 10.2144/000112534; Katagiri T, 2001, PLANT J, V26, P595, DOI 10.1046/j.1365-313x.2001.01060.x; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; KENT C, 1995, ANNU REV BIOCHEM, V64, P315, DOI 10.1146/annurev.bi.64.070195.001531; Li MY, 2006, PLANT PHYSIOL, V142, P750, DOI 10.1104/pp.106.085647; Lorenzin D, 2001, CAN J BOT, V79, P897, DOI 10.1139/cjb-79-8-897; MCDONNELL E, 1988, J EXP BOT, V39, P421, DOI 10.1093/jxb/39.4.421; McNeil SD, 2000, PLANT PHYSIOL, V123, P371, DOI 10.1104/pp.123.1.371; Meijer HJG, 2001, BIOCHEM J, V360, P491, DOI 10.1042/0264-6021:3600491; Meijer HJG, 2003, ANNU REV PLANT BIOL, V54, P265, DOI 10.1146/annurev.arplant.54.031902.134748; Michel V, 2006, EXP BIOL MED, V231, P490; Moffatt BA, 2001, PHYSIOL PLANTARUM, V113, P435, DOI 10.1034/j.1399-3054.2001.1130401.x; Mou ZL, 2002, PLANT CELL, V14, P2031, DOI 10.1105/tpc.001701; Nuccio ML, 2000, J BIOL CHEM, V275, P14095, DOI 10.1074/jbc.275.19.14095; Palavalli LH, 2006, BIOCHEMISTRY-US, V45, P6056, DOI 10.1021/bi060199d; Park J, 2004, PLANT PHYSIOL, V134, P129, DOI 10.1104/pp.103.031393; Perera IY, 2005, FEBS LETT, V579, P3427, DOI 10.1016/j.febslet.2005.05.018; Pessi G, 2004, P NATL ACAD SCI USA, V101, P6206, DOI 10.1073/pnas.0307742101; Potocky M, 2003, PLANTA, V217, P122, DOI 10.1007/s00425-002-0965-4; Qin CB, 2002, J BIOL CHEM, V277, P49685, DOI 10.1074/jbc.M209598200; RHODES D, 1993, ANNU REV PLANT PHYS, V44, P357, DOI 10.1146/annurev.pp.44.060193.002041; Rontein D, 2001, J BIOL CHEM, V276, P35523, DOI 10.1074/jbc.M106038200; Sawicki A, 2007, BIOCHEM J, V406, P469, DOI 10.1042/BJ20070284; Segel IH, 1975, ENZYME KINETICS BEHA; Smith DD, 2000, PHYSIOL PLANTARUM, V108, P286, DOI 10.1034/j.1399-3054.2000.108003286.x; SUMMERS PS, 1993, PLANT PHYSIOL, V103, P1269, DOI 10.1104/pp.103.4.1269; Tabuchi T, 2005, PLANT CELL PHYSIOL, V46, P505, DOI 10.1093/pcp/pci050; Tabuchi T, 2006, BIOSCI BIOTECH BIOCH, V70, P2330, DOI 10.1271/bbb.60309; TANAKA K, 1966, PLANT PHYSIOL, V41, P307, DOI 10.1104/pp.41.2.307; Tasseva G, 2004, PLANT PHYSIOL BIOCH, V42, P811, DOI 10.1016/j.plaphy.2004.10.001; Tasseva G, 2004, FEBS LETT, V566, P115, DOI 10.1016/j.febslet.2004.04.015; Thole JM, 2008, CURR OPIN PLANT BIOL, V11, P620, DOI 10.1016/j.pbi.2008.10.010; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Weretilnyk EA, 2001, PLANT PHYSIOL, V125, P856, DOI 10.1104/pp.125.2.856; Witola WH, 2006, J BIOL CHEM, V281, P21305, DOI 10.1074/jbc.M603260200; Witola WH, 2008, J BIOL CHEM, V283, P27636, DOI 10.1074/jbc.M804360200; Witola WH, 2007, EUKARYOT CELL, V6, P1618, DOI 10.1128/EC.00229-07; Wu SW, 2007, MOL BIOTECHNOL, V36, P102, DOI 10.1007/s12033-007-0009-1; WYNJONES RG, 1978, AUST J PLANT PHYSIOL, V5, P839, DOI 10.1071/PP9780801; YANG WJ, 1995, PLANT PHYSIOL, V107, P621, DOI 10.1104/pp.107.2.621	61	29	32	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31962	31971		10.1074/jbc.M109.022657	http://dx.doi.org/10.1074/jbc.M109.022657			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19762471	hybrid, Green Published			2022-12-27	WOS:000271572700052
J	Yoo, BH; Wu, X; Li, YL; Haniff, M; Sasazuki, T; Shirasawa, S; Eskelinen, EL; Rosen, KV				Yoo, Byong Hoon; Wu, Xue; Li, Yongling; Haniff, Mehnaaz; Sasazuki, Takehiko; Shirasawa, Senji; Eskelinen, Eeva-Liisa; Rosen, Kirill V.			Oncogenic ras-induced Down-regulation of Autophagy Mediator Beclin-1 Is Required for Malignant Transformation of Intestinal Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; ANOIKIS RESISTANCE; COLORECTAL-CANCER; K-RAS; PANCREATIC ADENOCARCINOMA; FAMILY PROTEINS; ACTIVATED RAS; CYCLE ARREST; IN-VIVO; GROWTH	Detachment of non-malignant epithelial cells from the extracellular matrix causes their growth arrest and, ultimately, death. By contrast, cells composing carcinomas, cancers of epithelial origin, can survive and proliferate without being attached to the extracellular matrix. These properties of tumor cells represent hallmarks of malignant transformation and are critical for cancer progression. Previously we identified several mechanisms by which ras, a major oncogene, blocks detachment-induced apoptosis of intestinal epithelial cells, but mechanisms by which Ras promotes proliferation of those cells that remain viable following detachment are unknown. We show here that detachment of non-malignant intestinal epithelial cells promotes formation of autophagosomes, vacuole-like structures that mediate autophagy (a process of cellular self-cannibalization), and that oncogenic ras prevents this autophagosome formation. We also found that ras activates a GTPase RhoA, that RhoA promotes activation of a protease calpain, and that calpain triggers degradation of Beclin-1, a critical mediator of autophagy, in these cells. The reversal of the effect of ras on Beclin-1 (achieved by expression of exogenous Beclin-1) promoted autophagosome formation following cell detachment, significantly reduced the fraction of detached cells in the S phase of the cell cycle and their rate of proliferation without affecting their viability. Furthermore, RNA interference-induced Beclin-1 down-regulation in non-malignant intestinal epithelial cells prevented detachment-dependent reduction of the fraction of these cells in the S phase of the cell cycle. Thus, ras oncogene promotes proliferation of those malignant intestinal epithelial cells that remain viable following detachment via a distinct novel mechanism that involves Ras-induced down-regulation of Beclin-1.	[Rosen, Kirill V.] Dalhousie Univ, Atlantic Res Ctr, CRC, Dept Pediat & Biochem, Halifax, NS B3H 4H7, Canada; [Yoo, Byong Hoon; Wu, Xue; Li, Yongling; Haniff, Mehnaaz; Rosen, Kirill V.] Dalhousie Univ, Atlantic Res Ctr, Dept Mol Biol, Halifax, NS B3H 4H7, Canada; [Sasazuki, Takehiko] Int Med Ctr Japan, Dept Pathol, Res Inst, Tokyo 1628655, Japan; [Shirasawa, Senji] Fukuoka Univ, Sch Med, Dept Cell Biol, Fukuoka 8140180, Japan; [Eskelinen, Eeva-Liisa] Univ Helsinki, Div Biochem, Dept Biol & Environm Sci, FIN-00014 Helsinki, Finland	Dalhousie University; Dalhousie University; National Center for Global Health & Medicine - Japan; Fukuoka University; University of Helsinki	Rosen, KV (corresponding author), Dalhousie Univ, Atlantic Res Ctr, CRC, Dept Pediat & Biochem, Rm C-302,5849 Univ Ave, Halifax, NS B3H 4H7, Canada.	kirill.rosen@dal.ca	Eskelinen, Eeva-Liisa/AAF-3496-2019	Eskelinen, Eeva-Liisa/0000-0003-0006-7785; Rosen, Kirill/0000-0002-4317-9907	Canadian Cancer Society Research Institute	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS))	This work was supported by a grant from the Canadian Cancer Society Research Institute (formerly the National Cancer Institute of Canada).	Aita VM, 1999, GENOMICS, V59, P59, DOI 10.1006/geno.1999.5851; Benaud CM, 2001, ONCOGENE, V20, P4554, DOI 10.1038/sj.onc.1204609; Berezovskaya O, 2005, CANCER RES, V65, P2378, DOI 10.1158/0008-5472.CAN-04-2649; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; Brink M, 2003, CARCINOGENESIS, V24, P703, DOI 10.1093/carcin/bgg009; Carragher NO, 2004, NEOPLASIA, V6, P53, DOI 10.1016/S1476-5586(04)80053-8; Chen JC, 2003, J BIOL CHEM, V278, P2807, DOI 10.1074/jbc.M207943200; Cox AD, 2003, ONCOGENE, V22, P8999, DOI 10.1038/sj.onc.1207111; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Derouet M, 2007, NEOPLASIA, V9, P536, DOI 10.1593/neo.07217; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Duxbury MS, 2004, ONCOGENE, V23, P465, DOI 10.1038/sj.onc.1207036; Duxbury MS, 2004, ONCOGENE, V23, P1448, DOI 10.1038/sj.onc.1207247; Edkins S, 2006, CANCER BIOL THER, V5, P928, DOI 10.4161/cbt.5.8.3251; Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270; FILMUS J, 1994, ONCOGENE, V9, P3627; FREEDMAN VH, 1974, CELL, V3, P355, DOI 10.1016/0092-8674(74)90050-6; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hoyer-Hansen M, 2005, CELL DEATH DIFFER, V12, P1297, DOI 10.1038/sj.cdd.4401651; Jacks T, 2002, CELL, V111, P923, DOI 10.1016/S0092-8674(02)01229-1; Jiang K, 2004, MOL CELL BIOL, V24, P5565, DOI 10.1128/MCB.24.12.5565-5576.2004; KhosraviFar R, 1998, ADV CANCER RES, V72, P57; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Lakshmikuttyamma A, 2004, CANCER EPIDEM BIOMAR, V13, P1604; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Li BX, 2009, AUTOPHAGY, V5, P303, DOI 10.4161/auto.5.3.7491; Li HB, 2009, J BIOL CHEM, V284, P2012, DOI 10.1074/jbc.M805612200; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liu ZP, 2006, J BIOL CHEM, V281, P14738, DOI 10.1074/jbc.M508664200; Liu ZP, 2005, J BIOL CHEM, V280, P37383, DOI 10.1074/jbc.M503724200; LJUBIMOV AV, 1992, INT J CANCER, V50, P562, DOI 10.1002/ijc.2910500412; Lu YL, 1999, ONCOGENE, V18, P7034, DOI 10.1038/sj.onc.1203183; MCCARTY KS, 1986, CANCER RES, V46, P4244; Orford K, 1999, J CELL BIOL, V146, P855, DOI 10.1083/jcb.146.4.855; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pollock CB, 2005, CANCER RES, V65, P1244, DOI 10.1158/0008-5472.CAN-04-1911; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; RAK J, 1995, J CELL BIOL, V131, P1587, DOI 10.1083/jcb.131.6.1587; Rosen K, 1998, CURR BIOL, V8, P1331, DOI 10.1016/S0960-9822(07)00564-7; Rosen K, 2000, J CELL BIOL, V149, P447, DOI 10.1083/jcb.149.2.447; Rosen K, 2001, J BIOL CHEM, V276, P37273, DOI 10.1074/jbc.M106424200; Sasaki T, 1990, J Enzyme Inhib, V3, P195, DOI 10.3109/14756369009035837; Scotlandi K, 2002, CANCER GENE THER, V9, P296, DOI 10.1038/sj.cgt.7700442; Shields JM, 2000, TRENDS CELL BIOL, V10, P147, DOI 10.1016/S0962-8924(00)01740-2; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Tsujimoto Y, 2005, CELL DEATH DIFFER, V12, P1528, DOI 10.1038/sj.cdd.4401777; Wang KKW, 1996, P NATL ACAD SCI USA, V93, P6687, DOI 10.1073/pnas.93.13.6687; Watnick RS, 2003, CANCER CELL, V3, P219, DOI 10.1016/S1535-6108(03)00030-8; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	55	45	51	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5438	5449		10.1074/jbc.M109.046789	http://dx.doi.org/10.1074/jbc.M109.046789			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	19778902	Green Published, hybrid			2022-12-27	WOS:000275327200037
J	Liu, L; Shi, XJ; Bharadwaj, KG; Ikeda, S; Yamashita, H; Yagyu, H; Schaffer, JE; Yu, YH; Goldberg, IJ				Liu, Li; Shi, XiaoJing; Bharadwaj, Kalyani G.; Ikeda, Shota; Yamashita, Haruyo; Yagyu, Hiroaki; Schaffer, Jean E.; Yu, Yi-Hao; Goldberg, Ira J.			DGAT1 Expression Increases Heart Triglyceride Content but Ameliorates Lipotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID OXIDATION; SKELETAL-MUSCLE; DIACYLGLYCEROL ACYLTRANSFERASE; LIPOPROTEIN-LIPASE; INSULIN-RESISTANCE; ACYL-COENZYME; UP-REGULATION; OBESITY RESISTANCE; CONSCIOUS DOG; MICE	Intracellular lipid accumulation in the heart is associated with cardiomyopathy, yet the precise role of triglyceride (TG) remains unclear. With exercise, wild type hearts develop physiologic hypertrophy. This was associated with greater TG stores and a marked induction of the TG-synthesizing enzyme diacylglycerol (DAG) acyltransferase 1 (DGAT1). Transgenic overexpression of DGAT1 in the heart using the cardiomyocyte-specific alpha-myosin heavy chain (MHC) promoter led to approximately a doubling of DGAT activity and TG content and reductions of similar to 35% in cardiac ceramide, 26% in DAG, and 20% in free fatty acid levels. Cardiac function assessed by echocardiography and cardiac catheterization was unaffected. These mice were then crossed with animals expressing long-chain acyl-CoA synthetase via the MHC promoter (MHC-ACS), which develop lipotoxic cardiomyopathy. MHC-DGAT1XMHC-ACS double transgenic male mice had improved heart function; fractional shortening increased by 74%, and diastolic function improved compared with MHC-ACS mice. The improvement of heart function correlated with a reduction in cardiac DAG and ceramide and reduced cardiomyocyte apoptosis but increased fatty acid oxidation. In addition, the survival of the mice was improved. Our study indicates that TG is not likely to be a toxic lipid species directly, but rather it is a feature of physiologic hypertrophy and may serve a cytoprotective role in lipid overload states. Moreover, induction of DGAT1 could be beneficial in the setting of excess heart accumulation of toxic lipids.	[Schaffer, Jean E.] Washington Univ, Sch Med, Div Cardiol, St Louis, MO 63110 USA; [Liu, Li; Shi, XiaoJing; Bharadwaj, Kalyani G.; Ikeda, Shota; Yamashita, Haruyo; Yagyu, Hiroaki; Yu, Yi-Hao; Goldberg, Ira J.] Columbia Univ Coll Phys & Surg, Dept Med, Div Prevent Med & Metab, New York, NY 10032 USA	Washington University (WUSTL); Columbia University	Goldberg, IJ (corresponding author), Columbia Univ, Dept Med, 630 W 168th St,PH10-305, New York, NY 10032 USA.	ijg3@columbia.edu	Liu, Li/C-6761-2011	Ikeda, Shota/0000-0003-1358-524X; Yu, Yi-Hao/0000-0003-2696-1486	National Institutes of Health [HL45095]; NHLBI [HL73029, DK 064989]; Burroughs Wellcome Foundation [1005935]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073029, R01HL045095, R37HL045095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064989, R56DK064989] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL45095 and HL73029 from the NHLBI (to I. J. G.) and DK 064989 (to J. S.). This work was also supported by Burroughs Wellcome Foundation Grant 1005935 (to J. S.).	Alsted TJ, 2009, AM J PHYSIOL-ENDOC M, V296, pE445, DOI 10.1152/ajpendo.90912.2008; Boudina S, 2007, CIRCULATION, V115, P3213, DOI 10.1161/CIRCULATIONAHA.106.679597; Burelle Y, 2004, AM J PHYSIOL-HEART C, V287, pH1055, DOI 10.1152/ajpheart.00925.2003; Burkart EM, 2007, J CLIN INVEST, V117, P3930, DOI 10.1172/JCI32578; Cabrero A, 2001, DIABETES, V50, P1883, DOI 10.2337/diabetes.50.8.1883; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Chandler MP, 2004, AM J PHYSIOL-HEART C, V287, pH1538, DOI 10.1152/ajpheart.00281.2004; Chen HC, 2003, J CLIN INVEST, V111, P1715, DOI [10.1172/JCI15859, 10.1172/JCI200315859]; Chen HC, 2002, DIABETES, V51, P3189, DOI 10.2337/diabetes.51.11.3189; Chen HC, 2002, J CLIN INVEST, V109, P1049, DOI [10.1172/JCI200214672, 10.1172/JCI0214672]; Chen N, 2005, DIABETES, V54, P3379, DOI 10.2337/diabetes.54.12.3379; Chiu HC, 2001, J CLIN INVEST, V107, P813, DOI 10.1172/JCI10947; Dhalla NS, 2000, CARDIOVASC RES, V47, P446, DOI 10.1016/S0008-6363(00)00078-X; Flavell DM, 2006, J MOL MED, V84, P126, DOI 10.1007/s00109-005-0002-8; FOLCH J, 1957, J BIOL CHEM, V226, P497; GOLDBERG DI, 1984, METABOLISM, V33, P964, DOI 10.1016/0026-0495(84)90252-X; Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755; Goodwin GW, 2000, AM J PHYSIOL-HEART C, V279, pH1490, DOI 10.1152/ajpheart.2000.279.4.H1490; Goossens GH, 2008, PHYSIOL BEHAV, V94, P206, DOI 10.1016/j.physbeh.2007.10.010; Gupte RS, 2007, J CARD FAIL, V13, P497, DOI 10.1016/j.cardfail.2007.04.003; Gupte RS, 2009, FREE RADICAL BIO MED, V47, P219, DOI 10.1016/j.freeradbiomed.2009.01.028; Gupte SA, 2008, CURR OPIN INVEST DR, V9, P993; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Ikeda S, 2002, BIOCHEM BIOPH RES CO, V296, P395, DOI 10.1016/S0006-291X(02)00883-5; Lardizabal KD, 2001, J BIOL CHEM, V276, P38862, DOI 10.1074/jbc.M106168200; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Liu L, 2007, J CLIN INVEST, V117, P1679, DOI 10.1172/JCI30565; Liu L, 2009, DIABETES, V58, P2516, DOI 10.2337/db08-1096; Lopaschuk GD, 2003, CIRC RES, V93, pE33, DOI 10.1161/01.RES.0000086964.07404.A5; MARKLUND SL, 1982, CANCER RES, V42, P1955; Maulik N, 1999, CIRCULATION, V100, P369; Meegalla RL, 2002, BIOCHEM BIOPH RES CO, V298, P317, DOI 10.1016/S0006-291X(02)02466-X; Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005; Oelkers P, 1998, J BIOL CHEM, V273, P26765, DOI 10.1074/jbc.273.41.26765; Okere IC, 2005, CLIN EXP PHARMACOL P, V32, P825, DOI 10.1111/j.1440-1681.2005.04272.x; Park TS, 2007, CURR OPIN LIPIDOL, V18, P277, DOI 10.1097/MOL.0b013e32814a57db; PREISS JE, 1987, METHOD ENZYMOL, V141, P294; Reid BN, 2008, J BIOL CHEM, V283, P13087, DOI 10.1074/jbc.M800533200; Ryder JW, 1999, FASEB J, V13, P2246, DOI 10.1096/fasebj.13.15.2246; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; Schenk S, 2007, J CLIN INVEST, V117, P1690, DOI 10.1172/JCI30566; SEKILI S, 1993, CIRC RES, V73, P705, DOI 10.1161/01.RES.73.4.705; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Son NH, 2007, J CLIN INVEST, V117, P2791, DOI 10.1172/JCI30335; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Suematsu N, 2003, CIRCULATION, V107, P1418, DOI 10.1161/01.CIR.0000055318.09997.1F; Szczepaniak LS, 2007, CIRC RES, V101, P759, DOI 10.1161/CIRCRESAHA.107.160457; TRIANA JF, 1991, CIRC RES, V69, P731, DOI 10.1161/01.RES.69.3.731; VOLK ME, 1952, J BIOL CHEM, V195, P493; Wongsiriroj N, 2008, J BIOL CHEM, V283, P13510, DOI 10.1074/jbc.M800777200; Woo YJ, 1998, CIRCULATION, V98, pII255; Yagyu H, 2003, J CLIN INVEST, V111, P419, DOI [10.1172/JCI200316751, 10.1172/JCI16751]; Yamashita H, 2008, AM J PHYSIOL-ENDOC M, V295, pE705, DOI 10.1152/ajpendo.90338.2008; Yen CLE, 2005, J LIPID RES, V46, P1502, DOI 10.1194/jlr.M500036-JLR200; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Yu YH, 2002, J BIOL CHEM, V277, P50876, DOI 10.1074/jbc.M207353200	58	172	177	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36312	36323		10.1074/jbc.M109.049817	http://dx.doi.org/10.1074/jbc.M109.049817			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19778901	hybrid, Green Published			2022-12-27	WOS:000272970500033
J	Huet, G; Merot, Y; Percevault, F; Tiffoche, C; Arnal, JF; Boujrad, N; Pakdel, F; Metivier, R; Flouriot, G				Huet, Guillaume; Merot, Yohann; Percevault, Frederic; Tiffoche, Christophe; Arnal, Jean-Francois; Boujrad, Noureddine; Pakdel, Farzad; Metivier, Raphael; Flouriot, Gilles			Repression of the Estrogen Receptor-alpha Transcriptional Activity by the Rho/Megakaryoblastic Leukemia 1 Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; SERUM RESPONSE FACTOR; RHO-GTPASES; DISTINCT MECHANISMS; COACTIVATOR; SRF; ACTIVATION; PROTEIN-1; AF-2; MEGAKARYOBLASTIC-LEUKEMIA-1	Although involved in processes leading to the emergence and development of hormone-dependent breast cancers, the estrogen receptor alpha (ER alpha) also prevents transformed cells from progressing toward a more aggressive phenotype. The transcriptional activity of ER alpha is mediated through two transactivation functions, called activation function 1 and 2, whose respective involvement varies in a cell-specific manner. Here, we identify the Rho/megakaryoblastic leukemia 1 (MKL1) signaling pathway as a main actor in controlling the cell-specific activity of both transactivation functions of ER alpha. Notably, we show that, when the coregulator MKL1 is sequestered in an inactive form by unpolymerized actin, the transcriptional activity of ER alpha mainly relies on the activation function 1. The activation of MKL1, which results from its dissociation from unpolymerized actin, promoted by the ability of Rho to support polymeric actin accumulation, silences the activation function 1 of ER alpha and allows the receptor to mainly act through its activation function 2. Importantly, this switch in the respective contribution exerted by both transactivation functions is correlated with an impaired ability of ER alpha to efficiently transactivate estrogen-regulated reporter genes. MKL1 is further shown to be present on estrogen-responsive genes in vivo. Interestingly, the Rho/MKL1 signaling pathway is activated during the epithelial-mesenchymal transition. A reduced transactivation efficiency of ER alpha, resulting from the activation of this pathway, may therefore suppress the protective role exerted by ER alpha toward tumor progression and invasiveness.	[Huet, Guillaume; Merot, Yohann; Percevault, Frederic; Boujrad, Noureddine; Pakdel, Farzad; Flouriot, Gilles] Univ Rennes 1, CNRS, Equipe Recepteurs Estrogenes & Destinee Cellulair, UMR 6026, F-35042 Rennes, France; [Tiffoche, Christophe; Metivier, Raphael] Univ Rennes 1, CNRS, Equipe Regulat Spatiotemporelle Transcript, UMR 6026, F-35042 Rennes, France; [Arnal, Jean-Francois] Inst Med Mol Rangueil, INSERM, U858, F-31432 Toulouse 4, France	Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm)	Flouriot, G (corresponding author), Univ Rennes 1, CNRS, Equipe Recepteurs Estrogenes & Destinee Cellulair, UMR 6026, Campus Beaulieu,Bat 13, F-35042 Rennes, France.	gilles.flouriot@univ-rennes1.fr	BOUJRAD, Noureddine/L-1367-2015; Flouriot, Gilles/K-1833-2015; percevault, frederic/K-1836-2015; Pakdel, Farzad/K-1700-2015; ARNAL, Jean Francois/K-7004-2014	Flouriot, Gilles/0000-0001-6250-4173; Pakdel, Farzad/0000-0002-3067-3156; ARNAL, Jean Francois/0000-0003-2229-6300	ARC; Ligue Contre le Cancer; Rennes Metropole; CNRS; University of Rennes	ARC(Australian Research Council); Ligue Contre le Cancer(Ligue nationale contre le cancer); Rennes Metropole(Region Bretagne); CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Rennes	This work was supported by the ARC, the Ligue Contre le Cancer, Rennes Metropole, the CNRS, and the University of Rennes 1.	AUSUBEL FM, 2007, CURRENT PROTOCOLS MO; BERRY M, 1990, EMBO J, V9, P2811, DOI 10.1002/j.1460-2075.1990.tb07469.x; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Busche S, 2008, J CELL SCI, V121, P1025, DOI 10.1242/jcs.014456; Cen B, 2003, MOL CELL BIOL, V23, P6597, DOI 10.1128/MCB.23.18.6597-6608.2003; Cho HJ, 2007, CELL BIOL INT, V31, P1225, DOI 10.1016/j.cellbi.2007.04.006; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Fan LZ, 2007, MOL BIOL CELL, V18, P1083, DOI 10.1091/mbc.E06-07-0602; Guarino M, 2007, PATHOLOGY, V39, P305, DOI 10.1080/00313020701329914; Huet G, 2008, BIOCHEM BIOPH RES CO, V365, P304, DOI 10.1016/j.bbrc.2007.10.178; Itoh K, 1999, NAT MED, V5, P221, DOI 10.1038/5587; Kobayashi Y, 2000, J BIOL CHEM, V275, P15645, DOI 10.1074/jbc.M000042200; Lavinsky RM, 1998, P NATL ACAD SCI USA, V95, P2920, DOI 10.1073/pnas.95.6.2920; Mazumdar A, 2001, NAT CELL BIOL, V3, P30, DOI 10.1038/35050532; McInerney EM, 1996, J BIOL CHEM, V271, P24172, DOI 10.1074/jbc.271.39.24172; Merot Y, 2004, J BIOL CHEM, V279, P26184, DOI 10.1074/jbc.M402148200; Metivier R, 2004, EMBO J, V23, P3653, DOI 10.1038/sj.emboj.7600377; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Metivier R, 2001, MOL ENDOCRINOL, V15, P1953, DOI 10.1210/me.15.11.1953; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Morita T, 2007, J CELL BIOL, V179, P1027, DOI 10.1083/jcb.200708174; Nakagawa K, 2005, GENES CELLS, V10, P835, DOI 10.1111/j.1365-2443.2005.00880.x; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; Peinado HC, 2004, INT J DEV BIOL, V48, P365, DOI 10.1387/ijdb.041794hp; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Platet N, 2004, CRIT REV ONCOL HEMAT, V51, P55, DOI 10.1016/j.critrevonc.2004.02.001; Posern G, 2004, EMBO J, V23, P3973, DOI 10.1038/sj.emboj.7600404; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Schultz JR, 2005, J BIOL CHEM, V280, P347, DOI 10.1074/jbc.M407879200; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Su LF, 2002, J BIOL CHEM, V277, P37037, DOI 10.1074/jbc.M111607200; Su LF, 2001, J BIOL CHEM, V276, P3231, DOI 10.1074/jbc.M005547200; TORA L, 1989, CELL, V59, P477, DOI 10.1016/0092-8674(89)90031-7; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Webb P, 1999, MOL ENDOCRINOL, V13, P1672, DOI 10.1210/me.13.10.1672	37	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33729	33739		10.1074/jbc.M109.045534	http://dx.doi.org/10.1074/jbc.M109.045534			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19826002	Green Published, hybrid			2022-12-27	WOS:000272165200003
J	Kuhn, ML; Falaschetti, CA; Ballicora, MA				Kuhn, Misty L.; Falaschetti, Christine A.; Ballicora, Miguel A.			Ostreococcus tauri ADP-glucose Pyrophosphorylase Reveals Alternative Paths for the Evolution of Subunit Roles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTTRANSLATIONAL REDOX-MODIFICATION; SITE-DIRECTED MUTAGENESIS; POTATO-TUBER; ESCHERICHIA-COLI; CHLAMYDOMONAS-REINHARDTII; PHYLOGENETIC ANALYSIS; STRUCTURAL-PROPERTIES; BACTERIAL GLYCOGEN; STARCH SYNTHESIS; GENOME ANALYSIS	ADP-glucose pyrophosphorylase controls starch synthesis in plants and is an interesting case to study the evolution and differentiation of roles in heteromeric enzymes. It includes two homologous subunits, small (S) and large (L), that originated from a common photosynthetic eukaryotic ancestor. In present day organisms, these subunits became complementary after loss of certain roles in a process described as subfunctionalization. For instance, the potato tuber enzyme has a noncatalytic L subunit that complements an S subunit with suboptimal allosteric properties. To understand the evolution of catalysis and regulation in this family, we artificially synthesized both subunit genes from the unicellular alga Ostreococcus tauri. This is among the most ancient species in the green lineage that diverged from the ancestor of all green plants and algae. After heterologous gene expression, we purified and characterized the proteins. The O. tauri enzyme was not redox-regulated, suggesting that redox regulation of ADP-glucose pyrophosphorylases appeared later in evolution. The S subunit had a typical low apparent affinity for the activator 3-phosphoglycerate, but it was atypically defective in the catalytic efficiency (V-max/K-m) for the substrate Glc1-P. The L subunit needed the S subunit for soluble expression. In the presence of a mutated S subunit (to avoid interference), the L subunit had a high apparent affinity for 3-phosphoglycerate and substrates suggesting a leading role in catalysis. Therefore, the subfunctionalization of the O. tauri enzyme was different from previously described cases. To the best of our knowledge, this is the first biochemical description of a system with alternative subfunctionalization paths.	[Kuhn, Misty L.; Falaschetti, Christine A.; Ballicora, Miguel A.] Loyola Univ, Dept Chem, Chicago, IL 60626 USA	Loyola University Chicago	Ballicora, MA (corresponding author), Loyola Univ, Dept Chem, 6525 N Sheridan Rd, Chicago, IL 60626 USA.	mballic@luc.edu		Ballicora, Miguel/0000-0002-5324-0724	National Science Foundation [MCB 0615982]	National Science Foundation(National Science Foundation (NSF))	This work was supported in part by National Science Foundation Grant MCB 0615982.	Ballicora MA, 2005, J BIOL CHEM, V280, P10189, DOI 10.1074/jbc.M413540200; Ballicora MA, 1998, PLANT PHYSIOL, V118, P265, DOI 10.1104/pp.118.1.265; Ballicora MA, 2004, PHOTOSYNTH RES, V79, P1, DOI 10.1023/B:PRES.0000011916.67519.58; Ballicora MA, 2000, J BIOL CHEM, V275, P1315, DOI 10.1074/jbc.275.2.1315; BALLICORA MA, 1995, PLANT PHYSIOL, V109, P245, DOI 10.1104/pp.109.1.245; Bejar CM, 2006, J BIOL CHEM, V281, P40473, DOI 10.1074/jbc.M607088200; Bejar CM, 2004, FEBS LETT, V573, P99, DOI 10.1016/j.febslet.2004.07.060; Boehlein SK, 2005, PLANT PHYSIOL, V138, P1552, DOI 10.1104/pp.105.060699; Courties C, 1998, J PHYCOL, V34, P844, DOI 10.1046/j.1529-8817.1998.340844.x; Crevillen P, 2005, J BIOL CHEM, V280, P8143, DOI 10.1074/jbc.M411713200; Cross JM, 2004, PLANT PHYSIOL, V135, P137, DOI 10.1104/pp.103.036699; D'Ovidio R, 2004, PLANT PHYSIOL, V135, P2424, DOI 10.1104/pp.104.044644; Derelle E, 2006, P NATL ACAD SCI USA, V103, P11647, DOI 10.1073/pnas.0604795103; Doan DNP, 1999, PLANT PHYSIOL, V121, P965, DOI 10.1104/pp.121.3.965; Force A, 1999, GENETICS, V151, P1531; Frueauf JB, 2003, PLANT J, V33, P503, DOI 10.1046/j.1365-313X.2003.01643.x; Frueauf JB, 2001, J BIOL CHEM, V276, P46319, DOI 10.1074/jbc.M107408200; Fu YB, 1998, PLANT PHYSIOL, V117, P989, DOI 10.1104/pp.117.3.989; Fu YB, 1998, J BIOL CHEM, V273, P25045, DOI 10.1074/jbc.273.39.25045; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HAUGEN TH, 1979, J BIOL CHEM, V254, P127; Hendriks JHM, 2003, PLANT PHYSIOL, V133, P838, DOI 10.1104/pp.103.024513; Hicks GR, 2001, PLANT PHYSIOL, V127, P1334; HILL MA, 1991, J BIOL CHEM, V266, P12455; Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43; Hwang SK, 2008, J BIOL CHEM, V283, P6640, DOI 10.1074/jbc.M707447200; Hwang SK, 2007, PHYTOCHEMISTRY, V68, P464, DOI 10.1016/j.phytochem.2006.11.027; Hwang SK, 2006, FEBS LETT, V580, P6741, DOI 10.1016/j.febslet.2006.11.029; Hwang SK, 2005, FEBS LETT, V579, P983, DOI 10.1016/j.febslet.2004.12.067; IGLESIAS AA, 1993, J BIOL CHEM, V268, P1081; IGLESIAS AA, 1994, PLANT PHYSIOL, V104, P1287, DOI 10.1104/pp.104.4.1287; IGLESIAS AA, 1991, PLANT PHYSIOL, V97, P1187, DOI 10.1104/pp.97.3.1187; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Jin XS, 2005, EMBO J, V24, P694, DOI 10.1038/sj.emboj.7600551; Laughlin MJ, 1998, PHYTOCHEMISTRY, V47, P621, DOI 10.1016/S0031-9422(97)00578-5; Lynch M, 2006, MOL BIOL EVOL, V23, P450, DOI 10.1093/molbev/msj050; Misumi O, 2008, J PLANT RES, V121, P3, DOI 10.1007/s10265-007-0133-9; Muller T, 2000, J COMPUT BIOL, V7, P761, DOI 10.1089/10665270050514918; Pedro CN, 2003, J BIOL CHEM, V278, P28508, DOI 10.1074/jbc.M304280200; Piganeau G, 2007, GENE, V406, P184, DOI 10.1016/j.gene.2007.09.015; Pils B, 2004, J MOL BIOL, V340, P399, DOI 10.1016/j.jmb.2004.04.063; PRESS WH, 1988, NUMERICAL RECIPES C, P347; Ral JP, 2004, PLANT PHYSIOL, V136, P3333, DOI 10.1104/pp.104.044131; Rastogi S, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-28; Sambrook J., 2001, MOL CLONING LAB MANU; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Thornton JW, 2004, NAT REV GENET, V5, P366, DOI 10.1038/nrg1324; Tiessen A, 2002, PLANT CELL, V14, P2191, DOI 10.1105/tpc.003640; Tocchini-Valentini GD, 2005, P NATL ACAD SCI USA, V102, P8933, DOI 10.1073/pnas.0502350102; Todd AE, 2002, STRUCTURE, V10, P1435, DOI 10.1016/S0969-2126(02)00861-4; Truman AW, 2008, CHEM BIOL, V15, P476, DOI 10.1016/j.chembiol.2008.03.019; Ventriglia T, 2008, PLANT PHYSIOL, V148, P65, DOI 10.1104/pp.108.122846; Wang SM, 1998, PLANT J, V13, P63, DOI 10.1046/j.1365-313X.1998.00009.x; Xiong AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh094; Yep A, 2004, ANAL BIOCHEM, V324, P52, DOI 10.1016/j.ab.2003.09.024	56	16	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34092	34102		10.1074/jbc.M109.037614	http://dx.doi.org/10.1074/jbc.M109.037614			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19737928	hybrid, Green Published			2022-12-27	WOS:000272165200042
J	Brown, NG; Shanker, S; Prasad, BVV; Palzkill, T				Brown, Nicholas G.; Shanker, Sreejesh; Prasad, B. V. Venkataram; Palzkill, Timothy			Structural and Biochemical Evidence That a TEM-1 beta-Lactamase N170G Active Site Mutant Acts via Substrate-assisted Catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL-ENZYME INTERMEDIATE; EXTENDED-SPECTRUM; DIRECTED MUTAGENESIS; PSEUDOMONAS-AERUGINOSA; CRYSTAL-STRUCTURE; KLEBSIELLA-PNEUMONIAE; BACTERIAL-RESISTANCE; RESOLUTION; SPECIFICITY; MECHANISM	TEM-1 beta-lactamase is the most common plasmid-encoded beta-lactamase in Gram-negative bacteria and is a model class A enzyme. The active site of class A beta-lactamases share several conserved residues including Ser(70), Glu(166), and Asn(170) that coordinate a hydrolytic water involved in deacylation. Unlike Ser(70) and Glu(166), the functional significance of residue Asn(170) is not well understood even though it forms hydrogen bonds with both Glu(166) and the hydrolytic water. The goal of this study was to examine the importance of Asn(170) for catalysis and substrate specificity of beta-lactam antibiotic hydrolysis. The codon for position 170 was randomized to create a library containing all 20 possible amino acids. The random library was introduced into Escherichia coli, and functional clones were selected on agar plates containing ampicillin. DNA sequencing of the functional clones revealed that only asparagine (wild type) and glycine at this position are consistent with wild-type function. The determination of kinetic parameters for several substrates revealed that the N170G mutant is very efficient at hydrolyzing substrates that contain a primary amine in the antibiotic R-group that would be close to the Asn(170) side chain in the acyl-intermediate. In addition, the x-ray structure of the N170G enzyme indicated that the position of an active site water important for deacylation is altered compared with the wildtype enzyme. Taken together, the results suggest the N170G TEM-1 enzyme hydrolyzes ampicillin efficiently because of substrate-assisted catalysis where the primary amine of the ampicillin R-group positions the hydrolytic water and allows for efficient deacylation.	[Brown, Nicholas G.; Shanker, Sreejesh; Prasad, B. V. Venkataram; Palzkill, Timothy] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Palzkill, Timothy] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Palzkill, T (corresponding author), 1 Baylor Plaza, Houston, TX 77030 USA.	timothyp@bcm.tmc.edu		Prasad, B.V.Venkataram/0000-0002-1172-2071; Brown, Nicholas/0000-0002-6141-0164	National Institutes of Health [AI32956]; Gulf Coast Consortia (National Institutes of Health) [T90 DK070109-05]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI032956, R37AI032956, R01AI032956] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T90DK070109] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gulf Coast Consortia (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant AI32956 (to T. P.). This work was also supported by a training fellowship from the Keck Center Pharmacoinformatics Training Program of the lulf Coast Consortia (National Institutes of Health Grant T90 DK070109-05).	ADACHI H, 1991, J BIOL CHEM, V266, P3186; Ali Shah A, 2004, RES MICROBIOL, V155, P409, DOI 10.1016/j.resmic.2004.02.009; ANDERSEN JF, 1992, J BACTERIOL, V174, P725, DOI 10.1128/jb.174.3.725-735.1992; Bae IK, 2007, DIAGN MICR INFEC DIS, V58, P465, DOI 10.1016/j.diagmicrobio.2007.02.013; Bouthors AT, 1998, BIOCHEM J, V330, P1443, DOI 10.1042/bj3301443; Bouthors AT, 1999, PROTEIN ENG, V12, P313, DOI 10.1093/protein/12.4.313; Cantu C, 1997, J BIOL CHEM, V272, P29144, DOI 10.1074/jbc.272.46.29144; CARTER P, 1987, SCIENCE, V237, P394, DOI 10.1126/science.3299704; CARTER P, 1988, NATURE, V332, P564, DOI 10.1038/332564a0; Chaibi EB, 1999, J ANTIMICROB CHEMOTH, V43, P447, DOI 10.1093/jac/43.4.447; Chen CC, 1996, BIOCHEMISTRY-US, V35, P12251, DOI 10.1021/bi961153v; CHRISTENSEN H, 1990, BIOCHEM J, V266, P853; CuppVickery JR, 1996, NAT STRUCT BIOL, V3, P632, DOI 10.1038/nsb0796-632; Dall'Acqua W, 2000, PROTEIN SCI, V9, P1; Damblon C, 1996, P NATL ACAD SCI USA, V93, P1747, DOI 10.1073/pnas.93.5.1747; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESCOBAR WA, 1994, BIOCHEMISTRY-US, V33, P7619, DOI 10.1021/bi00190a015; ESCOBAR WA, 1991, BIOCHEMISTRY-US, V30, P10783, DOI 10.1021/bi00108a025; Fersht A., 1985, ENZYME STRUCTURE MEC, P99; FRERE JM, 1985, CRC CR REV MICROBIOL, V11, P299; FRERE JM, 1995, MOL MICROBIOL, V16, P385, DOI 10.1111/j.1365-2958.1995.tb02404.x; Georgopapadakou NH, 2004, EXPERT OPIN INV DRUG, V13, P1307, DOI 10.1517/13543784.13.10.1307; Giakkoupi P, 2000, ANTIMICROB AGENTS CH, V44, P2247, DOI 10.1128/AAC.44.9.2247-2253.2000; Guillaume G, 1997, J BIOL CHEM, V272, P5438, DOI 10.1074/jbc.272.9.5438; HERZBERG O, 1987, SCIENCE, V236, P694, DOI 10.1126/science.3107125; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Huang WZ, 1996, J MOL BIOL, V258, P688, DOI 10.1006/jmbi.1996.0279; JELSCH C, 1993, PROTEINS, V16, P364, DOI 10.1002/prot.340160406; KNOX JR, 1995, ANTIMICROB AGENTS CH, V39, P2593, DOI 10.1128/AAC.39.12.2593; LAMOTTEBRASSEUR J, 1991, BIOCHEM J, V279, P213, DOI 10.1042/bj2790213; LEUNG YC, 1994, BIOCHEM J, V299, P671, DOI 10.1042/bj2990671; Lietz EJ, 2000, BIOCHEMISTRY-US, V39, P4971, DOI 10.1021/bi992681k; Livermore DM, 2006, TRENDS MICROBIOL, V14, P413, DOI 10.1016/j.tim.2006.07.008; Marciano DC, 2008, J MOL BIOL, V384, P151, DOI 10.1016/j.jmb.2008.09.009; Marciano DC, 2009, PROTEIN SCI, V18, P2080, DOI 10.1002/pro.220; Matagne A, 1998, BIOCHEM J, V330, P581, DOI 10.1042/bj3300581; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meroueh SO, 2005, J AM CHEM SOC, V127, P15397, DOI 10.1021/ja051592u; Minasov G, 2002, J AM CHEM SOC, V124, P5333, DOI 10.1021/ja0259640; Mustafi D, 2001, BIOCHEMISTRY-US, V40, P2397, DOI 10.1021/bi0021075; NEBERT DW, 1989, DNA-J MOLEC CELL BIO, V8, P1, DOI 10.1089/dna.1.1989.8.1; NORDMANN P, 1993, ANTIMICROB AGENTS CH, V37, P962, DOI 10.1128/AAC.37.5.962; NORDMANN P, 1994, ANTIMICROB AGENTS CH, V38, P104, DOI 10.1128/AAC.38.1.104; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Petrosino J, 1999, J BIOL CHEM, V274, P2394, DOI 10.1074/jbc.274.4.2394; Petrosino JF, 1996, J BACTERIOL, V178, P1821, DOI 10.1128/jb.178.7.1821-1828.1996; Poirel L, 2000, ANTIMICROB AGENTS CH, V44, P622, DOI 10.1128/AAC.44.3.622-632.2000; Poirel L, 2001, ANTIMICROB AGENTS CH, V45, P2598, DOI 10.1128/AAC.45.9.2598-2603.2001; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Smith CA, 2007, ACTA CRYSTALLOGR D, V63, P982, DOI 10.1107/S0907444907036955; STRYNADKA NCJ, 1992, NATURE, V359, P700, DOI 10.1038/359700a0; Strynadka NCJ, 1996, NAT STRUCT BIOL, V3, P688, DOI 10.1038/nsb0896-688; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Tranier S, 2000, J BIOL CHEM, V275, P28075; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Walsh TR, 2008, CURR OPIN INFECT DIS, V21, P367, DOI 10.1097/QCO.0b013e328303670b; Walther-Rasmussen J, 2007, J ANTIMICROB CHEMOTH, V60, P470, DOI 10.1093/jac/dkm226; Wang CX, 2006, J ANTIMICROB CHEMOTH, V57, P1261, DOI 10.1093/jac/dkl116; Zawadzke LE, 1996, BIOCHEMISTRY-US, V35, P16475, DOI 10.1021/bi962242a; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	63	31	31	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33703	33712		10.1074/jbc.M109.053819	http://dx.doi.org/10.1074/jbc.M109.053819			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19812041	Green Published, hybrid			2022-12-27	WOS:000272028500074
J	Aneja, R; Datt, M; Singh, B; Kumar, S; Sahni, G				Aneja, Rachna; Datt, Manish; Singh, Balwinder; Kumar, Shekhar; Sahni, Girish			Identification of a New Exosite Involved in Catalytic Turnover by the Streptokinase-Plasmin Activator Complex during Human Plasminogen Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; MACROMOLECULAR SUBSTRATE; CONFORMATIONAL ACTIVATION; SYNTHETIC PEPTIDES; KINETIC MECHANISM; CRYSTAL-STRUCTURE; SERINE PROTEASES; BETA-DOMAIN; AMINO-ACID; BINDING	With the goal of identifying hitherto unknown surface exosites of streptokinase involved in substrate human plasminogen recognition and catalytic turnover, synthetic peptides encompassing the 170 loop (CQFTPLNPDDDFRPGLKDTKLLC) in the beta-domain were tested for selective inhibition of substrate human plasminogen activation by the streptokinase-plasmin activator complex. Although a disulfide-constrained peptide exhibited strong inhibition, a linear peptide with the same sequence, or a disulfide-constrained variant with a single lysine to alanine mutation showed significantly reduced capabilities of inhibition. Alanine-scanning mutagenesis of the 170 loop of the beta-domain of streptokinase was then performed to elucidate its importance in streptokinase-mediated plasminogen activation. Some of the 170 loop mutants showed a remarkable decline in k(cat) without any alteration in apparent substrate affinity (K-m) as compared with wild-type streptokinase and identified the importance of Lys(180) as well as Pro(177) in the functioning of this loop. Remarkably, these mutants were able to generate amidolytic activity and non-proteolytic activation in "partner" plasminogen as wild-type streptokinase. Moreover, cofactor activities of the 170 loop mutants, pre-complexed with plasmin, against microplasminogen as the substrate showed a similar pattern of decline in k(cat) as that observed in the case of full-length plasminogen, with no concomitant change in K-m. These results strongly suggest that the 170 loop of the beta-domain of streptokinase is important for catalysis by the streptokinase-plasmin(ogen) activator complex, particularly in catalytic processing/turnover of substrate, although it does not seem to contribute significantly toward enzyme-substrate affinity per se.	[Aneja, Rachna; Datt, Manish; Singh, Balwinder; Kumar, Shekhar; Sahni, Girish] CSIR, Inst Microbial Technol, Dept Mol Biol & Prot Engn, Chandigarh 160036, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Sahni, G (corresponding author), CSIR, Inst Microbial Technol, Dept Mol Biol & Prot Engn, Sector 39-A, Chandigarh 160036, India.	sahni@imtech.res.in	Datt, Manish/AAD-6989-2019	Datt, Manish/0000-0002-9578-4113	The Institute of Microbial Technology, India	The Institute of Microbial Technology, India	This work was supported by intra-mural funds from The Institute of Microbial Technology, India.	BAJAJ SP, 1977, J BIOL CHEM, V252, P492; Bock PE, 2007, J THROMB HAEMOST, V5, P81, DOI 10.1111/j.1538-7836.2007.02496.x; Bode W, 2006, BLOOD CELL MOL DIS, V36, P122, DOI 10.1016/j.bcmd.2005.12.027; Boskovic DS, 2000, J BIOL CHEM, V275, P38561, DOI 10.1074/jbc.M006637200; Boxrud PD, 2000, J BIOL CHEM, V275, P14579, DOI 10.1074/jbc.275.19.14579; Boxrud PD, 2004, J BIOL CHEM, V279, P36633, DOI 10.1074/jbc.M405264200; Boxrud PD, 2004, J BIOL CHEM, V279, P36642, DOI 10.1074/jbc.M405265200; Boxrud PD, 2001, J BIOL CHEM, V276, P26084, DOI 10.1074/jbc.M101966200; CHASE T, 1969, BIOCHEMISTRY-US, V8, P2212, DOI 10.1021/bi00833a063; Chaudhary A, 1999, PROTEIN SCI, V8, P2791; DERENZO EC, 1967, J BIOL CHEM, V242, P533; DEUTSCH DG, 1970, SCIENCE, V170, P1095, DOI 10.1126/science.170.3962.1095; Dhar J, 2002, J BIOL CHEM, V277, P13257, DOI 10.1074/jbc.M108422200; FURIE B, 1982, J BIOL CHEM, V257, P3875; GONZALEZGRONOW M, 1978, J BIOL CHEM, V253, P1090; HIREL PH, 1989, P NATL ACAD SCI USA, V86, P8247, DOI 10.1073/pnas.86.21.8247; Huntington JA, 2005, J THROMB HAEMOST, V3, P1861, DOI 10.1111/j.1538-7836.2005.01363.x; JACKSON KW, 1982, BIOCHEMISTRY-US, V21, P6620, DOI 10.1021/bi00269a001; Kim DM, 2000, THROMB RES, V99, P93, DOI 10.1016/S0049-3848(00)00225-5; Krishnaswamy S, 2005, J THROMB HAEMOST, V3, P54, DOI 10.1111/j.1538-7836.2004.01021.x; LEE PP, 1988, BIOCHEMISTRY-US, V27, P7506, DOI 10.1021/bi00419a049; LIJNEN HR, 1991, THROMB HAEMOSTASIS, V66, P468; Lin LF, 2000, BIOCHEMISTRY-US, V39, P4740, DOI 10.1021/bi992028x; Lizano S, 2005, INFECT IMMUN, V73, P4451, DOI 10.1128/IAI.73.7.4451-4453.2005; MARKUS G, 1964, J BIOL CHEM, V239, P2637; McArthur JD, 2008, FASEB J, V22, P3146, DOI 10.1096/fj.08-109348; MCCLINTOCK DK, 1971, BIOCHEM BIOPH RES CO, V43, P694, DOI 10.1016/0006-291X(71)90670-X; Nihalani D, 1997, PROTEIN SCI, V6, P1284, DOI 10.1002/pro.5560060616; Nihalani D, 1998, PROTEIN SCI, V7, P637, DOI 10.1002/pro.5560070313; Petersen HH, 2001, EUR J BIOCHEM, V268, P4430, DOI 10.1046/j.1432-1327.2001.02365.x; RADEK JT, 1993, METHOD ENZYMOL, V223, P145; Rajamohan G, 2002, BIOCHEM J, V365, P379, DOI 10.1042/BJ20011647; REDDY KNN, 1972, J BIOL CHEM, V247, P1683; REED GL, 1995, BIOCHEMISTRY-US, V34, P10266, DOI 10.1021/bi00032a021; SHI GY, 1988, J BIOL CHEM, V263, P17071; SUMMARIA L, 1982, BIOCHEMISTRY-US, V21, P2056, DOI 10.1021/bi00538a012; Sundram V, 2003, J BIOL CHEM, V278, P30569, DOI 10.1074/jbc.M303799200; Tachias K, 1996, J BIOL CHEM, V271, P28749, DOI 10.1074/jbc.271.46.28749; Tharp AC, 2009, J BIOL CHEM, V284, P19511, DOI 10.1074/jbc.M109.005512; Wakeham N, 2002, PROTEIN ENG, V15, P753, DOI 10.1093/protein/15.9.753; Wang SG, 1999, BIOCHEMISTRY-US, V38, P5232, DOI 10.1021/bi981915h; Wang SG, 2000, EUR J BIOCHEM, V267, P3994, DOI 10.1046/j.1432-1327.2000.01434.x; Wang XQ, 1998, SCIENCE, V281, P1662, DOI 10.1126/science.281.5383.1662; Wang XQ, 1999, FEBS LETT, V459, P85, DOI 10.1016/S0014-5793(99)01214-4; WOHL RC, 1980, J BIOL CHEM, V255, P2005; WOHL RC, 1984, BIOCHEMISTRY-US, V23, P3799, DOI 10.1021/bi00312a002; Yadav S, 2008, BBA-PROTEINS PROTEOM, V1784, P1310, DOI 10.1016/j.bbapap.2008.05.013	47	18	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32642	32650		10.1074/jbc.M109.046573	http://dx.doi.org/10.1074/jbc.M109.046573			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19801674	Green Published, hybrid			2022-12-27	WOS:000272028400047
J	Brown, KK; Blaikie, FH; Smith, RAJ; Tyndall, JDA; Lue, H; Bernhagen, J; Winterbourn, CC; Hampton, MB				Brown, Kristin K.; Blaikie, Frances H.; Smith, Robin A. J.; Tyndall, Joel D. A.; Lue, Hongqi; Bernhagen, Juergen; Winterbourn, Christine C.; Hampton, Mark B.			Direct Modification of the Proinflammatory Cytokine Macrophage Migration Inhibitory Factor by Dietary Isothiocyanates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE ARREST; FACTOR MIF; PHENETHYL ISOTHIOCYANATE; CANCER CELLS; CRUCIFEROUS VEGETABLES; COVALENT MODIFICATION; ENZYMATIC-ACTIVITY; HEPATOMA-CELLS; APOPTOSIS; SULFORAPHANE	Isothiocyanates are a class of phytochemicals with widely reported anti-cancer and anti-inflammatory activity. However, knowledge of their activity at a molecular level is limited. The objective of this study was to identify biological targets of phenethyl isothiocyanate (PEITC) using an affinity purification approach. An analogue of PEITC was synthesized to enable conjugation to a solid-phase resin. The pleiotropic cytokine macrophage migration inhibitory factor (MIF) was the major protein captured from cell lysates. Site-directed mutagenesis and mass spectrometry showed that PEITC covalently modified the N-terminal proline residue of MIF. This resulted in complete loss of catalytic tautomerase activity and disruption of protein conformation, as determined by impaired recognition by a monoclonal antibody directed to the region that receptors and interacting proteins bind to MIF. The conformational change was supported by in silico modeling. Monoclonal antibody binding to plasma MIF was disrupted in humans consuming watercress, a major dietary source of PEITC. The isothiocyanates have significant potential for development as MIF inhibitors, and this activity may contribute to the biological properties of these phytochemicals.	[Brown, Kristin K.; Winterbourn, Christine C.; Hampton, Mark B.] Univ Otago, Dept Pathol, Free Radical Res Grp, Christchurch 8140, New Zealand; [Tyndall, Joel D. A.] Univ Otago, Natl Sch Pharm, Dunedin 9054, New Zealand; [Blaikie, Frances H.; Smith, Robin A. J.] Univ Otago, Dept Chem, Dunedin 9054, New Zealand; Univ Aachen, RWTH, Inst Biochem & Mol Biol, D-52074 Aachen, Germany	University of Otago; University of Otago; University of Otago; RWTH Aachen University	Hampton, MB (corresponding author), POB 4345, Christchurch 8140, New Zealand.	mark.hampton@otago.ac.nz	tyndall, joel/C-2803-2008; Hampton, Mark B/A-8490-2008	tyndall, joel/0000-0003-0783-1635; Hampton, Mark B/0000-0002-7349-3729; BROWN, KRISTIN/0000-0002-4991-8870	Canterbury-West Coast Division; National Division of the Cancer Society of New Zealand; Maurice and Phyllis Paykel Trust; University of Otago Oxidative Stress Theme; German Research Council (Deutsche Forschungsgemeinschaft) [BE 1977/4-1/FOR809]	Canterbury-West Coast Division; National Division of the Cancer Society of New Zealand; Maurice and Phyllis Paykel Trust; University of Otago Oxidative Stress Theme; German Research Council (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This work was supported by the Canterbury-West Coast Division and the National Division of the Cancer Society of New Zealand. Support also came from the Maurice and Phyllis Paykel Trust, the University of Otago Oxidative Stress Theme, and German Research Council (Deutsche Forschungsgemeinschaft) Grant BE 1977/4-1/FOR809 (to J.B.).	Bach JP, 2008, ONCOLOGY-BASEL, V75, P127, DOI 10.1159/000155223; Bendrat K, 1997, BIOCHEMISTRY-US, V36, P15356, DOI 10.1021/bi971153a; Bernhagen J, 1998, J MOL MED-JMM, V76, P151, DOI 10.1007/s001090050204; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; BLOOM BR, 1966, SCIENCE, V153, P80, DOI 10.1126/science.153.3731.80; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; Burger-Kentischer A, 2002, CIRCULATION, V105, P1561, DOI 10.1161/01.CIR.0000012942.49244.82; Caddick S, 2000, TETRAHEDRON LETT, V41, P3513, DOI 10.1016/S0040-4039(00)00410-X; CALLAHAN JF, 1989, J MED CHEM, V32, P391, DOI 10.1021/jm00122a017; Chiao JW, 2004, CARCINOGENESIS, V25, P1403, DOI 10.1093/carcin/bgh136; Cournia Z, 2009, J MED CHEM, V52, P416, DOI 10.1021/jm801100v; Cross JV, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-183; DEWEY TM, 1993, INORG CHEM, V32, P1729, DOI 10.1021/ic00061a032; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Drobnica J., 1977, CYANATES THEIR THIO, P1003; Emonts M, 2007, CLIN INFECT DIS, V44, P1321, DOI 10.1086/514344; Gamet-Payrastre L, 2000, CANCER RES, V60, P1426; Heiss E, 2001, J BIOL CHEM, V276, P32008, DOI 10.1074/jbc.M104794200; Herder C, 2006, DIABETES CARE, V29, P368, DOI 10.2337/diacare.29.02.06.dc05-1474; Hermanowski-Vosatka A, 1999, BIOCHEMISTRY-US, V38, P12841, DOI 10.1021/bi991352p; Higdon JV, 2007, PHARMACOL RES, V55, P224, DOI 10.1016/j.phrs.2007.01.009; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Hong F, 2005, CHEM RES TOXICOL, V18, P1917, DOI 10.1021/tx0502138; Hwang ES, 2006, J NUTR BIOCHEM, V17, P837, DOI 10.1016/j.jnutbio.2006.02.004; Kleemann R, 1999, EUR J BIOCHEM, V261, P753, DOI 10.1046/j.1432-1327.1999.00327.x; Kleemann R, 1998, J MOL BIOL, V280, P85, DOI 10.1006/jmbi.1998.1864; Kleemann R, 2000, EUR J BIOCHEM, V267, P7183, DOI 10.1046/j.1432-1327.2000.01823.x; Lee H, 2008, AM J CLIN PATHOL, V129, P772, DOI 10.1309/GFCLLRH8A68XKMJN; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Mi LX, 2008, J BIOL CHEM, V283, P22136, DOI 10.1074/jbc.M802330200; Mizue Y, 2005, P NATL ACAD SCI USA, V102, P14410, DOI 10.1073/pnas.0507189102; Morand EF, 2002, RHEUMATOLOGY, V41, P558, DOI 10.1093/rheumatology/41.5.558; Nakajima M, 2001, DRUG METAB DISPOS, V29, P1110; Palaniswamy UR, 2003, J AGR FOOD CHEM, V51, P5504, DOI 10.1021/jf034268w; Pham NA, 2004, MOL CANCER THER, V3, P1239; Rosengren E, 1996, MOL MED, V2, P143, DOI 10.1007/BF03402210; Rosengren E, 1997, FEBS LETT, V417, P85, DOI 10.1016/S0014-5793(97)01261-1; RUGGLI P, 1945, HELV CHIM ACTA, V28, P674, DOI 10.1002/hlca.660280197; Santos LL, 2008, CLIN EXP IMMUNOL, V152, P372, DOI 10.1111/j.1365-2249.2008.03639.x; Senter PD, 2002, P NATL ACAD SCI USA, V99, P144, DOI 10.1073/pnas.011569399; Stamps SL, 1998, BIOCHEMISTRY-US, V37, P10195, DOI 10.1021/bi9806955; Swope M, 1998, EMBO J, V17, P3534, DOI 10.1093/emboj/17.13.3534; Taylor MS, 2004, J AM CHEM SOC, V126, P10558, DOI 10.1021/ja046259p; Thomson SJ, 2006, CANCER RES, V66, P6772, DOI 10.1158/0008-5472.CAN-05-3809; Tomiyasu M, 2002, CLIN CANCER RES, V8, P3755; Traka M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002568; WEISER WY, 1989, P NATL ACAD SCI USA, V86, P7522, DOI 10.1073/pnas.86.19.7522; Winner M, 2008, CANCER RES, V68, P7253, DOI 10.1158/0008-5472.CAN-07-6227; Xiao D, 2007, CANCER RES, V67, P2239, DOI 10.1158/0008-5472.CAN-06-3645; Ye LX, 2002, CLIN CHIM ACTA, V316, P43, DOI 10.1016/S0009-8981(01)00727-6; Yu R, 1998, CANCER RES, V58, P402; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399; Zhang YS, 2000, CARCINOGENESIS, V21, P1175, DOI 10.1093/carcin/21.6.1175	54	63	66	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32425	32433		10.1074/jbc.M109.047092	http://dx.doi.org/10.1074/jbc.M109.047092			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19776019	hybrid, Green Published			2022-12-27	WOS:000272028400025
J	Anderson, KR; Torres, CA; Solomon, K; Becker, TC; Newgard, CB; Wright, CV; Hagman, J; Sussel, L				Anderson, Keith R.; Torres, Ciara A.; Solomon, Keely; Becker, Thomas C.; Newgard, Christopher B.; Wright, Christopher V.; Hagman, James; Sussel, Lori			Cooperative Transcriptional Regulation of the Essential Pancreatic Islet Gene NeuroD1 (Beta2) by Nkx2.2 and Neurogenin 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOCRINE PANCREAS; CELL-DIFFERENTIATION; B-CELL; BETA2/NEUROD-DEFICIENT MICE; RNA INTERFERENCE; MATURE ISLET; IN-VIVO; EXPRESSION; ALPHA; ZEBRAFISH	Nkx2.2 and NeuroD1 are two critical regulators of pancreatic beta cell development. Nkx2.2 is a homeodomain transcription factor that is essential for islet cell type specification and mature beta cell function. NeuroD1 is a basic helix-loop-helix transcription factor that is critical for islet beta cell maturation and maintenance. Although both proteins influence beta cell development directly downstream of the endocrine progenitor factor, neurogenin3 (Ngn3), a connection between the two proteins in the regulation of beta cell fate and function has yet to be established. In this study, we demonstrate that Nkx2.2 transcriptional activity is required to facilitate the activation of NeuroD1 by Ngn3. Furthermore, Nkx2.2 is necessary to maintain high levels of NeuroD1 expression in developing mouse and zebrafish islets and in mature beta cells. Interestingly, Nkx2.2 regulates NeuroD1 through two independent promoter elements, one that is bound and activated directly by Nkx2.2 and one that appears to be regulated by Nkx2.2 through an indirect mechanism. Together, these findings suggest that Nkx2.2 coordinately activates NeuroD1 with Ngn3 within the endocrine progenitor cell and also plays a role in the maintenance of NeuroD1 expression to regulate beta cell function in the mature islet. Collectively, these findings further define the conserved regulatory networks involved in islet beta cell formation and function.	[Anderson, Keith R.; Sussel, Lori] Univ Colorado, Hlth Sci Ctr, Dept Biochem, Denver, CO 80045 USA; [Anderson, Keith R.] Univ Colorado, Hlth Sci Ctr, Program Mol Biol, Denver, CO 80045 USA; [Torres, Ciara A.; Sussel, Lori] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; [Solomon, Keely; Wright, Christopher V.] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Becker, Thomas C.; Newgard, Christopher B.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27704 USA; [Becker, Thomas C.; Newgard, Christopher B.] Duke Univ, Med Ctr, Dept Pharmacol, Durham, NC 27704 USA; [Becker, Thomas C.; Newgard, Christopher B.] Duke Univ, Med Ctr, Dept Canc Biol & Med, Durham, NC 27704 USA; [Hagman, James] Natl Jewish Hlth Ctr, Integrated Dept Immunol, Denver, CO 80206 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Columbia University; Vanderbilt University; Duke University; Duke University; Duke University; National Jewish Health	Sussel, L (corresponding author), Columbia Univ, Dept Genet & Dev, 1150 St Nicholas Ave,Rm 607B, New York, NY 10032 USA.	lgs2@columbia.edu	Hagman, James/R-7013-2019	Hagman, James/0000-0002-5436-8455	National Institutes of Health [U01 DK072504, UO1DK072504, 5U01DK072473]; American Diabetes Association Regular Research Grant [1-2005-188]; Naomi Berrie Diabetes Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK072504, U01DK072473] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association Regular Research Grant(American Diabetes Association); Naomi Berrie Diabetes Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant U01 DK072504 (to L. S.), NIH supplement to UO1DK072504 (to C. T.), and NIH beta Cell Biology Consortium Grant 5U01DK072473 (a collaborative Bridging Project, to L. S. and C. B. N.). This work was also supported by American Diabetes Association Regular Research Grant, Juvenile Diabetes Research Foundation Regular Research Grant 1-2005-188 and the Naomi Berrie Diabetes Center (to L. S.).	Andrali SS, 2008, BIOCHEM J, V415, P1, DOI 10.1042/BJ20081029; Bain JR, 2004, DIABETES, V53, P2190, DOI 10.2337/diabetes.53.9.2190; Bewig B, 2000, BIOTECHNIQUES, V28, P870, DOI 10.2144/00285bm08; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Chao CS, 2007, DEV BIOL, V312, P523, DOI 10.1016/j.ydbio.2007.09.057; Cissell MA, 2003, J BIOL CHEM, V278, P751, DOI 10.1074/jbc.M205905200; Collombat P, 2005, DEVELOPMENT, V132, P2969, DOI 10.1242/dev.01870; Collombat P, 2006, MECH DEVELOP, V123, P501, DOI 10.1016/j.mod.2006.05.006; Doyle MJ, 2007, DEVELOPMENT, V134, P515, DOI 10.1242/dev.02763; Doyle MJ, 2007, DIABETES, V56, P1999, DOI 10.2337/db06-1766; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fitzsimmons D, 1996, CURR OPIN IMMUNOL, V8, P166, DOI 10.1016/S0952-7915(96)80054-9; Gasa R, 2004, P NATL ACAD SCI USA, V101, P13245, DOI 10.1073/pnas.0405301101; Gasa R, 2008, DIFFERENTIATION, V76, P381, DOI 10.1111/j.1432-0436.2007.00228.x; Gierl MS, 2006, GENE DEV, V20, P2465, DOI 10.1101/gad.381806; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Habener JF, 2005, ENDOCRINOLOGY, V146, P1025, DOI 10.1210/en.2004-1576; Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707; Huang HP, 2002, MOL ENDOCRINOL, V16, P541, DOI 10.1210/me.16.3.541; Huang HP, 2000, MOL CELL BIOL, V20, P3292, DOI 10.1128/MCB.20.9.3292-3307.2000; Itkin-Ansari P, 2005, DEV DYNAM, V233, P946, DOI 10.1002/dvdy.20443; Johansson KA, 2007, DEV CELL, V12, P457, DOI 10.1016/j.devcel.2007.02.010; Jorgensen MC, 2007, ENDOCR REV, V28, P685, DOI 10.1210/er.2007-0016; Kasahara H, 2001, J BIOL CHEM, V276, P4570, DOI 10.1074/jbc.M004995200; Kemp DM, 2003, REV ENDOCR METAB DIS, V4, P5, DOI 10.1023/A:1021809917576; Kim WY, 2001, DEVELOPMENT, V128, P417; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Knuesel M, 2003, MOL CELL PROTEOMICS, V2, P1225, DOI 10.1074/mcp.T300007-MCP200; Liu M, 2000, P NATL ACAD SCI USA, V97, P865, DOI 10.1073/pnas.97.2.865; Maier H, 2003, MOL CELL BIOL, V23, P1946, DOI 10.1128/MCB.23.6.1946-1960.2003; Mellitzer G, 2006, EMBO J, V25, P1344, DOI 10.1038/sj.emboj.7601011; Melloul D, 2002, DIABETOLOGIA, V45, P309, DOI 10.1007/s00125-001-0728-y; Miyata T, 1999, GENE DEV, V13, P1647, DOI 10.1101/gad.13.13.1647; Murtaugh LC, 2007, DEVELOPMENT, V134, P427, DOI 10.1242/dev.02770; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Naya FJ, 1997, GENE DEV, V11, P2323, DOI 10.1101/gad.11.18.2323; Pauls S, 2007, DEV BIOL, V304, P875, DOI 10.1016/j.ydbio.2007.01.024; PICTET R, 1972, DEV EMBRYONIC ENDOCR, P26; Prado CL, 2004, P NATL ACAD SCI USA, V101, P2924, DOI 10.1073/pnas.0308604100; Qi YC, 2001, DEVELOPMENT, V128, P2723; Raum JC, 2006, MOL CELL BIOL, V26, P5735, DOI 10.1128/MCB.00249-06; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Schisler JC, 2005, P NATL ACAD SCI USA, V102, P7297, DOI 10.1073/pnas.0502168102; Schisler JC, 2008, MOL CELL BIOL, V28, P3465, DOI 10.1128/MCB.01791-07; Schwitzgebel VM, 2001, MOL CELL ENDOCRINOL, V185, P99, DOI 10.1016/S0303-7207(01)00628-1; Sigvardsson M, 2002, MOL CELL BIOL, V22, P8539, DOI 10.1128/MCB.22.24.8539-8551.2002; Stoffel M, 1997, P NATL ACAD SCI USA, V94, P13209, DOI 10.1073/pnas.94.24.13209; Sussel L, 1998, DEVELOPMENT, V125, P2213; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Wang S, 2007, MECH DEVELOP, V124, P898, DOI 10.1016/j.mod.2007.08.004; Watada H, 2000, P NATL ACAD SCI USA, V97, P9443, DOI 10.1073/pnas.97.17.9443; Watada H, 2003, J BIOL CHEM, V278, P17130, DOI 10.1074/jbc.M213196200; Westerfield M, 1999, METHOD CELL BIOL, V60, P339; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	54	46	50	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31236	31248		10.1074/jbc.M109.048694	http://dx.doi.org/10.1074/jbc.M109.048694			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19759004	hybrid, Green Published			2022-12-27	WOS:000271378400051
J	Chandra, M; Mamidi, R; Ford, S; Hidalgo, C; Witt, C; Ottenheijm, C; Labeit, S; Granzier, H				Chandra, Murali; Mamidi, Ranganath; Ford, Steven; Hidalgo, Carlos; Witt, Christian; Ottenheijm, Coen; Labeit, Siegfried; Granzier, Henk			Nebulin Alters Cross-bridge Cycling Kinetics and Increases Thin Filament Activation A NOVEL MECHANISM FOR INCREASING TENSION AND REDUCING TENSION COST	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; NEMALINE MYOPATHY; STRIATED-MUSCLE; PSOAS FIBERS; LENGTH; ACTIN; EXPRESSION; FRAGMENTS; ARCHITECTURE; CONTRACTION	Nebulin is a giant filamentous F-actin-binding protein (similar to 800 kDa) that binds along the thin filament of the skeletal muscle sarcomere. Nebulin is one of the least well understood major muscle proteins. Although nebulin is usually viewed as a structural protein, here we investigated whether nebulin plays a role in muscle contraction by using skinned muscle fiber bundles from a nebulin knock-out (NEB KO) mouse model. We measured force-pCa (-log[Ca2+]) and force-ATPase relations, as well as the rate of tension re-development (k(tr)) in tibialis cranialis muscle fibers. To rule out any alterations in troponin (Tn) isoform expression and/or status of Tn phosphorylation, we studied fiber bundles that had been reconstituted with bacterially expressed fast skeletal muscle recombinant Tn. We also performed a detailed analysis of myosin heavy chain, myosin light chain, and myosin light chain 2 phosphorylation, which showed no significant differences between wild type and NEB KO. Our mechanical studies revealed that NEB KO fibers had increased tension cost (5.9 versus 4.4 pmol millinewtons(-1) mm(-1) s(-1)) and reductions in ktr (4.7 versus 7.3 s(-1)), calcium sensitivity (pCa(50) 5.74 versus 5.90), and cooperativity of activation (n(H) 3.64 versus 4.38). Our findings indicate the following: 1) in skeletal muscle nebulin increases thin filament activation, and 2) through altering cross-bridge cycling kinetics, nebulin increases force and efficiency of contraction. These novel properties of nebulin add a new level of understanding of skeletal muscle function and provide a mechanism for the severe muscle weakness in patients with nebulin-based nemaline myopathy.	[Hidalgo, Carlos; Ottenheijm, Coen; Granzier, Henk] Univ Arizona, Dept Physiol, Sarver Mol Cardiovasc Res Program, Tucson, AZ 85724 USA; [Chandra, Murali; Mamidi, Ranganath; Ford, Steven] Washington State Univ, Dept VCAPP, Pullman, WA 99163 USA; [Witt, Christian; Labeit, Siegfried] Heidelberg Univ, Med Fac Mannheim, D-68167 Mannheim, Germany	University of Arizona; Washington State University; Ruprecht Karls University Heidelberg	Granzier, H (corresponding author), Univ Arizona, Dept Physiol, Sarver Mol Cardiovasc Res Program, MRB 325,POB 245217, Tucson, AZ 85724 USA.	granzier@arizona.edu			National Institutes of Health [AR053897, HL062881, HL075643]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075643, R01HL062881] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053897] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR053897 and HL062881 (to H. G.) and HL075643 (to M. C.).	Bang ML, 2006, J CELL BIOL, V173, P905, DOI 10.1083/jcb.200603119; BRENNER B, 1988, P NATL ACAD SCI USA, V85, P3265, DOI 10.1073/pnas.85.9.3265; Campbell KB, 2001, ANN BIOMED ENG, V29, P384, DOI 10.1114/1.1366669; Castillo A, 2009, BIOPHYS J, V96, P1856, DOI 10.1016/j.bpj.2008.10.053; Chandra M, 2005, AM J PHYSIOL-HEART C, V289, pH2112, DOI 10.1152/ajpheart.00571.2005; DETOMBE PP, 1995, CIRC RES, V76, P734, DOI 10.1161/01.RES.76.5.734; Ding W, 2002, EXP PHYSIOL, V87, P691, DOI 10.1113/eph8702448; Gallon CE, 2006, ARCH BIOCHEM BIOPHYS, V456, P127, DOI 10.1016/j.abb.2006.06.008; Gokhin DS, 2009, AM J PHYSIOL-CELL PH, V296, pC1123, DOI 10.1152/ajpcell.00503.2008; Gordon AM, 2001, NEWS PHYSIOL SCI, V16, P49; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Hidalgo C, 2006, ARCH BIOCHEM BIOPHYS, V456, P216, DOI 10.1016/j.abb.2006.06.026; HUXLEY HE, 1969, SCIENCE, V164, P1356, DOI 10.1126/science.164.3886.1356; JIN JP, 1991, J BIOL CHEM, V266, P21215; KRUGER M, 1991, J CELL BIOL, V115, P97, DOI 10.1083/jcb.115.1.97; LABEIT S, 1991, FEBS LETT, V282, P313, DOI 10.1016/0014-5793(91)80503-U; LABEIT S, 1995, J MOL BIOL, V248, P308, DOI 10.1016/S0022-2836(95)80052-2; Lukoyanova N, 2002, CURR BIOL, V12, P383, DOI 10.1016/S0960-9822(02)00678-4; Lutz GJ, 2001, J EXP BIOL, V204, P4237; McElhinny AS, 2003, TRENDS CARDIOVAS MED, V13, P195, DOI 10.1016/S1050-1738(03)00076-8; McElhinny AS, 2001, J BIOL CHEM, V276, P583, DOI 10.1074/jbc.M005693200; Ogut O, 2003, J BIOL CHEM, V278, P3089, DOI 10.1074/jbc.M205853200; Ottenheijm CAC, 2009, HUM MOL GENET, V18, P2359, DOI 10.1093/hmg/ddp168; Pappas CT, 2008, MOL BIOL CELL, V19, P1837, DOI 10.1091/mbc.E07-07-0690; ROOT DD, 1994, BIOCHEMISTRY-US, V33, P12581, DOI 10.1021/bi00208a008; Root DD, 2001, BIOCHEMISTRY-US, V40, P1171, DOI 10.1021/bi0015010; Sewry CA, 2001, NEUROMUSCULAR DISORD, V11, P146, DOI 10.1016/S0960-8966(00)00172-3; SWEENEY HL, 1993, AM J PHYSIOL, V264, pC1085, DOI 10.1152/ajpcell.1993.264.5.C1085; Wallgren-Pettersson C, 2004, NEUROMUSCULAR DISORD, V14, P461, DOI 10.1016/j.nmd.2004.03.006; Wang K, 1996, J BIOL CHEM, V271, P4304; Wang K, 1996, ADV BIOPHYS, V33, P123; Witt CC, 2006, EMBO J, V25, P3843, DOI 10.1038/sj.emboj.7601242	32	79	79	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30889	30896		10.1074/jbc.M109.049718	http://dx.doi.org/10.1074/jbc.M109.049718			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19736309	hybrid, Green Published			2022-12-27	WOS:000271378400017
J	Fox, JT; Shin, WK; Caudill, MA; Stover, PJ				Fox, Jennifer T.; Shin, William K.; Caudill, Marie A.; Stover, Patrick J.			A UV-responsive Internal Ribosome Entry Site Enhances Serine Hydroxymethyltransferase 1 Expression for DNA Damage Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; IRES-MEDIATED TRANSLATION; MESSENGER-RNA TRANSLATION; TRACT-BINDING-PROTEIN; ONE-CARBON METABOLISM; THYMIDYLATE BIOSYNTHESIS; INDUCED PHOSPHORYLATION; DEPENDENT TRANSLATION; INHIBITS TRANSLATION; MYOTONIC-DYSTROPHY	Thymidine nucleotides are required for faithful DNA synthesis and repair, and their de novo biosynthesis is regulated by serine hydroxymethyltransferase 1 (SHMT1). The SHMT1 transcript contains a heavy chain ferritin, heterogeneous nuclear ribonucleoprotein H2, and CUG-binding protein 1-responsive internal ribosome entry site (IRES) that regulates SHMT1 translation. In this study a non-lethal dose of UVC is shown to increase SHMT1 IRES activity and protein levels in four different cell lines. The mechanism for the UV-induced activation of the SHMT1 IRES involves an increase in heavy chain ferritin and heterogeneous nuclear ribonucleoprotein H2 expression and the translocation of CUG-binding protein 1 from the nucleus to the cytoplasm. The UV-induced increase in SHMT1 translation is accompanied by an increase in the small ubiquitin-like modifier-dependent nuclear localization of the de novo thymidylate biosynthesis pathway and a decrease in DNA strand breaks, indicating a role for SHMT1 and nuclear folate metabolism in DNA repair.	[Fox, Jennifer T.; Stover, Patrick J.] Cornell Univ, Grad Field Biochem & Mol & Cellular Biol, Ithaca, NY 14853 USA; [Shin, William K.; Caudill, Marie A.; Stover, Patrick J.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University	Stover, PJ (corresponding author), Cornell Univ, Grad Field Biochem & Mol & Cellular Biol, 315 Savage Hall, Ithaca, NY 14853 USA.	pjs13@cornell.edu			USPHS [DK58144]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK058144, R01DK058144] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK58144 from the USPHS.	Anderson DD, 2007, CLIN CHEM LAB MED, V45, P1760, DOI 10.1515/CCLM.2007.355; Anderson DD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005839; BALLA G, 1992, J BIOL CHEM, V267, P18148; Bender K, 1997, J PHOTOCH PHOTOBIO B, V37, P1, DOI 10.1016/S1011-1344(96)07459-3; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; Bushell M, 2006, MOL CELL, V23, P401, DOI 10.1016/j.molcel.2006.06.012; Cheng Z, 2008, ONCOGENE, V27, P931, DOI 10.1038/sj.onc.1210710; Cormier Patrick, 2003, Prog Cell Cycle Res, V5, P469; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; Deng J, 2002, CURR BIOL, V12, P1279, DOI 10.1016/S0960-9822(02)01037-0; Dobbyn HC, 2008, ONCOGENE, V27, P1167, DOI 10.1038/sj.onc.1210723; Fox JT, 2009, J BIOL CHEM, V284, P31085, DOI 10.1074/jbc.M109.035576; Fritz G, 1999, MOL CELL BIOL, V19, P1768; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Girgis S, 1998, GENE, V210, P315, DOI 10.1016/S0378-1119(98)00085-7; GREEN JM, 1988, BIOCHEMISTRY-US, V27, P8014, DOI 10.1021/bi00421a007; Habelhah H, 2001, NAT CELL BIOL, V3, P325, DOI 10.1038/35060131; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Herbig K, 2002, J BIOL CHEM, V277, P38381, DOI 10.1074/jbc.M205000200; Holcik M, 2000, TRENDS GENET, V16, P469, DOI 10.1016/S0168-9525(00)02106-5; HORI TA, 1984, CANCER RES, V44, P703; Jiang HY, 2005, BIOCHEM J, V385, P371, DOI 10.1042/BJ20041164; Laiho M, 2003, ANN MED, V35, P391, DOI 10.1080/07853890310014605; Legrand-Poels S, 1998, J PHOTOCH PHOTOBIO B, V45, P1, DOI 10.1016/S1011-1344(98)00118-3; Lewis SM, 2007, MOL BIOL CELL, V18, P1302, DOI 10.1091/mbc.E06-06-0515; MacFarlane AJ, 2008, J BIOL CHEM, V283, P25846, DOI 10.1074/jbc.M802671200; Mazan-Mamczarz K, 2003, P NATL ACAD SCI USA, V100, P8354, DOI 10.1073/pnas.1432104100; Michalowski S, 1999, NUCLEIC ACIDS RES, V27, P3534, DOI 10.1093/nar/27.17.3534; Oppenheim EW, 2001, J BIOL CHEM, V276, P19855, DOI 10.1074/jbc.M100039200; Pham CG, 2004, CELL, V119, P529, DOI 10.1016/j.cell.2004.10.017; Pyronnet S, 2001, CURR OPIN GENET DEV, V11, P13, DOI 10.1016/S0959-437X(00)00150-7; Ravanat JL, 2001, J PHOTOCH PHOTOBIO B, V63, P88, DOI 10.1016/S1011-1344(01)00206-8; Reed MC, 2006, J NUTR, V136, P2653, DOI 10.1093/jn/136.10.2653; Sachs AB, 2000, CELL, V101, P243, DOI 10.1016/S0092-8674(00)80834-X; SCHIRCH V, 1989, ARCH BIOCHEM BIOPHYS, V269, P371, DOI 10.1016/0003-9861(89)90120-3; SCOTT JM, 1981, LANCET, V2, P337; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shinbo Y, 2006, CELL DEATH DIFFER, V13, P96, DOI 10.1038/sj.cdd.4401704; Spriggs KA, 2008, BIOL CELL, V100, P27, DOI 10.1042/BC20070098; STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H; STRONG WB, 1990, J BIOL CHEM, V265, P12149; Suh JR, 2001, ANNU REV NUTR, V21, P255, DOI 10.1146/annurev.nutr.21.1.255; Timchenko LT, 1996, NUCLEIC ACIDS RES, V24, P4407, DOI 10.1093/nar/24.22.4407; Timchenko NA, 2005, J BIOL CHEM, V280, P20549, DOI 10.1074/jbc.M409563200; Tornaletti S, 1999, BIOCHIMIE, V81, P139, DOI 10.1016/S0300-9084(99)80046-7; Ungureanu NH, 2006, J BIOL CHEM, V281, P15155, DOI 10.1074/jbc.M511319200; van Oordt WV, 2000, J CELL BIOL, V149, P307, DOI 10.1083/jcb.149.2.307; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wang QE, 2005, NUCLEIC ACIDS RES, V33, P4023, DOI 10.1093/nar/gki684; Woeller CF, 2007, J BIOL CHEM, V282, P29927, DOI 10.1074/jbc.M706264200; Woeller CF, 2007, J BIOL CHEM, V282, P17623, DOI 10.1074/jbc.M702526200; Wu SY, 2002, J BIOL CHEM, V277, P18077, DOI 10.1074/jbc.M110164200; Xie JY, 2003, P NATL ACAD SCI USA, V100, P8776, DOI 10.1073/pnas.1432696100; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032	55	31	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31097	31108		10.1074/jbc.M109.015800	http://dx.doi.org/10.1074/jbc.M109.015800			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19734144	Green Published, hybrid			2022-12-27	WOS:000271378400038
J	Kimura, N; Inoue, M; Okabayashi, S; Ono, F; Negishi, T				Kimura, Nobuyuki; Inoue, Makoto; Okabayashi, Sachi; Ono, Fumiko; Negishi, Takayuki			Dynein Dysfunction Induces Endocytic Pathology Accompanied by an Increase in Rab GTPases A POTENTIAL MECHANISM UNDERLYING AGE-DEPENDENT ENDOCYTIC DYSFUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; FAST AXONAL-TRANSPORT; SPORADIC ALZHEIMERS-DISEASE; CYNOMOLGUS MONKEY BRAINS; CYTOPLASMIC DYNEIN; DYNACTIN COMPLEX; NEURODEGENERATIVE DISEASES; DOWN-SYNDROME; CELLULAR-DISTRIBUTION; VESICLE TRANSPORT	Growing evidence suggests that endocytic dysfunction is intimately involved in early stage Alzheimer disease pathology, such as the accumulation of beta-amyloid precursor protein in enlarged early endosomes. However, it remains unclear how endocytic dysfunction is induced in an age-dependent manner. Cytoplasmic dynein, a microtubule-based motor protein, interacts with another microtubule-associated protein, dynactin. The resulting dynein-dynactin complex mediates minus end-directed vesicle transport, including endosome trafficking. We have previously shown that the interaction between dynein-dynactin complexes is clearly attenuated in aged monkey brains, suggesting that dynein-mediated transport dysfunction exists in aged brains. Our immunohistochemical analyses revealed that age-dependent endocytic pathology was accompanied by an increase in Rab GTPases in aged monkey brains. Here, we demonstrated that siRNA-induced dynein dysfunction reproduced the endocytic pathology accompanied by increased Rab GTPases seen in aged monkey brains and significantly disrupted exosome release. Moreover, it also resulted in endosomal beta-amyloid precursor protein accumulation characterized by increased beta-site cleavage. These findings suggest that dynein dysfunction may underlie age-dependent endocytic dysfunction via the up-regulation of Rab GTPases. In addition, this vicious circle may worsen endocytic dysfunction, ultimately leading to Alzheimer disease pathology.	[Kimura, Nobuyuki; Okabayashi, Sachi; Ono, Fumiko] Natl Inst Biomed Innovat, Tsukuba Primate Res Ctr, Lab Dis Control, Tsukuba, Ibaraki 3050843, Japan; [Inoue, Makoto] DNAVEC Res Inc, Tsukuba, Ibaraki 3058421, Japan; [Okabayashi, Sachi; Ono, Fumiko] Corp Prod & Res Lab Primates, Tsukuba, Ibaraki 3050843, Japan; [Negishi, Takayuki] Aoyama Gakuin Univ, Sch Sci & Engn, Dept Chem & Biol Sci, Sagamihara, Kanagawa 2298558, Japan	National Institute of Health Sciences - Japan; DNAVEC Corporation; Aoyama Gakuin University	Kimura, N (corresponding author), Natl Inst Biomed Innovat, Tsukuba Primate Res Ctr, Lab Dis Control, 1-1 Hachimandai, Tsukuba, Ibaraki 3050843, Japan.	kimura@nibio.go.jp			Aging and Health, Ministry of Health, Labor, and Welfare, Japan	Aging and Health, Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a grant-in-aid from Comprehensive Research on Aging and Health, Ministry of Health, Labor, and Welfare, Japan.	Allan V, 1996, CURR BIOL, V6, P630, DOI 10.1016/S0960-9822(09)00434-5; ANIENTO F, 1993, J CELL BIOL, V123, P1373, DOI 10.1083/jcb.123.6.1373; BRADY ST, 1985, NATURE, V317, P73, DOI 10.1038/317073a0; Cataldo AM, 2000, AM J PATHOL, V157, P277, DOI 10.1016/S0002-9440(10)64538-5; Cataldo AM, 2004, NEUROBIOL AGING, V25, P1263, DOI 10.1016/j.neurobiolaging.2004.02.027; Cataldo AM, 1997, J NEUROSCI, V17, P6142; Cataldo AM, 2008, AM J PATHOL, V173, P370, DOI 10.2353/ajpath.2008.071053; Caviston JP, 2007, P NATL ACAD SCI USA, V104, P10045, DOI 10.1073/pnas.0610628104; Deacon SW, 2003, J CELL BIOL, V160, P297, DOI 10.1083/jcb.200210066; DeLacalle S, 1996, NEUROSCIENCE, V75, P19, DOI 10.1016/0306-4522(96)00239-4; Driskell OJ, 2007, NAT CELL BIOL, V9, P113, DOI 10.1038/ncb1525; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; Fader CM, 2008, TRAFFIC, V9, P230, DOI 10.1111/j.1600-0854.2007.00677.x; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; GILL SR, 1991, J CELL BIOL, V115, P1639, DOI 10.1083/jcb.115.6.1639; GONG CX, 1995, J NEUROCHEM, V65, P732, DOI 10.1046/j.1471-4159.1995.65020732.x; GONG CX, 1993, J NEUROCHEM, V61, P921, DOI 10.1111/j.1471-4159.1993.tb03603.x; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Harrison RE, 2003, MOL CELL BIOL, V23, P6494, DOI 10.1128/MCB.23.18.6494-6506.2003; Holleran EA, 1998, INT REV CYTOL, V182, P69, DOI 10.1016/S0074-7696(08)62168-3; Ida N, 1996, J BIOL CHEM, V271, P22908, DOI 10.1074/jbc.271.37.22908; Jiang CH, 2001, P NATL ACAD SCI USA, V98, P1930, DOI 10.1073/pnas.98.4.1930; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Jordens I, 2005, TRAFFIC, V6, P1070, DOI 10.1111/j.1600-0854.2005.00336.x; Jouvenceau A, 2006, J PHYSIOL-PARIS, V99, P154, DOI 10.1016/j.jphysparis.2005.12.009; KARKI S, 1995, J BIOL CHEM, V270, P28806, DOI 10.1074/jbc.270.48.28806; Kimura N, 2005, NEUROPATH APPL NEURO, V31, P170, DOI 10.1111/j.1365-2990.2004.00624.x; Kimura N, 2003, BIOCHEM BIOPH RES CO, V310, P303, DOI 10.1016/j.bbrc.2003.09.012; Kimura N, 2001, BRAIN RES, V922, P30, DOI 10.1016/S0006-8993(01)03146-8; Kimura N, 2007, J NEUROSCI RES, V85, P2909, DOI 10.1002/jnr.21408; Kokubo H, 2005, NEUROBIOL AGING, V26, P409, DOI 10.1016/j.neurobiolaging.2004.04.008; Ladner CJ, 1996, J NEUROPATH EXP NEUR, V55, P924, DOI 10.1097/00005072-199608000-00008; Lebrand C, 2002, EMBO J, V21, P1289, DOI 10.1093/emboj/21.6.1289; LIN SXH, 1994, J CELL BIOL, V127, P1009, DOI 10.1083/jcb.127.4.1009; LIPPINCOTTSCHWARTZ J, 1987, CELL, V49, P669, DOI 10.1016/0092-8674(87)90543-5; LYE RJ, 1987, CELL, V51, P309, DOI 10.1016/0092-8674(87)90157-7; Martin M, 1999, MOL BIOL CELL, V10, P3717, DOI 10.1091/mbc.10.11.3717; MOOS T, 1995, BRAIN RES, V672, P14, DOI 10.1016/0006-8993(94)01329-G; Nakamura S, 1998, J MED PRIMATOL, V27, P244, DOI 10.1111/j.1600-0684.1998.tb00244.x; Niewiadomska G, 2005, ANN NY ACAD SCI, V1048, P287, DOI 10.1196/annals.1342.026; Niewiadomska G, 2003, NEUROREPORT, V14, P1701, DOI 10.1097/00001756-200309150-00009; Nixon RA, 2005, NEUROBIOL AGING, V26, P373, DOI 10.1016/j.neurobiolaging.2004.09.018; Norris CM, 1998, J NEUROPHYSIOL, V80, P1567, DOI 10.1152/jn.1998.80.3.1567; Norris EH, 2004, CURR TOP DEV BIOL, V60, P17; PASCHAL BM, 1987, J CELL BIOL, V105, P1273, DOI 10.1083/jcb.105.3.1273; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Ravikumar B, 2005, NAT GENET, V37, P771, DOI 10.1038/ng1591; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Riggs B, 2007, MOL BIOL CELL, V18, P3313, DOI 10.1091/mbc.E07-02-0146; Runnegar MT, 1999, BIOCHEM J, V342, P1, DOI 10.1042/0264-6021:3420001; Russo R, 2005, FEBS LETT, V579, P6027, DOI 10.1016/j.febslet.2005.09.054; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; SCHROER TA, 1991, J CELL BIOL, V115, P1309, DOI 10.1083/jcb.115.5.1309; Sharples RA, 2008, FASEB J, V22, P1469, DOI 10.1096/fj.07-9357com; TAMAI Y, 1989, MICROBIOL IMMUNOL, V33, P35, DOI 10.1111/j.1348-0421.1989.tb01495.x; Tanimukai H, 2005, AM J PATHOL, V166, P1761, DOI 10.1016/S0002-9440(10)62486-8; Traer CJ, 2007, NAT CELL BIOL, V9, P1370, DOI 10.1038/ncb1656; Trojanowski JQ, 2003, NEUROMOL MED, V4, P1, DOI 10.1385/NMM:4:1-2:1; Valetti C, 1999, MOL BIOL CELL, V10, P4107, DOI 10.1091/mbc.10.12.4107; VAUGHAN KT, 1995, J CELL BIOL, V131, P1507, DOI 10.1083/jcb.131.6.1507; Vogelsberg-Ragaglia V, 2001, EXP NEUROL, V168, P402, DOI 10.1006/exnr.2001.7630; WANG R, 1991, J BIOL CHEM, V266, P16960; WATERMANSTORER CM, 1995, P NATL ACAD SCI USA, V92, P1634, DOI 10.1073/pnas.92.5.1634; WatermanStorer CM, 1997, P NATL ACAD SCI USA, V94, P12180, DOI 10.1073/pnas.94.22.12180; Welte MA, 2004, CURR BIOL, V14, pR525, DOI 10.1016/j.cub.2004.06.045; Yoon SY, 2008, NEUROSCI LETT, V437, P111, DOI 10.1016/j.neulet.2008.03.083	66	32	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31291	31302		10.1074/jbc.M109.012625	http://dx.doi.org/10.1074/jbc.M109.012625			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19758999	Green Published, hybrid			2022-12-27	WOS:000271378400056
J	Sen, S; Webber, PJ; West, AB				Sen, Saurabh; Webber, Philip J.; West, Andrew B.			Dependence of Leucine-rich Repeat Kinase 2 (LRRK2) Kinase Activity on Dimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE-ASSOCIATED MUTATIONS; PARKINSONS-DISEASE; LEUCINE-RICH-REPEAT-KINASE-2 LRRK2; ACTIVATION LOOP; GTP-BINDING; AUTOPHOSPHORYLATION; PHOSPHORYLATION; IDENTIFICATION; PENETRANCE; EXPRESSION	Dominant missense mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are the most common known genetic cause of Parkinson disease. LRRK2 encodes a serine/threonine protein kinase, and pathogenic mutations may increase kinase activity. Intrinsic GTP binding in the GTPase domain may govern kinase activity through an internal signal transduction cascade. As with many protein kinases, LRRK2 self-interacts through mechanisms that may regulate enzymatic activity. We find that the disruption of either GTPase or kinase activity enhances the formation of high molecular weight oligomers and prevents the formation of LRRK2 dimer structures. In addition, brief application of the broad spectrum kinase inhibitor staurosporine ablates LRRK2 dimers and promotes LRRK2 high molecular weight oligomers. LRRK2 interactions with other proteins in cell lines are kinase-independent and include chaperones and cell cytoskeleton components, suggesting that LRRK2 self-assembly principally dictates complex size. To further explore the mechanics of kinase activation, we separate soluble LRRK2 protein that encodes the pathogenic G2019S mutation into high molecular weight oligomers, dimers, and monomers and find that kinase activity resides with dimeric LRRK2. Some PD-associated mutations that increase kinase activity in vitro significantly increase the proportion of dimer structures relative to total LRRK2 protein, providing additional insight into how pathogenic mutations may alter normal enzymatic regulation. Targeting and tracking LRRK2 dimerization may provide a clear way to observe LRRK2 kinase activity in living cells, and disruption of dimeric LRRK2 through kinase inhibition or other means may attenuate pathogenic increases in LRRK2 enzymatic output.	[Sen, Saurabh; Webber, Philip J.; West, Andrew B.] Univ Alabama, Dept Neurol, Ctr Neurodegenerat & Expt Therapeut, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	West, AB (corresponding author), 1719 6th Ave S, Birmingham, AL 35226 USA.	abwest@uab.edu		West, Andrew/0000-0002-3034-4061	National Institutes of Health [R00 NS058111]; Michael J. Fox Foundation for Parkinson's Research; American Parkinson's Disease Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS058111] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michael J. Fox Foundation for Parkinson's Research; American Parkinson's Disease Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R00 NS058111. This work was also supported by the Michael J. Fox Foundation for Parkinson's Research, the American Parkinson's Disease Association, and the benevolence of John A. and Ruth R. Jurenko.	Anand VS, 2009, FEBS J, V276, P466, DOI 10.1111/j.1742-4658.2008.06789.x; BISKUP S, 2008, BIOCHIM BIOPHYS ACTA, V1792, P625; Biskup S, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-102; Cheng JK, 2005, J BIOL CHEM, V280, P13477, DOI 10.1074/jbc.M414258200; Cobb MH, 2000, TRENDS BIOCHEM SCI, V25, P7, DOI 10.1016/S0968-0004(99)01508-X; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; Covy JP, 2009, BIOCHEM BIOPH RES CO, V378, P473, DOI 10.1016/j.bbrc.2008.11.048; Dachsel JC, 2007, PARKINSONISM RELAT D, V13, P382, DOI 10.1016/j.parkreldis.2007.01.008; Deng JP, 2008, P NATL ACAD SCI USA, V105, P1499, DOI 10.1073/pnas.0709098105; Du Y, 2005, J BIOL CHEM, V280, P42984, DOI 10.1074/jbc.M502671200; Funayama M, 2007, NEUROREPORT, V18, P273, DOI 10.1097/WNR.0b013e32801254b6; Gloeckner CJ, 2009, J NEUROCHEM, V109, P959, DOI 10.1111/j.1471-4159.2009.06024.x; Gloeckner CJ, 2006, HUM MOL GENET, V15, P223, DOI 10.1093/hmg/ddi439; Greggio E, 2008, J BIOL CHEM, V283, P16906, DOI 10.1074/jbc.M708718200; Greggio E, 2009, BIOCHEM BIOPH RES CO, V389, P449, DOI 10.1016/j.bbrc.2009.08.163; Greggio E, 2009, ASN NEURO, V1, DOI 10.1042/AN20090007; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Hulihan MM, 2008, LANCET NEUROL, V7, P591, DOI 10.1016/S1474-4422(08)70116-9; Ito G, 2007, BIOCHEMISTRY-US, V46, P1380, DOI 10.1021/bi061960m; Klein CL, 2009, J NEUROCHEM, V111, P703, DOI 10.1111/j.1471-4159.2009.06358.x; Lesage S, 2006, NEW ENGL J MED, V354, P422, DOI 10.1056/NEJMc055540; Leung IWL, 1998, J BIOL CHEM, V273, P32408, DOI 10.1074/jbc.273.49.32408; Leung IWL, 2001, J BIOL CHEM, V276, P1961, DOI 10.1074/jbc.M004092200; Lewis PA, 2007, BIOCHEM BIOPH RES CO, V357, P668, DOI 10.1016/j.bbrc.2007.04.006; Lorenz K, 2009, NAT MED, V15, P75, DOI 10.1038/nm.1893; Melrose HL, 2007, NEUROSCIENCE, V147, P1047, DOI 10.1016/j.neuroscience.2007.05.027; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Nitta RT, 2008, J BIOL CHEM, V283, P34935, DOI 10.1074/jbc.M804970200; Pelech Steven, 2006, J Biol, V5, P12, DOI 10.1186/jbiol45; Wang LZ, 2008, J NEUROSCI, V28, P3384, DOI 10.1523/JNEUROSCI.0185-08.2008; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; Zabetian CP, 2009, MOVEMENT DISORD, V24, P1034, DOI 10.1002/mds.22514	33	140	141	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36346	36356		10.1074/jbc.M109.025437	http://dx.doi.org/10.1074/jbc.M109.025437			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19826009	Green Published, hybrid			2022-12-27	WOS:000272970500036
J	Settivari, R; LeVora, J; Nass, R				Settivari, Raja; LeVora, Jennifer; Nass, Richard			The Divalent Metal Transporter Homologues SMF-1/2 Mediate Dopamine Neuron Sensitivity in Caenorhabditis elegans Models of Manganism and Parkinson Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-SYNUCLEIN; OXIDATIVE STRESS; C-ELEGANS; LIFE-SPAN; GENE-EXPRESSION; HEAVY-METAL; IRON; EXPOSURE; CELLS; DMT1	Parkinson disease (PD) and manganism are characterized by motor deficits and a loss of dopamine (DA) neurons in the substantia nigra pars compacta. Epidemiological studies indicate significant correlations between manganese exposure and the propensity to develop PD. The vertebrate divalent metal transporter-1 (DMT-1) contributes to maintaining cellular Mn2+ homeostasis and has recently been implicated in Fe2+-mediated neurodegeneration in PD. In this study we describe a novel model for manganism that incorporates the genetically tractable nematode Caenorhabditis elegans. We show that a brief exposure to Mn2+ increases reactive oxygen species and glutathione production, decreases oxygen consumption and head mitochondria membrane potential, and confers DA neuronal death. DA neurodegeneration is partially dependent on a putative homologue to DMT-1, SMF-1, as genetic knockdown or deletion partially inhibits the neuronal death. Mn2+ also amplifies the DA neurotoxicity of the PD-associated protein alpha-synuclein. Furthermore, both SMF-1 and SMF-2 are expressed in DA neurons and contribute to PD-associated neurotoxicant-induced DA neuron death. These studies describe a C. elegans model for manganism and show that DMT-1 homologues contribute to Mn2+- and PD-associated DA neuron vulnerability.	[Settivari, Raja; Nass, Richard] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Settivari, Raja; Nass, Richard] Indiana Univ Sch Med, Ctr Environm Hlth, Indianapolis, IN 46202 USA; [LeVora, Jennifer; Nass, Richard] Indiana Univ Sch Med, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Nass, R (corresponding author), Indiana Univ Sch Med, Dept Pharmacol & Toxicol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	ricnass@iupui.edu	Settivari, Raja/I-5200-2012	Settivari, Raja/0000-0001-9003-5917	NIEHS [R011ES014459, R01ES010563]; Dept. of Defense Manganese Health Research Program [W81XWH-05-1-0239]; National Institutes of Health Center for Research Resources; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010563, R01ES014459] Funding Source: NIH RePORTER	NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Dept. of Defense Manganese Health Research Program(United States Department of Defense); National Institutes of Health Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R011ES014459 and R01ES010563 from NIEHS. This work was also supported by Grant W81XWH-05-1-0239 from the Dept. of Defense Manganese Health Research Program (to R.N.).; We gratefully appreciate the technical assistance of Michelle Fullard, Marketa Marvanova, Shaoyu Zhou, and Randy Hunter. We are thankful to Eric A. Engleman and Gabriel Filippelli for assistance with determining C. elegans DA and Mn<SUP>2+</SUP> concentrations, respectively. We also appreciate early discussions with Michael Aschner. Some of the strains were provided by the Caenorhabditis Genetics Center, which is supported by the National Institutes of Health Center for Research Resources.	Aisen P, 2001, INT J BIOCHEM CELL B, V33, P940, DOI 10.1016/S1357-2725(01)00063-2; ALTSCHUL SF, 1991, J MOL BIOL, V219, P555, DOI 10.1016/0022-2836(91)90193-A; Aschner Judy L., 2005, Molecular Aspects of Medicine, V26, P353, DOI 10.1016/j.mam.2005.07.003; BARBEAU A, 1984, NEUROTOXICOLOGY, V5, P13; Bianchi L, 2006, WORMBOOK; BRENNER S, 1974, GENETICS, V77, P71; Bressler JP, 2004, ANN NY ACAD SCI, V1012, P142, DOI 10.1196/annals.1306.011; Brown DR, 2009, BIOCHEM BIOPH RES CO, V380, P377, DOI 10.1016/j.bbrc.2009.01.103; Burton NC, 2009, ENVIRON HEALTH PERSP, V117, P325, DOI [10.1289/ehp.0800035, 10.1289/ehp.1173c25]; Carvelli L, 2004, P NATL ACAD SCI USA, V101, P16046, DOI 10.1073/pnas.0403299101; CELLIER M, 1995, P NATL ACAD SCI USA, V92, P10089, DOI 10.1073/pnas.92.22.10089; Chen JY, 2001, TOXICOL APPL PHARM, V175, P160, DOI 10.1006/taap.2001.9245; Chen MK, 2006, NEUROTOXICOLOGY, V27, P229, DOI 10.1016/j.neuro.2005.10.008; CHIA SE, 1993, SCAND J WORK ENV HEA, V19, P264, DOI 10.5271/sjweh.1475; Cookson MR, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-9; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Crossgrove J, 2004, NMR BIOMED, V17, P544, DOI 10.1002/nbm.931; Culotta VC, 2005, EUKARYOT CELL, V4, P1159, DOI 10.1128/EC.4.7.1159-1165.2005; de Bie RMA, 2007, ARCH NEUROL-CHICAGO, V64, P886, DOI 10.1001/archneur.64.6.886; DESOLE MS, 1994, ARCH TOXICOL, V68, P566, DOI 10.1007/s002040050115; Dobson AW, 2003, BIOL TRACE ELEM RES, V93, P113, DOI 10.1385/BTER:93:1-3:113; Domico LM, 2006, NEUROTOXICOLOGY, V27, P816, DOI 10.1016/j.neuro.2006.07.009; EHRENBERG B, 1988, BIOPHYS J, V53, P785, DOI 10.1016/S0006-3495(88)83158-8; ELNABY SA, 1965, J NEUROL NEUROSUR PS, V28, P282; Erikson KM, 2007, TOXICOL SCI, V97, P459, DOI 10.1093/toxsci/kfm044; Fahn S, 2008, PARKINSON'S DISEASE: MOLECULAR AND THERAPEUTIC INSIGHTS FROM MODEL SYSTEMS, P3; FISHMAN BE, 1987, TOXICOLOGY, V45, P193, DOI 10.1016/0300-483X(87)90105-3; Garrick MD, 2003, BIOMETALS, V16, P41, DOI 10.1023/A:1020702213099; Gitler AD, 2009, NAT GENET, V41, P308, DOI 10.1038/ng.300; Gorell JM, 1999, NEUROTOXICOLOGY, V20, P239; HaMai D, 2004, ANN NY ACAD SCI, V1012, P129, DOI 10.1196/annals.1306.010; Higashi Y, 2004, J NEUROCHEM, V89, P1490, DOI 10.1111/j.1471-4159.2004.02445.x; HOLZGRAEFE M, 1986, J TOXICOL-CLIN TOXIC, V24, P235, DOI 10.3109/15563658608990461; HOPE IA, 1999, C ELEGANS PRACTICAL, P1; Hubert N, 2002, P NATL ACAD SCI USA, V99, P12345, DOI 10.1073/pnas.192423399; HURLEY LS, 1963, AM J PHYSIOL, V204, P493, DOI 10.1152/ajplegacy.1963.204.3.493; Jiang YM, 2006, J OCCUP ENVIRON MED, V48, P644, DOI 10.1097/01.jom.0000204114.01893.3e; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kampkotter A, 2007, PHARMACOL RES, V55, P139, DOI 10.1016/j.phrs.2006.11.006; Keen CL, 2000, MET IONS BIOL SYST, V37, P89; Lakso M, 2003, J NEUROCHEM, V86, P165, DOI 10.1046/j.1471-4159.2003.01809.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Levenson CW, 2004, EXP NEUROL, V190, P506, DOI 10.1016/j.expneurol.2004.08.014; Lin YT, 2006, FREE RADICAL BIO MED, V40, P1185, DOI 10.1016/j.freeradbiomed.2005.11.007; Liu XF, 1999, J BIOL CHEM, V274, P4863, DOI 10.1074/jbc.274.8.4863; Luk EEC, 2001, J BIOL CHEM, V276, P47556, DOI 10.1074/jbc.M108923200; Migheli R, 1999, J NEUROCHEM, V73, P1155, DOI 10.1046/j.1471-4159.1999.0731155.x; Miller GW, 1999, TRENDS PHARMACOL SCI, V20, P424, DOI 10.1016/S0165-6147(99)01379-6; Nass R, 2005, J NEUROCHEM, V94, P774, DOI 10.1111/j.1471-4159.2005.03205.x; Nass R, 2002, P NATL ACAD SCI USA, V99, P3264, DOI 10.1073/pnas.042497999; Nass R, 2003, ANNU REV PHARMACOL, V43, P521, DOI 10.1146/annurev.pharmtox.43.100901.135934; Nass R, 2001, PARKINSONISM RELAT D, V7, P185, DOI 10.1016/S1353-8020(00)00056-0; Nass R., 2007, CURR PROTOC TOXICOL; Nass R, 2008, PARKINSON'S DISEASE: MOLECULAR AND THERAPEUTIC INSIGHTS FROM MODEL SYSTEMS, P347, DOI 10.1016/B978-0-12-374028-1.00026-9; Nass R, 2008, MOL INTERV, V8, P284, DOI 10.1124/mi.8.6.6; Novillo A, 2005, INTEGR COMP BIOL, V45, P61, DOI 10.1093/icb/45.1.61; OESTREICHER E, 1994, BRAIN RES, V660, P8, DOI 10.1016/0006-8993(94)90833-8; Olivares D, 2009, INT J MOL SCI, V10, P1226, DOI 10.3390/ijms10031226; Papp-Wallace KM, 2006, ANNU REV MICROBIOL, V60, P187, DOI 10.1146/annurev.micro.60.080805.142149; PARENTI M, 1988, BRAIN RES, V473, P236, DOI 10.1016/0006-8993(88)90852-9; Pifl C, 2004, NEUROSCI LETT, V354, P34, DOI 10.1016/j.neulet.2003.09.064; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Portnoy ME, 2000, MOL CELL BIOL, V20, P7893, DOI 10.1128/MCB.20.21.7893-7902.2000; Racette BA, 2001, NEUROLOGY, V56, P8, DOI 10.1212/WNL.56.1.8; Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884; Rand JB, 1995, METHOD CELL BIOL, V48, P187; Rodier J, 1955, BRIT J IND MED, V12, P21; Salazar J, 2008, P NATL ACAD SCI USA, V105, P18578, DOI 10.1073/pnas.0804373105; Salvatore MF, 2005, MOL BRAIN RES, V139, P341, DOI 10.1016/j.molbrainres.2005.06.002; Schulz JB, 2000, EUR J BIOCHEM, V267, P4904, DOI 10.1046/j.1432-1327.2000.01595.x; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; SHI MM, 1994, J BIOL CHEM, V269, P26512; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; Springer W, 2005, HUM MOL GENET, V14, P3407, DOI 10.1093/hmg/ddi371; Stredrick DL, 2004, NEUROTOXICOLOGY, V25, P543, DOI 10.1016/j.neuro.2003.08.006; Supek F, 1996, P NATL ACAD SCI USA, V93, P5105, DOI 10.1073/pnas.93.10.5105; Takeda A, 2003, BRAIN RES REV, V41, P79, DOI 10.1016/S0165-0173(02)00234-5; Thiruchelvam M, 2003, EUR J NEUROSCI, V18, P589, DOI 10.1046/j.1460-9568.2003.02781.x; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Tomas-Camardiel M, 2002, MOL BRAIN RES, V103, P116, DOI 10.1016/S0169-328X(02)00192-4; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; Vartiainen S, 2006, NEUROBIOL DIS, V22, P477, DOI 10.1016/j.nbd.2005.12.021; Ved R, 2005, J BIOL CHEM, V280, P42655, DOI 10.1074/jbc.M505910200; Wang XQ, 2006, BRAIN RES, V1097, P1, DOI 10.1016/j.brainres.2006.04.046; Watts RJ, 2005, J ENVIRON ENG-ASCE, V131, P158, DOI 10.1061/(ASCE)0733-9372(2005)131:1(158); Witholt R, 2000, NEUROTOXICOL TERATOL, V22, P851, DOI 10.1016/S0892-0362(00)00108-2; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275; Zarse K, 2007, FASEB J, V21, P1271, DOI 10.1096/fj.06-6994com; ZAYED J, 1990, CAN J NEUROL SCI, V17, P286, DOI 10.1017/S0317167100030584; Zhang SZ, 2009, NEUROBIOL AGING, V30, P1466, DOI 10.1016/j.neurobiolaging.2007.11.025; Zhao F, 2009, TOXICOL SCI, V107, P156, DOI 10.1093/toxsci/kfn213	91	65	74	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35758	35768		10.1074/jbc.M109.051409	http://dx.doi.org/10.1074/jbc.M109.051409			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19801673	Green Published, hybrid			2022-12-27	WOS:000272645600053
J	Douzi, B; Durand, E; Bernard, C; Alphonse, S; Cambillau, C; Filloux, A; Tegoni, M; Voulhoux, R				Douzi, Badreddine; Durand, Eric; Bernard, Cedric; Alphonse, Sebastien; Cambillau, Christian; Filloux, Alain; Tegoni, Mariella; Voulhoux, Rome			The XcpV/GspI Pseudopilin Has a Central Role in the Assembly of a Quaternary Complex within the T2SS Pseudopilus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-2 SECRETION SYSTEM; CAMPESTRIS PV. CAMPESTRIS; GRAM-NEGATIVE BACTERIA; II PROTEIN SECRETION; PSEUDOMONAS-AERUGINOSA; COMPONENTS; PATHWAY; LOCALIZATION; APPARATUS; XPSG	Gram-negative bacteria use the sophisticated type II secretion system (T2SS) to secrete a large number of exoproteins into the extracellular environment. Five proteins of the T2SS, the pseudopilins GspG-H-I-J-K, are proposed to assemble into a pseudopilus involved in the extrusion of the substrate through the outer membrane channel. Recent structural data have suggested that the three pseudopilins GspI-J-K are organized in a trimeric complex located at the tip of the GspG-containing pseudopilus. In the present work we combined two biochemical techniques to investigate the protein-protein interaction network between the five Pseudomonas aeruginosa Xcp pseudopilins. The soluble domains of XcpT-U-V-W-X (respectively homologous to GspG-H-I-J-K) were purified, and the interactions were tested by surface plasmon resonance and affinity co-purification in all possible combinations. We found an XcpV(I)-W-J-X-K complex, which demonstrates that the crystallized trimeric complex also exists in the P. aeruginosa T2SS. Interestingly, our systematic approach revealed an additional and yet uncharacterized interaction between XcpU(H) and XcpW(J). This observation suggested the existence of a quaternary, rather than ternary, complex (XcpU(H)-V-I-W-J-X-K) at the tip of the pseudopilus. The assembly of this quaternary complex was further demonstrated by co-purification using affinity chromatography. Moreover, by testing various combinations of pseudopilins by surface plasmon resonance and affinity chromatography, we were able to dissect the different possible successive steps occurring during the formation of the quaternary complex. We propose a model in which XcpV(I) is the nucleator that first binds XcpX(K) and XcpW(J) at different sites. Then the ternary complex recruits XcpU(H) through a direct interaction with XcpW(J).	[Durand, Eric; Filloux, Alain; Voulhoux, Rome] Univ Aix Marseille 2, LISM UPR 9027, IMM, CNRS, F-13402 Marseille 20, France; [Douzi, Badreddine; Bernard, Cedric; Alphonse, Sebastien; Cambillau, Christian; Tegoni, Mariella] CNRS, UMR6098, F-13288 Marseille 9, France; [Douzi, Badreddine; Bernard, Cedric; Alphonse, Sebastien; Cambillau, Christian; Tegoni, Mariella] Univ Aix Marseille 1, F-13288 Marseille 9, France; [Douzi, Badreddine; Bernard, Cedric; Alphonse, Sebastien; Cambillau, Christian; Tegoni, Mariella] Univ Aix Marseille 2, F-13288 Marseille 9, France; [Douzi, Badreddine] Fac Pharm, Lab Malad Transmissibles & Subst Biologiquement A, LR99ES27, TU-5000 Monastir, Tunisia; [Filloux, Alain] Univ London Imperial Coll Sci Technol & Med, Ctr Mol Microbiol & Infect, Div Cell & Mol Biol, London SW7 2AZ, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Universite de Monastir; Imperial College London	Voulhoux, R (corresponding author), Univ Aix Marseille 2, LISM UPR 9027, IMM, CNRS, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.	voulhoux@ifr88.cnrs-mrs.fr	Voulhoux, Rome/AAT-5333-2021; douzi, Badreddine/Z-5707-2019; Douzi, Badreddine/ABA-4540-2021; Durand, Eric/E-6739-2017	Douzi, Badreddine/0000-0003-3140-4713; Durand, Eric/0000-0002-0577-8220; Alphonse, Sebastien/0000-0002-2054-2005	Agence Nationale de la Recherche Program [ANR-JC07-183230]; Royal Society	Agence Nationale de la Recherche Program(French National Research Agency (ANR)); Royal Society(Royal Society of London)	This work was supported by Agence Nationale de la Recherche Program "Jeune Chercheur" Grant ANR-JC07-183230 and by funds from the Royal Society ( to A. F.).	ABRAMOFF MD, 2004, BIOPHOTONICS INT, V11, P39; BALLY M, 1992, MOL MICROBIOL, V6, P1121, DOI 10.1111/j.1365-2958.1992.tb01550.x; Bleves S, 1998, MOL MICROBIOL, V27, P31, DOI 10.1046/j.1365-2958.1998.00653.x; Bogomolovas J, 2009, PROTEIN EXPRES PURIF, V64, P16, DOI 10.1016/j.pep.2008.10.003; Craig L, 2008, CURR OPIN STRUC BIOL, V18, P267, DOI 10.1016/j.sbi.2007.12.009; Douet V, 2004, RES MICROBIOL, V155, P71, DOI 10.1016/j.resmic.2003.10.001; Durand E, 2005, J BIOL CHEM, V280, P31378, DOI 10.1074/jbc.M505812200; Durand E, 2003, J BACTERIOL, V185, P2749, DOI 10.1128/JB.185.9.2749-2758.2003; Filloux A, 2004, BBA-MOL CELL RES, V1694, P163, DOI 10.1016/j.bbamcr.2004.05.003; Filloux A, 1998, FEMS MICROBIOL REV, V22, P177, DOI 10.1016/S0168-6445(98)00013-8; Hansen JK, 2006, J MOL MICROB BIOTECH, V11, P192, DOI 10.1159/000094054; Hu NT, 2002, BIOCHEM J, V365, P205, DOI 10.1042/BJ20020194; Kohler R, 2004, MOL MICROBIOL, V54, P647, DOI 10.1111/j.1365-2958.2004.04307.x; Korotkov KV, 2008, NAT STRUCT MOL BIOL, V15, P462, DOI 10.1038/nsmb.1426; Kuo WW, 2005, J BIOMED SCI, V12, P587, DOI 10.1007/s11373-005-7372-3; Lam AY, 2009, J STRUCT BIOL, V166, P8, DOI 10.1016/j.jsb.2008.11.008; Lu HM, 1997, MOL MICROBIOL, V25, P247, DOI 10.1046/j.1365-2958.1997.4561818.x; NUNN DN, 1993, J BACTERIOL, V175, P4375, DOI 10.1128/JB.175.14.4375-4382.1993; Pelicic V, 2008, MOL MICROBIOL, V68, P827, DOI 10.1111/j.1365-2958.2008.06197.x; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Veesler D, 2009, ANAL BIOCHEM, V388, P115, DOI 10.1016/j.ab.2009.02.018; Vignon G, 2003, J BACTERIOL, V185, P3416, DOI 10.1128/JB.185.11.3416-3428.2003; Voulhoux R, 2001, EMBO J, V20, P6735, DOI 10.1093/emboj/20.23.6735; Yanez ME, 2008, J MOL BIOL, V377, P91, DOI 10.1016/j.jmb.2007.08.041; Yanez ME, 2008, J MOL BIOL, V375, P471, DOI 10.1016/j.jmb.2007.10.035	25	47	47	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34580	34589		10.1074/jbc.M109.042366	http://dx.doi.org/10.1074/jbc.M109.042366			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19828448	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000272439600013
J	Maruyama, M; Arisaka, N; Goto, Y; Ohsawa, Y; Inoue, H; Fujiwara, H; Hattori, A; Tsujimoto, M				Maruyama, Masato; Arisaka, Naomi; Goto, Yoshikuni; Ohsawa, Yosuke; Inoue, Hideshi; Fujiwara, Hiroshi; Hattori, Akira; Tsujimoto, Masafumi			Histidine 379 of Human Laeverin/Aminopeptidase Q, a Nonconserved Residue within the Exopeptidase Motif, Defines Its Distinctive Enzymatic Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLACENTAL LEUCINE AMINOPEPTIDASE; MOLECULAR-CLONING; OXYTOCINASE SUBFAMILY; CATALYTIC-ACTIVITY; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; CDNA CLONING; CELL-LINES; EXPRESSION; SUBSTRATE	Human laeverin/aminopeptidase Q (LVRN/APQ) is a novel member of the M1 family of zinc aminopeptidases and is specifically expressed on the cell surface of human extravillous trophoblasts. Multiple sequence alignment of human M1 aminopeptidase revealed that the first Gly residue within the conserved exopeptidase motif of the M1 family, GXMEN motif, is uniquely substituted for His in human LVRN/APQ. In this study, we evaluated the roles of nonconserved His(379), comprising the exopeptidase motif in the enzymatic properties of human LVRN/APQ. We revealed that the substitution of His(379) with Gly caused significant changes in substrate specificity both toward fluorogenic substrates and natural peptide hormones. In addition, the susceptibilities of bestatin, a sensitive inhibitor for human LVRN/APQ, and natural inhibitory peptides were decreased in the H379G mutant. A molecular model suggested a conformational difference between wild-type and H379G human LVRN/APQs. These results indicate that His(379) of the enzyme plays essential roles in its distinctive enzymatic properties and contributes to maintaining the appropriate structure of the catalytic cavity of the enzyme. Our data may bring new insight into the biological significance of the unique exopeptidase motif of LVRN/APQ obtained during the evolution of primates.	[Maruyama, Masato; Arisaka, Naomi; Goto, Yoshikuni; Ohsawa, Yosuke; Hattori, Akira; Tsujimoto, Masafumi] RIKEN, Lab Cellular Biochem, Wako, Saitama 3510198, Japan; [Arisaka, Naomi; Tsujimoto, Masafumi] Saitama Univ, Grad Sch Sci & Engn, Dept Regulat Biol, Saitama 3388570, Japan; [Arisaka, Naomi; Inoue, Hideshi] Tokyo Univ Pharm & Life Sci, Lab Mol & Chem Biol, Sch Life Sci, Tokyo 1920392, Japan; [Fujiwara, Hiroshi] Kyoto Univ, Dept Gynecol & Obstet, Fac Med, Sakyo Ku, Kyoto 6068507, Japan; [Hattori, Akira] Kyoto Univ, Dept Syst Chemotherapy & Mol Sci, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan	RIKEN; Saitama University; Tokyo University of Pharmacy & Life Sciences; Kyoto University; Kyoto University	Hattori, A (corresponding author), RIKEN, Lab Cellular Biochem, Wako, Saitama 3510198, Japan.	ahattori@pharm.kyoto-u.ac.jp	FUJIWARA, Hiroshi/J-8401-2015	FUJIWARA, Hiroshi/0000-0003-3098-9406	Ministry of Education, Culture, Sports, Science, and Technology of Japan; RIKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN	This work was supported in part by grants- in- aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and a grant for the " Chemical Biology Research Program" from RIKEN.	Addlagatta A, 2006, P NATL ACAD SCI USA, V103, P13339, DOI 10.1073/pnas.0606167103; Albiston AL, 2001, J BIOL CHEM, V276, P48623, DOI 10.1074/jbc.C100512200; Bilban M, 2004, J CELL SCI, V117, P1319, DOI 10.1242/jcs.00971; Claperon M, 2008, BIOCHEM J, V416, P37, DOI 10.1042/BJ20080471; Claperon C, 2009, J BIOL CHEM, V284, P10618, DOI 10.1074/jbc.M806783200; CONSTAM DB, 1995, J BIOL CHEM, V270, P26931, DOI 10.1074/jbc.270.45.26931; Diaz-Perales A, 2005, J BIOL CHEM, V280, P14310, DOI 10.1074/jbc.M413222200; Fujiwara H, 2004, BIOCHEM BIOPH RES CO, V313, P962, DOI 10.1016/j.bbrc.2003.12.024; Fukasawa KM, 1996, J BIOL CHEM, V271, P30731, DOI 10.1074/jbc.271.48.30731; Goto Y, 2006, FEBS LETT, V580, P1833, DOI 10.1016/j.febslet.2006.02.041; Goto Y, 2008, BIOCHEM J, V416, P109, DOI 10.1042/BJ20080965; Goto Y, 2007, J BIOL CHEM, V282, P37074, DOI 10.1074/jbc.M707251200; Goto Y, 2006, J BIOL CHEM, V281, P23503, DOI 10.1074/jbc.M603191200; Haas CS, 2006, ARTHRITIS RHEUM-US, V54, P2047, DOI 10.1002/art.21953; Hattori A, 2004, BIOL PHARM BULL, V27, P777, DOI 10.1248/bpb.27.777; Hattori A, 1999, J BIOCHEM-TOKYO, V125, P931, DOI 10.1093/oxfordjournals.jbchem.a022371; HOOPER NM, 1994, FEBS LETT, V354, P1, DOI 10.1016/0014-5793(94)01079-X; IMAI K, 1992, BIOL REPROD, V46, P328, DOI 10.1095/biolreprod46.3.328; Ino K, 2003, LAB INVEST, V83, P1799, DOI 10.1097/01.LAB.0000101728.93907.75; Ino K, 2000, PLACENTA, V21, P63, DOI 10.1053/plac.1999.0456; INO K, 1994, JPN J CANCER RES, V85, P927, DOI 10.1111/j.1349-7006.1994.tb02970.x; Ito K, 2006, J BIOL CHEM, V281, P33664, DOI 10.1074/jbc.M605203200; Iturrioz X, 2001, BIOCHEMISTRY-US, V40, P14440, DOI 10.1021/bi011409j; Janneau JL, 2002, J CLIN ENDOCR METAB, V87, P5336, DOI 10.1210/jc.2002-021093; Kyrieleis OJP, 2005, J MOL BIOL, V349, P787, DOI 10.1016/j.jmb.2005.03.070; Laustsen PG, 2001, EUR J BIOCHEM, V268, P98, DOI 10.1046/j.1432-1327.2001.01848.x; LI L, 1993, GENOMICS, V17, P657, DOI 10.1006/geno.1993.1386; Lkhagvaa B, 2008, CYTOKINE, V44, P386, DOI 10.1016/j.cyto.2008.10.011; LOOK AT, 1986, J CLIN INVEST, V78, P914, DOI 10.1172/JCI112680; Luciani N, 1998, BIOCHEMISTRY-US, V37, P686, DOI 10.1021/bi971705p; Marchio S, 2004, CANCER CELL, V5, P151, DOI 10.1016/S1535-6108(04)00025-X; Maruyama M, 2007, J BIOL CHEM, V282, P20088, DOI 10.1074/jbc.M702650200; Matsumoto H, 2000, EUR J BIOCHEM, V267, P46, DOI 10.1046/j.1432-1327.2000.00949.x; MINAMI M, 1987, J BIOL CHEM, V262, P13873; Mishima Y, 2002, J NATL CANCER I, V94, P1020; Mitsui T, 2004, BIOL PHARM BULL, V27, P768, DOI 10.1248/bpb.27.768; Mizutani S, 2008, HEART FAIL REV, V13, P273, DOI 10.1007/s10741-007-9065-7; NANUS DM, 1993, P NATL ACAD SCI USA, V90, P7069, DOI 10.1073/pnas.90.15.7069; Nomura M, 2002, PLACENTA, V23, P631, DOI 10.1053/plac.2002.0861; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; Rangel R, 2007, P NATL ACAD SCI USA, V104, P4588, DOI 10.1073/pnas.0611653104; Rogi T, 1996, J BIOL CHEM, V271, P56, DOI 10.1074/jbc.271.1.56; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Sato Y, 2004, BIOL PHARM BULL, V27, P772, DOI 10.1248/bpb.27.772; Schomburg L, 1999, EUR J BIOCHEM, V265, P415, DOI 10.1046/j.1432-1327.1999.00753.x; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; Sitras V, 2009, PLACENTA, V30, P424, DOI 10.1016/j.placenta.2009.01.012; Tachibana T, 1996, HUM REPROD, V11, P497, DOI 10.1093/HUMREP/11.3.497; Tanioka T, 2003, J BIOL CHEM, V278, P32275, DOI 10.1074/jbc.M305076200; Thunnissen MMGM, 2001, NAT STRUCT BIOL, V8, P131, DOI 10.1038/84117; Tsujimoto M, 2005, BBA-PROTEINS PROTEOM, V1751, P9, DOI 10.1016/j.bbapap.2004.09.011; Vazeux G, 1996, J BIOL CHEM, V271, P9069, DOI 10.1074/jbc.271.15.9069; Vazeux G, 1998, BIOCHEM J, V334, P407, DOI 10.1042/bj3340407; Vazeux G, 1997, BIOCHEM J, V327, P883, DOI 10.1042/bj3270883; Ye SY, 2007, BIOL CHEM, V388, P399, DOI 10.1515/BC.2007.044	55	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34692	34702		10.1074/jbc.M109.066712	http://dx.doi.org/10.1074/jbc.M109.066712			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19819873	Green Published, hybrid			2022-12-27	WOS:000272439600025
J	Pertschy, B; Schneider, C; Gnadig, M; Schafer, T; Tollervey, D; Hurt, E				Pertschy, Brigitte; Schneider, Claudia; Gnaedig, Maren; Schaefer, Thorsten; Tollervey, David; Hurt, Ed			RNA Helicase Prp43 and Its Co-factor Pfa1 Promote 20 to 18 S rRNA Processing Catalyzed by the Endonuclease Nob1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERNAL TRANSCRIBED SPACER-1; SACCHAROMYCES-CEREVISIAE; MESSENGER-RNA; PRE-RIBOSOMES; NUCLEAR EXPORT; LARIAT-INTRON; BOX PROTEIN; PIN DOMAIN; YEAST; SUBUNIT	Many RNA nucleases and helicases participate in ribosome biogenesis, but how they cooperate with each other is largely unknown. Here we report that in vivo cleavage of the yeast pre-rRNA at site D, the 3'-end of the 18 S rRNA, requires functional interactions between PIN (PilT N terminus) domain protein Nob1 and the DEAH box RNA helicase Prp43. Nob1 showed specific cleavage on a D-site substrate analogue in vitro, which was abolished by mutations in the Nob1 PIN domain or the RNA substrate. Genetic analyses linked Nob1 to the late pre-40 S-associated factor Ltv1, the RNA helicase Prp43, and its cofactor Pfa1. In strains lacking Ltv1, mutation of Prp43 or Pfa1 led to a striking accumulation of 20 S pre-rRNA in the cytoplasm due to inhibition of site D cleavage. This phenotype was suppressed by increased dosage of wildtype Nob1 but not by Nob1 variants mutated in the catalytic site. In ltv1/pfa1 mutants the 20 S pre-rRNA was susceptible to 3' to 5' degradation by the cytoplasmic exosome. This degraded into the 3' region of the 18 S rRNA, strongly indicating that the pre-ribosomes are structurally defective.	[Pertschy, Brigitte; Gnaedig, Maren; Schaefer, Thorsten; Hurt, Ed] Heidelberg Univ, Zentrum Biochem, D-69120 Heidelberg, Germany; [Schneider, Claudia; Tollervey, David] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	Ruprecht Karls University Heidelberg; University of Edinburgh	Hurt, E (corresponding author), Heidelberg Univ, Zentrum Biochem, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	ed.hurt@bzh.uni-heidelberg.de	Tollervey, David/AAR-6662-2020; Ed Hurt, Dr./AAE-8874-2019	Tollervey, David/0000-0003-2894-2772; Ed Hurt, Dr./0000-0002-4535-8255; Schaefer, Thorsten/0000-0003-4867-8374; Schneider, Claudia/0000-0001-5597-2489; Pertschy, Brigitte/0000-0003-3558-0191	Austrian Science Fund (FWF) [J2612]; Human Frontiers Science Program; Wellcome Trust; Deutsche Forschungsgemeinschaft [Hu363/9-2]; Gottfried Wilhelm Leibniz Program; Fonds der Chemischen Industrie	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Human Frontiers Science Program(Human Frontier Science Program); Wellcome Trust(Wellcome TrustEuropean Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Gottfried Wilhelm Leibniz Program; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	Recipient of an Erwin Schrodinger Fellowship from the Austrian Science Fund (FWF; J2612).; Supported by a long term fellowship of the Human Frontiers Science Program and by the Wellcome Trust.; Recipient of grants from the Deutsche Forschungsgemeinschaft (Hu363/9-2 and the Gottfried Wilhelm Leibniz Program) and Fonds der Chemischen Industrie.	Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Araki Y, 2001, EMBO J, V20, P4684, DOI 10.1093/emboj/20.17.4684; Aravind L, 1999, TRENDS BIOCHEM SCI, V24, P342, DOI 10.1016/S0968-0004(99)01437-1; Arenas JE, 1997, P NATL ACAD SCI USA, V94, P11798, DOI 10.1073/pnas.94.22.11798; Bassler J, 2001, MOL CELL, V8, P517, DOI 10.1016/S1097-2765(01)00342-2; Bleichert F, 2007, MOL CELL, V27, P339, DOI 10.1016/j.molcel.2007.07.014; Bohnsack MT, 2008, EMBO REP, V9, P1230, DOI 10.1038/embor.2008.184; BOHNSACK MT, 2009, MOL CELL IN PRESS; Boon KL, 2006, MOL CELL BIOL, V26, P6016, DOI 10.1128/MCB.02347-05; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; Combs DJ, 2006, MOL CELL BIOL, V26, P523, DOI 10.1128/MCB.26.2.523-534.2006; de la Cruz J, 1998, EMBO J, V17, P1128, DOI 10.1093/emboj/17.4.1128; Eberle AB, 2009, NAT STRUCT MOL BIOL, V16, P49, DOI 10.1038/nsmb.1530; Fatica A, 2004, RNA, V10, P1698, DOI 10.1261/rna.7123504; Fatica A, 2003, MOL CELL BIOL, V23, P1798, DOI 10.1128/MCB.23.5.1798-1807.2003; Fatica A, 2002, CURR OPIN CELL BIOL, V14, P313, DOI 10.1016/S0955-0674(02)00336-8; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Granneman S, 2005, MOL CELL BIOL, V25, P10352, DOI 10.1128/MCB.25.23.10352-10364.2005; Granneman S, 2004, EXP CELL RES, V296, P43, DOI 10.1016/j.yexcr.2004.03.016; Grosshans H, 2000, GENE DEV, V14, P830; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Huntzinger E, 2008, RNA, V14, P2609, DOI 10.1261/rna.1386208; Jakovljevic J, 2004, MOL CELL, V14, P331, DOI 10.1016/S1097-2765(04)00215-1; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kos M, 2005, MOL CELL, V20, P53, DOI 10.1016/j.molcel.2005.08.022; Kressler D, 1999, MOL CELL BIOL, V19, P8633; Kressler D, 1997, MOL CELL BIOL, V17, P7283, DOI 10.1128/MCB.17.12.7283; Lacombe T, 2009, MOL MICROBIOL, V72, P69, DOI 10.1111/j.1365-2958.2009.06622.x; Lebaron S, 2005, MOL CELL BIOL, V25, P9269, DOI 10.1128/MCB.25.21.9269-9282.2005; Lebreton A, 2008, NATURE, V456, P993, DOI 10.1038/nature07480; Leeds NB, 2006, MOL CELL BIOL, V26, P513, DOI 10.1128/MCB.26.2.513-522.2006; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mangiarotti G, 1997, J BIOL CHEM, V272, P27818, DOI 10.1074/jbc.272.44.27818; Martin A, 2002, J BIOL CHEM, V277, P17743, DOI 10.1074/jbc.M200762200; Mitchell P, 1996, GENE DEV, V10, P502, DOI 10.1101/gad.10.4.502; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Schaeffer D, 2009, NAT STRUCT MOL BIOL, V16, P56, DOI 10.1038/nsmb.1528; Schafer T, 2003, EMBO J, V22, P1370, DOI 10.1093/emboj/cdg121; Schafer T, 2006, NATURE, V441, P651, DOI 10.1038/nature04840; Schneider C, 2009, NUCLEIC ACIDS RES, V37, P1127, DOI 10.1093/nar/gkn1020; Seiser RM, 2006, GENETICS, V174, P679, DOI 10.1534/genetics.106.062117; Simos G, 1996, EMBO J, V15, P5437, DOI 10.1002/j.1460-2075.1996.tb00927.x; Skruzny M, 2009, PLOS BIOL, V7, P164, DOI 10.1371/journal.pbio.1000008; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; STEVENS A, 1991, J BACTERIOL, V173, P7024, DOI 10.1128/jb.173.21.7024-7028.1991; Tanaka N, 2007, GENE DEV, V21, P2312, DOI 10.1101/gad.1580507; Tsai RT, 2007, MOL CELL BIOL, V27, P8027, DOI 10.1128/MCB.01213-07; Tschochner H, 2003, TRENDS CELL BIOL, V13, P255, DOI 10.1016/S0962-8924(03)00054-0; van Beekvelt CA, 2001, RNA, V7, P896, DOI 10.1017/S1355838201010196; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Weaver PL, 1997, MOL CELL BIOL, V17, P1354, DOI 10.1128/MCB.17.3.1354; YAFFE MP, 1984, P NATL ACAD SCI-BIOL, V81, P4819, DOI 10.1073/pnas.81.15.4819; YEH LCC, 1990, BIOCHEMISTRY-US, V29, P5911, DOI 10.1021/bi00477a005	55	140	141	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					35079	35091		10.1074/jbc.M109.040774	http://dx.doi.org/10.1074/jbc.M109.040774			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19801658	Green Published, hybrid			2022-12-27	WOS:000272439600062
J	Townsend, K; Mason, H; Blackford, AN; Miller, ES; Chapman, JR; Sedgwick, GG; Barone, G; Turnell, AS; Stewart, GS				Townsend, Kelly; Mason, Helen; Blackford, Andrew N.; Miller, Edward S.; Chapman, J. Ross; Sedgwick, Garry G.; Barone, Giancarlo; Turnell, Andrew S.; Stewart, Grant S.			Mediator of DNA Damage Checkpoint 1 (MDC1) Regulates Mitotic Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINDLE CHECKPOINT; CENTROSOME; INTEGRITY; CDC20; BRCA1; CYCLE	Human mediator of DNA damage checkpoint 1 (hMDC1) is an essential component of the cellular response to DNA double strand breaks. Recently, hMDC1 has been shown to associate with a subunit of the anaphase-promoting complex/cyclosome (APC/C) (Coster, G., Hayouka, Z., Argaman, L., Strauss, C., Friedler, A., Brandeis, M., and Goldberg, M. (2007) J. Biol. Chem. 282, 32053-32064), a key regulator of mitosis, suggesting a possible role for hMDC1 in controlling normal cell cycle progression. Here, we extend this work to show that hMDC1 regulates normal metaphase-to-anaphase transition through its ability to bind directly to the APC/C and modulate its E3 ubiquitin ligase activity. In support of a role for hMDC1 in controlling mitotic progression, depletion of hMDC1 by small interfering RNA results in a metaphase arrest that appears to be independent of both BubR1-dependent signaling pathways and ATM/ATR activation. Mitotic cells lacking hMDC1 exhibit markedly reduced levels of APC/C activity characterized by reduced levels of Cdc20, and a failure of Cdc20 to bind the APC/C and CREB-binding protein. We suggest therefore that hMDC1 functionally regulates the normal metaphase-to-anaphase transition by modulating the Cdc20-dependent activation of the APC/C.	[Barone, Giancarlo; Turnell, Andrew S.; Stewart, Grant S.] Univ Birmingham, Sch Med, Canc Res United Kingdon Inst Canc Sci, Birmingham B15 2TT, W Midlands, England; [Chapman, J. Ross] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; [Chapman, J. Ross] Univ Cambridge, Dept Zool, Cambridge CB2 1QN, England	University of Birmingham; University of Cambridge; University of Cambridge	Stewart, GS (corresponding author), Univ Birmingham, Sch Med, Canc Res United Kingdon Inst Canc Sci, Birmingham B15 2TT, W Midlands, England.	g.s.stewart@bham.ac.uk	Chapman, J Ross/C-7973-2012; Blackford, Andrew N/H-6575-2019	Blackford, Andrew N/0000-0003-1979-021X; Stewart, Grant/0000-0002-0960-3241; Chapman, Ross/0000-0002-6477-4254	Cancer Research-United Kingdom (CR-UK) [GSS C17183/A5592]; CR-UK Project [AST C10000/A7542]	Cancer Research-United Kingdom (CR-UK)(Cancer Research UK); CR-UK Project	This work was supported by Cancer Research-United Kingdom (CR-UK) Career Development Fellowship GSS C17183/A5592 and CR-UK Project Grant AST C10000/A7542.	Adelman CA, 2009, MOL CELL BIOL, V29, P483, DOI 10.1128/MCB.01525-08; Bharadwaj R, 2004, ONCOGENE, V23, P2016, DOI 10.1038/sj.onc.1207374; Coster G, 2007, J BIOL CHEM, V282, P32053, DOI 10.1074/jbc.M705890200; Cox J, 2006, TRENDS MOL MED, V12, P358, DOI 10.1016/j.molmed.2006.06.006; Griffith E, 2008, NAT GENET, V40, P232, DOI 10.1038/ng.2007.80; Hsu LC, 1998, P NATL ACAD SCI USA, V95, P12983, DOI 10.1073/pnas.95.22.12983; Huang XX, 2005, P NATL ACAD SCI USA, V102, P1065, DOI 10.1073/pnas.0409130102; Jeffers LJ, 2008, ONCOGENE, V27, P139, DOI 10.1038/sj.onc.1210595; Joukov V, 2006, CELL, V127, P539, DOI 10.1016/j.cell.2006.08.053; Ko MJ, 2006, ONCOGENE, V25, P298, DOI 10.1038/sj.onc.1209028; Kramer A, 2004, NAT CELL BIOL, V6, P884, DOI 10.1038/ncb1165; Li M, 2007, MOL CELL BIOL, V27, P3481, DOI 10.1128/MCB.02088-06; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; O'Driscoll M, 2006, NAT REV GENET, V7, P45, DOI 10.1038/nrg1746; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Rai R, 2008, CELL CYCLE, V7, P2225, DOI 10.4161/cc.7.14.6303; Rai R, 2006, CANCER CELL, V10, P145, DOI 10.1016/j.ccr.2006.07.002; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Tang JB, 2006, P NATL ACAD SCI USA, V103, P11964, DOI 10.1073/pnas.0604987103; Turnell AS, 2005, NATURE, V438, P690, DOI 10.1038/nature04151; Wolthuis R, 2008, MOL CELL, V30, P290, DOI 10.1016/j.molcel.2008.02.027	21	36	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33939	33948		10.1074/jbc.M109.009191	http://dx.doi.org/10.1074/jbc.M109.009191			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19826003	Green Published, hybrid			2022-12-27	WOS:000272165200026
J	Kereszturi, E; Sahin-Toth, M				Kereszturi, Eva; Sahin-Toth, Miklos			Intracellular Autoactivation of Human Cationic Trypsinogen Mutants Causes Reduced Trypsinogen Secretion and Acinar Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE PROTEINASE-INHIBITOR; HEREDITARY PANCREATITIS; ENDOPLASMIC-RETICULUM; CATHEPSIN-B; ACTIVATION; MUTATION; PEPTIDE; SPECIFICITY; EXPRESSION; PATHWAY	Mutations in the activation peptide of human cationic trypsinogen have been found in patients with chronic pancreatitis. Previous biochemical studies demonstrated that mutations p.D19A, p.D22G, and p.K23R strongly stimulate trypsinogen autoactivation. In the present study, we characterized the cell biological effects of these mutants using human embryonic kidney 293T and AR42J rat acinar cells. We found that relative to wild-type trypsinogen, secretion of the mutants from transfected cells was markedly decreased. This apparent secretion defect was completely rescued by inhibition of autoactivation via (1) inclusion of the small molecule trypsin inhibitor benzamidine in the growth medium; or (2) cotransfection with the physiological trypsin inhibitor SPINK1; or (3) by mutation of the catalytic Ser200 residue in trypsinogen. In contrast, extracellularly added SPINK1 or other nonpermeable proteinaceous trypsin inhibitors did not restore normal secretion of the mutants, indicating that intracellular autoactivation is responsible for the observed secretion loss. Acinar cells expressing the p. D22G mutant detached from the culture plate over time, became terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling-positive, and exhibited elevated levels of the proapoptotic transcription factor CHOP. The observations indicate that activation peptide mutants of human cationic trypsinogen undergo autoactivation intracellularly, which leads to decreased trypsinogen secretion and eventual acinar cell death. The results thus define a novel pathological pathway for parenchymal injury in hereditary chronic pancreatitis.	[Kereszturi, Eva; Sahin-Toth, Miklos] Boston Univ, Henry M Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02118 USA	Boston University	Sahin-Toth, M (corresponding author), 72 E Concord St,Evans 433, Boston, MA 02118 USA.	miklos@bu.edu		Sahin-Toth, Miklos/0000-0003-4513-9922	National Institutes of Health [DK058088]; Rosztoczy Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058088] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rosztoczy Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK058088 (to M.S.-T.). This work was also supported by a scholarship from the Rosztoczy Foundation (to E. K.).	Chen JM, 2003, MOL BIOL EVOL, V20, P1767, DOI 10.1093/molbev/msg183; Ferec C, 1999, J MED GENET, V36, P228; FIGARELLA C, 1988, BIOL CHEM H-S, V369, P293; Gaiser S, 2005, BIOCHEM BIOPH RES CO, V334, P721, DOI 10.1016/j.bbrc.2005.06.148; Hashimoto D, 2008, J CELL BIOL, V181, P1065, DOI 10.1083/jcb.200712156; JESSOP NW, 1980, IN VITRO CELL DEV B, V16, P212; Ji BA, 2009, J BIOL CHEM, V284, P17488, DOI 10.1074/jbc.M109.005520; Kereszturi E, 2009, HUM MUTAT, V30, P575, DOI 10.1002/humu.20853; Kiraly O, 2007, HUM MUTAT, V28, P469, DOI 10.1002/humu.20471; Kiraly O, 2006, PROTEIN EXPRES PURIF, V48, P104, DOI 10.1016/j.pep.2006.01.023; Kukor Z, 2002, J BIOL CHEM, V277, P21389, DOI 10.1074/jbc.M200878200; Lengyel Z, 1998, PROTEIN EXPRES PURIF, V12, P291, DOI 10.1006/prep.1997.0837; LOGSDON CD, 1985, J CELL BIOL, V100, P1200, DOI 10.1083/jcb.100.4.1200; LOGSDON CD, 1986, J BIOL CHEM, V261, P2096; Lu DS, 1999, J MOL BIOL, V292, P361, DOI 10.1006/jmbi.1999.3089; Nemoda Z, 2006, J BIOL CHEM, V281, P11879, DOI 10.1074/jbc.M600124200; Nemoda Z, 2005, J BIOL CHEM, V280, P29645, DOI 10.1074/jbc.M505661200; Ozsvari B, 2008, PANCREAS, V37, P182, DOI 10.1097/MPA.0b013e3181663066; Pal G, 1996, FEBS LETT, V385, P165, DOI 10.1016/0014-5793(96)00376-6; PAL G, 1994, FEBS LETT, V342, P57, DOI 10.1016/0014-5793(94)80584-9; RAJASEKARAN AK, 1993, J CELL SCI, V105, P333; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2007, TRENDS BIOCHEM SCI, V32, P469, DOI 10.1016/j.tibs.2007.09.003; Sahin-Toth M, 2000, BIOCHEM BIOPH RES CO, V278, P286, DOI 10.1006/bbrc.2000.3797; Sahin-Toth M, 2000, J BIOL CHEM, V275, P22750, DOI 10.1074/jbc.M002943200; Sahin-Toth M, 2006, ENDOCRIN METAB CLIN, V35, P303, DOI 10.1016/j.ecl.2006.02.002; Saluja AK, 2007, ANNU REV PHYSIOL, V69, P249, DOI 10.1146/annurev.physiol.69.031905.161253; Simon P, 2002, J BIOL CHEM, V277, P5404, DOI 10.1074/jbc.M108073200; SWAROVSKY B, 1988, EUR J CELL BIOL, V47, P101; Szepessy E, 2006, FEBS J, V273, P2942, DOI 10.1111/j.1742-4658.2006.05305.x; Teich N, 2000, GASTROENTEROLOGY, V119, P461, DOI 10.1053/gast.2000.9312; Teich N, 2002, J GASTROENTEROL, V37, P1, DOI 10.1007/s535-002-8125-1; Teich N, 2006, HUM MUTAT, V27, P721, DOI 10.1002/humu.20343; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203	35	38	38	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33392	33399		10.1074/jbc.M109.056812	http://dx.doi.org/10.1074/jbc.M109.056812			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801634	Green Published, hybrid			2022-12-27	WOS:000272028500045
J	Lee, JY; Johnson, J; Ding, ZW; Paetzel, M; Cornell, RB				Lee, Jaeyong; Johnson, Joanne; Ding, Ziwei; Paetzel, Mark; Cornell, Rosemary B.			Crystal Structure of a Mammalian CTP: Phosphocholine Cytidylyltransferase Catalytic Domain Reveals Novel Active Site Residues within a Highly Conserved Nucleotidyltransferase Fold	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA-SYNTHETASE; MEMBRANE-BINDING DOMAIN; TRANSITION-STATE; CTP-GLYCEROL-3-PHOSPHATE CYTIDYLYLTRANSFERASE; GLYCEROL-3-PHOSPHATE CYTIDYLYLTRANSFERASE; PHOSPHOETHANOLAMINE CYTIDYLYLTRANSFERASE; TRYPTOPHAN ACTIVATION; SECONDARY-STRUCTURE; RAT-LIVER; IDENTIFICATION	CTP:phosphocholine cytidylyltransferase (CCT) is the key regulatory enzyme in the synthesis of phosphatidylcholine, the most abundant phospholipid in eukaryotic cell membranes. The CCT-catalyzed transfer of a cytidylyl group from CTP to phosphocholine to form CDP-choline is regulated by a membrane lipid-dependent mechanism imparted by its C-terminal membrane binding domain. We present the first analysis of a crystal structure of a eukaryotic CCT. Adeletion construct of rat CCT alpha spanning residues 1-236 (CCT236) lacks the regulatory domain and as a result displays constitutive activity. The 2.2-angstrom structure reveals a CCT236 homodimer in complex with the reaction product, CDP-choline. Each chain is composed of a complete catalytic domain with an intimately associated N-terminal extension, which together with the catalytic domain contributes to the dimer interface. Although the CCT236 structure reveals elements involved in binding cytidine that are conserved with other members of the cytidylyltransferase superfamily, it also features nonconserved active site residues, His-168 and Tyr-173, that make key interactions with the beta-phosphate of CDP-choline. Mutagenesis and kinetic analyses confirmed their role in phosphocholine binding and catalysis. These results demonstrate structural and mechanistic differences in a broadly conserved protein fold across the cytidylyltransferase family. Comparison of the CCT236 structure with those of other nucleotidyltransferases provides evidence for substrate-induced active site loop movements and a disorder-to-order transition of a loop element in the catalytic mechanism.	[Lee, Jaeyong; Johnson, Joanne; Ding, Ziwei; Paetzel, Mark; Cornell, Rosemary B.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; [Cornell, Rosemary B.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada	Simon Fraser University; Simon Fraser University	Cornell, RB (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	cornell@sfu.ca		Paetzel, Mark/0000-0002-7408-5487	Canadian Institutes of Health Research [12134]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Grant 12134 from the Canadian Institutes of Health Research.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Attard GS, 2000, P NATL ACAD SCI USA, V97, P9032, DOI 10.1073/pnas.160260697; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bogan MJ, 2005, J BIOL CHEM, V280, P19613, DOI 10.1074/jbc.M414028200; BORK P, 1995, PROTEINS, V22, P259, DOI 10.1002/prot.340220306; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cornell RB, 2000, TRENDS BIOCHEM SCI, V25, P441, DOI 10.1016/S0968-0004(00)01625-X; Davies SMA, 2001, BIOCHEMISTRY-US, V40, P10522, DOI 10.1021/bi010904c; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FERSHT AR, 1988, BIOCHEMISTRY-US, V27, P1581, DOI 10.1021/bi00405a028; Fong DH, 2006, BBA-PROTEINS PROTEOM, V1764, P63, DOI 10.1016/j.bbapap.2005.10.015; Friesen JA, 1999, J BIOL CHEM, V274, P13384, DOI 10.1074/jbc.274.19.13384; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Helmink BA, 2003, BIOCHEMISTRY-US, V42, P5043, DOI 10.1021/bi027431+; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; Izard T, 2002, J MOL BIOL, V315, P487, DOI 10.1006/jmbi.2001.5272; Jackowski S, 2005, J BIOL CHEM, V280, P853, DOI 10.1074/jbc.R400031200; Johnson JE, 2003, J BIOL CHEM, V278, P514, DOI 10.1074/jbc.M206072200; Johnson JE, 1998, BIOCHEMISTRY-US, V37, P9509, DOI 10.1021/bi980340l; Johnson JE, 2007, BIOCHEM J, V406, P223, DOI 10.1042/BJ20070294; JONES S, 1995, PROG BIOPHYS MOL BIO, V63, P31, DOI 10.1016/0079-6107(94)00008-W; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kapustina M, 2007, STRUCTURE, V15, P1272, DOI 10.1016/j.str.2007.08.010; Karim M, 2003, BBA-MOL CELL BIOL L, V1633, P1, DOI 10.1016/S1388-1981(03)00067-2; Kent C, 2005, BBA-MOL CELL BIOL L, V1733, P53, DOI 10.1016/j.bbalip.2004.12.008; Kobayashi T, 2005, J MOL BIOL, V346, P105, DOI 10.1016/j.jmb.2004.11.034; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kwak BY, 2002, J BIOL CHEM, V277, P4343, DOI 10.1074/jbc.M109163200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; LEATHERBARROW RJ, 1985, P NATL ACAD SCI USA, V82, P7840, DOI 10.1073/pnas.82.23.7840; Li ZY, 2006, CELL METAB, V3, P321, DOI 10.1016/j.cmet.2006.03.007; Liang J, 1998, PROTEIN SCI, V7, P1884, DOI 10.1002/pro.5560070905; Lykidis A, 1998, J BIOL CHEM, V273, P14022, DOI 10.1074/jbc.273.22.14022; Malito E, 2006, J MOL BIOL, V364, P136, DOI 10.1016/j.jmb.2006.08.084; Martin SF, 2000, BIOCHEMISTRY-US, V39, P3410, DOI 10.1021/bi9919798; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neumann P, 2008, P NATL ACAD SCI USA, V105, P17390, DOI 10.1073/pnas.0805027105; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Park YS, 1997, J BIOL CHEM, V272, P15161, DOI 10.1074/jbc.272.24.15161; PARK YS, 1993, J BIOL CHEM, V268, P16648; Pattridge KA, 2003, J BIOL CHEM, V278, P51863, DOI 10.1074/jbc.M306174200; RAO ST, 1973, J MOL BIOL, V76, P241, DOI 10.1016/0022-2836(73)90388-4; Retailleau P, 2003, J MOL BIOL, V325, P39, DOI 10.1016/S0022-2836(02)01156-7; Shen N, 2008, NUCLEIC ACIDS RES, V36, P1288, DOI 10.1093/nar/gkm1153; Stevens SY, 2001, NAT STRUCT BIOL, V8, P947, DOI 10.1038/nsb1101-947; Sugimoto H, 2008, PROG LIPID RES, V47, P204, DOI 10.1016/j.plipres.2008.01.002; Taneva S, 2003, BIOCHEMISTRY-US, V42, P11768, DOI 10.1021/bi035234k; Taneva S, 2008, J BIOL CHEM, V283, P28137, DOI 10.1074/jbc.M802595200; Tie A, 2007, J LIPID RES, V48, P2172, DOI 10.1194/jlr.M600536-JLR200; Tsodikov OV, 2002, J COMPUT CHEM, V23, P600, DOI 10.1002/jcc.10061; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Veitch DP, 1998, EUR J BIOCHEM, V255, P227, DOI 10.1046/j.1432-1327.1998.2550227.x; VERMEULEN PS, 1993, J BIOL CHEM, V268, P7458; WANG YL, 1995, J BIOL CHEM, V270, P354, DOI 10.1074/jbc.270.1.354; Weber CH, 1999, STRUCTURE, V7, P1113, DOI 10.1016/S0969-2126(99)80178-6; Xie MT, 2004, J BIOL CHEM, V279, P28817, DOI 10.1074/jbc.M403311200; YANG W, 1995, J BIOL CHEM, V270, P23951, DOI 10.1074/jbc.270.41.23951	63	46	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33535	33548		10.1074/jbc.M109.053363	http://dx.doi.org/10.1074/jbc.M109.053363			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19783652	Green Published, hybrid			2022-12-27	WOS:000272028500059
J	Sotiropoulou, G; Pampalakis, G; Diamandis, EP				Sotiropoulou, Georgia; Pampalakis, Georgios; Diamandis, Eleftherios P.			Functional Roles of Human Kallikrein-related Peptidases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PROSTATE-SPECIFIC ANTIGEN; HUMAN TISSUE KALLIKREINS; PROTEOLYTIC CASCADE; SERINE-PROTEASE; CANCER-CELLS; E-CADHERIN; MESENCHYMAL TRANSITION; NETHERTON-SYNDROME; CRYSTAL-STRUCTURE; EMERGING ROLES	Kallikrein-related peptidases constitute a single family of 15 (chymo) trypsin-like proteases (KLK1-15) with pleiotropic physiological roles. Aberrant regulation of KLKs has been associated with diverse diseases such as hypertension, renal dysfunction, skin disorders, inflammation, neurodegeneration, and cancer. Recent studies suggested that coordinated activation and regulation of KLK activity are achieved via a complex network of interactions referred to as the "KLK activome." However, it remains to be validated whether these hypothetical KLK activation cascade pathways are operative in vivo. In addition, KLKs have emerged as versatile signaling molecules. In summary, KLKs represent attractive biomarkers for clinical applications and potential therapeutic targets for common human pathologies.	[Sotiropoulou, Georgia; Pampalakis, Georgios] Univ Patras, Dept Pharm, Rion 26500, Rion Patras, Greece; [Diamandis, Eleftherios P.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Diamandis, Eleftherios P.] Univ Hlth Network, Dept Clin Biochem, Toronto, ON M5G 2C4, Canada; [Diamandis, Eleftherios P.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A1, Canada	University of Patras; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Sotiropoulou, G (corresponding author), Univ Patras, Dept Pharm, Rion 26500, Rion Patras, Greece.	gdsotiro@upatras.gr		Diamandis, Eleftherios/0000-0002-1589-820X	Research Committee of the University of Patras [C. 186]; European Union-European Social Fund [PENED2003(03EDelta430)]; Greek Ministry of Development General Secretariat for Research and Technology	Research Committee of the University of Patras; European Union-European Social Fund(European Social Fund (ESF)); Greek Ministry of Development General Secretariat for Research and Technology(Greek Ministry of Development-GSRT)	This work was supported by K. Karatheodoris Program Grant C. 186 from the Research Committee of the University of Patras and by Grant PENED2003(03E Delta 430) from the European Union-European Social Fund (75%) and the Greek Ministry of Development General Secretariat for Research and Technology (25%). This is the tenth article in the Thematic Minireview Series on Proteolytic Enzymes. The first article was published in the November 7, 2008 issue; the second and third articles were published in the May 22, 2009 issue; the fourth and fifth articles were published in the July 31, 2009 issue; the sixth and seventh articles were published in the August 14, 2009 issue; the eighth article was published in the August 28, 2009 issue; and the ninth article was published in the November 6, 2009 issue. This minireview will be reprinted in the 2009 Minireview Compendium, which will be available in January, 2010.	Bayani J, 2008, MOL ONCOL, V2, P250, DOI 10.1016/j.molonc.2008.07.001; Bernett MJ, 2002, J BIOL CHEM, V277, P24562, DOI 10.1074/jbc.M202392200; BHOOLA KD, 1992, PHARMACOL REV, V44, P1; Blaber SI, 2004, FASEB J, V18, P920, DOI 10.1096/fj.03-1212fje; Borgono CA, 2004, NAT REV CANCER, V4, P876, DOI 10.1038/nrc1474; Brattsand M, 2005, J INVEST DERMATOL, V124, P198, DOI 10.1111/j.0022-202X.2004.23547.x; Briot A, 2009, J EXP MED, V206, P1135, DOI 10.1084/jem.20082242; Davies B, 2001, J NEUROSCI, V21, P6993, DOI 10.1523/JNEUROSCI.21-18-06993.2001; Debela M, 2008, BIOL CHEM, V389, P623, DOI 10.1515/BC.2008.075; Debela M, 2006, J BIOL CHEM, V281, P25678, DOI 10.1074/jbc.M602372200; Denmeade SR, 2005, CANCER BIOL THER, V4, P14; Deraison C, 2007, MOL BIOL CELL, V18, P3607, DOI 10.1091/mbc.E07-02-0124; Descargues P, 2005, NAT GENET, V37, P56, DOI 10.1038/ng1493; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Emami N, 2008, CLIN CHEM, V54, P1600, DOI 10.1373/clinchem.2008.105189; Gao J, 2007, PROSTATE, V67, P348, DOI 10.1002/pros.20465; Gomis-Ruth FX, 2002, J BIOL CHEM, V277, P27273, DOI 10.1074/jbc.M201534200; Goyal J, 1998, CANCER RES, V58, P4782; Henkhaus RS, 2008, BIOL CHEM, V389, P757, DOI 10.1515/BC.2008.087; HEUZEVOURCH N, 2009, J CELL MOL IN PRESS; Huang W, 2008, WORLD J GASTROENTERO, V14, P5810, DOI 10.3748/wjg.14.5810; Iwata A, 2003, HUM MOL GENET, V12, P2625, DOI 10.1093/hmg/ddg283; Johnson SK, 2007, CANCER, V109, P1811, DOI 10.1002/cncr.22606; Klokk TI, 2007, CANCER RES, V67, P5221, DOI 10.1158/0008-5472.CAN-06-4728; Klucky B, 2007, CANCER RES, V67, P8198, DOI 10.1158/0008-5472.CAN-07-0607; Kurlender L, 2005, BBA-REV CANCER, V1755, P1, DOI 10.1016/j.bbcan.2005.02.001; Laxmikanthan G, 2005, PROTEINS, V58, P802, DOI 10.1002/prot.20368; Lilja H, 2008, NAT REV CANCER, V8, P268, DOI 10.1038/nrc2351; Liu K, 2009, J CLIN INVEST, V119, P911, DOI 10.1172/JCI36728; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Lu JF, 2005, J INVEST DERMATOL, V124, P778, DOI 10.1111/j.0022-202X.2005.23641.x; Lundwall A, 2006, BIOL CHEM, V387, P637, DOI 10.1515/BC.2006.082; Luo LY, 2006, CLIN CANCER RES, V12, P742, DOI 10.1158/1078-0432.CCR-05-1696; Madan RA, 2006, EXPERT REV VACCINES, V5, P199, DOI 10.1586/14760584.5.2.199; Meneton P, 2001, P NATL ACAD SCI USA, V98, P2634, DOI 10.1073/pnas.051619598; Menez R, 2008, J MOL BIOL, V376, P1021, DOI 10.1016/j.jmb.2007.11.052; Michael IP, 2006, J BIOL CHEM, V281, P12743, DOI 10.1074/jbc.M600326200; Mitsui S, 2000, BIOCHEM BIOPH RES CO, V272, P205, DOI 10.1006/bbrc.2000.2761; Oikonomopoulou K, 2006, J BIOL CHEM, V281, P32095, DOI 10.1074/jbc.M513138200; Pampalakis G, 2004, BIOCHEM BIOPH RES CO, V320, P54, DOI 10.1016/j.bbrc.2004.04.205; Pampalakis G, 2007, BBA-REV CANCER, V1776, P22, DOI 10.1016/j.bbcan.2007.06.001; Pampalakis G, 2006, BIOL CHEM, V387, P773, DOI 10.1515/BC.2006.097; Pampalakis G, 2009, CANCER RES, V69, P3779, DOI 10.1158/0008-5472.CAN-08-1976; Picard N, 2005, J AM SOC NEPHROL, V16, P3602, DOI 10.1681/ASN.2004110923; Ryu O, 2002, EUR J ORAL SCI, V110, P358, DOI 10.1034/j.1600-0722.2002.21349.x; Shaw JLV, 2008, BIOL CHEM, V389, P1513, DOI 10.1515/BC.2008.171; Sun XY, 2001, CARCINOGENESIS, V22, P1775, DOI 10.1093/carcin/22.11.1775; Swedberg JE, 2009, CHEM BIOL, V16, P633, DOI 10.1016/j.chembiol.2009.05.008; Terayama R, 2005, GLIA, V52, P108, DOI 10.1002/glia.20226; Vandell AG, 2008, J NEUROCHEM, V107, P855, DOI 10.1111/j.1471-4159.2008.05658.x; Veveris-Lowe TL, 2005, ENDOCR-RELAT CANCER, V12, P631, DOI 10.1677/erc.1.00958; Wolf WC, 2001, AM J PATHOL, V159, P1797, DOI 10.1016/S0002-9440(10)63026-X; Yamasaki K, 2006, FASEB J, V20, P2068, DOI 10.1096/fj.06-6075com; Yoon H, 2009, BIOL CHEM, V390, P373, DOI 10.1515/BC.2009.026	54	177	181	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					32989	32994		10.1074/jbc.R109.027946	http://dx.doi.org/10.1074/jbc.R109.027946			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19819870	Green Published, hybrid			2022-12-27	WOS:000272028500001
J	Fluman, N; Cohen-Karni, D; Weiss, T; Bibi, E				Fluman, Nir; Cohen-Karni, Devora; Weiss, Tali; Bibi, Eitan			A Promiscuous Conformational Switch in the Secondary Multidrug Transporter MdfA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESISTANCE P-GLYCOPROTEIN; ESCHERICHIA-COLI; TRANSMEMBRANE SEGMENTS; SIMULTANEOUS BINDING; PROMOTE MATURATION; PROTEIN; MEMBRANE; RECOGNITION; DRUGS; IDENTIFICATION	Multidrug (Mdr) transporters are membrane proteins that actively export structurally dissimilar drugs from the cell, thereby rendering the cell resistant to toxic compounds. Similar to substrate-specific transporters, Mdr transporters also undergo substrate-induced conformational changes. However, the mechanism by which a variety of dissimilar substrates are able to induce similar transport-compatible conformational responses in a single transporter remains unclear. To address this major aspect of Mdr transport, we studied the conformational behavior of the Escherichia coli Mdr transporter MdfA. Our results show that indeed, different substrates induce similar conformational changes in the transporter. Intriguingly, in addition, we observed that compounds other than substrates are able to confer similar conformational changes when covalently attached at the putative Mdr recognition pocket of MdfA. Taken together, the results suggest that the Mdr-binding pocket of MdfA is conformationally sensitive. We speculate that the same conformational switch that usually drives active transport is triggered promiscuously by merely occupying the Mdr-binding site.	[Fluman, Nir; Cohen-Karni, Devora; Weiss, Tali; Bibi, Eitan] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Bibi, E (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	e.bibi@weizmann.ac.il	Weiss, Tali/AAA-5530-2022	Fluman, Nir/0000-0001-9909-0779; Bibi, Eitan/0000-0003-3700-2707	Israel Cancer Research Foundation; Minerva Foundation; Israel Science Foundation	Israel Cancer Research Foundation; Minerva Foundation; Israel Science Foundation(Israel Science Foundation)	This work was supported in part by the Israel Cancer Research Foundation, the Minerva Foundation, and the Israel Science Foundation.	Adler J, 2005, J BIOL CHEM, V280, P2721, DOI 10.1074/jbc.M412332200; Adler J, 2004, J BIOL CHEM, V279, P8957, DOI 10.1074/jbc.M313422200; Adler J, 2004, BIOCHEMISTRY-US, V43, P518, DOI 10.1021/bi035485t; Adler J, 2002, J BACTERIOL, V184, P3313, DOI 10.1128/JB.184.12.3313-3320.2002; AMBUDKAR SV, 1992, P NATL ACAD SCI USA, V89, P8472, DOI 10.1073/pnas.89.18.8472; Bolhuis H, 1996, J BIOL CHEM, V271, P24123, DOI 10.1074/jbc.271.39.24123; Bolhuis H, 1996, EMBO J, V15, P4239, DOI 10.1002/j.1460-2075.1996.tb00798.x; Cole SPC, 2006, TRENDS PHARMACOL SCI, V27, P438, DOI 10.1016/j.tips.2006.06.008; Dunham TD, 1999, J BIOL CHEM, V274, P1683, DOI 10.1074/jbc.274.3.1683; Edgar R, 1997, J BACTERIOL, V179, P2274, DOI 10.1128/jb.179.7.2274-2280.1997; Edgar R, 1999, EMBO J, V18, P822, DOI 10.1093/emboj/18.4.822; Fluman N, 2009, BBA-PROTEINS PROTEOM, V1794, P738, DOI 10.1016/j.bbapap.2008.11.020; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; KOSOWER EM, 1995, METHOD ENZYMOL, V251, P133, DOI 10.1016/0076-6879(95)51117-2; KUBISTA M, 1994, ANALYST, V119, P417, DOI 10.1039/an9941900417; Lewinson O, 2001, BIOCHEMISTRY-US, V40, P12612, DOI 10.1021/bi011040y; Loo TW, 2008, J BIOL CHEM, V283, P24860, DOI 10.1074/jbc.M803351200; Loo TW, 2007, J BIOL CHEM, V282, P32043, DOI 10.1074/jbc.M706175200; Loo TW, 2006, J BIOL CHEM, V281, P29436, DOI 10.1074/jbc.C600209200; Loo TW, 2009, J BIOL CHEM, V284, P24074, DOI 10.1074/jbc.M109.023267; Loo TW, 1997, J BIOL CHEM, V272, P709, DOI 10.1074/jbc.272.2.709; Loo TW, 2003, J BIOL CHEM, V278, P39706, DOI 10.1074/jbc.M308559200; Loo TW, 1998, J BIOL CHEM, V273, P14671, DOI 10.1074/jbc.273.24.14671; Mao QC, 2000, J BIOL CHEM, V275, P34166, DOI 10.1074/jbc.M004584200; Mitchell BA, 1999, J BIOL CHEM, V274, P3541, DOI 10.1074/jbc.274.6.3541; Nagano K, 2009, P NATL ACAD SCI USA, V106, P5854, DOI 10.1073/pnas.0901695106; Neyfakh AA, 2002, MOL MICROBIOL, V44, P1123, DOI 10.1046/j.1365-2958.2002.02965.x; Saier M H Jr, 1999, J Mol Microbiol Biotechnol, V1, P257; Saier MH, 2001, SEMIN CELL DEV BIOL, V12, P205, DOI 10.1006/scdb.2000.0246; Sigal N, 2005, BIOCHEMISTRY-US, V44, P14870, DOI 10.1021/bi051574p; Sigal N, 2006, J MOL MICROB BIOTECH, V11, P308, DOI 10.1159/000095633; Smirnova I, 2007, P NATL ACAD SCI USA, V104, P16504, DOI 10.1073/pnas.0708258104; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Vazquez-Laslop N, 2000, BIOCHEM SOC T, V28, P517, DOI 10.1042/0300-5127:0280517; Venter H, 2005, BIOCHEM SOC T, V33, P1008, DOI 10.1042/BST20051008	36	15	16	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32296	32304		10.1074/jbc.M109.050658	http://dx.doi.org/10.1074/jbc.M109.050658			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19808670	Green Published, hybrid			2022-12-27	WOS:000272028400011
J	Mirghomizadeh, F; Bullwinkel, J; Orinska, Z; Janssen, O; Petersen, A; Singh, PB; Bulfone-Paus, S				Mirghomizadeh, Farhad; Bullwinkel, Joern; Orinska, Zane; Janssen, Ottmar; Petersen, Arnd; Singh, Prim B.; Bulfone-Paus, Silvia			Transcriptional Regulation of Mouse Mast Cell Protease-2 by Interleukin-15	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; NON-CPG METHYLATION; BINDING PROTEIN; C/EBP-BETA; COMPLEX; REGION; GENES; YY1	Mast cells (MCs) play a critical role in innate and adaptive immunity through the release of cytokines, chemokines, lipid mediators, biogenic amines, and proteases. We recently showed that the activities of MC proteases are transcriptionally regulated by intracellularly retained interleukin-15 (IL-15), and we provided evidence that this cytokine acts as a specific regulator of mouse mast cell protease-2 (mMCP-2). Here, we show that in wild-type bone marrow-derived mast cells (BMMCs) IL-15 inhibits mMCP-2 transcription indirectly by inducing differential expression and mMCP-2 promoter binding of the bifunctional transcription factors C/EBP beta and YY1. In wild-type BMMCs, C/EBP beta expression predominates over YY1 expression, and thus C/EBP beta preferentially binds to the mMCP-2 promoter. In IL-15-deficient BMMCs, the opposite is found: YY1 expression predominates and binds to them MCP-2 promoter at the expense of C/EBP beta. Hypertranscription of the mMCP-2 gene in IL-15-deficient BMMCs is associated with histone acetylation and, intriguingly, with methylation of non-CpG dinucleotides within the MCP-2 promoter. This suggests a novel model of cytokine-controlled protease transcription: non-CpG methylation maintains a chromosomal domain in an "open" configuration that is permissive for gene expression.	[Bulfone-Paus, Silvia] Res Ctr Borstel, Dept Immunol & Cell Biol, Div Immunobiol, D-23845 Borstel, Germany; [Bullwinkel, Joern; Singh, Prim B.] Res Ctr Borstel, Dept Immunol & Cell Biol, Div Immunoepigenet, D-23845 Borstel, Germany; [Petersen, Arnd] Res Ctr Borstel, Dept Pneumol, Div Clin & Mol Allergol, D-23845 Borstel, Germany; [Janssen, Ottmar] Univ Kiel, Inst Immunol, D-24105 Kiel, Germany	Forschungszentrum Borstel; Forschungszentrum Borstel; Forschungszentrum Borstel; University of Kiel	Bulfone-Paus, S (corresponding author), Res Ctr Borstel, Dept Immunol & Cell Biol, Div Immunobiol, Parkallee 22, D-23845 Borstel, Germany.	sbulfone@fz-borstel.de	Singh, Prim/G-1088-2014; Janssen, Ottmar/E-9735-2010; Janssen, Ottmar/N-8769-2019; Bullwinkel, Jörn/AAW-4318-2021	Singh, Prim/0000-0002-9571-0974; Janssen, Ottmar/0000-0002-9612-8900; Janssen, Ottmar/0000-0002-9612-8900; Bullwinkel, Jörn/0000-0002-7525-6057	Deutsche Forschungsgemeinschaft [SFB415/A10]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported in part by the Deutsche Forschungsgemeinschaft Grant SFB415/A10 (to S.B.-P.).	Bauknecht T, 1996, J VIROL, V70, P7695, DOI 10.1128/JVI.70.11.7695-7705.1996; Bauknecht T, 1998, J VIROL, V72, P2113, DOI 10.1128/JVI.72.3.2113-2124.1998; Bullwinkel J, 2006, J CELL PHYSIOL, V206, P624, DOI 10.1002/jcp.20494; Delcuve GP, 2009, J CELL PHYSIOL, V219, P243, DOI 10.1002/jcp.21678; Dodge JE, 2002, GENE, V289, P41, DOI 10.1016/S0378-1119(02)00469-9; Duitman EH, 2008, MOL CELL BIOL, V28, P4851, DOI 10.1128/MCB.02178-07; Galli SJ, 2008, NAT REV IMMUNOL, V8, P478, DOI 10.1038/nri2327; GASTON K, 1995, NUCLEIC ACIDS RES, V23, P901, DOI 10.1093/nar/23.6.901; Huang CF, 1998, J CLIN IMMUNOL, V18, P169, DOI 10.1023/A:1020574820797; Ikeda R, 2008, INT J BIOCHEM CELL B, V40, P1956, DOI 10.1016/j.biocel.2008.02.004; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; Kim J, 2003, HUM MOL GENET, V12, P233, DOI 10.1093/hmg/ddg028; Ko CY, 2008, J BIOL CHEM, V283, P30919, DOI 10.1074/jbc.M804029200; Orinska Z, 2007, NAT MED, V13, P927, DOI 10.1038/nm1615; Pejler G, 2007, ADV IMMUNOL, V95, P167, DOI 10.1016/S0065-2776(07)95006-3; Ramsahoye BH, 2000, P NATL ACAD SCI USA, V97, P5237, DOI 10.1073/pnas.97.10.5237; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3; STOGER R, 1993, CELL, V73, P61, DOI 10.1016/0092-8674(93)90160-R; Walsh CP, 1999, GENE DEV, V13, P26, DOI 10.1101/gad.13.1.26; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002	22	8	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32635	32641		10.1074/jbc.M109.015446	http://dx.doi.org/10.1074/jbc.M109.015446			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19801677	Green Published, hybrid			2022-12-27	WOS:000272028400046
J	Apte, SS				Apte, Suneel S.			A Disintegrin-like and Metalloprotease (Reprolysin-type) with Thrombospondin Type 1 Motif (ADAMTS) Superfamily: Functions and Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CONTROLS CELL-MIGRATION; VON-WILLEBRAND-FACTOR; THROMBOTIC THROMBOCYTOPENIC PURPURA; WEILL-MARCHESANI-SYNDROME; CAENORHABDITIS-ELEGANS; EXTRACELLULAR-MATRIX; O-FUCOSYLATION; CHONDROITIN SULFATE; ORGAN SHAPE; GENE	Together with seven ADAMTS-like proteins, the 19 mammalian ADAMTS proteases constitute a superfamily. ADAMTS proteases are secreted zinc metalloproteases whose hallmark is an ancillary domain containing one or more thrombospondin type 1 repeats. ADAMTS-like proteins resemble ADAMTS ancillary domains and lack proteolytic activity. Vertebrate expansion of the superfamily reflects emergence of new substrates, duplication of proteolytic activities in new contexts, and cooperative functions of the duplicated genes. ADAMTS proteases are involved in maturation of procollagen and von Willebrand factor, as well as in extracellular matrix proteolysis relating to morphogenesis, angiogenesis, ovulation, cancer, and arthritis. New insights into ADAMTS mechanisms indicate significant regulatory roles for ADAMTS ancillary domains, propeptide processing, and glycosylation. ADAMTS-like proteins appear to have regulatory roles in the extracellular matrix.	Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Apte, SS (corresponding author), Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44195 USA.	aptes@ccf.org		Apte, Suneel/0000-0001-8441-1226	National Institutes of Health [AR43890, AR49930]; National Marfan Foundation; Arthritis Foundation; Yamanouchi USA Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049930, R01AR043890, R56AR049930] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Marfan Foundation; Arthritis Foundation; Yamanouchi USA Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health Grants AR43890 and AR49930. This work was also supported by the National Marfan Foundation, the Arthritis Foundation, and the Yamanouchi USA Foundation. This is the ninth article in the Thematic Minireview Series on Proteolytic Enzymes. The first article was published in the November 7, 2008 issue; the second and third articles were published in the May 22, 2009 issue; the fourth and fifth articles were published in the July 31, 2009 issue; the sixth and seventh articles were published in the August 14, 2009 issue; and the eighth article was published in the August 28, 2009 issue. This minireview will be reprinted in the 2009 Minireview Compendium, which will be available in January, 2010.	Ahram D, 2009, AM J HUM GENET, V84, P274, DOI 10.1016/j.ajhg.2009.01.007; Angerer L, 2006, DEV BIOL, V300, P267, DOI 10.1016/j.ydbio.2006.07.046; Blelloch R, 1999, DEV BIOL, V216, P382, DOI 10.1006/dbio.1999.9491; Blelloch R, 1999, NATURE, V399, P586, DOI 10.1038/21196; Brown HM, 2006, DEV BIOL, V300, P699, DOI 10.1016/j.ydbio.2006.10.012; Rodriguez-Manzaneque JC, 2009, INT J BIOCHEM CELL B, V41, P800, DOI 10.1016/j.biocel.2008.08.014; Charbonneau Noe L, 2004, Birth Defects Res C Embryo Today, V72, P37, DOI 10.1002/bdrc.20000; Colige A, 1999, AM J HUM GENET, V65, P308, DOI 10.1086/302504; Colige A, 2002, J BIOL CHEM, V277, P5756, DOI 10.1074/jbc.M105601200; Colige A, 2005, J BIOL CHEM, V280, P34397, DOI 10.1074/jbc.M506458200; Dagoneau N, 2004, AM J HUM GENET, V75, P801, DOI 10.1086/425231; de Groot R, 2009, BLOOD, V113, P5609, DOI 10.1182/blood-2008-11-187914; Dong JF, 2003, J BIOL CHEM, V278, P29633, DOI 10.1074/jbc.M301385200; Faivre L, 2003, J MED GENET, V40, P34, DOI 10.1136/jmg.40.1.34; Fernandes RJ, 2001, J BIOL CHEM, V276, P31502, DOI 10.1074/jbc.M103466200; Flannery CR, 2002, J BIOL CHEM, V277, P42775, DOI 10.1074/jbc.M205309200; Gao G, 2004, J BIOL CHEM, V279, P10042, DOI 10.1074/jbc.M312100200; Gerhardt S, 2007, J MOL BIOL, V373, P891, DOI 10.1016/j.jmb.2007.07.047; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Hashimoto G, 2004, J BIOL CHEM, V279, P32483, DOI 10.1074/jbc.M314216200; Hesselson D, 2004, CURR BIOL, V14, P2005, DOI 10.1016/j.cub.2004.11.006; Hirohata S, 2002, J BIOL CHEM, V277, P12182, DOI 10.1074/jbc.M109665200; Hofsteenge J, 2001, J BIOL CHEM, V276, P6485, DOI 10.1074/jbc.M008073200; Hurskainen TL, 1999, J BIOL CHEM, V274, P25555, DOI 10.1074/jbc.274.36.25555; Huxley-Jones J, 2005, INT J BIOCHEM CELL B, V37, P1838, DOI 10.1016/j.biocel.2005.03.009; Ihara S, 2008, FEBS J, V275, P4296, DOI 10.1111/j.1742-4658.2008.06573.x; Ihara S, 2007, EMBO J, V26, P2607, DOI 10.1038/sj.emboj.7601718; Jungers KA, 2005, GENE EXPR PATTERNS, V5, P609, DOI 10.1016/j.modgep.2005.03.004; Kashiwagi M, 2004, J BIOL CHEM, V279, P10109, DOI 10.1074/jbc.M312123200; Kashiwagi M, 2001, J BIOL CHEM, V276, P12501, DOI 10.1074/jbc.C000848200; Kawano T, 2009, DEVELOPMENT, V136, P1433, DOI 10.1242/dev.028472; Kern CB, 2006, DEV DYNAM, V235, P2238, DOI 10.1002/dvdy.20838; Koo BH, 2006, J BIOL CHEM, V281, P12485, DOI 10.1074/jbc.M511083200; Koo BH, 2007, J BIOL CHEM, V282, P16146, DOI 10.1074/jbc.M610161200; Kramerova IA, 2000, DEVELOPMENT, V127, P5475; Krampert M, 2005, J BIOL CHEM, V280, P23844, DOI 10.1074/jbc.M412212200; Kubota Y, 2004, CURR BIOL, V14, P2011, DOI 10.1016/j.cub.2004.10.047; Kubota Y, 2008, P NATL ACAD SCI USA, V105, P20804, DOI 10.1073/pnas.0804055106; Kuno K, 1997, J BIOL CHEM, V272, P556, DOI 10.1074/jbc.272.1.556; Kuno K, 1998, J BIOL CHEM, V273, P13912, DOI 10.1074/jbc.273.22.13912; LAPIERE CM, 1993, ARCH DERMATOL, V129, P1316, DOI 10.1001/archderm.129.10.1316; Le Goff C, 2006, DEVELOPMENT, V133, P1587, DOI 10.1242/dev.02308; Le Goff C, 2008, NAT GENET, V40, P1119, DOI 10.1038/ng.199; Lee NV, 2006, EMBO J, V25, P5270, DOI 10.1038/sj.emboj.7601400; Lee NV, 2005, J BIOL CHEM, V280, P34796, DOI 10.1074/jbc.M506980200; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; Li Z, 2009, BLOOD, V113, P6051, DOI 10.1182/blood-2008-07-170571; Liu YJ, 2006, ONCOGENE, V25, P2452, DOI 10.1038/sj.onc.1209287; Lo PHY, 2007, ONCOGENE, V26, P148, DOI 10.1038/sj.onc.1209767; Luque A, 2003, J BIOL CHEM, V278, P23656, DOI 10.1074/jbc.M212964200; Majerus EM, 2003, J BIOL CHEM, V278, P46643, DOI 10.1074/jbc.M309872200; Majerus EM, 2005, J BIOL CHEM, V280, P21773, DOI 10.1074/jbc.M502529200; McCulloch DR, 2009, GENE EXPR PATTERNS, V9, P314, DOI 10.1016/j.gep.2009.02.006; Mittaz L, 2004, BIOL REPROD, V70, P1096, DOI 10.1095/biolreprod.103.023911; Mittaz L, 2005, NEPHROL DIAL TRANSPL, V20, P419, DOI 10.1093/ndt/gfh603; Nishiwaki K, 2000, SCIENCE, V288, P2205, DOI 10.1126/science.288.5474.2205; Rao C, 2003, DEVELOPMENT, V130, P4665, DOI 10.1242/dev.00668; Richards JS, 2005, BIOL REPROD, V72, P1241, DOI 10.1095/biolreprod.104.038083; Ricketts LM, 2007, J BIOL CHEM, V282, P17014, DOI 10.1074/jbc.M700317200; Robinson PN, 2006, J MED GENET, V43, P769, DOI 10.1136/jmg.2005.039669; Rodriguez-Manzaneque JC, 2000, J BIOL CHEM, V275, P33471, DOI 10.1074/jbc.M002599200; Shindo T, 2000, J CLIN INVEST, V105, P1345, DOI 10.1172/JCI8635; Shozu M, 2005, J MOL ENDOCRINOL, V35, P343, DOI 10.1677/jme.1.01735; Silver DL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000003; Somerville RPT, 2004, J BIOL CHEM, V279, P51208, DOI 10.1074/jbc.M409036200; Somerville RPT, 2004, J BIOL CHEM, V279, P35159, DOI 10.1074/jbc.M402380200; Somerville RPT, 2003, J BIOL CHEM, V278, P9503, DOI 10.1074/jbc.M211009200; Stankunas K, 2008, DEV CELL, V14, P298, DOI 10.1016/j.devcel.2007.11.018; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417; Suga A, 2006, DEV BIOL, V295, P26, DOI 10.1016/j.ydbio.2006.02.041; Tortorella M, 2000, J BIOL CHEM, V275, P25791, DOI 10.1074/jbc.M001065200; Tortorella MD, 2009, CURR PHARM DESIGN, V15, P2359, DOI 10.2174/138161209788682433; TUDERMAN L, 1978, BIOCHEMISTRY-US, V17, P2948, DOI 10.1021/bi00608a002; Viloria CG, 2009, CANCER RES, V69, P4926, DOI 10.1158/0008-5472.CAN-08-4155; Wang LW, 2007, J BIOL CHEM, V282, P17024, DOI 10.1074/jbc.M701065200; Wang LW, 2009, J BIOL CHEM, V284, P30004, DOI 10.1074/jbc.M109.038059; Wang P, 2004, J BIOL CHEM, V279, P15434, DOI 10.1074/jbc.M312797200; Zheng XL, 2001, J BIOL CHEM, V276, P41059, DOI 10.1074/jbc.C100515200	78	351	364	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31493	31497		10.1074/jbc.R109.052340	http://dx.doi.org/10.1074/jbc.R109.052340			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19734141	Green Published, hybrid			2022-12-27	WOS:000271572700002
J	Harr, MW; Rong, YP; Bootman, MD; Roderick, HL; Distelhorst, CW				Harr, Michael W.; Rong, Yiping; Bootman, Martin D.; Roderick, H. Llewelyn; Distelhorst, Clark W.			Glucocorticoid-mediated Inhibition of Lck Modulates the Pattern of T Cell Receptor-induced Calcium Signals by Down-regulating Inositol 1,4,5-Trisphosphate Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; KAPPA-B ACTIVITY; TYROSINE PHOSPHORYLATION; NEGATIVE REGULATION; GENE-EXPRESSION; LYMPHOMA-CELLS; NUCLEAR FACTOR; ACTIVATION; KINASE; TRANSCRIPTION	Glucocorticoids are potent immunosuppressive agents that block upstream signaling events required for T cell receptor (TCR) activation. However, the mechanism by which glucocorticoids inhibit downstream responses, such as inositol 1,4,5-trisphosphate (IP3)-induced calcium signals, is not completely understood. Here we demonstrate that low concentrations of dexamethasone rapidly convert transient calcium elevations to oscillations after strong TCR stimulation. Dexamethasone converted the pattern of calcium signaling by inhibiting the Src family kinase Lck, which was shown to interact with and positively regulate Type I IP3 receptor. In addition, low concentrations of dexamethasone were sufficient to inhibit calcium oscillations and interleukin-2mRNA after weak TCR stimulation. Together, these findings indicate that by inhibiting Lck and subsequently down-regulating IP3 receptors, glucocorticoids suppress immune responses by weakening the strength of the TCR signal.	[Harr, Michael W.; Distelhorst, Clark W.] Case Western Reserve Univ, Dept Med, Div Hematol & Oncol, Cleveland, OH 44106 USA; [Rong, Yiping; Distelhorst, Clark W.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Distelhorst, Clark W.] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Distelhorst, Clark W.] Univ Hosp Cleveland, Cleveland, OH 44106 USA; [Bootman, Martin D.; Roderick, H. Llewelyn] Babraham Inst, Lab Mol & Cellular Signalling, Cambridge CB22 3AT, England; [Roderick, H. Llewelyn] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge	Distelhorst, CW (corresponding author), Case Western Reserve Univ, Dept Med, Div Hematol & Oncol, 10900 Euclid Ave,WRB 3-133, Cleveland, OH 44106 USA.	cwd@case.edu	Bootman, Martin/AAB-3330-2019	Bootman, Martin/0000-0002-6447-3451; Roderick, Hywel/0000-0001-7065-3523	BBSRC [BBS/E/B/0000H110] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [R01CA042755] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL080101] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/E/B/00001116, BBS/E/B/0000C116, BBS/E/B/0000H110] Funding Source: Medline; NCI NIH HHS [R01 CA042755] Funding Source: Medline; NHLBI NIH HHS [P01 HL080101] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADCOCK IM, 1995, AM J PHYSIOL-CELL PH, V268, pC331, DOI 10.1152/ajpcell.1995.268.2.C331; Ashwell JD, 2000, ANNU REV IMMUNOL, V18, P309, DOI 10.1146/annurev.immunol.18.1.309; AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bian XP, 1997, AM J PHYSIOL-CELL PH, V272, pC1241, DOI 10.1152/ajpcell.1997.272.4.C1241; Bokkala S, 1997, J BIOL CHEM, V272, P12454, DOI 10.1074/jbc.272.19.12454; Cui J, 2004, J BIOL CHEM, V279, P16311, DOI 10.1074/jbc.M400206200; Das J, 2006, J MED CHEM, V49, P6819, DOI 10.1021/jm060727j; Davis MC, 2008, J BIOL CHEM, V283, P10357, DOI 10.1074/jbc.M800269200; De Bosscher K, 2009, MOL ENDOCRINOL, V23, P281, DOI 10.1210/me.2008-0283; DeBosscher K, 1997, P NATL ACAD SCI USA, V94, P13504, DOI 10.1073/pnas.94.25.13504; deSouza N, 2007, J CELL BIOL, V179, P923, DOI 10.1083/jcb.200708200; Distelhorst CW, 2002, CELL DEATH DIFFER, V9, P6, DOI 10.1038/sj.cdd.4400969; DONNADIEU E, 1992, J BIOL CHEM, V267, P25864; Falkenstein E, 2000, PHARMACOL REV, V52, P513; Franchimont D, 2004, ANN NY ACAD SCI, V1024, P124, DOI 10.1196/annals.1321.009; Garnier J, 1996, METHOD ENZYMOL, V266, P540; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Heck S, 1997, EMBO J, V16, P4698, DOI 10.1093/emboj/16.15.4698; Jayaraman T, 1996, SCIENCE, V272, P1492, DOI 10.1126/science.272.5267.1492; LAM M, 1993, MOL ENDOCRINOL, V7, P686, DOI 10.1210/me.7.5.686; Latour S, 2001, CURR OPIN IMMUNOL, V13, P299, DOI 10.1016/S0952-7915(00)00219-3; Lee B, 2006, DEVELOPMENT, V133, P4355, DOI 10.1242/dev.02624; Lewis RS, 2003, BIOCHEM SOC T, V31, P925; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Lowenberg M, 2005, BLOOD, V106, P1703, DOI 10.1182/blood-2004-12-4790; Lowenberg M, 2007, TRENDS MOL MED, V13, P158, DOI 10.1016/j.molmed.2007.02.001; Lowenberg M, 2006, EMBO REP, V7, P1023, DOI 10.1038/sj.embor.7400775; Mariathasan S, 1998, J IMMUNOL, V161, P6030; Mustelin T, 2003, BIOCHEM J, V371, P15, DOI 10.1042/BJ20021637; Necela Brian M, 2004, Proc Am Thorac Soc, V1, P239, DOI 10.1513/pats.200402-005MS; NORTHROP JP, 1992, J EXP MED, V175, P1235, DOI 10.1084/jem.175.5.1235; Ofran Y, 2003, FEBS LETT, V544, P236, DOI 10.1016/S0014-5793(03)00456-3; OLSZOWY MW, 1995, J IMMUNOL, V155, P4236; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; PALIOGIANNI F, 1993, J CLIN INVEST, V91, P1481, DOI 10.1172/JCI116353; PARYS JB, 1995, CELL CALCIUM, V17, P239, DOI 10.1016/0143-4160(95)90070-5; Qiu J, 1998, ENDOCRINOLOGY, V139, P5103, DOI 10.1210/en.139.12.5103; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; RUDD C, 1989, BIOCHEM CELL BIOL, V67, P581, DOI 10.1139/o89-090; Sienaert I, 1997, J BIOL CHEM, V272, P25899, DOI 10.1074/jbc.272.41.25899; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; SZE PY, 1994, NEUROENDOCRINOLOGY, V59, P457, DOI 10.1159/000126692; VACCA A, 1992, J EXP MED, V175, P637, DOI 10.1084/jem.175.3.637; Van Laethem F, 2001, J EXP MED, V193, P803, DOI 10.1084/jem.193.7.803; Vanderheyden V, 2009, BBA-MOL CELL RES, V1793, P959, DOI 10.1016/j.bbamcr.2008.12.003; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; Wagner PG, 1999, J NEUROSCI RES, V57, P643, DOI 10.1002/(SICI)1097-4547(19990901)57:5<643::AID-JNR6>3.0.CO;2-E; WEISS A, 1986, ANNU REV IMMUNOL, V4, P593, DOI 10.1146/annurev.iy.04.040186.003113; Winslow MM, 2003, CURR OPIN IMMUNOL, V15, P299, DOI 10.1016/S0952-7915(03)00050-5; WOJCIKIEWICZ RJH, 1995, J BIOL CHEM, V270, P11678, DOI 10.1074/jbc.270.19.11678; WOJCIKIEWICZ RJH, 1994, J BIOL CHEM, V269, P7963; Zhong F, 2006, J CELL BIOL, V172, P127, DOI 10.1083/jcb.200506189	54	37	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31860	31871		10.1074/jbc.M109.005579	http://dx.doi.org/10.1074/jbc.M109.005579			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19776014	Green Published, hybrid			2022-12-27	WOS:000271572700041
J	Nickel, E; Nienhaus, K; Lu, CY; Yeh, SR; Nienhaus, GU				Nickel, Elena; Nienhaus, Karin; Lu, Changyuan; Yeh, Syun-Ru; Nienhaus, G. Ulrich			Ligand and Substrate Migration in Human Indoleamine 2,3-Dioxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOGLOBIN MUTANT L29W; X-RAY CRYSTALLOGRAPHY; STRUCTURAL DYNAMICS; HEME-PROTEINS; TRYPTOPHAN 2,3-DIOXYGENASE; INFRARED-SPECTROSCOPY; ELECTRIC-FIELDS; CARBON-MONOXIDE; BINDING; TOLERANCE	Human indoleamine 2,3-dioxygenase (hIDO), a monomeric heme enzyme, catalyzes the oxidative degradation of L-Trp and other indoleamine derivatives. Using Fourier transform infrared and optical absorption spectroscopy, we have investigated the interplay between ferrous hIDO, the ligand analog CO, and the physiological substrate L-Trp. These data provide the long sought evidence for two distinct L-Trp binding sites. Upon photodissociation from the heme iron at T > 200 K, CO escapes into the solvent. Concomitantly, L-Trp exits the active site and, depending on the L-Trp concentration, migrates to a secondary binding site or into the solvent. Although L-Trp is spectroscopically silent at this site, it is still noticeable due to its pronounced effect on the CO association kinetics, which are significantly slower than those of L-Trp-free hIDO. L-Trp returns to its initial site only after CO has rebound to the heme iron.	[Nienhaus, G. Ulrich] Karlsruhe Inst Technol, Inst Appl Phys, D-76128 Karlsruhe, Germany; [Nienhaus, G. Ulrich] Karlsruhe Inst Technol, Ctr Funct Nanostruct, D-76128 Karlsruhe, Germany; [Nienhaus, G. Ulrich] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Lu, Changyuan; Yeh, Syun-Ru] Yeshiva Univ Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; Univ Ulm, Inst Biophys, D-89069 Ulm, Germany	Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; University of Illinois System; University of Illinois Urbana-Champaign; Yeshiva University; Albert Einstein College of Medicine; Ulm University	Nienhaus, GU (corresponding author), Karlsruhe Inst Technol, Inst Appl Phys, D-76128 Karlsruhe, Germany.	uli@illinois.edu	Nienhaus, Gerd Ulrich/G-8698-2012	Nienhaus, Gerd Ulrich/0000-0002-5027-3192; Yeh, Syun-Ru/0000-0002-9858-386X	Deutsche Forschungsgemeinschaft (DFG) [Ni291/3]; Fonds der Chemischen Industrie; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086482] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG, Grant Ni291/3) and the Fonds der Chemischen Industrie (to G. U. N.).	ALBEN JO, 1982, P NATL ACAD SCI-BIOL, V79, P3744, DOI 10.1073/pnas.79.12.3744; Bourgeois D, 2003, P NATL ACAD SCI USA, V100, P8704, DOI 10.1073/pnas.1430900100; BRAUNSTEIN DP, 1993, BIOPHYS J, V65, P2447, DOI 10.1016/S0006-3495(93)81310-9; CHU K, 1995, PHYS REV LETT, V74, P2607, DOI 10.1103/PhysRevLett.74.2607; Forouhar F, 2007, P NATL ACAD SCI USA, V104, P473, DOI 10.1073/pnas.0610007104; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; FRAUENFELDER H, 1991, BER BUNSEN PHYS CHEM, V95, P272, DOI 10.1002/bbpc.19910950310; Guallar V, 2009, J BIOL CHEM, V284, P3106, DOI 10.1074/jbc.M806183200; HAYAISHI O, 1977, J BIOL CHEM, V252, P3548; Hummer G, 2004, P NATL ACAD SCI USA, V101, P15330, DOI 10.1073/pnas.0405295101; ISHIMURA Y, 1970, J BIOL CHEM, V245, P3593; Kriegl JM, 2003, P NATL ACAD SCI USA, V100, P7069, DOI 10.1073/pnas.1231856100; Lehle H, 2005, BIOPHYS J, V88, P1978, DOI 10.1529/biophysj.104.048140; LI TS, 1994, BIOCHEMISTRY-US, V33, P1433, DOI 10.1021/bi00172a021; Lim MH, 1997, NAT STRUCT BIOL, V4, P209, DOI 10.1038/nsb0397-209; Lu CY, 2009, J AM CHEM SOC, V131, P12866, DOI 10.1021/ja9029768; Macchiarulo A, 2007, BBA-PROTEINS PROTEOM, V1774, P1058, DOI 10.1016/j.bbapap.2007.06.007; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Muller AJ, 2005, NAT MED, V11, P312, DOI 10.1038/nm1196; Muller AJ, 2006, NAT REV CANCER, V6, P613, DOI 10.1038/nrc1929; Munn DH, 2007, J CLIN INVEST, V117, P1147, DOI 10.1172/JCI31178; NIENHAUS GU, 1989, NATURE, V338, P665, DOI 10.1038/338665a0; Nienhaus K, 2005, BIOCHEMISTRY-US, V44, P5095, DOI 10.1021/bi047513t; Nienhaus K, 2005, J AM CHEM SOC, V127, P40, DOI 10.1021/ja0466917; Nienhaus K, 2003, BIOCHEMISTRY-US, V42, P9647, DOI 10.1021/bi034788k; Nienhaus K, 2003, BIOCHEMISTRY-US, V42, P9633, DOI 10.1021/bi034787s; Nienhaus K, 2008, METHOD ENZYMOL, V437, P347, DOI 10.1016/S0076-6879(07)37018-3; Nienhaus K, 2007, BIOCHEMISTRY-US, V46, P14018, DOI 10.1021/bi7016798; Ostermann A, 2000, NATURE, V404, P205, DOI 10.1038/35004622; Papadopoulou ND, 2005, BIOCHEMISTRY-US, V44, P14318, DOI 10.1021/bi0513958; Park ES, 1999, J PHYS CHEM B, V103, P9813, DOI 10.1021/jp992329g; Park ES, 2002, J PHYS CHEM B, V106, P5800, DOI 10.1021/jp0203043; RAY GB, 1994, J AM CHEM SOC, V116, P162, DOI 10.1021/ja00080a019; Salter MD, 2008, J BIOL CHEM, V283, P35689, DOI 10.1074/jbc.M805727200; Schmidt M, 2005, P NATL ACAD SCI USA, V102, P11704, DOI 10.1073/pnas.0504932102; Schmidt M, 2004, P NATL ACAD SCI USA, V101, P4799, DOI 10.1073/pnas.0305983101; Schotte F, 2003, SCIENCE, V300, P1944, DOI 10.1126/science.1078797; SONO M, 1980, J BIOL CHEM, V255, P1339; Sugimoto H, 2006, P NATL ACAD SCI USA, V103, P2611, DOI 10.1073/pnas.0508996103; Takikawa O, 2005, BIOCHEM BIOPH RES CO, V338, P12, DOI 10.1016/j.bbrc.2005.09.032; Terentis AC, 2002, J BIOL CHEM, V277, P15788, DOI 10.1074/jbc.M200457200; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; Vallone B, 2004, PROTEINS, V56, P85, DOI 10.1002/prot.20113; Vogel KM, 1999, J AM CHEM SOC, V121, P9915, DOI 10.1021/ja990042r; YAMAMOTO S, 1967, J BIOL CHEM, V242, P5260	45	19	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31548	31554		10.1074/jbc.M109.039859	http://dx.doi.org/10.1074/jbc.M109.039859			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19767648	Green Published, hybrid			2022-12-27	WOS:000271572700008
J	Chawengsub, Y; Gauthier, KM; Nithipatikom, K; Hammock, BD; Falck, JR; Narsimhaswamy, D; Campbell, WB				Chawengsub, Yuttana; Gauthier, Kathryn M.; Nithipatikom, Kasem; Hammock, Bruce D.; Falck, John R.; Narsimhaswamy, Dubasi; Campbell, William B.			Identification of 13-Hydroxy-14,15-epoxyeicosatrienoic Acid as an Acid-stable Endothelium-derived Hyperpolarizing Factor in Rabbit Arteries	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLCHOLINE-INDUCED HYPOTENSION; ARACHIDONIC-ACID; SMOOTH-MUSCLE; DEPENDENT RELAXATION; NITRIC-OXIDE; TRIHYDROXYEICOSATRIENOIC ACIDS; 15-LIPOXYGENASE METABOLITE; EPOXYEICOSATRIENOIC ACIDS; VASCULAR RELAXATION; HEPOXILIN A(3)	Arachidonic acid (AA) is metabolized by endothelial 15-lipoxygenase (15-LO) to several vasodilatory eicosanoids such as 11,12,15-trihydroxyeicosatrienoic acid (11,12,15-THETA) and its proposed unstable precursor 15-hydroxy-11,12-epoxyeicosatrienoic acid (15-H-11,12-EETA). In the present study, the acid-stable 13-hydroxy-trans-14,15-epoxy-eicosatrienoic acid (13-H-14,15-EETA) was identified and its vascular activities characterized. Rabbit aorta, mesenteric arteries, and the combination of 15-LO and cytochrome P450 2J2 converted AA to two distinct HEETA metabolites. The HEETA metabolites were resistant to acidic hydrolysis but were hydrolyzed by recombinant sEH to a more polar metabolite identified by mass spectrometry as 13,14,15-THETA. Mass spectrometric analyses and HPLC comigration identified the HEETAs as threo-and erythro-diastereomers of 13-H-trans-14,15-EETA. Erythro-and threo-diastereomers of 13-H-trans-14,15-EETA relaxed endothelium-denuded rabbit small mesenteric arteries with maximum relaxations of 22.6 +/- 6.0% and 8.6 +/- 4.3%, respectively. Apamin (10(-7) M) inhibited the relaxations to the erythro-isomer(maximumrelaxation = 1.2 +/- 5.6%) and increasing [K+](o) from 4.6 to 30 mM blocked relaxations to both isomers. In cell-attached patches of mesenteric arterial smooth muscle cells (SMCs), erythro-13-H-trans-14,15-EETA (1-3 x 10(-6) M) increased mean open time of small conductance K+ channels (13-14 pS) from 0.0007 +/- 0.0007 to 0.0053 +/- 0.0042. This activation was inhibited by apamin. The erythro, but not the threo, isomer blocked angiotensin II-stimulated aortic SMC migration. These studies demonstrate that 13-H-14,15-EETAs induces vascular relaxation via K+ channel activation to cause SMC hyperpolarization. Thus, 13-H-14,15-EETA represents a new endothelial factor.	[Chawengsub, Yuttana; Gauthier, Kathryn M.; Nithipatikom, Kasem; Campbell, William B.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Falck, John R.; Narsimhaswamy, Dubasi] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Hammock, Bruce D.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Hammock, Bruce D.] Univ Calif Davis, Canc Res Ctr, Davis, CA 95616 USA	Medical College of Wisconsin; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California Davis; University of California System; University of California Davis	Campbell, WB (corresponding author), 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	wbcamp@mcw.edu	Dubasi, Narsimhaswamy/AAY-1958-2021; Falck, John R/B-3030-2011	Dubasi, Narsimhaswamy/0000-0002-6401-6293; Falck, John R/0000-0002-9219-7845	National Institutes of Health [HL-37981, GM-31278, ES-04699, ES-02710]; Robert A. Welch Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL037981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK038226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004699, R37ES002710, R01ES002710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031278] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-37981, GM-31278, ES-04699, and ES-02710. This work was also supported by the Robert A. Welch Foundation.	Aggarwal NT, 2008, ARTERIOSCL THROM VAS, V28, P2209, DOI 10.1161/ATVBAHA.108.177113; Aggarwal NT, 2008, HYPERTENSION, V51, P246, DOI 10.1161/HYPERTENSIONAHA.107.104125; BOLTON TB, 1986, BRIT J PHARMACOL, V87, P713, DOI 10.1111/j.1476-5381.1986.tb14589.x; Brandes RP, 1997, ATHEROSCLEROSIS, V135, P49, DOI 10.1016/S0021-9150(97)00145-7; BRASH AR, 1994, ANN NY ACAD SCI, V744, P25, DOI 10.1111/j.1749-6632.1994.tb52720.x; Campbell WB, 2003, AM J PHYSIOL-HEART C, V285, pH2648, DOI 10.1152/ajpheart.00412.2003; Chang MS, 1996, BIOCHEMISTRY-US, V35, P464, DOI 10.1021/bi952081v; Chawengsub Y, 2008, AM J PHYSIOL-HEART C, V294, pH1348, DOI 10.1152/ajpheart.01326.2007; CHEN G, 1988, BRIT J PHARMACOL, V95, P1165, DOI 10.1111/j.1476-5381.1988.tb11752.x; COREY EJ, 1983, TETRAHEDRON LETT, V24, P4921, DOI 10.1016/S0040-4039(01)99811-9; COREY EJ, 1984, TETRAHEDRON LETT, V25, P5123, DOI 10.1016/S0040-4039(01)81540-9; Cui LJ, 2008, J AM SOC MASS SPECTR, V19, P569, DOI 10.1016/j.jasms.2008.01.007; DEMBINSKAKIEC A, 1977, PROSTAGLANDINS, V14, P1025, DOI 10.1016/0090-6980(77)90282-9; DIETZE EC, 1991, BIOCHEM PHARMACOL, V42, P1163, DOI 10.1016/0006-2952(91)90250-9; Feletou M, 2004, PHARMACOL RES, V49, P565, DOI 10.1016/j.phrs.2003.10.017; FELETOU M, 1988, BRIT J PHARMACOL, V93, P515, DOI 10.1111/j.1476-5381.1988.tb10306.x; Feletou M, 2007, ANN MED, V39, P495, DOI 10.1080/07853890701491000; Fisslthaler B, 2001, HYPERTENSION, V38, P1427, DOI 10.1161/hy1201.096532; FORSTERMANN U, 1984, BRIT J PHARMACOL, V81, P623; Gauthier KM, 2008, AM J PHYSIOL-HEART C, V294, pH1467, DOI 10.1152/ajpheart.01052.2007; Gauthier KM, 2004, HYPERTENSION, V43, P413, DOI 10.1161/01.HYP.0000110945.84443.d2; GEBREMEDHIN D, 1992, AM J PHYSIOL, V263, pH519, DOI 10.1152/ajpheart.1992.263.2.H519; GILL SS, 1979, BIOCHEM BIOPH RES CO, V89, P965, DOI 10.1016/0006-291X(79)91872-2; Hamberg M, 1999, LIPIDS, V34, P1131, DOI 10.1007/s11745-999-0464-7; HAMBERG M, 1990, ARCH BIOCHEM BIOPHYS, V283, P409, DOI 10.1016/0003-9861(90)90662-I; HERLIHY JT, 1973, CIRC RES, V33, P275, DOI 10.1161/01.RES.33.3.275; Honda H, 2001, JPN J PHARMACOL, V85, P203, DOI 10.1254/jjp.85.203; Jiang HL, 2008, J PHARMACOL EXP THER, V326, P330, DOI 10.1124/jpet.107.134858; McCallum GP, 1996, J PHARMACOL EXP THER, V278, P1188; MONCADA S, 1987, TRENDS PHARMACOL SCI, V8, P365, DOI 10.1016/0165-6147(87)90090-3; MONCADA S, 1978, PHARMACOL REV, V30, P293; Mrsny RJ, 2004, P NATL ACAD SCI USA, V101, P7421, DOI 10.1073/pnas.0400832101; NARUMIYA S, 1981, J BIOL CHEM, V256, P9583; Natarajan R, 2003, FRONT BIOSCI-LANDMRK, V8, pS783, DOI 10.2741/1144; Nie D, 2007, FRONT BIOSCI, V12, P1574, DOI 10.2741/2170; Nigam S, 2004, J BIOL CHEM, V279, P29023, DOI 10.1074/jbc.M307576200; Pace-Asciak CR, 1999, ADV EXP MED BIOL, V447, P123; PANZA JA, 1993, CIRCULATION, V87, P1468, DOI 10.1161/01.CIR.87.5.1468; Pfister SL, 1996, AM J PHYSIOL-HEART C, V270, pH1021, DOI 10.1152/ajpheart.1996.270.3.H1021; Pfister SL, 2003, ARCH BIOCHEM BIOPHYS, V420, P142, DOI 10.1016/j.abb.2003.09.026; PFISTER SL, 1992, HYPERTENSION, V20, P682, DOI 10.1161/01.HYP.20.5.682; Pfister SL, 1997, HYPERTENSION, V29, P303, DOI 10.1161/01.HYP.29.1.303; Pfister SL, 1998, J BIOL CHEM, V273, P30879, DOI 10.1074/jbc.273.47.30879; PFISTER SL, 1988, PROSTAGLANDINS, V36, P515, DOI 10.1016/0090-6980(88)90047-0; PFISTER SL, 2001, IDENTIFICATION 11 12; POWELL WS, 1980, PROSTAGLANDINS, V20, P947, DOI 10.1016/0090-6980(80)90144-6; Reynaud D, 2003, THROMB RES, V112, P245, DOI 10.1016/j.thromres.2003.12.014; Roy U, 2005, BIOCHEM J, V390, P719, DOI 10.1042/BJ20050681; Russo G, 2002, VASC PHARMACOL, V38, P259, DOI 10.1016/S1537-1891(02)00250-1; SINGER HA, 1983, J PHARMACOL EXP THER, V226, P790; Taddei S, 2006, J AM COLL CARDIOL, V48, P508, DOI 10.1016/j.jacc.2006.04.074; Tang X, 2006, ARTERIOSCL THROM VAS, V26, P78, DOI 10.1161/01.ATV.0000191640.73313.ad; Tang X, 2006, AM J PHYSIOL-HEART C, V290, pH37, DOI 10.1152/ajpheart.00491.2005; TAYLOR SG, 1988, BRIT J PHARMACOL, V94, P853, DOI 10.1111/j.1476-5381.1988.tb11597.x; Vanhoutte PM, 2004, PHARMACOL RES, V49, P503, DOI 10.1016/j.phrs.2003.11.015; Voetsch B, 2004, HISTOCHEM CELL BIOL, V122, P353, DOI 10.1007/s00418-004-0675-z; WEISS RH, 1987, ARCH BIOCHEM BIOPHYS, V252, P334, DOI 10.1016/0003-9861(87)90039-7; Wittwer J, 2007, PROSTAG LEUKOTR ESS, V77, P67, DOI 10.1016/j.plefa.2007.08.001; Yeh HC, 2007, ARCH BIOCHEM BIOPHYS, V461, P159, DOI 10.1016/j.abb.2007.03.012; Zhang DX, 2005, AM J PHYSIOL-HEART C, V288, pH302, DOI 10.1152/ajpheart.00661.2004; Zhang DX, 2004, ENDOCRINOLOGY, V145, P1571, DOI 10.1210/en.2003-1448	61	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31280	31290		10.1074/jbc.M109.025627	http://dx.doi.org/10.1074/jbc.M109.025627			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19737933	hybrid, Green Published			2022-12-27	WOS:000271378400055
J	Lee, EF; Fedorova, A; Zobel, K; Boyle, MJ; Yang, H; Perugini, MA; Colman, PM; Huang, DCS; Deshayes, K; Fairlie, WD				Lee, Erinna F.; Fedorova, Anna; Zobel, Kerry; Boyle, Michelle J.; Yang, Hong; Perugini, Matthew A.; Colman, Peter M.; Huang, David C. S.; Deshayes, Kurt; Fairlie, W. Douglas			Novel Bcl-2 Homology-3 Domain-like Sequences Identified from Screening Randomized Peptide Libraries for Inhibitors of the Pro-survival Bcl-2 Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BH3-ONLY PROTEINS; BH3 DOMAINS; SCANNING MUTAGENESIS; FAMILY PROTEINS; BAX ACTIVATION; PHAGE DISPLAY; APOPTOSIS; BINDING; MCL-1; ANTAGONISTS	Interactions between Bcl-2 homology-3 (BH3)-only proteins and their pro-survival Bcl-2 family binding partners initiate the intrinsic apoptosis pathway. These interactions are mediated by a short helical motif, the BH3 domain, on the BH3-only protein, which inserts into a hydrophobic groove on the pro-survival molecule. To identify novel peptidic ligands that bind Mcl-1, a pro-survival protein relative of Bcl-2, both human and mouse Mcl-1 were screened against large randomized phage-displayed peptide libraries. We identified a number of 16-mer peptides with sub-micromolar affinity that were highly selective for Mcl-1, as well as being somewhat selective for the species of Mcl-1 (human or mouse) against which the library was panned. Interestingly, these sequences all strongly resembled natural BH3 domain sequences. By switching residues within the best of the human Mcl-1-binding sequences, or extending beyond the core sequence identified, we were able to alter the pro-survival protein interaction profile of this peptide such that it now bound all members tightly and was a potent killer when introduced into cells. Introduction of an amide lock constraint within this sequence also increased its helicity and binding to pro-survival proteins. These data provide new insights into the determinants of BH3 domain: pro-survival protein affinity and selectivity.	[Lee, Erinna F.; Boyle, Michelle J.; Yang, Hong; Colman, Peter M.; Huang, David C. S.; Fairlie, W. Douglas] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Fedorova, Anna; Zobel, Kerry; Deshayes, Kurt] Genentech Inc, San Francisco, CA 94080 USA; [Perugini, Matthew A.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia	Walter & Eliza Hall Institute; Roche Holding; Genentech; University of Melbourne	Deshayes, K (corresponding author), Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA.	deshayes.kurt@gene.com; fairlie@wehi.edu.au	Huang, David C. S./C-7586-2013; Fairlie, Walter/M-8401-2015; Boyle, Michelle/P-7297-2019; Boyle, Michelle/D-4223-2018; Lee, Erinna/N-1523-2015	Huang, David C. S./0000-0002-3101-4873; Fairlie, Walter/0000-0002-2498-1160; Boyle, Michelle/0000-0002-0268-232X; Boyle, Michelle/0000-0002-0268-232X; Lee, Erinna/0000-0003-1255-9808	National Health and Medical Research Council of Australia (NHRMC) [461221]; Leukemia and Lymphoma Society [SCOR 7015-02]; Cancer Council of Victoria [461239]; Leukemia Foundation of Australia Phillip Desbrow Post Doctoral Fellowship; Australian Cancer Research Foundation; NHMRC IRIISS [361646]; Victorian State Government	National Health and Medical Research Council of Australia (NHRMC)(National Health and Medical Research Council (NHMRC) of Australia); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Leukemia Foundation of Australia Phillip Desbrow Post Doctoral Fellowship; Australian Cancer Research Foundation; NHMRC IRIISS(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government	This work was supported by the National Health and Medical Research Council of Australia (NHRMC, fellowships to W. D. F., P. M. C., and D. C. S. H.; Program Grant 461221 to P. M. C., and D. C. S. H.), by the Leukemia and Lymphoma Society (Grant SCOR 7015-02), by the Cancer Council of Victoria (Grant-in-aid 461239 to W. D. F. and D. C. S. H.; Fellowship to E. F. L.), by the Leukemia Foundation of Australia Phillip Desbrow Post Doctoral Fellowship (to E. F. L.), and by the Australian Cancer Research Foundation (to P. M. C.). Infrastructure support from NHMRC IRIISS Grant 361646 and the Victorian State Government (OIS grant) is gratefully acknowledged.	Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104; Day CL, 2008, J MOL BIOL, V380, P958, DOI 10.1016/j.jmb.2008.05.071; Fairlie WD, 2004, J BIOL CHEM, V279, P2125, DOI 10.1074/jbc.M310103200; Fairlie WD, 2003, BIOCHEMISTRY-US, V42, P13193, DOI 10.1021/bi035303v; Fletchera JI, 2008, P NATL ACAD SCI USA, V105, P18081, DOI 10.1073/pnas.0808691105; Gallenne T, 2009, J CELL BIOL, V185, P279, DOI 10.1083/jcb.200809153; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; HERMES JD, 1989, GENE, V84, P143, DOI 10.1016/0378-1119(89)90148-0; Hinds MG, 2007, CELL DEATH DIFFER, V14, P128, DOI 10.1038/sj.cdd.4401934; Huang DCS, 1997, EMBO J, V16, P4628, DOI 10.1093/emboj/16.15.4628; HUTCHISON CA, 1986, P NATL ACAD SCI USA, V83, P710, DOI 10.1073/pnas.83.3.710; Kelekar A, 1998, TRENDS CELL BIOL, V8, P324, DOI 10.1016/S0962-8924(98)01321-X; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; KUNKEL TA, 1991, METHOD ENZYMOL, V204, P125; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Lee EF, 2008, CELL DEATH DIFFER, V15, P1609, DOI 10.1038/cdd.2008.86; Lee EF, 2007, CELL DEATH DIFFER, V14, P1711, DOI 10.1038/sj.cdd.4402178; Lee EF, 2008, J CELL BIOL, V180, P341, DOI 10.1083/jcb.200708096; Liu XQ, 2003, IMMUNITY, V19, P341, DOI 10.1016/S1074-7613(03)00234-6; Moriishi K, 1999, P NATL ACAD SCI USA, V96, P9683, DOI 10.1073/pnas.96.17.9683; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Pal G, 2003, J MOL BIOL, V332, P195, DOI 10.1016/S0022-2836(03)00898-2; Perugini MA, 2000, J BIOL CHEM, V275, P36758, DOI 10.1074/jbc.M005565200; Petros AM, 2000, PROTEIN SCI, V9, P2528, DOI 10.1017/S096183680000331X; Sadowsky JD, 2007, J AM CHEM SOC, V129, P139, DOI 10.1021/ja0662523; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Sidhu SS, 2007, METH MOL B, V352, P205; Skelton NJ, 2001, BIOCHEMISTRY-US, V40, P8487, DOI 10.1021/bi0103866; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Vajdos FF, 2002, J MOL BIOL, V320, P415, DOI 10.1016/S0022-2836(02)00264-4; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Van Parijs L, 1999, IMMUNITY, V11, P763, DOI 10.1016/S1074-7613(00)80150-8; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Weiss GA, 2000, P NATL ACAD SCI USA, V97, P8950, DOI 10.1073/pnas.160252097; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Yang B, 2004, BIOORG MED CHEM LETT, V14, P1403, DOI 10.1016/j.bmcl.2003.09.101; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zobel K, 2006, ACS CHEM BIOL, V1, P525, DOI 10.1021/cb600276q	41	28	29	3	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31315	31326		10.1074/jbc.M109.048009	http://dx.doi.org/10.1074/jbc.M109.048009			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19748896	Green Published, hybrid			2022-12-27	WOS:000271378400058
J	Palmieri, F; Rieder, B; Ventrella, A; Blanco, E; Do, PT; Nunes-Nesi, A; Trauth, AU; Fiermonte, G; Tjaden, J; Agrimi, G; Kirchberger, S; Paradies, E; Fernie, AR; Neuhaus, HE				Palmieri, Ferdinando; Rieder, Benjamin; Ventrella, Angela; Blanco, Emanuela; Do, Phuc Thi; Nunes-Nesi, Adriano; Trauth, A. Ulrike; Fiermonte, Giuseppe; Tjaden, Joachim; Agrimi, Gennaro; Kirchberger, Simon; Paradies, Eleonora; Fernie, Alisdair R.; Neuhaus, H. Ekkehard			Molecular Identification and Functional Characterization of Arabidopsis thaliana Mitochondrial and Chloroplastic NAD(+) Carrier Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-NUCLEOTIDE TRANSPORTER; BACTERIAL EXPRESSION; SACCHAROMYCES-CEREVISIAE; PHOSPHATE TRANSLOCATOR; ATP/ADP TRANSPORTERS; PLANT-MITOCHONDRIA; ORGAN DISTRIBUTION; SOLANUM-TUBEROSUM; ATP TRANSPORT; POTATO-TUBER	The Arabidopsis thaliana L. genome contains 58 membrane proteins belonging to the mitochondrial carrier family. Two mitochondrial carrier family members, here named AtNDT1 and AtNDT2, exhibit high structural similarities to the mitochondrial nicotinamide adenine dinucleotide (NAD(+)) carrier ScNDT1 from bakers' yeast. Expression of AtNDT1 or AtNDT2 restores mitochondrial NAD(+) transport activity in a yeast mutant lacking ScNDT. Localization studies with green fluorescent protein fusion proteins provided evidence that AtNDT1 resides in chloroplasts, whereas only AtNDT2 locates to mitochondria. Heterologous expression in Escherichia coli followed by purification, reconstitution in proteoliposomes, and uptake experiments revealed that both carriers exhibit a submillimolar affinity for NAD(+) and transport this compound in a counterexchange mode. Among various substrates ADP and AMP are the most efficient counter-exchange substrates for NAD(+). Atndt1- and Atndt2-promoter-GUS plants demonstrate that both genes are strongly expressed in developing tissues and in particular in highly metabolically active cells. The presence of both carriers is discussed with respect to the subcellular localization of de novo NAD(+) biosynthesis in plants and with respect to both the NAD(+)-dependent metabolic pathways and the redox balance of chloroplasts and mitochondria.	[Rieder, Benjamin; Trauth, A. Ulrike; Tjaden, Joachim; Kirchberger, Simon; Neuhaus, H. Ekkehard] Tech Univ Kaiserslautern, Fachbereich Biol, D-67663 Kaiserslautern, Germany; [Palmieri, Ferdinando; Ventrella, Angela; Blanco, Emanuela; Fiermonte, Giuseppe; Agrimi, Gennaro; Paradies, Eleonora] Univ Bari, Dept Pharmacobiol, Biochem & Mol Biol Lab, I-70125 Bari, Italy; [Palmieri, Ferdinando; Fiermonte, Giuseppe] CNR, Inst Biomembranes & Bioenerget, I-70125 Bari, Italy; [Do, Phuc Thi; Nunes-Nesi, Adriano; Fernie, Alisdair R.] Max Planck Inst Mol Pflanzenphysiol, D-14476 Potsdam, Germany	University of Kaiserslautern; Universita degli Studi di Bari Aldo Moro; Consiglio Nazionale delle Ricerche (CNR); Max Planck Society	Neuhaus, HE (corresponding author), Tech Univ Kaiserslautern, Fachbereich Biol, Erwin Schrodinger Str, D-67663 Kaiserslautern, Germany.	neuhaus@rhrk.uni-kl.de	Blanco, Emanuela/ABF-8934-2020; Fiermonte, Giuseppe/D-3680-2018; Agrimi, Gennaro/D-4001-2018; Paradies, Eleonora/K-4606-2014; Nunes-Nesi, Adriano/D-6430-2013; Do, Phuc Thi/A-2318-2014	Fiermonte, Giuseppe/0000-0002-6764-9395; Agrimi, Gennaro/0000-0002-5219-4412; Paradies, Eleonora/0000-0002-1668-7148; Do, Phuc Thi/0000-0002-2893-8223; Nunes-Nesi, Adriano/0000-0002-9581-9355; BLANCO, EMANUELA/0000-0001-9541-7148	Deutsche Forschungsgemeinschaft Reinhard Koselleck; Ministero dell'Universitae della Ricerca; Center of Excellence in Genomics; Italian Human ProteomeNet [RBRN07BMCT_009]	Deutsche Forschungsgemeinschaft Reinhard Koselleck(German Research Foundation (DFG)); Ministero dell'Universitae della Ricerca(Ministry of Education, Universities and Research (MIUR)); Center of Excellence in Genomics; Italian Human ProteomeNet	This work was supported by a Deutsche Forschungsgemeinschaft Reinhard Koselleck grant (to E. N.), the Ministero dell'Universitae della Ricerca, the Center of Excellence in Genomics, and the Italian Human ProteomeNet RBRN07BMCT_009 (to F. P.).	Abeijon C, 1997, TRENDS BIOCHEM SCI, V22, P203, DOI 10.1016/S0968-0004(97)01053-0; AQUILA H, 1987, FEBS LETT, V212, P1, DOI 10.1016/0014-5793(87)81546-6; Arai Y, 2008, PLANT CELL, V20, P3227, DOI 10.1105/tpc.108.062877; BECKER D, 1992, PLANT MOL BIOL, V20, P1195, DOI 10.1007/BF00028908; Bedhomme M, 2005, J BIOL CHEM, V280, P34823, DOI 10.1074/jbc.M506045200; Berkemeyer M, 1998, J BIOL CHEM, V273, P27927, DOI 10.1074/jbc.273.43.27927; Bouvier F, 2006, PLANT CELL, V18, P3088, DOI 10.1105/tpc.105.040741; Catoni E, 2003, FEBS LETT, V534, P87, DOI 10.1016/S0014-5793(02)03782-1; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Coffe V, 2004, J NEUROCHEM, V88, P885, DOI 10.1046/j.1471-4159.2003.02207.x; Endler A, 2006, PLANT PHYSIOL, V141, P196, DOI 10.1104/pp.106.079533; Farre EM, 2000, PLANT PHYSIOL, V123, P681, DOI 10.1104/pp.123.2.681; Fiermonte G, 2002, J BIOL CHEM, V277, P19289, DOI 10.1074/jbc.M201572200; Fiermonte G, 1998, J BIOL CHEM, V273, P24754, DOI 10.1074/jbc.273.38.24754; FIERMONTE G, 1993, BIOCHEM J, V294, P293, DOI 10.1042/bj2940293; Gibon Y, 1997, ANAL BIOCHEM, V251, P153, DOI 10.1006/abio.1997.2283; Glaser E, 1998, PLANT MOL BIOL, V38, P311, DOI 10.1023/A:1006020208140; Haferkamp I, 2004, NATURE, V432, P622, DOI 10.1038/nature03131; Haferkamp I, 2007, FEBS LETT, V581, P2375, DOI 10.1016/j.febslet.2007.02.020; Haferkamp I, 2006, MOL MICROBIOL, V60, P1534, DOI 10.1111/j.1365-2958.2006.05193.x; Heldt H.-W., 2005, PLANT BIOCH; Hunt L, 2007, PLANT J, V51, P341, DOI 10.1111/j.1365-313X.2007.03151.x; Kirchberger S, 2008, PLANT J, V56, P51, DOI 10.1111/j.1365-313X.2008.03583.x; Kirchberger S, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702484200; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; KNIGHT JS, 1995, PLANT CELL, V7, P1421, DOI 10.1105/tpc.7.9.1421; LEHNINGER AL, 1994, PRINZIPIEN BIOCH; Leroch M, 2005, J BIOL CHEM, V280, P17992, DOI 10.1074/jbc.M412462200; Leroch M, 2008, PLANT CELL, V20, P438, DOI 10.1105/tpc.107.057554; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Linka N, 2003, GENE, V306, P27, DOI 10.1016/S0378-1119(03)00429-3; Linka N, 2008, PLANT CELL, V20, P3241, DOI 10.1105/tpc.108.062042; Liu YJ, 2009, PLANT PHYSIOL, V150, P1248, DOI 10.1104/pp.109.136242; LODDENKOTTER B, 1993, P NATL ACAD SCI USA, V90, P2155, DOI 10.1073/pnas.90.6.2155; LUNN JE, 1993, BIOCHEM J, V290, P375, DOI 10.1042/bj2900375; Millar AH, 2003, PLANT PHYSIOL, V131, P443, DOI 10.1104/pp.009985; Mohlmann T, 1998, EUR J BIOCHEM, V252, P353, DOI 10.1046/j.1432-1327.1998.2520353.x; NEUBURGER M, 1985, PLANT PHYSIOL, V78, P405, DOI 10.1104/pp.78.2.405; NEUBURGER M, 1983, BIOCHEM J, V216, P443, DOI 10.1042/bj2160443; Neuhaus HE, 1996, BIOCHEM J, V318, P945, DOI 10.1042/bj3180945; Neuhaus HE, 2000, ANNU REV PLANT PHYS, V51, P111, DOI 10.1146/annurev.arplant.51.1.111; Noctor G, 2006, J EXP BOT, V57, P1603, DOI 10.1093/jxb/erj202; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Palmieri F, 1995, METHOD ENZYMOL, V260, P349, DOI 10.1016/0076-6879(95)60150-3; Palmieri F, 2006, BBA-BIOENERGETICS, V1757, P1249, DOI 10.1016/j.bbabio.2006.05.023; Palmieri L, 2001, EMBO J, V20, P5049, DOI 10.1093/emboj/20.18.5049; Palmieri L, 2008, PLANT PHYSIOL, V148, P1797, DOI 10.1104/pp.108.130310; Palmieri L, 2008, BIOCHEM J, V410, P621, DOI 10.1042/BJ20070867; Palmieri L, 2006, PLANT PHYSIOL, V142, P855, DOI 10.1104/pp.106.086975; Picault N, 2004, TRENDS PLANT SCI, V9, P138, DOI 10.1016/j.tplants.2004.01.007; Roux SJ, 2007, TRENDS PLANT SCI, V12, P522, DOI 10.1016/j.tplants.2007.09.003; Ruiz-Medrano R, 2001, CURR OPIN PLANT BIOL, V4, P202, DOI 10.1016/S1369-5266(00)00162-X; SARASTE M, 1982, FEBS LETT, V144, P250, DOI 10.1016/0014-5793(82)80648-0; Schippers JHM, 2008, PLANT CELL, V20, P2909, DOI 10.1105/tpc.107.056341; Schmitz-Esser S, 2004, J BACTERIOL, V186, P683, DOI 10.1128/JB.186.3.683-691.2004; Schwacke R, 2003, PLANT PHYSIOL, V131, P16, DOI 10.1104/pp.011577; SCHWARTZ JP, 1974, J BIOL CHEM, V249, P4138; Stengel A, 2007, BIOL CHEM, V388, P765, DOI 10.1515/BC.2007.099; STROTMANN H, 1969, BIOCHEM BIOPH RES CO, V35, P20, DOI 10.1016/0006-291X(69)90477-X; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thuswaldner S, 2007, J BIOL CHEM, V282, P8848, DOI 10.1074/jbc.M609130200; TOBIN A, 1980, PLANT PHYSIOL, V66, P225, DOI 10.1104/pp.66.2.225; Todisco S, 2006, J BIOL CHEM, V281, P1524, DOI 10.1074/jbc.M510425200; Trentmann O, 2007, PLOS BIOL, V5, P1938, DOI 10.1371/journal.pbio.0050231; Trentmann O, 2008, J BIOL CHEM, V283, P36486, DOI 10.1074/jbc.M806903200; VONHEIJNE G, 1989, EUR J BIOCHEM, V180, P535; Wang GD, 2007, PLANT J, V49, P1020, DOI 10.1111/j.1365-313X.2006.03013.x; Weigel D., 2002, ARABIDOPSIS LAB MANU; Weise A, 2000, PLANT CELL, V12, P1345, DOI 10.1105/tpc.12.8.1345; Wendt UK, 2000, PLANT J, V23, P723, DOI 10.1046/j.1365-313x.2000.00840.x; Weschke W, 2000, PLANT J, V21, P455, DOI 10.1046/j.1365-313x.2000.00695.x; Winkler HH, 1999, TRENDS BIOCHEM SCI, V24, P64, DOI 10.1016/S0968-0004(98)01334-6; YONUSCHOT GR, 1970, J BIOL CHEM, V245, P4193; ZARA V, 1991, EUR J BIOCHEM, V198, P405, DOI 10.1111/j.1432-1033.1991.tb16029.x; Zhang QH, 2002, SCIENCE, V295, P1895; Zrenner R, 2006, ANNU REV PLANT BIOL, V57, P805, DOI 10.1146/annurev.arplant.57.032905.105421; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	77	131	137	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31249	31259		10.1074/jbc.M109.041830	http://dx.doi.org/10.1074/jbc.M109.041830			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19745225	Green Published, hybrid			2022-12-27	WOS:000271378400052
J	Brien, G; Debaud, AL; Robert, X; Oliver, L; Trescol-Biemont, MC; Cauquil, N; Geneste, O; Aghajari, N; Vallette, FM; Haser, R; Bonnefoy-Berard, N				Brien, Gaelle; Debaud, Anne-Laure; Robert, Xavier; Oliver, Lisa; Trescol-Biemont, Marie-Claude; Cauquil, Nicolas; Geneste, Olivier; Aghajari, Nushin; Vallette, Francois M.; Haser, Richard; Bonnefoy-Berard, Nathalie			C-terminal Residues Regulate Localization and Function of the Antiapoptotic Protein Bfl-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL OUTER-MEMBRANE; BCL-W; ENDOPLASMIC-RETICULUM; INDUCE APOPTOSIS; B-CELLS; ANCHOR; FAMILY; BAX; ACTIVATION; SEQUESTERS	Unlike other antiapoptotic members of the Bcl-2 family, Bfl-1 does not contain a well defined C-terminal transmembrane domain, and whether the C-terminal tail of Bfl-1 functions as a membrane anchor is not yet clearly established. The molecular modeling study of the full-length Bfl-1 performed within this work suggests that Bfl-1 may co-exist in two distinct conformational states: one in which its C-terminal helix alpha 9 is inserted in the hydrophobic groove formed by the BH1-3 domains of Bfl-1 and one with its C terminus. Parallel analysis of the subcellular localization of Bfl-1 indicates that even if Bfl-1 may co-exist in two distinct conformational states, most of the endogenous protein is tightly associated with the mitochondria by its C terminus in both healthy and apoptotic peripheral blood lymphocytes as well as in malignant B cell lines. However, the helix alpha 9 of Bfl-1, and therefore the binding of Bfl-1 to mitochondria, is not absolutely required for the antiapoptotic activity of Bfl-1. A particular feature of Bfl-1 is the amphipathic character of its C-terminal helix alpha 9. Our data clearly indicate that this property of helix alpha 9 is required for the anchorage of Bfl-1 to the mitochondria but also regulates the antiapoptotic function Bfl-1.	[Brien, Gaelle; Debaud, Anne-Laure; Trescol-Biemont, Marie-Claude; Bonnefoy-Berard, Nathalie] INSERM, U851, F-69007 Lyon, France; [Brien, Gaelle; Debaud, Anne-Laure; Trescol-Biemont, Marie-Claude; Bonnefoy-Berard, Nathalie] Univ Lyon 1, IFR128, F-69003 Lyon, France; [Robert, Xavier; Aghajari, Nushin; Haser, Richard] Univ Lyon, Inst Biol & Chim Prot, IFR128 Biosci Lyon Gerland, Lab BioCristallog,CNRS UMR5086, F-69367 Lyon 07, France; [Oliver, Lisa; Vallette, Francois M.] Univ Nantes, Dept Rech Cancerol, F-44093 Nantes, France; [Oliver, Lisa; Vallette, Francois M.] INSERM, U601, F-44035 Nantes, France; [Cauquil, Nicolas; Geneste, Olivier] Inst Rech Servier, F-78290 Croissy Sur Seine, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Nantes Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Servier; Institut de Recherches Internationales Servier	Bonnefoy-Berard, N (corresponding author), INSERM, U851, 21 Tony Garnier, F-69007 Lyon, France.	nathalie.bonnefoy-berard@inserm.fr	Vallette, Francois M/K-9047-2015; Oliver, Lisa J/L-3070-2015; Aghajari, Nushin B.H./P-1906-2016; Bonnefoy, Nathalie/J-2536-2012; ROBERT, Xavier/C-3879-2015; Vallette, Francois/N-2361-2018	Vallette, Francois M/0000-0002-3296-8572; Oliver, Lisa J/0000-0002-5588-7564; Aghajari, Nushin B.H./0000-0002-2245-2679; Bonnefoy, Nathalie/0000-0003-4814-6722; ROBERT, Xavier/0000-0002-6174-8595; Mathieu, Anne-Laure/0000-0002-2893-7001	INSERM; Universite Claude Bernard Lyon I; Institut National du Cancer; Association pour la Recherche sur le Cancer and the Ligue contre le Cancer; Arthritis Foundation Courtin	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Claude Bernard Lyon I; Institut National du Cancer(Institut National du Cancer (INCA) France); Association pour la Recherche sur le Cancer and the Ligue contre le Cancer; Arthritis Foundation Courtin	This work was supported by institutional grants from INSERM and Universite Claude Bernard Lyon I. This work was also supported by the Institut National du Cancer, the Association pour la Recherche sur le Cancer and the Ligue contre le Cancer (Comite de Savoie, du Rhone et de la Drome), and the Arthritis Foundation Courtin.	AKAO Y, 1994, CANCER RES, V54, P2468; Brien G, 2007, ONCOGENE, V26, P5828, DOI 10.1038/sj.onc.1210363; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; D'Sa-Eipper C, 1998, ONCOGENE, V16, P3105, DOI 10.1038/sj.onc.1201851; Denisov AY, 2003, J BIOL CHEM, V278, P21124, DOI 10.1074/jbc.M301798200; DSaEipper C, 1996, CANCER RES, V56, P3879; Duriez PJ, 2000, J BIOL CHEM, V275, P18099, DOI 10.1074/jbc.M908925199; Er E, 2007, J BIOL CHEM, V282, P24938, DOI 10.1074/jbc.M703823200; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Herold MJ, 2006, J BIOL CHEM, V281, P13663, DOI 10.1074/jbc.M600266200; Hinds MG, 2003, EMBO J, V22, P1497, DOI 10.1093/emboj/cdg144; Jeong SY, 2004, EMBO J, V23, P2146, DOI 10.1038/sj.emboj.7600225; Kaufmann T, 2003, J CELL BIOL, V160, P53, DOI 10.1083/jcb.200210084; Ko JK, 2007, J CELL SCI, V120, P2912, DOI 10.1242/jcs.006197; Ko JK, 2003, FEBS LETT, V551, P29, DOI 10.1016/S0014-5793(03)00872-X; Kucharczak JF, 2005, CELL DEATH DIFFER, V12, P1225, DOI 10.1038/sj.cdd.4401684; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; LITHGOW T, 1994, CELL GROWTH DIFFER, V5, P411; Liu XQ, 2003, IMMUNITY, V19, P341, DOI 10.1016/S1074-7613(03)00234-6; NGUYEN M, 1993, J BIOL CHEM, V268, P25265; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Penin F, 2004, J BIOL CHEM, V279, P40835, DOI 10.1074/jbc.M404761200; ROUSSEL A, 1993, TRUBO FRODO BIOGRAPH; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Werner AB, 2002, J BIOL CHEM, V277, P22781, DOI 10.1074/jbc.M201469200; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; Wilson-Annan J, 2003, J CELL BIOL, V162, P877, DOI 10.1083/jcb.200302144; Yang WS, 2005, J CELL BIOCHEM, V94, P1234, DOI 10.1002/jcb.20381	30	21	22	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30257	30263		10.1074/jbc.M109.040824	http://dx.doi.org/10.1074/jbc.M109.040824			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19759007	hybrid, Green Published			2022-12-27	WOS:000271090000029
J	Polge, C; Jaquinod, M; Holzer, F; Bourguignon, J; Walling, L; Brouquisse, R				Polge, Cecile; Jaquinod, Michel; Holzer, Frances; Bourguignon, Jacques; Walling, Linda; Brouquisse, Renaud			Evidence for the Existence in Arabidopsis thaliana of the Proteasome Proteolytic Pathway ACTIVATION IN RESPONSE TO CADMIUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-CONJUGATING ENZYMES; LENS EPITHELIAL-CELLS; LEUCINE AMINOPEPTIDASE; OXIDATIVE STRESS; 20S PROTEASOME; 26S PROTEASOME; OXIDIZED PROTEINS; PEA-PLANTS; IMMUNOLOGICAL CHARACTERIZATION; DEPENDENT PROTEOLYSIS	Heavy metals are known to generate reactive oxygen species that lead to the oxidation and fragmentation of proteins, which become toxic when accumulated in the cell. In this study, we investigated the role of the proteasome during cadmium stress in the leaves of Arabidopsis thaliana plants. Using biochemical and proteomics approaches, we present the first evidence of an active proteasome pathway in plants. We identified and characterized the peptidases acting sequentially downstream from the proteasome in animal cells as follows: tripeptidyl-peptidase II, thimet oligopeptidase, and leucine aminopeptidase. We investigated the proteasome proteolytic pathway response in the leaves of 6-week-old A. thaliana plants grown hydroponically for 24, 48, and 144 h in the presence or absence of 50 mu M cadmium. The gene expression and proteolytic activity of the proteasome and the different proteases of the pathway were found to be up-regulated in response to cadmium. In an in vitro assay, oxidized bovine serum albumin and lysozyme were more readily degraded in the presence of 20 S proteasome and tripeptidyl-peptidase II than their nonoxidized form, suggesting that oxidized proteins are preferentially degraded by the Arabidopsis 20 S proteasome pathway. These results show that, in response to cadmium, the 20 S proteasome proteolytic pathway is up-regulated at both RNA and activity levels in Arabidopsis leaves and may play a role in degrading oxidized proteins generated by the stress.	[Polge, Cecile; Bourguignon, Jacques; Brouquisse, Renaud] Univ Grenoble 1, INRA, CNRS,CEA,UMR5168, Lab Physiol Cellulaire Vegetale,CEA,IRTSV, F-38054 Grenoble, France; [Jaquinod, Michel] Etud Dynam Proteomes, F-38054 Grenoble, France; [Holzer, Frances; Walling, Linda] Univ Calif Riverside, Ctr Plant Cell Biol, Dept Bot & Plant Sci, Riverside, CA 92521 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; University of California System; University of California Riverside	Brouquisse, R (corresponding author), Ctr INRA Sophia Antipolis, UMR, BP 167, F-06903 Sophia Antipolis, France.	renaud.brouquisse@sophia.inra.fr	Polge, Cécile/AAM-2467-2020; Schlattner, Uwe/D-1267-2009	Polge, Cécile/0000-0002-8730-5776; Schlattner, Uwe/0000-0003-1159-5911; Bourguignon, jacques/0000-0001-7517-0600	French "Program Inter-organismes CEA CNRS INRA INSERM de Toxicologie Nucleaire Environnementale"	French "Program Inter-organismes CEA CNRS INRA INSERM de Toxicologie Nucleaire Environnementale"	This work was supported by the French "Program Inter-organismes CEA CNRS INRA INSERM de Toxicologie Nucleaire Environnementale."	Asher G, 2006, BIOESSAYS, V28, P844, DOI 10.1002/bies.20447; Balestrasse KB, 2003, FUNCT PLANT BIOL, V30, P57, DOI 10.1071/FP02074; BARRETT AJ, 1995, METHOD ENZYMOL, V248, P529; BARTLING D, 1992, EUR J BIOCHEM, V205, P425, DOI 10.1111/j.1432-1033.1992.tb16796.x; BARTLING D, 1994, PLANT SCI, V99, P199, DOI 10.1016/0168-9452(94)90177-5; Basset G, 2002, PLANT PHYSIOL, V128, P1149, DOI 10.1104/pp.010612; Bestel-Corre G, 2002, ELECTROPHORESIS, V23, P122, DOI 10.1002/1522-2683(200201)23:1&lt;122::AID-ELPS122&gt;3.0.CO;2-4; Bolumar T, 2003, APPL ENVIRON MICROB, V69, P227, DOI 10.1128/AEM.69.1.227-232.2003; Book AJ, 2005, PLANT PHYSIOL, V138, P1046, DOI 10.1104/pp.104.057406; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brouquisse R, 1998, PLANT PHYSIOL, V117, P1281, DOI 10.1104/pp.117.4.1281; CARPENTER FH, 1973, J BIOL CHEM, V248, P294; Chao WS, 2000, PLANTA, V210, P563, DOI 10.1007/s004250050045; CHENG L, 1994, MOL GEN GENET, V243, P358, DOI 10.1007/BF00301072; Chondrogianni N, 2005, J BIOL CHEM, V280, P11840, DOI 10.1074/jbc.M413007200; Chondrogianni N, 2003, J BIOL CHEM, V278, P28026, DOI 10.1074/jbc.M301048200; DAVIES KJA, 1987, J BIOL CHEM, V262, P9908; Davies KJA, 2001, BIOCHIMIE, V83, P301, DOI 10.1016/S0300-9084(01)01250-0; Djebali W, 2008, PLANTA, V227, P625, DOI 10.1007/s00425-007-0644-6; Fowler JH, 2009, PLANT CELL, V21, P1239, DOI 10.1105/tpc.108.065029; Fu HY, 1999, PLANT J, V18, P529, DOI 10.1046/j.1365-313X.1999.00479.x; Fu HY, 1998, GENETICS, V149, P677; Grune T, 1997, FASEB J, V11, P526, DOI 10.1096/fasebj.11.7.9212076; Gu YQ, 1999, EUR J BIOCHEM, V263, P726, DOI 10.1046/j.1432-1327.1999.00548.x; Gu YQ, 1996, PLANT PHYSIOL, V110, P1257, DOI 10.1104/pp.110.4.1257; HURKMAN WJ, 1986, PLANT PHYSIOL, V81, P802, DOI 10.1104/pp.81.3.802; JahngenHodge J, 1997, J BIOL CHEM, V272, P28218, DOI 10.1074/jbc.272.45.28218; JUNGMANN J, 1993, NATURE, V361, P369, DOI 10.1038/361369a0; Kloetzel PM, 2004, CURR OPIN IMMUNOL, V16, P76, DOI 10.1016/j.coi.2003.11.004; Kurepa J, 2008, PLANT J, V53, P102, DOI 10.1111/j.1365-313X.2007.03322.x; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Liu J, 2008, FREE RADICAL BIO MED, V45, P475, DOI 10.1016/j.freeradbiomed.2008.04.041; Liu YZ, 2007, MOL VIS, V13, P31; Matsui M, 2006, BIOL CHEM, V387, P1535, DOI 10.1515/BC.2006.191; McCarthy I, 2001, PLANT CELL ENVIRON, V24, P1065, DOI 10.1046/j.1365-3040.2001.00750.x; Murphy AS, 2002, PLANT PHYSIOL, V128, P935, DOI 10.1104/pp.010519; Obin M, 1998, FASEB J, V12, P561, DOI 10.1096/fasebj.12.7.561; PACIFICI RE, 1993, J BIOL CHEM, V268, P15405; Pena LB, 2007, PHYTOCHEMISTRY, V68, P1139, DOI 10.1016/j.phytochem.2007.02.022; Pena LB, 2006, PLANT SCI, V171, P531, DOI 10.1016/j.plantsci.2006.06.003; Reinheckel T, 1998, BIOCHEM J, V335, P637, DOI 10.1042/bj3350637; Reits E, 2004, IMMUNITY, V20, P495, DOI 10.1016/S1074-7613(04)00074-3; REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357; Rock KL, 2004, NAT IMMUNOL, V5, P670, DOI 10.1038/ni1089; Romero A., 2008, ELECT J ENV AGR FOOD, V7, P3363; Romero-Puertas MC, 2002, PLANT CELL ENVIRON, V25, P677, DOI 10.1046/j.1365-3040.2002.00850.x; Sanchez-Moran E, 2004, PLANT CELL, V16, P2895, DOI 10.1105/tpc.104.024992; Sandalio LM, 2001, J EXP BOT, V52, P2115, DOI 10.1093/jexbot/52.364.2115; Sanita di Toppi L, 1999, ENVIRON EXP BOT, V41, P105, DOI 10.1016/S0098-8472(98)00058-6; Saric T, 2004, J BIOL CHEM, V279, P46723, DOI 10.1074/jbc.M406537200; Sarry JE, 2006, PROTEOMICS, V6, P2180, DOI 10.1002/pmic.200500543; Saveanu L, 2002, MOL IMMUNOL, V39, P203, DOI 10.1016/S0161-5890(02)00102-5; SHANG F, 1995, BIOCHEM J, V307, P297, DOI 10.1042/bj3070297; Shringarpure R, 2001, CELL MOL LIFE SCI, V58, P1442, DOI 10.1007/PL00000787; Shringarpure R, 2003, J BIOL CHEM, V278, P311, DOI 10.1074/jbc.M206279200; SKODA B, 1992, PLANT PHYSIOL, V99, P1515, DOI 10.1104/pp.99.4.1515; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; STADTMAN ER, 1993, ANNU REV BIOCHEM, V62, P797, DOI 10.1146/annurev.bi.62.070193.004053; TISLJAR U, 1990, BIOCHEM J, V267, P531, DOI 10.1042/bj2670531; Tomkinson B, 1999, TRENDS BIOCHEM SCI, V24, P355, DOI 10.1016/S0968-0004(99)01435-8; Vierstra RD, 1996, PLANT MOL BIOL, V32, P275, DOI 10.1007/BF00039386; WAGNER GJ, 1993, ADV AGRON, V51, P173, DOI 10.1016/S0065-2113(08)60593-3; Walling LL, 2006, CURR OPIN PLANT BIOL, V9, P227, DOI 10.1016/j.pbi.2006.03.009; WALLING LL, 1996, AMINOPEPTIDASES, P174; WANG CS, 1992, PLANT PHYSIOL, V99, P822, DOI 10.1104/pp.99.3.822; Xu GZ, 1999, CHEM RES TOXICOL, V12, P855, DOI 10.1021/tx990056a; Yang PZ, 2004, J BIOL CHEM, V279, P6401, DOI 10.1074/jbc.M311977200	67	83	84	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35412	35424		10.1074/jbc.M109.035394	http://dx.doi.org/10.1074/jbc.M109.035394			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19822524	Green Published, hybrid			2022-12-27	WOS:000272645600017
J	Lu, L; Wang, SY; Zheng, L; Li, XL; Suswam, EA; Zhang, XW; Wheeler, CG; Nabors, LB; Filippova, N; King, PH				Lu, Liang; Wang, Shuying; Zheng, Lei; Li, Xuelin; Suswam, Esther A.; Zhang, Xiaowen; Wheeler, Crystal G.; Nabors, L. B.; Filippova, Natalia; King, Peter H.			Amyotrophic Lateral Sclerosis-linked Mutant SOD1 Sequesters Hu Antigen R (HuR) and TIA-1-related Protein (TIAR) IMPLICATIONS FOR IMPAIRED POST-TRANSCRIPTIONAL REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA STABILITY; 3' UNTRANSLATED REGION; AU-RICH ELEMENTS; GROWTH-FACTOR; OXIDATIVE STRESS; BINDING PROTEINS; STABILIZATION; APOPTOSIS; BCL-2; GENE	Down-regulation of vascular endothelial growth factor (VEGF) in the mouse leads to progressive and selective degeneration of motor neurons similar to amyotrophic lateral sclerosis (ALS). In mice expressing ALS-associated mutant superoxide dismutase 1 (SOD1), VEGF mRNA expression in the spinal cord declines significantly prior to the onset of clinical manifestations. In vitro models suggest that dysregulation of VEGF mRNA stability contributes to that decline. Here, we show that the major RNA stabilizer, Hu Antigen R (HuR), and TIA-1-related protein (TIAR) colocalize with mutant SOD1 in mouse spinal cord extracts and cultured glioma cells. The colocalization was markedly reduced or abolished by RNase treatment. Immunoanalysis of transfected cells indicated that colocalization occurred in insoluble aggregates and inclusions. RNA immunoprecipitation showed a significant loss of VEGF mRNA binding to HuR and TIAR in mutant SOD1 cells, and there was marked depletion of HuR from polysomes. Ectopic expression of HuR in mutant SOD1 cells more than doubled the mRNA half-life of VEGF and significantly increased expression to that of wild-type SOD1 control. Cellular effects produced by mutant SOD1, including impaired mitochondrial function and oxidative stress-induced apoptosis, were reversed by HuR in a gene dose-dependent pattern. In summary, our findings indicate that mutant SOD1 impairs post-transcriptional regulation by sequestering key regulatory RNA-binding proteins. The rescue effect of HuR suggests that this impairment, whether related to VEGF or other potential mRNA targets, contributes to cytotoxicity in ALS.	[Lu, Liang; Wang, Shuying; Zheng, Lei; Li, Xuelin; Suswam, Esther A.; Zhang, Xiaowen; Nabors, L. B.; Filippova, Natalia; King, Peter H.] Univ Alabama, Dept Neurol, Birmingham, AL 35294 USA; [King, Peter H.] Univ Alabama, Dept Genet, Birmingham, AL 35294 USA; [Wheeler, Crystal G.] Univ Alabama, Dept Neurobiol, Birmingham, AL 35294 USA; [King, Peter H.] Univ Alabama, Dept Physiol & Biophys, Birmingham, AL 35294 USA; [Lu, Liang; Zheng, Lei; Li, Xuelin; King, Peter H.] Birmingham Vet Affairs Med Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham	King, PH (corresponding author), Sparks Ctr, Suite 260,1720-7th Ave S, Birmingham, AL 35233 USA.	pking@uab.edu	wang, shuying/HHZ-4516-2022; Nabors, Louis/ABB-8223-2021	Nabors, Louis/0000-0001-5926-2230; King, Peter/0000-0001-9391-7464; Filippova, Natalia/0000-0003-2128-5511	National Institutes of Health [NS058538, NS064133, NS057664]; NINDS [R01 CA112397]; NCI; Dept. of Veterans Affairs; NATIONAL CANCER INSTITUTE [R01CA112397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS058538, R01NS064133, K08NS057664] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003035] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Dept. of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants NS058538, NS064133 (to P. H. K.), NS057664 (to L. L.) from the NINDS, R01 CA112397 (to L. B. N.) from the NCI, and a Merit Review award from the Dept. of Veterans Affairs (to P. H. K.).	Abdelmohsen K, 2008, BIOL CHEM, V389, P243, DOI 10.1515/BC.2008.022; Bakheet T, 2001, NUCLEIC ACIDS RES, V29, P246, DOI 10.1093/nar/29.1.246; Bakheet T, 2006, NUCLEIC ACIDS RES, V34, pD111, DOI 10.1093/nar/gkj052; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Cherradi N, 2006, MOL ENDOCRINOL, V20, P916, DOI 10.1210/me.2005-0121; CROUCH SPM, 1993, J IMMUNOL METHODS, V160, P81, DOI 10.1016/0022-1759(93)90011-U; Doller A, 2008, CELL SIGNAL, V20, P2165, DOI 10.1016/j.cellsig.2008.05.007; Forch P, 2001, APOPTOSIS, V6, P463, DOI 10.1023/A:1012441824719; Galban S, 2008, MOL CELL BIOL, V28, P93, DOI 10.1128/MCB.00973-07; Gallouzi IE, 2000, P NATL ACAD SCI USA, V97, P3073, DOI 10.1073/pnas.97.7.3073; Hong X, 2007, J EXP THER ONCOL, V6, P219; Kawai T, 2004, MOL CELL BIOL, V24, P6773, DOI 10.1128/MCB.24.15.6773-6787.2004; Keene JD, 2001, P NATL ACAD SCI USA, V98, P7018, DOI 10.1073/pnas.111145598; Keil U, 2006, BRIT J PHARMACOL, V147, P199, DOI 10.1038/sj.bjp.0706459; Kim HH, 2008, CELL CYCLE, V7, P3124, DOI 10.4161/cc.7.20.6884; King P H, 2000, Nucleic Acids Res, V28, pE20, DOI 10.1093/nar/28.7.e20; Lal A, 2005, EMBO J, V24, P1852, DOI 10.1038/sj.emboj.7600661; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Lapucci A, 2002, J BIOL CHEM, V277, P16139, DOI 10.1074/jbc.M201377200; LEVY AP, 1995, J BIOL CHEM, V270, P13333, DOI 10.1074/jbc.270.22.13333; Levy NS, 1998, J BIOL CHEM, V273, P6417, DOI 10.1074/jbc.273.11.6417; Li XL, 2009, J NEUROCHEM, V108, P1032, DOI 10.1111/j.1471-4159.2008.05856.x; Lopez de Silanes I., 2005, RNA BIOL, V2, P11, DOI DOI 10.4161/RNA.2.1.1552; Lu L, 2007, J NEUROSCI, V27, P7929, DOI 10.1523/JNEUROSCI.1877-07.2007; Mita AC, 2008, CLIN CANCER RES, V14, P5000, DOI 10.1158/1078-0432.CCR-08-0746; Nabors LLB, 2003, CANCER RES, V63, P4181; Okado-Matsumoto A, 2002, P NATL ACAD SCI USA, V99, P9010, DOI 10.1073/pnas.132260399; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; Pasinelli P, 2004, NEURON, V43, P19, DOI 10.1016/j.neuron.2004.06.021; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Pullmann R, 2007, MOL CELL BIOL, V27, P6265, DOI 10.1128/MCB.00500-07; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; Schiavone N, 2000, FASEB J, V14, P174, DOI 10.1096/fasebj.14.1.174; Shinder GA, 2001, J BIOL CHEM, V276, P12791, DOI 10.1074/jbc.M010759200; Slater K, 2001, CURR OPIN BIOTECH, V12, P70, DOI 10.1016/S0958-1669(00)00177-4; Suswam EA, 2005, NUCLEIC ACIDS RES, V33, P4507, DOI 10.1093/nar/gki763; Suswam EA, 2005, INT J CANCER, V113, P911, DOI 10.1002/ijc.20675; Vukosavic S, 1999, J NEUROCHEM, V73, P2460, DOI 10.1046/j.1471-4159.1999.0732460.x; Yun H, 2005, J BIOL CHEM, V280, P9963, DOI 10.1074/jbc.M412994200	44	50	51	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33989	33998		10.1074/jbc.M109.067918	http://dx.doi.org/10.1074/jbc.M109.067918			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19805546	Green Published, hybrid			2022-12-27	WOS:000272165200031
J	Taurin, S; Sandbo, N; Yau, DM; Sethakorn, N; Kach, J; Dulin, NO				Taurin, Sebastien; Sandbo, Nathan; Yau, Douglas M.; Sethakorn, Nan; Kach, Jacob; Dulin, Nickolai O.			Phosphorylation of Myocardin by Extracellular Signal-regulated Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; MUSCLE GENE-EXPRESSION; TRANSCRIPTION FACTORS; DEPENDENT TRANSCRIPTION; PHENOTYPIC MODULATION; CELL DIFFERENTIATION; NUCLEAR-LOCALIZATION; PROTEIN-KINASE; MARKER GENES; SMOOTH	The contractile phenotype of smooth muscle (SM) cells is controlled by serum response factor (SRF), which drives the expression of SM-specific genes including SM alpha-actin, SM22, and others. Myocardin is a cardiac and SM-restricted coactivator of SRF that is necessary for SM gene transcription. Growth factors inducing proliferation of SM cells inhibit SM gene transcription, in a manner dependent on the activation of extracellular signal-regulated kinases ERK1/2. In this study, we found that ERK1/2 phosphorylates mouse myocardin (isoform B) at four sites (Ser(812), Ser(859), Ser(866), and Thr(893)), all of which are located within the transactivation domain of myocardin. The single mutation of each site either to alanine or to aspartate has no effect on the ability of myocardin to activate SRF. However, the phosphomimetic mutation of all four sites to aspartate (4XD) significantly impairs activation of SRF by myocardin, whereas the phosphodeficient mutation of all four sites to alanine (4XA) has no effect. This translates to a reduced ability of the 4XD (but not of 4XA) mutant of myocardin to stimulate expression of SM alpha-actin and SM22, as assessed by corresponding promoter, mRNA, or protein assays. Furthermore, we found that phosphorylation of myocardin at these sites impairs its interaction with acetyltransferase, cAMP response element-binding protein-binding protein, which is known to promote the transcriptional activity of myocardin. In conclusion, we describe a novel mode of modulation of SM gene transcription by ERK1/2 through a direct phosphorylation of myocardin.	[Taurin, Sebastien; Sandbo, Nathan; Yau, Douglas M.; Sethakorn, Nan; Kach, Jacob; Dulin, Nickolai O.] Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Chicago	Dulin, NO (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave,MC 6076, Chicago, IL 60637 USA.	ndulin@medicine.bsd.uchicago.edu	Sethakorn, Nan/AAH-7721-2020	Sethakorn, Nan/0000-0002-7395-3182; Taurin, Sebastien/0000-0003-2167-5253	National Institutes of Health [R01 HL071755, GM085058, T32 HL07605, T32 HD07009, T32 HL07237]; American Heart Association Postdoctoral Fellowship Awards [0720151Z, 0520109Z, 0825868G]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007009] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071755, T32HL007605, K08HL093367, T32HL007237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085058] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Postdoctoral Fellowship Awards(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL071755 ( to N.O.D.), GM085058 ( to N.O.D.), T32 HL07605 ( to D.M.Y.), T32 HD07009 ( to N.S.), and T32 HL07237 ( to J.K.) and by American Heart Association Postdoctoral Fellowship Awards 0720151Z ( to S. T.), 0520109Z ( to N.S.), and 0825868G ( to D.M.Y.).	Badorff C, 2005, CIRC RES, V97, P645, DOI 10.1161/01.RES.0000184684.88750.FE; Cao DS, 2005, MOL CELL BIOL, V25, P364, DOI 10.1128/MCB.25.1.364-376.2005; Chen JY, 2002, J MOL CELL CARDIOL, V34, P1345, DOI 10.1006/jmcc.2002.2086; Creemers EE, 2006, MOL CELL, V23, P83, DOI 10.1016/j.molcel.2006.05.026; Davis A, 2003, CELL SIGNAL, V15, P597, DOI 10.1016/S0898-6568(02)00148-1; Du KL, 2003, MOL CELL BIOL, V23, P2425, DOI 10.1128/MCB.23.7.2425-2437.2003; Dulin NO, 1999, MOL CELL BIOL, V19, P714; Hinson JS, 2007, AM J PHYSIOL-HEART C, V292, pH1170, DOI 10.1152/ajpheart.00864.2006; Hogarth DK, 2004, AM J PHYSIOL-CELL PH, V287, pC449, DOI 10.1152/ajpcell.00547.2003; Li SJ, 2003, P NATL ACAD SCI USA, V100, P9366, DOI 10.1073/pnas.1233635100; Liu ZP, 2005, DEV CELL, V9, P261, DOI 10.1016/j.devcel.2005.05.017; Lockman K, 2004, J BIOL CHEM, V279, P42422, DOI 10.1074/jbc.M405432200; Long XC, 2007, P NATL ACAD SCI USA, V104, P16570, DOI 10.1073/pnas.0708253104; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Muehlich S, 2008, MOL CELL BIOL, V28, P6302, DOI 10.1128/MCB.00427-08; Niu JX, 2002, BIOCHEM J, V365, P677, DOI 10.1042/BJ20020390; Oh J, 2004, MOL CELL BIOL, V24, P8519, DOI 10.1128/MCB.24.19.8519-8528.2004; Parmacek MS, 2007, CIRC RES, V100, P633, DOI 10.1161/01.RES.0000259563.61091.e8; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Sasazuki T, 2002, J BIOL CHEM, V277, P28853, DOI 10.1074/jbc.M203190200; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Yoshida T, 2003, CIRC RES, V92, P856, DOI 10.1161/01.RES.0000068405.49081.09; Yoshida T, 2007, AM J PHYSIOL-CELL PH, V292, pC886, DOI 10.1152/ajpcell.00449.2006	26	25	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33789	33794		10.1074/jbc.M109.048983	http://dx.doi.org/10.1074/jbc.M109.048983			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19776005	hybrid, Green Published			2022-12-27	WOS:000272165200009
J	Cuneo, MJ; Beese, LS; Hellinga, HW				Cuneo, Matthew J.; Beese, Lorena S.; Hellinga, Homme W.			Structural Analysis of Semi-specific Oligosaccharide Recognition by a Cellulose-binding Protein of Thermotoga maritima Reveals Adaptations for Functional Diversification of the Oligopeptide Periplasmic Binding Protein Fold	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; PEPTIDE BINDING; LIGAND-BINDING; TRANSPORT; SEQUENCE; BACTERIA; RECEPTOR; GENE; DISACCHARIDE; DEGRADATION	Periplasmic binding proteins (PBPs) constitute a protein superfamily that binds a wide variety of ligands. In prokaryotes, PBPs function as receptors for ATP-binding cassette or tripartite ATP-independent transporters and chemotaxis systems. In many instances, PBPs bind their cognate ligands with exquisite specificity, distinguishing, for example, between sugar epimers or structurally similar anions. By contrast, oligopeptide-binding proteins bind their ligands through interactions with the peptide backbone but do not distinguish between different side chains. The extremophile Thermotoga maritima possesses a remarkable array of carbohydrate-processing metabolic systems, including the hydrolysis of cellulosic polymers. Here, we present the crystal structure of a T. maritima cellobiose-binding protein (tm0031) that is homologous to oligopeptide-binding proteins. T. maritima cellobiose-binding protein binds a variety of lengths of beta(1 -> 4)-linked glucose oligomers, ranging from two rings (cellobiose) to five (cellopentaose). The structure reveals that binding is semi-specific. The disaccharide at the nonreducing end binds specifically; the other rings are located in a large solvent-filled groove, where the reducing end makes several contacts with the protein, thereby imposing an upper limit of the oligosaccharides that are recognized. Semi-specific recognition, in which a molecular class rather than individual species is selected, provides an efficient solution for the uptake of complex mixtures.	[Cuneo, Matthew J.; Beese, Lorena S.; Hellinga, Homme W.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University	Hellinga, HW (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Nanaline Duke Bldg, Durham, NC 27710 USA.	hwh@biochem.duke.edu	beese, lorena/G-4993-2010	Cuneo, Matthew/0000-0002-1475-6656	National Institutes of Health Pioneer Award [5 DP1 OD000122-02]; Homeland Security Advanced Research Projects Agency [W81XWH-05-C-0161]; United States Department of Energy; Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000122] Funding Source: NIH RePORTER	National Institutes of Health Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Homeland Security Advanced Research Projects Agency; United States Department of Energy(United States Department of Energy (DOE)); Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Pioneer Award 5 DP1 OD000122-02 and Homeland Security Advanced Research Projects Agency Grant W81XWH-05-C-0161 (to H.W.H.). Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract W-31-109-Eng-38.	AKSAMIT RR, 1974, BIOCHEMISTRY-US, V13, P4473, DOI 10.1021/bi00719a001; Alderkamp AC, 2007, FEMS MICROBIOL ECOL, V59, P108, DOI 10.1111/j.1574-6941.2006.00219.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bjorkman AJ, 1998, J MOL BIOL, V279, P651, DOI 10.1006/jmbi.1998.1785; Blow N, 2008, NAT METHODS, V5, P203, DOI 10.1038/nmeth0208-203; Boos W, 1998, MICROBIOL MOL BIOL R, V62, P204, DOI 10.1128/MMBR.62.1.204-229.1998; Bruns CM, 1997, NAT STRUCT BIOL, V4, P919, DOI 10.1038/nsb1197-919; BULIGA GS, 1986, CARBOHYD RES, V157, P139, DOI 10.1016/0008-6215(86)85065-0; Chhabra SR, 2003, J BIOL CHEM, V278, P7540, DOI 10.1074/jbc.M211748200; COHEN DS, 1994, PROTEIN SCI, V3, P1253, DOI 10.1002/pro.5560030811; Conners SB, 2005, J BACTERIOL, V187, P7267, DOI 10.1128/JB.187.21.7267-7282.2005; Conners SB, 2006, FEMS MICROBIOL REV, V30, P872, DOI 10.1111/j.1574-6976.2006.00039.x; Cuneo MJ, 2006, J MOL BIOL, V362, P259, DOI 10.1016/j.jmb.2006.06.084; Cuneo MJ, 2009, J MOL BIOL, V389, P157, DOI 10.1016/j.jmb.2009.04.008; Cuneo MJ, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-50; Duan XQ, 2002, BIOCHEMISTRY-US, V41, P706, DOI 10.1021/bi015784n; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fukami-Kobayashi K, 1999, J MOL BIOL, V286, P279, DOI 10.1006/jmbi.1998.2454; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hsiao CD, 1996, J MOL BIOL, V262, P225, DOI 10.1006/jmbi.1996.0509; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Karpowich NK, 2003, J BIOL CHEM, V278, P8429, DOI 10.1074/jbc.M212239200; Kelly DJ, 2001, FEMS MICROBIOL REV, V25, P405, DOI 10.1111/j.1574-6976.2001.tb00584.x; Kondoh O, 1997, J BACTERIOL, V179, P7734, DOI 10.1128/jb.179.24.7734-7741.1997; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Levdikov VM, 2005, J MOL BIOL, V345, P879, DOI 10.1016/j.jmb.2004.10.089; Marvin JS, 2001, NAT STRUCT BIOL, V8, P795, DOI 10.1038/nsb0901-795; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nanavati DA, 2006, APPL ENVIRON MICROB, V72, P1336, DOI 10.1128/AEM.72.2.1336-1345.2006; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; Quiocho FA, 1997, STRUCTURE, V5, P997, DOI 10.1016/S0969-2126(97)00253-0; SCHELLMAN JA, 1987, ANNU REV BIOPHYS BIO, V16, P115, DOI 10.1146/annurev.bb.16.060187.000555; SHARFF AJ, 1992, BIOCHEMISTRY-US, V31, P10657, DOI 10.1021/bi00159a003; Shouldice SR, 2003, J BIOL CHEM, V278, P41093, DOI 10.1074/jbc.M306821200; Sleigh SH, 1999, J MOL BIOL, V291, P393, DOI 10.1006/jmbi.1999.2929; Sugiyama S, 1996, J BIOL CHEM, V271, P9519, DOI 10.1074/jbc.271.16.9519; Tame JRH, 1995, STRUCTURE, V3, P1395, DOI 10.1016/S0969-2126(01)00276-3; Tame JRH, 1996, NAT STRUCT BIOL, V3, P998, DOI 10.1038/nsb1296-998; TAME JRH, 1994, SCIENCE, V264, P1578, DOI 10.1126/science.8202710; VanFossen AL, 2008, ANN NY ACAD SCI, V1125, P322, DOI 10.1196/annals.1419.017	42	20	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33217	33223		10.1074/jbc.M109.041624	http://dx.doi.org/10.1074/jbc.M109.041624			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801540	Green Published, hybrid			2022-12-27	WOS:000272028500026
J	Koike, S; Keino-Masu, K; Ohto, T; Sugiyama, F; Takahashi, S; Masu, M				Koike, Seiichi; Keino-Masu, Kazuko; Ohto, Tatsuyuki; Sugiyama, Fumihiro; Takahashi, Satoru; Masu, Masayuki			Autotaxin/Lysophospholipase D-mediated Lysophosphatidic Acid Signaling Is Required to Form Distinctive Large Lysosomes in the Visceral Endoderm Cells of the Mouse Yolk Sac	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO-ASSOCIATED KINASE; LIM-KINASE; LYSOPHOSPHOLIPASE-D; ACTIN; AUTOTAXIN; FUSION; PHOSPHORYLATION; TRAFFICKING; RECEPTORS; YEAST	Autotaxin, a lysophospholipase D encoded by the Enpp2 gene, is an exoenzyme that produces lysophosphatidic acid in the extracellular space. Lysophosphatidic acid acts on specific G protein-coupled receptors, thereby regulating cell growth, migration, and survival. Previous studies have revealed that Enpp2(-/-) mouse embryos die at about embryonic day (E) 9.5 because of angiogenic defects in the yolk sac. However, what cellular defects occur in Enpp2(-/-) embryos and what intracellular signaling pathways are involved in the phenotype manifestation remain unknown. Here, we show that Enpp2 is required to form distinctive large lysosomes in the yolk sac visceral endoderm cells. From E7.5 to E9.5, Enpp2 mRNA is abundantly expressed in the visceral endoderm cells. In Enpp2(-/-) mouse embryos, lysosomes in the visceral endoderm cells are fragmented. By using a whole embryo culture system combined with specific pharmacological inhibitors for intracellular signaling molecules, we show that lysophosphatidic acid receptors and the Rho-Rho-associated coiled-coil containing protein kinase (ROCK)-LIM kinase pathway are required to form large lysosomes. In addition, electroporation of dominant negative forms of Rho, ROCK, or LIM kinase also leads to the size reduction of lysosomes in wild-type visceral endoderm cells. In Enpp2(-/-) visceral endoderm cells, the steady-state levels of cofilin phosphorylation and actin polymerization are reduced. In addition, perturbations of actin turnover dynamics by actin inhibitors cytochalasin B and jasplakinolide result in the defect in lysosome formation. These results suggest that constitutive activation of the Rho-ROCK-LIM kinase pathway by extracellular production of lysophosphatidic acid by the action of autotaxin is required to maintain the large size of lysosomes in visceral endoderm cells.	[Koike, Seiichi; Keino-Masu, Kazuko; Ohto, Tatsuyuki; Masu, Masayuki] Univ Tsukuba, Inst Basic Med Sci, Dept Mol Neurobiol, Tsukuba, Ibaraki 3058577, Japan; [Ohto, Tatsuyuki] Univ Tsukuba, Grad Sch Comprehens Human Sci, Inst Clin Med, Dept Pediat, Tsukuba, Ibaraki 3058577, Japan; [Sugiyama, Fumihiro; Takahashi, Satoru] Univ Tsukuba, Lab Anim Resource Ctr, Tsukuba, Ibaraki 3058577, Japan	University of Tsukuba; University of Tsukuba; University of Tsukuba	Masu, M (corresponding author), Univ Tsukuba, Inst Basic Med Sci, Dept Mol Neurobiol, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058577, Japan.	mmasu@md.tsukuba.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Mitsubishi Foundation; Novartis Foundation (Japan)	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitsubishi Foundation; Novartis Foundation (Japan)(Novartis)	This work was supported in part by grants-in-aid for scientific research on priority areas and the 21st Century COE Program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and grants from The Mitsubishi Foundation and The Novartis Foundation (Japan).	Aizawa H, 2001, NAT NEUROSCI, V4, P367, DOI 10.1038/86011; Amano M, 2000, EXP CELL RES, V261, P44, DOI 10.1006/excr.2000.5046; Anliker B, 2004, SEMIN CELL DEV BIOL, V15, P457, DOI 10.1016/j.semcdb.2004.05.005; Barois N, 1998, J CELL SCI, V111, P1791; Bielinska M, 1999, INT J DEV BIOL, V43, P183; Birgbauer E, 2006, CELL MOL LIFE SCI, V63, P2695, DOI 10.1007/s00018-006-6155-y; Clair T, 2003, CANCER RES, V63, P5446; Davis MD, 2005, J BIOL CHEM, V280, P9833, DOI 10.1074/jbc.M412356200; Eitzen G, 2002, J CELL BIOL, V158, P669, DOI 10.1083/jcb.200204089; Eitzen G, 2001, EMBO J, V20, P5650, DOI 10.1093/emboj/20.20.5650; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Girao H, 2008, FEBS LETT, V582, P2112, DOI 10.1016/j.febslet.2008.04.011; Gu JL, 2002, P NATL ACAD SCI USA, V99, P9352, DOI 10.1073/pnas.102291599; Huijbregts RPH, 2000, TRAFFIC, V1, P195, DOI 10.1034/j.1600-0854.2000.010301.x; Ishizaki T, 1997, FEBS LETT, V404, P118, DOI 10.1016/S0014-5793(97)00107-5; JOLLIE WP, 1990, TERATOLOGY, V41, P361, DOI 10.1002/tera.1420410403; Kaji N, 2003, J BIOL CHEM, V278, P33450, DOI 10.1074/jbc.M305802200; Kamon H, 2006, EMBO J, V25, P4108, DOI 10.1038/sj.emboj.7601286; Kjeken R, 2004, MOL BIOL CELL, V15, P345, DOI 10.1091/mbc.e03-05-0334; Koike S, 2006, GENES CELLS, V11, P133, DOI 10.1111/j.1365-2443.2006.00924.x; LLOYD JB, 1990, TERATOLOGY, V41, P383, DOI 10.1002/tera.1420410404; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Mullins C, 2001, BIOESSAYS, V23, P333, DOI 10.1002/bies.1048; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; Ohta H, 2003, MOL PHARMACOL, V64, P994, DOI 10.1124/mol.64.4.994; OSUMIYAMASHITA N, 1994, DEV BIOL, V164, P409, DOI 10.1006/dbio.1994.1211; Qualmann B, 2003, BIOCHEM J, V371, P233, DOI 10.1042/bj20030139; Smythe E, 2006, J CELL SCI, V119, P4589, DOI 10.1242/jcs.03247; Stefan C, 2005, TRENDS BIOCHEM SCI, V30, P542, DOI 10.1016/j.tibs.2005.08.005; Symons M, 2003, CURR BIOL, V13, pR409, DOI 10.1016/S0960-9822(03)00324-5; Tam PPL, 1998, INT J DEV BIOL, V42, P895; Tanaka M, 2006, J BIOL CHEM, V281, P25822, DOI 10.1074/jbc.M605142200; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; van Meeteren LA, 2007, PROG LIPID RES, V46, P145, DOI 10.1016/j.plipres.2007.02.001; van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05; Van Troys M, 2008, EUR J CELL BIOL, V87, P649, DOI 10.1016/j.ejcb.2008.04.001; VANDEURS B, 1995, EUR J CELL BIOL, V66, P309; Wallar BJ, 2007, EXP CELL RES, V313, P560, DOI 10.1016/j.yexcr.2006.10.033; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; zu Heringdorf DM, 2007, BBA-BIOMEMBRANES, V1768, P923, DOI 10.1016/j.bbamem.2006.09.026	43	40	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33561	33570		10.1074/jbc.M109.012716	http://dx.doi.org/10.1074/jbc.M109.012716			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19808661	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000272028500061
J	Piette, C; Deprez, M; Roger, T; Noel, A; Foidart, JM; Munaut, C				Piette, Caroline; Deprez, Manuel; Roger, Thierry; Noel, Agnes; Foidart, Jean-Michel; Munaut, Carine			The Dexamethasone-induced Inhibition of Proliferation, Migration, and Invasion in Glioma Cell Lines Is Antagonized by Macrophage Migration Inhibitory Factor (MIF) and Can Be Enhanced by Specific MIF Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; GLUCOCORTICOID-RECEPTOR; RHEUMATOID-ARTHRITIS; HUMAN NEUROBLASTOMA; ENZYMATIC-ACTIVITY; SIGNALING PATHWAY; MALIGNANT GLIOMA; REGULATORY ROLE; BRAIN-TUMORS; MAP KINASE	Glioblastomas (GBMs) are the most frequent and malignant brain tumors in adults. Glucocorticoids (GCs) are routinely used in the treatment of GBMs for their capacity to reduce the tumor-associated edema. Few in vitro studies have suggested that GCs inhibit the migration and invasion of GBM cells through the induction of MAPK phosphatase 1 (MKP-1). Macrophage migration inhibitory factor (MIF), an endogenous GC antagonist is up-regulated in GBMs. Recently, MIF has been involved in tumor growth and migration/invasion and specific MIF inhibitors have been developed on their capacity to block its enzymatic tautomerase activity site. In this study, we characterized several glioma cell lines for their MIF production. U373 MG cells were selected for their very low endogenous levels of MIF. We showed that dexamethasone inhibits the migration and invasion of U373 MG cells, through a glucocorticoid receptor (GR)-dependent inhibition of the ERK1/2 MAPK pathway. Oppositely, we found that exogenous MIF increases U373 MG migration and invasion through the stimulation of the ERK1/2 MAP kinase pathway and that this activation is CD74 independent. Finally, we used the Hs 683 glioma cells that are resistant to GCs and produce high levels of endogenous MIF, and showed that the specific MIF inhibitor ISO-1 could restore dexamethasone sensitivity in these cells. Collectively, our results indicate an intricate pathway between MIF expression and GC resistance. They suggest that MIF inhibitors could increase the response of GBMs to corticotherapy.	[Piette, Caroline; Noel, Agnes; Foidart, Jean-Michel; Munaut, Carine] Univ Liege, CHU, GIGA R, Lab Tumor & Dev Biol, B-4000 Liege, Belgium; [Deprez, Manuel] Univ Liege, CHU, Dept Pathol, Neuropathol Lab, B-4000 Liege, Belgium; [Piette, Caroline] Univ Liege, CHR Citadelle, Dept Paediat, B-4000 Liege, Belgium; [Foidart, Jean-Michel] Univ Liege, CHR Citadelle, Dept Gynecol & Obstet, B-4000 Liege, Belgium; [Roger, Thierry] CHU Vaudois, Dept Med, CHU, Infect Dis Serv, CH-1011 Lausanne, Switzerland; [Roger, Thierry] Univ Lausanne, CH-1011 Lausanne, Switzerland	University of Liege; University of Liege; University of Liege; University of Liege; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne	Munaut, C (corresponding author), CHU Sart Tilman, LBTD, Tour Pathol B23 4, B-4000 Liege, Belgium.	c.munaut@ulg.ac.be	Munaut, Carine/K-8138-2019; Roger, Thierry/G-2007-2012	Roger, Thierry/0000-0002-9358-0109; Noel, Agnes/0000-0002-7670-6179; Piette, Caroline/0000-0003-1442-7681	EMBIC [LSHM-CT-2004-512040]; Fonds de la Recherche Scientifique Medicale; Fonds National de la Recherche Scientifique; Swiss National Science Foundation [310000-118266]; Fonds speciaux de la Recherche; Centre Anticancereux pres l'Universite de Liege; Fonds Leon Fredericq (University of Liege); Fonds Social Europeen; Fonds d'Investissements de la Recherche Scientifique; Interuniversity Attraction Poles Programme-Belgian Science Policy	EMBIC; Fonds de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS); Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Fonds speciaux de la Recherche; Centre Anticancereux pres l'Universite de Liege; Fonds Leon Fredericq (University of Liege)(University of Liege); Fonds Social Europeen(European Social Fund (ESF)); Fonds d'Investissements de la Recherche Scientifique; Interuniversity Attraction Poles Programme-Belgian Science Policy(Belgian Federal Science Policy Office)	This work was supported in part by Framework Programme 6-NOE (FP6) Grant LSHM-CT-2004-512040 (EMBIC), the Fonds de la Recherche Scientifique Medicale, the Fonds National de la Recherche Scientifique (F.N.R.S., Belgium), Swiss National Science Foundation Grant 310000-118266, the Fonds speciaux de la Recherche, the Centre Anticancereux pres l'Universite de Liege, the Fonds Leon Fredericq (University of Liege), the Fonds Social Europeen, the Fonds d'Investissements de la Recherche Scientifique (CHU, Liege, Belgium), and the Interuniversity Attraction Poles Programme-Belgian Science Policy (Brussels, Belgium).	Aeberli D, 2006, FEBS LETT, V580, P974, DOI 10.1016/j.febslet.2006.01.027; Bacher M, 1996, P NATL ACAD SCI USA, V93, P7849, DOI 10.1073/pnas.93.15.7849; Baugh JA, 2002, GENES IMMUN, V3, P170, DOI 10.1038/sj.gene.6363867; Bauman GS, 1999, J NEURO-ONCOL, V44, P223, DOI 10.1023/A:1006319417077; Bendrat K, 1997, BIOCHEMISTRY-US, V36, P15356, DOI 10.1021/bi971153a; Berdeli A, 2005, PEDIATR NEPHROL, V20, P1566, DOI 10.1007/s00467-005-1930-9; BERNHAGEN J, 1994, BIOCHEMISTRY-US, V33, P14144, DOI 10.1021/bi00251a025; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Brandes AA, 2003, SEMIN ONCOL, V30, P4, DOI 10.1053/j.seminoncol.2003.11.028; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; Casulari LA, 2006, BRAZ J MED BIOL RES, V39, P1233; Croxtall JD, 2000, BRIT J PHARMACOL, V130, P289, DOI 10.1038/sj.bjp.0703272; Daun JM, 2000, AM J PHYSIOL-REG I, V279, pR1043, DOI 10.1152/ajpregu.2000.279.3.R1043; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; Fingerle-Rowson G, 2009, MOL CELL BIOL, V29, P1922, DOI 10.1128/MCB.01907-08; Giese A, 1996, INT J CANCER, V67, P275, DOI 10.1002/(SICI)1097-0215(19960717)67:2<275::AID-IJC20>3.0.CO;2-9; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; Hermanowski-Vosatka A, 1999, BIOCHEMISTRY-US, V38, P12841, DOI 10.1021/bi991352p; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Ismaili N, 2004, ANN NY ACAD SCI, V1024, P86, DOI 10.1196/annals.1321.007; Kapoor GS, 2003, NEUROSURGERY, V52, P1425, DOI 10.1227/01.NEU.0000065135.28143.39; Kapoor GS, 2003, CANCER BIOL THER, V2, P330, DOI 10.4161/cbt.2.4.507; Kleemann R, 2000, NATURE, V408, P211, DOI 10.1038/35041591; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; Leng L, 2006, CELL RES, V16, P162, DOI 10.1038/sj.cr.7310022; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Lin YM, 2008, EUR J PHARMACOL, V593, P1, DOI 10.1016/j.ejphar.2008.06.111; Lubetsky JB, 2002, J BIOL CHEM, V277, P24976, DOI 10.1074/jbc.M203220200; Lue HQ, 2006, CELL SIGNAL, V18, P688, DOI 10.1016/j.cellsig.2005.06.013; Markert JM, 2001, PHYSIOL GENOMICS, V5, P21, DOI 10.1152/physiolgenomics.2001.5.1.21; Meyer-Siegler KL, 2006, J IMMUNOL, V177, P8730, DOI 10.4049/jimmunol.177.12.8730; Mitchell RA, 1999, J BIOL CHEM, V274, P18100, DOI 10.1074/jbc.274.25.18100; Munaut C, 2002, NEUROPATH APPL NEURO, V28, P452, DOI 10.1046/j.1365-2990.2002.00416.x; Murakami N, 1998, J CELL PHYSIOL, V176, P127, DOI 10.1002/(SICI)1097-4652(199807)176:1<127::AID-JCP15>3.0.CO;2-4; Oakley Robert H., 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P63; Onodera S, 2000, J BIOL CHEM, V275, P444, DOI 10.1074/jbc.275.1.444; ORTI E, 1993, J BIOL CHEM, V268, P7779; Piette C, 2006, ACTA NEUROPATHOL, V112, P651, DOI 10.1007/s00401-006-0100-x; Pross C, 2002, J SURG RES, V102, P57, DOI 10.1006/jsre.2001.6220; Reddy KB, 2003, CANCER METAST REV, V22, P395, DOI 10.1023/A:1023781114568; Ren Y, 2006, ONCOGENE, V25, P3501, DOI 10.1038/sj.onc.1209395; Rendon BE, 2007, J BIOL CHEM, V282, P29910, DOI 10.1074/jbc.M704898200; Roger T, 2005, EUR J IMMUNOL, V35, P3405, DOI 10.1002/eji.200535413; Rosengren E, 1996, MOL MED, V2, P143, DOI 10.1007/BF03402210; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Schwartz V, 2009, FEBS LETT, V583, P2749, DOI 10.1016/j.febslet.2009.07.058; Shiratsuchi T, 2002, J CELL PHYSIOL, V193, P340, DOI 10.1002/jcp.10181; Stupp R, 2007, ANN ONCOL, V18, P69, DOI 10.1093/annonc/mdm044; Swope M, 1998, EMBO J, V17, P3534, DOI 10.1093/emboj/17.13.3534; Vojtek AB, 1998, J BIOL CHEM, V273, P19925, DOI 10.1074/jbc.273.32.19925	50	51	55	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32483	32492		10.1074/jbc.M109.014589	http://dx.doi.org/10.1074/jbc.M109.014589			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19759012	hybrid, Green Published			2022-12-27	WOS:000272028400031
J	Pluciennik, A; Burdett, V; Lukianova, O; O'Donnell, M; Modrich, P				Pluciennik, Anna; Burdett, Vickers; Lukianova, Olga; O'Donnell, Mike; Modrich, Paul			Involvement of the beta Clamp in Methyl-directed Mismatch Repair in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL NUCLEAR ANTIGEN; DNA-POLYMERASE-III; CHROMOSOMAL REPLICATION MACHINE; ONE HOLOENZYME PARTICLE; ESCHERICHIA-COLI; SLIDING CLAMPS; GENE-PRODUCT; HELICASE-II; MUTL; COMPLEX	We have examined function of the bacterial beta replication clamp in the different steps of methyl-directed DNA mismatch repair. The mismatch-, MutS-, and MutL-dependent activation of MutH is unaffected by the presence or orientation of loaded beta clamp on either 3' or 5' heteroduplexes. Similarly, beta is not required for 3' or 5' mismatch- provoked excision when scored in the presence of gamma complex or in the presence of gamma complex and DNA polymerase III core components. However, mismatch repair does not occur in the absence of beta, an effect we attribute to a requirement for the clamp in the repair DNA synthesis step of the reaction. We have confirmed previous findings that beta clamp interacts specifically with MutS and MutL (Lopez de Saro, F. J., Marinus, M. G., Modrich, P., and O'Donnell, M. (2006) J. Biol. Chem. 281, 14340-14349) and show that the mutator phenotype conferred by amino acid substitution within the MutS N-terminal beta-interaction motif is the probable result of instability coupled with reduced activity in multiple steps of the repair reaction. In addition, we have found that the DNA polymerase III alpha catalytic subunit interacts strongly and specifically with both MutS and MutL. Because interactions of polymerase III holoenzyme components with MutS and MutL appear to be of limited import during the initiation and excision steps of mismatch correction, we suggest that their significance might lie in the control of replication fork events in response to the sensing of DNA lesions by the repair system.	[Pluciennik, Anna; Burdett, Vickers; Lukianova, Olga; Modrich, Paul] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [O'Donnell, Mike; Modrich, Paul] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; [O'Donnell, Mike] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA	Duke University; Duke University; Howard Hughes Medical Institute; Howard Hughes Medical Institute; Rockefeller University	Modrich, P (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.	modrich@biochem.duke.edu		Modrich, Paul/0000-0001-8708-9885; O'Donnell, Michael/0000-0001-9002-4214	National Institutes of Health [GM23719]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023719, R37GM023719] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM23719.	AU KG, 1992, J BIOL CHEM, V267, P12142; Blackwell LJ, 2001, J BIOL CHEM, V276, P34339, DOI 10.1074/jbc.M104256200; Burdett V, 2001, P NATL ACAD SCI USA, V98, P6765, DOI 10.1073/pnas.121183298; Clark AB, 2000, J BIOL CHEM, V275, P36498, DOI 10.1074/jbc.C000513200; COOPER DL, 1993, J BIOL CHEM, V268, P11823; DE LV, 1994, METHOD ENZYMOL, V235, P386; de Saro FJL, 2001, P NATL ACAD SCI USA, V98, P8376, DOI 10.1073/pnas.121009498; Dzantiev L, 2004, MOL CELL, V15, P31, DOI 10.1016/j.molcel.2004.06.016; Flores-Rozas H, 2000, NAT GENET, V26, P375, DOI 10.1038/81708; Genschel J, 2002, J BIOL CHEM, V277, P13302, DOI 10.1074/jbc.M111854200; Genschel J, 2009, J BIOL CHEM, V284, P21536, DOI 10.1074/jbc.M109.021287; Georgescu RE, 2008, CELL, V132, P43, DOI 10.1016/j.cell.2007.11.045; GRILLEY M, 1989, J BIOL CHEM, V264, P1000; GRILLEY M, 1993, J BIOL CHEM, V268, P11830; Hall MC, 1998, EMBO J, V17, P1535, DOI 10.1093/emboj/17.5.1535; Hsieh P, 2008, MECH AGEING DEV, V129, P391, DOI 10.1016/j.mad.2008.02.012; Iyer RR, 2008, J BIOL CHEM, V283, P13310, DOI 10.1074/jbc.M800606200; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Johnson RE, 1996, J BIOL CHEM, V271, P27987, DOI 10.1074/jbc.271.45.27987; KELMAN Z, 1995, ANNU REV BIOCHEM, V64, P171, DOI 10.1146/annurev.bi.64.070195.001131; Kleczkowska HE, 2001, GENE DEV, V15, P724, DOI 10.1101/gad.191201; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; KRISTENSEN CS, 1995, J BACTERIOL, V177, P52, DOI 10.1128/jb.177.1.52-58.1995; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; LAHUE RS, 1989, SCIENCE, V245, P160, DOI 10.1126/science.2665076; Lau PJ, 2003, J BIOL CHEM, V278, P14, DOI 10.1074/jbc.C200627200; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; Li F, 2008, MUTAT RES-FUND MOL M, V637, P101, DOI 10.1016/j.mrfmmm.2007.07.008; Li LS, 2008, J BIOL CHEM, V283, P21394, DOI 10.1074/jbc.M709954200; de Saro FJL, 2006, J BIOL CHEM, V281, P14340, DOI 10.1074/jbc.M601264200; NAKTINIS V, 1995, J BIOL CHEM, V270, P13358, DOI 10.1074/jbc.270.22.13358; ONRUST R, 1995, J BIOL CHEM, V270, P13348, DOI 10.1074/jbc.270.22.13348; Pavlov YI, 2003, CURR BIOL, V13, P744, DOI 10.1016/S0960-9822(03)00284-7; Pluciennik A, 2007, P NATL ACAD SCI USA, V104, P12709, DOI 10.1073/pnas.0705129104; PUKKILA PJ, 1983, GENETICS, V104, P571; RUNYON GT, 1993, BIOCHEMISTRY-US, V32, P602, DOI 10.1021/bi00053a028; Simmons LA, 2008, MOL CELL, V29, P291, DOI 10.1016/j.molcel.2007.10.036; Spampinato C, 2000, J BIOL CHEM, V275, P9863, DOI 10.1074/jbc.275.13.9863; STUDWELLVAUGHAN PS, 1993, J BIOL CHEM, V268, P11785; SU SS, 1986, P NATL ACAD SCI USA, V83, P5057, DOI 10.1073/pnas.83.14.5057; SU SS, 1988, J BIOL CHEM, V263, P6829; Viswanathan M, 2001, J BIOL CHEM, V276, P31053, DOI 10.1074/jbc.M105481200; WELSH KM, 1987, J BIOL CHEM, V262, P15624; Yamaguchi M, 1998, J BIOL CHEM, V273, P9197, DOI 10.1074/jbc.273.15.9197; Yao N, 2000, J BIOL CHEM, V275, P11440, DOI 10.1074/jbc.275.15.11440; Yao N, 1996, GENES CELLS, V1, P101, DOI 10.1046/j.1365-2443.1996.07007.x	47	36	36	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32782	32791		10.1074/jbc.M109.054528	http://dx.doi.org/10.1074/jbc.M109.054528			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19783657	hybrid, Green Published			2022-12-27	WOS:000272028400063
J	Gutsche, M; Sobotta, MC; Wabnitz, GH; Ballikaya, S; Meyer, AJ; Samstag, Y; Dick, TP				Gutsche, Marcus; Sobotta, Mirko C.; Wabnitz, Guido H.; Ballikaya, Seda; Meyer, Andreas J.; Samstag, Yvonne; Dick, Tobias P.			Proximity-based Protein Thiol Oxidation by H2O2-scavenging Peroxidases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-PEROXIDE; GLUTATHIONE PEROXIDASES; REDOX REGULATION; MAMMALIAN-CELLS; SULFENIC ACIDS; SPECIFICITY; PEROXIREDOXIN; ACTIVATION; CHEMISTRY; MECHANISM	H2O2 acts as a signaling molecule by oxidizing critical thiol groups on redox-regulated target proteins. To explain the efficiency and selectivity of H2O2-based signaling, it has been proposed that oxidation of target proteins may be facilitated by H2O2-scavenging peroxidases. Recently, a peroxidase-based protein oxidation relay has been identified in yeast, namely the oxidation of the transcription factor Yap1 by the peroxidase Orp1. It has remained unclear whether the protein oxidase function of Orp1 is a singular adaptation or whether it may represent a more general principle. Here we show that Orp1 is in fact not restricted to oxidizing Yap1 but can also form a highly efficient redox relay with the oxidant target protein roGFP (redox-sensitive green fluorescent protein) in mammalian cells. Orp1 mediates near quantitative oxidation of roGFP2 by H2O2, and the Orp1-roGFP2 redox relay effectively converts physiological H2O2 signals into measurable fluorescent signals in living cells. Furthermore, the oxidant relay phenomenon is not restricted to Orp1 as the mammalian peroxidase Gpx4 also mediates oxidation of proximal roGFP2 in living cells. Together, these findings support the concept that certain peroxidases harbor an intrinsic and powerful capacity to act as H2O2-dependent protein thiol oxidases when they are recruited into proximity of oxidizable target proteins.	[Dick, Tobias P.] DKFZ ZMBH Alliance, German Canc Res Ctr DKFZ A160, Redox Regulat Res Grp, D-69120 Heidelberg, Germany; [Wabnitz, Guido H.; Samstag, Yvonne] Univ Heidelberg, Inst Immunol, D-69120 Heidelberg, Germany; [Meyer, Andreas J.] Univ Heidelberg, Heidelberg Inst Plant Sci, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Dick, TP (corresponding author), DKFZ ZMBH Alliance, German Canc Res Ctr DKFZ A160, Redox Regulat Res Grp, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	t.dick@dkfz.de	Meyer, Andreas J/C-4734-2013	Meyer, Andreas J/0000-0001-8144-4364; Wabnitz, Guido/0000-0001-5101-9885	European Commission [MEXT 2761]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by European Commission Grant MEXT 2761 (to T. P. D.).	Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Bozonet SM, 2005, J BIOL CHEM, V280, P23319, DOI 10.1074/jbc.M502757200; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Claiborne A, 1999, BIOCHEMISTRY-US, V38, P15407, DOI 10.1021/bi992025k; Conrad M, 2005, MOL CELL BIOL, V25, P7637, DOI 10.1128/MCB.25.17.7637-7644.2005; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Fourquet S, 2008, ANTIOXID REDOX SIGN, V10, P1565, DOI 10.1089/ars.2008.2049; Gulow K, 2005, J IMMUNOL, V174, P5249, DOI 10.4049/jimmunol.174.9.5249; Gutscher M, 2008, NAT METHODS, V5, P553, DOI 10.1038/NMETH.1212; Jackson SH, 2004, NAT IMMUNOL, V5, P818, DOI 10.1038/ni1096; Lee CJ, 2004, NAT STRUCT MOL BIOL, V11, P1179, DOI 10.1038/nsmb856; Ma LH, 2007, J BIOL CHEM, V282, P31429, DOI 10.1074/jbc.M705953200; Maiorino M, 2007, J MOL BIOL, V365, P1033, DOI 10.1016/j.jmb.2006.10.033; Paulsen CE, 2009, CHEM BIOL, V16, P217, DOI 10.1016/j.chembiol.2009.01.003; Peskin AV, 2007, J BIOL CHEM, V282, P11885, DOI 10.1074/jbc.M700339200; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; Satoh T, 1996, BRAIN RES, V733, P9, DOI 10.1016/0006-8993(96)00527-6; Toledano MB, 2004, TRENDS BIOCHEM SCI, V29, P351, DOI 10.1016/j.tibs.2004.05.005; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tosatto SCE, 2008, ANTIOXID REDOX SIGN, V10, P1515, DOI 10.1089/ars.2008.2055; Veal EA, 2003, J BIOL CHEM, V278, P30896, DOI 10.1074/jbc.M303542200; Wabnitz GH, 2006, J IMMUNOL, V176, P1668, DOI 10.4049/jimmunol.176.3.1668; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85	26	297	301	0	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31532	31540		10.1074/jbc.M109.059246	http://dx.doi.org/10.1074/jbc.M109.059246			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19755417	Green Published, hybrid			2022-12-27	WOS:000271572700006
J	Chung, JS; Noguera-Mazon, V; Lancelin, JM; Kim, SK; Hirasawa, M; Hologne, M; Leustek, T; Knaff, DB				Chung, Jung-Sung; Noguera-Mazon, Valerie; Lancelin, Jean-Marc; Kim, Sung-Kun; Hirasawa, Masakazu; Hologne, Maggy; Leustek, Thomas; Knaff, David B.			Interaction Domain on Thioredoxin for Pseudomonas aeruginosa 5 '-Adenylylsulfate Reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI THIOREDOXIN; IRON-SULFUR CLUSTER; PROTEIN-PROTEIN INTERACTIONS; SITE-DIRECTED MUTAGENESIS; CRYSTAL-STRUCTURE; CHLAMYDOMONAS-REINHARDTII; NMR; GLUTAREDOXINS; RECOGNITION; ASSIGNMENT	NMR spectroscopy has been used to map the interaction domain on Escherichia coli thioredoxin for the thioredoxin-dependent 5'-adenylylsulfate reductase from Pseudomonas aeruginosa (PaAPR). Seventeen thioredoxin amino acids, all clustered around Cys-32 (the more surface-exposed of the two active-site cysteines), have been located at the PaAPR binding site. The center of the binding domain is dominated by nonpolar amino acids, with a smaller number of charged and polar amino acids located on the periphery of the site. Twelve of the amino acids detected by NMR have non-polar, hydrophobic side chains, including one aromatic amino acid (Trp-31). Four of the thioredoxin amino acids at the PaAPR binding site have polar side chains (Lys-36, Asp-61, Gln-62 and Arg-73), with three of the four having charged side chains. Site-directed mutagenesis experiments have shown that replacement of Lys-36, Asp-61, and Arg-73 and of the absolutely conserved Trp-31 significantly decreases the Vmax for the PaAPR-catalyzed reduction of 5'-adenylylsulfate, with E. coli thioredoxin serving as the electron donor. The most dramatic effect was observed with the W31A variant, which showed no activity as a donor to PaAPR. Although the thiol of the active-site Cys-256 of PaAPR is the point of the initial nucleophilic attack by reduced thioredoxin, mutagenic replacement of Cys-256 by serine has no effect on thioredoxin binding to PaAPR.	[Knaff, David B.] Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA; [Knaff, David B.] Texas Tech Univ, Ctr Biotechnol & Genom, Lubbock, TX 79409 USA; [Noguera-Mazon, Valerie; Lancelin, Jean-Marc; Hologne, Maggy] Univ Lyon 1, Lab RMN & Spectrometrie Masse Biomol, CNRS, ESCPE,UMR Sci Analyt 5180, F-69622 Villeurbanne, France; [Leustek, Thomas] Rutgers State Univ, Dept Plant Biol & Pathol, Biotechnol Ctr Agr & Environm, New Brunswick, NJ 08901 USA	Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Rutgers State University New Brunswick	Knaff, DB (corresponding author), Texas Tech Univ, Dept Chem & Biochem, 1 Circle Dr, Lubbock, TX 79409 USA.	david.knaff@ttu.edu	Lancelin, Jean-marc/AAC-5686-2019; Kim, Sung-Kun/I-4193-2019; Kim, Sung-Kun/A-7055-2008	Kim, Sung-Kun/0000-0002-2325-245X; HOLOGNE, Maggy/0000-0002-4977-7887	United States Department of Agriculture [2006-35318-16581]; Robert A. Welch Foundation [D-0710]	United States Department of Agriculture(United States Department of Agriculture (USDA)); Robert A. Welch Foundation(The Welch Foundation)	This work was supported by United States Department of Agriculture Grant 2006-35318-16581 (to T.L., S.-K.K., and D.B.K.) and Robert A. Welch Foundation Grant D-0710 (to D.B.K.).	Balmer Y, 2003, P NATL ACAD SCI USA, V100, P370, DOI 10.1073/pnas.232703799; Berndt C, 2008, BBA-MOL CELL RES, V1783, P641, DOI 10.1016/j.bbamcr.2008.02.003; Bick JA, 2000, J BACTERIOL, V182, P135, DOI 10.1128/JB.182.1.135-142.2000; Carroll KS, 2005, PLOS BIOL, V3, P1418, DOI 10.1371/journal.pbio.0030250; Carroll KS, 2005, BIOCHEMISTRY-US, V44, P14647, DOI 10.1021/bi051344a; CHANDRASEKHAR K, 1991, FEBS LETT, V284, P178, DOI 10.1016/0014-5793(91)80679-W; Chartron J, 2007, BIOCHEMISTRY-US, V46, P3942, DOI 10.1021/bi700130e; Chartron J, 2006, J MOL BIOL, V364, P152, DOI 10.1016/j.jmb.2006.08.080; Dai SD, 2007, NATURE, V448, P92, DOI 10.1038/nature05937; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DELAMOTTEGUERY F, 1991, EUR J BIOCHEM, V196, P287; EKLUND H, 1991, PROTEINS, V11, P13, DOI 10.1002/prot.340110103; FORMANKAY JD, 1991, BIOCHEMISTRY-US, V30, P2685, DOI 10.1021/bi00224a017; Gao Y, 2000, PLANT PHYSIOL, V123, P1087, DOI 10.1104/pp.123.3.1087; GLEASON FK, 1990, BIOCHEMISTRY-US, V29, P3701, DOI 10.1021/bi00467a016; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KATTI SK, 1990, J MOL BIOL, V212, P167, DOI 10.1016/0022-2836(90)90313-B; Kim SK, 2005, BBA-BIOENERGETICS, V1710, P103, DOI 10.1016/j.bbabio.2005.09.004; Kim SK, 2004, BIOCHEMISTRY-US, V43, P13478, DOI 10.1021/bi048811t; KRAUSE G, 1991, J BIOL CHEM, V266, P4056; Krimm I, 1998, EUR J BIOCHEM, V255, P185, DOI 10.1046/j.1432-1327.1998.2550185.x; Kumar JK, 2004, P NATL ACAD SCI USA, V101, P3759, DOI 10.1073/pnas.0308701101; LAURENT TC, 1964, J BIOL CHEM, V239, P3436; LEMASTER DM, 1988, BIOCHEMISTRY-US, V27, P142, DOI 10.1021/bi00401a022; Lillig CH, 1999, J BIOL CHEM, V274, P7695, DOI 10.1074/jbc.274.12.7695; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Maeda K, 2006, STRUCTURE, V14, P1701, DOI 10.1016/j.str.2006.09.012; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; Menchise V, 2001, BIOCHEM J, V359, P65, DOI 10.1042/0264-6021:3590065; NAVARRO JA, 1991, BIOCHEMISTRY-US, V30, P2192, DOI 10.1021/bi00222a024; NIKKOLA M, 1993, BIOCHEMISTRY-US, V32, P5093, DOI 10.1021/bi00070a017; Nooren IMA, 2003, J MOL BIOL, V325, P991, DOI 10.1016/S0022-2836(02)01281-0; Nooren IMA, 2003, EMBO J, V22, P3486, DOI 10.1093/emboj/cdg359; OBLONG JE, 1995, BIOCHEMISTRY-US, V34, P3319, DOI 10.1021/bi00010a022; RUSSEL M, 1990, J BACTERIOL, V172, P1923, DOI 10.1128/jb.172.4.1923-1929.1990; Savage H, 1997, STRUCTURE, V5, P895, DOI 10.1016/S0969-2126(97)00244-X; Schanda P, 2005, J BIOMOL NMR, V33, P199, DOI 10.1007/s10858-005-4425-x; Schurmann P, 2008, ANTIOXID REDOX SIGN, V10, P1235, DOI 10.1089/ars.2007.1931; Setterdahl AT, 2003, BIOCHEMISTRY-US, V42, P14877, DOI 10.1021/bi0302088; Singha NC, 2003, J BIOL CHEM, V278, P21421, DOI 10.1074/jbc.M302310200; Wangensteen OS, 2001, BBA-PROTEIN STRUCT M, V1547, P156, DOI 10.1016/S0167-4838(01)00178-9; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	43	2	2	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31181	31189		10.1074/jbc.M109.035634	http://dx.doi.org/10.1074/jbc.M109.035634			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19744922	hybrid, Green Published			2022-12-27	WOS:000271378400046
J	Wada, M; Saunders, TL; Morrow, J; Milne, GL; Walker, KP; Dey, SK; Brock, TG; Opp, MR; Aronoff, DM; Smith, WL				Wada, Masayuki; Saunders, Thomas L.; Morrow, Jason; Milne, Ginger L.; Walker, Kimberly P.; Dey, Sudhansu K.; Brock, Thomas G.; Opp, Mark R.; Aronoff, David M.; Smith, William L.			Two Pathways for Cyclooxygenase-2 Protein Degradation in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTAGLANDIN-E SYNTHASE-1; FATTY-ACIDS; GENE; MICE; LIPOPOLYSACCHARIDE; OXYGENATION; RECEPTOR; SLEEP; COX-2	COX-2, formally known as prostaglandin endoperoxide H synthase-2 (PGHS-2), catalyzes the committed step in prostaglandin biosynthesis. COX-2 is induced during inflammation and is overexpressed in colon cancer. In vitro, an 18-amino acid segment, residues 595-612, immediately upstream of the C-terminal endoplasmic reticulum targeting sequence is required for N-glycosylation of Asn(594), which permits COX-2 protein to enter the endoplasmic reticulum-associated protein degradation system. To determine the importance of this COX-2 degradation pathway in vivo, we engineered a del595-612 PGHS-2 (Delta 18 COX-2) knock-in mouse lacking this 18-amino acid segment. Delta 18 COX-2 knock-in mice do not exhibit the renal or reproductive abnormalities of COX-2 null mice. Delta 18 COX-2 mice do have elevated urinary prostaglandin E-2 metabolite levels and display a more pronounced and prolonged bacterial endotoxin-induced febrile response than wild type (WT) mice. Normal brain tissue, cultured resident peritoneal macrophages, and cultured skin fibroblasts from Delta 18 COX-2 mice overexpress Delta 18 COX-2 relative to WT COX-2 expression in control mice. These results indicate that COX-2 can be degraded via the endoplasmic reticulum-associated protein degradation pathway in vivo. Treatment of cultured cells from WT or Delta 18 COX-2 mice with flurbiprofen, which blocks substrate-dependent degradation, attenuates COX-2 degradation, and treatment of normal mice with ibuprofen increases the levels of COX-2 in brain tissue. Thus, substrate turnover-dependent COX-2 degradation appears to contribute to COX-2 degradation in vivo. Curiously, WT and Delta 18 COX-2 protein levels are similar in kidneys and spleens from WT and Delta 18 COX-2 mice. There must be compensatory mechanisms to maintain constant COX-2 levels in these tissues.	[Smith, William L.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Opp, Mark R.] Univ Michigan, Dept Anesthesiol, Ann Arbor, MI 48109 USA; [Saunders, Thomas L.; Brock, Thomas G.; Aronoff, David M.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Morrow, Jason; Milne, Ginger L.; Walker, Kimberly P.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Morrow, Jason; Milne, Ginger L.; Walker, Kimberly P.] Vanderbilt Univ, Dept Med, Nashville, TN 37232 USA; [Dey, Sudhansu K.] Univ Cincinnati, Coll Med, Div Reprod Sci, Perinatal Inst,Cincinnati Childrens Hosp,Med Ctr, Cincinnati, OH 45229 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Vanderbilt University; Vanderbilt University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Smith, WL (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, 1150 W Med Ctr Dr,5301 MSRB 3, Ann Arbor, MI 48109 USA.	smithww@umich.edu	Milne, Ginger/D-7648-2014	Milne, Ginger/0000-0003-3890-151X; Saunders, Thom/0000-0003-2015-101X; Opp, Mark/0000-0002-9831-9866; Aronoff, David/0000-0003-4587-6121	National Institutes of Health [GM 068848, HL085149, HL078727, DK48831, GM15431, HL080972, GM067189, HD012304, CA77839]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD012304, R01HD012304] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA077839] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085149, K08HL078727, R01HL080972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068848, P01GM067189, P50GM015431, P01GM015431] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM 068848 (to W. L. S.), HL085149 (to W. L. S.), HL078727 (to D. M. A.), DK48831 (to G. L. M.), GM15431 (to G. L. M.), HL080972 (to M. R. O.), GM067189 (to M. R. O.), HD012304 (to S. K. D.), and CA77839 (to S. K. D.).	Aronoff DM, 2007, PROG BRAIN RES, V162, P15, DOI 10.1016/S0079-6123(06)62002-5; Aronoff DM, 2007, J IMMUNOL, V178, P1628, DOI 10.4049/jimmunol.178.3.1628; Aronoff DM, 2001, AM J MED, V111, P304, DOI 10.1016/S0002-9343(01)00834-8; BREDER CD, 1995, J COMP NEUROL, V355, P296, DOI 10.1002/cne.903550208; Brown JR, 2005, J CLIN ONCOL, V23, P2840, DOI 10.1200/JCO.2005.09.051; Buchanan FG, 2007, CANCER RES, V67, P9380, DOI 10.1158/0008-5472.CAN-07-0710; Cheng Y, 2006, J CLIN INVEST, V116, P1391, DOI 10.1172/JCI27540; Chu V, 2001, BMC Physiol, V1, P6, DOI 10.1186/1472-6793-1-6; Doller A, 2007, MOL BIOL CELL, V18, P2137, DOI 10.1091/mbc.E06-09-0850; Francois H, 2007, J AM SOC NEPHROL, V18, P1466, DOI 10.1681/ASN.2006040343; Grosser T, 2006, J CLIN INVEST, V116, P4, DOI 10.1172/JCI27291; HARRIS RC, 1994, J CLIN INVEST, V94, P2504, DOI 10.1172/JCI117620; HERSCHMAN HR, 1993, J LIPID MEDIATOR, V6, P89; Kang YJ, 2007, PROG LIPID RES, V46, P108, DOI 10.1016/j.plipres.2007.01.001; Langenbach R, 1999, ANN NY ACAD SCI, V889, P52, DOI 10.1111/j.1749-6632.1999.tb08723.x; Li S, 1999, BRAIN RES, V825, P86, DOI 10.1016/S0006-8993(99)01225-1; LILES JH, 1992, LAB ANIM, V26, P241, DOI 10.1258/002367792780745706; Mbonye UR, 2008, J BIOL CHEM, V283, P8611, DOI 10.1074/jbc.M710137200; Mbonye UR, 2006, J BIOL CHEM, V281, P35770, DOI 10.1074/jbc.M608281200; MORHAM SG, 1995, CELL, V83, P473, DOI 10.1016/0092-8674(95)90125-6; MORITA I, 1995, J BIOL CHEM, V270, P10902, DOI 10.1074/jbc.270.18.10902; Morrow JD, 2005, BRAIN BEHAV IMMUN, V19, P28, DOI 10.1016/j.bbi.2004.02.003; Morrow JD, 2005, BRAIN BEHAV IMMUN, V19, P40, DOI 10.1016/j.bbi.2004.04.001; Murphey LJ, 2004, ANAL BIOCHEM, V334, P266, DOI 10.1016/j.ab.2004.08.019; Rouzer CA, 2003, CHEM REV, V103, P2239, DOI 10.1021/cr000068x; Rouzer CA, 2009, J LIPID RES, V50, pS29, DOI 10.1194/jlr.R800042-JLR200; Salmon AB, 2005, AM J PHYSIOL-ENDOC M, V289, pE23, DOI 10.1152/ajpendo.00575.2004; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Smith WL, 2008, TRENDS BIOCHEM SCI, V33, P27, DOI 10.1016/j.tibs.2007.09.013; Smith WL, 2001, J CLIN INVEST, V107, P1491, DOI 10.1172/JCI13271; Svenson KL, 2003, J APPL PHYSIOL, V94, P1650, DOI 10.1152/japplphysiol.01029.2003; Tanabe T, 2002, PROSTAG OTH LIPID M, V68-9, P95, DOI 10.1016/S0090-6980(02)00024-2; van der Donk WA, 2002, BIOCHEMISTRY-US, V41, P15451, DOI 10.1021/bi026938h; Yang PY, 2002, ANAL BIOCHEM, V308, P168, DOI 10.1016/S0003-2697(02)00218-X; Yu Y, 2007, J BIOL CHEM, V282, P1498, DOI 10.1074/jbc.M609930200	35	20	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30742	30753		10.1074/jbc.M109.052415	http://dx.doi.org/10.1074/jbc.M109.052415			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19758985	Green Published, hybrid			2022-12-27	WOS:000271378400002
J	Palijan, A; Fernandes, I; Bastien, Y; Tang, LQ; Verway, M; Kourelis, M; Tavera-Mendoza, LE; Li, Z; Bourdeau, V; Mader, S; Yang, XJ; White, JH				Palijan, Ana; Fernandes, Isabelle; Bastien, Yolande; Tang, Liqun; Verway, Mark; Kourelis, Maria; Tavera-Mendoza, Luz E.; Li, Zhi; Bourdeau, Veronique; Mader, Sylvie; Yang, Xiang Jiao; White, John H.			Function of Histone Deacetylase 6 as a Cofactor of Nuclear Receptor Coregulator LCoR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; TRANSCRIPTIONAL REPRESSION; HORMONE-RECEPTORS; GENE-EXPRESSION; CO-REPRESSOR; N-COR; COREPRESSOR; RECRUITMENT; HDAC6; ALPHA	Ligand-dependent corepressor LCoR was identified as a protein that interacts with the estrogen receptor alpha(ER alpha) ligand binding domain in a hormone-dependent manner. LCoR also interacts directly with histone deacetylase 3 (HDAC3) and HDAC6. Notably, HDAC6 has emerged as a marker of breast cancer prognosis. However, although HDAC3 is nuclear, HDAC6 is cytoplasmic in many cells. We found that HDAC6 is partially nuclear in estrogen-responsive MCF7 cells, colocalizes with LCoR, represses transactivation of estrogen- inducible reporter genes, and augments corepression by LCoR. In contrast, no repression was observed upon HDAC6 expression in COS7 cells, where it is exclusively cytoplasmic. LCoR binds to HDAC6 in vitro via a central domain, and repression by LCoR mutants lacking this domain was attenuated. Kinetic chromatin immunoprecipitation assays revealed hormone-dependent recruitment of LCoR to promoters of ER alpha-induced target genes in synchrony with ER alpha. HDAC6 was also recruited to these promoters, and repeat chromatin immunoprecipitation experiments confirmed the corecruitment of LCoR with ER alpha and with HDAC6. Remarkably, however, although we find evidence for corecruitment of LCoR and ER alpha on genes repressed by the receptor, LCoR and HDAC6 failed to coimmunoprecipitate, suggesting that they are part of distinct complexes on these genes. Although small interfering RNA-mediated knockdown of LCoR or HDAC6 augmented expression of an estrogen-sensitive reporter gene in MCF7 cells, unexpectedly their ablation led to reduced expression of some endogenous estrogen target genes. Taken together, these data establish that HDAC6 can function as a cofactor of LCoR but suggest that they may act in enhance expressing some target genes.	[Palijan, Ana; Fernandes, Isabelle; Bastien, Yolande; Tang, Liqun; Verway, Mark; Kourelis, Maria; Li, Zhi; White, John H.] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada; [Yang, Xiang Jiao; White, John H.] McGill Univ, Dept Med, Montreal, PQ H3G 1Y6, Canada; [Tavera-Mendoza, Luz E.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA; [Bourdeau, Veronique; Mader, Sylvie] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada; [Bourdeau, Veronique; Mader, Sylvie] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada	McGill University; McGill University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Universite de Montreal; Universite de Montreal	White, JH (corresponding author), McGill Univ, Dept Physiol, 3655 Drummond St, Montreal, PQ H3G Y6, Canada.	john.white@mcgill.ca	white, john h/N-9782-2013; Palijan, Ana/AAV-3310-2021	white, john h/0000-0002-4785-2687; 	Canadian Institutes of Health [MT-11704]; Canadian Cancer Society [018362]	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS))	This work was supported by Canadian Institutes of Health Research Grant MT-11704 ( to J.H.W.) and a grant from the Canadian Cancer Society (018362 to X.J.Y.).	Alarmo EL, 2009, CANCER LETT, V275, P35, DOI 10.1016/j.canlet.2008.09.028; Alland L, 1997, NATURE, V387, P49, DOI 10.1038/387049a0; Bertos NR, 2004, J BIOL CHEM, V279, P48246, DOI 10.1074/jbc.M408583200; Bourdeau V, 2004, MOL ENDOCRINOL, V18, P1411, DOI 10.1210/me.2003-0441; Bourdeau V, 2008, NUCLEIC ACIDS RES, V36, P76, DOI 10.1093/nar/gkm945; Boyault C, 2007, ONCOGENE, V26, P5468, DOI 10.1038/sj.onc.1210614; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Chang EC, 2006, ENDOCRINOLOGY, V147, P4831, DOI 10.1210/en.2006-0563; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Fernandes I, 2003, MOL CELL, V11, P139, DOI 10.1016/S1097-2765(03)00014-5; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; Glass CK, 2000, GENE DEV, V14, P121; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; Hazzalin CA, 2005, PLOS BIOL, V3, P2111, DOI 10.1371/journal.pbio.0030393; Heim KC, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-57; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Hsu MY, 2008, LAB INVEST, V88, P842, DOI 10.1038/labinvest.2008.55; Hu X, 1999, NATURE, V402, P93, DOI 10.1038/47069; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Kazuo M, 2008, ANN SURG ONCOL, V15, P1530, DOI 10.1245/s10434-007-9746-4; Kusumegi T, 2004, J BIOCHEM MOL TOXIC, V18, P1, DOI 10.1002/jbt.20004; Lemaire V, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.198102; Lopez-Garcia J, 2006, NUCLEIC ACIDS RES, V34, P6126, DOI 10.1093/nar/gkl875; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Metivier R, 2006, EMBO REP, V7, P161, DOI 10.1038/sj.embor.7400626; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Naughton C, 2007, MOL ENDOCRINOL, V21, P2615, DOI 10.1210/me.2007-0110; Palijan A, 2009, J BIOL CHEM, V284, P30275, DOI 10.1074/jbc.M109.051201; Perissi V, 1999, GENE DEV, V13, P3198, DOI 10.1101/gad.13.24.3198; Perissi V, 2008, MOL CELL, V29, P755, DOI 10.1016/j.molcel.2008.01.020; Renaud JP, 2000, CELL MOL LIFE SCI, V57, P1748, DOI 10.1007/PL00000656; Rodriguez-Gonzalez A, 2008, CANCER RES, V68, P2557, DOI 10.1158/0008-5472.CAN-07-5989; Rosenfeld MG, 2001, J BIOL CHEM, V276, P36865, DOI 10.1074/jbc.R100041200; Saji S, 2005, ONCOGENE, V24, P4531, DOI 10.1038/sj.onc.1208646; Smith CL, 2008, BIOESSAYS, V30, P15, DOI 10.1002/bies.20687; Tavera-Mendoza L, 2006, EMBO REP, V7, P180, DOI 10.1038/sj.embor.7400594; Tavera-Mendoza LE, 2008, P NATL ACAD SCI USA, V105, P8250, DOI 10.1073/pnas.0709279105; Verdel A, 2000, CURR BIOL, V10, P747, DOI 10.1016/S0960-9822(00)00542-X; Verdel A, 2003, ZYGOTE, V11, P323, DOI 10.1017/S0967199403002387; Westendorf JJ, 2002, MOL CELL BIOL, V22, P7982, DOI 10.1128/MCB.22.22.7982-7992.2002; White JH, 2004, VITAM HORM, V68, P123; White KA, 2005, J BIOL CHEM, V280, P7829, DOI 10.1074/jbc.M412707200; Yang Y, 2003, NOVON, V13, P153, DOI 10.2307/3393581; Yang YH, 2008, CANCER RES, V68, P4833, DOI 10.1158/0008-5472.CAN-08-0644; Yoshida N, 2004, CANCER SCI, V95, P496, DOI 10.1111/j.1349-7006.2004.tb03239.x; Zhang Y, 2008, MOL CELL BIOL, V28, P1688, DOI 10.1128/MCB.01154-06; Zhang ZH, 2004, CLIN CANCER RES, V10, P6962, DOI 10.1158/1078-0432.CCR-04-0455; Zhu P, 2006, CELL, V124, P615, DOI 10.1016/j.cell.2005.12.032	52	44	48	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30264	30274		10.1074/jbc.M109.045526	http://dx.doi.org/10.1074/jbc.M109.045526			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19744931	Green Published, hybrid			2022-12-27	WOS:000271090000030
J	Widenmaier, SB; Ao, ZL; Kim, SJ; Warnock, G; McIntosh, CHS				Widenmaier, Scott B.; Ao, Ziliang; Kim, Su-Jin; Warnock, Garth; McIntosh, Christopher H. S.			Suppression of p38 MAPK and JNK via Akt-mediated Inhibition of Apoptosis Signal-regulating Kinase 1 Constitutes a Core Component of the beta-Cell Pro-survival Effects of Glucose-dependent Insulinotropic Polypeptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED ENDOTHELIAL APOPTOSIS; ENDOPLASMIC-RETICULUM STRESS; TYPE-2 DIABETES-MELLITUS; PROTEIN-KINASE; PROAPOPTOTIC FUNCTION; PHYSIOLOGICAL ROLES; RECEPTOR AGONISTS; TNF-ALPHA; PHOSPHORYLATION; PATHWAY	Glucose-dependent insulinotropic polypeptide (GIP) potentiates glucose-stimulated insulin secretion, insulin biosynthesis, and beta-cell proliferation and survival. In previous studies GIP was shown to promote beta-cell survival by modulating the activity of multiple signaling modules and regulating gene transcription of pro- and anti-apoptotic bcl-2 family proteins. We have now evaluated the mechanisms by which GIP regulates the dynamic interactions between cytoplasmic bcl-2 family members and the mitochondria in INS-1 cells during apoptosis induced by treatment with staurosporine (STS), an activator of the mitochondria-mediated apoptotic pathway. STS induced translocation of bad and bimEL, activation of mitochondrial bax, release of mitochondrial cytochrome c, cleavage of caspase-3, and apoptosis. Each response was significantly diminished by GIP. Using selective enzyme inhibitors, overexpression of dominant-negative Akt, and Akt siRNA, it was demonstrated that GIP promoted beta-cell survival via Akt-dependent suppression of p38 MAPK and JNK and that combined inhibition was sufficient to explain the entire pro-survival responses to GIP during STS treatment. This signaling pathway also explained the pro-survival effects of GIP on INS-1 cells exposed to two other promoters of stress: thapsigargin (endoplasmic reticulum stress) and etoposide (genotoxic stress). Importantly, we discovered that GIP suppressed p38 MAPK and JNK via Akt-mediated changes in the phosphorylation state of the apoptosis signal-regulating kinase 1 in INS-1 cells and human islets, resulting in inhibition of its activity. Inhibition of apoptosis by GIP is therefore mediated via a key pathway involving Akt-dependent inhibition of apoptosis signal-regulating kinase 1, which subsequently prevents the pro-apoptotic actions of p38 MAPK and JNK.	[McIntosh, Christopher H. S.] Univ British Columbia, Fac Med, Dept Cellular & Physiol Sci, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada; [Widenmaier, Scott B.; Kim, Su-Jin; McIntosh, Christopher H. S.] Univ British Columbia, Diabet Res Grp, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada; [Ao, Ziliang; Warnock, Garth] Univ British Columbia, Dept Surg, Ike Barber Human Islet Transplantat Lab, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia; University of British Columbia	McIntosh, CHS (corresponding author), Univ British Columbia, Fac Med, Dept Cellular & Physiol Sci, Inst Life Sci, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	mcintoch@interchange.ubc.ca		Widenmaier, Scott/0000-0001-5684-2707	Canadian Institutes of Health Research; Canadian Foundation for Innovation; Michael Smith Foundation for Health Research (MSFHR); Natural Sciences and Engineering Research Council of Canada; MSFHR	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); MSFHR(Michael Smith Foundation for Health Research)	This work was supported by funding from the Canadian Institutes of Health Research and the Canadian Foundation for Innovation (to C. H. S. M.), the Michael Smith Foundation for Health Research (MSFHR) (to C. H. S. M. and G. W.), and scholarships from the Natural Sciences and Engineering Research Council of Canada and MSFHR (to S. B. W.).	Ahren B, 2004, HORM METAB RES, V36, P867, DOI 10.1055/s-2004-826178; Allen DA, 2005, J NUTR BIOCHEM, V16, P705, DOI 10.1016/j.jnutbio.2005.06.007; Beith JL, 2008, ENDOCRINOLOGY, V149, P2251, DOI 10.1210/en.2007-1557; Cai BB, 2006, J BIOL CHEM, V281, P25215, DOI 10.1074/jbc.M512627200; Danial NN, 2008, NAT MED, V14, P144, DOI 10.1038/nm1717; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Ding WG, 1997, DIABETES, V46, P615, DOI 10.2337/diabetes.46.4.615; Donath MY, 2008, ENDOCR REV, V29, P334, DOI 10.1210/er.2007-0033; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Ehses JA, 2003, ENDOCRINOLOGY, V144, P4433, DOI 10.1210/en.2002-0068; Ehses JA, 2002, J BIOL CHEM, V277, P37088, DOI 10.1074/jbc.M205055200; Ehses JA, 2001, J BIOL CHEM, V276, P23667, DOI 10.1074/jbc.M103023200; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039; Green BD, 2007, BEST PRACT RES CL EN, V21, P497, DOI 10.1016/j.beem.2007.09.003; Grethe S, 2006, CELL SIGNAL, V18, P531, DOI 10.1016/j.cellsig.2005.05.023; Grethe S, 2006, BIOCHEM BIOPH RES CO, V347, P781, DOI 10.1016/j.bbrc.2006.06.159; Haataja L, 2008, ENDOCR REV, V29, P303, DOI 10.1210/er.2007-0037; Hanke J, 2001, CELLS TISSUES ORGANS, V169, P113, DOI 10.1159/000047869; Harwood SM, 2005, ANN CLIN BIOCHEM, V42, P415, DOI 10.1258/000456305774538238; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Johnson JD, 2006, P NATL ACAD SCI USA, V103, P19575, DOI 10.1073/pnas.0604208103; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Kashima Y, 2001, J BIOL CHEM, V276, P46046, DOI 10.1074/jbc.M108378200; Kibbey RG, 2007, CELL METAB, V5, P253, DOI 10.1016/j.cmet.2007.02.008; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Kim BJ, 2006, J BIOL CHEM, V281, P21256, DOI 10.1074/jbc.M510644200; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kim SJ, 2005, J BIOL CHEM, V280, P28692, DOI 10.1074/jbc.M504913200; Kim SJ, 2005, J BIOL CHEM, V280, P22297, DOI 10.1074/jbc.M500540200; Kim SJ, 2008, MOL CELL BIOL, V28, P1644, DOI 10.1128/MCB.00325-07; Kim WH, 2005, CELL SIGNAL, V17, P1516, DOI 10.1016/j.cellsig.2005.03.020; Kim W, 2008, PHARMACOL REV, V60, P470, DOI 10.1124/pr.108.000604; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Laybutt DR, 2002, DIABETES, V51, P413, DOI 10.2337/diabetes.51.2.413; Leahy JL, 2005, ARCH MED RES, V36, P197, DOI 10.1016/j.arcmed.2005.01.003; Matsuzawa A, 2008, BBA-GEN SUBJECTS, V1780, P1325, DOI 10.1016/j.bbagen.2007.12.011; McIntosh CHS, 2008, FRONT BIOSCI-LANDMRK, V13, P1753, DOI 10.2741/2797; McIntosh CHS, 2009, VITAM HORM, V80, P409, DOI 10.1016/S0083-6729(08)00615-8; Parnaud G, 2008, DIABETOLOGIA, V51, P91, DOI 10.1007/s00125-007-0855-1; Petersen KF, 2006, AM J MED, V119, p10S, DOI 10.1016/j.amjmed.2006.01.009; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Pospisilik JA, 2003, DIABETES, V52, P741, DOI 10.2337/diabetes.52.3.741; Reed JC, 2006, CELL DEATH DIFFER, V13, P1378, DOI 10.1038/sj.cdd.4401975; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Salehi M, 2008, ENDOCR REV, V29, P367, DOI 10.1210/er.2007-0031; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Seleznev K, 2006, J BIOL CHEM, V281, P22275, DOI 10.1074/jbc.M604330200; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P9558, DOI 10.1073/pnas.95.16.9558; Sumara G, 2009, CELL, V136, P235, DOI 10.1016/j.cell.2008.11.018; Takeda K, 2008, ANNU REV PHARMACOL, V48, P199, DOI 10.1146/annurev.pharmtox.48.113006.094606; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Trumper A, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740233; Trumper A, 2001, MOL ENDOCRINOL, V15, P1559, DOI 10.1210/me.15.9.1559; Wajchenberg BL, 2007, ENDOCR REV, V28, P187, DOI 10.1210/er.2006-0038; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Widenmaier SB, 2009, J BIOL CHEM, V284, P10764, DOI 10.1074/jbc.M809116200; Xin MG, 2006, J BIOL CHEM, V281, P18859, DOI 10.1074/jbc.M512543200; Xin MG, 2005, J BIOL CHEM, V280, P10781, DOI 10.1074/jbc.M500084200; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yusta B, 2006, CELL METAB, V4, P391, DOI 10.1016/j.cmet.2006.10.001; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhang R, 2005, ONCOGENE, V24, P3954, DOI 10.1038/sj.onc.1208548	65	83	87	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30372	30382		10.1074/jbc.M109.060178	http://dx.doi.org/10.1074/jbc.M109.060178			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19748889	Green Published, hybrid			2022-12-27	WOS:000271090000040
J	Ludlow, MJ; Durai, L; Ennion, SJ				Ludlow, Melanie J.; Durai, Latha; Ennion, Steven J.			Functional Characterization of Intracellular Dictyostelium discoideum P2X Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTRACTILE VACUOLE; ATP SYNTHESIS; CA2+ INFLUX; CHANNELS; CELLS; EXPRESSION; DYNAMICS; SUBUNITS; KINETICS; CURRENTS	Indicative of cell surface P2X ion channel activation, extracellular ATP evokes a rapid and transient calcium influx in the model eukaryote Dictyostelium discoideum. Five P2X-like proteins (dP2XA-E) are present in this organism. However, their roles in purinergic signaling are unclear, because dP2XA proved to have an intracellular localization on the contractile vacuole where it is thought to be required for osmoregulation. To determine functional properties of the remaining four dP2X-like proteins and to assess their cellular roles, we recorded membrane currents from expressed cloned receptors and generated a quintuple knock-out Dictyostelium strain devoid of dP2X receptors. ATP evoked inward currents at dP2XB and dP2XE receptors but not at dP2XC or dP2XD. beta,gamma-Imido-ATP was more potent than ATP at dP2XB but a weak partial agonist at dP2XE. Currents in dP2XB and dP2XE were strongly inhibited by Na+ but insensitive to copper and the P2 receptor antagonists pyridoxal phosphate-6-azophenyl-2', 4'-disulfonic acid and suramin. Unusual for P2X channels, dP2XA and dP2XB were also Cl--permeable. The extracellular purinergic response to ATP persisted in p2xA/B/C/D/E quintuple knock-out Dictyostelium demonstrating that dP2X channels are not responsible. dP2XB, -C, -D, and -E were found to be intracellularly localized to the contractile vacuole with the ligand binding domain facing the lumen. However, quintuple p2xA/B/C/D/E null cells were still capable of regulating cell volume in water demonstrating that, contrary to previous findings, dP2X receptors are not required for osmoregulation. Responses to the calmodulin antagonist calmidazolium, however, were reduced in p2xA/B/C/D/E null cells suggesting that dP2X receptors play a role in intracellular calcium signaling.	[Ludlow, Melanie J.; Durai, Latha; Ennion, Steven J.] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England	University of Leicester	Ennion, SJ (corresponding author), Univ Leicester, Dept Cell Physiol & Pharmacol, Med Sci Bldg,Univ Rd, Leicester LE1 9HN, Leics, England.	se15@le.ac.uk		Ludlow, Melanie/0000-0002-0720-5581	Wellcome Trust [WT081601MA]; Biotechnology and Biological Sciences Research Council [C19146] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Wellcome Trust (Project Grant WT081601MA).	Agboh KC, 2004, J BIOL CHEM, V279, P41650, DOI 10.1074/jbc.M408203200; BARISH ME, 1983, J PHYSIOL-LONDON, V342, P309, DOI 10.1113/jphysiol.1983.sp014852; Bavan S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-17; Bo XN, 2003, MOL PHARMACOL, V63, P1407, DOI 10.1124/mol.63.6.1407; Burnstock G, 2009, ACTA PHYSIOL, V195, P415, DOI 10.1111/j.1748-1716.2009.01957.x; Clarke M, 2002, J CELL SCI, V115, P2893; COHEN SM, 1986, EMBO J, V5, P3361, DOI 10.1002/j.1460-2075.1986.tb04651.x; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Ennion S, 2000, J BIOL CHEM, V275, P29361, DOI 10.1074/jbc.M003637200; Evans RJ, 1996, J PHYSIOL-LONDON, V497, P413, DOI 10.1113/jphysiol.1996.sp021777; Faix J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh136; Fischer M, 2004, FEBS LETT, V577, P227, DOI 10.1016/j.febslet.2004.09.084; Fountain SJ, 2008, J BIOL CHEM, V283, P15122, DOI 10.1074/jbc.M801512200; Fountain SJ, 2007, NATURE, V448, P200, DOI 10.1038/nature05926; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Khakh BS, 1999, J NEUROSCI, V19, P7289, DOI 10.1523/JNEUROSCI.19-17-07289.1999; Kirsten JH, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-71; Kreppel L, 2004, NUCLEIC ACIDS RES, V32, pD332, DOI 10.1093/nar/gkh138; Kuehnel MP, 2009, J CELL SCI, V122, P505, DOI 10.1242/jcs.034207; Kuehnel MP, 2009, J CELL SCI, V122, P499, DOI 10.1242/jcs.034199; LEWIS C, 1995, NATURE, V377, P432, DOI 10.1038/377432a0; Ludlow MJ, 2008, CELL CALCIUM, V44, P567, DOI 10.1016/j.ceca.2008.04.001; Malchow D, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-31; MANSTEIN DJ, 1995, GENE, V162, P129, DOI 10.1016/0378-1119(95)00351-6; Marquez-Klaka B, 2007, J NEUROSCI, V27, P1456, DOI 10.1523/JNEUROSCI.3105-06.2007; MONIAKIS J, 1995, J BIOL CHEM, V270, P28276; Nebl T, 1997, J CELL SCI, V110, P2845; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Priel A, 2004, J GEN PHYSIOL, V123, P281, DOI 10.1085/jgp.200308986; Qiu F, 2009, AM J PHYSIOL-CELL PH, V296, pC250, DOI 10.1152/ajpcell.00433.2008; Riedel T, 2007, BIOPHYS J, V93, P846, DOI 10.1529/biophysj.106.103614; Roberts JA, 2008, J BIOL CHEM, V283, P20126, DOI 10.1074/jbc.M800294200; Ruppelt A, 2001, J NEUROCHEM, V77, P1256, DOI 10.1046/j.1471-4159.2001.00348.x; Schlatterer C, 1996, BIOCHEM J, V313, P661, DOI 10.1042/bj3130661; Striedinger K, 2007, GLIA, V55, P652, DOI 10.1002/glia.20494; Torres GE, 1999, J BIOL CHEM, V274, P6653, DOI 10.1074/jbc.274.10.6653; Vervoort EB, 2000, NUCLEIC ACIDS RES, V28, P2069, DOI 10.1093/nar/28.10.2069; Wen YJ, 2009, MOL BIOL CELL, V20, P4278, DOI 10.1091/mbc.E09-03-0243	39	24	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					35227	35239		10.1074/jbc.M109.045674	http://dx.doi.org/10.1074/jbc.M109.045674			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19833731	hybrid, Green Published			2022-12-27	WOS:000272439600075
J	Chen, Q; Pinon, DI; Miller, LJ; Dong, MQ				Chen, Quan; Pinon, Delia I.; Miller, Laurence J.; Dong, Maoqing			Molecular Basis of Glucagon-like Peptide 1 Docking to Its Intact Receptor Studied with Carboxyl-terminal Photolabile Probes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; PHOTOAFFINITY CROSS-LINKING; EXTRACELLULAR DOMAIN; CRYSTAL-STRUCTURE; AMINO-TERMINUS; PARATHYROID-HORMONE; SECRETIN RECEPTOR; SPATIAL APPROXIMATION; CALCITONIN RECEPTOR; GLP-1 RECEPTOR	The glucagon-like peptide 1 (GLP1) receptor is a member of Family B G protein-coupled receptors and represents an important drug target for type 2 diabetes. Despite recent solution of the structure of the amino-terminal domain of this receptor and that of several close family members, understanding of the molecular basis of natural ligand GLP1 binding to its intact receptor remains limited. The goal of this study was to explore spatial approximations between specific receptor residues within the carboxyl terminus of GLP1 and its receptor as normally docked. Therefore, we developed and characterized two high affinity, full-agonist photolabile GLP1 probes having sites for covalent attachment in positions 24 and 35. Both probes labeled the receptor specifically and saturably. Subsequent peptide mapping using chemical and proteinase cleavages of purified wild-type and mutant GLP1 receptor identified that the Arg(131)-Lys(136) segment at the juxtamembrane region of the receptor amino terminus contained the site of labeling for the position 24 probe, and the specific receptor residue labeled by this probe was identified as Glu(133) by radiochemical sequencing. Similarly, nearby residue Glu(125) within the same region of the receptor amino-terminal domain was identified as the site of labeling by the position 35 probe. These data represent the first direct demonstration of spatial approximation between GLP1 and its intact receptor as docked, providing two important constraints for the modeling of this interaction. This should expand our understanding of the molecular basis of natural agonist ligand binding to the GLP1 receptor and may be relevant to other family members.	[Chen, Quan; Pinon, Delia I.; Miller, Laurence J.; Dong, Maoqing] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Scottsdale, AZ 85259 USA	Mayo Clinic; Mayo Clinic Phoenix	Dong, MQ (corresponding author), Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA.	dongmq@mayo.edu			National Institutes of Health [DK46577]; American Diabetes Association [1-08-RA-42]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK046577, R01DK046577] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK46577. This work was also supported by American Diabetes Association Grant 1-08-RA-42.	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; ADELHORST K, 1994, J BIOL CHEM, V269, P6275; Al-Sabah S, 2003, BRIT J PHARMACOL, V140, P339, DOI 10.1038/sj.bjp.0705453; Andersen NH, 2002, BIOORGAN MED CHEM, V10, P79, DOI 10.1016/S0968-0896(01)00263-2; Behar V, 2000, J BIOL CHEM, V275, P9, DOI 10.1074/jbc.275.1.9; Bisello A, 1998, J BIOL CHEM, V273, P22498, DOI 10.1074/jbc.273.35.22498; BUGGY JJ, 1995, J BIOL CHEM, V270, P7474, DOI 10.1074/jbc.270.13.7474; CAO YJ, 1995, BIOCHEM BIOPH RES CO, V212, P673, DOI 10.1006/bbrc.1995.2021; Ceraudo E, 2008, MOL ENDOCRINOL, V22, P147, DOI 10.1210/me.2007-0361; Ceraudo E, 2008, J MOL NEUROSCI, V36, P245, DOI 10.1007/s12031-008-9073-7; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; de Maturana RL, 2004, PROTEIN PEPTIDE LETT, V11, P15, DOI 10.2174/0929866043478491; Dong MQ, 2008, MOL PHARMACOL, V74, P413, DOI 10.1124/mol.108.047209; Dong MQ, 2008, MOL ENDOCRINOL, V22, P1489, DOI 10.1210/me.2008-0025; Dong MQ, 2007, MOL PHARMACOL, V72, P280, DOI 10.1124/mol.107.035402; Dong MQ, 2004, J BIOL CHEM, V279, P31177, DOI 10.1074/jbc.M404113200; Dong MQ, 2004, J BIOL CHEM, V279, P2894, DOI 10.1074/jbc.M310407200; Dong MQ, 2004, J BIOL CHEM, V279, P1167, DOI 10.1074/jbc.M305719200; Dong MQ, 1999, J BIOL CHEM, V274, P903, DOI 10.1074/jbc.274.2.903; GALLWITZ B, 1994, EUR J BIOCHEM, V225, P1151, DOI 10.1111/j.1432-1033.1994.1151b.x; Gallwitz B, 1996, REGUL PEPTIDES, V63, P17, DOI 10.1016/0167-0115(96)00019-5; Gelling RW, 1997, ENDOCRINOLOGY, V138, P2640, DOI 10.1210/en.138.6.2640; Gensure RC, 2001, J BIOL CHEM, V276, P42692, DOI 10.1074/jbc.M106215200; Gensure RC, 2001, J BIOL CHEM, V276, P28650, DOI 10.1074/jbc.M100717200; Gourlet P, 1996, PEPTIDES, V17, P825, DOI 10.1016/0196-9781(96)00107-6; Grace CRR, 2007, P NATL ACAD SCI USA, V104, P4858, DOI 10.1073/pnas.0700682104; Grace CRR, 2004, P NATL ACAD SCI USA, V101, P12836, DOI 10.1073/pnas.0404702101; Graziano MP, 1996, RECEPTOR CHANNEL, V4, P9; Hadac EM, 1996, PANCREAS, V13, P130, DOI 10.1097/00006676-199608000-00003; HOLTMANN MH, 1995, J BIOL CHEM, V270, P14394, DOI 10.1074/jbc.270.24.14394; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Ji ZS, 1997, J BIOL CHEM, V272, P24393, DOI 10.1074/jbc.272.39.24393; JUPPNER H, 1994, ENDOCRINOLOGY, V134, P879, DOI 10.1210/en.134.2.879; Lin F, 2009, J MOL MODEL, V15, P53, DOI 10.1007/s00894-008-0372-2; Mann R, 2007, BIOCHEM SOC T, V35, P713, DOI 10.1042/BST0350713; Mannstadt M, 1998, J BIOL CHEM, V273, P16890, DOI 10.1074/jbc.273.27.16890; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Neidigh JW, 2001, BIOCHEMISTRY-US, V40, P13188, DOI 10.1021/bi010902s; Parker JC, 1998, J PEPT RES, V52, P398; Parthier C, 2007, P NATL ACAD SCI USA, V104, P13942, DOI 10.1073/pnas.0706404104; Pioszak AA, 2008, J BIOL CHEM, V283, P32900, DOI 10.1074/jbc.M805749200; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; POWERS SP, 1988, INT J PEPT PROT RES, V31, P429; Runge S, 2003, BRIT J PHARMACOL, V138, P787, DOI 10.1038/sj.bjp.0705120; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Stroop SD, 1996, ENDOCRINOLOGY, V137, P4752, DOI 10.1210/en.137.11.4752; Sun CH, 2007, P NATL ACAD SCI USA, V104, P7875, DOI 10.1073/pnas.0611397104; Tan YV, 2006, J BIOL CHEM, V281, P12792, DOI 10.1074/jbc.M513305200; THORNTON K, 1994, BIOCHEMISTRY-US, V33, P3532, DOI 10.1021/bi00178a009; ULRICH CD, 1993, GASTROENTEROLOGY, V105, P1534, DOI 10.1016/0016-5085(93)90162-6; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Wilmen A, 1997, PEPTIDES, V18, P301, DOI 10.1016/S0196-9781(96)00321-X; Xiao Q, 2000, J MOL ENDOCRINOL, V25, P321, DOI 10.1677/jme.0.0250321; Zang MW, 2003, MOL PHARMACOL, V63, P993, DOI 10.1124/mol.63.5.993	55	33	33	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34135	34144		10.1074/jbc.M109.038109	http://dx.doi.org/10.1074/jbc.M109.038109			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19815559	Green Published, hybrid			2022-12-27	WOS:000272165200046
J	Collar, CJ; Al-Salabi, MI; Stewart, ML; Barrett, MP; Wilson, WD; de Koning, HP				Collar, Catharine J.; Al-Salabi, Mohammed I.; Stewart, Mhairi L.; Barrett, Michael P.; Wilson, W. David; de Koning, Harry P.			Predictive Computational Models of Substrate Binding by a Nucleoside Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRYPANOSOMA-BRUCEI-BRUCEI; AFRICAN TRYPANOSOMES; SACCHAROMYCES-CEREVISIAE; FERRIPROTOPORPHYRIN-IX; NUCLEOBASE TRANSPORTER; RECOGNITION MOTIFS; ADENOSINE TRANSPORTER; ALLOPURINOL UPTAKE; CRYSTAL-STRUCTURE; RESISTANCE	Transporters play a vital role in both the resistance mechanisms of existing drugs and effective targeting of their replacements. Melarsoprol and diamidine compounds similar to pentamidine and furamidine are primarily taken up by trypanosomes of the genus Trypanosoma brucei through the P2 aminopurine transporter. In standardized competition experiments with [H-3] adenosine, P2 transporter inhibition constants (K-i) have been determined for a diverse dataset of adenosine analogs, diamidines, Food and Drug Administration-approved compounds and analogs thereof, and custom-designed trypanocidal compounds. Computational biology has been employed to investigate compound structure diversity in relation to P2 transporter interaction. These explorations have led to models for inhibition predictions of known and novel compounds to obtain information about the molecular basis for P2 transporter inhibition. A common pharmacophore for P2 transporter inhibition has been identified along with other key structural characteristics. Our model provides insight into P2 transporter interactions with known compounds and contributes to strategies for the design of novel antiparasitic compounds. This approach offers a quantitative and predictive tool for molecular recognition by specific transporters without the need for structural or even primary sequence information of the transport protein.	[de Koning, Harry P.] Univ Glasgow, Inst Biomed & Life Sci, Glasgow Biomed Res Ctr, Div Infect & Immun,Dept INfect & Immun, Glasgow G12 8TA, Lanark, Scotland; [Collar, Catharine J.; Wilson, W. David] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA	University of Glasgow; University System of Georgia; Georgia State University	de Koning, HP (corresponding author), Univ Glasgow, Inst Biomed & Life Sci, Glasgow Biomed Res Ctr, Div Infect & Immun,Dept INfect & Immun, 120 Univ Pl, Glasgow G12 8TA, Lanark, Scotland.			Barrett, Mike/0000-0001-9447-3519; De Koning, Harry/0000-0002-9963-1827	Bill and Melinda Gates Foundation; Consortium for Parasitic Drug Development; Georgia State University; David W. Boykin Graduate Fellowship in Medicinal Chemistry	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Consortium for Parasitic Drug Development; Georgia State University; David W. Boykin Graduate Fellowship in Medicinal Chemistry	This work was supported by the Bill and Melinda Gates Foundation through the Consortium for Parasitic Drug Development (to W. D. W., M. P. B., and H. d. K.), the Georgia State University Molecular Basis of Disease Fellowship, and the David W. Boykin Graduate Fellowship in Medicinal Chemistry (to C. J. C.).	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Al-Salabi MI, 2005, ANTIMICROB AGENTS CH, V49, P3682, DOI 10.1128/AAC.49.9.3682-3689.2005; Al-Salabi MI, 2003, MOL PHARMACOL, V63, P814, DOI 10.1124/mol.63.4.814; Al-Salabi MI, 2007, MOL PHARMACOL, V71, P921, DOI 10.1124/mol.106.031559; [Anonymous], 2008, SYBYL MOL MOD SOFTW; Baliani A, 2005, J MED CHEM, V48, P5570, DOI 10.1021/jm050177+; Barrett MP, 1999, PARASITOL TODAY, V15, P136, DOI 10.1016/S0169-4758(99)01414-3; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; Bray PG, 2006, MOL MICROBIOL, V62, P238, DOI 10.1111/j.1365-2958.2006.05368.x; Bray PG, 1999, J CELL BIOL, V145, P363, DOI 10.1083/jcb.145.2.363; CARTER NS, 1995, J BIOL CHEM, V270, P28153, DOI 10.1074/jbc.270.47.28153; CARTER NS, 1993, NATURE, V361, P173, DOI 10.1038/361173a0; Cascorbi I, 2006, PHARMACOL THERAPEUT, V112, P457, DOI 10.1016/j.pharmthera.2006.04.009; Congreve M, 2005, DRUG DISCOV TODAY, V10, P895, DOI 10.1016/S1359-6446(05)03484-7; De Koning HP, 1999, MOL PHARMACOL, V56, P1162, DOI 10.1124/mol.56.6.1162; de Koning HP, 2005, FEMS MICROBIOL REV, V29, P987, DOI 10.1016/j.femsre.2005.03.004; de Koning HP, 2004, ANTIMICROB AGENTS CH, V48, P1515, DOI 10.1128/AAC.48.5.1515-1519.2004; De Koning HP, 2003, INT J PARASITOL, V33, P821, DOI 10.1016/S0020-7519(03)00091-2; de Koning HP, 2001, INT J PARASITOL, V31, P512, DOI 10.1016/S0020-7519(01)00167-9; de Koning HP, 2001, MOL PHARMACOL, V59, P586; Fitch CD, 2004, LIFE SCI, V74, P1957, DOI 10.1016/j.lfs.2003.10.003; Geiser F, 2005, MOL PHARMACOL, V68, P589, DOI 10.1124/mol.104.010298; Kim SK, 2007, J CHEM INF MODEL, V47, P1225, DOI 10.1021/ci600501z; LANHAM SM, 1968, NATURE, V218, P1273, DOI 10.1038/2181273a0; Luscher A, 2007, CURR PHARM DESIGN, V13, P555, DOI 10.2174/138161207780162809; Matovu E, 2003, EUKARYOT CELL, V2, P1003, DOI 10.1128/EC.2.5.1003-1008.2003; Matovu E, 2001, MOL BIOCHEM PARASIT, V117, P73, DOI 10.1016/S0166-6851(01)00332-2; Molina-Arcas M, 2008, NUCLEOS NUCLEOT NUCL, V27, P769, DOI 10.1080/15257770802145819; Muegge I., 2006, DRUG DISCOV TODAY-TE, V3, P405, DOI [10.1016/j.ddtec.2006.12.002, DOI 10.1016/j.ddtec.2006.12.002, DOI 10.1016/J.DDTEC.2006.12.002]; Padan E, 2009, J EXP BIOL, V212, P1593, DOI 10.1242/jeb.026708; Papageorgiou I, 2008, INT J PARASITOL, V38, P641, DOI 10.1016/j.ijpara.2007.10.005; Papageorgiou IG, 2005, PARASITOLOGY, V130, P275, DOI 10.1017/S0031182004006626; Scrutton NS, 1996, BIOCHEM J, V319, P1; Song CM, 2009, BRIEF BIOINFORM, V10, P579, DOI 10.1093/bib/bbp023; Stewart ML, 2005, ANTIMICROB AGENTS CH, V49, P5169, DOI 10.1128/AAC.49.12.5169-5171.2005; Valdes R, 2009, J BIOL CHEM, V284, P19067, DOI 10.1074/jbc.M109.017947; Vickers MF, 2004, NUCLEOS NUCLEOT NUCL, V23, P361, DOI 10.1081/NCN-120028333; Wallace LJM, 2002, J BIOL CHEM, V277, P26149, DOI 10.1074/jbc.M202835200; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhang J, 2003, MOL PHARMACOL, V64, P1512, DOI 10.1124/mol.64.6.1512	40	27	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34028	34035		10.1074/jbc.M109.049726	http://dx.doi.org/10.1074/jbc.M109.049726			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19808668	Green Published, hybrid			2022-12-27	WOS:000272165200035
J	Mei, ZQ; Wang, F; Qi, YT; Zhou, ZY; Hu, Q; Li, H; Wu, JW; Shi, YG				Mei, Ziqing; Wang, Feng; Qi, Yutao; Zhou, Zhiyuan; Hu, Qi; Li, Han; Wu, Jiawei; Shi, Yigong			Molecular Determinants of MecA as a Degradation Tag for the ClpCP Protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP-DEPENDENT PROTEASES; COMPETENCE TRANSCRIPTION FACTOR; AAA PLUS PROTEASE; BACILLUS-SUBTILIS; METHANOCALDOCOCCUS-JANNASCHII; OPERATING PRINCIPLES; REGULATORY PARTICLE; TAGGING SYSTEM; PORE LOOPS; RECOGNITION	Regulated proteolysis by ATP-dependent proteases is universal in all living cells. In Bacillus subtilis, the degradation of the competence transcription factor ComK is mediated by a ternary complex involving the adaptor protein MecA and the ATP-dependent protease ClpCP. Here we demonstrate that a C-terminal, 98-amino acid domain of MecA (residues 121-218) serves as a non-recycling, degradation tag and targets a variety of fusion proteins to the ClpCP protease for degradation. MecA(121-218) facilitates productive oligomerization of ClpC, stimulates the ATPase activity of ClpC, and allows the activated ClpC complex to stably associate with ClpP. Importantly, the ClpCP protease undergoes dynamic cycles of assembly and disassembly, which are triggered by association with MecA and the degradation of MecA, respectively.	[Shi, Yigong] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, Minist Educ,Prot Sci Lab, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Shi, YG (corresponding author), Tsinghua Univ, Sch Med, Rm C331,Biomed Bldg, Beijing 100084, Peoples R China.	shi-lab@tsinghua.edu.cn	Mei, Ziqing/AHD-6788-2022; Wang, Feng/AAC-6221-2022	Mei, Ziqing/0000-0001-8554-6309; Wang, Feng/0000-0002-9403-4337; Shi, Yigong/0000-0003-2030-168X	Ministry of Science and Technology [2009CB918801]; National Natural Science Foundation of China [30888001]; Beijing Municipal Commissions of Education and Science and Technology	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Commissions of Education and Science and Technology	This work was supported by grants from the Ministry of Science and Technology (Grant 2009CB918801), Tsinghua University 985 Phase II funds, Project 30888001 supported by the National Natural Science Foundation of China, and Beijing Municipal Commissions of Education and Science and Technology.	Baker TA, 2006, TRENDS BIOCHEM SCI, V31, P647, DOI 10.1016/j.tibs.2006.10.006; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Baumeister W, 1997, CURR OPIN STRUC BIOL, V7, P273, DOI 10.1016/S0959-440X(97)80036-X; Benaroudj N, 2000, NAT CELL BIOL, V2, P833, DOI 10.1038/35041081; Bochtler M, 1999, ANNU REV BIOPH BIOM, V28, P295, DOI 10.1146/annurev.biophys.28.1.295; Chen I, 2005, SCIENCE, V310, P1456, DOI 10.1126/science.1114021; COOK PF, 1982, BIOCHEMISTRY-US, V21, P5794, DOI 10.1021/bi00266a011; DUBNAU D, 1990, J BACTERIOL, V172, P4048, DOI 10.1128/jb.172.7.4048-4055.1990; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; Goldberg AL, 2007, BIOCHEM SOC T, V35, P12, DOI 10.1042/BST0350012; GOLDBERG AL, 1992, EUR J BIOCHEM, V203, P9, DOI 10.1111/j.1432-1033.1992.tb19822.x; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Groll M, 2005, CHEMBIOCHEM, V6, P222, DOI 10.1002/cbic.200400313; HAHN J, 1994, J BACTERIOL, V176, P5753, DOI 10.1128/JB.176.18.5753-5761.1994; Hanna J, 2007, FEBS LETT, V581, P2854, DOI 10.1016/j.febslet.2007.03.053; Inobe T, 2008, CURR OPIN STRUC BIOL, V18, P43, DOI 10.1016/j.sbi.2007.12.014; Kanaoka Y, 1997, CELL, V90, P1085, DOI 10.1016/S0092-8674(00)80374-8; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Kirstein J, 2006, EMBO J, V25, P1481, DOI 10.1038/sj.emboj.7601042; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; Martin A, 2008, MOL CELL, V29, P441, DOI 10.1016/j.molcel.2008.02.002; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P139, DOI 10.1038/nsmb.1380; MSADEK T, 1994, P NATL ACAD SCI USA, V91, P5788, DOI 10.1073/pnas.91.13.5788; Persuh M, 1999, MOL MICROBIOL, V33, P886, DOI 10.1046/j.1365-2958.1999.01544.x; Persuh M, 2002, J BACTERIOL, V184, P2310, DOI 10.1128/JB.184.8.2310-2313.2002; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Prepiak P, 2007, MOL CELL, V26, P639, DOI 10.1016/j.molcel.2007.05.011; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Turgay K, 1997, GENE DEV, V11, P119, DOI 10.1101/gad.11.1.119; Turgay K, 1998, EMBO J, V17, P6730; VANSINDEREN D, 1994, J BACTERIOL, V176, P5762, DOI 10.1128/JB.176.18.5762-5770.1994; Wang F, 2009, J BIOL CHEM, V284, P34376, DOI 10.1074/jbc.M109.053033; Weber-Ban EU, 1999, NATURE, V401, P90, DOI 10.1038/43481; Yan N, 2004, NAT STRUCT MOL BIOL, V11, P420, DOI 10.1038/nsmb764; Yan NG, 2004, MOL CELL, V15, P999, DOI 10.1016/j.molcel.2004.08.022; Zhang F, 2009, MOL CELL, V34, P473, DOI 10.1016/j.molcel.2009.04.021; Zhang F, 2009, MOL CELL, V34, P485, DOI 10.1016/j.molcel.2009.04.022	39	22	23	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34366	34375		10.1074/jbc.M109.053017	http://dx.doi.org/10.1074/jbc.M109.053017			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19767395	hybrid, Green Published			2022-12-27	WOS:000272165200066
J	Cai, ZY; Shi, ZC; Sanchez, A; Zhang, TT; Liu, MY; Yang, JH; Wang, F; Zhang, DK				Cai, Zhenyu; Shi, Zhongcheng; Sanchez, Amir; Zhang, Tingting; Liu, Mingyao; Yang, Jianghua; Wang, Fen; Zhang, Dekai			Transcriptional Regulation of Tlr11 Gene Expression in Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; NF-KAPPA-B; INNATE IMMUNITY; DENDRITIC CELLS; IFN-GAMMA; INFLAMMATION; ETS; ESE-1; LIPOPOLYSACCHARIDE; RECOGNITION	As sensors of invading microorganisms, Toll-like receptors (TLRs) are expressed not only on macrophages and dendritic cells (DCs) but also on epithelial cells. In the TLR family, Tlr11 appears to have the unique feature in that it is expressed primarily on epithelial cells, although it is also expressed on DCs and macrophages. Here, we demonstrate that transcription of the Tlr11 gene is regulated through two cis-acting elements, one Ets-binding site and one interferon regulatory factor (IRF)-binding site. The Ets element interacts with the epithelium-specific transcription factors, ESE-1 and ESE-3, and the IRF motif interacts with IRF-8. Thus, Tlr11 expression on epithelial cells is regulated by the transcription factors that are presumably distinct from transcription factors that regulate the expression of TLRs in innate immune cells such as macrophages and DCs. Our results imply that the distinctive transcription regulatory machinery for TLRs on epithelium may represent a promising new avenue for the development of epithelia-specific therapeutic interventions.	[Cai, Zhenyu; Shi, Zhongcheng; Sanchez, Amir; Zhang, Tingting; Zhang, Dekai] Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Ctr Infect & Inflammatory Dis, Houston, TX 77030 USA; [Liu, Mingyao; Wang, Fen] Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Ctr Canc & Stem Cell Biol, Houston, TX 77030 USA; [Yang, Jianghua] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine	Zhang, DK (corresponding author), 2121 W Holcombe Blvd, Houston, TX 77030 USA.	dzhang@ibt.tamhsc.edu		Liu, Mingyao/0000-0001-7339-5048	National Institutes of Health [AI072263]; Texas A&M University Health Science Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI072263] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas A&M University Health Science Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI072263. This work was also supported by the Texas A&M University Health Science Center.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bals R, 2004, EUR RESPIR J, V23, P327, DOI 10.1183/09031936.03.00098803; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Cario E, 2007, GASTROENTEROLOGY, V132, P1359, DOI 10.1053/j.gastro.2007.02.056; Clement CG, 2008, AM J RESP CRIT CARE, V177, P1322, DOI 10.1164/rccm.200607-1038OC; Diamond G, 2000, IMMUNOL REV, V173, P27, DOI 10.1034/j.1600-065X.2000.917304.x; Edwards AD, 2003, EUR J IMMUNOL, V33, P827, DOI 10.1002/eji.200323797; EVANS SE, 2009, AM J RESP C IN PRESS; Grall FT, 2005, FEBS J, V272, P1676, DOI 10.1111/j.1742-4658.2005.04592.x; Gribar SC, 2008, J LEUKOCYTE BIOL, V83, P493, DOI 10.1189/jlb.0607358; Guillot L, 2004, J BIOL CHEM, V279, P2712, DOI 10.1074/jbc.M305790200; Guo Z, 2005, J IMMUNOL, V175, P7407, DOI 10.4049/jimmunol.175.11.7407; Heinz S, 2003, J BIOL CHEM, V278, P21502, DOI 10.1074/jbc.M301476200; Hornef MW, 2002, J EXP MED, V195, P559, DOI 10.1084/jem.20011788; Iwamura C, 2008, CURR ALLERGY ASTHM R, V8, P7, DOI 10.1007/s11882-008-0003-0; Johnson CM, 2007, J BIOL CHEM, V282, P31197, DOI 10.1074/jbc.M705151200; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kas K, 2000, J BIOL CHEM, V275, P2986, DOI 10.1074/jbc.275.4.2986; Lee J, 2006, NAT CELL BIOL, V8, P1327, DOI 10.1038/ncb1500; Liu Y, 2001, INFECT IMMUN, V69, P2788, DOI 10.1128/IAI.69.5.2788-2796.2001; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; POLITIS AD, 1992, J IMMUNOL, V148, P801; Rehli M, 2002, TRENDS IMMUNOL, V23, P375, DOI 10.1016/S1471-4906(02)02259-7; Rehli M, 2000, J BIOL CHEM, V275, P9773, DOI 10.1074/jbc.275.13.9773; Rhee SH, 2005, P NATL ACAD SCI USA, V102, P13610, DOI 10.1073/pnas.0502174102; Roger T, 2005, BIOCHEM J, V387, P355, DOI 10.1042/BJ20041243; Rudders S, 2001, J BIOL CHEM, V276, P3302, DOI 10.1074/jbc.M006507200; Schroder K, 2007, J LEUKOCYTE BIOL, V81, P1577, DOI 10.1189/jlb.0107036; Severa M, 2007, J IMMUNOL, V178, P6208, DOI 10.4049/jimmunol.178.10.6208; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Song JM, 2007, PLOS PATHOG, V3, P541, DOI 10.1371/journal.ppat.0030060; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Uehara A, 2007, MOL IMMUNOL, V44, P3100, DOI 10.1016/j.molimm.2007.02.007; Wang TY, 2001, J IMMUNOL, V167, P6924, DOI 10.4049/jimmunol.167.12.6924; Wu J, 2008, CELL RES, V18, P649, DOI 10.1038/cr.2008.57; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351	39	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33088	33096		10.1074/jbc.M109.050757	http://dx.doi.org/10.1074/jbc.M109.050757			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801549	Green Published, hybrid			2022-12-27	WOS:000272028500012
J	Jonsson, TJ; Johnson, LC; Lowther, WT				Joensson, Thomas J.; Johnson, Lynnette C.; Lowther, W. Todd			Protein Engineering of the Quaternary Sulfiredoxin center dot Peroxiredoxin Enzyme center dot Substrate Complex Reveals the Molecular Basis for Cysteine Sulfinic Acid Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; STRUCTURAL BASIS; THIOSULFINATE INTERMEDIATE; MAMMALIAN SULFIREDOXIN; 2-CYS PEROXIREDOXIN; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; REDUCTION; MECHANISM; DSBD	Oxidative stress can damage the active site cysteine of the antioxidant enzyme peroxiredoxin (Prx) to the sulfinic acid form, Prx-SO2-. This modification leads to inactivation. Sulfiredoxin (Srx) utilizes a unique ATP-Mg2+-dependent mechanism to repair the Prx molecule. Using selective protein engineering that involves disulfide bond formation and site-directed mutagenesis, a mimic of the enzyme.substrate complex has been trapped. Here, we present the 2.1 angstrom crystal structure of human Srx in complex with PrxI, ATP, and Mg2+. The Cys(52) sulfinic acid moiety was substituted by mutating this residue to Asp, leading to a replacement of the sulfur atom with a carbon atom. Because the Srx reaction cannot occur, the structural changes in the Prx active site that lead to the attack on ATP may be visualized. The local unfolding of the helix containing C52D resulted in the packing of Phe(50) in PrxI within a hydrophobic pocket of Srx. Importantly, this structural rearrangement positioned one of the oxygen atoms of Asp(52) within 4.3 angstrom of the gamma-phosphate of ATP bound to Srx. These observations support a mechanism where phosphorylation of Prx-SO2- is the first chemical step.	[Lowther, W. Todd] Wake Forest Univ, Sch Med, Struct Biol Ctr, Winston Salem, NC 27157 USA; Wake Forest Univ, Sch Med, Dept Biochem, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest University	Lowther, WT (corresponding author), Wake Forest Univ, Sch Med, Struct Biol Ctr, Med Ctr Blvd, Winston Salem, NC 27157 USA.	tlowther@wfubmc.edu			National Institutes of Health [R01GM072866]; American Heart Association Postdoctoral Fellowship [0725399U]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072866] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Postdoctoral Fellowship(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM072866 ( to W. T. L.). This work was also supported by American Heart Association Postdoctoral Fellowship 0725399U ( to T. J. J.).	Banatao DR, 2006, P NATL ACAD SCI USA, V103, P16230, DOI 10.1073/pnas.0607674103; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Bozonet SM, 2005, J BIOL CHEM, V280, P23319, DOI 10.1074/jbc.M502757200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chang TS, 2004, J BIOL CHEM, V279, P50994, DOI 10.1074/jbc.M409482200; Chevallet M, 2003, J BIOL CHEM, V278, P37146, DOI 10.1074/jbc.M305161200; Corn JE, 2007, STRUCTURE, V15, P773, DOI 10.1016/j.str.2007.05.006; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Giles GI, 2002, BIOL CHEM, V383, P375, DOI 10.1515/BC.2002.042; Haebel PW, 2002, EMBO J, V21, P4774, DOI 10.1093/emboj/cdf489; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Jeong W, 2006, J BIOL CHEM, V281, P14400, DOI 10.1074/jbc.M511082200; Joensson Thomas J., 2007, V44, P115; Jonsson TJ, 2008, J BIOL CHEM, V283, P22890, DOI [10.1074/jbc.C800124200, 10.1074/jbc.M803244200]; Jonsson TJ, 2008, NATURE, V451, P98, DOI 10.1038/nature06415; Jonsson TJ, 2005, BIOCHEMISTRY-US, V44, P8634, DOI 10.1021/bi050131i; Karplus P. Andrew, 2007, V44, P41; Lennon BW, 2000, SCIENCE, V289, P1190, DOI 10.1126/science.289.5482.1190; MATSUMURA M, 1991, METHOD ENZYMOL, V202, P336; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Phalen TJ, 2006, J CELL BIOL, V175, P779, DOI 10.1083/jcb.200606005; Purich DL, 2002, METHOD ENZYMOL, V354, P1; Roussel X, 2008, J BIOL CHEM, V283, P22371, DOI 10.1074/jbc.M800493200; Rozhkova A, 2004, EMBO J, V23, P1709, DOI 10.1038/sj.emboj.7600178; Schroder E, 2000, STRUCTURE, V8, P605, DOI 10.1016/S0969-2126(00)00147-7; Stirnimann CU, 2005, STRUCTURE, V13, P985, DOI 10.1016/j.str.2005.04.014; Verdine GL, 2003, ANNU REV BIOCHEM, V72, P337, DOI 10.1146/annurev.biochem.72.121801.161447; Vivancos AP, 2005, P NATL ACAD SCI USA, V102, P8875, DOI 10.1073/pnas.0503251102; Woo HA, 2005, J BIOL CHEM, V280, P3125, DOI 10.1074/jbc.C400496200; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8	35	38	38	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33305	33310		10.1074/jbc.M109.036400	http://dx.doi.org/10.1074/jbc.M109.036400			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19812042	Green Published, hybrid			2022-12-27	WOS:000272028500035
J	Ayon, R; Sones, W; Forrest, AS; Wiwchar, M; Valencik, ML; Sanguinetti, AR; Perrino, BA; Greenwood, IA; Leblanc, N				Ayon, Ramon; Sones, William; Forrest, Abigail S.; Wiwchar, Michael; Valencik, Maria L.; Sanguinetti, Amy R.; Perrino, Brian A.; Greenwood, Iain A.; Leblanc, Normand			Complex Phosphatase Regulation of Ca2+-activated Cl- Currents in Pulmonary Arterial Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED CHLORIDE CHANNELS; PROTEIN PHOSPHATASE; OKADAIC ACID; CALCINEURIN; PHOSPHORYLATION; 2A; INHIBITION; PP2A; INACTIVATION; CONDUCTANCE	The present study was undertaken to determine whether the two ubiquitously expressed Ca2+-independent phosphatases PP1 and PP2A regulate Ca2+-activated Cl- currents (I-Cl(Ca)) elicited by 500 nM [Ca2+](i) in rabbit pulmonary artery (PA) myocytes dialyzed with or without 3 mm ATP. Reverse transcription-PCR experiments revealed the expression of PP1 alpha, PP1 beta/delta, PP1 gamma, PP2A alpha, PP2A beta, PP2B alpha (calcineurin (CaN) A alpha), and PP2B beta (CaN A beta) but not PP2B gamma (CaN A gamma) in rabbit PA. Western blot and immunofluorescence experiments confirmed the presence of all three PP1 isoforms and PP2A. Intracellular dialysis with a peptide inhibitor of calcineurin (CaN-AIP); the nonselective PP1/PP2A inhibitors okadaic acid (0.5, 10, or 30 nM), calyculin A (10 nM), or cantharidin (100 nM); and the selective PP1 inhibitor NIPP-1 (100 pM) potently antagonized the recovery of I-Cl(Ca) in cells dialyzed with no ATP, whereas the PP2A-selective antagonist fostriecin (30 or 150 nM) was ineffective. The combined application of okadaic acid (10 nM) and CaN-autoinhibitory peptide (50 mu M) did not potentiate the response of I-Cl(Ca) in 0 ATP produced by maximally inhibiting CaN or PP1/PP2A alone. Consistent with the non-additive effects of either classes of phosphatases, the PP1 inhibitor NIPP-1 (100 pM) antagonized the recovery of I-Cl(Ca) induced by exogenous CaN A alpha (0.5 mu M). These results demonstrate that ICl( Ca) in PA myocytes is regulated by CaN and PP1 and/or PP2A. Our data also suggest the existence of a functional link between these two classes of phosphatases.	[Leblanc, Normand] Univ Nevada, Sch Med, Dept Pharmacol, Ctr Biomed Res Excellence, Reno, NV 89557 USA; [Perrino, Brian A.] Univ Nevada, Sch Med, Dept Physiol & Cell Biol, Ctr Biomed Res Excellence, Reno, NV 89557 USA; [Valencik, Maria L.] Univ Nevada, Sch Med, Dept Biochem, Ctr Biomed Res Excellence, Reno, NV 89557 USA; [Sones, William; Greenwood, Iain A.] Univ London, Div Basic Med Sci, London SW17 0RE, England	Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno; University of London	Leblanc, N (corresponding author), Univ Nevada, Sch Med, Dept Pharmacol, Ctr Biomed Res Excellence, MS 318, Reno, NV 89557 USA.	NLeblanc@Medicine.Nevada.edu	Ayon, Ramon/AAG-8431-2019	Ayon, Ramon/0000-0003-1016-8205; Leblanc, Normand/0000-0002-1090-9432; Greenwood, Iain/0000-0002-0603-0492	National Institutes of Health [5 RO1 HL 075477]; British Heart Foundation [PG/05/038]; National Institutes of Health; National Center for Research Resources [5 P20 RR15581, NCRR 5 P20 RR15581, 5 PPG HL 76611, NCRR 5 P20 RR018751]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018751, P20RR015581] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075477, P01HL076611, F31HL090023] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Heart Foundation(British Heart Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant 5 RO1 HL 075477. This work was also supported by British Heart Foundation Grants PG/05/038 (to I. A. G.). This work was also made possible by National Institutes of Health, National Center for Research Resources, Grants NCRR 5 P20 RR15581 (to N. L.), NCRR 5 P20 RR15581 and 5 PPG HL 76611 (to M. L. V.), and NCRR 5 P20 RR018751 (to B. A. P.), supporting two Centers of Biomedical Research Excellence at the University of Nevada School of Medicine (Reno, NV).	Angermann JE, 2006, J GEN PHYSIOL, V128, P73, DOI 10.1085/jgp.200609507; BARNES GN, 1995, J NEUROCHEM, V64, P340; BERGER HA, 1993, J BIOL CHEM, V268, P2037; BEULLENS M, 1992, J BIOL CHEM, V267, P16538; Beullens M, 2000, BIOCHEM J, V352, P651, DOI 10.1042/0264-6021:3520651; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Chipperfield AR, 2000, PROG BIOPHYS MOL BIO, V74, P175, DOI 10.1016/S0079-6107(00)00024-9; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; Cohen PTW, 2002, J CELL SCI, V115, P241; Comerford KM, 2006, J CELL PHYSIOL, V209, P211, DOI 10.1002/jcp.20726; Greenwood IA, 2004, J BIOL CHEM, V279, P38830, DOI 10.1074/jbc.M406234200; Greenwood IA, 2001, J PHYSIOL-LONDON, V534, P395, DOI 10.1111/j.1469-7793.2001.00395.x; Groschner K, 1996, BIOCHEM J, V318, P513, DOI 10.1042/bj3180513; Hartshorne DJ, 2004, J BIOL CHEM, V279, P37211, DOI 10.1074/jbc.R400018200; Hartzell HC, 2008, PHYSIOL REV, V88, P639, DOI 10.1152/physrev.00022.2007; HAYSTEAD TAJ, 1989, NATURE, V337, P78, DOI 10.1038/337078a0; HONKANEN RE, 1993, FEBS LETT, V330, P283, DOI 10.1016/0014-5793(93)80889-3; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; Large WA, 1996, AM J PHYSIOL-CELL PH, V271, pC435; Leblanc N, 2005, CAN J PHYSIOL PHARM, V83, P541, DOI 10.1139/Y05-040; Ledoux J, 2003, J PHYSIOL-LONDON, V552, P701, DOI 10.1113/jphysiol.2003.043836; Luo JX, 1998, AM J PHYSIOL-CELL PH, V274, pC1397, DOI 10.1152/ajpcell.1998.274.5.C1397; Marmorstein LY, 2002, J BIOL CHEM, V277, P30591, DOI 10.1074/jbc.M204269200; MCDANIEL NL, 1994, CAN J PHYSIOL PHARM, V72, P1380, DOI 10.1139/y94-199; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; OBARA K, 1993, AM J PHYSIOL, V264, pC296, DOI 10.1152/ajpcell.1993.264.2.C296; Perrino BA, 2002, EUR J BIOCHEM, V269, P3540, DOI 10.1046/j.1432-1033.2002.03040.x; PERRINO BA, 1995, J BIOL CHEM, V270, P340, DOI 10.1074/jbc.270.1.340; PERRINO BA, 1992, J BIOL CHEM, V267, P15965; PERRINO BA, 1998, BIOCH PHARM CALMODUL, P169; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Sheppeck JE, 1997, BIOORGAN MED CHEM, V5, P1739, DOI 10.1016/S0968-0896(97)00146-6; SHIMA H, 1993, BIOCHEM BIOPH RES CO, V194, P930, DOI 10.1006/bbrc.1993.1910; Strack S, 1997, J NEUROCHEM, V68, P2119; Tchivilev I, 2008, J BIOL CHEM, V283, P22193, DOI 10.1074/jbc.M803452200; Walsh AH, 1997, FEBS LETT, V416, P230, DOI 10.1016/S0014-5793(97)01210-6; Wang YX, 1997, P NATL ACAD SCI USA, V94, P14918, DOI 10.1073/pnas.94.26.14918; WIWCHAR M, 2009, BR J PHARM IN PRESS; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Zhou XB, 1996, J BIOL CHEM, V271, P19760, DOI 10.1074/jbc.271.33.19760	45	15	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32507	32521		10.1074/jbc.M109.050401	http://dx.doi.org/10.1074/jbc.M109.050401			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19767392	Green Published, hybrid			2022-12-27	WOS:000272028400033
J	Muradov, H; Boyd, KK; Haeri, M; Kerov, V; Knox, BE; Artemyev, NO				Muradov, Hakim; Boyd, Kimberly K.; Haeri, Mohammad; Kerov, Vasily; Knox, Barry E.; Artemyev, Nikolai O.			Characterization of Human Cone Phosphodiesterase-6 Ectopically Expressed in Xenopus laevis Rods	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTORECEPTOR CGMP PHOSPHODIESTERASE; CYCLIC-GMP PHOSPHODIESTERASE; LEBER CONGENITAL AMAUROSIS; ACID-RICH PROTEINS; LATERAL DIFFUSION; FUSION PROTEIN; GATED CHANNEL; BETA-SUBUNIT; RHODOPSIN; PHOTOTRANSDUCTION	PDE6 (phosphodiesterase-6) is the effector molecule in the vertebrate phototransduction cascade. Progress in understanding the structure and function of PDE6 has been hindered by lack of an expression system of the enzyme. Here we report ectopic expression and analysis of compartmentalization and membrane dynamics of the enhanced green fluorescent protein (EGFP) fusion protein of human cone PDE6C in rods of transgenic Xenopus laevis. EGFP-PDE6C is correctly targeted to the rod outer segments in transgenic Xenopus, where it displayed a characteristic striated pattern of EGFP fluorescence. Immunofluorescence labeling indicated significant and light-independent co-localization of EGFP-PDE6C with the disc rim marker peripherin-2 and endogenous frog PDE6. The diffusion of EGFP-PDE6C on disc membranes investigated with fluorescence recovery after photobleaching was markedly slower than theoretically predicted. The enzymatic characteristics of immunoprecipitated recombinant PDE6C were similar to known properties of the native bovine PDE6C. PDE6C was potently inhibited by the cone- and rod-specific PDE6 gamma-subunits. Thus, transgenic Xenopus laevis is a unique expression system for PDE6 well suited for analysis of the mechanisms of visual diseases linked to PDE6 mutations.	Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Haeri, Mohammad; Knox, Barry E.] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA; [Knox, Barry E.] SUNY Upstate Med Univ, Dept Ophthalmol, Syracuse, NY 13210 USA	University of Iowa; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center		nikolai-artemyev@uiowa.edu		Artemyev, Nikolai/0000-0002-5266-6854	National Institutes of Health [EY-10843]; NATIONAL EYE INSTITUTE [R01EY010843] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY-10843 (to N. O. A.).	ANANT JS, 1992, J BIOL CHEM, V267, P687; Burns ME, 2005, NEURON, V48, P387, DOI 10.1016/j.neuron.2005.10.014; CHANG B, 2009, P NATL ACAD IN PRESS; Chen J, 2008, MOL VIS, V14, P2509; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Cook TA, 2000, BIOCHEMISTRY-US, V39, P13516, DOI 10.1021/bi001070l; Dryja TP, 1999, INVEST OPHTH VIS SCI, V40, P1859; Fu YB, 2007, PFLUG ARCH EUR J PHY, V454, P805, DOI 10.1007/s00424-006-0194-y; GILLESPIE PG, 1989, J BIOL CHEM, V264, P12187; GILLESPIE PG, 1988, J BIOL CHEM, V263, P8133; GILLESPIE PG, 1989, MOL PHARMACOL, V36, P773; Granovsky AE, 1998, J BIOL CHEM, V273, P24485, DOI 10.1074/jbc.273.38.24485; Granovsky AE, 2001, J BIOL CHEM, V276, P21698, DOI 10.1074/jbc.M100626200; Granovsky AE, 2000, J BIOL CHEM, V275, P41258, DOI 10.1074/jbc.M008094200; HAMILTON SE, 1993, FEBS LETT, V318, P157, DOI 10.1016/0014-5793(93)80012-J; HAMILTON SE, 1990, J BIOL CHEM, V265, P11259; Jin S, 2003, FEBS LETT, V542, P142, DOI 10.1016/S0014-5793(03)00368-5; Karan S, 2008, VISION RES, V48, P442, DOI 10.1016/j.visres.2007.08.020; Korschen HG, 1999, NATURE, V400, P761, DOI 10.1038/23468; KORSCHEN HG, 1995, NEURON, V15, P627, DOI 10.1016/0896-6273(95)90151-5; Kroll KL, 1996, DEVELOPMENT, V122, P3173; Lamb TD, 2006, INVEST OPHTH VIS SCI, V47, P5138, DOI 10.1167/iovs.06-0849; Liu XQ, 2004, P NATL ACAD SCI USA, V101, P13903, DOI 10.1073/pnas.0405160101; LIU XR, 1994, EXP EYE RES, V59, P761, DOI 10.1006/exer.1994.1162; Loewen CJR, 2003, MOL BIOL CELL, V14, P3400, DOI 10.1091/mbc.e03-02-0077; Mani SS, 2001, J BIOL CHEM, V276, P36557, DOI 10.1074/jbc.M101685200; MCLAUGHLIN ME, 1995, P NATL ACAD SCI USA, V92, P3249, DOI 10.1073/pnas.92.8.3249; Moritz OL, 2001, J BIOL CHEM, V276, P28242, DOI 10.1074/jbc.M101476200; Muradov H, 2006, VISION RES, V46, P860, DOI 10.1016/j.visres.2005.09.015; Muradov H, 2007, BIOCHEMISTRY-US, V46, P9992, DOI 10.1021/bi700535s; Norton AW, 2005, J BIOL CHEM, V280, P1248, DOI 10.1074/jbc.M410475200; Pentia DC, 2006, J BIOL CHEM, V281, P5500, DOI 10.1074/jbc.M507488200; Poetsch A, 2001, J BIOL CHEM, V276, P48009, DOI 10.1074/jbc.M108941200; POO MM, 1974, NATURE, V247, P438, DOI 10.1038/247438a0; Ramamurthy V, 2004, P NATL ACAD SCI USA, V101, P13897, DOI 10.1073/pnas.0404197101; SAFFMAN PG, 1975, P NATL ACAD SCI USA, V72, P3111, DOI 10.1073/pnas.72.8.3111; Sohocki MM, 2000, MOL GENET METAB, V70, P142, DOI 10.1006/mgme.2000.3001; Wang Q, 2008, J BIOL CHEM, V283, P30015, DOI 10.1074/jbc.M803953200; WEY CL, 1981, BIOPHYS J, V33, P225, DOI 10.1016/S0006-3495(81)84883-7; White JB, 2004, MOL VIS, V10, P738; Zhang XJ, 2005, FRONT BIOSCI-LANDMRK, V10, P1191, DOI 10.2741/1612	41	24	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32662	32669		10.1074/jbc.M109.049916	http://dx.doi.org/10.1074/jbc.M109.049916			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19801642	Green Published, hybrid			2022-12-27	WOS:000272028400049
J	Shulla, A; Gallagher, T				Shulla, Ana; Gallagher, Tom			Role of Spike Protein Endodomains in Regulating Coronavirus Entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE RESPIRATORY SYNDROME; INFLUENZA-VIRUS HEMAGGLUTININ; MOUSE HEPATITIS-VIRUS; TYPE-1 ENVELOPE GLYCOPROTEIN; MEDIATED MEMBRANE-FUSION; CYSTEINE-RICH DOMAIN; MURINE CORONAVIRUS; CELL-FUSION; CYTOPLASMIC TAIL; PORE FORMATION	Enveloped viruses enter cells by viral glycoprotein-mediated binding to host cells and subsequent fusion of virus and host cell membranes. For the coronaviruses, viral spike (S) proteins execute these cell entry functions. The S proteins are set apart from other viral and cellular membrane fusion proteins by their extensively palmitoylated membrane-associated tails. Palmitate adducts are generally required for protein-mediated fusions, but their precise roles in the process are unclear. To obtain additional insights into the S-mediated membrane fusion process, we focused on these acylated carboxyl-terminal intravirion tails. Substituting alanines for the cysteines that are subject to palmitoylation had effects on both S incorporation into virions and S-mediated membrane fusions. In specifically dissecting the effects of endodomain mutations on the fusion process, we used antiviral heptad repeat peptides that bind only to folding intermediates in the S-mediated fusion process and found that mutants lacking three palmitoylated cysteines remained in transitional folding states nearly 10 times longer than native S proteins. This slower refolding was also reflected in the paucity of postfusion six-helix bundle configurations among the mutant S proteins. Viruses with fewer palmitoylated S protein cysteines entered cells slowly and had reduced specific infectivities. These findings indicate that lipid adducts anchoring S proteins into virus membranes are necessary for the rapid, productive S protein refolding events that culminate in membrane fusions. These studies reveal a previously unappreciated role for covalently attached lipids on the endodomains of viral proteins eliciting membrane fusion reactions.	[Shulla, Ana; Gallagher, Tom] Loyola Univ, Dept Microbiol & Immunol, Med Ctr, Maywood, IL 60153 USA	Loyola University Chicago	Gallagher, T (corresponding author), Loyola Univ, Dept Microbiol & Immunol, Med Ctr, 2160 S 1st Ave, Maywood, IL 60153 USA.	tgallag@lumc.edu			National Institutes of Health [R01 AI60030]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060030] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI60030.	Abrahamyan LG, 2005, J VIROL, V79, P106, DOI 10.1128/JVI.79.1.106-115.2005; Abrami L, 2008, P NATL ACAD SCI USA, V105, P5384, DOI 10.1073/pnas.0710389105; Aoki Y, 1998, VIROLOGY, V250, P140, DOI 10.1006/viro.1998.9361; Bissonnette MLZ, 2009, J MOL BIOL, V386, P14, DOI 10.1016/j.jmb.2008.12.029; Bos ECW, 1995, VIROLOGY, V214, P453, DOI 10.1006/viro.1995.0056; Boscarino JA, 2008, J VIROL, V82, P2989, DOI 10.1128/JVI.01906-07; Bosch BJ, 2005, VIROLOGY, V334, P306, DOI 10.1016/j.virol.2005.02.001; Bosch BJ, 2004, P NATL ACAD SCI USA, V101, P8455, DOI 10.1073/pnas.0400576101; Bosch BJ, 2003, J VIROL, V77, P8801, DOI 10.1128/JVI.77.16.8801-8811.2003; Broer R, 2006, J VIROL, V80, P1302, DOI 10.1128/JVI.80.3.1302-1310.2006; Cathomen T, 1998, J VIROL, V72, P1224, DOI 10.1128/JVI.72.2.1224-1234.1998; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Chang KW, 2001, ADV EXP MED BIOL, V494, P205; Chang KW, 2000, VIROLOGY, V269, P212, DOI 10.1006/viro.2000.0219; Chen BJ, 2005, J VIROL, V79, P13673, DOI 10.1128/JVI.79.21.13673-13684.2005; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Cohen FS, 2004, J MEMBRANE BIOL, V199, P1, DOI 10.1007/s00232-004-0669-8; de Haan CAM, 2003, J VIROL, V77, P11312, DOI 10.1128/JVI.77.21.11312-11323.2003; de Haan CAM, 1999, J VIROL, V73, P7441, DOI 10.1128/JVI.73.9.7441-7452.1999; DEGROOT RJ, 1987, J MOL BIOL, V196, P963, DOI 10.1016/0022-2836(87)90422-0; DELMAS B, 1990, J VIROL, V64, P5367, DOI 10.1128/JVI.64.11.5367-5375.1990; FLEMING JO, 1983, VIROLOGY, V131, P296, DOI 10.1016/0042-6822(83)90498-1; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; Gallagher TM, 1997, J VIROL, V71, P3129, DOI 10.1128/JVI.71.4.3129-3137.1997; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GREEN N, 1981, P NATL ACAD SCI-BIOL, V78, P6023, DOI 10.1073/pnas.78.10.6023; GROSSE B, 1994, VIROLOGY, V202, P814, DOI 10.1006/viro.1994.1403; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; HELSETH E, 1990, J VIROL, V64, P6314, DOI 10.1128/JVI.64.12.6314-6318.1990; KEMBLE GW, 1994, CELL, V76, P383, DOI 10.1016/0092-8674(94)90344-1; KRIJNSELOCKER J, 1994, J CELL BIOL, V124, P55, DOI 10.1083/jcb.124.1.55; Krueger DK, 2001, J VIROL, V75, P2792, DOI 10.1128/JVI.75.6.2792-2802.2001; Kuo LL, 2000, J VIROL, V74, P1393, DOI 10.1128/JVI.74.3.1393-1406.2000; Langosch D, 2007, CELL MOL LIFE SCI, V64, P850, DOI 10.1007/s00018-007-6439-x; Madu IG, 2009, J VIROL, V83, P7411, DOI 10.1128/JVI.00079-09; Markosyan RM, 2003, MOL BIOL CELL, V14, P926, DOI 10.1091/mbc.E02-09-0573; Masters PS, 2006, ADV EXP MED BIOL, V581, P163; Masters PS, 2005, CURR TOP MICROBIOL, V287, P133, DOI 10.1007/3-540-26765-4_5; Matsuyama S, 2002, J VIROL, V76, P11819, DOI 10.1128/JVI.76.23.11819-11826.2002; McReynolds S, 2008, BIOCHEMISTRY-US, V47, P6802, DOI 10.1021/bi800622t; McShane Marisa P, 2005, Methods Mol Biol, V292, P187; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Melikyan GB, 1999, MOL BIOL CELL, V10, P1821, DOI 10.1091/mbc.10.6.1821; Melkonian KA, 1999, J BIOL CHEM, V274, P3910, DOI 10.1074/jbc.274.6.3910; Mothes W, 2000, CELL, V103, P679, DOI 10.1016/S0092-8674(00)00170-7; Nguyen DH, 2000, J VIROL, V74, P3264, DOI 10.1128/JVI.74.7.3264-3272.2000; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ono A, 2001, P NATL ACAD SCI USA, V98, P13925, DOI 10.1073/pnas.241320298; OPSTELTEN DJE, 1995, J CELL BIOL, V131, P339, DOI 10.1083/jcb.131.2.339; PEDERSEN NC, 1981, AM J VET RES, V42, P368; Petit CM, 2007, VIROLOGY, V360, P264, DOI 10.1016/j.virol.2006.10.034; Qiu ZZ, 2006, J VIROL, V80, P5768, DOI 10.1128/JVI.00442-06; Rao PV, 1998, J VIROL, V72, P3278, DOI 10.1128/JVI.72.4.3278-3288.1998; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Rousso I, 2000, P NATL ACAD SCI USA, V97, P13523, DOI 10.1073/pnas.240459697; Sakai T, 2002, J VIROL, V76, P4603, DOI 10.1128/JVI.76.9.4603-4611.2002; Shang L, 2008, J VIROL, V82, P5417, DOI 10.1128/JVI.02666-07; Simmons G, 2004, P NATL ACAD SCI USA, V101, P4240, DOI 10.1073/pnas.0306446101; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; STURMAN LS, 1972, INFECT IMMUN, V6, P501, DOI 10.1128/IAI.6.4.501-507.1972; Supekar VM, 2004, P NATL ACAD SCI USA, V101, P17958, DOI 10.1073/pnas.0406128102; Thorp EB, 2006, J VIROL, V80, P1280, DOI 10.1128/JVI.80.3.1280-1289.2006; TOOZE J, 1984, EUR J CELL BIOL, V33, P281; Tripet B, 2004, J BIOL CHEM, V279, P20836, DOI 10.1074/jbc.M400759200; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; VEIT M, 1991, J VIROL, V65, P2491, DOI 10.1128/JVI.65.5.2491-2500.1991; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; WIGLER M, 1978, CELL, V14, P725, DOI 10.1016/0092-8674(78)90254-4; Wyss S, 2005, J VIROL, V79, P12231, DOI 10.1128/JVI.79.19.12231-12241.2005; Xu YH, 2004, J BIOL CHEM, V279, P30514, DOI 10.1074/jbc.M403760200; Yan Z, 2006, J STRUCT BIOL, V155, P162, DOI 10.1016/j.jsb.2006.03.024; Yang CL, 1996, J VIROL, V70, P248, DOI 10.1128/JVI.70.1.248-254.1996; YANG CL, 1995, P NATL ACAD SCI USA, V92, P9871, DOI 10.1073/pnas.92.21.9871; Yang L, 2002, SCIENCE, V297, P1877, DOI 10.1126/science.1074354; Ye R, 2004, J VIROL, V78, P9904, DOI 10.1128/JVI.78.18.9904-9917.2004; Yin HS, 2005, P NATL ACAD SCI USA, V102, P9288, DOI 10.1073/pnas.0503989102; Zelus BD, 2003, J VIROL, V77, P830, DOI 10.1128/JVI.77.2.830-840.2003; Zhang J, 2000, J VIROL, V74, P4634, DOI 10.1128/JVI.74.10.4634-4644.2000; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817	82	50	51	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32725	32734		10.1074/jbc.M109.043547	http://dx.doi.org/10.1074/jbc.M109.043547			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19801669	Green Published, hybrid			2022-12-27	WOS:000272028400057
J	Zhang, YB; Huypens, P; Adamson, AW; Chang, JS; Henagan, TM; Boudreau, A; Lenard, NR; Burk, D; Klein, J; Perwitz, N; Shin, JH; Fasshauer, M; Kralli, A; Gettys, TW				Zhang, Yubin; Huypens, Peter; Adamson, Aaron W.; Chang, Ji Suk; Henagan, Tara M.; Boudreau, Anik; Lenard, Natalie R.; Burk, David; Klein, Johannes; Perwitz, Nina; Shin, Jeho; Fasshauer, Mathias; Kralli, Anastasia; Gettys, Thomas W.			Alternative mRNA Splicing Produces a Novel Biologically Active Short Isoform of PGC-1 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-GAMMA COACTIVATOR-1; FATTY-ACID OXIDATION; TRANSCRIPTIONAL COACTIVATOR; HEPATIC GLUCONEOGENESIS; MITOCHONDRIAL BIOGENESIS; SKELETAL-MUSCLE; GENE-EXPRESSION; ADIPOSE-TISSUE; PROTEIN-KINASE; ACTIVATION	The transcriptional co-activator PGC-1 alpha regulates functional plasticity in adipose tissue by linking sympathetic input to the transcriptional program of adaptive thermogenesis. We report here a novel truncated form of PGC-1 alpha (NT-PGC-1 alpha) produced by alternative 3' splicing that introduces an in-frame stop codon into PGC-1 alpha mRNA. The expressed protein includes the first 267 amino acids of PGC-1 alpha and 3 additional amino acids from the splicing insert. NT-PGC-1 alpha contains the transactivation and nuclear receptor interaction domains but is missing key domains involved in nuclear localization, interaction with other transcription factors, and protein degradation. Expression and subcellular localization of NT-PGC-1 alpha are dynamically regulated in the context of physiological signals that regulate full-length PGC-1 alpha, but the truncated domain structure conveys unique properties with respect to protein-protein interactions, protein stability, and recruitment to target gene promoters. Therefore, NT-PGC-1 alpha is a co-expressed, previously unrecognized form of PGC-1 alpha with functions that are both unique from and complementary to PGC-1 alpha.	[Lenard, Natalie R.; Burk, David; Shin, Jeho; Gettys, Thomas W.] Pennington Biomed Res Ctr, Lab Nutrient Sensing & Adipocyte Signaling, Baton Rouge, LA 70808 USA; [Kralli, Anastasia] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Klein, Johannes; Perwitz, Nina] Univ Lubeck, Dept Internal Med 1, D-23538 Lubeck, Germany; [Fasshauer, Mathias] Univ Leipzig, Dept Internal Med 3, D-04103 Leipzig, Germany	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Scripps Research Institute; University of Lubeck; Leipzig University	Gettys, TW (corresponding author), Pennington Biomed Res Ctr, Lab Nutrient Sensing & Adipocyte Signaling, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	gettystw@pbrc.edu	Lenard, Natalie/AFQ-8559-2022; Burk, David/D-2056-2009; Huypens, Peter/B-3617-2010; Chang, Ji Suk/N-1957-2017; Gettys, Thomas W/N-1964-2017	Lenard, Natalie/0000-0002-2093-4869; Huypens, Peter/0000-0001-7922-5787; Gettys, Thomas W/0000-0001-7125-7995; Henagan, Tara/0000-0001-5314-0128	National Institutes of Health [RO1 DK 074772, P20-RR021945, 5 U42 RR006042-19]; CNRU Center [1P30 DK072476, T32 DK064584, DK064951, DK074660]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021945, U42RR006042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074772, T32DK064584, R21DK074660, R01DK064951, P30DK072476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM118430, P20GM103528] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CNRU Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK 074772 (to T. W. G.) and P20-RR021945 (to T. W. G.), CNRU Center Grant 1P30 DK072476, and Grants T32 DK064584 (to A. W. A.), DK064951 (to A. K.), and DK074660 (to A. K.). Tissues were procured by the National Disease Research Interchange (NDRI) with support from National Institutes of Health Grant 5 U42 RR006042-19.	Adamson AW, 2006, BIOCHEM J, V399, P285, DOI 10.1042/BJ20060659; Bogacka I, 2005, DIABETES, V54, P1392, DOI 10.2337/diabetes.54.5.1392; Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Commins SP, 1999, ENDOCRINOLOGY, V140, P292, DOI 10.1210/en.140.1.292; Cyert MS, 2001, J BIOL CHEM, V276, P20805, DOI 10.1074/jbc.R100012200; Fasshauer M, 2001, MOL CELL BIOL, V21, P319, DOI 10.1128/MCB.21.1.319-329.2001; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Green RE, 2003, BIOINFORMATICS, V19, pi118, DOI 10.1093/bioinformatics/btg1015; Grosso AR, 2008, NUCLEIC ACIDS RES, V36, P4823, DOI 10.1093/nar/gkn463; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Housley MP, 2009, J BIOL CHEM, V284, P5148, DOI 10.1074/jbc.M808890200; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Klein J, 1999, J BIOL CHEM, V274, P34795, DOI 10.1074/jbc.274.49.34795; Knutti D, 2001, P NATL ACAD SCI USA, V98, P9713, DOI 10.1073/pnas.171184698; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098; Miura S, 2008, ENDOCRINOLOGY, V149, P4527, DOI 10.1210/en.2008-0466; Monsalve M, 2000, MOL CELL, V6, P307, DOI 10.1016/S1097-2765(00)00031-9; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Oberkofler H, 2002, J BIOL CHEM, V277, P16750, DOI 10.1074/jbc.M200475200; Olson BL, 2008, GENE DEV, V22, P252, DOI 10.1101/gad.1624208; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Rim JS, 2002, J BIOL CHEM, V277, P34589, DOI 10.1074/jbc.M108866200; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sano M, 2007, J BIOL CHEM, V282, P25970, DOI 10.1074/jbc.M703634200; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Teyssier C, 2005, GENE DEV, V19, P1466, DOI 10.1101/gad.1295005; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Wallberg AE, 2003, MOL CELL, V12, P1137, DOI 10.1016/S1097-2765(03)00391-5; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang YB, 2005, FASEB J, V19, P1482, DOI 10.1096/fj.05-3851com	46	104	109	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32813	32826		10.1074/jbc.M109.037556	http://dx.doi.org/10.1074/jbc.M109.037556			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19773550	hybrid, Green Published			2022-12-27	WOS:000272028400066
J	Domanska, MK; Kiessling, V; Stein, A; Fasshauer, D; Tamm, LK				Domanska, Marta K.; Kiessling, Volker; Stein, Alexander; Fasshauer, Dirk; Tamm, Lukas K.			Single Vesicle Millisecond Fusion Kinetics Reveals Number of SNARE Complexes Optimal for Fast SNARE-mediated Membrane Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANAR SUPPORTED BILAYERS; FAST CNS SYNAPSE; TRANSMITTER RELEASE; EXOCYTOSIS; PROTEINS; SNAP-25; NEUROEXOCYTOSIS; BOTULINUM; ANATOMY; EVENTS	SNAREs mediate membrane fusion in intracellular vesicle traffic and neuronal exocytosis. Reconstitution of membrane fusion in vitro proved that SNAREs constitute the minimal fusion machinery. However, the slow fusion rates observed in these systems are incompatible with those required in neuro-transmission. Here we present a single vesicle fusion assay that records individual SNARE-mediated fusion events with millisecond time resolution. Docking and fusion of reconstituted synaptobrevin vesicles to target SNARE complex-containing planar membranes are distinguished by total internal reflection fluorescence microscopy as separate events. Docking and fusion are SNAP-25-dependent, require no Ca2+, and are efficient at room temperature. Analysis of the stochastic data with sequential and parallel multi-particle activation models reveals six to nine fast-activating steps. Of all the tested models, the kinetic model consisting of eight parallel reaction rates statistically fits the data best. This might be interpreted by fusion sites consisting of eight SNARE complexes that each activate in a single rate-limiting step in 8 ms.	[Domanska, Marta K.; Kiessling, Volker; Tamm, Lukas K.] Univ Virginia, Ctr Membrane Biol, Charlottesville, VA 22908 USA; [Domanska, Marta K.; Kiessling, Volker; Tamm, Lukas K.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Stein, Alexander; Fasshauer, Dirk] Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany	University of Virginia; University of Virginia; Max Planck Society	Tamm, LK (corresponding author), Univ Virginia, Ctr Membrane Biol, Charlottesville, VA 22908 USA.	Lkt2e@virginia.edu	Kiessling, Volker/A-3539-2008; Fasshauer, Dirk/B-1563-2013; Stein, Alexander/I-4950-2012	Fasshauer, Dirk/0000-0002-1040-4282; Stein, Alexander/0000-0002-2696-0611	National Institutes of Health [P01 GM72694]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM072694] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 GM72694.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bhalla A, 2006, NAT STRUCT MOL BIOL, V13, P323, DOI 10.1038/nsmb1076; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; Blumenthal R, 1996, J CELL BIOL, V135, P63, DOI 10.1083/jcb.135.1.63; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; Bowen ME, 2004, BIOPHYS J, V87, P3569, DOI 10.1529/biophysj.104.048637; Crane JM, 2005, LANGMUIR, V21, P1377, DOI 10.1021/la047654w; Fasshauer D, 2004, J BIOL CHEM, V279, P7613, DOI 10.1074/jbc.M312064200; Fasshauer D, 1999, J BIOL CHEM, V274, P15440, DOI 10.1074/jbc.274.22.15440; Fix M, 2004, P NATL ACAD SCI USA, V101, P7311, DOI 10.1073/pnas.0401779101; Floyd DL, 2008, P NATL ACAD SCI USA, V105, P15382, DOI 10.1073/pnas.0807771105; Han X, 2004, SCIENCE, V304, P289, DOI 10.1126/science.1095801; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hua YY, 2001, P NATL ACAD SCI USA, V98, P8065, DOI 10.1073/pnas.131214798; Jahn R, 1995, COLD SPRING HARB SYM, V60, P329, DOI 10.1101/SQB.1995.060.01.037; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; KALB E, 1992, BIOCHIM BIOPHYS ACTA, V1103, P307, DOI 10.1016/0005-2736(92)90101-Q; Kiessling V, 2006, BIOPHYS J, V91, P3313, DOI 10.1529/biophysj.106.091421; Liu TT, 2005, BIOPHYS J, V89, P2458, DOI 10.1529/biophysj.105.062539; Malsam J, 2008, CELL MOL LIFE SCI, V65, P2814, DOI 10.1007/s00018-008-8352-3; Montecucco C, 2005, TRENDS BIOCHEM SCI, V30, P367, DOI 10.1016/j.tibs.2005.05.002; Murray DH, 2009, BIOCHEMISTRY-US, V48, P4617, DOI 10.1021/bi9003217; Pobbati AV, 2006, SCIENCE, V313, P673, DOI 10.1126/science.1129486; Poirier MA, 1998, NAT STRUCT BIOL, V5, P765, DOI 10.1038/1799; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Schuette CG, 2004, P NATL ACAD SCI USA, V101, P2858, DOI 10.1073/pnas.0400044101; Sieber JJ, 2007, SCIENCE, V317, P1072, DOI 10.1126/science.1141727; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Stein A, 2007, NAT STRUCT MOL BIOL, V14, P904, DOI 10.1038/nsmb1305; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; TAMM LK, 1985, BIOPHYS J, V47, P105, DOI 10.1016/S0006-3495(85)83882-0; Wagner ML, 2001, BIOPHYS J, V81, P266, DOI 10.1016/S0006-3495(01)75697-4; Wagner ML, 2000, BIOPHYS J, V79, P1400, DOI 10.1016/S0006-3495(00)76392-2; Washbourne P, 2002, NAT NEUROSCI, V5, P19, DOI 10.1038/nn783; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wolfel M, 2003, J NEUROSCI, V23, P7059, DOI 10.1523/JNEUROSCI.23-18-07059.2003	38	133	134	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					32158	32166		10.1074/jbc.M109.047381	http://dx.doi.org/10.1074/jbc.M109.047381			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19759010	Green Published, hybrid			2022-12-27	WOS:000271572700070
J	Feng, HZ; Wei, B; Jin, JP				Feng, Han-Zhong; Wei, Bin; Jin, Jian-Ping			Deletion of a Genomic Segment Containing the Cardiac Troponin I Gene Knocks Down Expression of the Slow Troponin T Gene and Impairs Fatigue Tolerance of Diaphragm Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLU(180) NONSENSE MUTATION; N-TERMINAL TRUNCATION; SKELETAL-MUSCLE; NEMALINE MYOPATHY; FUNCTIONAL ADAPTATION; PROTEIN ISOFORMS; CONTRACTILITY; EVOLUTION; DISEASE; FIBERS	The loss of slow skeletal muscle troponin T (TnT) results in a recessive nemaline myopathy in the Amish featured with lethal respiratory failure. The genes encoding slow TnT and cardiac troponin I (TnI) are closely linked. Ex vivo promoter analysis suggested that the 5'-enhancer region of the slow TnT gene overlaps with the structure of the upstream cardiac TnI gene. Using transgenic expression of exogenous cardiac TnI to rescue the postnatal lethality of a mouse line in which the entire cardiac TnI gene was deleted, we investigated the effect of enhancer deletion on slow TnT gene expression in vivo and functional consequences. The levels of slow TnT mRNA and protein were significantly reduced in the diaphragm muscle of adult double transgenic mice. The slow TnT-deficient (ssTnT-KD) diaphragm muscle exhibited atrophy and decreased ratios of slow versus fast isoforms of TnT, TnI, and myosin. Consistent with the changes toward more fast myofilament contents, ssTnT-KD diaphragm muscle required stimulation at higher frequency for optimal tetanic force production. The ssTnT-KD diaphragm muscle also exhibited significantly reduced fatigue tolerance, showing faster and more declines of force with slower and less recovery from fatigue as compared with the wild type controls. The natural switch to more slow fiber contents during aging was partially blunted in the ssTnT-KD skeletal muscle. The data demonstrated a critical role of slow TnT in diaphragm function and in the pathogenesis and pathophysiology of Amish nemaline myopathy.	[Feng, Han-Zhong; Wei, Bin; Jin, Jian-Ping] Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48201 USA	Wayne State University	Jin, JP (corresponding author), Wayne State Univ, Sch Med, Dept Physiol, 540 E Canfield, Detroit, MI 48201 USA.	jjin@med.wayne.edu	Jin, Jian-Ping/AAD-1149-2020; Wei, Bin/M-2017-2014	Jin, JP/0000-0001-9932-1063	National Institutes of Health [AR-048816, HL-078773]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048816] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR-048816 and HL-078773 ( to J.- P. J.).	Barbato JC, 2005, J BIOL CHEM, V280, P6602, DOI 10.1074/jbc.M408525200; Brotto MA, 2006, AM J PHYSIOL-CELL PH, V290, pC567, DOI 10.1152/ajpcell.00422.2005; Cairns SP, 2007, J APPL PHYSIOL, V103, P359, DOI 10.1152/japplphysiol.01267.2006; Cairns SP, 2009, J APPL PHYSIOL, V106, P101, DOI 10.1152/japplphysiol.90878.2008; Chong SM, 2009, J MOL EVOL, V68, P448, DOI 10.1007/s00239-009-9202-0; Degens H., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P56; Feng HZ, 2008, J PHYSIOL-LONDON, V586, P3537, DOI 10.1113/jphysiol.2008.153577; Feng HZ, 2009, ARCH BIOCHEM BIOPHYS, V487, P36, DOI 10.1016/j.abb.2009.05.001; Feng HZ, 2008, J BIOL CHEM, V283, P33384, DOI 10.1074/jbc.M803302200; Gannon J, 2009, EUR J CELL BIOL, V88, P685, DOI 10.1016/j.ejcb.2009.06.004; Gomes AV, 2004, MOL CELL BIOCHEM, V263, P115, DOI 10.1023/B:MCBI.0000041853.20588.a0; Huang QQ, 1999, J MOL EVOL, V49, P780, DOI 10.1007/PL00006600; Huang XP, 1999, CIRC RES, V84, P1; Jin JP, 2008, CRIT REV EUKAR GENE, V18, P93, DOI 10.1615/CritRevEukarGeneExpr.v18.i2.10; Jin JP, 1998, GENE, V214, P121, DOI 10.1016/S0378-1119(98)00214-5; Jin JP, 2003, J BIOL CHEM, V278, P26159, DOI 10.1074/jbc.M303469200; Jin JP, 1996, BIOCHEM BIOPH RES CO, V225, P883, DOI 10.1006/bbrc.1996.1267; Johnston JJ, 2000, AM J HUM GENET, V67, P814, DOI 10.1086/303089; LARSSON L, 1979, J APPL PHYSIOL, V46, P451, DOI 10.1152/jappl.1979.46.3.451; LIN JJC, 1981, P NATL ACAD SCI-BIOL, V78, P2335, DOI 10.1073/pnas.78.4.2335; Perry SV, 1998, J MUSCLE RES CELL M, V19, P575; REISER PJ, 1994, AM J PHYSIOL-HEART C, V267, pH1589; SUBRAMANIAM A, 1993, J BIOL CHEM, V268, P4331; van Lunteren E, 2003, RESPIRATION, V70, P636, DOI 10.1159/000075211; Wang X, 2005, J BIOL CHEM, V280, P13241, DOI 10.1074/jbc.M413696200; Yu ZB, 2001, J BIOL CHEM, V276, P15753, DOI 10.1074/jbc.M011048200; Yu ZB, 2007, AM J PHYSIOL-CELL PH, V292, pC1192, DOI 10.1152/ajpcell.00462.2006	27	27	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31798	31806		10.1074/jbc.M109.020826	http://dx.doi.org/10.1074/jbc.M109.020826			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19797054	Green Published, hybrid			2022-12-27	WOS:000271572700034
J	Piscopo, DM; Johansen, EB; Derynck, R				Piscopo, Denise M.; Johansen, Eric B.; Derynck, Rik			Identification of the GATA Factor TRPS1 as a Repressor of the Osteocalcin Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER CELLS; MESENCHYMAL STEM-CELLS; ZINC-FINGER PROTEIN; SYNDROME TYPE-I; TRANSCRIPTION FACTOR; TRICHORHINOPHALANGEAL SYNDROME; OSTEOBLAST DIFFERENTIATION; BONE-FORMATION; OSTEOCLAST DIFFERENTIATION; CLEIDOCRANIAL DYSPLASIA	A proteomic analysis of proteins bound to the osteocalcin OSE2 sequence of the mouse osteocalcin promoter identified TRPS1 as a regulator of osteocalcin transcription. Mutations in the TRPS1 gene are responsible for human tricho-rhino-phalangeal syndrome, which is characterized by skeletal and craniofacial abnormalities. TRPS1 has been shown to bind regulatory promoter sequences containing GATA consensus binding sites and to repress transcription of genes involved in chondrocyte differentiation. Here we show that TRPS1 can directly bind the osteocalcin promoter in the presence or absence of Runx2. TRPS1 binds through a GATA binding sequence in the proximal promoter of the osteocalcin gene. The GATA binding site is conserved in mice, humans, and rats, although its location and orientation are not. Mutation of the mouse or human GATA binding sequence abrogates binding of TRPS1 to the osteocalcin promoter. We show that TRPS1 is expressed in osteosarcoma cells and upon induction of osteoblast differentiation in primary mouse bone marrow stromal cells and that TRPS1 regulates the expression of osteocalcin in both cell types. The expression of TRPS1 modulates mineralized bone matrix formation in differentiating osteoblast cells. These data suggest a role for TRPS1 in osteoblast differentiation, in addition to its previously described role in chondrogenesis.	[Derynck, Rik] Univ Calif San Francisco, Dept Cell & Tissue Biol, Cell Biol Program, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Dev Biol, San Francisco, CA 94143 USA; [Johansen, Eric B.] Univ Calif San Francisco, UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Johansen, Eric B.] Univ Calif San Francisco, Sandler Moore Mass Spectrometry Facil, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco	Derynck, R (corresponding author), Univ Calif San Francisco, Dept Cell & Tissue Biol, Cell Biol Program, 513 Parnassus Ave,Rm HSW 613, San Francisco, CA 94143 USA.	rik.derynck@ucsf.edu			National Institutes of Health [CA63101]; National Institutes of Health; Sandler Family Foundation; Gordon and Betty Moore Foundation; National Institutes of Health, NCI [P30 CA82103]; NATIONAL CANCER INSTITUTE [P30CA082103, R01CA063101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandler Family Foundation; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA63101 (to R. D.) and a National Institutes of Health Institutional Research Service Award (to D. P.). The UCSF Sandler-Moore Mass Spectrometry Core Facility was supported by the Sandler Family Foundation, the Gordon and Betty Moore Foundation, and National Institutes of Health, NCI, Grant P30 CA82103.	Alliston T, 2001, EMBO J, V20, P2254, DOI 10.1093/emboj/20.9.2254; Arco PGD, 2005, MOL CELL BIOL, V25, P2688, DOI 10.1128/MCB.25.7.2688-2697.2005; Blyth K, 2001, ONCOGENE, V20, P295, DOI 10.1038/sj.onc.1204090; BORTELL R, 1993, P NATL ACAD SCI USA, V90, P2300, DOI 10.1073/pnas.90.6.2300; Chang GTG, 2000, J NATL CANCER I, V92, P1414, DOI 10.1093/jnci/92.17.1414; Chang GTG, 2004, ENDOCR-RELAT CANCER, V11, P815, DOI 10.1677/erc.1.00853; Chang GTG, 1997, CANCER RES, V57, P4075; Chang GTG, 2002, APOPTOSIS, V7, P13, DOI 10.1023/A:1013504710343; Dennis JE, 1999, J BONE MINER RES, V14, P700, DOI 10.1359/jbmr.1999.14.5.700; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Drissi H, 2002, EXP CELL RES, V274, P323, DOI 10.1006/excr.2002.5474; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025; Fantauzzo KA, 2008, GENE EXPR PATTERNS, V8, P51, DOI 10.1016/j.modgep.2007.10.006; FELMAN AH, 1977, AM J ROENTGENOL, V129, P631, DOI 10.2214/ajr.129.4.631; FENG XH, 1995, J BIOL CHEM, V270, P24237, DOI 10.1074/jbc.270.41.24237; Galli C, 2009, J BIOL CHEM, V284, P12654, DOI 10.1074/jbc.M806628200; Geoffroy V, 1995, J BIOL CHEM, V270, P30973, DOI 10.1074/jbc.270.52.30973; GIEDION A, 1966, HELV PAEDIATR ACTA, V21, P475; GIEDION A, 1973, HELV PAEDIATR ACTA, V28, P249; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Huang WC, 2005, CANCER RES, V65, P2303, DOI 10.1158/0008-5472.CAN-04-3448; Ishimori N, 2008, J BONE MINER RES, V23, P1529, DOI 10.1359/JBMR.080414; Itoh S, 2008, GENES CELLS, V13, P355, DOI 10.1111/j.1365-2443.2008.01170.x; JIMENEZ CR, 1998, CURRENT PROTOCOLS PR; Kaiser FJ, 2003, J BIOL CHEM, V278, P38780, DOI 10.1074/jbc.M306259200; Kaiser FJ, 2003, HUM MOL GENET, V12, P1349, DOI 10.1093/hmg/ddg145; Kaiser FJ, 2007, BIOL CHEM, V388, P381, DOI 10.1515/BC.2007.051; Kern B, 2001, J BIOL CHEM, V276, P7101, DOI 10.1074/jbc.M006215200; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kunath M, 2002, MECH DEVELOP, V119, pS117, DOI 10.1016/S0925-4773(03)00103-5; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lian JB, 2003, CONNECT TISSUE RES, V44, P141, DOI 10.1080/03008200390152232; Ludecke HJ, 2001, AM J HUM GENET, V68, P81, DOI 10.1086/316926; MAJESKA RJ, 1980, ENDOCRINOLOGY, V107, P1494, DOI 10.1210/endo-107-5-1494; Malik TH, 2002, MOL CELL BIOL, V22, P8592, DOI 10.1128/MCB.22.24.8592-8600.2002; Malik TH, 2001, EMBO J, V20, P1715, DOI 10.1093/emboj/20.7.1715; MCCABE LR, 1994, J CELL BIOCHEM, V56, P274, DOI 10.1002/jcb.240560221; MERIKA M, 1993, MOL CELL BIOL, V13, P3999, DOI 10.1128/MCB.13.7.3999; MERRIMAN HL, 1995, BIOCHEMISTRY-US, V34, P13125, DOI 10.1021/bi00040a025; Momeni P, 2000, NAT GENET, V24, P71, DOI 10.1038/71717; Mueller MB, 2008, ARTHRITIS RHEUM-US, V58, P1377, DOI 10.1002/art.23370; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Napierala D, 2005, MOL GENET METAB, V86, P257, DOI 10.1016/j.ymgme.2005.07.012; Napierala D, 2008, HUM MOL GENET, V17, P2244, DOI 10.1093/hmg/ddn125; NIIKAWA N, 1986, AM J MED GENET, V24, P759, DOI 10.1002/ajmg.1320240420; Nishioka K, 2008, BONE, V43, P64, DOI 10.1016/j.bone.2008.03.009; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Otto F, 2003, J CELL BIOCHEM, V89, P9, DOI 10.1002/jcb.10491; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304; Pavesi G, 2006, NUCLEIC ACIDS RES, V34, pW566, DOI 10.1093/nar/gkl285; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; POCKWINSE SM, 1992, J CELL BIOCHEM, V49, P310, DOI 10.1002/jcb.240490315; Pratap J, 2006, CANCER METAST REV, V25, P589, DOI 10.1007/s10555-006-9032-0; Pritsker M, 2004, GENOME RES, V14, P99; Radvanyi L, 2005, P NATL ACAD SCI USA, V102, P11005, DOI 10.1073/pnas.0500904102; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schroeder Tania M., 2005, Birth Defects Research, V75, P213, DOI 10.1002/bdrc.20043; Shi MJ, 1998, J IMMUNOL, V161, P6751; STANFORD CM, 1995, J BIOL CHEM, V270, P9420, DOI 10.1074/jbc.270.16.9420; STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; Suemoto H, 2007, DEV BIOL, V312, P572, DOI 10.1016/j.ydbio.2007.10.001; van den Bemd GJCM, 2003, BIOCHEM BIOPH RES CO, V312, P578, DOI 10.1016/j.bbrc.2003.10.154; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; YEE JK, 1994, METHOD CELL BIOL, V43, P99; Yeung F, 2002, J BIOL CHEM, V277, P2468, DOI 10.1074/jbc.M105947200; Zhang Y, 2000, J BIOL CHEM, V275, P16979, DOI 10.1074/jbc.M001526200	71	39	43	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31690	31703		10.1074/jbc.M109.052316	http://dx.doi.org/10.1074/jbc.M109.052316			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19759027	Green Published, hybrid			2022-12-27	WOS:000271572700024
J	Salinas, M; Lazdunski, M; Lingueglia, E				Salinas, Miguel; Lazdunski, Michel; Lingueglia, Eric			Structural Elements for the Generation of Sustained Currents by the Acid Pain Sensor ASIC3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSING ION CHANNELS; GATED CATION CHANNEL; FUNCTIONAL EXPRESSION; MOLECULAR-CLONING; TISSUE ACIDOSIS; NEURONS; H+; PH; ION-CHANNEL-3; SITES	ASIC3 is an acid-sensing ion channel expressed in sensory neurons, where it participates in acidic and inflammatory pain. In addition to the "classical" transient current, ASIC3 generates a sustained current essential for pain perception. Using chimeras between the ASIC3 and ASIC1a channels we show that the first transmembrane domain (TM1), combined with the N-terminal domain, is the key structural element generating the low pH (< 6.5)-evoked sustained current. The TM1 domain also modulates the pH-dependent activation of the fast transient current thus contributing to a constitutive window current, another type of sustained current present near physiological pH. The C-terminal and the TM2 domains negatively regulate both types of sustained current, and the extracellular loop affects its kinetics. These data provide new information to aid understanding the mechanisms of the multifaceted pH gating of ASIC3. Together with the peak current, both components of the sustained current (window and sustained at pH < 6.5) allow ASIC3 to adapt its behavior to a wide range of extracellular pH variations by generating transient and/or sustained responses that contribute to nociceptor excitability.	[Lingueglia, Eric] UNSA, CNRS, Inst Pharmacol Mol & Cellulaire, UMR6097, F-06560 Valbonne, France; UNSA, CNRS, Inst NeuroMed Mol, UMR6097, F-06560 Valbonne, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Lingueglia, E (corresponding author), UNSA, CNRS, Inst Pharmacol Mol & Cellulaire, UMR6097, 660 Route Lucioles, F-06560 Valbonne, France.	lingueglia@ipmc.cnrs.fr	LINGUEGLIA, Eric/F-5509-2013; SALINAS, Miguel/N-6380-2016	LINGUEGLIA, Eric/0000-0003-3902-3405; SALINAS, Miguel/0000-0002-7445-123X	CNRS; Agence Nationale de la Recherche; Association Francaise contre les Myopathies; Association pour la Recherche sur le Cancer; Institut UPSA de la Douleur	CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Institut UPSA de la Douleur	This work was supported by the CNRS, the Agence Nationale de la Recherche, the Association Francaise contre les Myopathies, the Association pour la Recherche sur le Cancer, and the Institut UPSA de la Douleur.	Anzai N, 2002, J BIOL CHEM, V277, P16655, DOI 10.1074/jbc.M201087200; Babinski K, 1999, J NEUROCHEM, V72, P51, DOI 10.1046/j.1471-4159.1999.0720051.x; Baron A, 2001, J BIOL CHEM, V276, P35361, DOI 10.1074/jbc.M105208200; Bashari E, 2009, AM J PHYSIOL-CELL PH, V296, pC372, DOI 10.1152/ajpcell.00200.2008; Champigny G, 1998, J BIOL CHEM, V273, P15418, DOI 10.1074/jbc.273.25.15418; Chen XM, 2007, J PHYSIOL-LONDON, V579, P657, DOI 10.1113/jphysiol.2006.120733; Coric T, 2003, J BIOL CHEM, V278, P45240, DOI 10.1074/jbc.M304441200; de Weille JR, 1998, FEBS LETT, V433, P257, DOI 10.1016/S0014-5793(98)00916-8; Deval E, 2006, J BIOL CHEM, V281, P1796, DOI 10.1074/jbc.M509669200; Deval E, 2004, J BIOL CHEM, V279, P19531, DOI 10.1074/jbc.M313078200; Deval E, 2003, NEUROPHARMACOLOGY, V44, P662, DOI 10.1016/S0028-3908(03)00047-9; Deval E, 2008, EMBO J, V27, P3047, DOI 10.1038/emboj.2008.213; Donier E, 2005, J BIOL CHEM, V280, P38666, DOI 10.1074/jbc.M505981200; Ettaiche M, 2009, INVEST OPHTH VIS SCI, V50, P2417, DOI 10.1167/iovs.08-3028; Friese MA, 2007, NAT MED, V13, P1483, DOI 10.1038/nm1668; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Hruska-Hageman AM, 2004, J BIOL CHEM, V279, P46962, DOI 10.1074/jbc.M405874200; Issberner U, 1996, NEUROSCI LETT, V208, P191, DOI 10.1016/0304-3940(96)12576-3; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Li TB, 2009, J BIOL CHEM, V284, P4689, DOI 10.1074/jbc.M805302200; Lingueglia E, 2007, J BIOL CHEM, V282, P17325, DOI 10.1074/jbc.R700011200; Mantyh PW, 2002, NAT REV CANCER, V2, P201, DOI 10.1038/nrc747; Paukert M, 2008, J BIOL CHEM, V283, P572, DOI 10.1074/jbc.M706811200; Reeh PW, 1996, PROG BRAIN RES, V113, P143, DOI 10.1016/S0079-6123(08)61085-7; Salinas M, 2006, J PHYSIOL-LONDON, V570, P339, DOI 10.1113/jphysiol.2005.095810; Sherwood TW, 2008, J BIOL CHEM, V283, P1818, DOI 10.1074/jbc.M705118200; Smith ESJ, 2007, NEUROSCI LETT, V426, P12, DOI 10.1016/j.neulet.2007.07.047; STEEN KH, 1995, NEUROSCI LETT, V199, P29, DOI 10.1016/0304-3940(95)12002-L; Sutherland SP, 2001, P NATL ACAD SCI USA, V98, P711, DOI 10.1073/pnas.011404498; Waldmann R, 1997, J BIOL CHEM, V272, P20975, DOI 10.1074/jbc.272.34.20975; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wang WZ, 2006, J BIOL CHEM, V281, P29369, DOI 10.1074/jbc.M605122200; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Yagi J, 2006, CIRC RES, V99, P501, DOI 10.1161/01.RES.0000238388.79295.4c; YEN YT, 2009, MOL PAIN IN PRESS; Ziemann AE, 2008, NAT NEUROSCI, V11, P816, DOI 10.1038/nn.2132	36	45	45	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31851	31859		10.1074/jbc.M109.043984	http://dx.doi.org/10.1074/jbc.M109.043984			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19778905	Green Published, hybrid			2022-12-27	WOS:000271572700040
J	Ah-Seng, Y; Lopez, F; Pasta, F; Lane, D; Bouet, JY				Ah-Seng, Yoan; Lopez, Frederic; Pasta, Franck; Lane, David; Bouet, Jean-Yves			Dual Role of DNA in Regulating ATP Hydrolysis by the SopA Partition Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROKARYOTIC ACTIN HOMOLOG; PLASMID-PARTITION; F-PLASMID; P1 PLASMID; SEGREGATION; COMPLEX; BINDING; PARB; CENTROMERE; MECHANISM	In bacteria, mitotic stability of plasmids and many chromosomes depends on replicon-specific systems, which comprise a centromere, a centromere-binding protein and an ATPase. Dynamic self-assembly of the ATPase appears to enable active partition of replicon copies into cell-halves, but for Walker-box partition ATPases the molecular mechanism is unknown. ATPase activity appears to be essential for this process. DNA and centromere-binding proteins are known to stimulate the ATPase activity but molecular details of the stimulation mechanism have not been reported. We have investigated the interactions which stimulate ATP hydrolysis by the SopA partition ATPase of plasmid F. By using SopA and SopB proteins deficient in DNA binding, we have found that the intrinsic ability of SopA to hydrolyze ATP requires direct DNA binding by SopA but not by SopB. Our results show that two independent interactions of SopA act in synergy to stimulate its ATPase. SopA must interact with (i) DNA, through its ATP-dependent nonspecific DNA binding domain and (ii) SopB, which we show here to provide an arginine-finger motif. In addition, the latter interaction stimulates ATPase maximally when SopB is part of the partition complex. Hence, our data demonstrate that DNA acts on SopA in two ways, directly as nonspecific DNA and through SopB as centromeric DNA, to fully activate SopA ATP hydrolysis.	[Ah-Seng, Yoan; Pasta, Franck; Lane, David; Bouet, Jean-Yves] CNRS, Lab Microbiol & Genet Mol, F-31000 Toulouse, France; [Ah-Seng, Yoan; Pasta, Franck; Bouet, Jean-Yves] Univ Toulouse 3, Lab Microbiol & Genet Mol, F-31000 Toulouse, France; [Lopez, Frederic] CHU Rangueil, INSERM, Inst L Bugnard, F-31000 Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm)	Bouet, JY (corresponding author), Univ Toulouse 3, CNRS, LMGM, Bat IBCG,118 Route Narbonne, F-31062 Toulouse 9, France.	jean-yves.bouet@ibcg.biotoul.fr	Abraham, Ajith/A-1416-2008; Bouet, Jean-Yves/H-8469-2019; Hassanien, Aboul ella/O-5672-2014	Abraham, Ajith/0000-0002-0169-6738; Bouet, Jean-Yves/0000-0003-1488-5455; Hassanien, Aboul ella/0000-0002-9989-6681	l'Agence Nationale de la Recherche [ANR-06-BLAN-0280-01]	l'Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by l'Agence Nationale de la Recherche Grant ANR-06-BLAN-0280-01.	Ahmadian MR, 1997, NAT STRUCT BIOL, V4, P686, DOI 10.1038/nsb0997-686; Barilla D, 2005, EMBO J, V24, P1453, DOI 10.1038/sj.emboj.7600619; Barilla D, 2007, P NATL ACAD SCI USA, V104, P1811, DOI 10.1073/pnas.0607216104; Bouet JY, 2007, MOL MICROBIOL, V63, P468, DOI 10.1111/j.1365-2958.2006.05537.x; Bouet JY, 2006, MOL MICROBIOL, V62, P1447, DOI 10.1111/j.1365-2958.2006.05454.x; Bouet JY, 2009, J BIOL CHEM, V284, P165, DOI 10.1074/jbc.M802752200; Bouet JY, 2005, MOL MICROBIOL, V55, P511, DOI 10.1111/j.1365-2958.2004.04396.x; Bouet JY, 2000, J BIOL CHEM, V275, P8213, DOI 10.1074/jbc.275.11.8213; Bouet JY, 1999, EMBO J, V18, P1415, DOI 10.1093/emboj/18.5.1415; Castaing JP, 2008, MOL MICROBIOL, V70, P1000, DOI 10.1111/j.1365-2958.2008.06465.x; Davey MJ, 1997, J BIOL CHEM, V272, P15286, DOI 10.1074/jbc.272.24.15286; DAVIS MA, 1992, MOL MICROBIOL, V6, P1141, DOI 10.1111/j.1365-2958.1992.tb01552.x; Ebersbach G, 2005, ANNU REV GENET, V39, P453, DOI 10.1146/annurev.genet.38.072902.091252; Ebersbach G, 2001, P NATL ACAD SCI USA, V98, P15078, DOI 10.1073/pnas.261569598; Ebersbach G, 2006, MOL MICROBIOL, V61, P1428, DOI 10.1111/j.1365-2958.2006.05322.x; FRIEDMAN SA, 1988, PLASMID, V19, P103, DOI 10.1016/0147-619X(88)90049-2; FUNNELL BE, 1993, J BIOL CHEM, V268, P3616; Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; Gerdes K, 2000, MOL MICROBIOL, V37, P455, DOI 10.1046/j.1365-2958.2000.01975.x; Hatano T, 2007, MOL MICROBIOL, V64, P1198, DOI 10.1111/j.1365-2958.2007.05728.x; HAYAKAWA Y, 1985, J BACTERIOL, V163, P349, DOI 10.1128/JB.163.1.349-354.1985; Hester CM, 2007, P NATL ACAD SCI USA, V104, P20326, DOI 10.1073/pnas.0705196105; Jensen RB, 1997, J MOL BIOL, V269, P505, DOI 10.1006/jmbi.1997.1061; Leonard TA, 2005, EMBO J, V24, P270, DOI 10.1038/sj.emboj.7600530; Libante V, 2001, J MOL BIOL, V314, P387, DOI 10.1006/jmbi.2001.5158; Lim GE, 2005, P NATL ACAD SCI USA, V102, P17658, DOI 10.1073/pnas.0507222102; Marston AL, 1999, MOL CELL, V4, P673, DOI 10.1016/S1097-2765(00)80378-0; McIntosh JR, 2008, CELL, V135, P322, DOI 10.1016/j.cell.2008.08.038; MORI H, 1989, J BIOL CHEM, V264, P15535; Pratto F, 2008, NUCLEIC ACIDS RES, V36, P3676, DOI 10.1093/nar/gkn170; Ravin NV, 2003, J MOL BIOL, V329, P875, DOI 10.1016/S0022-2836(03)00525-4; Rosinski JA, 1999, J MOL EVOL, V49, P301, DOI 10.1007/PL00006552; Scheffzek K, 1998, TRENDS BIOCHEM SCI, V23, P257, DOI 10.1016/S0968-0004(98)01224-9; Schumacher MA, 2005, NATURE, V438, P516, DOI 10.1038/nature04149; van den Ent F, 2002, EMBO J, V21, P6935, DOI 10.1093/emboj/cdf672; WATANABE E, 1992, MOL GEN GENET, V234, P346, DOI 10.1007/BF00538693; Yates P, 1999, J MOL BIOL, V290, P627, DOI 10.1006/jmbi.1999.2909	38	49	49	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30067	30075		10.1074/jbc.M109.044800	http://dx.doi.org/10.1074/jbc.M109.044800			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19740757	Green Published, hybrid			2022-12-27	WOS:000271090000009
J	Lin, YC; Huang, JY; Kan, H; Frisbee, JC; Yu, HG				Lin, Yen-Chang; Huang, Jianying; Kan, Hong; Frisbee, Jefferson C.; Yu, Han-Gang			Rescue of a Trafficking Defective Human Pacemaker Channel via a Novel Mechanism ROLES OF Src, Fyn, AND Yes TYROSINE KINASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG QT SYNDROME; NUCLEOTIDE-GATED CHANNELS; PROTEIN TRAFFICKING; POTASSIUM CHANNEL; CARDIAC-ARRHYTHMIA; MODULATION; CELLS; ACTIVATION; EXPRESSION; INCREASES	Therapeutic strategies such as using channel blockers and reducing culture temperature have been used to rescue some long QT-associated voltage-gated potassium Kv trafficking defective mutant channels. A hyperpolarization-activated cyclic nucleotide-gated HCN4 pacemaker channel mutant (D553N) has been recently found in a patient associated with cardiac arrhythmias including long QT. D553N showed the defective trafficking to the cell surface, leading to little ionic current expression (loss-of-function). We show in this report that enhanced tyrosine phosphorylation mediated by Src, Fyn, and Yes kinases was able to restore the surface expression of D553N for normal current expression. Src or Yes, but not Fyn, significantly increased the current density and surface expression of D553N. Fyn accelerated the activation kinetics of the rescued D553N. Co-expression of D553N with Yes exhibited the slowest activation kinetics of D553N. Src, Fyn, and Yes significantly enhanced the tyrosine phosphorylation of D553N. A combination of Src, Fyn, and Yes rescued the current expression and the gating of D553N comparable with those of wild-type HCN4. In conclusion, we demonstrate a novel mechanism using three endogenous Src kinases to rescue a trafficking defective HCN4 mutant channel (D553N) by enhancing the tyrosine phosphorylation of the mutant channel protein.	[Lin, Yen-Chang; Huang, Jianying; Kan, Hong; Frisbee, Jefferson C.; Yu, Han-Gang] W Virginia Univ, Ctr Cardiovasc & Resp Sci, Morgantown, WV 26506 USA; [Lin, Yen-Chang; Huang, Jianying; Frisbee, Jefferson C.; Yu, Han-Gang] W Virginia Univ, Dept Physiol & Pharmacol, Morgantown, WV 26506 USA; [Kan, Hong] W Virginia Univ, Dept Cardiol, Morgantown, WV 26506 USA	West Virginia University; West Virginia University; West Virginia University	Yu, HG (corresponding author), W Virginia Univ, Dept Physiol, 1 Med Ctr Dr,Rm 3034 HSN, Morgantown, WV 26506 USA.	hyu@hsc.wvu.edu			National Institutes of Health [HL075023]; Office of Research and Graduate Programs/Health Sciences Center at West Virginia University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075023] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Research and Graduate Programs/Health Sciences Center at West Virginia University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL075023. This work was also supported by the Office of Research and Graduate Programs/Health Sciences Center at West Virginia University (to H.-G. Y.).	Arinsburg SS, 2006, J CARDIOVASC PHARM, V47, P578, DOI 10.1097/01.fjc.0000211740.47960.8b; Barraclough J, 2007, NEOPLASIA, V9, P745, DOI 10.1593/neo.07442; Delisle BP, 2004, CIRC RES, V94, P1418, DOI 10.1161/01.RES.0000128561.28701.ea; Delisle BP, 2003, J BIOL CHEM, V278, P35749, DOI 10.1074/jbc.M305787200; Fogle KJ, 2007, J NEUROSCI, V27, P2802, DOI 10.1523/JNEUROSCI.4376-06.2007; Furutani M, 1999, CIRCULATION, V99, P2290, DOI 10.1161/01.CIR.99.17.2290; Huang JY, 2008, J BIOL CHEM, V283, P29912, DOI 10.1074/jbc.M804205200; Kalia LV, 2004, ONCOGENE, V23, P8007, DOI 10.1038/sj.onc.1208158; Kanda S, 2005, J CELL SCI, V118, P961, DOI 10.1242/jcs.01686; Li CH, 2008, AM J PHYSIOL-CELL PH, V294, pC355, DOI 10.1152/ajpcell.00236.2007; Paulussen A, 2002, J BIOL CHEM, V277, P48610, DOI 10.1074/jbc.M206569200; Pian P, 2006, J GEN PHYSIOL, V128, P593, DOI 10.1085/jgp.200609648; Poolos NP, 2006, J NEUROSCI, V26, P7995, DOI 10.1523/JNEUROSCI.2069-06.2006; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Santoro B, 1997, P NATL ACAD SCI USA, V94, P14815, DOI 10.1073/pnas.94.26.14815; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Ueda K, 2004, J BIOL CHEM, V279, P27194, DOI 10.1074/jbc.M311953200; Wu JY, 2000, BBA-BIOMEMBRANES, V1463, P15, DOI 10.1016/S0005-2736(99)00233-3; Yu H, 2001, CIRC RES, V88, pE84, DOI 10.1161/hh1201.093511; Yu HG, 2004, PFLUG ARCH EUR J PHY, V447, P392, DOI 10.1007/s00424-003-1204-y; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zhou ZF, 1999, J BIOL CHEM, V274, P31123, DOI 10.1074/jbc.274.44.31123; Zhou ZF, 1998, J BIOL CHEM, V273, P21061, DOI 10.1074/jbc.273.33.21061; Zong XG, 2005, J BIOL CHEM, V280, P34224, DOI 10.1074/jbc.M506544200	24	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30433	30440		10.1074/jbc.M109.039180	http://dx.doi.org/10.1074/jbc.M109.039180			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19748888	hybrid, Green Published			2022-12-27	WOS:000271090000046
J	Xia, CW; Misra, I; Iyanagi, T; Kim, JJP				Xia, Chuanwu; Misra, Ila; Iyanagi, Takashi; Kim, Jung-Ja P.			Regulation of Interdomain Interactions by Calmodulin in Inducible Nitric-oxide Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME P450 OXIDOREDUCTASE; ELECTRON FLOW-THROUGH; CRYSTAL-STRUCTURE; REDUCTASE DOMAIN; STRUCTURAL BASIS; FLAVIN DOMAIN; BINDING DOMAINS; CONTROL ELEMENT; NO SYNTHASE; DIMER	Nitric-oxide synthases (NOSs) catalyze the conversion of L-arginine to nitric oxide and citrulline. There are three NOS isozymes, each with a different physiological role: neuronal NOS, endothelial NOS, and inducible NOS ( iNOS). NOSs consist of an N-terminal oxygenase domain and a C-terminal reductase domain, linked by a calmodulin (CaM)-binding region. CaM is required for NO production, but unlike other NOS isozymes, iNOS binds CaM independently of the exogenous Ca2+ concentration. We have co-expressed CaM and the FMN domain of human iNOS, which includes the CaM-binding region. The Ca2+-bound protein complex (CaCaM.FMN) forms an air-stable semiquinone when reduced with NADPH and reduces cytochrome c when reconstituted with the iNOS FAD/NADPH domain. We have solved the crystal structure of the CaCaM.FMN complex in four different conformations, each with a different relative orientation, between the FMN domain and the bound CaM. The CaM-binding region together with bound CaM forms a hinge, pivots on the conserved Arg(536), and regulates electron transfer from FAD to FMN and from FMN to heme by adjusting the relative orientation and distance among the three cofactors. In addition, the relative orientations of the N- and C-terminal lobes of CaM are also different among the four conformations, suggesting that the flexibility between the two halves of CaM also contributes to the fine tuning of the orientation/distance between the redox centers. The data demonstrate a possible mode for precise control of electron transfer by altering the distance and orientation	[Xia, Chuanwu; Misra, Ila; Kim, Jung-Ja P.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Iyanagi, Takashi] SPring 8 Ctr, Biomet Sci Lab, RIKEN, Mikazuki, Hyogo 6795148, Japan	Medical College of Wisconsin; Japan Synchrotron Radiation Research Institute; RIKEN	Kim, JJP (corresponding author), Med Coll Wisconsin, Dept Biochem, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	jjkim@mcw.edu			National Institutes of Health [GM52682]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052682] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM52682 ( to J. J. K.).	ABUSOUD HM, 1994, J BIOL CHEM, V269, P32047; Aoyagi M, 2003, EMBO J, V22, P766, DOI 10.1093/emboj/cdg078; BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Censarek P, 2004, FEBS LETT, V577, P465, DOI 10.1016/j.febslet.2004.10.048; Censarek P, 2002, BIOCHEMISTRY-US, V41, P8598, DOI 10.1021/bi025681k; CHO HJ, 1992, J EXP MED, V176, P599, DOI 10.1084/jem.176.2.599; Craig DH, 2002, J BIOL CHEM, V277, P33987, DOI 10.1074/jbc.M203118200; Crane BR, 1998, SCIENCE, V279, P2121, DOI 10.1126/science.279.5359.2121; Daff S, 2003, BIOCHEM SOC T, V31, P502, DOI 10.1042/bst0310502; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feng CJ, 2009, J BIOL INORG CHEM, V14, P133, DOI 10.1007/s00775-008-0431-2; Fischmann TO, 1999, NAT STRUCT BIOL, V6, P233, DOI 10.1038/6675; Gachhui R, 1998, J BIOL CHEM, V273, P5451, DOI 10.1074/jbc.273.10.5451; Garcin ED, 2004, J BIOL CHEM, V279, P37918, DOI 10.1074/jbc.M406204200; Gribovskaja I, 2005, BIOCHEMISTRY-US, V44, P7593, DOI 10.1021/bi0474517; Guan ZW, 2003, ARCH BIOCHEM BIOPHYS, V412, P65, DOI 10.1016/S0003-9861(03)00009-2; Hamdane D, 2009, J BIOL CHEM, V284, P11374, DOI 10.1074/jbc.M807868200; Haque MM, 2007, P NATL ACAD SCI USA, V104, P9254, DOI 10.1073/pnas.0700332104; Harrison DG, 1996, CLIN EXP PHARMACOL P, V23, P251, DOI 10.1111/j.1440-1681.1996.tb02606.x; Hooper WC, 2007, VASC PHARMACOL, V46, P315, DOI 10.1016/j.vph.2006.10.014; Hubbard PA, 2001, J BIOL CHEM, V276, P29163, DOI 10.1074/jbc.M101731200; Ilagan RP, 2009, BIOCHEMISTRY-US, V48, P3864, DOI 10.1021/bi8021087; Jachymova M, 2005, P NATL ACAD SCI USA, V102, P15833, DOI 10.1073/pnas.0506522102; Jones RJ, 2004, J BIOL CHEM, V279, P36876, DOI 10.1074/jbc.M402808200; Knott AB, 2009, ANTIOXID REDOX SIGN, V11, P541, DOI [10.1089/ars.2008.2234, 10.1089/ARS.2008.2234]; Knudsen GM, 2003, J BIOL CHEM, V278, P31814, DOI 10.1074/jbc.M303267200; Li HG, 2002, NITRIC OXIDE-BIOL CH, V7, P132, DOI 10.1016/S1089-8603(02)00127-1; Li HY, 2005, J INORG BIOCHEM, V99, P293, DOI 10.1016/j.jinorgbio.2004.10.016; LOWENSTEIN CJ, 1994, ANN INTERN MED, V120, P227, DOI 10.7326/0003-4819-120-3-199402010-00009; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Matsubara M, 1997, J BIOL CHEM, V272, P23050, DOI 10.1074/jbc.272.37.23050; Matsuda H, 1999, BBA-GEN SUBJECTS, V1473, P345, DOI 10.1016/S0304-4165(99)00193-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Nishida CR, 1999, J BIOL CHEM, V274, P14692, DOI 10.1074/jbc.274.21.14692; Panda K, 2001, J BIOL CHEM, V276, P23349, DOI 10.1074/jbc.M100687200; Panda K, 2006, J BIOL CHEM, V281, P36819, DOI 10.1074/jbc.M606129200; Raman CS, 1998, CELL, V95, P939, DOI 10.1016/S0092-8674(00)81718-3; RodriguezCrespo I, 1996, J BIOL CHEM, V271, P11462, DOI 10.1074/jbc.271.19.11462; Roman LJ, 2006, J BIOL CHEM, V281, P23111, DOI 10.1074/jbc.M603671200; Roman LJ, 2000, J BIOL CHEM, V275, P29225, DOI 10.1074/jbc.M004766200; Roman LJ, 2000, J BIOL CHEM, V275, P21914, DOI 10.1074/jbc.M002449200; Roman LJ, 2002, CHEM REV, V102, P1179, DOI 10.1021/cr000661e; Sagami I, 2001, J BIOL CHEM, V276, P30036, DOI 10.1074/jbc.M104123200; Siddhanta U, 1998, J BIOL CHEM, V273, P18950, DOI 10.1074/jbc.273.30.18950; Siddhanta U, 1996, J BIOL CHEM, V271, P7309, DOI 10.1074/jbc.271.13.7309; Simonovic M, 2006, J BIOL CHEM, V281, P34333, DOI 10.1074/jbc.M604613200; SMITH GCM, 1994, P NATL ACAD SCI USA, V91, P8710, DOI 10.1073/pnas.91.18.8710; Spratt DE, 2006, FEBS J, V273, P1759, DOI 10.1111/j.1742-4658.2006.05193.x; Spratt DE, 2007, BBA-PROTEINS PROTEOM, V1774, P1351, DOI 10.1016/j.bbapap.2007.07.019; STEVENSTRUSS R, 1995, BIOCHEMISTRY-US, V34, P15638, DOI 10.1021/bi00048a006; Stuehr DJ, 2004, J BIOL CHEM, V279, P36167, DOI 10.1074/jbc.R400017200; Tiso M, 2007, BIOCHEMISTRY-US, V46, P14418, DOI 10.1021/bi701646k; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Venema RC, 1996, J BIOL CHEM, V271, P6435, DOI 10.1074/jbc.271.11.6435; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; Welland A, 2008, BIOCHEMISTRY-US, V47, P9771, DOI 10.1021/bi800787m; Wolthers KR, 2007, BIOCHEMISTRY-US, V46, P11833, DOI 10.1021/bi701209p; Yamamoto K, 2005, ARCH BIOCHEM BIOPHYS, V440, P65, DOI 10.1016/j.abb.2005.05.027; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Zhang J, 2001, J BIOL CHEM, V276, P37506, DOI 10.1074/jbc.M105503200	62	76	77	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30708	30717		10.1074/jbc.M109.031682	http://dx.doi.org/10.1074/jbc.M109.031682			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19737939	Green Published, hybrid			2022-12-27	WOS:000271090000072
J	Chen, JH; Cai, ZW; Sheppard, DN				Chen, Jeng-Haur; Cai, Zhiwei; Sheppard, David N.			Direct Sensing of Intracellular pH by the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Cl- Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING DOMAINS; DEPENDENT HCO3-TRANSPORT; MURINE CELL-LINE; CHLORIDE CHANNEL; R-DOMAIN; ATP-HYDROLYSIS; MECHANISM; MUTATIONS; PORE; INHIBITION	In cystic fibrosis (CF), dysfunction of the cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channel disrupts epithelial ion transport and perturbs the regulation of intracellular pH (pH(i)). CFTR modulates pH(i) through its role as an ion channel and by regulating transport proteins. However, it is unknown how CFTR senses pH(i). Here, we investigate the direct effects of pH(i) on recombinant CFTR using excised membrane patches. By altering channel gating, acidic pH(i) increased the open probability (P-o) of wild-type CFTR, whereas alkaline pH(i) decreased P-o and inhibited Cl- flow through the channel. Acidic pH(i) potentiated the MgATP dependence of wild-type CFTR by increasing MgATP affinity and enhancing channel activity, whereas alkaline pH(i) inhibited the MgATP dependence of wildtype CFTR by decreasing channel activity. Because these data suggest that pH(i) modulates the interaction of MgATP with the nucleotide-binding domains (NBDs) of CFTR, we examined the pH(i) dependence of site-directed mutations in the two ATP-binding sites of CFTR that are located at the NBD1:NBD2 dimer interface (site 1: K464A-, D572N-, and G1349D-CFTR; site 2: G551D-, K1250M-, and D1370N-CFTR). Site 2 mutants, but not site 1 mutants, perturbed both potentiation by acidic pH(i) and inhibition by alkaline pH(i), suggesting that site 2 is a critical determinant of the pH(i) sensitivity of CFTR. The effects of pH(i) also suggest that site 2 might employ substrate-assisted catalysis to ensure that ATP hydrolysis follows NBD dimerization. We conclude that the CFTR Cl- channel senses directly pH(i). The direct regulation of CFTR by pH(i) has important implications for the regulation of epithelial ion transport.	[Chen, Jeng-Haur; Cai, Zhiwei; Sheppard, David N.] Univ Bristol, Sch Med Sci, Dept Physiol & Pharmacol, Bristol BS8 1TD, Avon, England	University of Bristol	Chen, JH (corresponding author), Univ Iowa, Howard Hughes Med Inst, Dept Internal Med, Roy J & Lucille A Carver Coll Med, 500 EMRB, Iowa City, IA 52242 USA.	jeng-haur-chen@uiowa.edu; D.N.Sheppard@bristol.ac.uk	Sheppard, David N/AAV-4187-2021; Chen, Jeng-Haur/E-1483-2011	Sheppard, David N/0000-0001-5533-9130; Chen, Jeng-Haur/0000-0001-6756-6939	Cystic Fibrosis Trust; University of Bristol; Overseas Research Student award	Cystic Fibrosis Trust; University of Bristol; Overseas Research Student award	This work was supported by the Cystic Fibrosis Trust.; Supported by the University of Bristol and an Overseas Research Student award. Current address and to whom correspondence may be addressed: Howard Hughes Medical Institute, Dept. of Internal Medicine, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, 500 EMRB, Iowa City, IA 52242. Tel.: 319-335-6540; Fax: 319-335-7623; E-mail: jeng-haur-chen@uiowa.edu.	Ahn W, 2001, J BIOL CHEM, V276, P17236, DOI 10.1074/jbc.M011763200; ANDERSON MP, 1991, SCIENCE, V251, P679, DOI 10.1126/science.1704151; Baker JMR, 2007, NAT STRUCT MOL BIOL, V14, P738, DOI 10.1038/nsmb1278; Barriere H, 2001, AM J PHYSIOL-CELL PH, V281, pC810, DOI 10.1152/ajpcell.2001.281.3.C810; Bompadre SG, 2007, J GEN PHYSIOL, V129, P285, DOI 10.1085/jgp.200609667; Cai Z, 1999, BRIT J PHARMACOL, V128, P108, DOI 10.1038/sj.bjp.0702748; Cai ZW, 2006, J BIOL CHEM, V281, P1970, DOI 10.1074/jbc.M510576200; CARSON MR, 1995, J BIOL CHEM, V270, P1711, DOI 10.1074/jbc.270.4.1711; Choi JY, 2001, NATURE, V410, P94, DOI 10.1038/35065099; Cotten JF, 1997, J BIOL CHEM, V272, P25617, DOI 10.1074/jbc.272.41.25617; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; Dousmanis AG, 2002, J GEN PHYSIOL, V119, P545, DOI 10.1085/jgp.20028594; ELGAVISH A, 1991, BIOCHEM BIOPH RES CO, V180, P342, DOI 10.1016/S0006-291X(05)81298-7; ELROYSTEIN O, 1989, P NATL ACAD SCI USA, V86, P6126, DOI 10.1073/pnas.86.16.6126; Ernst R, 2006, J BIOL CHEM, V281, P27471, DOI 10.1074/jbc.M601131200; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Hanekop N, 2006, FEBS LETT, V580, P1036, DOI 10.1016/j.febslet.2005.11.012; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Howell LD, 2000, BIOCHEM BIOPH RES CO, V271, P518, DOI 10.1006/bbrc.2000.2659; Ikuma M, 2000, P NATL ACAD SCI USA, V97, P8675, DOI 10.1073/pnas.140220597; Ko SBH, 2004, NAT CELL BIOL, V6, P343, DOI 10.1038/ncb1115; Ko SBH, 2002, EMBO J, V21, P5662, DOI 10.1093/emboj/cdf580; Lansdell KA, 2000, J PHYSIOL-LONDON, V524, P317, DOI 10.1111/j.1469-7793.2000.t01-1-00317.x; Lee MG, 1999, J BIOL CHEM, V274, P3414, DOI 10.1074/jbc.274.6.3414; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Li HY, 2009, BIODRUGS, V23, P203, DOI 10.2165/11313570-000000000-00000; Linsdell P, 2005, J BIOL CHEM, V280, P8945, DOI 10.1074/jbc.M414354200; MCCARTY NA, 1993, J GEN PHYSIOL, V102, P1, DOI 10.1085/jgp.102.1.1; Ostedgaard LS, 2000, P NATL ACAD SCI USA, V97, P5657, DOI 10.1073/pnas.100588797; POULSEN JH, 1994, P NATL ACAD SCI USA, V91, P5340, DOI 10.1073/pnas.91.12.5340; Ramjeesingh M, 1999, BIOCHEMISTRY-US, V38, P1463, DOI 10.1021/bi982243y; Reddy MM, 1998, AM J PHYSIOL-CELL PH, V275, pC1040, DOI 10.1152/ajpcell.1998.275.4.C1040; RICH DP, 1990, NATURE, V347, P358, DOI 10.1038/347358a0; RICH DP, 1993, J BIOL CHEM, V268, P20259; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; Schulte U, 1999, P NATL ACAD SCI USA, V96, P15298, DOI 10.1073/pnas.96.26.15298; Scott-Ward TS, 2007, P NATL ACAD SCI USA, V104, P16365, DOI 10.1073/pnas.0701562104; Sheppard David N., 1999, Physiological Reviews, V79, pS23; SHEPPARD DN, 1995, EMBO J, V14, P876, DOI 10.1002/j.1460-2075.1995.tb07069.x; Sheppard DN, 1997, J PHYSIOL-LONDON, V503, P333, DOI 10.1111/j.1469-7793.1997.333bh.x; Sigel H, 2005, CHEM SOC REV, V34, P875, DOI 10.1039/b505986k; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; TABCHARANI JA, 1993, NATURE, V366, P79, DOI 10.1038/366079a0; Vergani P, 2005, BIOCHEM SOC T, V33, P1003, DOI 10.1042/BST0331003; Vergani P, 2003, J GEN PHYSIOL, V121, P17, DOI 10.1085/jgp.20028673; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Welsh MJ, 2001, METABOLIC MOL BASES, P5121; Wilkinson DJ, 1997, AM J PHYSIOL-LUNG C, V273, pL127, DOI 10.1152/ajplung.1997.273.1.L127; WINTER MC, 1994, BIOPHYS J, V66, P1398, DOI 10.1016/S0006-3495(94)80930-0; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687; Zegarra-Moran O, 2002, BRIT J PHARMACOL, V137, P504, DOI 10.1038/sj.bjp.0704882; Zhang ZR, 2004, J MEMBRANE BIOL, V199, P15, DOI 10.1007/s00232-004-0672-0; Zhou Z, 2002, J GEN PHYSIOL, V120, P647, DOI 10.1085/jgp.20028685; Zifarelli G, 2008, J GEN PHYSIOL, V132, P185, DOI 10.1085/jgp.200809999	55	33	33	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35495	35506		10.1074/jbc.M109.072678	http://dx.doi.org/10.1074/jbc.M109.072678			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19837660	hybrid, Green Published			2022-12-27	WOS:000272645600026
J	White, C; Lee, J; Kambe, T; Fritsche, K; Petris, MJ				White, Carine; Lee, Jaekwon; Kambe, Taiho; Fritsche, Kevin; Petris, Michael J.			A Role for the ATP7A Copper-transporting ATPase in Macrophage Bactericidal Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOST-PATHOGEN INTERACTIONS; ACUTE-PHASE RESPONSE; TRACE-ELEMENTS; HYDROGEN-PEROXIDE; MENKES-DISEASE; SERUM COPPER; DEFICIENCY; ZINC; INFLAMMATION; MEMBRANE	Copper is an essential micronutrient that is necessary for healthy immune function. This requirement is underscored by an increased susceptibility to bacterial infection in copper-deficient animals; however, a molecular understanding of its importance in immune defense is unknown. In this study, we investigated the effect of proinflammatory agents on copper homeostasis in RAW264.7 macrophages. Interferon-gamma was found to increase expression of the high affinity copper importer, CTR1, and stimulate copper uptake. This was accompanied by copper-stimulated trafficking of the ATP7A copper exporter from the Golgi to vesicles that partially overlapped with phagosomal compartments. Silencing of ATP7A expression attenuated bacterial killing, suggesting a role for ATP7A-dependent copper transport in the bactericidal activity of macrophages. Significantly, a copper-sensitive mutant of Escherichia coli lacking the CopA copper-transporting ATPase was hypersensitive to killing by RAW264.7 macrophages, and this phenotype was dependent on ATP7A expression. Collectively, these data suggest that copper-transporting ATPases, CopA and ATP7A, in both bacteria and macrophage are unique determinants of bacteria survival and identify an unexpected role for copper at the host-pathogen interface.	[Petris, Michael J.] Univ Missouri, Dept Biochem, Christopher S Bond Life Sci Ctr 540D, Columbia, MO 65211 USA; [White, Carine; Petris, Michael J.] Univ Missouri, Dept Nutr Sci, Columbia, MO 65211 USA; [Fritsche, Kevin] Univ Missouri, Dept Anim Sci, Columbia, MO 65211 USA; [Petris, Michael J.] Univ Missouri, Bond Life Sci Ctr, Columbia, MO 65211 USA; [Lee, Jaekwon] Univ Nebraska, Dept Biochem, Redox Biol Ctr, Lincoln, NE 68588 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Nebraska System; University of Nebraska Lincoln	Petris, MJ (corresponding author), Univ Missouri, Dept Biochem, Christopher S Bond Life Sci Ctr 540D, Columbia, MO 65211 USA.	petrism@missouri.edu	Johnson, Michael D. L./B-4352-2012		National Institutes of Health [DK66333, DK59893, DK79209]; National Institutes of Health, NCI [R24 CA86307]; NATIONAL CANCER INSTITUTE [R24CA086307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK066333, R01DK059893, R01DK066333, R01DK079209] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK66333 and DK59893 (to M. J. P.) and DK79209 (to J. L.). The production of <SUP>64</SUP>Cu at Washington University School of Medicine is supported by National Institutes of Health, NCI, Grant R24 CA86307.	Agertt F, 2007, ARQ NEURO-PSIQUIAT, V65, P157, DOI 10.1590/S0004-282X2007000100032; Akcil E, 2003, BIOL TRACE ELEM RES, V93, P95, DOI 10.1385/BTER:93:1-3:95; AUER DE, 1989, VET REC, V124, P235, DOI 10.1136/vr.124.10.235; BABU U, 1990, J NUTR, V120, P1700, DOI 10.1093/jn/120.12.1700; BABU U, 1990, J NUTR, V120, P1692, DOI 10.1093/jn/120.12.1692; BEVERIDGE SJ, 1985, AGENTS ACTIONS, V17, P104, DOI 10.1007/BF01966692; BOYNE R, 1981, J COMP PATHOL, V91, P271, DOI 10.1016/0021-9975(81)90032-3; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Cesur S, 2005, J INFECTION, V50, P31, DOI 10.1016/j.jinf.2004.05.001; Chen YT, 2004, GENE, V337, P189, DOI 10.1016/j.gene.2004.05.008; Cobbold C, 2002, HUM MOL GENET, V11, P2855, DOI 10.1093/hmg/11.23.2855; CONFORTI A, 1983, BRIT J PHARMACOL, V79, P45, DOI 10.1111/j.1476-5381.1983.tb10493.x; CROCKER A, 1992, J NATL MED ASSOC, V84, P697; DEGHAIDY F S, 1989, Journal of the Egyptian Society of Parasitology, V19, P205; Del Rio MJ, 2004, ARCH MED RES, V35, P185, DOI 10.1016/j.arcmed.2004.01.001; DESJARDINS M, 1994, J CELL BIOL, V124, P677, DOI 10.1083/jcb.124.5.677; Doherty CP, 2007, J NUTR, V137, P1341, DOI 10.1093/jn/137.5.1341; DOLLWET HHA, 1985, TRACE ELEM MED, V2, P80; El Hawy Ahmed M., 1993, Journal of the Egyptian Society of Parasitology, V23, P55; ELZANOWSKA H, 1995, FREE RADICAL BIO MED, V18, P437, DOI 10.1016/0891-5849(94)00150-I; Failla ML, 2003, J NUTR, V133, p1443S, DOI 10.1093/jn/133.5.1443S; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; FOX PL, 1995, LIFE SCI, V56, P1749, DOI 10.1016/0024-3205(95)00146-W; FREELAND JH, 1976, AM J CLIN NUTR, V29, P745, DOI 10.1093/ajcn/29.7.745; Grass G, 2001, J BACTERIOL, V183, P2145, DOI 10.1128/JB.183.6.2145-2147.2001; GUNN TR, 1984, CLIN PEDIATR, V23, P514, DOI 10.1177/000992288402300915; HALLGREN R, 1987, J RHEUMATOL, V14, P548; Hamza I, 2003, P NATL ACAD SCI USA, V100, P1215, DOI 10.1073/pnas.0336230100; Hopkins RG, 1997, J NUTR, V127, P257, DOI 10.1093/jn/127.2.257; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Jiang Y, 2005, PLASMID, V54, P149, DOI 10.1016/j.plasmid.2005.03.002; JONES DG, 1981, RES VET SCI, V31, P151, DOI 10.1016/S0034-5288(18)32485-8; JONES DG, 1983, J COMP PATHOL, V93, P143, DOI 10.1016/0021-9975(83)90052-X; Jones P W, 2001, J Wound Care, V10, P205; Kadiiska MB, 2002, SPECTROCHIM ACTA A, V58, P1227, DOI 10.1016/S1386-1425(01)00713-2; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Koyanagi A, 2004, ANN TROP MED PARASIT, V98, P391, DOI 10.1179/000349804225003424; KREUDER J, 1993, EUR J PEDIATR, V152, P828, DOI 10.1007/BF02073380; LAMAND M, 1981, ANN RECH VET, V12, P133; Lee J, 2002, J BIOL CHEM, V277, P4380, DOI 10.1074/jbc.M104728200; Liu XP, 2001, FREE RADICAL BIO MED, V31, P894, DOI 10.1016/S0891-5849(01)00665-7; Mao XQ, 2007, J BIOL CHEM, V282, P6992, DOI 10.1074/jbc.M610552200; Meresse S, 1999, EMBO J, V18, P4394, DOI 10.1093/emboj/18.16.4394; MILANINO R, 1993, AGENTS ACTIONS, V39, P195, DOI 10.1007/BF01998974; Monty JF, 2005, J NUTR, V135, P2762, DOI 10.1093/jn/135.12.2762; MORIMOTO A, 1989, AM J PHYSIOL, V256, pR35, DOI 10.1152/ajpregu.1989.256.1.R35; Nairz M, 2008, EUR J IMMUNOL, V38, P1923, DOI 10.1002/eji.200738056; NEWBERNE PM, 1968, BRIT J EXP PATHOL, V49, P448; Petris MJ, 1996, EMBO J, V15, P6084, DOI 10.1002/j.1460-2075.1996.tb00997.x; Prentice AM, 2007, J NUTR, V137, P1334, DOI 10.1093/jn/137.5.1334; PROHASKA JR, 1981, SCIENCE, V213, P559; Prudovsky I, 2003, J CELL SCI, V116, P4871, DOI 10.1242/jcs.00872; Rankin S, 2002, INFECT IMMUN, V70, P3637, DOI 10.1128/IAI.70.7.3637-3648.2002; Rensing C, 2000, P NATL ACAD SCI USA, V97, P652, DOI 10.1073/pnas.97.2.652; Scaletti RW, 2003, J DAIRY SCI, V86, P1240, DOI 10.3168/jds.S0022-0302(03)73708-4; Schwan WR, 2005, INT J MED MICROBIOL, V295, P237, DOI 10.1016/j.ijmm.2005.05.005; Seyrek A, 2005, BIOL TRACE ELEM RES, V106, P107, DOI 10.1385/BTER:106:2:107; SHAH I, 1983, CANCER-AM CANCER SOC, V51, P851, DOI 10.1002/1097-0142(19830301)51:5<851::AID-CNCR2820510518>3.0.CO;2-Y; Shui WQ, 2008, P NATL ACAD SCI USA, V105, P16952, DOI 10.1073/pnas.0809218105; SRINIVAS U, 1988, SCAND J CLIN LAB INV, V48, P495, DOI 10.3109/00365518809085763; Stoyanov JV, 2003, FEBS LETT, V546, P391, DOI 10.1016/S0014-5793(03)00640-9; SUNDERMAN FW, 1970, CLIN CHEM, V16, P903; Uno H, 1987, Am J Med Genet Suppl, V3, P367; Voruganti VS, 2005, BURNS, V31, P711, DOI 10.1016/j.burns.2005.04.026; Wagner D, 2005, J IMMUNOL, V174, P1491, DOI 10.4049/jimmunol.174.3.1491; WARD WF, 1989, ADV EXP MED BIOL, V258, P287; Wardman P, 1996, RADIAT RES, V145, P523, DOI 10.2307/3579270; Yilmaz A, 2005, CLIN RHEUMATOL, V24, P331, DOI 10.1007/s10067-004-1028-y	68	340	342	4	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33949	33956		10.1074/jbc.M109.070201	http://dx.doi.org/10.1074/jbc.M109.070201			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19808669	Green Published, hybrid			2022-12-27	WOS:000272165200027
J	Hadian, K; Vincendeau, M; Maeusbacher, N; Nagel, D; Hauck, SM; Ueffing, M; Loyter, A; Werner, T; Wolff, H; Brack-Werner, R				Hadian, Kamyar; Vincendeau, Michelle; Maeusbacher, Nina; Nagel, Daniel; Hauck, Stefanie M.; Ueffing, Marius; Loyter, Abraham; Werner, Thomas; Wolff, Horst; Brack-Werner, Ruth			Identification of a Heterogeneous Nuclear Ribonucleoprotein-recognition Region in the HIV Rev Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; VIRUS PRODUCTION; HNRNP; TRANSLATION; RETROVIRUSES; REQUIREMENT; INFECTION; INTERACTS; TARGETS; EXPORT	The Rev protein is a key regulator of human immunodeficiency virus type 1 (HIV-1) gene expression. Rev is primarily known as an adaptor protein for nuclear export of HIV RNAs. However, Rev also contributes to numerous other processes by less well known mechanisms. Understanding the functional nature of Rev requires extensive knowledge of its cellular interaction partners. Here we demonstrate that Rev interacts with members of a large family of multifunctional host cell factors called hnRNPs. Rev employs amino acids 9-14 for specific binding to the heterogeneous nuclear ribonucleoproteins (hnRNP) A1, Q, K, R, and U. In addition, Rev interacts with hnRNP E1 and E2 by a different mechanism. The set of hnRNPs recognized by the N terminus of Rev feature RGG boxes. Exemplary testing of hnRNP A1 revealed a critical role of arginine residues within the RGG box for interaction with Rev. Finally, we demonstrate that expression levels of hnRNP A1, Q, K, R, and U influence HIV-1 production by persistently infected astrocytes, linking these hnRNPs to HIV replication. The novel interaction of HIV-1 Rev with functionally diverse hnRNPs lends further support to the idea that Rev is a multifunctional protein and may be involved in coupling HIV replication to diverse cellular processes and promoting virus-host cell interactions.	[Hadian, Kamyar; Vincendeau, Michelle; Maeusbacher, Nina; Nagel, Daniel; Wolff, Horst; Brack-Werner, Ruth] Helmholtz Zentrum Munchen, Res Ctr Environm Hlth, Inst Virol, D-85764 Neuherberg, Germany; [Hauck, Stefanie M.; Ueffing, Marius] Helmholtz Zentrum Munchen, Res Ctr Environm Hlth, Dept Prot Sci, D-85764 Neuherberg, Germany; [Loyter, Abraham] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel; [Werner, Thomas] Genomatix Software GmbH, D-80335 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Hebrew University of Jerusalem	Brack-Werner, R (corresponding author), Helmholtz Zentrum Munchen, Res Ctr Environm Hlth, Inst Virol, Ingolstaedter Landstr 1, D-85764 Neuherberg, Germany.	brack@helmholtz-muenchen.de	Hauck, Stefanie/B-3300-2013; Vincendeau, Michelle/AAD-4320-2022; Hadian, Kamyar/B-6314-2013; Brack-Werner, Ruth/M-4615-2014	Hauck, Stefanie/0000-0002-1630-6827; Hadian, Kamyar/0000-0001-8727-2575; Brack-Werner, Ruth/0000-0002-8651-9318	Deutsche Forschungsgemeinschaft [1710/1-3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant 1710/1-3 (to R.B.W.).	ARRIGO SJ, 1991, GENE DEV, V5, P808, DOI 10.1101/gad.5.5.808; Bolinger C, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-8; BRACKWERNER R, 1992, AIDS, V6, P273, DOI 10.1097/00002030-199203000-00003; Brandt S, 2007, PLOS PATHOG, V3, P518, DOI 10.1371/journal.ppat.0030054; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Carpenter B, 2006, BBA-REV CANCER, V1765, P85, DOI 10.1016/j.bbcan.2005.10.002; Cochrane AW, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-18; DAGOSTINO DM, 1992, MOL CELL BIOL, V12, P1375, DOI 10.1128/MCB.12.3.1375; Dowling D, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-18; Felber BK, 2007, ADV PHARMACOL, V55, P161, DOI 10.1016/S1054-3589(07)55005-2; FELBER BK, 1989, P NATL ACAD SCI USA, V86, P1495, DOI 10.1073/pnas.86.5.1495; Groom HCT, 2009, J GEN VIROL, V90, P1303, DOI 10.1099/vir.0.011460-0; Groom HCT, 2009, J GEN VIROL, V90, P1141, DOI 10.1099/vir.0.007963-0; Hauck SM, 2005, PROTEOMICS, V5, P3623, DOI 10.1002/pmic.200401223; He YW, 2009, MOL CARCINOGEN, V48, P167, DOI 10.1002/mc.20467; Jablonski JA, 2009, J VIROL, V83, P981, DOI 10.1128/JVI.01801-08; Kammler S, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-89; Kim CS, 2007, J VIROL, V81, P3852, DOI 10.1128/JVI.01311-06; Kim JH, 2000, J MOL BIOL, V298, P395, DOI 10.1006/jmbi.2000.3687; Kjems J, 2000, Adv Pharmacol, V48, P251; Kramer-Hammerle S, 2005, VIRUS RES, V111, P194, DOI 10.1016/j.virusres.2005.04.009; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; Lever AML, 2007, ADV PHARMACOL, V55, P1, DOI 10.1016/S1054-3589(07)55001-5; Ludwig E, 1999, J VIROL, V73, P8279, DOI 10.1128/JVI.73.10.8279-8289.1999; Ma J, 2008, VIROLOGY, V375, P253, DOI 10.1016/j.virol.2008.01.025; Makeyev AV, 2002, RNA, V8, P265, DOI 10.1017/S1355838202024627; MALIM MH, 1989, CELL, V58, P205, DOI 10.1016/0092-8674(89)90416-9; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mourelatos Z, 2001, EMBO J, V20, P5443, DOI 10.1093/emboj/20.19.5443; Nekhai S, 2006, FUTURE MICROBIOL, V1, P417, DOI 10.2217/17460913.1.4.417; Peters Reiner, 2006, V322, P259; Ptak RG, 2008, AIDS RES HUM RETROV, V24, P1497, DOI 10.1089/aid.2008.0113; Reed R, 2001, NAT CELL BIOL, V3, pE201, DOI 10.1038/ncb0901-e201; Stauber RH, 1998, BIOTECHNIQUES, V24, P462, DOI 10.2144/98243rr01; Stoltzfus CM, 2006, CURR HIV RES, V4, P43, DOI 10.2174/157016206775197655; Suhasini M, 2009, CURR HIV RES, V7, P91, DOI 10.2174/157016209787048474; Tschodrich-Rotter M, 1998, J MICROSC-OXFORD, V192, P114, DOI 10.1046/j.1365-2818.1998.00411.x; Valente ST, 2006, MOL CELL, V23, P597, DOI 10.1016/j.molcel.2006.07.021; Wadd S, 1999, J BIOL CHEM, V274, P28991, DOI 10.1074/jbc.274.41.28991; Wolff H, 2006, EXP CELL RES, V312, P443, DOI 10.1016/j.yexcr.2005.11.020; Wolff H, 2003, NUCLEIC ACIDS RES, V31, P2839, DOI 10.1093/nar/gkg390; Wolff H, 2006, BIOTECHNIQUES, V41, P688, DOI 10.2144/000112291; Woolaway K, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-28; Yedavalli VSRK, 2004, CELL, V119, P381, DOI 10.1016/j.cell.2004.09.029	44	28	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33384	33391		10.1074/jbc.M109.021659	http://dx.doi.org/10.1074/jbc.M109.021659			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19808671	Green Published, hybrid			2022-12-27	WOS:000272028500044
J	Bowerman, NA; Colf, LA; Garcia, KC; Kranz, DM				Bowerman, Natalie A.; Colf, Leremy A.; Garcia, K. Christopher; Kranz, David M.			Different Strategies Adopted by K-b and L-d to Generate T Cell Specificity Directed against Their Respective Bound Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-I MOLECULES; HIGH-AFFINITY; RECEPTOR RECOGNITION; ANTIGEN RECOGNITION; BINDING GROOVE; MHC COMPLEXES; CRYSTAL-STRUCTURE; SELF-PEPTIDES; REACTIVE CTL	Mouse T cell clone 2C recognizes two different major histocompatibility (MHC) ligands, the self MHC K-b and the allogeneic MHC L-d. Two distinct peptides, SIY (SIYRYYGL) and QL9 (QLSPFPFDL), act as strong and specific agonists when bound to K-b and L-d, respectively. To explore further the mechanisms involved in peptide potency and specificity, here we examined a collection of single amino acid peptide variants of SIY and QL9 for 1) T cell activity, 2) binding to their respective MHC, and 3) binding to the 2C T cell receptor (TCR) and high affinity TCR mutants. Characterization of SIY binding to MHC K-b revealed significant effects of three SIY residues that were clearly embedded within the K-b molecule. In contrast, QL9 binding to MHCLd was influenced by the majority of peptide side chains, distributed across the entire length of the peptide. Binding of the SIY-K-b complex to the TCR involved three SIY residues that were pointed toward the TCR, whereas again the majority of QL9 residues influenced binding of TCRs, and thus the QL9 residues had impacts on both L-d and TCR binding. In general, the magnitude of T cell activity mediated by a peptide variant was influenced more by peptide binding to MHC than by binding the TCR, especially for higher affinity TCRs. Findings with both systems, but QL9-L-d in particular, suggest that many single-residue substitutions, introduced into peptides to improve their binding to MHC and thus their vaccine potential, could impair T cell reactivity due to their dual impact on TCR binding.	[Kranz, David M.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Garcia, K. Christopher] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Colf, Leremy A.; Garcia, K. Christopher] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Colf, Leremy A.; Garcia, K. Christopher] Stanford Univ, Dept Biol Struct, Stanford, CA 94305 USA	University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Kranz, DM (corresponding author), Univ Illinois, Dept Biochem, 600 S Mathews Ave, Urbana, IL 61801 USA.	d-kranz@uiuc.edu			National Institutes of Health [GM55767, AI048540]; National Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI048540, R01AI048540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055767] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM55767 (to D. M. K.) and AI048540 (to K. C. G.). This work was also supported by a National Science Foundation predoctoral fellowship (to L. A. C.).	Allen P M, 1989, Int Immunol, V1, P141, DOI 10.1093/intimm/1.2.141; Balendiran GK, 1997, P NATL ACAD SCI USA, V94, P6880, DOI 10.1073/pnas.94.13.6880; Bergmann CC, 1996, J VIROL, V70, P3252, DOI 10.1128/JVI.70.5.3252-3257.1996; BEVAN MJ, 1984, IMMUNOL TODAY, V5, P128, DOI 10.1016/0167-5699(84)90233-0; BLUESTONE JA, 1993, J IMMUNOL, V151, P3943; Borbulevych OY, 2005, J IMMUNOL, V174, P4812, DOI 10.4049/jimmunol.174.8.4812; Bowerman NA, 2009, MOL IMMUNOL, V46, P3000, DOI 10.1016/j.molimm.2009.06.012; Brock R, 1996, P NATL ACAD SCI USA, V93, P13108, DOI 10.1073/pnas.93.23.13108; Brophy SE, 2007, MOL IMMUNOL, V44, P2184, DOI 10.1016/j.molimm.2006.11.016; Chervin AS, 2009, J IMMUNOL, V183, P1166, DOI 10.4049/jimmunol.0900054; Chervin AS, 2008, J IMMUNOL METHODS, V339, P175, DOI 10.1016/j.jim.2008.09.016; Cho BK, 2001, P NATL ACAD SCI USA, V98, P1723, DOI 10.1073/pnas.98.4.1723; Colf LA, 2007, CELL, V129, P135, DOI 10.1016/j.cell.2007.01.048; CORR M, 1992, J EXP MED, V176, P1681, DOI 10.1084/jem.176.6.1681; Daniels MA, 2000, J EXP MED, V191, P335, DOI 10.1084/jem.191.2.335; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Degano M, 2000, IMMUNITY, V12, P251, DOI 10.1016/S1074-7613(00)80178-8; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; Donermeyer DL, 2006, J IMMUNOL, V177, P6911, DOI 10.4049/jimmunol.177.10.6911; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; Felix NJ, 2007, NAT IMMUNOL, V8, P388, DOI 10.1038/ni1446; FREMONT DH, 1995, P NATL ACAD SCI USA, V92, P2479, DOI 10.1073/pnas.92.7.2479; Gillanders WE, 1997, INT IMMUNOL, V9, P81, DOI 10.1093/intimm/9.1.81; Holler PD, 2000, P NATL ACAD SCI USA, V97, P5387, DOI 10.1073/pnas.080078297; Holler PD, 2003, IMMUNITY, V18, P255, DOI 10.1016/S1074-7613(03)00019-0; Holler PD, 2003, NAT IMMUNOL, V4, P55, DOI 10.1038/ni863; Hornell TMC, 2001, J IMMUNOL, V167, P4207, DOI 10.4049/jimmunol.167.8.4207; Huseby ES, 2006, NAT IMMUNOL, V7, P1191, DOI 10.1038/ni1401; Iero M, 2009, CANCER IMMUNOL IMMUN, V58, P1159, DOI 10.1007/s00262-008-0610-6; Johansen TE, 1997, SCAND J IMMUNOL, V46, P137, DOI 10.1046/j.1365-3083.1997.d01-102.x; Jones LL, 2008, J IMMUNOL, V181, P6255, DOI 10.4049/jimmunol.181.9.6255; KRANZ DM, 1984, P NATL ACAD SCI-BIOL, V81, P573, DOI 10.1073/pnas.81.2.573; Lee PUY, 2000, J EXP MED, V191, P1355, DOI 10.1084/jem.191.8.1355; LIE WR, 1990, NATURE, V344, P439, DOI 10.1038/344439a0; Manning TC, 1998, IMMUNITY, V8, P413, DOI 10.1016/S1074-7613(00)80547-6; Parkhurst MR, 1996, J IMMUNOL, V157, P2539; Robinson RA, 1996, J IMMUNOL, V156, P4266; ROHREN EM, 1994, J IMMUNOL, V152, P5337; SAITO Y, 1993, J BIOL CHEM, V268, P21309; Schlueter CJ, 1996, J IMMUNOL, V157, P4478; SloanLancaster J, 1996, ANNU REV IMMUNOL, V14, P1, DOI 10.1146/annurev.immunol.14.1.1; SOLHEIM JC, 1993, J IMMUNOL, V151, P5387; Speir JA, 1998, IMMUNITY, V8, P553, DOI 10.1016/S1074-7613(00)80560-9; Stone JD, 2009, IMMUNOLOGY, V126, P165, DOI 10.1111/j.1365-2567.2008.03015.x; SYKULEV Y, 1994, P NATL ACAD SCI USA, V91, P11487, DOI 10.1073/pnas.91.24.11487; SYKULEV Y, 1994, IMMUNITY, V1, P15, DOI 10.1016/1074-7613(94)90005-1; Sykulev Y, 1998, IMMUNITY, V9, P475, DOI 10.1016/S1074-7613(00)80631-7; UDAKA K, 1992, CELL, V69, P989, DOI 10.1016/0092-8674(92)90617-L; UDAKA K, 1993, P NATL ACAD SCI USA, V90, P11272, DOI 10.1073/pnas.90.23.11272; Udaka K, 1996, J IMMUNOL, V157, P670; Valmori D, 1998, J IMMUNOL, V160, P1750; VANBLEEK GM, 1991, P NATL ACAD SCI USA, V88, P11032, DOI 10.1073/pnas.88.24.11032; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920; Wucherpfennig KW, 2007, SEMIN IMMUNOL, V19, P216, DOI 10.1016/j.smim.2007.02.012; Zhang B, 2007, J EXP MED, V204, P49, DOI 10.1084/jem.20062056; ZHANG WG, 1992, P NATL ACAD SCI USA, V89, P8403, DOI 10.1073/pnas.89.17.8403	56	18	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32551	32561		10.1074/jbc.M109.040501	http://dx.doi.org/10.1074/jbc.M109.040501			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19755422	Green Published, hybrid			2022-12-27	WOS:000272028400037
J	Niki, T; Tsutsui, S; Hirose, S; Aradono, S; Sugimoto, Y; Takeshita, K; Nishi, N; Hirashima, M				Niki, Toshiro; Tsutsui, Shoko; Hirose, Shigeru; Aradono, Sachiko; Sugimoto, Yasushi; Takeshita, Keisuke; Nishi, Nozomu; Hirashima, Mitsuomi			Galectin-9 Is a High Affinity IgE-binding Lectin with Anti-allergic Effect by Blocking IgE-Antigen Complex Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAST-CELLS; TIM-3 LIGAND; PROTEIN; IDENTIFICATION; SUPPRESSES; RECEPTOR; EXPRESSION; ECALECTIN; INDUCTION	Galectin (Gal)-9 was first described as an eosinophil chemoattractant. With the progress in research, Gal-9 has come to be known as a versatile immunomodulator that is involved in various aspects of immune regulations, and the entire picture of the function still remains elusive. To uncover as-yet unknown activity of Gal-9, we have been examining the effect of the protein in various disease animal models. Here we show that Gal-9 attenuated asthmatic reaction in guinea pigs and suppressed passive-cutaneous anaphylaxis in mice. These results indicate the mast cell stabilizing effect of Gal-9. In vitro studies of mast cell degranulation involving RBL-2H3 cells demonstrated that Gal-9 suppressed degranulation from the cells stimulated by IgE plus antigen and that the inhibitory effect was completely abrogated in the presence of lactose, indicating lectin activity of Gal-9 is critical. We found that Gal-9 strongly and specifically bound IgE, which is a heavily glycosylated immunoglobulin, and that the interaction prevented IgE-antigen complex formation, clarifying the mode of action of the anti-degranulation effect. Gal-9 is expressed by several mast cells including mouse mast cell line MC/9. The fact that immunological stimuli of MC/9 cells augmented Gal-9 secretion from the cells implies that Gal-9 is an autocrine regulator of mast cell function to suppress excessive degranulation. Collectively, these findings shed light on a novel function of Gal-9 in mast cells and suggest a beneficial utility of Gal-9 for the treatment of allergic disorders including asthma.	[Niki, Toshiro; Tsutsui, Shoko; Hirose, Shigeru; Aradono, Sachiko; Sugimoto, Yasushi; Takeshita, Keisuke; Hirashima, Mitsuomi] GalPharma Co Ltd, Div Res, FROM Kagawa, Kagawa 7610301, Japan; [Hirashima, Mitsuomi] Kagawa Univ, Fac Med, Dept Immunol, Miki, Kagawa 7610793, Japan; [Hirashima, Mitsuomi] Kagawa Univ, Fac Med, Dept Immunopathol, Miki, Kagawa 7610793, Japan	Kagawa University; Kagawa University	Niki, T (corresponding author), GalPharma Co Ltd, Div Res, FROM Kagawa, 2217-16 Hayashi Cho, Kagawa 7610301, Japan.	niki.t@galpharma.com		Nishi, Nozomu/0000-0001-7050-3226				ANDERSEN BR, 1966, J IMMUNOL, V97, P913; Anderson AC, 2007, SCIENCE, V318, P1141, DOI 10.1126/science.1148536; Bischoff SC, 2007, NAT REV IMMUNOL, V7, P93, DOI 10.1038/nri2018; Boushey HA, 2001, J ALLERGY CLIN IMMUN, V108, pS77, DOI 10.1067/mai.2001.116434; Bradding P, 2006, J ALLERGY CLIN IMMUN, V117, P1277, DOI 10.1016/j.jaci.2006.02.039; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; Chabot S, 2002, GLYCOBIOLOGY, V12, P111, DOI 10.1093/glycob/12.2.111; CHERAYIL BJ, 1989, J EXP MED, V170, P1959, DOI 10.1084/jem.170.6.1959; Cooper DNW, 2002, BBA-GEN SUBJECTS, V1572, P209, DOI 10.1016/S0304-4165(02)00310-0; DAGHER SF, 1995, P NATL ACAD SCI USA, V92, P1213, DOI 10.1073/pnas.92.4.1213; de Mora F, 2006, BRIT J DERMATOL, V155, P1109, DOI 10.1111/j.1365-2133.2006.07494.x; Elola MT, 2005, J BIOMED SCI, V12, P13, DOI 10.1007/s11373-004-8169-5; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Gregory Gregory D, 2006, Methods Mol Biol, V315, P35; Hirashima M, 1999, INT ARCH ALLERGY IMM, V120, P7, DOI 10.1159/000053584; HSU DK, 1992, J BIOL CHEM, V267, P14167; KANNER BI, 1983, P NATL ACAD SCI-BIOL, V80, P5744, DOI 10.1073/pnas.80.18.5744; Katoh S, 2007, AM J RESP CRIT CARE, V176, P27, DOI 10.1164/rccm.200608-1243OC; Matsumoto R, 1998, J BIOL CHEM, V273, P16976, DOI 10.1074/jbc.273.27.16976; Matsushita N, 2000, J BIOL CHEM, V275, P8355, DOI 10.1074/jbc.275.12.8355; MAZUREK N, 1983, NATURE, V303, P528, DOI 10.1038/303528a0; Nakae S, 2007, BLOOD, V110, P2565, DOI 10.1182/blood-2006-11-058800; Nishi N, 2005, FEBS LETT, V579, P2058, DOI 10.1016/j.febslet.2005.02.054; Niwa H, 2009, CLIN IMMUNOL, V132, P184, DOI 10.1016/j.clim.2009.04.012; Nobumoto A, 2008, GLYCOBIOLOGY, V18, P735, DOI 10.1093/glycob/cwn062; NOWAK TP, 1976, BIOCHEM BIOPH RES CO, V68, P650, DOI 10.1016/0006-291X(76)91195-5; Park JW, 2001, NUCLEIC ACIDS RES, V29, P3595, DOI 10.1093/nar/29.17.3595; Pivniouk VI, 2003, INT IMMUNOL, V15, P1431, DOI 10.1093/intimm/dxg148; Rivera J, 2006, J ALLERGY CLIN IMMUN, V117, P1214, DOI 10.1016/j.jaci.2006.04.015; ROSENBERG I, 1991, J BIOL CHEM, V266, P18731; Sato M, 2002, J BIOCHEM, V131, P255, DOI 10.1093/oxfordjournals.jbchem.a003096; Seki M, 2008, CLIN IMMUNOL, V127, P78, DOI 10.1016/j.clim.2008.01.006; Seki M, 2007, ARTHRITIS RHEUM-US, V56, P3968, DOI 10.1002/art.23076; Tureci O, 1997, J BIOL CHEM, V272, P6416, DOI 10.1074/jbc.272.10.6416; VLASSARA H, 1995, MOL MED, V1, P634, DOI 10.1007/BF03401604; Wada J, 1997, J CLIN INVEST, V99, P2452, DOI 10.1172/JCI119429; Wada J, 1997, J BIOL CHEM, V272, P6078, DOI 10.1074/jbc.272.9.6078; Wiener Z, 2007, J INVEST DERMATOL, V127, P906, DOI 10.1038/sj.jid.5700616; WOO HJ, 1990, J BIOL CHEM, V265, P7097; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271; ZUBERI RI, 1994, CELL IMMUNOL, V156, P1, DOI 10.1006/cimm.1994.1148	41	115	120	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32344	32352		10.1074/jbc.M109.035196	http://dx.doi.org/10.1074/jbc.M109.035196			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19776007	Green Published, hybrid			2022-12-27	WOS:000272028400017
J	Pacheco, S; Gomez, I; Arenas, I; Saab-Rincon, G; Rodriguez-Almazan, C; Gill, SS; Bravo, A; Soberon, M				Pacheco, Sabino; Gomez, Isabel; Arenas, Ivan; Saab-Rincon, Gloria; Rodriguez-Almazan, Claudia; Gill, Sarjeet S.; Bravo, Alejandra; Soberon, Mario			Domain II Loop 3 of Bacillus thuringiensis Cry1Ab Toxin Is Involved in a "Ping Pong" Binding Mechanism with Manduca sexta Aminopeptidase-N and Cadherin Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; PORE-FORMING TOXIN; HELIOTHIS-VIRESCENS; INSECTICIDAL TOXIN; MEMBRANE INSERTION; OLIGOMER FORMATION; DELTA-ENDOTOXINS; BT-R-1 RECEPTOR; LARVAL MIDGUT; PRE-PORE	Bacillus thuringiensis Cry toxins are used worldwide as insecticides in agriculture, in forestry, and in the control of disease transmission vectors. In the lepidopteran Manduca sexta, cadherin (Bt-R-1) and aminopeptidase-N (APN) function as Cry1A toxin receptors. The interaction with Bt-R-1 promotes cleavage of the amino-terminal end, including helix alpha-1 and formation of prepore oligomer that binds to APN, leading to membrane insertion and pore formation. Loops of domain II of Cry1Ab toxin are involved in receptor interaction. Here we show that Cry1Ab mutants located in domain II loop 3 are affected in binding to both receptors and toxicity against Manduca sexta larvae. Interaction with both receptors depends on the oligomeric state of the toxin. Monomers of loop 3 mutants were affected in binding to APN and to a cadherin fragment corresponding to cadherin repeat 12 but not with a fragment comprising cadherin repeats 7-12. In contrast, the oligomers of loop 3 mutants were affected in binding to both Bt-R-1 fragments but not to APN. Toxicity assays showed that either monomeric or oligomeric structures of Cry1Ab loop 3 mutations were severely affected in insecticidal activity. These data suggest that loop 3 is differentially involved in the binding with both receptor molecules, depending on the oligomeric state of the toxin and also that possibly a "ping pong" binding mechanism with both receptors is involved in toxin action.	[Pacheco, Sabino; Gomez, Isabel; Arenas, Ivan; Saab-Rincon, Gloria; Rodriguez-Almazan, Claudia; Bravo, Alejandra; Soberon, Mario] Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca 62250, Morelos, Mexico; [Gill, Sarjeet S.] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92506 USA	Universidad Nacional Autonoma de Mexico; University of California System; University of California Riverside	Soberon, M (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Apdo Postal 510-3, Cuernavaca 62250, Morelos, Mexico.	mario@ibt.unam.mx	Pacheco, Sabino/AFJ-9017-2022; Saab-RIncon, Gloria/AFO-4892-2022; de la Parra, Maria Alejandra Bravo/R-6740-2017	Saab-RIncon, Gloria/0000-0002-5251-1000; ARENAS, IVAN/0000-0003-0384-7437; Pacheco, Sabino/0000-0002-0208-0046; Bravo, Alejandra/0000-0002-7573-7475	National Institutes of Health [1R01 AI066014]; Consejo Nacional de Ciencia y Tecnologia [83135, 81639]; DGAPA-UNAM [IN218608-3, IN210208]; United States Department of Agriculture [2207-35607-17780]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066014] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); DGAPA-UNAM(Universidad Nacional Autonoma de Mexico); United States Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01 AI066014. This work was also supported by Consejo Nacional de Ciencia y Tecnologia Grants 83135 and 81639, DGAPA-UNAM Grants IN218608-3 and IN210208, and United States Department of Agriculture Grant 2207-35607-17780.	Abrami L, 2003, INFECT IMMUN, V71, P739, DOI 10.1128/IAI.71.2.739-746.2003; Atsumi S, 2005, APPL ENVIRON MICROB, V71, P3966, DOI 10.1128/AEM.71.7.3966-3977.2005; Atsumi S, 2008, FEBS J, V275, P4913, DOI 10.1111/j.1742-4658.2008.06634.x; Bartosch B, 2003, J BIOL CHEM, V278, P41624, DOI 10.1074/jbc.M305289200; Bel Y, 2006, GENE, V381, P71, DOI 10.1016/j.gene.2006.07.001; Bravo A, 2004, BBA-BIOMEMBRANES, V1667, P38, DOI 10.1016/j.bbamem.2004.08.013; Bravo A, 2007, TOXICON, V49, P423, DOI 10.1016/j.toxicon.2006.11.022; Chen J, 2005, CELL TISSUE RES, V321, P123, DOI 10.1007/s00441-005-1124-6; Chen J, 2007, P NATL ACAD SCI USA, V104, P13901, DOI 10.1073/pnas.0706011104; Flannagan RD, 2005, INSECT BIOCHEM MOLEC, V35, P33, DOI 10.1016/j.ibmb.2004.10.001; Gahan LJ, 2001, SCIENCE, V293, P857, DOI 10.1126/science.1060949; Gomez I, 2003, BIOCHEMISTRY-US, V42, P10482, DOI 10.1021/bi034440p; Gomez I, 2001, J BIOL CHEM, V276, P28906, DOI 10.1074/jbc.M103007200; Gomez I, 2002, J BIOL CHEM, V277, P30137, DOI 10.1074/jbc.M203121200; Gomez I, 2002, FEBS LETT, V513, P242, DOI 10.1016/S0014-5793(02)02321-9; Gomez I, 2006, J BIOL CHEM, V281, P34032, DOI 10.1074/jbc.M604721200; Griffitts JS, 2005, SCIENCE, V307, P922, DOI 10.1126/science.1104444; Hasuwa H, 2001, BIOCHEM BIOPH RES CO, V289, P782, DOI 10.1006/bbrc.2001.6053; Hua G, 2004, J BIOL CHEM, V279, P28051, DOI 10.1074/jbc.M400237200; Jenkins J L, 2000, Genet Eng (N Y), V22, P33; Jenkins JL, 2000, J BIOL CHEM, V275, P14423, DOI 10.1074/jbc.275.19.14423; Jimenez-Juarez N, 2007, J BIOL CHEM, V282, P21222, DOI 10.1074/jbc.M701314200; Jurat-Fuentes JL, 2004, EUR J BIOCHEM, V271, P3127, DOI 10.1111/j.1432-1033.2004.04238.x; Lopez S, 2004, TRENDS MICROBIOL, V12, P271, DOI 10.1016/j.tim.2004.04.003; Lorence A, 1997, FEBS LETT, V414, P303, DOI 10.1016/S0014-5793(97)01014-4; MASSON L, 1995, J BIOL CHEM, V270, P20309, DOI 10.1074/jbc.270.35.20309; Morin S, 2003, P NATL ACAD SCI USA, V100, P5004, DOI 10.1073/pnas.0831036100; Nagamatsu Y, 1998, BIOSCI BIOTECH BIOCH, V62, P727, DOI 10.1271/bbb.62.727; Nair MS, 2008, J BIOL CHEM, V283, P26324, DOI 10.1074/jbc.M802895200; Pacheco S, 2009, PEPTIDES, V30, P583, DOI 10.1016/j.peptides.2008.08.006; Pardo-Lopez L, 2006, BIOCHEMISTRY-US, V45, P10329, DOI 10.1021/bi060297z; RAJAMOHAN F, 1995, J BACTERIOL, V177, P2276, DOI 10.1128/jb.177.9.2276-2282.1995; Rajamohan F, 1996, J BIOL CHEM, V271, P25220, DOI 10.1074/jbc.271.41.25220; Sangadala S, 2001, INSECT BIOCHEM MOLEC, V32, P97, DOI 10.1016/S0965-1748(01)00086-8; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Smedley DP, 1996, MICROBIOL-SGM, V142, P1617, DOI 10.1099/13500872-142-7-1617; Soberon M, 2007, SCIENCE, V318, P1640, DOI 10.1126/science.1146453; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; VADLAMUDI RK, 1995, J BIOL CHEM, V270, P5490, DOI 10.1074/jbc.270.10.5490; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; WOLFERSBERGER M, 1987, COMP BIOCHEM PHYS A, V86, P301, DOI 10.1016/0300-9629(87)90334-3; Xie RY, 2005, J BIOL CHEM, V280, P8416, DOI 10.1074/jbc.M408403200; Xu XJ, 2005, APPL ENVIRON MICROB, V71, P948, DOI 10.1128/AEM.71.2.948-954.2005; Zhuang MB, 2002, J BIOL CHEM, V277, P13863, DOI 10.1074/jbc.M110057200	45	101	110	1	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32750	32757		10.1074/jbc.M109.024968	http://dx.doi.org/10.1074/jbc.M109.024968			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19808680	hybrid, Green Published			2022-12-27	WOS:000272028400060
J	Podobnik, M; Tyagi, R; Matange, N; Dermol, U; Gupta, AK; Mattoo, R; Seshadri, K; Visweswariah, SS				Podobnik, Marjetka; Tyagi, Richa; Matange, Nishad; Dermol, Urska; Gupta, Arun K.; Mattoo, Rohini; Seshadri, Kothandaraman; Visweswariah, Sandhya S.			A Mycobacterial Cyclic AMP Phosphodiesterase That Moonlights as a Modifier of Cell Wall Permeability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE PHOSPHODIESTERASE; TUBERCULOSIS; GLYCEROPHOSPHODIESTERASE; BIOSYNTHESIS; BIOCHEMISTRY; ARCHITECTURE; NUCLEASE; MEMBERS; RV1647	Mycobacterium tuberculosis utilizes many mechanisms to establish itself within the macrophage, and bacterially derived cAMP is important in modulating the host cellular response. Although the genome of M. tuberculosis is endowed with a number of mammalian-like adenylyl cyclases, only a single cAMP phosphodiesterase has been identified that can decrease levels of cAMP produced by the bacterium. We present the crystal structure of the full-length and sole cAMP phosphodiesterase, Rv0805, found in M. tuberculosis, whose orthologs are present only in the genomes of slow growing and pathogenic mycobacteria. The dimeric core catalytic domain of Rv0805 adopts a metallophosphoesterase-fold, and the C-terminal region builds the active site and contributes to multiple substrate utilization. Localization of Rv0805 to the cell wall is dependent on its C terminus, and expression of either wild type or mutationally inactivated Rv0805 in M. smegmatis alters cell permeability to hydrophobic cytotoxic compounds. Rv0805 may therefore play a key role in the pathogenicity of mycobacteria, not only by hydrolyzing bacterial cAMP, but also by moonlighting as a protein that can alter cell wall functioning.	[Podobnik, Marjetka; Dermol, Urska] Natl Inst Chem Slovenia, Lab Biosynth & Biotransformat, Ljubljana 1000, Slovenia; [Tyagi, Richa; Matange, Nishad; Mattoo, Rohini; Visweswariah, Sandhya S.] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India; [Seshadri, Kothandaraman] AstraZeneca India Private Ltd, Bangalore 560024, Karnataka, India	National Institute of Chemistry - Slovenia; Indian Institute of Science (IISC) - Bangalore; AstraZeneca	Podobnik, M (corresponding author), Natl Inst Chem Slovenia, Lab Biosynth & Biotransformat, Hajdrihova 19, Ljubljana 1000, Slovenia.	marjetka.podobnik@ki.si; sandhya@mrdg.iisc.ernet.in	tyagi, richa/A-7261-2015; Visweswariah, Sandhya/Q-7500-2019; matange, nishad/AAF-9653-2020	Visweswariah, Sandhya/0000-0003-2786-7344; Matange, Nishad/0000-0002-2947-3931; Mattoo, Rohini/0000-0003-2185-0031	Slovenian Research Agency; Department of Biotechnology, Government of India; Department of Science and Technology, Government of India	Slovenian Research Agency(Slovenian Research Agency - Slovenia); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Department of Science and Technology, Government of India(Department of Science & Technology (India))	This work was supported in part by grants from the Slovenian Research Agency (to M. P. and U. D.), the Department of Biotechnology, Government of India, and the Department of Science and Technology, Government of India for an Indo-Slovenian joint project.	Agarwal N, 2009, NATURE, V460, P98, DOI 10.1038/nature08123; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boyne ME, 2007, ANTIMICROB AGENTS CH, V51, P3562, DOI 10.1128/AAC.00383-07; Collins BM, 2005, NAT STRUCT MOL BIOL, V12, P594, DOI 10.1038/nsmb954; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Dass BKM, 2008, J BACTERIOL, V190, P3824, DOI 10.1128/JB.00138-08; DeLano W.L, PYMOL MOL GRAPHICS S; Delogu G, 2004, FEMS MICROBIOL LETT, V239, P33, DOI 10.1016/j.femsle.2004.08.015; Ding F, 2006, STRUCTURE, V14, P5, DOI 10.1016/j.str.2005.09.008; Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x; Hadler KS, 2008, J AM CHEM SOC, V130, P14129, DOI 10.1021/ja803346w; Hierro A, 2007, NATURE, V449, P1063, DOI 10.1038/nature06216; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; Jackson CJ, 2007, J MOL BIOL, V367, P1047, DOI 10.1016/j.jmb.2007.01.032; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kana BD, 2008, MOL MICROBIOL, V67, P672, DOI 10.1111/j.1365-2958.2007.06078.x; Keppetipola Niroshika, 2008, J Biol Chem, V283, P30942, DOI 10.1074/jbc.M805064200; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Liu J, 1999, P NATL ACAD SCI USA, V96, P4011, DOI 10.1073/pnas.96.7.4011; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rezwan M, 2007, J MICROBIOL METH, V68, P32, DOI 10.1016/j.mimet.2006.05.016; Richter W, 2002, PROTEINS, V46, P278, DOI 10.1002/prot.10049; Shenoy AR, 2005, BIOCHEM J, V387, P541, DOI 10.1042/BJ20041040; Shenoy AR, 2005, BIOCHEMISTRY-US, V44, P15695, DOI 10.1021/bi0512391; Shenoy AR, 2003, ANAL BIOCHEM, V319, P335, DOI 10.1016/S0003-2697(03)00286-0; Shenoy AR, 2007, J MOL BIOL, V365, P211, DOI 10.1016/j.jmb.2006.10.005; Shenoy AR, 2006, FEBS LETT, V580, P3344, DOI 10.1016/j.febslet.2006.05.034; Shenoy AR, 2006, TRENDS MICROBIOL, V14, P543, DOI 10.1016/j.tim.2006.10.005; Tyagi R, 2009, J BIOL CHEM, V284, P5217, DOI 10.1074/jbc.M805996200; Vandal OH, 2008, NAT MED, V14, P849, DOI 10.1038/nm.1795; Voegtli WC, 2000, BIOCHEMISTRY-US, V39, P15365, DOI 10.1021/bi0021030; WEININGER D, 1988, J CHEM INF COMP SCI, V28, P31, DOI 10.1021/ci00057a005; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; Zor T, 1996, ANAL BIOCHEM, V236, P302, DOI 10.1006/abio.1996.0171	34	51	53	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32846	32857		10.1074/jbc.M109.049635	http://dx.doi.org/10.1074/jbc.M109.049635			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19801656	Green Published, hybrid			2022-12-27	WOS:000272028400069
J	Schramm, VL				Schramm, Vern L.			Transition States	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							PURINE NUCLEOSIDE PHOSPHORYLASE; AMP NUCLEOSIDASE; 5'-METHYLTHIOADENOSINE NUCLEOSIDASE; ALLOSTERIC ACTIVATION; HYDROLYSIS; INHIBITORS; MECHANISM; NAD(+); TOXIN; PURIFICATION		Yeshiva Univ, Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10805 USA	Yeshiva University; Albert Einstein College of Medicine	Schramm, VL (corresponding author), Yeshiva Univ, Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10805 USA.	vern@aecom.yu.edu						BARNER HD, 1956, J BACTERIOL, V71, P149, DOI 10.1128/JB.71.2.149-157.1956; Basu I, 2007, J BIOL CHEM, V282, P21477, DOI 10.1074/jbc.M702287200; Berti PJ, 1997, J AM CHEM SOC, V119, P12079, DOI 10.1021/ja971317a; Chen XY, 2000, J AM CHEM SOC, V122, P1609, DOI 10.1021/ja992750i; CLELAND WW, 1976, ISOTOPE EFFECTS ENZY; DEWOLF WE, 1979, J BIOL CHEM, V254, P868; FLEISCHER B, 1983, J HISTOCHEM CYTOCHEM, V31, P1033, DOI 10.1177/31.8.6345657; Gandhi V, 2007, SEMIN ONCOL, V34, pS8, DOI 10.1053/j.seminoncol.2007.11.003; Gandour R. D., 1978, TRANSITION STATES BI; Ghanem M, 2009, CHEM BIOL, V16, P971, DOI 10.1016/j.chembiol.2009.07.012; Gutierrez JA, 2009, NAT CHEM BIOL, V5, P251, DOI 10.1038/nchembio.153; HORENSTEIN BA, 1993, BIOCHEMISTRY-US, V32, P9917, DOI 10.1021/bi00089a007; HORENSTEIN BA, 1991, BIOCHEMISTRY-US, V30, P10788, DOI 10.1021/bi00108a026; HORENSTEIN BA, 1993, BIOCHEMISTRY-US, V32, P7089, DOI 10.1021/bi00079a004; KLINE PC, 1993, BIOCHEMISTRY-US, V32, P13212, DOI 10.1021/bi00211a033; Lewandowicz A, 2003, J BIOL CHEM, V278, P31465, DOI 10.1074/jbc.C300259200; MENTCH F, 1984, J CHEM PHYS, V80, P2675, DOI 10.1063/1.447063; MENTCH F, 1987, BIOCHEMISTRY-US, V26, P921, DOI 10.1021/bi00377a037; MERKLER DJ, 1993, BIOCHEMISTRY-US, V32, P12993, DOI 10.1021/bi00211a007; Miles RW, 1998, BIOCHEMISTRY-US, V37, P8615, DOI 10.1021/bi980658d; PARKIN DW, 1984, J BIOL CHEM, V259, P9418; PARKIN DW, 1984, J BIOL CHEM, V259, P9411; PARKIN DW, 1991, BIOCHEMISTRY-US, V30, P4586, DOI 10.1021/bi00232a032; PAULING L, 1948, Am Sci, V36, P51; RISING KA, 1994, J AM CHEM SOC, V116, P6531, DOI 10.1021/ja00094a006; Rising KA, 1997, J AM CHEM SOC, V119, P27, DOI 10.1021/ja9621915; Saen-oon S, 2008, P NATL ACAD SCI USA, V105, P16543, DOI 10.1073/pnas.0808413105; Scheuring J, 1997, BIOCHEMISTRY-US, V36, P8215, DOI 10.1021/bi970379a; SCHRAMM VL, 1972, BIOCHEMISTRY-US, V11, P2777, DOI 10.1021/bi00765a007; SCHRAMM VL, 1968, BIOCHEMISTRY-US, V7, P3642, DOI 10.1021/bi00850a043; Singh V, 2007, J AM CHEM SOC, V129, P2783, DOI 10.1021/ja065082r; Singh V, 2006, J AM CHEM SOC, V128, P14691, DOI 10.1021/ja065419p; WHITE A, 1965, ANN NY ACAD SCI, V128, P489, DOI 10.1111/j.1749-6632.1965.tb11661.x; WOLFENDE.R, 1969, NATURE, V223, P704, DOI 10.1038/223704a0; Zhang Y, 2009, J AM CHEM SOC, V131, P4685, DOI 10.1021/ja808346y	35	6	6	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32201	32208		10.1074/jbc.X109.060111	http://dx.doi.org/10.1074/jbc.X109.060111			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19758992	Green Published, hybrid			2022-12-27	WOS:000272028400001
J	Tang, CR; Liu, YH; Kessler, PS; Vaughan, AM; Oram, JF				Tang, Chongren; Liu, Yuhua; Kessler, Peter S.; Vaughan, Ashley M.; Oram, John F.			The Macrophage Cholesterol Exporter ABCA1 Functions as an Anti-inflammatory Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY RESPONSE; ABCA1-DEFICIENT MACROPHAGES; APOLIPOPROTEIN INTERACTIONS; ATHEROSCLEROTIC LESIONS; CELLULAR CHOLESTEROL; GENE-EXPRESSION; STAT3; MICE; EFFLUX; INTERLEUKIN-10	ATP-binding cassette transporter A1 (ABCA1) is a cell membrane protein that exports excess cholesterol from cells to apolipoprotein (apo) A-I, the major protein in high density lipoproteins. Genetic studies have shown that ABCA1 protects against cardiovascular disease. The interaction of apoA-I with ABCA1 promotes cholesterol removal and activates signaling molecules, such as Janus kinase 2 (JAK2), that optimize the lipid export activity of ABCA1. Here we show that the ABCA1-mediated activation of JAK2 also activates STAT3, which is independent of the lipid transport function of ABCA1. ABCA1 contains two candidate STAT3 docking sites that are required for the apoA-I/ABCA1/JAK2 activation of STAT3. The interaction of apoA-I with ABCA1-expressing macrophages suppressed the ability of lysopolysaccaride to induce the inflammatory cytokines interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha, which was reversed by silencing STAT3 or ABCA1. Thus, the apoA-I/ABCA1 pathway in macrophages functions as an anti-inflammatory receptor through activation of JAK2/STAT3. These findings implicate ABCA1 as a direct molecular link between the cardioprotective effects of cholesterol export from arterial macrophages and suppressed inflammation.	[Tang, Chongren; Liu, Yuhua; Kessler, Peter S.; Vaughan, Ashley M.; Oram, John F.] Univ Washington, Dept Med, Div Metab Endocrinol & Nutr, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Oram, JF (corresponding author), Univ Washington, Dept Med, Div Metab Endocrinol & Nutr, Seattle, WA 98195 USA.	joram@u.washington.edu			National Institutes of Health [RO1 HL055362, HL085437, PO1 HL092969]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055362, R01HL085437, P01HL092969] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 HL055362, HL085437, and PO1 HL092969.	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Aiello RJ, 2002, ARTERIOSCL THROM VAS, V22, P630, DOI 10.1161/01.ATV.0000014804.35824.DA; Aiello RJ, 2003, ARTERIOSCL THROM VAS, V23, P972, DOI 10.1161/01.ATV.0000054661.21499.FB; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Brunham LR, 2009, ARTERIOSCL THROM VAS, V29, P548, DOI 10.1161/ATVBAHA.108.182303; Buettner C, 2006, CELL METAB, V4, P49, DOI 10.1016/j.cmet.2006.04.014; Cho HJ, 2007, PHYSIOL GENOMICS, V29, P149, DOI 10.1152/physiolgenomics.00051.2006; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Francone OL, 2005, ARTERIOSCL THROM VAS, V25, P1198, DOI 10.1161/01.ATV.0000166522.69552.99; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Koseki M, 2007, J LIPID RES, V48, P299, DOI 10.1194/jlr.M600428-JLR200; Matsukawa A, 2005, J IMMUNOL, V175, P3354, DOI 10.4049/jimmunol.175.5.3354; Matsukawa A, 2003, J IMMUNOL, V171, P6198, DOI 10.4049/jimmunol.171.11.6198; MENDEZ AJ, 1994, J CLIN INVEST, V94, P1698, DOI 10.1172/JCI117515; Murphy AJ, 2008, ARTERIOSCL THROM VAS, V28, P2071, DOI 10.1161/ATVBAHA.108.168690; Murray PJ, 2006, CURR OPIN PHARMACOL, V6, P379, DOI 10.1016/j.coph.2006.01.010; Oram JF, 2000, J BIOL CHEM, V275, P34508, DOI 10.1074/jbc.M006738200; Oram JF, 2005, PHYSIOL REV, V85, P1343, DOI 10.1152/physrev.00005.2005; Passarelli M, 2005, DIABETES, V54, P2198, DOI 10.2337/diabetes.54.7.2198; Potteaux S, 2004, ARTERIOSCL THROM VAS, V24, P1474, DOI 10.1161/01.ATV.0000134378.86443.cd; Renard CB, 2004, J CLIN INVEST, V114, P659, DOI 10.1172/JCI200417867; Schwartz K, 2000, BIOCHEM BIOPH RES CO, V274, P794, DOI 10.1006/bbrc.2000.3243; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Singaraja RR, 2006, CIRC RES, V99, P389, DOI 10.1161/01.RES.0000237920.70451.ad; Singaraja RR, 2003, ARTERIOSCL THROM VAS, V23, P1322, DOI 10.1161/01.ATV.0000078520.89539.77; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; Sun YP, 2009, J IMMUNOL, V182, P5899, DOI 10.4049/jimmunol.0804388; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Tang CR, 2006, J LIPID RES, V47, P107, DOI 10.1194/jlr.M500240-JLR200; Tang CR, 2004, J BIOL CHEM, V279, P7622, DOI 10.1074/jbc.M312571200; Tellier E, 2008, J CELL PHYSIOL, V214, P687, DOI 10.1002/jcp.21265; Van Eck M, 2002, P NATL ACAD SCI USA, V99, P6298, DOI 10.1073/pnas.092327399; Vaughan AM, 2003, J LIPID RES, V44, P1373, DOI 10.1194/jlr.M300078-JLR200; Vaughan AM, 2009, J LIPID RES, V50, P285, DOI 10.1194/jlr.M800366-JLR200; Wang Y, 2004, J LIPID RES, V45, P972, DOI 10.1194/jlr.M400011-JLR200; WILLIAMS KJ, 1995, ARTERIOSCL THROM VAS, V15, P551, DOI 10.1161/01.ATV.15.5.551; Williams LM, 2007, J BIOL CHEM, V282, P6965, DOI 10.1074/jbc.M609101200; Yvan-Charvet L, 2008, CIRCULATION, V118, P1837, DOI 10.1161/CIRCULATIONAHA.108.793869; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883; Zhu X, 2008, J BIOL CHEM, V283, P22930, DOI 10.1074/jbc.M801408200	41	195	210	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32336	32343		10.1074/jbc.M109.047472	http://dx.doi.org/10.1074/jbc.M109.047472			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19783654	Green Published, hybrid			2022-12-27	WOS:000272028400016
J	Ruiz, CA; Rotundo, RL				Ruiz, Carlos A.; Rotundo, Richard L.			Limiting Role of Protein Disulfide Isomerase in the Expression of Collagen-tailed Acetylcholinesterase Forms in Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT SKELETAL-MUSCLE; ENDOPLASMIC-RETICULUM; MOLECULAR-FORMS; MESSENGER-RNA; FIBRILLAR COLLAGENS; THIOREDOXIN FAMILY; SURFACE EXPRESSION; NEURAL REGULATION; BINDING PROTEIN; GOLGI-APPARATUS	The expression of acetylcholinesterase (AChE) in skeletal muscle is regulated by muscle activity; however, the underlying molecular mechanisms are incompletely understood. We show here that the expression of the synaptic collagen-tailed AChE form (ColQ-AChE) in quail muscle cultures can be regulated by muscle activity post-translationally. Inhibition of thiol oxidoreductase activity decreases expression of all active AChE forms. Likewise, primary quail myotubes transfected with protein disulfide isomerase (PDI) short hairpin RNAs showed a significant decrease of both the intracellular pool of all collagen-tailed AChE forms and cell surface AChE clusters. Conversely, overexpression of PDI, endoplasmic reticulum protein 72, or calnexin in muscle cells enhanced expression of all collagen-tailed AChE forms. Overexpression of PDI had the most dramatic effect with a 100% increase in the intracellular ColQ-AChE pool and cell surface enzyme activity. Moreover, the levels of PDI are regulated by muscle activity and correlate with the levels of ColQ-AChE and AChE tetramers. Finally, we demonstrate that PDI interacts directly with AChE intracellularly. These results show that collagen-tailed AChE form levels induced by muscle activity can be regulated by molecular chaperones and suggest that newly synthesized exportable proteins may compete for chaperone assistance during the folding process.	Univ Miami, Miller Sch Med, Dept Cell Biol & Anat, Miami, FL 33136 USA; Univ Miami, Miller Sch Med, Neurosci Program, Miami, FL 33136 USA	University of Miami; University of Miami	Rotundo, RL (corresponding author), Univ Miami, Sch Med, Dept Cell Biol & Anat R 124, 1600 NW 10th Ave, Miami, FL 33136 USA.	rrotundo@miami.edu			National Institutes of Health [AG005917, NS057994]; Ruth Kirschstein National Research Service Award;  [ARO 49497-LS-HIS]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS057994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG005917] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG005917 and NS057994 ( to R. L. R.).; 1 Supported by Training Grant ARO 49497-LS-HIS ( to R. L. R.) and a Ruth Kirschstein National Research Service Award for individual predoctoral fellows.	Ahtikoski AM, 2001, ACTA PHYSIOL SCAND, V172, P131, DOI 10.1046/j.1365-201X.2001.00848.x; ANGLISTER L, 1978, J MOL BIOL, V125, P293, DOI 10.1016/0022-2836(78)90404-7; Bottomley MJ, 2001, CURR BIOL, V11, P1114, DOI 10.1016/S0960-9822(01)00317-7; Bourne Y, 1999, J BIOL CHEM, V274, P2963, DOI 10.1074/jbc.274.5.2963; BROCKMAN SK, 1984, J NEUROSCI, V4, P131; Chang W, 1997, J BIOL CHEM, V272, P28925, DOI 10.1074/jbc.272.46.28925; CLIVE DR, 1994, EXP CELL RES, V214, P139, DOI 10.1006/excr.1994.1242; CRESNAR B, 1994, J NEUROSCI RES, V38, P294, DOI 10.1002/jnr.490380307; DELAPORTE S, 1984, DEV BIOL, V106, P450, DOI 10.1016/0012-1606(84)90244-6; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; FAMBROUGH DM, 1982, P NATL ACAD SCI-BIOL, V79, P1078, DOI 10.1073/pnas.79.4.1078; FERNANDEZVALLE C, 1989, J BIOL CHEM, V264, P14043; FULLEKRUG J, 1994, J CELL SCI, V107, P2719; Garcia SM, 2007, GENE DEV, V21, P3006, DOI 10.1101/gad.1575307; GELMAN MS, 1995, J BIOL CHEM, V270, P15085, DOI 10.1074/jbc.270.25.15085; HALL ZW, 1973, J NEUROBIOL, V4, P343, DOI 10.1002/neu.480040404; Han XY, 1999, J APPL PHYSIOL, V87, P90, DOI 10.1152/jappl.1999.87.1.90; Haugstetter J, 2005, J BIOL CHEM, V280, P8371, DOI 10.1074/jbc.M413924200; Hubatsch DA, 1997, AM J PHYSIOL-CELL PH, V273, pC2002, DOI 10.1152/ajpcell.1997.273.6.C2002; Keller SH, 1996, J BIOL CHEM, V271, P22871, DOI 10.1074/jbc.271.37.22871; Keller SH, 1998, J BIOL CHEM, V273, P17064, DOI 10.1074/jbc.273.27.17064; Knoblach B, 2003, MOL CELL PROTEOMICS, V2, P1104, DOI 10.1074/mcp.M300053-MCP200; KOENIG J, 1978, NATURE, V271, P75, DOI 10.1038/271075a0; Legay C, 2000, MICROSC RES TECHNIQ, V49, P56, DOI 10.1002/(SICI)1097-0029(20000401)49:1<56::AID-JEMT7>3.0.CO;2-R; Lumb RA, 2002, EMBO J, V21, P6763, DOI 10.1093/emboj/cdf685; MACPHEEQUIGLEY K, 1986, J BIOL CHEM, V261, P3565; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; MICHEL RN, 1994, J CELL BIOL, V127, P1061, DOI 10.1083/jcb.127.4.1061; OSBORNE CK, 1978, CANCER RES, V38, P94; OU WJ, 1995, J BIOL CHEM, V270, P18051, DOI 10.1074/jbc.270.30.18051; REEDER RH, 1972, J MOL BIOL, V67, P433, DOI 10.1016/0022-2836(72)90461-5; RIEGER F, 1984, DEV BIOL, V101, P181, DOI 10.1016/0012-1606(84)90128-3; RIEGER F, 1980, DEV BIOL, V76, P358, DOI 10.1016/0012-1606(80)90385-1; Rimer M, 1999, BIOCHEM BIOPH RES CO, V260, P251, DOI 10.1006/bbrc.1999.0893; ROSENBERRY TL, 1977, BIOCHEMISTRY-US, V16, P3550, DOI 10.1021/bi00635a008; Rossi S. G., 1998, Journal of Physiology Paris, V92, P486, DOI 10.1016/S0928-4257(99)80102-8; Rossi SG, 2000, J NEUROSCI, V20, P919, DOI 10.1523/JNEUROSCI.20-03-00919.2000; Rotundo RL, 2003, J NEUROCYTOL, V32, P743, DOI 10.1023/B:NEUR.0000020621.58197.d4; ROTUNDO RL, 1988, J BIOL CHEM, V263, P19398; ROTUNDO RL, 1980, CELL, V22, P583, DOI 10.1016/0092-8674(80)90368-2; ROTUNDO RL, 1984, J BIOL CHEM, V259, P3186; ROTUNDO RL, 1984, P NATL ACAD SCI-BIOL, V81, P479, DOI 10.1073/pnas.81.2.479; ROTUNDO RL, 1989, J BIOL CHEM, V264, P3146; RUBIN LL, 1985, P NATL ACAD SCI USA, V82, P7121, DOI 10.1073/pnas.82.20.7121; Ruiz CA, 2009, J BIOL CHEM, V284, P21488, DOI 10.1074/jbc.M109.030049; RUPP K, 1994, J BIOL CHEM, V269, P2501; Satoh M, 2005, CELL STRESS CHAPERON, V10, P211, DOI 10.1379/CSC-109R.1; Simon S, 1998, EMBO J, V17, P6178, DOI 10.1093/emboj/17.21.6178; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; VALLETTE FM, 1990, J NEUROCHEM, V54, P915, DOI 10.1111/j.1471-4159.1990.tb02338.x; Vattemi G, 2004, AM J PATHOL, V164, P1, DOI 10.1016/S0002-9440(10)63089-1; VIGNY M, 1976, FEBS LETT, V69, P277, DOI 10.1016/0014-5793(76)80703-X; VIGNY M, 1976, J NEUROCHEM, V27, P1347, DOI 10.1111/j.1471-4159.1976.tb02614.x; WADA I, 1991, J BIOL CHEM, V266, P19599; WEINBERG CB, 1979, DEV BIOL, V68, P631, DOI 10.1016/0012-1606(79)90233-1; WEINMANN R, 1974, P NATL ACAD SCI USA, V71, P1790, DOI 10.1073/pnas.71.5.1790; WEINMANN R, 1974, P NATL ACAD SCI USA, V71, P3426, DOI 10.1073/pnas.71.9.3426; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Ye JM, 1996, BIOCHEM BIOPH RES CO, V223, P153, DOI 10.1006/bbrc.1996.0861; ZYLBER EA, 1971, P NATL ACAD SCI USA, V68, P2861, DOI 10.1073/pnas.68.11.2861	60	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31753	31763		10.1074/jbc.M109.038471	http://dx.doi.org/10.1074/jbc.M109.038471			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19758986	hybrid, Green Published			2022-12-27	WOS:000271572700030
J	Thompson, JA; Paschall, CO; O'Donnell, M; Bloom, LB				Thompson, Jennifer A.; Paschall, Christopher O.; O'Donnell, Mike; Bloom, Linda B.			A Slow ATP-induced Conformational Change Limits the Rate of DNA Binding but Not the Rate of beta Clamp Binding by the Escherichia coli gamma Complex Clamp Loader	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-III HOLOENZYME; REPLICATION-FACTOR-C; CELL NUCLEAR ANTIGEN; SLIDING CLAMP; STRUCTURAL-ANALYSIS; LOADING MACHINE; DELTA-SUBUNIT; MECHANISM; DYNAMICS; PURIFICATION	In Escherichia coli, the gamma complex clamp loader loads the beta-sliding clamp onto DNA. The beta clamp tethers DNA polymerase III to DNA and enhances the efficiency of replication by increasing the processivity of DNA synthesis. In the presence of ATP, gamma complex binds beta and DNA to form a ternary complex. Binding to primed template DNA triggers gamma complex to hydrolyze ATP and release the clamp onto DNA. Here, we investigated the kinetics of forming a ternary complex by measuring rates of gamma complex binding beta and DNA. A fluorescence intensity-based beta binding assay was developed in which the fluorescence of pyrene covalently attached to beta increases when bound by gamma complex. Using this assay, an association rate constant of 2.3 x 10(7) M-1 s(-1) for gamma complex binding beta was determined. The rate of beta binding was the same in experiments in which gamma complex was preincubated with ATP before adding beta or added directly to beta and ATP. In contrast, when gamma complex is preincubated with ATP, DNA binding is faster than when gamma complex is added to DNA and ATP at the same time. Slow DNA binding in the absence of ATP preincubation is the result of a rate-limiting ATP-induced conformational change. Our results strongly suggest that the ATP-induced conformational changes that promote beta binding and DNA binding differ. The slow ATP-induced conformational change that precedes DNA binding may provide a kinetic preference for gamma complex to bind beta before DNA during the clamp loading reaction cycle.	[Thompson, Jennifer A.; Paschall, Christopher O.; Bloom, Linda B.] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [O'Donnell, Mike] Rockefeller Univ, New York, NY 10021 USA; [O'Donnell, Mike] Howard Hughes Med Inst, New York, NY 10021 USA	State University System of Florida; University of Florida; Rockefeller University; Howard Hughes Medical Institute	Bloom, LB (corresponding author), 1600 SW Archer Rd,JHMHC,Rm R3-234, Gainesville, FL 32610 USA.	lbloom@ufl.edu	Bloom, Linda B/F-3684-2014	O'Donnell, Michael/0000-0001-9002-4214	National Institutes of Health [R01 GM055596, R01 GM38839]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038839, R01GM055596] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM055596 (to L. B. B.) and R01 GM38839 (to M.O.D.).	Alley SC, 1999, BIOCHEMISTRY-US, V38, P7696, DOI 10.1021/bi9827971; Anderson SG, 2007, J BIOL CHEM, V282, P7035, DOI 10.1074/jbc.M610136200; Anderson SG, 2009, BIOCHEMISTRY-US, V48, P8516, DOI 10.1021/bi900912a; Ason B, 2000, J BIOL CHEM, V275, P3006, DOI 10.1074/jbc.275.4.3006; Ason B, 2003, J BIOL CHEM, V278, P10033, DOI 10.1074/jbc.M211741200; Bertram JG, 2000, J BIOL CHEM, V275, P28413, DOI 10.1074/jbc.M910441199; Bertram JG, 1998, J BIOL CHEM, V273, P24564, DOI 10.1074/jbc.273.38.24564; BLINKOWA AL, 1990, NUCLEIC ACIDS RES, V18, P1725, DOI 10.1093/nar/18.7.1725; Bloom LB, 1996, J BIOL CHEM, V271, P30699, DOI 10.1074/jbc.271.48.30699; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; BURGERS PMJ, 1981, P NATL ACAD SCI-BIOL, V78, P5391, DOI 10.1073/pnas.78.9.5391; DONG ZM, 1993, J BIOL CHEM, V268, P11758; FLOWER AM, 1990, P NATL ACAD SCI USA, V87, P3713, DOI 10.1073/pnas.87.10.3713; Georgescu RE, 2008, CELL, V132, P43, DOI 10.1016/j.cell.2007.11.045; Gomes XV, 2001, J BIOL CHEM, V276, P34776, DOI 10.1074/jbc.M011743200; Gomes XV, 2001, J BIOL CHEM, V276, P34768, DOI 10.1074/jbc.M011631200; GRIEP MA, 1988, BIOCHEMISTRY-US, V27, P5210, DOI 10.1021/bi00414a040; Hingorani MM, 1999, EMBO J, V18, P5131, DOI 10.1093/emboj/18.18.5131; Hingorani MM, 1998, J BIOL CHEM, V273, P24550, DOI 10.1074/jbc.273.38.24550; Indiani C, 2006, NAT REV MOL CELL BIO, V7, P751, DOI 10.1038/nrm2022; Jeruzalmi D, 2001, CELL, V106, P429, DOI 10.1016/S0092-8674(01)00463-9; Jeruzalmi D, 2001, CELL, V106, P417, DOI 10.1016/S0092-8674(01)00462-7; JOHANSON KO, 1986, J BIOL CHEM, V261, P1460; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Johnson A, 2006, J BIOL CHEM, V281, P35531, DOI 10.1074/jbc.M606090200; JOHNSSON MSA, 1992, CRIT REV ORAL BIOL M, V3, P61, DOI 10.1177/10454411920030010601; Kazmirski SL, 2004, P NATL ACAD SCI USA, V101, P16750, DOI 10.1073/pnas.0407904101; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Leu FP, 2000, J BIOL CHEM, V275, P34609, DOI 10.1074/jbc.M005495200; MAKI S, 1988, J BIOL CHEM, V263, P6547; McHenry CS, 2003, MOL MICROBIOL, V49, P1157, DOI 10.1046/j.1365-2958.2003.03645.x; Millar D, 2004, BIOCHEMISTRY-US, V43, P12723, DOI 10.1021/bi048349c; NAKTINIS V, 1995, J BIOL CHEM, V270, P13358, DOI 10.1074/jbc.270.22.13358; O'Donnell M, 2006, J BIOL CHEM, V281, P10653, DOI 10.1074/jbc.R500028200; OLSON MW, 1995, J BIOL CHEM, V270, P29570, DOI 10.1074/jbc.270.49.29570; ONRUST R, 1995, J BIOL CHEM, V270, P13348, DOI 10.1074/jbc.270.22.13348; Pritchard AE, 2000, EMBO J, V19, P6536, DOI 10.1093/emboj/19.23.6536; Schmidt SLG, 2001, J BIOL CHEM, V276, P34784, DOI 10.1074/jbc.M011633200; Sexton DJ, 1998, BIOCHEMISTRY-US, V37, P7749, DOI 10.1021/bi980088h; Snyder AK, 2004, J BIOL CHEM, V279, P4386, DOI 10.1074/jbc.M310430200; STUKENBERG PT, 1991, J BIOL CHEM, V266, P11328; TSUCHIHASHI Z, 1990, P NATL ACAD SCI USA, V87, P2516, DOI 10.1073/pnas.87.7.2516; Turner J, 1999, EMBO J, V18, P771, DOI 10.1093/emboj/18.3.771; Williams CR, 2004, J BIOL CHEM, V279, P4376, DOI 10.1074/jbc.M310429200; Zhuang ZH, 2006, P NATL ACAD SCI USA, V103, P2546, DOI 10.1073/pnas.0511263103; Zhuang ZH, 2006, BIOCHEMISTRY-US, V45, P7976, DOI 10.1021/bi0601205	47	19	19	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					32147	32157		10.1074/jbc.M109.045997	http://dx.doi.org/10.1074/jbc.M109.045997			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19759003	Green Published, hybrid			2022-12-27	WOS:000271572700069
J	Winter, U; Chen, X; Fasshauer, D				Winter, Ulrike; Chen, Xiong; Fasshauer, Dirk			A Conserved Membrane Attachment Site in alpha-SNAP Facilitates N-Ethylmaleimide-sensitive Factor (NSF)-driven SNARE Complex Disassembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUSION PROTEIN; ATPASE ACTIVITY; CORE COMPLEX; BETA-SNAP; IN-VITRO; NSF; BINDING; EXOCYTOSIS; SYNTAXIN; FAMILY	The ATPase NSF (N-ethylmaleimide-sensitive factor) and its SNAP (soluble N-ethylmaleimide-sensitive factor attachment protein) cofactor constitute the ubiquitous enzymatic machinery responsible for recycling of the SNARE (SNAP receptor) membrane fusion machinery. The enzyme uses the energy of ATP hydrolysis to dissociate the constituents of the SNARE complex, which is formed during the fusion of a transport vesicle with the acceptor membrane. However, it is still unclear how NSF and the SNAP adaptor work together to take the tight SNARE bundle apart. SNAPs have been reported to attach to membranes independently from SNARE complex binding. We have investigated how efficient the disassembly of soluble and membrane-bound substrates are, comparing the two. We found that SNAPs support disassembly of membrane-bound SNARE complexes much more efficiently. Moreover, we identified a putative, conserved membrane attachment site in an extended loop within the N-terminal domain of alpha-SNAP. Mutation of two highly conserved, exposed phenylalanine residues on the extended loop prevent SNAPs from facilitating disassembly of membrane-bound SNARE complexes. This implies that the disassembly machinery is adapted to attack membrane-bound SNARE complexes, probably in their relaxed cis-configuration.	[Winter, Ulrike; Chen, Xiong; Fasshauer, Dirk] Max Planck Inst Biophys Chem, Dept Neurobiol, Res Grp Struct Biochem, D-37077 Gottingen, Germany	Max Planck Society	Fasshauer, D (corresponding author), Max Planck Inst Biophys Chem, Dept Neurobiol, Res Grp Struct Biochem, Fassberg 11, D-37077 Gottingen, Germany.	dfassha@gwdg.de	Fasshauer, Dirk/B-1563-2013	Fasshauer, Dirk/0000-0002-1040-4282	Deutsche Forschungsgemeinschaft [SFB523]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the SFB523 of the Deutsche Forschungsgemeinschaft ( to U. W.).	Bar-On D, 2008, FEBS LETT, V582, P3563, DOI 10.1016/j.febslet.2008.08.040; Barnard RJO, 1997, J CELL BIOL, V139, P875, DOI 10.1083/jcb.139.4.875; Barszczewski M, 2008, MOL BIOL CELL, V19, P776, DOI 10.1091/mbc.E07-05-0498; Bitto E, 2008, PROTEINS, V70, P93, DOI 10.1002/prot.21468; Bowen ME, 2005, BIOPHYS J, V89, P690, DOI 10.1529/biophysj.104.054064; Bracher A, 2002, J BIOL CHEM, V277, P26517, DOI 10.1074/jbc.M203460200; Brunger AT, 2005, Q REV BIOPHYS, V38, P1, DOI 10.1017/S0033583505004051; Brunger AT, 2003, FEBS LETT, V555, P126, DOI 10.1016/S0014-5793(03)01107-4; Chen XC, 2002, NEURON, V33, P397, DOI 10.1016/S0896-6273(02)00583-4; CLARY DO, 1990, CELL, V61, P709, DOI 10.1016/0092-8674(90)90482-T; Fasshauer D, 2004, J BIOL CHEM, V279, P7613, DOI 10.1074/jbc.M312064200; Fasshauer D, 2002, NAT STRUCT BIOL, V9, P144, DOI 10.1038/nsb750; Fasshauer D, 1999, J BIOL CHEM, V274, P15440, DOI 10.1074/jbc.274.22.15440; Fasshauer D, 1998, BIOCHEMISTRY-US, V37, P10354, DOI 10.1021/bi980542h; Fleming KG, 1998, J BIOL CHEM, V273, P15675, DOI 10.1074/jbc.273.25.15675; Furst J, 2003, EMBO J, V22, P4365, DOI 10.1093/emboj/cdg420; GRIFF IC, 1992, J BIOL CHEM, V267, P12106; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; HAYASHI T, 1995, EMBO J, V14, P2317, DOI 10.1002/j.1460-2075.1995.tb07226.x; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Hibi T, 2000, BIOCHEM BIOPH RES CO, V271, P36, DOI 10.1006/bbrc.2000.2591; Hirling H, 1996, P NATL ACAD SCI USA, V93, P11945, DOI 10.1073/pnas.93.21.11945; Hohl TM, 1998, MOL CELL, V2, P539, DOI 10.1016/S1097-2765(00)80153-7; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Lauer JM, 2006, J BIOL CHEM, V281, P14823, DOI 10.1074/jbc.M512706200; MALHOTRA V, 1988, CELL, V54, P221, DOI 10.1016/0092-8674(88)90554-5; Margittai M, 1999, FEBS LETT, V446, P40, DOI 10.1016/S0014-5793(99)00028-9; Margittai M, 2001, J BIOL CHEM, V276, P13169, DOI 10.1074/jbc.M010653200; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Marz KE, 2003, J BIOL CHEM, V278, P27000, DOI 10.1074/jbc.M302003200; Matveeva EA, 1997, J BIOL CHEM, V272, P26413, DOI 10.1074/jbc.272.42.26413; MCMAHON HT, 1995, J BIOL CHEM, V270, P2213, DOI 10.1074/jbc.270.5.2213; MORGAN A, 1994, J BIOL CHEM, V269, P29347; MORGAN A, 1995, EMBO J, V14, P232, DOI 10.1002/j.1460-2075.1995.tb06996.x; NAGY A, 1976, BRAIN RES, V109, P285, DOI 10.1016/0006-8993(76)90531-X; Pabst S, 2002, J BIOL CHEM, V277, P7838, DOI 10.1074/jbc.M109507200; Pabst S, 2000, J BIOL CHEM, V275, P19808, DOI 10.1074/jbc.M002571200; Rice LM, 1997, FEBS LETT, V415, P49, DOI 10.1016/S0014-5793(97)01091-0; Rice LM, 1999, MOL CELL, V4, P85, DOI 10.1016/S1097-2765(00)80190-2; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; SCHIAVO G, 1995, NATURE, V378, P733, DOI 10.1038/378733a0; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Steel GJ, 1997, BIOCHEM J, V325, P511, DOI 10.1042/bj3250511; Stein A, 2007, NAT STRUCT MOL BIOL, V14, P904, DOI 10.1038/nsmb1305; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sudlow AW, 1996, FEBS LETT, V393, P185, DOI 10.1016/0014-5793(96)00880-0; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Ungermann C, 1998, NATURE, V396, P543, DOI 10.1038/25069; WHITEHEART SW, 1992, J BIOL CHEM, V267, P12239; WHITEHEART SW, 1993, NATURE, V362, P353, DOI 10.1038/362353a0; Wiederhold K, 2009, J BIOL CHEM, V284, P13143, DOI 10.1074/jbc.M900703200; Wimmer C, 2001, J BIOL CHEM, V276, P29091, DOI 10.1074/jbc.M011292200; Xu JH, 2002, J NEUROSCI, V22, P53, DOI 10.1523/JNEUROSCI.22-01-00053.2002; Zhao CX, 2007, FEBS LETT, V581, P2140, DOI 10.1016/j.febslet.2007.03.032	57	47	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31817	31826		10.1074/jbc.M109.045286	http://dx.doi.org/10.1074/jbc.M109.045286			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19762473	Green Published, hybrid			2022-12-27	WOS:000271572700036
J	Capp, C; Wu, JH; Hsieh, TS				Capp, Christopher; Wu, Jianhong; Hsieh, Tao-shih			Drosophila RecQ4 Has a 3 '-5 ' DNA Helicase Activity That Is Essential for Viability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROTHMUND-THOMSON-SYNDROME; SYNDROME GENE-PRODUCT; BIOCHEMICAL-CHARACTERIZATION; SUBSTRATE-SPECIFICITY; UNWINDING ACTIVITIES; GENOME STABILITY; FAMILY HELICASES; REPLICATION; PROTEIN; MAINTENANCE	Members of the RecQ family of proteins are highly conserved DNA helicases that have important functions in the maintenance of genomic stability. Deficiencies in RecQ4 have been linked to human diseases including Rothmund-Thomson, RAPADILINO, and Baller-Gerold syndromes, all of which are characterized by developmental defects, tumor propensity, and genetic instability. However, there are conflicting results shown in the literature regarding the DNA helicase activity of RecQ4. We report here the expression of Drosophila melanogaster RecQ4 with a baculoviral vector and its purification to near homogeneity. The purified protein has a DNA-dependent ATPase activity and is a 3'-5' DNA helicase dependent on hydrolysis of ATP. The presence of 5'-adenylyl-beta, gamma-imidodiphosphate (AMPPNP), a nonhydrolyzable ATP analog, promotes stable complex formation between RecQ4 and single-stranded DNA. Drosophila RecQ4 can also anneal complementary single strands; this activity was reduced in the presence of AMPPNP, possibly because of the stable protein-DNA complex formed under such conditions. A point mutation of the highly conserved lysine residue in the helicase domain, although retaining the wild type level of annealing activity, inactivated ATPase and helicase activities and eliminated stable complex formation. These results suggest that the helicase domain alone is responsible for the DNA unwinding action of the Drosophila enzyme. We generated a null recq4 mutant that is homozygous lethal, which we used to test the genetic function of the helicase-dead mutant in flies. Complementation tests showed that the helicase-dead mutant recq4 transgenes are incapable of rescuing the null mutation, demonstrating that the helicase activity has an essential biological function.	[Capp, Christopher; Wu, Jianhong; Hsieh, Tao-shih] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University	Hsieh, TS (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Box 3711, Durham, NC 27710 USA.	hsieh@biochem.duke.edu	Wu, Wan-lin/G-8937-2012; Hsieh, Tao-shih/G-9305-2012; Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wu, Jian/0000-0002-3394-1507	National Institutes of Health [GM29006]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029006] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM29006.	Bachrati CZ, 2008, CHROMOSOMA, V117, P219, DOI 10.1007/s00412-007-0142-4; Bohr VA, 2008, TRENDS BIOCHEM SCI, V33, P609, DOI 10.1016/j.tibs.2008.09.003; Brosh RM, 2002, J BIOL CHEM, V277, P23236, DOI 10.1074/jbc.M111446200; Burks LM, 2007, GENE, V391, P26, DOI 10.1016/j.gene.2006.11.019; Cheok CF, 2005, NUCLEIC ACIDS RES, V33, P3932, DOI 10.1093/nar/gki712; Dietschy T, 2009, J CELL SCI, V122, P1258, DOI 10.1242/jcs.037747; Fan W, 2008, J BIOL CHEM, V283, P29037, DOI 10.1074/jbc.M801928200; Hall MC, 1999, MOL MICROBIOL, V34, P867, DOI 10.1046/j.1365-2958.1999.01659.x; Hoki Y, 2003, HUM MOL GENET, V12, P2293, DOI 10.1093/hmg/ddg254; Kitao S, 1999, NAT GENET, V22, P82, DOI 10.1038/8788; Kitao S, 1998, GENOMICS, V54, P443, DOI 10.1006/geno.1998.5595; Larizza L, 2006, CANCER LETT, V232, P107, DOI 10.1016/j.canlet.2005.07.042; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; Machwe A, 2005, J BIOL CHEM, V280, P23397, DOI 10.1074/jbc.M414130200; Macris MA, 2006, DNA REPAIR, V5, P172, DOI 10.1016/j.dnarep.2005.09.005; Mann MB, 2005, HUM MOL GENET, V14, P813, DOI 10.1093/hmg/ddi075; Matsuno K, 2006, MOL CELL BIOL, V26, P4843, DOI 10.1128/MCB.02267-05; Muftuoglu M, 2008, BIOCHEMISTRY-US, V47, P10247, DOI 10.1021/bi800807n; Ozsoy AZ, 2003, NUCLEIC ACIDS RES, V31, P1554, DOI 10.1093/nar/gkg243; Park SJ, 2006, DNA CELL BIOL, V25, P696, DOI 10.1089/dna.2006.25.696; Petkovic M, 2005, J CELL SCI, V118, P4261, DOI 10.1242/jcs.02556; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Sangrithi MN, 2005, CELL, V121, P887, DOI 10.1016/j.cell.2005.05.015; Seki M, 2008, CELL CYCLE, V7, P2472, DOI 10.4161/cc.7.16.6462; Sharma S, 2005, J BIOL CHEM, V280, P28072, DOI 10.1074/jbc.M500264200; Siitonen HA, 2009, EUR J HUM GENET, V17, P151, DOI 10.1038/ejhg.2008.154; Van Maldergem L, 2006, J MED GENET, V43, P148, DOI 10.1136/jmg.2005.031781; Wang WS, 2003, MOL CELL BIOL, V23, P3527, DOI 10.1128/MCB.23.10.3527-3535.2003; Werner SR, 2006, BIOCHEM BIOPH RES CO, V345, P403, DOI 10.1016/j.bbrc.2006.04.093; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428; Wu JH, 2008, DEV BIOL, V323, P130, DOI 10.1016/j.ydbio.2008.08.006; Xu XH, 2009, EMBO J, V28, P568, DOI 10.1038/emboj.2009.13; Yin JH, 2004, HUM MOL GENET, V13, P2421, DOI 10.1093/hmg/ddh269	33	31	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30845	30852		10.1074/jbc.M109.008052	http://dx.doi.org/10.1074/jbc.M109.008052			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19759018	Green Published, hybrid			2022-12-27	WOS:000271378400012
J	Fox, JT; Stover, PJ				Fox, Jennifer T.; Stover, Patrick J.			Mechanism of the Internal Ribosome Entry Site-mediated Translation of Serine Hydroxymethyltransferase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLY(A) BINDING-PROTEIN; INITIATION-FACTOR 4A; MESSENGER-RNA; C-MYC; POLY(A)-BINDING PROTEIN; 3'-UNTRANSLATED REGION; DEPENDENT TRANSLATION; MYOTONIC-DYSTROPHY; HEPATITIS-C; IN-VITRO	The 5'-untranslated region (UTR) of serine hydroxymethyltransferase 1 (SHMT1) contains an internal ribosome entry site (IRES) that regulates SHMT1 expression, a rate-limiting enzyme in de novo thymidylate biosynthesis. In this study, we show that the SHMT1 IRES is the first example of a cellular IRES that is poly(A) tail-independent. Interactions between the 5'-UTR and 3'-UTR functionally replaced interactions between the poly( A) tail and the poly(A)-binding protein (PABP) to achieve maximal IRES-mediated translational efficiency. Depletion of the SHMT1 IRES-specific trans-acting factor (ITAF) CUG-binding protein 1 (CUGBP1) from in vitro translation extracts or deletion of the CUGBP1 binding site on the 3'-UTR of the SHMT1 transcript decreased the IRES activity of non-polyadenylylated biscis-tronic mRNAs relative to polyadenylylated biscistronic mRNAs and resulted in a requirement for PABP. We also identified a novel ITAF, heterogeneous nuclear ribonucleoprotein H2 (hnRNP H2), that stimulates SHMT1 IRES activity by binding to the 5'-UTR of the transcript and interacting with CUGBP1. Collectively, these data support a model for the IRES-mediated translation of SHMT1 whereby the circularization of the mRNA typically provided by the eukaryotic initiation factor (eIF) 4G/PABP/poly(A) tail interaction is achieved instead through the hnRNP H2/CUGBP1-mediated interaction of the 5'- and 3'-UTRs of the SHMT1 transcript. This circularization enhances the IRES activity of SHMT1 by facilitating the recruitment and/or recycling of ribosomal subunits, which bind to the transcript in the middle of the 5'UTR and migrate to the initiation codon via eIF4A-mediated scanning.	[Stover, Patrick J.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; Cornell Univ, Grad Field Biochem & Mol & Cellular Biol, Ithaca, NY 14853 USA	Cornell University; Cornell University	Stover, PJ (corresponding author), Cornell Univ, Div Nutr Sci, 315 Savage Hall, Ithaca, NY 14853 USA.	pjs13@cornell.edu			Public Health Service [DK58144]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058144, R37DK058144] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK58144 from the Public Health Service.	BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; Bonnal S, 2005, J BIOL CHEM, V280, P4144, DOI 10.1074/jbc.M411492200; Bordeleau ME, 2006, NAT CHEM BIOL, V2, P213, DOI 10.1038/nchembio776; Caputi M, 2001, J BIOL CHEM, V276, P43850, DOI 10.1074/jbc.M102861200; DANTHINNE X, 1993, MOL CELL BIOL, V13, P3340, DOI 10.1128/MCB.13.6.3340; Fox JT, 2009, J BIOL CHEM, V284, P31097, DOI 10.1074/jbc.M109.015800; GALLIE DR, 1991, GENE DEV, V5, P2108, DOI 10.1101/gad.5.11.2108; Giraud S, 2001, J BIOL CHEM, V276, P5668, DOI 10.1074/jbc.M005928200; Good PJ, 2000, J BIOL CHEM, V275, P28583, DOI 10.1074/jbc.M003083200; Hahn B, 1998, J VIROL, V72, P8782, DOI 10.1128/JVI.72.11.8782-8788.1998; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Herbig K, 2002, J BIOL CHEM, V277, P38381, DOI 10.1074/jbc.M205000200; Holcik M, 2003, MOL CELL BIOL, V23, P280, DOI 10.1128/MCB.23.1.280-288.2003; Honore B, 2004, EXP CELL RES, V294, P199, DOI 10.1016/j.yexcr.2003.11.011; Ito T, 1998, J VIROL, V72, P8789, DOI 10.1128/JVI.72.11.8789-8796.1998; Jacobson A., 1996, TRANSLATIONAL CONTRO, P451; JANG SK, 1988, J VIROL, V62, P2636, DOI 10.1128/JVI.62.8.2636-2643.1988; Johannes G, 1999, P NATL ACAD SCI USA, V96, P13118, DOI 10.1073/pnas.96.23.13118; Jopling CL, 2004, RNA, V10, P287, DOI 10.1261/rna.5138804; Khaleghpour K, 2001, MOL CELL, V7, P205, DOI 10.1016/S1097-2765(01)00168-X; Komar AA, 2005, J BIOL CHEM, V280, P23425, DOI 10.1074/jbc.R400041200; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Kuyumcu-Martinez NM, 2007, MOL CELL, V28, P68, DOI 10.1016/j.molcel.2007.07.027; Le Quesne JPC, 2001, J MOL BIOL, V310, P111, DOI 10.1006/jmbi.2001.4745; LUUKKONEN BGM, 1995, J VIROL, V69, P4086, DOI 10.1128/JVI.69.7.4086-4094.1995; Meulewaeter F, 2004, NUCLEIC ACIDS RES, V32, P1721, DOI 10.1093/nar/gkh338; Mitchell SA, 2003, MOL CELL, V11, P757, DOI 10.1016/S1097-2765(03)00093-5; MUNROE D, 1990, MOL CELL BIOL, V10, P3441, DOI 10.1128/MCB.10.7.3441; Paul S, 2006, EMBO J, V25, P4271, DOI 10.1038/sj.emboj.7601296; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; Roberts R, 1997, P NATL ACAD SCI USA, V94, P13221, DOI 10.1073/pnas.94.24.13221; Rogers GW, 1999, J BIOL CHEM, V274, P12236, DOI 10.1074/jbc.274.18.12236; SACHS AB, 1989, CELL, V58, P857, DOI 10.1016/0092-8674(89)90938-0; Sachs AB, 2000, NAT STRUCT BIOL, V7, P356, DOI 10.1038/75120; Stoneley M, 2004, ONCOGENE, V23, P3200, DOI 10.1038/sj.onc.1207551; Svitkin YV, 2001, RNA, V7, P1743; Tarun SZ, 1997, P NATL ACAD SCI USA, V94, P9046, DOI 10.1073/pnas.94.17.9046; TARUN SZ, 1995, GENE DEV, V9, P2997, DOI 10.1101/gad.9.23.2997; Thoma C, 2004, MOL CELL, V15, P925, DOI 10.1016/j.molcel.2004.08.021; Thoma C, 2008, RNA, V14, P1579, DOI 10.1261/rna.1043908; Timchenko LT, 1996, NUCLEIC ACIDS RES, V24, P4407, DOI 10.1093/nar/24.22.4407; Timchenko NA, 2005, J BIOL CHEM, V280, P20549, DOI 10.1074/jbc.M409563200; Uchida N, 2002, J BIOL CHEM, V277, P50286, DOI 10.1074/jbc.M203029200; Vlasova IA, 2008, MOL CELL, V29, P263, DOI 10.1016/j.molcel.2007.11.024; Wang SP, 1997, EMBO J, V16, P4107, DOI 10.1093/emboj/16.13.4107; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; Woeller CF, 2007, J BIOL CHEM, V282, P29927, DOI 10.1074/jbc.M706264200	48	22	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31085	31096		10.1074/jbc.M109.035576	http://dx.doi.org/10.1074/jbc.M109.035576			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19734143	Green Published, hybrid			2022-12-27	WOS:000271378400037
J	Hull, JJ; Lee, JM; Kajigaya, R; Matsumoto, S				Hull, J. Joe; Lee, Jae Min; Kajigaya, Ryosuke; Matsumoto, Shogo			Bombyx mori Homologs of STIM1 and Orai1 Are Essential Components of the Signal Transduction Cascade That Regulates Sex Pheromone Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOSYNTHESIS ACTIVATING NEUROPEPTIDE; OPERATED CALCIUM-ENTRY; MOTH HELICOVERPA-ZEA; CRAC CHANNEL; CA2+ ENTRY; SILKWORM; IDENTIFICATION; MECHANISMS; PROTEINS; SILKMOTH	Sex pheromone production in the pheromone gland (PG) of the silkmoth, Bombyx mori, is mediated by store-operated channels (SOCs) acting downstream of pheromone biosynthesis activating neuropeptide (PBAN) binding. Although recent studies have implicated STIM1 and Orai1 as essential components of SOCs, little is known about the molecular nature of the SOCs involved in sex pheromone production. In this study we cloned silkmoth homologs of STIM1 and Orai1 and sought to determine whether they comprise the PG SOC pathway. BmSTIM1 is expressed in multiple tissues and, in the PG, is encoded by two transcripts of differing size. BmOrai1A and BmOrai1B, which are identical except for a 37-residue N-terminal truncation in BmOrai1B, arise from alternative splicing of the bmorai1 locus and are expressed as independent transcripts in various tissues. In the PG, only BmOrai1B is actively transcribed. Fluorescent chimeras demonstrated that BmSTIM1 expression is restricted to the endoplasmic reticulum, whereas both BmOrai1A and BmOrai1B localize to the cell surface. In Ca2+-free medium, thapsigargin-mediated depletion of endoplasmic reticulum Ca2+ stores resulted in redistribution of BmSTIM1 to the plasma membrane, but only when the BmOrai1 homologs were also overexpressed. Translocation was dependent on the BmSTIM1 C terminus "CRAC activation domain." Ala mutation of Lys(380), Lys(383), Lys(384), Arg(382), and Arg(385) suggests that translocation involves electrostatic interactions. Translocation was also seen following PBAN stimulation in cells co-expressing BmSTIM1, BmOrai1B, and the PBAN receptor. In vivo RNA interference-mediated knockdown of BmSTIM1 and BmOrai1 significantly reduced sex pheromone production without affecting cell viability.	[Hull, J. Joe; Lee, Jae Min; Kajigaya, Ryosuke; Matsumoto, Shogo] RIKEN, Adv Sci Inst, Mol Entomol Lab, Wako, Saitama 3510198, Japan	RIKEN	Hull, JJ (corresponding author), Univ Wyoming, Dept Mol Biol, Mol Biol Dept 3944, 1000 E Univ Ave, Laramie, WY 82071 USA.	jhull1@uwyo.edu; smatsu@riken.jp			RIKEN; Targeted Proteins Research Program (TPRP); Ministry of Education, Culture, Sports, Science and Technology of Japan [20380040]	RIKEN; Targeted Proteins Research Program (TPRP)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Bioarchitect Research Program from RIKEN and the Targeted Proteins Research Program (TPRP) and Grants-in-aid for Scientific Research (B) 20380040 from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; Calloway N, 2009, MOL BIOL CELL, V20, P389, DOI 10.1091/mbc.E07-11-1132; Choi MY, 2003, P NATL ACAD SCI USA, V100, P9721, DOI 10.1073/pnas.1632485100; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; FONAGY A, 1992, J PESTIC SCI, V17, P47; Gross SA, 2007, J BIOL CHEM, V282, P19375, DOI 10.1074/jbc.M701962200; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; Hewavitharana T, 2007, CELL CALCIUM, V42, P173, DOI 10.1016/j.ceca.2007.03.009; Hull JJ, 2007, BIOSCI BIOTECH BIOCH, V71, P1993, DOI 10.1271/bbb.70175; Hull JJ, 2005, BIOCHEM BIOPH RES CO, V334, P69, DOI 10.1016/j.bbrc.2005.06.050; Hull JJ, 2004, J BIOL CHEM, V279, P51500, DOI 10.1074/jbc.M408142200; Ji W, 2008, P NATL ACAD SCI USA, V105, P13668, DOI 10.1073/pnas.0806499105; Jurenka RA, 1996, ARCH INSECT BIOCHEM, V33, P245, DOI 10.1002/(SICI)1520-6327(1996)33:3/4&lt;245::AID-ARCH6&gt;3.0.CO;2-R; JURENKA RA, 1991, P NATL ACAD SCI USA, V88, P8621, DOI 10.1073/pnas.88.19.8621; JURENKA RA, 2003, INSECT PHEROMONE BIO, V53; Kawasaki T, 2009, BIOCHEM BIOPH RES CO, V385, P49, DOI 10.1016/j.bbrc.2009.05.020; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; MATSUMOTO S, 1990, J INSECT PHYSIOL, V36, P427, DOI 10.1016/0022-1910(90)90060-S; Mita K, 2004, DNA RES, V11, P27, DOI 10.1093/dnares/11.1.27; Mita K, 2003, P NATL ACAD SCI USA, V100, P14121, DOI 10.1073/pnas.2234984100; Moto K, 2004, P NATL ACAD SCI USA, V101, P8631, DOI 10.1073/pnas.0402056101; Moto K, 2003, P NATL ACAD SCI USA, V100, P9156, DOI 10.1073/pnas.1531993100; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Ohnishi A, 2006, P NATL ACAD SCI USA, V103, P4398, DOI 10.1073/pnas.0511270103; Ozawa R, 1996, INSECT BIOCHEM MOLEC, V26, P259, DOI 10.1016/0965-1748(95)00088-7; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Putney JW, 2001, J CELL SCI, V114, P2223; Rafaeli A, 1996, INSECT BIOCHEM MOLEC, V26, P797, DOI 10.1016/S0965-1748(96)00029-X; RAFAELI A, 2003, INSECT PHEROMONE BIO, P109; Rafaeli A, 2009, GEN COMP ENDOCR, V162, P69, DOI 10.1016/j.ygcen.2008.04.004; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; Venkatachalam K, 2002, NAT CELL BIOL, V4, pE263, DOI 10.1038/ncb1102-e263; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Williams RT, 2001, BIOCHEM J, V357, P673, DOI 10.1042/0264-6021:3570673; Wu MM, 2007, CELL CALCIUM, V42, P163, DOI 10.1016/j.ceca.2007.03.003; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yoshiga T, 2000, GENE, V246, P339, DOI 10.1016/S0378-1119(00)00047-0; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zhang TY, 2005, BBA-GENE STRUCT EXPR, V1728, P44, DOI 10.1016/j.bbaexp.2005.01.009	46	28	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31200	31213		10.1074/jbc.M109.044198	http://dx.doi.org/10.1074/jbc.M109.044198			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19740753	Green Published, hybrid			2022-12-27	WOS:000271378400048
J	Giorgio, V; Bisetto, E; Soriano, ME; Dabbeni-Sala, F; Basso, E; Petronilli, V; Forte, MA; Bernardi, P; Lippe, G				Giorgio, Valentina; Bisetto, Elena; Soriano, Maria Eugenia; Dabbeni-Sala, Federica; Basso, Emy; Petronilli, Valeria; Forte, Michael A.; Bernardi, Paolo; Lippe, Giovanna			Cyclophilin D Modulates Mitochondrial F0F1-ATP Synthase by Interacting with the Lateral Stalk of the Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION PORE; BOVINE HEART-MITOCHONDRIA; BLUE NATIVE PAGE; ATP SYNTHASE; INHIBITOR PROTEIN; CYCLOSPORINE-A; F(0)F(1)ATP SYNTHASE; SUBUNIT COMPOSITION; RESPIRATORY-CHAIN; F1F0-ATP SYNTHASE	Blue native gel electrophoresis purification and immunoprecipitation of F0F1-ATP synthase from bovine heart mitochondria revealed that cyclophilin (CyP) D associates to the complex. Treatment of intact mitochondria with the membrane-permeable bifunctional reagent dimethyl 3,3-dithiobis-propionimidate (DTBP) cross-linked CyPD with the lateral stalk of ATP synthase, whereas no interactions with F-1 sector subunits, the ATP synthase natural inhibitor protein IF1, and the ATP/ADP carrier were observed. The ATP synthase-CyPD interactions have functional consequences on enzyme catalysis and are modulated by phosphate (increased CyPD binding and decreased enzyme activity) and cyclosporin (Cs) A (decreased CyPD binding and increased enzyme activity). Treatment of MgATP submitochondrial particles or intact mitochondria with CsA displaced CyPD from membranes and activated both hydrolysis and synthesis of ATP sustained by the enzyme. No effect of CsA was detected in CyPD-null mitochondria, which displayed a higher specific activity of the ATP synthase than wild-type mitochondria. Modulation by CyPD binding appears to be independent of IF1, whose association to ATP synthase was not affected by CsA treatment. These findings demonstrate that CyPD association to the lateral stalk of ATP synthase modulates the activity of the complex.	[Petronilli, Valeria; Bernardi, Paolo] Univ Padua, Dept Biomed Sci, I-35121 Padua, Italy; [Petronilli, Valeria; Bernardi, Paolo] Univ Padua, CNR, Inst Neurosci, I-35121 Padua, Italy; [Dabbeni-Sala, Federica] Univ Padua, Dept Pharmacol & Anesthesiol, I-35121 Padua, Italy; [Bisetto, Elena; Lippe, Giovanna] Univ Udine, Dept Biomed Sci, I-33100 Udine, Italy; [Forte, Michael A.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA	University of Padua; Consiglio Nazionale delle Ricerche (CNR); University of Padua; University of Padua; University of Udine; Oregon Health & Science University	Bernardi, P (corresponding author), Univ Padua, Dept Biomed Sci, Viale Giuseppe Colombo 3, I-35121 Padua, Italy.	bernardi@bio.unipd.it; giovanna.lippe@uniud.it	Bernardi, Paolo/C-3656-2008; Petronilli, Valeria/C-3558-2015; Basso, Emy/F-7687-2015; Giorgio, Valentina/O-1969-2015; Giorgio, Valentina/I-6110-2016	Bernardi, Paolo/0000-0001-9187-3736; Petronilli, Valeria/0000-0003-4026-6404; Basso, Emy/0000-0003-2962-7213; Giorgio, Valentina/0000-0002-4229-3054; Soriano, Maria Eugenia/0000-0002-7971-2961	National Institutes of Health [GM69883]; USPHS; Fondazione Cariparo "Models of mitochondrial diseases"; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069883] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); Fondazione Cariparo "Models of mitochondrial diseases"; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM69883 (to M. A. F. and P. B.) from the USPHS. This work was also supported by a grant from Fondazione Cariparo "Models of mitochondrial diseases" (to P. B.).	Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Baines CP, 2009, J MOL CELL CARDIOL, V46, P850, DOI 10.1016/j.yjmcc.2009.02.007; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Basso E, 2008, J BIOL CHEM, V283, P26307, DOI 10.1074/jbc.C800132200; BELOGRUDOV GI, 1995, J BIOL CHEM, V270, P2053, DOI 10.1074/jbc.270.5.2053; Belogrudov GI, 2008, ARCH BIOCHEM BIOPHYS, V473, P76, DOI 10.1016/j.abb.2008.02.022; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; Bisetto E, 2007, ELECTROPHORESIS, V28, P3178, DOI 10.1002/elps.200700066; Bisetto E, 2008, J BIOENERG BIOMEMBR, V40, P257, DOI 10.1007/s10863-008-9183-5; BOREL JF, 1977, IMMUNOLOGY, V32, P1017; Bowler MW, 2007, J BIOL CHEM, V282, P14238, DOI 10.1074/jbc.M700203200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Campanella M, 2008, CELL METAB, V8, P13, DOI 10.1016/j.cmet.2008.06.001; Chen C, 2006, J BIOL CHEM, V281, P13777, DOI 10.1074/jbc.M513369200; Chen C, 2004, J BIOL CHEM, V279, P31761, DOI 10.1074/jbc.M401353200; COLLINSON IR, 1994, BIOCHEMISTRY-US, V33, P7971, DOI 10.1021/bi00191a026; DAS AM, 1990, BIOCHEM J, V266, P355, DOI 10.1042/bj2660355; Di Pancrazio F, 2004, BBA-BIOENERGETICS, V1659, P52, DOI 10.1016/j.bbabio.2004.07.009; Dickson VK, 2006, EMBO J, V25, P2911, DOI 10.1038/sj.emboj.7601177; Dienhart M, 2002, J BIOL CHEM, V277, P39289, DOI 10.1074/jbc.M205720200; Dudkina NV, 2005, P NATL ACAD SCI USA, V102, P3225, DOI 10.1073/pnas.0408870102; Eubel H, 2003, PLANT PHYSIOL, V133, P274, DOI 10.1104/pp.103.024620; FISCHER G, 1989, NATURE, V337, P476, DOI 10.1038/337476a0; Gavin PD, 2003, BBA-BIOENERGETICS, V1607, P167, DOI 10.1016/j.bbabio.2003.09.013; Gledhill JR, 2007, P NATL ACAD SCI USA, V104, P15671, DOI 10.1073/pnas.0707326104; Green NS, 2001, PROTEIN SCI, V10, P1293, DOI 10.1110/ps.51201; Koppen M, 2007, MOL CELL BIOL, V27, P758, DOI 10.1128/MCB.01470-06; Krauskopf A, 2003, J BIOL CHEM, V278, P41685, DOI 10.1074/jbc.M301181200; Krauskopf A, 2002, BRIT J PHARMACOL, V135, P977, DOI 10.1038/sj.bjp.0704544; LIPPE G, 1991, BIOCHEM BIOPH RES CO, V181, P764, DOI 10.1016/0006-291X(91)91256-C; LIPPE G, 1988, BIOCHIM BIOPHYS ACTA, V933, P1, DOI 10.1016/0005-2728(88)90050-3; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Meyer B, 2007, MOL CELL PROTEOMICS, V6, P1690, DOI 10.1074/mcp.M700097-MCP200; Minauro-Sanmiguel F, 2005, P NATL ACAD SCI USA, V102, P12356, DOI 10.1073/pnas.0503893102; Nicolli A, 1996, J BIOL CHEM, V271, P2185, DOI 10.1074/jbc.271.4.2185; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; RITOV VB, 1992, GEN PHYSIOL BIOPHYS, V11, P49; Senior AE, 2007, CELL, V130, P220, DOI 10.1016/j.cell.2007.07.004; Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35; Thomas D, 2008, BIOL CELL, V100, P591, DOI 10.1042/BC20080022; Tomasetig L, 2002, BBA-BIOENERGETICS, V1556, P133, DOI 10.1016/S0005-2728(02)00344-4; Wang P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-226; Wittig I, 2008, BBA-BIOENERGETICS, V1777, P592, DOI 10.1016/j.bbabio.2008.04.027; Wittig I, 2008, MOL CELL PROTEOMICS, V7, P995, DOI 10.1074/mcp.M700465-MCP200; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Zharova TV, 2006, BIOCHEMISTRY-US, V45, P14552, DOI 10.1021/bi061520v	46	221	229	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33982	33988		10.1074/jbc.M109.020115	http://dx.doi.org/10.1074/jbc.M109.020115			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19801635	Green Published, hybrid			2022-12-27	WOS:000272165200030
J	Namkung, Y; Dipace, C; Urizar, E; Javitch, JA; Sibley, DR				Namkung, Yoon; Dipace, Concetta; Urizar, Eneko; Javitch, Jonathan A.; Sibley, David R.			G Protein-coupled Receptor Kinase-2 Constitutively Regulates D-2 Dopamine Receptor Expression and Signaling Independently of Receptor Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENYLATE-CYCLASE; DESENSITIZATION; TRAFFICKING; SENSITIZATION; ARRESTINS; MEMBRANE; BINDING; EZRIN; GAMMA; GRKS	We investigated the regulatory effects of GRK2 on D2 dopamine receptor signaling and found that this kinase inhibits both receptor expression and functional signaling in a phosphorylation-independent manner, apparently through different mechanisms. Overexpression of GRK2 was found to suppress receptor expression at the cell surface and enhance agonist-induced internalization, whereas short interfering RNA knockdown of endogenous GRK2 led to an increase in cell surface receptor expression and decreased agonist-mediated endocytosis. These effects were not due to GRK2-mediated phosphorylation of the D2 receptor as a phosphorylation-null receptor mutant was regulated similarly, and overexpression of a catalytically inactive mutant of GRK2 produced the same effects. The suppression of receptor expression is correlated with constitutive association of GRK2 with the receptor complex as we found that GRK2 and several of its mutants were able to co-immunoprecipitate with the D-2 receptor. Agonist pretreatment did not enhance the ability of GRK2 to co-immunoprecipitate with the receptor. We also found that overexpression of GRK2 attenuated the functional coupling of the D2 receptor and that this activity required the kinase activity of GRK2 but did not involve receptor phosphorylation, thus suggesting the involvement of an additional GRK2 substrate. Interestingly, we found that the suppression of functional signaling also required the G beta gamma binding activity of GRK2 but did not involve the GRK2 N-terminal RH domain. Our results suggest a novel mechanism by which GRK2 negatively regulates G protein-coupled receptor signaling in a manner that is independent of receptor phosphorylation.	[Namkung, Yoon; Sibley, David R.] NINDS, Mol Neuropharmacol Sect, NIH, Bethesda, MD 20892 USA; [Dipace, Concetta; Urizar, Eneko; Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Ctr Mol Recognit, New York, NY 10032 USA; [Dipace, Concetta; Urizar, Eneko; Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Dipace, Concetta; Urizar, Eneko; Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Columbia University; Columbia University; Columbia University	Sibley, DR (corresponding author), NINDS, Mol Neuropharmacol Sect, NIH, Rm 4S-04,MSC 9405,5625 Fishers Lane, Bethesda, MD 20892 USA.	sibley@helix.nih.gov	Sibley, David/AAC-3591-2019	Javitch, Jonathan/0000-0001-7395-2967	National Institutes of Health [MH54137 and DA022413]; NINDS competitive fellowship; Lieber Center for Schizophrenia Research and Treatment; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002263] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA022413] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS competitive fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Lieber Center for Schizophrenia Research and Treatment; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by the National Institutes of Health through the intramural research program of NINDS (to D. R. S.), Grants MH54137 and DA022413 (to J. A. J.), and a NINDS competitive fellowship (to Y. N.). This work was also supported by the Lieber Center for Schizophrenia Research and Treatment (to J. A. J.).	Cant SH, 2005, MOL BIOL CELL, V16, P3088, DOI 10.1091/mbc.E04-10-0877; Carman CV, 2000, J BIOL CHEM, V275, P10443, DOI 10.1074/jbc.275.14.10443; Dhami GK, 2006, PHARMACOL THERAPEUT, V111, P260, DOI 10.1016/j.pharmthera.2005.01.008; Ferguson SSG, 1996, CAN J PHYSIOL PHARM, V74, P1095, DOI 10.1139/y96-124; Ferguson SSG, 2007, TRENDS PHARMACOL SCI, V28, P173, DOI 10.1016/j.tips.2007.02.008; Freeman JLR, 2002, BIOCHEMISTRY-US, V41, P12850, DOI 10.1021/bi020145d; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Gardner B, 1996, BRIT J PHARMACOL, V118, P1544, DOI 10.1111/j.1476-5381.1996.tb15572.x; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Kapur S, 2001, BIOL PSYCHIAT, V50, P873, DOI 10.1016/S0006-3223(01)01251-3; Kim OJ, 2004, J BIOL CHEM, V279, P7999, DOI 10.1074/jbc.M308281200; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; KONG GH, 1994, J BIOL CHEM, V269, P13084; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; MONSMA FJ, 1989, NATURE, V342, P926, DOI 10.1038/342926a0; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Namkung Y, 2004, J BIOL CHEM, V279, P49533, DOI 10.1074/jbc.M408319200; Namkung Y, 2009, J BIOL CHEM, V284, P15038, DOI 10.1074/jbc.M900388200; Neve KA, 2004, J RECEPT SIG TRANSD, V24, P165, DOI 10.1081/LRST-200029981; Pao Christina S, 2002, Sci STKE, V2002, ppe42, DOI 10.1126/stke.2002.153.pe42; Perroy J, 2003, EMBO J, V22, P3816, DOI 10.1093/emboj/cdg383; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Reiter E, 2001, BIOCHEM BIOPH RES CO, V282, P71, DOI 10.1006/bbrc.2001.4534; Seeman P, 2007, SYNAPSE, V61, P1013, DOI 10.1002/syn.20453; SIBLEY DR, 1992, TRENDS PHARMACOL SCI, V13, P61, DOI 10.1016/0165-6147(92)90025-2; Stanasila L, 2006, J BIOL CHEM, V281, P4354, DOI 10.1074/jbc.M511989200; Sterne-Marr R, 2003, J BIOL CHEM, V278, P6050, DOI 10.1074/jbc.M208787200; Tandon R, 2008, SCHIZOPHR RES, V100, P4, DOI 10.1016/j.schres.2008.01.022; Tesmer VM, 2005, SCIENCE, V310, P1686, DOI 10.1126/science.1118890; Watts VJ, 1996, MOL PHARMACOL, V50, P966; Watts VJ, 2005, PHARMACOL THERAPEUT, V106, P405, DOI 10.1016/j.pharmthera.2004.12.005; Willets JM, 2003, TRENDS PHARMACOL SCI, V24, P626, DOI 10.1016/j.tips.2003.10.003	33	59	62	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34103	34115		10.1074/jbc.M109.055707	http://dx.doi.org/10.1074/jbc.M109.055707			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19815545	Green Published, hybrid			2022-12-27	WOS:000272165200043
J	Wong-Mauldin, K; Raussens, V; Forte, TM; Ryan, RO				Wong-Mauldin, Kasuen; Raussens, Vincent; Forte, Trudy M.; Ryan, Robert O.			Apolipoprotein A-V N-terminal Domain Lipid Interaction Properties in Vitro Explain the Hypertriglyceridemic Phenotype Associated with Natural Truncation Mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; SECONDARY STRUCTURE; PARTICLE-SIZE; HELIX; ORIENTATION; DIMYRISTOYLPHOSPHATIDYLCHOLINE; CHYLOMICRONS; TRIGLYCERIDE; CONFORMATION; PROTEINS	The N-terminal 146 residues of apolipoprotein (apo) A-V adopt a helix bundle conformation in the absence of lipid. Because similarly sized truncation mutants in human subjects correlate with severe hypertriglyceridemia, the lipid binding properties of apoA-V(1-146) were studied. Upon incubation with phospholipid in vitro, apoA-V(1-146) forms reconstituted high density lipoproteins 15-17 nm in diameter. Far UV circular dichroism spectroscopy analyses of lipid-bound apoA-V( 1-146) yielded an alpha-helix secondary structure content of 60%. Fourier transformed infrared spectroscopy analysis revealed that apoA-V(1-146) alpha-helix segments align perpendicular with respect to particle phospholipid fatty acyl chains. Fluorescence spectroscopy of single Trp variant apoA-V(1-146) indicates that lipid interaction is accompanied by a conformational change. The data are consistent with a model wherein apoA-V(1-146) alpha-helices circumscribe the perimeter of a disk-shaped bilayer. The ability of apoA-V(1-146) to solubilize dimyristoylphosphatidyl-choline vesicles at a rate faster than full-length apoA-V suggests that N- and C-terminal interactions in the full-length protein modulate its lipid binding properties. Preferential association of apoA-V(1-146) with murine plasma HDL, but not with VLDL, suggests that particle size is a determinant of its lipoprotein binding specificity. It may be concluded that defective lipoprotein binding of truncated apoA-V contributes to the hypertriglyceridemia phenotype associated with truncation mutations in human subjects.	[Wong-Mauldin, Kasuen; Forte, Trudy M.; Ryan, Robert O.] Childrens Hosp Oakland, Res Inst, Ctr Prevent Obes Diabet & Cardiovasc Dis, Oakland, CA 94609 USA; [Wong-Mauldin, Kasuen; Ryan, Robert O.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Raussens, Vincent] Univ Libre Bruxelles, Fac Sci, Lab Struct & Funct Biol Membranes, Ctr Struct Biol & Bioinformat, B-1050 Brussels, Belgium	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of California System; University of California Berkeley; Universite Libre de Bruxelles	Ryan, RO (corresponding author), Childrens Hosp Oakland, Res Inst, Ctr Prevent Obes Diabet & Cardiovasc Dis, 5700 Martin Luther King Jr Way, Oakland, CA 94609 USA.	rryan@chori.org		Mauldin, Kasuen/0000-0001-9220-8033	National Institutes of Health [HL-073061]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-073061.	Ajees AA, 2006, P NATL ACAD SCI USA, V103, P2126, DOI 10.1073/pnas.0506877103; Beckstead JA, 2003, BIOCHEMISTRY-US, V42, P9416, DOI 10.1021/bi034509t; Beckstead JA, 2007, J BIOL CHEM, V282, P15484, DOI 10.1074/jbc.M611797200; Beigneux AP, 2007, CELL METAB, V5, P279, DOI 10.1016/j.cmet.2007.02.002; BREITER DR, 1991, BIOCHEMISTRY-US, V30, P603, DOI 10.1021/bi00217a002; CONNELLY PW, 1981, BIOCHIM BIOPHYS ACTA, V666, P80, DOI 10.1016/0005-2760(81)90093-X; Fisher CA, 1997, BIOCHEM CELL BIOL, V75, P45, DOI 10.1139/bcb-75-1-45; GOORMAGHTIGH E, 1990, EUR J BIOCHEM, V193, P409, DOI 10.1111/j.1432-1033.1990.tb19354.x; JI Y, 1995, J BIOL CHEM, V270, P11290, DOI 10.1074/jbc.270.19.11290; KAMTEKAR S, 1995, FASEB J, V9, P1013, DOI 10.1096/fasebj.9.11.7649401; LINDGREN FT, 1972, BLOOD LIPIDS LIPOPRO, P181; LIU H, 1993, FEBS LETT, V316, P27, DOI 10.1016/0014-5793(93)81730-N; Lookene A, 2005, J BIOL CHEM, V280, P25383, DOI 10.1074/jbc.M501589200; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Marcais C, 2005, J CLIN INVEST, V115, P2862, DOI 10.1172/JCI24471; Martin DDO, 2006, J BIOL CHEM, V281, P20418, DOI 10.1074/jbc.M602077200; Merkel M, 2005, J BIOL CHEM, V280, P21553, DOI 10.1074/jbc.M411412200; Narayanaswami V, 2004, J BIOL CHEM, V279, P14273, DOI 10.1074/jbc.M313318200; Nelbach L, 2008, J LIPID RES, V49, P572, DOI 10.1194/jlr.M700281-JLR200; NICHOLS AV, 1986, METHOD ENZYMOL, V128, P417; Nilsson SK, 2007, BIOCHEMISTRY-US, V46, P3896, DOI 10.1021/bi7000533; O'Brien PJ, 2005, CLIN CHEM, V51, P351, DOI 10.1373/clinchem.2004.040824; Oliva CP, 2006, ATHEROSCLEROSIS, V188, P215, DOI 10.1016/j.atherosclerosis.2006.04.010; Oliva CP, 2005, ARTERIOSCL THROM VAS, V25, P411, DOI 10.1161/01.ATV.0000153087.36428.dd; Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852; Raussens V, 2005, BIOCHEM J, V387, P747, DOI 10.1042/BJ20041536; RAUSSENS V, 1995, J BIOL CHEM, V270, P12542, DOI 10.1074/jbc.270.21.12542; Raussens V, 1998, J BIOL CHEM, V273, P25825, DOI 10.1074/jbc.273.40.25825; REIJNGOUD DJ, 1982, BIOCHEMISTRY-US, V21, P2969, DOI 10.1021/bi00541a026; Ryan RO, 2003, PROTEIN EXPRES PURIF, V27, P98, DOI 10.1016/S1046-5928(02)00568-5; SCHIFFER M, 1967, BIOPHYS J, V7, P121, DOI 10.1016/S0006-3495(67)86579-2; SEGREST JP, 1992, J LIPID RES, V33, P141; Shu X, 2008, J LIPID RES, V49, P1670, DOI 10.1194/jlr.M800111-JLR200; Silva RAGD, 2007, J BIOL CHEM, V282, P9713, DOI 10.1074/jbc.M610380200; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; SUITS AG, 1989, P NATL ACAD SCI USA, V86, P2713, DOI 10.1073/pnas.86.8.2713; TAJIMA S, 1983, J BIOL CHEM, V258, P73; TALLMADGE DH, 1989, PHOTOCHEM PHOTOBIOL, V49, P381, DOI 10.1111/j.1751-1097.1989.tb09183.x; van der Vliet HN, 2001, J BIOL CHEM, V276, P44512, DOI 10.1074/jbc.M106888200; WALD JH, 1990, J BIOL CHEM, V265, P20037; Weers PMM, 2001, EUR J BIOCHEM, V268, P3728, DOI 10.1046/j.1432-1327.2001.02282.x; WETTERAU JR, 1982, J BIOL CHEM, V257, P961; WETTERAU JR, 1988, J BIOL CHEM, V263, P6240; WILSON C, 1991, SCIENCE, V252, P1817, DOI 10.1126/science.2063194; Wong K, 2008, BIOCHEMISTRY-US, V47, P8768, DOI 10.1021/bi800515c	45	8	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33369	33376		10.1074/jbc.M109.040972	http://dx.doi.org/10.1074/jbc.M109.040972			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19825998	hybrid, Green Published			2022-12-27	WOS:000272028500042
J	Kremer, SB; Gross, DS				Kremer, Selena B.; Gross, David S.			SAGA and Rpd3 Chromatin Modification Complexes Dynamically Regulate Heat Shock Gene Structure and Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; HISTONE ACETYLTRANSFERASE COMPLEX; IN-VIVO TARGET; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL ACTIVATION; CODING REGIONS; ADA-COMPLEX; YEAST; RECRUITMENT; PROMOTER	The chromatin structure of heat shock protein (HSP)-encoding genes undergoes dramatic alterations upon transcriptional induction, including, in extreme cases, domain-wide nucleosome disassembly. Here, we use a combination of gene knockout, in situ mutagenesis, chromatin immunoprecipitation, and expression assays to investigate the role of histone modification complexes in regulating heat shock gene structure and expression in Saccharomyces cerevisiae. Two histone acetyltransferases, Gcn5 and Esa1, were found to stimulate HSP gene transcription. A detailed chromatin immunoprecipitation analysis of the Gcn5-containing SAGA complex (signified by Spt3) revealed its presence within the promoter of every heat shock factor 1-regulated gene examined. The occupancy of SAGA increased substantially upon heat shock, peaking at several HSP promoters within 30-45 s of temperature upshift. SAGA was also efficiently recruited to the coding regions of certain HSP genes (where its presence mirrored that of pol II), although not at others. Robust and rapid recruitment of repressive, Rpd3-containing histone deacetylase complexes was also seen and at all HSP genes examined. A detailed analysis of HSP82 revealed that both Rpd3(L) and Rpd3(S) complexes (signified by Sap30 and Rco1, respectively) were recruited to the gene promoter, yet only Rpd3(S) was recruited to its open reading frame. A consensus URS1 cis-element facilitated the recruitment of each Rpd3 complex to the HSP82 promoter, and this correlated with targeted deacetylation of promoter nucleosomes. Collectively, our observations reveal that SAGA and Rpd3 complexes are rapidly and synchronously recruited to heat shock factor 1-activated genes and suggest that their opposing activities modulate heat shock gene chromatin structure and fine-tune transcriptional output.	[Kremer, Selena B.; Gross, David S.] Louisiana State Univ, Dept Biochem & Mol Biol, Hlth Sci Ctr, Shreveport, LA 71130 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Gross, DS (corresponding author), Louisiana State Univ, Dept Biochem & Mol Biol, Hlth Sci Ctr, 1501 Kings Highway, Shreveport, LA 71130 USA.	dgross@lsuhsc.edu			National Science Foundation [MCB-0450419, MCB-0747227]; Direct For Biological Sciences [0747227] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grants MCB-0450419 and MCB-0747227 (to D. S. G.).	Allard S, 1999, EMBO J, V18, P5108, DOI 10.1093/emboj/18.18.5108; Ansari A, 2005, GENE DEV, V19, P2969, DOI 10.1101/gad.1362305; Apone LM, 1998, MOL CELL, V2, P653, DOI 10.1016/S1097-2765(00)80163-X; Babiarz JE, 2006, GENE DEV, V20, P700, DOI 10.1101/gad.1386306; Balakrishnan SK, 2008, ONCOGENE, V27, P2661, DOI 10.1038/sj.onc.1210935; Bhaumik SR, 2004, GENE DEV, V18, P333, DOI 10.1101/gad.1148404; Bhaumik SR, 2001, GENE DEV, V15, P1935, DOI 10.1101/gad.911401; Boy-Marcotte E, 1999, MOL MICROBIOL, V33, P274, DOI 10.1046/j.1365-2958.1999.01467.x; Bryant GO, 2003, MOL CELL, V11, P1301, DOI 10.1016/S1097-2765(03)00144-8; Carrozza MJ, 2005, BBA-GENE STRUCT EXPR, V1731, P77, DOI 10.1016/j.bbaexp.2005.09.005; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chou S, 1999, GENETICS, V153, P1573; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; de Nadal E, 2004, NATURE, V427, P370, DOI 10.1038/nature02258; Deckert J, 2001, MOL CELL BIOL, V21, P2726, DOI 10.1128/MCB.21.8.2726-2735.2001; Dudley AM, 1999, GENE DEV, V13, P2940, DOI 10.1101/gad.13.22.2940; Eberharter A, 1999, MOL CELL BIOL, V19, P6621; Erkina TY, 2006, MOL CELL BIOL, V26, P7587, DOI 10.1128/MCB.00666-06; Erkina TY, 2008, MOL CELL BIOL, V28, P1207, DOI 10.1128/MCB.01069-07; Erkine AM, 1996, MOL CELL BIOL, V16, P7004; Erkine AM, 1999, MOL CELL BIOL, V19, P1627; Fishburn J, 2005, MOL CELL, V18, P369, DOI 10.1016/j.molcel.2005.03.029; GIARDINA C, 1995, MOL CELL BIOL, V15, P2737; Govind CK, 2007, MOL CELL, V25, P31, DOI 10.1016/j.molcel.2006.11.020; Govind CK, 2005, MOL CELL BIOL, V25, P5626, DOI 10.1128/MCB.25.13.5626-5638.2005; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Grant PA, 1999, J BIOL CHEM, V274, P5895, DOI 10.1074/jbc.274.9.5895; GROSS DS, 1990, J MOL BIOL, V216, P611, DOI 10.1016/0022-2836(90)90387-2; GROSS DS, 1993, EMBO J, V12, P3931, DOI 10.1002/j.1460-2075.1993.tb06071.x; GROSS DS, 1995, NUCLEUS, V1, P151; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; Hartley PD, 2009, CELL, V137, P445, DOI 10.1016/j.cell.2009.02.043; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Inouye S, 2007, J BIOL CHEM, V282, P33210, DOI 10.1074/jbc.M704471200; John S, 2000, GENE DEV, V14, P1196; Kadosh D, 1997, CELL, V89, P365, DOI 10.1016/S0092-8674(00)80217-2; Keogh MC, 2006, GENE DEV, V20, P660, DOI 10.1101/gad.1388106; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Larschan E, 2001, GENE DEV, V15, P1946, DOI 10.1101/gad.911501; Lee D, 1998, NATURE, V393, P389, DOI 10.1038/30770; Lee DK, 1999, GENE DEV, V13, P2934, DOI 10.1101/gad.13.22.2934; LEE SW, 1993, MOL CELL BIOL, V13, P727, DOI 10.1128/MCB.13.2.727; Lee TI, 2000, NATURE, V405, P701, DOI 10.1038/35015104; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Li B, 2009, J BIOL CHEM, V284, P7970, DOI 10.1074/jbc.M808220200; MCDANIEL D, 1989, MOL CELL BIOL, V9, P4789, DOI 10.1128/MCB.9.11.4789; Mercier PA, 1999, J CELL SCI, V112, P2765; Moqtaderi Z, 1998, MOL CELL, V2, P675, DOI 10.1016/S1097-2765(00)80165-3; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Myers LC, 2000, ANNU REV BIOCHEM, V69, P729, DOI 10.1146/annurev.biochem.69.1.729; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Nightingale KP, 1998, EMBO J, V17, P2865, DOI 10.1093/emboj/17.10.2865; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; PARK HO, 1989, MOL CELL BIOL, V9, P2025, DOI 10.1128/MCB.9.5.2025; Pray-Grant MG, 2002, MOL CELL BIOL, V22, P8774, DOI 10.1128/MCB.22.24.8774-8786.2002; Qiu HF, 2004, MOL CELL BIOL, V24, P4104, DOI 10.1128/MCB.24.10.4104-4117.2004; Reeves WM, 2005, MOL CELL BIOL, V25, P9092, DOI 10.1128/MCB.25.20.9092-9102.2005; Reid JL, 2000, MOL CELL, V6, P1297, DOI 10.1016/S1097-2765(00)00128-3; Robert F, 2004, MOL CELL, V16, P199, DOI 10.1016/j.molcel.2004.09.021; Rundlett SE, 1998, NATURE, V392, P831, DOI 10.1038/33952; Sakurai H, 1999, BIOCHEM BIOPH RES CO, V261, P734, DOI 10.1006/bbrc.1999.1113; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Sekinger EA, 2001, CELL, V105, P403, DOI 10.1016/S0092-8674(01)00329-4; Sekinger EA, 1999, EMBO J, V18, P7041, DOI 10.1093/emboj/18.24.7041; Sertil O, 2007, MOL CELL BIOL, V27, P2037, DOI 10.1128/MCB.02297-06; Sharma VM, 2007, MOL CELL BIOL, V27, P3199, DOI 10.1128/MCB.02311-06; Shivaswamy S, 2008, MOL CELL BIOL, V28, P2221, DOI 10.1128/MCB.01659-07; Singh BN, 2007, MOL CELL, V27, P806, DOI 10.1016/j.molcel.2007.07.013; Singh H, 2006, GENETICS, V172, P2169, DOI 10.1534/genetics.105.052738; SORGER PK, 1990, CELL, V62, P793, DOI 10.1016/0092-8674(90)90123-V; STRUHL K, 1985, P NATL ACAD SCI USA, V82, P8419, DOI 10.1073/pnas.82.24.8419; Suka N, 2001, MOL CELL, V8, P473, DOI 10.1016/S1097-2765(01)00301-X; SZENTGYORGYI C, 1995, MOL CELL BIOL, V15, P6754; SZENTGYORGYI C, 1987, J MOL BIOL, V193, P71, DOI 10.1016/0022-2836(87)90628-0; Taverna SD, 2006, MOL CELL, V24, P785, DOI 10.1016/j.molcel.2006.10.026; Uffenbeck SR, 2006, BIOCHEM CELL BIOL, V84, P477, DOI 10.1139/O06-079; Venturi CB, 2000, MOL CELL BIOL, V20, P6435, DOI 10.1128/MCB.20.17.6435-6448.2000; Vogelauer M, 2000, NATURE, V408, P495, DOI 10.1038/35044127; WESTWOOD JT, 1991, NATURE, V353, P822, DOI 10.1038/353822a0; Wyce A, 2007, MOL CELL, V27, P275, DOI 10.1016/j.molcel.2007.01.035; Yan Y, 2000, MOL CELL, V6, P1195, DOI 10.1016/S1097-2765(00)00116-7; Zanton SJ, 2004, P NATL ACAD SCI USA, V101, P16843, DOI 10.1073/pnas.0404988101; Zhao J, 2005, MOL CELL BIOL, V25, P8985, DOI 10.1128/MCB.25.20.8985-8999.2005	86	30	30	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32914	32931		10.1074/jbc.M109.058610	http://dx.doi.org/10.1074/jbc.M109.058610			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19759026	hybrid, Green Published			2022-12-27	WOS:000272028400075
J	Malmgren, S; Nicholls, DG; Taneera, J; Bacos, K; Koeck, T; Tamaddon, A; Wibom, R; Groop, L; Ling, C; Mulder, H; Sharoyko, VV				Malmgren, Siri; Nicholls, David G.; Taneera, Jalal; Bacos, Karl; Koeck, Thomas; Tamaddon, Ashkan; Wibom, Rolf; Groop, Leif; Ling, Charlotte; Mulder, Hindrik; Sharoyko, Vladimir V.			Tight Coupling between Glucose and Mitochondrial Metabolism in Clonal beta-Cells Is Required for Robust Insulin Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LACTATE-DEHYDROGENASE; REGULATED ANAPLEROSIS; PYRUVATE; LINES; OVEREXPRESSION; EXPRESSION; SHUTTLE; CANCER	The biochemical mechanisms underlying glucose-stimulated insulin secretion from pancreatic beta-cells are not completely understood. To identify metabolic disturbances in beta-cells that impair glucose-stimulated insulin secretion, we compared two INS-1-derived clonal beta-cell lines, which are glucose-responsive (832/13 cells) or glucose-unresponsive (832/2 cells). To this end, we analyzed a number of parameters in glycolytic and mitochondrial metabolism, including mRNA expression of genes involved in cellular energy metabolism. We found that despite a marked impairment of glucose-stimulated insulin secretion, 832/2 cells exhibited a higher rate of glycolysis. Still, no glucose-induced increases in respiratory rate, ATP production, or respiratory chain complex I, III, and IV activities were seen in the 832/2 cells. Instead, 832/2 cells, which expressed lactate dehydrogenase A, released lactate regardless of ambient glucose concentrations. In contrast, the glucose-responsive 832/13 line lacked lactate dehydrogenase and did not produce lactate. Accordingly, in 832/2 cells mRNA expression of genes for glycolytic enzymes were up-regulated, whereas mitochondria-related genes were down-regulated. This could account for a Warburg-like effect in the 832/2 cell clone, lacking in 832/13 cells as well as primary beta-cells. In human islets, mRNA expression of genes such as lactate dehydrogenase A and hexokinase I correlated positively with HbA(1c) levels, reflecting perturbed long term glucose homeostasis, whereas that of Slc2a2 (glucose transporter 2) correlated negatively with HbA(1c) and thus better metabolic control. We conclude that tight metabolic regulation enhancing mitochondrial metabolism and restricting glycolysis in 832/13 cells is required for clonal beta-cells to secrete insulin robustly in response to glucose. Moreover, a similar expression pattern of genes controlling glycolytic and mitochondrial metabolism in clonal beta-cells and human islets was observed, suggesting that a similar prioritization of mitochondrial metabolism is required in healthy human beta-cells. The 832 beta-cell lines may be helpful tools to resolve metabolic perturbations occurring in Type 2 diabetes.	[Malmgren, Siri; Nicholls, David G.; Bacos, Karl; Koeck, Thomas; Tamaddon, Ashkan; Mulder, Hindrik; Sharoyko, Vladimir V.] Lund Univ, Ctr Diabet, Dept Clin Sci Malmo, Unit Mol Metab, S-20502 Malmo, Sweden; [Malmgren, Siri; Taneera, Jalal; Groop, Leif; Ling, Charlotte] Lund Univ, Ctr Diabet, Dept Clin Sci Malmo, Unit Diabet & Endocrinol, S-20502 Malmo, Sweden; [Wibom, Rolf] Huddinge Univ Hosp, Karolinska Inst, Dept Lab Med, S-14186 Huddinge, Sweden	Lund University; Lund University; Karolinska Institutet	Sharoyko, VV (corresponding author), Malmo Univ Hosp, Clin Res Ctr, S-20502 Malmo, Sweden.	Vladimir.Sharoyko@med.lu.se	NICHOLLS, DAVID G/K-4300-2012; Ling, Charlotte/Q-2432-2015; Sharoyko, Vladimir/J-3625-2014; Mulder, Hindrik/E-1045-2012; Bacos, Karl/S-2236-2019	Ling, Charlotte/0000-0003-0587-7154; Sharoyko, Vladimir/0000-0002-3717-0471; Malmgren, Siri/0000-0002-4540-1102; Mulder, Hindrik/0000-0002-6593-8417; Bacos, Karl/0000-0002-2461-9073; Taneera, Jalal/0000-0002-3341-1063	Swedish Research Council [14196-06-3]; Crafoord and Albert Pahlsson Foundations; Faculty of Medicine at Lund University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Crafoord and Albert Pahlsson Foundations; Faculty of Medicine at Lund University	This work was supported by Swedish Research Council Grant 14196-06-3, the Crafoord and Albert Pahlsson Foundations, and the Faculty of Medicine at Lund University. We thank the Nordic Center for Islet Transplantation (Uppsala, Sweden) for providing human islets.	AIZAWA T, 1994, AM J PHYSIOL, V266, pC622, DOI 10.1152/ajpcell.1994.266.3.C622; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; Eto K, 1999, SCIENCE, V283, P981, DOI 10.1126/science.283.5404.981; Farfari S, 2000, DIABETES, V49, P718, DOI 10.2337/diabetes.49.5.718; Fransson U, 2006, DIABETOLOGIA, V49, P1578, DOI 10.1007/s00125-006-0263-y; GEMBAL M, 1992, J CLIN INVEST, V89, P1288, DOI 10.1172/JCI115714; Gribble FM, 2009, NAT MED, V15, P247, DOI 10.1038/nm0309-247; Hirose H, 1996, J BIOL CHEM, V271, P5633, DOI 10.1074/jbc.271.10.5633; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Ishihara H, 1999, J CLIN INVEST, V104, P1621, DOI 10.1172/JCI7515; Jensen MV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1287, DOI 10.1152/ajpendo.90604.2008; Jeppsson JO, 2002, CLIN CHEM LAB MED, V40, P78, DOI 10.1515/CCLM.2002.016; KELLY RP, 1991, J PHYSIOL-LONDON, V443, P175, DOI 10.1113/jphysiol.1991.sp018829; Koukourakis MI, 2005, NEOPLASIA, V7, P1, DOI 10.1593/neo.04373; Lu DH, 2002, P NATL ACAD SCI USA, V99, P2708, DOI 10.1073/pnas.052005699; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; Maechler P, 1999, NATURE, V402, P685, DOI 10.1038/45280; Minami K, 2000, AM J PHYSIOL-ENDOC M, V279, pE773, DOI 10.1152/ajpendo.2000.279.4.E773; Nicholls DG, 2008, ANN NY ACAD SCI, V1147, P53, DOI 10.1196/annals.1427.002; Nicholls DG, 2004, AGING CELL, V3, P35, DOI 10.1111/j.1474-9728.2003.00079.x; Nitert MD, 2008, J MOL ENDOCRINOL, V41, P1, DOI 10.1677/JME-07-0133; Rabilloud Thierry, 2008, V432, P83, DOI 10.1007/978-1-59745-028-7_6; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; SEKINE N, 1994, J BIOL CHEM, V269, P4895; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wibom R, 2002, ANAL BIOCHEM, V311, P139, DOI 10.1016/S0003-2697(02)00424-4; Yang SM, 2004, MOL ENDOCRINOL, V18, P2312, DOI 10.1210/me.2004-0148; Zawalich WS, 1996, AM J PHYSIOL-ENDOC M, V271, pE409, DOI 10.1152/ajpendo.1996.271.3.E409; Zhao C, 1998, FEBS LETT, V430, P213, DOI 10.1016/S0014-5793(98)00600-0	30	81	82	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32395	32404		10.1074/jbc.M109.026708	http://dx.doi.org/10.1074/jbc.M109.026708			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19797055	hybrid, Green Published			2022-12-27	WOS:000272028400022
J	Schultz, SJ; Zhang, MH; Champoux, JJ				Schultz, Sharon J.; Zhang, Miaohua; Champoux, James J.			Preferred Sequences within a Defined Cleavage Window Specify DNA 3 ' End-directed Cleavages by Retroviral RNases H	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 REVERSE-TRANSCRIPTASE; HUMAN-IMMUNODEFICIENCY-VIRUS; MURINE LEUKEMIA-VIRUS; DOUBLE-STRANDED DNA; CRYSTAL-STRUCTURE; ANGSTROM RESOLUTION; FINGERS SUBDOMAIN; VIRAL REPLICATION; PRIMER SELECTION; DRUG-RESISTANCE	The RNase H activity of reverse transcriptase carries out three types of cleavage termed internal, RNA 5' end-directed, and DNA 3' end-directed. Given the strong association between the polymerase domain of reverse transcriptase and a DNA 3' primer terminus, we asked whether the distance from the primer terminus is paramount for positioning DNA 3' end-directed cleavages or whether preferred sequences and/or a cleavage window are important as they are for RNA 5' end-directed cleavages. Using the reverse transcriptases of human immunodeficiency virus, type 1 (HIV-1) and Moloney murine leukemia virus (M-MuLV), we determined the effects of sequence, distance, and substrate end structure on DNA 3' end-directed cleavages. Utilizing sequence-matched substrates, our analyses showed that DNA 3' end-directed cleavages share the same sequence preferences as RNA 5' end-directed cleavages, but the sites must fall in a narrow window between the 15th and 20th nucleotides from the recessed end for HIV-1 reverse transcriptase and between the 17th and 20th nucleotides for M-MuLV. Substrates with an RNA 5' end recessed by 1 (HIV-1) or 2-3 (M-MuLV) bases on a longer DNA could accommodate both types of end-directed cleavage, but further recession of the RNA 5' end excluded DNA 3' end-directed cleavages. For HIV-1 RNase H, the inclusion of the cognate dNTP enhanced DNA 3' end-directed cleavages at the 17th and 18th nucleotides. These data demonstrate that all three modes of retroviral RNase H cleavage share sequence determinants that may be useful in designing assays to identify inhibitors of retroviral RNases H.	[Schultz, Sharon J.; Zhang, Miaohua; Champoux, James J.] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Champoux, JJ (corresponding author), Univ Washington, Sch Med, Dept Microbiol, Box 357242, Seattle, WA 98195 USA.	champoux@u.washington.edu			National Institutes of Health [CA51605]; NATIONAL CANCER INSTITUTE [R01CA051605, R37CA051605] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA51605.	Abbondanzieri EA, 2008, NATURE, V453, P184, DOI 10.1038/nature06941; Arts EJ, 1998, PROG NUCLEIC ACID RE, V58, P339; Basu VP, 2008, VIRUS RES, V134, P19, DOI 10.1016/j.virusres.2007.12.017; Beilhartz GL, 2009, J MOL BIOL, V388, P462, DOI 10.1016/j.jmb.2009.03.025; Bohlayer WP, 2006, BIOCHEMISTRY-US, V45, P7628, DOI 10.1021/bi051770w; Budihas SR, 2005, NUCLEIC ACIDS RES, V33, P1249, DOI 10.1093/nar/gki268; Champoux JJ, 2009, FEBS J, V276, P1506, DOI 10.1111/j.1742-4658.2009.06909.x; CHAMPOUX JJ, 1993, REVERSE TRANSCRIPTAS, P103; Das D, 2004, STRUCTURE, V12, P819, DOI 10.1016/j.str.2004.02.032; Dash C, 2008, NUCLEIC ACIDS RES, V36, P6363, DOI 10.1093/nar/gkn678; DESTEFANO JJ, 1993, BIOCHEMISTRY-US, V32, P6908, DOI 10.1021/bi00078a014; DESTEFANO JJ, 1994, NUCLEIC ACIDS RES, V22, P3793, DOI 10.1093/nar/22.18.3793; DESTEFANO JJ, 1995, NUCLEIC ACIDS RES, V23, P3901, DOI 10.1093/nar/23.19.3901; DESTEFANO JJ, 1993, NUCLEIC ACIDS RES, V21, P4330, DOI 10.1093/nar/21.18.4330; DESTEFANO JJ, 1992, BIOCHIM BIOPHYS ACTA, V1131, P270, DOI 10.1016/0167-4781(92)90025-U; DeStefano JJ, 2001, J BIOL CHEM, V276, P32515, DOI 10.1074/jbc.M103958200; Ding JP, 1998, J MOL BIOL, V284, P1095, DOI 10.1006/jmbi.1998.2208; FINSTON WI, 1984, J VIROL, V51, P26, DOI 10.1128/JVI.51.1.26-33.1984; Fisher TS, 2003, J MOL BIOL, V325, P443, DOI 10.1016/S0022-2836(02)01225-1; Fisher TS, 2002, J BIOL CHEM, V277, P22345, DOI 10.1074/jbc.M200282200; FUENTES GM, 1995, J BIOL CHEM, V270, P28169, DOI 10.1074/jbc.270.47.28169; FURFINE ES, 1991, J BIOL CHEM, V266, P406; Gao HQ, 1999, J MOL BIOL, V294, P1097, DOI 10.1006/jmbi.1999.3325; GOPALAKRISHNAN V, 1992, P NATL ACAD SCI USA, V89, P10763, DOI 10.1073/pnas.89.22.10763; GOTTE M, 1995, EMBO J, V14, P833, DOI 10.1002/j.1460-2075.1995.tb07061.x; Hang JQ, 2007, BIOCHEM BIOPH RES CO, V352, P341, DOI 10.1016/j.bbrc.2006.11.018; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320; KATI WM, 1992, J BIOL CHEM, V267, P25988; Kelleher CD, 2000, J BIOL CHEM, V275, P13061, DOI 10.1074/jbc.275.17.13061; Klumpp K, 2006, CURR PHARM DESIGN, V12, P1909, DOI 10.2174/138161206776873653; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Lim D, 2006, J VIROL, V80, P8379, DOI 10.1128/JVI.00750-06; Liu SX, 2008, SCIENCE, V322, P1092, DOI 10.1126/science.1163108; Mandal D, 2006, NUCLEIC ACIDS RES, V34, P2853, DOI 10.1093/nar/gkl360; Nikolenko GN, 2004, J VIROL, V78, P8761, DOI 10.1128/JVI.78.16.8761-8770.2004; Nowotny M, 2007, MOL CELL, V28, P264, DOI 10.1016/j.molcel.2007.08.015; Palaniappan C, 1996, J BIOL CHEM, V271, P2063, DOI 10.1074/jbc.271.47.29605; Paulson BA, 2007, VIROLOGY, V366, P361, DOI 10.1016/j.virol.2007.04.028; PELISKA JA, 1992, SCIENCE, V258, P1112, DOI 10.1126/science.1279806; REPASKE R, 1989, J VIROL, V63, P1460, DOI 10.1128/JVI.63.3.1460-1464.1989; Sarafianos SG, 2001, EMBO J, V20, P1449, DOI 10.1093/emboj/20.6.1449; Schultz SJ, 2008, VIRUS RES, V134, P86, DOI 10.1016/j.virusres.2007.12.007; Schultz SJ, 2000, J BIOL CHEM, V275, P32299, DOI 10.1074/jbc.M000021200; Schultz SJ, 2006, J BIOL CHEM, V281, P1943, DOI 10.1074/jbc.M510504200; Schultz SJ, 2004, J MOL BIOL, V344, P635, DOI 10.1016/j.jmb.2004.09.081; Schultz SJ, 2003, J VIROL, V77, P5275, DOI 10.1128/JVI.77.9.5275-5285.2003; SHINNICK TM, 1981, NATURE, V293, P543, DOI 10.1038/293543a0; TANESE N, 1991, J VIROL, V65, P4387, DOI 10.1128/JVI.65.8.4387-4397.1991; Telesnitsky A, 1993, REVERSE TRANSCRIPTAS; TISDALE M, 1991, J GEN VIROL, V72, P59, DOI 10.1099/0022-1317-72-1-59; Tramontano E, 2006, MINI-REV MED CHEM, V6, P727, DOI 10.2174/138955706777435733; Wisniewski M, 2000, P NATL ACAD SCI USA, V97, P11978, DOI 10.1073/pnas.210392297; Wisniewski M, 2002, J BIOL CHEM, V277, P28400, DOI 10.1074/jbc.M201645200; YU H, 1992, J BIOL CHEM, V267, P10888	55	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32225	32238		10.1074/jbc.M109.043158	http://dx.doi.org/10.1074/jbc.M109.043158			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19778906	Green Published, hybrid			2022-12-27	WOS:000272028400003
J	Sun, Q; Taurin, S; Sethakorn, N; Long, XC; Imamura, M; Wang, DZ; Zimmer, WE; Dulin, NO; Miano, JM				Sun, Qiang; Taurin, Sebastien; Sethakorn, Nan; Long, Xiaochun; Imamura, Masaaki; Wang, Da-Zhi; Zimmer, Warren E.; Dulin, Nickolai O.; Miano, Joseph M.			Myocardin-dependent Activation of the CArG Box-rich Smooth Muscle gamma-Actin Gene PREFERENTIAL UTILIZATION OF A SINGLE CArG ELEMENT THROUGH FUNCTIONAL ASSOCIATION WITH THE NKX3.1 HOMEODOMAIN PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; TINMAN HOMOLOG NKX-2.5; MASTER REGULATOR; EXPRESSION; PROMOTER; DIFFERENTIATION; SEQUENCE; TARGET; TISSUE; CELLS	Serum response factor (SRF) is a ubiquitously expressed transcription factor that binds a 10-bp element known as the CArG box, located in the proximal regulatory region of hundreds of target genes. SRF activates target genes in a cell- and context-dependent manner by assembling unique combinations of cofactors over CArG elements. One particularly strong SRF cofactor, myocardin (MYOCD), acts as a component of a molecular switch for smooth muscle cell (SMC) differentiation by activating cytoskeletal and contractile genes harboring SRF-binding CArG elements. Here we report that the human ACTG2 promoter, containing four conserved CArG elements, displays SMC-specific basal activity and is highly induced in the presence of MYOCD. Stable transfection of a non-SMC cell type with Myocd elicits elevations in endogenous Actg2 mRNA. Gel shift and luciferase assays reveal a strong bias for MYOCD-dependent transactivation through CArG2 of the human ACTG2 promoter. Substitution of CArG2 with other CArGs, including a consensus CArG element, fails to reconstitute full MYOCD-dependent ACTG2 promoter stimulation. Mutation of an adjacent binding site for NKX3.1 reduces MYOCD-dependent transactivation of the ACTG2 promoter. Co-immunoprecipitation, glutathione S-transferase pulldown, and luciferase assays show a physical and functional association between MYOCD and NKX3.1; no such functional relationship is evident with the related NKX2.5 transcription factor despite its interaction with MYOCD. These results demonstrate the ability of MYOCD to discriminate among several juxtaposed CArG elements, presumably through its novel partnership with NKX3.1, to optimally transactivate the human ACTG2 promoter.	[Miano, Joseph M.] Univ Rochester, Sch Med & Dent, Dept Med, Aab Cardiovasc Res Inst, Rochester, NY 14642 USA; [Taurin, Sebastien; Sethakorn, Nan; Dulin, Nickolai O.] Univ Chicago, Sect Pulm & Crit Care, Chicago, IL 60637 USA; [Wang, Da-Zhi] Univ N Carolina, Dept Cell & Dev Biol, Carolina Cardiovasc Biol Ctr, Chapel Hill, NC 27599 USA; [Zimmer, Warren E.] Texas A&M Hlth Sci Ctr, Coll Med, College Stn, TX 77840 USA	University of Rochester; University of Chicago; University of North Carolina; University of North Carolina Chapel Hill; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Miano, JM (corresponding author), Univ Rochester, Sch Med & Dent, Dept Med, Aab Cardiovasc Res Inst, Box CVRI,601 Elmwood Ave, Rochester, NY 14642 USA.	j.m.miano@rochester.edu	Sethakorn, Nan/AAH-7721-2020; Miano, Joseph/L-5634-2018	Sethakorn, Nan/0000-0002-7395-3182; Miano, Joseph/0000-0001-7522-3207; Long, Xiaochun/0000-0001-9714-0023; Taurin, Sebastien/0000-0003-2167-5253; Zimmer, Warren/0000-0002-0668-6096	National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007009] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA095608] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085635, R01HL075251, R01HL091168, R01HL071755, R01HL062572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES009106] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health grants.	Belaguli NS, 1999, MOL CELL BIOL, V19, P4582; Bhatia-Gaur R, 1999, GENE DEV, V13, P966, DOI 10.1101/gad.13.8.966; Bieberich CJ, 1996, J BIOL CHEM, V271, P31779, DOI 10.1074/jbc.271.50.31779; Browning CL, 1998, DEV BIOL, V194, P18, DOI 10.1006/dbio.1997.8808; Carson JA, 2000, J BIOL CHEM, V275, P39061, DOI 10.1074/jbc.M006532200; Cen B, 2003, MOL CELL BIOL, V23, P6597, DOI 10.1128/MCB.23.18.6597-6608.2003; Chen CY, 1997, MOL ENDOCRINOL, V11, P812, DOI 10.1210/me.11.6.812; Chen CY, 1996, DEV GENET, V19, P119, DOI 10.1002/(SICI)1520-6408(1996)19:2<119::AID-DVG3>3.0.CO;2-C; Chen CY, 1996, MOL CELL BIOL, V16, P6372; Chen JY, 2002, J MOL CELL CARDIOL, V34, P1345, DOI 10.1006/jmcc.2002.2086; Chi JT, 2007, PLOS GENET, V3, P1770, DOI 10.1371/journal.pgen.0030164; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Fillmore RA, 2002, GENE EXPRESSION, V10, P201, DOI 10.3727/000000002783992424; GALLAGHER PJ, 1991, J BIOL CHEM, V266, P23945; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Hayashi K, 2006, MOL CELL BIOL, V26, P9456, DOI 10.1128/MCB.00759-06; Hoggatt AM, 2002, CIRC RES, V91, P1151, DOI 10.1161/01.RES.0000047508.30800.4F; Huang JH, 2008, J CLIN INVEST, V118, P515, DOI [10.1172/JC133304, 10.1172/JCI33304]; Kim S, 1997, MOL CELL BIOL, V17, P2266, DOI 10.1128/MCB.17.4.2266; Kovacs AM, 1998, GENE EXPRESSION, V7, P115; LEUNG S, 1989, NUCLEIC ACIDS RES, V17, P1177, DOI 10.1093/nar/17.3.1177; Li L, 1997, DEV BIOL, V187, P311, DOI 10.1006/dbio.1997.8621; Li SJ, 2003, P NATL ACAD SCI USA, V100, P9366, DOI 10.1073/pnas.1233635100; Long XC, 2008, ARTERIOSCL THROM VAS, V28, P1505, DOI 10.1161/ATVBAHA.108.166066; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; MCHUGH KM, 1991, DEV BIOL, V148, P442, DOI 10.1016/0012-1606(91)90263-3; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Miano JM, 2000, J BIOL CHEM, V275, P9814, DOI 10.1074/jbc.275.13.9814; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Milyavsky M, 2007, CANCER CELL, V11, P133, DOI 10.1016/j.ccr.2006.11.022; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pipes GCT, 2005, DEV BIOL, V288, P502, DOI 10.1016/j.ydbio.2005.10.014; Qian J, 1996, DEV DYNAM, V207, P135; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; REECY JM, 1999, HEART DEV, P273; Rensen SSM, 2006, CARDIOVASC RES, V70, P136, DOI 10.1016/j.cardiores.2005.12.018; SAWTELL NM, 1989, J CELL BIOL, V109, P2929, DOI 10.1083/jcb.109.6.2929; Schneider A, 2000, MECH DEVELOP, V95, P163, DOI 10.1016/S0925-4773(00)00355-5; SCHWARTZ RJ, 1981, BIOCHEMISTRY-US, V20, P4122, DOI 10.1021/bi00517a027; Stanfel MN, 2006, GENESIS, V44, P550, DOI 10.1002/dvg.20250; Streb JW, 2005, J BIOL CHEM, V280, P4125, DOI 10.1074/jbc.M412466200; Sun Q, 2006, GENOME RES, V16, P197, DOI 10.1101/gr.4108706; Tanaka M, 1998, DEV GENET, V22, P239, DOI 10.1002/(SICI)1520-6408(1998)22:3<239::AID-DVG6>3.3.CO;2-G; van Eys GJ, 2007, TRENDS CARDIOVAS MED, V17, P26, DOI 10.1016/j.tcm.2006.11.001; VANDEKERCKHOVE J, 1978, J MOL BIOL, V126, P783, DOI 10.1016/0022-2836(78)90020-7; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Zhou JL, 2005, J BIOL CHEM, V280, P10861, DOI 10.1074/jbc.M411586200	49	29	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32582	32590		10.1074/jbc.M109.033910	http://dx.doi.org/10.1074/jbc.M109.033910			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19797053	Green Published, hybrid			2022-12-27	WOS:000272028400040
J	Daire, V; Giustiniani, J; Leroy-Gori, I; Quesnoit, M; Drevensek, S; Dimitrov, A; Perez, F; Pous, C				Daire, Vanessa; Giustiniani, Julien; Leroy-Gori, Ingrid; Quesnoit, Melanie; Drevensek, Stephanie; Dimitrov, Ariane; Perez, Franck; Poues, Christian			Kinesin-1 Regulates Microtubule Dynamics via a c-Jun N-terminal Kinase-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLUS-END; MOTOR PROTEINS; IN-VIVO; PHOSPHORYLATION; BINDING; MOTILITY; GROWTH; INSTABILITY; ASSOCIATION; MODULATION	In the kinesin family, all the molecular motors that have been implicated in the regulation of microtubule dynamics have been shown to stimulate microtubule depolymerization. Here, we report that kinesin-1 (also known as conventional kinesin or KIF5B) stimulates microtubule elongation and rescues. We show that microtubule-associated kinesin-1 carries the c-Jun N-terminal kinase (JNK) to allow its activation and that microtubule elongation requires JNK activity throughout the microtubule life cycle. We also show that kinesin-1 and JNK promoted microtubule rescues to similar extents. Stimulation of microtubule rescues by the kinesin-1/JNK pathway could not be accounted for by the rescue factor CLIP-170. Indeed only a dual inhibition of kinesin-1/JNK and CLIP-170 completely blocked rescues and led to extensive microtubule loss. We propose that the kinesin-1/JNK signaling pathway is a major regulator of microtubule dynamics in living cells and that it is required with the rescue factor CLIP-170 to allow cells to build their interphase microtubule network.	[Poues, Christian] Univ Paris 11, Fac Pharm, JE2493, IFR141, F-92296 Chatenay Malabry, France; [Quesnoit, Melanie; Dimitrov, Ariane; Perez, Franck] CNRS, UMR 144, F-75246 Paris 05, France; [Quesnoit, Melanie; Dimitrov, Ariane; Perez, Franck] Inst Curie, Sect Rech, F-75246 Paris 05, France; [Daire, Vanessa] Univ Paris Sud, Pharm Galen & Biopharm Lab, CNRS, Fac Pharm,IFR141,UMR BioCis 8076, F-92296 Chatenay Malabry, France; [Poues, Christian] Hop Antoine Beclere, AP HP, F-92141 Clamart, France	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP	Pous, C (corresponding author), Univ Paris 11, Fac Pharm, JE2493, IFR141, 5 Rue JB Clement, F-92296 Chatenay Malabry, France.	christian.pous@u-psud.fr	POÜS, Christian/R-5089-2018; Perez, Franck/A-1558-2014	Perez, Franck/0000-0002-9129-9401; POUS, Christian/0000-0002-2502-7854; Giustiniani, Julien/0000-0003-0373-5857	Ministere de la Recherche; Centre National de la Recherche Scientifique; Institut Curie; Ligue Nationale contre le Cancer; Institut de Recherche International Servier	Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut Curie; Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Institut de Recherche International Servier	This work was supported by the Grant ACI-BCMS 338 from the Ministere de la Recherche (to C. P.) by the Centre National de la Recherche Scientifique, and by the Institut Curie (to F. P.) and by a grant from the Ministere de la Recherche (to V. D.), a grant from the Ligue Nationale contre le Cancer (to J.G.), and a grant from the Institut de Recherche International Servier (to M. Q.).	Adio S, 2006, J MUSCLE RES CELL M, V27, P153, DOI 10.1007/s10974-005-9054-1; Akhmanova A, 2005, CURR OPIN CELL BIOL, V17, P47, DOI 10.1016/j.ceb.2004.11.001; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06; CANO E, 1995, J CELL SCI, V108, P3599; Carvalho P, 2003, TRENDS CELL BIOL, V13, P229, DOI 10.1016/S0962-8924(03)00074-6; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DHAMODHARAN R, 1995, J CELL SCI, V108, P1679; Dimitrov A, 2008, SCIENCE, V322, P1353, DOI 10.1126/science.1165401; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Giustiniani J, 2009, CELL SIGNAL, V21, P529, DOI 10.1016/j.cellsig.2008.12.004; Goshima G, 2003, J CELL BIOL, V162, P1003, DOI 10.1083/jcb.200303022; Gupta V, 2008, TRAFFIC, V9, P1850, DOI 10.1111/j.1600-0854.2008.00811.x; HOWARD J, 1993, METHOD CELL BIOL, V39, P137, DOI 10.1016/S0091-679X(08)60167-3; Howard J, 2007, CURR OPIN CELL BIOL, V19, P31, DOI 10.1016/j.ceb.2006.12.009; INGOLD AL, 1988, J CELL BIOL, V107, P2657, DOI 10.1083/jcb.107.6.2657; Inomata H, 2003, J BIOL CHEM, V278, P22946, DOI 10.1074/jbc.M212160200; Komarova YA, 2002, J CELL BIOL, V159, P589, DOI 10.1083/jcb.200208058; Komarova YA, 2002, J CELL SCI, V115, P3527; KOWALSKI RJ, 1993, CELL MOTIL CYTOSKEL, V26, P282, DOI 10.1002/cm.970260403; Krebs A, 2004, J MOL BIOL, V335, P139, DOI 10.1016/j.jmb.2003.10.039; Krylyshkina O, 2002, J CELL BIOL, V156, P349, DOI 10.1083/jcb.200105051; Lansbergen G, 2006, TRAFFIC, V7, P499, DOI 10.1111/j.1600-0854.2006.00400.x; Lee K, 2008, CELL CYCLE, V7, P216, DOI 10.4161/cc.7.2.5155; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; MacCorkle RA, 2004, J BIOL CHEM, V279, P40112, DOI 10.1074/jbc.M405481200; Marceiller J, 2005, EXP CELL RES, V304, P483, DOI 10.1016/j.yexcr.2004.12.007; MARKS DL, 1994, J CELL SCI, V107, P2417; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Mizumura K, 2006, J CELL PHYSIOL, V206, P363, DOI 10.1002/jcp.20465; Moores CA, 2006, J CELL SCI, V119, P3905, DOI 10.1242/jcs.03224; Mouthiers A, 2005, MOL ENDOCRINOL, V19, P1135, DOI 10.1210/me.2004-0188; Muto E, 2005, J CELL BIOL, V168, P691, DOI 10.1083/jcb.200409035; Parsons SF, 1997, CELL MOTIL CYTOSKEL, V36, P1; Phung-Koskas T, 2005, J BIOL CHEM, V280, P1123, DOI 10.1074/jbc.M409918200; RICKARD JE, 1991, J BIOL CHEM, V266, P17597; Rietdorf J, 2001, NAT CELL BIOL, V3, P992, DOI 10.1038/ncb1101-992; Rodionov V, 1999, P NATL ACAD SCI USA, V96, P115, DOI 10.1073/pnas.96.1.115; Tararuk T, 2006, J CELL BIOL, V173, P265, DOI 10.1083/jcb.200511055; Verhey KJ, 2001, TRENDS BIOCHEM SCI, V26, P545, DOI 10.1016/S0968-0004(01)01931-4; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Wu XF, 2006, TRENDS CELL BIOL, V16, P135, DOI 10.1016/j.tcb.2006.01.004; Zhu CJ, 2005, MOL BIOL CELL, V16, P3187, DOI 10.1091/mbc.E05-02-0167	44	41	42	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31992	32001		10.1074/jbc.M109.007906	http://dx.doi.org/10.1074/jbc.M109.007906			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19759393	Green Published, hybrid			2022-12-27	WOS:000271572700055
J	Pletnev, S; Gurskaya, NG; Pletneva, NV; Lukyanov, KA; Chudakov, DM; Martynov, VI; Popov, VO; Kovalchuk, MV; Wlodawer, A; Dauter, Z; Pletnev, V				Pletnev, Sergei; Gurskaya, Nadya G.; Pletneva, Nadya V.; Lukyanov, Konstantin A.; Chudakov, Dmitri M.; Martynov, Vladimir I.; Popov, Vladimir O.; Kovalchuk, Mikhail V.; Wlodawer, Alexander; Dauter, Zbigniew; Pletnev, Vladimir			Structural Basis for Phototoxicity of the Genetically Encoded Photosensitizer KillerRed	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED FLUORESCENT PROTEIN; INTERNAL WATER CHAIN; CRYSTAL-STRUCTURE; ELECTRON-TRANSFER; CHROMOPHORE FORMATION; MONOMERIC RED; CYTOCHROME F; CANCER-CELLS; WHOLE-BODY; PATHWAYS	KillerRed is the only known fluorescent protein that demonstrates notable phototoxicity, exceeding that of the other green and red fluorescent proteins by at least 1,000-fold. KillerRed could serve as an instrument to inactivate target proteins or to kill cell populations in photodynamic therapy. However, the nature of KillerRed phototoxicity has remained unclear, impeding the development of more phototoxic variants. Here we present the results of a high resolution crystallographic study of KillerRed in the active fluorescent and in the photobleached non-fluorescent states. A unique and striking feature of the structure is a water-filled channel reaching the chromophore area from the end cap of the beta-barrel that is probably one of the key structural features responsible for phototoxicity. A study of the structure-function relationship of KillerRed, supported by structure-based, site-directed mutagenesis, has also revealed the key residues most likely responsible for the phototoxic effect. In particular, Glu(68) and Ser(119), located adjacent to the chromophore, have been assigned as the primary trigger of the reaction chain.	[Dauter, Zbigniew] NCI, Synchrotron Radiat Res Sect, Macromol Crystallog Lab, SAIC Frederick Inc, Argonne, IL 60439 USA; [Gurskaya, Nadya G.; Pletneva, Nadya V.; Lukyanov, Konstantin A.; Chudakov, Dmitri M.; Martynov, Vladimir I.; Pletnev, Vladimir] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia; [Popov, Vladimir O.] Russian Acad Sci, AN Bach Inst Biochem, Moscow 117234, Russia; [Kovalchuk, Mikhail V.] Russian Acad Sci, Inst Crystallog, Moscow 119333, Russia; [Wlodawer, Alexander] NCI, Prot Struct Sect, Macromol Crystallog Lab, NIH, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Research Center of Biotechnology RAS; Russian Academy of Sciences; Russian Academy of Sciences; FSRC Crystallography & Photonics RAS; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Pletnev, S (corresponding author), SAIC Frederick Inc, Basic Res Program, Argonne, IL 60439 USA.	svp@ncifcrf.gov	Gurskaya, Nadya G/Q-1750-2016; Chudakov, Dmitriy M/G-7741-2014; Martynov, Vladimir I./S-3483-2016; Pletneva, Nadya/F-7839-2014; Pletnev, Vladimir/Q-6151-2016; Lukyanov, Konstantin A/D-4030-2013	Gurskaya, Nadya G/0000-0002-8028-8176; Chudakov, Dmitriy M/0000-0003-0430-790X; Martynov, Vladimir I./0000-0003-4923-6842; Lukyanov, Konstantin A/0000-0001-9845-2088; Popov, Vladimir/0000-0002-0133-7962; Pletneva, Nadya/0000-0001-9681-4022	National Institutes of Health Intramural Research Program, NCI, Center for Cancer Research; National Institutes of Health, NCI [HHSN2612008000001E]; Russian Foundation for Basic Research [07-04-00054, 08-04-01702-a]; Russian Federal Agency for Science and Innovations [02.513.12.3013]; Molecular and Cell Biology Program RAS; President of the Russian Federation [MD-2780.2009.4]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL CANCER INSTITUTE [ZIABC010348, ZIABC010378] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R24MD002780] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program, NCI, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Federal Agency for Science and Innovations(Federal Agency for Science & Innovations (FASI)); Molecular and Cell Biology Program RAS; President of the Russian Federation; United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program, NCI, Center for Cancer Research and by National Institutes of Health, NCI, Contract HHSN2612008000001E. This project was also supported in part by Russian Foundation for Basic Research Grants 07-04-00054 and 08-04-01702-a; by Russian Federal Agency for Science and Innovations Grant 02.513.12.3013; by the Molecular and Cell Biology Program RAS; and by grants from the President of the Russian Federation (MD-2780.2009.4). Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract W-31-109-Eng-38.	Agmon N, 2005, BIOPHYS J, V88, P2452, DOI 10.1529/biophysj.104.055541; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barondeau DP, 2006, J AM CHEM SOC, V128, P4685, DOI 10.1021/ja056635l; Barondeau DP, 2003, P NATL ACAD SCI USA, V100, P12111, DOI 10.1073/pnas.2133463100; Bisby RH, 1998, BIOCHEM BIOPH RES CO, V244, P263, DOI 10.1006/bbrc.1998.8245; Bulina ME, 2006, NAT PROTOC, V1, P947, DOI 10.1038/nprot.2006.89; Bulina ME, 2006, NAT BIOTECHNOL, V24, P95, DOI 10.1038/nbt1175; Buytaert E, 2007, BBA-REV CANCER, V1776, P86, DOI 10.1016/j.bbcan.2007.07.001; Carpentier P, 2009, FEBS LETT, V583, P2839, DOI 10.1016/j.febslet.2009.07.041; Chudakov DM, 2005, TRENDS BIOTECHNOL, V23, P605, DOI 10.1016/j.tibtech.2005.10.005; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Evdokimov AG, 2006, EMBO REP, V7, P1006, DOI 10.1038/sj.embor.7400787; Gilbert DL, 1999, REACTIVE OXYGEN SPEC, P138; Gurskaya NG, 2001, BMC BIOCHEM, V2, DOI 10.1186/1471-2091-2-6; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hoffman RM, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1992485; Hoffman RM, 2005, CURR TOP DEV BIOL, V70, P121, DOI 10.1016/S0070-2153(05)70006-5; Hoffman RM, 2005, NAT REV CANCER, V5, P796, DOI 10.1038/nrc1717; Krasnovskii AA, 2004, BIOFIZIKA+, V49, P305; Labas YA, 2002, P NATL ACAD SCI USA, V99, P4256, DOI 10.1073/pnas.062552299; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lin JP, 2005, SCIENCE, V310, P1311, DOI 10.1126/science.1118316; Lukyanov KA, 2000, J BIOL CHEM, V275, P25879, DOI 10.1074/jbc.C000338200; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Miyashita O, 2005, P NATL ACAD SCI USA, V102, P3558, DOI 10.1073/pnas.0409600102; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paschenko VZ, 2001, BIOELECTROCHEMISTRY, V53, P233, DOI 10.1016/S0302-4598(01)00098-8; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Petersen J, 2003, J BIOL CHEM, V278, P44626, DOI 10.1074/jbc.M307896200; Pletnev S, 2008, J BIOL CHEM, V283, P28980, DOI 10.1074/jbc.M800599200; Pletneva NV, 2007, RUSS J BIOORG CHEM+, V33, P390, DOI 10.1134/S1068162007040048; Pletneva N, 2007, ACTA CRYSTALLOGR D, V63, P1082, DOI 10.1107/S0907444907042461; Ponamarev MV, 1998, BIOCHEMISTRY-US, V37, P17199, DOI 10.1021/bi981814j; Pouwels LJ, 2008, BIOCHEMISTRY-US, V47, P10111, DOI 10.1021/bi8007164; Remington SJ, 2006, CURR OPIN STRUC BIOL, V16, P714, DOI 10.1016/j.sbi.2006.10.001; ROSENTHAL I, 1995, INT J RADIAT BIOL, V67, P85, DOI 10.1080/09553009514550111; Sainz G, 2000, BIOCHEMISTRY-US, V39, P9164, DOI 10.1021/bi0004596; Schuttrigkeit TA, 2006, CHEM PHYS, V323, P149, DOI 10.1016/j.chemphys.2005.09.039; Seitz G, 2006, J PEDIATR SURG, V41, P1369, DOI 10.1016/j.jpedsurg.2006.04.039; Serebrovskaya EO, 2009, P NATL ACAD SCI USA, V106, P9221, DOI 10.1073/pnas.0904140106; Shaner NC, 2007, J CELL SCI, V120, P4247, DOI 10.1242/jcs.005801; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shcherbo D, 2007, NAT METHODS, V4, P741, DOI 10.1038/NMETH1083; Sniegowski JA, 2005, J BIOL CHEM, V280, P26248, DOI 10.1074/jbc.M412327200; Tubbs JL, 2005, BIOCHEMISTRY-US, V44, P9833, DOI 10.1021/bi0472907; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Verkhusha VV, 2004, NAT BIOTECHNOL, V22, P289, DOI 10.1038/nbt943; Wall MA, 2000, NAT STRUCT BIOL, V7, P1133; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang YT, 2008, J COMMUN NETW-S KOR, V10, P38, DOI 10.1109/JCN.2008.6388326; Wilmann PG, 2005, J MOL BIOL, V349, P223, DOI 10.1016/j.jmb.2005.03.020; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Yanushevich YG, 2002, FEBS LETT, V511, P11, DOI 10.1016/S0014-5793(01)03263-X; Yarbrough D, 2001, P NATL ACAD SCI USA, V98, P462, DOI 10.1073/pnas.98.2.462; ZUBOVA NN, 2005, USP BIOL KHIM, V45, P1	58	103	110	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					32028	32039		10.1074/jbc.M109.054973	http://dx.doi.org/10.1074/jbc.M109.054973			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19737938	Green Published, hybrid			2022-12-27	WOS:000271572700058
J	Bach, C; Gilch, S; Rost, R; Greenwood, AD; Horsch, M; Hajj, GNM; Brodesser, S; Facius, A; Schadler, S; Sandhoff, K; Beckers, J; Leib-Mosch, C; Schatzl, HM; Vorberg, I				Bach, Christian; Gilch, Sabine; Rost, Romina; Greenwood, Alex D.; Horsch, Marion; Hajj, Glaucia N. M.; Brodesser, Susanne; Facius, Axel; Schaedler, Sandra; Sandhoff, Konrad; Beckers, Johannes; Leib-Moesch, Christine; Schaetzl, Hermann M.; Vorberg, Ina			Prion-induced Activation of Cholesterogenic Gene Expression by Srebp2 in Neuronal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEINS; MOLECULAR-BIOLOGY; CELLULAR PRION; SCRAPIE; IDENTIFICATION; BRAINS; LINE; DYSFUNCTION; MICROARRAY; ALZHEIMERS	Prion diseases are neurodegenerative diseases associated with the accumulation of a pathogenic isoform of the host-encoded prion protein. The cellular responses to prion infection are not well defined. By performing microarray analysis on cultured neuronal cells infected with prion strain 22L, in the group of up-regulated genes we observed predominantly genes of the cholesterol pathway. Increased transcript levels of at least nine enzymes involved in cholesterol synthesis, including the gene for the rate-limiting hydroxymethylglutaryl-CoA reductase, were detected. Up-regulation of cholesterogenic genes was attributable to a prion-dependent increase in the amount and activity of the sterol regulatory element-binding protein Srebp2, resulting in elevated levels of total and free cellular cholesterol. The up-regulation of cholesterol biosynthesis appeared to be a characteristic response of neurons to prion challenge, as cholesterogenic transcripts were also elevated in persistently infected GT-1 cells and prion-exposed primary hippocampal neurons but not in microglial cells and primary astrocytes. These results convincingly demonstrate that prion propagation not only depends on the availability of cholesterol but that neuronal cells themselves respond to prions with specific up-regulation of cholesterol biosynthesis.	[Schaetzl, Hermann M.; Vorberg, Ina] Tech Univ Munich, Inst Virol, D-81675 Munich, Germany; [Bach, Christian; Greenwood, Alex D.; Leib-Moesch, Christine] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Virol, D-85764 Neuherberg, Germany; [Horsch, Marion; Schaedler, Sandra; Beckers, Johannes] German Res Ctr Environm & Hlth, Helmholtz Zentrum Munchen, Inst Expt Genet, D-85764 Neuherberg, Germany; [Hajj, Glaucia N. M.] Ludwig Inst Canc Res, BR-01323903 Sao Paulo, Brazil; [Brodesser, Susanne; Sandhoff, Konrad] Univ Bonn, Kekule Inst Organ Chem & Biochem, Membrane Biol & Lipid Biochem Unit, LIMES, D-53121 Bonn, Germany; [Facius, Axel] German Res Ctr Environm & Hlth, Helmholtz Zentrum Munchen, Inst Bioinformat, D-85764 Neuherberg, Germany; [Beckers, Johannes] Tech Univ Munich, Inst Expt Genet, D-85350 Freising Weihenstephan, Germany; [Leib-Moesch, Christine] Heidelberg Univ, Med Fac Mannheim, Med Clin 3, D-68135 Mannheim, Germany	Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Ludwig Institute for Cancer Research; University of Bonn; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Ruprecht Karls University Heidelberg	Schatzl, HM (corresponding author), Tech Univ Munich, Inst Virol, Trogerstr 30, D-81675 Munich, Germany.	schaetzl@lrz.tum.de; vorberg@virologie.med.tum.de	Beckers, Johannes/K-7237-2012; Greenwood, Alex/GWU-8292-2022; Neurociencia, Inct/I-1011-2013; Hajj, Glaucia N M/I-8176-2015; Schatzl, Hermann/G-4958-2011	Beckers, Johannes/0000-0001-7874-3822; Hajj, Glaucia N M/0000-0003-2342-7384; Schatzl, Hermann/0000-0003-4972-8740	Deutsche Forschungsgemeinschaft [VO 1277/1-2, SFB 596]; Bayerischer Forschungsverbund FORPRION [TUM 7]; European Commission [TSEUR LSHB-CT-2005-018805]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bayerischer Forschungsverbund FORPRION; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by Deutsche Forschungsgemeinschaft Grants VO 1277/1-2, SFB 596 (Projects A8 and B14), by Bayerischer Forschungsverbund FORPRION (TUM 7), and by the European Commission Grant TSEUR LSHB-CT-2005-018805. This study was performed within the framework of EU FP6 Network of Excellence Neuroprion.	Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; Baker CA, 2003, P NATL ACAD SCI USA, V100, P675, DOI 10.1073/pnas.0237313100; Bate C, 2004, J BIOL CHEM, V279, P14983, DOI 10.1074/jbc.M313061200; Bate C, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-8; Booth S, 2004, J GEN VIROL, V85, P3459, DOI 10.1099/vir.0.80110-0; Brown AR, 2005, BIOCHEM BIOPH RES CO, V334, P86, DOI 10.1016/j.bbrc.2005.06.060; Bubner B, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-14; Budka H, 2003, BRIT MED BULL, V66, P121, DOI 10.1093/bmb/66.1.121; Burns M, 2002, ANN NY ACAD SCI, V977, P367, DOI 10.1111/j.1749-6632.2002.tb04839.x; Cronier S, 2004, P NATL ACAD SCI USA, V101, P12271, DOI 10.1073/pnas.0402725101; Cronier S, 2007, J VIROL, V81, P13794, DOI 10.1128/JVI.01502-07; DOHURA K, 1995, MICROB PATHOGENESIS, V18, P1, DOI 10.1016/S0882-4010(05)80008-7; Dooley KA, 1998, J BIOL CHEM, V273, P1349, DOI 10.1074/jbc.273.3.1349; Ertmer A, 2004, J BIOL CHEM, V279, P41918, DOI 10.1074/jbc.M405652200; Gilch S, 2006, MOL CELL NEUROSCI, V31, P346, DOI 10.1016/j.mcn.2005.10.008; Gilch S, 2007, FEBS J, V274, P5834, DOI 10.1111/j.1742-4658.2007.06105.x; Greenwood AD, 2005, J MOL BIOL, V349, P487, DOI 10.1016/j.jmb.2005.03.076; Horsch M, 2008, PROTEOMICS, V8, P1248, DOI 10.1002/pmic.200700725; Horton JD, 1999, CURR OPIN LIPIDOL, V10, P143, DOI 10.1097/00041433-199904000-00008; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Hwang D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.10; Julius C, 2008, J MOL BIOL, V375, P1222, DOI 10.1016/j.jmb.2007.11.003; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P2333, DOI 10.1073/pnas.94.6.2333; Kempster S, 2007, NEUROREPORT, V18, P479, DOI 10.1097/WNR.0b013e328058678d; Klingenstein R, 2006, J NEUROCHEM, V98, P748, DOI 10.1111/j.1471-4159.2006.03889.x; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Koh CHV, 2007, J CELL PHYSIOL, V211, P63, DOI 10.1002/jcp.20912; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopes MH, 2005, J NEUROSCI, V25, P11330, DOI 10.1523/JNEUROSCI.2313-05.2005; Maas E, 2007, J BIOL CHEM, V282, P18702, DOI 10.1074/jbc.M701309200; Mange A, 2000, J VIROL, V74, P3135, DOI 10.1128/JVI.74.7.3135-3140.2000; Marijanovic Z, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000426; Mok SWF, 2006, BIOCHEM BIOPH RES CO, V348, P697, DOI 10.1016/j.bbrc.2006.07.123; MOMOI T, 1976, BIOCHIM BIOPHYS ACTA, V441, P488; Ntambi JM, 2004, PROG LIPID RES, V43, P91, DOI 10.1016/S0163-7827(03)00039-0; Nunziante M, 2003, CHEMBIOCHEM, V4, P1268, DOI 10.1002/cbic.200300704; Ohm TG, 2003, PHARMACOPSYCHIATRY, V36, pS120; Priller J, 2006, J NEUROSCI, V26, P11753, DOI 10.1523/JNEUROSCI.2275-06.2006; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Riemer C, 2000, J VIROL, V74, P10245, DOI 10.1128/JVI.74.21.10245-10248.2000; Riemer C, 2004, BIOCHEM BIOPH RES CO, V323, P556, DOI 10.1016/j.bbrc.2004.08.124; Sakakura Y, 2001, BIOCHEM BIOPH RES CO, V286, P176, DOI 10.1006/bbrc.2001.5375; Sato R, 1996, J BIOL CHEM, V271, P26461, DOI 10.1074/jbc.271.43.26461; Schatzl HM, 1997, J VIROL, V71, P8821; Skinner PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-114; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sorensen G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-114; Tang Y, 2009, J VIROL, V83, P9464, DOI 10.1128/JVI.00352-09; TARABOULOS A, 1995, J CELL BIOL, V129, P121, DOI 10.1083/jcb.129.1.121; Turley SD, 1996, J LIPID RES, V37, P1953; Turley SD, 1998, AM J PHYSIOL-ENDOC M, V274, pE1099, DOI 10.1152/ajpendo.1998.274.6.E1099; Valenza M, 2005, J NEUROSCI, V25, P9932, DOI 10.1523/JNEUROSCI.3355-05.2005; Valenza M, 2006, PROG NEUROBIOL, V80, P165, DOI 10.1016/j.pneurobio.2006.09.005; Vey M, 1996, P NATL ACAD SCI USA, V93, P14945, DOI 10.1073/pnas.93.25.14945; Vorberg I, 2004, J INFECT DIS, V189, P431, DOI 10.1086/381166; Wadsworth JD, 2003, BRIT MED BULL, V66, P241, DOI 10.1093/bmb/66.1.241; WILLIAMS MA, 1980, J NEUROCHEM, V35, P266, DOI 10.1111/j.1471-4159.1980.tb12515.x; Xiang W, 2004, J VIROL, V78, P11051, DOI 10.1128/JVI.78.20.11051-11060.2004; Xiang W, 2007, J NEUROCHEM, V102, P834, DOI 10.1111/j.1471-4159.2007.04566.x; YAO JK, 1985, ANAL BIOCHEM, V150, P111, DOI 10.1016/0003-2697(85)90447-6	61	29	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31260	31269		10.1074/jbc.M109.004382	http://dx.doi.org/10.1074/jbc.M109.004382			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19748890	Green Published, hybrid			2022-12-27	WOS:000271378400053
J	Fusca, T; Bonza, MC; Luoni, L; Meneghelli, S; Marrano, CA; De Michelis, MI				Fusca, Tiziana; Bonza, Maria Cristina; Luoni, Laura; Meneghelli, Silvia; Marrano, Claudia Adriana; De Michelis, Maria Ida			Single Point Mutations in the Small Cytoplasmic Loop of ACA8, a Plasma Membrane Ca2+-ATPase of Arabidopsis thaliana, Generate Partially Deregulated Pumps	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-PUMP; CA2+ PUMP; H+-ATPASE; BINDING SITE; CA-2+ PUMP; DOMAIN; ACTIVATION; AUTOINHIBITION; INTERACTS; CONTAINS	ACA8 is a type 2B Ca2+-ATPase having a regulatory N terminus whose auto-inhibitory action can be suppressed by binding of calmodulin (CaM) or of acidic phospholipids. ACA8 N terminus is able to interact with a region of the small cytoplasmic loop connecting transmembrane domains 2 and 3. To determine the role of this interaction in auto-inhibition we analyzed single point mutants produced by mutagenesis of ACA8 Glu(252) to Asn(345) sequence. Mutation to Ala of any of six tested acidic residues (Glu(252), Asp(273), Asp(291), Asp(303), Glu(302), or Asp(332)) renders an enzyme that is less dependent on CaM for activity. These results highlight the relevance in ACA8 auto-inhibition of a negative charge of the surface area of the small cytoplasmic loop. The most deregulated of these mutants is D291A ACA8, which is less activated by controlled proteolysis or by acidic phospholipids; the D291A mutant has an apparent affinity for CaM higher than wildtype ACA8. Moreover, its phenotype is stronger than that of D291NACA8, suggesting a more direct involvement of this residue in the mechanism of auto-inhibition. Among the other produced mutants (I284A, N286A, P289A, P322A, V344A, and N345A), only P322A ACA8 is less dependent on CaM for activity than the wild type. The results reported in this study provide the first evidence that the small cytoplasmic loop of a type 2B Ca2+-ATPase plays a role in the attainment of the auto-inhibited state.	[Fusca, Tiziana; Bonza, Maria Cristina; Luoni, Laura; Meneghelli, Silvia; Marrano, Claudia Adriana; De Michelis, Maria Ida] Univ Milan, Dipartimento Biol L Gorini, Ist Biofis Consiglio Nazl Ric, Sez Milano, I-20133 Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); University of Milan	De Michelis, MI (corresponding author), Univ Milan, Dipartimento Biol L Gorini, Ist Biofis Consiglio Nazl Ric, Sez Milano, Via G Celoria 26, I-20133 Milan, Italy.	mariaida.demichelis@unimi.it	Bonza, Maria Cristina/B-1351-2017; De Michelis, Maria/A-7151-2011	Bonza, Maria Cristina/0000-0001-7096-2967; De Michelis, Maria/0000-0001-7684-9252; Luoni, Laura/0000-0002-6485-5417; MARRANO, Claudia Adriana/0000-0001-9525-6444	Italian Ministry for Instruction, University; Research in the PRIN 2005 and PRIN 2007 frames	Italian Ministry for Instruction, University; Research in the PRIN 2005 and PRIN 2007 frames(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This work was supported by the Italian Ministry for Instruction, University, and Research in the PRIN 2005 and PRIN 2007 frames.	Anthonisen AN, 2006, J BIOL CHEM, V281, P31572, DOI 10.1074/jbc.M605194200; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Baekgaard L, 2005, J BIOENERG BIOMEMBR, V37, P369, DOI 10.1007/s10863-005-9473-0; Baekgaard L, 2006, J BIOL CHEM, V281, P1058, DOI 10.1074/jbc.M508299200; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bonza C, 1998, PLANT PHYSIOL, V116, P845, DOI 10.1104/pp.116.2.845; Bonza MC, 2000, PLANT PHYSIOL, V123, P1495, DOI 10.1104/pp.123.4.1495; Bonza MC, 2004, PLANTA, V218, P814, DOI 10.1007/s00425-003-1160-y; Bonza MC, 2001, PHYSIOL PLANTARUM, V112, P315, DOI 10.1034/j.1399-3054.2001.1120303.x; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Bredeston LM, 2004, J BIOL CHEM, V279, P41619, DOI 10.1074/jbc.M403116200; CARAFOLI E, 1991, PHYSIOL REV, V71, P129, DOI 10.1152/physrev.1991.71.1.129; CHIESI M, 1991, BIOCHEMISTRY-US, V30, P7978, DOI 10.1021/bi00246a015; Clausen JD, 2004, P NATL ACAD SCI USA, V101, P2776, DOI 10.1073/pnas.0400122101; Corradi GR, 2007, J BIOL CHEM, V282, P35440, DOI 10.1074/jbc.M703377200; CUNNINGHAM KW, 1994, J CELL BIOL, V124, P351, DOI 10.1083/jcb.124.3.351; Curran AC, 2000, J BIOL CHEM, V275, P30301, DOI 10.1074/jbc.M002047200; DEMICHELIS MI, 1993, BOT ACTA, V106, P20, DOI 10.1111/j.1438-8677.1993.tb00333.x; Di Leva F, 2008, ARCH BIOCHEM BIOPHYS, V476, P65, DOI 10.1016/j.abb.2008.02.026; FALCHETTO R, 1992, PROTEIN SCI, V1, P1613, DOI 10.1002/pro.5560011209; FALCHETTO R, 1991, J BIOL CHEM, V266, P2930; Geisler M, 2000, BBA-BIOMEMBRANES, V1465, P52, DOI 10.1016/S0005-2736(00)00131-0; Hetherington AM, 2004, ANNU REV PLANT BIOL, V55, P401, DOI 10.1146/annurev.arplant.55.031903.141624; Hwang I, 2000, PLANT PHYSIOL, V122, P157, DOI 10.1104/pp.122.1.157; Jensen AML, 2006, EMBO J, V25, P2305, DOI 10.1038/sj.emboj.7601135; Luoni L, 2006, PHYSIOL PLANTARUM, V126, P175, DOI 10.1111/j.1399-3054.2006.00588.x; Luoni L, 2004, FEBS LETT, V574, P20, DOI 10.1016/j.febslet.2004.08.003; Mangialavori I, 2009, J BIOL CHEM, V284, P4823, DOI 10.1074/jbc.M806912200; Meneghelli S, 2008, MOL MEMBR BIOL, V25, P539, DOI 10.1080/09687680802508747; Meneghelli S, 2008, J BIOCHEM, V143, P253, DOI 10.1093/jb/mvm218; Morsomme P, 1996, EMBO J, V15, P5513, DOI 10.1002/j.1460-2075.1996.tb00936.x; Morsomme P, 1998, J BIOL CHEM, V273, P34837, DOI 10.1074/jbc.273.52.34837; Palmgren MG, 2001, ANNU REV PLANT PHYS, V52, P817, DOI 10.1146/annurev.arplant.52.1.817; RASICALDOGNO F, 1995, PLANT PHYSIOL, V108, P105, DOI 10.1104/pp.108.1.105; RASICALDOGNOV F, 1993, PLANT PHYSIOL, V103, P391, DOI 10.1104/pp.103.2.391; Sanders D, 2002, PLANT CELL, V14, pS401, DOI 10.1105/tpc.002899	37	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30881	30888		10.1074/jbc.M109.006148	http://dx.doi.org/10.1074/jbc.M109.006148			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19740735	Green Published, hybrid			2022-12-27	WOS:000271378400016
J	Hoshiba, T; Kawazoe, N; Tateishi, T; Chen, GP				Hoshiba, Takashi; Kawazoe, Naoki; Tateishi, Tetsuya; Chen, Guoping			Development of Stepwise Osteogenesis-mimicking Matrices for the Regulation of Mesenchymal Stem Cell Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MARROW STROMAL CELLS; BONE MORPHOGENETIC PROTEIN-2; ACTIVATED RECEPTOR-GAMMA; GROWTH-FACTOR-BETA; EXTRACELLULAR-MATRIX; IN-VITRO; GENE-EXPRESSION; OSTEOBLASTIC DIFFERENTIATION; BIGLYCAN; DECORIN	An extracellular microenvironment, including an extracellular matrix (ECM), is an important factor in regulating stem cell differentiation. During tissue development, the ECM is dynamically remodeled to regulate stem cell functions. Here, we developed matrices mimicking ECM remodeling during the osteogenesis of mesenchymal stem cells (MSCs). The matrices were prepared from cultured MSCs controlled at different stages of osteogenesis and referred to as "stepwise osteogenesis-mimicking matrices." The matrices supported the adhesion and proliferation of MSCs and showed different effects on the osteogenesis of MSCs. On the matrices mimicking the early stage of osteogenesis (early stage matrices), the osteogenesis occurred more rapidly than did that on the matrices mimicking undifferentiated stem cells (stem cell matrices) and the late stage of osteogenesis (late stage matrices). RUNX2 was similarly expressed when MSCs were cultured on both the early stage and late stage matrices but decreased on the stem cell matrices. PPARG expression in the MSCs cultured on the late stage matrices was higher than for those cultured on the stem cell and early stage matrices. This increase of PPARG expression was caused by the suppression of the amount of beta-catenin and downstream signal transduction. These results demonstrate that the osteogenesis-mimicking matrices had different effects on the osteogenesis of MSCs, and the early stage matrices provided a favorable microenvironment for the osteogenesis.	[Kawazoe, Naoki; Chen, Guoping] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton, Tsukuba, Ibaraki 3050044, Japan; Natl Inst Mat Sci, Ctr Biomat, Tsukuba, Ibaraki 3050044, Japan	National Institute for Materials Science; National Institute for Materials Science	Chen, GP (corresponding author), Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.	Guoping.Chen@nims.go.jp	Chen, Guoping/H-2593-2011	Chen, Guoping/0000-0001-6753-3678	World Premier International Research Center Initiative on Materials Nanoarchitectonics; Grant-in-Aid for Young Scientists [20800073]; Ministry of Education, Culture, Sports, Science and Technology, Japan [21-10589]; New Energy and Industrial Technology Development Organization of Japan	World Premier International Research Center Initiative on Materials Nanoarchitectonics; Grant-in-Aid for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization of Japan(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported in part by World Premier International Research Center Initiative on Materials Nanoarchitectonics and Grant-in-Aid for Young Scientists (Start-up) 20800073; Japan Society for the Promotion of Science Fellowship 21-10589 from the Ministry of Education, Culture, Sports, Science and Technology, Japan; and the New Energy and Industrial Technology Development Organization of Japan.	Abe E, 2000, J BONE MINER RES, V15, P663, DOI 10.1359/jbmr.2000.15.4.663; Adachi E, 1997, INT REV CYTOL, V173, P73; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Chen XD, 2002, J BONE MINER RES, V17, P331, DOI 10.1359/jbmr.2002.17.2.331; Chen XD, 2007, J BONE MINER RES, V22, P1943, DOI 10.1359/JBMR.070725; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064; Dallas SL, 2002, J BIOL CHEM, V277, P21352, DOI 10.1074/jbc.M111663200; Datta N, 2006, P NATL ACAD SCI USA, V103, P2488, DOI 10.1073/pnas.0505661103; Datta N, 2005, BIOMATERIALS, V26, P971, DOI 10.1016/j.biomaterials.2004.04.001; DUEY P, 1997, CELL, V89, P747; Gendron C, 2007, J BIOL CHEM, V282, P18294, DOI 10.1074/jbc.M701523200; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; Gutierrez J, 2006, J CELL PHYSIOL, V206, P58, DOI 10.1002/jcp.20428; Hocking AM, 1998, MATRIX BIOL, V17, P1; Jeon MJ, 2003, J BIOL CHEM, V278, P23270, DOI 10.1074/jbc.M211610200; Kamiya N, 2001, J Oral Sci, V43, P179; Kang S, 2007, J BIOL CHEM, V282, P14515, DOI 10.1074/jbc.M700030200; Kanzler B, 1998, DEVELOPMENT, V125, P2587; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Lehr HA, 1997, J HISTOCHEM CYTOCHEM, V45, P1559, DOI 10.1177/002215549704501112; Lian JB, 2006, REV ENDOCR METAB DIS, V7, P1, DOI 10.1007/s11154-006-9001-5; Liu GZ, 2009, J CELL BIOL, V185, P67, DOI 10.1083/jcb.200810137; MALAVAL L, 1994, J CELL PHYSIOL, V158, P555, DOI 10.1002/jcp.1041580322; Martin I, 2001, OSTEOARTHR CARTILAGE, V9, P112, DOI 10.1053/joca.2000.0366; Moreno M, 2005, EMBO J, V24, P1397, DOI 10.1038/sj.emboj.7600615; Moursi AM, 1996, J CELL SCI, V109, P1369; Nakamura M, 2005, J HISTOCHEM CYTOCHEM, V53, P1553, DOI 10.1369/jhc.5A6669.2005; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022; Okamura M, 2009, P NATL ACAD SCI USA, V106, P5819, DOI 10.1073/pnas.0901676106; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Park CH, 2005, BIOCHEM BIOPH RES CO, V328, P227, DOI 10.1016/j.bbrc.2004.12.151; Pham QP, 2008, BIOMATERIALS, V29, P2729, DOI 10.1016/j.biomaterials.2008.02.025; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Reichsman F, 1996, J CELL BIOL, V135, P819, DOI 10.1083/jcb.135.3.819; Riquelme C, 2001, J BIOL CHEM, V276, P3589, DOI 10.1074/jbc.M004602200; Santra M, 2002, J BIOL CHEM, V277, P35671, DOI 10.1074/jbc.M205317200; Sasano Y, 2000, HISTOCHEM J, V32, P591, DOI 10.1023/A:1026720003564; Schaefer JF, 2003, OSTEOARTHR CARTILAGE, V11, P233, DOI 10.1016/S1063-4584(02)00354-0; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; Suzawa M, 1999, ENDOCRINOLOGY, V140, P2125, DOI 10.1210/en.140.5.2125; Takeuchi T, 2008, TISSUE ENG PT A, V14, P267, DOI 10.1089/tea.2007.0188; Xu TS, 1998, NAT GENET, V20, P78, DOI 10.1038/1746	45	98	99	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31164	31173		10.1074/jbc.M109.054676	http://dx.doi.org/10.1074/jbc.M109.054676			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19762920	Green Published, hybrid			2022-12-27	WOS:000271378400044
J	Sahoo, SK; Kim, T; Kang, GB; Lee, JG; Eom, SH; Kim, DH				Sahoo, Sanjaya Kumar; Kim, Taeyong; Kang, Gil Bu; Lee, Jung-Gyu; Eom, Soo Hyun; Kim, Do Han			Characterization of Calumenin-SERCA2 Interaction in Mouse Cardiac Sarcoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ TRANSPORT ATPASE; HISTIDINE-RICH; CA2+-BINDING PROTEIN; RYANODINE RECEPTOR; CA2+-ATPASE SERCA; BINDING-PROTEIN; LUMINAL CALCIUM; PHOSPHOLAMBAN; ISOFORMS; CONTRACTILITY	Calumenin is a multiple EF-hand Ca2+-binding protein localized in the sarcoplasmic reticulum (SR) with C-terminal SR retention signal HDEF. Recently, we showed evidence that calumenin interacts with SERCA2 in rat cardiac SR (Sahoo, S. K., and Kim, D. H. (2008) Mol. Cells 26, 265-269). The present study was undertaken to further characterize the association of calumenin with SERCA2 in mouse heart by various gene manipulation approaches. Immunocytochemical analysis showed that calumenin and SERCA2 were partially co-localized in HL-1 cells. Knockdown (KD) of calumenin was conducted in HL-1 cells and 80% reduction of calumenin did not induce any expressional changes of other Ca2+-cycling proteins. But it enhanced Ca2+ transient amplitude and showed shortened time to reach peak and decreased time to reach 50% of baseline. Oxalate-supported Ca2+ uptake showed increased Ca2+ sensitivity of SERCA2 in calumenin KD HL-1 cells. Calumenin and SERCA2 interaction was significantly lower in the presence of thapsigargin, vanadate, or ATP, as compared with 1.3 mu M Ca2+, suggesting that the interaction is favored in the E1 state of SERCA2. A glutathione S-transferase-pulldown assay of calumenin deletion fragments and SERCA2 luminal domains suggested that regions of 132-222 amino acids of calumenin and 853-892 amino acids of SERCA2-L4 are the major binding partners. On the basis of our in vitro binding data and available information on three-dimensional structure of Ca2+-ATPases, a molecular model was proposed for the interaction between calumenin and SERCA2. Taken together, the present results suggest that calumenin is a novel regulator of SERCA2, and its expressional changes are tightly coupled with Ca2+-cycling of cardiomyocytes.	Gwangju Inst Sci & Technol, Dept Life Sci, Kwangju 500712, South Korea; Gwangju Inst Sci & Technol, Syst Biol Res Ctr, Kwangju 500712, South Korea	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST)	Kim, DH (corresponding author), 261 Cheomdan Gwagiro Oryong Dong, Kwangju 500712, South Korea.	dhkim@gist.ac.kr		Kim, Taeyong/0000-0002-4147-3635	Korea Ministry of Science and Technology Systems Biology Research [M1050301001-6N0301-0110]; Brain Korea 21; Gwangju Institute of Science and Technology Systems Biology Infrastructure Establishment	Korea Ministry of Science and Technology Systems Biology Research; Brain Korea 21(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); Gwangju Institute of Science and Technology Systems Biology Infrastructure Establishment	This work was supported by Korea Ministry of Science and Technology Systems Biology Research Grant M1050301001-6N0301-0110, Brain Korea 21 Project, and the Gwangju Institute of Science and Technology Systems Biology Infrastructure Establishment Grant (2009).	Arvanitis DA, 2007, AM J PHYSIOL-HEART C, V293, pH1581, DOI 10.1152/ajpheart.00278.2007; Asahi M, 2000, J BIOL CHEM, V275, P15034, DOI 10.1074/jbc.275.20.15034; Asahi M, 2003, TRENDS CARDIOVAS MED, V13, P152, DOI 10.1016/S1050-1738(03)00037-9; Asahi M, 2003, P NATL ACAD SCI USA, V100, P5040, DOI 10.1073/pnas.0330962100; Babu GJ, 2006, J BIOL CHEM, V281, P3972, DOI 10.1074/jbc.M508998200; BASSANI JWM, 1995, AM J PHYSIOL-CELL PH, V268, pC1313, DOI 10.1152/ajpcell.1995.268.5.C1313; Bluhm WF, 2000, AM J PHYSIOL-HEART C, V278, pH249, DOI 10.1152/ajpheart.2000.278.1.H249; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CAMPBELL AM, 1991, J BIOL CHEM, V266, P16050; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Daiho T, 2001, J BIOL CHEM, V276, P32771, DOI 10.1074/jbc.M101229200; Dode L, 2003, J BIOL CHEM, V278, P47877, DOI 10.1074/jbc.M306784200; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Dremina ES, 2004, BIOCHEM J, V383, P361, DOI 10.1042/BJ20040187; Fan GC, 2004, AM J PHYSIOL-HEART C, V287, pH1705, DOI 10.1152/ajpheart.01211.2003; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; Frank KF, 2003, CARDIOVASC RES, V57, P20, DOI 10.1016/S0008-6363(02)00694-6; Gregory KN, 2006, J MOL CELL CARDIOL, V40, P653, DOI 10.1016/j.yjmcc.2006.02.003; Gyorke S, 2008, CARDIOVASC RES, V77, P245, DOI 10.1093/cvr/cvm038; Gyorke I, 2004, BIOPHYS J, V86, P2121, DOI 10.1016/S0006-3495(04)74271-X; Hasenfuss G, 2002, J MOL CELL CARDIOL, V34, P951, DOI 10.1006/jmcc.2002.2037; Ihara Y, 2005, BIOCHEM BIOPH RES CO, V329, P1343, DOI 10.1016/j.bbrc.2005.02.112; John LM, 1998, J CELL BIOL, V142, P963, DOI 10.1083/jcb.142.4.963; Jung DH, 2006, BIOCHEM BIOPH RES CO, V343, P34, DOI 10.1016/j.bbrc.2006.02.115; Jung DH, 2004, GENE, V327, P185, DOI 10.1016/j.gene.2003.10.014; Koss KL, 1996, CIRC RES, V79, P1059, DOI 10.1161/01.RES.79.6.1059; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee HG, 2001, J BIOL CHEM, V276, P39533, DOI 10.1074/jbc.M010664200; Li Y, 2004, J CELL BIOL, V164, P35, DOI 10.1083/jcb.200307010; MACLENNAN DH, 1971, P NATL ACAD SCI USA, V68, P1231, DOI 10.1073/pnas.68.6.1231; MAHANEY JE, 1995, BIOCHEMISTRY-US, V34, P4864, DOI 10.1021/bi00014a044; Most P, 2004, J CLIN INVEST, V114, P1550, DOI 10.1172/JCI200421454; Mueller B, 2004, BIOCHEMISTRY-US, V43, P12846, DOI 10.1021/bi0489457; Papp S, 2008, OPEN CARDIOVASC MED, V2, P31, DOI 10.2174/1874192400802010031; Periasamy M, 2001, J MOL CELL CARDIOL, V33, P1053, DOI 10.1006/jmcc.2001.1366; PICK U, 1982, J BIOL CHEM, V257, P6111; Ramesh V, 2001, J BIOCHEM MOL BIOL, V34, P573; SAGARA Y, 1991, J BIOL CHEM, V266, P13503; Sahoo SK, 2008, MOL CELLS, V26, P265; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shimura M, 2008, CARDIOVASC RES, V77, P362, DOI 10.1093/cvr/cvm019; Terracciano CMN, 1998, J PHYSIOL-LONDON, V512, P651, DOI 10.1111/j.1469-7793.1998.651bd.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2003, P NATL ACAD SCI USA, V100, P467, DOI 10.1073/pnas.0237326100; Vangheluwe P, 2003, CELL CALCIUM, V34, P457, DOI 10.1016/S0143-4160(03)00126-X; VATIADAKI E, 2009, MOL BIOL CELL, V20, P306; Vorum H, 1998, BBA-PROTEIN STRUCT M, V1386, P121, DOI 10.1016/S0167-4838(98)00089-2; Watanabe A, 2004, J MOL CELL CARDIOL, V37, P691, DOI 10.1016/j.yjmcc.2004.06.009; Wehrens XHT, 2005, ANNU REV PHYSIOL, V67, P69, DOI 10.1146/annurev.physiol.67.040403.114521; White SM, 2004, AM J PHYSIOL-HEART C, V286, pH823, DOI 10.1152/ajpheart.00986.2003; Yabe D, 1997, J BIOL CHEM, V272, P18232, DOI 10.1074/jbc.272.29.18232	53	43	49	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31109	31121		10.1074/jbc.M109.031989	http://dx.doi.org/10.1074/jbc.M109.031989			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19740751	Green Published, hybrid			2022-12-27	WOS:000271378400039
J	Askew, EB; Bai, SX; Hnat, AT; Minges, JT; Wilson, EM				Askew, Emily B.; Bai, Suxia; Hnat, Andrew T.; Minges, John T.; Wilson, Elizabeth M.			Melanoma Antigen Gene Protein-A11 (MAGE-11) F-box Links the Androgen Receptor NH2-terminal Transactivation Domain to p160 Coactivators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECURRENT PROSTATE-CANCER; EPIDERMAL-GROWTH-FACTOR; MESSENGER-RIBONUCLEIC-ACID; COOH-TERMINAL INTERACTION; LIGAND-BINDING DOMAIN; ACTIVATION FUNCTION 2; SCF UBIQUITIN LIGASE; NUCLEAR RECEPTOR; STEROID-RECEPTOR; PHOSPHORYLATION SITES	Androgen-dependent transcriptional activity by the androgen receptor (AR) and its coregulators is required for male reproductive development and function. In humans and other primates, melanoma antigen gene protein-A11 (MAGE-11) is an AR selective coregulator that increases AR transcriptional activity. Here we show that the interaction between AR and MAGE-11 is mediated by AR NH2-terminal FXXLF motif binding to a highly conserved MAGE-11 F-box in the MAGE homology domain, and is modulated by serum stimulation of mitogen-activated protein kinase phosphorylation of MAGE-11 Ser-174. The MAGE-11-dependent increase in AR transcriptional activity is mediated by a direct interaction between MAGE-11 and transcriptional intermediary factor 2 (TIF2) through the NH2-terminal region of TIF2, and by a MAGE-11 FXXIF motif interaction with an F-box-like region in activation domain 1 of TIF2. The results suggest that MAGE-11 functions as a bridging factor to recruit AR coactivators through a novel FXX(L/I) F motif-F-box interaction paradigm.	[Askew, Emily B.; Bai, Suxia; Hnat, Andrew T.; Minges, John T.; Wilson, Elizabeth M.] Univ N Carolina, Labs Reprod Biol, Chapel Hill, NC 27599 USA; [Askew, Emily B.; Wilson, Elizabeth M.] Univ N Carolina, Curriculum Toxicol, Chapel Hill, NC 27599 USA; [Askew, Emily B.; Bai, Suxia; Hnat, Andrew T.; Minges, John T.; Wilson, Elizabeth M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Bai, Suxia; Hnat, Andrew T.; Minges, John T.; Wilson, Elizabeth M.] Univ N Carolina, Dept Pediat, Chapel Hill, NC 27599 USA; [Wilson, Elizabeth M.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Wilson, EM (corresponding author), Univ N Carolina, Labs Reprod Biol, CB7500, Chapel Hill, NC 27599 USA.	emw@med.unc.edu	Askew, Eldon W/F-5347-2014		National Institutes of Health United States Public Health Service [HD16910]; NICHD [P01-CA77739]; NCI, a United States Department of Defense [PC073586]; National Institutes of Health Eunice Kennedy Shriver [U54-HD35041]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD016910, R37HD016910, U54HD035041] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA077739] Funding Source: NIH RePORTER	National Institutes of Health United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NCI, a United States Department of Defense(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health Eunice Kennedy Shriver(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health United States Public Health Service Grants HD16910 from the NICHD and P01-CA77739 from the NCI, a United States Department of Defense PC073586 Fellowship Award, National Institutes of Health Eunice Kennedy Shriver cooperative Agreement U54-HD35041 as part of the Specialized Cooperative Centers Program in Reproduction, and Infertility Research from the NICHD.	Agoulnik IU, 2008, MOL ENDOCRINOL, V22, P2420, DOI 10.1210/me.2007-0481; Agoulnik IU, 2006, CANCER RES, V66, P10594, DOI 10.1158/0008-5472.CAN-06-1023; Archer CT, 2008, J BIOL CHEM, V283, P21789, DOI 10.1074/jbc.M803075200; Askew EB, 2007, J BIOL CHEM, V282, P25801, DOI 10.1074/jbc.M703268200; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Bai S, 2008, MOL HUM REPROD, V14, P107, DOI 10.1093/molehr/gam080; Bai S, 2008, MOL CELL BIOL, V28, P1947, DOI 10.1128/MCB.01672-07; Bai SX, 2005, MOL CELL BIOL, V25, P1238, DOI 10.1128/MCB.25.4.1238-1257.2005; Bevan CL, 1999, MOL CELL BIOL, V19, P8383; Chandra S, 2008, J BIOL CHEM, V283, P23950, DOI 10.1074/jbc.M800467200; Chen SY, 2006, MOL CELL BIOL, V26, P929, DOI 10.1128/MCB.26.3.929-939.2006; Chomez P, 2001, CANCER RES, V61, P5544; Craft N, 1999, NAT MED, V5, P280, DOI 10.1038/6495; Craig KL, 1999, PROG BIOPHYS MOL BIO, V72, P299, DOI 10.1016/S0079-6107(99)00010-3; CULIG Z, 1994, CANCER RES, V54, P5474; Dennis AP, 2001, FRONT BIOSCI, V6, pD954, DOI 10.2741/Dennis; ERICKSON AK, 1990, J BIOL CHEM, V265, P19728; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Giffin W, 1996, NATURE, V380, P265, DOI 10.1038/380265a0; Gioeli D, 2002, J BIOL CHEM, V277, P29304, DOI 10.1074/jbc.M204131200; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; Gregory CW, 2004, J BIOL CHEM, V279, P7119, DOI 10.1074/jbc.M307649200; Gregory CW, 1998, CANCER RES, V58, P5718; Gregory CW, 2001, CANCER RES, V61, P2892; Gregory CW, 2001, CANCER RES, V61, P4315; Han SJ, 2009, TRENDS ENDOCRIN MET, V20, P8, DOI 10.1016/j.tem.2008.10.001; Hao B, 2005, MOL CELL, V20, P9, DOI 10.1016/j.molcel.2005.09.003; He B, 2002, J BIOL CHEM, V277, P25631, DOI 10.1074/jbc.M202809200; He B, 2006, J BIOL CHEM, V281, P6648, DOI 10.1074/jbc.M511738200; He B, 2000, J BIOL CHEM, V275, P22986, DOI 10.1074/jbc.M002807200; He B, 2004, MOL CELL, V16, P425, DOI 10.1016/j.molcel.2004.09.036; He B, 2003, MOL CELL BIOL, V23, P2135, DOI 10.1128/MCB.23.6.2135-2150.2003; He B, 2002, J BIOL CHEM, V277, P10226, DOI 10.1074/jbc.M111975200; He B, 1999, J BIOL CHEM, V274, P37219, DOI 10.1074/jbc.274.52.37219; He B, 2001, J BIOL CHEM, V276, P42293, DOI 10.1074/jbc.M107492200; Heemers HV, 2007, ENDOCR REV, V28, P778, DOI 10.1210/er.2007-0019; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Hermand D, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-30; Hoang T, 2004, J BIOL CHEM, V279, P49120, DOI 10.1074/jbc.M409746200; Huang WB, 1999, J BIOL CHEM, V274, P25756, DOI 10.1074/jbc.274.36.25756; Jackson PK, 2002, MOL CELL, V9, P923, DOI 10.1016/S1097-2765(02)00538-5; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Karpf AR, 2009, MOL CANCER RES, V7, P523, DOI 10.1158/1541-7786.MCR-08-0400; Langley E, 1998, J BIOL CHEM, V273, P92, DOI 10.1074/jbc.273.1.92; LANGLEY E, 1995, J BIOL CHEM, V270, P29983; Lavery DN, 2008, BIOCHEMISTRY-US, V47, P3360, DOI 10.1021/bi702221e; Lavery DN, 2008, BIOCHEMISTRY-US, V47, P3352, DOI 10.1021/bi702220p; Lopez GN, 2001, J BIOL CHEM, V276, P22177, DOI 10.1074/jbc.M010718200; LUBAHN DB, 1988, MOL ENDOCRINOL, V2, P1265, DOI 10.1210/mend-2-12-1265; Mohler JL, 2004, CLIN CANCER RES, V10, P440, DOI 10.1158/1078-0432.CCR-1146-03; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; NEWMARK JR, 1992, P NATL ACAD SCI USA, V89, P6319, DOI 10.1073/pnas.89.14.6319; Nie L, 2008, J BIOL CHEM, V283, P684, DOI 10.1074/jbc.M704981200; Onate SA, 1998, J BIOL CHEM, V273, P12101, DOI 10.1074/jbc.273.20.12101; Onoyama I, 2008, CELL CYCLE, V7, P3307, DOI 10.4161/cc.7.21.6931; Ponguta LA, 2008, J BIOL CHEM, V283, P20989, DOI 10.1074/jbc.M802392200; QUARMBY VE, 1990, MOL ENDOCRINOL, V4, P22, DOI 10.1210/mend-4-1-22; QUIGLEY CA, 1995, ENDOCR REV, V16, P271, DOI 10.1210/er.16.3.271; ROGNER UC, 1995, GENOMICS, V29, P725, DOI 10.1006/geno.1995.9945; Rowan BG, 2000, MOL CELL BIOL, V20, P8720, DOI 10.1128/MCB.20.23.8720-8730.2000; Rowan BG, 2000, J BIOL CHEM, V275, P4475, DOI 10.1074/jbc.275.6.4475; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; SIMENTAL JA, 1991, J BIOL CHEM, V266, P510; Smaldone S, 2004, MOL CELL BIOL, V24, P1058, DOI 10.1128/MCB.24.3.1058-1069.2004; Sonnberg S, 2008, P NATL ACAD SCI USA, V105, P10955, DOI 10.1073/pnas.0802042105; TAN JA, 1988, MOL ENDOCRINOL, V2, P1276, DOI 10.1210/mend-2-12-1276; VANDERVOORN L, 1992, FEBS LETT, V307, P131, DOI 10.1016/0014-5793(92)80751-2; Verma S, 2004, MOL CELL BIOL, V24, P8716, DOI 10.1128/MCB.24.19.8716-8726.2004; Voegel JJ, 1998, EMBO J, V17, P507, DOI 10.1093/emboj/17.2.507; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Westbrook TF, 2008, NATURE, V452, P370, DOI 10.1038/nature06780; WONG CI, 1993, J BIOL CHEM, V268, P19004; Wu RC, 2007, CELL, V129, P1125, DOI 10.1016/j.cell.2007.04.039; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Yi P, 2005, MOL CELL BIOL, V25, P9687, DOI 10.1128/MCB.25.21.9687-9699.2005; Yuan X, 2009, UROL ONCOL-SEMIN ORI, V27, P36, DOI 10.1016/j.urolonc.2008.03.021; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; ZHOU ZX, 1995, MOL ENDOCRINOL, V9, P605, DOI 10.1210/me.9.5.605; ZHOU ZX, 1995, MOL ENDOCRINOL, V9, P208, DOI 10.1210/me.9.2.208; ZHOU ZX, 1994, J BIOL CHEM, V269, P13115	82	38	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34793	34808		10.1074/jbc.M109.065979	http://dx.doi.org/10.1074/jbc.M109.065979			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19828458	hybrid, Green Published			2022-12-27	WOS:000272439600035
J	Lu, HK; Rentero, C; Raftery, MJ; Borges, L; Bryant, K; Tedla, N				Lu, Hao Kim; Rentero, Carles; Raftery, Mark J.; Borges, Luis; Bryant, Katherine; Tedla, Nicodemus			Leukocyte Ig-like Receptor B4 (LILRB4) Is a Potent Inhibitor of Fc gamma RI-mediated Monocyte Activation via Dephosphorylation of Multiple Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR NECROSIS FACTOR; RHEUMATOID-ARTHRITIS; CROSS-LINKING; TYROSINE PHOSPHORYLATION; SIGNAL-TRANSDUCTION; MOUSE MACROPHAGES; DENDRITIC CELLS; BINDING DOMAIN; MYELOID CELLS; SH3 DOMAIN	The leukocyte immunoglobulin-like receptor (LILR) B4 belongs to a family of cell surface receptors that possesses cytoplasmic immunoreceptor tyrosine-based inhibitory motifs (ITIMs). LILRB4 is believed to down-regulate activation signals mediated by non-receptor tyrosine kinase cascades through the recruitment of SHP-1. However, the exact mechanisms of LILRB4-mediated inhibition are not fully elucidated. In this study, we demonstrate high level surface expression of LILRB4 on THP-1 cells and primary peripheral blood monocytes, which profoundly inhibited production of a key pro-inflammatory cytokine (TNF alpha) induced by Fc gamma RI (CD64). We also report that LILRB4 aggregated to sites of activation upon co-ligation with CD64 and that this may enhance its inhibitory effects. Crosslinking of CD64 on THP-1 cells markedly increased phosphorylation of multiple proteins including tyrosine kinases and signaling molecules (Lck, Syk, LAT, and Erk), an adaptor protein that targets protein-tyrosine kinases for degradation (c-Cbl) and a protein involved in the formation of actin cytoskeletal rearrangement (alpha-actinin-4). Co-ligation of LILRB4 considerably reduced CD64-mediated phosphorylation of Lck, Syk, LAT, Erk, and c-Cbl but not alpha-actinin-4, suggesting selective inhibition of signaling molecules. Treatment of cells with a broad-spectrum phosphatase inhibitor, sodium pervanadate (SP), significantly reversed LILRB4-mediated inhibition of TNF alpha production and protein tyrosine phosphorylation. In comparison, treatment with an SHP-1 specific inhibitor, sodium stibogluconate (SS) has no effects indicating involvement of phosphatase(s) other than SHP-1 in LILRB4 signaling. Collectively, our data show LILRB4 is a potent inhibitor of monocytes activation. This may provide a new potential therapeutic strategy for inflammatory conditions characterized by excessive TNF alpha production.	[Lu, Hao Kim; Bryant, Katherine; Tedla, Nicodemus] Univ New S Wales, Ctr Infect & Inflammat Res, Sydney, NSW 2052, Australia; [Rentero, Carles] Univ New S Wales, Ctr Vasc Res, Sydney, NSW 2052, Australia; [Raftery, Mark J.] Univ New S Wales, Bioanalyt Mass Spectrometry Facil, Sydney, NSW 2052, Australia; [Bryant, Katherine] Univ New S Wales, Sch Med Sci, S Western Sydney Clin Sch, Sydney, NSW 2052, Australia; [Borges, Luis] Amgen Inc, Seattle, WA 98119 USA	University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney; Amgen	Tedla, N (corresponding author), Univ New S Wales, Ctr Infect & Inflammat Res, Sydney, NSW 2052, Australia.	n.tedla@unsw.edu.au	Rentero Alfonso, Carles/L-4430-2017; Bryant, Katherine/E-8574-2010	Rentero Alfonso, Carles/0000-0003-4684-0278; Bryant, Katherine/0000-0002-8686-623X; Lu, Hao/0000-0002-3940-3283				AKERLEY WL, 1991, BLOOD, V77, P607; Akin O, 2008, CELL, V133, P841, DOI 10.1016/j.cell.2008.04.011; Araki N, 2000, J CELL SCI, V113, P3329; Bezman NA, 2008, J EXP MED, V205, P1775, DOI 10.1084/jem.20080240; Billadeau DD, 2002, J CLIN INVEST, V109, P161, DOI 10.1172/JCI14843; Borges L, 1997, J IMMUNOL, V159, P5192; BU JY, 1995, P NATL ACAD SCI USA, V92, P5106, DOI 10.1073/pnas.92.11.5106; Burshtyn DN, 1997, J BIOL CHEM, V272, P13066, DOI 10.1074/jbc.272.20.13066; CAMBIER JC, 1995, IMMUNOL TODAY, V16, P110, DOI 10.1016/0167-5699(95)80105-7; Cella M, 1997, J EXP MED, V185, P1743, DOI 10.1084/jem.185.10.1743; Chacko GW, 1996, J BIOL CHEM, V271, P10775, DOI 10.1074/jbc.271.18.10775; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Colonna M, 1999, J LEUKOCYTE BIOL, V66, P375, DOI 10.1002/jlb.66.3.375; Cortesini R, 2007, J PANCREAS, V8, P697; Couttas TA, 2008, J PROTEOME RES, V7, P2632, DOI 10.1021/pr700644t; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; DEBETS JMH, 1988, J IMMUNOL, V141, P1197; DEBETS JMH, 1990, J IMMUNOL, V144, P1304; Deckert M, 1998, J BIOL CHEM, V273, P8867, DOI 10.1074/jbc.273.15.8867; Dixson JD, 2003, J MOL EVOL, V56, P1, DOI 10.1007/s00239-002-2374-5; Djinovic-Carugo K, 2002, FEBS LETT, V513, P119, DOI 10.1016/S0014-5793(01)03304-X; Feldmann M, 2001, ANNU REV IMMUNOL, V19, P163, DOI 10.1146/annurev.immunol.19.1.163; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; FUKAMACHI H, 1994, J IMMUNOL, V152, P642; Goodchild A, 2005, J PROTEOME RES, V4, P473, DOI 10.1021/pr049760p; GRAZIANO RF, 1987, J IMMUNOL, V139, P3536; HAMERMAN JA, 2006, SCI STKE, V320, pRE1; Hartgroves LC, 2003, J BIOL CHEM, V278, P20389, DOI 10.1074/jbc.M301212200; Huynh OA, 2007, RHEUMATOLOGY, V46, P742, DOI 10.1093/rheumatology/kel405; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Katz HR, 2007, IMMUNOL REV, V217, P222, DOI 10.1111/j.1600-065X.2007.00522.x; Kemp SF, 2002, J ALLERGY CLIN IMMUN, V110, P341, DOI 10.1067/mai.2002.126811; Kockx M, 2009, J BIOL CHEM, V284, P24144, DOI 10.1074/jbc.M109.032615; LANGDON WY, 1989, P NATL ACAD SCI USA, V86, P1168, DOI 10.1073/pnas.86.4.1168; Lupher ML, 1997, J BIOL CHEM, V272, P33140, DOI 10.1074/jbc.272.52.33140; Mitchell A, 2008, EUR J IMMUNOL, V38, P3459, DOI 10.1002/eji.200838415; Miyake S, 1999, J BIOL CHEM, V274, P16619, DOI 10.1074/jbc.274.23.16619; Ota Y, 1996, J EXP MED, V184, P1713, DOI 10.1084/jem.184.5.1713; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; PAN L, 1990, J IMMUNOL, V145, P267; Park RK, 1998, J IMMUNOL, V160, P5018; Pathak MK, 2001, J IMMUNOL, V167, P3391, DOI 10.4049/jimmunol.167.6.3391; PELTZ G, 1988, MOL IMMUNOL, V25, P243, DOI 10.1016/0161-5890(88)90015-6; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Takeshita T, 1996, BIOCHEM BIOPH RES CO, V225, P1035, DOI 10.1006/bbrc.1996.1290; Tamai K, 2007, BIOCHEM BIOPH RES CO, V360, P721, DOI 10.1016/j.bbrc.2007.06.105; Tedla N, 2003, P NATL ACAD SCI USA, V100, P1174, DOI 10.1073/pnas.0337567100; Tridandapani S, 2000, J BIOL CHEM, V275, P20480, DOI 10.1074/jbc.M909462199; UNKELESS JC, 1975, J EXP MED, V142, P1520, DOI 10.1084/jem.142.6.1520; Vivier E, 1997, IMMUNOL TODAY, V18, P286, DOI 10.1016/S0167-5699(97)80025-4; WAAGE A, 1989, J EXP MED, V169, P333, DOI 10.1084/jem.169.1.333; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Willcox BE, 2003, NAT IMMUNOL, V4, P913, DOI 10.1038/ni961; Zhou H, 2007, TRANSPL P, V39, P3065, DOI 10.1016/j.transproceed.2007.02.098; Zhou JS, 2005, EUR J IMMUNOL, V35, P1530, DOI 10.1002/eji.200425895	55	30	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34839	34848		10.1074/jbc.M109.035683	http://dx.doi.org/10.1074/jbc.M109.035683			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19833736	Green Published, hybrid			2022-12-27	WOS:000272439600039
J	Mo, ZY; Zhu, YZ; Zhu, HL; Fan, JB; Chen, J; Liang, Y				Mo, Zhong-Ying; Zhu, Ying-Zhu; Zhu, Hai-Li; Fan, Jun-Bao; Chen, Jie; Liang, Yi			Low Micromolar Zinc Accelerates the Fibrillization of Human Tau via Bridging of Cys-291 and Cys-322	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; ISOTHERMAL TITRATION CALORIMETRY; ALZHEIMERS-DISEASE; PROTEIN-TAU; AMYLOID-BETA; PHF-TAU; AGGREGATION; BINDING; METALS; FIBRILLATION	A hallmark of a group of neurodegenerative diseases such as Alzheimer disease is the formation of neurofibrillary tangles, which are principally composed of bundles of filaments formed by microtubule-associated protein Tau. Clarifying how natively unstructured Tau protein forms abnormal aggregates is of central importance for elucidating the etiology of these diseases. There is considerable evidence showing that zinc, as an essential element that is highly concentrated in brain, is linked to the development or progression of these diseases. Herein, by using recombinant human Tau fragment Tau(244-372) and its mutants, we have investigated the effect of zinc on the aggregation of Tau. Low micromolar concentrations of Zn2+ dramatically accelerate fibril formation of wild-type Tau(244-372) under reducing conditions, compared with no Zn2+. Higher concentrations of Zn2+, however, induce wild-type Tau(244-372) to form granular aggregates in reducing conditions. Moreover, these non-fibrillar aggregates assemble into mature Tau filaments when Zn2+ has been chelated by EDTA. Unlike wild-type Tau(244-372), low micromolar concentrations of Zn2+ have no obvious effects on fibrillization kinetics of single mutants C291A and C322A and double mutant C291A/C322A under reducing conditions. The results from isothermal titration calorimetry show that one Zn2+ binds to one Tau molecule via tetrahedral coordination to Cys-291 and Cys-322 as well as two histidines, with moderate, micromolar affinity. Our data demonstrate that low micromolar zinc accelerates the fibrillization of human Tau protein via bridging Cys-291 and Cys-322 in physiological reducing conditions, providing clues to understanding the relationship between zinc dyshomeostasis and the etiology of neurodegenerative diseases.	[Mo, Zhong-Ying; Zhu, Ying-Zhu; Zhu, Hai-Li; Fan, Jun-Bao; Chen, Jie; Liang, Yi] Wuhan Univ, State Key Lab Virol, Coll Life Sci, Wuhan 430072, Peoples R China	Wuhan University	Liang, Y (corresponding author), Wuhan Univ, State Key Lab Virol, Coll Life Sci, Wuhan 430072, Peoples R China.	liangyi@whu.edu.cn	Liang, Yi/V-1396-2017; mo, zhongying/C-1955-2013; Fan, Jun-bao/E-7155-2012	Liang, Yi/0000-0002-7349-8300; Fan, Junbao/0000-0002-1709-3659	National Key Basic Research Foundation of China [2006CB910301]; National Natural Science Foundation of China [30770421, 30970599]	National Key Basic Research Foundation of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Key Basic Research Foundation of China Grant 2006CB910301 and by National Natural Science Foundation of China Grants 30770421 and 30970599.	Adlard PA, 2006, J ALZHEIMERS DIS, V10, P145; An WL, 2005, J NEUROCHEM, V92, P1104, DOI 10.1111/j.1471-4159.2004.02948.x; Aoyagi H, 2007, J BIOL CHEM, V282, P20309, DOI 10.1074/jbc.M611876200; ASSAF SY, 1984, NATURE, V308, P734, DOI 10.1038/308734a0; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Barghorn S, 2002, BIOCHEMISTRY-US, V41, P14885, DOI 10.1021/bi026469j; Barghorn Stefan, 2004, V299, P35; Barnham KJ, 2008, CURR OPIN CHEM BIOL, V12, P222, DOI 10.1016/j.cbpa.2008.02.019; Bhattacharya K, 2001, BIOCHEM BIOPH RES CO, V285, P20, DOI 10.1006/bbrc.2001.5116; Blumenthal J, 2008, J CELL SCI, V121, P3253, DOI 10.1242/jcs.033266; Boom A, 2009, BBA-MOL CELL RES, V1793, P1058, DOI 10.1016/j.bbamcr.2008.11.011; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Bush AI, 2000, CURR OPIN CHEM BIOL, V4, P184, DOI 10.1016/S1367-5931(99)00073-3; Chattopadhyay M, 2008, P NATL ACAD SCI USA, V105, P18663, DOI 10.1073/pnas.0807058105; Chirita CN, 2004, BIOCHEMISTRY-US, V43, P1704, DOI 10.1021/bi036034b; Congdon EE, 2008, J BIOL CHEM, V283, P13806, DOI 10.1074/jbc.M800247200; Cuajungco MP, 1997, BRAIN RES REV, V23, P219, DOI 10.1016/S0165-0173(97)00002-7; Dong JJ, 2006, J AM CHEM SOC, V128, P3540, DOI 10.1021/ja055973j; Fink AL, 2006, ACCOUNTS CHEM RES, V39, P628, DOI 10.1021/ar050073t; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Friedhoff P, 2000, BBA-MOL BASIS DIS, V1502, P122, DOI 10.1016/S0925-4439(00)00038-7; Friedhoff P, 1998, P NATL ACAD SCI USA, V95, P15712, DOI 10.1073/pnas.95.26.15712; Friedhoff P, 1998, BIOCHEMISTRY-US, V37, P10223, DOI 10.1021/bi980537d; Gaggelli E, 2005, J AM CHEM SOC, V127, P996, DOI 10.1021/ja045958z; Garai K, 2007, BIOCHEMISTRY-US, V46, P10655, DOI 10.1021/bi700798b; GOEDERT M, 1993, TRENDS NEUROSCI, V16, P460, DOI 10.1016/0166-2236(93)90078-Z; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; Harris FM, 2004, J BIOL CHEM, V279, P44795, DOI 10.1074/jbc.M408127200; Huang XD, 1997, J BIOL CHEM, V272, P26464, DOI 10.1074/jbc.272.42.26464; Hutchinson RW, 2005, ANAL BIOCHEM, V346, P225, DOI 10.1016/j.ab.2005.08.024; Jeganathan S, 2008, BIOCHEMISTRY-US, V47, P10526, DOI 10.1021/bi800783d; Jobling MF, 2001, BIOCHEMISTRY-US, V40, P8073, DOI 10.1021/bi0029088; Koh JY, 2001, MOL NEUROBIOL, V24, P99, DOI 10.1385/MN:24:1-3:099; Kuret J, 2005, BBA-MOL BASIS DIS, V1739, P167, DOI 10.1016/j.bbadis.2004.06.016; Lee YM, 2008, J MOL BIOL, V379, P545, DOI 10.1016/j.jmb.2008.04.004; Li DW, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000238; Liang Y, 2003, J BIOL CHEM, V278, P30098, DOI 10.1074/jbc.M304050200; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Maeda S, 2007, BIOCHEMISTRY-US, V46, P3856, DOI 10.1021/bi061359o; MANDELKOW E, 1995, NEUROBIOL AGING, V16, P347, DOI 10.1016/0197-4580(95)00026-B; Mandelkow E, 2007, BRAIN PATHOL, V17, P83, DOI 10.1111/j.1750-3639.2007.00053.x; MANDELKOW EM, 1993, TRENDS BIOCHEM SCI, V18, P480, DOI 10.1016/0968-0004(93)90011-B; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Nolan EM, 2009, ACCOUNTS CHEM RES, V42, P193, DOI 10.1021/ar8001409; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rosenberg KJ, 2008, P NATL ACAD SCI USA, V105, P7445, DOI 10.1073/pnas.0802036105; Sahara N, 2007, EUR J NEUROSCI, V25, P3020, DOI 10.1111/j.1460-9568.2007.05555.x; Sayre LM, 2000, J NEUROCHEM, V74, P270, DOI 10.1046/j.1471-4159.2000.0740270.x; SCHWEERS O, 1995, P NATL ACAD SCI USA, V92, P8463, DOI 10.1073/pnas.92.18.8463; SHIN RW, 1994, J NEUROSCI, V14, P7221; Sibille N, 2006, BIOCHEMISTRY-US, V45, P12560, DOI 10.1021/bi060964o; Skovronsky DM, 2006, ANNU REV PATHOL-MECH, V1, P151, DOI 10.1146/annurev.pathol.1.110304.100113; Soragni A, 2008, BIOCHEMISTRY-US, V47, P10841, DOI 10.1021/bi8008856; Soto C, 2006, TRENDS BIOCHEM SCI, V31, P150, DOI 10.1016/j.tibs.2006.01.002; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Talmard C, 2007, BIOCHEMISTRY-US, V46, P13658, DOI 10.1021/bi701355j; THOMPSON CM, 1988, NEUROTOXICOLOGY, V9, P1; Tougu V, 2008, J NEUROCHEM, V104, P1249, DOI 10.1111/j.1471-4159.2007.05061.x; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; von Bergen M, 2005, BBA-MOL BASIS DIS, V1739, P158, DOI 10.1016/j.bbadis.2004.09.010; Weiss JH, 2000, TRENDS PHARMACOL SCI, V21, P395, DOI 10.1016/S0165-6147(00)01541-8; WILLE H, 1992, J CELL BIOL, V118, P573, DOI 10.1083/jcb.118.3.573; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; Xu H, 2005, J BIOL INORG CHEM, V10, P529, DOI 10.1007/s00775-005-0007-3; Yamin G, 2003, J BIOL CHEM, V278, P27630, DOI 10.1074/jbc.M303302200; Yang F, 2006, J MOL BIOL, V362, P821, DOI 10.1016/j.jmb.2006.07.059; Yang LS, 1999, J NEUROSCI RES, V55, P36, DOI 10.1002/(SICI)1097-4547(19990101)55:1<36::AID-JNR5>3.3.CO;2-5; Yu WH, 2001, J NEUROSCI, V21, P2240, DOI 10.1523/JNEUROSCI.21-07-02240.2001	69	141	146	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34648	34657		10.1074/jbc.M109.058883	http://dx.doi.org/10.1074/jbc.M109.058883			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19826005	hybrid, Green Published			2022-12-27	WOS:000272439600020
J	Astuti, P; Pike, T; Widberg, C; Payne, E; Harding, A; Hancock, J; Gabrielli, B				Astuti, Puji; Pike, Tanya; Widberg, Charlotte; Payne, Elizabeth; Harding, Angus; Hancock, John; Gabrielli, Brian			MAPK Pathway Activation Delays G(2)/M Progression by Destabilizing Cdc25B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-REGULATED KINASE; CELL-CYCLE ARREST; PROTEIN-KINASE; DNA-DAMAGE; HELA-CELLS; G2 PHASE; MAMMALIAN-CELLS; EGG EXTRACTS; MITOSIS; PHOSPHORYLATION	Activation of the mitogen-activated protein kinase (MAPK) pathway by growth factors or phorbol esters during G(2) phase delays entry into mitosis; however, the role of the MAPK pathway during G(2)/M progression remains controversial. Here, we demonstrate that activation of the MAPK pathway with either epidermal growth factor or 12-O-tetradecanoylphorbol-13-acetate induces a G(2) phase delay independent of known G(2) phase checkpoint pathways but was specifically dependent on MAPK/extracellular signal-regulated kinase kinase (MEK1). Activation of MAPK signaling also blocked exit from a G(2) phase checkpoint arrest. Both the G(2) phase delay and blocked exit from the G(2) checkpoint arrest were mediated by the MEK1-dependent destabilization of the critical G(2)/M regulator cdc25B. Reintroduction of cdc25B overcame the MEK1-dependent G(2) phase delay. Thus, we have demonstrated a new function for MEK1 that controls G(2)/M progression by regulating the stability of cdc25B. This represents a novel mechanism by which factors that activate MAPK signaling can influence the timing of entry into mitosis, particularly exit from a G(2) phase checkpoint arrest.	[Gabrielli, Brian] Univ Queensland, Diamantina Inst Canc Immunol & Metab Med, Brisbane, Qld 4102, Australia; [Harding, Angus] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4102, Australia; [Hancock, John] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4102, Australia	University of Queensland; University of Queensland; University of Queensland	Gabrielli, B (corresponding author), Univ Queensland, Diamantina Inst Canc Immunol & Metab Med, Princess Alexandra Hosp, Brisbane, Qld 4102, Australia.	brianG@uq.edu.au	Harding, Angus/B-4120-2012; Payne, Elizabeth/H-8603-2013; Gabrielli, Brian G/B-3655-2011; Astuti, Puji/GLV-5075-2022	Gabrielli, Brian G/0000-0003-3933-1651; Astuti, Puji/0000-0003-3316-6149; Soliman, Tanya/0000-0002-4687-629X	Australian Research Council	Australian Research Council(Australian Research Council)	This work was supported by grants from the Australian Research Council.	Bansal P, 2007, CANCER RES, V67, P3356, DOI 10.1158/0008-5472.CAN-06-3685; Barboule N, 1999, FEBS LETT, V444, P32, DOI 10.1016/S0014-5793(99)00022-8; BARTH H, 1995, J CELL PHYSIOL, V162, P44, DOI 10.1002/jcp.1041620107; BARTH H, 1994, EXP CELL RES, V212, P383, DOI 10.1006/excr.1994.1158; Belanger LF, 2003, MOL CELL BIOL, V23, P4778, DOI 10.1128/MCB.23.14.4778-4787.2003; Boutros R, 2006, CURR OPIN CELL BIOL, V18, P185, DOI 10.1016/j.ceb.2006.02.003; Boutros R, 2007, NAT REV CANCER, V7, P495, DOI 10.1038/nrc2169; Bulavin DV, 2002, CURR OPIN GENET DEV, V12, P92, DOI 10.1016/S0959-437X(01)00270-2; Chun J, 2005, CELL CYCLE, V4, P148, DOI 10.4161/cc.4.1.1323; Colanzi A, 2003, J CELL BIOL, V161, P27, DOI 10.1083/jcb.200208099; Dangi S, 2006, CELL PROLIFERAT, V39, P261, DOI 10.1111/j.1365-2184.2006.00388.x; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; De Boer L, 2008, ONCOGENE, V27, P4261, DOI 10.1038/onc.2008.74; Dumesic PA, 2009, J CELL BIOL, V185, P409, DOI 10.1083/jcb.200804038; Edelmann HML, 1996, J BIOL CHEM, V271, P963, DOI 10.1074/jbc.271.2.963; El-Shemerly MYM, 1997, J BIOL CHEM, V272, P30599, DOI 10.1074/jbc.272.49.30599; Eymin B, 2006, CELL CYCLE, V5, P759, DOI 10.4161/cc.5.7.2625; Gabrielli BG, 1996, J CELL SCI, V109, P1081; Gabrielli BG, 1997, ONCOGENE, V15, P749, DOI 10.1038/sj.onc.1201254; Giroux S, 1999, CURR BIOL, V9, P369, DOI 10.1016/S0960-9822(99)80164-X; Goldstone S, 2001, ONCOGENE, V20, P921, DOI 10.1038/sj.onc.1204177; Harding A, 2005, CURR BIOL, V15, P869, DOI 10.1016/j.cub.2005.04.020; Isoda M, 2009, MOL BIOL CELL, V20, P2186, DOI 10.1091/mbc.E09-01-0008; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Kanemori Y, 2005, P NATL ACAD SCI USA, V102, P6279, DOI 10.1073/pnas.0501873102; Klingler-Hoffmann M, 2005, EUR J CELL BIOL, V84, P719, DOI 10.1016/j.ejcb.2005.04.002; Kohn EA, 2003, CANCER RES, V63, P31; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Lemaire M, 2006, CELL CYCLE, V5, P1649, DOI 10.4161/cc.5.15.3006; Lindqvist A, 2005, J CELL BIOL, V171, P35, DOI 10.1083/jcb.200503066; Liu X, 2004, ONCOGENE, V23, P763, DOI 10.1038/sj.onc.1207188; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Manke IA, 2005, MOL CELL, V17, P37, DOI 10.1016/j.molcel.2004.11.021; Mayor F, 2007, CELL CYCLE, V6, P528, DOI 10.4161/cc.6.5.3920; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; Nam HJ, 2008, CELL SIGNAL, V20, P1349, DOI 10.1016/j.cellsig.2008.03.008; O'Connell MJ, 2000, TRENDS CELL BIOL, V10, P296, DOI 10.1016/S0962-8924(00)01773-6; Qiu L, 2000, MOL BIOL CELL, V11, P2069, DOI 10.1091/mbc.11.6.2069; Roberts EC, 2002, MOL CELL BIOL, V22, P7226, DOI 10.1128/MCB.22.20.7226-7241.2002; ROSSOMANDO AJ, 1994, MOL CELL BIOL, V14, P1594, DOI 10.1128/MCB.14.3.1594; Schmitt E, 2006, J CELL SCI, V119, P4269, DOI 10.1242/jcs.03200; Scholl FA, 2009, CANCER RES, V69, P3772, DOI 10.1158/0008-5472.CAN-08-1963; Shinohara M, 2006, MOL BIOL CELL, V17, P5227, DOI 10.1091/mbc.E06-04-0284; Theis-Febvre N, 2003, ONCOGENE, V22, P220, DOI 10.1038/sj.onc.1206107; Uto K, 2004, EMBO J, V23, P3386, DOI 10.1038/sj.emboj.7600328; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015; Walter SA, 2000, MOL BIOL CELL, V11, P887, DOI 10.1091/mbc.11.3.887; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Wright JH, 1999, P NATL ACAD SCI USA, V96, P11335, DOI 10.1073/pnas.96.20.11335; Xiao Z, 2003, J BIOL CHEM, V278, P21767, DOI 10.1074/jbc.M300229200; Yan Y, 2005, ONCOGENE, V24, P3285, DOI 10.1038/sj.onc.1208492	51	31	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33781	33788		10.1074/jbc.M109.027516	http://dx.doi.org/10.1074/jbc.M109.027516			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19801682	Green Published, hybrid			2022-12-27	WOS:000272165200008
J	Mahapatra, S; Mehta, H; Woo, SB; Neet, KE				Mahapatra, Sidharth; Mehta, Hrishikesh; Woo, Sang B.; Neet, Kenneth E.			Identification of Critical Residues within the Conserved and Specificity Patches of Nerve Growth Factor Leading to Survival or Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P75 NEUROTROPHIN RECEPTOR; HIGH-AFFINITY RECEPTOR; AMINO-ACID-RESIDUES; PROTEIN-KINASE; ALZHEIMERS-DISEASE; RETROGRADE TRANSPORT; TRKA RECEPTOR; NGF RECEPTOR; MOLECULAR-CLONING; CRYSTAL-STRUCTURE	Afflicted neurons in Alzheimer disease have been shown to display an imbalance in the expression of TrkA and p75NTR at the cell surface, and administration of nerve growth factor (NGF) has been considered and attempted for treatment. However, wild-type NGF causes extensive elaboration of neurites while providing survival support. This study was aimed at developing recombinant NGF muteins that did not support neuritogenesis while maintaining the survival response. Critical residues were identified at the ligand-receptor interface by point mutagenesis that played a greater importance in neuritogenesis versus survival. By combining point mutations, two survival-selective recombinant NGF muteins, i.e./7-84-103 and KKE/7-84-103, were generated. Both muteins reduced neuritogenesis in PC12 (TrkA(+)/p75(NTR+)) cells by >90%, while concurrently retaining near wild-type survival activity in MG139 (TrkA(+) only) and PCNA fibroblast (p75(NTR+)-only) cells. Additionally, survival in both naive and terminally differentiated PC12 cells was shown to be intermediate between NGF and negative controls. Dose-response curves with 7-84-103 showed that the differentiation curve was shifted by about 100-fold, whereas the EC50 for survival was only increased by 3.3-fold. Surface plasmon resonance analysis revealed a 200-fold decrease in binding of 7-84-103 to TrkA. The retention of cell survival was attributed to maintenance of signaling through the Akt survival pathway with reduced MAPK signaling for differentiation. The effect of key mutations along the NGF receptor interface are transmitted inside the cell to enable the generation of survival-selective recombinant NGF muteins that may represent novel pharmacologic lead agents for the amelioration of Alzheimer disease.	[Mahapatra, Sidharth; Mehta, Hrishikesh; Woo, Sang B.; Neet, Kenneth E.] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Biochem & Mol Biol, N Chicago, IL 60064 USA	Chicago Medical School; Rosalind Franklin University Medical & Science	Neet, KE (corresponding author), Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Biochem & Mol Biol, 3333 Green Bay Rd, N Chicago, IL 60064 USA.	kenneth.neet@rosalindfranklin.edu	Mahapatra, Sidharth/H-4697-2019; Mehta, Hrishikesh/K-1108-2016	Mahapatra, Sidharth/0000-0002-2483-0610; Mehta, Hrishikesh/0000-0001-9140-9765	USPHS [NS24380]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024380] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS24380 from the USPHS.	BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; BARKER PA, 1993, J BIOL CHEM, V268, P15150; Barker PA, 2007, NEURON, V53, P1, DOI 10.1016/j.neuron.2006.12.018; Bartlett SE, 1997, BRAIN RES, V761, P257, DOI 10.1016/S0006-8993(97)00329-6; Bibel M, 1999, EMBO J, V18, P616, DOI 10.1093/emboj/18.3.616; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Bose R, 2006, CURR OPIN STRUC BIOL, V16, P668, DOI 10.1016/j.sbi.2006.10.012; BOTHWELL MA, 1977, J BIOL CHEM, V252, P8532; COHENCORY S, 1991, J NEUROSCI, V11, P462; CORDONCARDO C, 1991, CELL, V66, P173, DOI 10.1016/0092-8674(91)90149-S; Counts SE, 2004, ANN NEUROL, V56, P520, DOI 10.1002/ana.20233; Counts SE, 2005, J NEUROPATH EXP NEUR, V64, P263, DOI 10.1093/jnen/64.4.263; Crowder RJ, 1998, J NEUROSCI, V18, P2933; Cunningham ME, 1997, J BIOL CHEM, V272, P10957; Cunningham ME, 1998, EMBO J, V17, P7282, DOI 10.1093/emboj/17.24.7282; Dechant G, 2002, NAT NEUROSCI, V5, P1131, DOI 10.1038/nn1102-1131; DIAMOND J, 1992, J NEUROSCI, V12, P1467; ERNFORS P, 1990, P NATL ACAD SCI USA, V87, P5454, DOI 10.1073/pnas.87.14.5454; Fahnestock M, 2001, MOL CELL NEUROSCI, V18, P210, DOI 10.1006/mcne.2001.1016; Fan YX, 2004, J BIOL CHEM, V279, P38143, DOI 10.1074/jbc.M405760200; Friedman WJ, 1999, EXP CELL RES, V253, P131, DOI 10.1006/excr.1999.4705; GOMEZ N, 1991, NATURE, V353, P170, DOI 10.1038/353170a0; Gotoh N, 2008, CANCER SCI, V99, P1319, DOI 10.1111/j.1349-7006.2008.00840.x; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Grewal SS, 1999, CURR OPIN NEUROBIOL, V9, P544, DOI 10.1016/S0959-4388(99)00010-0; HALLBOOK F, 1991, NEURON, V6, P845, DOI 10.1016/0896-6273(91)90180-8; HERRUP K, 1987, J NEUROSCI, V7, P829; IBANEZ CF, 1991, EMBO J, V10, P2105, DOI 10.1002/j.1460-2075.1991.tb07743.x; IBANEZ CF, 1993, EMBO J, V12, P2281, DOI 10.1002/j.1460-2075.1993.tb05882.x; IBANEZ CF, 1992, CELL, V69, P329, DOI 10.1016/0092-8674(92)90413-7; IBANEZ CF, 1994, J NEUROBIOL, V25, P1349, DOI 10.1002/neu.480251104; IBANEZ CF, 1990, EMBO J, V9, P1477, DOI 10.1002/j.1460-2075.1990.tb08265.x; ILAG LL, 1994, J BIOL CHEM, V269, P19941; Jiang YP, 1999, SCIENCE, V283, P543, DOI 10.1126/science.283.5401.543; KAHLE P, 1992, J BIOL CHEM, V267, P22707; Kao SC, 2001, J BIOL CHEM, V276, P18169, DOI 10.1074/jbc.M008870200; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; KATZ DM, 1990, EXP NEUROL, V110, P1, DOI 10.1016/0014-4886(90)90046-U; Khursigara G, 1999, J BIOL CHEM, V274, P2597, DOI 10.1074/jbc.274.5.2597; KORSCHING S, 1993, J NEUROSCI, V13, P2739; KULLANDER K, 1994, J NEUROSCI RES, V39, P195, DOI 10.1002/jnr.490390210; Kullander K, 1997, J BIOL CHEM, V272, P9300; Lad SP, 2003, CNS NEUROL DISORD-DR, V2, P315, DOI 10.2174/1568007033482724; Lad SP, 2003, J NEUROSCI RES, V73, P614, DOI 10.1002/jnr.10695; Lad SP, 2003, J BIOL CHEM, V278, P24808, DOI 10.1074/jbc.M212270200; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; LINDSAY RM, 1988, J NEUROSCI, V8, P2394; LOEB DM, 1994, J BIOL CHEM, V269, P8901; MAHADEO D, 1994, J BIOL CHEM, V269, P6884; Mahapatra S., 2008, THESIS R FRANKLIN U; MCDONALD NQ, 1991, NATURE, V354, P411, DOI 10.1038/354411a0; MOBLEY WC, 1989, NEURON, V3, P655, DOI 10.1016/0896-6273(89)90276-6; MUFSON EJ, 1995, NEUROREPORT, V6, P1063, DOI 10.1097/00001756-199505090-00028; Mufson Elliott J., 2000, Journal of Comparative Neurology, V427, P19, DOI 10.1002/1096-9861(20001106)427:1<19::AID-CNE2>3.0.CO;2-A; Neet KE, 2001, CELL MOL LIFE SCI, V58, P1021, DOI 10.1007/PL00000917; NEET KE, 1987, METHOD ENZYMOL, V147, P186; Pellicena P, 2006, CURR OPIN STRUC BIOL, V16, P702, DOI 10.1016/j.sbi.2006.10.007; Petruska JC, 2004, NEUROSCI LETT, V361, P168, DOI 10.1016/j.neulet.2003.12.012; Qian XZ, 1998, NEURON, V21, P1017, DOI 10.1016/S0896-6273(00)80620-0; RABIZADEH S, 1993, SCIENCE, V261, P345, DOI 10.1126/science.8332899; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; REINHOLD DS, 1989, J BIOL CHEM, V264, P3538; Salehi A, 2000, EXP NEUROL, V161, P245, DOI 10.1006/exnr.1999.7252; Schlessinger Joseph, 2003, Sci STKE, V2003, pRE12, DOI 10.1126/stke.2003.191.re12; SCOTT J, 1983, NATURE, V302, P538, DOI 10.1038/302538a0; Segal RA, 2003, ANNU REV NEUROSCI, V26, P299, DOI 10.1146/annurev.neuro.26.041002.131421; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; Stroud Robert M, 2004, Sci STKE, V2004, pre7, DOI 10.1126/stke.2312004re7; TIMM DE, 1994, BIOCHEMISTRY-US, V33, P4667, DOI 10.1021/bi00181a602; Tuszynski MH, 2005, NAT MED, V11, P551, DOI 10.1038/nm1239; URFER R, 1994, EMBO J, V13, P5896, DOI 10.1002/j.1460-2075.1994.tb06935.x; Vaghefi H, 2004, J BIOL CHEM, V279, P15604, DOI 10.1074/jbc.M311500200; VAUGHN JL, 1977, IN VITRO CELL DEV B, V13, P213; Ward CW, 2007, TRENDS BIOCHEM SCI, V32, P129, DOI 10.1016/j.tibs.2007.01.001; Wehrman T, 2007, NEURON, V53, P25, DOI 10.1016/j.neuron.2006.09.034; Wiesmann C, 1999, NATURE, V401, P184, DOI 10.1038/43705; WOO SB, 1995, J BIOL CHEM, V270, P6278, DOI 10.1074/jbc.270.11.6278; Woo SB, 1998, PROTEIN SCI, V7, P1006; Woo SB, 1996, J BIOL CHEM, V271, P24433, DOI 10.1074/jbc.271.40.24433; Yoon SO, 1997, J BIOL CHEM, V272, P23231, DOI 10.1074/jbc.272.37.23231; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhang XW, 2007, NATURE, V450, P741, DOI 10.1038/nature05998; Zhang YZ, 2000, J NEUROSCI, V20, P5671, DOI 10.1523/JNEUROSCI.20-15-05671.2000	85	15	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33600	33613		10.1074/jbc.M109.058420	http://dx.doi.org/10.1074/jbc.M109.058420			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19762468	Green Published, hybrid			2022-12-27	WOS:000272028500064
J	Noguchi, A; Matsumura, S; Dezawa, M; Tada, M; Yanazawa, M; Ito, A; Akioka, M; Kikuchi, S; Sato, M; Ideno, S; Noda, M; Fukunari, A; Muramatsu, S; Itokazu, Y; Sato, K; Takahashi, H; Teplow, DB; Nabeshima, Y; Kakita, A; Imahori, K; Hoshi, M				Noguchi, Akihiko; Matsumura, Satoko; Dezawa, Mari; Tada, Mari; Yanazawa, Masako; Ito, Akane; Akioka, Manami; Kikuchi, Satoru; Sato, Michio; Ideno, Shouji; Noda, Munehiro; Fukunari, Atsushi; Muramatsu, Shin-ichi; Itokazu, Yutaka; Sato, Kazuki; Takahashi, Hitoshi; Teplow, David B.; Nabeshima, Yo-ichi; Kakita, Akiyoshi; Imahori, Kazutomo; Hoshi, Minako			Isolation and Characterization of Patient-derived, Toxic, High Mass Amyloid beta-Protein (A beta) Assembly from Alzheimer Disease Brains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MILD COGNITIVE IMPAIRMENT; TRANSGENIC MICE; NEURON LOSS; SYNAPTIC PLASTICITY; NATURAL OLIGOMERS; COMMON MECHANISM; NEURODEGENERATION; AGGREGATION; MEMORY; PATHOLOGY	Amyloid beta-protein (A beta) assemblies are thought to play primary roles in Alzheimer disease (AD). They are considered to acquire surface tertiary structures, not present in physiologic monomers, that are responsible for exerting toxicity, probably through abnormal interactions with their target(s). Therefore, A beta assemblies having distinct surface tertiary structures should cause neurotoxicity through distinct mechanisms. Aiming to clarify the molecular basis of neuronal loss, which is a central phenotype in neurodegenerative diseases such as AD, we report here the selective immunoisolation of neurotoxic 10-15-nm spherical A beta assemblies termed native amylospheroids (native ASPDs) from AD and dementia with Lewy bodies brains, using ASPD tertiary structure-dependent antibodies. In AD patients, the amount of native ASPDs was correlated with the pathologic severity of disease. Native ASPDs are anti-pan oligomer A11 antibody-negative, high mass (> 100 kDa) assemblies that induce degeneration particularly of mature neurons, including those of human origin, in vitro. Importantly, their immuno-specificity strongly suggests that native ASPDs have a distinct surface tertiary structure from other reported assemblies such as dimers, A beta-derived diffusible ligands, and A11-positive assemblies. Only ASPD tertiary structure-dependent antibodies could block ASPD-induced neurodegeneration. ASPDs bind presynaptic target(s) on mature neurons and have a mode of toxicity different from those of other assemblies, which have been reported to exert their toxicity through binding postsynaptic targets and probably perturbing glutamatergic synaptic transmission. Thus, our findings indicate that native ASPDs with a distinct toxic surface induce neuronal loss through a different mechanism from other A beta assemblies.	[Noguchi, Akihiko; Matsumura, Satoko; Yanazawa, Masako; Ito, Akane; Akioka, Manami; Kikuchi, Satoru; Sato, Michio; Hoshi, Minako] Mitsubishi Kagaku Inst Life Sci, Tokyo 1948511, Japan; [Dezawa, Mari; Itokazu, Yutaka; Nabeshima, Yo-ichi; Hoshi, Minako] Kyoto Univ, Kyoto 6068501, Japan; [Dezawa, Mari] Tohoku Univ, Sendai, Miyagi 9088575, Japan; [Tada, Mari; Takahashi, Hitoshi; Kakita, Akiyoshi] Niigata Univ, Niigata 9518585, Japan; [Ideno, Shouji; Noda, Munehiro; Fukunari, Atsushi] Mitsubishi Tanabe Pharma Corp, Osaka 5418505, Japan; [Muramatsu, Shin-ichi] Jichi Med Univ, Shimotsuke, Tochigi 3290498, Japan; [Sato, Kazuki] Fukuoka Womens Univ, Fukuoka 8138529, Japan; [Teplow, David B.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Imahori, Kazutomo] Univ Tokyo, Tokyo 1138654, Japan	Mitsubishi Kagaku Institute of Life Sciences (MITILS); Kyoto University; Tohoku University; Niigata University; Mitsubishi Tanabe Pharma Corporation; Jichi Medical University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Tokyo	Hoshi, M (corresponding author), Sakyo Ku, Kyoto 6068501, Japan.	minhoshi@lmls.med.kyoto-u.ac.jp	Muramatsu, Shin-ichi/K-9420-2013; Muramatsu, Shinichi/ABC-6093-2021	Muramatsu, Shin-ichi/0000-0002-3185-7790; Muramatsu, Shinichi/0000-0002-3185-7790	National Institutes of Health [NS038328]; Health and Labour Sciences; Ministry of Health, Labor, and Welfare; Special Coordination Funds for Promoting Science and Technology; Ministry of Education, Culture, Sports, Science, and Technology; Program for Promotion of Fundamental Studies in Health Sciences; National Institute of Biomedical Innovation; Mitsubishi Kagaku Institute of Life Sciences; Mitsubishi Chemical Corp.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038328] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Health and Labour Sciences; Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Special Coordination Funds for Promoting Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Promotion of Fundamental Studies in Health Sciences; National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Mitsubishi Kagaku Institute of Life Sciences; Mitsubishi Chemical Corp.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part, by National Institutes of Health Grant NS038328 (to D. B. T.), by Health and Labour Sciences Research Grants "Research on Nanotechnical Medical" (to M. H.) and "Research on Psychiatric and Neurological Diseases and Mental Health" (to M. D.) from the Ministry of Health, Labor, and Welfare, by Special Coordination Funds for Promoting Science and Technology (to M. H.) from the Ministry of Education, Culture, Sports, Science, and Technology, and by the Program for Promotion of Fundamental Studies in Health Sciences (to M. D.) from the National Institute of Biomedical Innovation The authors declare the following conflict of interest: this work was supported in part by a grant (to M. H.) from Mitsubishi Kagaku Institute of Life Sciences, which is a nonprofit organization financially supported by Mitsubishi Chemical Corp.; this grant expires in March 2009.	Ashe KH, 2001, LEARN MEMORY, V8, P301, DOI 10.1101/lm.43701; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Bondolfi L, 2002, J NEUROSCI, V22, P515, DOI 10.1523/JNEUROSCI.22-02-00515.2002; Bouwman FH, 2007, NEUROBIOL AGING, V28, P1070, DOI 10.1016/j.neurobiolaging.2006.05.006; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Calhoun ME, 1998, NATURE, V395, P755, DOI 10.1038/27351; Casas C, 2004, AM J PATHOL, V165, P1289, DOI 10.1016/S0002-9440(10)63388-3; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Deshpande A, 2006, J NEUROSCI, V26, P6011, DOI 10.1523/JNEUROSCI.1189-06.2006; Dezawa M, 2004, J CLIN INVEST, V113, P1701, DOI 10.1172/JCI200420935; DICKSON DW, 1989, NEUROBIOL AGING, V10, P402, DOI 10.1016/0197-4580(89)90075-4; GIASSON BI, 2004, NEUROPATHOLOGY DEMEN, P353; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hock B J Jr, 2001, Trends Genet, V17, pS7, DOI 10.1016/S0168-9525(01)02449-0; Hoshi M, 2003, P NATL ACAD SCI USA, V100, P6370, DOI 10.1073/pnas.1237107100; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; INCE PG, 2003, NEURODEGENERATION MO, P188; Iwatsubo T, 2007, NEUROPATHOLOGY, V27, P474, DOI 10.1111/j.1440-1789.2007.00785.x; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kepe V, 2006, METHOD ENZYMOL, V412, P144, DOI 10.1016/S0076-6879(06)12010-8; Khosravani H, 2008, J CELL BIOL, V181, P551, DOI 10.1083/jcb.200711002; Klein WL, 2004, NEUROBIOL AGING, V25, P569, DOI 10.1016/j.neurobiolaging.2004.02.010; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; KOSAKA K, 1990, J NEUROL, V237, P197, DOI 10.1007/BF00314594; Kuo YM, 1996, J BIOL CHEM, V271, P4077; Kuwano R, 2006, HUM MOL GENET, V15, P2170, DOI 10.1093/hmg/ddl142; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Larrieu S, 2002, NEUROLOGY, V59, P1594, DOI 10.1212/01.WNL.0000034176.07159.F8; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; LI YT, 1994, NEUROBIOL AGING, V15, P1, DOI 10.1016/0197-4580(94)90139-2; Lomakin A, 1996, P NATL ACAD SCI USA, V93, P1125, DOI 10.1073/pnas.93.3.1125; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Morrison JH, 1997, SCIENCE, V278, P412, DOI 10.1126/science.278.5337.412; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Perez M, 2005, NEUROSCIENCE, V130, P339, DOI 10.1016/j.neuroscience.2004.09.029; PODLISNY MB, 1995, J BIOL CHEM, V270, P9564, DOI 10.1074/jbc.270.16.9564; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Saido TC, 2006, NEUROSCI RES, V54, P235, DOI 10.1016/j.neures.2005.12.015; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Soto C, 2008, ARCH NEUROL-CHICAGO, V65, P184, DOI 10.1001/archneurol.2007.56; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wilcock DM, 2009, J NEUROSCI, V29, P7957, DOI 10.1523/JNEUROSCI.1339-09.2009; Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com	65	141	150	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32895	32905		10.1074/jbc.M109.000208	http://dx.doi.org/10.1074/jbc.M109.000208			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19759000	Green Published, hybrid			2022-12-27	WOS:000272028400073
J	Rosenfeld, SS; van Duffelen, M; Behnke-Parks, WM; Beadle, C; Corrreia, J; Xing, J				Rosenfeld, Steven S.; van Duffelen, Marilyn; Behnke-Parks, William M.; Beadle, Christopher; Corrreia, John; Xing, Jun			The ATPase Cycle of the Mitotic Motor CENP-E	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINESIN HEAD DOMAINS; CHROMOSOME ALIGNMENT; DIMERIC KINESIN; MICROTUBULE; HYDROLYSIS; PATHWAY; STRAIN; EG5; CONFORMATIONS; KINETOCHORES	We have previously shown that the mitotic motor centrosome protein E (CENP-E) is capable of walking for more than 250 steps on its microtubule track without dissociating. We have examined the kinetics of this molecular motor to see if its enzymology explains this remarkable degree of processivity. We find that like the highly processive transport motor kinesin 1, the enzymatic cycle of CENP-E is characterized by rapid ATP binding, multiple enzymatic turnovers per diffusive encounter, and gating of nucleotide binding. These features endow CENP-E with a high duty cycle, a prerequisite for processivity. However, unlike kinesin 1, neck linker docking in CENP-E is slow, occurring at a rate closer to that for Eg5, a mitotic kinesin that takes only 5-10 steps per processive run. These results suggest that like kinesin 1, features outside of the catalytic domain of CENP-E may also play a role in regulating the processive behavior of this motor.	[Behnke-Parks, William M.] Columbia Univ, Dept Biol, New York, NY 10032 USA; [Rosenfeld, Steven S.; van Duffelen, Marilyn; Beadle, Christopher] Columbia Univ, Dept Neurol, New York, NY 10032 USA; [Rosenfeld, Steven S.] Columbia Univ, Dept Cell Biol & Pathol, New York, NY 10032 USA; [Corrreia, John] Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA; [Xing, Jun] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA	Columbia University; Columbia University; Columbia University; University of Mississippi; University of Mississippi Medical Center; University of Alabama System; University of Alabama Birmingham	Rosenfeld, SS (corresponding author), Columbia Univ Coll Phys & Surg, Dept Neurol, 710 W 168th St, New York, NY 10032 USA.	sr2327@columbia.edu			National Institutes of Health, NIAMS [AR 0485675]	National Institutes of Health, NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health, NIAMS, Grant AR 0485675.	Cochran JC, 2006, BIOCHEMISTRY-US, V45, P12334, DOI 10.1021/bi0608562; Garcia-Saez I, 2004, J MOL BIOL, V340, P1107, DOI 10.1016/j.jmb.2004.05.053; Gennerich A, 2009, CURR OPIN CELL BIOL, V21, P59, DOI 10.1016/j.ceb.2008.12.002; GILBERT SP, 1995, NATURE, V373, P671, DOI 10.1038/373671a0; Goshima G, 2003, J CELL BIOL, V162, P1003, DOI 10.1083/jcb.200303022; Hackney DD, 2005, P NATL ACAD SCI USA, V102, P18338, DOI 10.1073/pnas.0505288102; HACKNEY DD, 1995, NATURE, V377, P448, DOI 10.1038/377448a0; Hall MC, 2002, J BIOL CHEM, V277, P3673, DOI 10.1074/jbc.M106120200; HIRATSUKA T, 1983, BIOCHIM BIOPHYS ACTA, V742, P496, DOI 10.1016/0167-4838(83)90267-4; Jiang W, 1997, J BIOL CHEM, V272, P7626, DOI 10.1074/jbc.272.12.7626; Jiang W, 1997, J BIOL CHEM, V272, P5616, DOI 10.1074/jbc.272.9.5616; Kim Y, 2008, J CELL BIOL, V181, P411, DOI 10.1083/jcb.200802189; Klumpp LM, 2004, P NATL ACAD SCI USA, V101, P3444, DOI 10.1073/pnas.0307691101; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; LIU S, 1995, ANAL BIOCHEM, V224, P199, DOI 10.1006/abio.1995.1030; Ma YZ, 1997, J BIOL CHEM, V272, P724, DOI 10.1074/jbc.272.2.724; McEwen BF, 2001, MOL BIOL CELL, V12, P2776, DOI 10.1091/mbc.12.9.2776; Moyer ML, 1998, BIOCHEMISTRY-US, V37, P800, DOI 10.1021/bi9711184; Putkey FR, 2002, DEV CELL, V3, P351, DOI 10.1016/S1534-5807(02)00255-1; Rosenfeld SS, 2003, J BIOL CHEM, V278, P18550, DOI 10.1074/jbc.M300849200; Rosenfeld SS, 2001, J BIOL CHEM, V276, P40167, DOI 10.1074/jbc.M103899200; Rosenfeld SS, 2005, J BIOL CHEM, V280, P35684, DOI 10.1074/jbc.M506561200; Schaar BT, 1997, J CELL BIOL, V139, P1373, DOI 10.1083/jcb.139.6.1373; Sindelar CV, 2002, NAT STRUCT BIOL, V9, P844, DOI 10.1038/nsb852; T Valentine M, 2007, CURR OPIN CELL BIOL, V19, P75, DOI 10.1016/j.ceb.2006.12.011; Thorn KS, 2000, J CELL BIOL, V151, P1093, DOI 10.1083/jcb.151.5.1093; Valentine MT, 2006, NAT CELL BIOL, V8, P470, DOI 10.1038/ncb1394; Weaver BAA, 2003, J CELL BIOL, V162, P551, DOI 10.1083/jcb.200303167; Wood KW, 1997, CELL, V91, P357, DOI 10.1016/S0092-8674(00)80419-5; Xing J, 2000, J BIOL CHEM, V275, P35413, DOI 10.1074/jbc.M004232200; Yao XB, 2000, NAT CELL BIOL, V2, P484, DOI 10.1038/35019518; Yardimci H, 2008, P NATL ACAD SCI USA, V105, P6016, DOI 10.1073/pnas.0711314105; Yildiz A, 2008, CELL, V134, P1030, DOI 10.1016/j.cell.2008.07.018	33	24	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32858	32868		10.1074/jbc.M109.041210	http://dx.doi.org/10.1074/jbc.M109.041210			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19759394	Green Published, hybrid			2022-12-27	WOS:000272028400070
J	Dennler, S; Andre, J; Verrecchia, F; Mauviel, A				Dennler, Sylviane; Andre, Jocelyne; Verrecchia, Franck; Mauviel, Alain			Cloning of the Human GLI2 Promoter TRANSCRIPTIONAL ACTIVATION BY TRANSFORMING GROWTH FACTOR-beta VIA SMAD3/beta-CATENIN COOPERATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; SIGNALING PATHWAY; HEDGEHOG; CATENIN; WNT; CANCER; MEDIATORS; COACTIVATOR; DOMAIN; SMAD2	GLI2 (GLI-Kruppel family member 2), a zinc finger transcription factor that mediates Hedgehog signaling, is implicated in the progression of an ever-growing number of human malignancies, including prostate and pancreatic cancer, as well as basal cell carcinoma of the skin. Its expression is up-regulated by transforming growth factor-beta (TGF-beta) in a variety of cell types, both normal and transformed. We report herein that TGF-beta driven GLI2 expression is transcriptional and does not result from stabilization of GLI2 transcripts. We describe the characterization of the 5'-flanking sequence of human GLI2 mRNA, the identification of a transcription start site, the cloning of similar to 1,600 bp of the regulatory promoter region and the identification and functional analysis of a TGF-beta-responsive region mapped to a 91-bp sequence between nucleotides -119 and -29 of the promoter. This region harbors SMAD and lymphoid enhancer factor/T cell factor binding sites that allow functional cooperation between SMAD3 and beta-catenin, recruited to the promoter in response to TGF-beta to drive GLI2 gene transcription.	[Dennler, Sylviane; Andre, Jocelyne; Verrecchia, Franck; Mauviel, Alain] Univ Paris Diderot, INSERM, U697, F-75010 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Mauviel, A (corresponding author), Hop St Louis, INSERM, U697, 1 Ave Claude Vellefaux, F-75010 Paris, France.	alain.mauviel@inserm.fr	Verrecchia, Franck/G-5535-2018; MAUVIEL, Alain/F-6251-2013	Verrecchia, Franck/0000-0003-4920-2554; Mauviel, Alain/0000-0002-0438-2793	Donation Henriette et Emile Goutiere; Canceropole Ile-de-France; INSERM	Donation Henriette et Emile Goutiere; Canceropole Ile-de-France(Region Ile-de-France); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by the Donation Henriette et Emile Goutiere (to A. M.), Canceropole Ile-de-France, and INSERM.	Altaba AR, 2002, NAT REV CANCER, V2, P361, DOI 10.1038/nrc796; Clifford RL, 2008, J BIOL CHEM, V283, P35337, DOI 10.1074/jbc.M803342200; de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Dennler S, 1999, ONCOGENE, V18, P1643, DOI 10.1038/sj.onc.1202729; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Edlund S, 2005, MOL CELL BIOL, V25, P1475, DOI 10.1128/MCB.25.4.1475-1488.2005; Evangelista M, 2006, CLIN CANCER RES, V12, P5924, DOI 10.1158/1078-0432.CCR-06-1736; Hirota M, 2008, CELL SIGNAL, V20, P1632, DOI 10.1016/j.cellsig.2008.05.003; Hoppler S, 2007, J CELL SCI, V120, P385, DOI 10.1242/jcs.03363; Hu M, 2008, CANCER CELL, V13, P394, DOI 10.1016/j.ccr.2008.03.007; Javelaud D, 2004, INT J BIOCHEM CELL B, V36, P1161, DOI 10.1016/S1357-2725(03)00255-3; Ji J, 2008, INT J CANCER, V122, P50, DOI 10.1002/ijc.23023; Kasper M, 2006, EUR J CANCER, V42, P437, DOI 10.1016/j.ejca.2005.08.039; Kelleher FC, 2006, ACTA ONCOL, V45, P375, DOI 10.1080/02841860600602946; Kim Y, 2007, CANCER RES, V67, P3583, DOI 10.1158/0008-5472.CAN-06-3040; Labbe E, 2000, P NATL ACAD SCI USA, V97, P8358, DOI 10.1073/pnas.150152697; Lauth M, 2007, CELL CYCLE, V6, P2458, DOI 10.4161/cc.6.20.4808; Lei S, 2004, J BIOL CHEM, V279, P42492, DOI 10.1074/jbc.M404025200; Maeda O, 2006, ONCOL REP, V16, P91; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mullor JL, 2001, CURR BIOL, V11, P769, DOI 10.1016/S0960-9822(01)00229-9; Narita S, 2008, CLIN CANCER RES, V14, P5769, DOI 10.1158/1078-0432.CCR-07-4282; Nishita M, 2000, NATURE, V403, P781, DOI 10.1038/35001602; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Paul S, 2008, NEOPLASMA, V55, P165; Roessler E, 2005, HUM MOL GENET, V14, P2181, DOI 10.1093/hmg/ddi222; Roose J, 1999, SCIENCE, V285, P1923, DOI 10.1126/science.285.5435.1923; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; TEN DP, 2004, TRENDS BIOCHEM SCI, V29, P265; Thiyagarajan S, 2007, CANCER RES, V67, P10642, DOI 10.1158/0008-5472.CAN-07-2015; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Wei Y, 2003, J BIOL CHEM, V278, P5188, DOI 10.1074/jbc.M207216200	38	103	106	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31523	31531		10.1074/jbc.M109.059964	http://dx.doi.org/10.1074/jbc.M109.059964			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19797115	Green Published, hybrid			2022-12-27	WOS:000271572700005
J	Huot, ME; Vogel, G; Richard, S				Huot, Marc-Etienne; Vogel, Gillian; Richard, Stephane			Identification of a Sam68 Ribonucleoprotein Complex Regulated by Epidermal Growth Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; RNA-BINDING PROTEINS; CELL-CYCLE PROGRESSION; MESSENGER-RNA; TYROSINE PHOSPHORYLATION; STRESS GRANULES; KH-DOMAIN; FUNCTIONAL INTERACTION; SIGNALING PATHWAY; HUMAN-BREAST	Sam68, Src associated in mitosis of 68 kDa, is a known RNA-binding protein and a signaling adaptor protein for tyrosine kinases. However, the proteins associated with Sam68 and the existence of a Sam68 complex, its mass, and regulation are, however, unknown. Herein we identify a large Sam68 complex with a mass > 1 MDa in HeLa cells that is composed of similar to 40 proteins using an immunoprecipitation followed by a mass spectrometry approach. Many of the proteins identified are RNA-binding proteins and are known components of a previously identified structure termed the spreading initiation center. The large Sam68 complex is a ribonucleoprotein complex, as treatment with RNases caused a shift in the molecular mass of the complex to 200-450 kDa. Moreover, treatment of HeLa cells with phorbol 12-myristate 13-acetate or epidermal growth factor induced the disassociation of Sam68 from the large complex and the appearance of Sam68 within the smaller complex. Actually, in certain cell lines such as breast cancer cell lines MCF-7 and BT-20, Sam68 exists in equilibrium between a large and a small complex. The appearance of the small Sam68 complex in cells correlates with the ability of Sam68 to promote the alternative splicing of CD44 and cell migration. Our findings show that Sam68 exists in equilibrium in transformed cells between two complexes and that extracellular signals, such as epidermal growth factor stimulation, promote alternative splicing by modulating the composition of the Sam68 complex.	Sir Mortimer B Davis Jewish Hosp, Terry Fox Mol Oncol Grp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; Sir Mortimer B Davis Jewish Hosp, Bloomfield Ctr Res Aging, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; McGill Univ, Dept Oncol, Montreal, PQ H3T 1E2, Canada; McGill Univ, Dept Med, Montreal, PQ H3T 1E2, Canada	Lady Davis Institute; McGill University; Lady Davis Institute; McGill University; McGill University; McGill University	Richard, S (corresponding author), Segal Canc Ctr, 3755 Cote Ste Catherine Rd, Montreal, PQ H3T 1E2, Canada.	stephane.richard@mcgill.ca			Fonds de la Recherche en Sante du Quebec; Cancer Research Society Inc.	Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Cancer Research Society Inc.	This work was supported by Canadian Institutes of Health Research Grant MT13377.; Supported by fellowships from the Fonds de la Recherche en Sante du Quebec and the Cancer Research Society Inc.	Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Antar LN, 2005, GENES BRAIN BEHAV, V4, P350, DOI 10.1111/j.1601-183X.2005.00128.x; Aubele M, 2008, BRIT J CANCER, V99, P1089, DOI 10.1038/sj.bjc.6604660; Babic I, 2006, ONCOGENE, V25, P4955, DOI 10.1038/sj.onc.1209504; Babic I, 2004, ONCOGENE, V23, P3781, DOI 10.1038/sj.onc.1207484; Batsche E, 2006, NAT STRUCT MOL BIOL, V13, P22, DOI 10.1038/nsmb1030; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Chawla G, 2009, MOL CELL BIOL, V29, P201, DOI 10.1128/MCB.01349-08; Chen TP, 1997, MOL CELL BIOL, V17, P5707, DOI 10.1128/MCB.17.10.5707; Chen TP, 1999, MOL BIOL CELL, V10, P3015, DOI 10.1091/mbc.10.9.3015; Cheng CH, 2006, MOL CELL BIOL, V26, P362, DOI 10.1128/MCB.26.1.362-370.2006; Cheung N, 2007, NAT CELL BIOL, V9, P1208, DOI 10.1038/ncb1642; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; de Hoog CL, 2004, CELL, V117, P649, DOI 10.1016/S0092-8674(04)00456-8; Denegri M, 2001, MOL BIOL CELL, V12, P3502, DOI 10.1091/mbc.12.11.3502; Di Fruscio M, 1999, P NATL ACAD SCI USA, V96, P2710, DOI 10.1073/pnas.96.6.2710; French J, 2002, HISTOCHEM J, V34, P223, DOI 10.1023/A:1021737413055; FUMAGALLI S, 1994, NATURE, V368, P871, DOI 10.1038/368871a0; Furic L, 2008, RNA, V14, P324, DOI 10.1261/rna.720308; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Harfmann AM, 1999, MOL BIOL CELL, V10, P3909, DOI 10.1091/mbc.10.11.3909; Henao-Mejia J, 2009, MOL CELL, V33, P87, DOI 10.1016/j.molcel.2008.11.024; Hong W, 2002, MOL CANCER RES, V1, P48; Huot ME, 2009, MOL CELL BIOL, V29, P1933, DOI 10.1128/MCB.01707-08; Inoue A, 2007, P NATL ACAD SCI USA, V104, P8983, DOI 10.1073/pnas.0607595104; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Li JL, 2002, J VIROL, V76, P8374, DOI 10.1128/JVI.76.16.8374-8382.2002; Lin Q, 1997, J BIOL CHEM, V272, P27274, DOI 10.1074/jbc.272.43.27274; Lukong KE, 2005, J BIOL CHEM, V280, P38639, DOI 10.1074/jbc.M505802200; Lukong KE, 2003, BBA-REV CANCER, V1653, P73, DOI 10.1016/j.bbcan.2003.09.001; Lukong KE, 2008, TRENDS GENET, V24, P416, DOI 10.1016/j.tig.2008.05.004; MAA MC, 1994, MOL CELL BIOL, V14, P5466, DOI 10.1128/MCB.14.8.5466; Matter N, 2002, NATURE, V420, P691, DOI 10.1038/nature01153; Mazroui R, 2002, HUM MOL GENET, V11, P3007, DOI 10.1093/hmg/11.24.3007; Miki T, 2005, CELL STRUCT FUNCT, V30, P51, DOI 10.1247/csf.30.51; Misteli T, 1998, J CELL BIOL, V143, P297, DOI 10.1083/jcb.143.2.297; Mokas S, 2009, MOL BIOL CELL, V20, P2673, DOI 10.1091/mbc.E08-10-1061; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Ning Jun-yu, 2005, Zhonghua Bing Li Xue Za Zhi, V34, P215; Ostrowski J, 2000, J BIOL CHEM, V275, P3619, DOI 10.1074/jbc.275.5.3619; Parker F, 1996, MOL CELL BIOL, V16, P2561; Paronetto MP, 2007, J CELL BIOL, V176, P929, DOI 10.1083/jcb.200701005; Paronetto MP, 2009, J CELL BIOL, V185, P235, DOI 10.1083/jcb.200811138; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; PYPE S, 1994, J BIOL CHEM, V269, P31457; Rahmouni S, 2005, MOL CELL BIOL, V25, P2227, DOI 10.1128/MCB.25.6.2227-2241.2005; Reddy TR, 1999, NAT MED, V5, P635, DOI 10.1038/9479; Richard S, 2008, ONCOGENE, V27, P548, DOI 10.1038/sj.onc.1210652; Richard S, 2005, PLOS GENET, V1, P676, DOI 10.1371/journal.pgen.0010074; RICHARD S, 1995, MOL CELL BIOL, V15, P186, DOI 10.1128/MCB.15.1.186; Seales EC, 2005, J BIOL CHEM, V280, P37610, DOI 10.1074/jbc.M508476200; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; TAYLOR SJ, 1994, NATURE, V368, P867, DOI 10.1038/368867a0; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; VOGEL LB, 1995, J BIOL CHEM, V270, P2506, DOI 10.1074/jbc.270.6.2506; Volk T, 2008, TRENDS GENET, V24, P94, DOI 10.1016/j.tig.2007.11.009; WENG ZG, 1994, MOL CELL BIOL, V14, P4509, DOI 10.1128/MCB.14.7.4509; WU J, 1993, SCIENCE, V262, P1065, DOI 10.1126/science.7694366; Yang HP, 2002, ONCOGENE, V21, P7187, DOI 10.1038/sj.onc.1205759; ZHENG CF, 1994, BIOCHEMISTRY-US, V33, P5595, DOI 10.1021/bi00184a031	61	18	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31903	31913		10.1074/jbc.M109.018465	http://dx.doi.org/10.1074/jbc.M109.018465			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19762470	Green Published, hybrid			2022-12-27	WOS:000271572700045
J	Korn, A; Ajlani, G; Lagoutte, B; Gall, A; Setif, P				Korn, Anja; Ajlani, Ghada; Lagoutte, Bernard; Gall, Andrew; Setif, Pierre			Ferredoxin:NADP(+) Oxidoreductase Association with Phycocyanin Modulates Its Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNECHOCYSTIS SP PCC-6803; FLASH-ABSORPTION-SPECTROSCOPY; FERREDOXIN-NADP(+) REDUCTASE; ELECTRON-TRANSFER; PHOTOSYSTEM-I; CATALYTIC MECHANISM; NONPHOTOSYNTHETIC TISSUES; SPINACH-CHLOROPLASTS; NADP+ OXIDOREDUCTASE; THYLAKOID MEMBRANES	In photosynthetic organisms, ferredoxin:NADP(+) oxidoreductase (FNR) is known to provide NADPH for CO2 assimilation, but it also utilizes NADPH to provide reduced ferredoxin. The cyanobacterium Synechocystis sp. strain PCC6803 produces two FNR isoforms, a small one (FNRS) similar to the one found in plant plastids and a large one (FNRL) that is associated with the phycobilisome, a light-harvesting complex. Here we show that a mutant lacking FNRL exhibits a higher NADP(+)/NADPH ratio. We also purified to homogeneity a phycobilisome subcomplex comprising FNRL, named FNRL-PC. The enzymatic activities of FNRL-PC were compared with those of FNRS. During NADPH oxidation, FNRL-PC exhibits a 30% decrease in the Michaelis constant K-m(NADPH), and a 70% increase in K-m(ferredoxin), which is in agreement with its predicted lower activity of ferredoxin reduction. During NADP(+) reduction, the FNRL-PC shows a 29/43% decrease in the rate of single electron transfer from reduced ferredoxin in the presence/absence of NADP(+). The increase in K-m(ferredoxin) and the rate decrease of single reduction are attributed to steric hindrance by the phycocyanin moiety of FNRL-PC. Both isoforms are capable of catalyzing the NADP(+) reduction under multiple turnover conditions. Furthermore, we obtained evidence that, under high ionic strength conditions, electron transfer from reduced ferredoxin is rate limiting during this process. The differences that we observe might not fully explain the in vivo properties of the Synechocystis mutants expressing only one of the isoforms. Therefore, we advocate that FNR localization and/or substrates availability are essential in vivo.	[Korn, Anja; Ajlani, Ghada; Lagoutte, Bernard; Gall, Andrew; Setif, Pierre] CEA, Inst Biol & Technol Saclay, CNRS, F-91191 Gif Sur Yvette, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Ajlani, G (corresponding author), CEA Saclay, IBiTecS, F-91191 Gif Sur Yvette, France.	gajlani@cea.fr; pierre.setif@cea.fr	Gall, Andrew/U-5819-2019	Gall, Andrew/0000-0002-5629-1834	Agence Nationale de la Recherche, France [ANR-07-CEXC-009]; European Commission [EU FP7-ENERGY-2007-1-RTD SOLAR-H2]	Agence Nationale de la Recherche, France(French National Research Agency (ANR)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported in part by the Agence Nationale de la Recherche, France ( PHYCOSYN, to G. A. and ANR-07-CEXC-009, to A. G.) and the European Commission ( EU FP7-ENERGY-2007-1-RTD SOLAR-H2, to P. S.).	AJLANI G, 1995, BBA-BIOENERGETICS, V1231, P189, DOI 10.1016/0005-2728(95)00086-X; Akashi T, 1999, J BIOL CHEM, V274, P29399, DOI 10.1074/jbc.274.41.29399; ALIVERTI A, 1995, FEBS LETT, V368, P220, DOI 10.1016/0014-5793(95)00648-S; Aliverti A, 2004, BBA-PROTEINS PROTEOM, V1696, P93, DOI 10.1016/j.bbapap.2003.09.011; Aliverti A, 2001, BIOCHEMISTRY-US, V40, P14501, DOI 10.1021/bi011224c; Arteni AA, 2009, BBA-BIOENERGETICS, V1787, P272, DOI 10.1016/j.bbabio.2009.01.009; Barth P, 2000, J BIOL CHEM, V275, P7030, DOI 10.1074/jbc.275.10.7030; BATIE CJ, 1984, J BIOL CHEM, V259, P1976; BATIE CJ, 1984, J BIOL CHEM, V259, P8832; BOTTIN H, 1992, BIOCHIM BIOPHYS ACTA, V1101, P48, DOI 10.1016/0167-4838(92)90465-P; Brettel K, 2001, BBA-BIOENERGETICS, V1507, P100, DOI 10.1016/S0005-2728(01)00202-X; BRUNS CM, 1995, J MOL BIOL, V247, P125, DOI 10.1006/jmbi.1994.0127; Carrillo N, 2003, EUR J BIOCHEM, V270, P1900, DOI 10.1046/j.1432-1033.2003.03566.x; Cassan N, 2005, J BIOL CHEM, V280, P25960, DOI 10.1074/jbc.M503742200; Corrado ME, 1996, EUR J BIOCHEM, V239, P662, DOI 10.1111/j.1432-1033.1996.0662u.x; Danielsson R, 2004, BBA-BIOENERGETICS, V1608, P53, DOI 10.1016/j.bbabio.2003.10.005; ELMORJANI K, 1986, ARCH MICROBIOL, V146, P186, DOI 10.1007/BF00402349; ENGEL PC, 1971, BIOCHEM J, V125, P879, DOI 10.1042/bj1250879; FORTI G, 1968, EUR J BIOCHEM, V3, P461, DOI 10.1111/j.1432-1033.1967.tb19553.x; GANTT E, 1972, J CELL BIOL, V54, P313, DOI 10.1083/jcb.54.2.313; GLAZER AN, 1985, ANNU REV BIOPHYS BIO, V14, P47, DOI 10.1146/annurev.bb.14.060185.000403; GLAZER AN, 1989, J BIOL CHEM, V264, P1; Gomez-Lojero C, 2003, BIOCHEMISTRY-US, V42, P13800, DOI 10.1021/bi0346998; Gou P, 2006, BIOCHEMISTRY-US, V45, P14389, DOI 10.1021/bi061779d; GREEN LS, 1991, PLANT PHYSIOL, V96, P1207, DOI 10.1104/pp.96.4.1207; Gummadova JO, 2007, J EXP BOT, V58, P3971, DOI 10.1093/jxb/erm252; Hanke GT, 2004, PHOTOSYNTH RES, V81, P317, DOI 10.1023/B:PRES.0000036885.01534.b8; Hanke GT, 2004, PLANT PHYSIOL, V134, P255, DOI 10.1104/pp.103.032755; Hanke GT, 2008, PLANT CELL ENVIRON, V31, P1017, DOI 10.1111/j.1365-3040.2008.01814.x; Hurley JK, 2002, BBA-BIOENERGETICS, V1554, P5, DOI 10.1016/S0005-2728(02)00188-3; Karplus PA, 2004, PHOTOSYNTH RES, V81, P303, DOI 10.1023/B:PRES.0000036884.57303.2e; Kondo K, 2005, PHOTOSYNTH RES, V84, P269, DOI 10.1007/s11120-004-7762-9; Kondo K, 2007, PLANT PHYSIOL, V144, P1200, DOI 10.1104/pp.107.099267; Kondo K, 2009, PHOTOSYNTH RES, V99, P217, DOI 10.1007/s11120-008-9399-6; Medina M, 1998, BIOCHEMISTRY-US, V37, P2715, DOI 10.1021/bi971795y; MORIGASAKI S, 1990, PLANT PHYSIOL, V93, P896, DOI 10.1104/pp.93.3.896; Nakajima M, 2002, PLANT CELL PHYSIOL, V43, P484, DOI 10.1093/pcp/pcf058; Okutani S, 2005, PLANT PHYSIOL, V139, P1451, DOI 10.1104/pp.105.070813; Onda Y, 2000, PLANT PHYSIOL, V123, P1037, DOI 10.1104/pp.123.3.1037; Palatnik JF, 1997, PLANT PHYSIOL, V115, P1721, DOI 10.1104/pp.115.4.1721; Poncelet M, 1998, MOL MICROBIOL, V28, P813, DOI 10.1046/j.1365-2958.1998.00844.x; ROGNER M, 1990, J BIOL CHEM, V265, P6189; SCHLUCHTER WM, 1992, BIOCHEMISTRY-US, V31, P3092, DOI 10.1021/bi00127a009; Setif P, 2002, BBA-BIOENERGETICS, V1555, P204, DOI 10.1016/S0005-2728(02)00279-7; SETIF PQY, 1994, BIOCHEMISTRY-US, V33, P8495, DOI 10.1021/bi00194a014; Shin M, 1971, METHOD ENZYMOL, V23, P440; Tejero J, 2007, ARCH BIOCHEM BIOPHYS, V459, P79, DOI 10.1016/j.abb.2006.10.023; Thomas JC, 2006, P NATL ACAD SCI USA, V103, P18368, DOI 10.1073/pnas.0607718103; Ughy B, 2004, MICROBIOL-SGM, V150, P4147, DOI 10.1099/mic.0.27498-0; van Thor JJ, 1999, EMBO J, V18, P4128, DOI 10.1093/emboj/18.15.4128; van Thor JJ, 2000, BBA-BIOENERGETICS, V1457, P129, DOI 10.1016/S0005-2728(00)00072-4; WHITBY LG, 1953, BIOCHEM J, V54, P437, DOI 10.1042/bj0540437; ZANETTI G, 1980, FEBS LETT, V111, P373, DOI 10.1016/0014-5793(80)80830-1	53	28	28	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31789	31797		10.1074/jbc.M109.024638	http://dx.doi.org/10.1074/jbc.M109.024638			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19759024	Green Published, hybrid			2022-12-27	WOS:000271572700033
J	Evjenth, R; Hole, K; Karlsen, OA; Ziegler, M; Arnesen, T; Lillehaug, JR				Evjenth, Rune; Hole, Kristine; Karlsen, Odd A.; Ziegler, Mathias; Arnesen, Thomas; Lillehaug, Johan R.			Human Naa50p (Nat5/San) Displays Both Protein N-alpha- and N-epsilon-Acetyltransferase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GCN5 TRANSCRIPTIONAL COACTIVATOR; TERMINAL ACETYLTRANSFERASES; COMPLEX; ACETYLATION; YEAST; MECHANISM; REQUIREMENTS; TIPIN; PHASE; NATA	Protein acetylation is a widespread modification that is mediated by site-selective acetyltransferases. KATs (lysine N-epsilon-acetyltransferases), modify the side chain of specific lysines on histones and other proteins, a central process in regulating gene expression. N-alpha-terminal acetylation occurs on the ribosome where the alpha amino group of nascent polypeptides is acetylated by NATs(N-terminal acetyltransferase). In yeast, three different NAT complexes were identified NatA, NatB, and NatC. NatA is composed of two main subunits, the catalytic subunit Naa10p (Ard1p) and Naa15p (Nat1p). Naa50p (Nat5) is physically associated with NatA. In man, hNaa50p was shown to have acetyltransferase activity and to be important for chromosome segregation. In this study, we used purified recombinant hNaa50p and multiple oligopeptide substrates to identify and characterize an N-alpha-acetyltransferase activity of hNaa50p. As the preferred substrate this activity acetylates oligopeptides with N termini Met-Leu-Xxx-Pro. Furthermore, hNaa50p autoacetylates lysines 34, 37, and 140 in vitro, modulating hNaa50p substrate specificity. In addition, histone 4 was detected as a hNaa50p KAT substrate in vitro. Our findings thus provide the first experimental evidence of an enzyme having both KAT and NAT activities.	[Lillehaug, Johan R.] Univ Bergen, Dept Mol Biol, N-5020 Bergen, Norway; [Hole, Kristine; Arnesen, Thomas] Univ Bergen, Dept Surg Sci, N-5020 Bergen, Norway; [Hole, Kristine; Arnesen, Thomas] Haukeland Hosp, Dept Surg, N-5021 Bergen, Norway	University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital	Lillehaug, JR (corresponding author), Thormohlensgate 55, N-5020 Bergen, Norway.	Johan.lillehaug@mbi.uib.no	; Arnesen, Thomas/J-7139-2017	Ziegler, Mathias/0000-0001-6961-2396; Arnesen, Thomas/0000-0002-3005-147X	Norwegian Cancer Society; Meltzer Foundation; Norwegian Health Region West	Norwegian Cancer Society(Norwegian Cancer Society); Meltzer Foundation; Norwegian Health Region West	This work was supported by The Norwegian Cancer Society, The Meltzer Foundation, and the Norwegian Health Region West.	Arnesen T, 2005, FEBS LETT, V579, P6428, DOI 10.1016/j.febslet.2005.10.036; Arnesen T, 2006, GENE, V371, P291, DOI 10.1016/j.gene.2005.12.008; Arnesen T, 2005, BIOCHEM J, V386, P433, DOI 10.1042/BJ20041071; Arnesen T, 2009, P NATL ACAD SCI USA, V106, P8157, DOI 10.1073/pnas.0901931106; Dormeyer W, 2005, MOL CELL PROTEOMICS, V4, P1226, DOI 10.1074/mcp.M500047-MCP200; Evjenth Rune, 2009, BMC Proc, V3 Suppl 6, pS5, DOI 10.1186/1753-6561-3-S6-S5; Gamberi C, 1997, MOL CELL BIOL, V17, P2587, DOI 10.1128/MCB.17.5.2587; Gautschi M, 2003, MOL CELL BIOL, V23, P7403, DOI 10.1128/MCB.23.20.7403-7414.2003; Gobom J, 1999, J MASS SPECTROM, V34, P105, DOI 10.1002/(SICI)1096-9888(199902)34:2<105::AID-JMS768>3.0.CO;2-4; Gotter AL, 2007, J MOL BIOL, V366, P36, DOI 10.1016/j.jmb.2006.10.097; Hou FJ, 2007, J CELL BIOL, V177, P587, DOI 10.1083/jcb.200701043; Kalkhoven E, 2004, BIOCHEM PHARMACOL, V68, P1145, DOI 10.1016/j.bcp.2004.03.045; Marmorstein R, 2004, METHOD ENZYMOL, V376, P106; PARK EC, 1992, EMBO J, V11, P2087, DOI 10.1002/j.1460-2075.1992.tb05267.x; Pimenta-Marques A, 2008, DEV BIOL, V323, P197, DOI 10.1016/j.ydbio.2008.08.021; Polevoda B, 2003, J MOL BIOL, V325, P595, DOI 10.1016/S0022-2836(02)01269-X; Polevoda B, 2008, J CELL BIOCHEM, V103, P492, DOI 10.1002/jcb.21418; Polevoda Bogdan, 2009, BMC Proc, V3 Suppl 6, pS2, DOI 10.1186/1753-6561-3-S6-S2; PUGH BF, 1990, CELL, V61, P1187, DOI 10.1016/0092-8674(90)90683-6; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Starheim KK, 2009, MOL CELL BIOL, V29, P3569, DOI 10.1128/MCB.01909-08; Tanner KG, 1999, J BIOL CHEM, V274, P18157, DOI 10.1074/jbc.274.26.18157; Trievel RC, 1999, P NATL ACAD SCI USA, V96, P8931, DOI 10.1073/pnas.96.16.8931; Williams BC, 2003, CURR BIOL, V13, P2025, DOI 10.1016/j.cub.2003.11.018; Yoshizawa-Sugata N, 2007, J BIOL CHEM, V282, P2729, DOI 10.1074/jbc.M605596200	25	73	76	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31122	31129		10.1074/jbc.M109.001347	http://dx.doi.org/10.1074/jbc.M109.001347			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19744929	Green Published, hybrid			2022-12-27	WOS:000271378400040
J	Hyry, M; Lantto, J; Myllyharju, J				Hyry, Marjo; Lantto, Juha; Myllyharju, Johanna			Missense Mutations That Cause Bruck Syndrome Affect Enzymatic Activity, Folding, and Oligomerization of Lysyl Hydroxylase 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSECT CELLS; CROSS-LINKS; COLLAGEN; EXPRESSION; IDENTIFICATION; 2-OXOGLUTARATE; GLYCOSYLATION; RESIDUES; ISOFORM; CLONING	Bruck syndrome is a rare autosomal recessive connective tissue disorder characterized by fragile bones, joint contractures, scoliosis, and osteoporosis. The telopeptides of bone collagen I are underhydroxylated in these patients, leading to abnormal collagen cross-linking. Three point mutations in lysyl hydroxylase (LH) 2, the enzyme responsible for the hydroxylation of collagen telopeptides, have been identified in Bruck syndrome. As none of them affects the residues known to be critical for LH activity, we studied their consequences at the molecular level by analyzing the folding and catalytic properties of the corresponding mutant recombinant polypeptides. Folding and oligomerization of the R594H and G597V mutants were abnormal, and their activity was reduced by > 95% relative to the wild type. The T604I mutation did not affect the folding properties, although the mutant retained only similar to 8% activity under standard assay conditions. As the reduced activity was caused by a 10-fold increase in the Km for 2-oxoglutarate, the mutation interferes with binding of this cosubstrate. In the presence of a saturating 2-oxoglutarate concentration, the activity of the T604I mutant was similar to 30% of that of the wild type. However, the T604I mutant did not generate detectable amounts of hydroxylysine in the N-terminal telopeptide of a recombinant procollagen I chain when coexpressed in insect cells. The low activity of the mutant LH2 polypeptides is in accordance with the markedly reduced extent of collagen telopeptide hydroxylation in Bruck syndrome, with consequent changes in the cross-linking of collagen fibrils and severe abnormalities in the skeletal structures.	[Myllyharju, Johanna] Univ Oulu, Oulu Ctr Cell Matrix Res, Bioctr Oulu, FIN-90014 Oulu, Finland; Univ Oulu, Dept Med Biochem & Mol Biol, FIN-90014 Oulu, Finland	University of Oulu; University of Oulu	Myllyharju, J (corresponding author), Univ Oulu, Oulu Ctr Cell Matrix Res, Bioctr Oulu, POB 5000, FIN-90014 Oulu, Finland.	johanna.myllyharju@oulu.fi			Academy of Finland [1114344, 1211128]; Sigrid Juselius Foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This work was supported by Academy of Finland Grants 1114344 and 1211128 and by the Sigrid Juselius Foundation.	Bank RA, 1999, P NATL ACAD SCI USA, V96, P1054, DOI 10.1073/pnas.96.3.1054; Brinckmann J, 2005, MATRIX BIOL, V24, P459, DOI 10.1016/j.matbio.2005.07.002; Clifton IJ, 2006, J INORG BIOCHEM, V100, P644, DOI 10.1016/j.jinorgbio.2006.01.024; CROSSEN R, 1998, BACULOVIRUS EXPRESSI; Eyre D, 2002, MOL GENET METAB, V76, P211, DOI 10.1016/S1096-7192(02)00036-7; Ha-Vinh R, 2004, AM J MED GENET A, V131A, P115, DOI 10.1002/ajmg.a.30231; Heikkinen J, 2000, J BIOL CHEM, V275, P36158, DOI 10.1074/jbc.M006203200; Kivirikko K. I., 1992, POSTTRANSLATIONAL MO, P1; KIVIRIKKO KI, 1982, METHOD ENZYMOL, V82, P245; Kivirikko KI, 1998, ADV ENZYMOL RAMB, V72, P325; Koski MK, 2007, J BIOL CHEM, V282, P37112, DOI 10.1074/jbc.M706554200; Krol BJ, 1996, J INVEST DERMATOL, V106, P11, DOI 10.1111/1523-1747.ep12326956; Myllyharju J, 2005, TOP CURR CHEM, V247, P115, DOI 10.1007/b103821; Myllyharju J, 1997, J BIOL CHEM, V272, P21824, DOI 10.1074/jbc.272.35.21824; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Myllyharju J, 1997, EMBO J, V16, P1173, DOI 10.1093/emboj/16.6.1173; Myllyharju J, 2000, BIOCHEM SOC T, V28, P353, DOI 10.1042/bst0280353; Nokelainen M, 1998, MATRIX BIOL, V16, P329, DOI 10.1016/S0945-053X(98)90004-X; Passoja K, 1998, P NATL ACAD SCI USA, V95, P10482, DOI 10.1073/pnas.95.18.10482; Passoja K, 1998, FEBS LETT, V434, P145, DOI 10.1016/S0014-5793(98)00966-1; Pirskanen A, 1996, J BIOL CHEM, V271, P9398, DOI 10.1074/jbc.271.16.9398; PUISTOLA U, 1980, BIOCHIM BIOPHYS ACTA, V611, P40, DOI 10.1016/0005-2744(80)90040-6; Rautavuoma K, 2004, P NATL ACAD SCI USA, V101, P14120, DOI 10.1073/pnas.0404966101; Rautavuoma K, 2002, J BIOL CHEM, V277, P23084, DOI 10.1074/jbc.M112077200; Ruotsalainen H, 2006, J CELL SCI, V119, P625, DOI 10.1242/jcs.02780; Salo AM, 2008, AM J HUM GENET, V83, P495, DOI 10.1016/j.ajhg.2008.09.004; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Sipila L, 2007, J BIOL CHEM, V282, P33381, DOI 10.1074/jbc.M704198200; Steinmann B., 2002, CONNECTIVE TISSUE IT, P431, DOI DOI 10.1002/0471221929.CH9; Takaluoma K, 2007, MATRIX BIOL, V26, P396, DOI 10.1016/j.matbio.2007.01.002; Takaluoma K, 2007, J BIOL CHEM, V282, P6588, DOI 10.1074/jbc.M608830200; Uzawa K, 2003, BIOCHEM BIOPH RES CO, V305, P484, DOI 10.1016/S0006-291X(03)00799-X; Valtavaara M, 1997, J BIOL CHEM, V272, P6831, DOI 10.1074/jbc.272.11.6831; Valtavaara M, 1998, J BIOL CHEM, V273, P12881, DOI 10.1074/jbc.273.21.12881; van der Slot AJ, 2004, MATRIX BIOL, V23, P251, DOI 10.1016/j.matbio.2004.06.001; van der Slot AJ, 2003, J BIOL CHEM, V278, P40967, DOI 10.1074/jbc.M307380200; Walker LC, 2005, MATRIX BIOL, V23, P515, DOI 10.1016/j.matbio.2004.11.002; Wang CG, 2002, MATRIX BIOL, V21, P559, DOI 10.1016/S0945-053X(02)00071-9; Wang CG, 2002, J BIOL CHEM, V277, P18568, DOI 10.1074/jbc.M201389200; Wang CG, 2009, J CELL MOL MED, V13, P508, DOI 10.1111/j.1582-4934.2008.00286.x; Yeowell HN, 1999, MATRIX BIOL, V18, P179, DOI 10.1016/S0945-053X(99)00013-X; Yeowell HN, 2000, MOL GENET METAB, V71, P212, DOI 10.1006/mgme.2000.3076	42	34	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30917	30924		10.1074/jbc.M109.021238	http://dx.doi.org/10.1074/jbc.M109.021238			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19762917	Green Published, hybrid			2022-12-27	WOS:000271378400020
J	Obexer, P; Hagenbuchner, J; Rupp, M; Salvador, C; Holzner, M; Deutsch, M; Porto, V; Kofler, R; Unterkircher, T; Ausserlechner, MJ				Obexer, Petra; Hagenbuchner, Judith; Rupp, Martina; Salvador, Christina; Holzner, Markus; Deutsch, Martin; Porto, Verena; Kofler, Reinhard; Unterkircher, Thomas; Ausserlechner, Michael J.			p16(INK4A) Sensitizes Human Leukemia Cells to FAS- and Glucocorticoid-induced Apoptosis via Induction of BBC3/Puma and Repression of MCL1 and BCL2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; TUMOR-SUPPRESSOR GENE; BH3-ONLY PROTEINS; C-MYC; CYCLE; PUMA; EXPRESSION; CANCER; DEATH; P53	Loss of CDKN2A/p16(INK4A) in hematopoietic stem cells is associated with enhanced self-renewal capacity and might facilitate progression of damaged stem cells into pre-cancerous cells that give rise to leukemia. This is also reflected by the frequent loss of the INK4A locus in acute lymphoblastic T-cell leukemia. T-cell acute lymphoblastic leukemia cells designed to conditionally express p16(INK4A) arrest in the G(0)/G(1) phase of the cell cycle and show increased sensitivity to glucocorticoid-and tumor necrosis factor receptor superfamily 6-induced apoptosis. To investigate the underlying molecular mechanism for increased death sensitivity, we interfered with specific steps of apoptosis signaling by expression of anti-apoptotic proteins. We found that alterations in cell death susceptibility resulted from changes in the composition of pro-and anti-apoptotic BCL2 proteins, i.e. repression of MCL1, BCL2, and PMAIP1/Noxa and the induction of pro-apoptotic BBC3/Puma. Interference with Puma induction by short hairpin RNA technology or retroviral expression of MCL1 or BCL2 significantly reduced both glucocorticoid-and FAS-induced cell death in p16(INK4A) reconstituted leukemia cells. These results suggest that Puma, in concert with MCL1 and BCL2 repression, critically mediates p16(INK4A) induced death sensitization and that in human T-cell leukemia the deletion of p(16INK4A) confers apoptosis resistance by shifting the balance of pro-and anti-apoptotic BCL2 proteins toward apoptosis protection.	[Salvador, Christina; Unterkircher, Thomas; Ausserlechner, Michael J.] Med Univ Innsbruck, Dept Pediat 2, Bioctr, A-6020 Innsbruck, Austria; [Obexer, Petra; Hagenbuchner, Judith; Rupp, Martina; Holzner, Markus; Deutsch, Martin; Porto, Verena; Kofler, Reinhard; Unterkircher, Thomas; Ausserlechner, Michael J.] Med Univ Innsbruck, Tyrolean Canc Res Inst, A-6020 Innsbruck, Austria; [Obexer, Petra; Hagenbuchner, Judith; Rupp, Martina] Med Univ Innsbruck, Dept Pediat 4, Bioctr, A-6020 Innsbruck, Austria; [Kofler, Reinhard] Med Univ Innsbruck, Div Mol Pathophysiol, Bioctr, A-6020 Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck	Ausserlechner, MJ (corresponding author), Med Univ Innsbruck, Dept Pediat 2, Bioctr, Innrain 66, A-6020 Innsbruck, Austria.	Michael.J.Ausserlechner@i-med.ac.at	Holzner, Markus/A-6215-2008; Salvador, Christina/AAQ-4798-2021	Holzner, Markus/0000-0003-2702-8612; Ausserlechner, Michael/0000-0002-1015-2302; Unterkircher, Thomas/0000-0001-5028-0571; Hagenbuchner, Judith/0000-0003-1396-3407	Kinderkrebshilfe Tirol; Vorarlberg; Provita Kinderleukamie Stiftung; Kinderkrebshilfe Sudtirol-Regenbogen; SVP-Frauen; Medizinischer Forschungsfond; Sudtiroler Krebshilfe; Austrian Science Fund [SFB-F021]; COMET Center ONCOTYROL; Tyrolean Cancer Research Institute; Tyrolean Cancer Societ; Department of Health-Care, Autonomy of South Tyrol	Kinderkrebshilfe Tirol; Vorarlberg; Provita Kinderleukamie Stiftung; Kinderkrebshilfe Sudtirol-Regenbogen; SVP-Frauen; Medizinischer Forschungsfond; Sudtiroler Krebshilfe; Austrian Science Fund(Austrian Science Fund (FWF)); COMET Center ONCOTYROL; Tyrolean Cancer Research Institute; Tyrolean Cancer Societ; Department of Health-Care, Autonomy of South Tyrol	This work was supported by grants from "Kinderkrebshilfe Tirol and Vorarlberg," "Provita Kinderleukamie Stiftung," "Kinderkrebshilfe Sudtirol-Regenbogen," "SVP-Frauen," "Medizinischer Forschungsfond," "Sudtiroler Krebshilfe," Austrian Science Fund SFB-F021, and the COMET Center ONCOTYROL. " The Tyrolean Cancer Research Institute is supported by the "Tiroler Landeskrankenanstalten Ges.m.b.H. Tiroler Landeskrankenanstalten Ges.m.b.H.," Tyrolean Cancer Society, and the Department of Health-Care, Autonomy of South Tyrol.	Ausserlechner MJ, 2006, MOL CANCER THER, V5, P1927, DOI 10.1158/1535-7163.MCT-05-0500; Ausserlechner MJ, 2005, LEUKEMIA, V19, P1051, DOI 10.1038/sj.leu.2403729; Ausserlechner MJ, 2001, J BIOL CHEM, V276, P10984, DOI 10.1074/jbc.M008188200; Borner C, 2003, MOL IMMUNOL, V39, P615, DOI 10.1016/S0161-5890(02)00252-3; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; CHENG J, 1990, MOL CELL BIOL, V10, P5502, DOI 10.1128/MCB.10.10.5502; Classon M, 2002, NAT REV CANCER, V2, P910, DOI 10.1038/nrc950; Distelhorst CW, 2002, CELL DEATH DIFFER, V9, P6, DOI 10.1038/sj.cdd.4400969; Ekholm SV, 2000, CURR OPIN CELL BIOL, V12, P676, DOI 10.1016/S0955-0674(00)00151-4; FIZZOTTI M, 1995, BLOOD, V85, P2685, DOI 10.1182/blood.V85.10.2685.bloodjournal85102685; Han J, 2006, J BIOL CHEM, V281, P10153, DOI 10.1074/jbc.M510349200; Han JW, 2001, P NATL ACAD SCI USA, V98, P11318, DOI 10.1073/pnas.201208798; Hartmann BL, 1999, ONCOGENE, V18, P713, DOI 10.1038/sj.onc.1202339; Hemann MT, 2004, P NATL ACAD SCI USA, V101, P9333, DOI 10.1073/pnas.0403286101; Hershko T, 2004, J BIOL CHEM, V279, P8627, DOI 10.1074/jbc.M312866200; Kees UR, 1997, BLOOD, V89, P4161, DOI 10.1182/blood.V89.11.4161; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Labi V, 2006, CELL DEATH DIFFER, V13, P1325, DOI 10.1038/sj.cdd.4401940; Loffler M, 1999, ONCOGENE, V18, P4626, DOI 10.1038/sj.onc.1202820; Marchetti MC, 2003, BLOOD, V101, P585, DOI 10.1182/blood-2002-06-1779; Mimeault M, 2009, AGEING RES REV, V8, P94, DOI 10.1016/j.arr.2008.12.001; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Obexer P, 2007, CELL DEATH DIFFER, V14, P534, DOI 10.1038/sj.cdd.4402017; OKUDA T, 1995, BLOOD, V85, P2321, DOI 10.1182/blood.V85.9.2321.bloodjournal8592321; Parson W, 2005, FASEB J, V19, P434, DOI 10.1096/fj.04-3062fje; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; QUELLE DE, 1995, CELL, V83, P993; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Werner AB, 2002, J BIOL CHEM, V277, P40760, DOI 10.1074/jbc.M204351200; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1	38	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30933	30940		10.1074/jbc.M109.051441	http://dx.doi.org/10.1074/jbc.M109.051441			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19737931	hybrid, Green Published			2022-12-27	WOS:000271378400022
J	Palijan, A; Fernandes, I; Verway, M; Kourelis, M; Bastien, Y; Tavera-Mendoza, LE; Sacheli, A; Bourdeau, V; Mader, S; White, JH				Palijan, Ana; Fernandes, Isabelle; Verway, Mark; Kourelis, Maria; Bastien, Yolande; Tavera-Mendoza, Luz E.; Sacheli, Aaron; Bourdeau, Veronique; Mader, Sylvie; White, John H.			Ligand-dependent Corepressor LCoR Is an Attenuator of Progesterone-regulated Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL BINDING-PROTEIN; RECEPTOR-INTERACTING PROTEIN; TRANSCRIPTIONAL COREPRESSOR; PIPSQUEAK PROTEIN; STEROID-HORMONES; ESTROGEN; CTBP; RECRUITMENT; PHOSPHORYLATION; REPRESSION	Ligand-dependent corepressor LCoR interacts with the progesterone receptor (PR) and estrogen receptor ER alpha in the presence of hormone. LCoR contains tandem N-terminal PXDLS motifs that recruit C-terminal-binding protein (CtBP) corepressors as well as a C-terminal helix-turn-helix (HTH) domain. Here, we analyzed the function of these domains in coregulation of PR- and ER alpha-regulated gene expression. LCoR and CtBP1 colocalize in nuclear bodies that also contain CtBP-interacting protein CtIP and polycomb group repressor complex marker BMI1. Coexpression of CtBP1 in MCF7 or T47D breast cancer cells augmented corepression by LCoR, whereas coexpression of CtIP did not, consistent with direct interaction of LCoR with CtBP1, but not CtIP. The N-terminal region containing the PXDLS motifs is necessary and sufficient for CTBP1 recruitment and essential for full corepression. However, LCoR function was also strongly dependent on the helix-turn-helix domain, as its deletion completely abolished corepression. LCoR, CtBP, and CtIP were recruited to endogenous PR- and ER alpha-stimulated genes in a hormone-dependent manner. Similarly, LCoR was recruited to estrogen-repressed genes, whereas hormone treatment reduced CtBP1 binding. Small interfering RNA-mediated knockdown of LCoR or CtBP1 augmented expression of progesterone- and estrogen-stimulated reporter genes as well as endogenous progesterone- stimulated target genes. In contrast, their ablation had gene-specific effects on ER alpha-regulated transcription that generally led to reduced gene expression. Taken together, these results show that multiple domains contribute to LCoR function. They also reveal a role for LCoR and CtBP1 as attenuators of progesterone-regulated transcription but suggest that LCoR and CtBP1 can act to enhance transcription of some genes.	[Palijan, Ana; Fernandes, Isabelle; Verway, Mark; Kourelis, Maria; Bastien, Yolande; Sacheli, Aaron; White, John H.] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada; [White, John H.] McGill Univ, Dept Med, Montreal, PQ H3G 1Y6, Canada; [Tavera-Mendoza, Luz E.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA; [Bourdeau, Veronique; Mader, Sylvie] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada; [Bourdeau, Veronique; Mader, Sylvie] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada	McGill University; McGill University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Universite de Montreal; Universite de Montreal	White, JH (corresponding author), McGill Univ, Dept Physiol, 3655 Drummond St, Montreal, PQ H3G 1Y6, Canada.	john.white@mcgill.ca	Palijan, Ana/AAV-3310-2021; white, john h/N-9782-2013	white, john h/0000-0002-4785-2687	Canadian Institutes of Health [MT-11704]	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant MT-11704 (to J. H. W.).	Aoyagi S, 2007, MOL ENDOCRINOL, V21, P843, DOI 10.1210/me.2006-0244; Aravind L, 2005, FEMS MICROBIOL REV, V29, P231, DOI 10.1016/j.fmrre.2004.12.008; Boonyaratanakornkit V, 2007, MOL ENDOCRINOL, V21, P359, DOI 10.1210/me.2006-0337; Bourdeau V, 2004, MOL ENDOCRINOL, V18, P1411, DOI 10.1210/me.2003-0441; BOYD JM, 1993, EMBO J, V12, P469, DOI 10.1002/j.1460-2075.1993.tb05679.x; Castet A, 2006, MOL ENDOCRINOL, V20, P1035, DOI 10.1210/me.2005-0227; Chinnadurai G, 2007, INT J BIOCHEM CELL B, V39, P1593, DOI 10.1016/j.biocel.2007.01.025; Chinnadurai G, 2006, BBA-REV CANCER, V1765, P67, DOI 10.1016/j.bbcan.2005.09.002; Chinnadurai G, 2002, MOL CELL, V9, P213, DOI 10.1016/S1097-2765(02)00443-4; Chinnadurai G, 2009, CANCER RES, V69, P731, DOI 10.1158/0008-5472.CAN-08-3349; Duffy MJ, 2005, CLIN CHEM, V51, P494, DOI 10.1373/clinchem.2004.046227; Edwards DP, 2005, ANNU REV PHYSIOL, V67, P335, DOI 10.1146/annurev.physiol.67.040403.120151; Fasano CA, 2007, CELL STEM CELL, V1, P87, DOI 10.1016/j.stem.2007.04.001; Fernandes I, 2003, MOL CELL, V11, P139, DOI 10.1016/S1097-2765(03)00014-5; Ghosh D, 1999, HUM REPROD, V14, P505, DOI 10.1093/humrep/14.2.505; GRONEMEYER H, 1991, ANNU REV GENET, V25, P89, DOI 10.1146/annurev.ge.25.120191.000513; Gurevich I, 2007, TOXICOL APPL PHARM, V223, P288, DOI 10.1016/j.taap.2007.05.019; Hall JM, 2005, MOL INTERV, V5, P343, DOI 10.1124/mi.5.6.7; Hernandez-Munoz I, 2005, MOL CELL BIOL, V25, P11047, DOI 10.1128/MCB.25.24.11047-11058.2005; Hildebrand JD, 2002, MOL CELL BIOL, V22, P5296, DOI 10.1128/MCB.22.15.5296-5307.2002; Horne AW, 2006, REPRODUCTION, V131, P733, DOI 10.1530/rep.1.00883; Hubler TR, 2003, ENDOCRINOLOGY, V144, P2380, DOI 10.1210/en.2003-0092; Jin W, 2007, BIOCHEM PHARMACOL, V74, P851, DOI 10.1016/j.bcp.2007.06.017; Katsanis N, 1998, GENOMICS, V47, P294, DOI 10.1006/geno.1997.5115; Kim JJ, 2005, BIOL REPROD, V73, P833, DOI 10.1095/biolreprod.105.043182; Kuppuswamy M, 2008, MOL CELL BIOL, V28, P269, DOI 10.1128/MCB.01077-07; Kusumegi T, 2004, J BIOCHEM MOL TOXIC, V18, P1, DOI 10.1002/jbt.20004; Lehmann M, 1998, J BIOL CHEM, V273, P28504, DOI 10.1074/jbc.273.43.28504; Mani-Telang P, 2007, DEV GENES EVOL, V217, P127, DOI 10.1007/s00427-006-0121-4; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Meloni AR, 1999, P NATL ACAD SCI USA, V96, P9574, DOI 10.1073/pnas.96.17.9574; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Otte AP, 2003, CURR OPIN GENET DEV, V13, P448, DOI 10.1016/S0959-437X(03)00108-4; Palijan A, 2009, J BIOL CHEM, V284, P30264, DOI 10.1074/jbc.M109.045526; Patel FA, 1999, J CLIN ENDOCR METAB, V84, P291, DOI 10.1210/jc.84.1.291; PEPE GJ, 1995, ENDOCR REV, V16, P608, DOI 10.1210/er.16.5.608; Perissi V, 2008, MOL CELL, V29, P755, DOI 10.1016/j.molcel.2008.01.020; Ren XJ, 2008, MOL CELL BIOL, V28, P2884, DOI 10.1128/MCB.00949-07; Richer JK, 2002, J BIOL CHEM, V277, P5209, DOI 10.1074/jbc.M110090200; Sanchez C, 2007, MOL CELL PROTEOMICS, V6, P820, DOI 10.1074/mcp.M600275-MCP200; Sewalt RGAB, 1999, MOL CELL BIOL, V19, P777; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Siegmund T, 2002, DEV GENES EVOL, V212, P152, DOI 10.1007/s00427-002-0219-2; Spector DL, 2001, J CELL SCI, V114, P2891; Stossi F, 2009, MOL CELL BIOL, V29, P1749, DOI 10.1128/MCB.01476-08; Takeuchi H, 2001, INSECT MOL BIOL, V10, P487, DOI 10.1046/j.0962-1075.2001.00288.x; Tavera-Mendoza L, 2006, EMBO REP, V7, P180, DOI 10.1038/sj.embor.7400594; Tavera-Mendoza LE, 2008, P NATL ACAD SCI USA, V105, P8250, DOI 10.1073/pnas.0709279105; Vo N, 2001, MOL CELL BIOL, V21, P6181, DOI 10.1128/MCB.21.18.6181-6188.2001; White JH, 2004, VITAM HORM, V68, P123; White KA, 2005, J BIOL CHEM, V280, P7829, DOI 10.1074/jbc.M412707200; Wong CW, 2002, P NATL ACAD SCI USA, V99, P14783, DOI 10.1073/pnas.192569699; Yu XC, 2004, MOL CELL BIOL, V24, P9478, DOI 10.1128/MCB.24.21.9478-9486.2004; Zhao LJ, 2006, J BIOL CHEM, V281, P4183, DOI 10.1074/jbc.M509051200	54	30	32	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30275	30287		10.1074/jbc.M109.051201	http://dx.doi.org/10.1074/jbc.M109.051201			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19744932	hybrid, Green Published			2022-12-27	WOS:000271090000031
J	Zhuang, J; Jiang, GC; Willers, H; Xia, F				Zhuang, Jing; Jiang, Guochun; Willers, Henning; Xia, Fen			Exonuclease Function of Human Mre11 Promotes Deletional Nonhomologous End Joining	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; DNA END; PROTEIN-KINASE; REPAIR; COMPLEX; RECOMBINATION; MECHANISMS; NUCLEASE; DISTINCT; COLLABORATE	DNAdouble-stranded breaks (DSBs) are lethal if not repaired and are highly mutagenic if misrepaired. Nonhomologous end joining (NHEJ) is one of the major DSB repair pathways and can rejoin the DSB ends either precisely or with mistakes. Recent evidence suggests the existence of two NHEJ subpathways: conservative NHEJ (C-NHEJ), which does not require microhomology and can join ends precisely; and deletional NHEJ (D-NHEJ), which utilizes microhomology to join the ends with small deletions. Little is known about how these NHEJ subpathways are regulated. Mre11 has been implicated in DNA damage response, thus we investigated whether Mre11 function also extended to NHEJ. We utilized an intrachromosomal NHEJ substrate in which DSBs are generated by the I-SceI to address this question. The cohesive ends are fully complementary and were either repaired by C-NHEJ or D-NHEJ with similar efficiency. We found that disruption of Mre11 by RNA interference in human cells led to a 10-fold decrease in the frequency of D-NHEJ compared with cells with functional Mre11. Interestingly, C-NHEJ was not affected by Mre11 status. Expression of wild type but not exonuclease-defective Mre11 mutants was able to rescue D-NHEJ in Mre11-deficient cells. Further mutational analysis suggested that additional mechanisms associated with methylation of Mre11 at the C-terminal glycine-arginine-rich domain contributed to the promotion of D-NHEJ by Mre11. This study provides new insights into the mechanisms by which Mre11 affects the accuracy of DSB end joining specifically through control of the D-NHEJ subpathway, thus illustrating the complexity of the Mre11 role in maintaining genomic stability.	[Zhuang, Jing; Jiang, Guochun; Xia, Fen] Vanderbilt Univ, Dept Radiat Oncol, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA; [Zhuang, Jing; Jiang, Guochun; Xia, Fen] Vanderbilt Univ, Dept Canc Biol, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA; [Willers, Henning] Massachusetts Gen Hosp, Lab Cellular & Mol Radiat Oncol, Ctr Canc, Boston, MA 02114 USA	Vanderbilt University; Vanderbilt University; Harvard University; Massachusetts General Hospital	Xia, F (corresponding author), Vanderbilt Univ, Dept Radiat Oncol, Med Ctr, Nashville, TN 37232 USA.	fen.xia@vanderbilt.edu	Xia, Fen/G-3708-2013; Jiang, Guochun/H-8809-2019	Jiang, Guochun/0000-0003-1911-5089	National Institutes of Health [R01 CA118158-02]; NATIONAL CANCER INSTITUTE [R01CA118158] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA118158-02 ( to F. X.).	Arthur LM, 2004, NUCLEIC ACIDS RES, V32, P1886, DOI 10.1093/nar/gkh343; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Bleuit JS, 2001, P NATL ACAD SCI USA, V98, P8298, DOI 10.1073/pnas.131007498; Boisvert FM, 2005, GENE DEV, V19, P671, DOI 10.1101/gad.1279805; Bressan DA, 1998, GENETICS, V150, P591; Buis J, 2008, CELL, V135, P85, DOI 10.1016/j.cell.2008.08.015; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Chen L, 2000, J BIOL CHEM, V275, P26196, DOI 10.1074/jbc.M000491200; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; Connelly JC, 2003, DNA REPAIR, V2, P795, DOI 10.1016/S1568-7864(03)00063-6; Dahm-Daphi J, 2005, ONCOGENE, V24, P1663, DOI 10.1038/sj.onc.1208396; de Jager M, 2001, MOL CELL, V8, P1129, DOI 10.1016/S1097-2765(01)00381-1; Dery U, 2008, MOL CELL BIOL, V28, P3058, DOI 10.1128/MCB.02025-07; Dinkelmann M, 2009, NAT STRUCT MOL BIOL, V16, P808, DOI 10.1038/nsmb.1639; Guirouilh-Barbat J, 2004, MOL CELL, V14, P611, DOI 10.1016/j.molcel.2004.05.008; Haber JE, 1998, CELL, V95, P583, DOI 10.1016/S0092-8674(00)81626-8; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hopfner KP, 2002, NATURE, V418, P562, DOI 10.1038/nature00922; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Leuther KK, 1999, EMBO J, V18, P1114, DOI 10.1093/emboj/18.5.1114; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Ma JL, 2003, MOL CELL BIOL, V23, P8820, DOI 10.1128/MCB.23.23.8820-8828.2003; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Modesti M, 2001, GENOME BIOL, V2; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Paull TT, 2001, P NATL ACAD SCI USA, V98, P6086, DOI 10.1073/pnas.111125998; PFEIFFER P, 1994, MOL CELL BIOL, V14, P888, DOI 10.1128/MCB.14.2.888; Rass E, 2009, NAT STRUCT MOL BIOL, V16, P819, DOI 10.1038/nsmb.1641; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Schulte-Uentrop L, 2008, NUCLEIC ACIDS RES, V36, P2561, DOI 10.1093/nar/gkn094; Takeda S, 2007, MOL CELL, V28, P351, DOI 10.1016/j.molcel.2007.10.016; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Wei LZ, 2008, MOL CELL BIOL, V28, P7380, DOI 10.1128/MCB.01075-08; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Weterings E, 2004, DNA REPAIR, V3, P1425, DOI 10.1016/j.dnarep.2004.06.003; Willers H, 2006, RADIAT RES, V166, P567, DOI 10.1667/RR0524.1; Willers H, 2000, ONCOGENE, V19, P632, DOI 10.1038/sj.onc.1203142; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; Williams RS, 2007, BIOCHEM CELL BIOL, V85, P509, DOI 10.1139/O07-069; Wiltzius JJW, 2005, NAT STRUCT MOL BIOL, V12, P403, DOI 10.1038/nsmb928; Xie AY, 2009, NAT STRUCT MOL BIOL, V16, P814, DOI 10.1038/nsmb.1640; Yun MH, 2009, NATURE, V459, P460, DOI 10.1038/nature07955; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037; Zhuang J, 2006, CANCER RES, V66, P1401, DOI 10.1158/0008-5472.CAN-05-3278	47	50	51	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30565	30573		10.1074/jbc.M109.059444	http://dx.doi.org/10.1074/jbc.M109.059444			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19744924	hybrid, Green Published			2022-12-27	WOS:000271090000059
J	Bahtiar, A; Matsumoto, T; Nakamura, T; Akiyama, M; Yogo, K; Ishida-Kitagawa, N; Ogawa, T; Takeya, T				Bahtiar, Anton; Matsumoto, Takahiro; Nakamura, Takashi; Akiyama, Motofusa; Yogo, Keiichiro; Ishida-Kitagawa, Norihiro; Ogawa, Takuya; Takeya, Tatsuo			Identification of a Novel L-Serine Analog That Suppresses Osteoclastogenesis in Vitro and Bone Turnover in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B LIGAND; RECEPTOR ACTIVATOR; NUCLEAR-FACTOR; BASE SYNTHESIS; PALMITOYLTRANSFERASE; METABOLISM; EXPRESSION; ENZYME; RANKL; CELLS	Osteoclasts are multinucleated giant cells with bone resorbing activity. We previously reported that the expression of the transcription factorNFAT2(NFATc1) induced by receptor activator of NF-kappa B ligand (RANKL) is essential for the formation of multinucleated cells. We subsequently identified L-Ser in the differentiation medium as necessary for the expression of NFAT2. Here we searched for serine analogs that antagonize the function of L-Ser and suppress the formation of osteoclasts in bone marrow as well as RAW264 cells. An analog thus identified, H-Ser(tBu)-OMe center dot HCl, appeared to suppress the production of 3-ketodihydrosphingosine by serine palmitoyltransferase, and the expression and localization of RANK, a cognate receptor of RANKL, in membrane lipid rafts was down-regulated in the analog-treated cells. The addition of lactosylceramide, however, rescued the osteoclastic formation. When administered in vivo, the analog significantly increased bone density in mice and prevented high bone turnover induced by treatment with soluble RANKL. These results demonstrate a close connection between the metabolism of L-Ser and bone remodeling and also the potential of the analog as a novel therapeutic tool for bone destruction.	[Bahtiar, Anton; Matsumoto, Takahiro; Nakamura, Takashi; Akiyama, Motofusa; Yogo, Keiichiro; Ishida-Kitagawa, Norihiro; Ogawa, Takuya; Takeya, Tatsuo] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan	Nara Institute of Science & Technology	Takeya, T (corresponding author), Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan.	ttakeya@bs.naist.jp	Bahtiar, Anton/AAE-7874-2021; Ogawa, Takuya/ABC-9628-2020; Akiyama, Motofusa/E-4101-2015	Ogawa, Takuya/0000-0001-9194-3079; Akiyama, Motofusa/0000-0001-6772-0027; Yogo, Keiichiro/0000-0003-2051-6891; Bahtiar, Anton/0000-0002-2924-3677				Akhila JS, 2007, CURR SCI INDIA, V93, P917; Boyce BF, 2008, ARCH BIOCHEM BIOPHYS, V473, P139, DOI 10.1016/j.abb.2008.03.018; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Ha H, 2003, J BIOL CHEM, V278, P18573, DOI 10.1074/jbc.M212626200; Hanada K, 2000, FEBS LETT, V474, P63, DOI 10.1016/S0014-5793(00)01579-9; Hanada K, 2000, J BIOL CHEM, V275, P8409, DOI 10.1074/jbc.275.12.8409; Hanada K, 1998, J BIOL CHEM, V273, P33787, DOI 10.1074/jbc.273.50.33787; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200; Ishida N, 2006, J BONE MINER RES, V21, P48, DOI 10.1359/JBMR.051001; Iwamoto T, 2001, J BIOL CHEM, V276, P46031, DOI 10.1074/jbc.M104464200; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Lloyd SAJ, 2008, CALCIFIED TISSUE INT, V82, P361, DOI 10.1007/s00223-008-9133-6; MERRILL AH, 1983, BIOCHIM BIOPHYS ACTA, V754, P284, DOI 10.1016/0005-2760(83)90144-3; Ogawa T, 2006, J BONE MINER METAB, V24, P373, DOI 10.1007/s00774-006-0705-0; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Tanaka S, 2005, IMMUNOL REV, V208, P30, DOI 10.1111/j.0105-2896.2005.00327.x; Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834; Tomimori Y, 2009, J BONE MINER RES, V24, P1194, DOI [10.1359/JBMR.090217, 10.1359/jbmr.090217]; Vaananen HK, 2008, ARCH BIOCHEM BIOPHYS, V473, P132, DOI 10.1016/j.abb.2008.03.037; WILLIAMS RD, 1984, ARCH BIOCHEM BIOPHYS, V228, P282, DOI 10.1016/0003-9861(84)90069-9	21	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34157	34166		10.1074/jbc.M109.058933	http://dx.doi.org/10.1074/jbc.M109.058933			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19837662	hybrid, Green Published			2022-12-27	WOS:000272165200048
J	Miyagi, K; Kiyonaka, S; Yamada, K; Miki, T; Mori, E; Kato, K; Numata, T; Sawaguchi, Y; Numaga, T; Kimura, T; Kanai, Y; Kawano, M; Wakamori, M; Nomura, H; Koni, I; Yamagishi, M; Mori, Y				Miyagi, Kyoko; Kiyonaka, Shigeki; Yamada, Kazunori; Miki, Takafumi; Mori, Emiko; Kato, Kenta; Numata, Tomohiro; Sawaguchi, Yuichi; Numaga, Takuro; Kimura, Toru; Kanai, Yoshikatsu; Kawano, Mitsuhiro; Wakamori, Minoru; Nomura, Hideki; Koni, Ichiro; Yamagishi, Masakazu; Mori, Yasuo			A Pathogenic C Terminus-truncated Polycystin-2 Mutant Enhances Receptor-activated Ca2+ Entry via Association with TRPC3 and TRPC7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-PERMEABLE CATION CHANNEL; KIDNEY-DISEASE; TRANSIENT RECEPTOR; EPITHELIAL-CELLS; CALCIUM-ENTRY; PKD2 GENE; G-PROTEIN; COMPLEX; IDENTIFICATION; LOCALIZATION	Mutations in PKD2 gene result in autosomal dominant polycystic kidney disease (ADPKD). PKD2 encodes polycystin-2 (TRPP2), which is a homologue of transient receptor potential (TRP) cation channel proteins. Here we identify a novel PKD2 mutation that generates a C-terminal tail-truncated TRPP2 mutant 697fsX with a frameshift resulting in an aberrant 17-amino acid addition after glutamic acid residue 697 from a family showing mild ADPKD symptoms. When recombinantly expressed in HEK293 cells, wild-type (WT) TRPP2 localized at the endoplasmic reticulum (ER) membrane significantly enhanced Ca2+ release from the ER upon muscarinic acetylcholine receptor (mAChR) stimulation. In contrast, 697fsX, which showed a predominant plasma membrane localization characteristic of TRPP2 mutants with C terminus deletion, prominently increased mAChR-activated Ca2+ influx in cells expressing TRPC3 or TRPC7. Coimmunoprecipitation, pulldown assay, and cross-linking experiments revealed a physical association between 697fsX and TRPC3 or TRPC7. 697fsX but not WT TRPP2 elicited a depolarizing shift of reversal potentials and an enhancement of single-channel conductance indicative of altered ion-permeating pore properties of mAChR-activated currents. Importantly, in kidney epithelial LLC-PK1 cells the recombinant 679fsX construct was codistributed with native TRPC3 proteins at the apical membrane area, but the WT construct was distributed in the basolateral membrane and adjacent intracellular areas. Our results suggest that heteromeric cation channels comprised of the TRPP2 mutant and the TRPC3 or TRPC7 protein induce enhanced receptor-activated Ca2+ influx that may lead to dysregulated cell growth in ADPKD.	[Mori, Yasuo] Kyoto Univ, Dept Synthet Chem & Biol Chem, Grad Sch Engn, Nishikyo Ku, Kyoto 6158510, Japan; [Kiyonaka, Shigeki; Mori, Yasuo] Japan Sci & Technol Agcy, CREST, Kyoto 6158510, Japan; [Miyagi, Kyoko; Yamada, Kazunori; Kawano, Mitsuhiro; Koni, Ichiro; Yamagishi, Masakazu] Kanazawa Univ, Grad Sch Med, Dept Internal Med, Div Rheumatol, Kanazawa, Ishikawa 9208641, Japan; [Nomura, Hideki] Kanazawa Univ Hosp, Dept Gen Med, Kanazawa, Ishikawa 9208641, Japan; [Kimura, Toru; Kanai, Yoshikatsu] Kyorin Univ, Sch Med, Dept Pharmacol & Toxicol, Tokyo 1818611, Japan; [Kanai, Yoshikatsu] Osaka Univ, Grad Sch Med, Dept Pharmacol, Suita, Osaka 5650871, Japan	Kyoto University; Japan Science & Technology Agency (JST); Kanazawa University; Kanazawa University; Kyorin University; Osaka University	Mori, Y (corresponding author), Kyoto Univ, Dept Synthet Chem & Biol Chem, Grad Sch Engn, Nishikyo Ku, Katsura Campus, Kyoto 6158510, Japan.	mori@sbchem.kyoto-u.ac.jp	Numata, Tomohiro/AAW-2453-2020; Wakamori, Minoru/AAE-2661-2019; Kiyonaka, Shigeki/AAM-7303-2021; Numata, Tomohiro/AAC-2330-2021	Numata, Tomohiro/0000-0002-5719-4884; Numata, Tomohiro/0000-0002-5719-4884; Wakamori, Minoru/0000-0001-8574-3310	Ministry of Education, Culture, Sport, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [20249015] Funding Source: KAKEN	Ministry of Education, Culture, Sport, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by research grants from the Ministry of Education, Culture, Sport, Science, and Technology of Japan.	Abramowitz J, 2009, FASEB J, V23, P297, DOI 10.1096/fj.08-119495; Ambudkar IS, 2006, TRENDS PHARMACOL SCI, V27, P25, DOI 10.1016/j.tips.2005.11.008; Bai CX, 2008, EMBO REP, V9, P472, DOI 10.1038/embor.2008.29; Bandyopadhyay BC, 2005, J BIOL CHEM, V280, P12908, DOI 10.1074/jbc.M410013200; BEAR JC, 1984, AM J MED GENET, V18, P45, DOI 10.1002/ajmg.1320180108; Boulay G, 1997, J BIOL CHEM, V272, P29672, DOI 10.1074/jbc.272.47.29672; Brenner JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000802; Bush EW, 2006, J BIOL CHEM, V281, P33487, DOI 10.1074/jbc.M605536200; Cai ZQ, 1999, J BIOL CHEM, V274, P28557, DOI 10.1074/jbc.274.40.28557; Chang MY, 2006, NEPHROL DIAL TRANSPL, V21, P2078, DOI 10.1093/ndt/gfl150; Chen XZ, 1999, NATURE, V401, P383, DOI 10.1038/43907; Chen XZ, 2001, BIOCHEM BIOPH RES CO, V282, P1251, DOI 10.1006/bbrc.2001.4720; Foggensteiner L, 2000, J AM SOC NEPHROL, V11, P814, DOI 10.1681/ASN.V115814; GABOW PA, 1993, NEW ENGL J MED, V329, P332, DOI 10.1056/NEJM199307293290508; Geng L, 2006, J CELL SCI, V119, P1383, DOI 10.1242/jcs.02818; Goel M, 2006, AM J PHYSIOL-RENAL, V290, pF1241, DOI 10.1152/ajprenal.00376.2005; Grimm DH, 2006, J BIOL CHEM, V281, P137, DOI 10.1074/jbc.M507845200; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Hateboer N, 1999, LANCET, V353, P103, DOI 10.1016/S0140-6736(98)03495-3; Hateboer N, 2000, KIDNEY INT, V57, P1444, DOI 10.1046/j.1523-1755.2000.00989.x; Hayashi T, 1997, GENOMICS, V44, P131, DOI 10.1006/geno.1997.4851; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Hogan PG, 2007, TRENDS BIOCHEM SCI, V32, P235, DOI 10.1016/j.tibs.2007.03.009; Inada H, 2008, EMBO REP, V9, P690, DOI 10.1038/embor.2008.89; JEFF H, 1997, CURRENT PROTOCOLS HU, P2; Jerman JC, 2000, BRIT J PHARMACOL, V130, P916, DOI 10.1038/sj.bjp.0703390; Jia YC, 2007, NAT NEUROSCI, V10, P559, DOI 10.1038/nn1870; JURMAN ME, 1994, BIOTECHNIQUES, V17, P876; Kiyonaka S, 2009, P NATL ACAD SCI USA, V106, P5400, DOI 10.1073/pnas.0808793106; Kotttgen M, 2008, J CELL BIOL, V182, P437, DOI 10.1083/jcb.200805124; Konoshita T, 2001, AM J KIDNEY DIS, V37, P113, DOI 10.1053/ajkd.2001.20595; Kottgen M, 2005, EMBO J, V24, P705, DOI 10.1038/sj.emboj.7600566; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Lehtonen S, 2000, J BIOL CHEM, V275, P32888, DOI 10.1074/jbc.M006624200; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; Li Q, 2005, HUM MOL GENET, V14, P1587, DOI 10.1093/hmg/ddi167; Li XG, 2005, NAT CELL BIOL, V7, P1202, DOI 10.1038/ncb1326; Li Y, 2005, J BIOL CHEM, V280, P41298, DOI 10.1074/jbc.M510082200; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Luo Y, 2003, MOL CELL BIOL, V23, P2600, DOI 10.1128/MCB.23.7.2600-2607.2003; Ma R, 2005, MOL CELL BIOL, V25, P8285, DOI 10.1128/MCB.25.18.8285-8298.2005; Mio K, 2005, BIOCHEM BIOPH RES CO, V333, P768, DOI 10.1016/j.bbrc.2005.05.181; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Mori Y, 1998, NEUROREPORT, V9, P507; Nakayama H, 2006, FASEB J, V20, P1660, DOI 10.1096/fj.05-5560com; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Nishida M, 2003, EMBO J, V22, P4677, DOI 10.1093/emboj/cdg457; Nomura H, 1998, J BIOL CHEM, V273, P25967, DOI 10.1074/jbc.273.40.25967; Numata T, 2008, CHANNELS, V2, P283, DOI 10.4161/chan.2.4.6695; Obermuller N, 1999, AM J PHYSIOL-RENAL, V277, pF914, DOI 10.1152/ajprenal.1999.277.6.F914; Okada T, 1999, J BIOL CHEM, V274, P27359, DOI 10.1074/jbc.274.39.27359; Onoe T, 2003, CLIN NEPHROL, V59, P406; Onohara N, 2006, EMBO J, V25, P5305, DOI 10.1038/sj.emboj.7601417; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Park EY, 2009, J BIOL CHEM, V284, P7214, DOI 10.1074/jbc.M805890200; Pennekamp P, 2002, CURR BIOL, V12, P938, DOI 10.1016/S0960-9822(02)00869-2; Philipp S, 2003, J BIOL CHEM, V278, P26629, DOI 10.1074/jbc.M304044200; Qian Q, 2003, HUM MOL GENET, V12, P1875, DOI 10.1093/hmg/ddg190; Roitbak T, 2004, MOL BIOL CELL, V15, P1334, DOI 10.1091/mbc.E03-05-0296; Rundle DR, 2004, J BIOL CHEM, V279, P29728, DOI 10.1074/jbc.M400544200; Shamshirsaz A, 2005, KIDNEY INT, V68, P2218, DOI 10.1111/j.1523-1755.2005.00678.x; Shimizu T, 2009, PFLUG ARCH EUR J PHY, V457, P795, DOI 10.1007/s00424-008-0558-6; Torra P, 1999, KIDNEY INT, V56, P28, DOI 10.1046/j.1523-1755.1999.00534.x; Trebak M, 2003, J BIOL CHEM, V278, P16244, DOI 10.1074/jbc.M300544200; Tsiokas L, 1999, P NATL ACAD SCI USA, V96, P3934, DOI 10.1073/pnas.96.7.3934; Tsiokas L, 1997, P NATL ACAD SCI USA, V94, P6965, DOI 10.1073/pnas.94.13.6965; Vassilev PM, 2001, BIOCHEM BIOPH RES CO, V282, P341, DOI 10.1006/bbrc.2001.4554; Wu GQ, 1998, CELL, V93, P177, DOI 10.1016/S0092-8674(00)81570-6; Yamaguchi T, 2004, J BIOL CHEM, V279, P40419, DOI 10.1074/jbc.M405079200	72	24	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34400	34412		10.1074/jbc.M109.015149	http://dx.doi.org/10.1074/jbc.M109.015149			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19812035	Green Published, hybrid			2022-12-27	WOS:000272165200070
J	Ralat, LA; Ren, M; Schilling, AB; Tang, WJ				Ralat, Luis A.; Ren, Min; Schilling, Alexander B.; Tang, Wei-Jen			Protective Role of Cys-178 against the Inactivation and Oligomerization of Human Insulin-degrading Enzyme by Oxidation and Nitrosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE MASS-SPECTROMETRY; AMYLOID BETA-PROTEIN; ELECTRON-CAPTURE DISSOCIATION; S-NITROSYLATION; NITRIC-OXIDE; MICROGLIAL CELLS; REACTIVE OXYGEN; MOLECULAR-BASIS; DEGRADATION; SUBSTRATE	Insulin-degrading enzyme (IDE), a 110-kDa metalloendopeptidase, hydrolyzes several physiologically relevant peptides, including insulin and amyloid-beta (A beta). Human IDE has 13 cysteines and is inhibited by hydrogen peroxide and S-nitrosoglutathione (GSNO), donors of reactive oxygen and nitrogen species, respectively. Here, we report that the oxidative burst of BV-2 microglial cells leads to oxidation or nitrosylation of secreted IDE, leading to the reduced activity. Hydrogen peroxide and GSNO treatment of IDE reduces the V-max for A beta degradation, increases IDE oligomerization, and decreases IDE thermostability. Additionally, this inhibitory response of IDE is substrate-dependent, biphasic for A beta degradation but monophasic for a shorter bradykinin-mimetic substrate. Our mutational analysis of IDE and peptide mass fingerprinting of GSNO-treated IDE using Fourier transformion cyclotron resonance mass spectrometer reveal a surprising interplay of Cys-178 with Cys-110 and Cys-819 for catalytic activity and with Cys-789 and Cys-966 for oligomerization. Cys-110 is near the zinc-binding catalytic center and is normally buried. The oxidation and nitrosylation of Cys-819 allow Cys-110 to be oxidized or nitrosylated, leading to complete inactivation of IDE. Cys-789 is spatially adjacent to Cys-966, and their nitrosylation and oxidation together trigger the oligomerization and inhibition of IDE. Interestingly, the Cys-178 modification buffers the inhibition caused by Cys-819 modification and prevents the oxidation or nitrosylation of Cys-110. The Cys-178 modification can also prevent the oligomerization-mediated inhibition. Thus, IDE can be intricately regulated by reactive oxygen or nitrogen species. The structure of IDE reveals the molecular basis for the long distance interactions of these cysteines and how they regulate IDE function.	[Ralat, Luis A.; Ren, Min; Tang, Wei-Jen] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Schilling, Alexander B.] Univ Illinois, Prote & Informat Serv Facil, Chicago, IL 60612 USA	University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Tang, WJ (corresponding author), Univ Chicago, Ben May Dept Canc Res, 929 E 57th St, Chicago, IL 60637 USA.	wtang@uchicago.edu		Tang, Wei-Jen/0000-0002-8267-8995	National Institutes of Health [GM 81539, F32 GM 87093]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM087093, R01GM081539] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 81539 (to W. J. T.) and Fellowship F32 GM 87093 (to L. A. R.). S The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. S1-S3.	Bashan N, 2009, PHYSIOL REV, V89, P27, DOI 10.1152/physrev.00014.2008; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chalmers MJ, 2004, PROTEOMICS, V4, P970, DOI 10.1002/pmic.200300650; Chalmers MJ, 2003, J PROTEOME RES, V2, P373, DOI 10.1021/pr030004d; Chen YY, 2008, J BIOL CHEM, V283, P35265, DOI 10.1074/jbc.M805287200; Cooper HJ, 2005, ANAL CHEM, V77, P6310, DOI 10.1021/ac058019d; Cordes CM, 2009, BIOCHEM PHARMACOL, V77, P1064, DOI 10.1016/j.bcp.2008.12.006; Dalpathado DS, 2006, BIOCHEMISTRY-US, V45, P8665, DOI 10.1021/bi060435k; Derakhshan B, 2007, CARDIOVASC RES, V75, P210, DOI 10.1016/j.cardiores.2007.04.023; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Foster MW, 2009, TRENDS MOL MED, V15, P391, DOI 10.1016/j.molmed.2009.06.007; Gibbons HM, 2006, BRAIN RES, V1084, P1, DOI 10.1016/j.brainres.2006.02.032; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Hakansson K, 2001, ANAL CHEM, V73, P4530, DOI 10.1021/ac0103470; Hanafy K A, 2001, Med Sci Monit, V7, P801; Hersh LB, 2006, CELL MOL LIFE SCI, V63, P2432, DOI 10.1007/s00018-006-6238-9; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; HEY C, 1995, N-S ARCH PHARMACOL, V351, P651; Horvath RJ, 2008, J NEUROCHEM, V107, P557, DOI 10.1111/j.1471-4159.2008.05633.x; Hultqvist M, 2009, TRENDS IMMUNOL, V30, P201, DOI 10.1016/j.it.2009.03.004; Huynh Mai-Loan, 2009, V519, P507, DOI 10.1007/978-1-59745-281-6_34; Im H, 2007, J BIOL CHEM, V282, P25453, DOI 10.1074/jbc.M701590200; Johnson GD, 2000, ANAL BIOCHEM, V286, P112, DOI 10.1006/abio.2000.4772; Kurochkin IV, 2001, TRENDS BIOCHEM SCI, V26, P421, DOI 10.1016/S0968-0004(01)01876-X; KUROCHKIN IV, 1994, FEBS LETT, V345, P33, DOI 10.1016/0014-5793(94)00387-4; Leissring MA, 2003, J BIOL CHEM, V278, P37314, DOI 10.1074/jbc.M305627200; LUNDBLAD RL, 1984, CHEM REAGENTS PROTEI, V1, P72; Malito E, 2008, CELL MOL LIFE SCI, V65, P2574, DOI 10.1007/s00018-008-8112-4; Malito E, 2008, BIOCHEMISTRY-US, V47, P12822, DOI 10.1021/bi801192h; Manolopoulou M, 2009, J BIOL CHEM, V284, P14177, DOI 10.1074/jbc.M900068200; Mehlhase J, 2000, IUBMB LIFE, V50, P331, DOI 10.1080/15216540051081137; MIRSKY A, 1949, ARCH BIOCHEM, V20, P1; MULLER D, 1991, EUR J BIOCHEM, V202, P285, DOI 10.1111/j.1432-1033.1991.tb16374.x; Neant-Fery M, 2008, P NATL ACAD SCI USA, V105, P9582, DOI 10.1073/pnas.0801261105; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; Qiu WQ, 1997, J BIOL CHEM, V272, P6641, DOI 10.1074/jbc.272.10.6641; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Renfrow MB, 2005, J BIOL CHEM, V280, P19136, DOI 10.1074/jbc.M411368200; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143	42	36	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34005	34018		10.1074/jbc.M109.030627	http://dx.doi.org/10.1074/jbc.M109.030627			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19808678	Green Published, hybrid			2022-12-27	WOS:000272165200033
J	Diacovich, L; Dumont, A; Lafitte, D; Soprano, E; Guilhon, AA; Bignon, C; Gorvel, JP; Bourne, Y; Meresse, S				Diacovich, Lautaro; Dumont, Audrey; Lafitte, Daniel; Soprano, Elodie; Guilhon, Aude-Agnes; Bignon, Christophe; Gorvel, Jean-Pierre; Bourne, Yves; Meresse, Stephane			Interaction between the SifA Virulence Factor and Its Host Target SKIP Is Essential for Salmonella Pathogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN CYTOSKELETON; ESCHERICHIA-COLI; III SECRETION; PROTEIN SIFA; EFFECTOR; IDENTIFICATION; EXPRESSION; VACUOLE; DOMAINS; GTPASES	SifA is a Salmonella effector that is translocated into infected cells by the pathogenicity island 2-encoded type 3 secretion system. SifA is a critical virulence factor. Previous studies demonstrated that, upon translocation, SifA binds the pleckstrin homology motif of the eukaryotic host protein SKIP. In turn, the SifA-SKIP complex regulates the mobilization of the molecular motor kinesin-1 on the bacterial vacuole. SifA exhibits multiple domains containing functional motifs. Here we performed a molecular dissection and a mutational study of SifA to evaluate the relative contribution of the different domains to SifA functions. Biochemical and crystallographic analysis confirmed that the N-terminal domain of SifA is sufficient to interact with the pleckstrin homology domain of SKIP, forming a 1:1 complex with a micromolar dissociation constant. Mutation of the tryptophan residue in the WXXXE motif, which has been proposed to mimic active form of GTPase, deeply affected the stability and the translocation of SifA while mutations of the glutamic residue had no functional impact. A SifA L130D mutant that does not bind SKIP showed a Delta sifA-like phenotype both in infected cells and in the mouse model of infection. We concluded that the WXXXE motif is essential for maintaining the tertiary structure of SifA, the functions of which require the interaction with the eukaryotic protein SKIP.	[Diacovich, Lautaro; Dumont, Audrey; Guilhon, Aude-Agnes; Gorvel, Jean-Pierre; Meresse, Stephane] Univ Mediterranee, Ctr Immunol Marseille Luminy, CNRS, INSERM,UMR 6102,U631, F-13288 Marseille 9, France; [Soprano, Elodie; Bignon, Christophe; Bourne, Yves] Univ Aix Marseille, CNRS, UMR 6098, F-13288 Marseille 9, France; [Lafitte, Daniel] Aix Marseille Univ, INSERM, UMR 911, F-13288 Marseille, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Meresse, S (corresponding author), Univ Mediterranee, Ctr Immunol Marseille Luminy, CNRS, INSERM,UMR 6102,U631, Parc Sci Luminy,Case 906, F-13288 Marseille 9, France.	meresse@ciml.univ-mrs.fr	Gorvel, Jean-Pierre/O-1332-2018; Meresse, Stephane/E-2192-2012; Bourne, Yves/AAC-4635-2022	Gorvel, Jean-Pierre/0000-0002-2829-9804; Meresse, Stephane/0000-0001-6578-5177; Bourne, Yves/0000-0003-3850-0548; lafitte, daniel/0000-0001-9921-7522; Diacovich, Lautaro/0000-0002-3339-0100	Equipe FRM; ANR [ANR-05-BLAN-0028-01]; CNRS; INSERM	Equipe FRM; ANR(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by Grant "Equipe FRM" ( to S. M.), the ANR ( Grant ANR-05-BLAN-0028-01 to Y. B. and S. M.), and institutional grants from CNRS and INSERM.	Alto NM, 2006, CELL, V124, P133, DOI 10.1016/j.cell.2005.10.031; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beuzon CR, 2001, MICROBES INFECT, V3, P1345, DOI 10.1016/S1286-4579(01)01496-4; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Boucrot E, 2005, SCIENCE, V308, P1174, DOI 10.1126/science.1110225; Boucrot E, 2003, J BIOL CHEM, V278, P14196, DOI 10.1074/jbc.M207901200; Boyer L, 2006, MOL BIOL CELL, V17, P2489, DOI 10.1091/mbc.E05-09-0876; Brown NF, 2006, MICROBIOL-SGM, V152, P2323, DOI 10.1099/mic.0.28995-0; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dumont Audrey, 2007, V394, P275, DOI 10.1007/978-1-59745-512-1_13; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Freeman JA, 2003, INFECT IMMUN, V71, P418, DOI 10.1128/IAI.71.1.418-427.2003; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7; Henry T, 2006, P NATL ACAD SCI USA, V103, P13497, DOI 10.1073/pnas.0605443103; Jackson LK, 2008, P NATL ACAD SCI USA, V105, P14141, DOI 10.1073/pnas.0801872105; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Lemmon MA, 2004, BIOCHEM SOC T, V32, P707, DOI 10.1042/BST0320707; LEVINE WC, 1991, J INFECT DIS, V164, P81, DOI 10.1093/infdis/164.1.81; LIM K, 1994, PROTEIN SCI, V3, P2233, DOI 10.1002/pro.5560031209; Mazurkiewicz P, 2008, MOL MICROBIOL, V67, P1371, DOI 10.1111/j.1365-2958.2008.06134.x; Meresse S, 2001, CELL MICROBIOL, V3, P567, DOI 10.1046/j.1462-5822.2001.00141.x; Miao EA, 2000, P NATL ACAD SCI USA, V97, P7539, DOI 10.1073/pnas.97.13.7539; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Nooren IMA, 2003, J MOL BIOL, V325, P991, DOI 10.1016/S0022-2836(02)01281-0; Nooren IMA, 2003, EMBO J, V22, P3486, DOI 10.1093/emboj/cdg359; Ohlson MB, 2008, CELL HOST MICROBE, V4, P434, DOI 10.1016/j.chom.2008.08.012; Patel JC, 2005, CURR OPIN MICROBIOL, V8, P10, DOI 10.1016/j.mib.2004.09.001; Poh J, 2008, CELL MICROBIOL, V10, P20, DOI 10.1111/j.1462-5822.2007.01010.x; Ramsden AE, 2007, CELL MICROBIOL, V9, P2517, DOI 10.1111/j.1462-5822.2007.00977.x; Reinicke AT, 2005, J BIOL CHEM, V280, P14620, DOI 10.1074/jbc.M500076200; Rytkonen A, 2007, P NATL ACAD SCI USA, V104, P3502, DOI 10.1073/pnas.0610095104; Salcedo SP, 2003, EMBO J, V22, P5003, DOI 10.1093/emboj/cdg517; Steele-Mortimer O, 2008, CURR OPIN MICROBIOL, V11, P38, DOI 10.1016/j.mib.2008.01.002; Stein MA, 1996, MOL MICROBIOL, V20, P151, DOI 10.1111/j.1365-2958.1996.tb02497.x; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Tsolis RM, 1999, ADV EXP MED BIOL, V473, P261; Vincentelli R, 2005, ANAL BIOCHEM, V346, P77, DOI 10.1016/j.ab.2005.07.039; WRAY C, 1978, RES VET SCI, V25, P139, DOI 10.1016/S0034-5288(18)32968-0	39	40	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33151	33160		10.1074/jbc.M109.034975	http://dx.doi.org/10.1074/jbc.M109.034975			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801640	Green Published, hybrid			2022-12-27	WOS:000272028500019
J	Ding, J; Ning, BF; Gong, WF; Wen, W; Wu, K; Liang, JQ; He, GP; Huang, SN; Sun, W; Han, T; Huang, L; Cao, GW; Wu, MC; Xie, WF; Wang, HY				Ding, Jin; Ning, Beifang; Gong, Wenfeng; Wen, Wen; Wu, Kun; Liang, Junqing; He, Guoping; Huang, Shanna; Sun, Wen; Han, Tao; Huang, Lei; Cao, Guangwen; Wu, Mengchao; Xie, Weifen; Wang, Hongyang			Cyclin D1 Induction by Benzo[a]pyrene-7,8-diol-9,10-epoxide via the Phosphatidylinositol 3-Kinase/Akt/MAPK- and p70(s6k)-dependent Pathway Promotes Cell Transformation and Tumorigenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; AP-1 TRANSACTIVATION; PHOSPHOINOSITIDE 3-KINASE; MAMMALIAN TARGET; NUCLEAR FACTOR; P53 MUTATIONS; DIOL-EPOXIDE; FACTOR-ALPHA; LUNG-CANCER; DNA-ADDUCTS	Benzo[a]pyrene-7,8-diol-9,10-epoxide (B[a]PDE), the major metabolite of B[a] P, has been well recognized as one ubiquitous carcinogen, but the molecular mechanism involved in its carcinogenic effect remains obscure. In the present study, we found that bronchial epithelial cells (Beas-2B) and hepatocytes treated with B[a]PDE presented a significant increase of cyclin D1 expression. Moreover, Akt, p70(s6k), and MAPKs including JNK, Erks, and p38 were notably activated in B[a]PDE-treated Beas-2B cells, whereas NF-kappa B, NFAT, and Egr-1 were not. Our results demonstrated that JNK and Erks were required in B[a]PDE-induced cyclin D1 expression because the inhibition of JNK or Erks by a selective chemical inhibitor or dominant negative mutant robustly impaired the cyclin D1 induction by B[a]PDE. Furthermore, we found that overexpression of the dominant negative mutant of p85 (regulatory subunit of phosphatidylinositol 3-kinase) or Akt dramatically suppressed B[a]PDE-induced JNK and Erk activation as well as cyclin D1 expression, suggesting that cyclin D1 induction by B[a]PDE is via the phosphatidylinositol 3-kinase/Akt/MAPK-dependent pathway. In addition, we clarified that p70s6k is also involved in B[a]PDE-induced cyclin D1 expression because rampamycin pretreatment dramatically reduced cyclin D1 induction by B[a]PDE. More importantly, we demonstrated that up-regulated cyclin D1 by B[a]PDE plays a critical role in oncogenic transformation and tumorigenesis of Beas-2B cells. These results not only broaden our knowledge of the molecular mechanism of B[a]PDE carcinogenicity but also lead to the further study of chemoprevention of B[a]PDE-associated human cancers.	[Ding, Jin; Gong, Wenfeng; Wen, Wen; Wu, Kun; Liang, Junqing; He, Guoping; Huang, Shanna; Sun, Wen; Han, Tao; Huang, Lei; Wu, Mengchao; Wang, Hongyang] Second Mil Med Univ, Eastern Hepatobiliary Surg Inst, Int Cooperat Lab Signal Transduct, Shanghai 200438, Peoples R China; [Ning, Beifang; Xie, Weifen] Second Mil Med Univ, Changzheng Hosp, Dept Gastroenterol, Shanghai 200438, Peoples R China; [Cao, Guangwen] Second Mil Med Univ, Dept Epidemiol, Shanghai 200438, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University	Wang, HY (corresponding author), Second Mil Med Univ, Eastern Hepatobiliary Surg Inst, Int Cooperat Lab Signal Transduct, 225 Changhai Rd, Shanghai 200438, Peoples R China.	hywangk@vip.sina.com	Wang, Hongyang/B-1340-2010		National Natural Science Foundation of China [30530790, 30921006, 2008ZX10002]; National High Tech Research and Development Program [2006AA02A412]; Shanghai Key Basic Science Foundation [07DJ14006, 06DJ14009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Tech Research and Development Program(National High Technology Research and Development Program of China); Shanghai Key Basic Science Foundation	This work was supported in part by National Natural Science Foundation of China Grants 30530790, 30921006, and 2008ZX10002; National High Tech Research and Development Program Grant 2006AA02A412; and Shanghai Key Basic Science Foundation Grants 07DJ14006 and 06DJ14009.	ALBERT RE, 1991, CARCINOGENESIS, V12, P1273, DOI 10.1093/carcin/12.7.1273; Alexandrov K, 2002, CARCINOGENESIS, V23, P1969, DOI 10.1093/carcin/23.12.1969; Arber N, 1997, CANCER RES, V57, P1569; Baird WM, 2005, ENVIRON MOL MUTAGEN, V45, P106, DOI 10.1002/em.20095; Baldo P, 2008, CURR CANCER DRUG TAR, V8, P647, DOI 10.2174/156800908786733513; Boldt S, 2002, CARCINOGENESIS, V23, P1831, DOI 10.1093/carcin/23.11.1831; Bostrom CE, 2002, ENVIRON HEALTH PERSP, V110, P451, DOI 10.1289/ehp.02110s3451; Cheng GZ, 2008, CURR CANCER DRUG TAR, V8, P2; Cheng MG, 1998, P NATL ACAD SCI USA, V95, P1091, DOI 10.1073/pnas.95.3.1091; Ding J, 2006, J BIOL CHEM, V281, P24405, DOI 10.1074/jbc.M600751200; Ding J, 2006, MOL CELL BIOCHEM, V287, P117, DOI 10.1007/s11010-005-9087-1; Eder AM, 1998, J BIOL CHEM, V273, P28025, DOI 10.1074/jbc.273.43.28025; Furuya F, 2006, P NATL ACAD SCI USA, V103, P1780, DOI 10.1073/pnas.0510849103; Gautschi O, 2007, LUNG CANCER, V55, P1, DOI 10.1016/j.lungcan.2006.09.024; Gladden AB, 2005, J CELL BIOCHEM, V96, P906, DOI 10.1002/jcb.20613; Hagemann C, 2001, CELL SIGNAL, V13, P863, DOI 10.1016/S0898-6568(01)00220-0; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Huang CS, 1999, J BIOL CHEM, V274, P29672, DOI 10.1074/jbc.274.42.29672; Huang CS, 1997, P NATL ACAD SCI USA, V94, P11957, DOI 10.1073/pnas.94.22.11957; Huang CS, 1996, MOL CELL BIOL, V16, P6427; Huang CS, 2001, MOL CELL BIOCHEM, V222, P29, DOI 10.1023/A:1017974131948; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; KARIN M, 1995, CURR BIOL, V5, P747, DOI 10.1016/S0960-9822(95)00151-5; Kashima H, 2009, ENDOCR-RELAT CANCER, V16, P113, DOI 10.1677/ERC-08-0117; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Klaunig JE, 2004, ANNU REV PHARMACOL, V44, P239, DOI 10.1146/annurev.pharmtox.44.101802.121851; Krawczak M, 1998, MUTAGENESIS, V13, P319, DOI 10.1093/mutage/13.4.319; Li JX, 2004, ONCOGENE, V23, P3932, DOI 10.1038/sj.onc.1207501; Manning BD, 2003, BIOCHEM SOC T, V31, P573, DOI 10.1042/BST0310573; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; Neve RM, 2002, ONCOGENE, V21, P4567, DOI 10.1038/sj.onc.1205555; Noh WC, 2004, CLIN CANCER RES, V10, P1013, DOI 10.1158/1078-0432.CCR-03-0043; Ouyang W, 2006, CARCINOGENESIS, V27, P864, DOI 10.1093/carcin/bgi321; Ouyang WM, 2008, ENVIRON HEALTH PERSP, V116, P1, DOI 10.1289/ehp.10403; Ouyang WM, 2007, MOL CARCINOGEN, V46, P32, DOI 10.1002/mc.20260; Ouyang WM, 2005, CANCER RES, V65, P9287, DOI 10.1158/0008-5472.CAN-05-0469; Pene F, 2002, ONCOGENE, V21, P6587, DOI 10.1038/sj.onc.1205923; Pervin S, 2007, CANCER RES, V67, P289, DOI 10.1158/0008-5472.CAN-05-4623; PHILLIPS DH, 1983, NATURE, V303, P468, DOI 10.1038/303468a0; Pontano LL, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-12; Roy PG, 2006, BREAST, V15, P718, DOI 10.1016/j.breast.2006.02.005; Samuels Y, 2006, CURR OPIN ONCOL, V18, P77, DOI 10.1097/01.cco.0000198021.99347.b9; Smith LE, 2000, JNCI-J NATL CANCER I, V92, P803, DOI 10.1093/jnci/92.10.803; Tokunaga E, 2008, CURR CANCER DRUG TAR, V8, P27, DOI 10.2174/156800908783497140; Watts RG, 1998, ONCOGENE, V17, P3493, DOI 10.1038/sj.onc.1202259; WEINSTATSASLOW D, 1995, NAT MED, V1, P1257, DOI 10.1038/nm1295-1257; WINSTON JT, 1993, MOL BIOL CELL, V4, P1133, DOI 10.1091/mbc.4.11.1133; WYNDER EL, 1950, JAMA-J AM MED ASSOC, V143, P329, DOI 10.1001/jama.1950.02910390001001; Yan YX, 1997, J BIOL CHEM, V272, P33181, DOI 10.1074/jbc.272.52.33181; Yang C, 2008, BIOCHEM J, V410, P167, DOI 10.1042/BJ20070781; Yasui M, 2006, CLIN CANCER RES, V12, P4720, DOI 10.1158/1078-0432.CCR-05-1213; Zhang XH, 2007, CURR CANCER DRUG TAR, V7, P305, DOI 10.2174/156800907780809741	52	24	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33311	33319		10.1074/jbc.M109.046417	http://dx.doi.org/10.1074/jbc.M109.046417			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801633	Green Published, hybrid			2022-12-27	WOS:000272028500036
J	Wang, M; Bridges, JP; Na, CL; Xu, Y; Weaver, TE				Wang, Mei; Bridges, James P.; Na, Cheng-Lun; Xu, Yan; Weaver, Timothy E.			Meckel-Gruber Syndrome Protein MKS3 Is Required for Endoplasmic Reticulum-associated Degradation of Surfactant Protein C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERSTITIAL LUNG-DISEASE; WPK RAT; SP-B; MUTATION; GENE; EXPRESSION; MECHANISMS; DOMINANT; DELETION; STRESS	Autosomal dominant mutations in the SFTPC gene are associated with idiopathic pulmonary fibrosis, a progressive lethal interstitial lung disease. Mutations that cause misfolding of the encoded proprotein surfactant protein C (SP-C) trigger endoplasmic reticulum (ER)-associated degradation, a pathway that segregates terminally misfolded substrate for retrotranslocation to the cytosol and degradation by proteasome. Microarray screens for genes involved in SP-C ER-associated degradation identified MKS3/TMEM67, a locus previously linked to the ciliopathy Meckel-Gruber syndrome. In this study, MKS3 was identified as a membrane glycoprotein predominantly localized to the ER. Expression of MKS3 was up-regulated by genetic or pharmacological inducers of ER stress. The ER lumenal domain of MKS3 interacted with a complex that included mutant SP-C and associated chaperones, whereas the region predicted to encode the transmembrane domains of MKS3 interacted with cytosolic p97. Deletion of the transmembrane and cytosolic domains abrogated interaction of MKS3 with p97 and resulted in accumulation of mutant SP-C proprotein; knockdown of MKS3 also inhibited degradation of mutant SP-C. These results support a model in which MKS3 links the ER lumenal quality control machinery with the cytosolic degradation apparatus.	Univ Cincinnati, Coll Med, Cincinnati Childrens Res Fdn, Div Pulm Biol, Cincinnati, OH 45229 USA; Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Weaver, TE (corresponding author), Cincinnati Childrens Hosp, Med Ctr, Div Pulm Biol, MLC 7029,3333 Burnet Ave, Cincinnati, OH 45229 USA.	tim.weaver@cchmc.org		Bridges, James P./0000-0002-4815-117X; , Yan/0000-0003-2025-027X	National Institutes of Health; NHLBI [P01-HL61646, R01-HL086492]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL061646, R01HL086492] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants P01-HL61646 and R01-HL086492 from NHLBI.	Baala L, 2007, AM J HUM GENET, V80, P186, DOI 10.1086/510499; Brancati F, 2009, HUM MUTAT, V30, pE432, DOI 10.1002/humu.20924; Bridges JP, 2006, J CELL BIOL, V172, P395, DOI 10.1083/jcb.200508016; Bridges JP, 2003, J BIOL CHEM, V278, P52739, DOI 10.1074/jbc.M309599200; Chibbar R, 2004, MODERN PATHOL, V17, P973, DOI 10.1038/modpathol.3800149; CONKRIGHT J, 2009, AM J RESP C IN PRESS; Cook SA, 2009, J AM SOC NEPHROL, V20, P753, DOI 10.1681/ASN.2008040412; Dawe HR, 2007, HUM MOL GENET, V16, P173, DOI 10.1093/hmg/ddl459; Dong M, 2008, MOL BIOL CELL, V19, P2620, DOI 10.1091/mbc.E07-07-0674; Gattone VH, 2004, ANAT REC PART A, V277A, P384, DOI 10.1002/ar.a.20022; Guo FK, 2004, ONCOGENE, V23, P5577, DOI 10.1038/sj.onc.1207752; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Khaddour Rana, 2007, Hum Mutat, V28, P523, DOI 10.1002/humu.9489; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Leitch CC, 2008, NAT GENET, V40, P443, DOI 10.1038/ng.97; Liang GQ, 2008, HUM MOL GENET, V17, P1109, DOI 10.1093/hmg/ddm383; Lin S, 1996, BBA-MOL CELL RES, V1312, P177, DOI 10.1016/0167-4889(95)00201-4; Mayhew TM, 2009, ANN ANAT, V191, P153, DOI 10.1016/j.aanat.2008.11.001; Mulugeta S, 2005, AM J RESP CELL MOL, V32, P521, DOI 10.1165/rcmb.2005-0009OC; Mulugeta S, 2007, AM J PHYSIOL-LUNG C, V293, pL720, DOI 10.1152/ajplung.00025.2007; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Nogee LM, 2001, NEW ENGL J MED, V344, P573, DOI 10.1056/NEJM200102223440805; Nogee LM, 2004, ANNU REV PHYSIOL, V66, P601, DOI 10.1146/annurev.physiol.66.032102.134711; Rice WR, 2002, AM J PHYSIOL-LUNG C, V283, pL256, DOI 10.1152/ajplung.00302.2001; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Schuberth C, 2005, NAT CELL BIOL, V7, P999, DOI 10.1038/ncb1299; Smith UM, 2006, NAT GENET, V38, P191, DOI 10.1038/ng1713; Soraisham AS, 2006, J PERINATOL, V26, P67, DOI 10.1038/sj.jp.7211417; TARTAKOFF AM, 1983, J CELL BIOL, V97, P1243, DOI 10.1083/jcb.97.4.1243; Thomas AQ, 2002, AM J RESP CRIT CARE, V165, P1322, DOI 10.1164/rccm.200112-123OC; Tian Y, 2007, MOL CELL BIOL, V27, P6383, DOI 10.1128/MCB.00254-07; Torres VE, 2006, NAT CLIN PRACT NEPHR, V2, P40, DOI 10.1038/ncpneph0070; Ueno T, 2004, J BIOL CHEM, V279, P16178, DOI 10.1074/jbc.M312029200; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang WJ, 2003, J CELL SCI, V116, P683, DOI 10.1242/jcs.00267; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x	37	9	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33377	33383		10.1074/jbc.M109.034371	http://dx.doi.org/10.1074/jbc.M109.034371			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19815549	hybrid, Green Published			2022-12-27	WOS:000272028500043
J	Liu, B; Lin, YH; Darwanto, A; Song, XH; Xu, GL; Zhang, KL				Liu, Bo; Lin, Yihui; Darwanto, Agus; Song, Xuehui; Xu, Guoliang; Zhang, Kangling			Identification and Characterization of Propionylation at Histone H3 Lysine 23 in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYLATION; LINE; BUTYRYLATION; ACETYLATION; HDOT1L; U937; GENE	Propionylation has been identified recently as a new type of protein post-translational modification. Bacterial propionyl-CoA synthetase and human histone H4 are propionylated at specific lysine residues that have been known previously to be acetylated. However, other proteins subject to this modification remain to be identified, and the modifying enzymes involved need to be characterized. In this work, we report the discovery of histone H3 propionylation in mammalian cells. Propionylation at H3 lysine Lys(23) was detected in the leukemia cell line U937 by mass spectrometry and Western analysis using a specific antibody. In this cell line, the propionylated form of Lys(23) accounted for 7%, a level at least 6-fold higher than in other leukemia cell lines (HL-60 and THP-1) or non-leukemia cell lines (HeLa and IMR-90). The propionylation level in U937 cells decreased remarkably during monocytic differentiation, indicating that this modification is dynamically regulated. Moreover, in vitro assays demonstrated that histone acetyltransferase p300 can catalyze H3 Lys(23) propionylation, whereas histone deacetylase Sir2 can remove this modification in the presence of NAD(+). These results suggest that histone propionylation might be generated by the same set of enzymes as for histone acetylation and that selection of donor molecules (propionyl-CoA versus acetylCoA) may determine the difference of modifications. Because like acetyl-CoA, propionyl-CoA is an important intermediate in biosynthesis and energy production, histone H3 Lys(23) propionylation may provide a novel epigenetic regulatory mark for cell metabolism.	[Liu, Bo; Lin, Yihui; Song, Xuehui; Xu, Guoliang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Darwanto, Agus; Zhang, Kangling] Loma Linda Univ, Sch Med, Dept Biochem, Loma Linda, CA 92350 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Loma Linda University	Xu, GL (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, 320 Yueyang Rd, Shanghai 200031, Peoples R China.	glxu@sibs.ac.cn; kzhang@llu.edu	Liu, Bo/AAU-9183-2020		Ministry of Science and Technology of China [2005CB522400, 2006CB943900]; National Science Foundation of China; Biochemistry Department of Loma Linda University	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Biochemistry Department of Loma Linda University	This work was supported by Grants 2005CB522400 and 2006CB943900 from the Ministry of Science and Technology of China and the National Science Foundation of China (to G.X.) and by the Biochemistry Department of Loma Linda University.	Boer J, 1998, MOL CELL BIOL, V18, P1236, DOI 10.1128/MCB.18.3.1236; Chen Y, 2007, MOL CELL PROTEOMICS, V6, P812, DOI 10.1074/mcp.M700021-MCP200; Dreyling MH, 1996, P NATL ACAD SCI USA, V93, P4804, DOI 10.1073/pnas.93.10.4804; Dutnall RN, 1998, COLD SPRING HARB SYM, V63, P501, DOI 10.1101/sqb.1998.63.501; Gal-Yam EN, 2008, ANNU REV MED, V59, P267, DOI 10.1146/annurev.med.59.061606.095816; Garrity J, 2007, J BIOL CHEM, V282, P30239, DOI 10.1074/jbc.M704409200; GRATTAGE LP, 1992, IMMUNOL CELL BIOL, V70, P97, DOI 10.1038/icb.1992.14; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; KING MT, 1985, ANAL BIOCHEM, V146, P173, DOI 10.1016/0003-2697(85)90412-9; Leemhuis H, 2008, CHEMBIOCHEM, V9, P499, DOI 10.1002/cbic.200700556; Lin YH, 2009, BLOOD, V114, P651, DOI 10.1182/blood-2009-03-209395; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Okada Y, 2006, NAT CELL BIOL, V8, P1017, DOI 10.1038/ncb1464; Ragg SJ, 1998, J IMMUNOL, V161, P1390; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Rice KL, 2007, ONCOGENE, V26, P6697, DOI 10.1038/sj.onc.1210755; Schwer B, 2008, CELL METAB, V7, P104, DOI 10.1016/j.cmet.2007.11.006; Seligson DB, 2005, NATURE, V435, P1262, DOI 10.1038/nature03672; Smith CM, 2003, ANAL BIOCHEM, V316, P23, DOI 10.1016/S0003-2697(03)00032-0; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Zhang K, 2009, J PROTEOME RES, V8, P900, DOI 10.1021/pr8005155; Zhang KL, 2002, ANAL BIOCHEM, V306, P259, DOI 10.1006/abio.2002.5719	22	84	87	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32288	32295		10.1074/jbc.M109.045856	http://dx.doi.org/10.1074/jbc.M109.045856			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19801601	hybrid, Green Published			2022-12-27	WOS:000272028400010
J	Fabian, M; Solomaha, E; Olson, JS; Maresso, AW				Fabian, Marian; Solomaha, Elena; Olson, John S.; Maresso, Anthony W.			Heme Transfer to the Bacterial Cell Envelope Occurs via a Secreted Hemophore in the Gram-positive Pathogen Bacillus anthracis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE PROTEIN SHP; STAPHYLOCOCCUS-AUREUS; IRON ACQUISITION; MACROMOLECULAR INTERACTIONS; HEMOGLOBIN RECEPTOR; HTSABC TRANSPORTER; CRYSTAL-STRUCTURE; AFFINITY BINDING; OUTER-MEMBRANE; NEAT DOMAINS	To initiate and sustain an infection in mammals, bacterial pathogens must acquire host iron. However, the host's compartmentalization of large amounts of iron in heme, which is bound primarily by hemoglobin in red blood cells, acts as a barrier to bacterial iron assimilation. Bacillus anthracis, the causative agent of the disease anthrax, secretes two NEAT ( near iron transporter) proteins, IsdX1 and IsdX2, which scavenge heme from host hemoglobin and promote growth under low iron conditions. The mechanism of heme transfer from these hemophores to the bacterial cell is not known. We present evidence that the heme-bound form of IsdX1 rapidly and directionally transfers heme to IsdC, a NEAT protein covalently attached to the cell wall, as well as to IsdX2. In both cases, the transfer of heme is mediated by a physical association between the donor and recipient. Unlike Staphylococcus aureus, whose NEAT proteins acquire heme from hemoglobin directly at the bacterial surface, B. anthracis secretes IsdX1 to capture heme in the extracellular milieu and relies on NEAT-NEAT interactions to deliver the bound heme to the envelope via IsdC. Understanding the mechanism of NEAT-mediated iron transport into pathogenic Gram-positive bacteria may provide an avenue for the development of therapeutics to combat infection.	[Maresso, Anthony W.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Fabian, Marian; Olson, John S.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77096 USA; [Solomaha, Elena] Univ Chicago, Biophys Core Facil, Chicago, IL 60637 USA	Baylor College of Medicine; Rice University; University of Chicago	Maresso, AW (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, 1 Baylor Plaza, Houston, TX 77030 USA.	maresso@bcm.tmc.edu		Olson, John/0000-0002-0760-5403	National Institutes of Health [AI069697, GM035649, HL047020, GM84348]; Robert A. Welch Foundation [C0612]; Baylor College of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI069697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084348, R01GM035649] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Baylor College of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI069697 (to A. W. M.), GM035649 and HL047020 (to J.S.O.), and GM84348 (to M. F.).; Supported by Robert A. Welch Foundation Grant C0612.; Supported by seed funds from the Baylor College of Medicine.	ABRAMOVA FA, 1993, P NATL ACAD SCI USA, V90, P2291, DOI 10.1073/pnas.90.6.2291; ALISON G, 2002, HEME CHLOROPHYLL BIL; Andreev YN, 2002, GEMATOL TRANSFUZIOL, V47, P5; Aranda R, 2007, J MOL BIOL, V374, P374, DOI 10.1016/j.jmb.2007.08.058; Ascoli F, 1981, Methods Enzymol, V76, P72; Bonomo RA, 2008, ENZYME-MEDIATED RESISTANCE TO ANTIBIOTICS: MECHANISMS, DISSEMINATION, AND PROSPECTS FOR INHIBITION, P1; Braun V, 2001, INT J MED MICROBIOL, V291, P67, DOI 10.1078/1438-4221-00103; Cescau S, 2007, BIOMETALS, V20, P603, DOI 10.1007/s10534-006-9050-y; Crosa JH., 2004, IRON TRANSPORT BACTE; De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; Dementieva IS, 2009, J MOL BIOL, V387, P175, DOI 10.1016/j.jmb.2009.01.030; Dryla A, 2003, MOL MICROBIOL, V49, P37, DOI 10.1046/j.1365-2958.2003.03542.x; Dryla A, 2007, J BACTERIOL, V189, P254, DOI 10.1128/JB.01366-06; Gat O, 2008, MOL MICROBIOL, V70, P983, DOI 10.1111/j.1365-2958.2008.06460.x; Genco CA, 2001, MOL MICROBIOL, V39, P1, DOI 10.1046/j.1365-2958.2001.02231.x; GREY MR, 2006, BIOTERRORISM SOURCEB; Grigg JC, 2007, MOL MICROBIOL, V63, P139, DOI 10.1111/j.1365-2958.2006.05502.x; HARGROVE MS, 1994, J BIOL CHEM, V269, P4207; Heinemann IU, 2008, ARCH BIOCHEM BIOPHYS, V474, P238, DOI 10.1016/j.abb.2008.02.015; Howell S, 1998, J MOL RECOGNIT, V11, P200, DOI 10.1002/(SICI)1099-1352(199812)11:1/6<200::AID-JMR423>3.0.CO;2-7; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236; Izadi-Pruneyre N, 2006, J BIOL CHEM, V281, P25541, DOI 10.1074/jbc.M603698200; Jensen GB, 2003, ENVIRON MICROBIOL, V5, P631, DOI 10.1046/j.1462-2920.2003.00461.x; Koch R, 1876, BEITR BIOL PFLANZ, V2, P277; Krieg S, 2009, P NATL ACAD SCI USA, V106, P1045, DOI 10.1073/pnas.0809406106; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LETOFFE S, 1994, P NATL ACAD SCI USA, V91, P9876, DOI 10.1073/pnas.91.21.9876; Letoffe S, 1999, MOL MICROBIOL, V33, P546, DOI 10.1046/j.1365-2958.1999.01499.x; LINCOLN RE, 1965, J INFECT DIS, V115, P481, DOI 10.1093/infdis/115.5.481; Liu MY, 2008, J BIOL CHEM, V283, P6668, DOI 10.1074/jbc.M708372200; Liu MY, 2005, INFECT IMMUN, V73, P5086, DOI 10.1128/IAI.73.8.5086-5092.2005; Mack J, 2004, BIOCHEM BIOPH RES CO, V320, P781, DOI 10.1016/j.bbrc.2004.06.025; Maresso AW, 2006, BIOMETALS, V19, P193, DOI 10.1007/s10534-005-4863-7; Maresso AW, 2008, PHARMACOL REV, V60, P128, DOI 10.1124/pr.107.07110; Maresso AW, 2006, J BACTERIOL, V188, P8145, DOI 10.1128/JB.01011-06; Maresso AW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000132; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Morton TA, 1998, METHOD ENZYMOL, V295, P268; Murphy Michael, 2006, Curr Protoc Protein Sci, VChapter 19, DOI 10.1002/0471142301.ps1914s45; Muryoi N, 2008, J BIOL CHEM, V283, P28125, DOI 10.1074/jbc.M802171200; Myszka DG, 2000, METHOD ENZYMOL, V323, P325; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; Neidhardt FC, 1990, PHYSL BACTERIAL CELL; Nygaard TK, 2006, J BIOL CHEM, V281, P20761, DOI 10.1074/jbc.M601832200; Pilpa RM, 2006, J MOL BIOL, V360, P435, DOI 10.1016/j.jmb.2006.05.019; Pilpa RM, 2009, J BIOL CHEM, V284, P1166, DOI 10.1074/jbc.M806007200; Pluym M, 2008, J INORG BIOCHEM, V102, P480, DOI 10.1016/j.jinorgbio.2007.11.011; Ran YC, 2007, J BIOL CHEM, V282, P31380, DOI 10.1074/jbc.M705967200; Reniere ML, 2007, BIOMETALS, V20, P333, DOI 10.1007/s10534-006-9032-0; ROSS JM, 1957, J PATHOL BACTERIOL, V73, P485, DOI 10.1002/path.1700730219; Sharp KH, 2007, J BIOL CHEM, V282, P10625, DOI 10.1074/jbc.M700234200; Skaar EP, 2004, MICROBES INFECT, V6, P390, DOI 10.1016/j.micinf.2003.12.008; Skaar EP, 2004, SCIENCE, V305, P1626, DOI 10.1126/science.1099930; Skaar EP, 2004, J BIOL CHEM, V279, P436, DOI 10.1074/jbc.M307952200; Skaar EP, 2006, J BACTERIOL, V188, P1071, DOI 10.1128/JB.188.3.1071-1080.2006; SMITH H, 1953, BRIT J EXP PATHOL, V34, P477; SMITH H, 1954, LANCET, V2, P474; SMITH H, 1955, BRIT J EXP PATHOL, V36, P460; Stojiljkovic I, 2002, DNA CELL BIOL, V21, P281, DOI 10.1089/104454902753759708; Taylor JM, 2002, MOL MICROBIOL, V43, P1603, DOI 10.1046/j.1365-2958.2002.02850.x; Torres VJ, 2006, J BACTERIOL, V188, P8421, DOI 10.1128/JB.01335-06; Vermeiren CL, 2006, BIOCHEMISTRY-US, V45, P12867, DOI 10.1021/bi0607711; Wandersman C, 2000, CURR OPIN MICROBIOL, V3, P215, DOI 10.1016/S1369-5274(00)00078-3; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Watanabe M, 2008, J BIOL CHEM, V283, P28649, DOI 10.1074/jbc.M803383200; Wilks A, 2007, NAT PROD REP, V24, P511, DOI 10.1039/b604193k; WITTENBERG JB, 1990, ANNU REV BIOPHYS BIO, V19, P217; Zhu H, 2008, J BIOL CHEM, V283, P18450, DOI 10.1074/jbc.M801466200	68	59	61	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					32138	32146		10.1074/jbc.M109.040915	http://dx.doi.org/10.1074/jbc.M109.040915			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19759022	Green Published, hybrid			2022-12-27	WOS:000271572700068
J	Pena, MMO; Melo, SP; Xing, YY; White, K; Barbour, KW; Berger, FG				Pena, Maria Marjorette O.; Melo, Sandra P.; Xing, Yang-Yang; White, Kenneth; Barbour, Karen W.; Berger, Franklin G.			The Intrinsically Disordered N-terminal Domain of Thymidylate Synthase Targets the Enzyme to the Ubiquitin-independent Proteasomal Degradation Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID SEQUENCE; ORNITHINE-DECARBOXYLASE; METHIONINE EXCISION; EUKARYOTIC PROTEINS; C-FOS; ACETYLATION; PROTEOMICS; TURNOVER; CELLS; DRUG	The ubiquitin-independent proteasomal degradation pathway is increasingly being recognized as important in regulation of protein turnover in eukaryotic cells. One substrate of this pathway is the pyrimidine biosynthetic enzyme thymidylate synthase (TS; EC 2.1.1.45), which catalyzes the reductive methylation of dUMP to form dTMP and is essential for DNA replication during cell growth and proliferation. Previous work from our laboratory showed that degradation of TS is ubiquitin-independent and mediated by an intrinsically disordered 27-residue region at the N-terminal end of the molecule. In the current study we show that this region, in cooperation with an alpha-helix formed by the next 15 residues, functions as a degron, i.e. it is capable of destabilizing a heterologous protein to which it is fused. Comparative analysis of the primary sequence of TS from a number of mammalian species revealed that the N-terminal domain is hypervariable among species yet is conserved with regard to its disordered nature, its high Pro content, and the occurrence of Pro at the penultimate site. Characterization of mutant proteins showed that Pro-2 protects the N terminus against N-alpha-acetylation, a post-translational process that inhibits TS degradation. However, although a free amino group at the N terminus is necessary, it is not sufficient for degradation of the polypeptide. The implications of these findings to the proteasome-targeting function of the N-terminal domain, particularly with regard to its intrinsic flexibility, are discussed.	[Pena, Maria Marjorette O.; Melo, Sandra P.; Xing, Yang-Yang; White, Kenneth; Barbour, Karen W.; Berger, Franklin G.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Berger, FG (corresponding author), Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA.	fgberger@mailbox.sc.edu			National Institutes of Health [CA44013]; NATIONAL CANCER INSTITUTE [R01CA044013] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA44013.	Arnesen T, 2009, P NATL ACAD SCI USA, V106, P8157, DOI 10.1073/pnas.0901931106; Basbous J, 2008, BIOCHIMIE, V90, P296, DOI 10.1016/j.biochi.2007.07.016; Baugh JM, 2009, J MOL BIOL, V386, P814, DOI 10.1016/j.jmb.2008.12.081; Berger FG, 2006, CANCER BIOL THER, V5, P1238, DOI 10.4161/cbt.5.9.3414; BERGER SH, 1985, MOL PHARMACOL, V28, P461; Bossis G, 2003, MOL CELL BIOL, V23, P7425, DOI 10.1128/MCB.23.20.7425-7436.2003; Brown CJ, 2002, J MOL EVOL, V55, P104, DOI 10.1007/s00239-001-2309-6; CARRERAS CW, 1995, ANNU REV BIOCHEM, V64, P721, DOI 10.1146/annurev.bi.64.070195.003445; Chen XY, 2004, MOL CELL, V16, P839, DOI 10.1016/j.molcel.2004.11.011; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; CIEOELA J, 2006, ACTA BIOCHIM POL, V53, P189; Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Ferron F, 2006, PROTEINS, V65, P1, DOI 10.1002/prot.21075; Forsthoefel AM, 2004, BIOCHEMISTRY-US, V43, P1972, DOI 10.1021/bi035894p; Frottin F, 2006, MOL CELL PROTEOMICS, V5, P2336, DOI 10.1074/mcp.M600225-MCP200; Giglione C, 2004, CELL MOL LIFE SCI, V61, P1455, DOI 10.1007/s00018-004-3466-8; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; HARDY LW, 1987, SCIENCE, V235, P448, DOI 10.1126/science.3099389; HERSHKO A, 1984, P NATL ACAD SCI-BIOL, V81, P7021, DOI 10.1073/pnas.81.22.7021; HIREL PH, 1989, P NATL ACAD SCI USA, V86, P8247, DOI 10.1073/pnas.86.21.8247; Isono O, 2008, J BIOL CHEM, V283, P34273, DOI 10.1074/jbc.M802527200; Jariel-Encontre I, 2008, BBA-REV CANCER, V1786, P153, DOI 10.1016/j.bbcan.2008.05.004; Jin YT, 2003, EMBO J, V22, P6365, DOI 10.1093/emboj/cdg600; JOHNSON GG, 1988, J BIOL CHEM, V263, P9079; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Li XT, 2007, MOL CELL, V26, P831, DOI 10.1016/j.molcel.2007.05.028; Lin SB, 2001, MOL PHARMACOL, V60, P474; Martinez A, 2008, PROTEOMICS, V8, P2809, DOI 10.1002/pmic.200701191; MAYER A, 1989, SCIENCE, V244, P1480, DOI 10.1126/science.2544030; Meinnel T, 2005, BIOCHIMIE, V87, P701, DOI 10.1016/j.biochi.2005.03.011; Meinnel T, 2006, BIOL CHEM, V387, P839, DOI 10.1515/BC.2006.107; NUSSBAUM RL, 1985, AM J HUM GENET, V37, P1192; Pena MMO, 2006, BIOCHEM J, V394, P355, DOI 10.1042/BJ20051479; Phan J, 2001, J BIOL CHEM, V276, P14170, DOI 10.1074/jbc.M009493200; Phan J, 2001, BIOCHEMISTRY-US, V40, P1897, DOI 10.1021/bi002413i; Polevoda B, 2000, J BIOL CHEM, V275, P36479, DOI 10.1074/jbc.R000023200; Polevoda B, 2003, J MOL BIOL, V325, P595, DOI 10.1016/S0022-2836(02)01269-X; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Schiffer CA, 1995, BIOCHEMISTRY-US, V34, P16279, DOI 10.1021/bi00050a007; SHIMIZU K, 1985, J BIOCHEM-TOKYO, V97, P845, DOI 10.1093/oxfordjournals.jbchem.a135125; Stapley BJ, 1999, PROTEIN SCI, V8, P587; Takeuchi J, 2007, EMBO J, V26, P123, DOI 10.1038/sj.emboj.7601476; Wang KH, 2008, J BIOL CHEM, V283, P24600, DOI 10.1074/jbc.M802213200; Yang Z, 2006, CANCER GENE THER, V13, P107, DOI 10.1038/sj.cgt.7700880; Yuksek K, 2009, J VIROL, V83, P612, DOI 10.1128/JVI.00832-08; Zhang MS, 2003, EMBO J, V22, P1488, DOI 10.1093/emboj/cdg158; Zhang MS, 2004, J BIOL CHEM, V279, P20959, DOI 10.1074/jbc.M314043200	50	28	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31597	31607		10.1074/jbc.M109.038455	http://dx.doi.org/10.1074/jbc.M109.038455			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19797058	hybrid, Green Published			2022-12-27	WOS:000271572700014
J	Yu, HB; Kunarso, G; Hong, FH; Stanton, LW				Yu, Hong-bing; Kunarso, Galih; Hong, Felicia Huimei; Stanton, Lawrence W.			Zfp206, Oct4, and Sox2 Are Integrated Components of a Transcriptional Regulatory Network in Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELF-RENEWAL; PLURIPOTENCY; NANOG; MAINTENANCE; EXPRESSION; DNA	Zfp206 (recently renamed Zscan10) encodes a zinc finger transcription factor specifically expressed in human and mouse embryonic stem cells (ESC). It has been shown that Zfp206 is required to maintain ESC in an undifferentiated, pluripotent state. Presented here are data showing that Zfp206 works together with two other transcription factors, Oct4 and Sox2, which are also essential regulators of ESC pluripotency. We show that Zfp206 binds to the Oct4 promoter and directly regulates Oct4 expression. Genome-wide mapping of Zfp206-binding sites in ESC identifies more than 3000 target genes, many of which encode transcription factors that are also targeted for regulation by Oct4 and Sox2. In addition, we show that Zfp206 physically interacts with both Oct4 and Sox2. These data demonstrate that Zfp206 is a key component of the core transcriptional regulatory network and together with Oct4 and Sox2 regulates differentiation of ESC.	Natl Univ Singapore, Dept Biol Sci, Singapore 117542, Singapore; [Yu, Hong-bing; Hong, Felicia Huimei; Stanton, Lawrence W.] Genome Inst Singapore, Dept Cell & Dev Biol, Singapore 138672, Singapore; [Kunarso, Galih] Genome Inst Singapore, Dept Computat & Math Biol, Singapore 138672, Singapore	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Stanton, LW (corresponding author), Genome Inst Singapore, Dept Cell & Dev Biol, 60 Biopolis St, Singapore 138672, Singapore.	stantonl@gis.a-star.edu.sg			Singapore's Agency for Science Technology and Research	Singapore's Agency for Science Technology and Research(Agency for Science Technology & Research (A*STAR))	This work was supported by Singapore's Agency for Science Technology and Research.	Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brayer KJ, 2008, CELL BIOCHEM BIOPHYS, V50, P111, DOI 10.1007/s12013-008-9008-5; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Davidson EH, 2008, P NATL ACAD SCI USA, V105, P20063, DOI 10.1073/pnas.0806007105; Edelstein LC, 2005, GENE, V359, P1, DOI 10.1016/j.gene.2005.06.022; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Lim LS, 2007, MOL BIOL CELL, V18, P1348, DOI 10.1091/mbc.E06-07-0624; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Pavesi G, 2001, Bioinformatics, V17 Suppl 1, pS207; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tam WL, 2008, STEM CELLS, V26, P2019, DOI 10.1634/stemcells.2007-1115; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wang ZX, 2007, STEM CELLS, V25, P2173, DOI 10.1634/stemcells.2007-0085; Wang ZX, 2007, J BIOL CHEM, V282, P12822, DOI 10.1074/jbc.M611814200; Wang ZX, 2008, STEM CELLS, V26, P2791, DOI 10.1634/stemcells.2008-0443; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481; Zhang W, 2006, NUCLEIC ACIDS RES, V34, P4780, DOI 10.1093/nar/gkl631; Zhang XF, 2008, J BIOL CHEM, V283, P35825, DOI 10.1074/jbc.M803481200	22	48	55	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31327	31335		10.1074/jbc.M109.016162	http://dx.doi.org/10.1074/jbc.M109.016162			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19740739	Green Published, hybrid			2022-12-27	WOS:000271378400059
J	Yan, XH; Lin, ZH; Chen, F; Zhao, XG; Chen, H; Ning, YH; Chen, YG				Yan, Xiaohua; Lin, Zhenghong; Chen, Feng; Zhao, Xingang; Chen, Hua; Ning, Yuanheng; Chen, Ye-Guang			Human BAMBI Cooperates with Smad7 to Inhibit Transforming Growth Factor-beta Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; TRANSCRIPTIONAL REGULATION; PSEUDORECEPTOR BAMBI; NEGATIVE REGULATION; CELL-LINES; RECEPTOR; TRANSDUCTION; EXPRESSION; MEMBRANE; GENE	Transforming growth factor beta (TGF-beta) and related growth factors are essential regulators of embryogenesis and tissue homeostasis. The signaling pathways mediated by their receptors and Smad proteins are precisely modulated by various means. Xenopus BAMBI (bone morphogenic protein (BMP) and activin membrane-bound inhibitor) has been shown to function as a general negative regulator of TGF-beta/BMP/activin signaling. Here, we provide evidence that human BAMBI (hBAMBI), like its Xenopus homolog, inhibits TGF-beta- and BMP-mediated transcriptional responses as well as TGF-beta-induced R-Smad phosphorylation and cell growth arrest, whereas knockdown of endogenous BAMBI enhances the TGF-beta-induced reporter expression. Mechanistically, in addition to interfering with the complex formation between the type I and type II receptors, hBAMBI cooperates with Smad7 to inhibit TGF-beta signaling. hBAMBI forms a ternary complex with Smad7 and the TGF-beta type I receptor ALK5/T beta RI and inhibits the interaction between ALK5/T beta RI and Smad3, thus impairing Smad3 activation. These findings provide a novel insight to understand the molecular mechanism underlying the inhibitory effect of BAMBI on TGF-beta signaling.	[Yan, Xiaohua; Lin, Zhenghong; Chen, Feng; Zhao, Xingang; Chen, Hua; Ning, Yuanheng; Chen, Ye-Guang] Tsinghua Univ, Dept Biol Sci & Biotechnol, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China	Tsinghua University	Chen, YG (corresponding author), Tsinghua Univ, Dept Biol Sci & Biotechnol, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	ygchen@tsinghua.edu.cn	Yan, Xiaohua/J-4922-2015; Chen, Ye-Guang/L-6998-2019	Yan, Xiaohua/0000-0002-7528-5771; Lin, Zhenghong/0000-0002-6354-0042	National Natural Science Foundation of China [30671033, 90713045]; 973 Program [2006CB943401, 2006CB910102]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China Grants 30671033 and 90713045 and 973 Program Grants (2006CB943401 and 2006CB910102).	BOYD FT, 1989, J BIOL CHEM, V264, P2272; CARCAMO J, 1994, MOL CELL BIOL, V14, P3810, DOI 10.1128/MCB.14.6.3810; Chen JQ, 2007, GENESIS, V45, P482, DOI 10.1002/dvg.20320; Degen WGJ, 1996, INT J CANCER, V65, P460, DOI 10.1002/(SICI)1097-0215(19960208)65:4<460::AID-IJC12>3.3.CO;2-B; Deheuninck J, 2009, CELL RES, V19, P47, DOI 10.1038/cr.2008.324; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Goumans MJ, 2009, CELL RES, V19, P116, DOI 10.1038/cr.2008.326; Grotewold L, 2001, MECH DEVELOP, V100, P327, DOI 10.1016/S0925-4773(00)00524-4; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Higashihori N, 2008, DEV DYNAM, V237, P1500, DOI 10.1002/dvdy.21529; Hill CS, 2009, CELL RES, V19, P36, DOI 10.1038/cr.2008.325; HUANG HC, 1995, EMBO J, V14, P5965, DOI 10.1002/j.1460-2075.1995.tb00285.x; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; Itoh S, 2007, CURR OPIN CELL BIOL, V19, P176, DOI 10.1016/j.ceb.2007.02.015; Karaulanov E, 2004, EMBO J, V23, P844, DOI 10.1038/sj.emboj.7600101; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Khin SS, 2009, INT J CANCER, V125, P328, DOI 10.1002/ijc.24318; Lin ZH, 2008, J BIOL CHEM, V283, P33053, DOI 10.1074/jbc.M804039200; Lonn P, 2009, CELL RES, V19, P21, DOI 10.1038/cr.2008.308; Loveland KL, 2003, ENDOCRINOLOGY, V144, P4180, DOI 10.1210/en.2002-0124; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2000, GENE DEV, V14, P627; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Miyazono K, 2000, J CELL SCI, V113, P1101; Miyazono K, 2003, CANCER SCI, V94, P230, DOI 10.1111/j.1349-7006.2003.tb01425.x; Moustakas A, 2001, J CELL SCI, V114, P4359; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Onichtchouk D, 1999, NATURE, V401, P480, DOI 10.1038/46794; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; Park SH, 2005, J BIOCHEM MOL BIOL, V38, P9; Sasaki T, 2004, ONCOL REP, V11, P1219; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Sekiya T, 2004, BIOCHEM BIOPH RES CO, V320, P680, DOI 10.1016/j.bbrc.2004.06.017; Sekiya T, 2004, J BIOL CHEM, V279, P6840, DOI 10.1074/jbc.M310876200; Shi WB, 2004, J CELL BIOL, V164, P291, DOI 10.1083/jcb.200307151; Souchelnytskyi S, 1998, J BIOL CHEM, V273, P25364, DOI 10.1074/jbc.273.39.25364; Suzuki C, 2002, J BIOL CHEM, V277, P39919, DOI 10.1074/jbc.M201901200; TEN DP, 2004, TRENDS BIOCHEM SCI, V29, P265; Tsang M, 2000, GENESIS, V28, P47, DOI 10.1002/1526-968X(200010)28:2<47::AID-GENE20>3.0.CO;2-S; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323; Wrighton KH, 2009, CELL RES, V19, P8, DOI 10.1038/cr.2008.327; Xi QR, 2008, J BIOL CHEM, V283, P1146, DOI 10.1074/jbc.M707479200; Yan XH, 2009, ACTA BIOCH BIOPH SIN, V41, P263, DOI 10.1093/abbs/gmp018; Zhang SP, 2007, MOL CELL BIOL, V27, P4488, DOI 10.1128/MCB.01636-06	51	110	114	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30097	30104		10.1074/jbc.M109.049304	http://dx.doi.org/10.1074/jbc.M109.049304			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19758997	Green Published, hybrid			2022-12-27	WOS:000271090000012
J	Hamill, KJ; Langbein, L; Jones, JCR; McLean, WHI				Hamill, Kevin J.; Langbein, Lutz; Jones, Jonathan C. R.; McLean, W. H. Irwin			Identification of a Novel Family of Laminin N-terminal Alternate Splice Isoforms STRUCTURAL AND FUNCTIONAL CHARACTERIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX; GAMMA-2 CHAIN; DIFFERENTIAL EXPRESSION; EXON USAGE; MOUSE; INTEGRIN; GENES; FIBRONECTIN; BINDING; PROTEIN	The laminins are a family of heterotrimeric basement membrane proteins that play roles in cellular adhesion, migration, and tissue morphogenesis. Through in silico analysis of the laminin-encoding genes, we identified a novel family of alternate splice isoforms derived from the 5'-end of the LAMA3 and LAMA5 genes. These isoforms resemble the netrins in that they contain a laminin N-terminal domain followed by a short stretch of laminin-type epidermal growth factor-like repeats. We suggest the terms LaNt (laminin N terminus) alpha 3 and LaNt alpha 5, for the predicted protein products of these mRNAs. RT-PCR confirmed the presence of these transcripts at the mRNA level. Moreover, they exhibit differential, tissue-specific, expression profiles. To confirm the existence of LaNt alpha 3 protein, we generated an antibody to a unique domain within the putative polypeptide. This antibody recognizes a protein at the predicted molecular mass of 64 kDa by immunoblotting. Furthermore, immunofluorescence analyses revealed a basement membrane staining in epithelial tissue for LaNt alpha 3 and LaNt alpha 3 localized along the substratum-associated surface of cultured keratinocytes. We have also tested the functionality LaNt alpha 3 through RNAi-mediated knockdown. Keratinocytes exhibiting specific knockdown of LaNt alpha 3 displayed impaired adhesion, stress resistance, and reduced ability to close scratch wounds in vitro.	[Hamill, Kevin J.; McLean, W. H. Irwin] Univ Dundee, Ninewells Hosp & Med Sch, Div Pathol & Neurosci, Epithelial Genet Grp,Human Genet Unit, Dundee DD1 9SY, Scotland; [Hamill, Kevin J.; Jones, Jonathan C. R.] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Langbein, Lutz] German Canc Res Ctr, Dept Genet Skin Carcinogenesis, D-69120 Heidelberg, Germany	University of Dundee; Northwestern University; Feinberg School of Medicine; Helmholtz Association; German Cancer Research Center (DKFZ)	Hamill, KJ (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Div Pathol & Neurosci, Epithelial Genet Grp,Human Genet Unit, Dundee DD1 9SY, Scotland.	k-hamill@northwestern.edu	Hamill, Kevin/F-8983-2012; McLean, William HI/C-6352-2009; Hamill, Kevin/ABF-9727-2020; Jones, Jonathan C R/T-9467-2017	Hamill, Kevin/0000-0002-7852-1944; Jones, Jonathan C R/0000-0002-1496-4922; McLean, William Henry Irwin/0000-0001-5539-5757	National Institutes of Health [R01 AR054184]; Dystrophic Epidermolysis Bullosa Research Association; MRC [G0700314] Funding Source: UKRI; Medical Research Council [G0700314] Funding Source: researchfish; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054184] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dystrophic Epidermolysis Bullosa Research Association; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AR054184 ( to J.C.R.J.), This work was also supported by grants from the Dystrophic Epidermolysis Bullosa Research Association ( to W. H. I. M.). Human tissue sections were provided by Northwestern University Skin Disease Research Center, Chicago, IL.	Airenne T, 1996, GENOMICS, V32, P54, DOI 10.1006/geno.1996.0076; Airenne T, 2000, CELL TISSUE RES, V300, P129, DOI 10.1007/s004410050054; Aoki-Suzuki M, 2005, BIOL PSYCHIAT, V57, P382, DOI 10.1016/j.biopsych.2004.11.022; Ashton GHS, 2004, J INVEST DERMATOL, V122, P78, DOI 10.1046/j.0022-202X.2003.22136.x; Aumailley M, 1998, J ANAT, V193, P1, DOI 10.1046/j.1469-7580.1998.19310001.x; Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; Barallobre MJ, 2005, BRAIN RES REV, V49, P22, DOI 10.1016/j.brainresrev.2004.11.003; Beaudoing E, 2000, GENOME RES, V10, P1001, DOI 10.1101/gr.10.7.1001; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; BOYD CD, 1993, MATRIX, V13, P457, DOI 10.1016/S0934-8832(11)80112-5; Cichon S, 1998, HUM MOL GENET, V7, P1671, DOI 10.1093/hmg/7.11.1671; Ferrigno O, 1997, J BIOL CHEM, V272, P20502, DOI 10.1074/jbc.272.33.20502; Gagnoux-Palacios L, 2001, J CELL BIOL, V153, P835, DOI 10.1083/jcb.153.4.835; GagnouxPalacios L, 1996, J BIOL CHEM, V271, P18437, DOI 10.1074/jbc.271.31.18437; Garbe JHO, 2002, BIOCHEM J, V362, P213, DOI 10.1042/0264-6021:3620213; Gonzales M, 1999, MOL BIOL CELL, V10, P259, DOI 10.1091/mbc.10.2.259; Hao JS, 2002, GENE, V283, P237, DOI 10.1016/S0378-1119(01)00850-2; Harlow E., 1988, ANTIBODIES LAB MANUA; Hayashi Y, 2002, BIOCHEM BIOPH RES CO, V299, P498, DOI 10.1016/S0006-291X(02)02642-6; JONES JCR, 1982, CELL MOTIL CYTOSKEL, V2, P197, DOI 10.1002/cm.970020302; Kim E, 2008, BIOESSAYS, V30, P38, DOI 10.1002/bies.20692; Kosmehl H, 1995, PATHOL RES PRACT, V191, P1105, DOI 10.1016/S0344-0338(11)80655-2; Langbein L, 2004, METHOD CELL BIOL, V78, P413; LANGHOFER M, 1993, J CELL SCI, V105, P753; Lee G, 2001, MOL CELLS, V12, P380; Lohi J, 2001, INT J CANCER, V94, P763, DOI 10.1002/ijc.1539; MATSUI C, 1995, J INVEST DERMATOL, V105, P648, DOI 10.1111/1523-1747.ep12324108; MAUCH JC, 1995, MATRIX BIOL, V14, P635, DOI 10.1016/S0945-053X(05)80027-7; McLean WHI, 2003, HUM MOL GENET, V12, P2395, DOI 10.1093/hmg/ddg234; Miosge N, 2002, ANAT EMBRYOL, V205, P355, DOI 10.1007/s00429-002-0256-7; Modrek B, 2003, NAT GENET, V34, P177, DOI 10.1038/ng1159; Nielsen PK, 2001, J BIOL CHEM, V276, P10906, DOI 10.1074/jbc.M008743200; Nikolopoulos SN, 2005, CELL CYCLE, V4, P429, DOI 10.4161/cc.4.3.1547; Nomizu M, 2001, BIOCHEMISTRY-US, V40, P15310, DOI 10.1021/bi011552c; O'Toole EA, 2001, CLIN EXP DERMATOL, V26, P525, DOI 10.1046/j.1365-2230.2001.00891.x; Odenthal U, 2004, J BIOL CHEM, V279, P44504, DOI 10.1074/jbc.M402455200; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Sakabe Noboru Jo, 2004, Genet Mol Res, V3, P532; Sandell LJ, 1996, CONNECT TISSUE RES, V35, P1, DOI 10.3109/03008209609029168; Schneiders FI, 2007, J BIOL CHEM, V282, P23750, DOI 10.1074/jbc.M703137200; Schor SL, 2003, CANCER RES, V63, P8827; Sehgal BU, 2006, J BIOL CHEM, V281, P35487, DOI 10.1074/jbc.M606317200; Stanco A, 2009, P NATL ACAD SCI USA, V106, P7595, DOI 10.1073/pnas.0811343106; Staquicinia FI, 2009, P NATL ACAD SCI USA, V106, P2903, DOI 10.1073/pnas.0813286106; Sugawara K, 2007, J HISTOCHEM CYTOCHEM, V55, P43, DOI 10.1369/jhc.6A6920.2006; Suzuki N, 2005, CONNECT TISSUE RES, V46, P142, DOI 10.1080/03008200591008527; Talts JF, 1998, FEBS LETT, V426, P71, DOI 10.1016/S0014-5793(98)00312-3; TIMPL R, 1993, EXPERIENTIA, V49, P417, DOI 10.1007/BF01923586; VERRANDO P, 1987, EXP CELL RES, V170, P116, DOI 10.1016/0014-4827(87)90121-2; White ES, 2008, J PATHOL, V216, P1, DOI 10.1002/path.2388; Yebra M, 2003, DEV CELL, V5, P695, DOI 10.1016/S1534-5807(03)00330-7; Yin Y, 2002, MOL CELL NEUROSCI, V19, P344, DOI 10.1006/mcne.2001.1089; Yuen HW, 2005, EXP CELL RES, V309, P198, DOI 10.1016/j.yexcr.2005.05.013; Yurchenco PD, 2004, CURR OPIN CELL BIOL, V16, P572, DOI 10.1016/j.ceb.2004.07.013; Zhang MQ, 1998, HUM MOL GENET, V7, P919, DOI 10.1093/hmg/7.5.919	55	17	18	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35588	35596		10.1074/jbc.M109.052811	http://dx.doi.org/10.1074/jbc.M109.052811			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19773554	Green Published, hybrid			2022-12-27	WOS:000272645600036
J	Abe, N; Almenar-Queralt, A; Lillo, C; Shen, ZX; Lozach, J; Briggs, SP; Williams, DS; Goldstein, LSB; Cavalli, V				Abe, Namiko; Almenar-Queralt, Angels; Lillo, Concepcion; Shen, Zhouxin; Lozach, Jean; Briggs, Steven P.; Williams, David S.; Goldstein, Lawrence S. B.; Cavalli, Valeria			Sunday Driver Interacts with Two Distinct Classes of Axonal Organelles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL-SPECIFIC PHOSPHOPROTEIN; I PROTEIN-I; SYNAPTIC VESICLE; SCAFFOLD PROTEIN; RETROGRADE TRANSPORT; MULTIVESICULAR BODIES; PLASMA-MEMBRANE; EARLY ENDOSOMES; INJURED NERVE; TETANUS-TOXIN	The extreme polarized morphology of neurons poses a challenging problem for intracellular trafficking pathways. The distant synaptic terminals must communicate via axonal transport with the cell soma for neuronal survival, function, and repair. Multiple classes of organelles transported along axons may establish and maintain the polarized morphology of neurons, as well as control signaling and neuronal responses to extracellular cues such as neurotrophic or stress factors. We reported previously that the motor-binding protein Sunday Driver (syd), also known as JIP3 or JSAP1, links vesicular axonal transport to injury signaling. To better understand syd function in axonal transport and in the response of neurons to injury, we developed a purification strategy based on anti-syd antibodies conjugated to magnetic beads to identify syd-associated axonal vesicles. Electron microscopy analyses revealed two classes of syd-associated vesicles of distinct morphology. To identify the molecular anatomy of syd vesicles, we determined their protein composition by mass spectrometry. Gene Ontology analyses of each vesicle protein content revealed their unique identity and indicated that one class of syd vesicles belongs to the endocytic pathway, whereas another may belong to an anterogradely transported vesicle pool. To validate these findings, we examined the transport and localization of components of syd vesicles within axons of mouse sciatic nerve. Together, our results lead us to propose that endocytic syd vesicles function in part to carry injury signals back to the cell body, whereas anterograde syd vesicles may play a role in axonal outgrowth and guidance.	[Abe, Namiko; Cavalli, Valeria] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Almenar-Queralt, Angels; Lozach, Jean; Goldstein, Lawrence S. B.] Univ Calif San Diego, Howard Hughes Med Inst, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Lillo, Concepcion; Williams, David S.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Lillo, Concepcion; Williams, David S.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Shen, Zhouxin; Briggs, Steven P.] Univ Calif San Diego, Sect Cell & Dev Biol, Div Biol Sci, La Jolla, CA 92093 USA; [Williams, David S.] Univ Calif Los Angeles, Dept Ophthalmol, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; [Williams, David S.] Univ Calif Los Angeles, Dept Neurosci, Jules Stein Eye Inst, Los Angeles, CA 90095 USA	Washington University (WUSTL); Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Cavalli, V (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, Campus Box 8108,660 S Euclid Ave, St Louis, MO 63110 USA.	cavalli@pcg.wustl.edu	Lillo, Concepcion/A-6321-2009; 2009, Secribsal/A-1266-2012	Lillo, Concepcion/0000-0001-5814-9826; 	NINDS National Institutes of Health [R01 NS060709]; NIGMS National Institutes of Health [GM35252]; NEI National Institutes of Health [EY07042]; National Science Foundation [0619411]; NATIONAL EYE INSTITUTE [R01EY007042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060709] Funding Source: NIH RePORTER	NINDS National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NEI National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Science Foundation(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by NINDS National Institutes of Health Grant R01 NS060709 ( to V. C.) and NIGMS National Institutes of Health Grant GM35252 ( to L. S. B. G.) and NEI National Institutes of Health Grant EY07042 ( to D. S. W.). This work was also supported by National Science Foundation Grant IBN 0619411 ( to S. P. B.).	Abe N, 2008, CURR OPIN NEUROBIOL, V18, P276, DOI 10.1016/j.conb.2008.06.005; Altick AL, 2009, J COMP NEUROL, V514, P641, DOI 10.1002/cne.22047; Ambron RT, 1996, J NEUROSCI, V16, P7469; Arantes RME, 2006, J NEUROSCI, V26, P4630, DOI 10.1523/JNEUROSCI.0009-06.2006; Becker EBE, 2006, NEURON, V49, P655, DOI 10.1016/j.neuron.2006.01.034; Bowman AB, 2000, CELL, V103, P583, DOI 10.1016/S0092-8674(00)00162-8; Brown HM, 2009, DEV NEUROBIOL, V69, P174, DOI 10.1002/dneu.20690; BURGER PM, 1989, NEURON, V3, P715, DOI 10.1016/0896-6273(89)90240-7; Byrd DT, 2001, NEURON, V32, P787, DOI 10.1016/S0896-6273(01)00532-3; Cavalli V, 2005, J CELL BIOL, V168, P775, DOI 10.1083/jcb.200410136; CHILCOTE TJ, 1995, J CELL BIOL, V129, P219, DOI 10.1083/jcb.129.1.219; Cui BX, 2007, P NATL ACAD SCI USA, V104, P13666, DOI 10.1073/pnas.0706192104; DECAMILLI P, 1983, J CELL BIOL, V96, P1355, DOI 10.1083/jcb.96.5.1355; Deinhardt K, 2006, NEURON, V52, P293, DOI 10.1016/j.neuron.2006.08.018; Delcroix JD, 2003, NEURON, V39, P69, DOI 10.1016/S0896-6273(03)00397-0; Ha HY, 2005, DEV BIOL, V277, P184, DOI 10.1016/j.ydbio.2004.09.019; Hanz S, 2003, NEURON, V40, P1095, DOI 10.1016/S0896-6273(03)00770-0; Hanz S, 2006, J NEUROCHEM, V99, P13, DOI 10.1111/j.1471-4159.2006.04089.x; Hirling H, 2009, NEUROSCIENCE, V158, P36, DOI 10.1016/j.neuroscience.2008.02.057; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Ibanez CF, 2007, TRENDS CELL BIOL, V17, P519, DOI 10.1016/j.tcb.2007.09.003; Idone V, 2008, J CELL BIOL, V180, P905, DOI 10.1083/jcb.200708010; Ikin AF, 1996, J BIOL CHEM, V271, P31783, DOI 10.1074/jbc.271.50.31783; Ikonomov OC, 2009, J BIOL CHEM, V284, P3750, DOI 10.1074/jbc.M806539200; Ito M, 1999, MOL CELL BIOL, V19, P7539; Kelkar N, 2003, P NATL ACAD SCI USA, V100, P9843, DOI 10.1073/pnas.1733944100; Kelkar N, 2000, MOL CELL BIOL, V20, P1030, DOI 10.1128/MCB.20.3.1030-1043.2000; Lalli G, 2002, J CELL BIOL, V156, P233, DOI 10.1083/jcb.200106142; MCMAHON HT, 1993, NATURE, V364, P346, DOI 10.1038/364346a0; Miura E, 2006, J NEUROCHEM, V97, P1431, DOI 10.1111/j.1471-4159.2006.03835.x; Montagnac G, 2009, CURR BIOL, V19, P184, DOI 10.1016/j.cub.2008.12.043; Morciano M, 2005, J NEUROCHEM, V95, P1732, DOI 10.1111/j.1471-4159.2005.03506.x; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; NIXON RA, 1995, TRENDS NEUROSCI, V18, P489, DOI 10.1016/0166-2236(95)92772-I; Ogawa S, 2004, P NATL ACAD SCI USA, V101, P14461, DOI 10.1073/pnas.0405786101; Ogura K, 1997, GENE DEV, V11, P1801, DOI 10.1101/gad.11.14.1801; PARTON RG, 1992, J CELL BIOL, V119, P123, DOI 10.1083/jcb.119.1.123; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; Perlson E, 2009, J NEUROSCI, V29, P9903, DOI 10.1523/JNEUROSCI.0813-09.2009; Prekeris R, 1999, J NEUROSCI, V19, P10324; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Rishal I, 2010, EXP NEUROL, V223, P5, DOI 10.1016/j.expneurol.2009.08.010; Sakamoto R, 2005, MOL BIOL CELL, V16, P483, DOI 10.1091/mbc.E04-07-0553; Salinas S, 2008, CURR OPIN CELL BIOL, V20, P445, DOI 10.1016/j.ceb.2008.04.002; Schweizer FE, 2006, CURR OPIN NEUROBIOL, V16, P298, DOI 10.1016/j.conb.2006.05.006; Takamori S, 2000, J NEUROSCI, V20, P4904; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Trischler M, 1999, J CELL SCI, V112, P4773; van der Goot FG, 2006, TRENDS CELL BIOL, V16, P514, DOI 10.1016/j.tcb.2006.08.003; van Niekerk EA, 2007, P NATL ACAD SCI USA, V104, P12913, DOI 10.1073/pnas.0611562104; VONMOLLARD GF, 1994, EUR J CELL BIOL, V65, P319; Wang Y, 2006, MOL MEMBR BIOL, V23, P377, DOI 10.1080/09687860600776734; Weible MW, 2004, J NEUROBIOL, V58, P230, DOI 10.1002/neu.10318; Willis D, 2005, J NEUROSCI, V25, P778, DOI 10.1523/JNEUROSCI.4235-04.2005; Xia CH, 2003, J CELL BIOL, V161, P55, DOI 10.1083/jcb.200301026; YAMAZAKI H, 1995, J CELL BIOL, V130, P1387, DOI 10.1083/jcb.130.6.1387; Yap CC, 2008, J CELL BIOL, V180, P827, DOI 10.1083/jcb.200707143; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4	59	46	46	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34628	34639		10.1074/jbc.M109.035022	http://dx.doi.org/10.1074/jbc.M109.035022			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19801628	Green Published, hybrid			2022-12-27	WOS:000272439600018
J	Cassola, A; Frasch, AC				Cassola, Alejandro; Frasch, Alberto C.			An RNA Recognition Motif Mediates the Nucleocytoplasmic Transport of a Trypanosome RNA-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-LOCALIZATION SIGNALS; RICH ELEMENT-BINDING; CELLULAR-LOCALIZATION; EXPORT PATHWAY; MESSENGER-RNAS; IN-VIVO; CRUZI; CYTOPLASM; EXPRESSION; SHUTTLES	RNA-binding proteins (RBPs) and RNA metabolism are considered to be important for modulating gene expression in trypanosomes, because these protozoan parasites mainly rely on post-transcriptional mechanisms to regulate protein levels. Previously, we have identified TcUBP1, a single RNA recognition motif (RRM)-type RBP from Trypanosoma cruzi. TcUBP1 is a cytoplasmic protein with roles in stabilization/degradation of mRNAs and in the protection of transcripts through their recruitment into cytoplasmic granules. We now show that TcUBP1, and the closely related protein TcUBP2, can be found in small amounts in the nucleus under normal conditions, and are able to accumulate in the nucleus under arsenite stress. The kinetics of nuclear accumulation, and export to the cytoplasm, are consistent with the shuttling of TcUBP1 between the nucleus and the cytoplasm. The sequence required for TcUBP1 nuclear accumulation was narrowed to the RRM, and point mutations affecting RNA binding abolished nuclear import. This RRM was also shown to be efficiently exported from the nucleus in unstressed parasites, a property that relied on the binding to RNA. TcUBP1 nuclear accumulation was dependent on active transcription, and colocalized with transcripts in the nucleus, suggesting nuclear binding of the mRNA. We propose that TcUBP1 could be linking the mRNA metabolism at both sides of the nuclear pore complex, using the RRM as a nuclear localization signal, and being exported as a cargo on mRNA.	[Cassola, Alejandro; Frasch, Alberto C.] Consejo Nacl Invest Cient & Tecn, UNSAM, Inst Tecnol Chascomus, Inst Invest Biotecnol, RA-1650 San Martin, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Frasch, AC (corresponding author), Consejo Nacl Invest Cient & Tecn, Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina.	cfrasch@iib.unsam.edu.ar		Cassola, Alejandro/0000-0001-7366-5327; Frasch, Alberto Carlos/0000-0001-7532-653X	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT, Argentina); Howard Hughes Medical Institute	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT, Argentina)(ANPCyT); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by grants from the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT, Argentina) (to A.C.F.) and an International Research Scholars Grant from the Howard Hughes Medical Institute (to A.C.F.).	Afonina E, 1998, J BIOL CHEM, V273, P13015, DOI 10.1074/jbc.273.21.13015; Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; BECKER A, 1995, GENE, V162, P37, DOI 10.1016/0378-1119(95)00313-U; Brune C, 2005, RNA, V11, P517, DOI 10.1261/rna.7291205; Caceres JF, 1998, GENE DEV, V12, P55, DOI 10.1101/gad.12.1.55; Cardarelli F, 2007, MOL THER, V15, P1313, DOI 10.1038/sj.mt.6300172; Cassola A, 2007, MOL MICROBIOL, V65, P655, DOI 10.1111/j.1365-2958.2007.05833.x; Clayton CE, 2002, EMBO J, V21, P1881, DOI 10.1093/emboj/21.8.1881; Clayton C, 2007, MOL BIOCHEM PARASIT, V156, P93, DOI 10.1016/j.molbiopara.2007.07.007; Clery A, 2008, CURR OPIN STRUC BIOL, V18, P290, DOI 10.1016/j.sbi.2008.04.002; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; Conti E, 2001, CURR OPIN CELL BIOL, V13, P310, DOI 10.1016/S0955-0674(00)00213-1; Cuevas IC, 2005, MOL BIOCHEM PARASIT, V139, P15, DOI 10.1016/j.molbiopara.2004.11.002; D'Orso I, 2003, TRENDS PARASITOL, V19, P151, DOI 10.1016/S1471-4922(03)00035-7; D'Orso I, 2002, J BIOL CHEM, V277, P50520, DOI 10.1074/jbc.M209092200; D'Orso I, 2001, J BIOL CHEM, V276, P34801, DOI 10.1074/jbc.M102120200; De Gaudenzi J, 2005, EUKARYOT CELL, V4, P2106, DOI 10.1128/EC.4.12.2106-2114.2005; De Gaudenzi JG, 2003, J BIOL CHEM, V278, P18884, DOI 10.1074/jbc.M301756200; Di Noia JM, 2000, J BIOL CHEM, V275, P10218, DOI 10.1074/jbc.275.14.10218; Dostie J, 2000, EMBO J, V19, P3142, DOI 10.1093/emboj/19.12.3142; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Fritz J, 2009, MOL CELL BIOL, V29, P1487, DOI 10.1128/MCB.01519-08; Hartmann C, 2007, EUKARYOT CELL, V6, P1964, DOI 10.1128/EC.00279-07; Hellman K, 2007, EUKARYOT CELL, V6, P2206, DOI 10.1128/EC.00176-07; Hoek M, 2000, J CELL SCI, V113, P3959; Hutten S, 2007, TRENDS CELL BIOL, V17, P193, DOI 10.1016/j.tcb.2007.02.003; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Jager AV, 2007, P NATL ACAD SCI USA, V104, P2035, DOI 10.1073/pnas.0611125104; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Kumar AO, 2008, BIOCHEM BIOPH RES CO, V367, P813, DOI 10.1016/j.bbrc.2008.01.027; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lei EP, 2002, DEV CELL, V2, P261, DOI 10.1016/S1534-5807(02)00134-X; Liang XH, 2003, EUKARYOT CELL, V2, P830, DOI 10.1128/EC.2.5.830-840.2003; Lichtenstein M, 2001, TRAFFIC, V2, P261, DOI 10.1034/j.1600-0854.2001.1o002.x; Marchetti MA, 2000, J CELL SCI, V113, P899; Nakielny S, 1999, CELL, V99, P677, DOI 10.1016/S0092-8674(00)81666-9; Noe G, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-107; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; PINOLROMA S, 1991, SCIENCE, V253, P312, DOI 10.1126/science.1857966; Reed R, 2001, NAT CELL BIOL, V3, pE201, DOI 10.1038/ncb0901-e201; Rong L, 2008, RNA, V14, P1318, DOI 10.1261/rna.950608; Sim S, 2009, MOL BIOL CELL, V20, P1555, DOI 10.1091/mbc.E08-11-1094; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Volpon L, 2005, BIOCHEMISTRY-US, V44, P3708, DOI 10.1021/bi047450e; Weis K, 2002, CURR OPIN CELL BIOL, V14, P328, DOI 10.1016/S0955-0674(02)00337-X; Weis K, 1998, TRENDS BIOCHEM SCI, V23, P185, DOI 10.1016/S0968-0004(98)01204-3; Wilkinson SM, 2002, J BIOL CHEM, V277, P17062, DOI 10.1074/jbc.M111126200; Zhang T, 2005, J CELL SCI, V118, P5453, DOI 10.1242/jcs.02669	49	40	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					35015	35028		10.1074/jbc.M109.031633	http://dx.doi.org/10.1074/jbc.M109.031633			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19801539	Green Published, hybrid			2022-12-27	WOS:000272439600056
J	Corsi, JM; Houbron, C; Billuart, P; Brunet, I; Bouvree, K; Eichmann, A; Girault, JA; Enslen, H				Corsi, Jean-Marc; Houbron, Christophe; Billuart, Pierre; Brunet, Isabelle; Bouvree, Karine; Eichmann, Anne; Girault, Jean-Antoine; Enslen, Herve			Autophosphorylation-independent and -dependent Functions of Focal Adhesion Kinase during Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHORYLATION; CONDITIONAL KNOCKOUT; FAK EXPRESSION; CELL-SURVIVAL; PYK2; SRC; MIGRATION; MOTILITY; ACTIN; P53	Focal adhesion kinase (FAK) regulates numerous cellular functions and is critical for processes ranging from embryo development to cancer progression. Although autophosphorylation on Tyr-397 appears required for FAK functions in vitro, its role in vivo has not been established. We addressed this question using a mutant mouse (fak Delta) deleted of exon 15, which encodes Tyr-397. The resulting mutant protein FAK(Delta/Delta) is an active kinase expressed at normal levels. Our results demonstrate that the requirement for FAK autophosphorylation varies during development. FAK(Delta/Delta) embryos developed normally up to embryonic day (E) 12.5, contrasting with the lethality at E8.5 of FAK-null embryos. Thus, autophosphorylation on Tyr-397 is not required for FAK to achieve its functions until late mid-gestation. However, FAK(Delta/Delta) embryos displayed hemorrhages, edema, delayed artery formation, vascular remodeling defects, multiple organ abnormalities, and overall developmental retardation at E13.5-14.5, and died thereafter demonstrating that FAK autophosphorylation is also necessary for normal development. Fibroblasts derived from mutant embryos had a normal stellate morphology and expression of focal adhesion proteins, Src family members, p53, and Pyk2. In contrast, in FAK(Delta/Delta) fibroblasts and endothelial cells, spreading and lamellipodia formation were altered with an increased size and number of focal adhesions, enriched in FAK(Delta/Delta). FAK mutation also decreased fibroblast proliferation. These results show that the physiological functions of FAK in vivo are achieved through both autophosphorylation-independent and autophosphorylation-dependent mechanisms.	[Corsi, Jean-Marc; Girault, Jean-Antoine; Enslen, Herve] INSERM, U839, F-75005 Paris, France; [Corsi, Jean-Marc; Girault, Jean-Antoine; Enslen, Herve] Univ Paris 06, F-75005 Paris, France; [Corsi, Jean-Marc; Girault, Jean-Antoine; Enslen, Herve] Inst Fer a Moulin, F-75005 Paris, France; [Houbron, Christophe; Billuart, Pierre] Univ Paris 05, Inst Cochin, F-75014 Paris, France; [Houbron, Christophe; Billuart, Pierre] CNRS, UMR81074, F-75014 Paris, France; [Brunet, Isabelle; Bouvree, Karine; Eichmann, Anne] Coll France, INSERM, U833, F-75005 Paris, France; [Enslen, Herve] INSERM, U567, Inst Cochin, F-75014 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Enslen, H (corresponding author), INSERM, U567, Inst Cochin, Bat G Roussy 5Eme Etage,27 Rue Faubourg St Jacque, F-75014 Paris, France.	herve.enslen@inserm.fr	Enslen, Hervé/AAH-4492-2021; Billuart, Pierre/K-3832-2017; Enslen, Hervé/M-3400-2017; Girault, Jean-Antoine/F-7518-2013	Enslen, Hervé/0000-0001-9741-5293; Billuart, Pierre/0000-0003-1913-1687; Enslen, Hervé/0000-0001-9741-5293; Girault, Jean-Antoine/0000-0002-7900-1705	Inserm [3746, 3138]; Association pour la Recherche sur le Cancer [ANR-05-2_42589]; Agence Nationale de la Recherche	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by Inserm, by Grant 3746 (to H. E.) and Grant 3138 (to J.A.G.) from the Association pour la Recherche sur le Cancer, and by Grant ANR-05-2_42589 from Agence Nationale de la Recherche (to J.A.G.).	Beggs HE, 2003, NEURON, V40, P501, DOI 10.1016/S0896-6273(03)00666-4; Braren R, 2006, J CELL BIOL, V172, P151, DOI 10.1083/jcb.200506184; Burgaya F, 1997, J BIOL CHEM, V272, P28720, DOI 10.1074/jbc.272.45.28720; Cance WG, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.120pe22; Chatzizacharias NA, 2008, HISTOL HISTOPATHOL, V23, P629, DOI 10.14670/HH-23.629; Corsi JM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-198; Cox BD, 2006, J CELL BIOCHEM, V99, P36, DOI 10.1002/jcb.20956; FURUTA Y, 1995, ONCOGENE, V11, P1989; Golubovskaya VM, 2005, J BIOL CHEM, V280, P25008, DOI 10.1074/jbc.M414172200; Grove M, 2007, J CELL BIOL, V176, P277, DOI 10.1083/jcb.200609021; Hakim ZS, 2007, MOL CELL BIOL, V27, P5352, DOI 10.1128/MCB.00068-07; Hanks SK, 2003, FRONT BIOSCI-LANDMRK, V8, pD982, DOI 10.2741/1114; ILLC D, 1995, NATURE, V377, P539; Katz BZ, 2003, J BIOL CHEM, V278, P29115, DOI 10.1074/jbc.M212396200; Lim ST, 2008, MOL CELL, V29, P9, DOI 10.1016/j.molcel.2007.11.031; Lim Y, 2008, J CELL BIOL, V180, P187, DOI 10.1083/jcb.200708194; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nikolopoulos SN, 2005, CELL CYCLE, V4, P429, DOI 10.4161/cc.4.3.1547; Owen JD, 1999, MOL CELL BIOL, V19, P4806; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Peng X, 2008, P NATL ACAD SCI USA, V105, P6638, DOI 10.1073/pnas.0802319105; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; Rico B, 2004, NAT NEUROSCI, V7, P1059, DOI 10.1038/nn1317; Ruest PJ, 2001, MOL CELL BIOL, V21, P7641, DOI 10.1128/MCB.21.22.7641-7652.2001; Schlaepfer DD, 2004, BBA-MOL CELL RES, V1692, P77, DOI 10.1016/j.bbamcr.2004.04.008; Schober M, 2007, J CELL BIOL, V176, P667, DOI 10.1083/jcb.200608010; Serrels B, 2007, NAT CELL BIOL, V9, P1046, DOI 10.1038/ncb1626; Shen TL, 2005, J CELL BIOL, V169, P941, DOI 10.1083/jcb.200411155; Sieg DJ, 1998, EMBO J, V17, P5933, DOI 10.1093/emboj/17.20.5933; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Tilghman RW, 2005, J CELL SCI, V118, P2613, DOI 10.1242/jcs.02380; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Toutant M, 2002, MOL CELL BIOL, V22, P7731, DOI 10.1128/MCB.22.22.7731-7743.2002; Vadali K, 2007, IUBMB LIFE, V59, P709, DOI 10.1080/15216540701694245; Vallejo-Illarramendi A, 2009, J CLIN INVEST, V119, P2218, DOI 10.1172/JCI38194; Wang HB, 2001, P NATL ACAD SCI USA, V98, P11295, DOI 10.1073/pnas.201201198; Weed SA, 2001, ONCOGENE, V20, P6418, DOI 10.1038/sj.onc.1204783; Weis SM, 2008, J CELL BIOL, V181, P43, DOI 10.1083/jcb.200710038	38	42	43	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34769	34776		10.1074/jbc.M109.067280	http://dx.doi.org/10.1074/jbc.M109.067280			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19776009	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000272439600032
J	Schartner, JM; Simonson, WT; Wernimont, SA; Nettenstrom, LM; Huttenlocher, A; Seroogy, CM				Schartner, Jill M.; Simonson, William T.; Wernimont, Sarah A.; Nettenstrom, Lauren M.; Huttenlocher, Anna; Seroogy, Christine M.			Gene Related to Anergy in Lymphocytes (GRAIL) Expression in CD4+T Cells Impairs Actin Cytoskeletal Organization during T Cell/Antigen-presenting Cell Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; SIGNAL-TRANSDUCTION; CYTOKINE PRODUCTION; REGULATORY CELLS; DENDRITIC CELLS; ACTIVATION; LFA-1; PROLIFERATION; INDUCTION; PROTEIN	GRAIL (gene related to anergy in lymphocytes), is an E3 ubiquitin ligase with increased expression in anergic CD4+ T cells. The expression of GRAIL has been shown to be both necessary and sufficient for the induction of T cell (T) anergy. To date, several subsets of anergic T cells have demonstrated altered interactions with antigen-presenting cells (APC) and perturbed TCR-mediated signaling. The role of GRAIL in mediating these aspects of T cell anergy remains unclear. We used flow cytometry and confocal microscopy to examine T/APC interactions in GRAIL-expressing T cells. Increased GRAIL expression resulted in reduced T/APC conjugation efficiency as assessed by flow cytometry. Examination of single T/APC conjugates by confocal microscopy revealed altered polarization of polymerized actin and LFA-1 to the T/APC interface. When GRAIL expression was knocked down, actin polarization to the T/APC interface was restored, demonstrating that GRAIL is necessary for alteration of actin cytoskeletal rearrangement under anergizing conditions. Interestingly, proximal TCR signaling including calcium flux and phosphorylation of Vav were not disrupted by expression of GRAIL in CD4+ T cells. In contrast, interrogation of distal signaling events demonstrated significantly decreased JNK phosphorylation in GRAIL-expressing T cells. In sum, GRAIL expression in CD4+ T cells mediates alterations in the actin cytoskeleton during T/APC interactions. Moreover, in this model, our data dissociates proximal T cell signaling events from functional unresponsiveness. These data demonstrate a novel role for GRAIL in modulating T/APC interactions and provide further insight into the cell biology of anergic T cells.	[Schartner, Jill M.; Nettenstrom, Lauren M.; Huttenlocher, Anna; Seroogy, Christine M.] Univ Wisconsin, Dept Pediat, Div Allergy Immunol & Rheumatol, Madison, WI 53792 USA; [Schartner, Jill M.] Univ Wisconsin, Dept Cellular & Mol Pathol, Madison, WI 53792 USA; [Simonson, William T.; Wernimont, Sarah A.] Univ Wisconsin, Dept Cellular & Mol Biol, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Seroogy, CM (corresponding author), Univ Wisconsin, Dept Pediat, Div Allergy Immunol & Rheumatol, H4-474 CSC,600 Highland Ave, Madison, WI 53792 USA.	cmseroogy@wisc.edu		Wernimont, Sarah/0000-0002-6894-7837	National Institutes of Health [1 R21 AI064234-01]; Midwest Athletes Against Childhood Cancer; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI064234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008692] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Midwest Athletes Against Childhood Cancer; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1 R21 AI064234-01. This work was also supported by Midwest Athletes Against Childhood Cancer.	Anandasabapathy N, 2003, IMMUNITY, V18, P535, DOI 10.1016/S1074-7613(03)00084-0; Burkhardt JK, 2008, ANNU REV IMMUNOL, V26, P233, DOI 10.1146/annurev.immunol.26.021607.090347; Costa GL, 2000, J IMMUNOL, V164, P3581, DOI 10.4049/jimmunol.164.7.3581; Dahlberg PE, 2007, CLIN EXP IMMUNOL, V149, P226, DOI 10.1111/j.1365-2249.2007.03402.x; DeSilva DR, 1996, J EXP MED, V183, P2017, DOI 10.1084/jem.183.5.2017; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Dong C, 2000, NATURE, V405, P91, DOI 10.1038/35011091; Dushek O, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003913; Egawa S, 2008, AM J PHYSIOL-GASTR L, V295, pG163, DOI 10.1152/ajpgi.90242.2008; Fehervari Z, 2004, INT IMMUNOL, V16, P1769, DOI 10.1093/intimm/dxh178; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; Gomez TS, 2006, IMMUNITY, V24, P741, DOI 10.1016/j.immuni.2006.03.022; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; Hickman SP, 2006, J IMMUNOL, V177, P2186, DOI 10.4049/jimmunol.177.4.2186; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; Huttenlocher A, 1996, J CELL BIOL, V134, P1551, DOI 10.1083/jcb.134.6.1551; JENKINS MK, 1990, J IMMUNOL, V144, P16; JENKINS MK, 1987, P NATL ACAD SCI USA, V84, P5409, DOI 10.1073/pnas.84.15.5409; Jeon MS, 2004, IMMUNITY, V21, P167, DOI 10.1016/j.immuni.2004.07.013; Jo EK, 2005, J EXP MED, V201, P1733, DOI 10.1084/jem.20042577; Krawczyk C, 2002, IMMUNITY, V16, P331, DOI 10.1016/S1074-7613(02)00291-1; Kuniyasu Y, 2000, INT IMMUNOL, V12, P1145, DOI 10.1093/intimm/12.8.1145; Li W, 1996, SCIENCE, V271, P1272, DOI 10.1126/science.271.5253.1272; MacKenzie DA, 2007, J BIOL CHEM, V282, P9696, DOI 10.1074/jbc.M604192200; Marangoni F, 2007, J EXP MED, V204, P369, DOI 10.1084/jem.20061334; McLachlan JB, 2009, IMMUNITY, V30, P277, DOI 10.1016/j.immuni.2008.11.013; Melino M, 2008, J IMMUNOL, V181, P7300, DOI 10.4049/jimmunol.181.10.7300; Morgan MM, 2001, J IMMUNOL, V167, P5708, DOI 10.4049/jimmunol.167.10.5708; MUELLER DL, 1995, CURR OPIN IMMUNOL, V7, P375, DOI 10.1016/0952-7915(95)80113-8; Onishi Y, 2008, P NATL ACAD SCI USA, V105, P10113, DOI 10.1073/pnas.0711106105; QUILL H, 1987, J IMMUNOL, V138, P3704; Rivas FV, 2004, MOL CELL BIOL, V24, P1628, DOI 10.1128/MCB.24.4.1628-1639.2004; Sabapathy K, 1999, CURR BIOL, V9, P116, DOI 10.1016/S0960-9822(99)80065-7; Schartner JM, 2007, SEMIN IMMUNOL, V19, P188, DOI 10.1016/j.smim.2007.02.010; Sechi AS, 2002, IMMUNOL REV, V189, P98, DOI 10.1034/j.1600-065X.2002.18909.x; Seroogy CM, 2004, J IMMUNOL, V173, P79, DOI 10.4049/jimmunol.173.1.79; Simonson WTN, 2006, J IMMUNOL, V177, P7707, DOI 10.4049/jimmunol.177.11.7707; Su L, 2006, J IMMUNOL, V177, P7559, DOI 10.4049/jimmunol.177.11.7559; Tamir A, 2000, J IMMUNOL, V165, P1243, DOI 10.4049/jimmunol.165.3.1243; Taylor JJ, 2009, J CLIN INVEST, V119, P1019, DOI 10.1172/JCI36534; Tran DQ, 2009, J IMMUNOL, V182, P2929, DOI 10.4049/jimmunol.0803827; VALITUTTI S, 1995, J EXP MED, V181, P577, DOI 10.1084/jem.181.2.577; Valitutti S, 2008, IMMUNITY, V29, P384, DOI 10.1016/j.immuni.2008.08.002; Wang Y, 2009, J BIOL CHEM, V284, P12645, DOI 10.1074/jbc.M807207200; Wang Y, 2008, INT IMMUNOL, V20, P1119, DOI 10.1093/intimm/dxn070; Wells AD, 2003, J IMMUNOL, V170, P4127, DOI 10.4049/jimmunol.170.8.4127; Yu X, 2000, J IMMUNOL, V164, P3543, DOI 10.4049/jimmunol.164.7.3543	47	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34674	34681		10.1074/jbc.M109.024497	http://dx.doi.org/10.1074/jbc.M109.024497			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19833735	Green Published, hybrid			2022-12-27	WOS:000272439600023
J	Jiao, CY; Delaroche, D; Burlina, F; Alves, ID; Chassaing, G; Sagan, S				Jiao, Chen-Yu; Delaroche, Diane; Burlina, Fabienne; Alves, Isabel D.; Chassaing, Gerard; Sagan, Sandrine			Translocation and Endocytosis for Cell-penetrating Peptide Internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOF MASS-SPECTROMETRY; HAMSTER OVARY CELLS; HEPARAN-SULFATE PROTEOGLYCANS; ANTENNAPEDIA HOMEODOMAIN; BIOLOGICAL-MEMBRANES; PLASMA-MEMBRANE; 3RD HELIX; SURFACE; DELIVERY; QUANTIFICATION	Cell-penetrating peptides (CPPs) share the property of cellular internalization. The question of how these peptides reach the cytoplasm of cells is still widely debated. Herein, we have used a mass spectrometry-based method that enables quantification of internalized and membrane-bound peptides. Internalization of the most used CPP was studied at 37 degrees C (endocytosis and translocation) and 4 degrees C (translocation) in wild type and proteoglycan-deficient Chinese hamster ovary cells. Both translocation and endocytosis are internalization pathways used by CPP. The choice of one pathway versus the other depends on the peptide sequence (not the number of positive changes), the extracellular peptide concentration, and the membrane components. There is no relationship between the high affinity of these peptides for the cell membrane and their internalization efficacy. Translocation occurs at low extracellular peptide concentration, whereas endocytosis, a saturable and cooperative phenomenon, is activated at higher concentrations. Translocation operates in a narrow time window, which implies a specific lipid/peptide co-import in cells.	[Sagan, Sandrine] Univ Paris 06, UMR 7203, CNRS, Ecole Normale Super,Lab Biomol, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN)	Sagan, S (corresponding author), Univ Paris 06, UMR 7203, CNRS, Ecole Normale Super,Lab Biomol, 4 Pl Jussieu, F-75005 Paris, France.	sandrine.sagan@upmc.fr	S, SAGAN/I-8132-2013; Alves, Isabel D/R-9613-2016; s, s/HIK-1178-2022; SAGAN, Sandrine/AAA-8537-2022; s, s/GYR-2278-2022; s, s/GVS-3323-2022; QI, DANDAN/GVR-9324-2022; s, s/HHD-0404-2022	S, SAGAN/0000-0003-0083-4411; Alves, Isabel D/0000-0003-3193-2436; Burlina, Fabienne/0000-0002-6042-680X	French Ministere de l'Enseignement Superieur et de la Recherche	French Ministere de l'Enseignement Superieur et de la Recherche	Recipient of a Ph.D. fellowship from the French Ministere de l'Enseignement Superieur et de la Recherche.	Abes R, 2008, NUCLEIC ACIDS RES, V36, P6343, DOI 10.1093/nar/gkn541; Alves ID, 2008, BBA-GEN SUBJECTS, V1780, P948, DOI 10.1016/j.bbagen.2008.04.004; Arbuzova A, 2000, BBA-BIOMEMBRANES, V1464, P35, DOI 10.1016/S0005-2736(99)00243-6; Aubry S, 2009, FASEB J, V23, P2956, DOI 10.1096/fj.08-127563; Aussedat B, 2006, BBA-BIOMEMBRANES, V1758, P375, DOI 10.1016/j.bbamem.2006.01.012; Berlose JP, 1996, EUR J BIOCHEM, V242, P372, DOI 10.1111/j.1432-1033.1996.0372r.x; Bucki R, 2000, BIOCHEMISTRY-US, V39, P5838, DOI 10.1021/bi992403l; Burlina F, 2005, ANGEW CHEM INT EDIT, V44, P4244, DOI 10.1002/anie.200500477; Burlina F, 2006, NAT PROTOC, V1, P200, DOI 10.1038/nprot.2006.30; Console S, 2003, J BIOL CHEM, V278, P35109, DOI 10.1074/jbc.M301726200; Czech MP, 2000, CELL, V100, P603, DOI 10.1016/S0092-8674(00)80696-0; Delaroche D, 2007, ANAL CHEM, V79, P1932, DOI 10.1021/ac061108l; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Duchardt F, 2007, TRAFFIC, V8, P848, DOI 10.1111/j.1600-0854.2007.00572.x; Dupont E, 2007, J BIOL CHEM, V282, P8994, DOI 10.1074/jbc.M609246200; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Fritz VMR, 1997, BBA-GENE STRUCT EXPR, V1354, P153, DOI 10.1016/S0167-4781(97)00117-6; Fuchs SM, 2004, BIOCHEMISTRY-US, V43, P2438, DOI 10.1021/bi035933x; Gerbal-Chaloin S, 2007, BIOL CELL, V99, P223, DOI 10.1042/BC20060123; Goodyear RJ, 2008, J NEUROSCI, V28, P9939, DOI 10.1523/JNEUROSCI.1124-08.2008; Gump JM, 2007, TRENDS MOL MED, V13, P443, DOI 10.1016/j.molmed.2007.08.002; Hallbrink M, 2004, BBA-BIOMEMBRANES, V1667, P222, DOI 10.1016/j.bbamem.2004.10.009; Haucke V, 2005, BIOCHEM SOC T, V33, P1285, DOI 10.1042/BST0331285; Iglesias-Bartolome R, 2006, FEBS J, V273, P1744, DOI 10.1111/j.1742-4658.2006.05194.x; IOZZO RV, 1987, J BIOL CHEM, V262, P1888; Ivanov Andrei I., 2008, V440, P15, DOI 10.1007/978-1-59745-178-9_2; Kirkpatrick CA, 2007, J CELL SCI, V120, P1829, DOI 10.1242/jcs.03432; Lee HL, 2008, J AM CHEM SOC, V130, P9364, DOI 10.1021/ja710798b; Liu AP, 2006, BIOPHYS J, V91, P4064, DOI 10.1529/biophysj.106.090852; Nakase I, 2007, BIOCHEMISTRY-US, V46, P492, DOI 10.1021/bi0612824; Poon GMK, 2007, BIOCHEM SOC T, V35, P788, DOI 10.1042/BST0350788; Puckett CA, 2009, J AM CHEM SOC, V131, P8738, DOI 10.1021/ja9025165; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; Saito M, 1999, BBA-MOL CELL BIOL L, V1438, P55, DOI 10.1016/S1388-1981(99)00037-2; Simonsen A, 2001, CURR OPIN CELL BIOL, V13, P485, DOI 10.1016/S0955-0674(00)00240-4; Ter-Avetisyan G, 2009, J BIOL CHEM, V284, P3370, DOI 10.1074/jbc.M805550200; THEODORE L, 1995, J NEUROSCI, V15, P7158; Tkachenko E, 2004, J CELL SCI, V117, P3189, DOI 10.1242/jcs.01190; Vives E, 2008, BBA-REV CANCER, V1786, P126, DOI 10.1016/j.bbcan.2008.03.001; Watkins CL, 2009, BIOCHEM J, V420, P179, DOI 10.1042/BJ20090042; Wolkers WF, 2003, BBA-BIOMEMBRANES, V1612, P154, DOI 10.1016/S0005-2736(03)00114-7; YANAGISHITA M, 1992, J BIOL CHEM, V267, P9451; Ziegler A, 2008, BIOPHYS J, V94, P2142, DOI 10.1529/biophysj.107.113472; Ziegler A, 2007, BIOCHEMISTRY-US, V46, P8138, DOI 10.1021/bi700416h	44	237	242	2	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33957	33965		10.1074/jbc.M109.056309	http://dx.doi.org/10.1074/jbc.M109.056309			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19833724	Green Published, hybrid			2022-12-27	WOS:000272165200028
J	Huang, ZH; Minshall, RD; Mazzone, T				Huang, Zhi Hua; Minshall, Richard D.; Mazzone, Theodore			Mechanism for Endogenously Expressed ApoE Modulation of Adipocyte Very Low Density Lipoprotein Metabolism ROLE IN ENDOCYTIC AND LIPASE-MEDIATED METABOLIC PATHWAYS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID TRANSPORT; APOLIPOPROTEIN-E EXPRESSION; NECROSIS-FACTOR-ALPHA; HUMAN ADIPOSE-TISSUE; CARDIOVASCULAR-DISEASE; GENE-TRANSCRIPTION; FREE-CHOLESTEROL; PLASMA-MEMBRANE; CELL-SURFACE; RECEPTOR	Triglyceride-rich lipoproteins distribute energy in the form of fatty acids to peripheral tissues. We have previously shown that the absence of endogenous adipocyte apoE expression impairs adipocyte triglyceride acquisition from apoE-containing triglyceride-rich lipoproteins in vitro and in vivo. Studies were performed to evaluate the mechanism(s) for this impairment. We excluded a role for secreted apoE in accounting for the difference in very low density lipoprotein (VLDL)-induced adipocyte triglyceride accumulation using cross-incubation studies to show that secreted apoE did not enhance triglyceride synthesis in apoE knockout (EKO) adipocytes incubated with apoE-containing VLDL. Subsequent experiments established that both endocytic and lipase-mediated pathways for lipid acquisition from VLDL were impaired in EKO adipocytes. Binding and internalization of VLDL to EKO adipocytes were significantly lower due to decreased expression or redistribution of low density lipoprotein receptor family proteins. An important role for the VLDL receptor for contributing to differences in VLDL binding between wild-type and EKO adipocytes was identified. Lipoprotein lipase-dependent adipocyte lipogenesis was also significantly decreased in EKO adipocytes even though they secreted as much or more lipolytic activity. This decrease was related to impaired fatty acid internalization in EKO cells. Evaluation of potential mechanisms revealed reduced caveolin-1 and plasma membrane raft expression in EKO adipocytes. Increasing caveolin expression in EKO adipocytes increased fatty acid internalization. Our results establish a role for endogenous adipocyte apoE in VLDL-induced adipocyte lipogenesis by impacting both endocytic and lipoprotein lipase-mediated metabolic pathways. Reduced adipocyte apoE expression, for example that accompanying obesity, will suppress adipocyte acquisition of lipid from apoE-containing VLDL.	[Mazzone, Theodore] Univ Illinois, Sect Endocrinol Diabet & Metab MC 797, Dept Med, Chicago, IL 60612 USA; [Minshall, Richard D.; Mazzone, Theodore] Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA; [Mazzone, Theodore] Univ Illinois, Dept Human Nutr, Chicago, IL 60612 USA; [Minshall, Richard D.] Univ Illinois, Dept Anesthesiol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Mazzone, T (corresponding author), Univ Illinois, Sect Endocrinol Diabet & Metab MC 797, Dept Med, 1819 W Polk St, Chicago, IL 60612 USA.	tmazzone@uic.edu			National Institutes of Health Grants [DK71711, HL60678]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL060678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071711, R56DK071711] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK71711 (to T. M.) and HL60678 (to R. D. M.).	Andersen OM, 2000, J BIOL CHEM, V275, P21017, DOI 10.1074/jbc.M000507200; Bernlohr DA, 1999, SEMIN CELL DEV BIOL, V10, P43, DOI 10.1006/scdb.1998.0271; Bist A, 1997, P NATL ACAD SCI USA, V94, P10693, DOI 10.1073/pnas.94.20.10693; Camp HS, 2002, TRENDS MOL MED, V8, P442, DOI 10.1016/S1471-4914(02)02396-1; Chiba T, 2003, ARTERIOSCL THROM VAS, V23, P1423, DOI 10.1161/01.ATV.0000085040.58340.36; Dubois SG, 2006, OBESITY, V14, P1543, DOI 10.1038/oby.2006.178; Ducharme NA, 2008, ENDOCRINOLOGY, V149, P942, DOI 10.1210/en.2007-1713; EDENS NK, 1990, J LIPID RES, V31, P1423; Espiritu DJ, 2008, DIABETES, V57, P2992, DOI 10.2337/db08-0592; Fantuzzi G, 2007, ARTERIOSCL THROM VAS, V27, P996, DOI 10.1161/ATVBAHA.106.131755; Festy F, 2005, HISTOCHEM CELL BIOL, V124, P113, DOI 10.1007/s00418-005-0014-z; Fisher C, 2006, MOL CELL, V22, P277, DOI 10.1016/j.molcel.2006.02.021; Gao JH, 2007, DIABETES, V56, P24, DOI 10.2337/db06-0144; Gilham D, 2005, METHODS, V36, P139, DOI 10.1016/j.ymeth.2004.11.003; Goudriaan JR, 2001, ARTERIOSCL THROM VAS, V21, P1488, DOI 10.1161/hq0901.095147; Haffner SM, 2006, OBESITY, V14, p121S, DOI 10.1038/oby.2006.291; Hajri T, 2007, DIABETES, V56, P1872, DOI 10.2337/db06-1699; Hofmann SM, 2008, DIABETES, V57, P5, DOI 10.2337/db07-0403; Hofmann SM, 2007, J CLIN INVEST, V117, P3271, DOI 10.1172/JCI31929; HOLDER JC, 1990, BIOCHEM J, V272, P735, DOI 10.1042/bj2720735; Huang ZH, 2007, AM J PHYSIOL-ENDOC M, V293, pE203, DOI 10.1152/ajpendo.00118.2007; Huang ZH, 2006, DIABETES, V55, P3394, DOI 10.2337/db06-0354; Huang ZH, 2009, AM J PHYSIOL-ENDOC M, V296, pE1110, DOI 10.1152/ajpendo.90964.2008; Kamp F, 2003, J BIOL CHEM, V278, P7988, DOI 10.1074/jbc.M206648200; Kampf JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1207, DOI 10.1152/ajpendo.00259.2007; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Liao JF, 2005, J LIPID RES, V46, P597, DOI 10.1194/jlr.D400023-JLR200; Lobo S, 2007, J LIPID RES, V48, P609, DOI 10.1194/jlr.M600441-JLR200; LOOKENE A, 1994, EUR J BIOCHEM, V222, P395, DOI 10.1111/j.1432-1033.1994.tb18878.x; MAZZONE T, 1989, J BIOL CHEM, V264, P1787; Mazzone T, 2008, LANCET, V371, P1800, DOI 10.1016/S0140-6736(08)60768-0; MEDH JD, 1995, J BIOL CHEM, V270, P536, DOI 10.1074/jbc.270.2.536; Meshulam T, 2006, BIOCHEMISTRY-US, V45, P2882, DOI 10.1021/bi051999b; Minshall RD, 2000, J CELL BIOL, V150, P1057, DOI 10.1083/jcb.150.5.1057; Ost A, 2005, J BIOL CHEM, V280, P5, DOI 10.1074/jbc.C400429200; Pilch PF, 2007, J LIPID RES, V48, P2103, DOI 10.1194/jlr.R700009-JLR200; Pohl J, 2004, BIOCHEMISTRY-US, V43, P4179, DOI 10.1021/bi035743m; Rao P, 2007, J CLIN ENDOCR METAB, V92, P4366, DOI 10.1210/jc.2007-1592; Rasouli N, 2005, AM J PHYSIOL-ENDOC M, V288, pE930, DOI 10.1152/ajpendo.00522.2004; Richards MR, 2006, J LIPID RES, V47, P665, DOI 10.1194/jlr.M500514-JLR200; Ring A, 2006, BBA-MOL CELL BIOL L, V1761, P416, DOI 10.1016/j.bbalip.2006.03.016; Sam S, 2008, DIABETES, V57, P2022, DOI 10.2337/db08-0157; Schaffer JE, 2002, AM J PHYSIOL-ENDOC M, V282, pE239, DOI 10.1152/ajpendo.00462.2001; SCHAFFER JE, 1994, CELL, V79, P427, DOI 10.1016/0092-8674(94)90252-6; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Shajahan AN, 2004, J BIOL CHEM, V279, P20392, DOI 10.1074/jbc.M308710200; TAKAHASHI S, 1995, J BIOL CHEM, V270, P15747, DOI 10.1074/jbc.270.26.15747; William WN, 2002, J ENDOCRINOL, V175, P735, DOI 10.1677/joe.0.1750735; Yue L, 2008, ENDOCRINOLOGY, V149, P4051, DOI 10.1210/en.2008-0340; Yue LL, 2004, J BIOL CHEM, V279, P47626, DOI 10.1074/jbc.M408461200; ZECHNER R, 1991, J BIOL CHEM, V266, P10583; Zhao YW, 2000, J BIOL CHEM, V275, P4759, DOI 10.1074/jbc.275.7.4759; Zhu X, 2008, J BIOL CHEM, V283, P22930, DOI 10.1074/jbc.M801408200	53	24	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31512	31522		10.1074/jbc.M109.004754	http://dx.doi.org/10.1074/jbc.M109.004754			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19767394	Green Published, hybrid			2022-12-27	WOS:000271572700004
J	Sawai, H; Sugimoto, H; Kato, Y; Asano, Y; Shiro, Y; Aono, S				Sawai, Hitomi; Sugimoto, Hiroshi; Kato, Yasuo; Asano, Yasuhisa; Shiro, Yoshitsugu; Aono, Shigetoshi			X-ray Crystal Structure of Michaelis Complex of Aldoxime Dehydratase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLE BOND SYNTHESIS; NITRILE-DEGRADING ENZYMES; MACROMOLECULAR STRUCTURES; DIFFRACTION; RESOLUTIONS; DISCOVERY; HYDRATASE; AMIDASE; PROGRAM; HEME	Aldoxime dehydratase (Oxd) catalyzes the dehydration of aldoximes (R-CH=N-OH) to their corresponding nitrile (R-C N). Oxd is a heme-containing enzyme that catalyzes the dehydration reaction as its physiological function. We have determined the first two structures of Oxd: the substrate-free OxdRE at 1.8 angstrom resolution and the n-butyraldoxime- and propionaldoxime-bound OxdREs at 1.8 and 1.6 angstrom resolutions, respectively. Unlike other heme enzymes, the organic substrate is directly bound to the heme iron in OxdRE. We determined the structure of the Michaelis complex of OxdRE by using the unique substrate binding and activity regulation properties of Oxd. The Michaelis complex was prepared by x-ray cryoradiolytic reduction of the ferric dead-end complex in which Oxd contains a Fe3+ heme form. The crystal structures reveal the mechanism of substrate recognition and the catalysis of OxdRE.	[Sugimoto, Hiroshi; Shiro, Yoshitsugu] RIKEN SPring 8 Ctr, Harima Inst, Sayo Cho, Hyogo 6795148, Japan; [Kato, Yasuo; Asano, Yasuhisa] Toyama Prefectural Univ, Fac Engn, Biotechnol Res Ctr, Toyama 9390398, Japan; Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan	RIKEN; Toyama Prefectural University; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB)	Sugimoto, H (corresponding author), RIKEN SPring 8 Ctr, Harima Inst, 1-1-1 Kouto, Sayo Cho, Hyogo 6795148, Japan.	sugimoto@spring8.or.jp; aono@ims.ac.jp	Sugimoto, Hiroshi/AAR-5442-2021; Shiro, Yoshitsugu Y/J-3757-2014; Sugimoto, Hiroshi/K-4041-2017; Sawai, Hitomi/AAW-5541-2021; Sawai, Hitomi/AAU-2584-2020; Aono, Shigetoshi/ABD-7618-2020; Asano, Yasuhisa/K-5898-2016	Shiro, Yoshitsugu Y/0000-0003-0695-8327; Sugimoto, Hiroshi/0000-0002-3140-8362; Aono, Shigetoshi/0000-0002-2870-3694; Asano, Yasuhisa/0000-0003-3645-3952; Sawai, Hitomi/0000-0002-0714-8337	Japan Society for the Promotion of Science [19370059]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was partly supported by Grant-in-aid for Scientific Research B 19370059 from the Japan Society for the Promotion of Science (to S.A.).	Asano Y, 2002, J BIOTECHNOL, V94, P65, DOI 10.1016/S0168-1656(01)00419-9; Banerjee A, 2002, APPL MICROBIOL BIOT, V60, P33, DOI 10.1007/s00253-002-1062-0; DeLano WL, 2005, DRUG DISCOV TODAY, V10, P213, DOI 10.1016/S1359-6446(04)03363-X; Ebihara Akio, 2005, Journal of Structural and Functional Genomics, V6, P21, DOI 10.1007/s10969-005-1103-x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Holm L, 1997, NUCLEIC ACIDS RES, V25, P231, DOI 10.1093/nar/25.1.231; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kato Y, 2000, APPL ENVIRON MICROB, V66, P2290, DOI 10.1128/AEM.66.6.2290-2296.2000; Kato Y, 2004, J BIOSCI BIOENG, V97, P250, DOI 10.1016/S1389-1723(04)70200-5; Kato Y, 1998, ARCH MICROBIOL, V170, P85, DOI 10.1007/s002030050618; Kawabata T, 2003, NUCLEIC ACIDS RES, V31, P3367, DOI 10.1093/nar/gkg581; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Kobayashi K, 2005, J BIOL CHEM, V280, P5486, DOI 10.1074/jbc.M410474200; Kobayashi K, 2006, CHEMBIOCHEM, V7, P2004, DOI 10.1002/cbic.200600261; Konishi K, 2006, P NATL ACAD SCI USA, V103, P564, DOI 10.1073/pnas.0505412103; Konishi K, 2004, J BIOL CHEM, V279, P47619, DOI 10.1074/jbc.M407223200; Lebedev AA, 2008, ACTA CRYSTALLOGR D, V64, P33, DOI 10.1107/S0907444907049839; Morris RJ, 2004, J SYNCHROTRON RADIAT, V11, P56, DOI 10.1107/S090904950302394X; Oinuma KI, 2003, J BIOL CHEM, V278, P29600, DOI 10.1074/jbc.M211832200; Oinuma KI, 2005, FEBS LETT, V579, P1394, DOI 10.1016/j.febslet.2005.01.037; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Sakai K, 2002, J APPL CRYSTALLOGR, V35, P270, DOI 10.1107/S0021889801021331; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Xie SX, 2003, BIOCHEMISTRY-US, V42, P12056, DOI 10.1021/bi035092u; Zhang C, 2000, J MOL BIOL, V299, P1075, DOI 10.1006/jmbi.2000.3678	29	42	42	2	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					32089	32096		10.1074/jbc.M109.018762	http://dx.doi.org/10.1074/jbc.M109.018762			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19740758	Green Published, hybrid			2022-12-27	WOS:000271572700063
J	Yamamoto, H; Fukui, K; Takahashi, H; Kitamura, S; Shiota, T; Terao, K; Uchida, M; Esaki, M; Nishikawa, S; Yoshihisa, T; Yamano, K; Endo, T				Yamamoto, Hayashi; Fukui, Kenji; Takahashi, Hisashi; Kitamura, Shingo; Shiota, Takuya; Terao, Kayoko; Uchida, Mayumi; Esaki, Masatoshi; Nishikawa, Shuh-ichi; Yoshihisa, Tohru; Yamano, Koji; Endo, Toshiya			Roles of Tom70 in Import of Presequence-containing Mitochondrial Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE; YEAST MITOCHONDRIA; PRECURSOR PROTEINS; RECEPTOR; TOM20; TRANSLOCATION; BINDING; RECOGNITION; PREPROTEIN; MACHINERY	Mitochondrial protein traffic requires precise recognition of the mitochondrial targeting signals by the import receptors on the mitochondrial surface including a general import receptor Tom20 and a receptor for presequence-less proteins, Tom70. Here we took a proteome-wide approach of mitochondrial protein import in vitro to find a set of presequence-containing precursor proteins for recognition by Tom70. The presequences of the Tom70-dependent precursor proteins were recognized by Tom20, whereas their mature parts exhibited Tom70-dependent import when attached to the presequence of Tom70-independent precursor proteins. The mature parts of the Tom70-dependent precursor proteins have the propensity to aggregate, and the presence of the receptor domain of Tom70 prevents their aggregate formation. Therefore Tom70 plays the role of a docking site for not only cytosolic chaperones but also aggregate-prone substrates to maintain their solubility for efficient transfer to downstream components of the mitochondrial import machineries.	[Uchida, Mayumi; Esaki, Masatoshi; Nishikawa, Shuh-ichi; Yamano, Koji; Endo, Toshiya] Nagoya Univ, Grad Sch Sci, Dept Chem, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Yoshihisa, Tohru] Nagoya Univ, Res Ctr Mat Sci, Japan Sci & Technol Agcy, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Nagoya University; Japan Science & Technology Agency (JST); Nagoya University	Endo, T (corresponding author), Nagoya Univ, Grad Sch Sci, Dept Chem, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	endo@biochem.chem.nagoya-u.ac.jp	Esaki, Masatoshi/L-6591-2017; Esaki, Masatoshi/ABS-6645-2022		Ministry of Education, Culture, Sports, Science, and Technology; Japan Science and Technology Agency; Uehara Memorial Foundation	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Uehara Memorial Foundation(Uehara Memorial Foundation)	This work was supported by grants-in aid for scientific research from Ministry of Education, Culture, Sports, Science, and Technology, a Core Research for Evolutional Science and Technology grant from Japan Science and Technology Agency, and a grant from the Uehara Memorial Foundation.	Abe Y, 2000, CELL, V100, P551, DOI 10.1016/S0092-8674(00)80691-1; Asai T, 2004, J BIOL CHEM, V279, P19464, DOI 10.1074/jbc.M401291200; Bohnert M, 2007, FEBS LETT, V581, P2802, DOI 10.1016/j.febslet.2007.03.004; Brix J, 1999, J BIOL CHEM, V274, P16522, DOI 10.1074/jbc.274.23.16522; Chan NC, 2006, J MOL BIOL, V358, P1010, DOI 10.1016/j.jmb.2006.02.062; DESHAIES RJ, 1988, NATURE, V332, P800, DOI 10.1038/332800a0; ENDO T, 1995, FEBS LETT, V359, P93, DOI 10.1016/0014-5793(95)00015-2; Endo T, 2002, BBA-MOL CELL RES, V1592, P3, DOI 10.1016/S0167-4889(02)00259-8; Endo T, 2009, BIOL CHEM, V390, P723, DOI 10.1515/BC.2009.087; HACHIYA N, 1995, NATURE, V376, P705, DOI 10.1038/376705a0; HINES V, 1993, J BIOL CHEM, V268, P449; HINES V, 1990, EMBO J, V9, P3191, DOI 10.1002/j.1460-2075.1990.tb07517.x; Kanamori T, 1999, P NATL ACAD SCI USA, V96, P3634, DOI 10.1073/pnas.96.7.3634; Koehler CM, 2004, ANNU REV CELL DEV BI, V20, P309, DOI 10.1146/annurev.cellbio.20.010403.105057; Li JX, 2009, J BIOL CHEM, V284, P23852, DOI 10.1074/jbc.M109.023986; LITHGOW T, 1994, J BIOL CHEM, V269, P15325; LITHGOW T, 1995, TRENDS BIOCHEM SCI, V20, P98, DOI 10.1016/S0968-0004(00)88972-0; LITHGOW T, 1995, J BIOL CHEM, V270, P14267, DOI 10.1074/jbc.270.24.14267; Matouschek A, 1997, EMBO J, V16, P6727, DOI 10.1093/emboj/16.22.6727; Meisinger C, 2008, CELL, V134, P22, DOI 10.1016/j.cell.2008.06.043; Muto T, 2001, J MOL BIOL, V306, P137, DOI 10.1006/jmbi.2000.4397; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; Saitoh T, 2007, EMBO J, V26, P4777, DOI 10.1038/sj.emboj.7601888; Sato T, 2005, P NATL ACAD SCI USA, V102, P17999, DOI 10.1073/pnas.0504495102; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Wu YK, 2006, NAT STRUCT MOL BIOL, V13, P589, DOI 10.1038/nsmb1106; Yamano K, 2008, J BIOL CHEM, V283, P3799, DOI 10.1074/jbc.M708339200; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3	30	79	79	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31635	31646		10.1074/jbc.M109.041756	http://dx.doi.org/10.1074/jbc.M109.041756			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19767391	hybrid, Green Published			2022-12-27	WOS:000271572700018
J	Brittain, JM; Piekarz, AD; Wang, YY; Kondo, T; Cummins, TR; Khanna, R				Brittain, Joel M.; Piekarz, Andrew D.; Wang, Yuying; Kondo, Takako; Cummins, Theodore R.; Khanna, Rajesh			An Atypical Role for Collapsin Response Mediator Protein 2 (CRMP-2) in Neurotransmitter Release via Interaction with Presynaptic Voltage-gated Calcium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CULTURED HIPPOCAMPAL-NEURONS; GROWTH CONE COLLAPSE; CA2+ CHANNELS; TRANSMITTER RELEASE; SYNAPTIC-TRANSMISSION; NERVE-TERMINALS; DEVELOPMENTAL-CHANGES; EXCITATORY SYNAPSES; ALZHEIMERS-DISEASE; SIGNALING PATHWAYS	Collapsin response mediator proteins (CRMPs) specify axon/dendrite fate and axonal growth of neurons through protein-protein interactions. Their functions in presynaptic biology remain unknown. Here, we identify the presynaptic N-type Ca2+ channel (CaV2.2) as a CRMP-2-interacting protein. CRMP-2 binds directly to CaV2.2 in two regions: the channel domain I-II intracellular loop and the distal C terminus. Both proteins co-localize within presynaptic sites in hippocampal neurons. Overexpression in hippocampal neurons of a CRMP-2 protein fused to enhanced green fluorescent protein caused a significant increase in Ca2+ channel current density, whereas lentivirus-mediated CRMP-2 knockdown abolished this effect. Interestingly, the increase in Ca2+ current density was not due to a change in channel gating. Rather, cell surface biotinylation studies showed an increased number of CaV2.2 at the cell surface in CRMP-2-overexpressing neurons. These neurons also exhibited a significant increase in vesicular release in response to a depolarizing stimulus. Depolarization of CRMP-2-enhanced green fluorescent protein-overexpressing neurons elicited a significant increase in release of glutamate compared with control neurons. Toxin block of Ca2+ entry via CaV2.2 abolished this stimulated release. Thus, the CRMP-2-Ca2+ channel interaction represents a novel mechanism for modulation of Ca2+ influx into nerve terminals and, hence, of synaptic strength.	[Brittain, Joel M.; Piekarz, Andrew D.; Wang, Yuying; Cummins, Theodore R.; Khanna, Rajesh] Indiana Univ Sch Med, Paul & Carole Stark Neurosci Res Inst, Indianapolis, IN 46202 USA; [Piekarz, Andrew D.; Cummins, Theodore R.; Khanna, Rajesh] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Kondo, Takako] Indiana Univ Sch Med, Dept Otolaryngol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Khanna, R (corresponding author), 950 W Walnut St,R2 Rm 478, Indianapolis, IN 46202 USA.	khanna5@iupui.edu	Tuluc, Petronel/C-2527-2011	Khanna, Rajesh/0000-0002-9066-2969	National Institutes of Health [NS053422]; Indiana State Department of Health Spinal Cord and Brain Injury Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053422, R56NS053422] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana State Department of Health Spinal Cord and Brain Injury Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health Grant NS053422 (to T. R. C.). This work was also supported by grants from the Indiana State Department of Health Spinal Cord and Brain Injury Fund (to R. K.).	Altier C, 2008, J RECEPT SIG TRANSD, V28, P71, DOI 10.1080/10799890801941947 ; Arimura N, 2000, J BIOL CHEM, V275, P23973, DOI 10.1074/jbc.M001032200; Arimura N, 2005, MOL CELL BIOL, V25, P9973, DOI 10.1128/MCB.25.22.9973-9984.2005; Arimura N, 2004, J NEUROBIOL, V58, P34, DOI 10.1002/neu.10269; AUGUSTINE GJ, 1987, ANNU REV NEUROSCI, V10, P633, DOI 10.1146/annurev.ne.10.030187.003221; Bisgaard CF, 2007, J MOL NEUROSCI, V32, P132, DOI 10.1007/s12031-007-0025-4; Bouzioukh F, 2006, EUR J NEUROSCI, V23, P2247, DOI 10.1111/j.1460-9568.2006.04783.x; Cao YQ, 2004, NEURON, V43, P387, DOI 10.1016/j.neuron.2004.07.014; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; Chan AW, 2007, CHANNELS, V1, DOI 10.4161/chan.3694; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; Chen A, 2007, NEUROCHEM INT, V50, P1078, DOI 10.1016/j.neuint.2006.11.008; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; Davies JN, 2008, CHANNELS, V2, P130, DOI 10.4161/chan.2.2.6214; Deo RC, 2004, EMBO J, V23, P9, DOI 10.1038/sj.emboj.7600021; DeWaard M, 1996, FEBS LETT, V380, P272, DOI 10.1016/0014-5793(96)00007-5; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; DONZANTI BA, 1988, LIFE SCI, V43, P913, DOI 10.1016/0024-3205(88)90267-6; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Goshima Y, 1999, J NEUROBIOL, V39, P579, DOI 10.1002/(SICI)1097-4695(19990615)39:4<579::AID-NEU11>3.0.CO;2-9; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; GOSLIN K, 1989, J CELL BIOL, V108, P1507, DOI 10.1083/jcb.108.4.1507; Grimm C, 2008, NEUROSCI LETT, V442, P44, DOI 10.1016/j.neulet.2008.06.066; Gupta A, 2007, J BIOL CHEM, V282, P5116, DOI 10.1074/jbc.M609254200; Henkel AW, 1996, J NEUROSCI, V16, P3960; Honnorat J, 1999, EUR J NEUROSCI, V11, P4226, DOI 10.1046/j.1460-9568.1999.00864.x; Hotta A, 2005, MOL BIOL CELL, V16, P32, DOI 10.1091/mbc.E04-08-0679; Hou ST, 2006, J NEUROSCI, V26, P2241, DOI 10.1523/JNEUROSCI.4485-05.2006; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Ilardi JM, 1999, NAT NEUROSCI, V2, P119, DOI 10.1038/5673; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Iwasaki S, 2000, J NEUROSCI, V20, P59, DOI 10.1523/JNEUROSCI.20-01-00059.2000; Joiner WJ, 2001, J BIOL CHEM, V276, P37980; Jones OT, 1997, J NEUROSCI, V17, P6152; Kang JS, 2008, CELL, V132, P137, DOI 10.1016/j.cell.2007.11.024; KATZ B, 1970, J PHYSIOL-LONDON, V207, P789, DOI 10.1113/jphysiol.1970.sp009095; Kay AR, 1999, NEURON, V24, P809, DOI 10.1016/S0896-6273(00)81029-6; Khanna R, 2006, NEUROSCIENCE, V140, P1201, DOI 10.1016/j.neuroscience.2006.04.053; Khanna R, 2006, NEUROSCIENCE, V138, P1115, DOI 10.1016/j.neuroscience.2005.12.050; Khanna R, 2007, EUR J NEUROSCI, V26, P547, DOI 10.1111/j.1460-9568.2007.05680.x; Khanna R, 2007, EUR J NEUROSCI, V26, P560, DOI 10.1111/j.1460-9568.2007.05681.x; Khanna R, 2007, J BIOCHEM MOL BIOL, V40, P302; Kisilevsky Alexandra E., 2008, V184, P45; Kowara R, 2005, J NEUROCHEM, V95, P466, DOI 10.1111/j.1471-4159.2005.03383.x; Lai MZ, 2005, NAT NEUROSCI, V8, P435, DOI 10.1038/nn1418; Leenders AGM, 2008, J NEUROSCI, V28, P11333, DOI 10.1523/JNEUROSCI.3078-08.2008; LEENDERS M, 2004, CURRENT PROTOCOLS NE; Li DJ, 2005, J NEUROSCI, V25, P1914, DOI 10.1523/JNEUROSCI.4790-04.2005; Lu SM, 2002, J BIOL CHEM, V277, P23515, DOI 10.1074/jbc.M201981200; Mochida S, 1996, NEURON, V17, P781, DOI 10.1016/S0896-6273(00)80209-3; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Nichols RA, 1996, NEUROSCI LETT, V211, P135, DOI 10.1016/0304-3940(96)12728-2; Nishimura T, 2003, NAT CELL BIOL, V5, P819, DOI 10.1038/ncb1039; Okamoto M, 1999, J BIOL CHEM, V274, P18446, DOI 10.1074/jbc.274.26.18446; Pan PY, 2005, J BIOL CHEM, V280, P25769, DOI 10.1074/jbc.M502356200; PANNEERSELVAM K, 1995, J BIOL CHEM, V270, P7975, DOI 10.1074/jbc.270.14.7975; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Prange O, 1999, J NEUROPHYSIOL, V81, P1810, DOI 10.1152/jn.1999.81.4.1810; Quach TT, 2008, FASEB J, V22, P401, DOI 10.1096/fj.07-9012com; Quinn CC, 2003, J NEUROSCI, V23, P2815; Reid B, 1999, J NEUROSCI, V19, P2511; Reid CA, 1998, J NEUROSCI, V18, P2849; Reid CA, 2003, TRENDS NEUROSCI, V26, P683, DOI 10.1016/j.tins.2003.10.003; Reid CA, 1997, J NEUROSCI, V17, P2738; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Ryu MJ, 2008, J NEUROCHEM, V104, P1260, DOI 10.1111/j.1471-4159.2007.05100.x; Schikorski T, 1997, J NEUROSCI, V17, P5858; Schmidt EF, 2007, ADV EXP MED BIOL, V600, P1; SCHOLZ KP, 1995, J NEUROSCI, V15, P4612; Sheng ZH, 1996, NATURE, V379, P451, DOI 10.1038/379451a0; Sheng ZH, 1997, P NATL ACAD SCI USA, V94, P5405, DOI 10.1073/pnas.94.10.5405; SHENG ZH, 1994, NEURON, V13, P1303, DOI 10.1016/0896-6273(94)90417-0; Stanley EF, 1997, TRENDS NEUROSCI, V20, P404, DOI 10.1016/S0166-2236(97)01091-6; Su KY, 2007, J NEUROSCI, V27, P2513, DOI 10.1523/JNEUROSCI.4497-06.2007; Tahimic CGT, 2006, BIOCHEM BIOPH RES CO, V340, P1244, DOI 10.1016/j.bbrc.2005.12.132; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Uchida Y, 2005, GENES CELLS, V10, P165, DOI 10.1111/j.1365-2443.2005.00827.x; Walker D, 1998, J BIOL CHEM, V273, P2361, DOI 10.1074/jbc.273.4.2361; Wang LH, 1997, J NEUROCHEM, V69, P2261; Weitzdoerfer R, 2001, J NEURAL TRANSM-SUPP, P95; WESTENBROEK RE, 1992, NEURON, V9, P1099, DOI 10.1016/0896-6273(92)90069-P; Willeumier K, 2006, J NEUROSCI, V26, P11333, DOI 10.1523/JNEUROSCI.1684-06.2006; Wong W, 2002, J BIOL CHEM, V277, P20423, DOI 10.1074/jbc.M109412200; Yamabhai M, 1998, J BIOL CHEM, V273, P31401, DOI 10.1074/jbc.273.47.31401; Yamaguchi K, 1998, BRAIN DEV-JPN, V20, P234, DOI 10.1016/S0387-7604(98)00027-8; Yamashita N, 2007, J NEUROSCI, V27, P12546, DOI 10.1523/JNEUROSCI.3463-07.2007; Yoshida H, 1998, J BIOL CHEM, V273, P9761, DOI 10.1074/jbc.273.16.9761; ZHANG JF, 1993, NEUROPHARMACOLOGY, V32, P1075, DOI 10.1016/0028-3908(93)90003-L; Zufferey R, 2002, CURR TOP MICROBIOL, V261, P107	90	149	153	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31375	31390		10.1074/jbc.M109.009951	http://dx.doi.org/10.1074/jbc.M109.009951			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19755421	hybrid, Green Published			2022-12-27	WOS:000271378400063
J	Fukunaka, A; Suzuki, T; Kurokawa, Y; Yamazaki, T; Fujiwara, N; Ishihara, K; Migaki, H; Okumura, K; Masuda, S; Yamaguchi-Iwai, Y; Nagao, M; Kambe, T				Fukunaka, Ayako; Suzuki, Tomoyuki; Kurokawa, Yayoi; Yamazaki, Tomohiro; Fujiwara, Naoko; Ishihara, Kaori; Migaki, Hitoshi; Okumura, Katsuzumi; Masuda, Seiji; Yamaguchi-Iwai, Yuko; Nagao, Masaya; Kambe, Taiho			Demonstration and Characterization of the Heterodimerization of ZnT5 and ZnT6 in the Early Secretory Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN ZINC TRANSPORTER; DIFFUSION FACILITATOR FAMILY; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL-CHARACTERIZATION; ALKALINE-PHOSPHATASES; ENDOPLASMIC-RETICULUM; VERTEBRATE CELLS; HOMEOSTASIS; PROTEINS; TRAFFICKING	The majority of CDF/ZnT zinc transporters form homooligomers. However, ZnT5, ZnT6, and their orthologues form hetero-oligomers in the early secretory pathway where they load zinc onto zinc-requiring enzymes and maintain secretory pathway functions. The details of this hetero-oligomerization remain to be elucidated, and much more is known about homo-oligomerization that occurs in other CDF/ZnT family proteins. Here, we addressed this issue using co-immunoprecipitation experiments, mutagenesis, and chimera studies of hZnT5 and hZnT6 in chicken DT40 cells deficient in ZnT5, ZnT6, and ZnT7 proteins. We found that hZnT5 and hZnT6 combine to form heterodimers but do not form complexes larger than heterodimers. Mutagenesis of hZnT6 indicated that the sites present in transmembrane domains II and V in which many CDF/ZnT proteins have conserved hydrophilic amino acid residues are not involved in zinc binding of hZnT6, although they are required for zinc transport in other CDF/ZnT family homo-oligomers. We also found that the long N-terminal half of hZnT5 is not necessary for its functional interaction with hZnT6, whereas the cytosolic C-terminal tail of hZnT5 is important in determining hZnT6 as a partner molecule for heterodimer formation. In DT40 cells, cZnT5 variant lacking the N-terminal half was endogenously induced during periods of endoplasmic reticulum stress and so seemed to function to supply zinc to zinc-requiring enzymes under these conditions. The results outlined here provide new information about the mechanism of action through heterodimerization of CDF/ZnT proteins that function in the early secretory pathway.	[Fukunaka, Ayako; Suzuki, Tomoyuki; Kurokawa, Yayoi; Yamazaki, Tomohiro; Fujiwara, Naoko; Ishihara, Kaori; Migaki, Hitoshi; Masuda, Seiji; Yamaguchi-Iwai, Yuko; Nagao, Masaya; Kambe, Taiho] Kyoto Univ, Div Integrated Life Sci, Grad Sch Biostudies, Kyoto 6068502, Japan; [Okumura, Katsuzumi] Mie Univ, Dept Life Sci, Fac Bioresources, Tsu, Mie 5148507, Japan	Kyoto University; Mie University	Kambe, T (corresponding author), Kyoto Univ, Div Life Sci, Grad Sch Biostudies, Kyoto 6068502, Japan.	kambe1@kais.kyoto-u.ac.jp		Kambe, Taiho/0000-0001-9757-063X	Ministry of Education, Culture, Sports, Science and Technology of Japan; Kato Memorial Bioscience Foundation; Fuji Foundation for Protein Research	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kato Memorial Bioscience Foundation; Fuji Foundation for Protein Research(Fuji Foundation for Protein Research)	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by funds from the Kato Memorial Bioscience Foundation and Fuji Foundation for Protein Research (to T. K.).	Blaudez D, 2003, PLANT CELL, V15, P2911, DOI 10.1105/tpc.017541; Cherezov V, 2008, STRUCTURE, V16, P1378, DOI 10.1016/j.str.2008.05.014; Chimienti F, 2003, CURR DRUG TARGETS, V4, P323, DOI 10.2174/1389450033491082; Cousins RJ, 2006, J BIOL CHEM, V281, P24085, DOI 10.1074/jbc.R600011200; Cragg RA, 2002, J BIOL CHEM, V277, P22789, DOI 10.1074/jbc.M200577200; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; Ellis CD, 2005, J BIOL CHEM, V280, P28811, DOI 10.1074/jbc.M505500200; Ellis CD, 2004, J CELL BIOL, V166, P325, DOI 10.1083/jcb.200401157; Fang Y, 2008, MOL BIOL CELL, V19, P1295, DOI 10.1091/mbc.E07-08-0805; Gaither LA, 2001, BIOMETALS, V14, P251, DOI 10.1023/A:1012988914300; Guffanti AA, 2002, MOL MICROBIOL, V45, P145, DOI 10.1046/j.1365-2958.2002.02998.x; Huang LP, 2002, J BIOL CHEM, V277, P26389, DOI 10.1074/jbc.M200462200; Ishihara K, 2006, J BIOL CHEM, V281, P17743, DOI 10.1074/jbc.M602470200; Jirakulaporn T, 2004, J BIOL CHEM, V279, P27807, DOI 10.1074/jbc.M401210200; Kambe T, 2004, CELL MOL LIFE SCI, V61, P49, DOI 10.1007/s00018-003-3148-y; Kambe T, 2002, J BIOL CHEM, V277, P19049, DOI 10.1074/jbc.M200910200; Kambe T, 2009, MOL CELL BIOL, V29, P129, DOI 10.1128/MCB.00963-08; Kambe T, 2008, GENESIS, V46, P214, DOI 10.1002/dvg.20382; Kambe Taiho, 2006, Genomics Proteomics & Bioinformatics, V4, P1, DOI 10.1016/S1672-0229(06)60010-7; Kawachi M, 2008, J BIOL CHEM, V283, P8374, DOI 10.1074/jbc.M707646200; Kirschke CP, 2003, J BIOL CHEM, V278, P4096, DOI 10.1074/jbc.M207644200; Kumanovics A, 2006, J BIOL CHEM, V281, P22566, DOI 10.1074/jbc.M604730200; Li LT, 2001, J BIOL CHEM, V276, P5036, DOI 10.1074/jbc.M008969200; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; MacDiarmid CW, 2002, J BIOL CHEM, V277, P39187, DOI 10.1074/jbc.M205052200; Montanini B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-107; Murakami M, 2008, CANCER SCI, V99, P1515, DOI 10.1111/j.1349-7006.2008.00854.x; Murgia C, 2009, NUTR METAB CARDIOVAS, V19, P431, DOI 10.1016/j.numecd.2008.09.004; Ohana E, 2009, J BIOL CHEM, V284, P17677, DOI 10.1074/jbc.M109.007203; Palmiter RD, 2004, PFLUG ARCH EUR J PHY, V447, P744, DOI 10.1007/s00424-003-1070-7; PALMITER RD, 1995, EMBO J, V14, P639, DOI 10.1002/j.1460-2075.1995.tb07042.x; Paulsen IT, 1997, J MEMBRANE BIOL, V156, P99, DOI 10.1007/s002329900192; Qiao W, 2009, MOL MICROBIOL, V72, P320, DOI 10.1111/j.1365-2958.2009.06644.x; Sekler I, 2007, MOL MED, V13, P337, DOI 10.2119/2007-00037.Sekler; Suzuki T, 2005, J BIOL CHEM, V280, P637, DOI 10.1074/jbc.M411247200; Suzuki T, 2005, J BIOL CHEM, V280, P30956, DOI 10.1074/jbc.M506902200; Valentine RA, 2007, J BIOL CHEM, V282, P14389, DOI 10.1074/jbc.M701752200; Wei YN, 2006, J BIOL CHEM, V281, P23492, DOI 10.1074/jbc.M602254200	39	82	84	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30798	30806		10.1074/jbc.M109.026435	http://dx.doi.org/10.1074/jbc.M109.026435			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19759014	hybrid, Green Published			2022-12-27	WOS:000271378400007
J	Kolandaivelu, S; Huang, J; Hurley, JB; Ramamurthy, V				Kolandaivelu, Saravanan; Huang, Jing; Hurley, James B.; Ramamurthy, Visvanathan			AIPL1, a Protein Associated with Childhood Blindness, Interacts with alpha-Subunit of Rod Phosphodiesterase (PDE6) and Is Essential for Its Proper Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEBER CONGENITAL AMAUROSIS; CYCLIC-GMP PHOSPHODIESTERASE; PHOTORECEPTOR CGMP-PHOSPHODIESTERASE; OUTER SEGMENTS; RETINAL DEGENERATION; CATALYTIC SUBUNITS; GAMMA-SUBUNIT; BETA-SUBUNIT; MODEL; PHOTOTRANSDUCTION	Mutations in the gene coding for AIPL1 cause Leber congenital amaurosis (LCA), a severe form of childhood blindness. The severity in disease is reflected in the complete loss of vision and rapid photoreceptor degeneration in the retinas of mice deficient in AIPL1. Our previous observations suggest that rod photoreceptor degeneration in retinas lacking AIPL1 is due to the massive reduction in levels of rod cGMP phosphodiesterase (PDE6) subunits (alpha, beta, and gamma). To date, the crucial link between AIPL1 and the stability of PDE6 subunits is not known. In this study using ex vivo pulse label analysis, we demonstrate that AIPL1 is not involved in the synthesis of PDE6 subunits. However, ex vivo pulse-chase analysis clearly shows that in the absence of AIPL1, rod PDE6 subunits are rapidly degraded by proteasomes. We further demonstrate that this rapid degradation of PDE6 is due to the essential role of AIPL1 in the proper assembly of synthesized individual PDE6 subunits. In addition, using a novel monoclonal antibody generated against AIPL1, we show that the catalytic subunit (alpha) of PDE6 associates with AIPL1 in retinal extracts. Our studies establish that AIPL1 interacts with the catalytic subunit (alpha) of PDE6 and is needed for the proper assembly of functional rod PDE6 subunits.	[Ramamurthy, Visvanathan] W Virginia Univ, Dept Ophthalmol, Inst Eye, Sensory Neurosci Res Ctr, Morgantown, WV 26506 USA; [Kolandaivelu, Saravanan; Ramamurthy, Visvanathan] W Virginia Univ, Dept Biochem, Sensory Neurosci Res Ctr, Morgantown, WV 26506 USA; [Huang, Jing; Hurley, James B.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Huang, Jing; Hurley, James B.] Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA	West Virginia University; West Virginia University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Ramamurthy, V (corresponding author), W Virginia Univ, Dept Ophthalmol, Inst Eye, Sensory Neurosci Res Ctr, 1 Stadium Dr,POB 9193, Morgantown, WV 26506 USA.	ramamurthyv@wvuh.com		Ramamurthy, Visvanathan/0000-0003-0289-3685	National Institutes of Health [EY017035]; NEI; COBRE [P20 RR15574]; Research to Prevent Blindness Challenge; International and West Virginia Lions Eye Foundation; Knight Templar Eye Foundation; Vision Core [P30EY1730]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015574] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY001730, R01EY017035] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); COBRE; Research to Prevent Blindness Challenge(Research to Prevent Blindness (RPB)); International and West Virginia Lions Eye Foundation; Knight Templar Eye Foundation; Vision Core; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY017035 from the NEI (to V. R.) and COBRE Grant P20 RR15574 (to the Sensory Neuroscience Research Center). This work was also supported by a Research to Prevent Blindness Challenge grant (to West Virginia University), the International and West Virginia Lions Eye Foundation (to West Virginia University) and a Knight Templar Eye Foundation grant (to S. K.), and Vision Core Grant P30EY1730 (to University of Washington).	ANANT JS, 1992, J BIOL CHEM, V267, P687; Artemyev NO, 1996, J BIOL CHEM, V271, P25382, DOI 10.1074/jbc.271.41.25382; Ausubel FM, 2003, CURRENT PROTOCOLS MO; BAEHR W, 1979, J BIOL CHEM, V254, P1669; CAMPBELL AM, 1984, LAB TECHNIQUES BIOCH, P86; Cote RH, 2004, INT J IMPOT RES, V16, pS28, DOI 10.1038/sj.ijir.3901212; CUNNICK J, 1992, BIOCHEM BIOPH RES CO, V184, P461, DOI 10.1016/0006-291X(92)91216-D; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; DETERRE P, 1988, P NATL ACAD SCI USA, V85, P2424, DOI 10.1073/pnas.85.8.2424; Dhamaraj S, 2004, ARCH OPHTHALMOL-CHIC, V122, P1029, DOI 10.1001/archopht.122.7.1029; Dyer MA, 2004, MOL BRAIN RES, V132, P208, DOI 10.1016/j.molbrainres.2004.10.011; FARBER DB, 1994, PROG RETIN EYE RES, V13, P31, DOI 10.1016/1350-9462(94)90004-3; FUNG BKK, 1990, BIOCHEMISTRY-US, V29, P2657, DOI 10.1021/bi00463a006; Hendrickson A, 2008, EXP EYE RES, V87, P415, DOI 10.1016/j.exer.2008.07.016; Hidalgo-De-Quintana J, 2008, INVEST OPHTH VIS SCI, V49, P2878, DOI 10.1167/iovs.07-1576; HURLEY JB, 1982, J BIOL CHEM, V257, P1094; HURWITZ RL, 1984, J BIOL CHEM, V259, P8612; HURWITZ RL, 1984, CYCLIC NUCLEOTIDE PR, V17, P239; Karan S, 2008, VISION RES, V48, P442, DOI 10.1016/j.visres.2007.08.020; Koenekoop RK, 2004, SURV OPHTHALMOL, V49, P379, DOI 10.1016/j.survophthal.2004.04.003; LEE RH, 1985, INVEST OPHTH VIS SCI, V26, P1569; Liu XQ, 2004, P NATL ACAD SCI USA, V101, P13903, DOI 10.1073/pnas.0405160101; Makino CL, 2006, INVEST OPHTH VIS SCI, V47, P2185, DOI 10.1167/iovs.05-1341; MIKI N, 1975, J BIOL CHEM, V250, P6320; Muradov H, 2006, VISION RES, V46, P860, DOI 10.1016/j.visres.2005.09.015; Muradov KG, 2003, BIOCHEMISTRY-US, V42, P3305, DOI 10.1021/bi027095x; Norton AW, 2005, J BIOL CHEM, V280, P1248, DOI 10.1074/jbc.M410475200; Petersen-Jones SM, 1999, INVEST OPHTH VIS SCI, V40, P1637; Piri N, 2006, EXP EYE RES, V83, P841, DOI 10.1016/j.exer.2006.04.003; QIN N, 1992, J BIOL CHEM, V267, P8458; Ramamurthy V, 2003, P NATL ACAD SCI USA, V100, P12630, DOI 10.1073/pnas.2134194100; Ramamurthy V, 2004, P NATL ACAD SCI USA, V101, P13897, DOI 10.1073/pnas.0404197101; Sakamoto K, 2009, HUM MOL GENET, V18, P178, DOI 10.1093/hmg/ddn327; Tsang SH, 1996, SCIENCE, V272, P1026, DOI 10.1126/science.272.5264.1026; van der Spuy J, 2005, MOL VIS, V11, P542; van der Spuy J, 2003, INVEST OPHTH VIS SCI, V44, P5396, DOI 10.1167/iovs.03-0686; van der Spuy J, 2002, HUM MOL GENET, V11, P823, DOI 10.1093/hmg/11.7.823; Zhang H, 2007, P NATL ACAD SCI USA, V104, P8857, DOI 10.1073/pnas.0701681104	38	43	43	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30853	30861		10.1074/jbc.M109.036780	http://dx.doi.org/10.1074/jbc.M109.036780			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19758987	Green Published, hybrid			2022-12-27	WOS:000271378400013
J	Pennati, A; Gadda, G				Pennati, Andrea; Gadda, Giovanni			Involvement of Ionizable Groups in Catalysis of Human Liver Glycolate Oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-HYDROXYACID OXIDASE; L-LACTATE DEHYDROGENASE; ACTIVE-SITE BASE; CHOLINE OXIDASE; FLAVOCYTOCHROME B(2); SUBSTRATE-BINDING; ACID OXIDASE; (S)-MANDELATE DEHYDROGENASE; SACCHAROMYCES-CEREVISIAE; PSEUDOMONAS-PUTIDA	Glycolate oxidase is a flavin-dependent, peroxisomal enzyme that oxidizes alpha-hydroxy acids to the corresponding alpha-keto acids, with reduction of oxygen to H2O2. In plants, the enzyme participates in photorespiration. In humans, it is a potential drug target for treatment of primary hyperoxaluria, a genetic disorder where overproduction of oxalate results in the formation of kidney stones. In this study, steady-state and pre-steady-state kinetic approaches have been used to determine how pH affects the kinetic steps of the catalytic mechanism of human glycolate oxidase. The enzyme showed a Ping-Pong Bi-Bi kinetic mechanism between pH 6.0 and 10.0. Both the overall turnover of the enzyme (k(cat)) and the rate constant for anaerobic substrate reduction of the flavin were pH-independent at pH values above 7.0 and decreased slightly at lower pH, suggesting the involvement of an unprotonated group acting as a base in the chemical step of glycolate oxidation. The second-order rate constant for capture of glycolate (k(cat)/ K-glycolate) and the K-d(app) for the formation of the enzyme-substrate complex suggested the presence of a protonated group with apparent pK(a) of 8.5 participating in substrate binding. The k(cat)/K-oxygen values were an order of magnitude faster when a group with pKa of 6.8 was unprotonated. These results are discussed in the context of the available three-dimensional structure of GOX.	[Gadda, Giovanni] Georgia State Univ, Dept Chem, Atlanta, GA 30302 USA; [Gadda, Giovanni] Georgia State Univ, Dept Biol, Atlanta, GA 30302 USA; [Gadda, Giovanni] Georgia State Univ, Ctr Biotechnol & Drug Design, Atlanta, GA 30302 USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; University System of Georgia; Georgia State University	Gadda, G (corresponding author), Georgia State Univ, Dept Chem, POB 4098, Atlanta, GA 30302 USA.	ggadda@gsu.edu	Gadda, Giovanni/M-2354-2016	Gadda, Giovanni/0000-0002-7508-4195	National Science Foundation [MCB-0545712]	National Science Foundation(National Science Foundation (NSF))	This work was supported in part by National Science Foundation Career Award MCB-0545712 (to G.G.).	Allison R D, 1979, Methods Enzymol, V63, P3; BELMOUDEN A, 1993, EUR J BIOCHEM, V214, P17, DOI 10.1111/j.1432-1033.1993.tb17891.x; BLANCHARD DE, 1946, J BIOL CHEM, V163, P137; CLELAND WW, 1982, METHOD ENZYMOL, V87, P390; CLELAND WW, 1975, BIOCHEMISTRY-US, V14, P3220, DOI 10.1021/bi00685a029; CLELAND WW, 1963, BIOCHIM BIOPHYS ACTA, V67, P188; DULEY J, 1974, GENETICS, V76, P93; Fan F, 2005, J AM CHEM SOC, V127, P2067, DOI 10.1021/ja044541q; FRY DW, 1979, BIOCHIM BIOPHYS ACTA, V568, P135, DOI 10.1016/0005-2744(79)90281-X; Gadda G, 2000, BIOCHEMISTRY-US, V39, P1406, DOI 10.1021/bi992255z; Gadda G, 2006, ARCH BIOCHEM BIOPHYS, V451, P182, DOI 10.1016/j.abb.2006.04.005; GAUME B, 1995, BIOCHIMIE, V77, P621, DOI 10.1016/0300-9084(96)88177-6; Ghanem M, 2005, BIOCHEMISTRY-US, V44, P893, DOI 10.1021/bi048056j; Ghanem M, 2003, BIOCHEMISTRY-US, V42, P15179, DOI 10.1021/bi035435o; GHISLA S, 1974, BIOCHEMISTRY-US, V13, P589, DOI 10.1021/bi00700a029; Holmes RP, 1998, J NEPHROL, V11, P32; JACQ C, 1972, EUR J BIOCHEM, V25, P41, DOI 10.1111/j.1432-1033.1972.tb01664.x; KUN E, 1954, J BIOL CHEM, V210, P269; Lehoux IE, 1999, BIOCHEMISTRY-US, V38, P9948, DOI 10.1021/bi9907532; LIDE DR, 2000, CRC HDB CHEM PHYS, P8; LINDQVIST Y, 1985, P NATL ACAD SCI USA, V82, P6855, DOI 10.1073/pnas.82.20.6855; LINDQVIST Y, 1989, J MOL BIOL, V209, P151, DOI 10.1016/0022-2836(89)90178-2; LINDQVIST Y, 1979, J BIOL CHEM, V254, P7403; LUTZ S, 2009, PROTEIN ENG HDB, V1, P8; MACHEROUX P, 1992, BIOCHIM BIOPHYS ACTA, V1132, P11, DOI 10.1016/0167-4781(92)90046-3; MACHEROUX P, 1993, EUR J BIOCHEM, V213, P1047, DOI 10.1111/j.1432-1033.1993.tb17852.x; MACHEROUX P, 1991, BIOCHEMISTRY-US, V30, P4612, DOI 10.1021/bi00232a036; MAEDAYORITA K, 1995, BIOCHIMIE, V77, P631, DOI 10.1016/0300-9084(96)88178-8; MASSEY V, 1994, J BIOL CHEM, V269, P22459; Mattevi A, 2006, TRENDS BIOCHEM SCI, V31, P276, DOI 10.1016/j.tibs.2006.03.003; Miller JR, 1999, J BIOL CHEM, V274, P23515, DOI 10.1074/jbc.274.33.23515; Mowat CG, 2000, BIOCHEMISTRY-US, V39, P3266, DOI 10.1021/bi9925975; MUH U, 1994, J BIOL CHEM, V269, P7989; Murray MS, 2008, BIOCHEMISTRY-US, V47, P2439, DOI 10.1021/bi701710r; NISHIMURA M, 1983, ARCH BIOCHEM BIOPHYS, V222, P397, DOI 10.1016/0003-9861(83)90536-2; POMPON D, 1985, EUR J BIOCHEM, V148, P145, DOI 10.1111/j.1432-1033.1985.tb08818.x; Roth JP, 2003, P NATL ACAD SCI USA, V100, P62, DOI 10.1073/pnas.252644599; Rungsrisuriyachai K, 2008, BIOCHEMISTRY-US, V47, P6762, DOI 10.1021/bi800650w; Rungsrisuriyachai K, 2009, ARCH BIOCHEM BIOPHYS, V483, P10, DOI 10.1016/j.abb.2008.12.018; SCHUMAN M, 1971, BIOCHIM BIOPHYS ACTA, V227, P500, DOI 10.1016/0005-2744(71)90003-9; SCHWAM H, 1979, BIOCHEMISTRY-US, V18, P2828, DOI 10.1021/bi00580a023; Sobrado P, 2003, BIOCHEMISTRY-US, V42, P15208, DOI 10.1021/bi035546n; Sobrado P, 2001, BIOCHEMISTRY-US, V40, P994, DOI 10.1021/bi002283d; Stenberg K, 1997, PROTEIN SCI, V6, P1009, DOI 10.1002/pro.5560060506; STENBERG K, 1995, EUR J BIOCHEM, V228, P408; STRICKLAND S, 1975, J BIOL CHEM, V250, P4048; Su QJ, 1999, BIOCHEMISTRY-US, V38, P8572, DOI 10.1021/bi990044o; TAN AK, 1993, BIOCHEMISTRY-US, V32, P2137, DOI 10.1021/bi00060a003; TOLBERT NE, 1949, J BIOL CHEM, V181, P905; Tsai CL, 2007, BIOCHEMISTRY-US, V46, P7844, DOI 10.1021/bi7005543; URBAN P, 1984, EUR J BIOCHEM, V144, P345, DOI 10.1111/j.1432-1033.1984.tb08470.x; USHIJIMA Y, 1973, ARCH BIOCHEM BIOPHYS, V155, P361, DOI 10.1016/0003-9861(73)90125-2; Vignaud C, 2007, ARCH BIOCHEM BIOPHYS, V465, P410, DOI 10.1016/j.abb.2007.06.021; Wagner MA, 2000, BIOCHEMISTRY-US, V39, P8825, DOI 10.1021/bi000350y; Williams E, 2000, BBA-GENE STRUCT EXPR, V1493, P246, DOI 10.1016/S0167-4781(00)00161-5; Xu Y, 2002, BIOCHEMISTRY-US, V41, P12313, DOI 10.1021/bi026258e	56	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31214	31222		10.1074/jbc.M109.040063	http://dx.doi.org/10.1074/jbc.M109.040063			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19758989	Green Published, hybrid			2022-12-27	WOS:000271378400049
J	Woo, SH; An, S; Lee, HC; Jin, HO; Seo, SK; Yoo, DH; Lee, KH; Rhee, CH; Choi, EJ; Hong, SI; Park, IC				Woo, Sang Hyeok; An, Sungkwan; Lee, Hyung-Chahn; Jin, Hyeon-Ok; Seo, Sung-Keum; Yoo, Doo-Hyun; Lee, Kee-Ho; Rhee, Chang Hun; Choi, Eui-Ju; Hong, Seok-Il; Park, In-Chul			A Truncated Form of p23 Down-regulates Telomerase Activity via Disruption of Hsp90 Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; CO-CHAPERONE P23; CASEIN KINASE-II; GLUCOCORTICOID-RECEPTOR; TYROSINE KINASE; IN-VITRO; HETEROPROTEIN COMPLEX; REVERSE-TRANSCRIPTASE; STRESS-PROTEIN; ATPASE CYCLE	The Hsp90-associated protein p23 modulates Hsp90 activity during the final stages of the chaperone pathway to facilitate maturation of client proteins. Previous reports indicate that p23 cleavage induced by caspases during cell death triggers destabilization of client proteins. However, the specific role of truncated p23 (Delta p23) in this process and the underlying mechanisms remain to be determined. One such client protein, hTERT, is a telomerase catalytic subunit regulated by several chaperone proteins, including Hsp90 and p23. In the present study, we examined the effects of p23 cleavage on hTERT stability and telomerase activity. Our data showed that overexpression of Delta p23 resulted in a decrease in hTERT levels, and a down-regulation in telomerase activity. Serine phosphorylation of Hsp90 was significantly reduced in cells expressing high levels of Delta p23 compared with those expressing full-length p23. Mutation analyses revealed that two serine residues (Ser-231 and Ser-263) in Hsp90 are important for activation of telomerase, and down-regulation of telomerase activity by Delta p23 was associated with inhibition of cell growth and sensitization of cells to cisplatin. Our data aid in determining the mechanism underlying the regulation of telomerase activity by the chaperone complex during caspase-dependent cell death.	[Hong, Seok-Il] Korea Inst Radiol & Med Sci, Dept Clin Pathol, Seoul 139706, South Korea; [Lee, Kee-Ho; Park, In-Chul] Korea Inst Radiol & Med Sci, Div Radiat Canc Res, Seoul 139706, South Korea; [Rhee, Chang Hun] Korea Inst Radiol & Med Sci, Dept Neurosurg, Seoul 139706, South Korea; [An, Sungkwan] Konkuk Univ, Funct Genoproteome Res Ctr, Seoul 143701, South Korea; [Woo, Sang Hyeok; Choi, Eui-Ju] Korea Univ, Sch Life Sci & Biotechnol, Seoul 136701, South Korea	Korea Institute of Radiological & Medical Sciences; Korea Institute of Radiological & Medical Sciences; Korea Institute of Radiological & Medical Sciences; Konkuk University; Korea University	Hong, SI (corresponding author), Korea Inst Radiol & Med Sci, Dept Clin Pathol, 215-4 Gongneung Dong, Seoul 139706, South Korea.	hongsicp@kcch.re.kr; parkic@kcch.re.kr			Ministry of Sciences and Technology, Korea	Ministry of Sciences and Technology, Korea	This work was supported by the National Nuclear R & D Program of the Ministry of Sciences and Technology, Korea.	Adinolfi E, 2003, J BIOL CHEM, V278, P37344, DOI 10.1074/jbc.M301508200; Bachand F, 1999, J BIOL CHEM, V274, P38027, DOI 10.1074/jbc.274.53.38027; Barati MT, 2006, J PROTEOME RES, V5, P1636, DOI 10.1021/pr0502469; Beattie TL, 1998, CURR BIOL, V8, P177, DOI 10.1016/S0960-9822(98)70067-3; Chen MS, 1996, J BIOL CHEM, V271, P32315, DOI 10.1074/jbc.271.50.32315; Cong YS, 2002, MICROBIOL MOL BIOL R, V66, P407, DOI 10.1128/MMBR.66.3.407-425.2002; Dittmar KD, 1997, J BIOL CHEM, V272, P21213, DOI 10.1074/jbc.272.34.21213; Dix MM, 2008, CELL, V134, P679, DOI 10.1016/j.cell.2008.06.038; Forsythe HL, 2001, J BIOL CHEM, V276, P15571, DOI 10.1074/jbc.C100055200; Freeman BC, 2000, GENE DEV, V14, P422; Gausdal G, 2004, LEUKEMIA, V18, P1989, DOI 10.1038/sj.leu.2403508; Hu JM, 2002, J VIROL, V76, P269, DOI 10.1128/JVI.76.1.269-279.2002; JOHNSON JL, 1994, MOL CELL BIOL, V14, P1956, DOI 10.1128/MCB.14.3.1956; Keppler BR, 2006, J BIOL CHEM, V281, P19840, DOI 10.1074/jbc.M511067200; Kim JH, 2005, GENE DEV, V19, P776, DOI 10.1101/gad.1289405; LEESMILLER SP, 1989, J BIOL CHEM, V264, P17275; LEESMILLER SP, 1989, J BIOL CHEM, V264, P2431; Li S, 2004, CANCER RES, V64, P4833, DOI 10.1158/0008-5472.CAN-04-0953; Massard C, 2006, ONCOGENE, V25, P4505, DOI 10.1038/sj.onc.1209487; Masutomi K, 2000, J BIOL CHEM, V275, P22568, DOI 10.1074/jbc.M000622200; MIMNAUGH EG, 1995, J BIOL CHEM, V270, P28654, DOI 10.1074/jbc.270.48.28654; Mimnaugh EG, 1996, J BIOL CHEM, V271, P22796, DOI 10.1074/jbc.271.37.22796; MIYATA Y, 1995, BIOCHEMISTRY-US, V34, P8123, DOI 10.1021/bi00025a019; Mollerup J, 2005, FEBS LETT, V579, P4187, DOI 10.1016/j.febslet.2005.06.045; Nair SC, 1996, CELL STRESS CHAPERON, V1, P237, DOI 10.1379/1466-1268(1996)001<0237:APOMCI>2.3.CO;2; Ogiso H, 2004, BIOCHEMISTRY-US, V43, P15510, DOI 10.1021/bi048736m; Osterhage JL, 2009, J BIOL CHEM, V284, P16061, DOI 10.1074/jbc.R900011200; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Rao RV, 2006, CELL DEATH DIFFER, V13, P415, DOI 10.1038/sj.cdd.4401761; Richter K, 2001, J CELL PHYSIOL, V188, P281, DOI 10.1002/jcp.1131; Scheibel T, 1999, P NATL ACAD SCI USA, V96, P1297, DOI 10.1073/pnas.96.4.1297; SCHULTE TW, 1995, J BIOL CHEM, V270, P24585, DOI 10.1074/jbc.270.41.24585; Siligardi G, 2004, J BIOL CHEM, V279, P51989, DOI 10.1074/jbc.M410562200; Sullivan WP, 2002, J BIOL CHEM, V277, P45942, DOI 10.1074/jbc.M207754200; Tanioka T, 2000, J BIOL CHEM, V275, P32775, DOI 10.1074/jbc.M003504200; TBARKA N, 1993, FEBS LETT, V322, P125, DOI 10.1016/0014-5793(93)81551-A; Toogun OA, 2007, P NATL ACAD SCI USA, V104, P5765, DOI 10.1073/pnas.0701442104; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Wandinger SK, 2006, EMBO J, V25, P367, DOI 10.1038/sj.emboj.7600930; Weaver AJ, 2000, J BIOL CHEM, V275, P23045, DOI 10.1074/jbc.M003410200; Weikl T, 2000, J MOL BIOL, V303, P583, DOI 10.1006/jmbi.2000.4157; Weikl T, 1999, J MOL BIOL, V293, P685, DOI 10.1006/jmbi.1999.3172; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Woo SH, 2005, J CELL BIOCHEM, V95, P120, DOI 10.1002/jcb.20329; Xu ZY, 1997, EUR J BIOCHEM, V246, P461, DOI 10.1111/j.1432-1033.1997.t01-1-00461.x; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079; Zhao YG, 2001, J BIOL CHEM, V276, P32822, DOI 10.1074/jbc.M105562200	47	20	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30871	30880		10.1074/jbc.M109.052720	http://dx.doi.org/10.1074/jbc.M109.052720			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19740745	Green Published, hybrid			2022-12-27	WOS:000271378400015
J	Katsuki, M; Drummond, DR; Osei, M; Cross, RA				Katsuki, Miho; Drummond, Douglas R.; Osei, Michael; Cross, Robert A.			Mal3 Masks Catastrophe Events in Schizosaccharomyces pombe Microtubules by Inhibiting Shrinkage and Promoting Rescue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLUS-END-TRACKING; DYNAMIC INSTABILITY; INTERPHASE MICROTUBULES; INDIVIDUAL MICROTUBULES; IN-VITRO; EB1; PROTEINS; HOMOLOG; POLYMERIZATION; MICROSCOPY	Schizosaccharomyces pombe Mal3 is a member of the EB family of proteins, which are proposed to be core elements in a tip-tracking network that regulates microtubule dynamics in cells. How Mal3 itself influences microtubule dynamics is unclear. We tested the effects of full-length recombinant Mal3 on dynamic microtubules assembled in vitro from purified S. pombe tubulin, using dark field video microscopy to avoid fluorescent tagging and data-averaging techniques to improve spatiotemporal resolution. We find that catastrophe occurs stochastically as a fast (<2.2 s) transition from constant speed growth to constant speed shrinkage with a constant probability that is independent of the Mal3 concentration. This implies that Mal3 neither stabilizes nor destabilizes microtubule tips. Mal3 does, however, stabilize the main part of the microtubule lattice, inhibiting shrinkage and increasing the frequency of rescues, consistent with recent models in which Mal3 on the lattice forms stabilizing lateral links between neighboring protofilaments. At high concentrations, Mal3 can entirely block shrinkage and induce very rapid rescue, making catastrophes impossible to detect, which may account for the apparent suppression of catastrophe by Mal3 and other EBs in vivo. Overall, we find that Mal3 stabilizes microtubules not by preventing catastrophe at the microtubule tip but by inhibiting lattice depolymerization and enhancing rescue. We argue that this implies that Mal3 binds microtubules in different modes at the tip and on the lattice.	[Katsuki, Miho; Drummond, Douglas R.; Osei, Michael; Cross, Robert A.] Marie Curie Reaerch Inst, Mol Motors Grp, Surrey RH8 0TL, England		Cross, RA (corresponding author), The Chart, Surrey RH8 0TL, England.	r.cross@mcri.ac.uk	Cross, Robert A/F-1798-2011	Cross, Robert A/0000-0002-0004-7832; Drummond, Douglas/0000-0003-4155-3747	Cancer Research UK [C19638/A6211]; Association for International Cancer Research [09-0221]; Medical Research Council [G0200542]; Marie Curie Cancer Care; MRC [G0200542] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Association for International Cancer Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Marie Curie Cancer Care; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from Cancer Research UK (Grant C19638/A6211), the Association for International Cancer Research (Grant 09-0221), the Medical Research Council (Grant G0200542), and Marie Curie Cancer Care.	Akhmanova A, 2005, CURR OPIN CELL BIOL, V17, P47, DOI 10.1016/j.ceb.2004.11.001; Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Bieling P, 2007, NATURE, V450, P1100, DOI 10.1038/nature06386; Bieling P, 2008, J CELL BIOL, V183, P1223, DOI 10.1083/jcb.200809190; Browning H, 2005, J BIOL CHEM, V280, P12299, DOI 10.1074/jbc.M413620200; Busch KE, 2004, CURR BIOL, V14, P548, DOI 10.1016/j.cub.2004.03.029; des Georges A, 2008, NAT STRUCT MOL BIOL, V15, P1102, DOI 10.1038/nsmb.1482; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Dimitrov A, 2008, SCIENCE, V322, P1353, DOI 10.1126/science.1165401; Dixit R, 2009, P NATL ACAD SCI USA, V106, P492, DOI 10.1073/pnas.0807614106; Drummond DR, 2000, CURR BIOL, V10, P766, DOI 10.1016/S0960-9822(00)00570-4; HORIO T, 1986, NATURE, V321, P605, DOI 10.1038/321605a0; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; Komarova Y, 2009, J CELL BIOL, V184, P691, DOI 10.1083/jcb.200807179; Manna T, 2008, BIOCHEMISTRY-US, V47, P779, DOI 10.1021/bi701912g; Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094; MITCHISON T, 1984, NATURE, V312, P232, DOI 10.1038/312232a0; Nakamura M, 2001, CURR BIOL, V11, P1062, DOI 10.1016/S0960-9822(01)00297-4; Sandblad L, 2006, CELL, V127, P1415, DOI 10.1016/j.cell.2006.11.025; Schek HT, 2007, CURR BIOL, V17, P1445, DOI 10.1016/j.cub.2007.07.011; Tirnauer JS, 2002, MOL BIOL CELL, V13, P3614, DOI 10.1091/mbc.E02-04-0210; Vitre B, 2008, NAT CELL BIOL, V10, P415, DOI 10.1038/ncb1703; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437	23	29	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29246	29250		10.1074/jbc.C109.052159	http://dx.doi.org/10.1074/jbc.C109.052159			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19740752	Green Submitted, hybrid, Green Accepted, Green Published			2022-12-27	WOS:000270896800003
J	Wu, MS; Le, HD; Wang, MT; Yurkov, V; Omelchenko, A; Hnatowich, M; Nix, J; Hryshko, LV; Zheng, L				Wu, Mousheng; Le, Hoa Dinh; Wang, Meitian; Yurkov, Vladimir; Omelchenko, Alexander; Hnatowich, Mark; Nix, Jay; Hryshko, Larry V.; Zheng, Lei			Crystal Structures of Progressive Ca2+ Binding States of the Ca2+ Sensor Ca2+ Binding Domain 1 (CBD1) from the CALX Na+/Ca2+ Exchanger Reveal Incremental Conformational Transitions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+-CA2+ EXCHANGER; DROSOPHILA-MELANOGASTER; CA2+-BINDING DOMAIN; MUTATIONAL ANALYSIS; MUTAGENESIS; ISOFORMS; MODEL; NCX1; SITE	Na+/Ca2+ exchangers (NCX) constitute a major Ca2+ export system that facilitates the re-establishment of cytosolic Ca2+ levels in many tissues. Ca2+ interactions at its Ca2+ binding domains (CBD1 and CBD2) are essential for the allosteric regulation of Na+/Ca2+ exchange activity. The structure of the Ca2+-bound form of CBD1, the primary Ca2+ sensor from canine NCX1, but not the Ca2+-free form, has been reported, although the molecular mechanism of Ca2+ regulation remains unclear. Here, we report crystal structures for three distinct Ca2+ binding states of CBD1 from CALX, a Na+/Ca2+ exchanger found in Drosophila sensory neurons. The fully Ca2+-bound CALX-CBD1 structure shows that four Ca2+ atoms bind at identical Ca2+ binding sites as those found in NCX1 and that the partial Ca2(+) occupancy and apoform structures exhibit progressive conformational transitions, indicating incremental regulation of CALX exchange by successive Ca2+ binding at CBD1. The structures also predict that the primary Ca2+ pair plays the main role in triggering functional conformational changes. Confirming this prediction, mutagenesis of Glu(455), which coordinates the primary Ca2+ pair, produces dramatic reductions of the regulatory Ca2+ affinity for exchange current, whereas mutagenesis of Glu(520), which coordinates the secondary Ca2+ pair, has much smaller effects. Furthermore, our structures indicate that Ca2+ binding only enhances the stability of the Ca2+ binding site of CBD1 near the hinge region while the overall structure of CBD1 remains largely unaffected, implying that the Ca2+ regulatory function of CBD1, and possibly that for the entire NCX family, is mediated through domain interactions between CBD1 and the adjacent CBD2 at this hinge.	[Wu, Mousheng; Zheng, Lei] Univ Texas Houston, Ctr Membrane Biol, Dept Biochem & Mol Biol, Med Sch Houston, Houston, TX 77030 USA; [Le, Hoa Dinh; Yurkov, Vladimir; Omelchenko, Alexander; Hnatowich, Mark; Hryshko, Larry V.] Univ Manitoba, Inst Cardiovasc Sci, St Boniface Hosp, Res Ctr, Winnipeg, MB R2H 2A6, Canada; [Wang, Meitian] Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland; [Nix, Jay] Univ Calif Berkeley, Lawrence Berkeley Lab, Mol Biol Consortium, Adv Light Source, Berkeley, CA 94720 USA	University of Texas System; University of Texas Health Science Center Houston; University of Manitoba; Children's Hospital Research Institute of Manitoba; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Zheng, L (corresponding author), 6431 Fannin St, Houston, TX 77030 USA.	lei.zheng@uth.tmc.edu	Wang, Meitian/D-3208-2013	Wang, Meitian/0000-0002-5340-3036; Hryshko, Larry/0000-0003-1079-8549	American Heart Association [0830353N]; Canadian Institutes of Health Research	American Heart Association(American Heart Association); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work supported by grants from the American Heart Association (0830353N to L. Z.) and the Canadian Institutes of Health Research (to L. V. H.).	BERS DM, 1994, METHOD CELL BIOL, V40, P3; BERS DM, 1991, EXCITATION CONTRACTI, P71; Besserer GM, 2007, P NATL ACAD SCI USA, V104, P18467, DOI 10.1073/pnas.0707417104; Blaustein MP, 1996, ANN NY ACAD SCI, V779, P300, DOI 10.1111/j.1749-6632.1996.tb44803.x; DeLano W.L, PYMOL MOL GRAPHICS S; Dyck C, 1998, J BIOL CHEM, V273, P12981, DOI 10.1074/jbc.273.21.12981; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hilge M, 2006, MOL CELL, V22, P15, DOI 10.1016/j.molcel.2006.03.008; Hilge M, 2009, P NATL ACAD SCI USA, V106, P14333, DOI 10.1073/pnas.0902171106; Hryshko LV, 1996, J GEN PHYSIOL, V108, P67, DOI 10.1085/jgp.108.1.67; Johnson E, 2008, J MOL BIOL, V377, P945, DOI 10.1016/j.jmb.2008.01.046; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Linck B, 1998, AM J PHYSIOL-CELL PH, V274, pC415, DOI 10.1152/ajpcell.1998.274.2.C415; MATSUOKA S, 1995, J GEN PHYSIOL, V105, P403, DOI 10.1085/jgp.105.3.403; MATSUOKA S, 1993, P NATL ACAD SCI USA, V90, P3870, DOI 10.1073/pnas.90.9.3870; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nicoll DA, 2002, ANN NY ACAD SCI, V976, P11; Nicoll DA, 2006, J BIOL CHEM, V281, P21577, DOI 10.1074/jbc.C600117200; Omelchenko A, 1998, J GEN PHYSIOL, V111, P691, DOI 10.1085/jgp.111.5.691; Ottolia M, 2004, BIOPHYS J, V87, P899, DOI 10.1529/biophysj.104.043471; Ottolia M, 2009, J BIOL CHEM, V284, P32735, DOI 10.1074/jbc.M109.055434; Schwarz EM, 1997, P NATL ACAD SCI USA, V94, P10249, DOI 10.1073/pnas.94.19.10249; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; TENEYCK LF, 1973, ACTA CRYSTALLOGR A, VA 29, P183, DOI 10.1107/S0567739473000458; Wang T, 2005, NEURON, V45, P367, DOI 10.1016/j.neuron.2004.12.046; Wu MS, 2009, J MOL BIOL, V387, P104, DOI 10.1016/j.jmb.2009.01.045; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	28	27	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2554	2561		10.1074/jbc.M109.059162	http://dx.doi.org/10.1074/jbc.M109.059162			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19815561	hybrid, Green Published			2022-12-27	WOS:000273697800034
J	Buvinic, S; Almarza, G; Bustamante, M; Casas, M; Lopez, J; Riquelme, M; Saez, JC; Huidobro-Toro, JP; Jaimovich, E				Buvinic, Sonja; Almarza, Gonzalo; Bustamante, Mario; Casas, Mariana; Lopez, Javiera; Riquelme, Manuel; Carlos Saez, Juan; Pablo Huidobro-Toro, Juan; Jaimovich, Enrique			ATP Released by Electrical Stimuli Elicits Calcium Transients and Gene Expression in Skeletal Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2 SIZE FORMS; EXTRACELLULAR ATP; NUCLEOTIDE RECEPTOR; CA2+ SIGNALS; ECTO-ATPASE; DIHYDROPYRIDINE RECEPTOR; FUNCTIONAL EXPRESSION; ADENINE-NUCLEOTIDES; P2Y(2) RECEPTORS; CELL-ACTIVATION	ATP released from cells is known to activate plasma membrane P2X (ionotropic) or P2Y (metabotropic) receptors. In skeletal muscle cells, depolarizing stimuli induce both a fast calcium signal associated with contraction and a slow signal that regulates gene expression. Here we show that nucleotides released to the extracellular medium by electrical stimulation are partly involved in the fast component and are largely responsible for the slow signals. In rat skeletal myotubes, a tetanic stimulus (45 Hz, 400 1-ms pulses) rapidly increased extracellular levels of ATP, ADP, and AMP after 15 s to 3 min. Exogenous ATP induced an increase in intracellular free Ca2+ concentration, with an EC50 value of 7.8 +/- 3.1 mu M. Exogenous ADP, UTP, and UDP also promoted calcium transients. Both fast and slow calcium signals evoked by tetanic stimulation were inhibited by either 100 mu M suramin or 2 units/ml apyrase. Apyrase also reduced fast and slow calcium signals evoked by tetanus (45 Hz, 400 0.3-ms pulses) in isolated mouse adult skeletal fibers. A likely candidate for the ATP release pathway is the pannexin-1 hemichannel; its blockers inhibited both calcium transients and ATP release. The dihydropyridine receptor co-precipitated with both the P2Y2 receptor and pannexin-1. As reported previously for electrical stimulation, 500 mu M ATP significantly increased mRNA expression for both c-fos and interleukin 6. Our results suggest that nucleotides released during skeletal muscle activity through pannexin-1 hemichannels act through P2X and P2Y receptors to modulate both Ca2+ homeostasis and muscle physiology.	[Buvinic, Sonja; Almarza, Gonzalo; Bustamante, Mario; Casas, Mariana; Jaimovich, Enrique] Univ Chile, Fac Med, Inst Ciencias Biomed, Ctr Estudios Mol Celula, Santiago 7, Chile; [Lopez, Javiera; Pablo Huidobro-Toro, Juan] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Ctr Regulac Celular & Patol, Santiago 8, Chile; [Riquelme, Manuel; Carlos Saez, Juan] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Ciencias Fisiol, Santiago 8, Chile	Universidad de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile	Jaimovich, E (corresponding author), Univ Chile, Fac Med, Inst Ciencias Biomed, Ctr Estudios Mol Celula, Casilla 70005, Santiago 7, Chile.	ejaimovi@med.uchile.cl	Buvinic, Sonja/I-2658-2013; Jaimovich, Enrique/AAY-7632-2020; Riquelme, Manuel/B-1082-2015	Riquelme, Manuel/0000-0002-1915-0434; Bustamante, Mario/0000-0002-0713-1818	Fondo de Investigacion Avanzada en Areas Prioritarias (Chile) [15010006]; Fondo Nacional de Desarrollo Cientifico y Tecnologico (Chile) [1080120]; FONDAP [13980001]; FONDECYT [3080016]	Fondo de Investigacion Avanzada en Areas Prioritarias (Chile); Fondo Nacional de Desarrollo Cientifico y Tecnologico (Chile)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); FONDAP; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by Grants from the Fondo de Investigacion Avanzada en Areas Prioritarias (Chile) 15010006, and the Fondo Nacional de Desarrollo Cientifico y Tecnologico (Chile) 1080120, FONDAP 13980001, and FONDECYT 3080016.	Abbracchio MP, 2006, PHARMACOL REV, V58, P281, DOI 10.1124/pr.58.3.3; Araya R, 2004, BRAIN RES REV, V47, P174, DOI 10.1016/j.brainresrev.2004.06.003; Araya R, 2005, J CELL SCI, V118, P27, DOI 10.1242/jcs.01553; Araya R, 2003, CELL COMMUN ADHES, V10, P451, DOI 10.1080/15419060390263038; BALOGH S, 1993, DEV BIOL, V155, P351, DOI 10.1006/dbio.1993.1034; Bannister RA, 2009, J GEN PHYSIOL, V133, P79, DOI 10.1085/jgp.200810105; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Belluardo N, 2005, CELL TISSUE RES, V320, P299, DOI 10.1007/s00441-005-1087-7; BENZ R, 1988, FEBS LETT, V231, P75, DOI 10.1016/0014-5793(88)80706-3; Betto R, 1999, J BIOL CHEM, V274, P7907, DOI 10.1074/jbc.274.12.7907; Braunstein Gavin M, 2004, J Cyst Fibros, V3, P99, DOI 10.1016/j.jcf.2004.01.006; Braunstein GM, 2001, J BIOL CHEM, V276, P6621, DOI 10.1074/jbc.M005893200; Burnstock G, 1997, NEUROPHARMACOLOGY, V36, P1127, DOI 10.1016/S0028-3908(97)00125-1; Burnstock G, 2006, PHARMACOL THERAPEUT, V110, P433, DOI 10.1016/j.pharmthera.2005.08.013; Buvinic S, 2002, BRIT J PHARMACOL, V136, P847, DOI 10.1038/sj.bjp.0704789; Buvinic S, 2006, J PHYSIOL-LONDON, V573, P427, DOI 10.1113/jphysiol.2006.105882; Caldwell RA, 1998, AM J PHYSIOL-CELL PH, V275, pC619, DOI 10.1152/ajpcell.1998.275.2.C619; Carrasco MA, 2003, AM J PHYSIOL-CELL PH, V284, pC1438, DOI 10.1152/ajpcell.00117.2002; Choi RCY, 2001, J NEUROSCI, V21, P9224, DOI 10.1523/JNEUROSCI.21-23-09224.2001; Choi RCY, 2003, J NEUROSCI, V23, P4445; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Collet C, 2002, PFLUG ARCH EUR J PHY, V443, P771, DOI 10.1007/s00424-001-0758-9; Communi D, 2001, J BIOL CHEM, V276, P41479, DOI 10.1074/jbc.M105912200; Cseri J, 2002, PFLUG ARCH EUR J PHY, V443, P731, DOI 10.1007/s00424-001-0757-x; CUNHA RA, 1993, PFLUG ARCH EUR J PHY, V424, P503, DOI 10.1007/BF00374914; da Silva RL, 2007, EXP PHYSIOL, V92, P139, DOI 10.1113/expphysiol.2006.035543; De Waard M, 2005, TRENDS PHARMACOL SCI, V26, P427, DOI 10.1016/j.tips.2005.06.008; DEJONGH KS, 1989, P NATL ACAD SCI USA, V86, P8585; DEJONGH KS, 1991, P NATL ACAD SCI USA, V88, P10778, DOI 10.1073/pnas.88.23.10778; Delgado J, 1997, BIOCHEM J, V327, P899, DOI 10.1042/bj3270899; Deli T, 2007, PFLUG ARCH EUR J PHY, V453, P519, DOI 10.1007/s00424-006-0146-6; Deli T, 2006, J MUSCLE RES CELL M, V27, P617, DOI 10.1007/s10974-006-9096-z; Eltit JM, 2006, J BIOL CHEM, V281, P12143, DOI 10.1074/jbc.M511218200; Eltit JM, 2004, BIOPHYS J, V86, P3042, DOI 10.1016/S0006-3495(04)74353-2; Eltzschig HK, 2006, CIRC RES, V99, P1100, DOI 10.1161/01.RES.0000250174.31269.70; EVANS RJ, 1992, NATURE, V357, P503, DOI 10.1038/357503a0; FILTZ TM, 1994, MOL PHARMACOL, V46, P8; Grabner M, 1999, J BIOL CHEM, V274, P21913, DOI 10.1074/jbc.274.31.21913; GRIERSON JP, 1995, J BIOL CHEM, V270, P4451, DOI 10.1074/jbc.270.9.4451; Grygorczyk R, 1997, AM J PHYSIOL-CELL PH, V272, pC1058; Hayato R, 2007, J PHYSIOL-LONDON, V584, P473, DOI 10.1113/jphysiol.2007.138370; Hazama A, 2000, J PHYSIOL-LONDON, V523, P1, DOI 10.1111/j.1469-7793.2000.t01-6-00001.x; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P6436, DOI 10.1073/pnas.0611280104; Iacobas DA, 2007, J MEMBRANE BIOL, V217, P83, DOI 10.1007/s00232-007-9039-7; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Jaimovich E, 2002, BIOL RES, V35, P195, DOI 10.4067/S0716-97602002000200010; Jaimovich E, 2000, AM J PHYSIOL-CELL PH, V278, pC998, DOI 10.1152/ajpcell.2000.278.5.C998; Juretic N, 2006, AM J PHYSIOL-CELL PH, V290, pC1428, DOI 10.1152/ajpcell.00449.2005; Juretic N, 2007, J CELL PHYSIOL, V210, P819, DOI 10.1002/jcp.20902; Kirley TL, 1997, J BIOL CHEM, V272, P1076, DOI 10.1074/jbc.272.2.1076; LAI Y, 1990, J BIOL CHEM, V265, P20839; Lamb GD, 2002, FRONT BIOSCI-LANDMRK, V7, pD834, DOI 10.2741/lamb; Lazarowski ER, 2004, J BIOL CHEM, V279, P36855, DOI 10.1074/jbc.M405367200; Lazarowski ER, 2003, MOL PHARMACOL, V64, P785, DOI 10.1124/mol.64.4.785; Lazarowski ER, 1997, J BIOL CHEM, V272, P24348, DOI 10.1074/jbc.272.39.24348; Leybaert L, 2003, CELL COMMUN ADHES, V10, P251, DOI 10.1080/15419060390262985; Li JH, 2005, CIRCULATION, V111, P2748, DOI 10.1161/CIRCULATIONAHA.104.510669; Li JH, 2003, J APPL PHYSIOL, V95, P577, DOI 10.1152/japplphysiol.00185.2003; Martinez-Pinna J, 2005, J BIOL CHEM, V280, P1490, DOI 10.1074/jbc.M407783200; Martinez-Pinna J, 2004, J PHYSIOL-LONDON, V555, P61, DOI 10.1113/jphysiol.2003.056846; May C, 2006, BIOCHEM PHARMACOL, V71, P1497, DOI 10.1016/j.bcp.2006.02.003; Megias A, 2001, BIOCHEM J, V353, P521, DOI 10.1042/0264-6021:3530521; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; PARR CE, 1994, P NATL ACAD SCI USA, V91, P3275, DOI 10.1073/pnas.91.8.3275; Protasi F, 2002, BIOPHYS J, V83, P3230, DOI 10.1016/S0006-3495(02)75325-3; Reigada D, 2008, NEUROSCIENCE, V157, P396, DOI 10.1016/j.neuroscience.2008.08.036; Rodrigues RJ, 2005, J NEUROSCI, V25, P6286, DOI 10.1523/JNEUROSCI.0628-05.2005; Roman RM, 1999, AM J PHYSIOL-GASTR L, V277, pG1222, DOI 10.1152/ajpgi.1999.277.6.G1222; Ryten M, 2002, J CELL BIOL, V158, P345, DOI 10.1083/jcb.200202025; Ryten M, 2001, DEV DYNAM, V221, P331, DOI 10.1002/dvdy.1147; SACKIN H, 1995, KIDNEY INT, V48, P1134, DOI 10.1038/ki.1995.397; Sandona D, 2005, FASEB J, V19, P1184, DOI 10.1096/fj.04-3333fje; Schenk U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160583; Schwiebert EM, 2003, BBA-BIOMEMBRANES, V1615, P7, DOI 10.1016/S0005-2736(03)00210-4; Scrivens M, 2006, EUR J PHARMACOL, V543, P166, DOI 10.1016/j.ejphar.2006.05.037; Semsarian C, 1999, NATURE, V400, P576, DOI 10.1038/23054; Shestopalov VI, 2008, CELL MOL LIFE SCI, V65, P376, DOI 10.1007/s00018-007-7200-1; SILINSKY EM, 1975, J PHYSIOL-LONDON, V247, P145, DOI 10.1113/jphysiol.1975.sp010925; Sorensen CE, 2001, J BIOL CHEM, V276, P32925, DOI 10.1074/jbc.M103313200; Stanfield P, 2006, NAT CELL BIOL, V8, P1323, DOI 10.1038/ncb1206-1323; Sugita M, 1998, EMBO J, V17, P898, DOI 10.1093/emboj/17.4.898; Szigeti GP, 2007, PFLUG ARCH EUR J PHY, V453, P509, DOI 10.1007/s00424-006-0145-7; TANABE T, 1990, NATURE, V346, P567, DOI 10.1038/346567a0; Taylor AL, 1998, AM J PHYSIOL-CELL PH, V275, pC1391, DOI 10.1152/ajpcell.1998.275.5.C1391; Todorov LD, 1996, J PHYSIOL-LONDON, V496, P731, DOI 10.1113/jphysiol.1996.sp021723; Tsim KWK, 2002, NEUROSIGNALS, V11, P58, DOI 10.1159/000057322; Urano T, 1997, CANCER RES, V57, P3281; Valdes JA, 2007, AM J PHYSIOL-CELL PH, V292, pC1960, DOI 10.1152/ajpcell.00320.2006; Vizi ES, 2000, J AUTONOM NERV SYST, V81, P278, DOI 10.1016/S0165-1838(00)00129-6; von Maltzahn J, 2006, CELL COMMUN ADHES, V13, P55, DOI 10.1080/15419060600631508; VONKUGELGEN I, 1985, J PHYSIOL-LONDON, V367, P435, DOI 10.1113/jphysiol.1985.sp015834; Watt WC, 1998, J BIOL CHEM, V273, P14053, DOI 10.1074/jbc.273.22.14053; Wells DG, 1995, DEV BIOL, V172, P585, DOI 10.1006/dbio.1995.8062; Yegutkin G, 2000, BRIT J PHARMACOL, V129, P921, DOI 10.1038/sj.bjp.0703136; Yeung D, 2006, FASEB J, V20, P610, DOI 10.1096/fj.05-4022com; Zimmermann H, 1999, TRENDS PHARMACOL SCI, V20, P231, DOI 10.1016/S0165-6147(99)01293-6	97	116	120	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34490	34505		10.1074/jbc.M109.057315	http://dx.doi.org/10.1074/jbc.M109.057315			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19822518	Green Published, hybrid			2022-12-27	WOS:000272439600003
J	Jacobson, EM; Yang, HY; Menconi, F; Wang, R; Osman, R; Skrabanek, L; Li, CW; Fadlalla, M; Gandhi, A; Chaturvedi, V; Smith, EP; Schwemberger, S; Osterburg, A; Babcock, GF; Tomer, Y				Jacobson, Eric M.; Yang, Heyi; Menconi, Francesca; Wang, Rong; Osman, Roman; Skrabanek, Luce; Li, Cheuk Wun; Fadlalla, Mohammed; Gandhi, Alisha; Chaturvedi, Vijaya; Smith, Eric P.; Schwemberger, Sandy; Osterburg, Andrew; Babcock, George F.; Tomer, Yaron			Employing a Recombinant HLA-DR3 Expression System to Dissect Major Histocompatibility Complex II-Thyroglobulin Peptide Dynamism A GENETIC, BIOCHEMICAL, AND REVERSE IMMUNOLOGICAL PERSPECTIVE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-II; B-CELL LINE; GRAVES-DISEASE; HLA-DR; CATHEPSIN-B; AUTOIMMUNE-THYROIDITIS; ANTIGEN PRESENTATION; ESCHERICHIA-COLI; BINDING EPITOPES; INVARIANT CHAIN	Previously, we have shown that statistical synergism between amino acid variants in thyroglobulin (Tg) and specific HLA-DR3 pocket sequence signatures conferred a high risk for autoimmune thyroid disease (AITD). Therefore, we hypothesized that this statistical synergism mirrors a biochemical interaction between Tg peptides and HLA-DR3, which is key to the pathoetiology of AITD. To test this hypothesis, we designed a recombinant HLA-DR3 expression system that was used to express HLA-DR molecules harboring either AITD susceptibility or resistance DR pocket sequences. Next, we biochemically generated the potential Tg peptidic repertoire available to HLA-DR3 by separately treating 20 purified human thyroglobulin samples with cathepsins B, D, or L, lysosomal proteases that are involved in antigen processing and thyroid biology. Sequences of the cathepsin-generated peptides were then determined by matrix-assisted laser desorption ionization time-of-flight-mass spectroscopy, and algorithmic means were employed to identify putative AITD-susceptible HLA-DR3 binders. From four predicted peptides, we identified two novel peptides that bound strongly and specifically to both recombinant AITD-susceptible HLA-DR3 protein and HLA-DR3 molecules expressed on stably transfected cells. Intriguingly, the HLA-DR3-binding peptides we identified had a marked preference for the AITD-susceptibility DR signatures and not to those signatures that were AITD-protective. Structural analyses demonstrated the profound influence that the pocket signatures have on the interaction of HLA-DR molecules with Tg peptides. Our study suggests that interactions between Tg and discrete HLA-DR pocket signatures contribute to the initiation of AITD.	[Li, Cheuk Wun; Fadlalla, Mohammed; Gandhi, Alisha; Chaturvedi, Vijaya; Smith, Eric P.; Tomer, Yaron] Univ Cincinnati, Coll Med, Div Endocrinol, Cincinnati, OH 45220 USA; [Tomer, Yaron] Univ Cincinnati, Coll Med, Cincinnati Vet Affairs Med Ctr, Cincinnati, OH 45220 USA; [Yang, Heyi; Wang, Rong] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Osman, Roman] Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA; [Skrabanek, Luce] Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA; [Skrabanek, Luce] Cornell Univ, Weill Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY 10021 USA; [Schwemberger, Sandy; Osterburg, Andrew; Babcock, George F.] Shriners Hosp Children, Cincinnati, OH 45229 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Cornell University; Cornell University	Jacobson, EM (corresponding author), Univ Cincinnati, Vontz Ctr Mol Studies, Div Endocrinol, 3125 Eden Ave, Cincinnati, OH 45267 USA.	Eric.Jacobson@uc.edu	Tomer, Yaron/GWU-8933-2022; Wang, Rong/A-8721-2009		NIDDK [DK61659, DK067555, DK073681]; American Thyroid Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061659, R01DK067555, R01DK073681, T35DK060444] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Thyroid Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK61659, DK067555, and DK073681 from NIDDK (to Y.T.). This work was also supported by a grant from the American Thyroid Association (to E.M.J.).	Ban Y, 2004, GENES IMMUN, V5, P203, DOI 10.1038/sj.gene.6364059; Ban Y, 2003, P NATL ACAD SCI USA, V100, P15119, DOI 10.1073/pnas.2434175100; BOTTAZZO GF, 1983, LANCET, V2, P1115; Brand OJ, 2009, HUM MOL GENET, V18, P1704, DOI 10.1093/hmg/ddp087; Chapman HA, 2006, CURR OPIN IMMUNOL, V18, P78, DOI 10.1016/j.coi.2005.11.011; CHIEZ RM, 1993, J EXP MED, V178, P27; CHIEZ RM, 1992, NATURE, V358, P764; DENG TL, 1993, GENE DEV, V7, P479, DOI 10.1101/gad.7.3.479; Doebele RC, 2003, J IMMUNOL, V170, P4683, DOI 10.4049/jimmunol.170.9.4683; DUNN AD, 1991, J BIOL CHEM, V266, P20198; DUNN AD, 1984, ENDOCRINOLOGY, V114, P375, DOI 10.1210/endo-114-2-375; Engelhard VH, 2006, CURR OPIN IMMUNOL, V18, P92, DOI 10.1016/j.coi.2005.11.015; Flynn JC, 2004, CELL IMMUNOL, V229, P79, DOI 10.1016/j.cellimm.2004.07.002; Frayser M, 1999, PROTEIN EXPRES PURIF, V15, P105, DOI 10.1006/prep.1998.0987; Friedrichs B, 2003, J CLIN INVEST, V111, P1733, DOI 10.1172/JCI200315990; FU XT, 1994, HUM IMMUNOL, V39, P253, DOI 10.1016/0198-8859(94)90268-2; Gauthier L, 1998, P NATL ACAD SCI USA, V95, P11828, DOI 10.1073/pnas.95.20.11828; Gebe JA, 2002, TISSUE ANTIGENS, V59, P78, DOI 10.1034/j.1399-0039.2002.590202.x; Gohlke H, 2004, J COMPUT CHEM, V25, P238, DOI 10.1022/jcc.10379; GORGA JC, 1987, J BIOL CHEM, V262, P16087; HAMMER J, 1995, J EXP MED, V181, P1847, DOI 10.1084/jem.181.5.1847; HANAFUSA T, 1983, LANCET, V2, P1111; HITZEL C, 1995, J IMMUNOL, V154, P1048; Hodge SE, 2006, THYROID, V16, P351, DOI 10.1089/thy.2006.16.351; HUNT DF, 1992, SCIENCE, V256, P1817, DOI 10.1126/science.1319610; Jacobson EM, 2008, J AUTOIMMUN, V30, P58, DOI 10.1016/j.jaut.2007.11.010; Jacobson EM, 2007, THYROID, V17, P949, DOI 10.1089/thy.2007.0153; Jardetzky TS, 1996, P NATL ACAD SCI USA, V93, P734, DOI 10.1073/pnas.93.2.734; Karras E, 2005, J AUTOIMMUN, V24, P291, DOI 10.1016/j.jaut.2005.02.002; LAH TT, 1995, FEBS LETT, V363, P85; LOMBARDI G, 1991, INT IMMUNOL, V3, P769, DOI 10.1093/intimm/3.8.769; Maehr R, 2005, J CLIN INVEST, V115, P2934, DOI 10.1172/JCI25485; Menconi F, 2008, P NATL ACAD SCI USA, V105, P14034, DOI 10.1073/pnas.0806584105; Muixi L, 2008, J IMMUNOL, V181, P795, DOI 10.4049/jimmunol.181.1.795; POSCH PE, 1995, HUM IMMUNOL, V42, P61, DOI 10.1016/0198-8859(94)00074-Z; Raju R, 2001, J IMMUNOL, V167, P1118, DOI 10.4049/jimmunol.167.2.1118; RODRIGUEZ GM, 1992, J IMMUNOL, V149, P2894; Sant AJ, 2005, IMMUNOL REV, V207, P261, DOI 10.1111/j.0105-2896.2005.00307.x; SHACKELFORD DA, 1983, J IMMUNOL, V130, P289; Shuja S, 1999, THYROID, V9, P569, DOI 10.1089/thy.1999.9.569; Shulman S, 1971, Adv Immunol, V14, P85, DOI 10.1016/S0065-2776(08)60284-9; STOCKEL J, 1994, J BIOL CHEM, V269, P29571; TODD JA, 1988, SCIENCE, V240, P1003, DOI 10.1126/science.3368786; Tomer Y, 2001, J CLIN ENDOCR METAB, V86, P1687, DOI 10.1210/jc.86.4.1687; Wucherpfennig KW, 2003, ANN NY ACAD SCI, V1005, P119, DOI 10.1196/annals.1288.013; Wucherpfennig KW, 2001, CURR OPIN IMMUNOL, V13, P650, DOI 10.1016/S0952-7915(01)00274-6; WUCHERPFENNIG KW, 1995, P NATL ACAD SCI USA, V92, P11935, DOI 10.1073/pnas.92.25.11935	47	21	21	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34231	34243		10.1074/jbc.M109.041574	http://dx.doi.org/10.1074/jbc.M109.041574			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19776016	Green Published, hybrid			2022-12-27	WOS:000272165200055
J	Imgrund, S; Hartmann, D; Farwanah, H; Eckhardt, M; Sandhoff, R; Degen, J; Gieselmann, V; Sandhoff, K; Willecke, K				Imgrund, Silke; Hartmann, Dieter; Farwanah, Hany; Eckhardt, Matthias; Sandhoff, Roger; Degen, Joachim; Gieselmann, Volkmar; Sandhoff, Konrad; Willecke, Klaus			Adult Ceramide Synthase 2 (CERS2)-deficient Mice Exhibit Myelin Sheath Defects, Cerebellar Degeneration, and Hepatocarcinomas	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILY-MEMBERS; SPHINGOLIPIDS; SPHINGOSINE; BIOSYNTHESIS; SPHINGANINE; DIHYDROCERAMIDE; METABOLISM; REDUCTASE; PATHWAYS; BRAIN	(Dihydro) ceramide synthase 2 (cers2, formerly called lass2) is the most abundantly expressed member of the ceramide synthase gene family, which includes six isoforms in mice. CERS2 activity has been reported to be specific toward very long fatty acid residues (C22-C24). In order to study the biological role of CERS2, we have inactivated its coding region in transgenic mice using gene-trapped embryonic stem cells that express lacZ reporter DNA under control of the cers2 promoter. The resulting mice lack ceramide synthase activity toward C24:1 in the brain as well as the liver and show only very low activity toward C18:0-C22:0 in liver and reduced activity toward C22: 0 residues in the brain. In addition, these mice exhibit strongly reduced levels of ceramide species with very long fatty acid residues (>= C22) in the liver, kidney, and brain. From early adulthood on, myelin stainability is progressively lost, biochemically accompanied by about 50% loss of compacted myelin and 80% loss of myelin basic protein. Starting around 9 months, both the medullary tree and the internal granular layer of the cerebellum show significant signs of degeneration associated with the formation of microcysts. Predominantly in the peripheral nervous system, we observed vesiculation and multifocal detachment of the inner myelin lamellae in about 20% of the axons. Beyond 7 months, the CERS2-deficient mice developed hepatocarcinomas with local destruction of tissue architecture and discrete gaps in renal parenchyma. Our results indicate that CERS2 activity supports different biological functions: maintenance of myelin, stabilization of the cerebellar as well as renal histological architecture, and protection against hepatocarcinomas.	[Imgrund, Silke; Degen, Joachim; Willecke, Klaus] Univ Bonn, Div Mol Genet, Inst Genet, D-53117 Bonn, Germany; [Hartmann, Dieter] Univ Bonn, Div Neuroanat, Inst Anat, D-53117 Bonn, Germany; [Farwanah, Hany; Sandhoff, Konrad] Univ Bonn, Inst Mol Biomed, LIMES Inst, D-53117 Bonn, Germany; [Eckhardt, Matthias; Gieselmann, Volkmar] Univ Bonn, Inst Biochem & Mol Biol, D-53117 Bonn, Germany; [Sandhoff, Roger] German Canc Res Ctr, D-69120 Heidelberg, Germany	University of Bonn; University of Bonn; University of Bonn; University of Bonn; Helmholtz Association; German Cancer Research Center (DKFZ)	Willecke, K (corresponding author), Univ Bonn, Div Mol Genet, Inst Genet, Romerstr 164, D-53117 Bonn, Germany.	k.willecke@uni-bonn.de			German Research Association [SFB 645]	German Research Association(German Research Foundation (DFG))	This work was supported by several grants from the Bonn Collaborative Research Center (SFB 645) "Regulation and Manipulation of Information Flow within Dynamic Protein and Lipid Environments" sponsored by the German Research Association (to K. W. (B2), K. S. (B3), and M. E. and V. G. (B5)).	Becker I, 2008, HISTOCHEM CELL BIOL, V129, P233, DOI 10.1007/s00418-007-0344-0; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRAUN PE, 1968, J BIOL CHEM, V243, P3775; Guillas I, 2001, EMBO J, V20, P2655, DOI 10.1093/emboj/20.11.2655; HIRSCHBERG K, 1993, BIOCHEM J, V290, P751, DOI 10.1042/bj2900751; Jennemann R, 2007, J BIOL CHEM, V282, P3083, DOI 10.1074/jbc.M610304200; Kihara A, 2007, PROG LIPID RES, V46, P126, DOI 10.1016/j.plipres.2007.03.001; Kolesnick RN, 2000, J CELL PHYSIOL, V184, P285; Kolter T, 1999, ANGEW CHEM INT EDIT, V38, P1532, DOI 10.1002/(SICI)1521-3773(19990601)38:11<1532::AID-ANIE1532>3.0.CO;2-U; Lahiri S, 2007, FEBS LETT, V581, P5289, DOI 10.1016/j.febslet.2007.10.018; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; MANDON EC, 1992, J BIOL CHEM, V267, P11144; Merrill AH, 2002, J BIOL CHEM, V277, P25843, DOI 10.1074/jbc.R200009200; Min Y, 2009, P NATL ACAD SCI USA, V106, P3154, DOI 10.1073/pnas.0813110106; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Mizutani Y, 2006, BIOCHEM J, V398, P531, DOI 10.1042/BJ20060379; NAGY A, 2003, MANIPULATING MOUSE E, P476; NORTON WT, 1973, J NEUROCHEM, V21, P759, DOI 10.1111/j.1471-4159.1973.tb07520.x; Ohanian J, 2001, CELL MOL LIFE SCI, V58, P2053, DOI 10.1007/PL00000836; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; PEWZNERJUNG Y, 2009, CHARL CER C CHARL SC; Rabionet M, 2008, J BIOL CHEM, V283, P13357, DOI 10.1074/jbc.M800870200; Riebeling C, 2003, J BIOL CHEM, V278, P43452, DOI 10.1074/jbc.M307104200; ROTHER J, 1992, BIOCHEM BIOPH RES CO, V189, P14, DOI 10.1016/0006-291X(92)91518-U; Sambrook J., 2001, MOL CLONING LAB MANU, V3rd ed.; Sandhoff R, 2002, J BIOL CHEM, V277, P20386, DOI 10.1074/jbc.M110641200; Schorling S, 2001, MOL BIOL CELL, V12, P3417, DOI 10.1091/mbc.12.11.3417; SRIBNEY M, 1966, BIOCHIM BIOPHYS ACTA, V125, P542, DOI 10.1016/0005-2760(66)90042-7; STOFFEL W, 1968, H-S Z PHYSIOL CHEM, V349, P1637, DOI 10.1515/bchm2.1968.349.2.1637; Tettamanti G, 2003, BIOCHIMIE, V85, P423, DOI 10.1016/S0300-9084(03)00047-6; Vallee B, 2005, EMBO J, V24, P730, DOI 10.1038/sj.emboj.7600562; Venkataraman K, 2002, J BIOL CHEM, V277, P35642, DOI 10.1074/jbc.M205211200; Wang BH, 2007, DNA SEQUENCE, V18, P92, DOI 10.1080/10425170601060947; Yaghootfam A, 2005, EUR J NEUROSCI, V21, P711, DOI 10.1111/j.1460-9568.2005.03891.x	34	199	206	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33549	33560		10.1074/jbc.M109.031971	http://dx.doi.org/10.1074/jbc.M109.031971			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801672	Green Published, hybrid			2022-12-27	WOS:000272028500060
J	Yu, MJ; Moreno, JL; Stains, JP; Keegan, AD				Yu, Minjun; Moreno, Jose L.; Stains, Joseph P.; Keegan, Achsah D.			Complex Regulation of Tartrate-resistant Acid Phosphatase (TRAP) Expression by Interleukin 4 (IL-4) IL-4 INDIRECTLY SUPPRESSES RECEPTOR ACTIVATOR OF NF-kappa B LIGAND (RANKL)-MEDIATED TRAP EXPRESSION BUT MODESTLY INDUCES ITS EXPRESSION DIRECTLY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROPHTHALMIA TRANSCRIPTION FACTOR; RANKL-INDUCED TRANSCRIPTION; MULTINUCLEATED GIANT-CELLS; OSTEOCLAST DIFFERENTIATION; BONE-RESORPTION; GENE-EXPRESSION; DENDRITIC CELLS; ACP 5; MICE; MACROPHAGES	Interleukin 4 (IL-4) inhibits receptor activator of NF-kappa B ligand (RANKL)-induced osteoclast formation and functional activity in a STAT6-dependent manner. IL-4 down-regulates expression of tartrate-resistant acid phosphatase (TRAP) in mature osteoclasts. To determine whether IL-4 regulates TRAP promoter activity, RAW264.7 cells were transfected with a TRAP promoter-luciferase reporter. Treatment with IL-4 alone modestly enhanced TRAP luciferase activity. However, IL-4 suppressed the ability of RANKL to up-regulate TRAP-luciferase activity, suggesting that IL-4 has multiple effects on TRAP transcription. IL-4 also reduced the RANKL-induced association of RNA polymerase II with the TRAP gene in osteoclasts. The TRAP promoter contains a STAT6-binding motif, and STAT6 bound to the endogenous TRAP promoter after IL-4 treatment. To determine the impact of STAT6 binding, we transfected cells with STAT6VT, a constitutively active STAT6 mutant. STAT6VT alone up-regulated TRAP-luciferase activity; this effect was abrogated by mutating the STAT6 binding site in the minimal TRAP promoter. STAT6VT did not inhibit the potent up-regulation of TRAP promoter activity caused by overexpression of NFATc1, PU.1, and microphthalmia transcription factor, downstream targets of macrophage colony-stimulating factor and RANKL. IL-4 down-regulated the expression of c-Fos and NFATc1 in mature osteoclasts. Knockdown of NFATc1 by short interfering RNA caused TRAP expression to be down-regulated, and ectopic expression of NFATc1 abrogated the IL-4-induced down-regulation of TRAP. These results suggest that STAT6 plays two distinct roles in TRAP expression. The IL-4-induced activation of STAT6 mediates suppression of the RANKL-induced TRAP promoter activity indirectly by inhibiting NFATc1 expression. However, in the absence of RANKL and osteoclast differentiation, STAT6 binds the TRAP promoter after IL-4 treatment and directly enhances TRAP expression.	[Yu, Minjun; Keegan, Achsah D.] Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Yu, Minjun; Keegan, Achsah D.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Moreno, Jose L.; Stains, Joseph P.] Univ Maryland, Sch Med, Dept Orthopaed, Baltimore, MD 21201 USA; [Keegan, Achsah D.] Univ Maryland, Sch Med, Program Oncol, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Keegan, AD (corresponding author), Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, 800 W Baltimore St, Baltimore, MD 21201 USA.	akeegan@som.umaryland.edu	yu, minjun/A-1617-2014; Yu, Minjun/B-6152-2015	yu, minjun/0000-0002-1154-5255; Yu, Minjun/0000-0001-8285-068X	National Institutes of Health [AI059775, AI038985]; USPHS; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI038985, R01AI038985, R01AI059775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052719] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI059775 and AI038985 from USPHS (to A.D.K.).	Abu-Amer Y, 2001, J CLIN INVEST, V107, P1375, DOI 10.1172/JCI10530; Akagawa KS, 1996, BLOOD, V88, P4029, DOI 10.1182/blood.V88.10.4029.bloodjournal88104029; ALCANTARA O, 1994, BIOCHEM J, V298, P421, DOI 10.1042/bj2980421; Angel NZ, 2000, J BONE MINER RES, V15, P103, DOI 10.1359/jbmr.2000.15.1.103; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Bendixen AC, 2001, P NATL ACAD SCI USA, V98, P2443, DOI 10.1073/pnas.041493198; Bennett BL, 1997, J BIOL CHEM, V272, P10212; BIZZARRI C, 1994, J BIOL CHEM, V269, P13817; Bune AJ, 2001, IMMUNOLOGY, V102, P103, DOI 10.1046/j.1365-2567.2001.01145.x; Cassady AI, 2003, J BONE MINER RES, V18, P1901, DOI 10.1359/jbmr.2003.18.10.1901; Chuvpilo S, 2002, IMMUNITY, V16, P881, DOI 10.1016/S1074-7613(02)00329-1; Daniel C, 2000, J BIOL CHEM, V275, P14255, DOI 10.1074/jbc.C000129200; Esfandiari E, 2006, J BONE MINER RES, V21, P1367, DOI 10.1359/JBMR.060611; Halleen JM, 1999, J BIOL CHEM, V274, P22907, DOI 10.1074/jbc.274.33.22907; Halleen JM, 2000, J BONE MINER RES, V15, P1337, DOI 10.1359/jbmr.2000.15.7.1337; Harris MB, 1999, MOL CELL BIOL, V19, P7264; Hayman AR, 2008, AUTOIMMUNITY, V41, P218, DOI 10.1080/08916930701694667; Hayman AR, 2003, J BONE MINER RES, V18, P1905, DOI 10.1359/jbmr.2003.18.10.1905; Hayman AR, 2001, J HISTOCHEM CYTOCHEM, V49, P675, DOI 10.1177/002215540104900601; Hayman AR, 1996, DEVELOPMENT, V122, P3151; Hirayama T, 2005, ARTHRITIS RHEUM-US, V52, P2719, DOI 10.1002/art.21286; Ikeda F, 2004, J CLIN INVEST, V114, P475, DOI 10.1172/JCI200419657; Janckila AJ, 2005, J LEUKOCYTE BIOL, V77, P209, DOI 10.1189/jlb.0504287; Janckila AJ, 2007, AM J CLIN PATHOL, V127, P556, DOI 10.1309/DGEA9BE2VE5VCFYH; Kaplan MH, 2007, BLOOD, V110, P4367, DOI 10.1182/blood-2007-06-098244; KASONO K, 1993, BONE MINER, V21, P179, DOI 10.1016/S0169-6009(08)80229-2; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; LACEY DL, 1994, J CELL BIOCHEM, V54, P365, DOI 10.1002/jcb.240540312; LEWIS DB, 1993, P NATL ACAD SCI USA, V90, P11618, DOI 10.1073/pnas.90.24.11618; Liu Y, 2003, J BIOL CHEM, V278, P20603, DOI 10.1074/jbc.M212093200; Luchin A, 2001, J BIOL CHEM, V276, P36703, DOI 10.1074/jbc.M106418200; Luchin A, 2000, J BONE MINER RES, V15, P451, DOI 10.1359/jbmr.2000.15.3.451; Mangashetti LS, 2005, J IMMUNOL, V175, P917, DOI 10.4049/jimmunol.175.2.917; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Matsumoto M, 2001, J BIOL CHEM, V276, P33086, DOI 10.1074/jbc.M104299200; Mohamed SGK, 2005, BIOCHEM BIOPH RES CO, V329, P839, DOI 10.1016/j.bbrc.2005.02.049; Moreno JL, 2003, BLOOD, V102, P1078, DOI 10.1182/blood-2002-11-3437; Moreno JL, 2007, J LEUKOCYTE BIOL, V82, P1542, DOI 10.1189/jlb.0107058; NAKANO Y, 1994, J BONE MINER RES, V9, P1533, DOI 10.1002/jbmr.5650091005; Okada Y, 1998, BONE, V22, P361, DOI 10.1016/S8756-3282(97)00296-2; Partington GA, 2004, BONE, V34, P237, DOI 10.1016/j.bone.2003.11.010; REDDY SV, 1993, J BONE MINER RES, V8, P1263; RIANCHO JA, 1993, BONE MINER, V21, P53, DOI 10.1016/S0169-6009(08)80120-1; RIANCHO JA, 1993, BIOCHEM BIOPH RES CO, V196, P678, DOI 10.1006/bbrc.1993.2303; RIANCHO JA, 1993, J BONE MINER RES, V8, P1337; ROODMAN GD, 1993, CALCIFIED TISSUE INT, V53, pS94, DOI 10.1007/BF01673412; Sandoval J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh091; Sato K, 2006, NAT MED, V12, P1410, DOI 10.1038/nm1515; Schroder AJ, 2002, J IMMUNOL, V168, P996, DOI 10.4049/jimmunol.168.3.996; Sharma SM, 2007, J BIOL CHEM, V282, P15921, DOI 10.1074/jbc.M609723200; Shi ZQ, 2004, GENE, V343, P117, DOI 10.1016/j.gene.2004.08.009; SHIOI A, 1991, J CELL BIOCHEM, V47, P272, DOI 10.1002/jcb.240470313; Suzuki K, 2003, J EXP MED, V198, P1717, DOI 10.1084/jem.20031701; Walsh NC, 2003, GENE, V307, P111, DOI 10.1016/S0378-1119(03)00449-9; Wang HY, 1998, J BIOL CHEM, V273, P9898, DOI 10.1074/jbc.273.16.9898; Wei S, 2002, J BIOL CHEM, V277, P6622, DOI 10.1074/jbc.M104957200	56	22	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32968	32979		10.1074/jbc.M109.001016	http://dx.doi.org/10.1074/jbc.M109.001016			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19801646	Green Published, hybrid			2022-12-27	WOS:000272028400080
J	Lee, JRE; Oestreich, AJ; Payne, JA; Gunawan, MS; Norgan, AP; Katzmann, DJ				Lee, Jacqueline R. E.; Oestreich, Andrea J.; Payne, Johanna A.; Gunawan, Mia S.; Norgan, Andrew P.; Katzmann, David J.			The HECT Domain of the Ubiquitin Ligase Rsp5 Contributes to Substrate Recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIVESICULAR BODY PATHWAY; WW-DOMAINS; SACCHAROMYCES-CEREVISIAE; MEMBRANE-PROTEINS; SORTING COMPLEX; DIRECT BINDING; NEDD4 FAMILY; YEAST; BODIES; DETERMINANTS	Ubiquitin modification of endosomal membrane proteins is a signal for active inclusion into the Multivesicular Body (MVB) pathway, resulting in lysosomal degradation. However, the endosome represents a dynamic site of protein sorting with a majority of proteins destined for recycling, rather than MVB targeting. Substrate recognition by ubiquitin ligases is therefore highly regulated. We have investigated substrate recognition by the Nedd4 ortholog Rsp5 as a model for understanding ligase-substrate interactions. Rsp5 interacts directly with its substrate Cps1 via a novel interaction mode. Perturbation of this mode of interaction revealed a compensatory role for the Rsp5 adaptor Bsd2. These results highlight the ability of Rsp5 to interact with substrates via multiple modalities, suggesting additional mechanisms of regulating this interaction and relevant outcomes.	[Lee, Jacqueline R. E.; Oestreich, Andrea J.; Payne, Johanna A.; Gunawan, Mia S.; Norgan, Andrew P.; Katzmann, David J.] Mayo Clin, Dept Biochem & Mol Biol, Coll Med, Rochester, MN 55905 USA	Mayo Clinic	Katzmann, DJ (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, Coll Med, 200 1st St SW, Rochester, MN 55905 USA.	Katzmann.David@mayo.edu		Eve, Jacqueline/0000-0002-3159-5620	National Institutes of Health [R01 GM73024]; American Heart Association [AHA0430369Z]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073024] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by Grant R01 GM73024 from the National Institutes of Health. This work was also supported by the American Heart Association Grant AHA0430369Z (to D.J.K.).	Berezin C, 2004, BIOINFORMATICS, V20, P1322, DOI 10.1093/bioinformatics/bth070; Blondel MO, 2004, MOL BIOL CELL, V15, P883, DOI 10.1091/mbc.E03-04-0202; Bruce MC, 2008, BIOCHEM J, V415, P155, DOI 10.1042/BJ20071708; Burd CG, 1997, MOL BIOL CELL, V8, P1089, DOI 10.1091/mbc.8.6.1089; Chang A, 2000, J BIOL CHEM, V275, P20562, DOI 10.1074/jbc.M002479200; Dunn R, 2004, J CELL BIOL, V165, P135, DOI 10.1083/jcb.200309026; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; Harty RN, 2000, P NATL ACAD SCI USA, V97, P13871, DOI 10.1073/pnas.250277297; Harty RN, 2001, J VIROL, V75, P10623, DOI 10.1128/JVI.75.22.10623-10629.2001; HEIN C, 1995, MOL MICROBIOL, V18, P77, DOI 10.1111/j.1365-2958.1995.mmi_18010077.x; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hettema EH, 2004, EMBO J, V23, P1279, DOI 10.1038/sj.emboj.7600137; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Hoeller D, 2006, NAT REV CANCER, V6, P776, DOI 10.1038/nrc1994; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Huang TT, 2006, NAT REV MOL CELL BIO, V7, P323, DOI 10.1038/nrm1908; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Kasanov J, 2001, CHEM BIOL, V8, P231, DOI 10.1016/S1074-5521(01)00005-9; Kato Y, 2002, J BIOL CHEM, V277, P10173, DOI 10.1074/jbc.M110490200; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Katzmann DJ, 2004, MOL BIOL CELL, V15, P468, DOI 10.1091/mbc.E03-07-0473; Leon S, 2008, MOL BIOL CELL, V19, P2379, DOI 10.1091/mbc.E08-01-0068; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; McNatt MW, 2007, MOL BIOL CELL, V18, P697, DOI 10.1091/mbc.E06-08-0663; Mizuno E, 2006, TRAFFIC, V7, P1017, DOI 10.1111/j.1600-0854.2006.00452.x; Morvan J, 2004, TRAFFIC, V5, P383, DOI 10.1111/j.1398-9219.2004.00183.x; Mund T, 2009, EMBO REP, V10, P501, DOI 10.1038/embor.2009.30; Nikko E, 2008, EMBO REP, V9, P1216, DOI 10.1038/embor.2008.199; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; Oestreich AJ, 2007, MOL BIOL CELL, V18, P707, DOI 10.1091/mbc.E06-08-0680; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Putz U, 2008, J BIOL CHEM, V283, P32621, DOI 10.1074/jbc.M804120200; Reggiori F, 2001, EMBO J, V20, P5176, DOI 10.1093/emboj/20.18.5176; Ren JH, 2007, MOL BIOL CELL, V18, P324, DOI 10.1091/mbc.E06-06-0557; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Rougier JS, 2005, AM J PHYSIOL-CELL PH, V288, pC692, DOI 10.1152/ajpcell.00460.2004; Row PE, 2006, J BIOL CHEM, V281, P12618, DOI 10.1074/jbc.M512615200; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shcherbik N, 2004, J BIOL CHEM, V279, P53892, DOI 10.1074/jbc.M410325200; Shearwin-Whyatt LM, 2004, J CELL SCI, V117, P3679, DOI 10.1242/jcs.01212; SIKORSKI RS, 1989, GENETICS, V122, P19; Soetens O, 2001, J BIOL CHEM, V276, P43949, DOI 10.1074/jbc.M102945200; Stamenova SD, 2004, J BIOL CHEM, V279, P16017, DOI 10.1074/jbc.M313479200; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Stawiecka-Mirota M, 2007, TRAFFIC, V8, P1280, DOI 10.1111/j.1600-0854.2007.00610.x; Strochlic TI, 2008, MOL BIOL CELL, V19, P4694, DOI 10.1091/mbc.E08-03-0296; Sullivan JA, 2007, MOL BIOL CELL, V18, P2429, DOI 10.1091/mbc.e07-01-0011; Urbanowski JL, 2001, TRAFFIC, V2, P622, DOI 10.1034/j.1600-0854.2001.20905.x; Verdecia MA, 2003, MOL CELL, V11, P249, DOI 10.1016/S1097-2765(02)00774-8; Watson H, 2007, MOL BIOL CELL, V18, P1781, DOI 10.1091/mbc.E06-10-0887; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Wendland B, 1998, CURR OPIN CELL BIOL, V10, P513, DOI 10.1016/S0955-0674(98)80067-7	53	17	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					32126	32137		10.1074/jbc.M109.048629	http://dx.doi.org/10.1074/jbc.M109.048629			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19744925	Green Published, hybrid			2022-12-27	WOS:000271572700067
J	Yin, WH; Park, JI; Loeser, RF				Yin, Weihong; Park, Jong-In; Loeser, Richard F.			Oxidative Stress Inhibits Insulin-like Growth Factor-I Induction of Chondrocyte Proteoglycan Synthesis through Differential Regulation of Phosphatidylinositol 3-Kinase-Akt and MEK-ERK MAPK Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOARTHRITIC ARTICULAR-CARTILAGE; RECEPTOR SUBSTRATE-1 IRS-1; ACTIVATED PROTEIN-KINASE; GENE-EXPRESSION; IGF-I; TYROSINE PHOSPHORYLATION; SERINE PHOSPHORYLATION; SUPEROXIDE-DISMUTASE; ENDOTHELIAL-CELLS; BINDING-PROTEINS	The ability of insulin-like growth factor I (IGF-I) to stimulate cartilage matrix synthesis is reduced in aged and osteoarthritic cartilage. Aging and osteoarthritis are associated with an increase in reactive oxygen species, which we hypothesized would interfere with normal IGF-I signaling. We compared IGF-I signaling in normal and osteoarthritic human articular chondrocytes and investigated the effects of oxidative stress induced by tert-butylhydroperoxide (tBHP). In normal human chondrocytes, IGF-I initiated a strong and sustained phosphorylation of IRS-1 (Tyr-612) and Akt (Ser-473) and transient ERK phosphorylation. In contrast, in osteoarthritic chondrocytes, which possessed elevated basal IRS-1 (Ser-312) and ERK phosphorylation, IGF-I failed to stimulate IRS-1 (Tyr-612) or Akt phosphorylation. In normal human chondrocytes, tBHP triggered strong IRS-1 (Ser-312 and Ser-616) and ERK phosphorylation and inhibited IGF-I-induced IRS-1 (Tyr-612) and Akt phosphorylation. Lentivirus-mediated overexpression of constitutively active (CA) Akt significantly enhanced proteoglycan synthesis, whereas both dominant negative Akt and CA MEK inhibited proteoglycan synthesis. CA Akt also promoted type II collagen and Sox9 expression, whereas tBHP treatment and CA MEK inhibited aggrecan, collagen II, and Sox9 mRNA expression. In osteoarthritic chondrocytes, the antioxidants Mn(III) tetrakis(4-benzoic acid) porphyrin and N-acetylcysteine increased the ratio of Akt to ERK phosphorylation and promoted IGF-I-mediated proteoglycan synthesis. Chemical inhibition of ERK significantly enhanced IGF-I phosphorylation of Akt and alleviated tBHP inhibition of Akt phosphorylation. These results demonstrate opposing roles for phosphatidylinositol 3-kinase-Akt and MEK-ERK in cartilage matrix synthesis and suggest that elevated levels of reactive oxygen species cause chondrocyte IGF-I resistance by altering the balance of Akt to ERK activity.	[Yin, Weihong; Loeser, Richard F.] Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Sect Mol Med, Winston Salem, NC 27157 USA; [Park, Jong-In] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	Wake Forest University; Wake Forest Baptist Medical Center; Medical College of Wisconsin	Loeser, RF (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Sect Mol Med, 300 S Hawthorne Rd, Winston Salem, NC 27157 USA.	rloeser@wfubmc.edu		Park, Jong-In/0000-0001-7248-4735	National Institutes of Health [AG-16697]; Ellison Medical Foundation/American Federation for Aging Research Postdoctoral Fellowship; NATIONAL INSTITUTE ON AGING [R01AG016697] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation/American Federation for Aging Research Postdoctoral Fellowship(Lawrence Ellison Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG-16697. This work was also supported by an Ellison Medical Foundation/American Federation for Aging Research Postdoctoral Fellowship.	Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Aigner T, 2006, ARTHRITIS RHEUM-US, V54, P3533, DOI 10.1002/art.22174; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Bobick BE, 2004, J BIOL CHEM, V279, P4588, DOI 10.1074/jbc.M309805200; Boileau C, 2006, ANN RHEUM DIS, V65, P573, DOI 10.1136/ard.2005.041855; Cao JJ, 2007, J BONE MINER RES, V22, P1271, DOI 10.1359/JBMR.070506; Clancy R, 2001, OSTEOARTHR CARTILAGE, V9, P294, DOI 10.1053/joca.2000.0388; CRISTOFALO VJ, 1989, J GERONTOL, V44, P55, DOI 10.1093/geronj/44.6.55; dAvis PY, 1997, BIOCHEM J, V324, P753, DOI 10.1042/bj3240753; Day BJ, 1997, ARCH BIOCHEM BIOPHYS, V347, P256, DOI 10.1006/abbi.1997.0341; Del Carlo M, 2003, ARTHRITIS RHEUM-US, V48, P3419, DOI 10.1002/art.11338; Del Carlo M, 2002, ARTHRITIS RHEUM, V46, P394, DOI 10.1002/art.10056; Engelman JA, 2000, MOL ENDOCRINOL, V14, P1557, DOI 10.1210/me.14.10.1557; Esposito DL, 2001, ENDOCRINOLOGY, V142, P2833, DOI 10.1210/en.142.7.2833; Ezzat VA, 2008, DIABETES OBES METAB, V10, P198, DOI 10.1111/j.1463-1326.2007.00709.x; Fan Z, 2007, AM J PATHOL, V171, P938, DOI 10.2353/ajpath.2007.061083; Fitzgerald JB, 2008, J BIOL CHEM, V283, P6735, DOI 10.1074/jbc.M708670200; Gao ZG, 2002, J BIOL CHEM, V277, P48115, DOI 10.1074/jbc.M209459200; Gual P, 2005, BIOCHIMIE, V87, P99, DOI 10.1016/j.biochi.2004.10.019; Gual P, 2003, DIABETOLOGIA, V46, P1532, DOI 10.1007/s00125-003-1223-4; Han Y, 2008, MOL CELL BIOL, V28, P4999, DOI 10.1128/MCB.00695-08; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Henrotin YE, 2003, OSTEOARTHR CARTILAGE, V11, P747, DOI 10.1016/S1063-4584(03)00150-X; Henrotin YE, 2006, J RHEUMATOL, V33, P1668; Kurz DJ, 2004, J CELL SCI, V117, P2417, DOI 10.1242/jcs.01097; Lefebvre V, 1998, MATRIX BIOL, V16, P529; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Lewis TS, 2000, MOL CELL, V6, P1343, DOI 10.1016/S1097-2765(00)00132-5; Liu YF, 2004, MOL CELL BIOL, V24, P9668, DOI 10.1128/MCB.24.21.9668-9681.2004; Liu YF, 2001, J BIOL CHEM, V276, P14459, DOI 10.1074/jbc.M007281200; Loeser RF, 2003, J RHEUMATOL, V30, P1565; Loeser RF, 2002, ARTHRITIS RHEUM, V46, P2349, DOI 10.1002/art.10496; Loeser RF, 2000, ARTHRITIS RHEUM, V43, P2110, DOI 10.1002/1529-0131(200009)43:9<2110::AID-ANR23>3.0.CO;2-U; Martel-Pelletier J, 1998, INFLAMM RES, V47, P90, DOI 10.1007/s000110050288; Martin G, 2005, OSTEOARTHR CARTILAGE, V13, P915, DOI 10.1016/j.joca.2005.03.009; Martin JA, 1997, J ORTHOP RES, V15, P491, DOI 10.1002/jor.1100150403; Meng D, 2007, FREE RADICAL BIO MED, V42, P1651, DOI 10.1016/j.freeradbiomed.2007.01.037; Messai H, 2000, MECH AGEING DEV, V115, P21, DOI 10.1016/S0047-6374(00)00107-X; Moeschel K, 2004, J BIOL CHEM, V279, P25157, DOI 10.1074/jbc.M402477200; Monteiro HP, 2008, ANTIOXID REDOX SIGN, V10, P843, DOI 10.1089/ars.2007.1853; Muehleman C, 1997, OSTEOARTHR CARTILAGE, V5, P23, DOI 10.1016/S1063-4584(97)80029-5; PASTERNACK RF, 1981, J INORG BIOCHEM, V15, P261, DOI 10.1016/S0162-0134(00)80161-0; Pelletier JP, 2003, ARTHRITIS RHEUM-US, V48, P1582, DOI 10.1002/art.11014; Phornphutkul C, 2004, J ENDOCRINOL, V183, P477, DOI 10.1677/joe.1.05873; Pombo-Suarez M, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-17; Regan E, 2005, ARTHRITIS RHEUM, V52, P3479, DOI 10.1002/art.21387; Rokutanda S, 2009, DEV BIOL, V328, P78, DOI 10.1016/j.ydbio.2009.01.009; Rui LY, 2001, J CLIN INVEST, V107, P181, DOI 10.1172/JCI10934; Ruiz-Romero C, 2009, MOL CELL PROTEOMICS, V8, P172, DOI 10.1074/mcp.M800292-MCP200; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Sen M, 2004, ARTHRITIS RHEUM-US, V50, P488, DOI 10.1002/art.20005; Shah R, 2005, ARTHRITIS RHEUM-US, V52, P2799, DOI 10.1002/art.21239; Shimoaka T, 2004, J BIOL CHEM, V279, P15314, DOI 10.1074/jbc.M312525200; Starkman BG, 2005, BIOCHEM J, V389, P723, DOI 10.1042/BJ20041636; Szabo C, 1996, FEBS LETT, V381, P82, DOI 10.1016/0014-5793(96)00087-7; Tsuji M, 1996, FEBS LETT, V381, P222, DOI 10.1016/0014-5793(96)00118-4; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Yagi R, 2005, J BIOL CHEM, V280, P30517, DOI 10.1074/jbc.M502751200; Yudoh K, 2005, ARTHRITIS RES THER, V7, pR380, DOI 10.1186/ar1499	61	123	133	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31972	31981		10.1074/jbc.M109.056838	http://dx.doi.org/10.1074/jbc.M109.056838			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19762915	Green Published, hybrid			2022-12-27	WOS:000271572700053
J	Mansouri, S; Choudhary, G; Sarzala, PM; Ratner, L; Hudak, KA				Mansouri, Sheila; Choudhary, Gunjan; Sarzala, Paulina M.; Ratner, Lee; Hudak, Katalin A.			Suppression of Human T-cell Leukemia Virus I Gene Expression by Pokeweed Antiviral Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOME-INACTIVATING PROTEINS; MOSAIC-VIRUS; PHYTOLACCA-AMERICANA; VIRAL-RNA; INHIBITION; TYPE-1; INFECTION; LYMPHOMA; DEPURINATION; TRANSLATION	Human T-cell leukemia virus I (HTLV-I) is a deltaretrovirus that is the causative agent of adult T-cell leukemia and the neurological disorder HTLV-I-associated myelopathy/tropical spastic paraparesis. Currently, no effective antiretroviral treatment options are available to restrict the development of diseases associated with the virus. In this work, we investigated the activity of pokeweed antiviral protein (PAP) on HTLV-I, when expressed from a proviral clone in 293T cells or in an HTLV-I immortalized cell line. PAP is a plant-derived N-glycosidase that exhibits antiviral activity against a number of viruses; however, its mode of action has not been clearly defined. Here, we describe the mechanism by which PAP inhibited production of HTLV-I. We show that PAP depurinated nucleotides within the gag open reading frame and suppressed the synthesis of viral proteins in part by decreasing the translational efficiency of HTLV-I gag/pol mRNA. Observed reduction in levels of viral mRNAs were not due to enhanced degradation; rather, decreased amounts of viral transactivator protein, Tax, led to feed-back inhibition of transcription from the viral promoter. Therefore, PAP efficiently suppressed HTLV-I gene expression at both translational and transcriptional levels, resulting in substantially diminished virus production. Significantly, no changes in viability or rates of cellular transcription or translation were observed in cells expressing PAP, indicating that this protein was not toxic. Antiviral activity, together with the absence of cytotoxicity, supports further investigation of this enzyme as a novel therapeutic agent against the progression of HTLV-I infection.	[Hudak, Katalin A.] York Univ, Dept Biol, Toronto, ON M3J 1P3, Canada; [Choudhary, Gunjan; Ratner, Lee] Washington Univ, Dept Med, St Louis, MO 63110 USA	York University - Canada; Washington University (WUSTL)	Hudak, KA (corresponding author), York Univ, Dept Biol, 4700 Keele St, Toronto, ON M3J 1P3, Canada.	hudak@yorku.ca		Ratner, Lee/0000-0003-2744-7294	National Institutes of Health Public Health Service Grants [CA94056, CA63417, CA10073, CA10521, CA109678]; Natural Sciences and Engineering Research Council of Canada; Premier's Research Excellence Award; NATIONAL CANCER INSTITUTE [R01CA063417, P50CA094056, R21CA109678] Funding Source: NIH RePORTER	National Institutes of Health Public Health Service Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Premier's Research Excellence Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Public Health Service Grants CA94056, CA63417, CA10073, CA10521 and CA109678 (to L. R.). This work was also supported by the Natural Sciences and Engineering Research Council of Canada and a Premier's Research Excellence Award (to K. A. H.).	Bieniasz PD, 2004, NAT IMMUNOL, V5, P1109, DOI 10.1038/ni1125; Butsch M, 2000, J VIROL, V74, P11531, DOI 10.1128/JVI.74.24.11531-11537.2000; Conti E, 2005, CURR OPIN CELL BIOL, V17, P316, DOI 10.1016/j.ceb.2005.04.005; Derse D, 2007, P NATL ACAD SCI USA, V104, P2915, DOI 10.1073/pnas.0609444104; ENDO Y, 1988, BIOCHEM BIOPH RES CO, V150, P1032, DOI 10.1016/0006-291X(88)90733-4; FOATOMASI L, 1982, ARCH VIROL, V71, P323, DOI 10.1007/BF01315062; Franchini G, 2003, ADV CANCER RES, V89, P69, DOI 10.1016/S0065-230X(03)01003-0; Gandhi R, 2008, J BIOL CHEM, V283, P32218, DOI 10.1074/jbc.M803785200; GESSAIN A, 1985, LANCET, V2, P407; GESSNER SL, 1980, J BIOL CHEM, V255, P3251; GILL PS, 1995, NEW ENGL J MED, V332, P1744, DOI 10.1056/NEJM199506293322603; Grone M, 1996, VIROLOGY, V218, P316, DOI 10.1006/viro.1996.0200; Harris RS, 2003, NAT IMMUNOL, V4, P641, DOI 10.1038/ni0703-641; HIDAKA M, 1988, EMBO J, V7, P519, DOI 10.1002/j.1460-2075.1988.tb02840.x; HOLLSBERG P, 1993, NEW ENGL J MED, V328, P1173, DOI 10.1056/NEJM199304223281608; Hudak KA, 2000, RNA, V6, P369, DOI 10.1017/S1355838200991337; HUR Y, 1995, P NATL ACAD SCI USA, V92, P8448, DOI 10.1073/pnas.92.18.8448; Iordanov MS, 1997, MOL CELL BIOL, V17, P3373, DOI 10.1128/MCB.17.6.3373; IRVIN JD, 1975, ARCH BIOCHEM BIOPHYS, V169, P522, DOI 10.1016/0003-9861(75)90195-2; KIMATA JT, 1994, VIROLOGY, V204, P656, DOI 10.1006/viro.1994.1581; Machuca A, 2000, J ACQ IMMUN DEF SYND, V24, P189; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Moriuchi M, 2001, J VIROL, V75, P192, DOI 10.1128/JVI.75.1.192-198.2001; MURPHY EL, 1989, INT J CANCER, V43, P250, DOI 10.1002/ijc.2910430214; Narayanan S, 2004, BIOCHEM J, V377, P233, DOI 10.1042/BJ20030797; NILSSON L, 1986, EUR J BIOCHEM, V161, P111, DOI 10.1111/j.1432-1033.1986.tb10130.x; Ohsugi T, 2007, J VIROL METHODS, V139, P93, DOI 10.1016/j.jviromet.2006.08.016; OSAME M, 1987, ANN NEUROL, V21, P117, DOI 10.1002/ana.410210203; Ouyang DY, 2005, CELL MOL IMMUNOL, V2, P419; Picard D, 2005, J BIOL CHEM, V280, P20069, DOI 10.1074/jbc.M413452200; Rajamohan F, 1999, BIOCHEM BIOPH RES CO, V260, P453, DOI 10.1006/bbrc.1999.0922; SODROSKI J, 1985, SCIENCE, V228, P1430, DOI 10.1126/science.2990028; STIRPE F, 1988, NUCLEIC ACIDS RES, V16, P1349, DOI 10.1093/nar/16.4.1349; TAJIMA K, 1990, INT J CANCER, V45, P237, DOI 10.1002/ijc.2910450206; TAKATSUKI K, 1985, CANCER RES, V45, P4644; Taylor GP, 2005, ONCOGENE, V24, P6047, DOI 10.1038/sj.onc.1208979; TAYLOR S, 1994, PLANT J, V5, P827, DOI 10.1046/j.1365-313X.1994.5060827.x; TOKUDOME S, 1989, CANCER RES, V49, P226; TOMLINSON JA, 1974, J GEN VIROL, V22, P225, DOI 10.1099/0022-1317-22-2-225; Tsukahara T, 2001, J VIROL, V75, P9553, DOI 10.1128/JVI.75.19.9553-9559.2001; Tumer NE, 1997, P NATL ACAD SCI USA, V94, P3866, DOI 10.1073/pnas.94.8.3866; Tung KWC, 2008, INT J BIOCHEM CELL B, V40, P2452, DOI 10.1016/j.biocel.2008.04.021; UCHIYAMA T, 1977, BLOOD, V50, P481, DOI 10.1182/blood.V50.3.481.481; Wagner E, 2002, J CELL SCI, V115, P3033; Wang P, 1999, NUCLEIC ACIDS RES, V27, P1900, DOI 10.1093/nar/27.8.1900; YAMAGUCHI K, 1993, CLIN HAEMATOL, V6, P899; Yoshida M, 2001, ANNU REV IMMUNOL, V19, P475, DOI 10.1146/annurev.immunol.19.1.475; ZARLING JM, 1990, NATURE, V347, P92, DOI 10.1038/347092a0; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707	49	24	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31453	31462		10.1074/jbc.M109.046235	http://dx.doi.org/10.1074/jbc.M109.046235			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19748897	hybrid, Green Published			2022-12-27	WOS:000271378400070
J	Genkov, T; Spreitzer, RJ				Genkov, Todor; Spreitzer, Robert J.			Highly Conserved Small Subunit Residues Influence Rubisco Large Subunit Catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE OXYGENASE; RIBULOSE-BISPHOSPHATE CARBOXYLASE/OXYGENASE; CHLAMYDOMONAS CHLOROPLAST GENE; SUBSTRATE-SPECIFICITY FACTOR; BETA-B LOOP; CO2/O-2 SPECIFICITY; THERMAL-STABILITY; CRYSTAL-STRUCTURE; COMPLEMENTING SUBSTITUTIONS; SUPPRESSOR MUTATIONS	The chloroplast enzyme ribulose 1,5-bisphosphate carboxylase/oxygenase (Rubisco) catalyzes the rate-limiting step of photosynthetic CO2 fixation. With a deeper understanding of its structure-function relationships and competitive inhibition by O-2, it may be possible to engineer an increase in agricultural productivity and renewable energy. The chloroplast-encoded large subunits form the active site, but the nuclear-encoded small subunits can also influence catalytic efficiency and CO2/O-2 specificity. To further define the role of the small subunit in Rubisco function, the 10 most conserved residues in all small subunits were substituted with alanine by transformation of a Chlamydomonas reinhardtii mutant that lacks the small subunit gene family. All the mutant strains were able to grow photosynthetically, indicating that none of the residues is essential for function. Three of the substitutions have little or no effect (S16A, P19A, and E92A), one primarily affects holoenzyme stability (L18A), and the remainder affect catalysis with or without some level of associated structural instability (Y32A, E43A, W73A, L78A, P79A, and F81A). Y32A and E43A cause decreases in CO2/O-2 specificity. Based on the x-ray crystal structure of Chlamydomonas Rubisco, all but one (Glu-92) of the conserved residues are in contact with large subunits and cluster near the amino-or carboxyl-terminal ends of large subunit alpha-helix 8, which is a structural element of the alpha/beta-barrel active site. Small subunit residues Glu-43 and Trp-73 identify a possible structural connection between active site alpha-helix 8 and the highly variable small subunit loop between beta-strands A and B, which can also influence Rubisco CO2/O-2 specificity.	[Genkov, Todor; Spreitzer, Robert J.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln	Spreitzer, RJ (corresponding author), Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA.	rspreitzer1@unl.edu			United States Department of Energy [DE-FG02-00ER15044]	United States Department of Energy(United States Department of Energy (DOE))	This work was supported in part by Grant DE-FG02-00ER15044 from the United States Department of Energy.	Andersson I, 1996, J MOL BIOL, V259, P160, DOI 10.1006/jmbi.1996.0310; Andersson I, 2008, PLANT PHYSIOL BIOCH, V46, P275, DOI 10.1016/j.plaphy.2008.01.001; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHEN Z, 1988, P NATL ACAD SCI USA, V85, P4696, DOI 10.1073/pnas.85.13.4696; CHEN ZX, 1992, PHOTOSYNTH RES, V31, P157, DOI 10.1007/BF00028792; CHEN ZX, 1993, PLANT PHYSIOL, V101, P1189, DOI 10.1104/pp.101.4.1189; Chua N. H, 1980, METHOD ENZYMOL, V69, P434; Cleland WW, 1998, CHEM REV, V98, P549, DOI 10.1021/cr970010r; CLONEY LP, 1993, PLANT MOL BIOL, V23, P1285, DOI 10.1007/BF00042362; Dhingra A, 2004, P NATL ACAD SCI USA, V101, P6315, DOI 10.1073/pnas.0400981101; Du YC, 2000, P NATL ACAD SCI USA, V97, P14206, DOI 10.1073/pnas.260503997; Du YC, 2000, J BIOL CHEM, V275, P19844, DOI 10.1074/jbc.M002321200; Esquivel MG, 2006, BIOCHEMISTRY-US, V45, P5745, DOI 10.1021/bi052588y; FITCHEN JH, 1990, P NATL ACAD SCI USA, V87, P5768, DOI 10.1073/pnas.87.15.5768; Flachmann R, 1997, PLANT PHYSIOL, V114, P131, DOI 10.1104/pp.114.1.131; FLACHMANN R, 1992, J BIOL CHEM, V267, P10576; Genkov T, 2006, ARCH BIOCHEM BIOPHYS, V451, P167, DOI 10.1016/j.abb.2006.04.012; Hansen S, 1999, J MOL BIOL, V288, P609, DOI 10.1006/jmbi.1999.2701; HARTMAN FC, 1994, ANNU REV BIOCHEM, V63, P197, DOI 10.1146/annurev.biochem.63.1.197; Hong SK, 1997, J BIOL CHEM, V272, P11114; JORDAN DB, 1981, NATURE, V291, P513, DOI 10.1038/291513a0; JORDAN DB, 1981, PLANT PHYSIOL, V67, P237, DOI 10.1104/pp.67.2.237; Kanevski I, 1999, PLANT PHYSIOL, V119, P133, DOI 10.1104/pp.119.1.133; Karkehabadi S, 2005, BIOCHEMISTRY-US, V44, P9851, DOI 10.1021/bi050537v; Khrebtukova I, 1996, P NATL ACAD SCI USA, V93, P13689, DOI 10.1073/pnas.93.24.13689; Kostov RV, 1997, PHOTOSYNTH RES, V54, P127, DOI 10.1023/A:1005967106993; KUEHN GD, 1978, BIOCHEM J, V175, P909, DOI 10.1042/bj1750909; LAING WA, 1974, PLANT PHYSIOL, V54, P678, DOI 10.1104/pp.54.5.678; LEE B, 1991, J BIOL CHEM, V266, P7417; NEWMAN J, 1993, J BIOL CHEM, V268, P25876; Papworth C.B., 1996, STRATEGIES, V9, P3, DOI DOI 10.1080/08924562.1996.11000299; PAUL K, 1991, BIOCHEMISTRY-US, V30, P10019, DOI 10.1021/bi00105a029; READ BA, 1992, BIOCHEMISTRY-US, V31, P5553, DOI 10.1021/bi00139a018; READ BA, 1994, ARCH BIOCHEM BIOPHYS, V312, P210, DOI 10.1006/abbi.1994.1301; READ BA, 1992, BIOCHEMISTRY-US, V31, P519, DOI 10.1021/bi00117a031; SCHNEIDER G, 1990, EMBO J, V9, P2045, DOI 10.1002/j.1460-2075.1990.tb07371.x; SCHREUDER HA, 1993, PROTEIN SCI, V2, P1136, DOI 10.1002/pro.5560020708; Shimogawara K, 1998, GENETICS, V148, P1821; Spreitzer RJ, 2005, P NATL ACAD SCI USA, V102, P17225, DOI 10.1073/pnas.0508042102; SPREITZER RJ, 1981, PLANT PHYSIOL, V67, P565, DOI 10.1104/pp.67.3.565; Spreitzer RJ, 2003, ARCH BIOCHEM BIOPHYS, V414, P141, DOI 10.1016/S0003-9861(03)00171-1; Spreitzer RJ, 2002, ANNU REV PLANT BIOL, V53, P449, DOI 10.1146/annurev.arplant.53.100301.135233; Spreitzer RJ, 2001, BIOCHEMISTRY-US, V40, P5615, DOI 10.1021/bi002943e; SPREITZER RJ, 1982, FEBS LETT, V148, P117, DOI 10.1016/0014-5793(82)81255-6; SPREITZER RJ, 1985, P NATL ACAD SCI USA, V82, P5460, DOI 10.1073/pnas.82.16.5460; SPREITZER RJ, 1987, CURR GENET, V11, P611, DOI 10.1007/BF00393924; SUGAWARA H, 1999, J BIOL CHEM, V276, P48159; Tabita FR, 2008, J EXP BOT, V59, P1515, DOI 10.1093/jxb/erm361; THOW G, 1994, BIOCHEMISTRY-US, V33, P5109, DOI 10.1021/bi00183a014; Uemura K, 1997, BIOCHEM BIOPH RES CO, V233, P568, DOI 10.1006/bbrc.1997.6497; VOORDOUW G, 1987, EUR J BIOCHEM, V163, P591, DOI 10.1111/j.1432-1033.1987.tb10908.x; WASMANN CC, 1989, P NATL ACAD SCI USA, V86, P1198, DOI 10.1073/pnas.86.4.1198	52	49	52	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30105	30112		10.1074/jbc.M109.044081	http://dx.doi.org/10.1074/jbc.M109.044081			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19734149	Green Published, hybrid			2022-12-27	WOS:000271090000013
J	Humphrey, RK; Yu, SM; Flores, LE; Jhala, US				Humphrey, Rohan K.; Yu, Shu-Mei; Flores, Luis E.; Jhala, Ulupi S.			Glucose Regulates Steady-state Levels of PDX1 via the Reciprocal Actions of GSK3 and AKT Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; HOMEODOMAIN TRANSCRIPTION FACTOR; INSULIN GENE-TRANSCRIPTION; DIABETES-MELLITUS; HOMEOBOX FACTOR; ACTIVATION; PROTEIN; GROWTH; EXPRESSION; PHOSPHORYLATION	The pancreatic beta cell is sensitive to even small changes in PDX1 protein levels; consequently, Pdx1 haploinsufficiency can inhibit beta cell growth and decrease insulin biosynthesis and gene expression, leading to compromised glucose-stimulated insulin secretion. Using metabolic labeling of primary islets and a cultured beta cell line, we show that glucose levels modulate PDX1 protein phosphorylation at a novel C-terminal GSK3 consensus that maps to serines 268 and 272. A decrease in glucose levels triggers increased turnover of the PDX1 protein in a GSK3-dependent manner, such that PDX1 phosphomutants are refractory to the destabilizing effect of low glucose. Glucose-stimulated activation of AKT and inhibition of GSK3 decrease PDX1 phosphorylation and delay degradation. Furthermore, direct pharmacologic inhibition of AKT destabilizes, and inhibition of GSK3 increases PDX1 protein stability. These studies define a novel functional role for the PDX1 C terminus in mediating the effects of glucose and demonstrate that glucose modulates PDX1 stability via the AKT-GSK3 axis.	[Humphrey, Rohan K.; Yu, Shu-Mei; Flores, Luis E.; Jhala, Ulupi S.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92037 USA	University of California System; University of California San Diego	Jhala, US (corresponding author), 3525 John Hopkins Court, San Diego, CA 92121 USA.	ujhala@ucsd.edu		Flores, Luis/0000-0003-1709-8748	National Institutes of Health [R01DK080147]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080147] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK080147 (to U. S. J.).; We are deeply grateful to Dr. Marc Montminy (The Salk Institute for Biological Studies, La Jolla, CA) for providing guidance and resources during the PDX1 phosphopeptide mapping studies. We also thank Dr. Greg Korbutt (Alberta Diabetes Institute, Canada) for help with islet isolation, Jill Meisenhelder and the laboratory of Dr. Tony Hunter (The Salk Institute, La Jolla CA) for use of phosphopeptide mapping facilities, and Dr. Doris Stoffers for a critical reading of the manuscript.	Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Andrali SS, 2008, BIOCHEM J, V415, P1, DOI 10.1042/BJ20081029; Arnott David, 2003, J Biomol Tech, V14, P205; Assmann A, 2009, MOL CELL BIOL, V29, P3219, DOI 10.1128/MCB.01489-08; Bernal-Mizrachi E, 2001, J CLIN INVEST, V108, P1631, DOI 10.1172/JCI13785; Bernal-Mizrachi E, 2004, J CLIN INVEST, V114, P928, DOI 10.1172/JCI200420016; Boucher MJ, 2006, J BIOL CHEM, V281, P6395, DOI 10.1074/jbc.M511597200; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Brissova M, 2005, AM J PHYSIOL-ENDOC M, V288, pE707, DOI 10.1152/ajpendo.00252.2004; Brissova M, 2002, J BIOL CHEM, V277, P11225, DOI 10.1074/jbc.M111272200; Dutta S, 1998, NATURE, V392, P560, DOI 10.1038/33311; Eto K, 2006, ENDOCRINOLOGY, V147, P2923, DOI 10.1210/en.2005-1336; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; Gauthier BR, 2004, J BIOL CHEM, V279, P31121, DOI 10.1074/jbc.M405030200; Guo SL, 2009, J BIOL CHEM, V284, P759, DOI 10.1074/jbc.M806314200; Guo X, 2008, GENE DEV, V22, P106, DOI 10.1101/gad.1590908; Han S, 2007, MOL CELL BIOL, V27, P6593, DOI 10.1128/MCB.01573-06; Hani EH, 1999, J CLIN INVEST, V104, pR41, DOI 10.1172/JCI7469; HARLOW E, 2006, ANTIBODIES LAB MANUA; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Jiang J, 2006, CELL CYCLE, V5, P2457, DOI 10.4161/cc.5.21.3406; Johnson JD, 2006, P NATL ACAD SCI USA, V103, P19575, DOI 10.1073/pnas.0604208103; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Khoo S, 2003, J BIOL CHEM, V278, P32969, DOI 10.1074/jbc.M301198200; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Kulkarni RN, 2004, J CLIN INVEST, V114, P828, DOI 10.1172/JCI200421845; Kushner JA, 2002, J CLIN INVEST, V109, P1193, DOI 10.1172/JCI200214439; Liu AH, 2004, MOL CELL BIOL, V24, P4372, DOI 10.1128/MCB.24.10.4372-4383.2004; Liu Z, 2008, DIABETOLOGIA, V51, P623, DOI 10.1007/s00125-007-0914-7; Lu M, 1996, ENDOCRINOLOGY, V137, P2959, DOI 10.1210/en.137.7.2959; Macfarlane WM, 1999, J BIOL CHEM, V274, P1011, DOI 10.1074/jbc.274.2.1011; MEISENHELDER J, 2001, CURRENT PROTOCOLS PR, V2; Mosley AL, 2004, J BIOL CHEM, V279, P54241, DOI 10.1074/jbc.M410379200; Mosley AL, 2004, MOL ENDOCRINOL, V18, P2279, DOI 10.1210/me.2003-0463; OHLSSON H, 1993, EMBO J, V12, P4251, DOI 10.1002/j.1460-2075.1993.tb06109.x; Ohsugi M, 2004, DIABETES, V53, P1496, DOI 10.2337/diabetes.53.6.1496; Parker D, 1998, MOL CELL, V2, P353, DOI 10.1016/S1097-2765(00)80279-8; PEERS B, 1994, MOL ENDOCRINOL, V8, P1798, DOI 10.1210/me.8.12.1798; Peshavaria M, 2000, MOL ENDOCRINOL, V14, P1907, DOI 10.1210/me.14.12.1907; Petersen HV, 1998, FEBS LETT, V431, P362, DOI 10.1016/S0014-5793(98)00776-5; Shapiro AMJ, 1996, CELL TRANSPLANT, V5, P631, DOI 10.1016/S0963-6897(96)00084-X; Sharma S, 1997, MOL CELL BIOL, V17, P2598, DOI 10.1128/MCB.17.5.2598; Srinivasan S, 2002, AM J PHYSIOL-ENDOC M, V283, pE784, DOI 10.1152/ajpendo.00177.2002; Stanojevic V, 2004, ENDOCRINOLOGY, V145, P2918, DOI 10.1210/en.2003-1188; Stoffers DA, 1997, NAT GENET, V15, P106, DOI 10.1038/ng0197-106; Stoffers DA, 1997, NAT GENET, V17, P138, DOI 10.1038/ng1097-138; Tanabe K, 2008, PLOS BIOL, V6, P307, DOI 10.1371/journal.pbio.0060037; Thomas GM, 1999, FEBS LETT, V458, P247, DOI 10.1016/S0014-5793(99)01161-8; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; Ueki K, 2006, NAT GENET, V38, P583, DOI 10.1038/ng1787; Waeber G, 1996, MOL ENDOCRINOL, V10, P1327, DOI 10.1210/me.10.11.1327; Watada H, 1996, DIABETES, V45, P1478, DOI 10.2337/diabetes.45.11.1478; Weng J, 2001, DIABETOLOGIA, V44, P249, DOI 10.1007/s001250051608; Wu H, 1999, BIOCHEM J, V344, P813, DOI 10.1042/0264-6021:3440813; Wu RC, 2007, CELL, V129, P1125, DOI 10.1016/j.cell.2007.04.039; Xavier GD, 2004, BIOCHEM J, V377, P149, DOI 10.1042/BJ20031260; Zhao Y, 2007, MOL CELL BIOL, V27, P4328, DOI 10.1128/MCB.00153-07; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	58	48	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3406	3416		10.1074/jbc.M109.006734	http://dx.doi.org/10.1074/jbc.M109.006734			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19833727	hybrid, Green Published			2022-12-27	WOS:000273829000055
J	Kang, JG; Park, SY; Ji, S; Jang, I; Park, S; Kim, HS; Kim, SM; Yook, JI; Park, YI; Roth, J; Cho, JW				Kang, Jeong Gu; Park, Sang Yoon; Ji, Suena; Jang, Insook; Park, Sujin; Kim, Hyun Sil; Kim, Sung-Min; Yook, Jong In; Park, Yong-Il; Roth, Juergen; Cho, Jin Won			O-GlcNAc Protein Modification in Cancer Cells Increases in Response to Glucose Deprivation through Glycogen Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED N-ACETYLGLUCOSAMINE; RNA-POLYMERASE-II; NUCLEOCYTOPLASMIC PROTEINS; TERMINAL DOMAIN; UP-REGULATION; GLYCOSYLATION; KINASE; AMP; GLCNACYLATION; INHIBITION	When cellular glucose concentrations fall below normal levels, in general the extent of protein O-GlcNAc modification (O-GlcNAcylation) decreases. However, recent reports demonstrated increased O-GlcNAcylation by glucose deprivation in HepG2 and Neuro-2a cells. Here, we report increased O-GlcNAcylation in non-small cell lung carcinoma A549 cells and various other cells in response to glucose deprivation. Although the level of O-GlcNAc transferase was unchanged, the enzyme contained less O-GlcNAc, and its activity was increased. Moreover, O-GlcNAcase activity was reduced. The studied cells contain glycogen, and we show that its degradation in response to glucose deprivation provides a source for UDP-GlcNAc required for increased O-GlcNAcylation under this condition. This required active glycogen phosphorylase and resulted in increased glutamine: fructose-6-phosphate amidotransferase, the first and rate-limiting enzyme in the hexosamine biosynthetic pathway. Interestingly, glucose deprivation reduced the amount of phosphofructokinase 1, a regulatory glycolytic enzyme, and blocked ATP synthesis. These findings suggest that glycogen is the source for increased O-GlcNAcylation but not for generating ATP in response to glucose deprivation and that this may be useful for cancer cells to survive.	[Kang, Jeong Gu; Park, Sang Yoon; Ji, Suena; Jang, Insook; Park, Sujin; Cho, Jin Won] Yonsei Univ, Dept Biol, Seoul 120749, South Korea; [Kim, Hyun Sil; Yook, Jong In] Yonsei Univ, Dept Oral Pathol, Oral Canc Res Inst, Seoul 120749, South Korea; [Roth, Juergen; Cho, Jin Won] Yonsei Univ, World Class Univ Integrated OMICS Biomed Sci, Seoul 120749, South Korea; [Kim, Sung-Min; Park, Yong-Il] Catholic Univ Korea, Dept Biotechnol, Puchon 420743, South Korea; [Kim, Sung-Min; Park, Yong-Il] Catholic Univ Korea, Biomat Engn Res Ctr, Puchon 420743, South Korea	Yonsei University; Yonsei University; Yonsei University; Catholic University of Korea; Catholic University of Korea	Cho, JW (corresponding author), Yonsei Univ, Dept Biol, 134 Shinchon Dong, Seoul 120749, South Korea.	chojw311@yonsei.ac.kr		Kim, Hyun Sil/0000-0003-3614-1764; Yook, Jong In/0000-0002-7318-6112	Korea Science and Engineering Foundation (KOSEF); Ministry of Education, Science, and Technology [R0A-2007-000-20011-0]; Korea Research Foundation [KRF-2006-005J04502]; World Class University [R31-2008-000-10086-0]	Korea Science and Engineering Foundation (KOSEF)(Korea Science and Engineering Foundation); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Research Foundation(National Research Foundation of Korea); World Class University	This work was supported by the Korea Science and Engineering Foundation (KOSEF) funded by Ministry of Education, Science, and Technology Grant R0A-2007-000-20011-0, Korea Research Foundation Grant KRF-2006-005J04502, and World Class University Project R31-2008-000-10086-0. This work was made possible through the use of research facilities in the Yonsei Center for Biotechnology.	Andrali SS, 2007, J BIOL CHEM, V282, P15589, DOI 10.1074/jbc.M701762200; Carling D, 2009, CELL METAB, V9, P7, DOI 10.1016/j.cmet.2008.12.007; Cheung WD, 2008, J BIOL CHEM, V283, P13009, DOI 10.1074/jbc.M801222200; Cheung WD, 2008, J BIOL CHEM, V283, P33935, DOI 10.1074/jbc.M806199200; Comer FI, 2001, BIOCHEMISTRY-US, V40, P7845, DOI 10.1021/bi0027480; Culmsee C, 2001, J MOL NEUROSCI, V17, P45, DOI 10.1385/JMN:17:1:45; Gao Y, 2003, ARCH BIOCHEM BIOPHYS, V415, P155, DOI 10.1016/S0003-9861(03)00234-0; Guinez C, 2006, GLYCOBIOLOGY, V16, P22, DOI 10.1093/glycob/cwj041; Guinez C, 2004, BIOCHEM BIOPH RES CO, V319, P21, DOI 10.1016/j.bbrc.2004.04.144; Hruz PW, 2001, MOL MEMBR BIOL, V18, P183; Kang HT, 2003, J BIOL CHEM, V278, P51223, DOI 10.1074/jbc.M307332200; KELLY WG, 1993, J BIOL CHEM, V268, P10416; Konrad RJ, 2002, BIOCHEM BIOPH RES CO, V293, P207, DOI 10.1016/S0006-291X(02)00200-0; Kuo M, 2008, BIOCHIMIE, V90, P679, DOI 10.1016/j.biochi.2008.03.005; Liu K, 2004, J NEUROCHEM, V89, P1044, DOI 10.1111/j.1471-4159.2004.02389.x; Love, 2005, SCI STKE, V2005, DOI DOI 10.1126/STKE.3122005RE13; MATHUPALA SP, 1995, J BIOL CHEM, V270, P16918, DOI 10.1074/jbc.270.28.16918; McBride A, 2009, ACTA PHYSIOL, V196, P99, DOI 10.1111/j.1748-1716.2009.01975.x; McClain DA, 1996, DIABETES, V45, P1003, DOI 10.2337/diabetes.45.8.1003; McCullough LD, 2005, J BIOL CHEM, V280, P20493, DOI 10.1074/jbc.M409985200; MONSIGNY M, 1979, EUR J BIOCHEM, V98, P39, DOI 10.1111/j.1432-1033.1979.tb13157.x; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; Ngoh GA, 2009, CIRC RES, V104, P41, DOI 10.1161/CIRCRESAHA.108.189431; Rodicio R, 2000, J BIOL CHEM, V275, P40952, DOI 10.1074/jbc.M007131200; Roquemore EP, 1996, BIOCHEMISTRY-US, V35, P3578, DOI 10.1021/bi951918j; Schnier JB, 2003, BIOCHEM BIOPH RES CO, V309, P126, DOI 10.1016/S0006-291X(03)01542-0; Taylor RP, 2008, J BIOL CHEM, V283, P6050, DOI 10.1074/jbc.M707328200; Taylor RP, 2009, J BIOL CHEM, V284, P3425, DOI 10.1074/jbc.M803198200; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Walgren JLE, 2003, AM J PHYSIOL-ENDOC M, V284, pE424, DOI 10.1152/ajpendo.00382.2002; Wells L, 2002, MOL CELL PROTEOMICS, V1, P791, DOI 10.1074/mcp.M200048-MCP200; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Yang WH, 2008, P NATL ACAD SCI USA, V105, P17345, DOI 10.1073/pnas.0806198105; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Ye F, 2004, J BIOCHEM BIOPH METH, V59, P201, DOI 10.1016/j.jbbm.2003.02.001; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016; Zachara NE, 2004, TRENDS CELL BIOL, V14, P218, DOI 10.1016/j.tcb.2004.03.005; Zhang FX, 2003, CELL, V115, P715, DOI 10.1016/S0092-8674(03)00974-7	40	60	66	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34777	34784		10.1074/jbc.M109.026351	http://dx.doi.org/10.1074/jbc.M109.026351			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19833729	Green Published, hybrid			2022-12-27	WOS:000272439600033
J	Marjoram, RJ; Voss, B; Pan, YM; Dickeson, SK; Zutter, MM; Hamm, HE; Santoro, SA				Marjoram, Robin J.; Voss, Bryan; Pan, Yumei; Dickeson, S. Kent; Zutter, Mary M.; Hamm, Heidi E.; Santoro, Samuel A.			Suboptimal Activation of Protease-activated Receptors Enhances alpha(2)beta(1) Integrin-mediated Platelet Adhesion to Collagen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT THROMBUS FORMATION; GLYCOPROTEIN-VI; ALPHA-2-BETA-1 INTEGRIN; GAMMA-CHAIN; PAR4; PEPTIDES; BINDING; MOUSE; FLOW; DETERMINANTS	Thrombin and fibrillar collagen are potent activators of platelets at sites of vascular injury. Both agonists cause platelet shape change, granule secretion, and aggregation to form the primary hemostatic plug. Human platelets express two thrombin receptors, protease-activated receptors 1 and 4 (PAR1 and PAR4) and two collagen receptors, the alpha(2)beta(1) integrin (alpha(2)beta(1)) and the glycoprotein VI (GPVI)/FcR gamma chain complex. Although these receptors and their signaling mechanisms have been intensely studied, it is not known whether and how these receptors cooperate in the hemostatic function of platelets. This study examined cooperation between the thrombin and collagen receptors in platelet adhesion by utilizing a collagen-related peptide (alpha 2-CRP) containing the alpha(2)beta(1)-specific binding motif, GFOGER, in conjunction with PAR-activating peptides. We demonstrate that platelet adhesion to alpha 2-CRP is substantially enhanced by suboptimal PAR activation (agonist concentrations that do not stimulate platelet aggregation) using the PAR4 agonist peptide and thrombin. The enhanced adhesion induced by suboptimal PAR4 activation was alpha(2)beta(1)-dependent and GPVI/FcR gamma-independent as revealed in experiments with alpha(2)beta(1)- or FcR gamma-deficient mouse platelets. We further show that suboptimal activation of other platelet G(q)-linked G protein-coupled receptors (GPCRs) produces enhanced platelet adhesion to alpha 2-CRP. The enhanced alpha(2)beta(1)-mediated platelet adhesion is controlled by phospholipase C (PLC), but is not dependent on granule secretion, activation of alpha(IIb)beta(3) integrin, or on phosphoinositol-3 kinase (PI3K) activity. In conclusion, we demonstrate a platelet priming mechanism initiated by suboptimal activation of PAR4 or other platelet G(q)-linked GPCRs through a PLC-dependent signaling cascade that promotes enhanced alpha(2)beta(1) binding to collagens containing GFOGER sites.	[Santoro, Samuel A.] Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37232 USA; [Voss, Bryan; Hamm, Heidi E.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Santoro, SA (corresponding author), Vanderbilt Univ, Sch Med, Dept Pathol, C3322 MCN 2561, Nashville, TN 37232 USA.	samuel.santoro@vanderbilt.edu			National Institutes of Health [P50 HLO81009]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL081009] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant P50 HLO81009.	Auger JM, 2005, FASEB J, V19, P825, DOI 10.1096/fj.04-1940fje; BAUMGARTNER HR, 1977, THROMB HAEMOSTASIS, V37, P1; Blair P, 2009, BLOOD REV, V23, P177, DOI 10.1016/j.blre.2009.04.001; Brass LF, 2003, CHEST, V124, p18S, DOI 10.1378/chest.124.3_suppl.18S; Chen H, 2003, MOL CELL BIOL, V23, P4764, DOI 10.1128/MCB.23.14.4764-4777.2003; Chen JC, 2002, AM J PATHOL, V161, P337, DOI 10.1016/S0002-9440(10)64185-5; Clemetson JM, 1999, J BIOL CHEM, V274, P29019, DOI 10.1074/jbc.274.41.29019; CORDINGLEY MG, 1989, J VIROL, V63, P5037, DOI 10.1128/JVI.63.12.5037-5045.1989; Covic L, 2000, BIOCHEMISTRY-US, V39, P5458, DOI 10.1021/bi9927078; DAVEY MG, 1967, NATURE, V216, P857, DOI 10.1038/216857a0; Dickeson SK, 1997, J BIOL CHEM, V272, P7661, DOI 10.1074/jbc.272.12.7661; Farndale RW, 2008, BIOCHEM SOC T, V36, P241, DOI 10.1042/BST0360241; Faruqi TR, 2000, J BIOL CHEM, V275, P19728, DOI 10.1074/jbc.M909960199; He L, 2003, BLOOD, V102, P3652, DOI 10.1182/blood-2003-04-1323; Holinstat M, 2006, J BIOL CHEM, V281, P26665, DOI 10.1074/jbc.M602174200; Inoue O, 2003, J CELL BIOL, V160, P769, DOI 10.1083/jcb.200208043; Jung SM, 2000, J BIOL CHEM, V275, P8016, DOI 10.1074/jbc.275.11.8016; Jung SM, 1998, J BIOL CHEM, V273, P14827, DOI 10.1074/jbc.273.24.14827; Kahn ML, 1999, J CLIN INVEST, V103, P879, DOI 10.1172/JCI6042; Kahn ML, 1998, NATURE, V394, P690, DOI 10.1038/29325; Kato K, 2003, BLOOD, V102, P1701, DOI 10.1182/blood-2003-03-0717; Kehrel B, 1998, BLOOD, V91, P491; Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35; Leger AJ, 2006, CIRCULATION, V113, P1244, DOI 10.1161/CIRCULATIONAHA.105.587758; Mangin P, 2006, BLOOD, V107, P4346, DOI 10.1182/blood-2005-10-4244; MOROI M, 1989, J CLIN INVEST, V84, P1440, DOI 10.1172/JCI114318; Munnix ICA, 2008, J THROMB HAEMOST, V6, P2132, DOI 10.1111/j.1538-7836.2008.03167.x; Nakanishi-Matsui M, 2000, NATURE, V404, P609, DOI 10.1038/35007085; Neeves KB, 2008, J THROMB HAEMOST, V6, P2193, DOI 10.1111/j.1538-7836.2008.03188.x; Nieswandt B, 2000, J BIOL CHEM, V275, P23998, DOI 10.1074/jbc.M003803200; Nieswandt B, 2001, EMBO J, V20, P2120, DOI 10.1093/emboj/20.9.2120; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; OTOOLE TE, 1990, CELL REGUL, V1, P883, DOI 10.1091/mbc.1.12.883; SANTORO SA, 1991, CELL REGUL, V2, P905, DOI 10.1091/mbc.2.11.905; SANTORO SA, 1994, METHOD ENZYMOL, V245, P147; Sarratt KL, 2005, BLOOD, V106, P1268, DOI 10.1182/blood-2004-11-4434; Shapiro MJ, 2000, J BIOL CHEM, V275, P25216, DOI 10.1074/jbc.M004589200; SHATTIL SJ, 1985, J BIOL CHEM, V260, P1107; Siljander PRM, 2004, J BIOL CHEM, V279, P47763, DOI 10.1074/jbc.M404685200; Smethurst PA, 2007, J BIOL CHEM, V282, P1296, DOI 10.1074/jbc.M606479200; STAATZ WD, 1989, J CELL BIOL, V108, P1917, DOI 10.1083/jcb.108.5.1917; Stricker TP, 2001, J BIOL CHEM, V276, P29375, DOI 10.1074/jbc.M102217200; Tsuji M, 1997, J BIOL CHEM, V272, P23528, DOI 10.1074/jbc.272.38.23528; van der Meijden PEJ, 2009, BLOOD, V114, P881, DOI 10.1182/blood-2008-07-171066; Voss B, 2007, MOL PHARMACOL, V71, P1399, DOI 10.1124/mol.106.033365; Zou ZY, 2009, BLOOD, V113, P6428, DOI 10.1182/blood-2008-08-175356	47	13	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34640	34647		10.1074/jbc.M109.020990	http://dx.doi.org/10.1074/jbc.M109.020990			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19815553	hybrid, Green Published			2022-12-27	WOS:000272439600019
J	Kalupov, T; Brillard-Bourdet, M; Dade, S; Serrano, H; Wartelle, J; Guyot, N; Juliano, L; Moreau, T; Belaaouaj, A; Gauthier, F				Kalupov, Timofey; Brillard-Bourdet, Michele; Dade, Sebastien; Serrano, Helene; Wartelle, Julien; Guyot, Nicolas; Juliano, Luiz; Moreau, Thierry; Belaaouaj, Azzaq; Gauthier, Francis			Structural Characterization of Mouse Neutrophil Serine Proteases and Identification of Their Substrate Specificities RELEVANCE TO MOUSE MODELS OF HUMAN INFLAMMATORY DISEASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; HUMAN CATHEPSIN-G; ACUTE LUNG INJURY; CYSTIC-FIBROSIS; CHROMOSOMAL LOCALIZATION; GENOMIC ORGANIZATION; LEUKOCYTE ELASTASE; HUMAN PROTEINASE-3; ANIMAL-MODELS; MURINE MODEL	It is widely accepted that neutrophil serine proteases (NSPs) play a critical role in neutrophil-associated lung inflammatory and tissue-destructive diseases. To investigate NSP pathogenic role(s), various mouse experimental models have been developed that mimic acutely or chronically injured human lungs. We and others are using mouse exposure to cigarette smoke as a model for chronic obstructive pulmonary disease with or without exacerbation. However, the relative contribution of NSPs to lung disease processes as well as their underlying mechanisms remains still poorly understood. And the lack of purified mouse NSPs and their specific substrates have hampered advances in these studies. In this work, we compared mouse and human NSPs and generated three-dimensional models of murine NSPs based on three-dimensional structures of their human homologs. Analyses of these models provided compelling evidence that peptide substrate specificities of human and mouse NSPs are different despite their conserved cleft and close structural resemblance. These studies allowed us to synthesize for the first time novel sensitive fluorescence resonance energy transfer substrates for individual mouse NSPs. Our findings and the newly identified substrates should better our understanding about the role of NSPs in the pathogenesis of cigarette-associated chronic obstructive pulmonary disease as well as other neutrophils-associated inflammatory diseases.	[Wartelle, Julien; Guyot, Nicolas; Belaaouaj, Azzaq; Gauthier, Francis] CHU Reims, Hop Maison Blanche, URCA, INSERM,AVENIR,EA 4303,IFR 53, F-51092 Reims, France; [Kalupov, Timofey; Brillard-Bourdet, Michele; Dade, Sebastien; Serrano, Helene; Moreau, Thierry] Univ Tours, IFR 135, INSERM, U618, F-37032 Tours, France; [Juliano, Luiz] Univ Fed Sao Paulo, Escola Paulista Med, Dept Biofis, BR-0404420 Sao Paulo, Brazil	CHU de Reims; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Reims Champagne-Ardenne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; Universidade Federal de Sao Paulo (UNIFESP)	Belaaouaj, A (corresponding author), CHU Reims, Hop Maison Blanche, URCA, INSERM,AVENIR,EA 4303,IFR 53, 45 Cognacq Jay St, F-51092 Reims, France.	azzaq.belaaouaj@univ-reims.fr; francis.gauthier@univ-tours.fr	Complexos, INCT Fluidos/H-9172-2013; Juliano, Luiz/D-7204-2012; Bentaher, Abderrazzaq/M-4424-2017; A, Bentaher/F-6531-2018	Juliano, Luiz/0000-0002-5589-2822; A, Bentaher/0000-0001-6001-5456; Dade, Sebastien/0000-0001-9329-7496	Agence Nationale de la Recherche (ANR) [ANR-07-PHYSIO-029-01]	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	This work was supported by the Agence Nationale de la Recherche (ANR), Contract ANR-07-PHYSIO-029-01.	ANDERSSON KB, 1988, NATURE, V332, P688, DOI 10.1038/332688a0; Attucci S, 2002, BIOCHEM J, V366, P965, DOI 10.1042/BJ20020321; Attucci S, 2006, J PHARMACOL EXP THER, V318, P803, DOI 10.1124/jpet.106.103440; Belaaouaj A, 2002, MICROBES INFECT, V4, P1259, DOI 10.1016/S1286-4579(02)01654-4; Belaaouaj A, 1999, MAMM GENOME, V10, P210; Belaaouaj K, 1997, MAMM GENOME, V8, P5, DOI 10.1007/s003359900337; BIRRER P, 1995, RESPIRATION, V62, P25; BODE W, 1989, BIOCHEMISTRY-US, V28, P1951, DOI 10.1021/bi00431a001; Delacourt C, 2002, AM J RESP CELL MOL, V26, P290, DOI 10.1165/ajrcmb.26.3.4611; ERIKSSON S, 1965, ACTA MED SCAND, VS177, P5; Ganz T, 1999, P ASSOC AM PHYSICIAN, V111, P390, DOI 10.1111/paa.1999.111.5.390; Hajjar E, 2007, FEBS LETT, V581, P5685, DOI 10.1016/j.febslet.2007.11.029; Hirche TO, 2004, AM J RESP CELL MOL, V30, P576, DOI 10.1165/rcmb.2003-0253OC; Hof P, 1996, EMBO J, V15, P5481, DOI 10.1002/j.1460-2075.1996.tb00933.x; HOHN PA, 1989, J BIOL CHEM, V264, P13412; Houghton AM, 2006, J CLIN INVEST, V116, P753, DOI 10.1172/JCI25617; JANOFF A, 1985, AM REV RESPIR DIS, V132, P417; Kawabata K, 2002, EUR J PHARMACOL, V451, P1, DOI 10.1016/S0014-2999(02)02182-9; Kessenbrock K, 2008, J CLIN INVEST, V118, P2438, DOI 10.1172/JCI34694; Korkmaz B, 2008, NAT PROTOC, V3, P991, DOI 10.1038/nprot.2008.63; Korkmaz B, 2007, J BIOL CHEM, V282, P1989, DOI 10.1074/jbc.M608700200; LAFUMA C, 1991, EUR RESPIR J, V4, P1004; Lane AA, 2003, CELL, V115, P305, DOI 10.1016/S0092-8674(03)00852-3; Lee WL, 2001, AM J RESP CRIT CARE, V164, P896, DOI 10.1164/ajrccm.164.5.2103040; Mahadeva R, 2002, THORAX, V57, P908, DOI 10.1136/thorax.57.10.908; Preston GA, 2002, J AM SOC NEPHROL, V13, P2840, DOI 10.1097/01.ASN.0000034911.03334.C3; Rehault S, 1999, J BIOL CHEM, V274, P13810, DOI 10.1074/jbc.274.20.13810; Sandford AJ, 1997, EUR RESPIR J, V10, P1380, DOI 10.1183/09031936.97.10061380; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SERVEAU C, 1992, FEBS LETT, V309, P405, DOI 10.1016/0014-5793(92)80817-Z; Wiesner O, 2005, FEBS LETT, V579, P5305, DOI 10.1016/j.febslet.2005.08.056; Wright JL, 2008, AM J PHYSIOL-LUNG C, V295, pL1, DOI 10.1152/ajplung.90200.2008	32	42	42	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34084	34091		10.1074/jbc.M109.042903	http://dx.doi.org/10.1074/jbc.M109.042903			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19833730	Green Published, hybrid			2022-12-27	WOS:000272165200041
J	Robinson, SD; Reynolds, LE; Kostourou, V; Reynolds, AR; da Silva, RG; Tavora, B; Baker, M; Marshall, JF; Hodivala-Dilke, KM				Robinson, Stephen D.; Reynolds, Louise E.; Kostourou, Vassiliki; Reynolds, Andrew R.; da Silva, Rita Graca; Tavora, Bernardo; Baker, Marianne; Marshall, John F.; Hodivala-Dilke, Kairbaan M.			alpha v beta 3 Integrin Limits the Contribution of Neuropilin-1 to Vascular Endothelial Growth Factor-induced Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR RECEPTOR-2; PATHOLOGICAL ANGIOGENESIS; COMPUTATIONAL MODEL; CYTOPLASMIC DOMAIN; TUMOR ANGIOGENESIS; CELL-MIGRATION; BLOOD-VESSELS; VEGF ISOFORMS; ANTI-VEGF; IN-VIVO	Both vascular endothelial growth factor receptors (VEGFR) and integrins are major regulators of VEGF-induced angiogenesis. Previous work has shown that beta 3 integrin can regulate negatively VEGFR2 expression. Here we show that beta 3 integrin can regulate negatively VEGF-mediated angiogenesis by limiting the interaction of the co-receptor NRP1 (neuropilin-1) with VEGFR2. In the presence of alpha v beta 3 integrin, NRP1 contributed minimally to VEGF-induced angiogenic processes in vivo, ex vivo, and in vitro. Conversely, when beta 3 integrin expression is absent or low or its function is blocked with RGD-mimetic inhibitors, VEGF-mediated responses became NRP1-dependent. Indeed, combined inhibition of beta 3 integrin and NRP1 decreased VEGF-mediated angiogenic responses further than individual inhibition of these receptors. We also show that alpha v beta 3 integrin can associate with NRP1 in a VEGF-dependent fashion. Our data suggest that beta 3 integrin may, in part, negatively regulate VEGF signaling by sequestering NRP1 and preventing it from interacting with VEGFR2.	[Tavora, Bernardo; Baker, Marianne; Hodivala-Dilke, Kairbaan M.] Queen Mary Univ London, John Vane Sci Ctr, Inst Canc, Tumour Biol Ctr,Adhes & Angiogenesis Lab, London EC1M 6BQ, England; [Marshall, John F.] Queen Mary Univ London, John Vane Sci Ctr, Inst Canc, Tumour Biol Ctr,Invas & Metastasis Lab, London EC1M 6BQ, England	University of London; Queen Mary University London; University of London; Queen Mary University London	Hodivala-Dilke, KM (corresponding author), Queen Mary Univ London, John Vane Sci Ctr, Inst Canc, Tumour Biol Ctr,Adhes & Angiogenesis Lab, Charterhouse Sq, London EC1M 6BQ, England.	k.hodivala-dilke@qmul.ac.uk		Hodivala-Dilke, Kairbaan/0000-0002-2859-749X; Kostourou, Vassiliki/0000-0001-7053-6247; Marshall, John/0000-0002-0494-2295; Robinson, Stephen/0000-0002-6606-7588	Cancer Research UK	Cancer Research UK(Cancer Research UK)	This work was supported by a grant from Cancer Research UK.	Alghisi GC, 2006, ENDOTHELIUM-J ENDOTH, V13, P113, DOI 10.1080/10623320600698037; ANDRADE SP, 1987, BRIT J EXP PATHOL, V68, P755; Barr MP, 2008, INT J ONCOL, V32, P41; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Cebe-Suarez S, 2006, CELL MOL LIFE SCI, V63, P601, DOI 10.1007/s00018-005-5426-3; Eliceiri BP, 2001, CIRC RES, V89, P1104, DOI 10.1161/hh2401.101084; Eliceiri BP, 1998, J CELL BIOL, V140, P1255, DOI 10.1083/jcb.140.5.1255; FRIEDLANDER M, 1995, SCIENCE, V270, P1500, DOI 10.1126/science.270.5241.1500; Fukasawa M, 2007, CANCER BIOL THER, V6, P1173; Gerhardt H, 2004, DEV DYNAM, V231, P503, DOI 10.1002/dvdy.20148; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Gustafsson E, 2001, J CELL SCI, V114, P671; Guttmann-Raviv N, 2006, CANCER LETT, V231, P1, DOI 10.1016/j.canlet.2004.12.047; Herzog Y, 2001, MECH DEVELOP, V109, P115, DOI 10.1016/S0925-4773(01)00518-4; Jain RK, 2006, NAT CLIN PRACT ONCOL, V3, P24, DOI 10.1038/ncponc0403; Jia HY, 2006, J BIOL CHEM, V281, P13493, DOI 10.1074/jbc.M512121200; Kawamura H, 2008, BLOOD, V112, P3638, DOI 10.1182/blood-2007-12-125856; Kawasaki T, 1999, DEVELOPMENT, V126, P4895; Krilleke D, 2007, J BIOL CHEM, V282, P28045, DOI 10.1074/jbc.M700319200; Mac Gabhann F, 2005, AM J PHYSIOL-HEART C, V288, pH2851, DOI 10.1152/ajpheart.01218.2004; Mac Gabhann F, 2007, AM J PHYSIOL-HEART C, V292, pH459, DOI 10.1152/ajpheart.00637.2006; Mahabeleshwar GH, 2006, J EXP MED, V203, P2495, DOI 10.1084/jem.20060807; Maubant S, 2006, BLOOD, V108, P3035, DOI 10.1182/blood-2006-05-023580; May T, 2005, J BIOTECHNOL, V120, P99, DOI 10.1016/j.jbiotec.2005.03.027; MECHTERSHEIMER G, 1994, VIRCHOWS ARCH, V425, P375; Nicosia RF, 1997, AM J PATHOL, V151, P1379; Pan Q, 2007, J BIOL CHEM, V282, P24049, DOI 10.1074/jbc.M703554200; Pan Q, 2007, CANCER CELL, V11, P53, DOI 10.1016/j.ccr.2006.10.018; Perron-Sierra F, 2002, BIOORG MED CHEM LETT, V12, P3291, DOI 10.1016/S0960-894X(02)00696-0; Phillips DR, 2001, THROMB HAEMOSTASIS, V86, P246; Presta M, 2005, ARTERIOSCL THROM VAS, V25, P71, DOI 10.1161/01.ATV.0000148863.24445.b4; Reynolds AR, 2009, NAT MED, V15, P392, DOI 10.1038/nm.1941; Reynolds AR, 2004, CANCER RES, V64, P8643, DOI 10.1158/0008-5472.CAN-04-2760; Reynolds LE, 2002, NAT MED, V8, P27, DOI 10.1038/nm0102-27; Reynolds LE, 2006, METH MOLEC MED, V120, P503; ROSEN EM, 1997, CIBA F SYMP, V212, P227; ROSEN EM, 1997, CIBA FOUND S, V219, P226; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; Schaffner-Reckinger E, 1998, J BIOL CHEM, V273, P12623, DOI 10.1074/jbc.273.20.12623; Schaffner-Reckinger E, 2001, THROMB HAEMOSTASIS, V85, P716, DOI 10.1055/s-0037-1615658; Shraga-Heled N, 2007, FASEB J, V21, P915, DOI 10.1096/fj.06-6277com; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Soker S, 2002, J CELL BIOCHEM, V85, P357, DOI 10.1002/jcb.10140; Soldi R, 1999, EMBO J, V18, P882, DOI 10.1093/emboj/18.4.882; Starzec A, 2007, PEPTIDES, V28, P2397, DOI 10.1016/j.peptides.2007.09.013; Starzec A, 2006, LIFE SCI, V79, P2370, DOI 10.1016/j.lfs.2006.08.005; Strieth S, 2006, INT J CANCER, V119, P423, DOI 10.1002/ijc.21838; Sulpice E, 2008, BLOOD, V111, P2036, DOI 10.1182/blood-2007-04-084269; Takahashi T, 1999, ONCOGENE, V18, P2221, DOI 10.1038/sj.onc.1202527; Takashima S, 2002, P NATL ACAD SCI USA, V99, P3657, DOI 10.1073/pnas.022017899; Thurston G, 1998, AM J PATHOL, V153, P1099, DOI 10.1016/S0002-9440(10)65654-4; Valdembri D, 2009, PLOS BIOL, V7, P115, DOI 10.1371/journal.pbio.1000025; Varner Judith A., 1996, P69; Veeravagu A, 2007, RECENT PAT ANTI-CANC, V2, P59, DOI 10.2174/157489207779561426; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; West H, 2005, DEVELOPMENT, V132, P1855, DOI 10.1242/dev.01732; Wey Jane S, 2004, Clin Adv Hematol Oncol, V2, P37; Whitaker GB, 2001, J BIOL CHEM, V276, P25520, DOI 10.1074/jbc.M102315200; Yuan L, 2002, DEVELOPMENT, V129, P4797	60	70	72	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33966	33981		10.1074/jbc.M109.030700	http://dx.doi.org/10.1074/jbc.M109.030700			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19837659	hybrid, Green Published			2022-12-27	WOS:000272165200029
J	Shukla, U; Hatani, T; Nakashima, K; Ogi, K; Sada, K				Shukla, Upasana; Hatani, Tomoko; Nakashima, Kenji; Ogi, Kazuhiro; Sada, Kiyonao			Tyrosine Phosphorylation of 3BP2 Regulates B Cell Receptor-mediated Activation of NFAT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADAPTER PROTEIN 3BP2; PHOSPHOTYROSINE-BINDING DOMAIN; LEUKEMIA RBL-2H3 CELLS; AFFINITY IGE RECEPTOR; ANTIGEN RECEPTOR; KINASE SYK; NEGATIVE REGULATION; GAMMA-CHAIN; SH2 DOMAINS; T-CELLS	Adaptor protein c-Abl SH3 domain-binding protein-2 (3BP2, also referred to SH3BP2) regulates immune receptor-mediated signal transduction. In this report we focused on the molecular mechanism of 3BP2 function in B cell receptor (BCR) signaling. Engagement of BCR induces tyrosine phosphorylation of 3BP2. Genetic analysis demonstrated that Syk is critical for BCR-mediated tyrosine phosphorylation of 3BP2. Mutational analysis of 3BP2 revealed that both Tyr(183) and Src homology 2 (SH2) domain are necessary for 3BP2-mediated BCR-induced activation of nuclear factor of activated T cells (NFAT). Point mutation of Tyr(183) or Arg(486) in the SH2 domain of 3BP2 diminished BCR-mediated tyrosine phosphorylation of 3BP2. Endogenous 3BP2 forms a complex with tyrosine-phosphorylated cellular signaling molecules. Peptide binding experiments demonstrated that only phosphorylated Tyr183 in 3BP2 could form a complex with the SH2 domain(s) of phospholipase C gamma 2 and Vav1 from B cell lysates. These interactions were represented by using bacterial glutathione S-transferase-phospholipase C gamma 2 or -Vav1 SH2 domain. Furthermore, pulldown and Far Western experiments showed that the 3BP2-SH2 domain directly binds to B cell linker protein (BLNK) after BCR stimulation. These results demonstrated that 3BP2 induces the protein complex with cellular signaling molecules through phosphorylation of Tyr(183) and SH2 domain leading to the activation of NFAT in B cells.	[Sada, Kiyonao] Univ Fukui, Div Microbiol, Dept Pathol Sci, Fac Med Sci, Fukui 9101193, Japan; [Hatani, Tomoko; Sada, Kiyonao] Univ Fukui, Org Life Sci Advancement Programs, Fukui 9101193, Japan	University of Fukui; University of Fukui	Sada, K (corresponding author), Univ Fukui, Div Microbiol, Dept Pathol Sci, Fac Med Sci, 23-3 Matsuoka Shimoaizuki, Fukui 9101193, Japan.	ksada@u-fukui.ac.jp	Sada, Kiyonao/H-7373-2015	Sada, Kiyonao/0000-0001-6124-3100	University of Fukui; Takeda Science Foundation; Osaka Medical Research Foundation; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, and Technology, Japan	University of Fukui; Takeda Science Foundation(Takeda Science Foundation (TSF)); Osaka Medical Research Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by research funding from the University of Fukui ( to K. S.), by the Takeda Science Foundation ( to K. S.), by the Osaka Medical Research Foundation for Incurable Diseases and by grants-in-aid from the Japan Society for the Promotion of Science and the Ministry of Education, Culture, Sports, and Technology, Japan.	Antony P, 2003, EXP CELL RES, V291, P11, DOI 10.1016/S0014-4827(03)00338-0; Bailet O, 2009, CANCER RES, V69, P2748, DOI 10.1158/0008-5472.CAN-08-2690; Cha HS, 2006, J PHARMACOL EXP THER, V317, P571, DOI 10.1124/jpet.105.097436; CHAN AC, 1995, EMBO J, V14, P2499, DOI 10.1002/j.1460-2075.1995.tb07247.x; Chen G, 2007, MOL CELL BIOL, V27, P3109, DOI 10.1128/MCB.01014-06; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; Chiu CW, 2002, EMBO J, V21, P6461, DOI 10.1093/emboj/cdf658; Chung SC, 2007, J CELL BIOL, V177, P317, DOI 10.1083/jcb.200702050; Coopman PJP, 2000, NATURE, V406, P742, DOI 10.1038/35021086; Costello PS, 1996, ONCOGENE, V13, P2595; de la Fuente MA, 2006, MOL CELL BIOL, V26, P5214, DOI 10.1128/MCB.00087-06; Deckert M, 1998, IMMUNITY, V9, P595, DOI 10.1016/S1074-7613(00)80657-3; Deckert M, 2006, ADV EXP MED BIOL, V584, P107; Foucault I, 2005, BLOOD, V105, P1106, DOI 10.1182/blood-2003-08-2965; Fu C, 1998, IMMUNITY, V9, P93, DOI 10.1016/S1074-7613(00)80591-9; Furlong MT, 1997, BBA-MOL CELL RES, V1355, P177, DOI 10.1016/S0167-4889(96)00131-0; Goitsuka R, 1998, J IMMUNOL, V161, P5804; Greenberg S, 1996, P NATL ACAD SCI USA, V93, P1103, DOI 10.1073/pnas.93.3.1103; Hao SL, 2003, EMBO J, V22, P4166, DOI 10.1093/emboj/cdg401; Hatani T, 2008, CURR MED CHEM, V15, P549; Ishiai M, 1999, IMMUNITY, V10, P117, DOI 10.1016/S1074-7613(00)80012-6; Krishnan S, 2008, J IMMUNOL, V181, P8145, DOI 10.4049/jimmunol.181.11.8145; KUROSAKI T, 1995, J EXP MED, V182, P1815, DOI 10.1084/jem.182.6.1815; Lupher ML, 1998, J BIOL CHEM, V273, P35273, DOI 10.1074/jbc.273.52.35273; Ma H, 2001, J IMMUNOL, V166, P1507, DOI 10.4049/jimmunol.166.3.1507; Maeno K, 2003, J BIOL CHEM, V278, P24912, DOI 10.1074/jbc.M301201200; Miah SMS, 2004, GENES CELLS, V9, P993, DOI 10.1111/j.1365-2443.2004.00784.x; Miah SMS, 2004, MOL CELL BIOL, V24, P71, DOI 10.1128/MCB.24.1.71-83.2004; Mocsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Pelosi M, 1999, J BIOL CHEM, V274, P14229, DOI 10.1074/jbc.274.20.14229; Poole A, 1997, EMBO J, V16, P2333, DOI 10.1093/emboj/16.9.2333; Qu XJ, 2005, BIOCHEMISTRY-US, V44, P3891, DOI 10.1021/bi048353o; Qu XJ, 2004, BLOOD, V103, P1779, DOI 10.1182/blood-2003-07-2260; Rao N, 2001, EMBO J, V20, P7085, DOI 10.1093/emboj/20.24.7085; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; Rudd CE, 1999, CELL, V96, P5, DOI 10.1016/S0092-8674(00)80953-8; Sada K, 2002, BLOOD, V100, P2138, DOI 10.1182/blood-2001-12-0340; Sada K, 2001, J BIOCHEM-TOKYO, V130, P177, DOI 10.1093/oxfordjournals.jbchem.a002970; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; Takata M, 1996, J EXP MED, V184, P31, DOI 10.1084/jem.184.1.31; TANIGUCHI T, 1991, J BIOL CHEM, V266, P15790; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; Turner M, 2000, IMMUNOL TODAY, V21, P148, DOI 10.1016/S0167-5699(99)01574-1; Ueki Y, 2001, NAT GENET, V28, P125, DOI 10.1038/88832; Ueki Y, 2007, CELL, V128, P71, DOI 10.1016/j.cell.2006.10.047; Williams BL, 1999, EMBO J, V18, P1832, DOI 10.1093/emboj/18.7.1832; Yankee TM, 1999, J IMMUNOL, V163, P5827; Zhang J, 1996, J EXP MED, V184, P71, DOI 10.1084/jem.184.1.71	50	31	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33719	33728		10.1074/jbc.M109.049999	http://dx.doi.org/10.1074/jbc.M109.049999			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19833725	Green Published, hybrid			2022-12-27	WOS:000272165200002
J	Viarre, V; Cascales, E; Ball, G; Michel, GPF; Filloux, A; Voulhoux, R				Viarre, Veronique; Cascales, Eric; Ball, Genevieve; Michel, Gerard P. F.; Filloux, Alain; Voulhoux, Rome			HxcQ Liposecretin Is Self-piloted to the Outer Membrane by Its N-terminal Lipid Anchor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENERAL SECRETORY PATHWAY; GRAM-NEGATIVE BACTERIA; PSEUDOMONAS-AERUGINOSA; PROTEIN SECRETION; II SECRETION; PILUS; SPECIFICITY; LIPOPROTEIN; CHAPERONE; SYSTEM	Secretins are an unusual and important class of bacterial outer membrane (OM) proteins. They are involved in the transport of single proteins or macromolecular structures such as pili, needle complexes, and bacteriophages across the OM. Secretins are multimeric ring-shaped structures that form large pores in the OM. The targeting of such macromolecular structures to the OM often requires special assistance, conferred by specific pilotins or pilot proteins. Here, we investigated HxcQ, the OM component of the second Pseudomonas aeruginosa type II secretion system. We found that HxcQ forms high molecular mass structures resistant to heat and SDS, revealing its secretin nature. Interestingly, we showed that HxcQ is a lipoprotein. Construction of a recombinant nonlipidated HxcQ (HxcQnl) revealed that lipidation is essential for HxcQ function. Further phenotypic analysis indicated that HxcQnl accumulates as multimers in the inner membrane of P. aeruginosa, a typical phenotype observed for secretins in the absence of their cognate pilotin. Our observations led us to the conclusion that the lipid anchor of HxcQ plays a pilotin role. The self-piloting of HxcQ to the OM was further confirmed by its correct multimeric OM localization when expressed in the heterologous host Escherichia coli. Altogether, our results reveal an original and unprecedented pathway for secretin transport to the OM.	[Voulhoux, Rome] CNRS, Lab Ingn Syst Macromol, IMM, UPR 9027, F-13402 Marseille 20, France; [Filloux, Alain] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, Ctr Mol Microbiol & Infect, London SW7 2AZ, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Imperial College London	Voulhoux, R (corresponding author), CNRS, Lab Ingn Syst Macromol, IMM, UPR 9027, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.	voulhoux@ifr88.cnrs-mrs.fr	CASCALES, ERIC/G-7420-2011; Voulhoux, Rome/AAT-5333-2021	CASCALES, ERIC/0000-0003-0611-9179; 	Agence Nationale de la Recherche [ANR-JC07-183230]; "ERA-NET Pathogenomics" [ANR-08-PATH-004-01]	Agence Nationale de la Recherche(French National Research Agency (ANR)); "ERA-NET Pathogenomics"	Research in the Rome 'Voulhoux laboratory was supported by Agence Nationale de la Recherche programs, "Young researcher" (Grant ANR-JC07-183230) and "ERA-NET Pathogenomics" (Grant ANR-08-PATH-004-01).	Babu MM, 2002, BIOINFORMATICS, V18, P641, DOI 10.1093/bioinformatics/18.4.641; Ball G, 2002, MOL MICROBIOL, V43, P475, DOI 10.1046/j.1365-2958.2002.02759.x; Bayan N, 2006, MOL MICROBIOL, V60, P1, DOI 10.1111/j.1365-2958.2006.05084.x; Bitter W, 2003, ARCH MICROBIOL, V179, P307, DOI 10.1007/s00203-003-0541-8; Bitter W, 1998, MOL MICROBIOL, V27, P209, DOI 10.1046/j.1365-2958.1998.00677.x; Bose N, 2005, J BACTERIOL, V187, P2225, DOI 10.1128/JB.187.7.2225-2232.2005; Bouley J, 2001, J MOL BIOL, V308, P205, DOI 10.1006/jmbi.2001.4594; Burghout P, 2004, J BACTERIOL, V186, P5366, DOI 10.1128/JB.186.16.5366-5375.2004; Cascales E, 2004, P NATL ACAD SCI USA, V101, P17228, DOI 10.1073/pnas.0405843101; Chami M, 2005, J BIOL CHEM, V280, P37732, DOI 10.1074/jbc.M504463200; Collin S, 2007, MOL MICROBIOL, V64, P1350, DOI 10.1111/j.1365-2958.2007.05743.x; Collins RF, 2004, J BIOL CHEM, V279, P39750, DOI 10.1074/jbc.M405971200; Crago AM, 1998, MOL MICROBIOL, V30, P47, DOI 10.1046/j.1365-2958.1998.01036.x; Daefler S, 1997, MOL MICROBIOL, V24, P465, DOI 10.1046/j.1365-2958.1997.3531727.x; Daniel A, 2006, MICROBIOL-SGM, V152, P2405, DOI 10.1099/mic.0.28860-0; De Groot A, 2001, J BACTERIOL, V183, P959, DOI 10.1128/JB.183.3.959-967.2001; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Filloux A, 2004, BBA-MOL CELL RES, V1694, P163, DOI 10.1016/j.bbamcr.2004.05.003; FURSTE JP, 1986, GENE, V48, P119, DOI 10.1016/0378-1119(86)90358-6; GENIN S, 1994, MOL GEN GENET, V243, P112, DOI 10.1007/BF00283883; Guilvout I, 2006, EMBO J, V25, P5241, DOI 10.1038/sj.emboj.7601402; Hardie KR, 1996, MOL MICROBIOL, V22, P967, DOI 10.1046/j.1365-2958.1996.01539.x; Hardie KR, 1996, EMBO J, V15, P978, DOI 10.1002/j.1460-2075.1996.tb00434.x; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; HU NT, 1995, MICROBIOL-UK, V141, P1395, DOI 10.1099/13500872-141-6-1395; HUSSAIN M, 1980, J BIOL CHEM, V255, P3707; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; Korotkov KV, 2009, STRUCTURE, V17, P255, DOI 10.1016/j.str.2008.11.011; Koster M, 1997, MOL MICROBIOL, V26, P789, DOI 10.1046/j.1365-2958.1997.6141981.x; Linderoth NA, 1996, J BACTERIOL, V178, P1962, DOI 10.1128/jb.178.7.1962-1970.1996; LUGTENBERG B, 1975, FEBS LETT, V58, P254, DOI 10.1016/0014-5793(75)80272-9; Michel GPF, 2007, J BACTERIOL, V189, P3776, DOI 10.1128/JB.00205-07; Michel Gerard P. F., 2009, P67; Newman JR, 1999, GENE, V227, P197, DOI 10.1016/S0378-1119(98)00601-5; Nudleman E, 2006, MOL MICROBIOL, V60, P16, DOI 10.1111/j.1365-2958.2006.05095.x; OSBORN MJ, 1972, J BIOL CHEM, V247, P3962; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Remaut H, 2004, CURR OPIN STRUC BIOL, V14, P161, DOI 10.1016/j.sbi.2004.03.004; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SANKARAN K, 1994, J BIOL CHEM, V269, P19701; Schmidt SA, 2001, J BACTERIOL, V183, P4848, DOI 10.1128/JB.183.16.4848-4859.2001; Schuch R, 2001, J BACTERIOL, V183, P6991, DOI 10.1128/JB.183.24.6991-6998.2001; Seo J, 2009, J BACTERIOL, V191, P898, DOI 10.1128/JB.01443-08; Seydel A, 1999, MOL MICROBIOL, V34, P810, DOI 10.1046/j.1365-2958.1999.01647.x; Shevchik VE, 1998, MICROBIOL-UK, V144, P3219, DOI 10.1099/00221287-144-11-3219; Shevchik VE, 1997, EMBO J, V16, P3007, DOI 10.1093/emboj/16.11.3007; Sohel I, 1996, J BACTERIOL, V178, P2613, DOI 10.1128/jb.178.9.2613-2628.1996; Tokuda H, 2004, BBA-MOL CELL RES, V1693, P5, DOI 10.1016/j.bbamcr.2004.02.005; Voulhoux R, 2001, EMBO J, V20, P6735, DOI 10.1093/emboj/20.23.6735; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; YAMAGUCHI K, 1988, CELL, V53, P423, DOI 10.1016/0092-8674(88)90162-6	51	55	55	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33815	33823		10.1074/jbc.M109.065938	http://dx.doi.org/10.1074/jbc.M109.065938			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19815547	Green Published, hybrid			2022-12-27	WOS:000272165200013
J	Li, F; Tian, L; Gu, LY; Li, GM				Li, Feng; Tian, Lei; Gu, Liya; Li, Guo-Min			Evidence That Nucleosomes Inhibit Mismatch Repair in Eukaryotic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SLIDING-CLAMP; MOLECULAR SWITCH; HMUTS-ALPHA; DNA-DAMAGE; BINDING; MUTL; RECONSTITUTION; ACETYLATION; RECOGNITION; MSH2-MSH6	The influence of chromatin structure on DNA metabolic processes, including DNA replication and repair, has been a matter of intensive studies in recent years. Although the human mismatch repair (MMR) reaction has been reconstituted using purified proteins, the influence of chromatin structure on human MMR is unknown. This study examines the interaction between human MutS alpha and a mismatch located within a nucleosome or between two nucleosomes. The results show that, whereas MutS alpha specifically recognizes both types of nucleosomal heteroduplexes, the protein bound the mismatch within a nucleosome with much lower efficiency than a naked heteroduplex or a heterology free of histone proteins but between two nucleosomes. Additionally, MutS alpha displays reduced ATPase- and ADP-binding activity when interacting with nucleosomal heteroduplexes. Interestingly, nucleosomes block ATP-induced MutS alpha sliding along the DNA helix when the mismatch is in between two nucleosomes. These findings suggest that nucleosomes may inhibit MMR in eukaryotic cells. The implications of these findings for our understanding of eukaryotic MMR are discussed.	[Li, Feng; Tian, Lei; Gu, Liya; Li, Guo-Min] Univ Kentucky, Coll Med, Markey Canc Ctr, Grad Ctr Toxicol, Lexington, KY 40536 USA	University of Kentucky	Li, GM (corresponding author), Univ Kentucky, Coll Med, Markey Canc Ctr, Grad Ctr Toxicol, Lexington, KY 40536 USA.	gmli@uky.edu	Li, Guo-Min/I-5016-2014	Li, Guo-Min/0000-0002-9842-4578; Li, Feng/0000-0002-9201-1668	National Institutes of Health [GM072756]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072756] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM072756 ( to G. M. L.).	Alexeev A, 2003, NAT STRUCT BIOL, V10, P182, DOI 10.1038/nsb901; Blackwell LJ, 1998, J BIOL CHEM, V273, P32055, DOI 10.1074/jbc.273.48.32055; Constantin N, 2005, J BIOL CHEM, V280, P39752, DOI 10.1074/jbc.M509701200; Downs JA, 2007, NATURE, V447, P951, DOI 10.1038/nature05980; DRUMMOND JT, 1995, SCIENCE, V268, P1909, DOI 10.1126/science.7604264; Gorman J, 2007, MOL CELL, V28, P359, DOI 10.1016/j.molcel.2007.09.008; Gradia S, 2000, J BIOL CHEM, V275, P3922, DOI 10.1074/jbc.275.6.3922; Gradia S, 1997, CELL, V91, P995, DOI 10.1016/S0092-8674(00)80490-0; Gradia S, 1999, MOL CELL, V3, P255, DOI 10.1016/S1097-2765(00)80316-0; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; Gu LY, 2006, METHOD ENZYMOL, V408, P303, DOI 10.1016/S0076-6879(06)08019-0; Guarne A, 2004, EMBO J, V23, P4134, DOI 10.1038/sj.emboj.7600412; Guo SL, 2004, J BIOL CHEM, V279, P16912, DOI 10.1074/jbc.M313213200; Hawk JD, 2005, P NATL ACAD SCI USA, V102, P8639, DOI 10.1073/pnas.0503415102; Iaccarino I, 2000, J BIOL CHEM, V275, P2080, DOI 10.1074/jbc.275.3.2080; Junop MS, 2001, MOL CELL, V7, P1, DOI 10.1016/S1097-2765(01)00149-6; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Li F, 2008, MUTAT RES-FUND MOL M, V637, P101, DOI 10.1016/j.mrfmmm.2007.07.008; Li GM, 1999, ONCOL RES, V11, P393; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; de Saro FJL, 2006, J BIOL CHEM, V281, P14340, DOI 10.1074/jbc.M601264200; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Loyola A, 2003, METHODS, V31, P96, DOI 10.1016/S1046-2023(03)00093-8; Manohar M, 2009, J BIOL CHEM, V284, P23312, DOI 10.1074/jbc.M109.003202; Mazur DJ, 2006, MOL CELL, V22, P39, DOI 10.1016/j.molcel.2006.02.010; MCGHEE JD, 1980, ANNU REV BIOCHEM, V49, P1115, DOI 10.1146/annurev.bi.49.070180.005343; Mendillo ML, 2005, J BIOL CHEM, V280, P22245, DOI 10.1074/jbc.M407545200; Pluciennik A, 2007, P NATL ACAD SCI USA, V104, P12709, DOI 10.1073/pnas.0705129104; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Simmons LA, 2008, MOL CELL, V29, P291, DOI 10.1016/j.molcel.2007.10.036; SIMPSON RT, 1976, BIOCHEMISTRY-US, V15, P4305, DOI 10.1021/bi00664a026; Smith BT, 2001, MOL CELL, V8, P1197, DOI 10.1016/S1097-2765(01)00402-6; Tian L, 2009, J BIOL CHEM, V284, P11557, DOI 10.1074/jbc.M900908200; Widlund HR, 1999, J BIOL CHEM, V274, P31847, DOI 10.1074/jbc.274.45.31847; Zhang Y, 2008, J BIOL CHEM, V283, P12730, DOI 10.1074/jbc.M800460200; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027	38	49	49	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33056	33061		10.1074/jbc.M109.049874	http://dx.doi.org/10.1074/jbc.M109.049874			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19808662	hybrid, Green Published			2022-12-27	WOS:000272028500008
J	Moreau, KL; King, J				Moreau, Kate L.; King, Jonathan			Hydrophobic Core Mutations Associated with Cataract Development in Mice Destabilize Human gamma D-Crystallin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN LENS PROTEINS; AGE-RELATED-CHANGES; GREEK KEY DOMAINS; DOMINANT CATARACT; TRYPTOPHAN FLUORESCENCE; MOLECULAR CHAPERONE; BACKBONE CLEAVAGE; MASS-SPECTROMETRY; ALPHA-CRYSTALLIN; S-CRYSTALLIN	The human eye lens is composed of fiber cells packed with crystallins up to 450 mg/ml. Human gamma D-crystallin (H gamma D-Crys) is a monomeric, two-domain protein of the lens central nucleus. Both domains of this long lived protein have double Greek key beta-sheet folds with well packed hydrophobic cores. Three mutations resulting in amino acid substitutions in the gamma-crystallin buried cores (two in the N-terminal domain(N-td) and one in the C-terminal domain (C-td)) cause early onset cataract in mice, presumably an aggregated state of the mutant crystallins. It has not been possible to identify the aggregating precursor within lens tissues. To compare in vivo cataract-forming phenotypes with in vitro unfolding and aggregation of gamma-crystallins, mouse mutant substitutions were introduced into H gamma D-Crys. The mutant proteins L5S, V75D, and I90F were expressed and purified from Escherichia coli. WT H gamma D-Crys unfolds in vitro through a three-state pathway, exhibiting an intermediate with the N-td unfolded and the C-td native-like. L5S and V75D in the N-td also displayed three-state unfolding transitions, with the first transition, unfolding of the N-td, shifted to significantly lower denaturant concentrations. I90F destabilized the C-td, shifting the overall unfolding transition to lower denaturant concentrations. During thermal denaturation, the mutant proteins exhibited lowered thermal stability compared with WT. Kinetic unfolding experiments showed that the N-tds of L5S and V75D unfolded faster than WT. I90F was globally destabilized and unfolded more rapidly. These results support models of cataract formation in which generation of partially unfolded species are precursors to the aggregated cataractous states responsible for light scattering.	[Moreau, Kate L.; King, Jonathan] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	King, J (corresponding author), 77 Massachusetts Ave,68-330, Cambridge, MA 02139 USA.	jaking@mit.edu			National Institutes of Health [GM17980, EY015834]; NATIONAL EYE INSTITUTE [R01EY015834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM017980, F32GM017980, P50GM068762, R37GM017980] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM17980 and EY015834 (to J.K.)	Ajaz MS, 1997, J BIOL CHEM, V272, P11250; Baldwin E, 1996, J MOL BIOL, V259, P542, DOI 10.1006/jmbi.1996.0338; Basak A, 2003, J MOL BIOL, V328, P1137, DOI 10.1016/S0022-2836(03)00375-9; BAX B, 1990, NATURE, V347, P776, DOI 10.1038/347776a0; BOYLE D, 1994, EXP EYE RES, V58, P9, DOI 10.1006/exer.1994.1190; Burdon KP, 2004, BRIT J OPHTHALMOL, V88, P79, DOI 10.1136/bjo.88.1.79; Chen JJ, 2008, BIOCHEMISTRY-US, V47, P10705, DOI 10.1021/bi800499k; Chen JJ, 2006, BIOCHEMISTRY-US, V45, P11552, DOI 10.1021/bi060988v; CHIOU SH, 1981, J BIOL CHEM, V256, P5176; CLARK AC, 1993, J BIOL CHEM, V268, P10773; Denisov VP, 2004, BIOPHYS J, V87, P3982, DOI 10.1529/biophysj.104.048454; Dobson CM, 2004, SEMIN CELL DEV BIOL, V15, P3, DOI 10.1016/j.semcdb.2003.12.008; Eakin CM, 2004, BIOCHEMISTRY-US, V43, P7808, DOI 10.1021/bi049792q; Evans P, 2004, J MOL BIOL, V343, P435, DOI 10.1016/j.jmb.2004.08.050; EVERETT CA, 1994, GENOMICS, V20, P429, DOI 10.1006/geno.1994.1197; FAGERHOLM P, 1982, CURR EYE RES, V1, P629, DOI 10.3109/02713688109001866; FAVOR J, 1983, MUTAT RES, V110, P367, DOI 10.1016/0027-5107(83)90153-7; FAVOR J, 1984, GENET RES, V44, P183, DOI 10.1017/S0016672300026380; Flaugh SL, 2006, J BIOL CHEM, V281, P30782, DOI 10.1074/jbc.M603882200; Flaugh SL, 2005, PROTEIN SCI, V14, P2030, DOI 10.1110/ps.051460505; Flaugh SL, 2005, PROTEIN SCI, V14, P571, DOI 10.1110/ps.041111405; Fu L, 2003, INVEST OPHTH VIS SCI, V44, P1155, DOI 10.1167/iovs.02-0950; Graw J, 2002, INVEST OPHTH VIS SCI, V43, P2998; Graw J, 2002, MAMM GENOME, V13, P452, DOI 10.1007/s00335-002-3021-6; Graw JC, 2004, INVEST OPHTH VIS SCI, V45, P1202, DOI 10.1167/iovs.03-0811; GREENE RF, 1974, J BIOL CHEM, V249, P5388; Hains PG, 2007, J PROTEOME RES, V6, P3935, DOI 10.1021/pr070138h; Hansen L, 2007, INVEST OPHTH VIS SCI, V48, P3937, DOI 10.1167/iovs.07-0013; Hanson SRA, 1998, EXP EYE RES, V67, P301, DOI 10.1006/exer.1998.0530; Hanson SRA, 2000, EXP EYE RES, V71, P195, DOI 10.1006/exer.2000.0868; Heon E, 1999, AM J HUM GENET, V65, P1261, DOI 10.1086/302619; HOENDERS HJ, 1983, J GERONTOL, V38, P278, DOI 10.1093/geronj/38.3.278; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; ISHIKAWA K, 1993, BIOCHEMISTRY-US, V32, P6171, DOI 10.1021/bi00075a009; Jaenicke R, 2001, CRIT REV BIOCHEM MOL, V36, P435, DOI 10.1080/20014091074237; Jung J, 2009, BIOCHEMISTRY-US, V48, P2597, DOI 10.1021/bi802292q; Kmoch S, 2000, HUM MOL GENET, V9, P1779, DOI 10.1093/hmg/9.12.1779; Knaus KJ, 2001, NAT STRUCT BIOL, V8, P770, DOI 10.1038/nsb0901-770; Kosinski-Collins MS, 2004, PROTEIN SCI, V13, P2223, DOI 10.1110/ps.04627004; Kosinski-Collins MS, 2003, PROTEIN SCI, V12, P480, DOI 10.1110/ps.0225503; Lampi KJ, 1998, EXP EYE RES, V67, P31, DOI 10.1006/exer.1998.0481; Lampi KJ, 1997, J BIOL CHEM, V272, P2268; LIM WA, 1992, BIOCHEMISTRY-US, V31, P4324, DOI 10.1021/bi00132a025; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Ma ZX, 1998, EXP EYE RES, V67, P21, DOI 10.1006/exer.1998.0482; Marsili S, 2004, EXP EYE RES, V79, P595, DOI 10.1016/j.exer.2004.06.008; Meehan S, 2004, J BIOL CHEM, V279, P3413, DOI 10.1074/jbc.M308203200; Messina-Baas O, 2006, MOL VIS, V12, P995; MILLA ME, 1994, NAT STRUCT BIOL, V1, P518, DOI 10.1038/nsb0894-518; Mills IA, 2007, PROTEIN SCI, V16, P2427, DOI 10.1110/ps.072970207; MILLSHENRY I, 2007, THESIS MIT CAMBRIDGE; Nandrot E, 2003, J MED GENET, V40, P262, DOI 10.1136/jmg.40.4.262; *NIH PREV BLINDN A, 2008, VIS PROBL US PREV AD, P22; Pande A, 2005, BIOCHEMISTRY-US, V44, P2491, DOI 10.1021/bi0479611; Pande A, 2000, P NATL ACAD SCI USA, V97, P1993, DOI 10.1073/pnas.040554397; Pande A, 2001, P NATL ACAD SCI USA, V98, P6116, DOI 10.1073/pnas.101124798; Papanikolopoulou K, 2008, MOL VIS, V14, P81; Santhiya ST, 2002, J MED GENET, V39, P352, DOI 10.1136/jmg.39.5.352; SIEZEN RJ, 1988, J MOL BIOL, V199, P475, DOI 10.1016/0022-2836(88)90619-5; Simkovsky R, 2006, P NATL ACAD SCI USA, V103, P3575, DOI 10.1073/pnas.0509087103; Sinha D, 1998, Mol Vis, V4, P8; Sinha D, 2001, J BIOL CHEM, V276, P9308, DOI 10.1074/jbc.M010583200; Slingsby C, 1999, EYE, V13, P395, DOI 10.1038/eye.1999.113; Stephan DA, 1999, P NATL ACAD SCI USA, V96, P1008, DOI 10.1073/pnas.96.3.1008; Sun H, 2005, J MED GENET, V42, P706, DOI 10.1136/jmg.2004.028274; TAKEMOTO L, 1991, EXP EYE RES, V53, P811, DOI 10.1016/0014-4835(91)90119-Y; TRUSCOTT RJW, 1977, EXP EYE RES, V25, P139, DOI 10.1016/0014-4835(77)90126-9; TRUSCOTT RJW, 1977, BIOCHIM BIOPHYS ACTA, V492, P43, DOI 10.1016/0005-2795(77)90212-4; Wahlbom M, 2007, J BIOL CHEM, V282, P18318, DOI 10.1074/jbc.M611368200; Waldburger CD, 1996, P NATL ACAD SCI USA, V93, P2629, DOI 10.1073/pnas.93.7.2629; Wang K, 2007, INVEST OPHTH VIS SCI, V48, P3719, DOI 10.1167/iovs.06-1487; Wistow G, 2005, FEBS J, V272, P2276, DOI 10.1111/j.1742-4658.2005.04655.x; Yamasaki M, 2008, NATURE, V455, P1255, DOI 10.1038/nature07394; Zhang ZL, 2003, EXP EYE RES, V77, P259, DOI 10.1016/S0014-4835(03)00159-3	74	43	43	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33285	33295		10.1074/jbc.M109.031344	http://dx.doi.org/10.1074/jbc.M109.031344			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19758984	Green Published, hybrid			2022-12-27	WOS:000272028500033
J	Fishman-Jacob, T; Reznichenko, L; Youdim, MBH; Mandel, SA				Fishman-Jacob, Tali; Reznichenko, Lydia; Youdim, Moussa B. H.; Mandel, Silvia A.			A Sporadic Parkinson Disease Model via Silencing of the Ubiquitin-Proteasome/E3 Ligase Component SKP1A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NIGRA-PARS-COMPACTA; F-BOX PROTEIN; SUBSTANTIA-NIGRA; GENE-EXPRESSION; NEURODEGENERATIVE DISEASES; UBIQUITIN-PROTEASOME; INTERACTING PROTEIN; DOPAMINE NEURONS; PC12 CELLS; COMPLEX	The aim of this study was to develop a new model of sporadic Parkinson disease (PD) based on silencing of the SKP1A gene, a component of the ubiquitin-proteasome/E3 ligase complex, Skp1, Cullin 1, F-box protein, which was found to be highly decreased in the substantia nigra of sporadic PD patients. Initially, an embryonic mouse substantia nigra-derived cell line (SN4741 cells) was infected with short hairpin RNA lentiviruses encoding the murine transcript of the SKP1A gene or with scrambled vector. SKP1A silencing resulted in increased susceptibility to neuronal damages induced by the parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium ion and serum starvation, in parallel with a decline in the expression of the dopaminergic markers, dopamine transporter and vesicular monoamine transporter-2. SKP1A-deficient cells presented a delay in completion of the cell cycle and the inability to arrest at the G(0)/G(1) phase when induced to differentiate. Instead, the cells progressed through S phase, developing rounded aggregates with characteristics of aggresomes including immunoreactivity for gamma-tubulin, alpha-synuclein, ubiquitin, tyrosine hydroxylase, Hsc-70 (70-kDa heat shock cognate protein), and proteasome subunit, and culminating in a lethal phenotype. Conversely, stably enforced expression of wild type SKP1A duplicated the survival index of naive SN4741 cells under proteasomal inhibition injury, suggesting a new structural role of SKP1 in dopaminergic neuronal function, besides its E3 ligase activity. These results link, for the first time, SKP1 to dopamine neuronal function and survival, suggesting an essential role in sporadic PD. In summary, this new model has reproduced to a significant extent the molecular alterations described in sporadic PD at the cellular level, implicating Skp1 as a potential modifier in sporadic PD neurodegeneration.	[Mandel, Silvia A.] Technion Israel Inst Technol, Fac Med, Dept Mol Pharmacol, IL-31096 Haifa, Israel; Technion Israel Inst Technol, Eve Topf & Natl Parkinson Fdn Ctr Neurodegenerat, IL-31096 Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology	Mandel, SA (corresponding author), Technion Israel Inst Technol, Fac Med, Dept Mol Pharmacol, POB 9697, IL-31096 Haifa, Israel.	mandel@tx.technion.ac.il			Eve Topf and National Parkinson Foundation Centers of Excellence for Neurodegenerative Diseases Research	Eve Topf and National Parkinson Foundation Centers of Excellence for Neurodegenerative Diseases Research	This work was supported by the Eve Topf and National Parkinson Foundation Centers of Excellence for Neurodegenerative Diseases Research.	Ardley HC, 2003, MOL BIOL CELL, V14, P4541, DOI 10.1091/mbc.E03-02-0078; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; BATISTATOU A, 1993, J CELL BIOL, V122, P523, DOI 10.1083/jcb.122.3.523; Chelli B, 2004, BIOCHEM PHARMACOL, V68, P125, DOI 10.1016/j.bcp.2004.03.008; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Cookson MR, 2003, HUM MOL GENET, V12, P2957, DOI 10.1093/hmg/ddg328; Copani A, 2001, TRENDS NEUROSCI, V24, P25, DOI 10.1016/S0166-2236(00)01663-5; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Farrer MJ, 2006, NAT REV GENET, V7, P306, DOI 10.1038/nrg1831; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Galan JM, 2001, MOL CELL BIOL, V21, P3105, DOI 10.1128/MCB.21.9.3105-3117.2001; Galter D, 2003, NEUROBIOL DIS, V14, P637, DOI 10.1016/j.nbd.2003.09.001; Gassen M, 1998, MOVEMENT DISORD, V13, P661, DOI 10.1002/mds.870130409; Grunblatt E, 2004, J NEURAL TRANSM, V111, P1543, DOI 10.1007/s00702-004-0212-1; Hauser MA, 2005, ARCH NEUROL-CHICAGO, V62, P917, DOI 10.1001/archneur.62.6.917; HJELLE JJ, 1983, PHARMACOL BIOCHEM BE, V18, P155, DOI 10.1016/0091-3057(83)90164-8; Imai Y, 2002, MOL CELL, V10, P55, DOI 10.1016/S1097-2765(02)00583-X; Jackson-Lewis V, 2007, NAT PROTOC, V2, P141, DOI 10.1038/nprot.2006.342; Jellinger KA, 2003, MOVEMENT DISORD, V18, pS2, DOI 10.1002/mds.10557; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Levites Y, 2002, J BIOL CHEM, V277, P30574, DOI 10.1074/jbc.M202832200; Macleod MR, 2001, BRAIN RES, V889, P308, DOI 10.1016/S0006-8993(00)03173-5; Mandel S, 2007, EXPERT OPIN DRUG DIS, V2, P1225, DOI 10.1517/17460441.2.9.1225; Mandel SA, 2007, PARKINSONISM RELAT D, V13, pS242, DOI 10.1016/S1353-8020(08)70009-9; MARDH G, 1986, BIOCHEMISTRY-US, V25, P7279, DOI 10.1021/bi00371a005; Marx FP, 2007, FASEB J, V21, P1759, DOI 10.1096/fj.06-6734com; McNaught KSP, 2002, EUR J NEUROSCI, V16, P2136, DOI 10.1046/j.1460-9568.2002.02301.x; McNaught KSP, 2002, NEUROSCI LETT, V326, P155, DOI 10.1016/S0304-3940(02)00296-3; McNaught KSP, 2001, NEUROSCI LETT, V297, P191, DOI 10.1016/S0304-3940(00)01701-8; Miller RM, 2006, NEUROBIOL DIS, V21, P305, DOI 10.1016/j.nbd.2005.07.010; Moran LB, 2006, NEUROGENETICS, V7, P1, DOI 10.1007/s10048-005-0020-2; Murata S, 2003, INT J BIOCHEM CELL B, V35, P572, DOI 10.1016/S1357-2725(02)00394-1; Nelson RF, 2007, J NEUROSCI, V27, P5163, DOI 10.1523/JNEUROSCI.0206-07.2007; Olzmann JA, 2008, CURR MED CHEM, V15, P47; Perez FA, 2005, P NATL ACAD SCI USA, V102, P2174, DOI 10.1073/pnas.0409598102; Reznichenko L, 2005, J NEUROCHEM, V93, P1157, DOI 10.1111/j.1471-4159.2005.03085.x; Riddle EL, 2005, AAPS J, V7, pE847, DOI 10.1208/aapsj070481; Sagi Y, 2007, NEUROBIOL DIS, V25, P35, DOI 10.1016/j.nbd.2006.07.020; Semple CAM, 2003, GENOME RES, V13, P1389, DOI 10.1101/gr.980303; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; Son JH, 1999, J NEUROSCI, V19, P10, DOI 10.1523/JNEUROSCI.19-01-00010.1999; Spruck CH, 2002, CELL CYCLE, V1, P248, DOI 10.4161/cc.1.4.132; Staropoli JF, 2005, J MOL NEUROSCI, V27, P175, DOI 10.1385/JMN:27:2:175; Staropoli JF, 2003, NEURON, V37, P735, DOI 10.1016/S0896-6273(03)00084-9; Stenoien DL, 1999, HUM MOL GENET, V8, P731, DOI 10.1093/hmg/8.5.731; Wang C, 2005, J NEUROCHEM, V93, P422, DOI 10.1111/j.1471-4159.2005.03023.x; Weinreb O, 2003, FASEB J, V17, P935, DOI 10.1096/fj.02-0712fje; Wileman T, 2007, ANNU REV MICROBIOL, V61, P149, DOI 10.1146/annurev.micro.57.030502.090836; Zhang YL, 2005, AM J MED GENET B, V137B, P5, DOI 10.1002/ajmg.b.30195; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zhou HX, 2007, INT J BIOL SCI, V3, P242	52	32	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32835	32845		10.1074/jbc.M109.034223	http://dx.doi.org/10.1074/jbc.M109.034223			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19748892	hybrid, Green Published			2022-12-27	WOS:000272028400068
J	Pedraza, N; Rafel, M; Navarro, I; Encinas, M; Aldea, M; Gallego, C				Pedraza, Neus; Rafel, Marta; Navarro, Isis; Encinas, Mario; Aldea, Marti; Gallego, Carme			Mixed Lineage Kinase Phosphorylates Transcription Factor E47 and Inhibits TrkB Expression to Link Neuronal Death and Survival Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; LOOP-HELIX PROTEINS; C-JUN; SIGNALING PATHWAY; FAMILY; GROWTH; DOMAIN; MEMBER; CELLS; JNK	E47 is a basic helix-loop-helix transcription factor involved in neuronal differentiation and survival. Wehad previously shown that the basic helix-loop-helix protein E47 binds to E-box sequences within the promoter of the TrkB gene and activates its transcription. Proper expression of the TrkB receptor plays a key role in development and function of the vertebrate nervous system, and altered levels of TrkB have been associated with important human diseases. Here we show that E47 interacts with MLK2, a mixed lineage kinase (MLK) involved in JNK-mediated activation of programmed cell death. MLK2 enhances phosphorylation of the AD2 activation domain of E47 in vivo in a JNK-independent manner and phosphorylates in vitro defined serine and threonine residues within a loop-helix structure of AD2 that also contains a putative MLK docking site. Although these residues are essential for MLK2-mediated inactivation of E47, inhibition of MLKs by CEP11004 causes up-regulation of TrkB at a transcriptional level in cerebellar granule neurons and differentiating neuroblastoma cells. These findings allow us to propose a novel mechanism by which MLK regulates TrkB expression through phosphorylation of an activation domain of E47. This molecular link would explain why MLK inhibitors not only prevent activation of cell death processes but also enhance cell survival signaling as a key aspect of their neuroprotective potential.	[Pedraza, Neus; Rafel, Marta; Navarro, Isis; Encinas, Mario; Aldea, Marti; Gallego, Carme] Univ Lleida, IRBLLEIDA, Dept Ciencies Med Basiques, Lleida 25008, Catalonia, Spain	Institut de Recerca Biomedica - IRB Lleida; Universitat de Lleida	Gallego, C (corresponding author), Mt Serrat Roig 2, Lleida 25008, Catalonia, Spain.	carme.gallego@cmb.udl.cat	Gallego, Carme/B-3151-2010; Rafel-Borrell, Marta/W-4613-2019; Pedraza González, Neus/C-6390-2011; Encinas, Mario/B-5600-2009; Gallego, Carme/K-6573-2014; Rafel Borrell, Marta/C-6428-2011; Aldea, Marti/K-3962-2014	Rafel-Borrell, Marta/0000-0001-9266-4696; Pedraza González, Neus/0000-0003-4749-5111; Encinas, Mario/0000-0003-3509-7431; Gallego, Carme/0000-0001-6961-3524; Rafel Borrell, Marta/0000-0001-9266-4696; Aldea, Marti/0000-0002-8710-5336	Ministry of Science and Innovation of Spain; Consolider-Ingenio 2010; Fundacio La Caixa; European Union	Ministry of Science and Innovation of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consolider-Ingenio 2010(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacio La Caixa(La Caixa FoundationEuropean Commission); European Union(European Commission)	This work was supported by the Ministry of Science and Innovation of Spain, Consolider-Ingenio 2010, Fundacio La Caixa, and the European Union (Fondo Europeo de Desarrollo Regional).	ARONHEIM A, 1993, P NATL ACAD SCI USA, V90, P8063, DOI 10.1073/pnas.90.17.8063; BLACKWELL TK, 1990, SCIENCE, V250, P1104, DOI 10.1126/science.2174572; Boissiere F, 1997, EXP NEUROL, V145, P245, DOI 10.1006/exnr.1997.6443; Chadee DN, 2004, NAT CELL BIOL, V6, P770, DOI 10.1038/ncb1152; Cole F, 2004, DEV CELL, V7, P843, DOI 10.1016/j.devcel.2004.10.009; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Deshmukh M, 1997, MOL PHARMACOL, V51, P897, DOI 10.1124/mol.51.6.897; DOROW DS, 1993, EUR J BIOCHEM, V213, P701, DOI 10.1111/j.1432-1033.1993.tb17810.x; Eckey M, 2003, MOL CELL ENDOCRINOL, V213, P71, DOI 10.1016/j.mce.2003.10.035; Encinas M, 2000, J NEUROCHEM, V75, P991, DOI 10.1046/j.1471-4159.2000.0750991.x; Funato N, 2001, MOL CELL BIOL, V21, P7416, DOI 10.1128/MCB.21.21.7416-7428.2001; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; Gines S, 2006, EUR J NEUROSCI, V23, P649, DOI 10.1111/j.1460-9568.2006.04590.x; Handley ME, 2007, INT IMMUNOL, V19, P923, DOI 10.1093/intimm/dxm050; Handley ME, 2007, INT J EXP PATHOL, V88, P111, DOI 10.1111/j.1365-2613.2007.00531.x; Harris CA, 2002, J NEUROSCI, V22, P103, DOI 10.1523/JNEUROSCI.22-01-00103.2002; Hirai S, 1997, J BIOL CHEM, V272, P15167, DOI 10.1074/jbc.272.24.15167; ING YL, 1994, ONCOGENE, V9, P1745; Johnson SE, 1996, MOL CELL BIOL, V16, P1604; King AM, 2007, J IMMUNOL, V178, P3521, DOI 10.4049/jimmunol.178.6.3521; Lei L, 2007, CELL MOL LIFE SCI, V64, P522, DOI 10.1007/s00018-006-6328-8; Leung IWL, 2001, J BIOL CHEM, V276, P1961, DOI 10.1074/jbc.M004092200; Liu YF, 2000, J BIOL CHEM, V275, P19035, DOI 10.1074/jbc.C000180200; Liu YH, 2004, MOL CELL BIOL, V24, P2662, DOI 10.1128/MCB.24.7.2662-2672.2004; Lluis F, 2005, EMBO J, V24, P974, DOI 10.1038/sj.emboj.7600528; Marcora E, 2003, P NATL ACAD SCI USA, V100, P9578, DOI 10.1073/pnas.1133382100; Maroney AC, 1998, J NEUROSCI, V18, P104; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Massari ME, 1996, MOL CELL BIOL, V16, P121; Neufeld B, 2000, J BIOL CHEM, V275, P20239, DOI 10.1074/jbc.C901040199; Nie L, 2003, EMBO J, V22, P5780, DOI 10.1093/emboj/cdg567; Page JL, 2004, J BIOL CHEM, V279, P30966, DOI 10.1074/jbc.M402224200; Phelan DR, 2001, J BIOL CHEM, V276, P10801, DOI 10.1074/jbc.M008237200; Phelan DR, 1999, MOL REPROD DEV, V52, P135, DOI 10.1002/(SICI)1098-2795(199902)52:2&lt;135::AID-MRD3&gt;3.0.CO;2-N; QUONG MW, 1993, MOL CELL BIOL, V13, P792, DOI 10.1128/MCB.13.2.792; ROBINSON GLWG, 1995, MOL CELL BIOL, V15, P1398; Sakuma H, 1997, J BIOL CHEM, V272, P28622, DOI 10.1074/jbc.272.45.28622; Silva RM, 2005, MOVEMENT DISORD, V20, P653, DOI 10.1002/mds.20390; Sloan SR, 1996, MOL CELL BIOL, V16, P6900; SMEAL T, 1991, NATURE, V354, P494, DOI 10.1038/354494a0; Swenson KI, 2003, MOL BIOL CELL, V14, P156, DOI 10.1091/mbc.E02-02-0115; Takekawa M, 2005, MOL CELL, V18, P295, DOI 10.1016/j.molcel.2005.04.001; Teramoto H, 1996, J BIOL CHEM, V271, P27225, DOI 10.1074/jbc.271.44.27225; Tibbles LA, 1996, EMBO J, V15, P7026, DOI 10.1002/j.1460-2075.1996.tb01094.x; VANDAM H, 1995, EMBO J, V14, P1798, DOI 10.1002/j.1460-2075.1995.tb07168.x; Wang LH, 2005, J PHARMACOL EXP THER, V312, P1007, DOI 10.1124/jpet.104.077800; Wang LH, 2004, ANNU REV PHARMACOL, V44, P451, DOI 10.1146/annurev.pharmtox.44.101802.121840; YAN MH, 1994, NATURE, V372, P798; Zhao ZS, 2005, BIOCHEM J, V386, P201, DOI 10.1042/BJ20041638	49	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32980	32988		10.1074/jbc.M109.038729	http://dx.doi.org/10.1074/jbc.M109.038729			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19801649	Green Published, hybrid			2022-12-27	WOS:000272028400081
J	Petroutsos, D; Terauchi, AM; Busch, A; Hirschmann, I; Merchant, SS; Finazzi, G; Hippler, M				Petroutsos, Dimitris; Terauchi, Aimee M.; Busch, Andreas; Hirschmann, Ingrid; Merchant, Sabeeha S.; Finazzi, Giovanni; Hippler, Michael			PGRL1 Participates in Iron-induced Remodeling of the Photosynthetic Apparatus and in Energy Metabolism in Chlamydomonas reinhardtii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC ELECTRON FLOW; CHLOROPHYLL-PROTEIN COMPLEX; ALGA RHODELLA-VIOLACEA; PHOTOSYSTEM-I; STATE TRANSITIONS; REDOX REGULATION; C3 PLANTS; DEFICIENCY; TRANSPORT; GENE	PGRL1 RNA and protein levels are increased in iron-deficient Chlamydomonas reinhardtii cells. In an RNAi strain, which accumulates lower PGRL1 levels in both iron-replete and -starved conditions, the photosynthetic electron transfer rate is decreased, respiratory capacity in iron-sufficient conditions is increased, and the efficiency of cyclic electron transfer under iron-deprivation is diminished. Pgrl1-kd cells exhibit iron deficiency symptoms at higher iron concentrations than wild-type cells, although the cells are not more depleted in cellular iron relative to wild-type cells as measured by mass spectrometry. Thiol-trapping experiments indicate iron-dependent and redox-induced conformational changes in PGRL1 that may provide a link between iron metabolism and the partitioning of photosynthetic electron transfer between linear and cyclic flow. We propose, therefore, that PGRL1 in C. reinhardtii may possess a dual function in the chloroplast; that is, iron sensing and modulation of electron transfer.	[Petroutsos, Dimitris; Busch, Andreas; Hirschmann, Ingrid; Hippler, Michael] Univ Munster, Inst Plant Biochem & Biotechnol, D-48143 Munster, Germany; [Terauchi, Aimee M.; Merchant, Sabeeha S.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Terauchi, Aimee M.; Merchant, Sabeeha S.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Finazzi, Giovanni] UPMC, CNRS, UMR 7141, Inst Biol Physicochim, F-75005 Paris, France	University of Munster; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite	Hippler, M (corresponding author), Univ Munster, Inst Plant Biochem & Biotechnol, Hindenburgpl 55, D-48143 Munster, Germany.	mhippler@uni-muenster.de	Petroutsos, Dimitris/AAB-1976-2021; Petroutsos, Dimitris/E-4958-2011	Petroutsos, Dimitris/0000-0002-9656-661X; Petroutsos, Dimitris/0000-0002-9656-661X; Michael, Hippler/0000-0001-9670-6101	German Science Foundation; Institutional Ruth L. Kirschstein National Research Service Award [GM070104]; UCLA graduate division; Department of Energy [DE-FD02-04ER15529]	German Science Foundation(German Research Foundation (DFG)); Institutional Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA graduate division; Department of Energy(United States Department of Energy (DOE))	This work was supported by the German Science Foundation (to M. H.), an Institutional Ruth L. Kirschstein National Research Service Award GM070104 and a Dissertation Year Fellowship from the UCLA graduate division (to A. M. T.) and by Department of Energy Grant DE-FD02-04ER15529 (to S. S. M.).	Allen AE, 2008, P NATL ACAD SCI USA, V105, P10438, DOI 10.1073/pnas.0711370105; Allen JF, 2002, CELL, V110, P273, DOI 10.1016/S0092-8674(02)00870-X; Allen MD, 2007, EUKARYOT CELL, V6, P1841, DOI 10.1128/EC.00205-07; ARNON DI, 1959, NATURE, V184, P10; Bailey S, 2008, BBA-BIOENERGETICS, V1777, P269, DOI 10.1016/j.bbabio.2008.01.002; Bibby TS, 2001, NATURE, V412, P743, DOI 10.1038/35089098; Boekema EJ, 2001, NATURE, V412, P745, DOI 10.1038/35089104; Breyton C, 2006, BIOCHEMISTRY-US, V45, P13465, DOI 10.1021/bi061439s; BURNAP RL, 1993, PLANT PHYSIOL, V103, P893, DOI 10.1104/pp.103.3.893; Busch A, 2008, PLANT J, V55, P201, DOI 10.1111/j.1365-313X.2008.03490.x; Cardol P, 2008, P NATL ACAD SCI USA, V105, P7881, DOI 10.1073/pnas.0802762105; Chen JC, 2008, EUKARYOT CELL, V7, P541, DOI 10.1128/EC.00463-07; Clemens S, 2009, FRONT BIOSCI-LANDMRK, V14, P1955, DOI 10.2741/3355; Collet JF, 2003, J BIOL CHEM, V278, P45325, DOI 10.1074/jbc.M307818200; DalCorso G, 2008, CELL, V132, P273, DOI 10.1016/j.cell.2007.12.028; Desquilbet TE, 2003, PLANT CELL PHYSIOL, V44, P1141, DOI 10.1093/pcp/pcg139; Doan JM, 2003, FEBS LETT, V533, P59, DOI 10.1016/S0014-5793(02)03748-1; Eberhard S, 2008, ANNU REV GENET, V42, P463, DOI 10.1146/annurev.genet.42.110807.091452; Finazzi G, 2005, J EXP BOT, V56, P383, DOI 10.1093/jxb/erh230; Finazzi G, 1999, BBA-BIOENERGETICS, V1413, P117, DOI 10.1016/S0005-2728(99)00089-4; Ghezzi P, 2005, BIOCHEM SOC T, V33, P1378, DOI 10.1042/BST0331378; GUIKEMA JA, 1984, PLANT PHYSIOL, V74, P90, DOI 10.1104/pp.74.1.90; Hanke GT, 2008, PHOTOCHEM PHOTOBIOL, V84, P1302, DOI 10.1111/j.1751-1097.2008.00411.x; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; Hippler M, 1997, BIOCHEMISTRY-US, V36, P6343, DOI 10.1021/bi970082c; Johnson GN, 2005, J EXP BOT, V56, P407, DOI 10.1093/jxb/eri106; Joliot P, 2006, BBA-BIOENERGETICS, V1757, P362, DOI 10.1016/j.bbabio.2006.02.018; Kang HJ, 2008, BIOCHEM BIOPH RES CO, V371, P63, DOI 10.1016/j.bbrc.2008.03.156; KINDLE KL, 1990, P NATL ACAD SCI USA, V87, P1228, DOI 10.1073/pnas.87.3.1228; KUCHKA MR, 1989, CELL, V58, P869, DOI 10.1016/0092-8674(89)90939-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAUDENBACH DE, 1988, J BACTERIOL, V170, P5018, DOI 10.1128/jb.170.11.5018-5026.1988; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long JC, 2008, GENETICS, V179, P137, DOI 10.1534/genetics.107.083824; MAXWELL PC, 1976, BIOCHEMISTRY-US, V15, P3975, DOI 10.1021/bi00663a011; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Merchant SS, 2006, BBA-MOL CELL RES, V1763, P578, DOI 10.1016/j.bbamcr.2006.04.007; Molnar A, 2009, PLANT J, V58, P165, DOI 10.1111/j.1365-313X.2008.03767.x; Moseley JL, 2002, EMBO J, V21, P6709, DOI 10.1093/emboj/cdf666; Munekaga Y, 2004, NATURE, V429, P579, DOI 10.1038/nature02598; Munekage Y, 2002, CELL, V110, P361, DOI 10.1016/S0092-8674(02)00867-X; Nagamori S, 2002, J BIOCHEM, V132, P629, DOI 10.1093/oxfordjournals.jbchem.a003266; Nandha B, 2007, BBA-BIOENERGETICS, V1767, P1252, DOI 10.1016/j.bbabio.2007.07.007; Naumann B, 2005, J BIOL CHEM, V280, P20431, DOI 10.1074/jbc.M414486200; Naumann B, 2007, PROTEOMICS, V7, P3964, DOI 10.1002/pmic.200700407; Noguchi K, 2008, MITOCHONDRION, V8, P87, DOI 10.1016/j.mito.2007.09.003; Oelze ML, 2008, BBA-GEN SUBJECTS, V1780, P1261, DOI 10.1016/j.bbagen.2008.03.015; Ort DR, 2002, CURR OPIN PLANT BIOL, V5, P193, DOI 10.1016/S1369-5266(02)00259-5; Pesaresi P, 2007, CURR OPIN PLANT BIOL, V10, P600, DOI 10.1016/j.pbi.2007.07.007; Redding K, 1998, EMBO J, V17, P50, DOI 10.1093/emboj/17.1.50; Rohr J, 2004, PLANT J, V40, P611, DOI 10.1111/j.1365-313X.2004.02227.x; Romero-Isart N, 2002, J INORG BIOCHEM, V88, P388, DOI 10.1016/S0162-0134(01)00347-6; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Shikanai T, 2007, ANNU REV PLANT BIOL, V58, P199, DOI 10.1146/annurev.arplant.58.091406.110525; Steigmiller S, 2008, P NATL ACAD SCI USA, V105, P3745, DOI 10.1073/pnas.0708356105; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; Strzepek RF, 2004, NATURE, V431, P689, DOI 10.1038/nature02954; Taiz L., 2018, FUNDAMENTALS PLANT P; Terauchi AM, 2009, J BIOL CHEM, V284, P25867, DOI 10.1074/jbc.M109.023622; Varsano T, 2006, J BIOL CHEM, V281, P10305, DOI 10.1074/jbc.M511057200; WITT HT, 1979, BIOCHIM BIOPHYS ACTA, V505, P355, DOI 10.1016/0304-4173(79)90008-9; Zumbrennen KB, 2009, MOL CELL BIOL, V29, P2219, DOI 10.1128/MCB.00004-09	62	71	73	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32770	32781		10.1074/jbc.M109.050468	http://dx.doi.org/10.1074/jbc.M109.050468			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19783661	Green Published, hybrid			2022-12-27	WOS:000272028400062
J	Kim, ST; Takeuchi, K; Sun, ZYJ; Touma, M; Castro, CE; Fahmy, A; Lang, MJ; Wagner, G; Reinherz, EL				Kim, Sun Taek; Takeuchi, Koh; Sun, Zhen-Yu J.; Touma, Maki; Castro, Carlos E.; Fahmy, Amr; Lang, Matthew J.; Wagner, Gerhard; Reinherz, Ellis L.			The alpha beta T Cell Receptor Is an Anisotropic Mechanosensor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYMIC SELECTION; FG LOOP; CD3-EPSILON-GAMMA HETERODIMER; ECTODOMAIN FRAGMENT; CRYSTAL-STRUCTURE; TCR; COMPLEX; ACTIVATION; THYMOCYTES; MODEL	Thymus-derived lymphocytes protect mammalian hosts against virus- or cancer-related cellular alterations through immune surveillance, eliminating diseased cells. In this process, T cell receptors (TCRs) mediate both recognition and T cell activation via their dimeric alpha beta, CD3 epsilon gamma, CD3 epsilon delta, and CD3 zeta zeta subunits using an unknown structural mechanism. Here, site-specific binding topology of anti-CD3 monoclonal antibodies (mAbs) and dynamic TCR quaternary change provide key clues. Agonist mAbs footprint to the membrane distal CD3 epsilon lobe that they approach diagonally, adjacent to the lever-like C beta FG loop that facilitates antigen (pMHC)-triggered activation. In contrast, a non-agonist mAb binds to the cleft between CD3 epsilon and CD3 gamma in a perpendicular mode and is stimulatory only subsequent to an external tangential but not a normal force (similar to 50 piconewtons) applied via optical tweezers. Specific pMHC but not irrelevant pMHC activates a T cell upon application of a similar force. These findings suggest that the TCR is an anisotropic mechanosensor, converting mechanical energy into a biochemical signal upon specific pMHC ligation during immune surveillance. Activating anti-CD3 mAbs mimic this force via their intrinsic binding mode. A common TCR quaternary change rather than conformational alterations can better facilitate structural signal initiation, given the vast array of TCRs and their specific pMHC ligands.	[Kim, Sun Taek; Touma, Maki; Reinherz, Ellis L.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol,Lab Immunobiol, Boston, MA 02115 USA; [Kim, Sun Taek; Touma, Maki; Reinherz, Ellis L.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Takeuchi, Koh; Sun, Zhen-Yu J.; Fahmy, Amr; Wagner, Gerhard] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Castro, Carlos E.; Lang, Matthew J.] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Lang, Matthew J.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Reinherz, EL (corresponding author), 77 Ave Louis Pasteur,HIM 419, Boston, MA 02115 USA.	ellis_reinherz@dfci.harvard.edu	Castro, Carlos E/D-8756-2016; Takeuchi, Koh/B-4971-2010	Castro, Carlos E/0000-0001-7023-6105; Takeuchi, Koh/0000-0002-6227-4627	National Institutes of Health [AI19807, AI37581, GM47467, EB002026]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019807, R01AI037581, R37AI019807, R56AI019807] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM047467] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI19807 (to E. L. R.) and AI37581, GM47467, and EB002026 (to G. W.).	Altan-Bonnet G, 2005, PLOS BIOL, V3, P1925, DOI 10.1371/journal.pbio.0030356; Arnett KL, 2004, P NATL ACAD SCI USA, V101, P16268, DOI 10.1073/pnas.0407359101; Brau RR, 2006, BIOPHYS J, V91, P1069, DOI 10.1529/biophysj.106.082602; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1045, DOI 10.1146/annurev.bi.63.070194.005145; Davis SJ, 2006, NAT IMMUNOL, V7, P803, DOI 10.1038/ni1369; Fahmy A, 2002, J AM CHEM SOC, V124, P1241, DOI 10.1021/ja011240x; Ferentz AE, 2000, Q REV BIOPHYS, V33, P29, DOI 10.1017/S0033583500003589; Ghendler Y, 1998, J EXP MED, V187, P1529, DOI 10.1084/jem.187.9.1529; Ghendler Y, 1998, P NATL ACAD SCI USA, V95, P10061, DOI 10.1073/pnas.95.17.10061; Ghendler Y, 1997, EUR J IMMUNOL, V27, P2279, DOI 10.1002/eji.1830270923; Haks MC, 1998, EMBO J, V17, P1871, DOI 10.1093/emboj/17.7.1871; HAVRAN WL, 1987, NATURE, V330, P170, DOI 10.1038/330170a0; Hayes SM, 2002, IMMUNITY, V16, P827, DOI 10.1016/S1074-7613(02)00320-5; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; Kern PS, 1998, IMMUNITY, V9, P519, DOI 10.1016/S1074-7613(00)80635-4; Kjer-Nielsen L, 2004, P NATL ACAD SCI USA, V101, P7675, DOI 10.1073/pnas.0402295101; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; Kuhns MS, 2007, IMMUNITY, V26, P357, DOI 10.1016/j.immuni.2007.01.015; Kulathu Y, 2008, EMBO J, V27, P1333, DOI 10.1038/emboj.2008.62; Kung C, 2005, NATURE, V436, P647, DOI 10.1038/nature03896; LETOURNEUR F, 1992, SCIENCE, V255, P79, DOI 10.1126/science.1532456; Ma ZY, 2008, FASEB J, V22, P1002, DOI 10.1096/fj.07-9331hyp; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; Minguet S, 2008, TRENDS BIOCHEM SCI, V33, P51, DOI 10.1016/j.tibs.2007.10.008; Mizoguchi A, 2003, INT IMMUNOL, V15, P97, DOI 10.1093/intimm/dxg006; Moody AM, 2001, EUR J IMMUNOL, V31, P2791, DOI 10.1002/1521-4141(200109)31:9<2791::AID-IMMU2791>3.0.CO;2-X; Nishida T, 2004, J IMMUNOL, V172, P6634, DOI 10.4049/jimmunol.172.11.6634; Palmer E, 2009, NAT REV IMMUNOL, V9, P206, DOI 10.1038/nri2469; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; ROBB RJ, 1981, J EXP MED, V154, P1455, DOI 10.1084/jem.154.5.1455; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Ruggeri ZM, 2007, THROMB HAEMOSTASIS, V98, P55, DOI 10.1160/TH07-04-0279; Sasada T, 2002, J EXP MED, V195, P1419, DOI 10.1084/jem.20020119; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; SHINKAI Y, 1995, IMMUNITY, V2, P401; Sprent J, 2002, ANNU REV IMMUNOL, V20, P551, DOI 10.1146/annurev.immunol.20.100101.151926; Sun ZYJ, 2004, P NATL ACAD SCI USA, V101, P16867, DOI 10.1073/pnas.0407576101; Sun ZYJ, 2001, CELL, V105, P913, DOI 10.1016/S0092-8674(01)00395-6; Takahashi H, 2000, NAT STRUCT BIOL, V7, P220; Teixeiro E, 2009, SCIENCE, V323, P502, DOI 10.1126/science.1163612; Touma M, 2007, J IMMUNOL, V178, P3668, DOI 10.4049/jimmunol.178.6.3668; Touma M, 2006, J IMMUNOL, V176, P6812, DOI 10.4049/jimmunol.176.11.6812; van Mameren J, 2009, NATURE, V457, P745, DOI 10.1038/nature07581; Wang JH, 1998, EMBO J, V17, P10, DOI 10.1093/emboj/17.1.10; Wulfing C, 1998, P NATL ACAD SCI USA, V95, P6302, DOI 10.1073/pnas.95.11.6302; Yokosuka T, 2008, IMMUNITY, V29, P589, DOI 10.1016/j.immuni.2008.08.011	46	268	273	2	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31028	31037		10.1074/jbc.M109.052712	http://dx.doi.org/10.1074/jbc.M109.052712			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19755427	Green Published, hybrid			2022-12-27	WOS:000271378400032
J	Wada, T; Kikuchi, J; Nishimura, N; Shimizu, R; Kitamura, T; Furukawa, Y				Wada, Taeko; Kikuchi, Jiro; Nishimura, Noriko; Shimizu, Rumi; Kitamura, Toshio; Furukawa, Yusuke			Expression Levels of Histone Deacetylases Determine the Cell Fate of Hematopoietic Progenitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; STEM-CELLS; TRANSCRIPTION FACTOR; GENE-EXPRESSION; DEFICIENT MICE; SELF-RENEWAL; DIFFERENTIATION; ACID; PROLIFERATION; INHIBITORS	Histone deacetylases (HDACs) are globally implicated in the growth and differentiation of mammalian cells; however, relatively little is known about their specific roles in hematopoiesis. In this study, we investigated the expression of HDACs in human hematopoietic cells and their functions during hematopoiesis. The expression of HDACs was very low in hematopoietic progenitor cells, which was accompanied by histone hyperacetylation. HDACs were detectable in more differentiated progenitors and erythroid precursors but down-regulated in mature myeloid cells especially granulocytes. In contrast, acute myeloid leukemias showed HDAC overexpression and histone hypoacetylation. Transcription of the HDAC1 gene was repressed by CCAAT/enhancer binding proteins during myeloid differentiation, and activated by GATA-1 during erythromegakaryocytic differentiation. Small interfering RNA-mediated knockdown of HDAC1 enhanced myeloid differentiation in immature hematopoietic cell lines and perturbed erythroid differentiation in progenitor cells. Myeloid but not erythromegakaryocytic differentiation was blocked in mice transplanted with HDAC1-overexpressing hematopoietic progenitor cells. These findings suggest that HDAC is not merely an auxiliary factor of genetic elements but plays a direct role in the cell fate decision of hematopoietic progenitors.	[Furukawa, Yusuke] Jichi Med Univ, Div Stem Cell Regulat, Ctr Mol Med, Jichi Med Sch, Shimotsuke, Tochigi 3290498, Japan; [Kitamura, Toshio] Univ Tokyo, Div Cellular Therapy, Inst Med Sci, Tokyo 1088639, Japan; [Kitamura, Toshio] Univ Tokyo, Div Stem Cell Signaling, Inst Med Sci, Tokyo 1088639, Japan	Jichi Medical University; University of Tokyo; University of Tokyo	Furukawa, Y (corresponding author), Jichi Med Univ, Div Stem Cell Regulat, Ctr Mol Med, Jichi Med Sch, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	furuyu@jichi.ac.jp	Furukawa, Yusuke/Y-1342-2018; Kitamura, Toshio/AAA-2071-2021	Furukawa, Yusuke/0000-0002-7249-6418; 	High-Tech Research Center Project for Private Universities; MEXT; Vehicle Racing Commemorative Foundation; Sankyo Foundation of Life Science	High-Tech Research Center Project for Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Vehicle Racing Commemorative Foundation; Sankyo Foundation of Life Science	This work was supported in part by the High-Tech Research Center Project for Private Universities: Matching Fund Subsidy from MEXT 2002-2006 and grants from the Vehicle Racing Commemorative Foundation and the Sankyo Foundation of Life Science ( to Y. F.).	Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bug G, 2005, CANCER RES, V65, P2537, DOI 10.1158/0008-5472.CAN-04-3011; Byrd JC, 2005, BLOOD, V105, P959, DOI 10.1182/blood-2004-05-1693; De Felice LD, 2005, CANCER RES, V65, P1505, DOI 10.1158/0008-5472.CAN-04-3063; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Frohling S, 2005, J CLIN ONCOL, V23, P6285, DOI 10.1200/JCO.2005.05.010; Furukawa Y, 2000, BRIT J HAEMATOL, V110, P663, DOI 10.1046/j.1365-2141.2000.02253.x; Gaboli M, 2001, GENE DEV, V15, P1625, DOI 10.1101/gad.902301; Gilliland DG, 2002, SEMIN HEMATOL, V39, P6, DOI 10.1053/shem.2002.36921; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; GURNEY AL, 1994, SCIENCE, V265, P1445, DOI 10.1126/science.8073287; Haumaitre C, 2008, MOL CELL BIOL, V28, P6373, DOI 10.1128/MCB.00413-08; Heyworth C, 1999, GENE DEV, V13, P1847, DOI 10.1101/gad.13.14.1847; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Inoue K, 2006, J CELL SCI, V119, P1985, DOI 10.1242/jcs.02913; Iwasaki H, 2006, GENE DEV, V20, P3010, DOI 10.1101/gad.1493506; Kikuchi J, 2007, STEM CELLS, V25, P2439, DOI 10.1634/stemcells.2007-0207; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kramer OH, 2003, EMBO J, V22, P3411, DOI 10.1093/emboj/cdg315; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Ledran MH, 2008, CELL STEM CELL, V3, P85, DOI 10.1016/j.stem.2008.06.001; Li JW, 2002, GENE DEV, V16, P687, DOI 10.1101/gad.962502; Lin RJ, 1998, NATURE, V391, P811, DOI 10.1038/35895; Ling KW, 2004, J EXP MED, V200, P871, DOI 10.1084/jem.20031556; MARTIN DIK, 1990, NATURE, V344, P444, DOI 10.1038/344444a0; NAGAI T, 1994, BLOOD, V84, P1074, DOI 10.1182/blood.V84.4.1074.bloodjournal8441074; O'Connor OA, 2006, J CLIN ONCOL, V24, P166, DOI 10.1200/JCO.2005.01.9679; Ono R, 2005, J CLIN INVEST, V115, P919, DOI 10.1172/JCI200522725; Orkin S H, 1998, Stem Cells, V16 Suppl 2, P79; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Parcells BW, 2006, STEM CELLS, V24, P1174, DOI 10.1634/stemcells.2005-0519; Schuettengruber B, 2003, MOL CELL BIOL, V23, P6993, DOI 10.1128/MCB.23.19.6993-7004.2003; Senese S, 2007, MOL CELL BIOL, V27, P4784, DOI 10.1128/MCB.00494-07; Shen SM, 2008, NAT NEUROSCI, V11, P1024, DOI 10.1038/nn.2172; STELZER GT, 1993, ANN NY ACAD SCI, V677, P265, DOI 10.1111/j.1749-6632.1993.tb38783.x; TANAKA T, 1995, CELL, V80, P353, DOI 10.1016/0092-8674(95)90418-2; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Terui Y, 1998, EXP HEMATOL, V26, P236; Tong Q, 2005, MOL CELL BIOL, V25, P706, DOI 10.1128/MCB.25.2.706-715.2005; Wang JX, 1998, P NATL ACAD SCI USA, V95, P10860, DOI 10.1073/pnas.95.18.10860; Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yamamura K, 2006, BRIT J HAEMATOL, V135, P242, DOI 10.1111/j.1365-2141.2006.06275.x; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yoshihara H, 2007, CELL STEM CELL, V1, P685, DOI 10.1016/j.stem.2007.10.020; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zhang ZH, 2005, BREAST CANCER RES TR, V94, P11, DOI 10.1007/s10549-005-6001-1; Zhao KW, 2004, BLOOD, V104, P3731, DOI 10.1182/blood-2004-04-1630; Zhu P, 2004, CANCER CELL, V5, P455, DOI 10.1016/S1535-6108(04)00114-X	50	59	59	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30673	30683		10.1074/jbc.M109.042242	http://dx.doi.org/10.1074/jbc.M109.042242			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19736310	hybrid, Green Published			2022-12-27	WOS:000271090000069
J	Zhou, Z; Fan, JB; Zhu, HL; Shewmaker, F; Yan, X; Chen, X; Chen, J; Xiao, GF; Guo, L; Liang, Y				Zhou, Zheng; Fan, Jun-Bao; Zhu, Hai-Li; Shewmaker, Frank; Yan, Xu; Chen, Xi; Chen, Jie; Xiao, Geng-Fu; Guo, Lin; Liang, Yi			Crowded Cell-like Environment Accelerates the Nucleation Step of Amyloidogenic Protein Misfolding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN PRION PROTEIN; MUSCLE CREATINE-KINASE; IN-VITRO CONVERSION; ALPHA-SYNUCLEIN; TAU-PHOSPHORYLATION; ALZHEIMERS-DISEASE; QUALITY-CONTROL; FIBRILS; AGGREGATION; FIBRILLATION	To understand the role of a crowded physiological environment in the pathogenesis of neurodegenerative diseases, we report the following. 1) The formation of fibrous aggregates of the human Tau fragment Tau-(244-441), when hyperphosphorylated by glycogen synthase kinase-3 beta, is dramatically facilitated by the addition of crowding agents. 2) Fibril formation of nonphosphorylated Tau-(244 -441) is only promoted moderately by macromolecular crowding. 3) Macromolecular crowding dramatically accelerates amyloid formation by human prion protein. A sigmoidal equation has been used to fit these kinetic data, including published data of human alpha-synuclein, yielding lag times and apparent rate constants for the growth of fibrils for these amyloidogenic proteins. These biochemical data indicate that crowded cell-like environments significantly accelerate the nucleation step of fibril formation of human Tau fragment/human prion protein/human alpha-synuclein (a significant decrease in the lag time). These results can in principle be predicted based on some known data concerning protein concentration effects on fibril formation both in vitro and in vivo. Furthermore, macromolecular crowding causes human prion protein to form short fibrils and nonfibrillar particles with lower conformational stability and higher protease resistance activity, compared with those formed in dilute solutions. Our data demonstrate that a crowded physiological environment could play an important role in the pathogenesis of neurodegenerative diseases by accelerating amyloidogenic protein misfolding and inducing human prion fibril fragmentation, which is considered to be an essential step in prion replication.	[Zhou, Zheng; Fan, Jun-Bao; Zhu, Hai-Li; Yan, Xu; Chen, Xi; Chen, Jie; Xiao, Geng-Fu; Guo, Lin; Liang, Yi] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Shewmaker, Frank] NIDDK, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA	Wuhan University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Liang, Y (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	liangyi@whu.edu.cn	Fan, Jun-bao/E-7155-2012; Liang, Yi/V-1396-2017; Zhou, Zheng/AAK-2669-2021	Liang, Yi/0000-0002-7349-8300; Zhou, Zheng/0000-0002-3124-6041; Fan, Junbao/0000-0002-1709-3659	National Key Basic Research Foundation of China [2006CB910301]; National Natural Science Foundation of China [30770421, 30970599]	National Key Basic Research Foundation of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was authored, in part, by National Institutes of Health staff. This work was supported by National Key Basic Research Foundation of China Grant 2006CB910301 and National Natural Science Foundation of China Grants 30770421 and 30970599.	Abraha A, 2000, J CELL SCI, V113, P3737; Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Barghorn Stefan, 2004, V299, P35; Baron GS, 2002, EMBO J, V21, P1031, DOI 10.1093/emboj/21.5.1031; Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; Baskakov IV, 2005, BIOCHEMISTRY-US, V44, P2339, DOI 10.1021/bi048322t; Bellotti V, 1999, CELL MOL LIFE SCI, V55, P977, DOI 10.1007/s000180050348; Bellotti V, 2008, CURR OPIN STRUC BIOL, V18, P771, DOI 10.1016/j.sbi.2008.10.001; Berriman J, 2003, P NATL ACAD SCI USA, V100, P9034, DOI 10.1073/pnas.1530287100; Bocharova OV, 2006, J BIOL CHEM, V281, P2373, DOI 10.1074/jbc.M510840200; Bocharova OV, 2005, PROTEIN SCI, V14, P1222, DOI 10.1110/ps.041186605; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; Bokvist M, 2007, J AM CHEM SOC, V129, P14848, DOI 10.1021/ja076059o; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Chattopadhyay M, 2008, P NATL ACAD SCI USA, V105, P18663, DOI 10.1073/pnas.0807058105; Cohlberg JA, 2002, BIOCHEMISTRY-US, V41, P1502, DOI 10.1021/bi011711s; Colby DW, 2006, NAT CHEM BIOL, V2, P319, DOI 10.1038/nchembio792; Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321; Derkatch IL, 1996, GENETICS, V144, P1375; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Du F, 2006, J MOL BIOL, V364, P469, DOI 10.1016/j.jmb.2006.09.018; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Ellis RJ, 2001, CURR OPIN STRUC BIOL, V11, P114, DOI 10.1016/S0959-440X(00)00172-X; Engel R, 2008, J BIOL CHEM, V283, P27383, DOI 10.1074/jbc.M802393200; Fink AL, 2006, ACCOUNTS CHEM RES, V39, P628, DOI 10.1021/ar050073t; Friedhoff P, 1998, P NATL ACAD SCI USA, V95, P15712, DOI 10.1073/pnas.95.26.15712; Ganusova EE, 2006, MOL CELL BIOL, V26, P617, DOI 10.1128/MCB.26.2.617-629.2006; Geschwind DH, 2003, NEURON, V40, P457, DOI 10.1016/S0896-6273(03)00681-0; GOEDERT M, 1993, TRENDS NEUROSCI, V16, P460, DOI 10.1016/0166-2236(93)90078-Z; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Hanger DP, 2007, J BIOL CHEM, V282, P23645, DOI 10.1074/jbc.M703269200; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hatters DM, 2002, J BIOL CHEM, V277, P7824, DOI 10.1074/jbc.M110429200; Homouz D, 2008, P NATL ACAD SCI USA, V105, P11754, DOI 10.1073/pnas.0803672105; Hong M, 1997, J BIOL CHEM, V272, P25326, DOI 10.1074/jbc.272.40.25326; Jackson GS, 1999, SCIENCE, V283, P1935, DOI 10.1126/science.283.5409.1935; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X; Liang Y, 2003, J BIOL CHEM, V278, P30098, DOI 10.1074/jbc.M304050200; LOVESTONE S, 1994, CURR BIOL, V4, P1077, DOI 10.1016/S0960-9822(00)00246-3; MANDELKOW EM, 1993, TRENDS BIOCHEM SCI, V18, P480, DOI 10.1016/0968-0004(93)90011-B; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; Meriin AB, 2002, J CELL BIOL, V157, P997, DOI 10.1083/jcb.200112104; Minton AP, 2006, J CELL SCI, V119, P2863, DOI 10.1242/jcs.03063; MORISHIMAKAWASHIMA M, 1995, J BIOL CHEM, V270, P823, DOI 10.1074/jbc.270.2.823; Notari S, 2008, J BIOL CHEM, V283, P30557, DOI 10.1074/jbc.M801877200; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; Osherovich LZ, 2001, CELL, V106, P183, DOI 10.1016/S0092-8674(01)00440-8; Parchi P, 2000, P NATL ACAD SCI USA, V97, P10168, DOI 10.1073/pnas.97.18.10168; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Shtilerman MD, 2002, BIOCHEMISTRY-US, V41, P3855, DOI 10.1021/bi0120906; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Soto C, 2006, TRENDS BIOCHEM SCI, V31, P150, DOI 10.1016/j.tibs.2006.01.002; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Stohr J, 2008, P NATL ACAD SCI USA, V105, P2409, DOI 10.1073/pnas.0712036105; Sun Y, 2008, J MOL BIOL, V376, P1155, DOI 10.1016/j.jmb.2007.12.053; Sun Y, 2007, J BIOL CHEM, V282, P9090, DOI 10.1074/jbc.M608623200; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; TERAVANESYAN MD, 1993, MOL MICROBIOL, V7, P683, DOI 10.1111/j.1365-2958.1993.tb01159.x; Uversky VN, 2002, FEBS LETT, V515, P99, DOI 10.1016/S0014-5793(02)02446-8; van den Berg B, 2000, EMBO J, V19, P3870, DOI 10.1093/emboj/19.15.3870; Wang YP, 2007, P NATL ACAD SCI USA, V104, P10252, DOI 10.1073/pnas.0703676104; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Winklhofer KF, 2008, EMBO J, V27, P336, DOI 10.1038/sj.emboj.7601930; Xue WF, 2008, P NATL ACAD SCI USA, V105, P8926, DOI 10.1073/pnas.0711664105; Yin SM, 2003, PROTEIN EXPRES PURIF, V32, P104, DOI 10.1016/S1046-5928(03)00195-5; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Zhou BR, 2004, J BIOL CHEM, V279, P55109, DOI 10.1074/jbc.M409086200; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817	78	82	83	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30148	30158		10.1074/jbc.M109.002832	http://dx.doi.org/10.1074/jbc.M109.002832			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19748895	Green Published, hybrid			2022-12-27	WOS:000271090000018
J	Lawrence, SH; Ramirez, UD; Selwood, T; Stith, L; Jaffe, EK				Lawrence, Sarah H.; Ramirez, Ursula D.; Selwood, Trevor; Stith, Linda; Jaffe, Eileen K.			Allosteric Inhibition of Human Porphobilinogen Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUATERNARY STRUCTURE ISOFORMS; ALAD PORPHYRIA; MORPHEEINS; MODEL; IODOCHLORHYDROXYQUIN; PURIFICATION; CATALYSIS; PROTEINS; ENSEMBLE; KINETICS	Porphobilinogen synthase (PBGS) catalyzes the first common step in tetrapyrrole (e.g. heme, chlorophyll) biosynthesis. Human PBGS exists as an equilibrium of high activity octamers, low activity hexamers, and alternate dimer configurations that dictate the stoichiometry and architecture of further assembly. It is posited that small molecules can be found that inhibit human PBGS activity by stabilizing the hexamer. Such molecules, if present in the environment, could potentiate disease states associated with reduced PBGS activity, such as lead poisoning and ALAD porphyria, the latter of which is associated with human PBGS variants whose quaternary structure equilibrium is shifted toward the hexamer (Jaffe, E. K., and Stith, L. (2007) Am. J. Hum. Genet. 80, 329-337). Hexamer-stabilizing inhibitors of human PBGS were identified using in silico pre-screening (docking) of similar to 111,000 structures to a hexamer-specific surface cavity of a human PBGS crystal structure. Seventy-seven compounds were evaluated in vitro; three provided 90-100% conversion of octamer to hexamer in a native PAGE mobility shift assay. Based on chemical purity, two (ML-3A9 and ML-3H2) were subjected to further evaluation of their effect on the quaternary structure equilibrium and enzymatic activity. Naturally occurring ALAD porphyria-associated human PBGS variants are shown to have an increased susceptibility to inhibition by both ML-3A9 and ML-3H2. ML-3H2 is a structural analog of amebicidal drugs, which have porphyria-like side effects. Data support the hypothesis that human PBGS hexamer stabilization may explain these side effects. The current work identifies allosteric ligands of human PBGS and, thus, identifies human PBGS as a medically relevant allosteric enzyme.	[Lawrence, Sarah H.; Ramirez, Ursula D.; Selwood, Trevor; Stith, Linda; Jaffe, Eileen K.] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Jaffe, EK (corresponding author), 333 Cottman Ave, Philadelphia, PA 19111 USA.	Eileen.Jaffe@fccc.edu			National Institutes of Health [R01 ES003654, R21 AI063324, P30 CA006927, T32 CA009035]; Cynthia Myers; NATIONAL CANCER INSTITUTE [T32CA009035, P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI063324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES003654] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cynthia Myers; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 ES003654 (to E. K. J.), R21 AI063324 (to E. K. J.), P30 CA006927 (to the Fox Chase Cancer Center), and T32 CA009035 (to the Institute for Cancer Research).; We acknowledge the contributions of Cynthia Myers of the Fox Chase Cancer Center Organic Synthesis Facility for the chemical and spectral analyses reported.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ANDERSON PM, 1979, J BIOL CHEM, V254, P6924; Benkovic SJ, 2008, BIOCHEMISTRY-US, V47, P3317, DOI 10.1021/bi800049z; Breinig S, 2003, NAT STRUCT BIOL, V10, P757, DOI 10.1038/nsb963; BURCKHALTER JH, 1951, J AM CHEM SOC, V73, P4837, DOI 10.1021/ja01154a108; DESPAUX N, 1979, BIOCHIMIE, V61, P1021; DILL KA, 1997, NAT STRUCT BIOL, V4, P19, DOI DOI 10.1038/NSB0197-10; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; Halgren TA, 1999, J COMPUT CHEM, V20, P730, DOI 10.1002/(SICI)1096-987X(199905)20:7<730::AID-JCC8>3.0.CO;2-T; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Hayouka Z, 2007, P NATL ACAD SCI USA, V104, P8316, DOI 10.1073/pnas.0700781104; He MM, 2005, SCIENCE, V310, P1022, DOI 10.1126/science.1116304; Hilser VJ, 2006, CHEM REV, V106, P1545, DOI 10.1021/cr040423+; Jaffe EK, 2007, AM J HUM GENET, V80, P329, DOI 10.1086/511444; JAFFE EK, 1995, BIOCHEMISTRY-US, V34, P244, DOI 10.1021/bi00001a029; Jaffe EK, 2005, TRENDS BIOCHEM SCI, V30, P490, DOI 10.1016/j.tibs.2005.07.003; James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X; Jorgensen WL, 2000, BIOORG MED CHEM LETT, V10, P1155, DOI 10.1016/S0960-894X(00)00172-4; Kashlan OB, 2003, BIOCHEMISTRY-US, V42, P1696, DOI 10.1021/bi020634d; KAUFFMAN RE, 1990, PEDIATRICS, V86, P797; KAYA AH, 1994, GENOMICS, V19, P242, DOI 10.1006/geno.1994.1054; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Lawrence SH, 2008, CHEM BIOL, V15, P586, DOI 10.1016/j.chembiol.2008.04.012; Lawrence SH, 2008, BIOCHEM MOL BIOL EDU, V36, P274, DOI 10.1002/bmb.20211; Linderstrom-Lang K, 1959, ENZYMES, P443; Maruno M, 2001, BLOOD, V97, P2972, DOI 10.1182/blood.V97.10.2972; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; MONOD J, 1963, J MOL BIOL, V6, P306, DOI 10.1016/S0022-2836(63)80091-1; Selwood T, 2008, BIOCHEMISTRY-US, V47, P3245, DOI 10.1021/bi702113z; Shekhar C, 2008, CHEM BIOL, V15, P413, DOI 10.1016/j.chembiol.2008.05.001; STOHS SJ, 1984, J INVEST DERMATOL, V82, P195, DOI 10.1111/1523-1747.ep12259839; Tang L, 2006, J BIOL CHEM, V281, P6682, DOI 10.1074/jbc.M511134200; Tang L, 2005, J BIOL CHEM, V280, P15786, DOI 10.1074/jbc.M500218200; Whitten ST, 2006, BIOCHEMISTRY-US, V45, P10163, DOI 10.1021/bi060855+	34	24	25	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35807	35817		10.1074/jbc.M109.026294	http://dx.doi.org/10.1074/jbc.M109.026294			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19812033	Green Published, hybrid			2022-12-27	WOS:000272645600057
J	Sato, A; Arimura, T; Makita, N; Ishikawa, T; Aizawa, Y; Ushinohama, H; Aizawa, Y; Kimura, A				Sato, Akinori; Arimura, Takuro; Makita, Naomasa; Ishikawa, Taisuke; Aizawa, Yoshiyasu; Ushinohama, Hiroya; Aizawa, Yoshifusa; Kimura, Akinori			Novel Mechanisms of Trafficking Defect Caused by KCNQ1 Mutations Found in Long QT Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTASSIUM CHANNEL GENE; ENDOPLASMIC-RETICULUM; CARDIAC-ARRHYTHMIAS; DILATED CARDIOMYOPATHY; PROTEIN TRAFFICKING; HERG; KVLQT1; IDENTIFICATION; EXPRESSION; JERVELL	Long QT syndrome (LQTS) is a hereditary arrhythmia caused by mutations in genes for cardiac ion channels, including a potassium channel, KvLQT1. Inheritance of LQTS is usually autosomal-dominant, but autosomal-recessive inheritance can be observed in patients with LQTS accompanied by hearing loss. In this study, we investigated the functional alterations caused by KCNQ1 mutations, a deletion (delV595) and a frameshift (P631fs/19), which were identified in compound heterozygous state in two patients with autosomal-recessive LQTS not accompanied by hearing loss. Functional analyses showed that both mutations impaired cell surface expression due to trafficking defects. The mutations severely affected outward potassium currents without apparent dominant negative effects. It was found that delV595 impaired subunit binding, whereas P631fs/19 was retained in endoplasmic reticulum due to the newly added 19-amino acid sequence containing two retention motifs (R(633)GR and (RLR)-L-646). This is the first report of novel mechanisms for trafficking abnormality of cardiac ion channels, providing us new insights into the molecular mechanisms of LQTS.	[Sato, Akinori; Arimura, Takuro; Ishikawa, Taisuke; Kimura, Akinori] Tokyo Med & Dent Univ, Dept Mol Pathogenesis, Med Res Inst, Bunkyo Ku, Tokyo 1138510, Japan; [Sato, Akinori; Aizawa, Yoshiyasu; Aizawa, Yoshifusa] Niigata Univ, Div Cardiol, Grad Sch Med & Dent Sci, Niigata 9518510, Japan; [Makita, Naomasa] Nagasaki Univ, Dept Mol Physiol, Grad Sch Biomed Sci, Nagasaki 8528523, Japan; [Ushinohama, Hiroya] Fukuoka Childrens Hosp, Dept Pediat Cardiol, Fukuoka 8100063, Japan	Tokyo Medical & Dental University (TMDU); Niigata University; Nagasaki University	Kimura, A (corresponding author), 1-5-45 Yushima,Bunkyo Ku, Tokyo 1138510, Japan.	akitis@mri.tmd.ac.jp	Aizawa, Yoshiyasu/L-8334-2013; Kimura, Akinori/I-5989-2018; Arimura, Takuro/AAA-2745-2022; Ishikawa, Taisuke/D-1567-2019	Aizawa, Yoshiyasu/0000-0002-8323-4229; Kimura, Akinori/0000-0002-4933-2132; Arimura, Takuro/0000-0002-0929-3140; Ishikawa, Taisuke/0000-0001-8195-4700	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Japan-Korea Collaboration Program; Japan Society for Promotion of Science; Ministry of Health, Labor, and Welfare, Japan	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan-Korea Collaboration Program; Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, grants from the Japan-Korea Collaboration Program and from the Japan-France Collaboration Program from the Japan Society for Promotion of Science, and research grants from the Ministry of Health, Labor, and Welfare, Japan.	Aizawa Y, 2007, J CARDIOVASC ELECTR, V18, P972, DOI 10.1111/j.1540-8167.2007.00889.x; Anderson CL, 2006, CIRCULATION, V113, P365, DOI 10.1161/CIRCULATIONAHA.105.570200; Arimura T, 2007, BIOCHEM BIOPH RES CO, V357, P162, DOI 10.1016/j.bbrc.2007.03.128; Chen L, 2007, P NATL ACAD SCI USA, V104, P20990, DOI 10.1073/pnas.0710527105; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Delisle BP, 2004, CIRC RES, V94, P1418, DOI 10.1161/01.RES.0000128561.28701.ea; Goldenberg I, 2008, J AM COLL CARDIOL, V51, P2291, DOI 10.1016/j.jacc.2008.02.068; Gong QM, 2002, AM J PHYSIOL-HEART C, V283, pH77, DOI 10.1152/ajpheart.00008.2002; Inagaki N, 2006, BIOCHEM BIOPH RES CO, V342, P379, DOI 10.1016/j.bbrc.2006.01.154; Jespersen T, 2007, CARDIOVASC RES, V74, P64, DOI 10.1016/j.cardiores.2007.01.008; Kanki H, 2004, J BIOL CHEM, V279, P33976, DOI 10.1074/jbc.M404539200; Lehnart SE, 2007, CIRCULATION, V116, P2325, DOI 10.1161/CIRCULATIONAHA.107.711689; Li XD, 1997, J BIOL CHEM, V272, P705, DOI 10.1074/jbc.272.2.705; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Margeta-Mitrovic M, 2002, METHODS, V27, P311, DOI 10.1016/S1046-2023(02)00088-9; Michelsen K, 2005, EMBO REP, V6, P717, DOI 10.1038/sj.embor.7400480; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Napolitano C, 2005, JAMA-J AM MED ASSOC, V294, P2975, DOI 10.1001/jama.294.23.2975; Neyroud N, 1999, CIRC RES, V84, P290, DOI 10.1161/01.RES.84.3.290; Neyroud N, 1997, NAT GENET, V15, P186, DOI 10.1038/ng0297-186; Novotny T, 2006, PACE, V29, P1013, DOI 10.1111/j.1540-8159.2006.00478.x; Phartiyal P, 2008, J BIOL CHEM, V283, P3702, DOI 10.1074/jbc.M708999200; Phartiyal P, 2007, J BIOL CHEM, V282, P9874, DOI 10.1074/jbc.M610875200; Robinson JM, 2005, NEURON, V45, P223, DOI 10.1016/j.neuron.2004.12.043; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Schmitt N, 2000, EMBO J, V19, P332, DOI 10.1093/emboj/19.3.332; Schmitt N, 2007, BIOCHEM BIOPH RES CO, V358, P304, DOI 10.1016/j.bbrc.2007.04.127; Schulteis CT, 1998, J BIOL CHEM, V273, P26210, DOI 10.1074/jbc.273.40.26210; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; Wilson AJ, 2005, CARDIOVASC RES, V67, P476, DOI 10.1016/j.cardiores.2005.04.036; Wu L, 2008, J BIOL CHEM, V283, P6968, DOI 10.1074/jbc.M709721200; Yang WP, 1997, P NATL ACAD SCI USA, V94, P4017, DOI 10.1073/pnas.94.8.4017; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhou ZF, 1998, J BIOL CHEM, V273, P21061, DOI 10.1074/jbc.273.33.21061	37	13	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					35122	35133		10.1074/jbc.M109.017293	http://dx.doi.org/10.1074/jbc.M109.017293			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19825999	hybrid, Green Published			2022-12-27	WOS:000272439600066
J	Wang, Z; Cui, BW; Gorovsky, MA				Wang, Zhe; Cui, Bowen; Gorovsky, Martin A.			Histone H2B Ubiquitylation Is Not Required for Histone H3 Methylation at Lysine 4 in Tetrahymena	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; REPAIR GENE RAD6; TRANSCRIPTIONAL ACTIVATION; CHROMATIN MODIFICATIONS; UBIQUITINATION; THERMOPHILA; YEAST; COMPLEX; MONOUBIQUITINATION; TRANSFORMATION	Ubiquitylation of histone H2B and/or a component of the system that ubiquitylates H2B is required for methylation of histone H3 at lysine 4 (H3K4) in yeasts and probably in humans. In this study, the single ubiquitylation site was mapped to conserved lysine 115 of the C-terminal region of histone H2B in the single-cell model organism Tetrahymena thermophila. In strains lacking H2B ubiquitylation, H3K4 methylation was not detectably affected. As in other organisms, the E2 ubiquitin-conjugating enzyme Ubc2 and the E3 ubiquitin ligase Bre1 were required for H2B ubiquitylation. However, neither enzyme was required for H3K4 methylation. These studies argue that, in T. thermophila, the histone ubiquitylation mechanism is not required for H3K4 methylation, demonstrating that different organisms can speak different languages in the "cross-talk" among post-translational modifications on different histones.	[Wang, Zhe; Cui, Bowen; Gorovsky, Martin A.] Univ Rochester, Dept Biol, Rochester, NY 14627 USA	University of Rochester	Gorovsky, MA (corresponding author), Univ Rochester, Dept Biol, Rochester, NY 14627 USA.	goro@mail.rochester.edu	Cui, Bowen/F-1038-2011		National Institutes of Health [R01 GM021793]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021793] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM021793.	ALLIS CD, 1979, P NATL ACAD SCI USA, V76, P4857, DOI 10.1073/pnas.76.10.4857; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Briggs SD, 2002, NATURE, V418, P498, DOI 10.1038/nature00970; BRUNS PJ, 1974, J EXP ZOOL, V188, P337, DOI 10.1002/jez.1401880309; CassidyHanley D, 1997, GENETICS, V146, P135; Chen HY, 1998, J BIOL CHEM, V273, P13165, DOI 10.1074/jbc.273.21.13165; Cui BW, 2006, MOL CELL BIOL, V26, P7719, DOI 10.1128/MCB.01139-06; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Foster ER, 2009, J CELL BIOL, V184, P631, DOI 10.1083/jcb.200812088; GAERTIG J, 1994, NUCLEIC ACIDS RES, V22, P5391, DOI 10.1093/nar/22.24.5391; GAERTIG J, 1992, P NATL ACAD SCI USA, V89, P9196, DOI 10.1073/pnas.89.19.9196; GLOVER CV, 1979, THESIS U ROCHESTER R; GOLDKNOPF IL, 1977, P NATL ACAD SCI USA, V74, P864, DOI 10.1073/pnas.74.3.864; Gorovsky M A, 1975, Methods Cell Biol, V9, P311, DOI 10.1016/S0091-679X(08)60080-1; Hai B, 1997, P NATL ACAD SCI USA, V94, P1310, DOI 10.1073/pnas.94.4.1310; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Hwang WW, 2003, MOL CELL, V11, P261, DOI 10.1016/S1097-2765(02)00826-2; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kao CF, 2004, GENE DEV, V18, P184, DOI 10.1101/gad.1149604; Kim J, 2005, MOL CELL, V20, P759, DOI 10.1016/j.molcel.2005.11.012; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; KOKEN M, 1991, P NATL ACAD SCI USA, V88, P3832, DOI 10.1073/pnas.88.9.3832; KOKEN MHM, 1991, P NATL ACAD SCI USA, V88, P8865, DOI 10.1073/pnas.88.20.8865; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu XW, 1996, NUCLEIC ACIDS RES, V24, P3023, DOI 10.1093/nar/24.15.3023; LIU Y, 2003, THESIS U ROCHESTER R; Liu YF, 2004, P NATL ACAD SCI USA, V101, P1679, DOI 10.1073/pnas.0305421101; Miao W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004429; Ng HH, 2003, J BIOL CHEM, V278, P33625, DOI 10.1074/jbc.C300270200; Ng HH, 2002, J BIOL CHEM, V277, P34655, DOI 10.1074/jbc.C200433200; Pham AD, 2000, SCIENCE, V289, P2357, DOI 10.1126/science.289.5488.2357; Pogulis R J, 1996, Methods Mol Biol, V57, P167; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Sridhar VV, 2007, NATURE, V447, P735, DOI 10.1038/nature05864; STARGELL LA, 1993, GENE DEV, V7, P2641, DOI 10.1101/gad.7.12b.2641; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Tanny JC, 2007, GENE DEV, V21, P835, DOI 10.1101/gad.1516207; THORNE AW, 1987, EMBO J, V6, P1005, DOI 10.1002/j.1460-2075.1987.tb04852.x; Turner BM, 2007, NAT CELL BIOL, V9, P2, DOI 10.1038/ncb0107-2; Wang HB, 2006, MOL CELL, V22, P383, DOI 10.1016/j.molcel.2006.03.035; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; WEST MHP, 1980, NUCLEIC ACIDS RES, V8, P4671, DOI 10.1093/nar/8.20.4671; Wolffe A., 1998, CHROMATIN STRUCTURE; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Xiao TJ, 2005, MOL CELL BIOL, V25, P637, DOI 10.1128/MCB.25.2.637-651.2005; Zhu B, 2005, MOL CELL, V20, P601, DOI 10.1016/j.molcel.2005.09.025; Zofall M, 2007, J BIOL CHEM, V282, P14065, DOI 10.1074/jbc.M700292200	51	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34870	34879		10.1074/jbc.M109.046250	http://dx.doi.org/10.1074/jbc.M109.046250			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19822522	Green Published, hybrid			2022-12-27	WOS:000272439600042
J	Ricks, TK; Trejo, J				Ricks, Tiffany K.; Trejo, JoAnn			Phosphorylation of Protease-activated Receptor-2 Differentially Regulates Desensitization and Internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCARINIC ACETYLCHOLINE-RECEPTOR; ARRESTIN-DEPENDENT ENDOCYTOSIS; BREAST-CANCER CELLS; COUPLED RECEPTOR; BETA-ARRESTIN; CLATHRIN ADAPTER; DOWN-REGULATION; FACTOR VIIA; BETA(2)-ADRENERGIC RECEPTOR; MEDIATES UBIQUITINATION	Protease-activated receptor 2 (PAR2) is a G protein-coupled receptor irreversibly activated by extracellular proteases. Activated PAR2 couples to multiple heterotrimeric G-protein subtypes including G alpha(q), G alpha(i), and G alpha(12/13). Most activated G protein-coupled receptors are rapidly desensitized and internalized following phosphorylation and beta-arrestin binding. However, the role of phosphorylation in regulation of PAR2 signaling and trafficking is not known. To investigate the function of phosphorylation, we generated a PAR2 mutant in which all serines and threonines in the C-tail were converted to alanines and designated it PAR2 0P. In mammalian cells, the addition of agonist induced a rapid and robust increase in phosphorylation of wild-type PAR2 but not the 0P mutant, suggesting that the major sites of phosphorylation occur within the C-tail domain. Moreover, desensitization of PAR2 0P signaling was markedly impaired compared with the wild-type receptor. Wild-type phosphorylated PAR2 internalized through a canonical dynamin, clathrin- and beta-arrestin-dependent pathway. Strikingly, PAR20P mutant internalization proceeded through a dynamin-dependent but clathrin- and beta-arrestin-independent pathway in both a constitutive and agonist-dependent manner. Collectively, our studies show that PAR2 phosphorylation is essential for beta-arrestin binding and uncoupling from heterotrimeric G-protein signaling and that the presence of serine and threonine residues in the PAR2 C-tail hinder constitutive internalization through a non-canonical pathway. Thus, our studies reveal a novel function for phosphorylation that differentially regulates PAR2 desensitization and endocytic trafficking.	[Trejo, JoAnn] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA	University of California System; University of California San Diego; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Trejo, J (corresponding author), Univ Calif San Diego, Sch Med, Dept Pharmacol, 9500 Gilman Dr,Biomed Sci Bldg,Rm 3018, La Jolla, CA 92093 USA.	joanntrejo@ucsd.edu		TREJO, JOANN/0000-0003-4405-6228	National Institutes of Health [HL073328]; American Heart Association Established Investigator; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073328] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Established Investigator(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL073328 (to J.T.) and an American Heart Association Established Investigator Award (to J.T.).	Arora P, 2007, J CELL SCI, V120, P921, DOI 10.1242/jcs.03409; Awasthi V, 2007, ARTERIOSCL THROM VAS, V27, P1447, DOI 10.1161/ATVBAHA.107.143438; Bohm SK, 1996, J BIOL CHEM, V271, P22003; Bohm SK, 1996, BIOCHEM J, V314, P1009; Camerer E, 2000, P NATL ACAD SCI USA, V97, P5255, DOI 10.1073/pnas.97.10.5255; Compton SJ, 2002, BIOCHEM J, V368, P495, DOI 10.1042/BJ20020706; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Dery O, 1999, J BIOL CHEM, V274, P18524, DOI 10.1074/jbc.274.26.18524; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Ge L, 2004, J BIOL CHEM, V279, P55419, DOI 10.1074/jbc.M410312200; Ge L, 2003, J BIOL CHEM, V278, P34418, DOI 10.1074/jbc.M300573200; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Gullapalli A, 2006, MOL BIOL CELL, V17, P1228, DOI 10.1091/mbc.E05-09-0899; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Haribabu B, 1997, J BIOL CHEM, V272, P28726, DOI 10.1074/jbc.272.45.28726; Hasdemir B, 2007, J BIOL CHEM, V282, P29646, DOI 10.1074/jbc.M702974200; Jacob C, 2005, J BIOL CHEM, V280, P31936, DOI 10.1074/jbc.M506338200; Jacob C, 2005, J BIOL CHEM, V280, P16076, DOI 10.1074/jbc.M500109200; Kim J, 2005, P NATL ACAD SCI USA, V102, P1442, DOI 10.1073/pnas.0409532102; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Lamaze C, 2001, MOL CELL, V7, P661, DOI 10.1016/S1097-2765(01)00212-X; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Lee KB, 1998, J BIOL CHEM, V273, P12967, DOI 10.1074/jbc.273.21.12967; Luttrell LM, 2003, J MOL ENDOCRINOL, V30, P117, DOI 10.1677/jme.0.0300117; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Morris DR, 2006, CANCER RES, V66, P307, DOI 10.1158/0008-5472.CAN-05-1735; Murray SR, 1998, J BIOL CHEM, V273, P24987, DOI 10.1074/jbc.273.39.24987; NYSTEDT S, 1994, P NATL ACAD SCI USA, V91, P9208, DOI 10.1073/pnas.91.20.9208; Paing MM, 2006, MOL CELL BIOL, V26, P3231, DOI 10.1128/MCB.26.8.3231-3242.2006; Paing MM, 2002, J BIOL CHEM, V277, P1292, DOI 10.1074/jbc.M109160200; PalsRylaarsdam R, 1997, J BIOL CHEM, V272, P14152, DOI 10.1074/jbc.272.22.14152; PalsRylaarsdam R, 1997, J BIOL CHEM, V272, P23682, DOI 10.1074/jbc.272.38.23682; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Ren XR, 2005, P NATL ACAD SCI USA, V102, P1448, DOI 10.1073/pnas.0409534102; Roosterman D, 2003, AM J PHYSIOL-CELL PH, V284, pC1319, DOI 10.1152/ajpcell.00540.2002; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Stalheim L, 2005, MOL PHARMACOL, V67, P78, DOI 10.1124/mol.104.006072; Tanowitz M, 2002, J BIOL CHEM, V277, P50219, DOI 10.1074/jbc.C200536200; Tobin AB, 2008, BRIT J PHARMACOL, V153, pS167, DOI 10.1038/sj.bjp.0707662; Trejo J, 2000, J BIOL CHEM, V275, P31255, DOI 10.1074/jbc.M003770200; Trejo J, 1999, J BIOL CHEM, V274, P2216, DOI 10.1074/jbc.274.4.2216; Vines CM, 2003, J BIOL CHEM, V278, P41581, DOI 10.1074/jbc.C300291200; Whistler JL, 2002, SCIENCE, V297, P615, DOI 10.1126/science.1073308; Wolfe BL, 2007, J CELL BIOL, V177, P905, DOI 10.1083/jcb.200610154; Wolfe BL, 2007, TRAFFIC, V8, P462, DOI 10.1111/j.1600-0854.2007.00551.x; Zoudilova M, 2007, J BIOL CHEM, V282, P20634, DOI 10.1074/jbc.M701391200	49	48	50	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34444	34457		10.1074/jbc.M109.048942	http://dx.doi.org/10.1074/jbc.M109.048942			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19815543	Green Published, hybrid			2022-12-27	WOS:000272165200074
J	Wang, XF; Lin, G; Martins-Taylor, K; Zeng, H; Xu, RH				Wang, Xiaofang; Lin, Ge; Martins-Taylor, Kristen; Zeng, Hui; Xu, Ren-He			Inhibition of Caspase-mediated Anoikis Is Critical for Basic Fibroblast Growth Factor-sustained Culture of Human Pluripotent Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAINTAIN PLURIPOTENCY; INDUCED APOPTOSIS; SELF-RENEWAL; DIFFERENTIATION; FGF; MAINTENANCE; DERIVATION; PATHWAYS; SURVIVAL	Apoptosis and proliferation are two dynamically and tightly regulated processes that together maintain the homeostasis of renewable tissues. Anoikis is a subtype of apoptosis induced by detachment of adherent cells from the extracellular matrix. By using the defined mTeSR1 medium and collecting freshly detached cells, we found here that human pluripotent stem (PS) cells including embryonic stem (ES) cells and induced pluripotent stem cells are subject to constant anoikis in culture, which is escalated in the absence of basic fibroblast growth factor (bFGF). Withdrawal of bFGF also promotes apoptosis and differentiation of the remaining adherent cells without affecting their cell cycle progression. Insulinlike growth factor 2 (IGF2) has previously been reported to act downstream of FGF signaling to support self-renewal of human ES cells. However, we found that IGF2 cannot substitute bFGF in the TeSR1-supported culture, although endogenous IGF signaling is required to sustain self-renewal of human ES cells. On the other hand, all of the bFGF withdrawal effects observed here can be markedly prevented by the caspase inhibitor z-VAD-FMK. We further demonstrated that the bFGF-repressed anoikis is dependent on activation of ERK and AKT and associated with inhibition of Bcl-2-interacting mediator of cell death and the caspase-ROCK1-myosin signaling. Anoikis is independent of pre-detachment apoptosis and differentiation of the cells. Because previous studies of human PS cells have been focused on attached cells, our findings revealed a neglected role of bFGF in sustaining self-renewal of human PS cells: preventing them from anoikis via inhibition of caspase activation.	[Wang, Xiaofang; Lin, Ge; Martins-Taylor, Kristen; Zeng, Hui; Xu, Ren-He] Univ Connecticut, Ctr Hlth, Stem Cell Inst, Dept Genet & Dev Biol, Farmington, CT 06030 USA; [Zeng, Hui] Cent S Univ, Xiang Ya Hosp, Dept Hematol, Changsha 410008, Hunan, Peoples R China	University of Connecticut; Central South University	Xu, RH (corresponding author), Univ Connecticut, Ctr Hlth, Stem Cell Inst, Dept Genet & Dev Biol, 263 Farmington Ave, Farmington, CT 06030 USA.	renhexu@uchc.edu	Xu, Ren-He/AAK-7392-2021; Xu, Ren-He/M-3125-2016	Martins-Taylor, Kristen/0000-0002-7004-5867	Connecticut Stem Cell Research Grants [06SCB14, 06SCD02]	Connecticut Stem Cell Research Grants	This work was supported by Connecticut Stem Cell Research Grants 06SCB14 and 06SCD02 (to R.X.).	Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Chiarugi P, 2008, BIOCHEM PHARMACOL, V76, P1352, DOI 10.1016/j.bcp.2008.07.023; Downward J, 2004, SEMIN CELL DEV BIOL, V15, P177, DOI 10.1016/j.semcdb.2004.01.002; Dvorak P, 2005, FOLIA HISTOCHEM CYTO, V43, P203; Eiselleova L, 2009, STEM CELLS, V27, P1847, DOI 10.1002/stem.128; Filipczyk AA, 2007, STEM CELL RES, V1, P45, DOI 10.1016/j.scr.2007.09.002; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; Gilmore AP, 2005, CELL DEATH DIFFER, V12, P1473, DOI 10.1038/sj.cdd.4401723; Greber B, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-46; Grossmann J, 2002, APOPTOSIS, V7, P247, DOI 10.1023/A:1015312119693; Kang HB, 2005, STEM CELLS DEV, V14, P395, DOI 10.1089/scd.2005.14.395; Levenstein ME, 2006, STEM CELLS, V24, P568, DOI 10.1634/stemcells.2005-0247; Li J, 2007, DIFFERENTIATION, V75, P299, DOI 10.1111/j.1432-0436.2006.00143.x; Lu J, 2006, P NATL ACAD SCI USA, V103, P5688, DOI 10.1073/pnas.0601383103; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; MASON IJ, 1994, CELL, V78, P547, DOI 10.1016/0092-8674(94)90520-7; Mayshar Y, 2008, STEM CELLS, V26, P767, DOI 10.1634/stemcells.2007-1037; McDevitt TC, 2008, CURR OPIN BIOTECH, V19, P527, DOI 10.1016/j.copbio.2008.08.005; Mills JC, 1999, J CELL BIOL, V146, P703, DOI 10.1083/jcb.146.4.703; Minambres R, 2006, J CELL SCI, V119, P271, DOI 10.1242/jcs.02723; Peluso JJ, 2003, BIOCHEM PHARMACOL, V66, P1363, DOI 10.1016/S0006-2952(03)00486-6; Pera MF, 2004, J CELL SCI, V117, P1269, DOI 10.1242/jcs.00970; Rossant J, 2008, CELL, V132, P527, DOI 10.1016/j.cell.2008.01.039; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Valentijn AJ, 2004, BIOCHEM SOC T, V32, P421, DOI 10.1042/BST0320421; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; White J, 2005, STEM CELL REV, V1, P131, DOI 10.1385/SCR:1:2:131; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Yao S, 2006, P NATL ACAD SCI USA, V103, P6907, DOI 10.1073/pnas.0602280103; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zeng H, 2009, STEM CELLS, V27, P2435, DOI 10.1002/stem.192	43	54	60	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34054	34064		10.1074/jbc.M109.052290	http://dx.doi.org/10.1074/jbc.M109.052290			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19828453	Green Published, hybrid			2022-12-27	WOS:000272165200038
J	Lerat, H; Kammoun, HL; Hainault, I; Merour, E; Higgs, MR; Callens, C; Lemon, SM; Foufelle, F; Pawlotsky, JM				Lerat, Herve; Kammoun, Helene L.; Hainault, Isabelle; Merour, Emilie; Higgs, Martin R.; Callens, Celine; Lemon, Stanley M.; Foufelle, Fabienne; Pawlotsky, Jean-Michel			Hepatitis C Virus Proteins Induce Lipogenesis and Defective Triglyceride Secretion in Transgenic Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHASE; ENDOPLASMIC-RETICULUM STRESS; CORE PROTEIN; NONSTRUCTURAL PROTEINS; LIPID DROPLET; STEATOSIS; LIVER; HYPOBETALIPOPROTEINEMIA; HEPATOCYTES; CHOLESTEROL	Chronic hepatitis C virus (HCV) infection is associated with altered lipid metabolism and hepatocellular steatosis. Virus-induced steatosis is a cytopathic effect of HCV replication. The goal of this study was to examine the mechanisms underlying HCV-induced lipid metabolic defects in a transgenic mouse model expressing the full HCV protein repertoire at levels corresponding to natural human infection. In this model, expression of the HCV full-length open reading frame was associated with hepatocellular steatosis and reduced plasma triglyceride levels. Triglyceride secretion was impaired, whereas lipogenesis was activated. Increased lipogenic enzyme transcription was observed, resulting from maturational activation and nuclear translocation of sterol regulatory element-binding protein 1c (SREBP1c). However, endoplasmic reticulum (ER) stress markers were expressed at similar levels in both HCV transgenic mice and their wild type counterparts, suggesting that SREBP1c proteolytic cleavage in the presence of HCV proteins was independent of ER stress. In conclusion, transgenic mice expressing the HCV full-length polyprotein at low levels have decreased plasma triglyceride levels and develop hepatocellular steatosis in the same way as HCV-infected patients. In these mice, SREBP1c activation by one or several HCV proteins induces de novo triglyceride synthesis via the lipogenic pathway, in a manner independent of ER stress, whereas triglyceride secretion is simultaneously reduced.	[Lerat, Herve; Merour, Emilie; Higgs, Martin R.; Pawlotsky, Jean-Michel] Hop Henri Mondor, INSERM, U955, F-94010 Creteil, France; [Kammoun, Helene L.; Hainault, Isabelle; Callens, Celine; Foufelle, Fabienne] Univ Paris 06, INSERM, U872, F-75270 Paris, France; [Lemon, Stanley M.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA; [Pawlotsky, Jean-Michel] Univ Paris 12, Hop Henri Mondor, Dept Virol, Natl Reference Ctr Viral Hepatitis B C & Delta, F-94010 Creteil, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; University of Texas System; University of Texas Medical Branch Galveston; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Lerat, H (corresponding author), Hop Henri Mondor, INSERM, U955, 51 Ave Marechal de Lattre de Tassigny, F-94010 Creteil, France.	herve.lerat@inserm.fr	Pawlotsky, Jean-Michel/R-8159-2018; Higgs, Martin/AAK-2108-2021; LERAT, Hervé/D-4331-2019	Higgs, Martin/0000-0002-8218-0089; LERAT, Hervé/0000-0002-8505-378X; FOUFELLE, Fabienne/0000-0002-0752-622X; Pawlotsky, Jean-Michel/0000-0003-0745-7559	National Institutes of Health [U19-AI40035]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI040035] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant U19-AI40035.	[Anonymous], 2002, HEPATOLOGY, V36, pS3, DOI 10.1053/jhep.2002.37117; Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; BACH N, 1992, HEPATOLOGY, V15, P572, DOI 10.1002/hep.1840150403; Baiocchi L, 1998, LIVER TRANSPLANT SUR, V4, P441, DOI 10.1002/lt.500040613; BLAKE WL, 1994, BIOCHEM BIOPH RES CO, V205, P1257, DOI 10.1006/bbrc.1994.2800; Boulant S, 2007, J GEN VIROL, V88, P2204, DOI 10.1099/vir.0.82898-0; Castera L, 2003, GUT, V52, P288, DOI 10.1136/gut.52.2.288; Castera L, 2005, AM J GASTROENTEROL, V100, P711, DOI 10.1111/j.1572-0241.2005.40898.x; Choukhi A, 1998, J VIROL, V72, P3851, DOI 10.1128/JVI.72.5.3851-3858.1998; Dai CY, 2008, J HEPATOL, V49, P9, DOI 10.1016/j.jhep.2008.03.016; Disson O, 2004, GASTROENTEROLOGY, V126, P859, DOI 10.1053/j.gastro.2003.12.005; Domitrovich AM, 2005, J BIOL CHEM, V280, P39802, DOI 10.1074/jbc.M510391200; Erdtmann L, 2003, J BIOL CHEM, V278, P18256, DOI 10.1074/jbc.M209732200; Gerber M A, 1997, Clin Liver Dis, V1, P529, DOI 10.1016/S1089-3261(05)70319-6; Hegarty BD, 2005, P NATL ACAD SCI USA, V102, P791, DOI 10.1073/pnas.0405067102; Hezode C, 2004, J VIRAL HEPATITIS, V11, P455, DOI 10.1111/j.1365-2893.2004.00528.x; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Ishii S, 2004, P NATL ACAD SCI USA, V101, P15597, DOI 10.1073/pnas.0405238101; Jackel-Cram C, 2007, J HEPATOL, V46, P999, DOI 10.1016/j.jhep.2006.10.019; Keasler VV, 2006, VIROLOGY, V347, P466, DOI 10.1016/j.virol.2005.11.050; Kim KH, 2007, BIOCHEM BIOPH RES CO, V355, P883, DOI 10.1016/j.bbrc.2007.02.044; Kumar D, 2002, HEPATOLOGY, V36, P1266, DOI 10.1053/jhep.2002.36370; Lerat H, 2002, GASTROENTEROLOGY, V122, P352, DOI 10.1053/gast.2002.31001; McPherson S, 2008, J HEPATOL, V49, P1046, DOI 10.1016/j.jhep.2008.06.022; Mirandola S, 2006, GASTROENTEROLOGY, V130, P1661, DOI 10.1053/j.gastro.2006.02.035; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Negro F, 2002, HEPATOLOGY, V36, P1050, DOI 10.1053/jhep.2002.37118; Oem JK, 2008, J GEN VIROL, V89, P1225, DOI 10.1099/vir.0.83491-0; Pavio N, 2003, J VIROL, V77, P3578, DOI 10.1128/JVI.77.6.3578-3585.2003; Pawlotsky JM, 2007, GASTROENTEROLOGY, V132, P1979, DOI 10.1053/j.gastro.2007.03.116; Perlemuter G, 2002, FASEB J, V16, P185, DOI 10.1096/fj.01-0396com; Petit JM, 2003, AM J GASTROENTEROL, V98, P1150, DOI 10.1016/S0002-9270(03)00106-0; Piodi A, 2008, HEPATOLOGY, V48, P16, DOI 10.1002/hep.22288; Poynard T, 2003, HEPATOLOGY, V38, P75, DOI 10.1053/jhep.2003.50267; Sato R, 1999, J BIOL CHEM, V274, P24714, DOI 10.1074/jbc.274.35.24714; Serfaty L, 2001, J HEPATOL, V34, P428, DOI 10.1016/S0168-8278(00)00036-2; SERFATY L, 2007, GASTROENTEROL CLIN B, V31; Shavinskaya A, 2007, J BIOL CHEM, V282, P37158, DOI 10.1074/jbc.M707329200; Siagris D, 2006, J VIRAL HEPATITIS, V13, P56, DOI 10.1111/j.1365-2893.2005.00655.x; Spahr L, 2001, J HEPATOL, V35, P308, DOI 10.1016/S0168-8278(01)00082-4; Tada S, 2009, HEPATOL RES, V39, P195, DOI 10.1111/j.1872-034X.2008.00439.x; Tardif KD, 2002, J VIROL, V76, P7453, DOI 10.1128/JVI.76.15.7453-7459.2002; Waris G, 2007, J VIROL, V81, P8122, DOI 10.1128/JVI.00125-07; Yang W, 2008, HEPATOLOGY, V48, P1396, DOI 10.1002/hep.22508	44	74	76	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33466	33474		10.1074/jbc.M109.019810	http://dx.doi.org/10.1074/jbc.M109.019810			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19808675	Green Accepted, Green Submitted, Green Published, hybrid			2022-12-27	WOS:000272028500053
J	Nagy, R; Grob, H; Weder, B; Green, P; Klein, M; Frelet-Barrand, A; Schjoerring, JK; Brearley, C; Martinoia, E				Nagy, Reka; Grob, Hanne; Weder, Barbara; Green, Porntip; Klein, Markus; Frelet-Barrand, Annie; Schjoerring, Jan K.; Brearley, Charles; Martinoia, Enrico			The Arabidopsis ATP-binding Cassette Protein AtMRP5/AtABCC5 Is a High Affinity Inositol Hexakisphosphate Transporter Involved in Guard Cell Signaling and Phytate Storage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYPHOSPHATE KINASES; SOYBEAN SEEDS; THALIANA; PHOSPHATE; VACUOLES; RESISTANCE; CHANNELS; CALCIUM; ATMRP5; FAMILY	Arabidopsis possesses a superfamily of ATP-binding cassette (ABC) transporters. Among these, the multidrug resistance-associated protein AtMRP5/AtABCC5 regulates stomatal aperture and controls plasma membrane anion channels of guard cells. Remarkably, despite the prominent role of AtMRP5 in conferring partial drought insensitivity upon Arabidopsis, we know little of the biochemical function of AtMRP5. Our phylogenetic analysis showed that AtMRP5 is closely related to maize MRP4, mutation of which confers a low inositol hexakisphosphate kernel phenotype. We now show that insertion mutants of AtMRP5 display a low inositol hexakisphosphate phenotype in seed tissue and that this phenotype is associated with alterations of mineral cation and phosphate status. By heterologous expression in yeast, we demonstrate that AtMRP5 encodes a specific and high affinity ATP-dependent inositol hexakisphosphate transporter that is sensitive to inhibitors of ABC transporters. Moreover, complementation of the mrp5-1 insertion mutants of Arabidopsis with the AtMRP5 cDNA driven from a guard cell-specific promoter restores the sensitivity of the mutant to abscisic acid-mediated inhibition of stomatal opening. Additionally, we show that mutation of residues of the Walker B motif prevents restoring the multiple phenotypes associated with mrp5-1. Our findings highlight a novel function of plant ABC transporters that may be relevant to other kingdoms. They also extend the signaling repertoire of this ubiquitous inositol polyphosphate signaling molecule.	[Nagy, Reka; Grob, Hanne; Weder, Barbara; Frelet-Barrand, Annie; Martinoia, Enrico] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Martinoia, Enrico] Pohang Univ Sci & Technol, Div Mol Life Sci, POSTECH UZH Global Res Lab, Pohang 790784, South Korea; [Klein, Markus] R&D Innnovat Cube, Philip Morris Int, Tobacco Appl Biol, Tobacco Technol, CH-2000 Neuchatel, Switzerland; [Schjoerring, Jan K.] Univ Copenhagen, Fac Life Sci, DK-1871 Frederiksberg C, Denmark; [Green, Porntip; Brearley, Charles] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England	University of Zurich; Pohang University of Science & Technology (POSTECH); Philip Morris International Inc; University of Copenhagen; University of East Anglia	Nagy, R (corresponding author), Univ Zurich, Inst Plant Biol, Zollikerstr 107, CH-8008 Zurich, Switzerland.	rnagy@botinst.uzh.ch; C.Brearley@uea.ac.uk	Schjoerring, Jan K./A-5387-2009; frelet barrand, annie/E-5479-2015; FRELET-BARRAND, Annie/AFX-2878-2022; Martinoia, Enrico/AAH-8712-2021; Frelet-Barrand, Annie/S-1951-2017	Schjoerring, Jan K./0000-0002-2852-3298; FRELET-BARRAND, Annie/0000-0002-0849-9040; Brearley, Charles/0000-0001-6179-9109; Green, Porntip/0000-0002-1968-0574	Swiss National Foundation [3100AO-117790]; Forschungskredit der Universitat Zurich; European Union [FOOD-CT-2006-0016253]; Biotechnology and Biological Sciences Research Council [BB/C514090/1]	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Forschungskredit der Universitat Zurich; European Union(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by Swiss National Foundation Grant 3100AO-117790 (to E. M.), by funds from the Forschungskredit der Universitat Zurich (to R. N.), by European Union Project Public Health Impact on Long Term, Low Level Mixed Element Exposure (PHIME) Contract FOOD-CT-2006-0016253 (to J. K. S.), and by Biotechnology and Biological Sciences Research Council Grant BB/C514090/1 (to C. B.).	ADAMS CA, 1985, CROP SCI, V25, P255, DOI 10.2135/cropsci1985.0011183X002500020013x; Bentsink L, 2003, THEOR APPL GENET, V106, P1234, DOI 10.1007/s00122-002-1177-9; Casaravilla C, 2006, FEBS J, V273, P3192, DOI 10.1111/j.1742-4658.2006.05328.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cominelli E, 2005, CURR BIOL, V15, P1196, DOI 10.1016/j.cub.2005.05.048; Craxton A, 1997, BIOCHEM J, V328, P75, DOI 10.1042/bj3280075; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Dorsch JA, 2003, PHYTOCHEMISTRY, V62, P691, DOI 10.1016/S0031-9422(02)00610-6; Frelet A, 2006, FEBS LETT, V580, P1064, DOI 10.1016/j.febslet.2006.01.024; Gaedeke N, 2001, EMBO J, V20, P1875, DOI 10.1093/emboj/20.8.1875; Hatzack F, 2001, BIOCHEM J, V354, P473, DOI 10.1042/0264-6021:3540473; Hetherington AM, 2001, CELL, V107, P711, DOI 10.1016/S0092-8674(01)00606-7; Illies C, 2007, SCIENCE, V318, P1299, DOI 10.1126/science.1146824; Jaquinod M, 2007, MOL CELL PROTEOMICS, V6, P394, DOI 10.1074/mcp.M600250-MCP200; Klein M, 2003, PLANT J, V33, P119, DOI 10.1046/j.1365-313X.2003.016012.x; Lebaudy A, 2008, P NATL ACAD SCI USA, V105, P5271, DOI 10.1073/pnas.0709732105; Lee M, 2008, NAT CELL BIOL, V10, P1217, DOI 10.1038/ncb1782; Lee YS, 2007, SCIENCE, V316, P109, DOI 10.1126/science.1139080; Lemtiri-Chlieh F, 2003, P NATL ACAD SCI USA, V100, P10091, DOI 10.1073/pnas.1133289100; Lemtiri-Chlieh F, 2000, P NATL ACAD SCI USA, V97, P8687, DOI 10.1073/pnas.140217497; Lott JNA., 1984, SEED PHYSL, P139; MacRobbie EAC, 1998, PHILOS T ROY SOC B, V353, P1475, DOI 10.1098/rstb.1998.0303; Marty F, 1997, ADV BOT RES, V25, P1, DOI 10.1016/S0065-2296(08)60146-9; Mitchell J, 2008, CURR BIOL, V18, P1600, DOI 10.1016/j.cub.2008.08.073; Mitsuhashi N, 2005, PLANT PHYSIOL, V138, P1607, DOI 10.1104/pp.105.060269; Mulugu S, 2007, SCIENCE, V316, P106, DOI 10.1126/science.1139099; Murphy AM, 2008, PLANT J, V56, P638, DOI 10.1111/j.1365-313X.2008.03629.x; Negi J, 2008, NATURE, V452, P483, DOI 10.1038/nature06720; Odom AR, 2000, SCIENCE, V287, P2026, DOI 10.1126/science.287.5460.2026; Otegui MS, 2002, PLANT CELL, V14, P1311, DOI 10.1105/tpc.010486; Raboy V, 2000, PLANT PHYSIOL, V124, P355, DOI 10.1104/pp.124.1.355; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; Sarmah B, 2005, DEV CELL, V9, P133, DOI 10.1016/j.devcel.2005.05.002; SCHWIEBERT EM, 1995, CELL, V81, P1063, DOI 10.1016/S0092-8674(05)80011-X; Shi JR, 2007, NAT BIOTECHNOL, V25, P930, DOI 10.1038/nbt1322; Shi JR, 2003, PLANT PHYSIOL, V131, P507, DOI 10.1104/pp.014258; Stevenson-Paulik J, 2005, P NATL ACAD SCI USA, V102, P12612, DOI 10.1073/pnas.0504172102; Suh SJ, 2007, J BIOL CHEM, V282, P1916, DOI 10.1074/jbc.M607926200; Sweetman D, 2006, BIOCHEM J, V394, P95, DOI 10.1042/BJ20051331; Sweetman D, 2007, FEBS LETT, V581, P4165, DOI 10.1016/j.febslet.2007.07.046; Tommasini R, 1996, P NATL ACAD SCI USA, V93, P6743, DOI 10.1073/pnas.93.13.6743; Turner BL, 2002, PHILOS T ROY SOC B, V357, P449, DOI 10.1098/rstb.2001.0837; Vahisalu T, 2008, NATURE, V452, P487, DOI 10.1038/nature06608; VAJANAPHANICH M, 1994, NATURE, V371, P711, DOI 10.1038/371711a0; Yang L, 2006, J CELL SCI, V119, P1320, DOI 10.1242/jcs.02836; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	47	139	154	2	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33614	33622		10.1074/jbc.M109.030247	http://dx.doi.org/10.1074/jbc.M109.030247			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19797057	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000272028500065
J	Noma, K; Kimura, K; Minatohara, K; Nakashima, H; Nagao, Y; Mizoguchi, A; Fujiyoshi, Y				Noma, Kentaro; Kimura, Kazushi; Minatohara, Keiichiro; Nakashima, Hisako; Nagao, Yasuaki; Mizoguchi, Akira; Fujiyoshi, Yoshinori			Triple N-Glycosylation in the Long S5-P Loop Regulates the Activation and Trafficking of the Kv12.2 Potassium Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIMULATED ACTION-POTENTIALS; CELL-SURFACE EXPRESSION; K+ CHANNEL; BETA-SUBUNITS; SIALIC-ACID; FUNCTIONAL-PROPERTIES; LINKED GLYCOSYLATION; HERG CHANNEL; IN-VITRO; GLYCANS	Mammalian voltage-dependent potassium (Kv) channels regulate the excitability of nerve and muscle cells. Kv12.2 features the longest S5-P loop among all known mammalian Kv channels with the most N-linked glycosylation sites (three sites). Despite its unique structural features, Kv12.2 is not well characterized. Because glycosylation plays important roles in the folding, trafficking, and function of various Kv channels, we focused on the N-glycosylation of Kv12.2. We show that Kv12.2 is N-glycosylated in Chinese hamster ovary (CHO) cells and in cultured neurons as well as in the mouse brain. As an effect of N-glycosylation on the function of Kv12.2, we demonstrate that removal of sugar chains causes a depolarizing shift in the steady-state activation without a significant reduction in current amplitude. Unlike the previously reported shift for Shaker-type Kv channels, this shift does not appear to be due to negatively charged sialic acid residues in the sugar chains. We next examined the trafficking in CHO cells to address whether the unglycosylated Kv12.2 channels are utilized in vivo. Although double mutants, retaining only one glycosylation site, are trafficked to the surface of CHO cells irrespective of the position of the glycosylated site, unglycosylated channels are not trafficked to the cell surface. Furthermore, we could not detect unglycosylated channels in the mouse brain. Our data suggest that only glycosylated Kv12.2 channels show proper voltage dependence and are utilized in vivo.	[Noma, Kentaro; Minatohara, Keiichiro; Fujiyoshi, Yoshinori] Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan; [Kimura, Kazushi; Nakashima, Hisako; Nagao, Yasuaki; Mizoguchi, Akira] Mie Univ, Grad Sch Med, Dept Neural Regenerat & Cell Commun, Tsu, Mie 5148507, Japan	Kyoto University; Mie University	Fujiyoshi, Y (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan.	yoshi@em.biophys.kyoto-u.ac.jp	Kimura, Kazushi/ABB-4007-2020; Fujiyoshi, Yoshinori/E-5989-2012	Fujiyoshi, Yoshinori/0000-0002-8070-1493	Japan New Energy and Industrial Technology Development Organization	Japan New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported by Grants-in-aid for Specially Promoted Research and the Japan New Energy and Industrial Technology Development Organization.	Bauer CK, 2001, J MEMBRANE BIOL, V182, P1; Becchetti A, 2002, EUR J NEUROSCI, V16, P415, DOI 10.1046/j.1460-9568.2002.02079.x; Bennett E, 1997, J GEN PHYSIOL, V109, P327, DOI 10.1085/jgp.109.3.327; Bennett ES, 2002, J PHYSIOL-LONDON, V538, P675, DOI 10.1113/jphysiol.2001.013285; Brooks NL, 2006, FEBS J, V273, P3287, DOI 10.1111/j.1742-4658.2006.05339.x; Burda P, 1999, BBA-GEN SUBJECTS, V1426, P239, DOI 10.1016/S0304-4165(98)00127-5; Clancy SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006330; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; Dun W, 1999, PFLUG ARCH EUR J PHY, V439, P141, DOI 10.1007/s004240051138; Engeland B, 1998, J PHYSIOL-LONDON, V513, P647, DOI 10.1111/j.1469-7793.1998.647ba.x; Ganetzky B, 1999, ANN NY ACAD SCI, V868, P356, DOI 10.1111/j.1749-6632.1999.tb11297.x; Gong QM, 2002, AM J PHYSIOL-HEART C, V283, pH77, DOI 10.1152/ajpheart.00008.2002; Grosso S, 2004, J CHILD NEUROL, V19, P604, DOI 10.1177/088307380401900807; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; Hebert DN, 1997, J CELL BIOL, V139, P613, DOI 10.1083/jcb.139.3.613; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Jiang M, 2005, J PHYSIOL-LONDON, V569, P75, DOI 10.1113/jphysiol.2005.093682; Johnson D, 2008, PFLUG ARCH EUR J PHY, V456, P393, DOI 10.1007/s00424-007-0378-0; LANDOLTMARTICORENA C, 1994, BIOCHEM J, V302, P253, DOI 10.1042/bj3020253; Liu J, 2002, J GEN PHYSIOL, V120, P723, DOI 10.1085/jgp.20028687; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; MALETICSAVATIC M, 1995, J NEUROSCI, V15, P3840; Misonou H, 2004, CRIT REV BIOCHEM MOL, V39, P125, DOI 10.1080/10409230490475417; Miyake A, 1999, J BIOL CHEM, V274, P25018, DOI 10.1074/jbc.274.35.25018; Mizoguchi A, 2002, J CELL BIOL, V156, P555, DOI 10.1083/jcb.200103113; Napp J, 2005, J BIOL CHEM, V280, P29506, DOI 10.1074/jbc.M504228200; Petrecca K, 1999, J PHYSIOL-LONDON, V515, P41, DOI 10.1111/j.1469-7793.1999.041ad.x; Pongs O, 1999, ANN NY ACAD SCI, V868, P344, DOI 10.1111/j.1749-6632.1999.tb11296.x; RECIOPINTO E, 1990, NEURON, V5, P675, DOI 10.1016/0896-6273(90)90221-Z; Shi GY, 1996, NEURON, V16, P843, DOI 10.1016/S0896-6273(00)80104-X; Sutachan JJ, 2005, BRAIN RES, V1058, P30, DOI 10.1016/j.brainres.2005.07.050; Thornhill WB, 1996, J BIOL CHEM, V271, P19093, DOI 10.1074/jbc.271.32.19093; Torres YP, 2007, J BIOL CHEM, V282, P24485, DOI 10.1074/jbc.R700022200; TRETTER V, 1991, EUR J BIOCHEM, V199, P647, DOI 10.1111/j.1432-1033.1991.tb16166.x; Trudeau MC, 1999, J NEUROSCI, V19, P2906; Ufret-Vincenty CA, 2001, AM J PHYSIOL-CELL PH, V281, pC464, DOI 10.1152/ajpcell.2001.281.2.C464; Vacher H, 2008, PHYSIOL REV, V88, P1407, DOI 10.1152/physrev.00002.2008; Vanoni O, 2008, MOL BIOL CELL, V19, P4086, DOI 10.1091/mbc.E08-05-0459; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Watanabe I, 2004, J BIOL CHEM, V279, P8879, DOI 10.1074/jbc.M309802200; Watanabe I, 2003, J PHYSIOL-LONDON, V550, P51, DOI 10.1113/jphysiol.2003.040337; Watanabe I, 2007, BRAIN RES, V1144, P1, DOI 10.1016/j.brainres.2007.01.092; YU FH, 2004, SCI STKE; Zhu I, 2009, BRAIN RES, V1251, P16, DOI 10.1016/j.brainres.2008.11.033; Zou AR, 2003, AM J PHYSIOL-CELL PH, V285, pC1356, DOI 10.1152/ajpcell.00179.2003	47	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33139	33150		10.1074/jbc.M109.021519	http://dx.doi.org/10.1074/jbc.M109.021519			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19808681	hybrid, Green Published			2022-12-27	WOS:000272028500018
J	Gubern, A; Barcelo-Torns, M; Barneda, D; Lopez, JM; Masgrau, R; Picatoste, F; Chalfant, CE; Balsinde, J; Balboa, MA; Claro, E				Gubern, Albert; Barcelo-Torns, Miquel; Barneda, David; Lopez, Jose M.; Masgrau, Roser; Picatoste, Fernando; Chalfant, Charles E.; Balsinde, Jesus; Balboa, Maria A.; Claro, Enrique			JNK and Ceramide Kinase Govern the Biogenesis of Lipid Droplets through Activation of Group IVA Phospholipase A(2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARACHIDONIC-ACID RELEASE; C2 DOMAIN; CALCIUM; PHOSPHORYLATION; TRANSLOCATION; CERAMIDE-1-PHOSPHATE; 1-PHOSPHATE; MACROPHAGES; PROTEINS; BINDING	The biogenesis of lipid droplets (LD) induced by serum depends on group IVA phospholipase A(2) (cPLA(2)alpha). This work dissects the pathway leading to cPLA(2)alpha activation and LD biogenesis. Both processes were Ca2+-independent, as they took place after pharmacological blockade of Ca2+ transients elicited by serum or chelation with 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid tetrakis(acetoxymethyl ester). The single mutation D43N in cPLA(2)alpha, which abrogates its Ca2+ binding capacity and translocation to membranes, did not affect enzyme activation and formation of LD. In contrast, the mutation S505A did not affect membrane relocation of the enzyme in response to Ca2+ but prevented its phosphorylation, activation, and the appearance of LD. Expression of specific activators of different mitogen-activated protein kinases showed that phosphorylation of cPLA(2)alpha at Ser-505 is due to JNK. This was confirmed by pharmacological inhibition and expression of a dominant-negative form of the upstream activator MEKK1. LD biogenesis was accompanied by increased synthesis of ceramide 1-phosphate. Overexpression of its synthesizing enzyme ceramide kinase increased phosphorylation of cPLA(2)alpha at Ser-505 and formation of LD, and its down-regulation blocked the phosphorylation of cPLA(2)alpha and LD biogenesis. These results demonstrate that LD biogenesis induced by serum is regulated by JNK and ceramide kinase.	[Gubern, Albert; Barcelo-Torns, Miquel; Barneda, David; Lopez, Jose M.; Masgrau, Roser; Picatoste, Fernando; Claro, Enrique] Univ Autonoma Barcelona, Inst Neurociencies, E-08193 Barcelona, Spain; [Gubern, Albert; Barcelo-Torns, Miquel; Barneda, David; Lopez, Jose M.; Masgrau, Roser; Picatoste, Fernando; Claro, Enrique] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain; [Chalfant, Charles E.] Virginia Commonwealth Univ, Sch Med, Dept Biochem, Richmond, VA 23298 USA; [Balsinde, Jesus; Balboa, Maria A.] Consejo Super Invest Cient, Inst Mol Biol & Genet, E-47003 Valladolid, Spain; [Balsinde, Jesus; Balboa, Maria A.] Ctr Invest Biomed Red Diabet & Enfermedades Metab, E-47003 Valladolid, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Virginia Commonwealth University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM	Claro, E (corresponding author), Univ Autonoma Barcelona, Inst Neurociencies, Edifici M2,Campus UAB, E-08193 Barcelona, Spain.	enrique.claro@uab.es	Lopez, Jose M/D-1654-2011; Lopez, Jose/AAF-3798-2020; Claro, Enrique/D-5612-2009; Gubern, Albert/C-9902-2011; Masgrau, Roser/D-3047-2011; Balboa, María A./V-9493-2018; Balsinde, Jesús/C-7833-2018	Lopez, Jose M/0000-0002-4104-6262; Lopez, Jose/0000-0002-4104-6262; Claro, Enrique/0000-0002-7592-7906; Gubern, Albert/0000-0001-6458-1498; Masgrau, Roser/0000-0002-6722-5939; Balboa, María A./0000-0002-2130-5298; Balsinde, Jesús/0000-0002-4157-6714; Barneda, David/0000-0002-4436-4100	National Institutes of Health [HL-072925, CA-117990]; Spanish Ministry of Education and Science [SAF 2004-01698, SAF 2007-60055, SAF 2007-67154, BFU2009-07823]; Spanish Ministry of Health [PI05/1723]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072925] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry of Education and Science(Spanish Government); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-072925 and CA-117990, Grants SAF 2004-01698, SAF 2007-60055, SAF 2007-67154, and BFU2009-07823 from the Spanish Ministry of Education and Science, and Grant PI05/1723 from the Spanish Ministry of Health.	Balboa MA, 2000, BIOCHEM BIOPH RES CO, V267, P145, DOI 10.1006/bbrc.1999.1964; Balsinde J, 2000, J IMMUNOL, V164, P5398, DOI 10.4049/jimmunol.164.10.5398; Bittova L, 1999, J BIOL CHEM, V274, P9665, DOI 10.1074/jbc.274.14.9665; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bostrom P, 2007, NAT CELL BIOL, V9, P1286, DOI 10.1038/ncb1648; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Burke JE, 2009, CARDIOVASC DRUG THER, V23, P49, DOI 10.1007/s10557-008-6132-9; Casas J, 2006, J BIOL CHEM, V281, P6106, DOI 10.1074/jbc.M505230200; Casas J, 2006, MOL BIOL CELL, V17, P155, DOI 10.1091/mbc.e05-06-0545; Casas J, 2009, J IMMUNOL, V183, P2767, DOI 10.4049/jimmunol.0901530; Chalfant CE, 2005, J CELL SCI, V118, P4605, DOI 10.1242/jcs.02637; Cole NB, 2002, J BIOL CHEM, V277, P6344, DOI 10.1074/jbc.M108414200; Du L, 2009, J BIOL CHEM, V284, P2383, DOI 10.1074/jbc.M804396200; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; Gijon MA, 2000, J BIOL CHEM, V275, P20146, DOI 10.1074/jbc.M908941199; Gijon MA, 1999, J CELL BIOL, V145, P1219, DOI 10.1083/jcb.145.6.1219; Gomez-Munoz A, 2006, BBA-BIOMEMBRANES, V1758, P2049, DOI 10.1016/j.bbamem.2006.05.011; Gubern A, 2008, J BIOL CHEM, V283, P27369, DOI 10.1074/jbc.M800696200; Gubern A, 2009, J BIOL CHEM, V284, P5697, DOI 10.1074/jbc.M806173200; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hutter-Paier B, 2004, NEURON, V44, P227, DOI 10.1016/j.neuron.2004.08.043; Lamour NF, 2009, J BIOL CHEM, V284, P26897, DOI 10.1074/jbc.M109.001677; Lamour NF, 2005, MOL INTERV, V5, P358, DOI 10.1124/mi.5.6.8; Lee JG, 2008, CELL SIGNAL, V20, P105, DOI 10.1016/j.cellsig.2007.09.003; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Mosior M, 1998, J BIOL CHEM, V273, P2184, DOI 10.1074/jbc.273.4.2184; Murphy DJ, 2001, PROG LIPID RES, V40, P325, DOI 10.1016/S0163-7827(01)00013-3; Pavicevic Z, 2008, J LIPID RES, V49, P724, DOI 10.1194/jlr.M700419-JLR200; Perisic O, 1999, J BIOL CHEM, V274, P14979, DOI 10.1074/jbc.274.21.14979; Pettus BJ, 2003, J BIOL CHEM, V278, P38206, DOI 10.1074/jbc.M304816200; Pettus BJ, 2004, J BIOL CHEM, V279, P11320, DOI 10.1074/jbc.M309262200; Qiu ZH, 1998, J BIOL CHEM, V273, P8203, DOI 10.1074/jbc.273.14.8203; Sheridan AM, 2001, J BIOL CHEM, V276, P29899, DOI 10.1074/jbc.M103758200; Six DA, 2003, J BIOL CHEM, V278, P23842, DOI 10.1074/jbc.M301386200; Stahelin RV, 2007, J BIOL CHEM, V282, P20467, DOI 10.1074/jbc.M701396200; Subramanian P, 2005, J BIOL CHEM, V280, P17601, DOI 10.1074/jbc.M414173200; Sun XH, 1999, J CELL BIOCHEM, V73, P458, DOI 10.1002/(SICI)1097-4644(19990615)73:4<458::AID-JCB4>3.0.CO;2-0; Wijesinghe DS, 2007, METHOD ENZYMOL, V434, P265, DOI 10.1016/S0076-6879(07)34015-9; Wijesinghe DS, 2005, J LIPID RES, V46, P2706, DOI 10.1194/jlr.M500313-JLR200; Wolins NE, 2006, FEBS LETT, V580, P5484, DOI 10.1016/j.febslet.2006.08.040	40	42	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32359	32369		10.1074/jbc.M109.061515	http://dx.doi.org/10.1074/jbc.M109.061515			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19778898	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000272028400019
J	Ma, L; Xu, MX; Forman, JR; Clarke, J; Oberhauser, AF				Ma, Liang; Xu, Meixiang; Forman, Julia R.; Clarke, Jane; Oberhauser, Andres F.			Naturally Occurring Mutations Alter the Stability of Polycystin-1 Polycystic Kidney Disease (PKD) Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-FORCE MICROSCOPY; AUTOSOMAL-DOMINANT; PATHOGENIC MUTATIONS; MECHANICAL STABILITY; MOLECULAR-GENETICS; PROTEINS; TITIN; MECHANOTRANSDUCTION; MECHANOSENSATION; REGION	Mutations in polycystin-1 (PC1) can cause autosomal dominant polycystic kidney disease, which is a leading cause of renal failure. The available evidence suggests that PC1 acts as a mechanosensor, receiving signals from the primary cilia, neighboring cells, and extracellular matrix. PC1 is a large membrane protein that has a long N-terminal extracellular region (about 3000 amino acids) with a multimodular structure including 16 Ig-like polycystic kidney disease (PKD) domains, which are targeted by many naturally occurring missense mutations. Nothing is known about the effects of these mutations on the biophysical properties of PKD domains. Here we investigate the effects of several naturally occurring mutations on the mechanical stability of the first PKD domain of human PC1 (HuPKDd1). We found that several missense mutations alter the mechanical unfolding pathways of HuPKDd1, resulting in distinct mechanical phenotypes. Moreover, we found that these mutations also alter the thermodynamic stability of a structurally homologous archaeal PKD domain. Based on these findings, we hypothesize that missense mutations may cause autosomal dominant polycystic kidney disease by altering the stability of the PC1 ectodomain, thereby perturbing its ability to sense mechanical signals.	[Ma, Liang; Xu, Meixiang; Oberhauser, Andres F.] Dept Neurosci & Cell Biol, Cambridge CB2 1EW, England; [Forman, Julia R.; Clarke, Jane] Univ Cambridge, Chem Lab, MRC Ctr Prot Engn, Cambridge CB2 1EW, England; [Oberhauser, Andres F.] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA	MRC Laboratory Molecular Biology; University of Cambridge; University of Texas System; University of Texas Medical Branch Galveston	Oberhauser, AF (corresponding author), Dept Neurosci & Cell Biol, Lensfield Rd, Cambridge CB2 1EW, England.	afoberha@utmb.edu			National Institutes of Health [R01DK073394]; John Sealy Memorial Endowment Fund; Polycystic Kidney Foundation [116a2r]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073394] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John Sealy Memorial Endowment Fund; Polycystic Kidney Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK073394 (to A.F.O.). This work was also supported by grants from the John Sealy Memorial Endowment Fund for Biomedical Research and the Polycystic Kidney Foundation (Grant 116a2r).	Alenghat FJ, 2004, EXP CELL RES, V301, P23, DOI 10.1016/j.yexcr.2004.08.003; Bateman A, 1996, EMBO J, V15, P6050, DOI 10.1002/j.1460-2075.1996.tb00993.x; Best RB, 2002, P NATL ACAD SCI USA, V99, P12143, DOI 10.1073/pnas.192351899; Best RB, 2001, BIOPHYS J, V81, P2344, DOI 10.1016/S0006-3495(01)75881-X; Brucale M, 2009, CHEMBIOCHEM, V10, P176, DOI 10.1002/cbic.200800581; Bullard B, 2002, J MUSCLE RES CELL M, V23, P435, DOI 10.1023/A:1023454305437; Burtey S, 2002, J MED GENET, V39, P422, DOI 10.1136/jmg.39.6.422; Bycroft M, 1999, EMBO J, V18, P297, DOI 10.1093/emboj/18.2.297; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; FLORIN EL, 1995, BIOSENS BIOELECTRON, V10, P895, DOI 10.1016/0956-5663(95)99227-C; Forman JR, 2005, J MOL BIOL, V349, P861, DOI 10.1016/j.jmb.2005.04.008; GABOW PA, 1990, AM J KIDNEY DIS, V16, P403, DOI 10.1016/S0272-6386(12)80051-5; Garcia TI, 2009, PROTEINS, V75, P706, DOI 10.1002/prot.22281; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Jing H, 2002, STRUCTURE, V10, P1453, DOI 10.1016/S0969-2126(02)00840-7; Kaletta T, 2003, NEPHRON EXP NEPHROL, V93, pE9, DOI 10.1159/000066650; Klein DCG, 2003, CHEMPHYSCHEM, V4, P1367, DOI 10.1002/cphc.200300844; Li HB, 2000, NAT STRUCT BIOL, V7, P1117; Li HB, 2002, NATURE, V418, P998, DOI 10.1038/nature00938; Li LW, 2005, J MOL BIOL, V345, P817, DOI 10.1016/j.jmb.2004.11.021; Mathura VS, 2003, BIOINFORMATICS, V19, P1381, DOI 10.1093/bioinformatics/btg164; Miller E, 2006, BIOPHYS J, V91, P3848, DOI 10.1529/biophysj.106.088989; Nauli SM, 2004, BIOESSAYS, V26, P844, DOI 10.1002/bies.20069; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Oberhauser AF, 2001, P NATL ACAD SCI USA, V98, P468, DOI 10.1073/pnas.021321798; Oberhauser AF, 2002, J MOL BIOL, V319, P433, DOI 10.1016/S0022-2836(02)00306-6; Oberhauser AF, 1998, NATURE, V393, P181, DOI 10.1038/30270; Oberhauser AF, 2008, J BIOL CHEM, V283, P6617, DOI 10.1074/jbc.R700050200; Pace C N, 1986, Methods Enzymol, V131, P266; Phakdeekitcharoen B, 2000, KIDNEY INT, V58, P1400, DOI 10.1046/j.1523-1755.2000.00302.x; Qian F, 2005, J BIOL CHEM, V280, P40723, DOI 10.1074/jbc.M509650200; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Randles LG, 2006, J BIOL CHEM, V281, P24216, DOI 10.1074/jbc.M603593200; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Rossetti S, 2003, LANCET, V361, P2196, DOI 10.1016/S0140-6736(03)13773-7; Rossetti S, 2002, KIDNEY INT, V61, P1588, DOI 10.1046/j.1523-1755.2002.00326.x; Rossetti S, 2001, AM J HUM GENET, V68, P46, DOI 10.1086/316939; Rossetti S, 2007, J AM SOC NEPHROL, V18, P2143, DOI 10.1681/ASN.2006121387; Sandford R, 1997, HUM MOL GENET, V6, P1483, DOI 10.1093/hmg/6.9.1483; Steward A, 2002, PROTEIN SCI, V11, P2179, DOI 10.1110/ps.0212702; Sutters M, 2003, J LAB CLIN MED, V141, P91, DOI 10.1067/mlc.2003.13; Thomas R, 1999, AM J HUM GENET, V65, P39, DOI 10.1086/302460; Torres VE, 2006, NAT CLIN PRACT NEPHR, V2, P40, DOI 10.1038/ncpneph0070; Wilson PD, 2004, INT J BIOCHEM CELL B, V36, P1868, DOI 10.1016/j.biocel.2004.03.012; Wu GQ, 2000, MOL GENET METAB, V69, P1, DOI 10.1006/mgme.1999.2943	45	18	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32942	32949		10.1074/jbc.M109.021832	http://dx.doi.org/10.1074/jbc.M109.021832			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19759016	Green Published, hybrid			2022-12-27	WOS:000272028400077
J	MacKenzie, DA; Tailford, LE; Hemmings, AM; Juge, N				MacKenzie, Donald A.; Tailford, Louise E.; Hemmings, Andrew M.; Juge, Nathalie			Crystal Structure of a Mucus-binding Protein Repeat Reveals an Unexpected Functional Immunoglobulin Binding Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLETE GENOME SEQUENCE; CELL-SURFACE; PEPTOSTREPTOCOCCUS-MAGNUS; LACTOBACILLUS-PLANTARUM; STAPHYLOCOCCUS-AUREUS; INTESTINAL MUCUS; ADHESION PROPERTIES; PROBIOTIC STRAINS; DOMAIN; IGA	Lactobacillus reuteri mucus-binding protein (MUB) is a cell-surface protein that is involved in bacterial interaction with mucus and colonization of the digestive tract. The 353-kDa mature protein is representative of a broadly important class of adhesins that have remained relatively poorly characterized due to their large size and highly modular nature. MUB contains two different types of repeats (Mub1 and Mub2) present in six and eight copies, respectively, and shown to be responsible for the adherence to intestinal mucus. Here we report the 1.8-A resolution crystal structure of a type 2 Mub repeat (184 amino acids) comprising two structurally related domains resembling the functional repeat found in a family of immunoglobulin (Ig)-binding proteins. The N-terminal domain bears striking structural similarity to the repeat unit of Protein L (PpL) from Peptostreptococcus magnus, suggesting binding in a non-immune Fab-dependent manner. A distorted PpL-like fold is also seen in the C-terminal domain. As with PpL, Mub repeats were able to interact in vitro with a large repertoire of mammalian Igs, including secretory IgA. This hitherto undetected activity is consistent with the current model that antibody responses against commensal flora are of broad specificity and low affinity.	[Hemmings, Andrew M.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Hemmings, Andrew M.] Univ E Anglia, Sch Chem, Norwich NR4 7TJ, Norfolk, England; Inst Food Res, Norwich NR4 7UA, Norfolk, England	University of East Anglia; University of East Anglia; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia	Hemmings, AM (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England.	a.hemmings@uea.ac.uk; nathalie.juge@bbsrc.ac.uk	HEMMINGS, ANDREW MICHAEL/E-5517-2011	HEMMINGS, ANDREW MICHAEL/0000-0003-3053-3134; Juge, Nathalie/0000-0001-8515-1315	Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council [BBS/E/F/00042268] Funding Source: researchfish; Medical Research Council [G0500367] Funding Source: researchfish; BBSRC [BBS/E/F/00042268] Funding Source: UKRI; MRC [G0500367] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was supported by a Biotechnology and Biological Sciences Research Council core strategic grant.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Agniswamy J, 2006, STRUCTURE, V14, P225, DOI 10.1016/j.str.2005.10.012; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Beckingham JA, 2001, BIOCHEM J, V353, P395, DOI 10.1042/0264-6021:3530395; Beckingham JA, 1999, BIOCHEM J, V340, P193, DOI 10.1042/0264-6021:3400193; BJORCK L, 1988, J IMMUNOL, V140, P1194; BJORCK L, 1984, J IMMUNOL, V133, P969; Boekhorst J, 2006, MICROBIOL-SGM, V152, P273, DOI 10.1099/mic.0.28415-0; Bolotin A, 2001, GENOME RES, V11, P731, DOI 10.1101/gr.GR-1697R; Buck BL, 2005, APPL ENVIRON MICROB, V71, P8344, DOI 10.1128/AEM.71.12.8344-8351.2005; Bumbaca D, 2007, PROTEINS, V66, P547, DOI 10.1002/prot.21205; Collado MC, 2007, CURR MICROBIOL, V55, P260, DOI 10.1007/s00284-007-0144-8; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de Vrese M, 2007, J NUTR, V137, p803S, DOI 10.1093/jn/137.3.803S; DERRICK JP, 1994, J MOL BIOL, V243, P906, DOI 10.1006/jmbi.1994.1691; Desvaux M, 2006, FEMS MICROBIOL LETT, V256, P1, DOI 10.1111/j.1574-6968.2006.00122.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enokizono J, 1997, J MOL BIOL, V270, P8, DOI 10.1006/jmbi.1997.1090; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; FORSGREN A, 1966, J IMMUNOL, V97, P822; Gill H, 2008, ADV EXP MED BIOL, V606, P423, DOI 10.1007/978-0-387-74087-4_17; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; GOWARD CR, 1993, TRENDS BIOCHEM SCI, V18, P136, DOI 10.1016/0968-0004(93)90021-E; Graille M, 2002, J BIOL CHEM, V277, P47500, DOI 10.1074/jbc.M206105200; Graille M, 2001, STRUCTURE, V9, P679, DOI 10.1016/S0969-2126(01)00630-X; Granato D, 2004, INFECT IMMUN, V72, P2160, DOI 10.1128/IAI.72.4.2160-2169.2004; GUSS B, 1986, EMBO J, V5, P1567, DOI 10.1002/j.1460-2075.1986.tb04398.x; Harding MM, 1999, ACTA CRYSTALLOGR D, V55, P1432, DOI 10.1107/S0907444999007374; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Housden NG, 2003, BIOCHEM SOC T, V31, P716, DOI 10.1042/BST0310716; KASTERN W, 1992, J BIOL CHEM, V267, P12820; Kazeeva TN, 2009, BIOCHEMISTRY-MOSCOW+, V74, P12, DOI 10.1134/S0006297909010027; Kirjavainen PV, 1998, FEMS MICROBIOL LETT, V167, P185, DOI 10.1016/S0378-1097(98)00387-5; Kleerebezem M, 2003, P NATL ACAD SCI USA, V100, P1990, DOI 10.1073/pnas.0337704100; Krishnan V, 2007, STRUCTURE, V15, P893, DOI 10.1016/j.str.2007.06.015; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Langley R, 2005, J IMMUNOL, V174, P2926, DOI 10.4049/jimmunol.174.5.2926; LANGONE JJ, 1982, ADV IMMUNOL, V32, P157; Lebeer S, 2008, MICROBIOL MOL BIOL R, V72, P728, DOI 10.1128/MMBR.00017-08; Lee YK, 2003, J MED MICROBIOL, V52, P925, DOI 10.1099/jmm.0.05009-0; Leo JC, 2009, MOL IMMUNOL, V46, P1860, DOI 10.1016/j.molimm.2009.02.024; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Li XJ, 2008, J APPL MICROBIOL, V104, P1082, DOI 10.1111/j.1365-2672.2007.03636.x; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; Ma YL, 2006, LETT APPL MICROBIOL, V42, P369, DOI 10.1111/j.1472-765X.2006.01844.x; Macfarlane S, 2007, J APPL MICROBIOL, V102, P1187, DOI 10.1111/j.1365-2672.2007.03287.x; Macfarlane S, 2004, CLIN INFECT DIS, V38, P1690, DOI 10.1086/420823; MACIASRODRIGUEZ ME, 2009, J APPL MICROBIOL, DOI DOI 10.1111/I.1365-2672.2009.04368; Macpherson AJ, 2008, MUCOSAL IMMUNOL, V1, P11, DOI 10.1038/mi.2007.6; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Miyoshi Y, 2006, BIOSCI BIOTECH BIOCH, V70, P1622, DOI 10.1271/bbb.50688; Munoz-Provencio D, 2009, ARCH MICROBIOL, V191, P153, DOI 10.1007/s00203-008-0436-9; MURPHY JP, 1994, MOL MICROBIOL, V12, P911, DOI 10.1111/j.1365-2958.1994.tb01079.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; NILSON BHK, 1992, J BIOL CHEM, V267, P2234; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ouwehand AC, 2001, INT J FOOD MICROBIOL, V64, P119, DOI 10.1016/S0168-1605(00)00440-2; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Pleass RJ, 2001, J BIOL CHEM, V276, P8197, DOI 10.1074/jbc.M009396200; Pretzer G, 2005, J BACTERIOL, V187, P6128, DOI 10.1128/JB.187.17.6128-6136.2005; Reuter G, 2001, Curr Issues Intest Microbiol, V2, P43; Rojas M, 2002, APPL ENVIRON MICROB, V68, P2330, DOI 10.1128/AEM.68.5.2330-2336.2002; Roos S, 2002, MICROBIOL-SGM, V148, P433, DOI 10.1099/00221287-148-2-433; SAUERERIKSSON AE, 1995, STRUCTURE, V3, P265, DOI 10.1016/S0969-2126(01)00157-5; Schwarz-Linek U, 2006, MICROBES INFECT, V8, P2291, DOI 10.1016/j.micinf.2006.03.011; SJODAHL J, 1977, EUR J BIOCHEM, V73, P343, DOI 10.1111/j.1432-1033.1977.tb11324.x; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Sun J, 2007, LETT APPL MICROBIOL, V44, P79, DOI 10.1111/j.1472-765X.2006.02031.x; Svensson HG, 2004, BIOCHEMISTRY-US, V43, P2445, DOI 10.1021/bi034873s; Tallon R, 2007, J APPL MICROBIOL, V102, P442, DOI 10.1111/j.1365-2672.2006.03086.x; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Vesterlund S, 2006, MICROBIOL-SGM, V152, P1819, DOI 10.1099/mic.0.28522-0; Walter J, 2008, APPL ENVIRON MICROB, V74, P4985, DOI 10.1128/AEM.00753-08; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WIKSTROM M, 1994, BIOCHEMISTRY-US, V33, P14011, DOI 10.1021/bi00251a008; WIKSTROM M, 1995, J MOL BIOL, V250, P128, DOI 10.1006/jmbi.1995.0364; Woof JM, 2005, IMMUNOL REV, V206, P64, DOI 10.1111/j.0105-2896.2005.00290.x	83	59	62	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32444	32453		10.1074/jbc.M109.040907	http://dx.doi.org/10.1074/jbc.M109.040907			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19758995	hybrid, Green Published			2022-12-27	WOS:000272028400027
J	Matamoros, T; Nevot, M; Martinez, MA; Menendez-Arias, L				Matamoros, Tania; Nevot, Maria; Angel Martinez, Miguel; Menendez-Arias, Luis			Thymidine Analogue Resistance Suppression by V75I of HIV-1 Reverse Transcriptase EFFECTS OF SUBSTITUTING VALINE 75 ON STAVUDINE EXCISION AND DISCRIMINATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; BORANOPHOSPHATE NUCLEOTIDE ANALOGS; PRIMER UNBLOCKING ACTIVITY; TERMINATED DNA-SYNTHESIS; DRUG-RESISTANCE; ZIDOVUDINE RESISTANCE; MULTIDRUG-RESISTANCE; 3'-AZIDO-3'-DEOXYTHYMIDINE AZT; DIDEOXYNUCLEOSIDE RESISTANCE; PHYSIOLOGICAL CONCENTRATIONS	Val(75) of HIV-1 reverse transcriptase (RT) plays a role in positioning the template nucleotide +1 during the formation of the ternary complex. Mutations, such as V75M and V75A, emerge in patients infected with HIV-1 group M subtype B and group O variants, after failing treatment with stavudine (d4T) and other nucleoside RT inhibitors. V75I is an accessory mutation of the Q151M multidrug resistance complex of HIV-1 RT and is rarely associated with thymidine analogue resistance mutations (TAMs). In vitro, it confers resistance to acyclovir. TAMs confer resistance to zidovudine (AZT) and d4T by increasing the rate of ATP-mediated excision of the terminal nucleotide monophosphate (primer unblocking). In a wild-type HIV-1 group O RT sequence context, V75A and V75M conferred increased excision activity on d4T-terminated primers, in the presence of PPi. In contrast, V75I decreased the PPi-mediated unblocking efficiency on AZT and d4T-terminated primers, in different sequence contexts (i.e. wild-type group M subtype B or group O RTs). Interestingly, in the sequence context of an excision-proficient RT (i.e. M41L/A62V/T69SSS/K70R/T215Y), the introduction of V75I led to a significant decrease of its ATP-dependent excision activity on AZT-, d4T-, and acyclovir-terminated primers. The excision rate of d4T- monophosphate in the presence of ATP(3.2mM) was about 10 times higher for M41L/A62V/T69SSS/K70R/T215Y than for the mutant M41L/A62V/T69SSS/K70R/V75I/T215Y RT. The antagonistic effect of V75I with TAMs was further demonstrated in phenotypic assays. Recombinant HIV-1 containing the M41L/A62V/T69SSS/K70R/V75I/T215Y RT showed 18.3- and 1.5-fold increased susceptibility to AZT and d4T, respectively, in comparison with virus containing the M41L/A62V/T69SSS/K70R/T215Y RT.	[Matamoros, Tania; Menendez-Arias, Luis] CSIC, Ctr Biol Mol Severo Ochoa, Madrid 28049, Spain; [Matamoros, Tania; Menendez-Arias, Luis] Univ Autonoma Madrid, E-28049 Madrid, Spain; [Nevot, Maria; Angel Martinez, Miguel] Hosp Badalona Germans Trias & Pujol, Lab Retrovirol, Fundacio IrsiCaixa, Barcelona 08916, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa	Menendez-Arias, L (corresponding author), CSIC, Ctr Biol Mol Severo Ochoa, C Nicolas Cabrera 1,Campus Cantoblanco, Madrid 28049, Spain.	lmenendez@cbm.uam.es	Martinez, Miguel Angel/K-6435-2014; Nevot, Maria/AAC-7839-2022; Nevot, Maria/E-6187-2016; Arias, Luis Menendez/N-7447-2016; Menendez Arias, Luis/G-2436-2016; Matamoros, Tania/F-2580-2016	Martinez, Miguel Angel/0000-0002-6681-4950; Nevot, Maria/0000-0003-4947-4648; Nevot, Maria/0000-0003-4947-4648; Arias, Luis Menendez/0000-0002-1251-6640; Matamoros, Tania/0000-0001-9268-0696	Spanish Ministry of Science and Innovation [BIO2007/60319, BFU2006/01066, PI07/0098]; Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE) [36771/08]; Fondo de Investigacion Sanitaria [RD06/0006]; Fundacion Ramon Areces	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE); Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Fundacion Ramon Areces	This work was supported by Spanish Ministry of Science and Innovation Grant BIO2007/60319, Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE) Grant 36771/08, the Fondo de Investigacion Sanitaria (through "Red Tematica de Investigacion Cooperativa en SIDA" Grant RD06/0006), and an institutional grant from the Fundacion Ramon Areces. This work was also supported by Spanish Ministry of Science and Innovation Grants BFU2006/01066 and PI07/0098 (to M. A. M.).	Alvarez M, 2009, J MOL BIOL, V392, P872, DOI 10.1016/j.jmb.2009.07.081; Arion D, 1998, BIOCHEMISTRY-US, V37, P15908, DOI 10.1021/bi981200e; Arion D, 2000, J BIOL CHEM, V275, P9251, DOI 10.1074/jbc.275.13.9251; Ariyoshi K, 2003, JAIDS-J ACQ IMM DEF, V33, P336, DOI 10.1097/00126334-200307010-00007; Basavapathruni A, 2007, FASEB J, V21, P3795, DOI 10.1096/fj.07-8697rev; Boretto J, 2001, ANAL BIOCHEM, V292, P139, DOI 10.1006/abio.2001.5045; Boyer PL, 2006, PLOS PATHOG, V2, P101, DOI 10.1371/journal.ppat0020010; Boyer PL, 2002, J VIROL, V76, P3248, DOI 10.1128/JVI.76.7.3248-3256.2002; Brandin E, 2003, AIDS RES HUM RETROV, V19, P543, DOI 10.1089/088922203322230905; Cases-Gonzalez CE, 2007, J MOL BIOL, V365, P298, DOI 10.1016/j.jmb.2006.09.073; Coakley EP, 2000, AIDS, V14, pF9, DOI 10.1097/00002030-200001280-00002; De Clercq E., 2009, V189, P53, DOI 10.1007/978-3-540-79086-0_3; Descamps D, 2004, J MED VIROL, V74, P197, DOI 10.1002/jmv.20174; Deval J, 2005, J BIOL CHEM, V280, P3838, DOI 10.1074/jbc.M411559200; Deval J, 2002, J BIOL CHEM, V277, P42097, DOI 10.1074/jbc.M206725200; Deval J, 2004, J BIOL CHEM, V279, P25489, DOI 10.1074/jbc.M313534200; Ding JP, 1998, J MOL BIOL, V284, P1095, DOI 10.1006/jmbi.1998.2208; Fitzgibbon JE, 2001, ANTIVIR THER, V6, P231; Frankel FA, 2005, ANTIMICROB AGENTS CH, V49, P2657, DOI 10.1128/AAC.49.7.2657-2664.2005; Gotte M, 1998, J BIOL CHEM, V273, P10139, DOI 10.1074/jbc.273.17.10139; Gotte M, 2000, J VIROL, V74, P3579, DOI 10.1128/JVI.74.8.3579-3585.2000; Hammond JL, 2001, ANTIMICROB AGENTS CH, V45, P1621, DOI 10.1128/AAC.45.6.1621-1628.2001; He KH, 1998, J ORG CHEM, V63, P5769, DOI 10.1021/jo972002g; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Iversen AKN, 1996, J VIROL, V70, P1086, DOI 10.1128/JVI.70.2.1086-1090.1996; KATI WM, 1992, J BIOL CHEM, V267, P25988; KELLAM P, 1994, ANTIMICROB AGENTS CH, V38, P23, DOI 10.1128/AAC.38.1.23; Kisic M, 2008, J MOL BIOL, V382, P327, DOI 10.1016/j.jmb.2008.07.030; Kosalaraksa P, 1999, J VIROL, V73, P5356, DOI 10.1128/JVI.73.7.5356-5363.1999; LACEY SF, 1994, ANTIMICROB AGENTS CH, V38, P1428, DOI 10.1128/AAC.38.6.1428; LARDER BA, 1990, ANTIMICROB AGENTS CH, V34, P436, DOI 10.1128/AAC.34.3.436; LIN PF, 1994, J INFECT DIS, V170, P1157, DOI 10.1093/infdis/170.5.1157; Maeda Y, 1998, J INFECT DIS, V177, P1207, DOI 10.1086/515282; Marchand B, 2003, J BIOL CHEM, V278, P35362, DOI 10.1074/jbc.M304262200; Marchand B, 2007, J BIOL CHEM, V282, P3337, DOI 10.1074/jbc.M607710200; Mas A, 2002, J MOL BIOL, V323, P181, DOI 10.1016/S0022-2836(02)00911-7; Mas A, 2000, EMBO J, V19, P5752, DOI 10.1093/emboj/19.21.5752; Matamoros T, 2005, J MOL BIOL, V349, P451, DOI 10.1016/j.jmb.2005.04.004; Matamoros T, 2004, J BIOL CHEM, V279, P24569, DOI 10.1074/jbc.M312658200; Matamoros T, 2008, J MOL BIOL, V375, P1234, DOI 10.1016/j.jmb.2007.11.021; MCCARTHY JG, 1990, BIOCHEMISTRY-US, V29, P6071, DOI 10.1021/bi00477a027; McColl DJ, 2008, ANTIVIR THER, V13, P189; McMahon MA, 2008, J BIOL CHEM, V283, P31289, DOI 10.1074/jbc.C800188200; Menendez-Arias L, 2001, J BIOL CHEM, V276, P27470, DOI 10.1074/jbc.M104342200; Menendez-Arias L, 2008, VIRUS RES, V134, P124, DOI 10.1016/j.virusres.2007.12.015; Menendez-Arias L, 2006, CURR PHARM DESIGN, V12, P1811, DOI 10.2174/138161206776873608; Meyer P, 2000, EMBO J, V19, P3520, DOI 10.1093/emboj/19.14.3520; Meyer PR, 2007, J MOL BIOL, V369, P41, DOI 10.1016/j.jmb.2007.03.006; Meyer PR, 1999, MOL CELL, V4, P35, DOI 10.1016/S1097-2765(00)80185-9; Meyer PR, 2003, J VIROL, V77, P6127, DOI 10.1128/JVI.77.11.6127-6137.2003; Meyer PR, 2000, ANTIMICROB AGENTS CH, V44, P3465, DOI 10.1128/AAC.44.12.3465-3472.2000; Miranda LR, 2005, ANTIMICROB AGENTS CH, V49, P2648, DOI 10.1128/AAC.49.7.2648-2656.2005; PAUWELS R, 1988, J VIROL METHODS, V20, P309, DOI 10.1016/0166-0934(88)90134-6; Pellegrin I, 1999, AIDS, V13, P1705, DOI 10.1097/00002030-199909100-00014; Petropoulos CJ, 2000, ANTIMICROB AGENTS CH, V44, P920, DOI 10.1128/AAC.44.4.920-928.2000; Ray AS, 2002, J BIOL CHEM, V277, P40479, DOI 10.1074/jbc.M205303200; Rhee SY, 2007, PLOS COMPUT BIOL, V3, P836, DOI 10.1371/journal.pcbi.0030087; Rhee SY, 2004, ANTIMICROB AGENTS CH, V48, P3122, DOI 10.1128/AAC.48.8.3122-3126.2004; Rodes B, 2005, AIDS RES HUM RETROV, V21, P602, DOI 10.1089/aid.2005.21.602; Sarafianos SG, 1999, P NATL ACAD SCI USA, V96, P10027, DOI 10.1073/pnas.96.18.10027; Sarafianos SG, 2009, J MOL BIOL, V385, P693, DOI 10.1016/j.jmb.2008.10.071; Schinazi RF, 2006, ANTIVIR RES, V71, P322, DOI 10.1016/j.antiviral.2006.03.012; Selmi B, 2003, J BIOL CHEM, V278, P40464, DOI 10.1074/jbc.M302928200; Selmi B, 2001, J BIOL CHEM, V276, P13965, DOI 10.1074/jbc.M009837200; Shaw BR, 2000, METHOD ENZYMOL, V313, P226; SHIRASAKA T, 1995, P NATL ACAD SCI USA, V92, P2398, DOI 10.1073/pnas.92.6.2398; Smith AJ, 2006, CURR PHARM DESIGN, V12, P1827, DOI 10.2174/138161206776873572; Tachedjian G, 1996, J VIROL, V70, P7171, DOI 10.1128/JVI.70.10.7171-7181.1996; Tchesnokov EP, 2009, J BIOL CHEM, V284, P21496, DOI 10.1074/jbc.M109.024026; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; van der Ende ME, 2003, AIDS, V17, pS55, DOI 10.1097/00002030-200317003-00008; Villena C, 2007, J VIROL, V81, P4713, DOI 10.1128/JVI.02135-06; Vivet-Boudou V, 2006, CELL MOL LIFE SCI, V63, P163, DOI 10.1007/s00018-005-5367-x; White KL, 2006, ANTIVIR THER, V11, P155; White KL, 2005, AIDS, V19, P1751, DOI 10.1097/01.aids.0000189851.21441.f1	75	13	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32792	32802		10.1074/jbc.M109.038885	http://dx.doi.org/10.1074/jbc.M109.038885			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19801659	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000272028400064
J	Wang, XM; She, H; Mao, ZX				Wang, Xuemin; She, Hua; Mao, Zixu			Phosphorylation of Neuronal Survival Factor MEF2D by Glycogen Synthase Kinase 3 beta in Neuronal Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOCYTE-ENHANCER FACTOR-2; CEREBELLAR GRANULE NEURONS; CYCLIN-DEPENDENT KINASE-5; TRANSCRIPTION FACTOR MEF2; PROTEIN-KINASE; SIGNALING PATHWAY; GENE-EXPRESSION; BETA-CATENIN; CELLS; TAU	Glycogen synthase kinase 3 beta (GSK3 beta) has been identified to play important roles in neuronal death. Evidence from both in vitro and in vivo studies indicates that increased GSK3 beta activity contributes to neurodegeneration and to the pathogenesis of Alzheimer disease. But the molecular mechanisms that underlie GSK3 beta-mediated neurotoxicity remain poorly understood. We reported here that myocyte enhancer factor 2D (MEF2D), a nuclear transcription factor known to promote neuronal survival, is directly phosphorylated by GSK3 beta. Our data showed that phosphorylation of MEF2D by GSK3 beta at three specific residues in its transactivation domain inhibits MEF2D transcriptional activity. Withdrawal of neuronal activity in cerebellar granule neurons activated GSK3 beta in the nucleus, leading to GSK3 beta-dependent inhibition of MEF2 function. This inhibition contributed to GSK3 beta-mediated neuronal toxicity. Overexpression of MEF2D mutant that is resistant to GSK3 beta inhibition protected cerebellar granule neurons from either GSK3 beta activation-or neuronal activity deprivation-induced toxicity. These results identify survival factor MEF2D as a novel downstream effector targeted by GSK3 beta and define a molecular link between activation of GSK3 beta and neuronal survival machinery which may underlie in part GSK3 beta-mediated neurotoxicity.	[Mao, Zixu] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA	Emory University; Emory University	Mao, ZX (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA.	zmao@pharm.emory.edu			National Institutes of Health [NS048254, AG023695, ES015317, ES016731-010002]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES016731, R01ES015317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048254] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023695] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NS048254, AG023695, ES015317, and ES016731-010002 (to Z. M.).	Beurel E, 2006, PROG NEUROBIOL, V79, P173, DOI 10.1016/j.pneurobio.2006.07.006; Bijur GN, 2001, J BIOL CHEM, V276, P37436, DOI 10.1074/jbc.M105725200; Blair LAC, 1999, J NEUROSCI, V19, P1940; Cho JH, 2003, J BIOL CHEM, V278, P187, DOI 10.1074/jbc.M206236200; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; EMBI N, 1980, EUR J BIOCHEM, V107, P519, DOI 10.1111/j.1432-1033.1980.tb06059.x; Engel T, 2008, NEURODEGENER DIS, V5, P247, DOI 10.1159/000113715; Gong XM, 2003, NEURON, V38, P33, DOI 10.1016/S0896-6273(03)00191-0; Hetman M, 2000, J NEUROSCI, V20, P2567; HUGHES K, 1993, EMBO J, V12, P803, DOI 10.1002/j.1460-2075.1993.tb05715.x; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Kaytor MD, 2002, CURR OPIN NEUROBIOL, V12, P275, DOI 10.1016/S0959-4388(02)00320-3; Li MT, 2000, MOL CELL BIOL, V20, P9356, DOI 10.1128/MCB.20.24.9356-9363.2000; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu LD, 2003, P NATL ACAD SCI USA, V100, P8532, DOI 10.1073/pnas.1332804100; LIU ML, 1994, J BIOL CHEM, V269, P28514; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; Mao ZX, 1999, J BIOL CHEM, V274, P31102, DOI 10.1074/jbc.274.43.31102; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; Mishra R, 2007, J BIOL CHEM, V282, P30393, DOI 10.1074/jbc.M705895200; Mora A, 2001, J NEUROCHEM, V78, P199, DOI 10.1046/j.1471-4159.2001.00410.x; Mussmann R, 2007, J BIOL CHEM, V282, P12030, DOI 10.1074/jbc.M609637200; Nair VD, 2008, J BIOL CHEM, V283, P15469, DOI 10.1074/jbc.M707238200; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Takashima A, 1998, NEUROSCI RES, V31, P317, DOI 10.1016/S0168-0102(98)00061-3; Tang XL, 2005, J NEUROSCI, V25, P4823, DOI 10.1523/JNEUROSCI.1331-05.2005; Tian B, 2009, NAT CELL BIOL, V11, P211, DOI 10.1038/ncb1829; Wang HZ, 2008, J IMMUNOL, V181, P6797, DOI 10.4049/jimmunol.181.10.6797; Wang XM, 2005, J BIOL CHEM, V280, P16705, DOI 10.1074/jbc.M501819200; Wen Y, 2008, J NEUROSCI, V28, P2624, DOI 10.1523/JNEUROSCI.5245-07.2008; Wiedmann M, 2005, J NEUROSCI RES, V81, P226, DOI 10.1002/jnr.20556; Xu Q, 2000, J BIOL CHEM, V275, P36750, DOI 10.1074/jbc.M005030200	33	47	48	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32619	32626		10.1074/jbc.M109.067785	http://dx.doi.org/10.1074/jbc.M109.067785			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19801631	Green Published, hybrid			2022-12-27	WOS:000272028400044
J	Holberger, LE; Hayes, CS				Holberger, Laura E.; Hayes, Christopher S.			Ribosomal Protein S12 and Aminoglycoside Antibiotics Modulate A-site mRNA Cleavage and Transfer-Messenger RNA Activity in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDYL-TRANSFER-RNA; TAGGED PROTEINS; QUALITY-CONTROL; TAGGING SYSTEM; HYPER-ACCURATE; STOP CODONS; RPSL GENE; TRANSLATION; TMRNA; STREPTOMYCIN	Translational pausing in Escherichia coli can lead to mRNA cleavage within the ribosomal A-site. A-site mRNA cleavage is thought to facilitate transfer-messenger RNA (tmRNA).SmpB-mediated recycling of stalled ribosome complexes. Here, we demonstrate that the aminoglycosides paromomycin and streptomycin inhibit A-site cleavage of stop codons during inefficient translation termination. Aminoglycosides also induced stop codon read-through, suggesting that these antibiotics alleviate ribosome pausing during termination. Streptomycin did not inhibit A-site cleavage in rpsL mutants, which express streptomycin-resistant variants of ribosomal protein S12. However, rpsL strains exhibited reduced A-site mRNA cleavage compared with rpsL(+) cells. Additionally, tmRNA.SmpB-mediated SsrA peptide tagging was significantly reduced in several rpsL strains but could be fully restored in a subset of mutants when treated with streptomycin. The streptomycin-dependent rpsL(P90K) mutant also showed significantly lower levels of A-site cleavage and tmRNA.SmpB activity. Mutations in rpsD (encoding ribosomal protein S4), which suppressed streptomycin dependence, were able to partially restore A-site cleavage to rpsL(P90K) cells but failed to increase tmRNA.SmpB activity. Taken together, these results show that perturbations to A-site structure and function modulate A-site mRNA cleavage and tmRNA.SmpB activity. We propose that tmRNA.SmpB binds to streptomycin-resistant rpsL ribosomes less efficiently, leading to a partial loss of ribosome rescue function in these mutants.	[Holberger, Laura E.; Hayes, Christopher S.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Hayes, Christopher S.] Univ Calif Santa Barbara, Dept Biomol Sci, Santa Barbara, CA 93106 USA; [Hayes, Christopher S.] Univ Calif Santa Barbara, Engn Program, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Hayes, CS (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Life Sci Technol Bldg,Rm 3105, Santa Barbara, CA 93106 USA.	chayes@lifesci.ucsb.edu	Hayes, Christopher/A-5505-2009	Holberger, Laura/0000-0002-6704-8522	National Institutes of Health [GM078634]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078634] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM078634.	Abo T, 2002, GENES CELLS, V7, P629, DOI 10.1046/j.1365-2443.2002.00549.x; BENZER S, 1962, P NATL ACAD SCI USA, V48, P1114, DOI 10.1073/pnas.48.7.1114; BILGIN N, 1992, J MOL BIOL, V224, P1011, DOI 10.1016/0022-2836(92)90466-W; BISWAS DK, 1972, P NATL ACAD SCI USA, V69, P2141, DOI 10.1073/pnas.69.8.2141; Borovinskaya MA, 2007, NAT STRUCT MOL BIOL, V14, P727, DOI 10.1038/nsmb1271; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; CHANG FN, 1972, ANTIMICROB AGENTS CH, V2, P294, DOI 10.1128/AAC.2.4.294; Choy JS, 2007, J BACTERIOL, V189, P6564, DOI 10.1128/JB.00860-07; Corvaisier S, 2003, J BIOL CHEM, V278, P14788, DOI 10.1074/jbc.M212830200; DAVIES J, 1964, P NATL ACAD SCI USA, V51, P883, DOI 10.1073/pnas.51.5.883; Devaraj A, 2009, RNA, V15, P255, DOI 10.1261/rna.1320109; Diner EJ, 2009, J MOL BIOL, V386, P300, DOI 10.1016/j.jmb.2008.12.064; DONG HJ, 1995, J MOL BIOL, V248, P551, DOI 10.1006/jmbi.1995.0242; GARVIN RT, 1974, P NATL ACAD SCI USA, V71, P3814, DOI 10.1073/pnas.71.10.3814; Garza-Sanchez F, 2008, J MOL BIOL, V378, P505, DOI 10.1016/j.jmb.2008.02.065; Garza-Sanchez F, 2006, J BIOL CHEM, V281, P34258, DOI 10.1074/jbc.M608052200; Garza-Sanchez F, 2009, MOL MICROBIOL, V73, P882, DOI 10.1111/j.1365-2958.2009.06813.x; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Hayes CS, 1998, J BIOL CHEM, V273, P17326, DOI 10.1074/jbc.273.28.17326; Hayes CS, 2003, MOL CELL, V12, P903, DOI 10.1016/S1097-2765(03)00385-X; Hayes CS, 2002, J BIOL CHEM, V277, P33825, DOI 10.1074/jbc.M205405200; Hayes CS, 2002, P NATL ACAD SCI USA, V99, P3440, DOI 10.1073/pnas.052707199; Herman C, 1998, GENE DEV, V12, P1348, DOI 10.1101/gad.12.9.1348; Ivanova N, 2005, NUCLEIC ACIDS RES, V33, P3529, DOI 10.1093/nar/gki666; Ivanova N, 2004, J MOL BIOL, V338, P33, DOI 10.1016/j.jmb.2004.02.043; JORGENSEN F, 1990, J MOL BIOL, V215, P511, DOI 10.1016/S0022-2836(05)80164-0; Karimi R, 1996, EMBO J, V15, P1149, DOI 10.1002/j.1460-2075.1996.tb00453.x; KARIMI R, 1994, EUR J BIOCHEM, V226, P355, DOI 10.1111/j.1432-1033.1994.tb20059.x; Karzai AW, 1999, EMBO J, V18, P3793, DOI 10.1093/emboj/18.13.3793; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Kurita D, 2007, NUCLEIC ACIDS RES, V35, P7248, DOI 10.1093/nar/gkm677; Kurland C.G., 1996, ESCHERICHIA COLI SAL, P979; Luidalepp Hannes, 2005, RNA Biol, V2, P70, DOI 10.4161/rna.2.2.2020; Mikkelsen NE, 1999, P NATL ACAD SCI USA, V96, P6155, DOI 10.1073/pnas.96.11.6155; MODOLELL J, 1970, P NATL ACAD SCI USA, V67, P1148, DOI 10.1073/pnas.67.3.1148; Moore SD, 2007, ANNU REV BIOCHEM, V76, P101, DOI 10.1146/annurev.biochem.75.103004.142733; Nonin-Lecomte S, 2009, EMBO REP, V10, P160, DOI 10.1038/embor.2008.243; Ogle JM, 2003, TRENDS BIOCHEM SCI, V28, P259, DOI 10.1016/S0968-0004(03)00066-5; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; ORIAS E, 1966, J BACTERIOL, V91, P2210, DOI 10.1128/JB.91.6.2210-2215.1966; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Richards J, 2006, MOL MICROBIOL, V62, P1700, DOI 10.1111/j.1365-2958.2006.05472.x; Roche ED, 1999, EMBO J, V18, P4579, DOI 10.1093/emboj/18.16.4579; Roche ED, 2001, J BIOL CHEM, V276, P28509, DOI 10.1074/jbc.M103864200; RUUSALA T, 1984, EMBO J, V3, P2575, DOI 10.1002/j.1460-2075.1984.tb02176.x; Schroeder R, 2000, EMBO J, V19, P1, DOI 10.1093/emboj/19.1.1; Sharma D, 2007, J MOL BIOL, V374, P1065, DOI 10.1016/j.jmb.2007.10.003; Sundermeier TR, 2005, P NATL ACAD SCI USA, V102, P2316, DOI 10.1073/pnas.0409694102; Sunohara T, 2004, RNA, V10, P378, DOI 10.1261/rna.5169404; Takahashi T, 2003, J BIOL CHEM, V278, P27672, DOI 10.1074/jbc.M211724200; TIMMS AR, 1995, MUTAGENESIS, V10, P463, DOI 10.1093/mutage/10.5.463; TIMMS AR, 1992, MOL GEN GENET, V232, P89, DOI 10.1007/BF00299141; VONAHSEN U, 1991, NATURE, V353, P368, DOI 10.1038/353368a0; Yamamoto Y, 2003, RNA, V9, P408, DOI 10.1261/rna.2174803; Youngman EM, 2007, MOL CELL, V28, P533, DOI 10.1016/j.molcel.2007.09.015	56	24	24	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					32188	32200		10.1074/jbc.M109.062745	http://dx.doi.org/10.1074/jbc.M109.062745			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19776006	Green Published, hybrid			2022-12-27	WOS:000271572700073
J	Bernard, K; Wang, W; Narlawar, R; Schmidt, B; Kirk, KL				Bernard, Karen; Wang, Wei; Narlawar, Rajeshwar; Schmidt, Boris; Kirk, Kevin L.			Curcumin Cross-links Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Polypeptides and Potentiates CFTR Channel Activity by Distinct Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING DOMAINS; CHLORIDE CHANNEL; PLASMA-MEMBRANE; DELTA-F508 CFTR; PROTEIN; CELLS; MUTATION; DISEASE; DIMERIZATION; ULTRAVIOLET	Cystic fibrosis (CF) is caused by loss-of-function mutations in the CFTR chloride channel. Wild type and mutant CFTR channels can be activated by curcumin, a well tolerated dietary compound with some appeal as a prospective CF therapeutic. However, we show here that curcumin has the unexpected effect of cross-linking CFTR polypeptides into SDS-resistant oligomers. This effect occurred for CFTR channels in microsomes as well as in intact cells and at the same concentrations that are effective for promoting CFTR channel activity (5-50 mu M). Both mature CFTR polypeptides at the cell surface and immature CFTR protein in the endoplasmic reticulum were cross-linked by curcumin, although the latter pool was more susceptible to this modification. Curcumin cross-linked two CF mutant channels (Delta F508 and G551D) as well as a variety of deletion constructs that lack the major cytoplasmic domains. In vitro cross-linking could be prevented by high concentrations of oxidant scavengers (i.e. reduced glutathione and sodium azide) indicating a possible oxidation reaction with the CFTR polypeptide. Importantly, cyclic derivatives of curcumin that lack the reactive beta diketone moiety had no cross-linking activity. One of these cyclic derivatives stimulated the activities of wild type CFTR channels, Lambda 1198-CFTR channels, and G551D-CFTR channels in excised membrane patches. Like the parent compound, the cyclic derivative irreversibly activated CFTR channels in excised patches during prolonged exposure (> 5 min). Our results raise a note of caution about secondary biochemical effects of reactive compounds like curcumin in the treatment of CF. Cyclic curcumin derivatives may have better therapeutic potential in this regard.	[Bernard, Karen; Wang, Wei; Kirk, Kevin L.] Univ Alabama, Dept Physiol & Biophys, Birmingham, AL 35294 USA; [Bernard, Karen; Wang, Wei; Kirk, Kevin L.] Univ Alabama, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35294 USA; [Narlawar, Rajeshwar; Schmidt, Boris] Tech Univ Darmstadt, Clemens Schopf Inst Chem & Biochem, D-64287 Darmstadt, Germany	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Technical University of Darmstadt	Kirk, KL (corresponding author), Univ Alabama, Dept Physiol & Biophys, 982B MCLM, Birmingham, AL 35294 USA.	klkirk@uab.edu	Schmidt, Boris/M-7886-2019; Narlawar, Rajeshwar/E-4981-2010; Schmidt, Boris/D-3293-2009	Schmidt, Boris/0000-0003-1662-2392; Schmidt, Boris/0000-0003-1662-2392	NCRR [S10 RR13795, S10 RR16849]; UAB Health Services Foundation General Endowment Fund; UAB Comprehensive Cancer Center [P30 CA13148]; National Institutes of Health [DK56796]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR016849, S10RR013795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056796, R56DK056796] Funding Source: NIH RePORTER	NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); UAB Health Services Foundation General Endowment Fund; UAB Comprehensive Cancer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr. Ge Li for technical assistance. We thank the UAB Mass Spectrometry Shared Facility for assistance with the MALDI-TOF analysis (supported by NCRR Shared Instrumentation Grants (S10 RR13795, S10 RR16849), UAB Health Services Foundation General Endowment Fund, and the UAB Comprehensive Cancer Center Core Support Grant (P30 CA13148).; This work was supported, in whole or in part, by National Institutes of Health Grant DK56796 (to K. L. K.).	Aleksandrov AA, 2007, PFLUG ARCH EUR J PHY, V453, P693, DOI 10.1007/s00424-006-0140-z; Aleksandrov L, 2001, J BIOL CHEM, V276, P12918, DOI 10.1074/jbc.M100515200; Anand P, 2008, BIOCHEM PHARMACOL, V76, P1590, DOI 10.1016/j.bcp.2008.08.008; Arnbjerg J, 2007, J PHYS CHEM A, V111, P5756, DOI 10.1021/jp0711971; Barrondo S, 2009, NEUROPHARMACOLOGY, V56, P455, DOI 10.1016/j.neuropharm.2008.09.018; Berger AL, 2005, J BIOL CHEM, V280, P5221, DOI 10.1074/jbc.M412972200; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; CHIGNELL CF, 1994, PHOTOCHEM PHOTOBIOL, V59, P295, DOI 10.1111/j.1751-1097.1994.tb05037.x; Cormet-Boyaka E, 2004, P NATL ACAD SCI USA, V101, P8221, DOI 10.1073/pnas.0400459101; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; Davis P B, 2001, Pediatr Rev, V22, P257, DOI 10.1542/pir.22-8-257; Egan ME, 2004, SCIENCE, V304, P600, DOI 10.1126/science.1093941; Forman HJ, 2009, MOL ASPECTS MED, V30, P1, DOI 10.1016/j.mam.2008.08.006; FRIZZELL RA, 1995, AM J RESP CRIT CARE, V151, pS54, DOI 10.1164/ajrccm/151.3_Pt_2.S54; Fujiwara H, 2008, DIABETES RES CLIN PR, V80, P185, DOI 10.1016/j.diabres.2007.12.004; GREGORY RJ, 1991, MOL CELL BIOL, V11, P3886, DOI 10.1128/MCB.11.8.3886; Grubb BR, 2006, AM J RESP CELL MOL, V34, P355, DOI 10.1165/rcmb.2005-0286OC; Hegedus T, 2006, BBA-BIOMEMBRANES, V1758, P565, DOI 10.1016/j.bbamem.2006.03.006; Hirasawa M, 2005, PHOTOSYNTH RES, V86, P325, DOI 10.1007/s11120-005-6966-y; Holy J, 2004, CELL MOTIL CYTOSKEL, V58, P253, DOI 10.1002/cm.20012; Hung WC, 2008, BIOPHYS J, V94, P4331, DOI 10.1529/biophysj.107.126888; HYDE SC, 1990, NATURE, V346, P362, DOI 10.1038/346362a0; Jung YJ, 2007, BBA-MOL CELL RES, V1773, P383, DOI 10.1016/j.bbamcr.2006.11.004; Lao Christopher D, 2006, BMC Complement Altern Med, V6, P10, DOI 10.1186/1472-6882-6-10; Li CY, 2004, J BIOL CHEM, V279, P24673, DOI 10.1074/jbc.M400688200; Lipecka J, 2006, J PHARMACOL EXP THER, V317, P500, DOI 10.1124/jpet.105.097667; LUKACS GL, 1993, J BIOL CHEM, V268, P21592; Mathews CJ, 1998, J PHYSIOL-LONDON, V508, P365, DOI 10.1111/j.1469-7793.1998.365bq.x; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Murthy M, 2005, EUR J PHARMACOL, V516, P118, DOI 10.1016/j.ejphar.2005.04.037; Narlawar R, 2008, CHEMMEDCHEM, V3, P165, DOI 10.1002/cmdc.200700218; Noel S, 2006, J PHARMACOL EXP THER, V319, P349, DOI 10.1124/jpet.106.104521; Norez C, 2006, TRAFFIC, V7, P562, DOI 10.1111/j.1600-0854.2006.00409.x; Pasyk S, 2009, BIOCHEM J, V418, P185, DOI 10.1042/BJ20081424; Pattison DI, 2006, EXP SUPPL, V96, P131; Raghuram V, 2001, P NATL ACAD SCI USA, V98, P1300, DOI 10.1073/pnas.031538898; Ramjeesingh M, 2003, BIOCHEM J, V374, P793, DOI 10.1042/BJ20030683; Shen HR, 1996, J PHOTOCH PHOTOBIO B, V35, P213, DOI 10.1016/S1011-1344(96)07300-9; Song YL, 2004, J BIOL CHEM, V279, P40629, DOI 10.1074/jbc.M407308200; Stanwell C, 1996, BIOCHEM PHARMACOL, V52, P475, DOI 10.1016/0006-2952(96)00250-X; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Verna LK, 1998, CELL BIOL TOXICOL, V14, P237, DOI 10.1023/A:1007474912498; Wang J, 2009, BIOCHEM PHARMACOL, V78, P178, DOI 10.1016/j.bcp.2009.03.031; Wang SS, 2000, CELL, V103, P169, DOI 10.1016/S0092-8674(00)00096-9; Wang W, 2005, J BIOL CHEM, V280, P23622, DOI 10.1074/jbc.M503118200; Wang W, 2007, J BIOL CHEM, V282, P4533, DOI 10.1074/jbc.M609942200; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; Yang BX, 2008, J AM SOC NEPHROL, V19, P1300, DOI 10.1681/ASN.2007070828; Yuan LY, 2009, MOL ASPECTS MED, V30, P29, DOI 10.1016/j.mam.2008.08.003; Zerhusen B, 1999, J BIOL CHEM, V274, P7627, DOI 10.1074/jbc.274.12.7627; Zhu XC, 2007, REDOX REP, V12, P45, DOI 10.1179/135100007X162176	51	28	28	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30754	30765		10.1074/jbc.M109.056010	http://dx.doi.org/10.1074/jbc.M109.056010			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19740743	Green Published, hybrid			2022-12-27	WOS:000271378400003
J	Falsone, SF; Kungl, AJ; Rek, A; Cappai, R; Zangger, K				Falsone, S. Fabio; Kungl, Andreas J.; Rek, Angelika; Cappai, Roberto; Zangger, Klaus			The Molecular Chaperone Hsp90 Modulates Intermediate Steps of Amyloid Assembly of the Parkinson-related Protein alpha-Synuclein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRIL FORMATION; LEWY BODIES; CONFORMATIONAL-CHANGES; ATP HYDROLYSIS; LIVING CELLS; AGGREGATION; OLIGOMERS; DISEASE; TOXICITY; COMPLEX	alpha-Synuclein is an intrinsically unstructured protein that binds to membranes, forms fibrils, and is involved in neurodegeneration. Weused a reconstituted in vitro system to show that the molecular chaperone Hsp90 influenced alpha-synuclein vesicle binding and amyloid fibril formation, two processes that are tightly coupled to alpha-synuclein folding. Binding of Hsp90 to monomeric alpha-synuclein occurred in the low micromolar range, involving regions of alpha-synuclein that are critical for vesicle binding and amyloidogenesis. As a consequence, both processes were affected. In the absence of ATP, the accumulation of non-amyloid alpha-synuclein oligomers prevailed over fibril formation, whereas ATP favored fibril growth. This suggests that Hsp90 modulates the assembly of alpha-synuclein in an ATP-dependent manner. We propose that Hsp90 affects these folding processes by restricting conformational fluctuations of alpha-synuclein.	[Falsone, S. Fabio; Zangger, Klaus] Graz Univ, Inst Chem, A-8010 Graz, Austria; [Kungl, Andreas J.; Rek, Angelika] Graz Univ, Inst Pharmaceut Sci, A-8010 Graz, Austria; [Cappai, Roberto] Univ Melbourne, Dept Pathol, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia	University of Graz; University of Graz; University of Melbourne	Falsone, SF (corresponding author), Graz Univ, Inst Chem, Heinrichstr 28, A-8010 Graz, Austria.	fabio.falsone@uni-graz.at	Cappai, Roberto/B-3347-2010	Cappai, Roberto/0000-0002-9505-8496; Zangger, Klaus/0000-0003-1682-1594; Falsone, Salvatore Fabio/0000-0002-3724-5824; Kungl, Andreas/0000-0003-3362-797X	Austrian Science Fund [P20020]	Austrian Science Fund(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund number P20020 (to K.Z.).	Barral JM, 2004, SEMIN CELL DEV BIOL, V15, P17, DOI 10.1016/j.semcdb.2003.12.010; Beyer K, 2006, ACTA NEUROPATHOL, V112, P237, DOI 10.1007/s00401-006-0104-6; Bodner CR, 2009, J MOL BIOL, V390, P775, DOI 10.1016/j.jmb.2009.05.066; Cantuti-Castelvetri I, 2005, J NEUROPATH EXP NEUR, V64, P1058, DOI 10.1097/01.jnen.0000190063.90440.69; Chandra S, 2003, J BIOL CHEM, V278, P15313, DOI 10.1074/jbc.M213128200; Dedmon MM, 2005, J BIOL CHEM, V280, P14733, DOI 10.1074/jbc.m413024200; Dedmon MM, 2002, P NATL ACAD SCI USA, V99, P12681, DOI 10.1073/pnas.202331299; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dickey CA, 2007, J CLIN INVEST, V117, P648, DOI 10.1172/JCI29715; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Gall C, 2007, PROTEIN SCI, V16, P2510, DOI 10.1110/ps.073062707; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Grimminger V, 2004, J BIOL CHEM, V279, P7378, DOI 10.1074/jbc.M312403200; Hessling M, 2009, NAT STRUCT MOL BIOL, V16, P287, DOI 10.1038/nsmb.1565; Huang CJ, 2006, J MOL BIOL, V364, P323, DOI 10.1016/j.jmb.2006.08.062; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Liang J, 2008, HUM MOL GENET, V17, P3784, DOI 10.1093/hmg/ddn276; Liu J, 2009, J NEUROSCI, V29, P1480, DOI 10.1523/JNEUROSCI.6202-08.2009; Lotz GP, 2008, J CELL SCI, V121, P717, DOI 10.1242/jcs.015610; Luk KC, 2008, BIOCHEMISTRY-US, V47, P12614, DOI 10.1021/bi801475r; McClellan AJ, 2005, CELL, V121, P739, DOI 10.1016/j.cell.2005.03.024; McLaughlin SH, 2002, J MOL BIOL, V315, P787, DOI 10.1006/jmbi.2001.5245; McLean PJ, 2002, J NEUROCHEM, V83, P846, DOI 10.1046/j.1471-4159.2002.01190.x; Mickler M, 2009, NAT STRUCT MOL BIOL, V16, P281, DOI 10.1038/nsmb.1557; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Nomanbhoy TK, 1996, J BIOL CHEM, V271, P10004, DOI 10.1074/jbc.271.17.10004; Outeiro TF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001867; Pountney DL, 2005, NEUROTOX RES, V7, P59, DOI 10.1007/BF03033776; Pratt WB, 2008, J BIOL CHEM, V283, P22885, DOI 10.1074/jbc.R800023200; Rekas A, 2004, J MOL BIOL, V340, P1167, DOI 10.1016/j.jmb.2004.05.054; Richter K, 2008, J BIOL CHEM, V283, P17757, DOI 10.1074/jbc.M800540200; Schulte TW, 1998, CANCER CHEMOTH PHARM, V42, P273, DOI 10.1007/s002800050817; Southworth DR, 2008, MOL CELL, V32, P631, DOI 10.1016/j.molcel.2008.10.024; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tetzlaff JE, 2008, J BIOL CHEM, V283, P17962, DOI 10.1074/jbc.M802283200; Uryu K, 2006, AM J PATHOL, V168, P947, DOI 10.2353/ajpath.2006.050770; Uversky VN, 2007, J NEUROCHEM, V103, P17, DOI 10.1111/j.1471-4159.2007.04764.x; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105; Walter S, 2002, ANGEW CHEM INT EDIT, V41, P1098, DOI 10.1002/1521-3773(20020402)41:7<1098::AID-ANIE1098>3.0.CO;2-9; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Wright JA, 2009, FASEB J, V23, P2384, DOI 10.1096/fj.09-130039; Yamin G, 2003, FEBS LETT, V542, P147, DOI 10.1016/S0014-5793(03)00367-3; Zhou Y, 2004, J BIOL CHEM, V279, P39155, DOI 10.1074/jbc.M405456200	50	92	92	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31190	31199		10.1074/jbc.M109.057240	http://dx.doi.org/10.1074/jbc.M109.057240			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19759002	Green Published, hybrid			2022-12-27	WOS:000271378400047
J	Jepson, JEC; Reenan, RA				Jepson, James E. C.; Reenan, Robert A.			Adenosine-to-Inosine Genetic Recoding Is Required in the Adult Stage Nervous System for Coordinated Behavior in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EVOLUTIONARY CONSERVATION; LOCOMOTOR-ACTIVITY; MELANOGASTER; DEAMINASE; EXPRESSION; MUTANTS; TARGETS; CELLS; SLEEP; ADAR	Adenosine deaminases acting on RNA (ADARs) catalyze the deamination of adenosine to inosine in double-stranded RNA templates, a process known as RNA editing. In Drosophila, multiple ADAR isoforms are generated from a single locus (dAdar) via post-transcriptional modifications. Collectively, these isoforms act to edit a wide range of transcripts involved in neuronal signaling, as well as the precursors of endogenous small interfering RNAs. The phenotypic consequences of a loss of dADAR activity have been well characterized and consist of profound behavioral defects manifested at the adult stage, including extreme uncoordination, seizures, and temperature-sensitive paralysis. However, the spatio-temporal requirements of adenosine to inosine editing for correct behavior are unclear. Using transgenic RNA interference, we show that network-wide editing in the nervous system is required for normal adult locomotion. Regulated restoration of editing activity demonstrates that the neuronal requirement of dADAR activity has a significant adult stage component. Furthermore we show that in relation to behavior there are no observable genetic interactions between dAdar and several loci encoding RNA interference components, suggesting that editing of neuronal transcripts is the key mode of ADAR activity for normal behavior in Drosophila.	[Jepson, James E. C.; Reenan, Robert A.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA	Brown University	Reenan, RA (corresponding author), Brown Univ, Dept Mol Biol Cell Biol & Biochem, SFH Life Sci Bldg,185 Meeting St, Providence, RI 02912 USA.	Robert_Reenan@brown.edu		jepson, james/0000-0002-3357-2801	Ellison Medical Foundation Senior Scholar award	Ellison Medical Foundation Senior Scholar award(Lawrence Ellison Foundation)	This work was supported by an Ellison Medical Foundation Senior Scholar award.	Agosto J, 2008, NAT NEUROSCI, V11, P354, DOI 10.1038/nn2046; BASILIO C, 1962, P NATL ACAD SCI USA, V48, P613, DOI 10.1073/pnas.48.4.613; BASS BL, 2001, RNA EDITING, P94; Bhalla T, 2004, NAT STRUCT MOL BIOL, V11, P950, DOI 10.1038/nsmb825; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cirelli C, 2005, NATURE, V434, P1087, DOI 10.1038/nature03486; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Grauso M, 2002, GENETICS, V160, P1519; Hanrahan CJ, 2000, GENETICS, V155, P1149; Helfrich-Forster C, 2002, J NEUROGENET, V16, P73, DOI 10.1080/01677060290024592; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; Hoopengardner B, 2003, SCIENCE, V301, P832, DOI 10.1126/science.1086763; Ingleby L, 2009, J GEN PHYSIOL, V133, P17, DOI 10.1085/jgp.200810133; Jin YF, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-98; Jones AK, 2009, J NEUROSCI, V29, P4287, DOI 10.1523/JNEUROSCI.5251-08.2009; Kawahara Y, 2007, EMBO REP, V8, P763, DOI 10.1038/sj.embor.7401011; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; Keegan LP, 2005, EMBO J, V24, P2183, DOI 10.1038/sj.emboj.7600691; Keegan LP, 2001, NAT REV GENET, V2, P869, DOI 10.1038/35098584; Liu X, 2007, NEURON, V56, P1090, DOI 10.1016/j.neuron.2007.10.036; Liu Y, 1999, J BIOL CHEM, V274, P18351, DOI 10.1074/jbc.274.26.18351; Maas S, 1996, J BIOL CHEM, V271, P12221, DOI 10.1074/jbc.271.21.12221; Martin JR, 1998, LEARN MEMORY, V5, P179; Okamura K, 2008, NAT REV MOL CELL BIO, V9, P673, DOI 10.1038/nrm2479; Palladino MJ, 2000, CELL, V102, P437, DOI 10.1016/S0092-8674(00)00049-0; Palladino MJ, 2000, RNA, V6, P1004, DOI 10.1017/S1355838200000248; Parisky KM, 2008, NEURON, V60, P672, DOI 10.1016/j.neuron.2008.10.042; Peixoto AA, 1998, GENETICS, V148, P827; Reenan RA, 2005, NATURE, V434, P409, DOI 10.1038/nature03364; Roman G, 2001, P NATL ACAD SCI USA, V98, P12602, DOI 10.1073/pnas.221303998; Salvaterra Paul M., 2001, Gene Expression Patterns, V1, P73, DOI 10.1016/S1567-133X(01)00011-4; Scadden ADJ, 2001, EMBO REP, V2, P1107, DOI 10.1093/embo-reports/kve244; Seeburg PH, 2003, CURR OPIN NEUROBIOL, V13, P279, DOI 10.1016/S0959-4388(03)00062-X; Semenov EP, 1999, J NEUROCHEM, V72, P66, DOI 10.1046/j.1471-4159.1999.0720066.x; Smith L A, 1998, J Neurogenet, V12, P227; Stapleton M, 2006, RNA, V12, P1922, DOI 10.1261/rna.254306; Tonkin LA, 2003, SCIENCE, V302, P1725, DOI 10.1126/science.1091340; Tonkin LA, 2002, EMBO J, V21, P6025, DOI 10.1093/emboj/cdf607; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; Wu JS, 2006, NAT PROTOC, V1, P2110, DOI 10.1038/nprot.2006.336; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Yang WD, 2005, J BIOL CHEM, V280, P3946, DOI 10.1074/jbc.M407876200	45	28	29	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31391	31400		10.1074/jbc.M109.035048	http://dx.doi.org/10.1074/jbc.M109.035048			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19759011	hybrid, Green Published			2022-12-27	WOS:000271378400064
J	Jha, P; Manickam, B; Matta, B; Bora, PS; Bora, NS				Jha, Purushottam; Manickam, Balasubramanian; Matta, Bharati; Bora, Puran S.; Bora, Nalini S.			Proteolytic Cleavage of Type I Collagen Generates an Autoantigen in Autoimmune Uveitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MELANIN-ASSOCIATED ANTIGEN; COMPLEMENT REGULATORY PROTEINS; ANTERIOR UVEITIS; MATRIX METALLOPROTEINASES; TISSUE INHIBITORS; FIBROBLASTS; EXPRESSION; INDUCTION; EAAU; SPECIFICITY	This study was initiated to induce experimental autoimmune anterior uveitis (EAAU) in Lewis rats by melanin-associated antigen (MAA; 22-kDa fragment of type I collagen alpha 2 chain) derived from rat iris and ciliary body (CB), to localize MAA within the eye, and to investigate the possible mechanism of MAA generation in vivo. The EAAU model replicates idiopathic human anterior uveitis. Lewis rats sensitized to rat MAA developed anterior uveitis, and EAAU induced by rat MAA can be adoptively transferred to naive syngenic rats by MAA-primed T cells. Animals immunized with rat MAA developed cellular immunity to the antigen. MAA was detected only in the iris and CB of the eye. Iris and CB were the major source of matrix metalloproteinase-1 (MMP-1) in the naive eye, and ocular expression of MMP-1 was up-regulated, whereas expression of tissue inhibitor of metalloproteinase 1 decreased before the onset of EAAU. These results demonstrated that EAAU can be induced by autologous MAA. Uveitogenic antigen is present only in the iris and CB of the eye, and the imbalance between MMP-1 and tissue inhibitor of metalloproteinase 1 may play a role in the generation of MAA in vivo. Collectively, the evidence presented here suggests that MAA is an autoantigen in EAAU. These observations may extend to idiopathic human anterior uveitis and facilitate the development of antigen-specific therapy.	[Jha, Purushottam; Manickam, Balasubramanian; Matta, Bharati; Bora, Puran S.; Bora, Nalini S.] Univ Arkansas Med Sci, Dept Ophthalmol, Jones Eye Inst, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Bora, NS (corresponding author), Univ Arkansas Med Sci, Dept Ophthalmol, Jones Eye Inst, 4301 W Markham,Mail Slot 523, Little Rock, AR 72205 USA.	nbora@uams.edu		Bora, Puran/0000-0003-4781-1217	National Institutes of Health [EY016205, EY 014623]; Pat and Willard Walker Eye Research Center; Jones Eye Institute and Arkansas Master Tobacco Settlement; Arkansas Biosciences Institute, University of Arkansas for Medical Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY016205, R01EY014623] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pat and Willard Walker Eye Research Center; Jones Eye Institute and Arkansas Master Tobacco Settlement; Arkansas Biosciences Institute, University of Arkansas for Medical Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY016205 and EY 014623. This work was also supported by the Pat and Willard Walker Eye Research Center, the Jones Eye Institute and Arkansas Master Tobacco Settlement, and the Arkansas Biosciences Institute, University of Arkansas for Medical Sciences (Little Rock, AR).	Abe T, 1997, EXP EYE RES, V65, P703, DOI 10.1006/exer.1997.0379; Akiyama K, 1997, RES COMMUN MOL PATH, V95, P115; Atassi MZ, 2008, AUTOIMMUNITY, V41, P123, DOI 10.1080/08916930801929021; BLOCHMICHEL E, 1987, AM J OPHTHALMOL, V103, P234, DOI 10.1016/S0002-9394(14)74235-7; Bora Nalini S, 2007, Chem Immunol Allergy, V92, P213, DOI 10.1159/000099272; Bora NS, 2004, J IMMUNOL, V172, P7086, DOI 10.4049/jimmunol.172.11.7086; Bora NS, 1997, INVEST OPHTH VIS SCI, V38, P2171; BORA NS, 1995, INVEST OPHTH VIS SCI, V36, P1056; BROEKHUYSE RM, 1991, EXP EYE RES, V52, P465, DOI 10.1016/0014-4835(91)90044-F; Burger D, 1998, ARTHRITIS RHEUM, V41, P1748, DOI 10.1002/1529-0131(199810)41:10<1748::AID-ART7>3.3.CO;2-V; CHEDEKEL MR, 1992, PIGM CELL RES, V5, P240, DOI 10.1111/j.1600-0749.1992.tb00543.x; Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318; Davidson A, 2001, NEW ENGL J MED, V345, P340, DOI 10.1056/NEJM200108023450506; FIELDS GB, 1987, J BIOL CHEM, V262, P6221; FLING SP, 1991, J IMMUNOL, V147, P483; Gaton DD, 1999, INVEST OPHTH VIS SCI, V40, P363; Gritz DC, 2004, OPHTHALMOLOGY, V111, P491, DOI 10.1016/j.ophtha.2003.06.014; Higashikata T, 2006, ATHEROSCLEROSIS, V185, P165, DOI 10.1016/j.atherosclerosis.2005.05.039; Jha P, 2006, INVEST OPHTH VIS SCI, V47, P1030, DOI 10.1167/iovs.05-1062; Jha P, 2007, INVEST OPHTH VIS SCI, V48, P5091, DOI 10.1167/iovs.07-0651; Jha P, 2006, J IMMUNOL, V176, P7221, DOI 10.4049/jimmunol.176.12.7221; Kielty Cay M., 1993, P103; KIM MC, 1995, CURR EYE RES, V14, P703, DOI 10.3109/02713689508998498; KIVIRIKKO KI, 1992, HYDROXYLATION PROLIN, P1; Krane SM, 1996, J BIOL CHEM, V271, P28509, DOI 10.1074/jbc.271.45.28509; Leonardi A, 2003, INVEST OPHTH VIS SCI, V44, P183, DOI 10.1167/iovs.02-0420; MACNAUL KL, 1990, J BIOL CHEM, V265, P17238; MARSHALL GE, 1993, BRIT J OPHTHALMOL, V77, P515, DOI 10.1136/bjo.77.8.515; Matsuo A, 1997, AM J PATHOL, V150, P1253; Matta B, 2008, AM J PATHOL, V173, P1440, DOI 10.2353/ajpath.2008.080150; NORDLUND JJ, 1989, J INVEST DERMATOL S, V92, P53; Ottl J, 2000, CHEM BIOL, V7, P119, DOI 10.1016/S1074-5521(00)00077-6; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; Searle A.G., 1968, COMP GENETICS COAT C; Sohn JH, 2000, INVEST OPHTH VIS SCI, V41, P3492; Van Den Steen PE, 2002, FASEB J, V16, DOI 10.1096/fj.01-0688com; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; WOODS AC, 1962, UVEITIS ASS COLL DIS; Wu CT, 2005, ANN NY ACAD SCI, V1050, P134, DOI 10.1196/annals.1313.015	40	15	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31401	31411		10.1074/jbc.M109.033381	http://dx.doi.org/10.1074/jbc.M109.033381			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19755419	Green Published, hybrid			2022-12-27	WOS:000271378400065
J	Torrie, LS; Wyllie, S; Spinks, D; Oza, SL; Thompson, S; Harrison, JR; Gilbert, IH; Wyatt, PG; Fairlamb, AH; Frearson, JA				Torrie, Leah S.; Wyllie, Susan; Spinks, Daniel; Oza, Sandra L.; Thompson, Stephen; Harrison, Justin R.; Gilbert, Ian H.; Wyatt, Paul G.; Fairlamb, Alan H.; Frearson, Julie A.			Chemical Validation of Trypanothione Synthetase A POTENTIAL DRUG TARGET FOR HUMAN TRYPANOSOMIASIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AFRICAN TRYPANOSOMES; REDUCTASE; BRUCEI; GLUTATHIONE; METABOLISM; BIOSYNTHESIS; SENSITIVITY; LEISHMANIA; SPERMIDINE; INHIBITORS	In the search for new therapeutics for the treatment of human African trypanosomiasis, many potential drug targets in Trypanosoma brucei have been validated by genetic means, but very few have been chemically validated. Trypanothione synthetase (TryS; EC 6.3.1.9; spermidine/glutathionylspermidine: glutathione ligase (ADP-forming)) is one such target. To identify novel inhibitors of T. brucei TryS, we developed an in vitro enzyme assay, which was amenable to high throughput screening. The subsequent screen of a diverse compound library resulted in the identification of three novel series of TryS inhibitors. Further chemical exploration resulted in leads with nanomolar potency, which displayed mixed, uncompetitive, and allosteric-type inhibition with respect to spermidine, ATP, and glutathione, respectively. Representatives of all three series inhibited growth of bloodstream T. brucei in vitro. Exposure to one of our lead compounds (DDD86243; 2 x EC50 for 72 h) decreased intracellular trypanothione levels to <10% of wild type. In addition, there was a corresponding 5-fold increase in the precursor metabolite, glutathione, providing strong evidence that DDD86243 was acting on target to inhibit TryS. This was confirmed with wild-type, TryS single knock-out, and TryS-overexpressing cell lines showing expected changes in potency to DDD86243. Taken together, these data provide initial chemical validation of TryS as a drug target in T. brucei.	[Frearson, Julie A.] Univ Dundee, Coll Life Sci, James Black Ctr, Div Biol Chem & Drug Discovery, Dundee DD1 5EH, Scotland	University of Dundee	Frearson, JA (corresponding author), Univ Dundee, Coll Life Sci, James Black Ctr, Div Biol Chem & Drug Discovery, Dow St, Dundee DD1 5EH, Scotland.	j.a.frearson@dundee.ac.uk	Wyllie, Susan/AAI-4430-2021; Fairlamb, Alan/A-5272-2009	Fairlamb, Alan/0000-0001-5134-0329; Wyatt, Paul/0000-0002-0397-245X; Oza, Sandra/0000-0001-9404-7931; Wyllie, Susan/0000-0001-8810-5605; Gilbert, Ian/0000-0002-5238-1314	Wellcome Trust [WT077705, WT079838, WT083481]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Wellcome Trust Grants WT077705, WT079838, and WT083481.	Ariyanayagam MR, 2005, BIOCHEM J, V391, P425, DOI 10.1042/BJ20050911; Augustyns K, 2001, CURR PHARM DESIGN, V7, P1117, DOI 10.2174/1381612013397564; Barrett MP, 1999, PARASITOL TODAY, V15, P136, DOI 10.1016/S0169-4758(99)01414-3; BENSON TJ, 1992, BIOCHEM J, V286, P9, DOI 10.1042/bj2860009; Cogan EB, 1999, ANAL BIOCHEM, V271, P29, DOI 10.1006/abio.1999.4100; Comini M, 2003, BIOL CHEM, V384, P653, DOI 10.1515/BC.2003.072; Comini MA, 2004, FREE RADICAL BIO MED, V36, P1289, DOI 10.1016/j.freeradbiomed.2004.02.008; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; FAIRLAMB AH, 1992, ANNU REV MICROBIOL, V46, P695, DOI 10.1146/annurev.micro.46.1.695; FAIRLAMB AH, 1985, SCIENCE, V227, P1485, DOI 10.1126/science.3883489; Fairlamb AH, 2003, TRENDS PARASITOL, V19, P488, DOI 10.1016/j.pt.2003.09.002; Frearson JA, 2007, TRENDS PARASITOL, V23, P589, DOI 10.1016/j.pt.2007.08.019; Fyfe PK, 2008, J BIOL CHEM, V283, P17672, DOI 10.1074/jbc.M801850200; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Krauth-Siegel RL, 2003, BIOL CHEM, V384, P539, DOI 10.1515/BC.2003.062; Krieger S, 2000, MOL MICROBIOL, V35, P542, DOI 10.1046/j.1365-2958.2000.01721.x; Muller S, 2003, TRENDS PARASITOL, V19, P320, DOI 10.1016/S1471-4922(03)00141-7; Oza SL, 2008, FEBS J, V275, P5408, DOI 10.1111/j.1742-4658.2008.06670.x; Oza SL, 2002, J BIOL CHEM, V277, P35853, DOI 10.1074/jbc.M204403200; Oza SL, 2003, MOL BIOCHEM PARASIT, V131, P25, DOI 10.1016/S0166-6851(03)00176-2; Patterson S, 2009, CHEMMEDCHEM, V4, P1341, DOI 10.1002/cmdc.200900098; Raz B, 1997, ACTA TROP, V68, P139, DOI 10.1016/S0001-706X(97)00079-X; SHIM H, 1988, J GEN MICROBIOL, V134, P807; SPINKS D, 2009, Patent No. 9098112; Stuart K, 2008, J CLIN INVEST, V118, P1301, DOI 10.1172/JCI33945; Wilkinson SR, 2003, J BIOL CHEM, V278, P31640, DOI 10.1074/jbc.M303035200; Wyllie S, 2009, MOL MICROBIOL, V74, P529, DOI 10.1111/j.1365-2958.2009.06761.x; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	28	59	59	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36137	36145		10.1074/jbc.M109.045336	http://dx.doi.org/10.1074/jbc.M109.045336			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19828449	Green Published, hybrid			2022-12-27	WOS:000272970500015
J	Bonnet, N; Standley, KN; Bianchi, EN; Stadelmann, V; Foti, M; Conway, SJ; Ferrari, SL				Bonnet, Nicolas; Standley, Kara N.; Bianchi, Estelle N.; Stadelmann, Vincent; Foti, Michelangelo; Conway, Simon J.; Ferrari, Serge L.			The Matricellular Protein Periostin Is Required for Sost Inhibition and the Anabolic Response to Mechanical Loading and Physical Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIODONTAL-LIGAMENT; PARATHYROID-HORMONE; IN-VIVO; BONE-FORMATION; OVARIECTOMIZED RATS; THERAPEUTIC TARGETS; GENE-EXPRESSION; MESSENGER-RNA; EXERCISE; MICE	Periostin (gene Postn) is a secreted extracellular matrix protein involved in cell recruitment and adhesion and plays an important role in odontogenesis. In bone, periostin is preferentially expressed in the periosteum, but its functional significance remains unclear. We investigated Postn(-/-) mice and their wild type littermates to elucidate the role of periostin in the skeletal response to moderate physical activity and direct axial compression of the tibia. Furthermore, we administered a sclerostin-blocking antibody to these mice in order to demonstrate the influence of sustained Sost expression in their altered bone phenotypes. Cancellous and cortical bone microarchitecture as well as bending strength were altered in Postn(-/-) compared with Postn(+/+) mice. Exercise and axial compression both significantly increased bone mineral density and trabecular and cortical microarchitecture as well as biomechanical properties of the long bones in Postn(-/-) mice by increasing the bone formation activity, particularly at the periosteum. These changes correlated with an increase of periostin expression and a consecutive decrease of Sost in the stimulated bones. In contrast, mechanical stimuli had no effect on the skeletal properties of Postn(-/-) mice, where base- line expression of Sost levels were higher than Postn(+/+) and remained unchanged following axial compression. In turn, the concomitant injection of sclerostin-blocking antibody rescued the bone biomechanical response in Postn(-/-) mice. Taken together, these results indicate that the matricellular periostin protein is required for Sost inhibition and thereby plays an important role in the determination of bone mass and microstructural in response to loading.	[Bonnet, Nicolas] Univ Hosp Geneva, Dept Rehabil & Geriatr, World Hlth Org Collaborating Ctr Osteoporosis Pre, Div Bone Dis,Serv Bone Dis, CH-1211 Geneva 14, Switzerland; [Foti, Michelangelo] Univ Hosp Geneva, Dept Cellular Physiol & Metab, CH-1211 Geneva 14, Switzerland; [Standley, Kara N.; Conway, Simon J.] Indiana Univ Sch Med, Wells Ctr Pediat Res, Riley Heart Res Ctr, Indianapolis, IN 46202 USA; [Stadelmann, Vincent] Ecole Polytech Fed Lausanne, Lab Biomech Orthoped, CH-1015 Lausanne, Switzerland	University of Geneva; World Health Organization; University of Geneva; Indiana University System; Indiana University Bloomington; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Bonnet, N (corresponding author), Univ Hosp Geneva, Dept Rehabil & Geriatr, World Hlth Org Collaborating Ctr Osteoporosis Pre, Div Bone Dis,Serv Bone Dis, Rue Micheli du Crest 24, CH-1211 Geneva 14, Switzerland.	Nicolas.bonnet@unige.ch	Ferrari, Serge/ABD-2730-2020; Stadelmann, Vincent A./X-1543-2018	Ferrari, Serge/0000-0002-1372-4417; Stadelmann, Vincent/0000-0002-8741-2184; Foti, Michelangelo/0000-0001-7199-4135; Bonnet, Nicolas/0000-0001-9832-5767	National Institutes of Health [R01HL060714, R01HL092508, T32 HL079995]; Swiss National Science Foundation [3100A0-116633/1, 310030-120280]; European Community [HEALTH-F2-2008-201099]; Riley Children's Foundation; Indiana University Department of Pediatrics/Cardiology; Societe Francaise de Rhumatologie; GRIO; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060714, T32HL079995, R01HL092508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Community(European Commission); Riley Children's Foundation; Indiana University Department of Pediatrics/Cardiology; Societe Francaise de Rhumatologie; GRIO; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL060714 and R01HL092508 (to S. J. C.) and T32 HL079995 (to K. S.). These studies were also supported by Swiss National Science Foundation Grants 3100A0-116633/1 (to S. L. F.) and 310030-120280 (to M. F.), by the seventh Framework program of the European Community (HEALTH-F2-2008-201099) (to S. L. F.), the Riley Children's Foundation (to S. J. C.), and the Indiana University Department of Pediatrics/Cardiology (to S. J. C.). This work was further supported by a grant from the "Societe Francaise de Rhumatologie" and the GRIO (to N. B.).	Afanador E, 2005, ARCH ORAL BIOL, V50, P1023, DOI 10.1016/j.archoralbio.2005.04.002; Armstrong VJ, 2007, J BIOL CHEM, V282, P20715, DOI 10.1074/jbc.M703224200; Bao SD, 2004, CANCER CELL, V5, P329, DOI 10.1016/S1535-6108(04)00081-9; BARENGOLTS EI, 1994, BONE MINER, V26, P133, DOI 10.1016/S0169-6009(08)80058-X; Baril P, 2007, ONCOGENE, V26, P2082, DOI 10.1038/sj.onc.1210009; Bonnet N, 2007, J APPL PHYSIOL, V103, P524, DOI 10.1152/japplphysiol.01319.2006; BOURRIN S, 1995, J BONE MINER RES, V10, P1745; Bouxsein ML, 2005, J BONE MINER RES, V20, P635, DOI 10.1359/JBMR.041204; CHAMBERS TJ, 1993, BONE MINER, V20, P167, DOI 10.1016/S0169-6009(08)80025-6; de Souza RL, 2005, J BONE MINER RES, V20, P2159, DOI 10.1359/JBMR.050812; Dorn GW, 2007, NEW ENGL J MED, V357, P1552, DOI 10.1056/NEJMcibr074816; Engelke K, 2006, OSTEOPOROSIS INT, V17, P133, DOI 10.1007/s00198-005-1938-9; FERRETTI JL, 1995, CALCIFIED TISSUE INT, V57, P399, DOI 10.1007/BF00301939; Foti M, 1997, MOL BIOL CELL, V8, P1377, DOI 10.1091/mbc.8.7.1377; FROST HM, 1987, ANAT RECORD, V219, P1, DOI 10.1002/ar.1092190104; Gillan L, 2002, CANCER RES, V62, P5358; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x; Horiuchi K, 1999, J BONE MINER RES, V14, P1239, DOI 10.1359/jbmr.1999.14.7.1239; Huang CZ, 2008, INT J PRECIS ENG MAN, V9, P11; Iida-Klein A, 2003, J CLIN DENSITOM, V6, P25, DOI 10.1385/JCD:6:1:25; Iwamoto J, 1999, BONE, V24, P163, DOI 10.1016/S8756-3282(98)00189-6; Iwamoto J, 1998, J Orthop Sci, V3, P257, DOI 10.1007/s007760050051; Kashimaa TG, 2009, HUM PATHOL, V40, P226, DOI 10.1016/j.humpath.2008.07.008; Katsuragi N, 2004, CIRCULATION, V110, P1806, DOI 10.1161/01.CIR.0000142607.33398.54; Kii I, 2006, BIOCHEM BIOPH RES CO, V342, P766, DOI 10.1016/j.bbrc.2006.02.016; Lee KCL, 2002, BONE, V31, P407, DOI 10.1016/S8756-3282(02)00842-6; Li XD, 2009, J BONE MINER RES, V24, P578, DOI 10.1359/JBMR.081206; Li X, 2007, J BIOL CHEM, V282, P33086, DOI 10.1074/jbc.M705194200; Litvin J, 2006, CARDIOVASC PATHOL, V15, P24, DOI 10.1016/j.carpath.2005.09.001; Litvin J, 2005, ANAT REC PART A, V287A, P1205, DOI 10.1002/ar.a.20237; Litvin J, 2004, J CELL BIOCHEM, V92, P1044, DOI 10.1002/jcb.20115; Miyauchi A, 2006, J BONE MINER METAB, V24, P498, DOI 10.1007/s00774-006-0716-x; Nakazawa T, 2004, J ORTHOP RES, V22, P520, DOI 10.1016/j.orthres.2003.10.007; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Norris RA, 2008, DEV BIOL, V316, P200, DOI 10.1016/j.ydbio.2008.01.003; Norris RA, 2007, J CELL BIOCHEM, V101, P695, DOI 10.1002/jcb.21224; Ogita M, 2008, ENDOCRINOLOGY, V149, P5713, DOI 10.1210/en.2008-0369; Onyia JE, 2005, J CELL BIOCHEM, V95, P403, DOI 10.1002/jcb.20438; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Phillips JA, 2008, MATRIX BIOL, V27, P609, DOI 10.1016/j.matbio.2008.05.003; Rios H, 2005, MOL CELL BIOL, V25, P11131, DOI 10.1128/MCB.25.24.11131-11144.2005; Rios HF, 2008, J PERIODONTOL, V79, P1480, DOI [10.1902/jop.2008.070624, 10.1902/jop.2008.070624 ]; Robling A. G., 2001, Journal of Musculoskeletal & Neuronal Interactions, V1, P249; Robling AG, 2002, FASEB J, V16, P324, DOI 10.1096/fj.02-0393fje; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Ruan K, 2009, CELL MOL LIFE SCI, V66, P2219, DOI 10.1007/s00018-009-0013-7; Sawakami K, 2006, J BIOL CHEM, V281, P23698, DOI 10.1074/jbc.M601000200; Seeman E, 2002, LANCET, V359, P1841, DOI 10.1016/S0140-6736(02)08706-8; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Shimazaki M, 2008, J EXP MED, V205, P295, DOI 10.1084/jem.20071297; Sinaki Mehrsheed, 2007, Phys Med Rehabil Clin N Am, V18, P593, DOI 10.1016/j.pmr.2007.04.002; Snider P, 2008, CIRC RES, V102, P752, DOI 10.1161/CIRCRESAHA.107.159517; Stadelmann VA, 2009, COMPUT METHOD BIOMEC, V12, P95, DOI [10.1080/10255840802178053, 10.1080/10255840903077287]; TAKESHITA S, 1993, BIOCHEM J, V294, P271, DOI 10.1042/bj2940271; TURNER CH, 1993, BONE, V14, P595, DOI 10.1016/8756-3282(93)90081-K; Waarsing JH, 2004, BONE, V34, P163, DOI 10.1016/j.bone.2003.08.012; Waarsing JH, 2002, 9 C INT SOC BON MORP; Wilde J, 2003, CELL TISSUE RES, V312, P345, DOI 10.1007/s00441-002-0664-2; Zehnacker Carol Hamilton, 2007, J Geriatr Phys Ther, V30, P79; Zhu SM, 2009, J CELL PHYSIOL, V218, P584, DOI 10.1002/jcp.21633	61	153	159	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35939	35950		10.1074/jbc.M109.060335	http://dx.doi.org/10.1074/jbc.M109.060335			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19837663	Green Published, hybrid			2022-12-27	WOS:000272645600069
J	Luo, Y; Jian, W; Stavreva, D; Fu, XQ; Hager, G; Bungert, J; Huang, SM; Qiu, Y				Luo, Yi; Jian, Wei; Stavreva, Diana; Fu, Xueqi; Hager, Gordon; Bungert, Joerg; Huang, Suming; Qiu, Yi			Trans-regulation of Histone Deacetylase Activities through Acetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; IN-VIVO; COMPLEX; TRANSCRIPTION; PROTEIN; YEAST; METHYLATION; INHIBITION; REPRESSION; DOMAINS	HDAC1 and -2 are highly conserved enzymes and often coexist in the same coregulator complexes. Understanding the regulation of histone deacetylase activities is extremely important because these enzymes play key roles in epigenetic regulation in normal and cancer cells. We previously showed that HDAC1 is required for glucocorticoid receptor-mediated transcription activation and that its activity is regulated through acetylation by p300 during the induction cycle. Here, we showed that HDAC2 is also required for glucocorticoid receptor-mediated gene activation. HDAC2, however, is regulated through a different mechanism from that of HDAC1. HDAC2 is not acetylated by p300, although 5 of 6 acetylated lysine residues in HDAC1 are also present in HDAC2. More importantly, the activity of HDAC2 is inhibited by acetylated HDAC1. Additionally, we showed that acetylated HDAC1 can trans-regulate HDAC2 through heterodimerization. Thus, this study uncovered fundamental differences between HDAC1 and HDAC2. It also unveiled a new mechanism of collaborative regulation by HDAC1/2 containing coregulator complexes.	[Luo, Yi; Jian, Wei; Qiu, Yi] Univ Florida, Dept Anat & Cell Biol, Gainesville, FL 32610 USA; [Bungert, Joerg; Huang, Suming] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Stavreva, Diana; Hager, Gordon] NCI, Lab Receptor Biol & Gene Express, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Luo, Yi; Fu, Xueqi] Jilin Univ, Coll Life Sci, Changchun 130023, Peoples R China	State University System of Florida; University of Florida; State University System of Florida; University of Florida; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Jilin University	Qiu, Y (corresponding author), Rm 356,1376 Mowry Rd, Gainesville, FL 32610 USA.	qiuy@ufl.edu	Stavreva, Diana/AAW-8964-2020	, Yi/0000-0002-3282-6072	National Institutes of Health [R01 HL090589, R01 HL091929, R01 DK52356]; Florida Department of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090589, R01HL091929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052356] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Department of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL090589 and R01 HL091929 (to S. H.) and R01 DK52356 (to J. B.). This work was also supported by grants from the Florida Department of Health (to Y. Q. and S. H.).	Barnes PJ, 2005, EXPERT OPIN THER TAR, V9, P1111, DOI 10.1517/14728222.9.6.1111; Carmen AA, 1996, J BIOL CHEM, V271, P15837, DOI 10.1074/jbc.271.26.15837; Chang S, 2005, J BIOL CHEM, V280, P796, DOI 10.1074/jbc.M409053200; Cho YS, 2005, GENOMICS, V86, P606, DOI 10.1016/j.ygeno.2005.07.007; David G, 2002, J BIOL CHEM, V277, P23658, DOI 10.1074/jbc.M203690200; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; Huang S, 2000, MOL CELL BIOL, V20, P2248, DOI 10.1128/MCB.20.6.2248-2259.2000; Ito K, 2006, J EXP MED, V203, P7, DOI 10.1084/jem.20050466; Kramer PR, 1999, J BIOL CHEM, V274, P28590, DOI 10.1074/jbc.274.40.28590; Kurash JK, 2008, MOL CELL, V29, P392, DOI 10.1016/j.molcel.2007.12.025; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Latham JA, 2007, NAT STRUCT MOL BIOL, V14, P1017, DOI 10.1038/nsmb1307; Lee MG, 2006, MOL CELL BIOL, V26, P6395, DOI 10.1128/MCB.00723-06; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Ng HH, 2000, TRENDS BIOCHEM SCI, V25, P121; Pflum MKH, 2001, J BIOL CHEM, V276, P47733, DOI 10.1074/jbc.M105590200; Qiu Y, 2006, MOL CELL, V22, P669, DOI 10.1016/j.molcel.2006.04.019; Reid G, 2005, ONCOGENE, V24, P4894, DOI 10.1038/sj.onc.1208662; Sengupta N, 2004, J CELL BIOCHEM, V93, P57, DOI 10.1002/jcb.20179; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Smith CL, 2008, BIOESSAYS, V30, P15, DOI 10.1002/bies.20687; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Taplick J, 2001, J MOL BIOL, V308, P27, DOI 10.1006/jmbi.2001.4569; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Trivedi CM, 2007, NAT MED, V13, P324, DOI 10.1038/nm1552; Tsai CC, 2004, VITAM HORM, V68, P93; Tsai SC, 2002, J BIOL CHEM, V277, P31826, DOI 10.1074/jbc.M204149200; Vannini A, 2004, P NATL ACAD SCI USA, V101, P15064, DOI 10.1073/pnas.0404603101; Vannini A, 2007, EMBO REP, V8, P879, DOI 10.1038/sj.embor.7401047; Walker D, 1999, METHODS, V19, P386, DOI 10.1006/meth.1999.0874; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Zhang Y, 2006, J BIOL CHEM, V281, P2401, DOI 10.1074/jbc.C500241200; Zupkovitz G, 2006, MOL CELL BIOL, V26, P7913, DOI 10.1128/MCB.01220-06	37	54	58	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34901	34910		10.1074/jbc.M109.038356	http://dx.doi.org/10.1074/jbc.M109.038356			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19822520	Green Published, hybrid			2022-12-27	WOS:000272439600045
J	Navon, A; Ciechanover, A				Navon, Ami; Ciechanover, Aaron			The 26 S Proteasome: From Basic Mechanisms to Drug Targeting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							NF-KAPPA-B; UNFOLDED PROTEIN RESPONSE; 20S PROTEASOME; MULTIUBIQUITIN-CHAIN; MULTIPLE-MYELOMA; UBIQUITIN CHAINS; CRYSTAL-STRUCTURE; ANTICANCER DRUGS; CANCER-THERAPY; CORE PARTICLE	The regulated degradation of proteins within eukaryotes and bacterial cells is catalyzed primarily by large multimeric proteases in ATP-dependent manner. In eukaryotes, the 26 S proteasome is essential for the rapid destruction of key regulatory proteins, such as cell cycle regulators and transcription factors, whose fast and tuned elimination is necessary for the proper control of the fundamental cell processes they regulate. In addition, the 26 S proteasome is responsible for cell quality control by eliminating defective proteins from the cytosol and endoplasmic reticulum. These defective proteins can be misfolded proteins, nascent prematurely terminated polypeptides, or proteins that fail to assemble into complexes. These diverse activities and its central role in apoptosis have made the proteasome an important target for drug development, in particular to combat malignancies.	[Navon, Ami] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Ciechanover, Aaron] Technion Israel Inst Technol, Canc & Vasc Biol Res Ctr, Rappaport Fac Med, IL-31096 Haifa, Israel; [Ciechanover, Aaron] Technion Israel Inst Technol, Res Inst, IL-31096 Haifa, Israel	Weizmann Institute of Science; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology	Navon, A (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel.	ami.navon@weizmann.ac.il	Ciechanover, Aaron J/C-9166-2017		Israel Science Foundation; Minerva Foundation (Germany); German-Israeli Foundation for Scientific Research and Development; Foundation for Promotion of Research in the Technion	Israel Science Foundation(Israel Science Foundation); Minerva Foundation (Germany); German-Israeli Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development); Foundation for Promotion of Research in the Technion	The work performed in the laboratory of A.N. was supported by the Israel Science Foundation, the Minerva Foundation (Germany), the German-Israeli Foundation for Scientific Research and Development, and a special gift from Rolando Uziel. The work performed in the laboratory of A. C. was supported by grants from the Dr. Miriam and Sheldon Adelson Foundation for Medical Research, the Israel Science Foundation, the German-Israeli Foundation for Scientific Research and Development, the European Union Networks of Excellence NeuroNE and Rubicon, a professorship from the Israel Cancer Research Fund USA, and a grant from the Foundation for Promotion of Research in the Technion. This is the eleventh article in the Thematic Minireview Series on Proteolytic Enzymes. The first article was published in the November 7, 2008 issue; the second and third articles in the May 22, 2009 issue; the fourth and fifth articles in the July 31, 2009 issue; the sixth and seventh articles in the August 14, 2009 issue; the eighth article in the August 28, 2009 issue; the ninth article in the November 6, 2009 issue; and the tenth article in the November 27, 2009 issue. This mini-review will be reprinted in	Adams J, 2004, CANCER INVEST, V22, P304, DOI 10.1081/CNV-120030218; Adams J, 2004, CANCER CELL, V5, P417, DOI 10.1016/S1535-6108(04)00120-5; AKI M, 1994, J BIOCHEM, V115, P257, DOI 10.1093/oxfordjournals.jbchem.a124327; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Ben-Saadon R, 2006, MOL CELL, V24, P701, DOI 10.1016/j.molcel.2006.10.022; Bertolaet BL, 2001, NAT STRUCT BIOL, V8, P417, DOI 10.1038/87575; BRANNIGAN JA, 1995, NATURE, V378, P416, DOI 10.1038/378416a0; Braun BC, 1999, NAT CELL BIOL, V1, P221, DOI 10.1038/12043; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chauhan D, 2005, CANCER CELL, V8, P407, DOI 10.1016/j.ccr.2005.10.013; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Corey EJ, 1999, CHEM PHARM BULL, V47, P1; Crosas B, 2006, CELL, V127, P1401, DOI 10.1016/j.cell.2006.09.051; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; Ferrell K, 2000, TRENDS BIOCHEM SCI, V25, P83, DOI 10.1016/S0968-0004(99)01529-7; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Groll M, 2006, STRUCTURE, V14, P451, DOI 10.1016/j.str.2005.11.019; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Hanna J, 2003, MOL CELL BIOL, V23, P9251, DOI 10.1128/MCB.23.24.9251-9261.2003; Hartmann-Petersen R, 2001, ARCH BIOCHEM BIOPHYS, V386, P89, DOI 10.1006/abbi.2000.2178; Hendil KB, 2002, J MOL BIOL, V315, P627, DOI 10.1006/jmbi.2001.5285; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hideshima T, 2002, J BIOL CHEM, V277, P16639, DOI 10.1074/jbc.M200360200; Hiyama H, 1999, J BIOL CHEM, V274, P28019, DOI 10.1074/jbc.274.39.28019; Hochstrasser M, 2006, CELL, V124, P27, DOI 10.1016/j.cell.2005.12.025; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; ImajohOhmi S, 1995, BIOCHEM BIOPH RES CO, V217, P1070, DOI 10.1006/bbrc.1995.2878; Jakob C, 2007, BLOOD, V109, P2100, DOI 10.1182/blood-2006-04-016360; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Kravtsova-Ivantsiv Y, 2009, MOL CELL, V33, P496, DOI 10.1016/j.molcel.2009.01.023; Lam YA, 2002, NATURE, V416, P763, DOI 10.1038/416763a; Lee AH, 2003, P NATL ACAD SCI USA, V100, P9946, DOI 10.1073/pnas.1334037100; Lee SJ, 2008, BRIT J HAEMATOL, V143, P511, DOI 10.1111/j.1365-2141.2008.07378.x; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; Lopes UG, 1997, J BIOL CHEM, V272, P12893, DOI 10.1074/jbc.272.20.12893; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; Medalia N, 2009, J BIOL CHEM, V284, P22952, DOI 10.1074/jbc.M809643200; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Nakanishi C, 2005, NAT REV CANCER, V5, P297, DOI 10.1038/nrc1588; Nickell S, 2007, BIOCHEM BIOPH RES CO, V353, P115, DOI 10.1016/j.bbrc.2006.11.141; Orlowski RZ, 2008, CLIN CANCER RES, V14, P1649, DOI 10.1158/1078-0432.CCR-07-2218; Orlowski RZ, 1998, CANCER RES, V58, P4342; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Ravid T, 2007, NAT CELL BIOL, V9, P422, DOI 10.1038/ncb1558; Richardson PG, 2006, ANNU REV MED, V57, P33, DOI 10.1146/annurev.med.57.042905.122625; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Saeki Y, 2009, EMBO J, V28, P359, DOI 10.1038/emboj.2008.305; Schreiner P, 2008, NATURE, V453, P548, DOI 10.1038/nature06924; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; vanNocker S, 1996, MOL CELL BIOL, V16, P6020; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Voorhees PM, 2006, ANNU REV PHARMACOL, V46, P189, DOI 10.1146/annurev.pharmtox.46.120604.141300; Walters KJ, 2002, BIOCHEMISTRY-US, V41, P1767, DOI 10.1021/bi011892y; Walz J, 1998, J STRUCT BIOL, V121, P19, DOI 10.1006/jsbi.1998.3958; Wang QH, 2003, BIOCHEMISTRY-US, V42, P13529, DOI 10.1021/bi035391j; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939; Xie YM, 2000, P NATL ACAD SCI USA, V97, P2497, DOI 10.1073/pnas.060025497; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041	70	140	143	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33713	33718		10.1074/jbc.R109.018481	http://dx.doi.org/10.1074/jbc.R109.018481			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19812037	hybrid, Green Published			2022-12-27	WOS:000272165200001
J	Roca, H; Varsos, ZS; Sud, S; Craig, MJ; Ying, C; Pienta, KJ				Roca, Hernan; Varsos, Zachary S.; Sud, Sudha; Craig, Matthew J.; Ying, Chi; Pienta, Kenneth J.			CCL2 and Interleukin-6 Promote Survival of Human CD11b(+) Peripheral Blood Mononuclear Cells and Induce M2-type Macrophage Polarization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-ASSOCIATED MACROPHAGES; MONOCYTE CHEMOATTRACTANT PROTEIN-1; MANNOSE RECEPTOR; PROSTATE-CANCER; ALTERNATIVE ACTIVATION; IN-VIVO; DEATH; PROGRESSION; CASPASE-8; APOPTOSIS	CCL2 and interleukin (IL)-6 are among the most prevalent cytokines in the tumor microenvironment, with expression generally correlating with tumor progression and metastasis. CCL2 and IL-6 induced expression of each other in CD11b(+) cells isolated from human peripheral blood. It was demonstrated that both cytokines induce up-regulation of the antiapoptotic proteins cFLIPL (cellular caspase-8 (FLICE)-like inhibitory protein), Bcl-2, and Bcl-X-L and inhibit the cleavage of caspase-8 and subsequent activation of the caspase-cascade, thus protecting cells from apoptosis under serum deprivation stress. Furthermore, both cytokines induced hyperactivation of autophagy in these cells. Upon CCL2 or IL-6 stimulation, CD11b(+) cells demonstrated a significant increase in the mannose receptor (CD206) and the CD14(+)/CD206(+) double-positive cells, suggesting a polarization of macrophages toward the CD206(+) M2-type phenotype. Caspase-8 inhibitors mimicked the cytokine-induced up-regulation of autophagy and M2 polarization. Furthermore, E64D and leupeptin, which are able to function as inhibitors of autophagic degradation, reversed the effect of caspase-8 inhibitors in the M2-macrophage polarization, indicating a role of autophagy in this mechanism. Additionally, in patients with advanced castrate-resistant prostate cancer, metastatic lesions exhibited an increased CD14(+)/CD206(+) double-positive cell population compared with normal tissues. Altogether, these findings suggest a role for CCL2 and IL-6 in the survival of myeloid monocytes recruited to the tumor microenvironment and their differentiation toward tumor-promoting M2-type macrophages via inhibition of caspase-8 cleavage and enhanced autophagy.	[Roca, Hernan; Varsos, Zachary S.; Pienta, Kenneth J.] Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA; [Sud, Sudha; Craig, Matthew J.; Ying, Chi; Pienta, Kenneth J.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Pienta, Kenneth J.] Univ Michigan, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Roca, Hernan; Varsos, Zachary S.; Sud, Sudha; Craig, Matthew J.; Ying, Chi; Pienta, Kenneth J.] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Roca, H (corresponding author), 1500 E Med Ctr Dr,7431 CCC, Ann Arbor, MI 48109 USA.	rocach@umich.edu	Pienta, Kenneth/E-7679-2015	Pienta, Kenneth/0000-0002-4138-2186	National Institutes of Health [CA093900, P50 CA69568]; American Cancer Society Clinical Research; Cancer Center [P30CA46592]; Southwest Oncology Group [CA32102]; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE [P01CA093900, P30CA046592, U10CA032102, P50CA069568] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Clinical Research(American Cancer Society); Cancer Center; Southwest Oncology Group; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA093900 (to K.J.P.). This work was also supported by American Cancer Society Clinical Research Professorship, National Institutes of Health SPORE in Prostate Cancer Grant P50 CA69568, Cancer Center Grant P30CA46592, Southwest Oncology Group Grant CA32102, and funds from the Prostate Cancer Foundation (to K.J.P.).	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bell BD, 2008, P NATL ACAD SCI USA, V105, P16677, DOI 10.1073/pnas.0808597105; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Brigati C, 2002, CLIN EXP METASTAS, V19, P247, DOI 10.1023/A:1015587423262; Cavarretta IT, 2007, ONCOGENE, V26, P2822, DOI 10.1038/sj.onc.1210097; Chun HJ, 2002, NATURE, V419, P395, DOI 10.1038/nature01063; Conti I, 2004, SEMIN CANCER BIOL, V14, P149, DOI 10.1016/j.semcancer.2003.10.009; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Degterev A, 2008, NAT REV MOL CELL BIO, V9, P378, DOI 10.1038/nrm2393; Devitt A, 1998, NATURE, V392, P505, DOI 10.1038/33169; East L, 2002, BBA-GEN SUBJECTS, V1572, P364, DOI 10.1016/S0304-4165(02)00319-7; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gu L, 2000, NATURE, V404, P407, DOI 10.1038/35006097; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kataoka T, 2005, CRIT REV IMMUNOL, V25, P31, DOI 10.1615/CritRevImmunol.v25.i1.30; Katsenelson NS, 2001, MODERN PATHOL, V14, P40, DOI 10.1038/modpathol.3880254; Kiener PA, 1997, J EXP MED, V185, P1511, DOI 10.1084/jem.185.8.1511; Krueger A, 2001, J BIOL CHEM, V276, P20633, DOI 10.1074/jbc.M101780200; KRUSKAL BA, 1992, J EXP MED, V176, P1673, DOI 10.1084/jem.176.6.1673; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Loberg RD, 2007, CANCER RES, V67, P9417, DOI 10.1158/0008-5472.CAN-07-1286; Loberg RD, 2006, NEOPLASIA, V8, P578, DOI 10.1593/neo.06280; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; MANTOVANI A, 1992, IMMUNOL TODAY, V13, P265, DOI 10.1016/0167-5699(92)90008-U; Mantovani A, 2004, SEMIN CANCER BIOL, V14, P155, DOI 10.1016/j.semcancer.2003.10.001; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; MANTOVANI A, 1994, LAB INVEST, V71, P5; Marsden VS, 2002, NATURE, V419, P634, DOI 10.1038/nature01101; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Menetrier-Caux C, 1998, BLOOD, V92, P4778, DOI 10.1182/blood.V92.12.4778; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Nowicki A, 1996, INT J CANCER, V65, P112, DOI 10.1002/(SICI)1097-0215(19960103)65:1<112::AID-IJC19>3.3.CO;2-R; Perlman H, 1999, J EXP MED, V190, P1679, DOI 10.1084/jem.190.11.1679; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Roca H, 2008, J BIOL CHEM, V283, P25057, DOI 10.1074/jbc.M801073200; Roca H, 2008, AUTOPHAGY, V4, P969, DOI 10.4161/auto.6822; SHEPHERD VL, 1990, AM J RESP CELL MOL, V2, P335, DOI 10.1165/ajrcmb/2.4.335; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; SIEGALL CB, 1990, CANCER RES, V50, P7786; STAHL P, 1980, CELL, V19, P207, DOI 10.1016/0092-8674(80)90402-X; Taylor PR, 2005, TRENDS IMMUNOL, V26, P104, DOI 10.1016/j.it.2004.12.001; Tricot G, 2000, LANCET, V355, P248, DOI 10.1016/S0140-6736(00)00019-2; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645	49	375	386	0	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34342	34354		10.1074/jbc.M109.042671	http://dx.doi.org/10.1074/jbc.M109.042671			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19833726	Green Published, hybrid			2022-12-27	WOS:000272165200064
J	Zhao, JP; Zhang, YJ; Ithychanda, SS; Tu, YZ; Chen, K; Qin, J; Wu, CY				Zhao, Jianping; Zhang, Yongjun; Ithychanda, Sujay Subbayya; Tu, Yizeng; Chen, Ka; Qin, Jun; Wu, Chuanyue			Migfilin Interacts with Src and Contributes to Cell-Matrix Adhesion-mediated Survival Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILY KINASES; CRYSTAL-STRUCTURE; C-SRC; REGULATES ANOIKIS; CANCER-CELLS; INTEGRINS; APOPTOSIS; GROWTH; BETA; ACTIVATION	Integrin-mediated cell-extracellular matrix (ECM) adhesion is essential for protection of epithelial cells against apoptosis, but the underlying mechanism is incompletely understood. Here we show that migfilin, an integrin-proximal adaptor protein, interacts with Src and contributes to cell-ECM-mediated survival signaling. Loss of cell-ECM adhesion markedly reduces the migfilin level in untransformed epithelial cells and concomitantly induces apoptosis. Overexpression of migfilin substantially desensitizes cell detachment-induced apoptosis. Conversely, depletion of migfilin promotes apoptosis despite the presence of cell-ECM adhesion. At the molecular level migfilin directly interacts with Src, and the migfilin binding surface overlaps with the inhibitory intramolecular interaction sites in Src. Consequently, the binding of migfilin activates Src, resulting in suppression of apoptosis. Our results reveal a novel mechanism by which cell-ECM adhesion regulates Src activation and survival signaling. This migfilin-mediated signaling pathway is dysfunctional in multiple types of carcinoma cells, which likely contributes to aberrant Src activation and anoikis resistance in the cancerous cells.	[Wu, Chuanyue] Univ Pittsburgh, Dept Pathol, Sch Med, Pittsburgh, PA 15261 USA; [Ithychanda, Sujay Subbayya; Qin, Jun] Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Cleveland Clinic Foundation	Wu, CY (corresponding author), Univ Pittsburgh, Dept Pathol, Sch Med, 707B Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	carywu@pitt.edu	Zhao, Jianping/K-5242-2012; Ithychanda, Sujay Subbayya/C-7792-2011; Qin, Jun/D-5559-2009	Ithychanda, Sujay Subbayya/0000-0001-8979-246X; Qin, Jun/0000-0002-2647-9270	National Institutes of Health [GM65188, DK54639, GM62823]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065188, R01GM062823] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM65188 and DK54639 (to C.W.) and GM62823 (to J.Q.).	Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Belsches-Jablonski AP, 2001, ONCOGENE, V20, P1465, DOI 10.1038/sj.onc.1204205; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; Chen K, 2008, J BIOL CHEM, V283, P2508, DOI 10.1074/jbc.M707307200; Chiarugi P, 2008, BIOCHEM PHARMACOL, V76, P1352, DOI 10.1016/j.bcp.2008.07.023; Coll ML, 2002, ONCOGENE, V21, P2908, DOI 10.1038/sj.onc.1205388; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DONG Z, 2002, SCI STKE, pPL7; Frame MC, 2004, J CELL SCI, V117, P989, DOI 10.1242/jcs.01111; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Gilmore AP, 2005, CELL DEATH DIFFER, V12, P1473, DOI 10.1038/sj.cdd.4401723; Grossmann J, 2002, APOPTOSIS, V7, P247, DOI 10.1023/A:1015312119693; Harburger DS, 2009, J BIOL CHEM, V284, P11485, DOI 10.1074/jbc.M809233200; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ithychanda SS, 2009, J BIOL CHEM, V284, P4713, DOI 10.1074/jbc.M807719200; Ke N, 2004, CANCER RES, V64, P8208, DOI 10.1158/0008-5472.CAN-04-2134; Kloeker S, 2004, J BIOL CHEM, V279, P6824, DOI 10.1074/jbc.M307978200; Lad Y, 2008, J BIOL CHEM, V283, P35154, DOI 10.1074/jbc.M802592200; Larjava H, 2008, EMBO REP, V9, P1203, DOI 10.1038/embor.2008.202; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094; MEREDITH JE, 1993, MOL BIOL CELL, V4, P953, DOI 10.1091/mbc.4.9.953; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Orford K, 1999, J CELL BIOL, V146, P855, DOI 10.1083/jcb.146.4.855; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3; Reginato MJ, 2005, MOL CELL BIOL, V25, P4591, DOI 10.1128/MCB.25.11.4591-4601.2005; Russello SV, 2004, FRONT BIOSCI-LANDMRK, V9, P139; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Shi XH, 2007, J BIOL CHEM, V282, P20455, DOI 10.1074/jbc.M611680200; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Simpson CD, 2008, CANCER LETT, V272, P177, DOI 10.1016/j.canlet.2008.05.029; Summy JM, 2006, CLIN CANCER RES, V12, P1398, DOI 10.1158/1078-0432.CCR-05-2692; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Thomas JW, 1998, J BIOL CHEM, V273, P577, DOI 10.1074/jbc.273.1.577; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; Van Slyke P, 2005, MOL CELL BIOL, V25, P3831, DOI 10.1128/MCB.25.9.3831-3841.2005; Wang SC, 2001, ONCOGENE, V20, P6960, DOI 10.1038/sj.onc.1204873; Wei L, 2004, ONCOGENE, V23, P9052, DOI 10.1038/sj.onc.1208091; Williams JC, 1997, J MOL BIOL, V274, P757, DOI 10.1006/jmbi.1997.1426; Windham TC, 2002, ONCOGENE, V21, P7797, DOI 10.1038/sj.onc.1205989; Wu CY, 2005, J CELL SCI, V118, P659, DOI 10.1242/jcs.01639; Wu Y, 2002, ONCOGENE, V21, P6801, DOI 10.1038/sj.onc.1205849; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yamaguchi H, 2008, J BIOL CHEM, V283, P19112, DOI 10.1074/jbc.M709882200; Yamaki N, 2007, EXP CELL RES, V313, P2821, DOI 10.1016/j.yexcr.2007.05.010; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; YU H, 1993, FEBS LETT, V324, P87, DOI 10.1016/0014-5793(93)81538-B; Zhang YJ, 2006, J BIOL CHEM, V281, P12397, DOI 10.1074/jbc.M512107200; Zhang YJ, 2009, J CELL BIOL, V184, P785, DOI 10.1083/jcb.200810155	54	31	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34308	34320		10.1074/jbc.M109.045021	http://dx.doi.org/10.1074/jbc.M109.045021			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19833732	Green Published, hybrid			2022-12-27	WOS:000272165200061
J	Del Vecchio, M; Pogni, R; Baratto, MC; Nobbs, A; Rappuoli, R; Pizza, M; Balducci, E				Del Vecchio, Mariangela; Pogni, Rebecca; Baratto, Maria Camilla; Nobbs, Angela; Rappuoli, Rino; Pizza, Mariagrazia; Balducci, Enrico			Identification of an Iron-Sulfur Cluster That Modulates the Enzymatic Activity in NarE, a Neisseria meningitidis ADP-ribosyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-OLEOVORANS RUBREDOXIN; CRYSTAL-STRUCTURE; ADENYLATE-CYCLASE; PROTEIN-SYNTHESIS; RIBOSYLATION; TOXIN; ENTEROTOXIN; INHIBITION; CHOLERAGEN; MECHANISM	In prokaryotes, mono-ADP-ribose transfer enzymes represent a family of exotoxins that display activity in a variety of bacterial pathogens responsible for causing disease in plants and animals, including those affecting mankind, such as diphtheria, cholera, and whooping cough. We report here that NarE, a putative ADP-ribosylating toxin previously identified from Neisseria meningitidis, which shares structural homologies with Escherichia coli heat labile enterotoxin and toxin from Vibrio cholerae, possesses an iron-sulfur center. The recombinant protein was expressed in E. coli, and when purified at high concentration, NarE is a distinctive golden brown in color. Evidence from UV-visible spectrophotometry and EPR spectroscopy revealed characteristics consistent of an iron-binding protein. The presence of iron was determined by colorimetric method and by an atomic absorption spectrophotometer. To identify the amino acids involved in binding iron, a combination of site-directed mutagenesis and UV-visible and enzymatic assays were performed. All four cysteine residues were individually replaced by serine. Substitution of Cys(67) and Cys(128) into serine caused a drastic reduction in the E-420/E-280 ratio, suggesting that these two residues are essential for the formation of a stable coordination. This modification led to a consistent loss in ADP-ribosyltransferase activity, while decrease in NAD-glycohydrolase activity was less dramatic in these mutants, indicating that the correct assembly of the iron-binding site is essential for transferase but not hydrolase activity. This is the first observation suggesting that a member of the ADP-ribosyltransferase family contains an Fe-S cluster implicated in catalysis. This observation may unravel novel functions exerted by this class of enzymes.	[Del Vecchio, Mariangela; Nobbs, Angela; Rappuoli, Rino; Pizza, Mariagrazia] Novartis Vaccines & Diagnost, I-53100 Siena, Italy; [Pogni, Rebecca; Baratto, Maria Camilla] Univ Siena, Dept Chem, I-53100 Siena, Italy; [Balducci, Enrico] Univ Camerino, Dept Comparat Morphol & Biochem, I-62032 Camerino, Italy; [Del Vecchio, Mariangela] Univ Piemonte Orientale, DiSCAFF, I-28100 Novara, Italy	Novartis; University of Siena; University of Camerino; University of Eastern Piedmont Amedeo Avogadro	Balducci, E (corresponding author), Ctr Ric, Via Fiorentina 1, I-53100 Siena, Italy.	enrico.balducci@novartis.com	Nobbs, Angela/AAS-3926-2020	Nobbs, Angela/0000-0003-3813-4410; Balducci, Enrico/0000-0001-6147-9033	Novartis Vaccines Diagnostics	Novartis Vaccines Diagnostics	This work was supported by Novartis Vaccines & Diagnostics.	AKTORIES K, 1989, J CELL BIOL, V109, P1385, DOI 10.1083/jcb.109.4.1385; AlaAldeen DAA, 1996, J MED MICROBIOL, V45, P419, DOI 10.1099/00222615-45-6-419; ANTOINE R, 1994, J BIOL CHEM, V269, P6450; BACHMAYE.H, 1967, P NATL ACAD SCI USA, V57, P122, DOI 10.1073/pnas.57.1.122; Balducci E, 2005, ANAL BIOCHEM, V344, P278, DOI 10.1016/j.ab.2005.06.024; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Berkovitch F, 2004, SCIENCE, V303, P76, DOI 10.1126/science.1088493; Chen CJ, 2006, BIOCHEM BIOPH RES CO, V349, P79, DOI 10.1016/j.bbrc.2006.07.205; DeHaan L, 1996, INFECT IMMUN, V64, P5413, DOI 10.1128/IAI.64.12.5413-5416.1996; Duelund L, 2000, SPECTROCHIM ACTA A, V56, P331, DOI 10.1016/S1386-1425(99)00243-7; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; GILL DM, 1985, CIBA F SYMP, V112, P57; HONJO T, 1968, J BIOL CHEM, V243, P3553; IGLEWSKI BH, 1975, P NATL ACAD SCI USA, V72, P2284, DOI 10.1073/pnas.72.6.2284; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; LOCHT C, 1986, SCIENCE, V232, P1258, DOI 10.1126/science.3704651; LODE ET, 1971, J BIOL CHEM, V246, P791; Masignani V, 2004, INT J MED MICROBIOL, V293, P471, DOI 10.1078/1438-4221-00296; Masignani V, 2003, MOL MICROBIOL, V50, P1055, DOI 10.1046/j.1365-2958.2003.03770.x; MEYER J, 1995, BIOCHEM BIOPH RES CO, V212, P827, DOI 10.1006/bbrc.1995.2043; MOSS J, 1981, P NATL ACAD SCI-BIOL, V78, P4809, DOI 10.1073/pnas.78.8.4809; MOSS J, 1976, P NATL ACAD SCI USA, V73, P4424, DOI 10.1073/pnas.73.12.4424; MOSS J, 1977, J BIOL CHEM, V252, P2455; MOSS J, 1988, ADV ENZYMOL RAMB, V61, P303; PEISACH J, 1971, J BIOL CHEM, V246, P5877; Perkins-Balding D, 2004, MICROBIOL MOL BIOL R, V68, P154, DOI 10.1128/MMBR.68.1.154-171.2004; PIZZA M, 1994, J EXP MED, V180, P2147, DOI 10.1084/jem.180.6.2147; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Porello SL, 1998, BIOCHEMISTRY-US, V37, P6465, DOI 10.1021/bi972433t; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; Rutherford JC, 2001, P NATL ACAD SCI USA, V98, P14322, DOI 10.1073/pnas.261381198; UEDA K, 1985, ANNU REV BIOCHEM, V54, P73, DOI 10.1146/annurev.biochem.54.1.73; Wada K, 2005, FEBS LETT, V579, P6543, DOI 10.1016/j.febslet.2005.10.046; Yoo SJ, 2000, J BIOL INORG CHEM, V5, P475, DOI 10.1007/s007750050008	35	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33040	33047		10.1074/jbc.M109.057547	http://dx.doi.org/10.1074/jbc.M109.057547			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19744927	Green Published, hybrid			2022-12-27	WOS:000272028500006
J	Doolittle, MH; Neher, SB; Ben-Zeev, O; Jo, LL; Gallagher, CM; Hosseini, M; Yin, F; Wong, H; Walter, P; Peterfy, M				Doolittle, Mark H.; Neher, Saskia B.; Ben-Zeev, Osnat; Jo Ling-liao; Gallagher, Ciara M.; Hosseini, Maryam; Yin, Fen; Wong, Howard; Walter, Peter; Peterfy, Miklos			RETRACTED: Lipase Maturation Factor LMF1, Membrane Topology and Interaction with Lipase Proteins in the Endoplasmic Reticulum (Retracted article. See vol. 294, pg. 12263, 2019)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							FLUORESCENCE PROTEASE PROTECTION; N-TERMINAL DOMAIN; LIPOPROTEIN-LIPASE; HEPATIC LIPASE; TRANSMEMBRANE ORGANIZATION; SUBCELLULAR-LOCALIZATION; DEFICIENCY CLD/CLD; EPITOPE INSERTION; P-GLYCOPROTEIN; MOUSE	Lipase maturation factor 1 (LMF1) is predicted to be a polytopic protein localized to the endoplasmic reticulum (ER) membrane. It functions in the post-translational attainment of enzyme activity for both lipoprotein lipase and hepatic lipase. By using transmembrane prediction methods in mouse and human orthologs, models of LMF1 topology were constructed and tested experimentally. Employing a tagging strategy that used insertion of ectopic glycan attachment sites and terminal fusions of green fluorescent protein, we established a five-transmembrane model, thus dividing LMF1 into six domains. Three domains were found to face the cytoplasm (the amino-terminal domain and loops B and D), and the other half was oriented to the ER lumen (loops A and C and the carboxyl-terminal domain). This representative model shows the arrangement of an evolutionarily conserved domain within LMF1 (DUF1222) that is essential to lipase maturation. DUF1222 comprises four of the six domains, with the two largest ones facing the ER lumen. We showed for the first time, using several naturally occurring variants featuring DUF1222 truncations, that Lmf1 interacts physically with lipoprotein lipase and hepatic lipase and localizes the lipase interaction site to loop C within DUF1222. We discuss the implication of our results with regard to lipase maturation and DUF1222 domain structure.	[Doolittle, Mark H.; Ben-Zeev, Osnat; Jo Ling-liao; Hosseini, Maryam; Yin, Fen; Wong, Howard; Peterfy, Miklos] Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA; [Doolittle, Mark H.; Ben-Zeev, Osnat; Hosseini, Maryam; Yin, Fen; Wong, Howard; Peterfy, Miklos] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Neher, Saskia B.; Gallagher, Ciara M.; Walter, Peter] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Walter, Peter] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Jo Ling-liao; Hosseini, Maryam; Yin, Fen; Peterfy, Miklos] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Cedars Sinai Medical Center	Doolittle, MH (corresponding author), Vet Affairs Greater Los Angeles Healthcare Syst, 11301 Wilshire Blvd,Bldg 113,Rm 312, Los Angeles, CA 90073 USA.	markdool@ucla.edu; mpeterfy@ucla.edu			National Institutes of Health [HL24841]; Cedars-Sinai Medical Center; United States Department of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL028481] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cedars-Sinai Medical Center; United States Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL24841. This work was also supported by the Cedars-Sinai Medical Center and the United States Department of Veterans Affairs.	Ben-Zeev O, 2004, J BIOL CHEM, V279, P6171, DOI 10.1074/jbc.M310051200; Ben-Zeev O, 2002, J BIOL CHEM, V277, P10727, DOI 10.1074/jbc.M108128200; BENZEEV O, 1992, J BIOL CHEM, V267, P6219; Boedeker JC, 2001, J LIPID RES, V42, P1858; Briquet-Laugier V, 1999, J LIPID RES, V40, P2044; Briquet-Laugier V, 1999, METH MOL B, V109, P81; COLEMAN T, 1995, J BIOL CHEM, V270, P12518, DOI 10.1074/jbc.270.21.12518; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; DAVIS RC, 1990, J BIOL CHEM, V265, P17960; Deber CM, 2001, PROTEIN SCI, V10, P212, DOI 10.1110/ps.30301; Doolittle MH, 2009, J LIPID RES, V50, P1173, DOI 10.1194/jlr.M800603-JLR200; Doolittle MH, 1998, J LIPID RES, V39, P934; Dowhan W, 2009, ANNU REV BIOCHEM, V78, P515, DOI 10.1146/annurev.biochem.77.060806.091251; Fink JL, 2006, NUCLEIC ACIDS RES, V34, pD213, DOI 10.1093/nar/gkj069; Gonzalez-Baro MR, 2001, J BIOL CHEM, V276, P43182, DOI 10.1074/jbc.M107885200; Hasham SN, 2006, CLIN CHIM ACTA, V372, P179, DOI 10.1016/j.cca.2006.04.020; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Joyce CW, 2000, MOL BIOL CELL, V11, P3675, DOI 10.1091/mbc.11.11.3675; KAST C, 1995, BIOCHEMISTRY-US, V34, P4402, DOI 10.1021/bi00013a032; Kast C, 1996, J BIOL CHEM, V271, P9240, DOI 10.1074/jbc.271.16.9240; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lin S, 1999, J BIOL CHEM, V274, P23276, DOI 10.1074/jbc.274.33.23276; Liscum L, 1999, BBA-MOL CELL BIOL L, V1438, P19, DOI 10.1016/S1388-1981(99)00043-8; Lorenz H, 2006, NAT METHODS, V3, P205, DOI 10.1038/nmeth857; Lorenz H, 2006, NAT PROTOC, V1, P276, DOI 10.1038/nprot.2006.42; Man WC, 2006, J BIOL CHEM, V281, P1251, DOI 10.1074/jbc.M508733200; Mead JR, 2002, J MOL MED, V80, P753, DOI 10.1007/s00109-002-0384-9; OLIVECRONA T, 1985, J BIOL CHEM, V260, P2552; Ott CM, 2002, J CELL SCI, V115, P2003; Perret B, 2002, J LIPID RES, V43, P1163, DOI 10.1194/jlr.R100020-JLR200; Peterfy M, 2005, J BIOL CHEM, V280, P32883, DOI 10.1074/jbc.M503885200; Peterfy M, 2007, NAT GENET, V39, P1483, DOI 10.1038/ng.2007.24; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Reue K, 1996, J LIPID RES, V37, P1387; Santamarina-Fojo S, 2004, ARTERIOSCL THROM VAS, V24, P1750, DOI 10.1161/01.ATV.0000140818.00570.2d; Scow RO, 1998, CHEM PHYS LIPIDS, V93, P149, DOI 10.1016/S0009-3084(98)00039-5; Skach WR, 2007, J CELL BIOL, V179, P1333, DOI 10.1083/jcb.200711107; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L; Turner RJ, 2003, J MEMBRANE BIOL, V192, P149, DOI 10.1007/s00232-002-1071-z; Wong H, 2002, J LIPID RES, V43, P993, DOI 10.1194/jlr.R200007-JLR200; YIN F, 2009, J LIPID RES IN PRESS	41	25	28	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33623	33633		10.1074/jbc.M109.049395	http://dx.doi.org/10.1074/jbc.M109.049395			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19783858	hybrid, Green Published			2022-12-27	WOS:000272028500066
J	Hong, SK; Yoon, S; Moelling, C; Arthan, D; Park, JI				Hong, Seung-Keun; Yoon, Seunghee; Moelling, Cas; Arthan, Dumrongkiet; Park, Jong-In			Noncatalytic Function of ERK1/2 Can Promote Raf/MEK/ERK-mediated Growth Arrest Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; THYROID CARCINOMA-CELLS; INHIBITORY FACTOR/JAK/STAT PATHWAY; ONCOGENE INDUCES DIFFERENTIATION; LUNG-CANCER CELLS; REGULATED KINASE; CYCLE ARREST; INDUCED SENESCENCE; HA-RAS; CELLULAR SENESCENCE	Kinase activity is known as the key biochemical property of MAPKs. Here, we report that ERK1/2 also utilizes its noncatalytic function to mediate certain signal transductions. Sustained activation of the Raf/MEK/ERK pathway induces growth arrest, accompanied by changes in cell cycle regulators (decreased retinoblastoma phosphorylation, E2F1 down-regulation, and/or p21(CIP1) up-regulation) and cell type-specific changes in morphology and expression of c-Myc or RET in the human tumor lines LNCaP, U251, and TT. Ablation of ERK1/2 by RNA interference abrogated all these effects. However, active site-disabled ERK mutants (ERK1-K71R, ERK2-K52R, and ERK2-D147A), which competitively inhibit activation of endogenous ERK1/2, could not block Raf/MEK-induced growth arrest as well as changes in the cell cycle regulators, although they effectively blocked phosphorylation of the ERK1/2 catalytic activity readouts, p90(RSK) and ELK1, as well as the cell type-specific changes. Because this indicated a potential noncatalytic ERK1/2 function, we generated stable lines of the tumor cells in which both ERK1 and ERK2 were significantly knocked down, and we further investigated the possibility using rat-derived kinase-deficient ERK mutants (ERK2-K52R and ERK2-T183A/Y185F) that were not targeted by human small hairpin RNA. Indeed, ERK2-K52R selectively restored Raf-induced growth inhibitory signaling in ERK1/2-depleted cells, as manifested by regained cellular ability to undergo growth arrest and to control the cell cycle regulators without affecting c-Myc and morphology. However, ERK2-T183A/Y185F was less effective, indicating the requirement of TEY site phosphorylation. Our study suggests that functions of ERK1/2 other than its "canonical" kinase activity are also involved in the pathway-mediated growth arrest signaling.	[Hong, Seung-Keun; Yoon, Seunghee; Moelling, Cas; Arthan, Dumrongkiet; Park, Jong-In] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Park, JI (corresponding author), Med Coll Wisconsin, Dept Biochem, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	jipark@mcw.edu		Park, Jong-In/0000-0001-7248-4735	FAMRI Young Investigator Award [062438]; Department of Defense Prostate Cancer Research Program Grant [W81XWH-07-01-0089]; American Cancer Society IRG [2204256]; Wisconsin Breast Cancer Showhouse	FAMRI Young Investigator Award; Department of Defense Prostate Cancer Research Program Grant(United States Department of Defense); American Cancer Society IRG(American Cancer Society); Wisconsin Breast Cancer Showhouse	This work was supported by FAMRI Young Investigator Award 062438, Department of Defense Prostate Cancer Research Program Grant W81XWH-07-01-0089, American Cancer Society IRG Grant 2204256, and the Wisconsin Breast Cancer Showhouse ( to J. P.).	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; BESSARD A, 2008, ONCOGENE; Binetruy B, 2007, STEM CELLS, V25, P1090, DOI 10.1634/stemcells.2006-0612; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; CARSON EB, 1995, CANCER RES, V55, P2048; Carson-Walter EB, 1998, ONCOGENE, V17, P367, DOI 10.1038/sj.onc.1201938; Casar B, 2008, MOL CELL, V31, P708, DOI 10.1016/j.molcel.2008.07.024; Chambard JC, 2007, BBA-MOL CELL RES, V1773, P1299, DOI 10.1016/j.bbamcr.2006.11.010; Chuderland D, 2005, MOL BIOTECHNOL, V29, P57, DOI 10.1385/MB:29:1:57; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Duncia JV, 1998, BIOORG MED CHEM LETT, V8, P2839, DOI 10.1016/S0960-894X(98)00522-8; Ebisuya M, 2005, J CELL SCI, V118, P2997, DOI 10.1242/jcs.02505; Fanton CP, 2001, J BIOL CHEM, V276, P18871, DOI 10.1074/jbc.M011514200; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fischer AM, 2005, IMMUNITY, V23, P431, DOI 10.1016/j.immuni.2005.08.013; FROST JA, 1994, P NATL ACAD SCI USA, V91, P3844, DOI 10.1073/pnas.91.9.3844; Groth A, 2000, J BIOL CHEM, V275, P27473; Turjanski AG, 2009, J AM CHEM SOC, V131, P6141, DOI 10.1021/ja8071995; Han JH, 2007, TRENDS BIOCHEM SCI, V32, P364, DOI 10.1016/j.tibs.2007.06.007; Kim EJ, 2005, J BIOL CHEM, V280, P4913, DOI 10.1074/jbc.M410542200; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; KORTENJANN M, 1994, MOL CELL BIOL, V14, P4815, DOI 10.1128/MCB.14.7.4815; La Thangue NB, 2003, NAT CELL BIOL, V5, P587, DOI 10.1038/ncb0703-587; LAZAR DF, 1995, J BIOL CHEM, V270, P20801, DOI 10.1074/jbc.270.35.20801; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Lefloch R, 2008, MOL CELL BIOL, V28, P511, DOI 10.1128/MCB.00800-07; Lewis TS, 2000, MOL CELL, V6, P1343, DOI 10.1016/S1097-2765(00)00132-5; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Liu SY, 2008, P NATL ACAD SCI USA, V105, P5248, DOI 10.1073/pnas.0704242105; MABRY M, 1989, J CLIN INVEST, V84, P194, DOI 10.1172/JCI114140; Malumbres M, 2000, MOL CELL BIOL, V20, P2915, DOI 10.1128/MCB.20.8.2915-2925.2000; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Mostoslavsky G, 2006, P NATL ACAD SCI USA, V103, P16406, DOI 10.1073/pnas.0608130103; NAKAGAWA T, 1987, P NATL ACAD SCI USA, V84, P5923, DOI 10.1073/pnas.84.16.5923; Olsen CL, 2002, ONCOGENE, V21, P6328, DOI 10.1038/sj.onc.1205780; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; Park JI, 2005, CYTOKINE, V29, P125, DOI 10.1016/j.cyto.2004.10.005; Park JI, 2005, EXP CELL RES, V303, P79, DOI 10.1016/j.yexcr.2004.09.028; Park JI, 2003, MOL CELL BIOL, V23, P543, DOI 10.1128/MCB.23.2.543-554.2003; Philipova R, 2005, J CELL SCI, V118, P5767, DOI 10.1242/jcs.02683; Ravi RK, 1998, J CLIN INVEST, V101, P153, DOI 10.1172/JCI831; Ravi RK, 1999, J CELL BIOCHEM, V72, P458, DOI 10.1002/(SICI)1097-4644(19990315)72:4<458::AID-JCB2>3.0.CO;2-C; Ravi RK, 1999, AM J RESP CELL MOL, V20, P543, DOI 10.1165/ajrcmb.20.4.3406; ROBBINS DJ, 1993, J BIOL CHEM, V268, P5097; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Roper E, 2001, EMBO REP, V2, P145, DOI 10.1093/embo-reports/kve020; Rubio CA, 2003, EUR J CLIN INVEST, V33, P406, DOI 10.1046/j.1365-2362.2003.01151.x; Saba-El-Leil MK, 2003, EMBO REP, V4, P964, DOI 10.1038/sj.embor.embor939; SAMUELS ML, 1993, MOL CELL BIOL, V13, P6241, DOI 10.1128/MCB.13.10.6241; Sanz-Moreno V, 2003, MOL CELL BIOL, V23, P3079, DOI 10.1128/MCB.23.9.3079-3090.2003; SEGER R, 1992, J BIOL CHEM, V267, P14373; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shapiro PS, 1999, MOL CELL BIOL, V19, P3551; Sharrocks AD, 2002, BIOCHEM SOC T, V30, P1; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; Sun PQ, 2007, CELL, V128, P295, DOI 10.1016/j.cell.2006.11.050; Takahashi A, 2006, NAT CELL BIOL, V8, P1291, DOI 10.1038/ncb1491; Vantaggiato Chiara, 2006, J Biol, V5, P14, DOI 10.1186/jbiol38; VINDELOV LL, 1983, CYTOMETRY, V3, P323, DOI 10.1002/cyto.990030503; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; WOOD KW, 1993, P NATL ACAD SCI USA, V90, P5016, DOI 10.1073/pnas.90.11.5016; Woods D, 1997, MOL CELL BIOL, V17, P5598, DOI 10.1128/MCB.17.9.5598; Ye XF, 2007, MOL CELL, V27, P183, DOI 10.1016/j.molcel.2007.05.034; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997; Zhuang D, 2008, ONCOGENE, V27, P6623, DOI 10.1038/onc.2008.258	72	65	66	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33006	33018		10.1074/jbc.M109.012591	http://dx.doi.org/10.1074/jbc.M109.012591			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19805545	Green Published, hybrid			2022-12-27	WOS:000272028500003
J	Noguchi, Y; Young, JD; Aleman, JO; Hansen, ME; Kelleher, JK; Stephanopoulos, G				Noguchi, Yasushi; Young, Jamey D.; Aleman, Jose O.; Hansen, Michael E.; Kelleher, Joanne K.; Stephanopoulos, Gregory			Effect of Anaplerotic Fluxes and Amino Acid Availability on Hepatic Lipoapoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MASS ISOTOPOMER DISTRIBUTIONS; ENDOPLASMIC-RETICULUM STRESS; BIDIRECTIONAL REACTION STEPS; FATTY LIVER-DISEASE; HEPATOCYTE LIPOAPOPTOSIS; METABOLIC NETWORKS; INDUCED APOPTOSIS; BETA-CELLS; RAT-LIVER; EXPRESSION	To identify metabolic pathways involved in hepatic lipoapoptosis, metabolic flux analysis using [U-C-13(5)]glutamine as an isotopic tracer was applied to quantify phenotypic changes in H4IIEC3 hepatoma cells treated with either palmitate alone (PA-cells) or both palmitate and oleate in combination (PA/OA-cells). Our results indicate that palmitate inhibited glycolysis and lactate dehydrogenase fluxes while activating citric acid cycle (CAC) flux and glutamine uptake. This decoupling of glycolysis and CAC fluxes occurred during the period following palmitate exposure but preceding the onset of apoptosis. Oleate co-treatment restored most fluxes to their control levels, resulting in steatotic lipid accumulation while preventing apoptosis. In addition, palmitate strongly increased the cytosolic NAD(+)/NADH ratio, whereas oleate co-treatment had the opposite effect on cellular redox. We next examined the influence of amino acids on these free fatty acid-induced phenotypic changes. Increased medium amino acids enhanced reactive oxygen species (ROS) generation and apoptosis in PA-cells but not in PA/OA-cells. Overloading the medium with non-essential amino acids induced apoptosis, but essential amino acid overloading partially ameliorated apoptosis. Glutamate was the most effective single amino acid in promoting ROS. Amino acid overloading also increased cellular palmitoyl-ceramide; however, ceramide synthesis inhibitors had no effect on measurable indicators of apoptosis. Our results indicate that free fatty acid-induced ROS generation and apoptosis are accompanied by the decoupling of glycolysis and CAC fluxes leading to abnormal cytosolic redox states. Amino acids play a modulatory role in these processes via a mechanism that does not involve ceramide accumulation.	[Noguchi, Yasushi; Young, Jamey D.; Aleman, Jose O.; Hansen, Michael E.; Kelleher, Joanne K.; Stephanopoulos, Gregory] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Kelleher, Joanne K.] Massachusetts Gen Hosp, Shriners Burn Hosp, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital	Stephanopoulos, G (corresponding author), MIT, Dept Chem Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	gregstep@mit.edu	Hansen, Michael Adsetts Edberg/C-9028-2011; Young, Jamey/A-5857-2012	Hansen, Michael Adsetts Edberg/0000-0001-7879-2106; Aleman, Jose/0000-0003-3753-6717	National Institutes of Health [DK075850, ES013925]; NATIONAL CANCER INSTITUTE [R01CA160458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK072856, R01DK075850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013925] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK075850 and ES013925.	Antoniewicz MR, 2007, ANAL CHEM, V79, P7554, DOI 10.1021/ac0708893; Antoniewicz MR, 2007, METAB ENG, V9, P277, DOI 10.1016/j.ymben.2007.01.003; Antoniewicz MR, 2006, METAB ENG, V8, P324, DOI 10.1016/j.ymben.2006.01.004; BAQUET A, 1991, BIOCHEM J, V273, P57, DOI 10.1042/bj2730057; Barreyro FJ, 2007, J BIOL CHEM, V282, P27141, DOI 10.1074/jbc.M704391200; BLEMINGS KP, 1994, J NUTR, V124, P1215, DOI 10.1093/jn/124.8.1215; Busch AK, 2005, DIABETES, V54, P2917, DOI 10.2337/diabetes.54.10.2917; Chan C, 2003, METAB ENG, V5, P1, DOI 10.1016/S1096-7176(02)00011-3; DUDEK SM, 1995, J BIOL CHEM, V270, P29323, DOI 10.1074/jbc.270.49.29323; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Fernandez CA, 1996, J MASS SPECTROM, V31, P255, DOI 10.1002/(SICI)1096-9888(199603)31:3<255::AID-JMS290>3.0.CO;2-3; Fiehn O, 2000, NAT BIOTECHNOL, V18, P1157, DOI 10.1038/81137; Guo FF, 2007, CELL METAB, V5, P103, DOI 10.1016/j.cmet.2007.01.001; Guo W, 2007, AM J PHYSIOL-ENDOC M, V293, pE576, DOI 10.1152/ajpendo.00523.2006; Hansson PK, 2004, BBA-MOL CELL BIOL L, V1684, P54, DOI 10.1016/j.bbalip.2004.06.005; Hardy S, 2003, J BIOL CHEM, V278, P31861, DOI 10.1074/jbc.M300190200; Jousse C, 1998, BIOCHEM J, V334, P147, DOI 10.1042/bj3340147; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Madsen K., 2004, METHODS NONLINEAR LE; Malhi H, 2006, J BIOL CHEM, V281, P12093, DOI 10.1074/jbc.M510660200; Miller TA, 2005, BIOCHEM BIOPH RES CO, V336, P309, DOI 10.1016/j.bbrc.2005.08.088; MORAND C, 1994, ARCH BIOCHEM BIOPHYS, V309, P254, DOI 10.1006/abbi.1994.1110; Okere IC, 2006, AM J PHYSIOL-HEART C, V291, pH38, DOI 10.1152/ajpheart.01295.2005; Rarnanathan A, 2005, P NATL ACAD SCI USA, V102, P5992, DOI 10.1073/pnas.0502267102; SIESS EA, 1977, BIOCHEM J, V166, P225, DOI 10.1042/bj1660225; Srivastava S, 2008, BIOTECHNOL BIOENG, V99, P399, DOI 10.1002/bit.21568; Styczynski MP, 2007, ANAL CHEM, V79, P966, DOI 10.1021/ac0614846; Sudhandiran G, 2003, J BIOL CHEM, V278, P25120, DOI 10.1074/jbc.M301975200; Suryawan A, 1998, AM J CLIN NUTR, V68, P72, DOI 10.1093/ajcn/68.1.72; Swagell CD, 2006, NUTRITION, V22, P672, DOI 10.1016/j.nut.2006.03.005; Tikunov Y, 2005, PLANT PHYSIOL, V139, P1125, DOI 10.1104/pp.105.068130; Tserng KY, 2003, ANAL BIOCHEM, V323, P84, DOI 10.1016/j.ab.2003.08.026; Turpin SM, 2006, AM J PHYSIOL-ENDOC M, V291, pE1341, DOI 10.1152/ajpendo.00095.2006; Unger RH, 2001, DIABETES, V50, pS118, DOI 10.2337/diabetes.50.2007.S118; Vieu C, 2002, J LIPID RES, V43, P510; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Wiechert W, 1999, BIOTECHNOL BIOENG, V66, P69; Wiechert W, 1997, BIOTECHNOL BIOENG, V55, P118, DOI 10.1002/(SICI)1097-0290(19970705)55:1<118::AID-BIT13>3.0.CO;2-I; Wieckowska A, 2007, HEPATOLOGY, V46, P582, DOI 10.1002/hep.21768; Wong MS, 2004, PHYSIOL GENOMICS, V16, P247, DOI 10.1152/physiolgenomics.00088.2003; Yoo H, 2008, J BIOL CHEM, V283, P20621, DOI 10.1074/jbc.M706494200; Young JD, 2008, BIOTECHNOL BIOENG, V99, P686, DOI 10.1002/bit.21632; Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784; Zivkovic AM, 2007, AM J CLIN NUTR, V86, P285, DOI 10.1093/ajcn/86.2.285	45	52	60	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33425	33436		10.1074/jbc.M109.049478	http://dx.doi.org/10.1074/jbc.M109.049478			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19758988	Green Published, hybrid			2022-12-27	WOS:000272028500049
J	Zhang, GF; Kombu, RS; Kasumov, T; Han, Y; Sadhukhan, S; Zhang, JY; Sayre, LM; Ray, D; Gibson, KM; Anderson, VA; Tochtrop, GP; Brunengraber, H				Zhang, Guo-Fang; Kombu, Rajan S.; Kasumov, Takhar; Han, Yong; Sadhukhan, Sushabhan; Zhang, Jianye; Sayre, Lawrence M.; Ray, Dale; Gibson, K. Michael; Anderson, Vernon A.; Tochtrop, Gregory P.; Brunengraber, Henri			Catabolism of 4-Hydroxyacids and 4-Hydroxynonenal via 4-Hydroxy-4-phosphoacyl-CoAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID OXIDATION; PERFUSED-RAT-LIVER; CHROMATOGRAPHY MASS-SPECTROMETRY; NADP+-DEPENDENT OXIDOREDUCTASE; GAMMA-HYDROXYBUTYRATE; STABLE-ISOTOPE; SEMIALDEHYDE DEHYDROGENASE; SUCCINIC SEMIALDEHYDE; 4-HYDROXYBUTYRIC ACID; LIPID-PEROXIDATION	4-Hydroxyacids are products of ubiquitously occurring lipid peroxidation (C-9, C-6) or drugs of abuse (C-4, C-5). We investigated the catabolism of these compounds using a combination of metabolomics and mass isotopomer analysis. Livers were perfused with various concentrations of unlabeled and labeled saturated 4-hydroxyacids (C-4 to C-11) or 4-hydroxynonenal. All the compounds tested form a new class of acyl-CoA esters, 4-hydroxy-4-phosphoacyl-CoAs, characterized by liquid chromatography-tandem mass spectrometry, accurate mass spectrometry, and P-31-NMR. All 4-hydroxyacids with five or more carbons are metabolized by two new pathways. The first and major pathway, which involves 4-hydroxy-4-phosphoacyl-CoAs, leads in six steps to the isomerization of 4-hydroxyacyl-CoA to 3-hydroxyacyl-CoAs. The latter are intermediates of physiological beta-oxidation. The second and minor pathway involves a sequence of beta-oxidation, alpha-oxidation, and beta-oxidation steps. In mice deficient in succinic semialdehyde dehydrogenase, high plasma concentrations of 4-hydroxybutyrate result in high concentrations of 4-hydroxy-4-phospho-butyryl-CoA in brain and liver. The high concentration of 4-hydroxy-4-phosphobutyryl-CoA may be related to the cerebral dysfunction of subjects ingesting 4-hydroxybutyrate and to the mental retardation of patients with 4-hydroxybutyric aciduria. Our data illustrate the potential of the combination of metabolomics and mass isotopomer analysis for pathway discovery.	[Brunengraber, Henri] Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA; [Han, Yong; Sadhukhan, Sushabhan; Zhang, Jianye; Sayre, Lawrence M.; Tochtrop, Gregory P.] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA; [Anderson, Vernon A.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Ray, Dale] Case Western Reserve Univ, Cleveland Ctr Struct Biol, Cleveland, OH 44106 USA; [Gibson, K. Michael] Michigan Technol Univ, Dept Biol Sci, Houghton, MI 49931 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Michigan Technological University	Brunengraber, H (corresponding author), Case Western Reserve Univ, Sch Med, Dept Nutr, WG48,10900 Euclid Ave, Cleveland, OH 44106 USA.	hxb8@case.edu	Sadhukhan, Sushabhan/AAS-7136-2020	Sadhukhan, Sushabhan/0000-0002-3302-5875	National Institutes of Health [R33DK070291, R01ES013925]; Cleveland Mt. Sinai Health Care Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R33DK070291] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040270] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cleveland Mt. Sinai Health Care Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Roadmap Grant R33DK070291 and Grant R01ES013925 (to H. B.). This work was also supported by a grant from the Cleveland Mt. Sinai Health Care Foundation.	Anderson IB, 2006, ANN EMERG MED, V47, P177, DOI 10.1016/j.annemergmed.2005.10.012; Benderdour M, 2003, J BIOL CHEM, V278, P45154, DOI 10.1074/jbc.M306285200; Bennaars-Eiden A, 2002, J BIOL CHEM, V277, P50693, DOI 10.1074/jbc.M209493200; Bian F, 2005, J BIOL CHEM, V280, P9265, DOI 10.1074/jbc.M412850200; Brunengraber H, 1997, ANNU REV NUTR, V17, P559, DOI 10.1146/annurev.nutr.17.1.559; BRUNENGRABER H, 1973, J BIOL CHEM, V248, P2656; CADENAS E, 1983, BIOCHEM J, V214, P479, DOI 10.1042/bj2140479; Choudhary S, 2003, INVEST OPHTH VIS SCI, V44, P2675, DOI 10.1167/iovs.02-0965; Coleman TM, 2005, TETRAHEDRON LETT, V46, P4307, DOI 10.1016/j.tetlet.2005.04.106; Dalluge JJ, 2002, ANAL BIOANAL CHEM, V374, P835, DOI 10.1007/s00216-002-1554-x; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Fernandez CA, 1996, J MASS SPECTROM, V31, P255, DOI 10.1002/(SICI)1096-9888(199603)31:3<255::AID-JMS290>3.0.CO;2-3; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Foulon V, 2005, J BIOL CHEM, V280, P9802, DOI 10.1074/jbc.M413362200; Gibson KM, 1998, NEUROPEDIATRICS, V29, P14, DOI 10.1055/s-2007-973527; GIBSON KM, 1990, BIOMED ENVIRON MASS, V19, P89, DOI 10.1002/bms.1200190207; Gioacchini AM, 1999, RAPID COMMUN MASS SP, V13, P1573, DOI 10.1002/(SICI)1097-0231(19990815)13:15<1573::AID-RCM675>3.0.CO;2-Z; Goodacre R, 2007, J NUTR, V137, p259S, DOI 10.1093/jn/137.1.259S; Grawert T, 2009, ANGEW CHEM INT EDIT, V48, P5756, DOI 10.1002/anie.200900548; Hecht S, 2001, P NATL ACAD SCI USA, V98, P14837, DOI 10.1073/pnas.201399298; Hogema BM, 2001, NAT GENET, V29, P212, DOI 10.1038/ng727; ISHIKAWA T, 1986, J BIOL CHEM, V261, P1576; Kasumov T, 2005, BIOCHEM J, V389, P397, DOI 10.1042/BJ20050144; KAUFMAN EE, 1988, J NEUROCHEM, V51, P1079, DOI 10.1111/j.1471-4159.1988.tb03071.x; KAUFMAN EE, 1987, J NEUROCHEM, V48, P1935, DOI 10.1111/j.1471-4159.1987.tb05758.x; KAUFMAN EE, 1991, NEUROCHEM RES, V16, P965, DOI 10.1007/BF00965839; Koster J F, 1986, Free Radic Res Commun, V1, P273, DOI 10.3109/10715768609051637; KREBS HA, 1970, BIOCHEM J, V119, P525, DOI 10.1042/bj1190525; Luckey SW, 2001, ARCH BIOCHEM BIOPHYS, V389, P77, DOI 10.1006/abbi.2001.2307; Minkler PE, 2008, ANAL BIOCHEM, V376, P275, DOI 10.1016/j.ab.2008.02.022; Mitchell GA, 2008, MOL GENET METAB, V94, P4, DOI 10.1016/j.ymgme.2007.12.005; Pardi D, 2006, CNS DRUGS, V20, P993, DOI 10.2165/00023210-200620120-00004; Poli G, 2008, MED RES REV, V28, P569, DOI 10.1002/med.20117; POULOS A, 1993, BIOCHEM J, V292, P457, DOI 10.1042/bj2920457; POWERS L, 1995, J MASS SPECTROM, V30, P747, DOI 10.1002/jms.1190300514; Reszko AE, 2004, J BIOL CHEM, V279, P19574, DOI 10.1074/jbc.M400162200; ROSIERS CD, 1988, ANAL BIOCHEM, V173, P96, DOI 10.1016/0003-2697(88)90165-0; Schaur R. J., 2003, Molecular Aspects of Medicine, V24, P149, DOI 10.1016/S0098-2997(03)00009-8; SCHERF U, 1991, APPL ENVIRON MICROB, V57, P2699, DOI 10.1128/AEM.57.9.2699-2702.1991; Schneider C, 2008, J BIOL CHEM, V283, P15539, DOI 10.1074/jbc.R800001200; Siems Werner, 2003, Molecular Aspects of Medicine, V24, P167, DOI 10.1016/S0098-2997(03)00011-6; Siems WG, 1998, J BIOCHEM, V123, P534; Silva MFB, 2008, J INHERIT METAB DIS, V31, P205, DOI 10.1007/s10545-008-0841-x; SKORIN C, 1992, BIOCHEM J, V281, P561, DOI 10.1042/bj2810561; VAMECQ J, 1990, BIOCHEM CELL BIOL, V68, P846, DOI 10.1139/o90-125; Verhoeven NM, 1997, EUR J PEDIATR, V156, pS83, DOI 10.1007/PL00014279; Wong C Guin Ting, 2004, Toxicol Rev, V23, P3, DOI 10.2165/00139709-200423010-00002	47	50	52	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33521	33534		10.1074/jbc.M109.055665	http://dx.doi.org/10.1074/jbc.M109.055665			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19759021	Green Published, hybrid			2022-12-27	WOS:000272028500058
J	Dalmonte, ME; Forte, E; Genova, ML; Giuffre, A; Sarti, P; Lenaz, G				Dalmonte, Maria Elena; Forte, Elena; Genova, Maria Luisa; Giuffre, Alessandro; Sarti, Paolo; Lenaz, Giorgio			Control of Respiration by Cytochrome c Oxidase in Intact Cells ROLE OF THE MEMBRANE POTENTIAL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO CONTROL; OXIDATIVE-PHOSPHORYLATION; MITOCHONDRIAL DISEASES; ELECTRON-TRANSFER; STEADY-STATE; GRADIENT; COMPLEX; CHAIN; FLUX; PH	Metabolic control analysis was applied to intact HepG2 cells. The effect on the control coefficient of cytochrome c oxidase (CcOX) over cell respiration of both the electrical (Delta psi) and chemical (Delta pH) component of the mitochondrial transmembrane proton electrochemical gradient (Delta mu(H+)) was investigated. The overall O-2 consumption and specific CcOX activity of actively phosphorylating cells were titrated with cyanide under conditions in which Delta psi and Delta pH were selectively modulated by addition of ionophores. In the absence of ionophores, CcOX displayed a high control coefficient (C-IV = 0.73), thus representing an important site of regulation of mitochondrial oxidative phosphorylation. A high control coefficient value (C-IV = 0.85) was also measured in the presence of nigericin, i.e. when Delta psi is maximal, and in the presence of nigericin and valinomycin (C-IV = 0.77), when Delta mu(H+) is abolished. In contrast, CcOX displayed a markedly lower control coefficient (C-IV = 0.30) upon addition of valinomycin, when Delta psi is converted into Delta pH. These results show that Delta psi is responsible for the tight control of CcOX over respiration in actively phosphorylating cells.	[Dalmonte, Maria Elena; Forte, Elena; Sarti, Paolo] Univ Roma La Sapienza, Dept Biochem Sci, I-00185 Rome, Italy; [Giuffre, Alessandro] CNR, Inst Mol Biol & Pathol, I-00185 Rome, Italy; [Dalmonte, Maria Elena; Genova, Maria Luisa; Lenaz, Giorgio] Univ Bologna, Dept Biochem, I-40126 Bologna, Italy	Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); University of Bologna	Sarti, P (corresponding author), Univ Roma La Sapienza, Dept Biochem Sci, I-00185 Rome, Italy.	paolo.sarti@uniroma1.it	Sarti, Paolo/D-2946-2009; Giuffrè, Alessandro/K-4341-2015; Genova, Maria Luisa/H-6921-2012; Lenaz, Giorgio/B-5751-2013; Forte, Elena/K-6015-2015	Giuffrè, Alessandro/0000-0001-5301-0681; Genova, Maria Luisa/0000-0002-9176-3630; Sarti, Paolo/0000-0002-8219-4827; FORTE, Elena/0000-0001-9049-6916	Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy	Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy(Ministry of Education, Universities and Research (MIUR))	This work was partially supported by Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy (to P.S. and G.L.).	ANTONINI G, 1991, J BIOL CHEM, V266, P13193; Bloch D, 2004, P NATL ACAD SCI USA, V101, P529, DOI 10.1073/pnas.0306036101; BRAND MD, 1988, BIOCHEM J, V255, P535; Brunori M, 2005, J INORG BIOCHEM, V99, P324, DOI 10.1016/j.jinorgbio.2004.10.011; BRUNORI M, 1985, EMBO J, V4, P2365, DOI 10.1002/j.1460-2075.1985.tb03940.x; Brzezinski P, 2008, J BIOENERG BIOMEMBR, V40, P521, DOI 10.1007/s10863-008-9181-7; CAPITANIO N, 1990, BIOCHEMISTRY-US, V29, P2939, DOI 10.1021/bi00464a008; CHANCE B, 1955, J BIOL CHEM, V217, P409; GREGORY L, 1989, BIOCHEMISTRY-US, V28, P2655, DOI 10.1021/bi00432a044; HEINRICH R, 1974, EUR J BIOCHEM, V42, P97, DOI 10.1111/j.1432-1033.1974.tb03319.x; Huttemann M, 2008, J BIOENERG BIOMEMBR, V40, P445, DOI 10.1007/s10863-008-9169-3; Kacser H, 1979, BIOCHEM SOC T, V7, P1149, DOI 10.1042/bst0071149; Kacser H, 1973, Symp Soc Exp Biol, V27, P65; Kadenbach B, 2009, TRENDS MOL MED, V15, P139, DOI 10.1016/j.molmed.2009.02.004; KHOLODENKO BN, 1993, FEBS LETT, V320, P71, DOI 10.1016/0014-5793(93)81660-R; Kunz WS, 2000, J BIOL CHEM, V275, P27741; LORUSSO M, 1995, J BIOENERG BIOMEMBR, V27, P101, DOI 10.1007/BF02110337; Mazat JP, 2001, BBA-BIOENERGETICS, V1504, P20, DOI 10.1016/S0005-2728(00)00236-X; Moreno-Sanchez R, 1999, EUR J BIOCHEM, V264, P427, DOI 10.1046/j.1432-1327.1999.00621.x; Namslauer I, 2009, P NATL ACAD SCI USA, V106, P3402, DOI 10.1073/pnas.0811450106; Nicholls D., 2002, BIOENERGETICS; NICHOLLS P, 1990, BIOCHEM CELL BIOL, V68, P1128, DOI 10.1139/o90-168; PAPA S, 1981, BIOCHEM J, V194, P395, DOI 10.1042/bj1940395; Piccoli C, 2006, BIOCHEM J, V396, P573, DOI 10.1042/BJ20060077; Rossignol R, 2000, BIOCHEM J, V347, P45, DOI 10.1042/0264-6021:3470045; SARTI P, 1990, J BIOL CHEM, V265, P5554; Telford JE, 2009, J BIOL CHEM, V284, P9109, DOI 10.1074/jbc.M809101200; Verkhovsky MI, 2001, BIOCHEMISTRY-US, V40, P7077, DOI 10.1021/bi010030u; Villani G, 2000, FREE RADICAL BIO MED, V29, P202, DOI 10.1016/S0891-5849(00)00303-8; Villani G, 1998, J BIOL CHEM, V273, P31829, DOI 10.1074/jbc.273.48.31829; Villani G, 1997, P NATL ACAD SCI USA, V94, P1166, DOI 10.1073/pnas.94.4.1166; Villani G, 2007, METHOD CELL BIOL, V80, P121, DOI 10.1016/S0091-679X(06)80005-1	32	59	59	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32331	32335		10.1074/jbc.M109.050146	http://dx.doi.org/10.1074/jbc.M109.050146			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19776013	Green Published, hybrid			2022-12-27	WOS:000272028400015
J	Francois, IEJA; Bink, A; Vandercappellen, J; Ayscough, KR; Toulmay, A; Schneiter, R; van Gyseghem, E; Van den Mooter, G; Borgers, M; Vandenbosch, D; Coenye, T; Cammue, BPA; Thevissen, K				Francois, Isabelle E. J. A.; Bink, Anna; Vandercappellen, Jo; Ayscough, Kathryn R.; Toulmay, Alexandre; Schneiter, Roger; van Gyseghem, Elke; Van den Mooter, Guy; Borgers, Marcel; Vandenbosch, Davy; Coenye, Tom; Cammue, Bruno P. A.; Thevissen, Karin			Membrane Rafts Are Involved in Intracellular Miconazole Accumulation in Yeast Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID RAFTS; ACTIN CYTOSKELETON; AZOLE ANTIFUNGALS; CANDIDA-ALBICANS; SURFACE; ATPASE; SPHINGOLIPIDS; RESISTANCE; ASSOCIATION; ERGOSTEROL	Azoles inhibit ergosterol biosynthesis, resulting in ergosterol depletion and accumulation of toxic 14 alpha-methylated sterols in membranes of susceptible yeast. We demonstrated previously that miconazole induces actin cytoskeleton stabilization in Saccharomyces cerevisiae prior to induction of reactive oxygen species, pointing to an ancillary mode of action. Using a genome-wide agar-based screening, we demonstrate in this study that S. cerevisiae mutants affected in sphingolipid and ergosterol biosynthesis, namely ipt1, sur1, skn1, and erg3 deletion mutants, are miconazole-resistant, suggesting an involvement of membrane rafts in its mode of action. This is supported by the antagonizing effect of membrane raft-disturbing compounds on miconazole antifungal activity as well as on miconazole-induced actin cytoskeleton stabilization and reactive oxygen species accumulation. These antagonizing effects point to a primary role for membrane rafts in miconazole antifungal activity. We further show that this primary role of membrane rafts in miconazole action consists of mediating intracellular accumulation of miconazole in yeast cells.	[Cammue, Bruno P. A.] Katholieke Univ Leuven, Ctr Microbial & Plant Genet, B-3001 Heverlee, Belgium; [Ayscough, Kathryn R.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Toulmay, Alexandre; Schneiter, Roger] Univ Fribourg, Div Biochem, CH-1700 Fribourg, Switzerland; [van Gyseghem, Elke; Van den Mooter, Guy] Katholieke Univ Leuven, Lab Pharmaceut Technol & Biopharm, B-3000 Louvain, Belgium; [Borgers, Marcel] Barrier Therapeut NV, B-2440 Geel, Belgium; [Vandenbosch, Davy] Univ Ghent, Lab Farmaceut Microbiol, B-9000 Ghent, Belgium	KU Leuven; University of Sheffield; University of Fribourg; KU Leuven; Ghent University	Cammue, BPA (corresponding author), Katholieke Univ Leuven, Ctr Microbial & Plant Genet, Kasteelpk Arenberg 20, B-3001 Heverlee, Belgium.	bruno.cammue@agr.kuleuven.ac.be	Coenye, Tom/A-6291-2014; Meis, Jacques F/A-9241-2010; Thevissen, Karin/B-7003-2015; Coenye, Tom/Z-1928-2019; Cammue, Bruno/M-9575-2013	Coenye, Tom/0000-0002-6407-0601; Meis, Jacques F/0000-0003-3253-6080; Thevissen, Karin/0000-0003-0275-9072; Coenye, Tom/0000-0002-6407-0601; Vandercappellen, Jo/0000-0001-8073-5493; Schneiter, Roger/0000-0002-9102-8396	IWT-Vlaanderen [030023]; Industrial Research Fund; Medical Research Council [G0601600] Funding Source: researchfish; MRC [G0601600] Funding Source: UKRI	IWT-Vlaanderen(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Industrial Research Fund; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Grant 030023 from IWT-Vlaanderen and by a postdoctoral fellowship from the Industrial Research Fund (Katholieke Universiteit Leuven; to K. T.).	Bagnat M, 2001, MOL BIOL CELL, V12, P4129, DOI 10.1091/mbc.12.12.4129; Balguerie A, 2002, EUKARYOT CELL, V1, P1021, DOI 10.1128/EC.1.6.1021-1031.2002; DENOLLIN S, 1977, ANTIMICROB AGENTS CH, V11, P500, DOI 10.1128/AAC.11.3.500; Eisenkolb M, 2002, MOL BIOL CELL, V13, P4414, DOI 10.1091/mbc.E02-02-0116; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Francois Isabelle E. J. A., 2006, Anti-Infective Agents in Medicinal Chemistry, V5, P3, DOI 10.2174/187152106774755554; Gaigg B, 2005, J BIOL CHEM, V280, P22515, DOI 10.1074/jbc.M413472200; Gaigg B, 2006, J BIOL CHEM, V281, P34135, DOI 10.1074/jbc.M603791200; Gong XH, 2001, P NATL ACAD SCI USA, V98, P9104, DOI 10.1073/pnas.161282998; Gourlay CW, 2005, BIOCHEM SOC T, V33, P1260, DOI 10.1042/BST0331260; Gourlay CW, 2004, J CELL BIOL, V164, P803, DOI 10.1083/jcb.200310148; Kelly SL, 1997, J BIOL CHEM, V272, P9986, DOI 10.1074/jbc.272.15.9986; Kirkham M, 2005, BBA-MOL CELL RES, V1745, P273, DOI 10.1016/j.bbamcr.2005.06.002; Kobayashi D, 2002, ANTIMICROB AGENTS CH, V46, P3113, DOI 10.1128/AAC.46.10.3113-3117.2002; Kohli A, 2002, ANTIMICROB AGENTS CH, V46, P1046, DOI 10.1128/AAC.46.4.1046-1052.2002; Loffler J, 2000, FEMS MICROBIOL LETT, V185, P59, DOI 10.1016/S0378-1097(00)00071-9; Lupetti A, 2002, TRENDS MOL MED, V8, P76, DOI 10.1016/S1471-4914(02)02280-3; Rajendran L, 2005, J CELL SCI, V118, P1099, DOI 10.1242/jcs.01681; Siafakas AR, 2006, EUKARYOT CELL, V5, P488, DOI 10.1128/EC.5.3.488-498.2006; Thevissen K, 2007, J BIOL CHEM, V282, P21592, DOI 10.1074/jbc.M608505200; Wang QQ, 2002, P NATL ACAD SCI USA, V99, P12853, DOI 10.1073/pnas.202115499; WATSON PF, 1989, BIOCHEM BIOPH RES CO, V164, P1170, DOI 10.1016/0006-291X(89)91792-0; Zaremberg V, 2005, J BIOL CHEM, V280, P38047, DOI 10.1074/jbc.M502849200	23	25	30	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32680	32685		10.1074/jbc.M109.014571	http://dx.doi.org/10.1074/jbc.M109.014571			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19783660	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000272028400051
J	Gallego-Sandin, S; Rodriguez-Garcia, A; Alonso, MT; Garcia-Sancho, J				Gallego-Sandin, Sonia; Rodriguez-Garcia, Arancha; Teresa Alonso, Maria; Garcia-Sancho, Javier			The Endoplasmic Reticulum of Dorsal Root Ganglion Neurons Contains Functional TRPV1 Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-INDUCED CA2+ RELEASE; VANILLOID RECEPTOR; CAPSAICIN RECEPTOR; CELL-DEATH; SENSORY NEURONS; ION CHANNELS; INTRACELLULAR CALCIUM; TARGETED AEQUORIN; CHROMAFFIN CELLS; PROTEIN-KINASE	Transient receptor potential vanilloid type 1 (TRPV1) is a plasma membrane Ca2+ channel involved in transduction of painful stimuli. Dorsal root ganglion (DRG) neurons express ectopic but functional TRPV1 channels in the endoplasmic reticulum (ER) (TRPV1(ER)). We have studied the properties of TRPV1(ER) in DRG neurons and HEK293T cells expressing TRPV1. Activation of TRPV1ER with capsaicin or other vanilloids produced an increase of cytosolic Ca2+ due to Ca2+ release from the ER. The decrease of [Ca2+](ER) was directly revealed by an ER-targeted aequorin Ca2+ probe, expressed in DRG neurons using a herpes amplicon virus. The sensitivity of TRPV1(ER) to capsaicin was smaller than the sensitivity of the plasma membrane TRPV1 channels. The low affinity of TRPV1(ER) was not related to protein kinase A- or C-mediated phosphorylations, but it was due to inactivation by cytosolic Ca2+ because the sensitivity to capsaicin was increased by loading the cells with the Ca2+ chelator BAPTA. Decreasing [Ca2+](ER) did not affect the sensitivity of TRPV1ER to capsaicin. Disruption of the TRPV1 calmodulin-binding domains at either the C terminus (Delta 35AA) or the N terminus (K155A) increased 10-fold the affinity of TRPV1(ER) for capsaicin, suggesting that calmodulin is involved in the inactivation. The lack of TRPV1 sensitizers, such as phosphatylinositol 4,5-bisphosphate, in the ER could contribute to decrease the affinity for capsaicin. The low sensitivity of TRPV1(ER) to agonists may be critical for neuron health, because otherwise Ca2+ depletion of ER could lead to ER stress, unfolding protein response, and cell death.	[Garcia-Sancho, Javier] Univ Valladolid, Inst Biol & Genet Mol, Valladolid 47003, Spain; CSIC, Valladolid 47003, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Universidad de Valladolid; Consejo Superior de Investigaciones Cientificas (CSIC)	Garcia-Sancho, J (corresponding author), Univ Valladolid, Inst Biol & Genet Mol, C Sanz & Fores S-N, Valladolid 47003, Spain.	jgsancho@ibgm.uva.es	Alonso Alonso, Maria Teresa/K-5003-2014; Garcia-Sancho, Javier/K-2975-2014	Garcia-Sancho, Javier/0000-0003-4573-7930	Spanish Ministerio de Ciencia e Innovacion (MICINN) [BFI2007-60157]; Instituto de Salud Carlos III [RD06/0010/0000]; Junta de Castilla y Leon [gr175]	Spanish Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Junta de Castilla y Leon(Junta de Castilla y Leon)	This work was supported in part by Spanish Ministerio de Ciencia e Innovacion (MICINN) Grant BFI2007-60157, Instituto de Salud Carlos III Grant RD06/0010/0000, and Junta de Castilla y Leon Grant gr175.	Alonso MT, 1998, CELL CALCIUM, V24, P87, DOI 10.1016/S0143-4160(98)90076-8; Alonso MT, 1999, J CELL BIOL, V144, P241, DOI 10.1083/jcb.144.2.241; Alvarez J, 2002, CELL CALCIUM, V32, P251, DOI 10.1016/S0143416002001860; Appendino G, 1996, J MED CHEM, V39, P3123, DOI 10.1021/jm960063l; Barrero MJ, 1997, J BIOL CHEM, V272, P27694, DOI 10.1074/jbc.272.44.27694; BERS DM, 1994, METHOD CELL BIOL, V40, P3; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; De Petrocellis L, 2001, J NEUROCHEM, V77, P1660, DOI 10.1046/j.1471-4159.2001.00406.x; DRAY A, 1990, NEUROSCI LETT, V110, P52, DOI 10.1016/0304-3940(90)90786-9; Eun SY, 2001, BIOCHEM BIOPH RES CO, V285, P1114, DOI 10.1006/bbrc.2001.5272; Garcia AG, 2006, PHYSIOL REV, V86, P1093, DOI 10.1152/physrev.00039.2005; Gilabert R, 1997, J NEUROSCI METH, V71, P191, DOI 10.1016/S0165-0270(96)00144-6; Grycova L, 2008, BIOCHEM BIOPH RES CO, V375, P680, DOI 10.1016/j.bbrc.2008.08.094; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Jambrina E, 2003, J BIOL CHEM, V278, P14134, DOI 10.1074/jbc.M211388200; Kanzaki M, 1999, NAT CELL BIOL, V1, P165, DOI 10.1038/11086; Karai LJ, 2004, J BIOL CHEM, V279, P16377, DOI 10.1074/jbc.M310891200; Kim AY, 2008, CELL, V133, P475, DOI 10.1016/j.cell.2008.02.053; Kisseleva MV, 2002, J BIOL CHEM, V277, P6266, DOI 10.1074/jbc.M105969200; Klein RM, 2008, J BIOL CHEM, V283, P26208, DOI 10.1074/jbc.M801912200; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Lam PMW, 2007, J NEUROCHEM, V102, P801, DOI 10.1111/j.1471-4159.2007.04569.x; Levitan IB, 1999, NEURON, V22, P645, DOI 10.1016/S0896-6273(00)80722-9; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Liu BY, 2005, J NEUROSCI, V25, P4835, DOI 10.1523/JNEUROSCI.1296-05.2005; Liu M, 2003, J BIOL CHEM, V278, P5462, DOI 10.1074/jbc.M209111200; Lukacs V, 2007, J NEUROSCI, V27, P7070, DOI 10.1523/JNEUROSCI.1866-07.2007; Manjarres IM, 2008, PFLUG ARCH EUR J PHY, V455, P961, DOI 10.1007/s00424-007-0349-5; Matta JA, 2007, J PHYSIOL-LONDON, V578, P397, DOI 10.1113/jphysiol.2006.121988; Montell C, 2004, NAT CELL BIOL, V6, P690, DOI 10.1038/ncb0804-690; MONTERO M, 1995, EMBO J, V14, P5467, DOI 10.1002/j.1460-2075.1995.tb00233.x; Montero M, 2000, NAT CELL BIOL, V2, P57, DOI 10.1038/35000001; Morenilla-Palao C, 2004, J BIOL CHEM, V279, P25665, DOI 10.1074/jbc.M311515200; Novakova-Tousova K, 2007, NEUROSCIENCE, V149, P144, DOI 10.1016/j.neuroscience.2007.07.039; Numazaki M, 2003, P NATL ACAD SCI USA, V100, P8002, DOI 10.1073/pnas.1337252100; Nunez L, 2007, J PHYSIOL-LONDON, V580, P385, DOI 10.1113/jphysiol.2006.126524; Olah Z, 2001, J BIOL CHEM, V276, P31163, DOI 10.1074/jbc.M101607200; Olah Z, 2001, J BIOL CHEM, V276, P11021, DOI 10.1074/jbc.M008392200; Planells-Cases R, 2005, PFLUG ARCH EUR J PHY, V451, P151, DOI 10.1007/s00424-005-1423-5; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Qin F., 2007, V179, P509; Rohacs T, 2008, MOL NEUROBIOL, V37, P153, DOI 10.1007/s12035-008-8027-y; Rosenbaum T, 2004, J GEN PHYSIOL, V123, P53, DOI 10.1085/jgp.200308906; Rosenbaum T, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-4; Saimi Y, 2002, ANNU REV PHYSIOL, V64, P289, DOI 10.1146/annurev.physiol.64.100301.111649; Shin JS, 2001, NEUROSCI LETT, V299, P135, DOI 10.1016/S0304-3940(00)01777-8; Stein AT, 2006, J GEN PHYSIOL, V128, P509, DOI 10.1085/jgp.200609576; Thebault S, 2005, J BIOL CHEM, V280, P39423, DOI 10.1074/jbc.M503544200; Thomas KC, 2007, J PHARMACOL EXP THER, V321, P830, DOI 10.1124/jpet.107.119412; TRIPATHY A, 1995, BIOPHYS J, V69, P106, DOI 10.1016/S0006-3495(95)79880-0; Tsuzuki K, 2004, J NEUROSCI, V24, P762, DOI 10.1523/JNEUROSCI.4658-03.2004; Turner H, 2003, BIOCHEM J, V371, P341, DOI 10.1042/BJ20021381; Villalobos C, 1996, FASEB J, V10, P654, DOI 10.1096/fasebj.10.5.8621065; Zhang XM, 2005, EMBO J, V24, P4211, DOI 10.1038/sj.emboj.7600893; Zhao LH, 2006, CURR OPIN CELL BIOL, V18, P444, DOI 10.1016/j.ceb.2006.06.005; Zhu MX, 2005, PFLUG ARCH EUR J PHY, V451, P105, DOI 10.1007/s00424-005-1427-1	59	69	72	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32591	32601		10.1074/jbc.M109.019687	http://dx.doi.org/10.1074/jbc.M109.019687			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19778904	hybrid, Green Published			2022-12-27	WOS:000272028400041
J	Hess, CN; Kou, RQ; Johnson, RP; Li, GK; Michel, T				Hess, Connie Ng; Kou, Ruqin; Johnson, Rosalyn P.; Li, Gordon K.; Michel, Thomas			ADP Signaling in Vascular Endothelial Cells ADP-DEPENDENT ACTIVATION OF THE ENDOTHELIAL ISOFORM OF NITRIC-OXIDE SYNTHASE REQUIRES THE EXPRESSION BUT NOT THE KINASE ACTIVITY OF AMP-ACTIVATED PROTEIN KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE AMPK; IN-VIVO; EXTRACELLULAR NUCLEOTIDES; ENOS PHOSPHORYLATION; GROWTH-FACTOR; P2 RECEPTORS; NO SYNTHESIS; PATHWAYS; MIGRATION; ROLES	ADP responses underlie therapeutic approaches to many cardiovascular diseases, and ADP receptor antagonists are in widespread clinical use. The role of ADP in platelet biology has been extensively studied, yet ADP signaling pathways in endothelial cells remain incompletely understood. We found that ADP promoted phosphorylation of the endothelial isoform of nitric-oxide synthase (eNOS) at Ser(1179) and Ser(635) and dephosphorylation at Ser(116) in cultured endothelial cells. Although eNOS activity was stimulated by both ADP and ATP, only ADP signaling was significantly inhibited by the P2Y(1) receptor antagonist MRS 2179 or by knockdown of P2Y(1) using small interfering RNA (siRNA). ADP activated the small GTPase Rac1 and promoted endothelial cell migration. siRNA-mediated knockdown of Rac1 blocked ADP-dependent eNOS Ser(1179) and Ser(635) phosphorylation, as well as eNOS activation. We analyzed pathways known to regulate eNOS, including phosphoinositide 3-kinase/Akt, ERK1/2, Src, and calcium/calmodulin-dependent kinase kinase-beta (CaMKK beta) using the inhibitors wortmannin, PD98059, PP2, and STO-609, respectively. None of these inhibitors altered ADP-modulated eNOS phosphorylation. In contrast, siRNA-mediated knockdown of AMP-activated protein kinase (AMPK) inhibited ADP-dependent eNOS Ser(635) phosphorylation and eNOS activity but did not affect eNOS Ser(1179) phosphorylation. Importantly, the AMPK enzyme inhibitor compound C had no effect on ADP-stimulated eNOS activity, despite completely blocking AMPK activity. CaMKK beta knockdown suppressed ADP-stimulated eNOS activity, yet inhibition of CaMKK beta kinase activity using STO-609 failed to affect eNOS activation by ADP. These data suggest that the expression, but not the kinase activity, of AMPK and CaMKK beta is necessary for ADP signaling to eNOS.	[Hess, Connie Ng; Kou, Ruqin; Johnson, Rosalyn P.; Li, Gordon K.; Michel, Thomas] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Michel, T (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiovasc, 75 Francis St,Thorn Bldg,Rm 1210A, Boston, MA 02115 USA.	thomas_michel@harvard.edu			National Institutes of Health [HL46457, H48743, GM36259, 5T32HL07609-22]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL046457, R29HL046457, T32HL007609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036259, R37GM036259] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL46457, H48743, and GM36259 (to T.M.) and 5T32HL07609-22 (to C.N.H.).	Armesilla AL, 1999, MOL CELL BIOL, V19, P2032; Baurand A, 2003, CARDIOVASC DRUG REV, V21, P67; Boo YC, 2002, J BIOL CHEM, V277, P3388, DOI 10.1074/jbc.M108789200; Burnstock G, 2007, CELL MOL LIFE SCI, V64, P1471, DOI 10.1007/s00018-007-6497-0; Burnstock G, 2002, ARTERIOSCL THROM VAS, V22, P364, DOI 10.1161/hq0302.105360; BUSCONI L, 1993, J BIOL CHEM, V268, P8410; Butt E, 2000, J BIOL CHEM, V275, P5179, DOI 10.1074/jbc.275.7.5179; Buvinic S, 2002, BRIT J PHARMACOL, V136, P847, DOI 10.1038/sj.bjp.0704789; Cale JM, 2006, BIOCHEM J, V398, P279, DOI 10.1042/BJ20060371; Chen ZP, 1999, FEBS LETT, V443, P285, DOI 10.1016/S0014-5793(98)01705-0; da Silva CG, 2006, CIRC RES, V98, pE39, DOI 10.1161/01.RES.0000215436.92414.1d; da Silva CG, 2009, CIRCULATION, V119, P871, DOI 10.1161/CIRCULATIONAHA.108.764571; Drury AN, 1929, J PHYSIOL-LONDON, V68, P213, DOI 10.1113/jphysiol.1929.sp002608; DUBYAK GR, 1993, AM J PHYSIOL, V265, pC577, DOI 10.1152/ajpcell.1993.265.3.C577; Dudzinski DM, 2007, CARDIOVASC RES, V75, P247, DOI 10.1016/j.cardiores.2007.03.023; Erlinge D, 2008, PURINERG SIGNAL, V4, P1, DOI 10.1007/s11302-007-9078-7; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gelinas DS, 2002, BRIT J PHARMACOL, V137, P1021, DOI 10.1038/sj.bjp.0704956; Gonzalez E, 2006, J BIOL CHEM, V281, P3210, DOI 10.1074/jbc.M510434200; Gonzalez E, 2004, J BIOL CHEM, V279, P40659, DOI 10.1074/jbc.M407051200; GORDON JL, 1986, BIOCHEM J, V233, P309, DOI 10.1042/bj2330309; Guns PJDF, 2005, BRIT J PHARMACOL, V146, P288, DOI 10.1038/sj.bjp.0706326; Hardie DG, 2008, FEBS LETT, V582, P81, DOI 10.1016/j.febslet.2007.11.018; Haynes MP, 2003, J BIOL CHEM, V278, P2118, DOI 10.1074/jbc.M210828200; Hirsch E, 2009, TRENDS BIOCHEM SCI, V34, P244, DOI 10.1016/j.tibs.2009.02.003; Hu YL, 2002, J VASC RES, V39, P465, DOI 10.1159/000067202; Hurley RL, 2006, J BIOL CHEM, V281, P36662, DOI 10.1074/jbc.M606676200; Jia SD, 2008, NATURE, V454, P776, DOI 10.1038/nature07091; Kaczmarek E, 2005, THROMB HAEMOSTASIS, V93, P735, DOI 10.1160/TH04-09-0576; Kim EK, 2004, J BIOL CHEM, V279, P19970, DOI 10.1074/jbc.M402165200; Kou RQ, 2002, J BIOL CHEM, V277, P29669, DOI 10.1074/jbc.M204519200; Kou RQ, 2002, BIOCHEMISTRY-US, V41, P4982, DOI 10.1021/bi016017r; Kou RQ, 2007, J BIOL CHEM, V282, P32719, DOI 10.1074/jbc.M706815200; Kou R, 2009, J BIOL CHEM, V284, P14734, DOI 10.1074/jbc.M808664200; LEROY EC, 1984, J CLIN INVEST, V74, P1003, DOI 10.1172/JCI111467; Levine YC, 2007, J BIOL CHEM, V282, P20351, DOI 10.1074/jbc.M702182200; Li C, 2007, VASC PHARMACOL, V47, P257, DOI 10.1016/j.vph.2007.07.001; LOSCALZO J, 1995, PROG CARDIOVASC DIS, V38, P87, DOI 10.1016/S0033-0620(05)80001-5; Maddika S, 2009, NAT CELL BIOL, V11, P409, DOI 10.1038/ncb1848; MICHEL T, 1993, P NATL ACAD SCI USA, V90, P6252, DOI 10.1073/pnas.90.13.6252; Michell BJ, 2001, J BIOL CHEM, V276, P17625, DOI 10.1074/jbc.C100122200; MILLS DCB, 1968, J PHYSIOL-LONDON, V195, P715, DOI 10.1113/jphysiol.1968.sp008484; Morrow VA, 2003, J BIOL CHEM, V278, P31629, DOI 10.1074/jbc.M212831200; Mount PF, 2007, J MOL CELL CARDIOL, V42, P271, DOI 10.1016/j.yjmcc.2006.05.023; Partovian C, 2005, CIRC RES, V97, P482, DOI 10.1161/01.RES.0000179775.04114.45; Pillois X, 2002, CIRC RES, V90, P678, DOI 10.1161/01.RES.0000013700.98464.8E; Reihill JA, 2007, BIOCHEM BIOPH RES CO, V354, P1084, DOI 10.1016/j.bbrc.2007.01.110; ROBINSON LJ, 1995, P NATL ACAD SCI USA, V92, P11776, DOI 10.1073/pnas.92.25.11776; Shen JZ, 2008, CIRC RES, V102, P448, DOI 10.1161/CIRCRESAHA.107.165795; SHIMOKAWA H, 1991, CIRCULATION, V83, P652, DOI 10.1161/01.CIR.83.2.652; Stahmann N, 2006, MOL CELL BIOL, V26, P5933, DOI 10.1128/MCB.00383-06; Sud N, 2008, AM J PHYSIOL-LUNG C, V294, pL582, DOI 10.1152/ajplung.00353.2007; Waschke J, 2004, AM J PHYSIOL-HEART C, V287, pH704, DOI 10.1152/ajpheart.01076.2003; Wihlborg AK, 2004, ARTERIOSCL THROM VAS, V24, P1810, DOI 10.1161/01.ATV.0000142376.30582.ed; Woods A, 2003, J BIOL CHEM, V278, P28434, DOI 10.1074/jbc.M303946200; Yamamoto K, 2006, NAT MED, V12, P133, DOI 10.1038/nm1338; Zhang H, 1997, J CARDIOVASC PHARM, V30, P767, DOI 10.1097/00005344-199712000-00011; ZICHE M, 1994, J CLIN INVEST, V94, P2036, DOI 10.1172/JCI117557	58	23	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32209	32224		10.1074/jbc.M109.032656	http://dx.doi.org/10.1074/jbc.M109.032656			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19783664	hybrid, Green Published			2022-12-27	WOS:000272028400002
J	Sinha, S; Dutta, S; Datta, K; Ghosh, AK; Mukhopadhyay, D				Sinha, Sutapa; Dutta, Shamit; Datta, Kaustubh; Ghosh, Asish K.; Mukhopadhyay, Debabrata			Von Hippel-Lindau Gene Product Modulates TIS11B Expression in Renal Cell Carcinoma IMPACT ON VASCULAR ENDOTHELIAL GROWTH FACTOR EXPRESSION IN HYPOXIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; PRIMARY RESPONSE GENE; FACTOR MESSENGER-RNA; ZINC-FINGER PROTEIN; PERMEABILITY FACTOR; HIF-ALPHA; ANGIOGENESIS; INDUCTION; DISEASE; FAMILY	TIS11B belongs to a group of RNA-binding proteins (including TIS11/tristetraprolin and TIS11D) that share characteristic tandem CCCH-type zinc-finger domains and can be rapidly induced by multiple stimuli. TIS11B has been shown to regulate vascular endothelial growth factor (VEGF) mRNA stability in adrenocorticotropic hormone-stimulated primary adrenocortical cells. TIS11B has also been documented as a negative regulator of VEGF during development, but nothing has yet been reported in the context of human cancers. The Von Hippel-Lindau (VHL) tumor suppressor protein regulates VEGF gene expression at both the transcriptional and post-transcriptional levels in normoxia. However, whether it can do so in hypoxia is still unclear. Here, we report a unique regulatory function of VHL in VEGF expression in hypoxia that is mediated through modulation of TIS11B protein levels in renal cancer cells. In normoxia, we detected increased expression of the microRNA hsa-miR-29b in the VHL-overexpressing renal cancer cell line 786-O. We also show that this increased expression of hsa-miR29b decreased TIS11B protein expression by post-transcriptional regulation in normoxia. In contrast, in hypoxia, increased TIS11B expression paralleled an increased TIS11B mRNA stability in VHL-overexpressing 786-O cells. This VHL-mediated TIS11B up-regulation in hypoxia may be important for TIS11B-regulated gene expression: we observed a down-regulation of VEGF mRNA in hypoxia in VHL-overexpressing cells compared with parental 786-O cells, and this effect was reversible by silencing TIS11B expression.	[Sinha, Sutapa; Dutta, Shamit; Mukhopadhyay, Debabrata] Mayo Clin Fdn, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Datta, Kaustubh] Mayo Clin Fdn, Dept Urol Res, Rochester, MN 55905 USA; [Ghosh, Asish K.] Mayo Clin Fdn, Div Hematol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Mukhopadhyay, D (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Gugg 1321C,200 1st St SW, Rochester, MN 55905 USA.	mukhopadhyay.debabrata@mayo.edu			National Institutes of Health [CA78383]; NATIONAL CANCER INSTITUTE [R01CA078383, R29CA078383] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA78383.	Bell SE, 2006, DEV DYNAM, V235, P3144, DOI 10.1002/dvdy.20949; Brown EJ, 1996, CELL, V86, P517, DOI 10.1016/S0092-8674(00)80125-7; BROWN LF, 1993, AM J PATHOL, V143, P1255; Busse M, 2008, EUR J CELL BIOL, V87, P31, DOI 10.1016/j.ejcb.2007.07.005; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Carrick DM, 2007, ARCH BIOCHEM BIOPHYS, V462, P278, DOI 10.1016/j.abb.2007.04.011; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Cherradi N, 2006, MOL ENDOCRINOL, V20, P916, DOI 10.1210/me.2005-0121; Ciais D, 2004, ONCOGENE, V23, P8673, DOI 10.1038/sj.onc.1207939; CORPS AN, 1995, FEBS LETT, V368, P160, DOI 10.1016/0014-5793(95)00635-M; Datta K, 2005, ONCOGENE, V24, P7850, DOI 10.1038/sj.onc.1208912; FOLKMAN J, 1989, NATURE, V339, P58, DOI 10.1038/339058a0; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; Folkman J, 1996, SCI AM, V275, P150, DOI 10.1038/scientificamerican0996-150; Gnarra JR, 1996, P NATL ACAD SCI USA, V93, P10589, DOI 10.1073/pnas.93.20.10589; GOMPERTS M, 1992, FEBS LETT, V306, P1, DOI 10.1016/0014-5793(92)80825-2; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Iliopoulos O, 1996, P NATL ACAD SCI USA, V93, P10595, DOI 10.1073/pnas.93.20.10595; ILIOPOULOS O, 1995, NAT MED, V1, P822, DOI 10.1038/nm0895-822; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaelin WG, 1998, TRENDS GENET, V14, P423, DOI 10.1016/S0168-9525(98)01558-3; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Levy AP, 1997, KIDNEY INT, V51, P575, DOI 10.1038/ki.1997.82; Levy NS, 1998, J BIOL CHEM, V273, P6417, DOI 10.1074/jbc.273.11.6417; Maher ER, 1997, MEDICINE, V76, P381, DOI 10.1097/00005792-199711000-00001; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; MILLAUER B, 1994, NATURE, V367, P576, DOI 10.1038/367576a0; Mukhopadhyay D, 2004, SEMIN CANCER BIOL, V14, P123, DOI 10.1016/j.semcancer.2003.09.019; Mukhopadhyay D, 1997, MOL CELL BIOL, V17, P5629, DOI 10.1128/MCB.17.9.5629; Pichiorri F, 2008, P NATL ACAD SCI USA, V105, P12885, DOI 10.1073/pnas.0806202105; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; SHWEIKI D, 1995, P NATL ACAD SCI USA, V92, P768, DOI 10.1073/pnas.92.3.768; SHWEIKI D, 1992, NATURE, V359, P845; Siemeister G, 1996, CANCER RES, V56, P2299; Stumpo DJ, 2004, MOL CELL BIOL, V24, P6445, DOI 10.1128/MCB.24.14.6445-6455.2004; TAKAHASHI A, 1994, CANCER RES, V54, P4233; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; VARNUM BC, 1991, MOL CELL BIOL, V11, P1754, DOI 10.1128/MCB.11.3.1754; WIZIGMANNVOOS S, 1995, CANCER RES, V55, P1358	43	22	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32610	32618		10.1074/jbc.M109.058065	http://dx.doi.org/10.1074/jbc.M109.058065			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19801654	hybrid, Green Published			2022-12-27	WOS:000272028400043
J	Garrey, SM; Blech, M; Riffell, JL; Hankins, JS; Stickney, LM; Diver, M; Hsu, YHR; Kunanithy, V; Mackie, GA				Garrey, Stephen M.; Blech, Michaela; Riffell, Jenna L.; Hankins, Janet S.; Stickney, Leigh M.; Diver, Melinda; Hsu, Ying-Han Roger; Kunanithy, Vitharani; Mackie, George A.			Substrate Binding and Active Site Residues in RNases E and G ROLE OF THE 5 '-SENSOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; MESSENGER-RNA; RIBOSOMAL-RNA; CAFA PROTEIN; DEGRADATION; CLEAVAGE; DOMAIN; RIBONUCLEASE; MATURATION; DECAY	The paralogous endoribonucleases, RNase E and RNase G, play major roles in intracellular RNA metabolism in Escherichia coli and related organisms. To assay the relative importance of the principal RNA binding sites identified by crystallographic analysis, we introduced mutations into the 5'-sensor, the S1 domain, and the Mg+2/Mn+2 binding sites. The effect of such mutations has been measured by assays of activity on several substrates as well as by an assay of RNA binding. RNase E R169Q and the equivalent mutation in RNase G (R171Q) exhibit the strongest reductions in both activity (the k(cat) decrease similar to 40- to 100-fold) and RNA binding consistent with a key role for the 5'-sensor. Our analysis also supports a model in which the binding of substrate results in an increase in catalytic efficiency. Although the phosphate sensor plays a key role in vitro, it is unexpectedly dispensable in vivo. A strain expressing only RNase E R169Q as the sole source of RNase E activity is viable, exhibits a modest reduction in doubling time and colony size, and accumulates immature 5 S rRNA. Our results point to the importance of alternative RNA binding sites in RNase E and to alternative pathways of RNA recognition.	[Garrey, Stephen M.; Blech, Michaela; Riffell, Jenna L.; Hankins, Janet S.; Stickney, Leigh M.; Diver, Melinda; Hsu, Ying-Han Roger; Kunanithy, Vitharani; Mackie, George A.] Univ British Columbia, Life Sci Ctr, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Mackie, GA (corresponding author), Univ British Columbia, Life Sci Ctr, Dept Biochem & Mol Biol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	gamackie@interchange.ubc.ca	Hankins, Jane/N-3362-2018	Diver, Melinda/0000-0001-5037-7322	Canadian Institutes of Health Research [MOP-5396]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Grant MOP-5396 from the Canadian Institutes of Health Research.	Baker KE, 2003, MOL MICROBIOL, V47, P75, DOI 10.1046/j.1365-2958.2003.03292.x; Briant DJ, 2003, MOL MICROBIOL, V50, P1381, DOI 10.1046/j.1365-2958.2003.03775.x; Callaghan AJ, 2005, NATURE, V437, P1187, DOI 10.1038/nature04084; Carpousis AJ, 2007, ANNU REV MICROBIOL, V61, P71, DOI 10.1146/annurev.micro.61.080706.093440; Carpousis AJ, 2003, GENE DEV, V17, P2351, DOI 10.1101/gad.1147003; CARPOUSIS AJ, 1994, CELL, V76, P889, DOI 10.1016/0092-8674(94)90363-8; Coburn GA, 1999, PROG NUCLEIC ACID RE, V62, P55; Condon C, 2002, NUCLEIC ACIDS RES, V30, P5339, DOI 10.1093/nar/gkf691; CORMACK RS, 1993, P NATL ACAD SCI USA, V90, P9006, DOI 10.1073/pnas.90.19.9006; de la Sierra-Gallay IL, 2008, NAT STRUCT MOL BIOL, V15, P206, DOI 10.1038/nsmb.1376; Deana A, 2008, NATURE, V451, P355, DOI 10.1038/nature06475; Diwa AA, 2002, MOL MICROBIOL, V46, P959, DOI 10.1046/j.1365-2958.2002.03231.x; GHORA BK, 1978, CELL, V15, P1055, DOI 10.1016/0092-8674(78)90289-1; Jiang XQ, 2004, P NATL ACAD SCI USA, V101, P9211, DOI 10.1073/pnas.0401382101; Jiang XQ, 2000, J BACTERIOL, V182, P2468, DOI 10.1128/JB.182.9.2468-2475.2000; Jourdan SS, 2008, MOL MICROBIOL, V67, P102, DOI 10.1111/j.1365-2958.2007.06028.x; Joyce SA, 1998, J MOL BIOL, V282, P241, DOI 10.1006/jmbi.1998.2027; Kaberdin VR, 1998, P NATL ACAD SCI USA, V95, P11637, DOI 10.1073/pnas.95.20.11637; Kaberdin VR, 2000, J MOL BIOL, V301, P257, DOI 10.1006/jmbi.2000.3962; Khemici V, 2008, MOL MICROBIOL, V70, P799, DOI 10.1111/j.1365-2958.2008.06454.x; Koslover DJ, 2008, STRUCTURE, V16, P1238, DOI 10.1016/j.str.2008.04.017; Li ZW, 2002, RNA, V8, P97, DOI 10.1017/S1355838202014929; Li ZW, 1999, EMBO J, V18, P2878, DOI 10.1093/emboj/18.10.2878; Lin-Chao S, 1999, P NATL ACAD SCI USA, V96, P12406, DOI 10.1073/pnas.96.22.12406; MACKIE GA, 1992, J BIOL CHEM, V267, P1054; Mackie GA, 1998, NATURE, V395, P720, DOI 10.1038/27246; Masse E, 2003, GENE DEV, V17, P2374, DOI 10.1101/gad.1127103; MCDOWALL KJ, 1995, NATURE, V374, P287, DOI 10.1038/374287a0; MCDOWALL KJ, 1994, J BIOL CHEM, V269, P10790; McDowall KJ, 1996, J MOL BIOL, V255, P349, DOI 10.1006/jmbi.1996.0027; MISRA TK, 1979, J BIOL CHEM, V254, P1154; Ow MC, 2002, GENE DEV, V16, P1102, DOI 10.1101/gad.983502; Ow MC, 2000, MOL MICROBIOL, V38, P854, DOI 10.1046/j.1365-2958.2000.02186.x; Py B, 1996, NATURE, V381, P169, DOI 10.1038/381169a0; Schubert M, 2004, J MOL BIOL, V341, P37, DOI 10.1016/j.jmb.2004.05.061; Spickler C, 2001, J BACTERIOL, V183, P1106, DOI 10.1128/JB.183.3.1106-1109.2001; Tock MR, 2000, J BIOL CHEM, V275, P8726, DOI 10.1074/jbc.275.12.8726; Umitsuki G, 2001, GENES CELLS, V6, P403, DOI 10.1046/j.1365-2443.2001.00430.x; Wachi M, 2001, BIOCHEM BIOPH RES CO, V289, P1301, DOI 10.1006/bbrc.2001.6115; Wachi M, 1999, BIOCHEM BIOPH RES CO, V259, P483, DOI 10.1006/bbrc.1999.0806; Wicki J, 2007, BIOCHEMISTRY-US, V46, P6996, DOI 10.1021/bi700359e; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428	42	44	44	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31843	31850		10.1074/jbc.M109.063263	http://dx.doi.org/10.1074/jbc.M109.063263			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19778900	hybrid, Green Published			2022-12-27	WOS:000271572700039
J	Hou, TY; Ward, SM; Murad, JM; Watson, NP; Israel, MA; Duffield, GE				Hou, Tim Y.; Ward, Sarah M.; Murad, Joana M.; Watson, Nathan P.; Israel, Mark A.; Duffield, Giles E.			ID2 (Inhibitor of DNA Binding 2) Is a Rhythmically Expressed Transcriptional Repressor Required for Circadian Clock Output in Mouse Liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTANT MICE; ACYL-COA; GENE-EXPRESSION; INSULIN SENSITIVITY; RESPONSE ELEMENT; LIPID-METABOLISM; MOLECULAR CLOCK; ADIPOSE-TISSUE; FEEDBACK LOOPS; PROTEIN	Id2 is a helix-loop-helix transcription factor gene expressed in a circadian manner in multiple tissues with a phase-locked relationship with canonical clock genes (1). Our previous studies have identified circadian phenotypes in Id2 null mice, including enhanced photo-entrainment and disruption of activity rhythms, and have demonstrated a potent inhibitory effect of ID proteins upon CLOCK-BMAL1 transactivation of clock gene and clock-controlled gene activity (1). We have now begun to explore the potential role that ID2 may play in specifically regulating clock output. Here we show that ID2 protein is rhythmically expressed in mouse liver. Time-of-day-specific liver gene expression in Id2(+/+) and Id2(-/-) mice under circadian conditions was studied using DNA microarray analysis, identifying 651 differentially expressed genes, including a subset of 318 genes deemed rhythmically expressed in other studies. Examination of individual time courses reveals that these genes are dysregulated in a highly time-specific manner. A cohort of different functional groups were identified, including genes associated with glucose and lipid metabolism, e.g. serum protein Igfbp1 and lipoprotein lipase. We also reveal that the Id2(-/-) mice show a reduction in lipid storage in the liver and white adipose tissue, suggesting that disruption of normal circadian activity of components of lipid metabolism can result in overt physiological alterations. These data reveal a role for the transcriptional repressor ID2 as a circadian output regulator in the periphery.	[Hou, Tim Y.; Ward, Sarah M.; Duffield, Giles E.] Univ Notre Dame, Dept Biol Sci, Galvin Life Sci Ctr, Notre Dame, IN 46556 USA; [Murad, Joana M.; Watson, Nathan P.; Israel, Mark A.] Dartmouth Hitchcock Med Ctr, Norris Cotton Canc Ctr, Lebanon, NH 03756 USA; [Murad, Joana M.; Watson, Nathan P.; Israel, Mark A.] Dartmouth Hitchcock Med Ctr, Dept Pediat, Lebanon, NH 03756 USA	University of Notre Dame; Dartmouth College; Norris Cotton Cancer Center; Dartmouth College	Duffield, GE (corresponding author), Univ Notre Dame, Dept Biol Sci, Galvin Life Sci Ctr, Notre Dame, IN 46556 USA.	duffield.2@nd.edu		Watson, Nathan/0000-0002-9913-5575	University of Notre Dame; McDonald & Braco undergraduate research grant; Fisher graduate fellowship; Royal Society university research fellowship; Theodora B. Betz Foundation	University of Notre Dame; McDonald & Braco undergraduate research grant; Fisher graduate fellowship; Royal Society university research fellowship(Royal Society of London); Theodora B. Betz Foundation	This work was supported by a University of Notre Dame research grant ( to G. E. D.) a McDonald & Braco undergraduate research grant ( to T. Y. H.), a Fisher graduate fellowship ( to S. M. W.), a Royal Society university research fellowship ( to G. E. D.), and a Theodora B. Betz Foundation grant ( to M. A. I.).. S The on-line version of this article ( available at http://www.jbc.org) contains supplemental text, references, Fig. S1, and Tables S1-S7.	Abu-Elheiga L, 2005, P NATL ACAD SCI USA, V102, P12011, DOI 10.1073/pnas.0505714102; Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Andres-Barquin PJ, 2000, HISTOL HISTOPATHOL, V15, P603, DOI 10.14670/HH-15.603; Brosnan JT, 2006, J NUTR, V136, p1636S, DOI 10.1093/jn/136.6.1636S; Cao JS, 2004, J BIOL CHEM, V279, P18878, DOI 10.1074/jbc.M313272200; Cawley NX, 2004, ENDOCRINOLOGY, V145, P5807, DOI 10.1210/en.2004-0847; Cheng P, 2001, P NATL ACAD SCI USA, V98, P7408, DOI 10.1073/pnas.121170298; Chevallier J, 2008, J BIOL CHEM, V283, P27871, DOI 10.1074/jbc.M801463200; Coggins KG, 2002, NAT MED, V8, P91, DOI 10.1038/nm0202-91; Dongol B, 2007, J LIPID RES, V48, P1781, DOI 10.1194/jlr.M700119-JLR200; Duffield GE, 2002, CURR BIOL, V12, P551, DOI 10.1016/S0960-9822(02)00765-0; Duffield GE, 2003, J NEUROENDOCRINOL, V15, P991, DOI 10.1046/j.1365-2826.2003.01082.x; Duffield GE, 2009, CURR BIOL, V19, P297, DOI 10.1016/j.cub.2008.12.052; Garner B, 2002, J LIPID RES, V43, P205; Grechez-Cassiau A, 2004, J BIOL CHEM, V279, P1141, DOI 10.1074/jbc.M305369200; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Gunn TM, 2001, GENETICS, V158, P1683; Harada N, 2007, MOL CELL BIOL, V27, P1881, DOI 10.1128/MCB.01122-06; Heintzen C, 2001, CELL, V104, P453, DOI 10.1016/S0092-8674(01)00232-X; HOGENESCH JB, 2000, DATABASE CIRCADIAN G; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Ing NH, 2006, MOL REPROD DEV, V73, P967, DOI 10.1002/mrd.20510; Ishida N, 2007, NEUROSCI RES, V57, P483, DOI 10.1016/j.neures.2006.12.012; Jogl G, 2003, CELL, V112, P113, DOI 10.1016/S0092-8674(02)01228-X; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kasuya F, 2006, PROTEIN EXPRES PURIF, V47, P405, DOI 10.1016/j.pep.2005.11.006; Kim KH, 1997, ANNU REV NUTR, V17, P77, DOI 10.1146/annurev.nutr.17.1.77; Kumar KG, 2008, CELL METAB, V8, P468, DOI 10.1016/j.cmet.2008.10.011; Kuriyama H, 2005, CELL METAB, V1, P41, DOI 10.1016/j.cmet.2004.11.004; LEBOEUF RC, 1994, GENOMICS, V23, P296, DOI 10.1006/geno.1994.1501; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lee K, 2000, SCIENCE, V289, P107, DOI 10.1126/science.289.5476.107; Lehto M, 2001, J LIPID RES, V42, P1203; Li XL, 2002, MOL CELL BIOL, V22, P8226, DOI 10.1128/MCB.22.23.8226-8240.2002; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; LOEBER G, 1994, FEBS LETT, V344, P181, DOI 10.1016/0014-5793(94)00386-6; Lu YC, 2008, J LIPID RES, V49, P2582, DOI 10.1194/jlr.M800232-JLR200; Matsumoto K, 2006, BIOL PHARM BULL, V29, P539, DOI 10.1248/bpb.29.539; McCarthy JJ, 2007, PHYSIOL GENOMICS, V31, P86, DOI 10.1152/physiolgenomics.00066.2007; Merkel M, 1998, J CLIN INVEST, V102, P893, DOI 10.1172/JCI2912; Miettinen HE, 2001, J CLIN INVEST, V108, P1717, DOI 10.1172/JCI13288; Miller BH, 2007, P NATL ACAD SCI USA, V104, P3342, DOI 10.1073/pnas.0611724104; Nakaya Y, 2000, AM J CLIN NUTR, V71, P54; Norton JD, 2000, J CELL SCI, V113, P3897; Noshiro M, 2007, J BIOL RHYTHM, V22, P299, DOI 10.1177/0748730407302461; Ohgaki S, 2007, J ATHEROSCLER THROMB, V14, P179, DOI 10.5551/jat.E504; Orso E, 2000, NAT GENET, V24, P192, DOI 10.1038/72869; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; PANDA S, 2006, CIRCA BIOINFORMATION; Park E, 2002, BBA-GENE STRUCT EXPR, V1574, P403, DOI 10.1016/S0167-4781(01)00364-5; Peirson SN, 2006, BIOCHEM BIOPH RES CO, V351, P800, DOI 10.1016/j.bbrc.2006.10.118; PROKAZOVA NV, 1994, LIPIDS, V29, P1, DOI 10.1007/BF02537083; Rahmouni K, 2008, J CLIN INVEST, V118, P1458, DOI 10.1172/JCI32357; RAMSAY RR, 1993, ARCH BIOCHEM BIOPHYS, V302, P307, DOI 10.1006/abbi.1993.1216; Reddy AB, 2006, CURR BIOL, V16, P1107, DOI 10.1016/j.cub.2006.04.026; Rossner MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002762; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Shimba S, 2005, P NATL ACAD SCI USA, V102, P12071, DOI 10.1073/pnas.0502383102; Sonnino S, 2007, GLYCOBIOLOGY, V17, p1R, DOI 10.1093/glycob/cwl052; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Villarroya F, 2004, CURR MED CHEM, V11, P795, DOI 10.2174/0929867043455747; Walker JR, 2005, METHOD ENZYMOL, V393, P366, DOI 10.1016/S0076-6879(05)93016-4; Wolfrum C, 2005, NAT MED, V11, P418, DOI 10.1038/nm1211; Wong H, 2002, J LIPID RES, V43, P993, DOI 10.1194/jlr.R200007-JLR200; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Yanai H, 2006, J ATHEROSCLER THROMB, V13, P281, DOI 10.5551/jat.13.281; Yen FT, 2008, J BIOL CHEM, V283, P25650, DOI 10.1074/jbc.M801027200; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zandbergen F, 2005, BIOCHEM J, V392, P313, DOI 10.1042/BJ20050636	75	23	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31735	31745		10.1074/jbc.M109.013961	http://dx.doi.org/10.1074/jbc.M109.013961			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19740747	Green Published, hybrid			2022-12-27	WOS:000271572700028
J	Katre, UV; Mazumder, S; Prusti, RK; Mohanty, S				Katre, Uma V.; Mazumder, Suman; Prusti, Rabi K.; Mohanty, Smita			Ligand Binding Turns Moth Pheromone-binding Protein into a pH Sensor EFFECT ON THE ANTHERAEA POLYPHEMUS PBP1 CONFORMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTHERAEA-POLYPHEMUS; BOMBYX-MORI; NMR STRUCTURE; RELEASE; FLUORESCENCE; SPECIFICITY; RECEPTORS; CHANNELS	In moths, pheromone-binding proteins (PBPs) are responsible for the transport of the hydrophobic pheromones to the membrane-bound receptors across the aqueous sensillar lymph. We report here that recombinant Antheraea polyphemus PBP1 (ApolPBP1) picks up hydrophobic molecule(s) endogenous to the Escherichia coli expression host that keeps the protein in the "open" (bound) conformation at high pH but switches to the "closed" (free) conformation at low pH. This finding has bearing on the solution structures of undelipidated lepidopteran moth PBPs determined thus far. Picking up a hydrophobic molecule from the host expression system could be a common feature for lipid-binding proteins. Thus, delipidation is critical for bacterially expressed lipid-binding proteins. We have shown for the first time that the delipidated ApolPBP1 exists primarily in the closed form at all pH levels. Thus, current views on the pH-induced conformational switch of PBPs hold true only for the ligand-bound open conformation of the protein. Binding of various ligands to delipidated ApolPBP1 studied by solution NMR revealed that the protein in the closed conformation switches to the open conformation only at or above pH 6.0 with a protein to ligand stoichiometry of similar to 1:1. Mutation of His(70) and His(95) to alanine drives the equilibrium toward the open conformation even at low pH for the ligand-bound protein by eliminating the histidine-dependent pH-induced conformational switch. Thus, the delipidated double mutant can bind ligand even at low pH in contrast to the wild type protein as revealed by fluorescence competitive displacement assay using 1-aminoanthracene and solution NMR.	[Katre, Uma V.; Mazumder, Suman; Prusti, Rabi K.; Mohanty, Smita] Auburn Univ, Dept Chem & Biochem, Auburn, AL 36849 USA	Auburn University System; Auburn University	Mohanty, S (corresponding author), Auburn Univ, Dept Chem & Biochem, Auburn, AL 36849 USA.	mohansm@auburn.edu	Mohanty, Smita/AAP-2969-2021	Gabale, Uma/0000-0001-7919-8758	National Institutes of Health [DK082397]; United States Department of Agriculture Presidential Early Career Award for Scientists and Engineers [2003-35302-12930]; National Science Foundation [IBN-0628064]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK082397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture Presidential Early Career Award for Scientists and Engineers(United States Department of Agriculture (USDA)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK082397 (to S. M.). This work was also supported by United States Department of Agriculture Presidential Early Career Award for Scientists and Engineers Award 2003-35302-12930 and National Science Foundation Grant IBN-0628064.	Bette S, 2002, INSECT BIOCHEM MOLEC, V32, P241, DOI 10.1016/S0965-1748(01)00171-0; Campanacci V, 2001, J BIOL CHEM, V276, P20078, DOI 10.1074/jbc.M100713200; Damberger F, 2000, PROTEIN SCI, V9, P1038, DOI 10.1110/ps.9.5.1038; Damberger FF, 2007, J MOL BIOL, V373, P811, DOI 10.1016/j.jmb.2007.07.078; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L, PYMOL MOL GRAPHICS S; DU GH, 1995, BIOCHEMISTRY-US, V34, P8726, DOI 10.1021/bi00027a023; Fielding L, 2007, PROG NUCL MAG RES SP, V51, P219, DOI 10.1016/j.pnmrs.2007.04.001; Grolli S, 2006, FEBS J, V273, P5131, DOI 10.1111/j.1742-4658.2006.05510.x; Horst R, 2001, P NATL ACAD SCI USA, V98, P14374, DOI 10.1073/pnas.251532998; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Lautenschlager C, 2005, BIOCHEM BIOPH RES CO, V335, P1044, DOI 10.1016/j.bbrc.2005.07.176; Leal WS, 2005, J CHEM ECOL, V31, P2493, DOI 10.1007/s10886-005-7458-4; Lee D, 2002, FEBS LETT, V531, P314, DOI 10.1016/S0014-5793(02)03548-2; Mohanty S, 2004, J MOL BIOL, V337, P443, DOI 10.1016/j.jmb.2004.01.009; Mohanty S, 2003, J BIOMOL NMR, V27, P393, DOI 10.1023/A:1025880932197; Oldham NJ, 2001, CHEM SENSES, V26, P529, DOI 10.1093/chemse/26.5.529; PRESTWICH GD, 1993, PROTEIN SCI, V2, P420; RAMING K, 1989, FEBS LETT, V256, P215, DOI 10.1016/0014-5793(89)81751-X; Sandler BH, 2000, CHEM BIOL, V7, P143, DOI 10.1016/S1074-5521(00)00078-8; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Smita M., 2008, CURR CHEM BIOL, V2, P83, DOI DOI 10.2174/2212796810802010083; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Wojtasek H, 1999, J BIOL CHEM, V274, P30950, DOI 10.1074/jbc.274.43.30950; Xu W, 2008, BIOCHEM BIOPH RES CO, V372, P559, DOI 10.1016/j.bbrc.2008.05.087; Zubkov S, 2005, J MOL BIOL, V354, P1081, DOI 10.1016/j.jmb.2005.10.015	27	24	24	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					32167	32177		10.1074/jbc.M109.013383	http://dx.doi.org/10.1074/jbc.M109.013383			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19758993	Green Published, hybrid			2022-12-27	WOS:000271572700071
J	Pennacchietti, E; Lammens, TM; Capitani, G; Franssen, MCR; John, RA; Bossa, F; De Biase, D				Pennacchietti, Eugenia; Lammens, Tijs M.; Capitani, Guido; Franssen, Maurice C. R.; John, Robert A.; Bossa, Francesco; De Biase, Daniela			Mutation of His(465) Alters the pH-dependent Spectroscopic Properties of Escherichia coli Glutamate Decarboxylase and Broadens the Range of Its Activity toward More Alkaline pH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRIDOXAL 5'-PHOSPHATE; ACID DECARBOXYLASE; AMINO-ACIDS; PHOSPHORYLASE; RESISTANCE; BINDING; ENZYME; SITE; AMINOTRANSFERASE; ACTIVATION	Glutamate decarboxylase (GadB) from Escherichia coli is a hexameric, pyridoxal 5'-phosphate-dependent enzyme catalyzing CO2 release from the alpha-carboxyl group of L-glutamate to yield gamma-aminobutyrate. GadB exhibits an acidic pH optimum and undergoes a spectroscopically detectable and strongly cooperative pH-dependent conformational change involving at least six protons. Crystallographic studies showed that at mildly alkaline pH GadB is inactive because all active sites are locked by the C termini and that the 340 nm absorbance is an aldamine formed by the pyridoxal 5'-phosphate-Lys(276) Schiff base with the distal nitrogen of His(465), the penultimate residue in the GadB sequence. Herein we show that His(465) has a massive influence on the equilibrium between active and inactive forms, the former being favored when this residue is absent. His(465) contributes with n approximate to 2.5 to the overall cooperativity of the system. The residual cooperativity (n approximate to 3) is associated with the conformational changes still occurring at the N-terminal ends regardless of the mutation. His(465), dispensable for the cooperativity that affects enzyme activity, is essential to include the conformational change of the N termini into the cooperativity of the whole system. In the absence of His(465,) a 330-nm absorbing species appears, with fluorescence emission spectra more complex than model compounds and consisting of two maxima at 390 and 510 nm. Because His(465) mutants are active at pH well above 5.7, they appear to be suitable for biotechnological applications.	[Pennacchietti, Eugenia; Bossa, Francesco; De Biase, Daniela] Univ Roma La Sapienza, Dipartimento Sci Biochim A Rossi Fanelli, Fdn Cenci Bolognetti, Ist Pasteur, I-00185 Rome, Italy; [Franssen, Maurice C. R.] Univ Wageningen & Res Ctr, Organ Chem Lab, NL-6703 HB Wageningen, Netherlands; [Capitani, Guido] Paul Scherrer Inst, CH-5232 Villigen, Switzerland; [John, Robert A.] Cardiff Univ, Sch Biosci, Cardiff CF1 3US, S Glam, Wales	Fondazione Cenci Bolognetti; Sapienza University Rome; Wageningen University & Research; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Cardiff University	De Biase, D (corresponding author), Univ Roma La Sapienza, Dipartimento Sci Biochim, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	daniela.debiase@uniroma1.it	De Biase, Daniela/H-3678-2019; Franssen, Maurice C.R./R-4026-2019; Messier, Claude/A-2322-2008	De Biase, Daniela/0000-0003-3536-9927; Franssen, Maurice C.R./0000-0002-3615-9115; Messier, Claude/0000-0002-4791-1763	Istituto Pasteur-Fondazione Cenci Bolognetti; Italian Ministero dell'Istruzione dell'Universita e della Ricerca	Istituto Pasteur-Fondazione Cenci Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti); Italian Ministero dell'Istruzione dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR))	This work was supported by the Istituto Pasteur-Fondazione Cenci Bolognetti and the Italian Ministero dell'Istruzione dell'Universita e della Ricerca (to D. D. B. and F. B.).	Amend JP, 1997, PURE APPL CHEM, V69, P935, DOI 10.1351/pac199769050935; Bertoldi M, 2002, BIOCHEMISTRY-US, V41, P9153, DOI 10.1021/bi025649q; Capitani G, 2003, EMBO J, V22, P4027, DOI 10.1093/emboj/cdg403; De Biase D, 1999, MOL MICROBIOL, V32, P1198, DOI 10.1046/j.1365-2958.1999.01430.x; DeBiase D, 1996, PROTEIN EXPRES PURIF, V8, P430; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Gale EF, 1940, BIOCHEM J, V34, P392, DOI 10.1042/bj0340392; Gut H, 2006, EMBO J, V25, P2643, DOI 10.1038/sj.emboj.7601107; Gut H, 2009, J MOL BIOL, V392, P334, DOI 10.1016/j.jmb.2009.06.080; Harris TK, 2002, IUBMB LIFE, V53, P85, DOI 10.1080/15216540211468; HONIKEL KO, 1972, J BIOL CHEM, V247, P1057; Hurst LD, 2002, TRENDS GENET, V18, P604, DOI 10.1016/S0168-9525(02)02813-5; Ikushiro H, 1998, BIOCHEMISTRY-US, V37, P3043, DOI 10.1021/bi971995+; JOHNSON GF, 1970, J BIOL CHEM, V245, P5560; Kulikova T, 2007, NUCLEIC ACIDS RES, V35, pD16, DOI 10.1093/nar/gkl913; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lammens TM, 2009, GREEN CHEM, V11, P1562, DOI 10.1039/b913741f; Lin JS, 1996, APPL ENVIRON MICROB, V62, P3094, DOI 10.1128/AEM.62.9.3094-3100.1996; METZLER DE, 1973, BIOCHEMISTRY-US, V12, P5377, DOI 10.1021/bi00750a022; MISONO H, 1977, J BIOCHEM-TOKYO, V82, P535; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; OLEARY MH, 1971, BIOCHIM BIOPHYS ACTA, V242, P484, DOI 10.1016/0005-2744(71)90241-5; OLEARY MH, 1974, J BIOL CHEM, V249, P3737; PETERSON EA, 1954, J AM CHEM SOC, V76, P169, DOI 10.1021/ja01630a045; Ro HS, 1996, FEBS LETT, V398, P141, DOI 10.1016/S0014-5793(96)01222-7; SHALTIEL S, 1970, BIOCHEM BIOPH RES CO, V41, P594, DOI 10.1016/0006-291X(70)90054-9; SHUKUYA R, 1960, J BIOL CHEM, V235, P1653; Stern A, 2007, NUCLEIC ACIDS RES, V35, pW506, DOI 10.1093/nar/gkm382; Tramonti A, 2002, EUR J BIOCHEM, V269, P4913, DOI 10.1046/j.1432-1033.2002.03149.x; Tramonti A, 1998, J BIOL CHEM, V273, P1939, DOI 10.1074/jbc.273.4.1939; Ueno H, 2000, J MOL CATAL B-ENZYM, V10, P67, DOI 10.1016/S1381-1177(00)00114-4; VAZQUEZ MA, 1991, BIOCHEM J, V279, P759, DOI 10.1042/bj2790759; Wernersson R, 2003, NUCLEIC ACIDS RES, V31, P3537, DOI 10.1093/nar/gkg609; Zhang JS, 2005, PROTEIN SCI, V14, P1190, DOI 10.1110/ps.041258305; Zhou XZ, 1999, BIOCHEMISTRY-US, V38, P311, DOI 10.1021/bi981455s	35	39	45	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31587	31596		10.1074/jbc.M109.049577	http://dx.doi.org/10.1074/jbc.M109.049577			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19797049	Green Published, hybrid			2022-12-27	WOS:000271572700013
J	Sun, QM; Zhou, H; Binmadi, NO; Basile, JR				Sun, Qiangming; Zhou, Hua; Binmadi, Nada O.; Basile, John R.			Hypoxia-inducible Factor-1-mediated Regulation of Semaphorin 4D Affects Tumor Growth and Vascularity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED ANGIOGENESIS; FACTOR-I; ACTIVATION; TRANSCRIPTION; EXPRESSION; FACTOR-1; PATHWAY; PROTEIN	Tumor progression and metastasis depend on the ability of cancer cells to initiate angiogenesis to ensure delivery of oxygen, nutrients, and growth factors to tumor cells and provide access to the systemic circulation. Hypoxia-inducible factor-1 (HIF-1) can activate expression of a broad range of genes that mediate many of the adaptive responses to decreased oxygen concentration, such as enhanced glucose uptake and formation of new blood vessels. Acting through Plexin-B1 on endothelial cells, Semaphorin 4D (Sema4D) has been shown to promote angiogenesis and enhance invasive growth and proliferation in some tumors. Here we show that the gene for Sema4D, the product of which is elevated in head and neck squamous cell carcinoma (HNSCC) cells, contains upstream hypoxia response elements (HRE) and is strongly induced in hypoxia in a HIF-1-dependent manner. Knocking down Sema4D expression with short hairpin (sh) RNA reduces in vitro endothelial cell migration and growth and vascularity of HNSCC xenografts expressing a degradation resistant HIF-1 alpha subunit. We also demonstrate a correlation between HIF-1 activity and Sema4D expression in HNSCC specimens. These findings indicate that Sema4D is induced by hypoxia in a HIF-1-dependent manner and influences endothelial cell migration and tumor vascularity. Expression of Sema4D may be a strategy by which carcinomas promote angiogenesis and therefore could represent a therapeutic target for these malignancies.	[Basile, John R.] Univ Maryland, Sch Dent, Dept Oncol & Diagnost Sci, Baltimore, MD 21201 USA; [Basile, John R.] Marlene & Stuart Greenebaum Canc Ctr, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Basile, JR (corresponding author), Univ Maryland, Sch Dent, Dept Oncol & Diagnost Sci, 650 W Baltimore St, 7 North, Baltimore, MD 21201 USA.	jbasile@umaryland.edu	Binmadi, Nada O./O-5009-2016	Binmadi, Nada O./0000-0002-2200-6206				Amornphimoltham P, 2004, CLIN CANCER RES, V10, P4029, DOI 10.1158/1078-0432.CCR-03-0249; Basile JR, 2007, J BIOL CHEM, V282, P6899, DOI 10.1074/jbc.M609570200; Basile JR, 2006, P NATL ACAD SCI USA, V103, P9017, DOI 10.1073/pnas.0508825103; Basile JR, 2005, MOL CELL BIOL, V25, P6889, DOI 10.1128/MCB.25.16.6889-6898.2005; Basile JR, 2004, CANCER RES, V64, P5212, DOI 10.1158/0008-5472.CAN-04-0126; BISMUTH G, 2002, SCI STKE, pRE4; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Ch'ng E, 2007, CANCER-AM CANCER SOC, V110, P164, DOI 10.1002/cncr.22764; Down TA, 2002, GENOME RES, V12, P458, DOI 10.1101/gr.216102; Fazzari P, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-55; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Granziero L, 2003, BLOOD, V101, P1962, DOI 10.1182/blood-2002-05-1339; Hirota K, 2006, CRIT REV ONCOL HEMAT, V59, P15, DOI 10.1016/j.critrevonc.2005.12.003; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Kreuter M, 2002, ANN HEMATOL, V81, pS74; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; Siebold C, 2005, P NATL ACAD SCI USA, V102, P16836, DOI 10.1073/pnas.0504997102; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Torres-Vazquez J, 2004, DEV CELL, V7, P117, DOI 10.1016/j.devcel.2004.06.008; Vajkoczy P, 2002, J CLIN INVEST, V109, P777, DOI 10.1172/JCI200214105; VANDEWOUDE GF, 1997, CIBA F SYMP, V212, P130; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; 1999, CELL, V97, P551	24	53	64	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					32066	32074		10.1074/jbc.M109.057166	http://dx.doi.org/10.1074/jbc.M109.057166			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19762474	Green Published, hybrid			2022-12-27	WOS:000271572700061
J	Wilkinson, IC; Hall, CJ; Veverka, V; Shi, JY; Muskett, FW; Stephens, PE; Taylor, RJ; Henry, AJ; Carr, MD				Wilkinson, Ian C.; Hall, Catherine J.; Veverka, Vaclav; Shi, Jiye Y.; Muskett, Frederick W.; Stephens, Paul E.; Taylor, Richard J.; Henry, Alistair J.; Carr, Mark D.			High Resolution NMR-based Model for the Structure of a scFv-IL-1 beta Complex POTENTIAL FOR NMR AS A KEY TOOL IN THERAPEUTIC ANTIBODY DESIGN AND DEVELOPMENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-STRUCTURE DETERMINATION; LIQUID-CRYSTALLINE PHASE; CHAIN FV FRAGMENT; CHEMICAL-SHIFT; ANGSTROM RESOLUTION; BINDING-SITE; FAB FRAGMENT; SPECTROSCOPY; NEUTRALIZATION; RESTRAINTS	Monoclonal antibodies have recently started to deliver on their promise as highly specific and active drugs; however, a more effective, knowledge-based approach to the selection, design, and optimization of potential therapeutic antibodies is currently limited by the surprising lack of detailed structural information for complexes formed with target proteins. Here we show that complexes formed with minimal antigen binding single chain variable fragments (scFv) reliably reflect all the features of the binding interface present in larger Fab fragments, which are commonly used as therapeutics, and report the development of a robust, reliable, and relatively rapid approach to the determination of high resolution models for scFv-target protein complexes. This NMR spectroscopy-based approach combines experimental determination of the interaction surfaces and relative orientations of the scFv and target protein, with NMR restraint-driven, semiflexible docking of the proteins to produce a reliable and highly informative model of the complex. Experience with scFvs and Fabs targeted at a number of secreted regulatory proteins suggests that the approach will be applicable to many therapeutic antibodies targeted at proteins, and its application is illustrated for a potential therapeutic antibody targeted at the cytokine IL-1 beta. The detailed structural information that can be obtained by this approach has the potential to have a major impact on the rational design and development of an increasingly important class of biological pharmaceuticals.	[Wilkinson, Ian C.; Hall, Catherine J.; Veverka, Vaclav; Muskett, Frederick W.; Carr, Mark D.] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England; [Shi, Jiye Y.; Stephens, Paul E.; Taylor, Richard J.; Henry, Alistair J.] UCB Celltech, Slough SL1 3WE, Berks, England	University of Leicester; Celltech Group Ltd	Carr, MD (corresponding author), Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England.	mdc12@le.ac.uk	Veverka, Vaclav/P-5251-2019; Veverka, Vaclav/G-9174-2014; Shi, Jiye/G-2745-2012	Veverka, Vaclav/0000-0003-3782-5279; Veverka, Vaclav/0000-0003-3782-5279; Shi, Jiye/0000-0002-9628-8680; Carr, Mark/0000-0002-3939-0996	UCB-Celltech; Wellcome Trust	UCB-Celltech(UCB Pharma SA); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by UCB-Celltech and Wellcome Trust grants ( to M. D. C.).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ay J, 2000, J MOL BIOL, V301, P239, DOI 10.1006/jmbi.2000.3971; BAX A, 1994, CURR OPIN STRUC BIOL, V4, P738, DOI 10.1016/S0959-440X(94)90173-2; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BIRD RE, 1988, SCIENCE, V242, P423, DOI 10.1126/science.3140379; CHARBONNIER JB, 1995, P NATL ACAD SCI USA, V92, P11721, DOI 10.1073/pnas.92.25.11721; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cornilescu G, 1998, J AM CHEM SOC, V120, P6836, DOI 10.1021/ja9812610; DESPLANCQ D, 1994, PROTEIN ENG, V7, P1027, DOI 10.1093/protein/7.8.1027; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; DRISCOLL PC, 1990, BIOCHEMISTRY-US, V29, P3542, DOI 10.1021/bi00466a018; Faelber K, 2001, J MOL BIOL, V313, P83, DOI 10.1006/jmbi.2001.5036; FREUND C, 1993, FEBS LETT, V320, P97, DOI 10.1016/0014-5793(93)80070-B; FREUND C, 1994, BIOCHEMISTRY-US, V33, P3296, DOI 10.1021/bi00177a021; GRIFFITHS AD, 1993, EMBO J, V12, P725, DOI 10.1002/j.1460-2075.1993.tb05706.x; Hubbard SJ., 1993, COMPUTER PROGRAM; Hwang WC, 2006, J BIOL CHEM, V281, P34610, DOI 10.1074/jbc.M603275200; Josephson K, 2002, STRUCTURE, V10, P981, DOI 10.1016/S0969-2126(02)00791-8; Kanelis V, 2001, IUBMB LIFE, V52, P291, DOI 10.1080/152165401317291147; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kontaxis G, 2000, J MAGN RESON, V143, P184, DOI 10.1006/jmre.1999.1979; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LANE DP, 1993, CURR OPIN IMMUNOL, V5, P268, DOI 10.1016/0952-7915(93)90016-L; Lee YC, 2002, J MOL BIOL, V320, P107, DOI 10.1016/S0022-2836(02)00403-5; Lefranc MP, 1997, IMMUNOL TODAY, V18, P509, DOI 10.1016/S0167-5699(97)01163-8; Li S, 2008, STRUCTURE, V16, P216, DOI 10.1016/j.str.2007.11.009; Malby RL, 1998, J MOL BIOL, V279, P901, DOI 10.1006/jmbi.1998.1794; Meiler J, 2000, J BIOMOL NMR, V16, P245, DOI 10.1023/A:1008378624590; Mirza O, 2000, J IMMUNOL, V165, P331, DOI 10.4049/jimmunol.165.1.331; Nybakken GE, 2005, NATURE, V437, P764, DOI 10.1038/nature03956; Pavlou AK, 2005, EUR J PHARM BIOPHARM, V59, P389, DOI 10.1016/j.ejpb.2004.11.007; PRASAD L, 1993, J BIOL CHEM, V268, P10705; PRIESTLE JP, 1989, P NATL ACAD SCI USA, V86, P9667, DOI 10.1073/pnas.86.24.9667; Renshaw PS, 2005, EMBO J, V24, P2491, DOI 10.1038/sj.emboj.7600732; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Tsai CJ, 1996, J MOL BIOL, V260, P604, DOI 10.1006/jmbi.1996.0424; Vajdos FF, 2002, J MOL BIOL, V320, P415, DOI 10.1016/S0022-2836(02)00264-4; VandeWater J, 1997, CLIN IMMUNOL IMMUNOP, V85, P229, DOI 10.1006/clin.1997.4434; Veverka V, 2008, ONCOGENE, V27, P585, DOI 10.1038/sj.onc.1210693; Veverka V, 2009, J BIOL CHEM, V284, P10890, DOI 10.1074/jbc.M807994200; Waters LC, 2007, ONCOGENE, V26, P4941, DOI 10.1038/sj.onc.1210305; Williamson RA, 1997, BIOCHEMISTRY-US, V36, P13882, DOI 10.1021/bi9712091; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908	45	33	37	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31928	31935		10.1074/jbc.M109.025304	http://dx.doi.org/10.1074/jbc.M109.025304			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19776018	Green Published, hybrid			2022-12-27	WOS:000271572700048
J	Ganjam, GK; Dimova, EY; Unterman, TG; Kietzmann, T				Ganjam, Goutham Kumar; Dimova, Elitsa Y.; Unterman, Terry G.; Kietzmann, Thomas			FoxO1 and HNF-4 Are Involved in Regulation of Hepatic Glucokinase Gene Expression by Resveratrol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR FOXO1; PROTEIN-KINASE-B; FACTOR-BINDING PROTEIN-1; INSULIN-RESPONSE UNIT; CALORIE RESTRICTION; PROMOTER ACTIVITY; CELL-SURVIVAL; PEROXISOME PROLIFERATOR; DEPENDENT REGULATION; LENTIVIRUS VECTOR	Resveratrol, a polyphenol derived from grapes, exerts important effects on glucose and lipid metabolism, yet detailed mechanisms mediating these effects remain unknown. The liver plays a central role in energy homeostasis, and glucokinase (GK) is a key enzyme involved in glucose utilization. Resveratrol activates SIRT1 (sirtuin 1), which promotes deacetylation of the forkhead transcription factor FoxO1. Previously, we reported that FoxO1 can suppress and that HNF-4 can stimulate GK expression in the liver. Here, we examined the role of FoxO1 and HNF-4 in mediating resveratrol effects on liver GK expression. Resveratrol suppressed hepatic GK expression in vivo and in isolated hepatocytes, and knocking down FoxO1 with shRNAs disrupted this effect. Reporter gene, gel shift, supershift assay, and chromatin immunoprecipitation studies show that FoxO1 binds to the GK promoter and that the interplay between FoxO1 and HNF-4 within the GK promoter is essential for mediating the effects of resveratrol. Resveratrol promotes deacetylation of FoxO1 and enhances its recruitment to the FoxO-binding element. Conversely, resveratrol suppresses recruitment of HNF-4 to its binding site, and knockdown of FoxO1 blocks this effect of resveratrol. Coprecipitation and chromatin immunoprecipitation studies show that resveratrol enhances interaction between FoxO1 and HNF-4, reduces binding of HNF-4 to its own site, and promotes its recruitment to the FoxO site in a FoxO1-dependent manner. These results provide the first evidence that resveratrol represses GK expression via FoxO1 and that the interaction between FoxO1 and HNF-4 contributes to these effects of resveratrol.	[Unterman, Terry G.] Univ Illinois, Coll Med, Dept Med, Chicago, IL 60612 USA; Univ Kaiserslautern, Fac Chem, Dept Biochem, D-67663 Kaiserslautern, Germany; [Ganjam, Goutham Kumar] Univ Marburg, Dept Nutrient Physiol, D-35043 Marburg, Germany; [Dimova, Elitsa Y.; Kietzmann, Thomas] Univ Oulu, Dept Biochem, FI-90014 Oulu, Finland; [Unterman, Terry G.] Univ Illinois, Coll Med, Dept Physiol & Biophys, Chicago, IL 60612 USA; [Unterman, Terry G.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Kaiserslautern; Philipps University Marburg; Finland National Institute for Health & Welfare; University of Oulu; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Unterman, TG (corresponding author), Univ Illinois, Coll Med, Dept Med, 820 S Damen Ave, Chicago, IL 60612 USA.	unterman@uic.edu; tkietzm@gwdg.de		Kietzmann, Thomas/0000-0003-0242-8636; Dimova, Elitsa/0000-0003-2745-8145	National Institutes of Health [DK41430]; Fonds der Chemischen Industrie; Deutsche Krebshilfe [106929]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK041430, R01DK041430] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Deutsche Krebshilfe(Deutsche Krebshilfe); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK41430 (to T. G. U.). This work was also supported by the Department of Veterans Affairs Merit Review Program (to T. G. U.) as well as by grants from Fonds der Chemischen Industrie (to T. K.) and Deutsche Krebshilfe 106929 (to T. K.).	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Armoni M, 2006, J BIOL CHEM, V281, P19881, DOI 10.1074/jbc.M600320200; Ayala JE, 1999, DIABETES, V48, P1885, DOI 10.2337/diabetes.48.9.1885; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Bonello S, 2007, ARTERIOSCL THROM VAS, V27, P755, DOI 10.1161/01.ATV.0000258979.92828.bc; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Buteau J, 2007, J BIOL CHEM, V282, P287, DOI 10.1074/jbc.M606118200; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; COLONNO RJ, 1978, CELL, V15, P93, DOI 10.1016/0092-8674(78)90085-5; Daitoku H, 2003, DIABETES, V52, P642, DOI 10.2337/diabetes.52.3.642; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Daitoku H, 2007, J BIOCHEM, V141, P769, DOI 10.1093/jb/mvm104; Dimova EY, 2005, THROMB HAEMOSTASIS, V93, P1176, DOI 10.1160/TH04-11-0761; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Fan WQ, 2009, J BIOL CHEM, V284, P12188, DOI 10.1074/jbc.M808915200; Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Fukuoka M, 2003, INT J MOL MED, V12, P503; Fulda S, 2006, CANCER DETECT PREV, V30, P217, DOI 10.1016/j.cdp.2006.03.007; Ghosh AK, 2001, J BIOL CHEM, V276, P8507, DOI 10.1074/jbc.M008541200; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Guo SD, 2001, J BIOL CHEM, V276, P8516, DOI 10.1074/jbc.M008542200; Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184; Harikumar KB, 2008, CELL CYCLE, V7, P1020, DOI 10.4161/cc.7.8.5740; Heilbronn LK, 2005, OBES RES, V13, P574, DOI 10.1038/oby.2005.61; Hirota K, 2003, J BIOL CHEM, V278, P13056, DOI 10.1074/jbc.C200553200; Hirota K, 2008, J BIOL CHEM, V283, P32432, DOI 10.1074/jbc.M806179200; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Immenschuh S, 1998, BIOCHEM J, V334, P141, DOI 10.1042/bj3340141; Iynedjian PB, 1998, BIOCHEM J, V333, P705, DOI 10.1042/bj3330705; IYNEDJIAN PB, 1995, J CLIN INVEST, V95, P1966, DOI 10.1172/JCI117880; IYNEDJIAN PB, 1993, BIOCHEM J, V293, P1; IYNEDJIAN PB, 1989, J BIOL CHEM, V264, P21824; JETTON TL, 1994, J BIOL CHEM, V269, P3641; Jungermann K, 1996, ANNU REV NUTR, V16, P179, DOI 10.1146/annurev.nu.16.070196.001143; Kaestner KH, 2000, GENE DEV, V14, P142; Kamei Y, 2008, ENDOCRINOLOGY, V149, P2293, DOI 10.1210/en.2007-1461; Kietzmann T, 2004, METHOD ENZYMOL, V381, P357; Kietzmann T, 1997, BIOCHEM J, V321, P17, DOI 10.1042/bj3210017; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; KIM JJ, 2009, DIABETES IN PRESS; Kim S, 2004, DIABETES, V53, pS66, DOI 10.2337/diabetes.53.2007.S66; Kim SY, 2004, J BIOL CHEM, V279, P30823, DOI 10.1074/jbc.M313223200; Kimura Y, 2000, J PHARM PHARMACOL, V52, P1287, DOI 10.1211/0022357001777270; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Kitamura T, 2006, NAT MED, V12, P534, DOI 10.1038/nm1392; Klein A, 2008, MOL BIOL CELL, V19, P3667, DOI 10.1091/mbc.E08-01-0042; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Kruger M, 1997, N-S ARCH PHARMACOL, V356, P433, DOI 10.1007/PL00005073; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Li TG, 2006, J BIOL CHEM, V281, P28745, DOI 10.1074/jbc.M605815200; Liu Q, 2004, P NATL ACAD SCI USA, V101, P4302, DOI 10.1073/pnas.0400265101; MAGNUSON MA, 1992, J CELL BIOCHEM, V48, P115, DOI 10.1002/jcb.240480202; MAGNUSON MA, 1989, P NATL ACAD SCI USA, V86, P4838, DOI 10.1073/pnas.86.13.4838; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Matsumoto M, 2006, J CLIN INVEST, V116, P2464, DOI 10.1172/JCI27047; Matsuzaki H, 2005, P NATL ACAD SCI USA, V102, P11278, DOI 10.1073/pnas.0502738102; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; PRINTZ RL, 1993, ANNU REV NUTR, V13, P463, DOI 10.1146/annurev.nu.13.070193.002335; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Roth U, 2004, BIOL CHEM, V385, P239, DOI 10.1515/BC.2004.018; Roth U, 2004, J BIOL CHEM, V279, P2623, DOI 10.1074/jbc.M308391200; Roth U, 2002, BIOCHEM J, V365, P223, DOI 10.1042/BJ20020340; Schmoll D, 2000, J BIOL CHEM, V275, P36324, DOI 10.1074/jbc.M003616200; SLADEK FM, 1993, RECEPTOR, V3, P223; Tang TTL, 2003, J BIOL CHEM, V278, P30125, DOI 10.1074/jbc.M302042200; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; VANDERCAMMEN A, 1991, EUR J BIOCHEM, V200, P545, DOI 10.1111/j.1432-1033.1991.tb16217.x; Vogt PK, 2005, CELL CYCLE, V4, P908, DOI 10.4161/cc.4.7.1796; Wang F, 2009, MOL BIOL CELL, V20, P801, DOI 10.1091/mbc.E08-06-0647; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Wolfrum C, 2004, NATURE, V432, P1027, DOI 10.1038/nature03047; Yeagley D, 2001, J BIOL CHEM, V276, P33705, DOI 10.1074/jbc.M101215200; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Yoshida K, 2007, ENDOCRINOLOGY, V148, P2904, DOI 10.1210/en.2006-1149; Zhang JD, 2006, BIOCHEM J, V397, P519, DOI 10.1042/BJ20050977; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200; Zhao HH, 2001, J BIOL CHEM, V276, P27907, DOI 10.1074/jbc.M104278200; Zhao XS, 2004, BIOCHEM J, V378, P839, DOI 10.1042/BJ20031450	85	59	59	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30783	30797		10.1074/jbc.M109.045260	http://dx.doi.org/10.1074/jbc.M109.045260			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19740748	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000271378400006
J	Morii, H; Kiyonari, S; Ishino, Y; Koga, Y				Morii, Hiroyuki; Kiyonari, Shinichi; Ishino, Yoshizumi; Koga, Yosuke			A Novel Biosynthetic Pathway of Archaetidyl-myo-inositol via Archaetidyl-myo-inositol Phosphate from CDP-archaeol and D-Glucose 6-Phosphate in Methanoarchaeon Methanothermobacter thermautotrophicus Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLAR ETHER LIPIDS; METHANOBACTERIUM-THERMOAUTOTROPHICUM; INOSITOL-1-PHOSPHATE SYNTHASE; SACCHAROMYCES-CEREVISIAE; 1-PHOSPHATE CYCLASE; TETRAETHER LIPIDS; COMPONENT PARTS; KEY ENZYME; IN-VITRO; METABOLISM	Ether-type inositol phospholipids are ubiquitously distributed in Archaea membranes. The present paper describes a novel biosynthetic pathway of the archaeal inositol phospholipid. To study the biosynthesis of archaetidylinositol in vitro, we prepared two possible substrates: CDP-archaeol, which was chemically synthesized, and myo-[14C] inositol 1-phosphate, which was enzymatically prepared from [14C] glucose 6-phosphate with the inositol 1-phosphate (IP) synthase of this organism. The complete structure of the IP synthase reaction product was determined to be 1L-myo-inositol 1-phosphate, based on gas liquid chromatography with a chiral column. When the two substrates were incubated with the Methanothermobacter thermautotrophicus membrane fraction, archaetidylinositol phosphate (AIP) was formed along with a small amount of archaetidylinositol (AI). The two products were identified by fast atom bombardment-mass spectrometry and chemical analyses. AI was formed from AIP by incubation with the membrane fraction, but AIP was not formed from AI. This finding indicates that archaeal AI was synthesized from CDP-archaeol and D-glucose 6-phosphate via myo-inositol 1-phosphate and AIP. Although the relevant enzymes were not isolated, three enzymes are implied: IP synthase, AIP synthase, and AIP phosphatase. AIP synthase was homologous to yeast phosphatidylinositol synthase, and we confirmed AIP synthase activity by cloning the encoding gene (MTH1691) and expressing it in Escherichia coli. AIP synthase is a newly found member of the enzyme superfamily CDP-alcohol phosphatidyltransferase, which includes a wide range of enzymes that attach polar head groups to ester-and ether-type phospholipids of bacterial and archaeal origin. This is the first report of the biosynthesis of ether-type inositol phospholipids in Archaea.	[Morii, Hiroyuki] Univ Occupat & Environm Hlth, Dept Chem, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan; [Kiyonari, Shinichi; Ishino, Yoshizumi] Kyushu Univ, Lab Prot Chem & Engn, Dept Genet Resources Technol, Grad Sch Bioresource & Bioenvironm Sci,Fac Agr, Fukuoka 8128581, Japan	University of Occupational & Environmental Health - Japan; Kyushu University	Morii, H (corresponding author), Univ Occupat & Environm Hlth, Dept Chem, Yahatanishi Ku, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	h-morii@health.uoeh-u.ac.jp	Kiyonari, Shinichi/I-7329-2014	Ishino, Yoshizumi/0000-0001-9419-0826	Japan Society for the Promotion of Science [C16580067]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grant-in-aid for Scientific Research (KAKENHI) C16580067 from the Japan Society for the Promotion of Science.	Bachhawat N, 2000, TRENDS GENET, V16, P111, DOI 10.1016/S0168-9525(99)01966-6; BALLOU CE, 1960, J AM CHEM SOC, V82, P3333, DOI 10.1021/ja01498a026; BARNETT JEG, 1970, BIOCHEM J, V119, P183, DOI 10.1042/bj1190183; BARTLETT GR, 1959, J BIOL CHEM, V234, P468; CARMAN GM, 1992, METHOD ENZYMOL, V209, P305; CHEN IW, 1965, BIOCHEM BIOPH RES CO, V19, P144, DOI 10.1016/0006-291X(65)90133-6; CHEN IW, 1966, ARCH BIOCHEM BIOPHYS, V117, P154, DOI 10.1016/0003-9861(66)90138-X; Daiyasu Hiromi, 2005, Archaea, V1, P399, DOI 10.1155/2005/452563; EISENBER.F, 1967, J BIOL CHEM, V242, P1375; Grochowski LL, 2006, J BACTERIOL, V188, P2836, DOI 10.1128/JB.188.8.2836-2844.2006; KANFER J, 1964, J BIOL CHEM, V239, P1720; KOGA Y, 1993, SYST APPL MICROBIOL, V16, P342, DOI 10.1016/S0723-2020(11)80264-X; Koga Y, 2008, SYST APPL MICROBIOL, V31, P169, DOI 10.1016/j.syapm.2008.02.005; Koga Y, 2007, MICROBIOL MOL BIOL R, V71, P97, DOI 10.1128/MMBR.00033-06; LOEWUS MW, 1980, J BIOL CHEM, V255, P1710; MOLDOVEANU N, 1988, BIOCHIM BIOPHYS ACTA, V960, P164, DOI 10.1016/0005-2760(88)90062-8; Morii H, 2000, J BIOL CHEM, V275, P36568, DOI 10.1074/jbc.M005925200; MORII H, 1993, FEMS MICROBIOL LETT, V109, P283, DOI 10.1111/j.1574-6968.1993.tb06182.x; Morii H, 2003, J BACTERIOL, V185, P1181, DOI 10.1128/JB.185.4.1181-1189.2003; MORII H, 1988, AGR BIOL CHEM TOKYO, V52, P3149, DOI 10.1080/00021369.1988.10869195; Morii H, 2007, J BACTERIOL, V189, P4053, DOI 10.1128/JB.01875-06; Neelon K, 2005, J BIOL CHEM, V280, P11475, DOI 10.1074/jbc.M500469200; NISHIHARA M, 1995, J BIOCHEM-TOKYO, V117, P933, DOI 10.1093/oxfordjournals.jbchem.a124822; NISHIHARA M, 1989, BIOCHEMISTRY-US, V28, P95, DOI 10.1021/bi00427a014; NISHIHARA M, 1987, J BIOCHEM-TOKYO, V101, P1007, DOI 10.1093/oxfordjournals.jbchem.a121942; NISHIHARA M, 1987, J BIOCHEM-TOKYO, V101, P997, DOI 10.1093/oxfordjournals.jbchem.a121969; PIZER FL, 1959, J AM CHEM SOC, V81, P915, DOI 10.1021/ja01513a040; Rodrigues MV, 2007, J BACTERIOL, V189, P5405, DOI 10.1128/JB.00465-07; SHERMAN WR, 1969, J BIOL CHEM, V244, P5703; SHERMAN WR, 1981, J NEUROCHEM, V36, P1947, DOI 10.1111/j.1471-4159.1981.tb10819.x; Smith DR, 1997, J BACTERIOL, V179, P7135, DOI 10.1128/jb.179.22.7135-7155.1997; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STEINER MR, 1972, BIOCHIM BIOPHYS ACTA, V260, P222, DOI 10.1016/0005-2760(72)90035-5; WACHTERSHAUSER G, 1988, MICROBIOL REV, V52, P452; Williams JG, 1998, J BIOL CHEM, V273, P13482, DOI 10.1074/jbc.273.22.13482; ZHANG DL, 1990, J AM CHEM SOC, V112, P1264, DOI 10.1021/ja00159a067; ZHANG DL, 1993, J AM CHEM SOC, V115, P1270, DOI 10.1021/ja00057a008	37	25	28	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30766	30774		10.1074/jbc.M109.034652	http://dx.doi.org/10.1074/jbc.M109.034652			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19740749	hybrid, Green Published			2022-12-27	WOS:000271378400004
J	Oki, T; Eto, K; Izawa, K; Yamanishi, Y; Inagaki, N; Frampton, J; Kitamura, T; Kitaura, J				Oki, Toshihiko; Eto, Koji; Izawa, Kumi; Yamanishi, Yoshinori; Inagaki, Naoki; Frampton, Jon; Kitamura, Toshio; Kitaura, Jiro			Evidence That Integrin alpha IIb beta 3-dependent Interaction of Mast Cells with Fibrinogen Exacerbates Chronic Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FC-EPSILON-RI; CYTOKINE PRODUCTION; IN-VIVO; ACTIVATION; ADHESION; IGE; MICE; FIBRIN(OGEN); EXPRESSION; PLATELETS	Integrin alpha IIb beta 3 is expressed in mast cells as well as in megakaryocytes/platelets. A recent study has shown that surface expression levels of integrin alpha V beta 3 are elevated in integrin alpha IIb-deficient bone marrow-derived mast cells (BMMCs) as compared with wild-type (WT) counterparts, but the underlying mechanism remains obscure. Here we demonstrate by transducing integrin alpha IIb into integrin alpha IIb-deficient BMMCs that surface expression levels of integrin alpha V beta 3 are inversely related to those of integrin alpha IIb beta 3. Thus, competitive association of integrin beta 3 with integrin alpha IIb or integrin alpha V determines surface expression levels of integrin alpha IIb beta 3 or alpha V beta 3 in mast cells. We compared WT and integrin alpha IIb-deficient BMMCs as well as integrin alpha IIb-deficient BMMCs transduced with integrin alpha IIb(WT) or non-functional alpha IIb(D163A) mutant and found that enhancement of proliferation, degranulation, cytokine production, and migration of BMMCs through interaction with fibrinogen (FB) depended on integrin alpha IIb beta 3. In addition, elevated surface expression of integrin alpha V beta 3 failed to compensate for loss of FB-associated functions in integrin alpha IIb-deficient BMMCs while enhancing adhesion to vitronectin or von Willebrand factor. Importantly, integrin alpha IIb deficiency strongly suppressed chronic inflammation with the remarkable increase of mast cells induced by continuous intraperitoneal administration of FB, although it did not affect acute allergic responses or mast cell numbers in tissues in steady states. Interestingly, soluble FB promoted cytokine production of BMMCs in response to Staphylococcus aureus with FB-binding capacity, through integrin alpha IIb beta 3-dependent recognition of this pathogen. Collectively, integrin alpha IIb beta 3 in mast cells plays an important part in FB-associated, chronic inflammation and innate immune responses.	[Kitaura, Jiro] Univ Tokyo, Inst Med Sci, Adv Clin Res Ctr, Div Cellular Therapy,Minato Ku, Tokyo 1088639, Japan; [Eto, Koji] Univ Tokyo, Inst Med Sci, Ctr Stem Cell & Regenerat Med, Div Stem Cell Therapy, Tokyo 1088639, Japan; [Inagaki, Naoki] Gifu Pharmaceut Univ, Dept Pharmacol, Gifu 5028585, Japan; [Frampton, Jon] Univ Birmingham, Div Immun & Infect, MRC, Ctr Immune Regulat, Birmingham B15 2TT, W Midlands, England	University of Tokyo; University of Tokyo; Gifu Pharmaceutical University; University of Birmingham	Kitaura, J (corresponding author), Univ Tokyo, Inst Med Sci, Adv Clin Res Ctr, Div Cellular Therapy,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	kitaura-tky@umin.ac.jp	Kitamura, Toshio/AAA-2071-2021		Ministry of Education, Science, Technology, Sports and Culture; Ministry of Health and Welfare, Japan; Medical Research Council [G9818340B] Funding Source: researchfish	Ministry of Education, Science, Technology, Sports and Culture; Ministry of Health and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the Ministry of Education, Science, Technology, Sports and Culture and the Ministry of Health and Welfare, Japan.	Artis D, 2000, EUR J IMMUNOL, V30, P1656, DOI 10.1002/1521-4141(200006)30:6&lt;1656::AID-IMMU1656&gt;3.0.CO;2-Z; Berlanga O, 2005, EXP HEMATOL, V33, P403, DOI 10.1016/j.exphem.2005.01.011; BIANCHINE PJ, 1992, J IMMUNOL, V149, P3665; Drew AF, 2001, BLOOD, V97, P3691, DOI 10.1182/blood.V97.12.3691; Edelson BT, 2004, BLOOD, V103, P2214, DOI 10.1182/blood-2003-08-2978; Emambokus NR, 2003, IMMUNITY, V19, P33, DOI 10.1016/S1074-7613(03)00173-0; Eto K, 2002, P NATL ACAD SCI USA, V99, P12819, DOI 10.1073/pnas.202380099; Fitzgerald JR, 2006, NAT REV MICROBIOL, V4, P445, DOI 10.1038/nrmicro1425; Fitzgerald JR, 2006, MOL MICROBIOL, V59, P212, DOI 10.1111/j.1365-2958.2005.04922.x; Flick MJ, 2007, J CLIN INVEST, V117, P3224, DOI 10.1172/JCI30134; Flick MJ, 2004, J CLIN INVEST, V113, P1596, DOI 10.1172/JCI200420741; Furumoto Y, 2004, J BIOL CHEM, V279, P49177, DOI 10.1074/jbc.M404730200; Gerber DJ, 1996, P NATL ACAD SCI USA, V93, P14698, DOI 10.1073/pnas.93.25.14698; Gurish MF, 2001, J EXP MED, V194, P1243, DOI 10.1084/jem.194.9.1243; Hata D, 1998, J EXP MED, V187, P1235, DOI 10.1084/jem.187.8.1235; Honda S, 1998, J CLIN INVEST, V102, P1183, DOI 10.1172/JCI3206; INAGAKI N, 1986, INT ARCH ALLER A IMM, V81, P58, DOI 10.1159/000234108; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; Kawakami T, 2005, J IMMUNOL, V175, P4167, DOI 10.4049/jimmunol.175.7.4167; Kawakami T, 2002, NAT REV IMMUNOL, V2, P773, DOI 10.1038/nri914; KIEFFER N, 1991, J CELL BIOL, V113, P451, DOI 10.1083/jcb.113.2.451; KINASHI T, 1994, BLOOD, V83, P1033; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kitaura J, 2005, BLOOD, V105, P3222, DOI 10.1182/blood-2004-11-4205; Kitaura J, 2005, J IMMUNOL, V174, P4495, DOI 10.4049/jimmunol.174.8.4495; Kitaura J, 2003, P NATL ACAD SCI USA, V100, P12911, DOI 10.1073/pnas.1735525100; Knight PA, 2002, AM J PATHOL, V161, P771, DOI 10.1016/S0002-9440(10)64236-8; Lengweiler S, 1999, BIOCHEM BIOPH RES CO, V262, P167, DOI 10.1006/bbrc.1999.1172; Loughman A, 2005, MOL MICROBIOL, V57, P804, DOI 10.1111/j.1365-2958.2005.04731.x; Marshall JS, 2004, NAT REV IMMUNOL, V4, P787, DOI 10.1038/nri1460; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x; NAGAI H, 1995, BIOL PHARM BULL, V18, P239; Oki T, 2006, J IMMUNOL, V176, P52, DOI 10.4049/jimmunol.176.1.52; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; Suehiro K, 1996, J BIOL CHEM, V271, P10365, DOI 10.1074/jbc.271.17.10365; Szaba FM, 2002, BLOOD, V99, P1053, DOI 10.1182/blood.V99.3.1053; Tang LP, 1998, P NATL ACAD SCI USA, V95, P8841, DOI 10.1073/pnas.95.15.8841; Wong MX, 2002, J IMMUNOL, V168, P6455, DOI 10.4049/jimmunol.168.12.6455	39	10	10	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31463	31472		10.1074/jbc.M109.030213	http://dx.doi.org/10.1074/jbc.M109.030213			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19755424	Green Published, hybrid			2022-12-27	WOS:000271378400071
J	Kapralov, A; Vlasova, II; Feng, WH; Maeda, A; Walson, K; Tyurin, VA; Huang, ZT; Aneja, RK; Carcillo, J; Bayir, H; Kagan, VE				Kapralov, Alexandr; Vlasova, Irina I.; Feng, Weihong; Maeda, Akihiro; Walson, Karen; Tyurin, Vladimir A.; Huang, Zhentai; Aneja, Rajesh K.; Carcillo, Joseph; Bayir, Huelya; Kagan, Valerian E.			Peroxidase Activity of Hemoglobin.Haptoglobin Complexes COVALENT AGGREGATION AND OXIDATIVE STRESS IN PLASMA AND MACROPHAGES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCAVENGER RECEPTOR; HAPTOGLOBIN GENOTYPE; LIPID-PEROXIDATION; HYDROGEN-PEROXIDE; HUMAN HEMOGLOBIN; CARDIOLIPIN OXIDATION; CROSS-LINKING; CYTOCHROME-C; ANTIOXIDANT; MYOGLOBIN	As a hemoprotein, hemoglobin (Hb) can, in the presence of H2O2, act as a peroxidase. In red blood cells, this activity is regulated by the reducing environment. For stroma-free Hb this regulation is lost, and the potential for Hb to become a peroxidase is high and further increased by inflammatory cells generating superoxide. The latter can be converted into H2O2 and feed Hb peroxidase activity. Haptoglobins (Hp) bind with extracellular Hb and reportedly weaken Hb peroxidase activity. Here we demonstrate that: (i) Hb peroxidase activity is retained upon binding with Hp; (ii) in the presence of H2O2, Hb.Hp peroxidase complexes undergo covalent cross-linking; (iii) peroxidase activity of Hb.Hp complexes and aggregates consumes reductants such as ascorbate and nitric oxide; (iv) cross-linked Hb.Hp aggregates are taken up by macrophages at rates exceeding those for noncovalently cross-linked Hb.Hp complexes; (v) the engulfed Hb.Hp aggregates activate superoxide production and induce intracellular oxidative stress (deplete endogenous glutathione and stimulate lipid peroxidation); (vi) Hb.Hp aggregates cause cytotoxicity to macrophages; and (vii) Hb.Hp aggregates are present in septic plasma. Overall, our data suggest that under conditions of severe inflammation and oxidative stress, peroxidase activity of Hb.Hp covalent aggregates may cause macrophage dysfunction and microvascular vasoconstriction, which are commonly seen in severe sepsis and hemolytic diseases.	[Kapralov, Alexandr; Vlasova, Irina I.; Feng, Weihong; Maeda, Akihiro; Walson, Karen; Tyurin, Vladimir A.; Huang, Zhentai; Bayir, Huelya; Kagan, Valerian E.] Univ Pittsburgh, Ctr Free Rad & Antioxidant Hlth, Pittsburgh, PA 15219 USA; [Kapralov, Alexandr; Vlasova, Irina I.; Feng, Weihong; Maeda, Akihiro; Tyurin, Vladimir A.; Huang, Zhentai; Bayir, Huelya; Kagan, Valerian E.] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA 15219 USA; [Walson, Karen; Aneja, Rajesh K.; Carcillo, Joseph; Bayir, Huelya] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15219 USA; [Walson, Karen; Bayir, Huelya] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15219 USA; [Vlasova, Irina I.] Res Inst Physicochem Med, Moscow 119992, Russia	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Lopukhin Federal Research & Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency	Kagan, VE (corresponding author), 100 Technol Dr,Suite 350, Pittsburgh, PA 15219 USA.	kagan@pitt.edu	Maeda, Akihiro/K-5190-2015; Huang, Zhentai/C-6926-2012	Huang, Zhentai/0000-0002-8102-464X; Tyurin, Vladimir/0000-0002-3474-1697; Kagan, Valerian E./0000-0002-7245-1885; Kapralov, Oleksandr/0000-0002-3006-916X	National Institutes of Health [HL70755, HD057587, NS061817, AHA-0535365N]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD057587] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM076344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061817] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL70755, HD057587, NS061817, and AHA-0535365N.	Aird WC, 2003, MAYO CLIN PROC, V78, P869, DOI 10.4065/78.7.869; Alayash AI, 2001, ANTIOXID REDOX SIGN, V3, P313, DOI 10.1089/152308601300185250; Angelo M, 2008, METHOD ENZYMOL, V436, P131, DOI 10.1016/S0076-6879(08)36008-X; Armour J, 2001, J APPL PHYSIOL, V90, P795, DOI 10.1152/jappl.2001.90.3.795; Asleh R, 2005, CIRC RES, V96, P435, DOI 10.1161/01.RES.0000156653.05853.b9; Asleh R, 2003, CIRC RES, V92, P1193, DOI 10.1161/01.RES.0000076889.23082.F1; Asleh R, 2006, CIRC RES, V99, P1419, DOI 10.1161/01.RES.0000251741.65179.56; Atkinson SH, 2006, PLOS MED, V3, P652, DOI 10.1371/journal.pmed.0030172; Bachli EB, 2006, J LEUKOCYTE BIOL, V79, P312, DOI 10.1189/jlb.0605309; Berger MM, 2007, CRIT CARE MED, V35, pS584, DOI 10.1097/01.CCM.0000279189.81529.C4; Blum S, 2007, J AM COLL CARDIOL, V49, P82, DOI 10.1016/j.jacc.2006.08.044; Buehler PW, 2009, BLOOD, V113, P2578, DOI 10.1182/blood-2008-08-174466; CADENAS E, 1989, ANNU REV BIOCHEM, V58, P79, DOI 10.1146/annurev.bi.58.070189.000455; Catala A, 2009, CHEM PHYS LIPIDS, V157, P1, DOI 10.1016/j.chemphyslip.2008.09.004; Cepinskas G, 2008, J CLIN BIOCHEM NUTR, V42, P175, DOI 10.3164/jcbn.2008026; CERDA S, 1990, J IMMUNOL METHODS, V134, P51, DOI 10.1016/0022-1759(90)90111-8; Chaichana KL, 2007, STROKE, V38, P3266, DOI 10.1161/STROKEAHA.107.490003; Comporti MM, 1998, FREE RADICAL RES, V28, P623, DOI 10.3109/10715769809065818; COOPER GS, 1990, MEDICINE, V69, P114, DOI 10.1097/00005792-199069020-00005; DEMONTELLANO PRO, 1992, ANNU REV PHARMACOL, V32, P89, DOI 10.1146/annurev.pharmtox.32.1.89; EVERSE J, 1994, METHOD ENZYMOL, V231, P547; FREI B, 1989, P NATL ACAD SCI USA, V86, P6377, DOI 10.1073/pnas.86.16.6377; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; GIULIVI C, 1990, J BIOL CHEM, V265, P19453; GOODE HF, 1993, CRIT CARE MED, V21, P1770, DOI 10.1097/00003246-199311000-00029; Graversen JH, 2002, INT J BIOCHEM CELL B, V34, P309, DOI 10.1016/S1357-2725(01)00144-3; GUTTERIDGE JMC, 1987, BIOCHIM BIOPHYS ACTA, V917, P219, DOI 10.1016/0005-2760(87)90125-1; Han S, 2002, IMMUNOLOGY, V106, P53, DOI 10.1046/j.1365-2567.2002.01404.x; Hubel CA, 1997, FREE RADICAL BIO MED, V23, P597, DOI 10.1016/S0891-5849(97)00010-5; HULTQUIST DE, 1971, NATURE-NEW BIOL, V229, P252, DOI 10.1038/newbio229252a0; HWANG PK, 1980, J BIOL CHEM, V255, P3038; Jeffers A, 2006, FREE RADICAL BIO MED, V41, P1557, DOI 10.1016/j.freeradbiomed.2006.08.017; Jia YP, 2007, J BIOL CHEM, V282, P4894, DOI 10.1074/jbc.M609955200; Kapralov AA, 2007, BIOCHEMISTRY-US, V46, P14232, DOI 10.1021/bi701237b; KAYE D, 1963, J IMMUNOL, V91, P65; Keszler A, 2006, FREE RADICAL BIO MED, V40, P507, DOI 10.1016/j.freeradbiomed.2005.09.005; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Langlois MR, 1996, CLIN CHEM, V42, P1589; LAVIALLE F, 1976, EUR J BIOCHEM, V64, P287, DOI 10.1111/j.1432-1033.1976.tb10299.x; Liu L, 2004, CELL, V116, P617, DOI 10.1016/S0092-8674(04)00131-X; Long CL, 2003, J SURG RES, V109, P144, DOI 10.1016/S0022-4804(02)00083-5; Madsen M, 2004, J BIOL CHEM, V279, P51561, DOI 10.1074/jbc.M409629200; MARTIN WJ, 1984, AM REV RESPIR DIS, V130, P209; Mason RP, 2004, FREE RADICAL BIO MED, V36, P1214, DOI 10.1016/j.freeradbiomed.2004.02.077; MCCORMICK DJ, 1990, J PROTEIN CHEM, V9, P735, DOI 10.1007/BF01024768; Melamed-Frank M, 2001, BLOOD, V98, P3693, DOI 10.1182/blood.V98.13.3693; NIELSEN MJ, 2009, ANTIOXID RE IN PRESS; PERUTZ MF, 1990, ANNU REV PHYSIOL, V52, P1; Reeder BJ, 2005, CURR MED CHEM, V12, P2741, DOI 10.2174/092986705774463021; Reeder BJ, 2004, ANTIOXID REDOX SIGN, V6, P954, DOI 10.1089/ars.2004.6.954; Reeder BJ, 2002, BIOCHEMISTRY-US, V41, P367, DOI 10.1021/bi011335b; Schaer DJ, 2007, ANTIOXID REDOX SIGN, V9, P991, DOI 10.1089/ars.2007.1576; Schroder E, 2008, CURR OPIN PHARMACOL, V8, P153, DOI 10.1016/j.coph.2007.12.012; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Strauss JG, 2002, BIOCHEM J, V368, P69, DOI 10.1042/BJ20020306; Su DH, 1997, INFECT IMMUN, V65, P1258, DOI 10.1128/IAI.65.4.1258-1266.1997; Svistunenko DA, 2005, BBA-BIOENERGETICS, V1707, P127, DOI 10.1016/j.bbabio.2005.01.004; Takeya R, 2006, ANTIOXID REDOX SIGN, V8, P1523, DOI 10.1089/ars.2006.8.1523; Thomas Philip, 2005, Journal of Pharmacological and Toxicological Methods, V51, P187, DOI 10.1016/j.vascn.2004.08.014; Tyurina YY, 2006, MOL PHARMACOL, V70, P706, DOI 10.1124/mol.106.022731; Vallelian F, 2008, FREE RADICAL BIO MED, V45, P1150, DOI 10.1016/j.freeradbiomed.2008.07.013; Venkatesh B, 2005, BIOPOLYMERS, V80, P18, DOI 10.1002/bip.20194; Vlasova II, 2006, J BIOL CHEM, V281, P14554, DOI 10.1074/jbc.M509507200; WAKS M, 1963, BIOCHIM BIOPHYS ACTA, V67, P417	65	75	78	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30395	30407		10.1074/jbc.M109.045567	http://dx.doi.org/10.1074/jbc.M109.045567			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19740759	Green Published, hybrid			2022-12-27	WOS:000271090000042
J	Singh, DK; Rosenhouse-Dantsker, A; Nichols, CG; Enkvetchakul, D; Levitan, I				Singh, Dev K.; Rosenhouse-Dantsker, Avia; Nichols, Colin G.; Enkvetchakul, Decha; Levitan, Irena			Direct Regulation of Prokaryotic Kir Channel by Cholesterol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECTIFYING K+ CHANNELS; SENSITIVE POTASSIUM CHANNELS; LIPID RAFTS; ACETYLCHOLINE-RECEPTOR; MEMBRANE MICRODOMAINS; ENDOTHELIAL-CELLS; BILAYER-MEMBRANES; CRYSTAL-STRUCTURE; IN-VIVO; CAVEOLAE	Our earlier studies have shown that channel activity of Kir2 subfamily of inward rectifiers is strongly suppressed by the elevation of cellular cholesterol. The goal of this study is to determine whether cholesterol suppresses Kir channels directly. To achieve this goal, purified prokaryotic Kir (KirBac1.1) channels were incorporated into liposomes of defined lipid composition, and channel activity was assayed by Rb-86(+) uptake. Our results show that Rb-86(+) flux through KirBac1.1 is strongly inhibited by cholesterol. Incorporation of 5% ( mass cholesterol/phospholipid) cholesterol into the liposome suppresses Rb-86(+) flux by >50%, and activity is completely inhibited at 12-15%. However, epicholesterol, a stereoisomer of cholesterol with similar physical properties, has significantly less effect on KirBac-mediated Rb-86(+) uptake than cholesterol. Furthermore, analysis of multiple sterols suggests that cholesterol-induced inhibition of KirBac1.1 channels is mediated by specific interactions rather than by changes in the physical properties of the lipid bilayer. In contrast to the inhibition of KirBac1.1 activity, cholesterol had no effect on the activity of reconstituted KscA channels (at up to 250 mu g/mg of phospholipid). Taken together, these observations demonstrate that cholesterol suppresses Kir channels in a pure protein-lipid environment and suggest that the interaction is direct and specific.	[Singh, Dev K.; Rosenhouse-Dantsker, Avia; Levitan, Irena] Univ Illinois, Dept Med, Chicago, IL 60612 USA; [Nichols, Colin G.] Washington Univ, Dept Cell Biol & Physiol, St Louis, MO 63104 USA; [Enkvetchakul, Decha] St Louis Univ, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Washington University (WUSTL); Saint Louis University	Singh, DK (corresponding author), Univ Illinois, Dept Med, Chicago, IL 60612 USA.	dksingh@uic.edu; denkvetc@slu.edu; levitan@uic.edu	Nichols, Colin/D-6336-2012; Singh, Dev Karam/AFF-8404-2022; Singh, Dev Karam/AAF-1014-2022		National Institutes of Health [HL073965, HL083298, HL54171, DK069424]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073965, R01HL083298, R01HL054171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069424] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL073965 and HL083298 ( to I. L.), HL54171 ( to C. G. N.), and DK069424 ( to D. E.).	Ahn KW, 2000, J BIOCHEM MOL BIOL, V33, P541; Andersen O S, 1999, Methods Enzymol, V294, P208; BARRANTES FJ, 1993, FASEB J, V7, P1460, DOI 10.1096/fasebj.7.15.8262330; Bichet D, 2003, NAT REV NEUROSCI, V4, P957, DOI 10.1038/nrn1244; BITTMAN R, 1972, BIOCHEMISTRY-US, V11, P4831, DOI 10.1021/bi00775a029; Burger K, 2000, CELL MOL LIFE SCI, V57, P1577, DOI 10.1007/PL00000643; CRIADO M, 1982, BIOCHEMISTRY-US, V21, P3622, DOI 10.1021/bi00258a015; Cuello LG, 1998, BIOCHEMISTRY-US, V37, P3229, DOI 10.1021/bi972997x; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Enkvetchakul D, 2005, J BIOL CHEM, V280, P35785, DOI 10.1074/jbc.C500355200; Enkvetchakul D, 2004, J BIOL CHEM, V279, P47076, DOI 10.1074/jbc.C400417200; Enkvetchakul D, 2007, J GEN PHYSIOL, V130, P329, DOI 10.1085/jgp.200709764; Epshtein Y, 2009, P NATL ACAD SCI USA, V106, P8055, DOI 10.1073/pnas.0809847106; EVANS E, 1987, J PHYS CHEM-US, V91, P4219, DOI 10.1021/j100300a003; Fang Y, 2006, CIRC RES, V98, P1064, DOI 10.1161/01.RES.0000218776.87842.43; Fang Y, 2005, AM J PHYSIOL-CELL PH, V289, pC1134, DOI 10.1152/ajpcell.00077.2005; Gidwani A, 2001, BIOCHEMISTRY-US, V40, P12422, DOI 10.1021/bi010496c; Gimpl G, 1997, BIOCHEMISTRY-US, V36, P10959, DOI 10.1021/bi963138w; Haider S, 2007, BIOCHEMISTRY-US, V46, P3643, DOI 10.1021/bi062210f; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Heginbotham L, 1998, J GEN PHYSIOL, V111, P741, DOI 10.1085/jgp.111.6.741; Hibino H, 2007, EUR J NEUROSCI, V26, P2539, DOI 10.1111/j.1460-9568.2007.05876.x; Hua XX, 1996, CELL, V87, P415, DOI 10.1016/S0092-8674(00)81362-8; Inanobe A, 2007, CHANNELS, V1, P40, DOI 10.4161/chan.3842; Kahya N, 2006, MOL MEMBR BIOL, V23, P29, DOI 10.1080/09687860500489099; Krishnan MN, 2005, J GEN PHYSIOL, V126, P271, DOI 10.1085/jgp.200509323; Kubo Y, 2005, PHARMACOL REV, V57, P509, DOI 10.1124/pr.57.4.11; Kuo AL, 2005, STRUCTURE, V13, P1463, DOI 10.1016/j.str.2005.07.011; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Levitan I, 2009, IUBMB LIFE, V61, P781, DOI 10.1002/iub.192; Logothetis DE, 2007, PFLUG ARCH EUR J PHY, V455, P83, DOI 10.1007/s00424-007-0276-5; Logothetis DE, 2007, J PHYSIOL-LONDON, V582, P953, DOI 10.1113/jphysiol.2007.133157; Lopatin AN, 2001, J MOL CELL CARDIOL, V33, P625, DOI 10.1006/jmcc.2001.1344; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Lundbaek JA, 1996, BIOCHEMISTRY-US, V35, P3825, DOI 10.1021/bi952250b; Lundbaek JA, 2004, J GEN PHYSIOL, V123, P599, DOI 10.1085/jgp.200308996; Maguy A, 2006, CARDIOVASC RES, V69, P798, DOI 10.1016/j.cardiores.2005.11.013; MARSH D, 1978, P NATL ACAD SCI USA, V75, P4329, DOI 10.1073/pnas.75.9.4329; Martens JR, 2000, J BIOL CHEM, V275, P7443, DOI 10.1074/jbc.275.11.7443; Martens JR, 2004, TRENDS PHARMACOL SCI, V25, P16, DOI 10.1016/j.tips.2003.11.007; Martens JR, 2001, J BIOL CHEM, V276, P8409, DOI 10.1074/jbc.M009948200; Mohler ER, 2007, BIOCHEM BIOPH RES CO, V358, P317, DOI 10.1016/j.bbrc.2007.04.138; MORRIS S, 2006, RECENT RES DEV BIOPH; MURARI R, 1986, BIOCHEMISTRY-US, V25, P1062, DOI 10.1021/bi00353a017; NEEDHAM D, 1990, BIOPHYS J, V58, P997, DOI 10.1016/S0006-3495(90)82444-9; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; O'Connell KMS, 2005, J CELL SCI, V118, P2155, DOI 10.1242/jcs.02348; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Rohacs T, 1999, J BIOL CHEM, V274, P36065, DOI 10.1074/jbc.274.51.36065; Rohlf F. J., 1994, STAT TABLES; Romanenko VG, 2004, BIOPHYS J, V87, P3850, DOI 10.1529/biophysj.104.043273; Romanenko VG, 2002, BIOPHYS J, V83, P3211, DOI 10.1016/S0006-3495(02)75323-X; Sampson LJ, 2007, CARDIOVASC RES, V76, P61, DOI 10.1016/j.cardiores.2007.05.020; Sampson LJ, 2004, CIRC RES, V95, P1012, DOI 10.1161/01.RES.0000148634.47095.ab; SOKAL RR, 1994, BIOMETRY; Tikku S, 2007, AM J PHYSIOL-CELL PH, V293, pC440, DOI 10.1152/ajpcell.00492.2006; Wang S, 2009, J BIOL CHEM, V284, P2854, DOI 10.1074/jbc.M807474200; Wang XL, 2005, J BIOL CHEM, V280, P11656, DOI 10.1074/jbc.M410987200; Xu XL, 2000, BIOCHEMISTRY-US, V39, P843, DOI 10.1021/bi992543v; YEAGLE PL, 1991, BIOCHIMIE, V73, P1303, DOI 10.1016/0300-9084(91)90093-G; YEAGLE PL, 1985, BIOCHIM BIOPHYS ACTA, V822, P267, DOI 10.1016/0304-4157(85)90011-5; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103	64	54	54	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30727	30736		10.1074/jbc.M109.011221	http://dx.doi.org/10.1074/jbc.M109.011221			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19740741	Green Published, hybrid			2022-12-27	WOS:000271090000074
J	Lu, XY; Liu, J; Legerski, RJ				Lu, Xiaoyan; Liu, Jia; Legerski, Randy J.			Cyclin E Is Stabilized in Response to Replication Fork Barriers Leading to Prolonged S Phase Arrest	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-BOX PROTEIN; CELL-CYCLE; DNA-REPLICATION; BREAST-CANCER; DEPENDENT REGULATION; MAMMALIAN CDC6; MESSENGER-RNA; CHECKPOINT; ACTIVATION; COMPLEX	Cyclin E is a regulator of cyclin-dependent protein kinases (Cdks) and is involved in mediating the cell cycle transition from G(1) to S phase. Here, we describe a novel function for cyclin E in the long term maintenance of checkpoint arrest in response to replication barriers. Exposure of cells to mitomycin C or UV irradiation, but not ionizing radiation, induces stabilization of cyclin E. Stabilization of cyclin E reduces the activity of Cdk2-cyclin A, resulting in a slowing of S phase progression and arrest. In addition, cyclin E is shown to be required for stabilization of Cdc6, which is required for activation of Chk1 and the replication checkpoint pathway. Furthermore, the stabilization of cyclin E in response to replication fork barriers depends on ATR, but not Nbs1 or Chk1. These results indicate that in addition to its well studied role in promoting cell cycle progression, cyclin E also has a role in regulating cell cycle arrest in response to DNA damage.	[Lu, Xiaoyan; Liu, Jia; Legerski, Randy J.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Legerski, RJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genet, 1515 Holcombe Blvd, Houston, TX 77030 USA.	rlegersk@mdanderson.org			NCI [CA097175]; Cancer Center [CA16672]; NATIONAL CANCER INSTITUTE [P01CA097175, P30CA016672] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA097175 from the NCI. DNA sequencing resources were supported by the Cancer Center Support Grant CA16672.	Abukhdeir Abde M., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000744; Akkari YMN, 2000, MOL CELL BIOL, V20, P8283, DOI 10.1128/MCB.20.21.8283-8289.2000; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Blomberg I, 1999, MOL CELL BIOL, V19, P6183; Borlado LR, 2008, CARCINOGENESIS, V29, P237, DOI 10.1093/carcin/bgm268; Borriello A, 2007, CELL CYCLE, V6, P1053, DOI 10.4161/cc.6.9.4142; Bortner DM, 1997, MOL CELL BIOL, V17, P453, DOI 10.1128/MCB.17.1.453; Clay-Farrace L, 2003, EMBO J, V22, P704, DOI 10.1093/emboj/cdg046; Clurman BE, 1996, GENE DEV, V10, P1979, DOI 10.1101/gad.10.16.1979; Coverley D, 2002, NAT CELL BIOL, V4, P523, DOI 10.1038/ncb813; Ekholm-Reed S, 2004, J CELL BIOL, V165, P789, DOI 10.1083/jcb.200404092; Erlandsson F, 2003, INT J CANCER, V104, P369, DOI 10.1002/ijc.10949; Geng LY, 2007, MOL CELL BIOL, V27, P2625, DOI 10.1128/MCB.02072-06; Geng Y, 2007, MOL CELL, V25, P127, DOI 10.1016/j.molcel.2006.11.029; Gupta-Rossi N, 2001, J BIOL CHEM, V276, P34371, DOI 10.1074/jbc.M101343200; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hermand D, 2007, MOL CELL, V26, P553, DOI 10.1016/j.molcel.2007.04.014; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Keyomarsi K, 2003, NAT MED, V9, P152, DOI 10.1038/nm0203-152; KEYOMARSI K, 1995, ONCOGENE, V11, P941; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Lambert S, 2005, BIOCHIMIE, V87, P591, DOI 10.1016/j.biochi.2004.10.020; Liu LL, 2009, CELL CYCLE, V8, P628, DOI 10.4161/cc.8.4.7791; Liu LH, 2009, INT J BIOCHEM CELL B, V41, P1410, DOI 10.1016/j.biocel.2008.12.014; Loeb KR, 2000, CARCINOGENESIS, V21, P379, DOI 10.1093/carcin/21.3.379; Mailand N, 2005, CELL, V122, P915, DOI 10.1016/j.cell.2005.08.013; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McDonald WH, 1999, MOL CELL BIOL, V19, P5352; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Mladenov E, 2007, J CELL PHYSIOL, V211, P468, DOI 10.1002/jcp.20957; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Murakami H, 2002, NAT CELL BIOL, V4, P384, DOI 10.1038/ncb789; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Neganova I, 2008, J ANAT, V213, P30, DOI 10.1111/j.1469-7580.2008.00931.x; Oehlmann M, 2004, J CELL BIOL, V165, P181, DOI 10.1083/jcb.200311044; OHTSUBO M, 1993, SCIENCE, V259, P1908, DOI 10.1126/science.8384376; Park EA, 2007, P NATL ACAD SCI USA, V104, P16739, DOI 10.1073/pnas.0707804104; Petersen BO, 2000, GENE DEV, V14, P2330, DOI 10.1101/gad.832500; Petersen BO, 1999, EMBO J, V18, P396, DOI 10.1093/emboj/18.2.396; Pichierri P, 2004, EMBO J, V23, P1178, DOI 10.1038/sj.emboj.7600113; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Reed SE, 2004, CANCER RES, V64, P795, DOI 10.1158/0008-5472.CAN-03-3417; RESNITZKY D, 1994, MOL CELL BIOL, V14, P1669, DOI 10.1128/MCB.14.3.1669; Sandhu C, 2000, CANCER DETECT PREV, V24, P107; Singer JD, 1999, GENE DEV, V13, P2375, DOI 10.1101/gad.13.18.2375; Spruck CH, 2002, CANCER RES, V62, P4535; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; van Drogen F, 2006, MOL CELL, V23, P37, DOI 10.1016/j.molcel.2006.05.020; Wang HY, 2009, J BIOL CHEM, V284, P18236, DOI 10.1074/jbc.M109.002584; Welcker M, 2003, MOL CELL, V12, P381, DOI 10.1016/S1097-2765(03)00287-9; Whitfield ML, 2000, MOL CELL BIOL, V20, P4188, DOI 10.1128/MCB.20.12.4188-4198.2000; WIMMEL A, 1994, ONCOGENE, V9, P995; Won KA, 1996, EMBO J, V15, P4182, DOI 10.1002/j.1460-2075.1996.tb00793.x; Woo RA, 2003, CELL CYCLE, V2, P316, DOI 10.4161/cc.2.4.468; Yeh ES, 2006, J BIOL CHEM, V281, P241, DOI 10.1074/jbc.M505770200; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	57	20	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35325	35337		10.1074/jbc.M109.035949	http://dx.doi.org/10.1074/jbc.M109.035949			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19812034	Green Published, hybrid			2022-12-27	WOS:000272645600009
J	Chen, MY; Philipp, M; Wang, JB; Premont, RT; Garrison, TR; Caron, MG; Lefkowitz, RJ; Chen, W				Chen, Minyong; Philipp, Melanie; Wang, Jiangbo; Premont, Richard T.; Garrison, Tiffany R.; Caron, Marc G.; Lefkowitz, Robert J.; Chen, Wei			G Protein-coupled Receptor Kinases Phosphorylate LRP6 in the Wnt Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MECHANISM; INHIBITION; MESODERM	Wnt ligands conduct their functions in canonical Wnt signaling by binding to two receptors, the single transmembrane low density lipoprotein receptor-related proteins 5 and 6 (LRP5/6) and seven transmembrane (7TM) Frizzled receptors. Subsequently, phosphorylation of serine/threonine residues within five repeating signature PPPSP motifs on LRP6 is responsible for LRP6 activation. GSK3 beta, a cytosolic kinase for phosphorylation of a downstream effector beta-catenin, was proposed to participate in such LRP6 phosphorylation. Here, we report a new class of membrane-associated kinases for LRP6 phosphorylation. We found that G protein-coupled receptor kinases 5 and 6 (GRK5/6), traditionally known to phosphorylate and desensitize 7TM G protein-coupled receptors, directly phosphorylate the PPPSP motifs on single transmembrane LRP6 and regulate Wnt/LRP6 signaling. GRK5/6-induced LRP6 activation is inhibited by the LRP6 antagonist Dickkopf. Depletion of GRK5 markedly reduces Wnt3A-stimulated LRP6 phosphorylation in cells. In zebrafish, functional knock-down of GRK5 results in reduced Wnt signaling, analogous to LRP6 knock-down, as assessed by decreased abundance of beta-catenin and lowered expression of the Wnt target genes cdx4, vent, and axin2. Expression of GRK5 rescues the diminished beta-catenin and axin2 response caused by GRK5 depletion. Thus, our findings identify GRK5/6 as novel kinases for the single transmembrane receptor LRP6 during Wnt signaling.	[Chen, Minyong; Wang, Jiangbo; Premont, Richard T.; Garrison, Tiffany R.; Caron, Marc G.; Lefkowitz, Robert J.; Chen, Wei] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Philipp, Melanie; Caron, Marc G.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Lefkowitz, Robert J.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University; Howard Hughes Medical Institute	Chen, W (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	w.chen@duke.edu	Philipp, Melanie/B-5198-2016; Wang, Jiangbo/F-9246-2011; Lefkowitz, Robert/AAW-2649-2021	Philipp, Melanie/0000-0003-2714-965X; Chen, Wei/0000-0002-9934-4000; Premont, Richard/0000-0002-8053-5026	National Institutes of Health [5R01 CA113656-03]; Pediatric Brain Tumor Foundation; Susan G. Komen for the Cure; Alexander and Margaret Stewart Trust; NATIONAL CANCER INSTITUTE [R01CA113656] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR012546] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pediatric Brain Tumor Foundation; Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Alexander and Margaret Stewart Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01 CA113656-03 (to W.C.). This work was also supported by the Pediatric Brain Tumor Foundation (to W.C.), Susan G. Komen for the Cure (to W.C.), and the Alexander and Margaret Stewart Trust Fund (to W.C.).	Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Bryja V, 2007, P NATL ACAD SCI USA, V104, P6690, DOI 10.1073/pnas.0611356104; Chen W, 2001, P NATL ACAD SCI USA, V98, P14889, DOI 10.1073/pnas.211572798; Chen W, 2003, SCIENCE, V301, P1394, DOI 10.1126/science.1083195; Davidson AJ, 2003, NATURE, V425, P300, DOI 10.1038/nature01973; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Dicker F, 1999, P NATL ACAD SCI USA, V96, P5476, DOI 10.1073/pnas.96.10.5476; Ding S, 2003, P NATL ACAD SCI USA, V100, P7632, DOI 10.1073/pnas.0732087100; Fuerer C, 2008, EMBO REP, V9, P134, DOI 10.1038/sj.embor.7401159; Gainetdinov RR, 2003, NEURON, V38, P291, DOI 10.1016/S0896-6273(03)00192-2; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; PREMONT RT, 1994, J BIOL CHEM, V269, P6832; PREMONT RT, 1995, FASEB J, V9, P175, DOI 10.1096/fasebj.9.2.7781920; Ramel MC, 2005, DEV BIOL, V287, P237, DOI 10.1016/j.ydbio.2005.08.012; Ramel MC, 2004, DEVELOPMENT, V131, P3991, DOI 10.1242/dev.01277; Shimizu T, 2005, DEV BIOL, V279, P125, DOI 10.1016/j.ydbio.2004.12.007; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; van Amerongen R, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.135re9; Wan M, 2008, GENE DEV, V22, P2968, DOI 10.1101/gad.1702708; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Wei Q, 2007, J BIOL CHEM, V282, P15903, DOI 10.1074/jbc.M701927200; Weidinger G, 2005, CURR BIOL, V15, P489, DOI 10.1016/j.cub.2005.01.041; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540	32	48	53	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					35040	35048		10.1074/jbc.M109.047456	http://dx.doi.org/10.1074/jbc.M109.047456			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19801552	hybrid, Green Published			2022-12-27	WOS:000272439600058
J	Timmerman, P; Barderas, R; Desmet, J; Altschuh, D; Shochat, S; Hollestelle, MJ; Hoppener, JWM; Monasterio, A; Casal, JI; Meloen, RH				Timmerman, Peter; Barderas, Rodrigo; Desmet, Johan; Altschuh, Daniele; Shochat, Susana; Hollestelle, Martine J.; Hoppener, Jo W. M.; Monasterio, Alberto; Ignacio Casal, J.; Meloen, Rob H.			A Combinatorial Approach for the Design of Complementarity-determining Region-derived Peptidomimetics with in Vitro Anti-tumoral Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLON-CANCER CELLS; MONOCLONAL-ANTIBODY; SYNTHETIC MOLECULE; PANCREATIC-CANCER; VARIABLE REGIONS; GROWTH-FACTOR; PHASE-II; GASTRIN; BINDING; PEPTIDES	The great success of therapeutic monoclonal antibodies has fueled research toward mimicry of their binding sites and the development of new strategies for peptide-based mimetics production. Here, we describe a new combinatorial approach for the production of peptidomimetics using the complementarity-determining regions (CDRs) from gastrin17 (pyroEGP-WLEEEEEAYGWMDF-NH2) antibodies as starting material for cyclic peptide synthesis in a microarray format. Gastrin17 is a trophic factor in gastrointestinal tumors, including pancreatic cancer, which makes it an interesting target for development of therapeutic antibodies. Screening of microarrays containing bicyclic peptidomimetics identified a high number of gastrin binders. A strong correlation was observed between gastrin binding and overall charge of the peptidomimetic. Most of the best gastrin binders proceeded from CDRs containing charged residues. In contrast, CDRs from high affinity antibodies containing mostly neutral residues failed to yield good binders. Our experiments revealed essential differences in the mode of antigen binding between CDR-derived peptidomimetics (K-d values in micromolar range) and the parental monoclonal antibodies (Kd values in nanomolar range). However, chemically derived peptidomimetics from gastrin binders were very effective in gastrin neutralization studies using cell-based assays, yielding a neutralizing activity in pancreatic tumoral cell lines comparable with that of gastrin-specific monoclonal antibodies. These data support the use of combinatorial CDR-peptide microarrays as a tool for the development of a new generation of chemically synthesized cyclic peptidomimetics with functional activity.	[Timmerman, Peter; Meloen, Rob H.] Pepscan Therapeut BV, NL-8243 RC Lelystad, Netherlands; [Timmerman, Peter] Univ Amsterdam, Fac Sci, Vant Hoff Inst Mol Sci, NL-1018 WS Amsterdam, Netherlands; [Barderas, Rodrigo; Ignacio Casal, J.] Ctr Invest Biol, Funct Prote Lab, Madrid 28040, Spain; [Desmet, Johan] Algonomics NV, B-9052 Ghent, Belgium; [Altschuh, Daniele; Shochat, Susana] Univ Strasbourg, Ecole Super Biotechnol Strasbourg, Biosensor Grp, F-67412 Illkirch Graffenstaden, France; [Hollestelle, Martine J.; Hoppener, Jo W. M.] Univ Med Ctr Utrecht, Dept Metab & Endocrine Dis, NL-3584 EA Utrecht, Netherlands; [Monasterio, Alberto] Proteomika SL, Derio 48160, Spain; [Meloen, Rob H.] Univ Utrecht, Acad Biomed Ctr, NL-3584 CL Utrecht, Netherlands	Pepscan Therapeutics B.V.; University of Amsterdam; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Utrecht University; Utrecht University Medical Center; Utrecht University	Timmerman, P (corresponding author), Pepscan Therapeut BV, Zuidersluisweg 2, NL-8243 RC Lelystad, Netherlands.	p.timmerman@pepscan.com; icasal@cib.csic.es	Timmerman, Peter/H-9214-2019; Barderas, Rodrigo/K-3560-2014; Casal, Ignacio/M-2312-2014; Altschuh, Danièle/P-8658-2016	Timmerman, Peter/0000-0001-6687-5297; Barderas, Rodrigo/0000-0003-3539-7469; Casal, Ignacio/0000-0003-1085-2840; 	European Commission [COOP-CT-2004-512691]; Dutch Ministry of Economic Affairs [TSGE2017]	European Commission(European CommissionEuropean Commission Joint Research Centre); Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands)	This work was supported in part by European Commission FP6 Cooperative Research Project COOP-CT-2004-512691.; Supported by the Dutch Ministry of Economic Affairs Grant TSGE2017.	Adams GP, 2005, NAT BIOTECHNOL, V23, P1147, DOI 10.1038/nbt1137; Barderas R, 2008, P NATL ACAD SCI USA, V105, P9029, DOI 10.1073/pnas.0801221105; Barderas R, 2008, INT J CANCER, V122, P2351, DOI 10.1002/ijc.23395; Barderas R, 2006, J IMMUNOL METHODS, V312, P182, DOI 10.1016/j.jim.2006.03.005; Blaskovich MA, 2000, NAT BIOTECHNOL, V18, P1065, DOI 10.1038/80257; Braden BC, 1998, IMMUNOL REV, V163, P45, DOI 10.1111/j.1600-065X.1998.tb01187.x; Brett BT, 2002, J CLIN ONCOL, V20, P4225, DOI 10.1200/JCO.2002.11.151; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Casset F, 2003, BIOCHEM BIOPH RES CO, V307, P198, DOI 10.1016/S0006-291X(03)01131-8; Dumoulin M, 2003, NATURE, V424, P783, DOI 10.1038/nature01870; Famulok M, 2001, CHEM BIOL, V8, P931, DOI 10.1016/S1074-5521(01)00070-9; FOOTE J, 1992, J MOL BIOL, V224, P487, DOI 10.1016/0022-2836(92)91010-M; Gilliam AD, 2007, EXPERT OPIN BIOL TH, V7, P397, DOI 10.1517/14712598.7.3.397; Gilliam AD, 2004, EJSO-EUR J SURG ONC, V30, P536, DOI 10.1016/j.ejso.2004.03.009; Haupt K, 1998, TRENDS BIOTECHNOL, V16, P468, DOI 10.1016/S0167-7799(98)01222-0; Hayden EC, 2008, NAT MED, V14, P108, DOI 10.1038/nm0208-108; Heap CJ, 2005, J GEN VIROL, V86, P1791, DOI 10.1099/vir.0.80812-0; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Hur K, 2006, J CANCER RES CLIN, V132, P85, DOI 10.1007/s00432-005-0043-y; KANG CY, 1988, SCIENCE, V240, P1034, DOI 10.1126/science.3368787; KieberEmmons T, 1997, CURR OPIN BIOTECH, V8, P435, DOI 10.1016/S0958-1669(97)80065-1; Kourlas H, 2007, CLIN THER, V29, P1850, DOI 10.1016/j.clinthera.2007.09.008; Laune D, 2000, J IMMUNOL METHODS, V239, P63, DOI 10.1016/S0022-1759(00)00177-0; Laune D, 1997, J BIOL CHEM, V272, P30937, DOI 10.1074/jbc.272.49.30937; Monnet C, 1999, J BIOL CHEM, V274, P3789, DOI 10.1074/jbc.274.6.3789; Muller YA, 1998, STRUCTURE, V6, P1153, DOI 10.1016/S0969-2126(98)00116-6; Park BW, 2000, NAT BIOTECHNOL, V18, P194, DOI 10.1038/72651; Qiu XQ, 2007, NAT BIOTECHNOL, V25, P921, DOI 10.1038/nbt1320; Reichert JM, 2005, NAT BIOTECHNOL, V23, P1073, DOI 10.1038/nbt0905-1073; Revets H, 2005, EXPERT OPIN BIOL TH, V5, P111, DOI 10.1517/14712598.5.1.111; Roguska MA, 1996, PROTEIN ENG, V9, P895, DOI 10.1093/protein/9.10.895; SINGH P, 1986, CANCER RES, V46, P1612; Singh P, 1996, CANCER RES, V56, P4111; SMITH JP, 1995, AM J PHYSIOL-REG I, V268, pR135, DOI 10.1152/ajpregu.1995.268.1.R135; Smith JP, 1996, AM J PHYSIOL-REG I, V270, pR1078, DOI 10.1152/ajpregu.1996.270.5.R1078; Sun JZ, 2005, ONCOGENE, V24, P4701, DOI 10.1038/sj.onc.1208391; Sun JZ, 2004, CANCER RES, V64, P3586, DOI 10.1158/0008-5472.CAN-03-2673; Takaishi S, 2009, AM J PATHOL, V175, P365, DOI 10.2353/ajpath.2009.081165; Takasaki W, 1997, NAT BIOTECHNOL, V15, P1266, DOI 10.1038/nbt1197-1266; TAN MH, 1986, CANCER INVEST, V4, P15, DOI 10.3109/07357908609039823; Timmerman P, 2005, CHEMBIOCHEM, V6, P821, DOI 10.1002/cbic.200400374; Timmerman P, 2007, J MOL RECOGNIT, V20, P283, DOI 10.1002/jmr.846; Timmerman P, 2004, MOL DIVERS, V8, P61, DOI 10.1023/B:MODI.0000025650.94399.bb; WATSON SA, 1988, BRIT J SURG, V75, P342, DOI 10.1002/bjs.1800750416; Yu HG, 2004, BIOCHEM PHARMACOL, V67, P135, DOI 10.1016/j.bcp.2003.08.015; Zhang X, 1996, NAT BIOTECHNOL, V14, P472, DOI 10.1038/nbt0496-472	46	27	33	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34126	34134		10.1074/jbc.M109.041459	http://dx.doi.org/10.1074/jbc.M109.041459			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19808684	Green Published, hybrid			2022-12-27	WOS:000272165200045
J	Sossey-Alaoui, K; Bialkowska, K; Plow, EF				Sossey-Alaoui, Khalid; Bialkowska, Katarzyna; Plow, Edward F.			The miR200 Family of MicroRNAs Regulates WAVE3-dependent Cancer Cell Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; WISKOTT-ALDRICH-SYNDROME; MIR-200 FAMILY; E-CADHERIN; LAMELLIPODIA FORMATION; REDUCED EXPRESSION; SYNDROME PROTEIN; ACTIN-FILAMENTS; REPRESSORS ZEB1; DOWN-REGULATION	MicroRNAs are small non-coding RNAs that are directly involved in the regulation of gene expression by either translational repression or degradation of target mRNAs. Because of the high level of conservation of the target motifs, known as seed sequences, within the 3'-untranslated regions, a single microRNA can regulate numerous target genes simultaneously, making this class of RNAs a powerful regulator of gene expression. The miR200 family of microRNAs has recently been shown to regulate the process of epithelial to mesenchymal transition during tumor progression and metastasis. Here, we report that the expression of WAVE3, an actin cytoskeleton remodeling and metastasis promoter protein, is regulated by miR200 microRNAs. We show a clear inverse correlation between expression levels of WAVE3 and miR200 microRNAs in invasive versus non-invasive cancer cells. miR200 directly targets the 3'-untranslated regions of the WAVE3 mRNA and inhibits its expression. The miR200-mediated down-regulation of WAVE3 results in a significant reduction in the invasive phenotype of cancer cells, which is specific to the loss of WAVE3 expression. Re-expression of a miR200-resistant WAVE3 reverses miR200-mediated inhibition of cancer cell invasion. Loss of WAVE3 expression downstream of miR200 also results in a dramatic change in cell morphology resembling that of a mesenchymal to epithelial transition. In conclusion, a novel mechanism for the regulation of WAVE3 expression in cancer cells has been identified, which controls the invasive properties and morphology of cancer cells associated with their metastatic potential.	[Sossey-Alaoui, Khalid; Bialkowska, Katarzyna; Plow, Edward F.] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Sossey-Alaoui, K (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, 9500 Euclid Ave,NB-50, Cleveland, OH 44195 USA.	sosseyk@ccf.org			United States Department of Defense [W81XWH-08-1-0236]; National Institutes of Health [P01HL073311, P50HL077107]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL073311, P50HL077107] Funding Source: NIH RePORTER	United States Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by startup funds from United States Department of Defense Grant W81XWH-08-1-0236 ( to K. S. A.) and by National Institutes of Health Grants P01HL073311 and P50HL077107 ( to E. F. P.).	Akao Y, 2006, BIOL PHARM BULL, V29, P903, DOI 10.1248/bpb.29.903; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Berx G, 2007, CLIN EXP METASTAS, V24, P587, DOI 10.1007/s10585-007-9114-6; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Cano A, 2008, TRENDS CELL BIOL, V18, P357, DOI 10.1016/j.tcb.2008.05.005; Cory GOC, 2002, NATURE, V418, P732, DOI 10.1038/418732a; Dahl JP, 2003, J NEUROSCI, V23, P3343; DERRY JMJ, 1994, CELL, V78, P635, DOI 10.1016/0092-8674(94)90528-2; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fuchs IB, 2002, ANTICANCER RES, V22, P3415; Fukuoka M, 2001, J CELL BIOL, V152, P471, DOI 10.1083/jcb.152.3.471; Gregory PA, 2008, CELL CYCLE, V7, P3112, DOI 10.4161/cc.7.20.6851; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hurteau GJ, 2007, CANCER RES, V67, P7972, DOI 10.1158/0008-5472.CAN-07-1058; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Korpal M, 2008, RNA BIOL, V5, P115, DOI 10.4161/rna.5.3.6558; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Oda A, 2005, BLOOD, V105, P3141, DOI 10.1182/blood-2003-04-1319; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Savagner P, 2001, BIOESSAYS, V23, P912, DOI 10.1002/bies.1132; Sossey-Alaoui K, 2005, EXP CELL RES, V308, P135, DOI 10.1016/j.yexcr.2005.04.011; Sossey-Alaoui K, 2005, J BIOL CHEM, V280, P21748, DOI 10.1074/jbc.M500503200; Sossey-Alaoui K, 2003, MAMM GENOME, V14, P314, DOI 10.1007/s00335-002-2247-7; Sossey-Alaoui K, 2002, ONCOGENE, V21, P5967, DOI 10.1038/sj.onc.1205734; Sossey-Alaoui K, 2007, J BIOL CHEM, V282, P26257, DOI 10.1074/jbc.M701484200; Sossey-Alaoui K, 2007, AM J PATHOL, V170, P2112, DOI 10.2353/ajpath.2007.060975; Spaderna S, 2007, Verh Dtsch Ges Pathol, V91, P21; Spaderna Simone, 2009, Gastroenterology, V136, P1835, DOI 10.1053/j.gastro.2009.03.009; Stovold CF, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-11; Suetsugu S, 2003, DEV CELL, V5, P595, DOI 10.1016/S1534-5807(03)00297-1; Suetsugu S, 1999, BIOCHEM BIOPH RES CO, V260, P296, DOI 10.1006/bbrc.1999.0894; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Takenawa T, 2001, J CELL SCI, V114, P1801; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wang WG, 2004, CANCER RES, V64, P8585, DOI 10.1158/0008-5472.CAN-04-1136; Westphal RS, 2000, EMBO J, V19, P4589, DOI 10.1093/emboj/19.17.4589; Yamazaki D, 2003, NATURE, V424, P452, DOI 10.1038/nature01770; Yan C, 2003, EMBO J, V22, P3602, DOI 10.1093/emboj/cdg350; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025	53	94	98	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33019	33029		10.1074/jbc.M109.034553	http://dx.doi.org/10.1074/jbc.M109.034553			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801681	Green Published, hybrid			2022-12-27	WOS:000272028500004
J	Heiss, EH; Schachner, D; Werner, ER; Dirsch, VM				Heiss, Elke H.; Schachner, Daniel; Werner, Ernst R.; Dirsch, Verena M.			Active NF-E2-related Factor (Nrf2) Contributes to Keep Endothelial NO Synthase (eNOS) in the Coupled State ROLE OF REACTIVE OXYGEN SPECIES (ROS), eNOS, AND HEME OXYGENASE (HO-1) LEVELS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; FLUORESCENT DYE 2'-7'-DICHLOROFLUORESCEIN; TRANSCRIPTION FACTOR NRF2; FREE-RADICAL FORMATION; OXIDATIVE STRESS; CARBON-MONOXIDE; SHEAR-STRESS; HORSERADISH-PEROXIDASE; MOLECULAR-MECHANISMS; DIRECT INHIBITION	The aim of our study was to examine in detail the impact of NF-E2-related factor (Nrf2) activation on endothelial cell function with focus on redox homeostasis and the endothelial nitric oxide synthase (eNOS) system. We administered 2-cyano-3,12-dioxooleana-1,9-dien-28-oic imidazolide (CDDO-IM), a known activator of Nrf2, to primary human umbilical vein endothelial cells. Activation of Nrf2 by CDDO-IM increased the amount of bioavailable nitric oxide (NO), a major contributor to vascular homeostasis, in naive and stressed cells. Concomitantly, intracellular reactive oxygen species were dose-and time-dependently reduced. In apparent contrast to elevated NO levels, eNOS protein expression was transiently decreased in an Nrf2-dependent manner. Employing pharmacological inhibitors as well as a small interfering RNA approach, we identified de novo protein synthesis of heme oxygenase 1 (HO-1) and its enzymatic activity as cause for the observed reduction of eNOS. We hypothesize that under redox stress, when the availability of tetrahydrobiopterin, a pivotal stoichiometric cofactor for eNOS, is limited, activation of Nrf2 leads (a) to transient reduction of eNOS protein levels and (b) to an antioxidant defense in human umbilical vein endothelial cells. Both activities ensure that a stoichiometric ratio of eNOS and tetrahydrobiopterin is sustained and that the risk of eNOS uncoupling is reduced. Our study is the first to provide a causal link between Nrf2 activation and eNOS expression and NO levels, respectively.	[Heiss, Elke H.; Schachner, Daniel; Dirsch, Verena M.] Univ Vienna, Dept Pharmacognosy, A-1090 Vienna, Austria; [Werner, Ernst R.] Innsbruck Med Univ, Div Biol Chem, Bioctr, A-6020 Innsbruck, Austria	University of Vienna; Medical University of Innsbruck	Heiss, EH (corresponding author), Univ Vienna, Dept Pharmacognosy, Althanstr 14, A-1090 Vienna, Austria.	elke.heiss@univie.ac.at	Heiss, Elke/B-6086-2015	Heiss, Elke/0000-0001-7618-5505; Werner, Ernst R./0000-0003-1948-3391; Dirsch, Verena/0000-0002-9261-5293	"Hochschuljubilaumsstiftung der Stadt Wien" [H-01509/2007]; Austrian Research Funds "zur Forderung der wissenschaftlichen Forschung" [P19764]	"Hochschuljubilaumsstiftung der Stadt Wien"; Austrian Research Funds "zur Forderung der wissenschaftlichen Forschung"(Austrian Science Fund (FWF))	This work was supported in part by grants from the "Hochschuljubilaumsstiftung der Stadt Wien" (Grant H-01509/2007 to E. H. H.) and the Austrian Research Funds "zur Forderung der wissenschaftlichen Forschung" (Grant P19764 to E. R. W.).	Ahmad R, 2006, J BIOL CHEM, V281, P35764, DOI 10.1074/jbc.M607160200; Ali F, 2009, J BIOL CHEM, V284, P18882, DOI 10.1074/jbc.M109.009886; Batzlsperger CA, 2007, CARDIOVASC DRUG THER, V21, P347, DOI 10.1007/s10557-007-6051-1; Cai SJ, 2005, CARDIOVASC RES, V65, P823, DOI 10.1016/j.cardiores.2004.10.040; Chen XL, 2006, AM J PHYSIOL-HEART C, V290, pH1862, DOI 10.1152/ajpheart.00651.2005; Chen XL, 2003, J BIOL CHEM, V278, P703, DOI 10.1074/jbc.M203161200; Cosentino F, 2003, CIRCULATION, V107, P1017, DOI 10.1161/01.CIR.0000051367.92927.07; Crabtree MJ, 2009, J BIOL CHEM, V284, P1136, DOI 10.1074/jbc.M805403200; Dai G, 2007, CIRC RES, V101, P723, DOI 10.1161/CIRCRESAHA.107.152942; Dekker RJ, 2005, AM J PATHOL, V167, P609, DOI 10.1016/S0002-9440(10)63002-7; Dikalov S, 2007, HYPERTENSION, V49, P717, DOI 10.1161/01.HYP.0000258594.87211.6b; Durante W, 1998, INT J MOL MED, V2, P255; Fledderus JO, 2008, ARTERIOSCL THROM VAS, V28, P1339, DOI 10.1161/ATVBAHA.108.165811; Fleming I, 2003, AM J PHYSIOL-REG I, V284, pR1, DOI 10.1152/ajpregu.00323.2002; Fleming I, 1999, CARDIOVASC RES, V43, P532, DOI 10.1016/S0008-6363(99)00094-2; Forstermann U, 2006, BIOL CHEM, V387, P1521, DOI 10.1515/BC.2006.190; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; FURCHGOTT RF, 1991, BLOOD VESSELS, V28, P52; Gallis B, 1999, J BIOL CHEM, V274, P30101, DOI 10.1074/jbc.274.42.30101; Heiss EH, 2007, J BIOL CHEM, V282, P26759, DOI 10.1074/jbc.M703229200; Heller R, 2001, J BIOL CHEM, V276, P40, DOI 10.1074/jbc.M004392200; Hink U, 2001, CIRC RES, V88, pE14; Hosoya T, 2005, J BIOL CHEM, V280, P27244, DOI 10.1074/jbc.M502551200; Iori E, 2008, LIFE SCI, V82, P383, DOI 10.1016/j.lfs.2007.11.021; Itoh K, 2004, MOL CELL BIOL, V24, P36, DOI 10.1128/MCB.24.1.36-45.2004; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Jyrkkanen HK, 2008, CIRC RES, V103, pE1, DOI 10.1161/CIRCRESAHA.108.176883; Kang KW, 2005, ANTIOXID REDOX SIGN, V7, P1664, DOI 10.1089/ars.2005.7.1664; Kinderlerer AR, 2008, J BIOL CHEM, V283, P14636, DOI 10.1074/jbc.M800362200; Kirkby KA, 2006, AM J PHYSIOL-RENAL, V290, pF563, DOI 10.1152/ajprenal.00220.2005; Le Brocq M, 2008, ANTIOXID REDOX SIGN, V10, P1631, DOI 10.1089/ars.2007.2013; Leikert JF, 2002, CIRCULATION, V106, P1614, DOI 10.1161/01.CIR.0000034445.31543.43; Leikert JF, 2001, FEBS LETT, V506, P131, DOI 10.1016/S0014-5793(01)02901-5; Levonen AL, 2007, ARTERIOSCL THROM VAS, V27, P741, DOI 10.1161/01.ATV.0000258868.80079.4d; Liby K, 2005, CANCER RES, V65, P4789, DOI 10.1158/0008-5472.CAN-04-4539; Marchesi E, 1999, FREE RADICAL BIO MED, V26, P148, DOI 10.1016/S0891-5849(98)00174-9; Noriega GO, 2003, BBA-MOL BASIS DIS, V1638, P173, DOI 10.1016/S0925-4439(03)00081-4; Parmar KM, 2006, J CLIN INVEST, V116, P49, DOI 10.1172/JCI24787; Rathel Thomas R., 2003, Biol Proced Online, V5, P136, DOI 10.1251/bpo55; Rota C, 1999, J BIOL CHEM, V274, P28161, DOI 10.1074/jbc.274.40.28161; Rota C, 1999, FREE RADICAL BIO MED, V27, P873, DOI 10.1016/S0891-5849(99)00137-9; Samudio I, 2005, J BIOL CHEM, V280, P36273, DOI 10.1074/jbc.M507518200; Sugiyama T, 2009, J BIOL CHEM, V284, P12691, DOI 10.1074/jbc.M809295200; Sussan TE, 2009, P NATL ACAD SCI USA, V106, P250, DOI 10.1073/pnas.0804333106; Tabe Y, 2007, CANCER BIOL THER, V6, P1967, DOI 10.4161/cbt.6.12.4982; Thorup C, 1999, AM J PHYSIOL-RENAL, V277, pF882, DOI 10.1152/ajprenal.1999.277.6.F882; True AL, 2007, CIRC RES, V101, P893, DOI 10.1161/CIRCRESAHA.107.158998; Wang J, 2007, ARTERIOSCL THROM VAS, V27, P1283, DOI 10.1161/ATVBAHA.107.144659; Wang YP, 2000, MOL ENDOCRINOL, V14, P1550, DOI 10.1210/me.14.10.1550; Warabi E, 2007, FREE RADICAL BIO MED, V42, P260, DOI 10.1016/j.freeradbiomed.2006.10.043; Werner ER, 1996, REV PHYSIOL BIOCH P, V127, P97, DOI 10.1007/BFb0048266; Xue MZ, 2008, DIABETES, V57, P2809, DOI 10.2337/db06-1003; Yore MM, 2006, MOL CANCER THER, V5, P3232, DOI 10.1158/1535-7163.MCT-06-0444; Zabalgoitia M, 2008, FREE RADICAL BIO MED, V44, P284, DOI 10.1016/j.freeradbiomed.2007.08.012; Fokko ZA, 2007, BBA-MOL CELL BIOL L, V1771, P972, DOI 10.1016/j.bbalip.2007.04.021; Zhang CH, 2008, BASIC RES CARDIOL, V103, P398, DOI 10.1007/s00395-008-0733-0	56	73	86	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31579	31586		10.1074/jbc.M109.009175	http://dx.doi.org/10.1074/jbc.M109.009175			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19797052	Green Published, hybrid			2022-12-27	WOS:000271572700012
J	Kiel, C; Filchtinski, D; Spoerner, M; Schreiber, G; Kalbitzer, HR; Herrmann, C				Kiel, Christina; Filchtinski, Daniel; Spoerner, Michael; Schreiber, Gideon; Kalbitzer, Hans Robert; Herrmann, Christian			Improved Binding of Raf to Ras.GDP Is Correlated with Biological Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN ASSOCIATION; P-31 NMR-SPECTROSCOPY; DISSOCIATION STIMULATOR; EFFECTOR SPECIFICITY; BIOCHEMICAL-ANALYSIS; STRUCTURAL BASIS; H-RAS; R-RAS; COMPLEX; DOMAIN	The GTP-binding protein Ras plays a central role in the regulation of various cellular processes, acting as a molecular switch that triggers signaling cascades. Only Ras bound to GTP is able to interact strongly with effector proteins like Raf kinase, phosphatidylinositol 3-kinase, and RalGDS, whereas in the GDP-bound state, the stability of the complex is strongly decreased, and signaling is interrupted. To determine whether this process is only controlled by the stability of the complex, we used computer-aided protein design to improve the interaction between Ras and effector. We challenged the Ras.Raf complex in this study because Raf among all effectors shows the highest Ras affinity and the fastest association kinetics. The proposed mutations were characterized as to their changes in dynamics and binding strength. We demonstrate that Ras-Raf interaction can only be improved at the cost of a loss in specificity of Ras.GTP versus Ras.GDP. As shown by NMR spectroscopy, the Raf mutation A85K leads to a shift of Ras switch I in the GTP-bound as well as in the GDP-bound state, thereby increasing the complex stability. In a luciferase-based reporter gene assay, Raf A85K is associated with higher signaling activity, which appears to be a mere matter of Ras-Raf affinity.	[Filchtinski, Daniel; Herrmann, Christian] Ruhr Univ Bochum, Fak Chem & Biochem, D-44780 Bochum, Germany; [Kiel, Christina] Max Planck Inst Mol Physiol, Abt Strukturelle Biol, D-44227 Dortmund, Germany; [Spoerner, Michael; Kalbitzer, Hans Robert] Univ Regensburg, Inst Biophys & Phys Biochem, D-93053 Regensburg, Germany; [Schreiber, Gideon] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Kiel, Christina] Ctr Genom Regulat, Grp Design Biol Syst, Barcelona 08003, Spain	Ruhr University Bochum; Max Planck Society; University of Regensburg; Weizmann Institute of Science; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	Herrmann, C (corresponding author), Ruhr Univ Bochum, Fak Chem & Biochem, Univ Str 150, D-44780 Bochum, Germany.	chr.herrmann@rub.de	Spörner, Michael/B-9018-2012; Spoerner, Michael/C-9035-2012	Kiel, Christina/0000-0001-8454-6008; Kalbitzer, Hans Robert/0000-0002-6514-2355	Deutsche Forschungsgemeinschaft [SFB 642]; German-Israeli Foundation for Scientific Research and Development; Gerhard C. Starck foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German-Israeli Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development); Gerhard C. Starck foundation	The work was supported by Deutsche Forschungsgemeinschaft Grant SFB 642, by the German-Israeli Foundation for Scientific Research and Development, and by a grant from the Gerhard C. Starck foundation ( to D. F.).	Block C, 1996, NAT STRUCT BIOL, V3, P244, DOI 10.1038/nsb0396-244; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cox AD, 2003, ONCOGENE, V22, P8999, DOI 10.1038/sj.onc.1207111; EMERSON SD, 1995, BIOCHEMISTRY-US, V34, P6911, DOI 10.1021/bi00021a001; Fridman M, 2000, J BIOL CHEM, V275, P30363, DOI 10.1074/jbc.M003193200; Geyer M, 1996, BIOCHEMISTRY-US, V35, P10308, DOI 10.1021/bi952858k; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HAUSSER KH, 1991, NMR MED BIOL STRUCTU; Herrmann C, 2003, CURR OPIN STRUC BIOL, V13, P122, DOI 10.1016/S0959-440X(02)00007-6; Herrmann C, 1996, J BIOL CHEM, V271, P6794, DOI 10.1074/jbc.271.12.6794; HERRMANN C, 1995, J BIOL CHEM, V270, P2901, DOI 10.1074/jbc.270.7.2901; Huang L, 1998, NAT STRUCT BIOL, V5, P422, DOI 10.1038/nsb0698-422; Jaitner BK, 1997, J BIOL CHEM, V272, P29927, DOI 10.1074/jbc.272.47.29927; Janknecht R, 1996, MOL CELL BIOL, V16, P1550; JANKNECHT R, 1993, BIOCHIM BIOPHYS ACTA, V1155, P346, DOI 10.1016/0304-419X(93)90014-4; Khokhlatchev A, 2002, CURR BIOL, V12, P253, DOI 10.1016/S0960-9822(02)00683-8; Kiel C, 2004, P NATL ACAD SCI USA, V101, P9223, DOI 10.1073/pnas.0401160101; Kiel C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000397; KODAKI T, 1994, CURR BIOL, V4, P798, DOI 10.1016/S0960-9822(00)00177-9; Linnemann T, 1999, J BIOL CHEM, V274, P13556, DOI 10.1074/jbc.274.19.13556; Linnemann T, 2002, J BIOL CHEM, V277, P7831, DOI 10.1074/jbc.M110800200; Maurer T, 1996, J MAGN RESON SER B, V113, P177, DOI 10.1006/jmrb.1996.0172; MORRISON DK, 1988, P NATL ACAD SCI USA, V85, P8855, DOI 10.1073/pnas.85.23.8855; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; Nassar N, 1996, NAT STRUCT BIOL, V3, P723, DOI 10.1038/nsb0896-723; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; RAPP UR, 1983, P NATL ACAD SCI-BIOL, V80, P4218, DOI 10.1073/pnas.80.14.4218; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Rohrer M, 2001, BIOCHEMISTRY-US, V40, P1884, DOI 10.1021/bi002164y; Rudolph MG, 2001, J BIOL CHEM, V276, P23914, DOI 10.1074/jbc.M011600200; Scheffzek K, 2001, STRUCTURE, V9, P1043, DOI 10.1016/S0969-2126(01)00674-8; Schreiber G, 1996, NAT STRUCT BIOL, V3, P427, DOI 10.1038/nsb0596-427; Selzer T, 2000, NAT STRUCT BIOL, V7, P537; Selzer T, 1999, J MOL BIOL, V287, P409, DOI 10.1006/jmbi.1999.2615; SHAKA AJ, 1985, J MAGN RESON, V64, P547, DOI 10.1016/0022-2364(85)90122-2; Shaul Y, 2005, PROTEINS, V60, P341, DOI 10.1002/prot.20489; Shields JM, 2000, TRENDS CELL BIOL, V10, P147, DOI 10.1016/S0962-8924(00)01740-2; SPAARGAREN M, 1994, P NATL ACAD SCI USA, V91, P12609, DOI 10.1073/pnas.91.26.12609; Spoerner M, 2005, BIOCHEMISTRY-US, V44, P2225, DOI 10.1021/bi0488000; Spoerner M, 2004, FEBS LETT, V578, P305, DOI 10.1016/j.febslet.2004.11.020; Spoerner M, 2001, P NATL ACAD SCI USA, V98, P4944, DOI 10.1073/pnas.081441398; Spoerner M, 2007, FEBS J, V274, P1419, DOI 10.1111/j.1742-4658.2007.05681.x; STEPHENS LR, 1993, BIOCHIM BIOPHYS ACTA, V1179, P27, DOI 10.1016/0167-4889(93)90072-W; Stieglitz B, 2008, EMBO J, V27, P1995, DOI 10.1038/emboj.2008.125; Sydor JR, 1998, BIOCHEMISTRY-US, V37, P14292, DOI 10.1021/bi980764f; TUCKER J, 1986, EMBO J, V5, P1351, DOI 10.1002/j.1460-2075.1986.tb04366.x; Vavvas D, 1998, J BIOL CHEM, V273, P5439, DOI 10.1074/jbc.273.10.5439; Vetter IR, 1999, FEBS LETT, V451, P175, DOI 10.1016/S0014-5793(99)00555-4; Vijayakumar M, 1998, J MOL BIOL, V278, P1015, DOI 10.1006/jmbi.1998.1747; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Wohlgemuth S, 2005, J MOL BIOL, V348, P741, DOI 10.1016/j.jmb.2005.02.048; ZHOU HX, 1993, BIOPHYS J, V64, P1711, DOI 10.1016/S0006-3495(93)81543-1; Zhou HX, 1996, J CHEM PHYS, V105, P7235, DOI 10.1063/1.472530; Zhou HX, 1997, P NATL ACAD SCI USA, V94, P12372, DOI 10.1073/pnas.94.23.12372	56	25	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31893	31902		10.1074/jbc.M109.031153	http://dx.doi.org/10.1074/jbc.M109.031153			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19776012	hybrid, Green Published			2022-12-27	WOS:000271572700044
J	Noguchi, Y; Hirabayashi, T; Katori, S; Kawamura, Y; Sanbo, M; Hirabayashi, M; Kiyonari, H; Nakao, K; Uchimura, A; Yagi, T				Noguchi, Yukiko; Hirabayashi, Takahiro; Katori, Shota; Kawamura, Yoshimi; Sanbo, Makoto; Hirabayashi, Masumi; Kiyonari, Hiroshi; Nakao, Kazuki; Uchimura, Arikuni; Yagi, Takeshi			Total Expression and Dual Gene-regulatory Mechanisms Maintained in Deletions and Duplications of the Pcdha Cluster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTOCADHERIN-ALPHA FAMILY; CENTRAL-NERVOUS-SYSTEM; BETA-GLOBIN; GAMMA PROTOCADHERINS; SEQUENCE-ANALYSIS; PURKINJE-CELLS; CONTROL REGION; MESSENGER-RNA; HOXD COMPLEX; MOUSE	The clustered protocadherin-alpha (Pcdha) genes, which are expressed in the vertebrate brain, encode diverse membrane proteins whose functions are involved in axonal projection and in learning and memory. The Pcdha cluster consists of 14 tandemly arranged genes (Pcdha1-Pcdha12, Pcdhac1, and Pcdhac2, from 5' to 3'). Each first exon ( the variable exons) is transcribed from its own promoter, and spliced to the constant exons, which are common to all the Pcdha genes. Cerebellar Purkinje cells show dual expression patterns for Pcdha. In individual Purkinje cells, different sets of the 5' genes in the cluster, Pcdha1-12, are randomly expressed, whereas both 3' genes, Pcdhac1 and Pcdhac2, are expressed constitutively. To elucidate the relationship between the genomic structure of the Pcdha cluster and their expression in Purkinje cells, we deleted or duplicated multiple variable exons and analyzed the expression of Pcdha genes in the mouse brain. In all mutant mice, transcript levels of the constant exons and the dual expression patterns were maintained. In the deletion mutants, the missing genes were flexibly compensated by the remaining variable exons. On the other hand, in duplication mutants, the levels of the duplicated genes were trimmed. These results indicate that the Pcdha genes are comprehensively regulated as a cluster unit, and that the regulators that randomly and constitutively drive Pcdha gene expression are intact in the deleted or duplicated mutant alleles. These dual regulatory mechanisms may play important roles in the diversity and fundamental functions of neurons.	[Noguchi, Yukiko; Yagi, Takeshi] Osaka Univ, Grad Sch Med, Course Med Biosignaling, Suita, Osaka 5650871, Japan; [Hirabayashi, Takahiro; Katori, Shota; Kawamura, Yoshimi; Uchimura, Arikuni; Yagi, Takeshi] Osaka Univ, Grad Sch Frontier Biosci, Labs Integrated Biol, KOKORO Biol Grp, Suita, Osaka 5650871, Japan; [Sanbo, Makoto; Hirabayashi, Masumi] Natl Inst Physiol Sci, Ctr Genet Anal Behav, Sect Mammalian Transgenesis, Okazaki, Aichi 4448787, Japan; [Kiyonari, Hiroshi; Nakao, Kazuki] RIKEN Ctr Dev Biol, Lab Anim Resources & Genet Engn, Chuo Ku, Kobe, Hyogo 6500047, Japan	Osaka University; Osaka University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); RIKEN	Yagi, T (corresponding author), 1-3 Yamadaoka, Suita, Osaka 5650871, Japan.	yagi@fbs.osaka-u.ac.jp	Kiyonari, Hiroshi/N-7936-2015; Kawamura, Yoshimi/L-1289-2013; Hirabayashi, Masumi/C-8935-2019	Hirabayashi, Masumi/0000-0002-1059-5883; Uchimura, Arikuni/0000-0003-2435-7082; Kawamura, Yoshimi/0000-0002-9864-7974	Ministry of Education, Science, Sports, and Culture of Japan; Uehara Memorial Foundation; Takeda Foundation; National Institute for Physiological Sciences, Japan	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Foundation(Takeda Science Foundation (TSF)); National Institute for Physiological Sciences, Japan	This work was supported by grants-in-aid from the Ministry of Education, Science, Sports, and Culture of Japan, the Uehara Memorial Foundation, the Takeda Foundation, and in part by a grant from the Co-operative Study Program of the National Institute for Physiological Sciences, Japan.	Esumi S, 2005, NAT GENET, V37, P171, DOI 10.1038/ng1500; Esumi S, 2006, NAT PROTOC, V1, P2143, DOI 10.1038/nprot.2006.343; FOLEY KP, 1992, GENE DEV, V6, P730, DOI 10.1101/gad.6.5.730; Fukuda E, 2008, EUR J NEUROSCI, V28, P1362, DOI 10.1111/j.1460-9568.2008.06428.x; Gurskaya NG, 2001, FEBS LETT, V507, P16, DOI 10.1016/S0014-5793(01)02930-1; Hardison R, 1997, GENE, V205, P73, DOI 10.1016/S0378-1119(97)00474-5; Hasegawa S, 2008, MOL CELL NEUROSCI, V38, P66, DOI 10.1016/j.mcn.2008.01.016; Herault Y, 1998, NAT GENET, V20, P381, DOI 10.1038/3861; Imai T, 2008, CURR OPIN NEUROBIOL, V18, P251, DOI 10.1016/j.conb.2008.07.009; Junghans D, 2008, EUR J NEUROSCI, V27, P559, DOI 10.1111/j.1460-9568.2008.06052.x; Kaneko R, 2006, J BIOL CHEM, V281, P30551, DOI 10.1074/jbc.M605677200; Katori S, 2009, J NEUROSCI, V29, P9137, DOI 10.1523/JNEUROSCI.5478-08.2009; Kawamoto S, 2000, FEBS LETT, V470, P263, DOI 10.1016/S0014-5793(00)01338-7; KIM DG, 1992, MOL CELL BIOL, V12, P3636, DOI 10.1128/MCB.12.8.3636; Kmita M, 2000, NAT GENET, V26, P451, DOI 10.1038/82593; Kmita M, 2002, DEVELOPMENT, V129, P5521, DOI 10.1242/dev.00151; Kmita M, 2002, NATURE, V420, P145, DOI 10.1038/nature01189; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; KOZAK M, 1987, J MOL BIOL, V196, P947, DOI 10.1016/0022-2836(87)90418-9; LIU YC, 1993, BIOCHEMISTRY-US, V32, P10714, DOI 10.1021/bi00091a023; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Montavon T, 2008, GENE DEV, V22, P346, DOI 10.1101/gad.1631708; Morishita H, 2004, EUR J NEUROSCI, V20, P2843, DOI 10.1111/j.1460-9568.2004.03803.x; Mutoh T, 2004, EXP CELL RES, V294, P494, DOI 10.1016/j.yexcr.2003.11.019; NORDQUIST DT, 1988, J NEUROSCI, V8, P4780; OBATA S, 1995, J CELL SCI, V108, P3765; Ribich S, 2006, P NATL ACAD SCI USA, V103, P19719, DOI 10.1073/pnas.0609445104; SANO K, 1993, EMBO J, V12, P2249, DOI 10.1002/j.1460-2075.1993.tb05878.x; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Serafini T, 1999, CELL, V98, P133, DOI 10.1016/S0092-8674(00)81008-9; Spitz F, 2005, NAT GENET, V37, P889, DOI 10.1038/ng1597; Spitz F, 2003, CELL, V113, P405, DOI 10.1016/S0092-8674(03)00310-6; Stamatoyannopoulos G, 2001, MOL BASIS BLOOD DIS; Sugino H, 2000, GENOMICS, V63, P75, DOI 10.1006/geno.1999.6066; Takeda J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S14; Takei Y, 2001, GENOMICS, V72, P321, DOI 10.1006/geno.2000.6468; Tanimoto K, 1999, NATURE, V398, P344, DOI 10.1038/18698; Tasic B, 2002, MOL CELL, V10, P21, DOI 10.1016/S1097-2765(02)00578-6; Vidal F, 1998, MOL REPROD DEV, V51, P274, DOI 10.1002/(SICI)1098-2795(199811)51:3&lt;274::AID-MRD6&gt;3.0.CO;2-M; Wang XZ, 2002, GENE DEV, V16, P1890, DOI 10.1101/gad.1004802; Wang XZ, 2002, NEURON, V36, P843, DOI 10.1016/S0896-6273(02)01090-5; Weiner JA, 2005, P NATL ACAD SCI USA, V102, P8, DOI 10.1073/pnas.0407931101; WIJGERDE M, 1995, NATURE, V377, P209, DOI 10.1038/377209a0; Wu Q, 2001, GENOME RES, V11, P389, DOI 10.1101/gr.167301; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; YAGI T, 1993, NATURE, V366, P742, DOI 10.1038/366742a0; YAGI T, 1993, ANAL BIOCHEM, V214, P77, DOI 10.1006/abio.1993.1459; Yagi T, 2008, DEV GROWTH DIFFER, V50, pS131, DOI 10.1111/j.1440-169X.2008.00991.x; Zou C, 2007, NEUROSCIENCE, V144, P579, DOI 10.1016/j.neuroscience.2006.10.011	49	34	35	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					32002	32014		10.1074/jbc.M109.046938	http://dx.doi.org/10.1074/jbc.M109.046938			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19797050	Green Published, hybrid			2022-12-27	WOS:000271572700056
J	Rossi, MN; Carbone, M; Mostocotto, C; Mancone, C; Tripodi, M; Maione, R; Amati, P				Rossi, Marianna N.; Carbone, Mariarosaria; Mostocotto, Cassandra; Mancone, Carmine; Tripodi, Marco; Maione, Rossella; Amati, Paolo			Mitochondrial Localization of PARP-1 Requires Interaction with Mitofilin and Is Involved in the Maintenance of Mitochondrial DNA Integrity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLY(ADP-RIBOSE) POLYMERASE-1; PROTEOMIC ANALYSIS; HYDROGEN-PEROXIDE; COILED-COIL; CELL-DEATH; NUCLEAR; PROTEIN; TRANSCRIPTION; DAMAGE; NAD(+)	Poly(ADP-ribose) polymerase-1 (PARP-1) is a predominantly nuclear enzyme that exerts numerous functions in cellular physiology and pathology, from maintenance of DNA stability to transcriptional regulation. Through a proteomic analysis of PARP-1 co-immunoprecipitation complexes, we identified Mitofilin, a mitochondrial protein, as a new PARP-1 interactor. This result prompted us to further investigate the presence and the role of the enzyme in mitochondria. Using laser confocal microscopy and Western blot analysis of purified mitochondria, we demonstrated the mitochondrial localization of a fraction of PARP-1. Further, the effects of overexpressing or down-regulating Mitofilin showed that this protein promotes and is required for PARP-1 mitochondrial localization. We also report several lines of evidence suggesting that intramitochondrial PARP-1 plays a role in mitochondrialDNA(mtDNA) damage signaling and/or repair. First, we show that PARP-1 binds to different regions throughout the mtDNA. Moreover, we demonstrated that the depletion of either PARP-1 or Mitofilin, which abrogates the mitochondrial localization of the enzyme, leads to the accumulation of mtDNA damage. Finally, we show that DNA ligase III, known to be required for mtDNA repair, participates in a PARP-1-containing complex bound to mtDNA. This work highlights a new environment for PARP-1, opening the possibility that at least some of the nuclear functions of the enzyme can be also extended to mtDNA metabolism.	[Rossi, Marianna N.; Carbone, Mariarosaria; Mostocotto, Cassandra; Tripodi, Marco; Maione, Rossella; Amati, Paolo] Univ Roma La Sapienza, Inst Pasteur, Fdn Cenci Bolognetti, Dept Cellular Biotechnol & Hematol, I-00161 Rome, Italy; [Mancone, Carmine; Tripodi, Marco] Ist Ricovero & Cura Carattere Sci, Natl Inst Infect Dis L Spallanzani, I-00149 Rome, Italy	Fondazione Cenci Bolognetti; Sapienza University Rome; IRCCS Lazzaro Spallanzani	Amati, P (corresponding author), Univ Roma La Sapienza, Inst Pasteur, Fdn Cenci Bolognetti, Dept Cellular Biotechnol & Hematol, Viale Regina Elena 324, I-00161 Rome, Italy.	amati@bce.uniroma1.it	Tripodi, Marco/ABO-1160-2022; Tripodi, Marco/F-1143-2011; Rossi, Marianna Nicoletta/S-5083-2019	Tripodi, Marco/0000-0001-6135-971X; Tripodi, Marco/0000-0001-6135-971X; Rossi, Marianna Nicoletta/0000-0003-4485-7738; Mancone, Carmine/0000-0002-9569-5030	Associazione Italiana per la Ricerca sul Cancro (AIRC) [4179]; Agenzia Spaziale Italiana	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Agenzia Spaziale Italiana(Agenzia Spaziale Italiana (ASI))	This work was supported by Grant 4179 from the Associazione Italiana per la Ricerca sul Cancro (AIRC) and the Agenzia Spaziale Italiana from Molecules to Man (ASI MOMA) project.	Atilano SR, 2005, INVEST OPHTH VIS SCI, V46, P1256, DOI 10.1167/iovs.04-1395; Bolender N, 2008, EMBO REP, V9, P42, DOI 10.1038/sj.embor.7401126; BURZIO LO, 1981, BIOCHEM BIOPH RES CO, V103, P369, DOI 10.1016/0006-291X(81)91702-2; Carbone M, 2008, ONCOGENE, V27, P6083, DOI 10.1038/onc.2008.221; Cipriani G, 2005, J BIOL CHEM, V280, P17227, DOI 10.1074/jbc.M414526200; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Dantzer F, 1999, BIOCHIMIE, V81, P69, DOI 10.1016/S0300-9084(99)80040-6; Dement GA, 2007, EXP CELL RES, V313, P77, DOI 10.1016/j.yexcr.2006.09.014; Di Lisa F, 2001, FEBS LETT, V492, P4, DOI 10.1016/S0014-5793(01)02198-6; Dohi T, 2004, J CLIN INVEST, V114, P1117, DOI 10.1172/JCI200422222; Druzhyna N, 2000, DIABETES, V49, P1849, DOI 10.2337/diabetes.49.11.1849; Du LN, 2003, J BIOL CHEM, V278, P18426, DOI 10.1074/jbc.M301295200; Gieffers C, 1997, EXP CELL RES, V232, P395, DOI 10.1006/excr.1997.3539; Jae-Kyung M, 2003, CELL MOL BIOL, V49, P739; Jarrett SG, 2007, OPHTHALMIC RES, V39, P213, DOI 10.1159/000104683; John GB, 2005, MOL BIOL CELL, V16, P1543, DOI 10.1091/mbc.e04-08-0697; Kameoka M, 2004, J VIROL, V78, P8931, DOI 10.1128/JVI.78.16.8931-8934.2004; Kang D, 2007, MITOCHONDRION, V7, P39, DOI 10.1016/j.mito.2006.11.017; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Lai Y, 2008, J NEUROCHEM, V104, P1700, DOI 10.1111/j.1471-4159.2007.05114.x; Lakshmipathy U, 2001, NUCLEIC ACIDS RES, V29, P668, DOI 10.1093/nar/29.3.668; Larsen NB, 2005, MITOCHONDRION, V5, P89, DOI 10.1016/j.mito.2005.02.002; Leppard JB, 2003, MOL CELL BIOL, V23, P5919, DOI 10.1128/MCB.23.16.5919-5927.2003; Malanga M, 2005, BIOCHEM CELL BIOL, V83, P354, DOI 10.1139/o05-038; Mancone C, 2007, PROTEOMICS, V7, P143, DOI 10.1002/pmic.200600339; MASMOUDI A, 1988, J NEUROCHEM, V51, P188, DOI 10.1111/j.1471-4159.1988.tb04854.x; MASMOUDI A, 1987, BIOCHEMISTRY-US, V26, P1965, DOI 10.1021/bi00381a027; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; Milano J, 2000, NUCLEIC ACIDS RES, V28, P968, DOI 10.1093/nar/28.4.968; Mosgoeller W, 1996, J CELL SCI, V109, P409; Odgren PR, 1996, J CELL SCI, V109, P2253; Poitras MF, 2007, NEUROSCIENCE, V148, P198, DOI 10.1016/j.neuroscience.2007.04.062; Psarra AMG, 2008, BBA-MOL CELL RES, V1783, P1, DOI 10.1016/j.bbamcr.2007.10.021; Rozen S, 2000, Methods Mol Biol, V132, P365; Salazar JJ, 1997, MUTAT RES-DNA REPAIR, V385, P139, DOI 10.1016/S0921-8777(97)00047-5; Saxena A, 2002, J BIOL CHEM, V277, P26921, DOI 10.1074/jbc.M200620200; Scovassi AI, 2004, FASEB J, V18, P1487, DOI 10.1096/fj.04-1841rev; Simbulan-Rosenthal CM, 2003, ONCOGENE, V22, P8460, DOI 10.1038/sj.onc.1206897; Strub A, 2000, BIOL CHEM, V381, P943, DOI 10.1515/BC.2000.115; Van Laar VS, 2008, NEUROBIOL DIS, V29, P477, DOI 10.1016/j.nbd.2007.11.007; Velsor LW, 2004, TOXICOL APPL PHARM, V199, P10, DOI 10.1016/j.taap.2004.03.005; Wang YF, 2009, EXP NEUROL, V218, P193, DOI 10.1016/j.expneurol.2009.03.020; Xie J, 2007, FEBS LETT, V581, P3545, DOI 10.1016/j.febslet.2007.06.052; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221	46	123	127	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31616	31624		10.1074/jbc.M109.025882	http://dx.doi.org/10.1074/jbc.M109.025882			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19762472	hybrid, Green Published			2022-12-27	WOS:000271572700016
J	Sonobe, Y; Takeuchi, H; Kataoka, K; Li, H; Jin, S; Mimuro, M; Hashizume, Y; Sano, Y; Kanda, T; Mizuno, T; Suzumura, A				Sonobe, Yoshifumi; Takeuchi, Hideyuki; Kataoka, Kunio; Li, Hua; Jin, Shijie; Mimuro, Maya; Hashizume, Yoshio; Sano, Yasuteru; Kanda, Takashi; Mizuno, Tetsuya; Suzumura, Akio			Interleukin-25 Expressed by Brain Capillary Endothelial Cells Maintains Blood-Brain Barrier Function in a Protein Kinase C epsilon-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; TIGHT-JUNCTION; P-GLYCOPROTEIN; MOUSE-BRAIN; IN-VITRO; MICROGLIA; PERMEABILITY; INFLAMMATION; LYMPHOCYTES; DISRUPTION	Interleukin (IL)-25, a member of the IL-17 family of cytokines, is expressed in the brains of normal mice. However, the cellular source of IL-25 and its function in the brain remain to be elucidated. Here, we show that IL-25 plays an important role in preventing infiltration of the inflammatory cells into the central nervous system. Brain capillary endothelial cells (BCECs) express IL-25. However, it is down-regulated by inflammatory cytokines, including tumor necrosis factor (TNF)-alpha, IL-17, interferon-gamma, IL-1 beta, and IL-6 in vitro, and is also reduced in active multiple sclerosis (MS) lesions and in the inflamed spinal cord of experimental autoimmune encephalomyelitis, an animal model of MS. Furthermore, IL-25 restores the reduced expression of tight junction proteins, occludin, junction adhesion molecule, and claudin-5, induced by TNF-alpha in BCECs and consequently repairs TNF-alpha-induced blood-brain barrier (BBB) permeability. IL-25 induces protein kinase C epsilon (PKC epsilon) phosphorylation, and up-regulation of claudin-5 is suppressed by PKC epsilon inhibitor peptide in the IL-25-stimulated BCECs. These results suggest that IL-25 is produced by BCECs and protects against inflammatory cytokine-induced excessive BBB collapse through a PKC epsilon-dependent pathway. These novel functions of IL-25 in maintaining BBB integrity may help us understand the pathophysiology of inflammatory brain diseases such as MS.	[Sonobe, Yoshifumi; Takeuchi, Hideyuki; Kataoka, Kunio; Li, Hua; Jin, Shijie; Mizuno, Tetsuya; Suzumura, Akio] Nagoya Univ, Environm Med Res Inst, Dept Neuroimmunol, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Mimuro, Maya; Hashizume, Yoshio] Aichi Med Univ, Inst Med Sci Aging, Dept Neuropathol, Nagakute, Aichi 4801195, Japan; [Sano, Yasuteru; Kanda, Takashi] Yamaguchi Univ, Grad Sch Med, Dept Neurol & Clin Neurosci, Ube, Yamaguchi 7558505, Japan	Nagoya University; Aichi Medical University; Yamaguchi University	Sonobe, Y (corresponding author), Nagoya Univ, Environm Med Res Inst, Dept Neuroimmunol, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	sonobe@riem.nagoya-u.ac.jp		Takeuchi, Hideyuki/0000-0001-5912-7581	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labour, and Welfare of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by Grant-in-aid for Scientific Research Grant C, by the 21st Century COE Program "Integrated Molecular Medicine for Neuronal and Neoplastic Disorders" from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and by Health and Labour Science research grants for research on intractable diseases from the Ministry of Health, Labour, and Welfare of Japan.	Afonso PV, 2007, J IMMUNOL, V179, P2576, DOI 10.4049/jimmunol.179.4.2576; Angkasekwinai P, 2007, J EXP MED, V204, P1509, DOI 10.1084/jem.20061675; Dohgu S, 2004, CELL MOL NEUROBIOL, V24, P491, DOI 10.1023/B:CEMN.0000022776.47302.ce; Dohgu S, 2007, CELL MOL NEUROBIOL, V27, P889, DOI 10.1007/s10571-007-9209-2; Fabis MJ, 2007, P NATL ACAD SCI USA, V104, P5656, DOI 10.1073/pnas.0701252104; FABRY Z, 1995, J IMMUNOL, V155, P325; Fallon PG, 2006, J EXP MED, V203, P1105, DOI 10.1084/jem.20051615; Fleegal MA, 2005, AM J PHYSIOL-HEART C, V289, pH2012, DOI 10.1152/ajpheart.00495.2005; Forster C, 2008, J PHYSIOL-LONDON, V586, P1937, DOI 10.1113/jphysiol.2007.146852; Forster C, 2007, J PHYSIOL-LONDON, V580, P937, DOI 10.1113/jphysiol.2007.129007; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Ge SJ, 2008, J NEUROCHEM, V104, P1219, DOI 10.1111/j.1471-4159.2007.05056.x; Gonzalez-Mariscal L, 2008, BBA-BIOMEMBRANES, V1778, P729, DOI 10.1016/j.bbamem.2007.08.018; Hirase T, 1997, J CELL SCI, V110, P1603; Ifergan I, 2006, ANN NEUROL, V60, P45, DOI 10.1002/ana.20875; Ikeda K, 2003, BLOOD, V101, P3594, DOI 10.1182/blood-2002-09-2817; Kang CM, 2005, AM J RESP CELL MOL, V33, P290, DOI 10.1165/rcmb.2005-0003OC; Kassiotis G, 1999, EUR J IMMUNOL, V29, P774, DOI 10.1002/(SICI)1521-4141(199903)29:03<774::AID-IMMU774>3.0.CO;2-T; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Kleinschek MA, 2007, J EXP MED, V204, P161, DOI 10.1084/jem.20061738; Kraus J, 2004, ANN NEUROL, V56, P192, DOI 10.1002/ana.20161; KRIZBAI I, 1995, J NEUROCHEM, V65, P459; Liang JF, 2008, BRAIN RES, V1210, P11, DOI 10.1016/j.brainres.2008.03.012; Lu TS, 2008, J IMMUNOL, V181, P6406, DOI 10.4049/jimmunol.181.9.6406; Minagar A, 2003, ENDOTHELIUM-J ENDOTH, V10, P299, DOI 10.1080/10623320390272299; Minagar A, 2003, MULT SCLER J, V9, P540, DOI 10.1191/1352458503ms965oa; Mizuno T, 2008, FASEB J, V22, P1797, DOI 10.1096/fj.07-099499; Morita K, 1999, J CELL BIOL, V147, P185, DOI 10.1083/jcb.147.1.185; Ohtsuki S, 2008, J NEUROCHEM, V104, P147, DOI 10.1111/j.1471-4159.2007.05008.x; Owyang AM, 2006, J EXP MED, V203, P843, DOI 10.1084/jem.20051496; Pan GH, 2001, J IMMUNOL, V167, P6559, DOI 10.4049/jimmunol.167.11.6559; Park JH, 1999, AM J PHYSIOL-CELL PH, V277, pC1066, DOI 10.1152/ajpcell.1999.277.6.C1066; Qi X, 2008, J CLIN INVEST, V118, P173, DOI 10.1172/JCI32636; Ronaldson PT, 2009, J CEREBR BLOOD F MET, V29, P1084, DOI 10.1038/jcbfm.2009.32; SAWADA M, 1993, NEUROSCI LETT, V155, P175, DOI 10.1016/0304-3940(93)90701-L; Sonobe Y, 2008, BIOCHEM BIOPH RES CO, V370, P129, DOI 10.1016/j.bbrc.2008.03.059; Sonobe Y, 2007, TOHOKU J EXP MED, V213, P329, DOI 10.1620/tjem.213.329; Stamatovic SM, 2006, J BIOL CHEM, V281, P8379, DOI 10.1074/jbc.M513122200; Suzuki T, 2008, J BIOL CHEM, V283, P3574, DOI 10.1074/jbc.M709141200; SUZUMURA A, 1987, J NEUROIMMUNOL, V15, P263, DOI 10.1016/0165-5728(87)90121-4; SUZUMURA A, 1994, J NEUROIMMUNOL, V53, P209, DOI 10.1016/0165-5728(94)90031-0; Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752; Takeuchi H, 2005, J BIOL CHEM, V280, P10444, DOI 10.1074/jbc.M413863200; Tamachi T, 2006, J ALLERGY CLIN IMMUN, V118, P606, DOI 10.1016/j.jaci.2006.04.051; TATSUTA T, 1992, J BIOL CHEM, V267, P20383; Wang JY, 2008, P NATL ACAD SCI USA, V105, P3915, DOI 10.1073/pnas.0709592105; Wang YH, 2007, J EXP MED, V204, P1837, DOI 10.1084/jem.20070406; Weiler F, 2005, J CELL PHYSIOL, V204, P83, DOI 10.1002/jcp.20268; Wosik K, 2007, J NEUROSCI, V27, P9032, DOI 10.1523/JNEUROSCI.2088-07.2007; Yoo J, 2003, AM J PHYSIOL-CELL PH, V285, pC300, DOI 10.1152/ajpcell.00267.2002; Zaph C, 2008, J EXP MED, V205, P2191, DOI 10.1084/jem.20080720; Zhong ZH, 2008, NAT NEUROSCI, V11, P420, DOI 10.1038/nn2073; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	53	68	75	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31834	31842		10.1074/jbc.M109.025940	http://dx.doi.org/10.1074/jbc.M109.025940			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19776017	Green Published, hybrid			2022-12-27	WOS:000271572700038
J	Sohy, D; Yano, H; de Nadai, P; Urizar, E; Guillabert, A; Javitch, JA; Parmentier, M; Springael, JY				Sohy, Denis; Yano, Hideaki; de Nadai, Patricia; Urizar, Eneko; Guillabert, Aude; Javitch, Jonathan A.; Parmentier, Marc; Springael, Jean-Yves			Hetero-oligomerization of CCR2, CCR5, and CXCR4 and the Protean Effects of "Selective" Antagonists	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOKINE RECEPTOR GENE; COUPLED RECEPTORS; HIV-1 INFECTION; HETERODIMERIZATION; REVEALS; COOPERATIVITY; DIMERIZATION; ACTIVATION; EXPRESSION; MUTATION	Chemokine receptors constitute an attractive family of drug targets in the frame of inflammatory diseases. However, targeting specific chemokine receptors may be complicated by their ability to form dimers or higher order oligomers. Using a combination of luminescence complementation and bioluminescence resonance energy transfer assays, we demonstrate for the first time the existence of hetero-oligomeric complexes composed of at least three chemokine receptors (CCR2, CCR5, and CXCR4). We show in T cells and monocytes that negative binding cooperativity takes place between the binding pockets of these receptors, demonstrating their functional interaction in leukocytes. We also show that specific antagonists of one receptor (TAK-779 or AMD3100) lead to functional cross-inhibition of the others. Finally, using the air pouch model in mice, we show that the CCR2 and CCR5 antagonist TAK-779 inhibits cell recruitment promoted by the CXCR4 agonist SDF-1 alpha, demonstrating that cross-inhibition by antagonists also occurs in vivo. Thus, antagonists of the therapeutically important chemokine receptors regulate the functional properties of other receptors to which they do not bind directly with important implications for the use of these agents in vivo.	[Parmentier, Marc; Springael, Jean-Yves] Univ Libre Bruxelles, Inst Rech Interdisciplinaire Biol Humaine & Mol, B-1070 Brussels, Belgium; [Yano, Hideaki; Urizar, Eneko; Javitch, Jonathan A.] Columbia Univ, Ctr Mol Recognit, Coll Phys & Surg, New York, NY 10128 USA; [Yano, Hideaki; Urizar, Eneko; Javitch, Jonathan A.] Columbia Univ, Dept Psychiat, Coll Phys & Surg, New York, NY 10128 USA; [Yano, Hideaki; Javitch, Jonathan A.] Columbia Univ, Dept Pharmacol, Coll Phys & Surg, New York, NY 10128 USA	Universite Libre de Bruxelles; Columbia University; Columbia University; Columbia University	Parmentier, M (corresponding author), Univ Libre Bruxelles, Inst Rech Interdisciplinaire Biol Humaine & Mol, Campus Erasme,808 Route Lennik, B-1070 Brussels, Belgium.	mparment@ulb.ac.be		de NADAI, Patricia/0000-0001-6084-7447; Javitch, Jonathan/0000-0001-7395-2967; Parmentier, Marc/0000-0001-8081-4685; Yano, Hideaki/0000-0001-9242-3884	National Institutes of Health [DA022413, MH54137]; Actions de Recherche Concertees of the Communaute Francaise de Belgique; Belgian State, Belgian Science Policy; European Union [LSHB-CT-2005-518167/ INNOCHEM]; French Agence Nationale de Recherche sur le SIDA; Fonds de la Recherche Scientifique Medicale of Belgium; Fondation Medicale Reine Elisabeth;  [P6-14]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA022413] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Actions de Recherche Concertees of the Communaute Francaise de Belgique; Belgian State, Belgian Science Policy(Belgian Federal Science Policy Office); European Union(European Commission); French Agence Nationale de Recherche sur le SIDA(ANRS); Fonds de la Recherche Scientifique Medicale of Belgium(Fonds de la Recherche Scientifique - FNRS); Fondation Medicale Reine Elisabeth; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA022413 and MH54137 (to J. A. J.). This work was also supported by the Actions de Recherche Concertees of the Communaute Francaise de Belgique; the Interuniversity Attraction Poles Programme (P6-14), Belgian State, Belgian Science Policy, the Walloon region (Programme d'Excellence "CIBLES"); European Union Grant LSHB-CT-2005-518167/ INNOCHEM; the French Agence Nationale de Recherche sur le SIDA; the Fonds de la Recherche Scientifique Medicale of Belgium; and the Fondation Medicale Reine Elisabeth.	Benkirane M, 1997, J BIOL CHEM, V272, P30603, DOI 10.1074/jbc.272.49.30603; Blanpain C, 1999, BLOOD, V94, P1899; Chabre M, 2009, TRENDS PHARMACOL SCI, V30, P182, DOI 10.1016/j.tips.2009.01.003; Contento RL, 2008, P NATL ACAD SCI USA, V105, P10101, DOI 10.1073/pnas.0804286105; El-Asmar L, 2005, MOL PHARMACOL, V67, P460, DOI 10.1124/mol.104.003624; Ellis J, 2006, J BIOL CHEM, V281, P38812, DOI 10.1074/jbc.M602494200; Filizola M, 2005, FEBS J, V272, P2926, DOI 10.1111/j.1742-4658.2005.04730.x; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Gomes I, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0007.2000; Guo W, 2005, P NATL ACAD SCI USA, V102, P17495, DOI 10.1073/pnas.0508950102; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Hamatake M, 2009, CANCER SCI, V100, P95, DOI 10.1111/j.1349-7006.2008.00997.x; Hernanz-Falcon P, 2004, NAT IMMUNOL, V5, P216, DOI 10.1038/ni1027; Horuk R, 2009, NAT REV DRUG DISCOV, V8, P23, DOI 10.1038/nrd2734; Huang YX, 1996, NAT MED, V2, P1240, DOI 10.1038/nm1196-1240; Isik N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003424; Issafras H, 2002, J BIOL CHEM, V277, P34666, DOI 10.1074/jbc.M202386200; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Lagane B, 2005, MOL PHARMACOL, V67, P1966, DOI 10.1124/mol.104.009779; LEVITZKI A, 1974, J THEOR BIOL, V44, P367, DOI 10.1016/0022-5193(74)90167-2; Loening AM, 2006, PROTEIN ENG DES SEL, V19, P391, DOI 10.1093/protein/gzl023; Mellado M, 2001, EMBO J, V20, P2497, DOI 10.1093/emboj/20.10.2497; Paulmurugan R, 2004, CANCER RES, V64, P2113, DOI 10.1158/0008-5472.CAN-03-2972; Pease JE, 2006, BRIT J PHARMACOL, V147, pS212, DOI 10.1038/sj.bjp.0706475; Percherancier Y, 2005, J BIOL CHEM, V280, P9895, DOI 10.1074/jbc.M411151200; Reggio PH, 2006, AAPS J, V8, pE322; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Samson M, 1996, BIOCHEMISTRY-US, V35, P3362, DOI 10.1021/bi952950g; Sohy D, 2007, J BIOL CHEM, V282, P30062, DOI 10.1074/jbc.M705302200; Springael JY, 2007, PHARMACOL THERAPEUT, V115, P410, DOI 10.1016/j.pharmthera.2007.06.004; Springael JY, 2006, MOL PHARMACOL, V69, P1652, DOI 10.1124/mol.105.019414; Springael JY, 2005, CYTOKINE GROWTH F R, V16, P611, DOI 10.1016/j.cytogfr.2005.05.005; Wells TNC, 2006, TRENDS PHARMACOL SCI, V27, P41, DOI 10.1016/j.tips.2005.11.001; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang WB, 2002, J BIOL CHEM, V277, P24515, DOI 10.1074/jbc.M200889200	36	130	133	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31270	31279		10.1074/jbc.M109.054809	http://dx.doi.org/10.1074/jbc.M109.054809			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19758998	Green Published, hybrid			2022-12-27	WOS:000271378400054
J	Jaric, J; Bilokapic, S; Lesjak, S; Crnkovic, A; Ban, N; Weygand-Durasevic, I				Jaric, Jelena; Bilokapic, Silvija; Lesjak, Sonja; Crnkovic, Ana; Ban, Nenad; Weygand-Durasevic, Ivana			Identification of Amino Acids in the N-terminal Domain of Atypical Methanogenic-type Seryl-tRNA Synthetase Critical for tRNA Recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUAL-MODE RECOGNITION; ESCHERICHIA-COLI; THERMUS-THERMOPHILUS; CRYSTAL-STRUCTURE; METHANOSARCINA-BARKERI; SUBSTRATE RECOGNITION; STRUCTURAL-CHANGES; TRANSFER RNA(SER); BINDING DOMAIN; ACTIVE-SITE	Seryl-tRNA synthetase (SerRS) from methanogenic archaeon Methanosarcina barkeri, contains an idiosyncratic N-terminal domain, composed of an antiparallel beta-sheet capped by a helical bundle, connected to the catalytic core by a short linker peptide. It is very different from the coiled-coil tRNA binding domain in bacterial-type SerRS. Because the crystal structure of the methanogenic-type SerRS.tRNA complex has not been obtained, a docking model was produced, which indicated that highly conserved helices H2 and H3 of the N-terminal domain may be important for recognition of the extra arm of tRNA(Ser). Based on structural information and the docking model, we have mutated various positions within the N-terminal region and probed their involvement in tRNA binding and serylation. Total loss of activity and inability of the R76A variant to form the complex with cognate tRNA identifies Arg(76) located in helix H2 as a crucial tRNA-interacting residue. Alteration of Lys(79) positioned in helix H2 and Arg(94) in the loop between helix H2 and beta-strand A4 have a pronounced effect on SerRS.tRNA(Ser) complex formation and dissociation constants (K-D) determined by surface plasmon resonance. The replacement of residues Arg(38) ( located in the loop between helix H1 and beta-strand A2), Lys(141) and Asn(142) (from H3), and Arg(143) (between H3 and H4) moderately affect both the serylation activity and the K-D values. Furthermore, we have obtained a striking correlation between these results and in vivo effects of these mutations by quantifying the efficiency of suppression of bacterial amber mutations, after coexpression of the genes for M. barkeri suppressor tRNA(Ser) and a set of mMbSerRS variants in Escherichia coli.	[Jaric, Jelena; Bilokapic, Silvija; Lesjak, Sonja; Crnkovic, Ana; Weygand-Durasevic, Ivana] Univ Zagreb, Dept Chem, Fac Sci, HR-10000 Zagreb, Croatia; [Ban, Nenad] ETH, Inst Mol Biol & Biophys, Swiss Fed Inst Technol, CH-8093 Zurich, Switzerland	University of Zagreb; Swiss Federal Institutes of Technology Domain; ETH Zurich	Weygand-Durasevic, I (corresponding author), Univ Zagreb, Dept Chem, Fac Sci, Horvatovac 102A, HR-10000 Zagreb, Croatia.	weygand@chem.pmf.hr	Crnkovic, Ana/AAB-7199-2020; Bilokapic, Silvija/H-5108-2018; Crnkovic, Ana/GQZ-1733-2022	Crnkovic, Ana/0000-0002-0581-1887	Ministry of Science, Education and Sports of the Republic of Croatia Project [119-0982913-1358]; Swiss National Science Foundation; Scientific Cooperation between Eastern Europe and Switzerland ( SCOPES); Unity through Knowledge Fund [10/07]	Ministry of Science, Education and Sports of the Republic of Croatia Project; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Scientific Cooperation between Eastern Europe and Switzerland ( SCOPES); Unity through Knowledge Fund	This work was supported by Ministry of Science, Education and Sports of the Republic of Croatia Project (119-0982913-1358), grants from the Swiss National Science Foundation, the Scientific Cooperation between Eastern Europe and Switzerland ( SCOPES) program of the Swiss National Science Foundation, and Unity through Knowledge Fund project 10/07.	Ataide SF, 2006, ACS CHEM BIOL, V1, P285, DOI 10.1021/cb600200k; Bilokapic S, 2004, EUR J BIOCHEM, V271, P694, DOI 10.1111/j.1432-1033.2003.03971.x; Bilokapic S, 2008, FEBS J, V275, P2831, DOI 10.1111/j.1742-4658.2008.06423.x; Bilokapic S, 2006, EMBO J, V25, P2498, DOI 10.1038/sj.emboj.7601129; Bilokapic S, 2009, J BIOL CHEM, V284, P10706, DOI 10.1074/jbc.M808501200; BIOU V, 1994, SCIENCE, V263, P1404, DOI 10.1126/science.8128220; Bullock TL, 2000, NAT STRUCT BIOL, V7, P497; Chenal A, 2002, PROTEIN ENG, V15, P383, DOI 10.1093/protein/15.5.383; Chimnaronk S, 2005, EMBO J, V24, P3369, DOI 10.1038/sj.emboj.7600811; COULONDRE C, 1977, J MOL BIOL, V117, P577, DOI 10.1016/0022-2836(77)90059-6; Cusack S, 1996, EMBO J, V15, P2834, DOI 10.1002/j.1460-2075.1996.tb00644.x; CUSACK S, 1990, NATURE, V347, P249, DOI 10.1038/347249a0; de Pouplana LR, 2001, CELL, V104, P191, DOI 10.1016/S0092-8674(01)00204-5; EBEL JP, 1973, BIOCHIMIE, V55, P547, DOI 10.1016/S0300-9084(73)80415-8; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Frugier M, 2000, EMBO J, V19, P2371, DOI 10.1093/emboj/19.10.2371; FUJINAGA M, 1993, J MOL BIOL, V234, P222, DOI 10.1006/jmbi.1993.1576; Geslain R, 2006, J BIOL CHEM, V281, P38217, DOI 10.1074/jbc.M607862200; GIEGE R, 1993, PROG NUCLEIC ACID RE, V45, P129, DOI 10.1016/S0079-6603(08)60869-7; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; Gruic-Sovulj I, 2006, J MOL BIOL, V361, P128, DOI 10.1016/j.jmb.2006.06.008; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Helm M, 2000, RNA, V6, P1356, DOI 10.1017/S1355838200001047; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Ibba M, 1997, SCIENCE, V278, P1119, DOI 10.1126/science.278.5340.1119; Itoh Y, 2008, RNA BIOL, V5, P169, DOI 10.4161/rna.5.3.6876; Kim HS, 1998, J BACTERIOL, V180, P6446, DOI 10.1128/JB.180.24.6446-6449.1998; Klipcan L, 2008, STRUCTURE, V16, P1095, DOI 10.1016/j.str.2008.03.020; Korencic D, 2004, J BIOL CHEM, V279, P48780, DOI 10.1074/jbc.M408753200; Lenhard B, 1999, NUCLEIC ACIDS RES, V27, P721, DOI 10.1093/nar/27.3.721; Lesjak S, 2009, FEMS MICROBIOL LETT, V294, P111, DOI 10.1111/j.1574-6968.2009.01560.x; NORMANLY J, 1986, NATURE, V321, P213, DOI 10.1038/321213a0; Nozawa K, 2009, NATURE, V457, P1163, DOI 10.1038/nature07611; Polycarpo CR, 2006, FEBS LETT, V580, P6695, DOI 10.1016/j.febslet.2006.11.028; Rees B, 2000, J MOL BIOL, V299, P1157, DOI 10.1006/jmbi.2000.3792; RIESNER D, 1976, EUR J BIOCHEM, V68, P71, DOI 10.1111/j.1432-1033.1976.tb10765.x; RIGLER R, 1976, EUR J BIOCHEM, V65, P307, DOI 10.1111/j.1432-1033.1976.tb10418.x; ROGERS MJ, 1988, P NATL ACAD SCI USA, V85, P6627, DOI 10.1073/pnas.85.18.6627; Sauter C, 2000, J MOL BIOL, V299, P1313, DOI 10.1006/jmbi.2000.3791; Shimada N, 2001, J BIOL CHEM, V276, P46770, DOI 10.1074/jbc.M105150200; Sprinzl M, 2005, NUCLEIC ACIDS RES, V33, pD139, DOI 10.1093/nar/gki012; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsai YC, 2006, BIOCHEMISTRY-US, V45, P9675, DOI 10.1021/bi060993z; Tumbula D, 1999, GENETICS, V152, P1269; VINCENT C, 1995, NUCLEIC ACIDS RES, V23, P1113, DOI 10.1093/nar/23.7.1113; WEYGANDDURASEVI.I, 2005, AMINOACYL TRNA SYNTH, P177; WEYGANDDURASEVIC I, 1993, P NATL ACAD SCI USA, V90, P2010, DOI 10.1073/pnas.90.5.2010; Woese CR, 2000, MICROBIOL MOL BIOL R, V64, P202, DOI 10.1128/MMBR.64.1.202-236.2000; YAREMCHUK AD, 1992, FEBS LETT, V310, P157, DOI 10.1016/0014-5793(92)81319-H; Yowler BC, 2004, BIOCHEMISTRY-US, V43, P9725, DOI 10.1021/bi0494673; Zhang CM, 2006, J MOL BIOL, V361, P300, DOI 10.1016/j.jmb.2006.06.015; Zhang CM, 2003, BIOCHEMISTRY-US, V42, P10931, DOI 10.1021/bi034812u	52	12	12	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30643	30651		10.1074/jbc.M109.044099	http://dx.doi.org/10.1074/jbc.M109.044099			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19734148	Green Published, hybrid			2022-12-27	WOS:000271090000066
J	Richter, K; Brar, S; Ray, M; Pisitkun, P; Bolland, S; Verkoczy, L; Diaz, M				Richter, Kathleen; Brar, Sukhdev; Ray, Madhumita; Pisitkun, Prapaporn; Bolland, Silvia; Verkoczy, Laurent; Diaz, Marilyn			Speckled-like Pattern in the Germinal Center (SLIP-GC), a Nuclear GTPase Expressed in Activation-induced Deaminase-expressing Lymphomas and Germinal Center B Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUPUS NEPHRITIS; MRL/LPR MICE; AID; LINES; HYPERMUTATION; PROTEIN; BURKITTS; GROWTH; BLAST	We identified a novel GTPase, SLIP-GC, with expression limited to a few tissues, in particular germinal center B cells. It lacks homology to any known proteins, indicating that it may belong to a novel family of GTPases. SLIP-GC is expressed in germinal center B cells and in lymphomas derived from germinal center B cells such as large diffuse B cell lymphomas. In cell lines, SLIP-GC is expressed in lymphomas that express activation-induced deaminase ( AID) and that likely undergo somatic hypermutation. SLIP-GC is a nuclear protein, and it localizes to replication factories. Reduction of SLIP-GC levels in the Burkitt lymphoma cell line Raji and in non-Hodgkin lymphoma cell lines resulted in an increase in DNA breaks and apoptosis that was AID-dependent, as simultaneous reduction of AID abrogated the deleterious effects of SLIP-GC reduction. These results strongly suggest that SLIP-GC is a replication-related protein in germinal center B cells whose reduction is toxic to cells through an AID-dependent mechanism.	[Richter, Kathleen; Brar, Sukhdev; Ray, Madhumita; Diaz, Marilyn] NIEHS, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA; [Pisitkun, Prapaporn; Bolland, Silvia] NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA; [Verkoczy, Laurent] Duke Univ, Duke Human Vaccine Inst, Med Ctr, Durham, NC 27710 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Duke University	Diaz, M (corresponding author), NIEHS, Mol Genet Lab, NIH, D3-01,111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	diaz@niehs.nih.gov		Diaz, Marilyn/0000-0002-3046-2746	National Institutes of Health Grant (Intramural Research Program, NIEHS) [1Z01ES101603-2008]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000912] Funding Source: NIH RePORTER	National Institutes of Health Grant (Intramural Research Program, NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant (Intramural Research Program, NIEHS) 1Z01ES101603-2008.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDRADE LEC, 1991, J EXP MED, V173, P1407, DOI 10.1084/jem.173.6.1407; BECKWITH M, 1990, J NATL CANCER I, V82, P501, DOI 10.1093/jnci/82.6.501; BENJAMIN D, 1982, J IMMUNOL, V129, P1336; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; BOGUSKI MS, 1995, NAT GENET, V10, P369, DOI 10.1038/ng0895-369; Brar SS, 2004, J BIOL CHEM, V279, P26395, DOI 10.1074/jbc.M403503200; Camacho SA, 1998, IMMUNOL TODAY, V19, P511, DOI 10.1016/S0167-5699(98)01327-9; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Faili A, 2002, NAT IMMUNOL, V3, P815, DOI 10.1038/ni826; FU XD, 1990, NATURE, V343, P437, DOI 10.1038/343437a0; Gabay C, 1999, EUR J HAEMATOL, V63, P180; Horton P, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P147; Jiang CC, 2007, J IMMUNOL, V178, P7422, DOI 10.4049/jimmunol.178.11.7422; Jiang CC, 2009, IMMUNOLOGY, V126, P102, DOI 10.1111/j.1365-2567.2008.02882.x; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; Madden TL, 1996, METHOD ENZYMOL, V266, P131; Morimoto T, 2002, MICROBIOL-SGM, V148, P3539, DOI 10.1099/00221287-148-11-3539; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Pasqualucci L, 2008, NAT GENET, V40, P108, DOI 10.1038/ng.2007.35; PULVERTAFT RJV, 1964, LANCET, V1, P238; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390; Somanathan S, 2001, J CELL BIOCHEM, V81, P56, DOI 10.1002/1097-4644(20010401)81:1<56::AID-JCB1023>3.0.CO;2-#; Staudt L M, 1999, Int Rev Immunol, V18, P381, DOI 10.3109/08830189909088490; Strausberg RL, 2000, TRENDS GENET, V16, P103, DOI 10.1016/S0168-9525(99)01937-X; WEIGERT MG, 1970, NATURE, V228, P1045, DOI 10.1038/2281045a0; Xiao Z, 2007, MOL IMMUNOL, V44, P2659, DOI 10.1016/j.molimm.2006.12.006; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161	31	12	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30652	30661		10.1074/jbc.M109.014506	http://dx.doi.org/10.1074/jbc.M109.014506			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19734146	Green Published, hybrid			2022-12-27	WOS:000271090000067
J	Vigetti, D; Genasetti, A; Karousou, E; Viola, M; Clerici, M; Bartolini, B; Moretto, P; De Luca, G; Hascall, VC; Passi, A				Vigetti, Davide; Genasetti, Anna; Karousou, Evgenia; Viola, Manuela; Clerici, Moira; Bartolini, Barbara; Moretto, Paola; De Luca, Giancarlo; Hascall, Vincent C.; Passi, Alberto			Modulation of Hyaluronan Synthase Activity in Cellular Membrane Fractions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; POLYACRYLAMIDE-GEL ELECTROPHORESIS; CHONDROITIN SULFATE DISACCHARIDES; FLUOROPHORE-LABELED HYALURONAN; TUBULAR EPITHELIAL-CELLS; EPIDERMAL-GROWTH-FACTOR; HUMAN SKIN FIBROBLASTS; ACID SYNTHESIS; MESOTHELIAL CELLS; PLASMA-MEMBRANE	Hyaluronan ( HA), the only non-sulfated glycosaminoglycan, is involved in morphogenesis, wound healing, inflammation, angiogenesis, and cancer. In mammals, HA is synthesized by three homologous HA synthases, HAS1, HAS2, and HAS3, that polymerize the HA chain using UDP-glucuronic acid and UDP-N-acetylglucosamine as precursors. Since the amount of HA is critical in several pathophysiological conditions, we developed a non-radioactive assay for measuring the activity of HA synthases (HASs) in eukaryotic cells and addressed the question of HAS activity during intracellular protein trafficking. We prepared three cellular fractions: plasma membrane, cytosol ( containing membrane proteins mainly from the endoplasmic reticulum and Golgi), and nuclei. After incubation with UDP-sugar precursors, newly synthesized HA was quantified by polyacrylamide gel electrophoresis of fluorophore-labeled saccharides and high performance liquid chromatography. This new method measured HAS activity not only in the plasma membrane fraction but also in the cytosolic membranes. This new technique was used to evaluate the effects of 4-methylumbeliferone, phorbol 12-myristate 13-acetate, interleukin 1 beta, platelet-derived growth factor BB, and tunicamycin on HAS activities. We found that HAS activity can be modulated by post-translational modification, such as phosphorylation and N-glycosylation. Interestingly, we detected a significant increase in HAS activity in the cytosolic membrane fraction after tunicamycin treatment. Since this compound is known to induce HA cable structures, this result links HAS activity alteration with the capability of the cell to promote HA cable formation.	[Vigetti, Davide; Genasetti, Anna; Karousou, Evgenia; Viola, Manuela; Clerici, Moira; Bartolini, Barbara; Moretto, Paola; De Luca, Giancarlo; Passi, Alberto] Univ Insubria, Dipartimento Sci Biomed Sperimentali & Clin, I-21100 Varese, Italy; [Hascall, Vincent C.] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44195 USA	University of Insubria; Cleveland Clinic Foundation	Passi, A (corresponding author), Univ Insubria, Dipartimento Sci Biomed Sperimentali & Clin, Via JH Dunant 5, I-21100 Varese, Italy.	alberto.passi@uninsubria.it	passi, alberto g/A-1752-2018; Vigetti, Davide/C-9861-2010; Viola, Manuela/B-7120-2011	passi, alberto g/0000-0003-3328-3089; Vigetti, Davide/0000-0002-6339-8453; Viola, Manuela/0000-0002-0634-6390	Fondazione Comunitaria del Varesotto-ONLUS; PRIN 2007	Fondazione Comunitaria del Varesotto-ONLUS; PRIN 2007(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This work was supported by Fondazione Comunitaria del Varesotto-ONLUS ( to D. V.) and PRIN 2007 ( to G. D. L.).	Brown J, 2000, LAB INVEST, V80, P37, DOI 10.1038/labinvest.3780006; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Campo GM, 2006, MOL CELL BIOCHEM, V292, P169, DOI 10.1007/s11010-006-9230-7; Carracedo A, 2006, CANCER CELL, V9, P301, DOI 10.1016/j.ccr.2006.03.005; Chao H, 2005, J BIOL CHEM, V280, P27513, DOI 10.1074/jbc.M411544200; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; de la Motte CA, 1999, J BIOL CHEM, V274, P30747, DOI 10.1074/jbc.274.43.30747; Ding K, 2001, J BIOL CHEM, V276, P3885, DOI 10.1074/jbc.M005238200; Evanko SP, 1999, J HISTOCHEM CYTOCHEM, V47, P1331, DOI 10.1177/002215549904701013; FURUKAWA K, 1979, BIOCHIM BIOPHYS ACTA, V585, P575, DOI 10.1016/0304-4165(79)90190-9; FURUKAWA K, 1977, BIOCHIM BIOPHYS ACTA, V499, P278, DOI 10.1016/0304-4165(77)90010-1; Gao F, 2006, J BIOMED MATER RES B, V78B, P385, DOI 10.1002/jbm.b.30499; Goentzel BJ, 2006, BIOCHEM J, V396, P347, DOI 10.1042/BJ20051782; HAMILTON TC, 1983, CANCER RES, V43, P5379; Hascall VC, 2004, BBA-GEN SUBJECTS, V1673, P3, DOI 10.1016/j.bbagen.2004.02.013; Heldin P, 2003, BRAZ J MED BIOL RES, V36, P967, DOI 10.1590/S0100-879X2003000800002; HELDIN P, 1989, BIOCHEM J, V258, P919, DOI 10.1042/bj2580919; HELDIN P, 1992, BIOCHEM J, V283, P165, DOI 10.1042/bj2830165; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; HONDA A, 1991, J CELL SCI, V98, P91; HONDA A, 1989, BIOCHIM BIOPHYS ACTA, V1014, P305, DOI 10.1016/0167-4889(89)90227-9; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Itano N, 2004, J BIOL CHEM, V279, P18679, DOI 10.1074/jbc.M313178200; Itano N, 1996, J BIOL CHEM, V271, P9875, DOI 10.1074/jbc.271.17.9875; Jacobson A, 2000, BIOCHEM J, V348, P29, DOI 10.1042/0264-6021:3480029; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Jokela TA, 2008, J BIOL CHEM, V283, P7666, DOI 10.1074/jbc.M706001200; Kakizaki I, 2004, J BIOL CHEM, V279, P33281, DOI 10.1074/jbc.M405918200; Karousou EG, 2005, BIOMED CHROMATOGR, V19, P761, DOI 10.1002/bmc.511; Karousou EG, 2004, ELECTROPHORESIS, V25, P2919, DOI 10.1002/elps.200406034; Karousou EG, 2004, J PHARMACEUT BIOMED, V34, P791, DOI 10.1016/S0731-7085(03)00568-5; KLEWES L, 1994, J CELL PHYSIOL, V160, P539, DOI 10.1002/jcp.1041600317; Kyossev Z, 2007, ANAL BIOCHEM, V371, P62, DOI 10.1016/j.ab.2007.08.025; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Lee JY, 2000, CURR OPIN CELL BIOL, V12, P581, DOI 10.1016/S0955-0674(00)00135-6; LEMBACH KJ, 1976, J CELL PHYSIOL, V89, P277, DOI 10.1002/jcp.1040890211; Mack JA, 2003, FASEB J, V17, P1352, DOI 10.1096/fj.02-0959fje; Majors AK, 2003, J BIOL CHEM, V278, P47223, DOI 10.1074/jbc.M304871200; Milinkovic M, 2004, BLOOD, V103, P740, DOI 10.1182/blood-2003-05-1500; Mitropoulou TN, 2001, ELECTROPHORESIS, V22, P2458, DOI 10.1002/1522-2683(200107)22:12<2458::AID-ELPS2458>3.0.CO;2-8; Mullegger J, 2003, BIOL CHEM, V384, P175, DOI 10.1515/BC.2003.019; Nakamura T, 1997, BIOCHEM MOL BIOL INT, V43, P263; NAKAMURA T, 1995, BIOCHEM BIOPH RES CO, V208, P470, DOI 10.1006/bbrc.1995.1362; NG KF, 1989, J BIOL CHEM, V264, P11776; OHASHI Y, 1988, BIOCHEM INT, V16, P293; Ori M, 2006, DEVELOPMENT, V133, P631, DOI 10.1242/dev.02225; POOLE RJ, 1984, PLANT PHYSIOL, V74, P549, DOI 10.1104/pp.74.3.549; PREHM P, 1983, BIOCHEM J, V211, P181, DOI 10.1042/bj2110181; Prinetti A, 2000, J BIOL CHEM, V275, P11658, DOI 10.1074/jbc.275.16.11658; Raio L, 2005, MATRIX BIOL, V24, P166, DOI 10.1016/j.matbio.2005.01.006; Recklies AD, 2001, BIOCHEM J, V354, P17, DOI 10.1042/0264-6021:3540017; Ren J, 2009, J BIOL CHEM, V284, P16621, DOI 10.1074/jbc.M806430200; Rilla K, 2005, J BIOL CHEM, V280, P31890, DOI 10.1074/jbc.M504736200; Rilla K, 2004, J INVEST DERMATOL, V123, P708, DOI 10.1111/j.0022-202X.2004.23409.x; Scheibner KA, 2006, J IMMUNOL, V177, P1272, DOI 10.4049/jimmunol.177.2.1272; Selbi W, 2006, KIDNEY INT, V70, P1287, DOI 10.1038/sj.ki.5001760; Selbi W, 2006, J AM SOC NEPHROL, V17, P1553, DOI 10.1681/ASN.2005080879; Spicer A P, 2001, Methods Mol Biol, V171, P373; Spicer Andrew P, 2004, Birth Defects Res C Embryo Today, V72, P89, DOI 10.1002/bdrc.20006; SUDHAKARAN PR, 2007, J BIOSCIENCE, V4, P413; SUZUKI M, 1995, BIOCHEM J, V307, P817, DOI 10.1042/bj3070817; TAKAHASHI K, 1990, IN VITRO CELL DEV B, V26, P265; Teder P, 2002, SCIENCE, V296, P155, DOI 10.1126/science.1069659; Tlapak-Simmons VL, 2005, J BIOL CHEM, V280, P13012, DOI 10.1074/jbc.M409788200; TOMIDA M, 1977, J CELL PHYSIOL, V91, P323, DOI 10.1002/jcp.1040910217; Toole BP, 1990, CURR OPIN CELL BIOL, V2, P839, DOI 10.1016/0955-0674(90)90081-O; ULLRICH SJ, 1983, EXP CELL RES, V148, P377, DOI 10.1016/0014-4827(83)90160-X; van den Boom M, 2006, CIRC RES, V98, P36, DOI 10.1161/01.RES.0000199263.67107.c0; Vigetti D, 2006, J BIOL CHEM, V281, P8254, DOI 10.1074/jbc.M508516200; Vigetti D, 2008, J BIOL CHEM, V283, P4448, DOI 10.1074/jbc.M709051200; Vigetti D, 2006, FASEB J, V20, P1118, DOI 10.1096/fj.05-4504com; Vigetti D, 2009, GLYCOBIOLOGY, V19, P537, DOI 10.1093/glycob/cwp022; Yamada, 2004, SHORT PROTOCOLS CELL	73	52	53	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30684	30694		10.1074/jbc.M109.040386	http://dx.doi.org/10.1074/jbc.M109.040386			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19737932	Green Published, hybrid			2022-12-27	WOS:000271090000070
J	Eisinger, DA; Ammer, H				Eisinger, Daniela A.; Ammer, Hermann			Down-regulation of c-Cbl by Morphine Accounts for Persistent ERK1/2 Signaling in delta-Opioid Receptor-expressing HEK293 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; PROTEIN-COUPLED RECEPTORS; EGF RECEPTOR; KINASE; PHOSPHORYLATION; BETA; SRC; UBIQUITINATION; MEMBRANE; INTERNALIZATION	Opioids display ligand-specific differences in the time course of ERK1/2 signaling. Whereas full agonists, like etorphine, induce only transient activation of ERK1/2, the partial agonist morphine mediates persistent stimulation of mitogenic signaling. Here we report that in stably delta-opioid receptor (DOR)-expressing HEK293 (HEK/DOR) cells, the transient nature of etorphine-induced ERK1/2 signaling is due to desensitization of epidermal growth factor (EGF) receptor-mediated activation of the Ras/Raf-1/ERK1/2 cascade. Desensitization of ERK1/2 activity by etorphine is associated with down-regulation of EGF receptors, an effect mediated by the ubiquitin ligase c-Cbl. In contrast, chronic morphine treatment failed to desensitize EGF receptors, resulting in unimpeded ERK1/2 signaling. The failure of morphine to desensitize ERK1/2 signaling is mediated by persistent activation of c-Src, which induces degradation of c-Cbl. The role of c-Src in opioid-specific ERK1/2 signaling is further demonstrated by pretreatment of the cells with PP2 and SKI-I as well as overexpression of a dominant negative c-Src mutant (c-Src(dn)) or a c-Src-resistant c-Cbl mutant (CblY3F), both of which facilitate desensitization of ERK1/2 signaling by morphine. Conversely, overexpression of c-Src as well as down-regulation of c-Cbl by small interfering RNA results in persistent etorphine-induced stimulation of ERK1/2 activity. Subcellular fractionation experiments finally attributed the ability of morphine to persistently activate c-Src to its redistribution from Triton X-100-insensitive membrane rafts to DOR and EGF receptor containing high density membrane compartments implicated in ERK1/2 signaling. These results demonstrate that agonist-specific differences in the temporal and spatial pattern of c-Src activation determine the kinetics of DOR-mediated regulation of ERK1/2 signaling.	[Eisinger, Daniela A.; Ammer, Hermann] Univ Munich, Inst Pharmacol Toxicol & Pharm, D-80539 Munich, Germany	University of Munich	Eisinger, DA (corresponding author), Univ Munich, Inst Pharmacol Toxicol & Pharm, Koeniginstr 16, D-80539 Munich, Germany.	eisinger@lrz.uni-muenchen.de		Ammer, Hermann/0000-0003-4935-0207				Adachi T, 2002, J CELL PHYSIOL, V192, P151, DOI 10.1002/jcp.10124; AMMER H, 1993, BIOCHEM J, V295, P263, DOI 10.1042/bj2950263; Andre A, 2008, BBA-BIOMEMBRANES, V1778, P1483, DOI 10.1016/j.bbamem.2008.03.017; Audet N, 2005, J BIOL CHEM, V280, P7808, DOI 10.1074/jbc.M411695200; Bao J, 2003, P NATL ACAD SCI USA, V100, P2438, DOI 10.1073/pnas.0437945100; Belcheva MM, 2002, J PHARMACOL EXP THER, V303, P909, DOI 10.1124/jpet.102.038554; Belcheva MM, 2003, MOL PHARMACOL, V64, P1391, DOI 10.1124/mol.64.6.1391; Berhow MT, 1996, J NEUROSCI, V16, P4707; Burke P, 2001, MOL BIOL CELL, V12, P1897, DOI 10.1091/mbc.12.6.1897; CARR DJJ, 1995, IMMUNOPHARMACOLOGY, V31, P59, DOI 10.1016/0162-3109(95)00033-6; Chakrabarti S, 2003, MOL BRAIN RES, V119, P144, DOI 10.1016/j.molbrainres.2003.09.002; Chakrabarti S, 2003, P NATL ACAD SCI USA, V100, P13686, DOI 10.1073/pnas.2335885100; Chakrabarti S, 2001, P NATL ACAD SCI USA, V98, P4209, DOI 10.1073/pnas.071031798; COOPER JA, 1986, MOL CELL BIOL, V6, P4467, DOI 10.1128/MCB.6.12.4467; Daub H, 1997, EMBO J, V16, P7032, DOI 10.1093/emboj/16.23.7032; de Diesbach P, 2008, EXP CELL RES, V314, P1465, DOI 10.1016/j.yexcr.2008.01.015; de Melker AA, 2001, J CELL SCI, V114, P2167; Duan L, 2003, J BIOL CHEM, V278, P28950, DOI 10.1074/jbc.M304474200; Eisinger DA, 2004, J PHARMACOL EXP THER, V309, P776, DOI 10.1124/jpet.103.061788; Eisinger DA, 2002, J NEUROSCI, V22, P10192; Eisinger DA, 2008, CELL SIGNAL, V20, P2324, DOI 10.1016/j.cellsig.2008.09.002; Ferrer-Alcon M, 2004, MOL BRAIN RES, V121, P114, DOI 10.1016/j.molbrainres.2003.11.009; Freedman NJ, 2002, J BIOL CHEM, V277, P48261, DOI 10.1074/jbc.M204431200; Grewal JS, 2001, J BIOL CHEM, V276, P27335, DOI 10.1074/jbc.M103578200; Gupta K, 2002, CANCER RES, V62, P4491; Gurevich VV, 2008, MOL PHARMACOL, V74, P312, DOI 10.1124/mol.108.049015; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Huang P, 2007, BIOCHEM PHARMACOL, V73, P534, DOI 10.1016/j.bcp.2006.10.032; Jacob C, 2005, J BIOL CHEM, V280, P16076, DOI 10.1074/jbc.M500109200; Keith DE, 1996, J BIOL CHEM, V271, P19021, DOI 10.1074/jbc.271.32.19021; Kim J, 2003, BIOCHEMISTRY-US, V42, P2887, DOI 10.1021/bi026942t; Kodama H, 2002, J MOL CELL CARDIOL, V34, P139, DOI 10.1006/jmcc.2001.1496; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; Levitt ES, 2009, J BIOL CHEM, V284, P22108, DOI 10.1074/jbc.M109.030411; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Li KW, 2006, PROTEOMICS, V6, P2003, DOI 10.1002/pmic.200500045; Lin FT, 1998, J BIOL CHEM, V273, P31640, DOI 10.1074/jbc.273.48.31640; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Liu YT, 2007, J CELL PHYSIOL, V211, P205, DOI 10.1002/jcp.20924; Mao JR, 2002, J NEUROSCI, V22, P7650; Marie N, 2008, CELL SIGNAL, V20, P1209, DOI 10.1016/j.cellsig.2008.02.010; Martini L, 2007, CURR OPIN NEUROBIOL, V17, P556, DOI 10.1016/j.conb.2007.10.004; Narita M, 2002, NEUROSCI LETT, V324, P97, DOI 10.1016/S0304-3940(02)00141-6; Oksvold MP, 2003, ONCOGENE, V22, P8509, DOI 10.1038/sj.onc.1207117; Patel HH, 2008, ANNU REV PHARMACOL, V48, P359, DOI 10.1146/annurev.pharmtox.48.121506.124841; Pennock S, 2008, MOL CELL BIOL, V28, P3020, DOI 10.1128/MCB.01809-07; Pierce KL, 2001, ONCOGENE, V20, P1532, DOI 10.1038/sj.onc.1204184; Roepstorff K, 2008, HISTOCHEM CELL BIOL, V129, P563, DOI 10.1007/s00418-008-0401-3; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Rubio I, 2006, BIOCHEM J, V398, P243, DOI 10.1042/BJ20060160; Sood A, 2001, ENDOCR RES, V27, P215, DOI 10.1081/ERC-100107182; Swaminathan G, 2006, J CELL PHYSIOL, V209, P21, DOI 10.1002/jcp.20694; Tanowitz M, 2002, J BIOL CHEM, V277, P50219, DOI 10.1074/jbc.C200536200; Tegeder I, 2004, PHARMACOL REV, V56, P351, DOI 10.1124/pr.56.3.2; Tian GC, 2001, BIOCHEMISTRY-US, V40, P7084, DOI 10.1021/bi0100586; Timpson P, 2005, CANCER RES, V65, P3273, DOI 10.1158/0008-5472.CAN-04-2118; Xue LZ, 1998, CELL SIGNAL, V10, P339, DOI 10.1016/S0898-6568(98)00011-4; Yokouchi M, 2001, J BIOL CHEM, V276, P35185, DOI 10.1074/jbc.M102219200; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Zhang J, 1999, J RECEPT SIGNAL TR R, V19, P301, DOI 10.3109/10799899909036653; Zhang L, 2009, J BIOL CHEM, V284, P1990, DOI 10.1074/jbc.M807971200; Zheng H, 2008, P NATL ACAD SCI USA, V105, P9421, DOI 10.1073/pnas.0802253105; Zheng H, 2008, MOL PHARMACOL, V73, P178, DOI 10.1124/mol.107.039842; Zimmerman B, 2009, CELL SIGNAL, V21, P103, DOI 10.1016/j.cellsig.2008.09.013	65	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34819	34828		10.1074/jbc.M109.042937	http://dx.doi.org/10.1074/jbc.M109.042937			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19828455	hybrid, Green Published			2022-12-27	WOS:000272439600037
J	Roussel, X; Kriznik, A; Richard, C; Rahuel-Clermont, S; Branlant, G				Roussel, Xavier; Kriznik, Alexandre; Richard, Christelle; Rahuel-Clermont, Sophie; Branlant, Guy			Catalytic Mechanism of Sulfiredoxin from Saccharomyces cerevisiae Passes through an Oxidized Disulfide Sulfiredoxin Intermediate That Is Reduced by Thioredoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SULFINIC ACID; ESCHERICHIA-COLI; THIOSULFINATE INTERMEDIATE; MAMMALIAN SULFIREDOXIN; 2-CYS PEROXIREDOXIN; HYDROGEN-PEROXIDE; THIOL PEROXIDASE; ACTIVE-SITE; REDUCTION; OXIDATION	Sulfiredoxin catalyzes the ATP-dependent reduction of over-oxidized eukaryotic 2-Cys peroxiredoxin PrxSO(2) into sulfenic PrxSOH. Recent mechanistic studies on sulfiredoxins have validated a catalytic mechanism that includes formation of a phosphoryl intermediate on the sulfinyl moiety of PrxSO(2), followed by an attack of the catalytic cysteine of sulfiredoxin on the phosphoryl intermediate that leads to formation of a thiosulfinate intermediate PrxSO-S-sulfiredoxin. Formation of this intermediate implies the recycling of sulfiredoxin into the reduced form. In this study, we have investigated how the reductase activity of the Saccharomyces cerevisiae sulfiredoxin is regenerated. The results show that an oxidized sulfiredoxin under disulfide state is formed between the catalytic Cys(84) and Cys(48). This oxidized sulfiredoxin species is shown to be catalytically competent along the sulfiredoxin-recycling process and is reduced selectively by thioredoxin. The lack of Cys(48) in the mammalian sulfiredoxins and the low efficiency of reduction of the thiosulfinate intermediate by thioredoxin suggest a recycling mechanism in mammals different from that of sulfiredoxin from Saccharomyces cerevisiae.	[Roussel, Xavier; Kriznik, Alexandre; Richard, Christelle; Rahuel-Clermont, Sophie; Branlant, Guy] Nancy Univ, Fac Sci & Tech, ARN RNP Struct Fonct Maturat Enzymol Mol & Struct, Unite Mixte Rech CNRS UHP AREMS 7214, F-54506 Vandoeuvre Les Nancy, France	Universite de Lorraine	Rahuel-Clermont, S (corresponding author), Nancy Univ, Fac Sci & Tech, ARN RNP Struct Fonct Maturat Enzymol Mol & Struct, Unite Mixte Rech CNRS UHP AREMS 7214, Blvd Aiguillettes,BP 70239, F-54506 Vandoeuvre Les Nancy, France.	sophie.rahuel@maem.uhp-nancy.fr	Kriznik, Alexandre/S-1523-2019; Rahuel-Clermont, Sophie/AAB-3451-2020	Kriznik, Alexandre/0000-0003-2627-8273; Rahuel-Clermont, Sophie/0000-0001-5143-0105; Roussel, Xavier/0000-0003-2923-4559	CNRS; University of Nancy I; Institut Fe de ratif de Recherche 111 Bioingenierie; French Agence Nationale de la Recherche Program [ANR-06-BLAN-0369]	CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Nancy I; Institut Fe de ratif de Recherche 111 Bioingenierie; French Agence Nationale de la Recherche Program(French National Research Agency (ANR))	This work was supported in part by the CNRS, the University of Nancy I, the Institut Fe de ratif de Recherche 111 Bioingenierie, and by the French Agence Nationale de la Recherche Program ANR-06-BLAN-0369.; Supported by the French Research Ministry.	Aran M, 2008, FEBS J, V275, P1450, DOI 10.1111/j.1742-4658.2008.06299.x; Baker LMS, 2003, J BIOL CHEM, V278, P9203, DOI 10.1074/jbc.M209888200; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; BITEAU B, 2005, THESIS U PARIS SUD F; Bondareva AA, 2007, FREE RADICAL BIO MED, V43, P911, DOI 10.1016/j.freeradbiomed.2007.05.026; Bozonet SM, 2005, J BIOL CHEM, V280, P23319, DOI 10.1074/jbc.M502757200; Chang TS, 2004, J BIOL CHEM, V279, P50994, DOI 10.1074/jbc.M409482200; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Jeong W, 2006, J BIOL CHEM, V281, P14400, DOI 10.1074/jbc.M511082200; Jonsson TJ, 2008, J BIOL CHEM, V283, P22890, DOI [10.1074/jbc.C800124200, 10.1074/jbc.M803244200]; Kang SW, 1998, J BIOL CHEM, V273, P6303, DOI 10.1074/jbc.273.11.6303; Kong W, 2000, BIOCHEM J, V351, P107, DOI 10.1042/0264-6021:3510107; Lim JC, 2008, J BIOL CHEM, V283, P28873, DOI 10.1074/jbc.M804087200; Mossner E, 1998, PROTEIN SCI, V7, P1233; Mulrooney SB, 1997, PROTEIN SCI, V6, P2188; Olry A, 2004, BIOCHEMISTRY-US, V43, P11616, DOI 10.1021/bi049306z; Reddie KG, 2008, CURR OPIN CHEM BIOL, V12, P746, DOI 10.1016/j.cbpa.2008.07.028; Roussel X, 2008, J BIOL CHEM, V283, P22371, DOI 10.1074/jbc.M800493200; Seo JH, 2009, J BIOL CHEM, V284, P13455, DOI 10.1074/jbc.M900641200; Toledano MB, 2004, TRENDS BIOCHEM SCI, V29, P351, DOI 10.1016/j.tibs.2004.05.005; Vivancos AP, 2005, P NATL ACAD SCI USA, V102, P8875, DOI 10.1073/pnas.0503251102; Woo HA, 2009, ANTIOXID REDOX SIGN, V11, P739, DOI 10.1089/ARS.2008.2360; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8	25	26	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33048	33055		10.1074/jbc.M109.035352	http://dx.doi.org/10.1074/jbc.M109.035352			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801666	hybrid, Green Published			2022-12-27	WOS:000272028500007
J	Saberwal, G; Horvath, E; Hu, LP; Zhu, CL; Hjort, E; Eklund, EA				Saberwal, Gurveen; Horvath, Elizabeth; Hu, Liping; Zhu, Chunliu; Hjort, Elizabeth; Eklund, Elizabeth A.			The Interferon Consensus Sequence Binding Protein (ICSBP/IRF8) Activates Transcription of the FANCF Gene during Myeloid Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE-PHOSPHATASE; GP91(PHOX) EXPRESSION; LEUKEMIA; CELLS; PU.1; ANEMIA; DNA; P67(PHOX); COOPERATE; APOPTOSIS	The interferon consensus sequence binding protein ( ICSBP) is an interferon regulatory transcription factor with leukemia-suppressor activity. ICSBP regulates genes that are involved in phagocyte function, proliferation, and apoptosis. In murine models ICSBP deficiency results in a myeloproliferative disorder (MPD) with increased mature neutrophils. Over time this MPD progresses to acute myeloid leukemia (AML), suggesting that ICSBP deficiency is adequate for MPD, but additional genetic lesions are required for AML. The hypothesis of these studies is that dysregulation of key target genes predisposes to disease progression under conditions of decreased ICSBP expression. To investigate this hypothesis, we used chromatin co-immunoprecipitation to identify genes involved the ICSBP-leukemia suppressor effect. In the current studies, we identify the gene encoding Fanconi F (FANCF) as an ICSBP target gene. FancF participates in a repair of cross-linked DNA. We identify a FANCF promoter cis element, which is activated by ICSBP in differentiating myeloid cells. We also determine that DNA cross-link repair is impaired in ICSBP-deficient myeloid cells in a FancF-dependent manner. This effect is observed in differentiating cells, suggesting that ICSBP protects against the genotoxic stress of myelopoiesis. Decreased ICSBP expression is found in human AML and chronic myeloid leukemia during blast crisis (CML-BC). Our studies suggest that ICSBP deficiency may be functionally important for accumulation of chromosomal abnormalities during disease progression in these myeloid malignancies.	[Saberwal, Gurveen; Horvath, Elizabeth; Hu, Liping; Zhu, Chunliu; Hjort, Elizabeth; Eklund, Elizabeth A.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Saberwal, Gurveen; Horvath, Elizabeth; Hu, Liping; Zhu, Chunliu; Hjort, Elizabeth; Eklund, Elizabeth A.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Horvath, Elizabeth; Eklund, Elizabeth A.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Eklund, EA (corresponding author), Northwestern Univ, Feinberg Sch Med, 303 E Super St,Lurie 5-105, Chicago, IL 60611 USA.	e-eklund@northwestern.edu			National Institutes of Health [R01 HL 088747]; Veterans Affairs Merit Review; Leukemia and Lymphoma Society Translational Research Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088747] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review(US Department of Veterans Affairs); Leukemia and Lymphoma Society Translational Research Award(Leukemia and Lymphoma Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL 088747 ( to E. A. E.). This work was also supported by a Veterans Affairs Merit Review and a Leukemia and Lymphoma Society Translational Research Award ( to E. A. E.).	Ahn B, 2004, MOL CELLS, V18, P249; de Winter JP, 2000, HUM MOL GENET, V9, P2665, DOI 10.1093/hmg/9.18.2665; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Donahue SL, 2002, J BIOL CHEM, V277, P46243, DOI 10.1074/jbc.M207937200; DRIGGERS PH, 1990, P NATL ACAD SCI USA, V87, P3743, DOI 10.1073/pnas.87.10.3743; Dubchak I, 2000, GENOME RES, V10, P1304, DOI 10.1101/gr.142200; Eklund EA, 1999, J IMMUNOL, V163, P6095; Eklund EA, 1998, J BIOL CHEM, V273, P13957, DOI 10.1074/jbc.273.22.13957; Hao SX, 2000, MOL CELL BIOL, V20, P1149, DOI 10.1128/MCB.20.4.1149-1161.2000; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Huang WQ, 2008, J BIOL CHEM, V283, P7921, DOI 10.1074/jbc.M706710200; Huang WQ, 2007, J BIOL CHEM, V282, P6629, DOI 10.1074/jbc.M607760200; Huang WQ, 2006, MOL CELL BIOL, V26, P6311, DOI 10.1128/MCB.00036-06; Kautz B, 2001, J BIOL CHEM, V276, P37868; Kim KM, 2000, EXP MOL MED, V32, P246, DOI 10.1038/emm.2000.41; Konieczna I, 2008, J CLIN INVEST, V118, P853, DOI 10.1172/JCI33742; LARRICK JW, 1980, J IMMUNOL, V125, P6; Loots GG, 2002, GENOME RES, V12, P832, DOI 10.1101/gr.225502; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; Oberley MJ, 2003, METHOD ENZYMOL, V371, P577; Qian ZJ, 2002, P NATL ACAD SCI USA, V99, P14925, DOI 10.1073/pnas.222491799; Rehli M, 2000, J BIOL CHEM, V275, P9773, DOI 10.1074/jbc.275.13.9773; SARAS J, 1994, J BIOL CHEM, V269, P24082; Scheller M, 1999, BLOOD, V94, P3764, DOI 10.1182/blood.V94.11.3764.423k03_3764_3771; Schmidt M, 2004, BLOOD, V103, P4142, DOI 10.1182/blood-2003-01-0285; Schmidt M, 1998, BLOOD, V91, P22, DOI 10.1182/blood.V91.1.22.22_22_29; Schmidt M, 2001, BLOOD, V97, P3648, DOI 10.1182/blood.V97.11.3648; Taniguchi T, 2006, BLOOD, V107, P4223, DOI 10.1182/blood-2005-10-4240; *U MICH, ONC RES ADD; Wang IM, 2000, J IMMUNOL, V165, P271, DOI 10.4049/jimmunol.165.1.271; Xie Y, 2000, BRIT J HAEMATOL, V111, P1057, DOI 10.1111/j.1365-2141.2000.02450.x; Yanagisawa J, 1997, J BIOL CHEM, V272, P8539, DOI 10.1074/jbc.272.13.8539; Yaneva M, 2006, J IMMUNOL, V176, P6906, DOI 10.4049/jimmunol.176.11.6906; Zhu CL, 2004, J BIOL CHEM, V279, P50874, DOI 10.1074/jbc.M405736200	34	17	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33242	33254		10.1074/jbc.M109.010231	http://dx.doi.org/10.1074/jbc.M109.010231			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801548	Green Published, hybrid			2022-12-27	WOS:000272028500029
J	Shawgo, ME; Shelton, SN; Robertson, JD				Shawgo, Mary E.; Shelton, Shary N.; Robertson, John D.			Caspase-9 Activation by the Apoptosome Is Not Required for Fas-mediated Apoptosis in Type II Jurkat Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; ETOPOSIDE-INDUCED APOPTOSIS; ALPHA-DEPENDENT APOPTOSIS; SMALL-MOLECULE INHIBITORS; STRESS-INDUCED APOPTOSIS; X-LINKED INHIBITOR; CD95 TYPE-I; STRUCTURAL BASIS; CANCER-CELLS; CD95-MEDIATED APOPTOSIS	Activation of executioner caspases during receptor-mediated apoptosis in type II cells requires the engagement of the mitochondrial apoptotic pathway. Although it is well established that recruitment of mitochondria in this context involves the cleavage of Bid to truncated Bid (tBid), the precise post-mitochondrial signaling responsible for executioner caspase activation is controversial. Here, we used distinct clones of type II Jurkat T-lymphocytes in which the mitochondrial apoptotic pathway had been inhibited to investigate the molecular requirements necessary for Fas-induced apoptosis. Cells over-expressing either Bcl-2 or Bcl-x(L) were protected from apoptosis induced by agonistic anti-Fas antibody. By comparison, Apaf-1-deficient Jurkat cells were sensitive to anti-Fas, exhibiting Bid cleavage, Bak activation, the release of cytochrome c and Smac, and activation of executioner caspase-3. Inhibiting downstream caspase activation with the pharmacological inhibitor Z-DEVD-fmk or by expressing the BIR1/BIR2 domains of X-linked inhibitor of apoptosis protein (XIAP) decreased all anti-Fas-induced apoptotic changes. Additionally, pretreatment of Bcl-x(L)-over-expressing cells with a Smac mimetic sensitized these cells to Fas-induced apoptosis. Combined, our findings strongly suggest that Fas-mediated activation of executioner caspases and induction of apoptosis do not depend on apoptosome-mediated caspase-9 activation in prototypical type II cells.	[Robertson, John D.] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA; Univ Kansas, Med Ctr, Kansas Univ Canc Ctr, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Robertson, JD (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	jrobertson3@kumc.edu			National Institutes of Health [K22 ES011647]; National Center for Research Resources [P20 RR016475];  [T32 ES007079]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475, P20RR016443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K22ES011647, T32ES007079] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants K22 ES011647 (to J. D. R.), P20 RR016475 from the IDeA Networks of Biomedical Research Excellence Program of the National Center for Research Resources, and T32 ES007079.	Adrain C, 2001, EMBO J, V20, P6627, DOI 10.1093/emboj/20.23.6627; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Bockbrader KM, 2005, ONCOGENE, V24, P7381, DOI 10.1038/sj.onc.1208888; Chai JJ, 2001, CELL, V104, P769, DOI 10.1016/S0092-8674(02)02034-2; Chai JJ, 2000, NATURE, V406, P855, DOI 10.1038/35022514; Chen DJ, 2009, ANTI-CANCER DRUG, V20, P646, DOI 10.1097/CAD.0b013e32832ced78; Denault JB, 2007, BIOCHEM J, V405, P11, DOI 10.1042/BJ20070288; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Fadeel B, 1999, BIOCHEM BIOPH RES CO, V266, P699, DOI 10.1006/bbrc.1999.1888; Fakler M, 2009, BLOOD, V113, P1710, DOI 10.1182/blood-2007-09-114314; Franklin EE, 2007, BIOCHEM J, V405, P115, DOI 10.1042/BJ20061576; Han ZY, 1997, J BIOL CHEM, V272, P13432, DOI 10.1074/jbc.272.20.13432; Jost PJ, 2009, NATURE, V460, P1035, DOI 10.1038/nature08229; Kandasamy K, 2003, CANCER RES, V63, P1712; Kaufmann T, 2007, CELL, V129, P423, DOI 10.1016/j.cell.2007.03.017; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li L, 2004, SCIENCE, V305, P1471, DOI 10.1126/science.1098231; Li SC, 2002, J BIOL CHEM, V277, P26912, DOI 10.1074/jbc.M200726200; Liu HT, 2005, J BIOL CHEM, V280, P11578, DOI 10.1074/jbc.M414385200; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; McKenzie MD, 2008, DIABETES, V57, P1284, DOI 10.2337/db07-1692; McStay GP, 2008, CELL DEATH DIFFER, V15, P322, DOI 10.1038/sj.cdd.4402260; Oost TK, 2004, J MED CHEM, V47, P4417, DOI 10.1021/jm040037k; Park CM, 2005, BIOORG MED CHEM LETT, V15, P771, DOI 10.1016/j.bmcl.2004.11.010; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Petrucci E, 2007, GYNECOL ONCOL, V105, P481, DOI 10.1016/j.ygyno.2007.01.011; Pop C, 2007, BIOCHEMISTRY-US, V46, P4398, DOI 10.1021/bi602623b; Riedl SJ, 2001, CELL, V104, P791, DOI 10.1016/S0092-8674(02)02036-6; Robertson JD, 2002, J BIOL CHEM, V277, P29803, DOI 10.1074/jbc.M204185200; Samraj AK, 2006, J BIOL CHEM, V281, P29652, DOI 10.1074/jbc.M603487200; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Scaffidi C, 1999, J BIOL CHEM, V274, P22532, DOI 10.1074/jbc.274.32.22532; Schmitz I, 1999, CELL DEATH DIFFER, V6, P821, DOI 10.1038/sj.cdd.4400569; Scott FL, 2005, EMBO J, V24, P645, DOI 10.1038/sj.emboj.7600544; Shawgo ME, 2008, J BIOL CHEM, V283, P35532, DOI 10.1074/jbc.M807656200; Shelton SN, 2009, J BIOL CHEM, V284, P11247, DOI 10.1074/jbc.M809392200; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Sun HY, 2004, J MED CHEM, V47, P4147, DOI 10.1021/jm0499108; Sun XM, 2002, J BIOL CHEM, V277, P11345, DOI 10.1074/jbc.M109893200; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wilkinson JC, 2004, MOL CELL BIOL, V24, P7003, DOI 10.1128/MCB.24.16.7003-7014.2004; Wu G, 2000, NATURE, V408, P1008, DOI 10.1038/35050012; Wu TYH, 2003, CHEM BIOL, V10, P759, DOI 10.1016/S1074-5521(03)00157-1; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761	52	18	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33447	33455		10.1074/jbc.M109.032359	http://dx.doi.org/10.1074/jbc.M109.032359			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19758996	Green Published, hybrid			2022-12-27	WOS:000272028500051
J	Coleman, JA; Kwok, MCM; Molday, RS				Coleman, Jonathan A.; Kwok, Michael C. M.; Molday, Robert S.			Localization, Purification, and Functional Reconstitution of the P-4-ATPase Atp8a2, a Phosphatidylserine Flippase in Photoreceptor Disc Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASE; GLYCOPROTEIN MULTIDRUG TRANSPORTER; OUTER SEGMENT DISK; AMINOPHOSPHOLIPID TRANSLOCASE; LIPID ASYMMETRY; PLASMA-MEMBRANE; RIM PROTEIN; BOVINE; DRS2P; ABCR	P-4-ATPases comprise a relatively new subfamily of P-type ATPases implicated in the energy-dependent translocation of aminophospholipids across cell membranes. In this study, we report on the localization and functional properties of Atp8a2, a member of the P-4-ATPase subfamily that has not been studied previously. Reverse transcription-PCR revealed high expression of atp8a2 mRNA in the retina and testis. Within the retina, immunofluorescence microscopy and subcellular fractionation studies localized Atp8a2 to outer segment disc membranes of rod and cone photoreceptor cells. Atp8a2 purified from photoreceptor outer segments by immunoaffinity chromatography exhibited ATPase activity that was stimulated by phosphatidylserine and to a lesser degree phosphatidylethanolamine but not by phosphatidylcholine or other membrane lipids. Purified Atp8a2 was reconstituted into liposomes containing fluorescent-labeled phosphatidylserine to measure the ability of Atp8a2 to flip phosphatidylserine across the lipid bilayer. Fluorescence measurements showed that Atp8a2 flipped fluorescent-labeled phosphatidylserine from the inner leaflet of liposomes (equivalent to the exocytoplasmic leaflet of cell membranes) to the outer leaflet (equivalent to cytoplasmic leaflet) in an ATP-dependent manner. Our studies provide the first direct biochemical evidence that purified P-4-ATPases can translocate aminophospholipids across membranes and further implicates Atp8a2 in the generation and maintenance of phosphatidylserine asymmetry in photoreceptor disc membranes.	[Molday, Robert S.] Univ British Columbia, Dept Biochem & Mol Biol, Ctr Macular Res, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Ophthalmol & Visual Sci, Ctr Macular Res, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Molday, RS (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Ctr Macular Res, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	molday@interchange.ubc.ca		Coleman, Jonathan/0000-0003-0001-6195	National Institutes of Health [EY 02422]; Canadian Institutes of Health Research [MT 5822]; NATIONAL EYE INSTITUTE [R01EY002422] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY 02422. This work was also supported by Canadian Institutes of Health Research Grant MT 5822.	Alder-Baerens N, 2006, MOL BIOL CELL, V17, P1632, DOI 10.1091/mbc.E05-10-0912; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; AULAND ME, 1994, P NATL ACAD SCI USA, V91, P10938, DOI 10.1073/pnas.91.23.10938; Beharry S, 2004, J BIOL CHEM, V279, P53972, DOI 10.1074/jbc.M405216200; Bull LN, 1998, NAT GENET, V18, P219, DOI 10.1038/ng0398-219; Bungert S, 2001, J BIOL CHEM, V276, P23539, DOI 10.1074/jbc.M101902200; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen CY, 1999, J CELL BIOL, V147, P1223, DOI 10.1083/jcb.147.6.1223; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; COOK NJ, 1989, J BIOL CHEM, V264, P6996; Darland-Ransom M, 2008, SCIENCE, V320, P528, DOI 10.1126/science.1155847; Devaux PF, 2008, BBA-BIOMEMBRANES, V1778, P1591, DOI 10.1016/j.bbamem.2008.03.007; Eckford PDW, 2005, BIOCHEM J, V389, P517, DOI 10.1042/BJ20050047; Folmer DE, 2009, BBA-MOL CELL BIOL L, V1791, P628, DOI 10.1016/j.bbalip.2009.02.008; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GONZALEZROMO P, 1992, ANAL BIOCHEM, V200, P235, DOI 10.1016/0003-2697(92)90458-J; Grayson C, 2000, HUM MOL GENET, V9, P1873, DOI 10.1093/hmg/9.12.1873; Halleck MS, 1999, PHYSIOL GENOMICS, V1, P139, DOI 10.1152/physiolgenomics.1999.1.3.139; Hua ZL, 2002, MOL BIOL CELL, V13, P3162, DOI 10.1091/mbc.E02-03-0172; Illing M, 1997, J BIOL CHEM, V272, P10303, DOI 10.1074/jbc.272.15.10303; Kwok MCM, 2008, MOL CELL PROTEOMICS, V7, P1053, DOI 10.1074/mcp.M700571-MCP200; Lenoir G, 2009, J BIOL CHEM, V284, P17956, DOI 10.1074/jbc.M109.013722; Lev S, 2001, CELL MOL NEUROBIOL, V21, P575, DOI 10.1023/A:1015183500719; MACKENZIE D, 1982, J BIOL CHEM, V257, P7100; Manno S, 2002, P NATL ACAD SCI USA, V99, P1943, DOI 10.1073/pnas.042688399; MATSUDA T, 1994, J BIOL CHEM, V269, P30358; MCINTYRE JC, 1991, BIOCHEMISTRY-US, V30, P11819, DOI 10.1021/bi00115a012; Meguro M, 2001, NAT GENET, V28, P19, DOI 10.1038/ng0501-19; MILJANICH GP, 1981, J MEMBRANE BIOL, V60, P249, DOI 10.1007/BF01992562; MOLDAY LL, 1990, J BIOL CHEM, V265, P18690; Molday RS, 2009, BBA-MOL CELL BIOL L, V1791, P573, DOI 10.1016/j.bbalip.2009.02.004; MOLDAY RS, 1987, J CELL BIOL, V105, P2589, DOI 10.1083/jcb.105.6.2589; MORIYAMA Y, 1988, J BIOL CHEM, V263, P8521; MORROT G, 1990, FEBS LETT, V266, P29, DOI 10.1016/0014-5793(90)81498-D; Muthusamy BP, 2009, BBA-MOL CELL BIOL L, V1791, P612, DOI 10.1016/j.bbalip.2009.03.004; Natarajan P, 2004, P NATL ACAD SCI USA, V101, P10614, DOI 10.1073/pnas.0404146101; OPDENKAMP JAF, 1979, ANNU REV BIOCHEM, V48, P47, DOI 10.1146/annurev.bi.48.070179.000403; Pacione LR, 2003, ANNU REV NEUROSCI, V26, P657, DOI 10.1146/annurev.neuro.26.041002.131416; PAPERMASTER DS, 1974, BIOCHEMISTRY-US, V13, P2438, DOI 10.1021/bi00708a031; Puts CF, 2009, BBA-MOL CELL BIOL L, V1791, P603, DOI 10.1016/j.bbalip.2009.02.005; Romsicki Y, 2001, BIOCHEMISTRY-US, V40, P6937, DOI 10.1021/bi0024456; Saito K, 2004, MOL BIOL CELL, V15, P3418, DOI 10.1091/mbc.E03-11-0829; Soupene E, 2006, BRIT J HAEMATOL, V133, P436, DOI 10.1111/j.1365-2141.2006.06051.x; Stapelbroek JM, 2009, P NATL ACAD SCI USA, V106, P9709, DOI 10.1073/pnas.0807919106; Sun H, 1999, J BIOL CHEM, V274, P8269, DOI 10.1074/jbc.274.12.8269; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Wang L, 2004, DEV BIOL, V267, P203, DOI 10.1016/j.ydbio.2003.11.004; WANG YS, 1992, NEURON, V9, P429, DOI 10.1016/0896-6273(92)90181-C; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Wetzel RK, 1999, J NEUROSCI, V19, P9878; WU G, 1993, BIOCHEMISTRY-US, V32, P879, DOI 10.1021/bi00054a020; ZACHOWSKI A, 1989, NATURE, V340, P75, DOI 10.1038/340075a0; ZIMMERMAN ML, 1993, BIOCHEMISTRY-US, V32, P12257, DOI 10.1021/bi00096a040	54	134	137	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32670	32679		10.1074/jbc.M109.047415	http://dx.doi.org/10.1074/jbc.M109.047415			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19778899	Green Published, hybrid			2022-12-27	WOS:000272028400050
J	Kim, SH; Ryan, TA				Kim, Sung Hyun; Ryan, Timothy A.			A Distributed Set of Interactions Controls mu 2 Functionality in the Role of AP-2 as a Sorting Adaptor in Synaptic Vesicle Endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; AP2 COMPLEX; STRUCTURAL EXPLANATION; DILEUCINE MOTIF; RECOGNITION; SYNAPSES; SIGNALS; PROTEIN; PHOSPHORYLATION; SYNAPTOTAGMIN	The mechanisms of how, following exocytosis, the approximately nine types of synaptic vesicle (SV) transmembrane proteins are accurately resorted to form SVs are poorly understood. The time course of SV endocytosis is very sensitive to perturbations in clathrin and dynamin, supporting the model that SV endocytosis occurs through a clathrin-mediated pathway. We recently demonstrated that removal of the clathrin adaptor protein AP-2, the key protein thought to coordinate cargo selection into clathrin-coated pits, results in a significant impairment in endocytosis kinetics. Endocytosis, however, still proceeds in the absence of AP-2, bringing into question the role of AP-2 in cargo sorting in this process. Using quantitative endocytosis assays at nerve terminals, we examined how endocytosis depends on the integrity of mu 2 function. Our experiments indicate that no single perturbation in mu 2 prevents restoration of endocytic function when mutated mu 2 replaces native mu 2, whereas introduction of multiple distributed mutations significantly impairs endocytosis. We also examined whether the presence of AP-2 is important for the functionality of the previously identified endocytic motif in an SV cargo protein, the dileucine motif in vGlut-1. These data show that while mutations in the dileucine motif slow the retrieval of vGlut-1, they only do so in the presence of AP-2. These data thus indicate that AP-2 plays a role in cargo selection but that no single aspect of mu 2 function is critical, implying that a more distributed network of interactions supports AP-2 function in SV endocytosis.	[Kim, Sung Hyun; Ryan, Timothy A.] Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA	Cornell University	Ryan, TA (corresponding author), Weill Cornell Med Coll, Dept Biochem, 1300 York Ave, New York, NY 10065 USA.	taryan@med.cornell.edu	Kim, Sung Hyun/AAI-8554-2020; Ryan, Timothy/AAO-8286-2020	Ryan, Timothy/0000-0003-2533-9548; Kim, Sung Hyun/0000-0002-3166-9941	National Institutes of Health [36942]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036942] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 36942 (to T. A. R.).	AIKEN C, 1994, CELL, V76, P853, DOI 10.1016/0092-8674(94)90360-3; Atluri PP, 2006, J NEUROSCI, V26, P2313, DOI 10.1523/JNEUROSCI.4425-05.2006; Balaji J, 2008, J NEUROSCI, V28, P6742, DOI 10.1523/JNEUROSCI.1082-08.2008; Balaji J, 2007, P NATL ACAD SCI USA, V104, P20576, DOI 10.1073/pnas.0707574105; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Byland R, 2007, MOL BIOL CELL, V18, P414, DOI 10.1091/mbc.E06-06-0535; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Conner SD, 2003, J CELL BIOL, V162, P773, DOI 10.1083/jcb.200304069; Conner SD, 2002, J CELL BIOL, V156, P921, DOI 10.1083/jcb.200108123; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Fernandez-Alfonso T, 2006, NEURON, V51, P179, DOI 10.1016/j.neuron.2006.06.008; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Haucke V, 2000, EMBO J, V19, P6011, DOI 10.1093/emboj/19.22.6011; Haucke V, 1999, SCIENCE, V285, P1268, DOI 10.1126/science.285.5431.1268; Honing S, 2005, MOL CELL, V18, P519, DOI 10.1016/j.molcel.2005.04.019; Jung N, 2007, J CELL BIOL, V179, P1497, DOI 10.1083/jcb.200708107; Kelly BT, 2008, NATURE, V456, P976, DOI 10.1038/nature07422; Kim SH, 2009, J NEUROSCI, V29, P3865, DOI 10.1523/JNEUROSCI.5639-08.2009; Motley AM, 2006, MOL BIOL CELL, V17, P5298, DOI 10.1091/mbc.E06-05-0452; Olusanya O, 2001, CURR BIOL, V11, P896, DOI 10.1016/S0960-9822(01)00240-8; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Rapoport I, 1997, EMBO J, V16, P2240, DOI 10.1093/emboj/16.9.2240; Ricotta D, 2002, J CELL BIOL, V156, P791, DOI 10.1083/jcb.200111068; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; Schweizer FE, 2006, CURR OPIN NEUROBIOL, V16, P298, DOI 10.1016/j.conb.2006.05.006; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Voglmaier SM, 2006, NEURON, V51, P71, DOI 10.1016/j.neuron.2006.05.027; Wu LG, 2007, J NEUROSCI, V27, P11793, DOI 10.1523/JNEUROSCI.3471-07.2007	33	17	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32803	32812		10.1074/jbc.M109.039149	http://dx.doi.org/10.1074/jbc.M109.039149			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19762466	hybrid, Green Published			2022-12-27	WOS:000272028400065
J	Reubold, TF; Wohlgemuth, S; Eschenburg, S				Reubold, Thomas F.; Wohlgemuth, Sabine; Eschenburg, Susanne			A New Model for the Transition of APAF-1 from Inactive Monomer to Caspase-activating Apoptosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-FREE-EXTRACTS; CYTOCHROME-C; PROCASPASE-9 ACTIVATION; NUCLEOTIDE EXCHANGE; APOPTOTIC PROGRAM; DEATH; DATP; HYDROLYSIS; LIFE; OLIGOMERIZATION	The cytosolic adaptor protein Apaf-1 is a key player in the intrinsic pathway of apoptosis. Binding of mitochondrially released cytochrome c and of dATP or ATP to Apaf-1 induces the formation of the heptameric apoptosome complex, which in turn activates procaspase-9. We have re-investigated the chain of events leading from monomeric autoinhibited Apaf-1 to the functional apoptosome in vitro. We demonstrate that Apaf-1 does not require energy from nucleotide hydrolysis to eventually form the apoptosome. Despite a low intrinsic hydrolytic activity of the autoinhibited Apaf-1 monomer, nucleotide hydrolysis does not occur at any stage of the process. Rather, mere binding of ATP in concert with the binding of cytochrome c primes Apaf-1 for assembly. Contradicting the current view, there is no strict requirement for an adenine base in the nucleotide. On the basis of our results, we present a new model for the mechanism of apoptosome assembly.	[Eschenburg, Susanne] Max Planck Inst Mol Physiol, Dept Biol Struct, D-44227 Dortmund, Germany	Max Planck Society	Eschenburg, S (corresponding author), Max Planck Inst Mol Physiol, Dept Biol Struct, Otto Hahn Str 11, D-44227 Dortmund, Germany.	susanne.eschenburg@mpi-dortmund.mpg.de			European Union [LSHG-CT-2005-512028]	European Union(European Commission)	This work was supported by European Union Grant 3D Repertoire LSHG-CT-2005-512028.	Bao Q, 2007, CELL DEATH DIFFER, V14, P56, DOI 10.1038/sj.cdd.4402028; Bao Q, 2007, MOL CELL, V25, P181, DOI 10.1016/j.molcel.2006.12.013; Chandra D, 2006, CELL, V125, P1333, DOI 10.1016/j.cell.2006.05.026; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Danot O, 2009, STRUCTURE, V17, P172, DOI 10.1016/j.str.2009.01.001; de Almeida CJG, 2005, CELL MOL LIFE SCI, V62, P1532, DOI 10.1007/s00018-005-4511-y; Debatin KM, 2004, CANCER IMMUNOL IMMUN, V53, P153, DOI 10.1007/s00262-003-0474-8; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Friedlander RM, 2003, NEW ENGL J MED, V348, P1365, DOI 10.1056/NEJMra022366; Genini D, 2000, J BIOL CHEM, V275, P29, DOI 10.1074/jbc.275.1.29; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hu YM, 1998, J BIOL CHEM, V273, P33489, DOI 10.1074/jbc.273.50.33489; Hu YM, 1999, EMBO J, V18, P3586, DOI 10.1093/emboj/18.13.3586; Jiang XJ, 2000, J BIOL CHEM, V275, P31199, DOI 10.1074/jbc.C000405200; JOHN J, 1990, BIOCHEMISTRY-US, V29, P6058, DOI 10.1021/bi00477a025; Kim HE, 2005, P NATL ACAD SCI USA, V102, P17545, DOI 10.1073/pnas.0507900102; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kumar S, 2007, CELL DEATH DIFFER, V14, P32, DOI 10.1038/sj.cdd.4402060; Lelpe DD, 2004, J MOL BIOL, V343, P1, DOI 10.1016/j.jmb.2004.08.023; Leoni LM, 1998, P NATL ACAD SCI USA, V95, P9567, DOI 10.1073/pnas.95.16.9567; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Marquenet E, 2007, MOL CELL, V28, P187, DOI 10.1016/j.molcel.2007.08.014; Nagata S, 2006, IUBMB LIFE, V58, P358, DOI 10.1080/15216540600746401; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Opferman JT, 2008, CELL DEATH DIFFER, V15, P234, DOI 10.1038/sj.cdd.4402182; Proell M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002119; Rathmell JC, 2002, CELL, V109, pS97, DOI 10.1016/S0092-8674(02)00704-3; Riedl SJ, 2005, NATURE, V434, P926, DOI 10.1038/nature03465; Rodriguez J, 1999, GENE DEV, V13, P3179, DOI 10.1101/gad.13.24.3179; Saleh A, 1999, J BIOL CHEM, V274, P17941, DOI 10.1074/jbc.274.25.17941; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Shi YG, 2008, METHOD ENZYMOL, V442, P141, DOI 10.1016/S0076-6879(08)01407-9; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Stennicke HR, 1999, J BIOL CHEM, V274, P8359, DOI 10.1074/jbc.274.13.8359; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; Yin Q, 2006, MOL CELL, V22, P259, DOI 10.1016/j.molcel.2006.03.030; Yu XC, 2005, STRUCTURE, V13, P1725, DOI 10.1016/j.str.2005.09.006; Zermati Y, 2007, MOL CELL, V28, P624, DOI 10.1016/j.molcel.2007.09.030; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	45	47	51	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32717	32724		10.1074/jbc.M109.014027	http://dx.doi.org/10.1074/jbc.M109.014027			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19801675	hybrid, Green Published			2022-12-27	WOS:000272028400056
J	Sagana, RL; Yan, M; Cornett, AM; Tsui, JL; Stephenson, DA; Huang, SK; Moore, BB; Ballinger, MN; Melonakos, J; Kontos, CD; Aronoff, DM; Peters-Golden, M; White, ES				Sagana, Rommel L.; Yan, Mei; Cornett, Ashley M.; Tsui, Jessica L.; Stephenson, David A.; Huang, Steven K.; Moore, Bethany B.; Ballinger, Megan N.; Melonakos, Janet; Kontos, Christopher D.; Aronoff, David M.; Peters-Golden, Marc; White, Eric S.			Phosphatase and Tensin Homologue on Chromosome 10 (PTEN) Directs Prostaglandin E-2-mediated Fibroblast Responses via Regulation of E Prostanoid 2 Receptor Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PTEN; GENOME-WIDE ANALYSIS; GROWTH-FACTOR-BETA; INHIBITS FIBROBLAST; MYOFIBROBLAST DIFFERENTIATION; NEGATIVE REGULATION; LUNG FIBROBLASTS; CARCINOMA CELLS; CANCER CELLS; SUBTYPE EP4	Prostaglandin E-2 (PGE(2)) is an arachidonic acid metabolite that counters transforming growth factor-beta-induced fibroblast activation via E prostanoid 2 (EP2) receptor binding. Phosphatase and tensin homologue on chromosome 10 ( PTEN) is a lipid phosphatase that, by antagonizing the phosphoinositol 3-kinase (PI3K) pathway, also inhibits fibroblast activation. Here, we show that PTEN directly regulates PGE(2) inhibition of fibroblast activation by augmenting EP2 receptor expression. The increase in collagen production and alpha-smooth muscle actin expression observed in fibroblasts in which PTEN is deficient was resistant to the usual suppressive effects of PGE(2). This was due to marked down-regulation of EP2, a G(s) protein-coupled receptor (GPCR) that mediates the inhibitory actions of this prostanoid via cAMP. pten(-/-) or PTEN-inhibited fibroblasts in which the PI3K pathway was blocked demonstrated a restoration of EP2 receptor expression, due to augmented gene transcription and mRNA instability. Importantly, restoration of the balance between PI3K and PTEN reestablished the inhibitory effect of PGE2 on fibroblast activation. No such influence of PTEN was observed on alternative E prostanoid GPCRs. Moreover, our studies identified a positive feedback loop in which cAMP signaling enhanced EP2 receptor expression, independent of PTEN. Therefore, our findings indicate that PTEN regulates the antifibrotic effects of PGE(2) by a specific and permissive effect on EP2 receptor expression. Further, our data imply that cAMP signaling circumvents EP2 down-regulation in pten-deficient cells to restore EP2 receptor expression. This is the first description, to our knowledge, of PI3K/PTEN balance directing GPCR expression, and provides a novel mechanism for cellular effects of PTEN.	[Sagana, Rommel L.; Yan, Mei; Cornett, Ashley M.; Tsui, Jessica L.; Stephenson, David A.; Huang, Steven K.; Moore, Bethany B.; Ballinger, Megan N.; Peters-Golden, Marc; White, Eric S.] Univ Michigan, Sch Med, Div Pulm & Crit Care Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Huang, Steven K.] Univ Michigan, Sch Med, Div Infect Dis, Dept Internal Med, Ann Arbor, MI 48109 USA; [Moore, Bethany B.; Aronoff, David M.; Peters-Golden, Marc; White, Eric S.] Univ Michigan, Sch Med, Grad Program Immunol, Ann Arbor, MI 48109 USA; [White, Eric S.] Univ Michigan, Sch Med, Grad Program Cellular & Mol Biol, Ann Arbor, MI 48109 USA; [Melonakos, Janet] Duke Univ, Sch Med, Dept Med, Div Cardiol, Durham, NC 27708 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Duke University	White, ES (corresponding author), Univ Michigan, Sch Med, Div Pulm & Crit Care Med, Dept Internal Med, 6301 MSRB 3 SPC5642,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	docew@umich.edu		Aronoff, David/0000-0003-4587-6121; Kontos, Christopher/0000-0002-8056-3115; White, Eric/0000-0003-4060-8443; Moore, Bethany/0000-0003-3051-745X; Ballinger, Megan/0000-0002-2202-3049	National Institutes of Health [HL085083, HL094311, AI065543, HL083385]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083385, R01HL085083, R01HL094311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065543, R56AI065543] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants HL085083 (to E.S.W.), HL094311 (to M.P.-G.), AI065543 (to B.B.M.), and HL083385 (to C.D.K.). Downloaded from www. jbc. org at unknown institution, on November 23, 2009	Buchanan FG, 2003, J BIOL CHEM, V278, P35451, DOI 10.1074/jbc.M302474200; Chen XF, 2001, ONCOGENE, V20, P6073, DOI 10.1038/sj.onc.1204736; Conkright MD, 2003, MOL CELL, V11, P1101, DOI 10.1016/S1097-2765(03)00134-5; Dautzenberg FM, 2002, BIOCHEM BIOPH RES CO, V298, P303, DOI 10.1016/S0006-291X(02)02463-4; Eng C, 1998, NAT GENET, V19, P223, DOI 10.1038/897; Han SW, 2007, J BIOL CHEM, V282, P7961, DOI 10.1074/jbc.M610308200; Hjelmeland AB, 2005, CANCER RES, V65, P11276, DOI 10.1158/0008-5472.CAN-05-3016; Kohyama T, 2001, AM J PHYSIOL-LUNG C, V281, pL1257, DOI 10.1152/ajplung.2001.281.5.L1257; Kolodsick JE, 2003, AM J RESP CELL MOL, V29, P537, DOI 10.1165/rcmb.2002-0243OC; Li DM, 1997, CANCER RES, V57, P2124; Li DM, 1998, P NATL ACAD SCI USA, V95, P15406, DOI 10.1073/pnas.95.26.15406; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; McMenamin ME, 1999, CANCER RES, V59, P4291; Mutoh M, 2002, CANCER RES, V62, P28; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Oh JM, 2009, CARCINOGENESIS, V30, P141, DOI 10.1093/carcin/bgn236; Pap T, 2000, ARTHRITIS RES, V2, P59, DOI 10.1186/ar69; Paramio JM, 1999, ONCOGENE, V18, P7462, DOI 10.1038/sj.onc.1203151; Park MJ, 2007, J BIOL CHEM, V282, P30485, DOI 10.1074/jbc.M701081200; Sanchez T, 2005, P NATL ACAD SCI USA, V102, P4312, DOI 10.1073/pnas.0409784102; Schmid AC, 2004, FEBS LETT, V566, P35, DOI 10.1016/j.febslet.2004.03.102; Sheng HM, 2001, J BIOL CHEM, V276, P18075, DOI 10.1074/jbc.M009689200; Smock SL, 1999, GENE, V237, P393, DOI 10.1016/S0378-1119(99)00323-6; Souza JP, 2006, AM J OPHTHALMOL, V142, P625, DOI 10.1016/j.ajo.2006.05.053; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Thomas PE, 2007, AM J PHYSIOL-LUNG C, V293, pL417, DOI 10.1152/ajplung.00489.2006; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Wang XY, 2007, MOL CARCINOGEN, V46, P912, DOI 10.1002/mc.20320; White ES, 2006, AM J RESP CRIT CARE, V173, P112, DOI 10.1164/rccm.200507-1058OC; White ES, 2005, AM J RESP CELL MOL, V32, P135, DOI 10.1165/rcmb.2004-0126OC; White ES, 2003, AM J RESP CRIT CARE, V168, P436, DOI 10.1164/rccm.200301-041OC; WILBORN J, 1995, J CLIN INVEST, V95, P1861, DOI 10.1172/JCI117866; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102; Zhou P, 2008, NEUROBIOL DIS, V29, P543, DOI 10.1016/j.nbd.2007.11.010	35	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32264	32271		10.1074/jbc.M109.004796	http://dx.doi.org/10.1074/jbc.M109.004796			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19808686	hybrid, Green Published			2022-12-27	WOS:000272028400007
J	Beard, WA; Shock, DD; Batra, VK; Pedersen, LC; Wilson, SH				Beard, William A.; Shock, David D.; Batra, Vinod K.; Pedersen, Lars C.; Wilson, Samuel H.			DNA Polymerase beta Substrate Specificity SIDE CHAIN MODULATION OF THE "A-RULE"	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED-FIT MECHANISM; ABASIC SITE; STRUCTURAL BASIS; NUCLEOTIDE INCORPORATION; CRYSTAL-STRUCTURES; BASE SUBSTITUTION; TERNARY COMPLEXES; TEMPLATE-PRIMER; MINOR-GROOVE; T-OPPOSITE	Apurinic/apyrimidinic (AP) sites are continuously generated in genomic DNA. Left unrepaired, AP sites represent noninstructional premutagenic lesions that are impediments to DNA synthesis. When DNA polymerases encounter an AP site, they generally insert dAMP. This preferential insertion is referred to as the A-rule. Crystallographic structures of DNA polymerase (pol) beta, a family X polymerase, with active site mismatched nascent base pairs indicate that the templating (i.e. coding) base is repositioned outside of the template binding pocket thereby diminishing interactions with the incorrect incoming nucleotide. This effectively produces an abasic site because the template pocket is devoid of an instructional base. However, the template pocket is not empty; an arginine residue (Arg-283) occupies the space vacated by the templating nucleotide. In this study, we analyze the kinetics of pol beta insertion opposite an AP site and show that the preferential incorporation of dAMP is lost with the R283A mutant. The crystallographic structures of pol beta bound to gapped DNA with an AP site analog (tertrahydrofuran) in the gap (binary complex) and with an incoming nonhydrolyzable dATP analog (ternary complex) were solved. These structures reveal that binding of the dATP analog induces a closed polymerase conformation, an unstable primer terminus, and an upstream shift of the templating residue even in the absence of a template base. Thus, dATP insertion opposite an abasic site and dATP misinsertions have common features.	[Beard, William A.; Shock, David D.; Batra, Vinod K.; Pedersen, Lars C.; Wilson, Samuel H.] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Wilson, SH (corresponding author), NIEHS, Struct Biol Lab, NIH, 111 TW Alexander Dr,POB 12233,MD F3-01, Res Triangle Pk, NC 27709 USA.	wilson5@niehs.nih.gov	Pedersen, Lars/C-6173-2019; Wilson, Samuel H/E-6644-2019	Pedersen, Lars/0000-0002-4488-4077; Wilson, Samuel H/0000-0002-1702-5293	National Institutes of Health, NIEHS [Z01-ES0500158, Z01-ES050161]; National Institutes of Health [1U19CA105010]; NATIONAL CANCER INSTITUTE [U19CA105010] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES050158, ZIAES102645, Z01ES050161] Funding Source: NIH RePORTER	National Institutes of Health, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by Research Projects Z01-ES0500158 and Z01-ES050161 (to S. H. W.) in the Intramural Research Program, National Institutes of Health, NIEHS, and was in association with National Institutes of Health Grant 1U19CA105010.	Batra VK, 2008, MOL CELL, V30, P315, DOI 10.1016/j.molcel.2008.02.025; Batra VK, 2006, P NATL ACAD SCI USA, V103, P17231, DOI 10.1073/pnas.0605069103; Batra VK, 2006, STRUCTURE, V14, P757, DOI 10.1016/j.str.2006.01.011; Beard WA, 1996, J BIOL CHEM, V271, P12141, DOI 10.1074/jbc.271.21.12141; Beard WA, 2004, J BIOL CHEM, V279, P31921, DOI 10.1074/jbc.M404016200; Beard WA, 2006, CHEM REV, V106, P361, DOI 10.1021/cr0404904; Beard WA, 2002, J BIOL CHEM, V277, P47393, DOI 10.1074/jbc.M210036200; Beard WA, 2002, J BIOL CHEM, V277, P8235, DOI 10.1074/jbc.M107286200; Beard WA, 1995, METHOD ENZYMOL, V262, P98; BEARD WA, 1995, PRACTICAL APPROACH, V2, P15; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; Berdis AJ, 2001, BIOCHEMISTRY-US, V40, P7180, DOI 10.1021/bi0101594; Berg BJV, 2001, J BIOL CHEM, V276, P3408, DOI 10.1074/jbc.M002884200; Bose-Basu B, 2004, BIOCHEMISTRY-US, V43, P8911, DOI 10.1021/bi049641n; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen J, 2008, NUCLEIC ACIDS RES, V36, P253, DOI 10.1093/nar/gkm622; CUNIASSE P, 1987, NUCLEIC ACIDS RES, V15, P8003, DOI 10.1093/nar/15.19.8003; CUNIASSE P, 1990, J MOL BIOL, V213, P303, DOI 10.1016/S0022-2836(05)80192-5; Efrati E, 1997, J BIOL CHEM, V272, P2559; Freisinger E, 2004, EMBO J, V23, P1494, DOI 10.1038/sj.emboj.7600158; Garcia-Diaz M, 2005, NAT STRUCT MOL BIOL, V12, P97, DOI 10.1038/nsmb876; Guckian KM, 2000, J AM CHEM SOC, V122, P2213, DOI 10.1021/ja9934854; Haracska L, 2001, J BIOL CHEM, V276, P6861, DOI 10.1074/jbc.M008021200; Hogg M, 2004, EMBO J, V23, P1483, DOI 10.1038/sj.emboj.7600150; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kiefer JR, 1998, NATURE, V391, P304, DOI 10.1038/34693; Kirby TW, 2005, BIOCHEMISTRY-US, V44, P15230, DOI 10.1021/bi0511742; Krahn JM, 2004, STRUCTURE, V12, P1823, DOI 10.1016/j.str.2004.08.001; Krahn JM, 2003, STRUCTURE, V11, P121, DOI 10.1016/S0969-2126(02)00930-9; KUNKEL TA, 1986, J BIOL CHEM, V261, P160; Li Y, 2004, NAT STRUCT MOL BIOL, V11, P784, DOI 10.1038/nsmb792; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3610, DOI 10.1021/bi00769a018; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Ling H, 2004, MOL CELL, V13, P751, DOI 10.1016/S1097-2765(04)00101-7; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Nair DT, 2009, STRUCTURE, V17, P530, DOI 10.1016/j.str.2009.02.015; Nair DT, 2005, SCIENCE, V309, P2219, DOI 10.1126/science.1116336; Nakamura J, 1999, CANCER RES, V59, P2522; Nakamura J, 1998, CANCER RES, V58, P222; Osheroff WP, 1999, J BIOL CHEM, V274, P20749, DOI 10.1074/jbc.274.30.20749; Osheroff WP, 2000, J BIOL CHEM, V275, P28033; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patterson TA, 2000, PROTEIN EXPRES PURIF, V18, P100, DOI 10.1006/prep.1999.1167; PazElizur T, 1997, BIOCHEMISTRY-US, V36, P1766, DOI 10.1021/bi9621324; Pelletier H, 1996, BIOCHEMISTRY-US, V35, P12762, DOI 10.1021/bi9529566; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Radhakrishnan R, 2006, BIOCHEMISTRY-US, V45, P15142, DOI 10.1021/bi061353z; Reineks EZ, 2004, BIOCHEMISTRY-US, V43, P393, DOI 10.1021/bi034948s; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; SAWAYA MR, 1994, SCIENCE, V264, P1930, DOI 10.1126/science.7516581; Sheriff A, 2008, BIOCHEMISTRY-US, V47, P8527, DOI 10.1021/bi800324r; SIROVER MA, 1976, SCIENCE, V194, P1434, DOI 10.1126/science.1006310; STEITZ TA, 1994, SCIENCE, V266, P2022, DOI 10.1126/science.7528445; Strauss BS, 2002, DNA REPAIR, V1, P125, DOI 10.1016/S1568-7864(01)00014-3; Sun LP, 2000, BIOCHEMISTRY-US, V39, P14603, DOI 10.1021/bi001446v; WILDE JA, 1989, J AM CHEM SOC, V111, P1894, DOI 10.1021/ja00187a062; Wolfle WT, 2003, GENE DEV, V17, P2191, DOI 10.1101/gad.1108603; Xiang Y, 2008, PROTEINS, V70, P231, DOI 10.1002/prot.21668; Zahn KE, 2007, BIOCHEMISTRY-US, V46, P10551, DOI 10.1021/bi7008807	62	54	55	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31680	31689		10.1074/jbc.M109.029843	http://dx.doi.org/10.1074/jbc.M109.029843			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19759017	Green Published, hybrid			2022-12-27	WOS:000271572700023
J	McGillicuddy, FC; Chiquoine, EH; Hinkle, CC; Kim, RJ; Shah, R; Roche, HM; Smyth, EM; Reilly, MP				McGillicuddy, Fiona C.; Chiquoine, Elise H.; Hinkle, Christine C.; Kim, Roy J.; Shah, Rachana; Roche, Helen M.; Smyth, Emer M.; Reilly, Muredach P.			Interferon gamma Attenuates Insulin Signaling, Lipid Storage, and Differentiation in Human Adipocytes via Activation of the JAK/STAT Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; MONOCYTE CHEMOATTRACTANT PROTEIN-1; ADIPOSE-TISSUE; FACTOR-ALPHA; MACROPHAGE POLARIZATION; 3T3-L1 ADIPOCYTES; GENE-EXPRESSION; RECEPTOR-GAMMA; JAK KINASES; OBESITY	Recent reports demonstrate T-cell infiltration of adipose tissue in early obesity. We hypothesized that interferon (IFN) gamma, a major T-cell inflammatory cytokine, would attenuate human adipocyte functions and sought to establish signaling mechanisms. Differentiated human adipocytes were treated with IFN gamma +/- pharmacological inhibitors prior to insulin stimulation. [H-3]Glucose uptake and AKT phosphorylation were assessed as markers of insulin sensitivity. IFN gamma induced sustained loss of insulin-stimulated glucose uptake in human adipocytes, coincident with reduced Akt phosphorylation and down-regulation of the insulin receptor, insulin receptor substrate-1, and GLUT4. Loss of adipocyte triglyceride storage was observed with IFN gamma co-incident with reduced expression of peroxisome proliferator-activated receptor gamma, adiponectin, perilipin, fatty acid synthase, and lipoprotein lipase. Treatment with IFN gamma also blocked differentiation of pre-adipocytes to the mature phenotype. IFN gamma-induced robust STAT1 phosphorylation and SOCS1 mRNA expression, with modest, transient STAT3 phosphorylation and SOCS3 induction. Preincubation with a non-selective JAK inhibitor restored glucose uptake and Akt phosphorylation while completely reversing IFN gamma suppression of adipogenic mRNAs and adipocyte differentiation. Specific inhibition of JAK2 or JAK3 failed to block IFN gamma effects suggesting a predominant role for JAK1-STAT1. We demonstrate that IFN gamma attenuates insulin sensitivity and suppresses differentiation in human adipocytes, an effect most likely mediated via sustained JAK-STAT1 pathway activation.	[Reilly, Muredach P.] Univ Penn, Med Ctr, Cardiovasc Inst, Sch Med, Philadelphia, PA 19104 USA; [Kim, Roy J.; Reilly, Muredach P.] Univ Penn, Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Smyth, Emer M.; Reilly, Muredach P.] Univ Penn, Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA; [Kim, Roy J.; Shah, Rachana] Childrens Hosp Philadelphia, Div Pediat Endocrinol, Philadelphia, PA 19104 USA; [McGillicuddy, Fiona C.; Roche, Helen M.] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Nutrigenom Res Grp, Dublin 4, Ireland	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University College Dublin	Reilly, MP (corresponding author), Univ Penn, Med Ctr, Cardiovasc Inst, Sch Med, 609 BRB 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	muredach@mail.med.upenn.edu	Roche, Helen M/AAF-4164-2019	Roche, Helen M/0000-0002-0628-3318; Reilly, Muredach/0000-0002-3035-9386; Shah, Rachana/0000-0001-7866-557X; McGillicuddy, Fiona/0000-0003-3623-3503	National Institutes of Health [RO1 HL-073278]; NHLBI [P50 HL-083799-SCCOR]; Science Foundation of Ireland PI Programme Grant [06/IM.1/B105]; National Center for Research Resources [RFA-RM-06-002]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073278, P50HL083799] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Science Foundation of Ireland PI Programme Grant(Science Foundation Ireland); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	* This work was supported, in whole or in part, by National Institutes of Health Grants RO1 HL-073278 and P50 HL-083799-SCCOR ( to M. P. R.) from the NHLBI, Science Foundation of Ireland PI Programme Grant 06/IM.1/B105 ( to H. M. R.), and Clinical and Translational Science Award RFA-RM-06-002 from the National Center for Research Resources ( NCRR). Downloaded from www.jbc.org at unknown institution, on November 10, 2009	Alexander WS, 2002, NAT REV IMMUNOL, V2, P410, DOI 10.1038/nri818; Antuna-Puente B, 2008, DIABETES METAB, V34, P2, DOI 10.1016/j.diabet.2007.09.004; Bach EA, 1997, ANNU REV IMMUNOL, V15, P563, DOI 10.1146/annurev.immunol.15.1.563; Bendinelli P, 2000, MOL CELL ENDOCRINOL, V168, P11, DOI 10.1016/S0303-7207(00)00313-0; Briscoe J, 1996, EMBO J, V15, P799, DOI 10.1002/j.1460-2075.1996.tb00415.x; Caldenhoven E, 1999, J LEUKOCYTE BIOL, V65, P391, DOI 10.1002/jlb.65.3.391; Chen AR, 2005, OBES RES, V13, P1311, DOI 10.1038/oby.2005.159; Eguchi J, 2008, CELL METAB, V7, P86, DOI 10.1016/j.cmet.2007.11.002; Elmendorf JS, 1998, J BIOL CHEM, V273, P13289, DOI 10.1074/jbc.273.21.13289; Emanuelli B, 2001, J BIOL CHEM, V276, P47944, DOI 10.1074/jbc.M104602200; Fenkci S, 2006, J INVEST MED, V54, P455, DOI 10.2310/6650.2006.06010; Ferrante AW, 2007, J INTERN MED, V262, P408, DOI 10.1111/j.1365-2796.2007.01852.x; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Franckhauser S, 2008, DIABETOLOGIA, V51, P1306, DOI 10.1007/s00125-008-0998-8; Goossens GH, 2008, PHYSIOL BEHAV, V94, P206, DOI 10.1016/j.physbeh.2007.10.010; Han YL, 1996, J BIOL CHEM, V271, P5947, DOI 10.1074/jbc.271.10.5947; Hong F, 2002, J CLIN INVEST, V110, P1503, DOI 10.1172/JCI200215841; HORVATH CM, 2004, SCI STKE, pTR9; HOTAMISLIGIL GS, 1994, DIABETES, V43, P1271, DOI 10.2337/diabetes.43.11.1271; HOTAMISLIGIL GS, 1994, P NATL ACAD SCI USA, V91, P4854, DOI 10.1073/pnas.91.11.4854; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; KERN PA, 1995, J CLIN INVEST, V95, P2111, DOI 10.1172/JCI117899; KIMURA T, 1994, SCIENCE, V264, P1921, DOI 10.1126/science.8009222; Kintscher U, 2008, ARTERIOSCL THROM VAS, V28, P1304, DOI 10.1161/ATVBAHA.108.165100; Kohlhuber F, 1997, MOL CELL BIOL, V17, P695, DOI 10.1128/MCB.17.2.695; Krause CD, 2006, CELL RES, V16, P55, DOI 10.1038/sj.cr.7310008; LANG CH, 1992, ENDOCRINOLOGY, V130, P43, DOI 10.1210/en.130.1.43; Li L, 2008, DIABETES OBES METAB, V10, P921, DOI 10.1111/j.1463-1326.2007.00832.x; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Ozato K, 2007, J BIOL CHEM, V282, P20065, DOI 10.1074/jbc.R700003200; Permana PA, 2006, BIOCHEM BIOPH RES CO, V341, P507, DOI 10.1016/j.bbrc.2006.01.012; Rausch ME, 2008, INT J OBESITY, V32, P451, DOI 10.1038/sj.ijo.0803744; Rocha VZ, 2008, CIRC RES, V103, P467, DOI 10.1161/CIRCRESAHA.108.177105; Rotter V, 2003, J BIOL CHEM, V278, P45777, DOI 10.1074/jbc.M301977200; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; SAKATSUME M, 1995, J BIOL CHEM, V270, P17528, DOI 10.1074/jbc.270.29.17528; Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; Shi H, 2006, DIABETES, V55, P699, DOI 10.2337/diabetes.55.03.06.db05-0841; Shoelson SE, 2003, INT J OBESITY, V27, pS49, DOI 10.1038/sj.ijo.0802501; Smit LS, 1996, MOL ENDOCRINOL, V10, P519, DOI 10.1210/me.10.5.519; Tamori Y, 2002, DIABETES, V51, P2045, DOI 10.2337/diabetes.51.7.2045; Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004; Vaisse C, 1996, NAT GENET, V14, P95, DOI 10.1038/ng0996-95; Wabitsch M, 2001, INT J OBESITY, V25, P8, DOI 10.1038/sj.ijo.0801520; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wu HZ, 2007, CIRCULATION, V115, P1029, DOI 10.1161/CIRCULATIONAHA.106.638379; Zhang B, 1996, MOL ENDOCRINOL, V10, P1457, DOI 10.1210/me.10.11.1457	52	175	179	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31936	31944		10.1074/jbc.M109.061655	http://dx.doi.org/10.1074/jbc.M109.061655			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19776010	Green Published, hybrid			2022-12-27	WOS:000271572700049
J	Mosessian, S; Avliyakulov, NK; Mulholland, DJ; Boontheung, P; Loo, JA; Wu, H				Mosessian, Sherly; Avliyakulov, Nuraly K.; Mulholland, David J.; Boontheung, Pinmanee; Loo, Joseph A.; Wu, Hong			Analysis of PTEN Complex Assembly and Identification of Heterogeneous Nuclear Ribonucleoprotein C as a Component of the PTEN-associated Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID PHOSPHATASE-ACTIVITY; TUMOR-SUPPRESSOR PTEN; GEL-ELECTROPHORESIS; PROTEIN STABILITY; CELL-MIGRATION; MESSENGER-RNA; PDZ DOMAIN; PHOSPHORYLATION; LOCALIZATION; MULTIPLE	PTEN (phosphatase and tensin homolog deleted on chromosome 10) is well characterized for its role in antagonizing the phosphoinositide 3-kinase pathway. Previous studies using size-exclusion chromatography demonstrated PTEN recruitment into high molecular mass complexes and hypothesized that PTEN phosphorylation status and PDZ binding domain may be required for such complex formation. In this study, we set out to test the structural requirements for PTEN complex assembly and identify the component(s) of the PTEN complex(es). Our results demonstrated that the PTEN catalytic function and PDZ binding domain are not absolutely required for its complex formation. On the other hand, PTEN phosphorylation status has a significant impact on its complex assembly. Our results further demonstrate enrichment of the PTEN complex in nuclear lysates, suggesting a mechanism through which PTEN phosphorylation may regulate its complex assembly. These results prompted further characterization of other protein components within the PTEN complex(es). Using size-exclusion chromatography and two-dimensional difference gel electrophoresis followed by mass spectrometry analysis, we identified heterogeneous nuclear ribonucleoprotein C (hnRNP C) as a novel protein recruited to higher molecular mass fractions in the presence of PTEN. Further analysis indicates that endogenous hnRNP C and PTEN interact and co-localize within the nucleus, suggesting a potential role for PTEN, alongside hnRNP C, in RNA regulation.	[Mosessian, Sherly; Mulholland, David J.; Wu, Hong] Univ Calif Los Angeles, Inst Mol Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Avliyakulov, Nuraly K.; Loo, Joseph A.] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Boontheung, Pinmanee; Loo, Joseph A.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Wu, H (corresponding author), Univ Calif Los Angeles, Inst Mol Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	hwu@mednet.ucla.edu		Mosessian, Sherly/0000-0002-8665-5053	National Institutes of Health [P50 CA092131, R01 CA107166]; National Cancer Institute/National Institutes of Health [U01 CA84128-06]; Prostate Cancer Foundation; Department of Defense [PC031130]; W. M. Keck Foundation; Jonsson Comprehensive Cancer Center; dean's office at the David Geffen School of Medicine; Chancellor's Bioscience Facility grant; UCLA; NATIONAL CANCER INSTITUTE [F32CA112988, P50CA092131, R01CA107166, U01CA084128] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Prostate Cancer Foundation; Department of Defense(United States Department of Defense); W. M. Keck Foundation(W.M. Keck Foundation); Jonsson Comprehensive Cancer Center; dean's office at the David Geffen School of Medicine; Chancellor's Bioscience Facility grant; UCLA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported, in whole or in part, by National Institutes of Health Grants P50 CA092131 and R01 CA107166 (to H. W.), National Cancer Institute/National Institutes of Health Grant U01 CA84128-06, the Prostate Cancer Foundation, and Department of Defense Grant PC031130 (to H. W.). The UCLA Mass Spectrometry and Proteomics Technology Center was established with a grant from the W. M. Keck Foundation. The functional proteomics laboratory (DIGE Shared Resource) was supported by the Jonsson Comprehensive Cancer Center, the dean's office at the David Geffen School of Medicine, and a Chancellor's Bioscience Facility grant, UCLA.	Adey NB, 2000, CANCER RES, V60, P35; Ali IU, 1999, JNCI-J NATL CANCER I, V91, P1922, DOI 10.1093/jnci/91.22.1922; Carracedo A, 2008, CELL, V133, P550, DOI 10.1016/j.cell.2008.04.023; Chang CJ, 2008, MOL CELL BIOL, V28, P3281, DOI 10.1128/MCB.00310-08; CHOI YD, 1986, SCIENCE, V231, P1534, DOI 10.1126/science.3952495; Crockett DK, 2005, PROTEOMICS, V5, P1250, DOI 10.1002/pmic.200401046; Ford LP, 2000, MOL CELL BIOL, V20, P9084, DOI 10.1128/MCB.20.23.9084-9091.2000; Georgescu MM, 1999, P NATL ACAD SCI USA, V96, P10182, DOI 10.1073/pnas.96.18.10182; Gil A, 2006, MOL BIOL CELL, V17, P4002, DOI 10.1091/mbc.E06-05-0380; GORLACH M, 1992, EMBO J, V11, P3289, DOI 10.1002/j.1460-2075.1992.tb05407.x; Holcik M, 2003, MOL CELL BIOL, V23, P280, DOI 10.1128/MCB.23.1.280-288.2003; Hossain MN, 2007, MOL CELL BIOCHEM, V296, P151, DOI 10.1007/s11010-006-9308-2; Kotelevets L, 2004, FASEB J, V18, P115, DOI 10.1096/fj.04-1942fje; Li DM, 1997, CANCER RES, V57, P2124; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Miller SJ, 2002, FEBS LETT, V528, P145, DOI 10.1016/S0014-5793(02)03274-X; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Odriozola L, 2007, J BIOL CHEM, V282, P23306, DOI 10.1074/jbc.M611240200; Radu A, 2003, MOL CELL BIOL, V23, P6139, DOI 10.1128/MCB.23.17.6139-6149.2003; Raftopoulou M, 2004, SCIENCE, V303, P1179, DOI 10.1126/science.1092089; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Stone JR, 2002, J BIOL CHEM, V277, P15621, DOI 10.1074/jbc.M112153200; Sumitomo M, 2004, CANCER CELL, V5, P67, DOI 10.1016/S1535-6108(03)00331-3; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; SWANSON MS, 1987, MOL CELL BIOL, V7, P1731, DOI 10.1128/MCB.7.5.1731; Takahashi Y, 2006, EMBO J, V25, P910, DOI 10.1038/sj.emboj.7600979; Tamguney T, 2007, J CELL SCI, V120, P4071, DOI 10.1242/jcs.015230; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Tonge R, 2001, PROTEOMICS, V1, P377; Torres J, 2003, J BIOL CHEM, V278, P30652, DOI 10.1074/jbc.M212610200; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Vazquez F, 2001, J BIOL CHEM, V276, P48627, DOI 10.1074/jbc.C100556200; Venables JP, 2008, MOL CELL BIOL, V28, P6033, DOI 10.1128/MCB.00726-08; Weng LP, 2001, HUM MOL GENET, V10, P599, DOI 10.1093/hmg/10.6.599; Wu XY, 2000, P NATL ACAD SCI USA, V97, P4233, DOI 10.1073/pnas.97.8.4233; Wu Y, 2000, J BIOL CHEM, V275, P21477, DOI 10.1074/jbc.M909741199; Yu ZB, 2002, J BIOL CHEM, V277, P40247, DOI 10.1074/jbc.M207608200	43	16	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30159	30166		10.1074/jbc.M109.027995	http://dx.doi.org/10.1074/jbc.M109.027995			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19740742	Green Published, hybrid			2022-12-27	WOS:000271090000019
J	Puklin-Faucher, E; Vogel, V				Puklin-Faucher, Eileen; Vogel, Viola			Integrin Activation Dynamics between the RGD-binding Site and the Headpiece Hinge	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATCH BONDS; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; A-DOMAIN; EXTRACELLULAR SEGMENT; LIGAND RECOGNITION; STRUCTURAL BASIS; HYBRID DOMAIN; FORCE; ALPHA(5)BETA(1)	Integrins form mechanical links between the extracellular matrix and the cytoskeleton. Although integrin activation is known to be regulated by an allosteric conformational change, which can be induced from the extracellular or intracellular end of the molecule, little is known regarding the sequence of structural events by which signals propagate between distant sites. Here, we reveal with molecular dynamics simulations of the FnIII(10)-bound alpha(V)beta(3) integrin headpiece how the binding pocket and interdomain beta A/hybrid domain hinge on the distal end of the beta A domain are allosterically linked via a hydrophobic T-junction between the middle of the alpha 1 helix and top of the alpha 7 helix. The key results of this study are: 1) that this T-junction is induced by ligand binding and hinge opening, and thus displays bidirectionality; 2) that formation of this junction can be accelerated by ligand-mediated force; and 3) how formation of this junction is inhibited by Ca2+ in place of Mg2+ at the site adjacent to the metal ion-dependent adhesion site ("ADMIDAS"). Together with recent experimental evidence that integrin complexes can form catch bonds (i.e. become strengthened under force), as well as earlier evidence that Ca2+ at the ADMIDAS results in lower binding affinity, these simulations provide a common structural model for the dynamic process by which integrins become activated.	[Puklin-Faucher, Eileen; Vogel, Viola] ETH, Lab Biologically Oriented Mat, Dept Mat, CH-8049 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Vogel, V (corresponding author), ETH, Lab Biologically Oriented Mat, Dept Mat, CH-8049 Zurich, Switzerland.	viola.vogel@mat.ethz.ch	Vogel, Viola/O-8025-2015	Vogel, Viola/0000-0003-2898-7671	ETH Zurich; Swiss National Supercomputing Center (CSCS, ALPS Project); National Institutes of Health Roadmap for Medical Research [PN2 EY016586]; NATIONAL EYE INSTITUTE [PN2EY016586] Funding Source: NIH RePORTER	ETH Zurich(ETH Zurich); Swiss National Supercomputing Center (CSCS, ALPS Project); National Institutes of Health Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by ETH Zurich, the Swiss National Supercomputing Center (CSCS, ALPS Project), and National Institutes of Health Roadmap for Medical Research Grant PN2 EY016586 to the Nanotechnology Center for Mechanics in Regenerative Medicine.	Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; Barton SJ, 2004, BIOCHEM J, V380, P401, DOI 10.1042/BJ20031973; Chen JF, 2003, NAT STRUCT BIOL, V10, P995, DOI 10.1038/nsb1011; Craig D, 2004, STRUCTURE, V12, P2049, DOI 10.1016/j.str.2004.09.009; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; Guo B, 2006, P NATL ACAD SCI USA, V103, P9844, DOI 10.1073/pnas.0601255103; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Isralewitz B, 2001, J MOL GRAPH MODEL, V19, P13, DOI 10.1016/S1093-3263(00)00133-9; Jin M, 2004, STRUCTURE, V12, P2137, DOI 10.1016/j.str.2004.10.005; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Katz AK, 1996, J AM CHEM SOC, V118, P5752, DOI 10.1021/ja953943i; Kong F, 2009, J CELL BIOL, V185, P1275, DOI 10.1083/jcb.200810002; Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8; Lu H, 2000, BIOPHYS J, V79, P51, DOI 10.1016/S0006-3495(00)76273-4; Luo BH, 2004, J BIOL CHEM, V279, P27466, DOI 10.1074/jbc.M404354200; Luo BH, 2003, P NATL ACAD SCI USA, V100, P2403, DOI 10.1073/pnas.0438060100; Luo BH, 2009, J BIOL CHEM, V284, P3917, DOI 10.1074/jbc.M806312200; Luque I, 2000, PROTEINS, P63; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Marinelli L, 2003, J MED CHEM, V46, P4393, DOI 10.1021/jm020577m; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; MOULD AP, 1995, J BIOL CHEM, V270, P26270, DOI 10.1074/jbc.270.44.26270; Mould AP, 2003, J BIOL CHEM, V278, P51622, DOI 10.1074/jbc.M306655200; Mould AP, 2003, J BIOL CHEM, V278, P17028, DOI 10.1074/jbc.M213139200; Mould AP, 2002, J BIOL CHEM, V277, P19800, DOI 10.1074/jbc.M201571200; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Puklin-Faucher E, 2006, J CELL BIOL, V175, P349, DOI 10.1083/jcb.200602071; Sarangapani KK, 2004, J BIOL CHEM, V279, P2291, DOI 10.1074/jbc.M310396200; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takagi J, 2003, EMBO J, V22, P4607, DOI 10.1093/emboj/cdg445; Tchesnokova V, 2008, J BIOL CHEM, V283, P7823, DOI 10.1074/jbc.M707804200; Thomas WE, 2002, CELL, V109, P913, DOI 10.1016/S0092-8674(02)00796-1; Thomas WE, 2008, ANNU REV BIOPHYS, V37, P399, DOI 10.1146/annurev.biophys.37.032807.125804; Valdramidou D, 2008, J BIOL CHEM, V283, P32704, DOI 10.1074/jbc.M802066200; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Wriggers W, 1997, PROTEINS, V29, P1; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yakovenko O, 2008, J BIOL CHEM, V283, P11596, DOI 10.1074/jbc.M707815200; Zhu C, 2005, BIORHEOLOGY, V42, P443; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018	44	49	52	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36557	36568		10.1074/jbc.M109.041194	http://dx.doi.org/10.1074/jbc.M109.041194			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19762919	Green Published, hybrid			2022-12-27	WOS:000272970500057
J	Pao-Chun, L; Chan, PM; Chan, W; Manser, E				Pao-Chun, Lin; Chan, Perry M.; Chan, Wing; Manser, Ed			Cytoplasmic ACK1 Interaction with Multiple Receptor Tyrosine Kinases Is Mediated by Grb2 AN ANALYSIS OF ACK1 EFFECTS ON Axl SIGNALING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; EGF RECEPTOR; PROTEIN-KINASE; BREAST-CANCER; AXL RECEPTOR; DOWN-REGULATION; GROWTH ARREST; MAP KINASE; CELL-LINES; EXPRESSION	ACK1 (activated Cdc42-associated kinase 1), a cytoplsmic tyrosine kinase, is implicated in metastatic behavior, cell spreading and migration, and epidermal growth factor receptor (EGFR) signaling. The function of ACK1 in the regulation of receptor tyrosine kinases requires a C-terminal region that demonstrates a significant homology to the EGFR binding domain of MIG6. In this study, we have identified additional receptor tyrosine kinases, including Axl, leukocyte tyrosine kinase, and anaplastic lymphoma kinase, that can bind to the ACK1/MIG6 homology region. Unlike the interaction between MIG6 and EGFR, our data suggest that these receptor tyrosine kinases require the adaptor protein Grb2 for efficient binding, which interacts with highly conserved proline-rich regions that are conserved between ACK1 and MIG6. We have focused on Axl and compared how ACK1/Axl differs from the ACK1/EGFR axis by investigating effects of knockdown of endogenous ACK1. Although EGFR activation promotes ACK1 turnover, Axl activation by GAS6 does not; interestingly, the reciprocal down-regulation of GAS6-stimulated Axl is blocked by removing ACK1. Thus, ACK1 functions in part to control Axl receptor levels. Silencing of ACK1 also leads to diminished ruffling and migration in DU145 and COS7 cells upon GAS6-Axl signaling. The ability of ACK1 to modulate Axl and perhaps anaplastic lymphoma kinase (altered in anaplastic large cell lymphomas) might explain why ACK1 can promote metastatic and transformed behavior in a number of cancers.	[Manser, Ed] ASTAR Neurosci Res Partnership, sGSK Grp, Singapore 138673, Singapore; Inst Mol & Cell Biol, Singapore 138673, Singapore	Agency for Science Technology & Research (A*STAR); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Manser, E (corresponding author), ASTAR Neurosci Res Partnership, sGSK Grp, 61 Biopolis Dr, Singapore 138673, Singapore.	ed.manser@imb.a-star.edu.sg	Manser, Edward/ABD-2301-2020		GSK (Singapore)	GSK (Singapore)(GlaxoSmithKline)	This work is supported by the GSK (Singapore) research fund.	Allen MP, 2002, MOL CELL BIOL, V22, P599, DOI 10.1128/MCB.22.2.599-613.2002; Anastasi S, 2003, ONCOGENE, V22, P4221, DOI 10.1038/sj.onc.1206516; BEN-NERIAH Y, 1988, NATURE, V333, P672, DOI 10.1038/333672a0; Berclaz G, 2001, ANN ONCOL, V12, P819, DOI 10.1023/A:1011126330233; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; Challier C, 1996, LEUKEMIA, V10, P781; Chan W, 2009, J BIOL CHEM, V284, P8185, DOI 10.1074/jbc.M806877200; CHARDIN P, 1993, SCIENCE, V260, P1338, DOI 10.1126/science.8493579; Chen WS, 1999, INT J CANCER, V83, P579, DOI 10.1002/(SICI)1097-0215(19991126)83:5<579::AID-IJC1>3.0.CO;2-R; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; CRAVEN RJ, 1995, INT J CANCER, V60, P791, DOI 10.1002/ijc.2910600611; Demarchi F, 2001, J BIOL CHEM, V276, P31738, DOI 10.1074/jbc.M104457200; Eisenmann KM, 1999, NAT CELL BIOL, V1, P507, DOI 10.1038/70302; Fehrenbacher N, 2009, MOL ONCOL, V3, P297, DOI 10.1016/j.molonc.2009.06.004; Fiorentino L, 2000, MOL CELL BIOL, V20, P7735, DOI 10.1128/MCB.20.20.7735-7750.2000; Fridell YWC, 1996, MOL CELL BIOL, V16, P135; GALE NW, 1993, NATURE, V363, P88, DOI 10.1038/363088a0; Galisteo ML, 2006, P NATL ACAD SCI USA, V103, P9796, DOI 10.1073/pnas.0603714103; Goruppi S, 1999, ONCOGENE, V18, P4224, DOI 10.1038/sj.onc.1202788; Goruppi S, 1997, MOL CELL BIOL, V17, P4442, DOI 10.1128/MCB.17.8.4442; Goruppi S, 2001, MOL CELL BIOL, V21, P902, DOI 10.1128/MCB.21.3.902-915.2001; Grovdal LM, 2008, EXP CELL RES, V314, P1292, DOI 10.1016/j.yexcr.2007.12.017; Gustavsson A, 2004, J BIOL CHEM, V279, P22893, DOI 10.1074/jbc.M309693200; Hackel PO, 2001, BIOL CHEM, V382, P1649, DOI 10.1515/BC.2001.200; Hafizi S, 2006, CYTOKINE GROWTH F R, V17, P295, DOI 10.1016/j.cytogfr.2006.04.004; Hasanbasic I, 2004, AM J PHYSIOL-HEART C, V287, pH1207, DOI 10.1152/ajpheart.00020.2004; Hoehn GT, 1996, ONCOGENE, V12, P903; Hopper NA, 2000, MOL CELL, V6, P65, DOI 10.1016/S1097-2765(00)00008-3; Howlin J, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2087; Ito T, 1999, THYROID, V9, P563, DOI 10.1089/thy.1999.9.563; Iwahara T, 1997, ONCOGENE, V14, P439, DOI 10.1038/sj.onc.1200849; Jacob ANK, 1999, CANCER DETECT PREV, V23, P325; Jiang XJ, 2003, MOL BIOL CELL, V14, P858, DOI 10.1091/mbc.E02-08-0532; Kranenburg O, 1999, J BIOL CHEM, V274, P35301, DOI 10.1074/jbc.274.50.35301; Lee WP, 2002, ONCOGENE, V21, P329, DOI 10.1038/sj.onc.1205066; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; LI W, 1994, MOL CELL BIOL, V14, P509, DOI 10.1128/MCB.14.1.509; Lin M, 2004, BREAST CANCER RES TR, V84, P49, DOI 10.1023/B:BREA.0000018424.43445.f3; Lin WC, 1999, CLIN CANCER RES, V5, P1745; Ling L, 1996, J BIOL CHEM, V271, P18355, DOI 10.1074/jbc.271.31.18355; LIU E, 1988, P NATL ACAD SCI USA, V85, P1952, DOI 10.1073/pnas.85.6.1952; Lougheed JC, 2004, J BIOL CHEM, V279, P44039, DOI 10.1074/jbc.M406703200; Mahajan NP, 2005, CANCER RES, V65, P10514, DOI 10.1158/0008-5472.CAN-05-1127; MANFIOLETTI G, 1993, MOL CELL BIOL, V13, P4976, DOI 10.1128/MCB.13.8.4976; MANSER E, 1993, NATURE, V363, P364, DOI 10.1038/363364a0; MARU Y, 1990, ONCOGENE RES, V5, P199; Meric F, 2002, CLIN CANCER RES, V8, P361; Modzelewska K, 2006, J BIOL CHEM, V281, P37527, DOI 10.1074/jbc.M604342200; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; QUONG RYY, 1994, MELANOMA RES, V4, P313, DOI 10.1097/00008390-199410000-00008; Sainaghi PP, 2005, J CELL PHYSIOL, V204, P36, DOI 10.1002/jcp.20265; Satoh T, 1996, FEBS LETT, V386, P230, DOI 10.1016/0014-5793(96)00449-8; Schmitz AAP, 2000, EXP CELL RES, V261, P1, DOI 10.1006/excr.2000.5049; SCHNEIDER C, 1988, CELL, V54, P787, DOI 10.1016/S0092-8674(88)91065-3; Shen F, 2007, MOL BIOL CELL, V18, P732, DOI 10.1091/mbc.E06-02-0142; Shieh YS, 2005, NEOPLASIA, V7, P1058, DOI 10.1593/neo.05640; SHIOTA M, 1995, BLOOD, V86, P1954, DOI 10.1182/blood.V86.5.1954.bloodjournal8651954; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Stenhoff J, 2004, BIOCHEM BIOPH RES CO, V319, P871, DOI 10.1016/j.bbrc.2004.05.070; Teo M, 2001, J BIOL CHEM, V276, P18392, DOI 10.1074/jbc.M008795200; van der Horst EH, 2005, P NATL ACAD SCI USA, V102, P15901, DOI 10.1073/pnas.0508014102; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Yang WN, 1999, J BIOL CHEM, V274, P8524, DOI 10.1074/jbc.274.13.8524; Yeow-Fong L, 2005, FEBS LETT, V579, P5040, DOI 10.1016/j.febslet.2005.07.093; Zhang XW, 2007, NATURE, V450, P741, DOI 10.1038/nature05998	67	28	34	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34954	34963		10.1074/jbc.M109.072660	http://dx.doi.org/10.1074/jbc.M109.072660			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19815557	Green Published, hybrid			2022-12-27	WOS:000272439600051
J	Gilio, K; Munnix, ICA; Mangin, P; Cosemans, JMEM; Feijge, MAH; Van der Meijden, PEJ; Olieslagers, S; Chrzanowska-Wodnicka, MB; Lillian, R; Schoenwaelder, S; Koyasu, S; Sage, SO; Jackson, SP; Heemskerk, JWM				Gilio, Karen; Munnix, Imke C. A.; Mangin, Pierre; Cosemans, Judith M. E. M.; Feijge, Marion A. H.; Van der Meijden, Paola E. J.; Olieslagers, Serve; Chrzanowska-Wodnicka, Magdalena B.; Lillian, Rivka; Schoenwaelder, Simone; Koyasu, Shigeo; Sage, Stewart O.; Jackson, Shaun P.; Heemskerk, Johan W. M.			Non-redundant Roles of Phosphoinositide 3-Kinase Isoforms alpha and beta in Glycoprotein VI-induced Platelet Signaling and Thrombus Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-IA PI3K; PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE; P85-ALPHA SUBUNIT; COUPLED RECEPTORS; MICE LACKING; GAMMA-CHAIN; GP-VI; COLLAGEN; ACTIVATION; INTEGRIN	Platelets are activated by adhesion to vascular collagen via the immunoglobulin receptor, glycoprotein VI ( GPVI). This causes potent signaling toward activation of phospholipase C gamma 2, which bears similarity to the signaling pathway evoked by T- and B-cell receptors. Phosphoinositide 3-kinase (PI3K) plays an important role in collagen-induced platelet activation, because this activity modulates the autocrine effects of secreted ADP. Here, we identified the PI3K isoforms directly downstream of GPVI in human and mouse platelets and determined their role in GPVI-dependent thrombus formation. The targeting of platelet PI3K alpha or -beta strongly and selectively suppressed GPVI-induced Ca2+ mobilization and inositol 1,4,5-triphosphate production, thus demonstrating enhancement of phospholipase C gamma 2 by PI3K alpha/beta. That PI3K alpha and -beta have a non-redundant function in GPVI-induced platelet activation and thrombus formation was concluded from measurements of: (i) serine phosphorylation of Akt, (ii) dense granule secretion, (iii) intracellular Ca2+ increases and surface expression of phosphatidylserine under flow, and (iv) thrombus formation, under conditions where PI3K alpha/beta was blocked or p85 alpha was deficient. In contrast, GPVI-induced platelet activation was insensitive to inhibition or deficiency of PI3K alpha or -gamma. Furthermore, PI3K alpha/beta, but not PI3K gamma, contributed to GPVI-induced Rap1b activation and, surprisingly, also to Rap1b-independent platelet activation via GPVI. Together, these findings demonstrate that both PI3K alpha and -beta isoforms are required for full GPVI-dependent platelet Ca2+ signaling and thrombus formation, partly independently of Rap1b. This provides a new mechanistic explanation for the anti-thrombotic effect of PI3K inhibition and makes PI3K alpha an interesting new target for anti-platelet therapy.	[Gilio, Karen; Munnix, Imke C. A.; Cosemans, Judith M. E. M.; Feijge, Marion A. H.; Van der Meijden, Paola E. J.; Heemskerk, Johan W. M.] Univ Maastricht, Dept Biochem, Cardiovasc Res Inst Maastricht, NL-6200 MD Maastricht, Netherlands; [Olieslagers, Serve] Univ Maastricht, Dept Cardiol, Cardiovasc Res Inst Maastricht, NL-6200 MD Maastricht, Netherlands; [Mangin, Pierre; Lillian, Rivka; Schoenwaelder, Simone; Jackson, Shaun P.] Monash Univ, Australian Ctr Blood Dis, Alfred Med Res Ctr & Educ Precinct, Melbourne, Vic 3800, Australia; [Chrzanowska-Wodnicka, Magdalena B.] Blood Res Inst, Milwaukee, WI 53233 USA; [Koyasu, Shigeo] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo 1608582, Japan; [Sage, Stewart O.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England	Maastricht University; Maastricht University; Monash University; Versiti Blood Center of Wisconsin; Keio University; University of Cambridge	Heemskerk, JWM (corresponding author), Univ Maastricht, Dept Biochem, Cardiovasc Res Inst Maastricht, POB 616, NL-6200 MD Maastricht, Netherlands.	jwm.heemskerk@bioch.unimaas.nl	Mangin, Pierre/H-9354-2016; Schoenwaelder, Simone/E-9506-2011; Koyasu, Shigeo/J-5583-2015; Cosemans, Judith MEM/C-8161-2016; Jackson, Shaun P/E-9633-2011; Heemskerk, Johan/AAM-8323-2021	Koyasu, Shigeo/0000-0001-9585-3038; Cosemans, Judith MEM/0000-0001-7429-0109; Heemskerk, Johan/0000-0002-2848-5121; Sage, Stewart/0000-0001-8578-3558; Chrzanowska, Magdalena/0000-0003-4182-2126; van der Meijden, Paola/0000-0002-6532-2583; Jackson, Shaun/0000-0002-4750-1991; Schoenwaelder, Simone/0000-0003-0465-5840	EU [EST 2005020706]; Netherlands Heart Foundation [2002-B014]; Netherlands Organization for Scientific Research [NWO 11.400.0076]	EU(European Commission); Netherlands Heart Foundation(Netherlands Heart Foundation); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by Grants from the EU ( Marie Curie EST 2005020706), the Netherlands Heart Foundation (2002-B014), and the Netherlands Organization for Scientific Research (NWO 11.400.0076).	Ali K, 2004, NATURE, V431, P1007, DOI 10.1038/nature02991; Auger JM, 2005, FASEB J, V19, P825, DOI 10.1096/fj.04-1940fje; Canobbio I, 2009, BLOOD, V114, P2193, DOI 10.1182/blood-2009-03-208074; Cauwenbergbs S, 2007, BRIT J HAEMATOL, V136, P480, DOI 10.1111/j.1365-2141.2006.06453.x; Chaussade C, 2007, BIOCHEM J, V404, P449, DOI 10.1042/BJ20070003; Chrzanowska-Wodnicka M, 2005, J CLIN INVEST, V115, P680, DOI 10.1172/JCI200522973; Condliffe AM, 2005, BLOOD, V106, P1432, DOI 10.1182/blood-2005-03-0944; Cosemans JMEM, 2006, BLOOD, V108, P3045, DOI 10.1182/blood-2006-03-006338; Falet H, 2000, BLOOD, V96, P3786, DOI 10.1182/blood.V96.12.3786.h8003786_3786_3792; Feijge MAH, 1998, BRIT J HAEMATOL, V102, P850, DOI 10.1046/j.1365-2141.1998.00844.x; Gibbins JM, 1998, J BIOL CHEM, V273, P34437, DOI 10.1074/jbc.273.51.34437; Guillermet-Guibert J, 2008, P NATL ACAD SCI USA, V105, P8292, DOI 10.1073/pnas.0707761105; Heemskerk JWM, 2005, TRENDS CARDIOVAS MED, V15, P86, DOI 10.1016/j.tcm.2005.03.003; Heemskerk JWM, 1997, EUR J BIOCHEM, V249, P547, DOI 10.1111/j.1432-1033.1997.00547.x; Heemskerk JWM, 2001, J PHYSIOL-LONDON, V535, P625, DOI 10.1111/j.1469-7793.2001.00625.x; Hirsch E, 2001, FASEB J, V15, P2019, DOI 10.1096/fj.00-0810fje; Jackson SP, 2007, BLOOD, V109, P5087, DOI 10.1182/blood-2006-12-027698; Jackson SP, 2005, NAT MED, V11, P507, DOI 10.1038/nm1232; JandrotPerrus M, 1997, J BIOL CHEM, V272, P27035, DOI 10.1074/jbc.272.43.27035; Kim S, 2007, BLOOD, V110, P4206, DOI 10.1182/blood-2007-03-080804; Knight CG, 1999, CARDIOVASC RES, V41, P450, DOI 10.1016/S0008-6363(98)00306-X; Kuijpers MJE, 2003, FASEB J, V17, P685, DOI 10.1096/fj.02-0381fje; Lagrue AH, 1999, FEBS LETT, V448, P95, DOI 10.1016/S0014-5793(99)00340-3; Lecut C, 2004, ARTERIOSCL THROM VAS, V24, P1727, DOI 10.1161/01.ATV.0000137974.85068.93; Lova P, 2003, J BIOL CHEM, V278, P131, DOI 10.1074/jbc.M204821200; Lu PJ, 1998, BIOCHEMISTRY-US, V37, P9776, DOI 10.1021/bi980163o; Maxwell MJ, 2004, J BIOL CHEM, V279, P32196, DOI 10.1074/jbc.M400746200; Munnix ICA, 2007, ARTERIOSCL THROM VAS, V27, P2484, DOI 10.1161/ATVBAHA.107.151100; Nesbitt WS, 2006, J MOL MED, V84, P989, DOI 10.1007/s00109-006-0101-1; Nieswandt B, 2001, BLOOD, V97, P3829, DOI 10.1182/blood.V97.12.3829; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; Pasquet JM, 1999, BIOCHEM J, V342, P171, DOI 10.1042/0264-6021:3420171; Pasquet JM, 2000, EMBO J, V19, P2793, DOI 10.1093/emboj/19.12.2793; Rittenhouse SE, 1996, BLOOD, V88, P4401, DOI 10.1182/blood.V88.12.4401.bloodjournal88124401; Savage B, 1999, BLOOD, V94, P2704, DOI 10.1182/blood.V94.8.2704.420k41_2704_2715; Scharenberg AM, 1998, CELL, V94, P5, DOI 10.1016/S0092-8674(00)81214-3; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schoenwaelder SM, 2007, J BIOL CHEM, V282, P28648, DOI 10.1074/jbc.M704358200; Senis YA, 2005, PLATELETS, V16, P191, DOI 10.1080/09537100400016711; Siljander P, 2001, ARTERIOSCL THROM VAS, V21, P618, DOI 10.1161/01.ATV.21.4.618; Siljander PRM, 2004, BLOOD, V103, P1333, DOI 10.1182/blood-2003-03-00869; Stephens L, 2005, CURR OPIN PHARMACOL, V5, P357, DOI 10.1016/j.coph.2005.03.002; Suire S, 2006, NAT CELL BIOL, V8, P1303, DOI 10.1038/ncb1494; Suzuki H, 1999, SCIENCE, V283, P390, DOI 10.1126/science.283.5400.390; Terauchi Y, 1999, NAT GENET, V21, P230, DOI 10.1038/6023; Vanhaesebroeck B, 1999, EXP CELL RES, V253, P239, DOI 10.1006/excr.1999.4701; Vogt PK, 2008, CANCER CELL, V14, P107, DOI 10.1016/j.ccr.2008.07.008; Watanabe N, 2003, BLOOD, V102, P541, DOI 10.1182/blood-2002-11-3327; Watson SP, 1998, IMMUNOL TODAY, V19, P260, DOI 10.1016/S0167-5699(98)01267-5; Woulfe D, 2004, J CLIN INVEST, V113, P441, DOI 10.1172/JCI200420267; Woulfe D, 2002, J BIOL CHEM, V277, P23382, DOI 10.1074/jbc.M202212200	52	88	93	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33750	33762		10.1074/jbc.M109.048439	http://dx.doi.org/10.1074/jbc.M109.048439			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19815551	Green Published, hybrid			2022-12-27	WOS:000272165200005
J	Li, J; Kato, M; Chuang, DT				Li, Jun; Kato, Masato; Chuang, David T.			Pivotal Role of the C-terminal DW-motif in Mediating Inhibition of Pyruvate Dehydrogenase Kinase 2 by Dichloroacetate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIHYDROLIPOYL ACETYLTRANSFERASE; PHOSPHORYLATION SITES; MAMMALIAN PYRUVATE; METABOLIC SWITCH; LIPOYL DOMAIN-2; COMPLEX; PYRUVATE-DEHYDROGENASE-KINASE-2; EXPRESSION; HYPOXIA; CANCER	The mitochondrial pyruvate dehydrogenase complex (PDC) is down-regulated by phosphorylation catalyzed by pyruvate dehydrogenase kinase (PDK) isoforms 1-4. Overexpression of PDK isoforms and therefore reduced PDC activity prevails in cancer and diabetes. In the present study, we investigated the role of the invariant C-terminal DW-motif in inhibition of human PDK2 by dichloroacetate (DCA). Substitutions were made in the DW-motif (Asp-382 and Trp-383) and its interacting residues (Tyr-145 and Arg-149) in the other subunit of PDK2 homodimer. Single and double mutants show 20-60% residual activities that are not stimulated by the PDC core. The R149A and Y145F/R149A mutants show drastic increases in apparent IC50 values for DCA, whereas binding affinities for DCA are comparable with wild-type PDK2. Both R149A and Y145F variants exhibit increased similar affinities for ADP and ATP, mimicking the effects of DCA. The R149A and the DW-motif mutations (D382A/W383A) forestall binding of the lipoyl domain of PDC to these mutants, analogous to wild-type PDK2 in the presence of DCA and ADP. In contrast, the binding of a dihydrolipoamide mimetic AZD7545 is largely unaffected in these PDK2 variants. Our results illuminate the pivotal role of the DW-motif in mediating communications between the DCA-, the nucleotide-, and the lipoyl domain-binding sites. This signaling network locks PDK2 in the inactive closed conformation, which is in equilibrium with the active open conformation without DCA and ADP. These results implicate the DW-motif anchoring site as a drug target for the inhibition of aberrant PDK activity in cancer and diabetes.	[Li, Jun; Chuang, David T.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Kato, Masato; Chuang, David T.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Chuang, DT (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.	David.Chuang@UTSouthwestern.edu			National Institutes of Health [DK62306, DK26758]; Welch Foundation [I-1286]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK026758, R01DK062306, R56DK062306] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK62306 and DK26758. This work was also supported by Welch Foundation Grant I-1286.	Baker JC, 2000, J BIOL CHEM, V275, P15773, DOI 10.1074/jbc.M909488199; Bao HY, 2004, BIOCHEMISTRY-US, V43, P13432, DOI 10.1021/bi049488x; Bersin RM, 1997, AM HEART J, V134, P841, DOI 10.1016/S0002-8703(97)80007-5; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Bowker-Kinley MM, 1998, BIOCHEM J, V329, P191, DOI 10.1042/bj3290191; Cairns RA, 2007, P NATL ACAD SCI USA, V104, P9445, DOI 10.1073/pnas.0611662104; Green T, 2008, J BIOL CHEM, V283, P15789, DOI 10.1074/jbc.M800311200; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; Harris RA, 1997, J BIOL CHEM, V272, P19746, DOI 10.1074/jbc.272.32.19746; Harris RA, 2001, ADV ENZYME REGUL, V41, P269, DOI 10.1016/S0065-2571(00)00020-0; Henderson GN, 1997, J CLIN PHARMACOL, V37, P416, DOI 10.1002/j.1552-4604.1997.tb04319.x; Hiromasa Y, 2006, J BIOL CHEM, V281, P12568, DOI 10.1074/jbc.M513514200; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; Kato M, 2005, EMBO J, V24, P1763, DOI 10.1038/sj.emboj.7600663; Kato M, 2007, STRUCTURE, V15, P992, DOI 10.1016/j.str.2007.07.001; Kato M, 2008, STRUCTURE, V16, P1849, DOI 10.1016/j.str.2008.10.010; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Klyuyeva A, 2008, BIOCHEMISTRY-US, V47, P8358, DOI 10.1021/bi800631h; Klyuyeva A, 2007, FEBS LETT, V581, P2988, DOI 10.1016/j.febslet.2007.05.052; Knoechel TR, 2006, BIOCHEMISTRY-US, V45, P402, DOI 10.1021/bi051402s; Kolobova E, 2001, BIOCHEM J, V358, P69, DOI 10.1042/0264-6021:3580069; Korotchkina LG, 2001, J BIOL CHEM, V276, P37223, DOI 10.1074/jbc.M103069200; Korotchkina LG, 2001, J BIOL CHEM, V276, P5731, DOI 10.1074/jbc.M007558200; Koukourakis MI, 2005, NEOPLASIA, V7, P1, DOI 10.1593/neo.04373; LIU SJ, 1995, J BIOL CHEM, V270, P793, DOI 10.1074/jbc.270.2.793; Lu CW, 2008, J BIOL CHEM, V283, P28106, DOI 10.1074/jbc.M803508200; Mayers RM, 2003, BIOCHEM SOC T, V31, P1165; Michelakis ED, 2008, BRIT J CANCER, V99, P989, DOI 10.1038/sj.bjc.6604554; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; PATEL MS, 1990, FASEB J, V4, P3224, DOI 10.1096/fasebj.4.14.2227213; PRATT ML, 1979, J BIOL CHEM, V254, P7191; RADKE GA, 1993, BIOCHEM BIOPH RES CO, V190, P982, DOI 10.1006/bbrc.1993.1146; Reed LJ, 2001, J BIOL CHEM, V276, P38329, DOI 10.1074/jbc.R100026200; REED LJ, 1985, CURR TOP CELL REGUL, V27, P41; ROCHE TE, 1974, BIOCHEM BIOPH RES CO, V59, P1341, DOI 10.1016/0006-291X(74)90461-6; Roche TE, 2003, EUR J BIOCHEM, V270, P1050, DOI 10.1046/j.1432-1033.2003.03468.x; SALE GJ, 1981, EUR J BIOCHEM, V120, P535, DOI 10.1111/j.1432-1033.1981.tb05733.x; Stacpoole P, 1989, Compr Ther, V15, P28; Steussy CN, 2001, J BIOL CHEM, V276, P37443, DOI 10.1074/jbc.M104285200; Sugden MC, 2003, AM J PHYSIOL-ENDOC M, V284, pE855, DOI 10.1152/ajpendo.00526.2002; TEAGUE WM, 1979, BIOCHEM BIOPH RES CO, V87, P244, DOI 10.1016/0006-291X(79)91672-3; Tso SC, 2006, J BIOL CHEM, V281, P27197, DOI 10.1074/jbc.M604339200; Tuganova A, 2002, BIOCHEM J, V366, P129, DOI 10.1042/BJ20020301; WARBURG O, 1956, SCIENCE, V124, P269; WHITEHOUSE S, 1974, BIOCHEM J, V141, P761, DOI 10.1042/bj1410761; Wu PF, 1998, BIOCHEM J, V329, P197, DOI 10.1042/bj3290197; Wynn RM, 2008, J BIOL CHEM, V283, P25305, DOI 10.1074/jbc.M802249200; YEAMAN SJ, 1978, BIOCHEMISTRY-US, V17, P2364, DOI 10.1021/bi00605a017	48	24	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34458	34467		10.1074/jbc.M109.065557	http://dx.doi.org/10.1074/jbc.M109.065557			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19833728	Green Published, hybrid			2022-12-27	WOS:000272165200075
J	Yamada, H; Padilla-Parra, S; Park, SJ; Itoh, T; Chaineau, M; Monaldi, I; Cremona, O; Benfenati, F; De Camilli, P; Coppey-Moisan, M; Tramier, M; Galli, T; Takei, K				Yamada, Hiroshi; Padilla-Parra, Sergi; Park, Sun-Joo; Itoh, Toshiki; Chaineau, Mathilde; Monaldi, Ilaria; Cremona, Ottavio; Benfenati, Fabio; De Camilli, Pietro; Coppey-Moisan, Maite; Tramier, Marc; Galli, Thierry; Takei, Kohji			Dynamic Interaction of Amphiphysin with N-WASP Regulates Actin Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; XENOPUS EGG EXTRACTS; MEMBRANE CURVATURE; ARP2/3 COMPLEX; PROTEIN AMPHIPHYSIN; WIP COMPLEX; LIVE CELLS; DOMAINS; CYTOSKELETON; CDC42	Amphiphysin 1, an endocytic adaptor concentrated at synapses that couples clathrin-mediated endocytosis to dynamin-dependent fission, was also shown to have a regulatory role in actin dynamics. Here, we report that amphiphysin 1 interacts with N-WASP and stimulates N-WASP- and Arp2/3-dependent actin polymerization. Both the Src homology 3 and the N-BAR domains are required for this stimulation. Acidicliposome-triggered, N-WASP dependent actin polymerization is strongly impaired in brain cytosol of amphiphysin 1 knock-out mice. FRET-FLIM analysis of Sertoli cells, where endogenously expressed amphiphysin 1 co-localizes with N-WASP in peripheral ruffles, confirmed the association between the two proteins in vivo. This association undergoes regulation and is enhanced by stimulating phosphatidylserine receptors on the cell surface with phosphatidylserine-containing liposomes that trigger ruffle formation. These results indicate that actin regulation is a key function of amphiphysin 1 and that such function cooperates with the endocytic adaptor role and membrane shaping/curvature sensing properties of the protein during the endocytic reaction.	[Yamada, Hiroshi; Takei, Kohji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurosci, Kita Ku, Okayama 7008558, Japan; [Padilla-Parra, Sergi; Chaineau, Mathilde; Coppey-Moisan, Maite; Tramier, Marc; Galli, Thierry] Univ Paris Diderot, Inst Jacques Monod, UMR 7592, CNRS, F-75205 Paris 13, France; [Padilla-Parra, Sergi; Chaineau, Mathilde; Coppey-Moisan, Maite; Tramier, Marc; Galli, Thierry] Univ Paris 06, F-75205 Paris 13, France; [Park, Sun-Joo] Kobe Univ, Grad Sch Med, Div Lipid Biochem, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Park, Sun-Joo] Pukyong Natl Univ, Dept Chem, Pusan 608737, South Korea; [Itoh, Toshiki] Kobe Univ, Grad Sch Med, Div Membrane Biol, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Chaineau, Mathilde; Galli, Thierry] Univ Paris 06, INSERM, U950, F-75013 Paris, France; [Monaldi, Ilaria; Benfenati, Fabio] Italian Inst Technol, Dept Neurosci & Brain Technol, I-16163 Genoa, Italy; [Monaldi, Ilaria; Benfenati, Fabio] Univ Genoa, Dept Expt Med, I-16132 Genoa, Italy; [Monaldi, Ilaria; Benfenati, Fabio] Ist Nazl Neurosci, I-16132 Genoa, Italy; [Cremona, Ottavio] Univ Vita Salute San Raffaele, Cancro Inst Mol Oncol, Fdn Italiana Ric, I-20141 Milan, Italy; [Cremona, Ottavio] Ist Nazl Neurosci, I-20141 Milan, Italy; [De Camilli, Pietro] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Cell Biol & Neurobiol, New Haven, CT 06510 USA	Okayama University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Kobe University; Pukyong National University; Kobe University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Istituto Italiano di Tecnologia - IIT; University of Genoa; Vita-Salute San Raffaele University; Howard Hughes Medical Institute; Yale University	Takei, K (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurosci, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	kohji@md.okayama-u.ac.jp	Cremona, Ottavio/AAB-8793-2019; YAMADA, Hiroshi/B-2251-2011; Yamada, Hiroshi/AGZ-4497-2022	Cremona, Ottavio/0000-0001-9462-1040; YAMADA, Hiroshi/0000-0002-9328-3446; Yamada, Hiroshi/0000-0002-9328-3446; Coppey-Moisan, Maite/0000-0002-6246-4973; Galli, Thierry/0000-0001-8514-7455; Tramier, Marc/0000-0001-8200-6446; Padilla-Parra, Sergi/0000-0002-8010-9481; Takei, Kohji/0000-0002-6555-9425	National Institutes of Health; Ministry of Education, Science, Sports, and Culture of Japan; United States-Japan Brain Research Collaborative; INSERM; INSERM-Japan Society for the Promotion of Science; Foundation pour la Recherche Medicale; CNRS; European Union-Marie-Curie [MRTN-CT-2005-019481]; Ministero dell'Istruzione, dell'Universita e della Ricerca (Italy); Compagnia di San Paolo, Torino, Italy; Ministry of Education, Science, and Technology [2009-0065739]; Fondazione Telethon Funding Source: Custom	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); United States-Japan Brain Research Collaborative; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); INSERM-Japan Society for the Promotion of Science; Foundation pour la Recherche Medicale(Fondation pour la Recherche Medicale); CNRS(Centre National de la Recherche Scientifique (CNRS)); European Union-Marie-Curie(European Commission); Ministero dell'Istruzione, dell'Universita e della Ricerca (Italy)(Ministry of Education, Universities and Research (MIUR)); Compagnia di San Paolo, Torino, Italy(Compagnia di San Paolo); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Fondazione Telethon(Fondazione Telethon)	This work was supported, in whole or in part, by a National Institutes of Health grant (to P.D.C.). This work was also supported in part by grants from the Ministry of Education, Science, Sports, and Culture of Japan, a grant from the United States-Japan Brain Research Collaborative (to K. T.), grants from INSERM (to T.G.), an INSERM-Japan Society for the Promotion of Science grant (to K. T. and T. G.), grants from Foundation pour la Recherche Medicale and from CNRS ( to M. C. M.), European Union-Marie-Curie Fellowship MRTN-CT-2005-019481 (to S. P. P.), grants from Ministero dell'Istruzione, dell'Universita e della Ricerca (Italy) (to F.B. and O.C.), grants from Compagnia di San Paolo, Torino, Italy (to F. B.), and by Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology Grant 2009-0065739 (to S.P.).	Bauerfeind R, 1997, J BIOL CHEM, V272, P30984, DOI 10.1074/jbc.272.49.30984; BERNSTEIN BW, 1989, NEURON, V3, P257, DOI 10.1016/0896-6273(89)90039-1; Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940; Cestra G, 1999, J BIOL CHEM, V274, P32001, DOI 10.1074/jbc.274.45.32001; DECAMILLI P, 1993, J EXP MED, V178, P2219, DOI 10.1084/jem.178.6.2219; Di Paolo G, 2002, NEURON, V33, P789, DOI 10.1016/S0896-6273(02)00601-3; DUNKLEY PR, 1988, BRAIN RES, V441, P59, DOI 10.1016/0006-8993(88)91383-2; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; Gold ES, 2000, IMMUNITY, V12, P285, DOI 10.1016/S1074-7613(00)80181-8; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Kamitani A, 2002, BIOCHEM BIOPH RES CO, V294, P261, DOI 10.1016/S0006-291X(02)00470-9; Kessels MM, 2004, J CELL SCI, V117, P3077, DOI 10.1242/jcs.01290; Kinuta M, 2002, P NATL ACAD SCI USA, V99, P2842, DOI 10.1073/pnas.261715599; Lebensohn AM, 2006, METHOD ENZYMOL, V406, P156, DOI 10.1016/S0076-6879(06)06013-7; Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362; Ma L, 1998, J CELL BIOL, V140, P1125; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Miki H, 1996, EMBO J, V15, P5326, DOI 10.1002/j.1460-2075.1996.tb00917.x; Mundigl O, 1998, J NEUROSCI, V18, P93; MUNN AL, 1995, MOL BIOL CELL, V6, P1721, DOI 10.1091/mbc.6.12.1721; Otsuki M, 2003, J BIOL CHEM, V278, P6461, DOI 10.1074/jbc.M207433200; Padilla-Parra S, 2008, BIOPHYS J, V95, P2976, DOI 10.1529/biophysj.108.131276; Padrick SB, 2008, MOL CELL, V32, P426, DOI 10.1016/j.molcel.2008.10.012; Park SJ, 2005, EMBO J, V24, P1557, DOI 10.1038/sj.emboj.7600586; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Peterson JR, 2004, NAT STRUCT MOL BIOL, V11, P747, DOI 10.1038/nsmb796; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Schmid SL, 1998, CURR OPIN CELL BIOL, V10, P504, DOI 10.1016/S0955-0674(98)80066-5; SIVADON P, 1995, MOL GEN GENET, V246, P485, DOI 10.1007/BF00290452; Slepnev VI, 2000, J BIOL CHEM, V275, P17583, DOI 10.1074/jbc.M910430199; Suetsugu S, 1998, EMBO J, V17, P6516, DOI 10.1093/emboj/17.22.6516; Takano K, 2008, EMBO J, V27, P2817, DOI 10.1038/emboj.2008.216; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Tramier M, 2002, BIOPHYS J, V83, P3570, DOI 10.1016/S0006-3495(02)75357-5; Watanabe M, 2001, BIOCHEM BIOPH RES CO, V287, P739, DOI 10.1006/bbrc.2001.5650; Wegner AM, 2008, J BIOL CHEM, V283, P15912, DOI 10.1074/jbc.M801555200; Wigge P, 1997, MOL BIOL CELL, V8, P2003, DOI 10.1091/mbc.8.10.2003; Yamada H, 2007, MOL BIOL CELL, V18, P4669, DOI 10.1091/mbc.E07-04-0296; Yarar D, 2007, DEV CELL, V13, P43, DOI 10.1016/j.devcel.2007.04.014; Yoshida Y, 2004, EMBO J, V23, P3483, DOI 10.1038/sj.emboj.7600355	44	46	46	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34244	34256		10.1074/jbc.M109.064204	http://dx.doi.org/10.1074/jbc.M109.064204			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19759398	Green Published, hybrid			2022-12-27	WOS:000272165200056
J	Kansanen, E; Jyrkkanen, HK; Volger, OL; Leinonen, H; Kivela, AM; Hakkinen, SK; Woodcock, SR; Schopfer, FJ; Horrevoets, AJ; Yla-Herttuala, S; Freeman, BA; Levonen, AL				Kansanen, Emilia; Jyrkkanen, Henna-Kaisa; Volger, Oscar L.; Leinonen, Hanna; Kivela, Annukka M.; Hakkinen, Sanna-Kaisa; Woodcock, Steven R.; Schopfer, Francisco J.; Horrevoets, Anton J.; Yla-Herttuala, Seppo; Freeman, Bruce A.; Levonen, Anna-Liisa			Nrf2-dependent and -independent Responses to Nitro-fatty Acids in Human Endothelial Cells IDENTIFICATION OF HEAT SHOCK RESPONSE AS THE MAJOR PATHWAY ACTIVATED BY NITRO-OLEIC ACID	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NRF2 ENHANCES SUSCEPTIBILITY; TRANSCRIPTION FACTOR NRF2; OXIDIZED PHOSPHOLIPIDS; NITROLINOLEIC ACID; OXIDATIVE STRESS; GENE-EXPRESSION; FACTOR-1; INFLAMMATION; APOPTOSIS; PROTEINS	Electrophilic fatty acid derivatives, including nitrolinoleic acid and nitro-oleic acid (OA-NO2), can mediate anti-inflammatory and pro-survival signaling reactions. The transcription factor Nrf2, activated by electrophilic fatty acids, suppresses redox-sensitive pro-inflammatory gene expression and protects against vascular endothelial oxidative injury. It was therefore postulated that activation of Nrf2 by OA-NO2 accounts in part for its anti-inflammatory actions, motivating the characterization of Nrf2-dependent and -independent effects of OA-NO2 on gene expression using genome-wide transcriptional profiling. Control and Nrf2-small interfering RNA-transfected human endothelial cells were treated with vehicle, oleic acid, or OA-NO2, and differential gene expression profiles were determined. Although OA-NO2 significantly induced the expression of Nrf2-dependent genes, including heme oxygenase-1 and glutamatecysteine ligase modifier subunit, the majority of OA-NO2-regulated genes were regulated by Nrf2-independent pathways. Moreover, gene set enrichment analysis revealed that the heat shock response is the major pathway activated by OA-NO2, with robust induction of a number of heat shock genes regulated by the heat shock transcription factor. Inasmuch as the heat shock response mediates anti-inflammatory and cytoprotective actions, this mechanism is proposed to contribute to the protective cell signaling functions of nitro-fatty acids and other electrophilic fatty acid derivatives.	[Woodcock, Steven R.; Schopfer, Francisco J.; Freeman, Bruce A.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA; [Kansanen, Emilia; Jyrkkanen, Henna-Kaisa; Leinonen, Hanna; Kivela, Annukka M.; Hakkinen, Sanna-Kaisa; Yla-Herttuala, Seppo; Levonen, Anna-Liisa] Univ Kuopio, AI Virtanen Inst Mol Sci, Dept Biotechnol & Mol Med, FIN-70211 Kuopio, Finland; [Volger, Oscar L.; Horrevoets, Anton J.] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, NL-1081 BT Amsterdam, Netherlands	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Eastern Finland; Vrije Universiteit Amsterdam	Freeman, BA (corresponding author), Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA.	freerad@pitt.edu; anna-liisa.levonen@uku.fi	Schopfer, Francisco/AAW-6505-2021; Schopfer, Francisco Jose/AAE-8125-2020; Freeman, Bruce A/H-9342-2012; Woodcock, Steven/AAE-9199-2020	Schopfer, Francisco Jose/0000-0001-9526-695X; Levonen, Anna-Liisa/0000-0002-6575-2137; Kansanen, Emilia/0000-0001-6029-8097; Yla-Herttuala, Seppo/0000-0001-7593-2708; Kivela, Annukka/0000-0003-0899-8445	National Institutes of Health [R01 HL58115, R01 HL64937]; Finnish Cultural Foundation; Academy of Finland; Finnish Foundation of Cardiovascular Research; Sigrid Juselius Foundation; American Diabetes Association [7-08-JF-52]; American Heart Association [0665418U]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064937, R01HL058115] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Academy of Finland(Academy of Finland); Finnish Foundation of Cardiovascular Research; Sigrid Juselius Foundation(Sigrid Juselius Foundation); American Diabetes Association(American Diabetes Association); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL58115 and R01 HL64937 ( to B. A. F.). This work was also supported by the Finnish Cultural Foundation ( to E. K. and A. L. L.), the Academy of Finland, the Finnish Foundation of Cardiovascular Research, the Sigrid Juselius Foundation ( to A. L. L.), American Diabetes Association Grant 7-08-JF-52, and American Heart Association Grant 0665418U ( to F. J. S.).	Ahn SG, 2003, GENE DEV, V17, P516, DOI 10.1101/gad.1044503; Anckar J, 2007, ADV EXP MED BIOL, V594, P78; Baker LMS, 2007, J BIOL CHEM, V282, P31085, DOI 10.1074/jbc.M704085200; Baker PRS, 2005, J BIOL CHEM, V280, P42464, DOI 10.1074/jbc.M504212200; Banning A, 2005, MOL CELL BIOL, V25, P4914, DOI 10.1128/MCB.25.12.4914-4923.2005; Batthyany C, 2006, J BIOL CHEM, V281, P20450, DOI 10.1074/jbc.M602814200; Carbone DL, 2005, J PHARMACOL EXP THER, V315, P8, DOI 10.1124/jpet.105.088088; Chen XL, 2006, AM J PHYSIOL-HEART C, V290, pH1862, DOI 10.1152/ajpheart.00651.2005; Chen XL, 2003, J BIOL CHEM, V278, P703, DOI 10.1074/jbc.M203161200; Coles B, 2002, CIRC RES, V91, P375, DOI 10.1161/01.RES.0000032114.68919.EF; Cui T, 2006, J BIOL CHEM, V281, P35686, DOI 10.1074/jbc.M603357200; Dai G, 2007, CIRC RES, V101, P723, DOI 10.1161/CIRCRESAHA.107.152942; Ferreira AM, 2009, BIOCHEM J, V417, P223, DOI 10.1042/BJ20080701; Fledderus JO, 2008, ARTERIOSCL THROM VAS, V28, P1339, DOI 10.1161/ATVBAHA.108.165811; Freeman BA, 2008, J BIOL CHEM, V283, P15515, DOI 10.1074/jbc.R800004200; Fu Q, 2008, CIRC RES, V103, P369, DOI 10.1161/CIRCRESAHA.108.174607; Gil RR, 2008, AM J ROENTGENOL, V191, P1046, DOI 10.2214/AJR.07.2691; Harrison EM, 2008, AM J PHYSIOL-RENAL, V295, pF397, DOI 10.1152/ajprenal.00361.2007; Hosoya T, 2005, J BIOL CHEM, V280, P27244, DOI 10.1074/jbc.M502551200; Ichikawa T, 2008, ENDOCRINOLOGY, V149, P4086, DOI 10.1210/en.2007-1639; Itoh K, 2004, MOL CELL BIOL, V24, P36, DOI 10.1128/MCB.24.1.36-45.2004; Jacobs AT, 2007, J BIOL CHEM, V282, P33412, DOI 10.1074/jbc.M706799200; Jaiswal AK, 2000, FREE RADICAL BIO MED, V29, P254, DOI 10.1016/S0891-5849(00)00306-3; Jo SK, 2006, J AM SOC NEPHROL, V17, P3082, DOI 10.1681/ASN.2005101077; Jyrkkanen HK, 2008, CIRC RES, V103, pE1, DOI 10.1161/CIRCRESAHA.108.176883; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Koizumi S, 2007, J BIOL CHEM, V282, P8715, DOI 10.1074/jbc.M609427200; Kronke G, 2003, J BIOL CHEM, V278, P51006, DOI 10.1074/jbc.M304103200; Levonen AL, 2004, BIOCHEM J, V378, P373, DOI 10.1042/BJ20031049; Levonen AL, 2007, ARTERIOSCL THROM VAS, V27, P741, DOI 10.1161/01.ATV.0000258868.80079.4d; Liebler DC, 2008, CHEM RES TOXICOL, V21, P117, DOI 10.1021/tx700235t; Liu HY, 2008, AM J PHYSIOL-RENAL, V295, pF942, DOI 10.1152/ajprenal.90236.2008; Long AD, 2001, J BIOL CHEM, V276, P19937, DOI 10.1074/jbc.M010192200; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morimoto RI, 1998, NAT BIOTECHNOL, V16, P833, DOI 10.1038/nbt0998-833; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Nadtochiy SM, 2009, CARDIOVASC RES, V82, P333, DOI 10.1093/cvr/cvn323; Ostling P, 2007, J BIOL CHEM, V282, P7077, DOI 10.1074/jbc.M607556200; Park KJ, 2003, J BIOL CHEM, V278, P35272, DOI 10.1074/jbc.M305095200; Rainer J, 2006, NUCLEIC ACIDS RES, V34, pW498, DOI 10.1093/nar/gkl038; Ran RQ, 2004, GENE DEV, V18, P1466, DOI 10.1101/gad.1188204; Rangasamy T, 2005, J EXP MED, V202, P47, DOI 10.1084/jem.20050538; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Rossig L, 2001, BASIC RES CARDIOL, V96, P11, DOI 10.1007/s003950170073; RUBBO H, 1994, J BIOL CHEM, V269, P26066; RUDOLPH V, 2009, CARDIOVASC IN PRESS; Rudolph V, 2009, J BIOL CHEM, V284, P1461, DOI 10.1074/jbc.M802298200; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Schopfer FJ, 2009, FREE RADICAL BIO MED, V46, P1250, DOI 10.1016/j.freeradbiomed.2008.12.025; Schopfer FJ, 2005, P NATL ACAD SCI USA, V102, P2340, DOI 10.1073/pnas.0408384102; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thimmulappa RK, 2006, J CLIN INVEST, V116, P984, DOI 10.1172/JCI25790; Trinklein ND, 2004, MOL BIOL CELL, V15, P1254, DOI 10.1091/mbc.E03-10-0738; Trott A, 2008, MOL BIOL CELL, V19, P1104, DOI 10.1091/mbc.E07-10-1004; Vila A, 2008, CHEM RES TOXICOL, V21, P432, DOI 10.1021/tx700347w; Villacorta L, 2007, AM J PHYSIOL-HEART C, V293, pH770, DOI 10.1152/ajpheart.00261.2007; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; Wright MM, 2006, P NATL ACAD SCI USA, V103, P4299, DOI 10.1073/pnas.0506541103; Xu QB, 2002, ARTERIOSCL THROM VAS, V22, P1547, DOI 10.1161/01.ATV.0000029720.59649.50	62	128	133	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33233	33241		10.1074/jbc.M109.064873	http://dx.doi.org/10.1074/jbc.M109.064873			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19808663	Green Published, hybrid			2022-12-27	WOS:000272028500028
J	Takahashi, H; Martin-Brown, S; Washburn, MP; Florens, L; Conaway, JW; Conaway, RC				Takahashi, Hidehisa; Martin-Brown, Skylar; Washburn, Michael P.; Florens, Laurence; Conaway, Joan W.; Conaway, Ronald C.			Proteomics Reveals a Physical and Functional Link between Hepatocyte Nuclear Factor 4 alpha and Transcription Factor IID	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TATA-BINDING PROTEIN; RNA-POLYMERASE-II; SPECTRAL ABUNDANCE FACTORS; GENERAL INITIATION-FACTORS; IDENTIFICATION TECHNOLOGY; DEUBIQUITINATING ENZYME; MOLECULAR-CLONING; CRYSTAL-STRUCTURE; IN-VITRO; PROMOTER SELECTIVITY	Proteomic analyses have contributed substantially to our understanding of diverse cellular processes. Improvements in the sensitivity of mass spectrometry approaches are enabling more in-depth analyses of protein-protein networks and, in some cases, are providing surprising new insights into well established, longstanding problems. Here, we describe such a proteomic analysis that exploits MudPIT mass spectrometry and has led to the discovery of a physical and functional link between the orphan nuclear receptor hepatocyte nuclear factor 4 alpha (HNF4 alpha) and transcription factor IID (TFIID). A systematic characterization of the HNF4 alpha-TFIID link revealed that the HNF4 alpha DNA-binding domain binds directly to the TATA box-binding protein (TBP) and, through this interaction, can target TBP or TFIID to promoters containing HNF4 alpha-binding sites in vitro. Supporting the functional significance of this interaction, an HNF4 alpha mutation that blocks binding of TBP to HNF4 alpha interferes with HNF4 alpha transactivation activity in cells. These findings identify an unexpected role for the HNF4 alpha DNA-binding domain in mediating key regulatory interactions and provide new insights into the roles of HNF4 alpha and TFIID in RNA polymerase II transcription.	[Takahashi, Hidehisa; Martin-Brown, Skylar; Washburn, Michael P.; Florens, Laurence; Conaway, Joan W.; Conaway, Ronald C.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Conaway, Joan W.; Conaway, Ronald C.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66103 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Conaway, RC (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	rcc@stowers-institute.org	Hidehisa, Takahashi/E-2175-2012	Florens, Laurence/0000-0002-9310-6650; Washburn, Michael/0000-0001-7568-2585; Conaway, Joan/0000-0002-2786-0663	NIGMS [R37 GM41628]; Stowers Institute for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041628] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Stowers Institute for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R37 GM41628 from NIGMS (to R.C.C.). This work was also supported by the Stowers Institute for Medical Research.	Albright SR, 2000, GENE, V242, P1, DOI 10.1016/S0378-1119(99)00495-3; ALBRITTON LM, 1989, CELL, V57, P659, DOI 10.1016/0092-8674(89)90134-7; Andel F, 1999, SCIENCE, V286, P2153, DOI 10.1126/science.286.5447.2153; AUBLE DT, 1994, GENE DEV, V8, P1920, DOI 10.1101/gad.8.16.1920; Auble DT, 1997, MOL CELL BIOL, V17, P4842, DOI 10.1128/MCB.17.8.4842; Barrero MJ, 2006, MOL CELL, V24, P233, DOI 10.1016/j.molcel.2006.09.020; Bartoov-Shifman R, 2002, J BIOL CHEM, V277, P25914, DOI 10.1074/jbc.M201582200; Bogan AA, 2000, J MOL BIOL, V302, P831, DOI 10.1006/jmbi.2000.4099; CAREY M, 1990, SCIENCE, V247, P710, DOI 10.1126/science.2405489; CHEN WS, 1994, GENE DEV, V8, P2466, DOI 10.1101/gad.8.20.2466; Cler E, 2009, CELL MOL LIFE SCI, V66, P2123, DOI 10.1007/s00018-009-0009-3; COMAI L, 1994, SCIENCE, V266, P1966, DOI 10.1126/science.7801123; COMAI L, 1992, CELL, V68, P965, DOI 10.1016/0092-8674(92)90039-F; CONAWAY RC, 1993, ANNU REV BIOCHEM, V62, P161; Dasgupta A, 2002, P NATL ACAD SCI USA, V99, P2666, DOI 10.1073/pnas.052397899; DYNLACHT BD, 1993, NATURE, V363, P176, DOI 10.1038/363176a0; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Florens L, 2006, METHODS, V40, P303, DOI 10.1016/j.ymeth.2006.07.028; Florens Laurence, 2006, V328, P159; Ford J, 1997, MOL ENDOCRINOL, V11, P1467, DOI 10.1210/me.11.10.1467; Geiger JH, 1996, SCIENCE, V272, P830, DOI 10.1126/science.272.5263.830; Giguere V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689; GOODRICH JA, 1993, CELL, V75, P519, DOI 10.1016/0092-8674(93)90386-5; Gorski JJ, 2007, EMBO J, V26, P1560, DOI 10.1038/sj.emboj.7601601; Gupta RK, 2004, TRENDS MOL MED, V10, P521, DOI 10.1016/j.molmed.2004.09.004; HadzopoulouCladaras M, 1997, J BIOL CHEM, V272, P539; Hamazaki J, 2006, EMBO J, V25, P4524, DOI 10.1038/sj.emboj.7601338; Hertz R, 1998, NATURE, V392, P512, DOI 10.1038/33185; HISATAKE K, 1995, P NATL ACAD SCI USA, V92, P8195, DOI 10.1073/pnas.92.18.8195; Hu X, 2006, P NATL ACAD SCI USA, V103, P9506, DOI 10.1073/pnas.0603702103; JACQ X, 1994, CELL, V79, P107, DOI 10.1016/0092-8674(94)90404-9; Johnson KM, 2004, METHOD ENZYMOL, V380, P207; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; KOKUBO T, 1994, NATURE, V367, P484, DOI 10.1038/367484a0; KOKUBO T, 1993, MOL CELL BIOL, V13, P7859, DOI 10.1128/MCB.13.12.7859; Lavery DN, 2005, BIOCHEM J, V391, P449, DOI 10.1042/BJ20050872; Leurent C, 2004, EMBO J, V23, P719, DOI 10.1038/sj.emboj.7600111; Leurent C, 2002, EMBO J, V21, P3424, DOI 10.1093/emboj/cdf342; Li JX, 2000, GENE DEV, V14, P464; Liu WL, 2008, MOL CELL, V29, P81, DOI 10.1016/j.molcel.2007.11.003; LOBO SM, 1992, CELL, V71, P1029, DOI 10.1016/0092-8674(92)90397-U; Lu P, 2008, J BIOL CHEM, V283, P33685, DOI 10.1074/jbc.M806213200; Makino Y, 1999, GENES CELLS, V4, P529, DOI 10.1046/j.1365-2443.1999.00277.x; Malik S, 2000, MOL CELL, V5, P753, DOI 10.1016/S1097-2765(00)80254-3; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; Malik S, 2002, MOL CELL BIOL, V22, P5626, DOI 10.1128/MCB.22.15.5626-5637.2002; MALIK S, 1995, NUCLEIC ACIDS RES, V23, P1536, DOI 10.1093/nar/23.9.1536; McDonald WH, 2004, RAPID COMMUN MASS SP, V18, P2162, DOI 10.1002/rcm.1603; MENGUS G, 1995, EMBO J, V14, P1520, DOI 10.1002/j.1460-2075.1995.tb07138.x; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Mousson F, 2008, MOL CELL PROTEOMICS, V7, P845, DOI 10.1074/mcp.M700306-MCP200; Muldrow TA, 1999, MOL CELL BIOL, V19, P2835; Myers LC, 2000, ANNU REV BIOCHEM, V69, P729, DOI 10.1146/annurev.biochem.69.1.729; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; Paoletti AC, 2006, P NATL ACAD SCI USA, V103, P18928, DOI 10.1073/pnas.0606379103; Qiu XB, 2006, EMBO J, V25, P5742, DOI 10.1038/sj.emboj.7601450; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Sato S, 2004, MOL CELL, V14, P685, DOI 10.1016/j.molcel.2004.05.006; SCHULMAN IG, 1995, P NATL ACAD SCI USA, V92, P8288, DOI 10.1073/pnas.92.18.8288; SIMMEN KA, 1992, NUCLEIC ACIDS RES, V20, P5889, DOI 10.1093/nar/20.22.5889; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Sprouse RO, 2008, P NATL ACAD SCI USA, V105, P13304, DOI 10.1073/pnas.0801901105; Stoffel M, 1997, P NATL ACAD SCI USA, V94, P13209, DOI 10.1073/pnas.94.24.13209; Taatjes DJ, 2004, NAT REV MOL CELL BIO, V5, P403, DOI 10.1038/nrm1369; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; TAGGART AKP, 1992, CELL, V71, P1015, DOI 10.1016/0092-8674(92)90396-T; Tatarakis A, 2008, MOL CELL, V31, P531, DOI 10.1016/j.molcel.2008.07.013; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Tora L, 2002, GENE DEV, V16, P673, DOI 10.1101/gad.976402; VERRIJZER CP, 1995, CELL, V81, P1115, DOI 10.1016/S0092-8674(05)80016-9; Warnmark A, 2001, J BIOL CHEM, V276, P45939, DOI 10.1074/jbc.M107875200; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; WIDOM RL, 1991, MOL CELL BIOL, V11, P677, DOI 10.1128/MCB.11.2.677; Wisely GB, 2002, STRUCTURE, V10, P1225, DOI 10.1016/S0969-2126(02)00829-8; Yao TT, 2006, NAT CELL BIOL, V8, P994, DOI 10.1038/ncb1460; YOKOMORI K, 1993, GENE DEV, V7, P2587, DOI 10.1101/gad.7.12b.2587; ZHOU Q, 1992, GENE DEV, V6, P1964, DOI 10.1101/gad.6.10.1964; ZOMERDIJK JCBM, 1994, SCIENCE, V266, P2015, DOI 10.1126/science.7801130; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	80	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32405	32412		10.1074/jbc.M109.017954	http://dx.doi.org/10.1074/jbc.M109.017954			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19805548	Green Published, hybrid			2022-12-27	WOS:000272028400023
J	Vembar, SS; Jin, Y; Brodsky, JL; Hendershot, LM				Vembar, Shruthi S.; Jin, Yi; Brodsky, Jeffrey L.; Hendershot, Linda M.			The Mammalian Hsp40 ERdj3 Requires Its Hsp70 Interaction and Substrate-binding Properties to Complement Various Yeast Hsp40-dependent Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; POSTTRANSLATIONAL PROTEIN TRANSLOCATION; CELL-WALL INTEGRITY; ER DNAJ HOMOLOG; ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; ATPASE ACTIVITY; MOLECULAR CHAPERONE; CO-CHAPERONE; PLASMODIUM-FALCIPARUM	Heat shock proteins of 70 kDa (Hsp70s) and their J domain-containing Hsp40 cofactors are highly conserved chaperone pairs that facilitate a large number of cellular processes. The observation that each Hsp70 partners with many J domain-containing proteins (JDPs) has led to the hypothesis that Hsp70 function is dictated by cognate JDPs. If this is true, one might expect highly divergent Hsp70-JDP pairs to be unable to function in vivo. However, we discovered that, when a yeast cytosolic JDP, Ydj1, was targeted to the mammalian endoplasmic reticulum (ER), it interacted with the ER-lumenal Hsp70, BiP, and bound to BiP substrates. Conversely, when a mammalian ER-lumenal JDP, ERdj3, was directed to the yeast cytosol, it rescued the temperature-sensitive growth phenotype of yeast-containing mutant alleles in two cytosolic JDPs, HLJ1 and YDJ1, and activated the ATP hydrolysis rate of Ssa1, the yeast cytosolic Hsp70 that partners with Hlj1 and Ydj1. Surprisingly, ERdj3 mutants that were compromised for substrate binding were unable to rescue the hlj1ydj1 growth defect even though they stimulated the ATPase activity of Ssa1. Yet, J domain mutants of ERdj3 that were defective for interaction with Ssa1 restored the growth of hlj1ydj1 yeast. Taken together, these data suggest that the substrate binding properties of certain JDPs, not simply the formation of unique Hsp70-JDP pairs, are critical to specify in vivo function.	[Jin, Yi; Hendershot, Linda M.] St Jude Childrens Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA; [Vembar, Shruthi S.; Brodsky, Jeffrey L.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Jin, Yi; Hendershot, Linda M.] Univ Tennessee, Ctr Hlth Sci, Dept Mol Sci, Memphis, TN 38163 USA	St Jude Children's Research Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Tennessee System; University of Tennessee Health Science Center	Hendershot, LM (corresponding author), St Jude Childrens Hosp, Dept Genet & Tumor Cell Biol, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	linda.hendershot@stjude.org	Hendershot, Linda/N-8124-2018; Vembar, Shruthi Sridhar/AAE-2479-2019	Hendershot, Linda/0000-0002-5473-0274; 	National Institutes of Health [GM75061, GM54068]; Cancer Center CORE [CA21765]; American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075061, R01GM054068] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center CORE; American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM75061 (to J. L. B.) and GM54068 (to L. M. H.). This work was supported by Cancer Center CORE Grant CA21765 and the American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital (to L. M. H.).	Becker J, 1996, MOL CELL BIOL, V16, P4378; Bhangoo MK, 2007, MOL BIOL CELL, V18, P3414, DOI 10.1091/mbc.E07-01-0088; Botha M, 2007, INT J BIOCHEM CELL B, V39, P1781, DOI 10.1016/j.biocel.2007.02.011; BRODSKY JL, 1993, J CELL BIOL, V123, P1355, DOI 10.1083/jcb.123.6.1355; BRODSKY JL, 1995, P NATL ACAD SCI USA, V92, P9643, DOI 10.1073/pnas.92.21.9643; CAPLAN AJ, 1991, J CELL BIOL, V114, P609, DOI 10.1083/jcb.114.4.609; CAPLAN AJ, 1992, CELL, V71, P1143, DOI 10.1016/S0092-8674(05)80063-7; CAPLAN AJ, 1992, J BIOL CHEM, V267, P18890; CAPLAN AJ, 1995, J BIOL CHEM, V270, P5251, DOI 10.1074/jbc.270.10.5251; Cheetham ME, 1998, CELL STRESS CHAPERON, V3, P28, DOI 10.1379/1466-1268(1998)003<0028:SFAEOD>2.3.CO;2; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Chung KT, 2002, J BIOL CHEM, V277, P47557, DOI 10.1074/jbc.M208377200; Cintron NS, 2006, J BIOL CHEM, V281, P26235, DOI 10.1074/jbc.M605417200; Corsi AK, 1997, J CELL BIOL, V137, P1483, DOI 10.1083/jcb.137.7.1483; Craig EA, 2006, REV PHYSIOL BIOCH P, V156, P1, DOI 10.1007/s10254-005-0001-8; CYR DM, 1992, J BIOL CHEM, V267, P20927; Fliss AE, 1999, J BIOL CHEM, V274, P34045, DOI 10.1074/jbc.274.48.34045; Gall WE, 2000, CURR BIOL, V10, P1349, DOI 10.1016/S0960-9822(00)00771-5; Gassler CS, 1998, P NATL ACAD SCI USA, V95, P15229, DOI 10.1073/pnas.95.26.15229; Goeckeler JL, 2002, MOL BIOL CELL, V13, P2760, DOI 10.1091/mbc.02-04-0051; Hendershot L, 1996, P NATL ACAD SCI USA, V93, P5269, DOI 10.1073/pnas.93.11.5269; Hennessy F, 2005, PROTEIN SCI, V14, P1697, DOI 10.1110/ps.051406805; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jin Y, 2008, EMBO J, V27, P2873, DOI 10.1038/emboj.2008.207; Jin Y, 2009, BIOCHEMISTRY-US, V48, P41, DOI 10.1021/bi8015923; Johnson JL, 2001, J CELL BIOL, V152, P851, DOI 10.1083/jcb.152.4.851; Kushnirov VV, 2000, CURR BIOL, V10, P1443, DOI 10.1016/S0960-9822(00)00802-2; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; Li JZ, 2003, STRUCTURE, V11, P1475, DOI 10.1016/j.str.2003.10.012; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; LORENZ MC, 1995, GENE, V158, P113, DOI 10.1016/0378-1119(95)00144-U; Lu Z, 1998, J BIOL CHEM, V273, P5970, DOI 10.1074/jbc.273.10.5970; Lu Z, 1998, J BIOL CHEM, V273, P27824, DOI 10.1074/jbc.273.43.27824; LUKE MM, 1991, J CELL BIOL, V114, P623, DOI 10.1083/jcb.114.4.623; Marcus NY, 2007, ARCH BIOCHEM BIOPHYS, V468, P147, DOI 10.1016/j.abb.2007.10.001; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; McClellan AJ, 1998, MOL BIOL CELL, V9, P3533, DOI 10.1091/mbc.9.12.3533; Metzger MB, 2008, J BIOL CHEM, V283, P32302, DOI 10.1074/jbc.M806424200; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; NELSON RJ, 1992, CELL, V71, P97, DOI 10.1016/0092-8674(92)90269-I; Nicoll WS, 2007, INT J BIOCHEM CELL B, V39, P736, DOI 10.1016/j.biocel.2006.11.006; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; Nishikawa S, 1997, J BIOL CHEM, V272, P12889, DOI 10.1074/jbc.272.20.12889; Oka M, 1998, J BIOL CHEM, V273, P29727, DOI 10.1074/jbc.273.45.29727; Park SH, 2007, MOL BIOL CELL, V18, P153, DOI 10.1091/mbc.E06-04-0338; Pesce ER, 2008, INT J BIOCHEM CELL B, V40, P2914, DOI 10.1016/j.biocel.2008.06.011; Rudiger S, 2001, EMBO J, V20, P1042, DOI 10.1093/emboj/20.5.1042; Sahi C, 2007, P NATL ACAD SCI USA, V104, P7163, DOI 10.1073/pnas.0702357104; SCHLENSTEDT G, 1995, J CELL BIOL, V129, P979, DOI 10.1083/jcb.129.4.979; Shaner L, 2008, CURR GENET, V54, P1, DOI 10.1007/s00294-008-0193-y; Shen Y, 2005, MOL BIOL CELL, V16, P40, DOI 10.1091/mbc.E04-05-0434; Shen Y, 2002, J BIOL CHEM, V277, P15947, DOI 10.1074/jbc.M112214200; Silberstein S, 1998, J CELL BIOL, V143, P921, DOI 10.1083/jcb.143.4.921; STIRLING CJ, 1992, MOL BIOL CELL, V3, P129, DOI 10.1091/mbc.3.2.129; Suh WC, 1998, P NATL ACAD SCI USA, V95, P15223, DOI 10.1073/pnas.95.26.15223; Tsai J, 1996, J BIOL CHEM, V271, P9347, DOI 10.1074/jbc.271.16.9347; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; WEI JY, 1995, J BIOL CHEM, V270, P26670, DOI 10.1074/jbc.270.44.26670; Wright CM, 2007, GENETICS, V175, P1649, DOI 10.1534/genetics.106.066274; Yang XX, 2006, FEMS YEAST RES, V6, P195, DOI 10.1111/j.1567-1364.2006.00026.x; Youker RT, 2004, MOL BIOL CELL, V15, P4787, DOI 10.1091/mbc.E04-07-0584; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492	66	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32462	32471		10.1074/jbc.M109.000729	http://dx.doi.org/10.1074/jbc.M109.000729			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19748898	Green Published, hybrid			2022-12-27	WOS:000272028400029
J	Wen, DY; Vecchi, MM; Gu, S; Su, LH; Dolnikova, J; Huang, YM; Foley, SF; Garber, E; Pederson, N; Meier, W				Wen, Dingyi; Vecchi, Malgorzata M.; Gu, Sheng; Su, Lihe; Dolnikova, Jana; Huang, Yao-Ming; Foley, Susan F.; Garber, Ellen; Pederson, Nels; Meier, Werner			Discovery and Investigation of Misincorporation of Serine at Asparagine Positions in Recombinant Proteins Expressed in Chinese Hamster Ovary Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA SYNTHETASE; HIGH-LEVEL EXPRESSION; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; AMINO-ACIDS; CODON; MISTRANSLATION; GENE; STARVATION; BINDING	Misincorporation of amino acids in proteins expressed in Escherichia coli has been well documented but not in proteins expressed in mammalian cells under normal recombinant protein production conditions. Here we report for the first time that Ser can be incorporated at Asn positions in proteins expressed in Chinese hamster ovary cells. This misincorporation was discovered as a result of intact mass measurement, peptide mapping analysis, and tandem mass spectroscopy sequencing. Our analyses showed that the substitution was not related to specific protein molecules or DNA codons and was not site-specific. We believe that the incorporation of Ser at sites coded for Asn was due to mischarging of tRNA(Asn) rather than to codon misreading. The rationale for substitution of Asn by Ser and not by other amino acids is also discussed. Further investigation indicated that the substitution was due to the starvation for Asn in the cell culture medium and that the substitution could be limited by using the Asn-rich feed. These observations demonstrate that the quality of expressed proteins should be closely monitored when altering cell culture conditions.	[Wen, Dingyi; Vecchi, Malgorzata M.; Gu, Sheng; Su, Lihe; Dolnikova, Jana; Huang, Yao-Ming; Foley, Susan F.; Garber, Ellen; Pederson, Nels; Meier, Werner] Biogen Idec Inc, Cambridge, MA 02412 USA	Biogen	Wen, DY (corresponding author), Biogen Idec Inc, 14 Cambridge Ctr, Cambridge, MA 02412 USA.	dingyi.wen@biogenidec.com		Huang, Yao-ming/0000-0002-7895-0167				An S, 2005, J BIOL CHEM, V280, P34465, DOI 10.1074/jbc.M507550200; ANDRULIS IL, 1979, J BIOL CHEM, V254, P629; Apostol I, 1997, J BIOL CHEM, V272, P28980, DOI 10.1074/jbc.272.46.28980; ARFIN SM, 1977, P NATL ACAD SCI USA, V74, P2367, DOI 10.1073/pnas.74.6.2367; BARKER DG, 1979, J MOL BIOL, V133, P217, DOI 10.1016/0022-2836(79)90531-X; Berthet-Colominas C, 1998, EMBO J, V17, P2947, DOI 10.1093/emboj/17.10.2947; Birch JR, 2006, ADV DRUG DELIVER REV, V58, P671, DOI 10.1016/j.addr.2005.12.006; BRINKMANN U, 1989, GENE, V85, P109, DOI 10.1016/0378-1119(89)90470-8; Calderone TL, 1996, J MOL BIOL, V262, P407, DOI 10.1006/jmbi.1996.0524; CUSACK S, 1995, NAT STRUCT BIOL, V2, P824, DOI 10.1038/nsb1095-824; George E, 1989, Med J Malaysia, V44, P259; Gruic-Sovulj I, 2005, J BIOL CHEM, V280, P23978, DOI 10.1074/jbc.M414260200; Gruic-Sovulj I, 2007, FEBS LETT, V581, P5110, DOI 10.1016/j.febslet.2007.09.058; Hati S, 2006, J BIOL CHEM, V281, P27862, DOI 10.1074/jbc.M605856200; Ibba M, 1999, SCIENCE, V286, P1893, DOI 10.1126/science.286.5446.1893; Ishitobi M, 2003, CANCER LETT, V200, P1, DOI 10.1016/S0304-3835(03)00387-2; Jnaoui K, 2002, J VIROL, V76, P8138, DOI 10.1128/JVI.76.16.8138-8147.2002; JOHNSTON TC, 1984, MOL GEN GENET, V195, P459, DOI 10.1007/BF00341447; Kaye EM, 1997, J CHILD NEUROL, V12, P242, DOI 10.1177/088307389701200404; Klannemark M, 2000, DIABETIC MED, V17, P599, DOI 10.1046/j.1464-5491.2000.00343.x; LAGERKVIST U, 1978, P NATL ACAD SCI USA, V75, P1759, DOI 10.1073/pnas.75.4.1759; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Lincecum TL, 2003, MOL CELL, V11, P951, DOI 10.1016/S1097-2765(03)00098-4; Low D, 2007, J CHROMATOGR B, V848, P48, DOI 10.1016/j.jchromb.2006.10.033; LUSTIG F, 1981, J BIOL CHEM, V256, P2635; Mascarenhas A. P., 2009, V22, P155; McClendon CL, 2006, PROTEIN ENG DES SEL, V19, P195, DOI 10.1093/protein/gzl001; Newberry KJ, 2002, EMBO J, V21, P2778, DOI 10.1093/emboj/21.11.2778; Nomanbhoy TK, 1999, MOL CELL, V4, P519, DOI 10.1016/S1097-2765(00)80203-8; Park SG, 2008, P NATL ACAD SCI USA, V105, P11043, DOI 10.1073/pnas.0802862105; PARKER J, 1980, MOL GEN GENET, V177, P439, DOI 10.1007/BF00271482; PARKER J, 1983, J BIOL CHEM, V258, P7; PARKER J, 1989, MICROBIOL REV, V53, P273, DOI 10.1128/MMBR.53.3.273-298.1989; PARKER J, 1978, P NATL ACAD SCI USA, V75, P1091, DOI 10.1073/pnas.75.3.1091; POSCHL E, 1994, EMBO J, V13, P3741, DOI 10.1002/j.1460-2075.1994.tb06683.x; PRECUP J, 1987, J BIOL CHEM, V262, P11351; Reichert JM, 2005, NAT BIOTECHNOL, V23, P1073, DOI 10.1038/nbt0905-1073; ROSENBERGER RF, 1991, MUTAT RES, V256, P255, DOI 10.1016/0921-8734(91)90016-5; ROSENBERGER RF, 1993, TRENDS BIOTECHNOL, V11, P498, DOI 10.1016/0167-7799(93)90027-7; ROSENBERGER RF, 1994, DEV BIOL STAND, V83, P21; Ruan BF, 2005, J BIOL CHEM, V280, P25887, DOI 10.1074/jbc.M502174200; Sankaranarayanan R, 2001, ACTA BIOCHIM POL, V48, P323; SANTOS MAS, 1993, TRENDS BIOTECHNOL, V11, P500, DOI 10.1016/0167-7799(93)90028-8; Schimmel P, 2008, PROTEIN SCI, V17, P1643, DOI 10.1110/ps.037242.108; SCORER CA, 1991, NUCLEIC ACIDS RES, V19, P3511, DOI 10.1093/nar/19.13.3511; SEETHARAM R, 1988, BIOCHEM BIOPH RES CO, V155, P518, DOI 10.1016/S0006-291X(88)81117-3; Seewoster T, 1995, APPL MICROBIOL BIOT, V44, P344; Silvian LF, 1999, SCIENCE, V285, P1074, DOI 10.1126/science.285.5430.1074; SPANJAARD RA, 1990, NUCLEIC ACIDS RES, V18, P5031, DOI 10.1093/nar/18.17.5031; Splan KE, 2008, METHODS, V44, P119, DOI 10.1016/j.ymeth.2007.10.009; Splan KE, 2008, J BIOL CHEM, V283, P7128, DOI 10.1074/jbc.M709902200; STANNERS CP, 1978, J CELL PHYSIOL, V95, P125, DOI 10.1002/jcp.1040950202; Stevens C, 2007, J BIOL CHEM, V282, P13791, DOI 10.1074/jbc.M605649200; Tukalo M, 2005, NAT STRUCT MOL BIOL, V12, P923, DOI 10.1038/nsmb986; Walz R, 2004, NEUROLOGY, V63, P557, DOI 10.1212/01.WNL.0000133400.34423.AD; Wen DY, 2005, BIOCHEMISTRY-US, V44, P16491, DOI 10.1021/bi0517483; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026	57	60	65	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32686	32694		10.1074/jbc.M109.059360	http://dx.doi.org/10.1074/jbc.M109.059360			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19783658	Green Published, hybrid			2022-12-27	WOS:000272028400052
J	Gildemeister, OS; Sage, JM; Knight, KL				Gildemeister, Otto S.; Sage, Jay M.; Knight, Kendall L.			Cellular Redistribution of Rad51 in Response to DNA Damage NOVEL ROLE FOR Rad51C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMOLOGOUS RECOMBINATION; NUCLEAR FOCI; GLYCOSYLASE MOGG1; REPAIR PROTEINS; BRCA2; XRCC3; LOCALIZATION; EXPRESSION; CELLS; DEFICIENCY	Exposure of cells to DNA-damaging agents results in a rapid increase in the formation of subnuclear complexes containing Rad51. To date, it has not been determined to what extent DNA damage-induced cytoplasmic to nuclear transport of Rad51 may contribute to this process. We have analyzed subcellular fractions of HeLa and HCT116 cells and found a significant increase in nuclear Rad51 levels following exposure to a modest dose of ionizing radiation (2 grays). We also observed a DNA damage-induced increase in nuclear Rad51 in the Brca2-defective cell line Capan-1. To address a possible Brca2-independent mechanism for Rad51 nuclear transport, we analyzed subcellular fractions for two other Rad51-interacting proteins, Rad51C and Xrcc3. Rad51C has a functional nuclear localization signal, and although we found that the subcellular distribution of Xrcc3 was not significantly affected by DNA damage, there was a damage-induced increase in nuclear Rad51C. Furthermore, RNA interference-mediated depletion of Rad51C in HeLa and Capan-1 cells resulted in lower steady-state levels of nuclear Rad51 as well as a diminished DNA damage-induced increase. Our results provide important insight into the cellular regulation of Rad51 nuclear entry and a role for Rad51C in this process.	[Gildemeister, Otto S.; Sage, Jay M.; Knight, Kendall L.] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Knight, KL (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Aaron Lazare Med Res Bldg,Rm 913,364 Plantat St, Worcester, MA 01605 USA.	kendall.knight@umassmed.edu			National Institutes of Health [GM044772, GM065851]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065851, R01GM044772] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM044772 and GM065851 ( to K. L. K.).	Abbott DW, 1998, J NATL CANCER I, V90, P978, DOI 10.1093/jnci/90.13.978; Arias-Lopez C, 2006, EMBO REP, V7, P219, DOI 10.1038/sj.embor.7400587; Badie S, 2009, J CELL BIOL, V185, P587, DOI 10.1083/jcb.200811079; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Bennett BT, 2009, METHODS, V48, P63, DOI 10.1016/j.ymeth.2009.02.009; Bennett BT, 2005, J CELL BIOCHEM, V96, P1095, DOI 10.1002/jcb.20640; Brieger A, 2005, MOL CARCINOGEN, V43, P51, DOI 10.1002/mc.20081; Chen FQ, 1997, MUTAT RES-DNA REPAIR, V384, P205, DOI 10.1016/S0921-8777(97)00020-7; Chen JJ, 1999, CANCER RES, V59, p1752S; Chen PL, 1998, P NATL ACAD SCI USA, V95, P5287, DOI 10.1073/pnas.95.9.5287; Conlon KA, 2004, DNA REPAIR, V3, P1601, DOI 10.1016/j.dnarep.2004.06.011; Conlon KA, 2003, DNA REPAIR, V2, P1337, DOI 10.1016/j.dnarep.2003.08.002; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; Davies OR, 2007, NAT STRUCT MOL BIOL, V14, P475, DOI 10.1038/nsmb1251; Dosanjh MK, 1998, NUCLEIC ACIDS RES, V26, P1179, DOI 10.1093/nar/26.5.1179; Esashi F, 2005, NATURE, V434, P598, DOI 10.1038/nature03404; Esashi F, 2007, NAT STRUCT MOL BIOL, V14, P468, DOI 10.1038/nsmb1245; Essers J, 2002, EMBO J, V21, P2030, DOI 10.1093/emboj/21.8.2030; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Forget AL, 2004, J CELL BIOCHEM, V93, P429, DOI 10.1002/jcb.20232; French CA, 2003, J BIOL CHEM, V278, P45445, DOI 10.1074/jbc.M308621200; French CA, 2002, J BIOL CHEM, V277, P19322, DOI 10.1074/jbc.M201402200; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Godthelp BC, 2002, NUCLEIC ACIDS RES, V30, P2172, DOI 10.1093/nar/30.10.2172; Goggins M, 1996, CANCER RES, V56, P5360; Golub EI, 1997, NUCLEIC ACIDS RES, V25, P4106, DOI 10.1093/nar/25.20.4106; HAAF T, 1995, P NATL ACAD SCI USA, V92, P2298, DOI 10.1073/pnas.92.6.2298; Haaf T, 1999, J CELL BIOL, V144, P11, DOI 10.1083/jcb.144.1.11; Hannay JAF, 2007, MOL CANCER THER, V6, P1650, DOI 10.1158/1535-7163.MCT-06-0636; Hasselbach L, 2005, EUR J GYNAECOL ONCOL, V26, P589; Henson SE, 2006, MUTAT RES-FUND MOL M, V601, P113, DOI 10.1016/j.mrfmmm.2006.06.016; Ip SCY, 2008, NATURE, V456, P357, DOI 10.1038/nature07470; Iwanaga R, 2004, ONCOGENE, V23, P8581, DOI 10.1038/sj.onc.1207976; Kanamoto T, 2002, EMBO J, V21, P1219, DOI 10.1093/emboj/21.5.1219; Klein HL, 2008, DNA REPAIR, V7, P686, DOI 10.1016/j.dnarep.2007.12.008; Knudsen NO, 2007, NUCLEIC ACIDS RES, V35, P2609, DOI 10.1093/nar/gkl1166; Kovalenko OV, 2006, NUCLEIC ACIDS RES, V34, P5081, DOI 10.1093/nar/gkl665; Kovalenko OV, 1997, NUCLEIC ACIDS RES, V25, P4946, DOI 10.1093/nar/25.24.4946; Kraakman-van der Zwet M, 2002, MOL CELL BIOL, V22, P669, DOI 10.1128/MCB.22.2.669-679.2002; Kuznetsov S, 2007, J CELL BIOL, V176, P581, DOI 10.1083/jcb.200608130; Lee SA, 2009, DNA REPAIR, V8, P170, DOI 10.1016/j.dnarep.2008.10.002; Li X, 2008, CELL RES, V18, P99, DOI 10.1038/cr.2008.1; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; Lio YC, 2004, J BIOL CHEM, V279, P42313, DOI 10.1074/jbc.M405212200; Liu N, 2005, J CELL BIOCHEM, V95, P942, DOI 10.1002/jcb.20457; Liu N, 1998, MOL CELL, V1, P783, DOI 10.1016/S1097-2765(00)80078-7; Liu YL, 2004, SCIENCE, V303, P243, DOI 10.1126/science.1093037; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Masson JY, 2001, P NATL ACAD SCI USA, V98, P8440, DOI 10.1073/pnas.111005698; Miller KA, 2002, J BIOL CHEM, V277, P8406, DOI 10.1074/jbc.M108306200; Mirzoeva OK, 2001, MOL CELL BIOL, V21, P281, DOI 10.1128/MCB.21.1.281-288.2001; Mladenov E, 2006, GENES CELLS, V11, P513, DOI 10.1111/j.1365-2443.2006.00958.x; Orelli BJ, 2001, BREAST CANCER RES, V3, P294, DOI 10.1186/bcr310; PAINE PL, 1975, NATURE, V254, P109, DOI 10.1038/254109a0; Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc.01-06-0308; Plescia J, 2005, CANCER CELL, V7, P457, DOI 10.1016/j.ccr.2005.03.035; Raderschall E, 1999, P NATL ACAD SCI USA, V96, P1921, DOI 10.1073/pnas.96.5.1921; Raderschall E, 2002, J CELL SCI, V115, P153; Raderschall E, 2002, CANCER RES, V62, P219; Richardson C, 2004, ONCOGENE, V23, P546, DOI 10.1038/sj.onc.1207098; Rijkers T, 1998, MOL CELL BIOL, V18, P6423, DOI 10.1128/MCB.18.11.6423; Rodrigue A, 2006, EMBO J, V25, P222, DOI 10.1038/sj.emboj.7600914; San Filippo J, 2006, J BIOL CHEM, V281, P11649, DOI 10.1074/jbc.M601249200; Schild D, 2000, J BIOL CHEM, V275, P16443, DOI 10.1074/jbc.M001473200; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Shen ZY, 1996, J BIOL CHEM, V271, P148, DOI 10.1074/jbc.271.1.148; Spain BH, 1999, P NATL ACAD SCI USA, V96, P13920, DOI 10.1073/pnas.96.24.13920; Takata M, 2001, MOL CELL BIOL, V21, P2858, DOI 10.1128/MCB.21.8.2858-2866.2001; Tarsounas M, 2003, ONCOGENE, V22, P1115, DOI 10.1038/sj.onc.1206263; Tashiro S, 2000, J CELL BIOL, V150, P283, DOI 10.1083/jcb.150.2.283; Tashiro S, 1996, ONCOGENE, V12, P2165; TEBBS RS, 1995, P NATL ACAD SCI USA, V92, P6354, DOI 10.1073/pnas.92.14.6354; Tembe V, 2007, CELL SIGNAL, V19, P1113, DOI 10.1016/j.cellsig.2007.03.001; Thorslund T, 2007, ONCOGENE, V26, P7720, DOI 10.1038/sj.onc.1210870; van Veelen LR, 2005, MUTAT RES-FUND MOL M, V574, P22, DOI 10.1016/j.mrfmmm.2005.01.019; Wiese C, 2002, NUCLEIC ACIDS RES, V30, P1001, DOI 10.1093/nar/30.4.1001; Wyman C, 2004, CURR BIOL, V14, pR629, DOI 10.1016/j.cub.2004.07.049; Yamaguchi-Iwai Y, 1998, MOL CELL BIOL, V18, P6430, DOI 10.1128/MCB.18.11.6430; Yang HJ, 2005, NATURE, V433, P653, DOI 10.1038/nature03234; Yoshikawa K, 2000, INT J CANCER, V88, P28, DOI 10.1002/1097-0215(20001001)88:1<28::AID-IJC5>3.0.CO;2-4; Yu DS, 2003, MOL CELL, V12, P1029, DOI 10.1016/S1097-2765(03)00394-0; Yuan SSF, 1999, CANCER RES, V59, P3547	84	60	65	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31945	31952		10.1074/jbc.M109.024646	http://dx.doi.org/10.1074/jbc.M109.024646			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19783859	Green Published, hybrid			2022-12-27	WOS:000271572700050
J	Panja, D; Dagyte, G; Bidinosti, M; Wibrand, K; Kristiansen, AM; Sonenberg, N; Bramham, CR				Panja, Debabrata; Dagyte, Girstaute; Bidinosti, Michael; Wibrand, Karin; Kristiansen, Ase-Marit; Sonenberg, Nahum; Bramham, Clive R.			Novel Translational Control in Arc-dependent Long Term Potentiation Consolidation in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; INITIATION-FACTOR 4E; TOP MESSENGER-RNAS; RAT DENTATE GYRUS; SYNAPTIC PLASTICITY; PROTEIN-SYNTHESIS; MAMMALIAN TARGET; ACTIN POLYMERIZATION; KINASE; PHOSPHORYLATION	Regulation of translation factor activity plays a major role in protein synthesis-dependent forms of synaptic plasticity. We examined translational control across the critical period of Arc synthesis underlying consolidation of long term potentiation (LTP) in the dentate gyrus of intact, anesthetized rats. LTP induction by high frequency stimulation (HFS) evoked phosphorylation of the cap-binding protein eukaryotic initiation factor 4E (eIF4E) and dephosphorylation of eIF2 alpha on a protracted time course matching the time-window of Arc translation. Local infusion of the ERK inhibitor U0126 inhibited LTP maintenance and Arc protein expression, blocked changes in eIF4E and eIF2 alpha phosphorylation state, and prevented initiation complex (eIF4F) formation. Surprisingly, inhibition of the mTOR protein complex 1 (mTORC1) with rapamycin did not impair LTP maintenance or Arc synthesis nor did it inhibit eIF4F formation or phosphorylation of eIF4E. Rapamycin nonetheless blocked mTOR signaling to p70 S6 kinase and ribosomal protein S6 and inhibited synthesis of components of the translational machinery. Using immunohistochemistry and in situ hybridization, we show that Arc protein expression depends on dual, ERK-dependent transcription and translation. Arc translation is selectively blocked by pharmacological inhibition of mitogen-activated protein kinase-interacting kinase (MNK), the kinase coupling ERK to eIF4E phosphorylation. Furthermore, MNK signaling was required for eIF4F formation. These results support a dominant role for ERK-MNK signaling in control of translational initiation and Arc synthesis during LTP consolidation in the dentate gyrus. In contrast, mTORC1 signaling is activated but nonessential for Arc synthesis and LTP. The work, thus, identifies translational control mechanisms uniquely tuned to Arc-dependent LTP consolidation in live rats.	[Bramham, Clive R.] Univ Bergen, Dept Biomed, N-5009 Bergen, Norway; [Bramham, Clive R.] Univ Bergen, Bergen Mental Hlth Res Ctr, N-5009 Bergen, Norway; [Bidinosti, Michael; Sonenberg, Nahum] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada	University of Bergen; University of Bergen; McGill University	Bramham, CR (corresponding author), Univ Bergen, Dept Biomed, Jonas Lies Vei 91, N-5009 Bergen, Norway.	clive.bramham@biomed.uib.no	Bramham, Clive/Q-1854-2018; Panja, Debabrata/E-8595-2010	Bramham, Clive/0000-0001-5958-7115; Panja, Debabrata/0000-0003-4774-1167	Norwegian Research Council; University of Bergen	Norwegian Research Council(Research Council of NorwayEuropean Commission); University of Bergen	This work was funded by the Norwegian Research Council and the University of Bergen.	Banko JL, 2005, J NEUROSCI, V25, P9581, DOI 10.1523/JNEUROSCI.2423-05.2005; Bekinschtein P, 2007, NEUROBIOL LEARN MEM, V87, P303, DOI 10.1016/j.nlm.2006.08.007; Belelovsky K, 2005, EUR J NEUROSCI, V22, P2560, DOI 10.1111/j.1460-9568.2005.04428.x; Belelovsky K, 2009, J NEUROSCI, V29, P7424, DOI 10.1523/JNEUROSCI.3809-08.2009; Bianchini A, 2008, CARCINOGENESIS, V29, P2279, DOI 10.1093/carcin/bgn221; Bliss TVP, 2007, HIPPOCAMPUS BOOK, P343; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Bramham CR, 2010, EXP BRAIN RES, V200, P125, DOI 10.1007/s00221-009-1959-2; Buxade M, 2008, J BIOL CHEM, V283, P57, DOI 10.1074/jbc.M705286200; Cammalleri M, 2003, P NATL ACAD SCI USA, V100, P14368, DOI 10.1073/pnas.2336098100; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Chotiner JK, 2003, NEUROSCIENCE, V116, P743, DOI 10.1016/S0306-4522(02)00797-2; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; Gelinas JN, 2007, J BIOL CHEM, V282, P27527, DOI 10.1074/jbc.M701077200; Gingras AC, 2003, CURR TOP MICROBIOL, V279, P169; Giorgi C, 2007, CELL, V130, P179, DOI 10.1016/j.cell.2007.05.028; Hamilton TL, 2006, BIOCHEM SOC T, V34, P12, DOI 10.1042/BST0340012; Huang F, 2005, J NEUROSCI, V25, P7199, DOI 10.1523/JNEUROSCI.1779-05.2005; Huang F, 2007, J NEUROSCI, V27, P9054, DOI 10.1523/JNEUROSCI.2410-07.2007; Isotani S, 1999, J BIOL CHEM, V274, P34493, DOI 10.1074/jbc.274.48.34493; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; Jung MY, 2006, MOL CELL BIOL, V26, P4277, DOI 10.1128/MCB.02470-05; Kanhema T, 2006, J NEUROCHEM, V99, P1328, DOI 10.1111/j.1471-4159.2006.04158.x; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Kelly MP, 2003, J NEUROSCI, V23, P6443; Klann E, 2004, NAT REV NEUROSCI, V5, P931, DOI 10.1038/nrn1557; Knauf U, 2001, MOL CELL BIOL, V21, P5500, DOI 10.1128/MCB.21.16.5500-5511.2001; Kulla A, 2008, HIPPOCAMPUS, V18, P48, DOI 10.1002/hipo.20366; Larsen MH, 2005, BRAIN RES, V1064, P161, DOI 10.1016/j.brainres.2005.09.039; Lehman JA, 2003, J BIOL CHEM, V278, P28130, DOI 10.1074/jbc.M300376200; Liao L, 2007, J PROTEOME RES, V6, P1059, DOI 10.1021/pr060358f; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Messaoudi E, 2002, J NEUROSCI, V22, P7453; Messaoudi E, 2007, J NEUROSCI, V27, P10445, DOI 10.1523/JNEUROSCI.2883-07.2007; Meyuhas O, 2000, EUR J BIOCHEM, V267, P6321, DOI 10.1046/j.1432-1327.2000.01719.x; Miyashita T, 2009, J NEUROSCI, V29, P898, DOI 10.1523/JNEUROSCI.4588-08.2009; Naie K, 2007, EUR J NEUROSCI, V25, P3264, DOI 10.1111/j.1460-9568.2007.05583.x; NAIRN AC, 1987, J BIOL CHEM, V262, P17299; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Nelson SB, 2008, NEURON, V60, P477, DOI 10.1016/j.neuron.2008.10.020; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Proud CG, 2007, BIOCHEM J, V403, P217, DOI 10.1042/BJ20070024; Pyronnet S, 1999, EMBO J, V18, P270, DOI 10.1093/emboj/18.1.270; Ramirez-Amaya V, 2005, J NEUROSCI, V25, P1761, DOI 10.1523/JNEUROSCI.4342-04.2005; Rao VR, 2006, NAT NEUROSCI, V9, P887, DOI 10.1038/nn1708; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Rodriguez JJ, 2005, EUR J NEUROSCI, V21, P2384, DOI 10.1111/j.1460-9568.2005.04068.x; Rosenblum K, 2002, J NEUROSCI, V22, P5432; Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; RYAZANOV AG, 1988, NATURE, V334, P170, DOI 10.1038/334170a0; Scheetz AJ, 2000, NAT NEUROSCI, V3, P211, DOI 10.1038/72915; Scheper GC, 2002, EUR J BIOCHEM, V269, P5350, DOI 10.1046/j.1432-1033.2002.03291.x; Scheper GC, 2002, J BIOL CHEM, V277, P3303, DOI 10.1074/jbc.M103607200; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Stolovich M, 2002, MOL CELL BIOL, V22, P8101, DOI 10.1128/MCB.22.23.8101-8113.2002; Sutton MA, 2007, NEURON, V55, P648, DOI 10.1016/j.neuron.2007.07.030; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Tang H, 2001, MOL CELL BIOL, V21, P8671, DOI 10.1128/MCB.21.24.8671-8683.2001; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Tsokas P, 2005, J NEUROSCI, V25, P5833, DOI 10.1523/JNEUROSCI.0599-05.2005; Tsokas P, 2007, J NEUROSCI, V27, P5885, DOI 10.1523/JNEUROSCI.4548-06.2007; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Vazdarjanova A, 2002, J NEUROSCI, V22, P10067; VAZDARJANOVA A, 2002, SOC NEUR ABSTR; Waltereit R, 2001, J NEUROSCI, V21, P5484, DOI 10.1523/JNEUROSCI.21-15-05484.2001; Wang XM, 1998, J BIOL CHEM, V273, P9373, DOI 10.1074/jbc.273.16.9373; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; Waung MW, 2008, NEURON, V59, P84, DOI 10.1016/j.neuron.2008.05.014; Wu J, 2004, NEUROSCIENCE, V123, P507, DOI 10.1016/j.neuroscience.2003.09.013; Ying SW, 2002, J NEUROSCI, V22, P1532, DOI 10.1523/JNEUROSCI.22-05-01532.2002; Zhang YG, 2001, J BIOL CHEM, V276, P20913, DOI 10.1074/jbc.M009047200	76	88	93	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31498	31511		10.1074/jbc.M109.056077	http://dx.doi.org/10.1074/jbc.M109.056077			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19755425	Green Published, hybrid			2022-12-27	WOS:000271572700003
J	Monette, A; Ajamian, L; Lopez-Lastra, M; Mouland, AJ				Monette, Anne; Ajamian, Lara; Lopez-Lastra, Marcelo; Mouland, Andrew J.			Human Immunodeficiency Virus Type 1 (HIV-1) Induces the Cytoplasmic Retention of Heterogeneous Nuclear Ribonucleoprotein A1 by Disrupting Nuclear Import IMPLICATIONS FOR HIV-1 GENE EXPRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-BINDING-PROTEIN; VIROLOGICAL SYNAPSE FORMATION; PORE COMPLEX COMPOSITION; MAJOR CAPSID PROTEIN; TRANS-ACTING FACTOR; HNRNP A/B PROTEINS; MESSENGER-RNA; GENOMIC RNA; CELL-CYCLE; TRANSLATION INITIATION	Human immunodeficiency virus type 1 (HIV-1) co-opts host proteins and cellular machineries to its advantage at every step of the replication cycle. Here we show that HIV-1 enhances heterogeneous nuclear ribonucleoprotein (hnRNP) A1 expression and promotes the relocalization of hnRNP A1 to the cytoplasm. The latter was dependent on the nuclear export of the unspliced viral genomic RNA (vRNA) and to alterations in the abundance and localization of the FG-repeat nuclear pore glycoprotein p62. hnRNP A1 and vRNA remain colocalized in the cytoplasm supporting a post-nuclear function during the late stages of HIV-1 replication. Consistently, we show that hnRNP A1 acts as an internal ribosomal entry site trans-acting factor up-regulating internal ribosome entry site-mediated translation initiation of the HIV-1 vRNA. The up-regulation and cytoplasmic retention of hnRNP A1 by HIV-1 would ensure abundant expression of viral structural proteins in cells infected with HIV-1.	Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, HIV RNA Trafficking Lab 1, Montreal, PQ H3T 1E2, Canada; [Monette, Anne; Ajamian, Lara; Mouland, Andrew J.] McGill Univ, Div Expt Med, Dept Med, Montreal, PQ H3A 2B4, Canada; [Lopez-Lastra, Marcelo] Pontificia Univ Catolica Chile, Mol Virol Lab, Ctr Invest Med, Inst Milenio Inmunol & Inmunoterapia,Fac Med, Santiago 8330024, Chile; [Mouland, Andrew J.] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3T 1E2, Canada	Lady Davis Institute; McGill University; McGill University; Pontificia Universidad Catolica de Chile; McGill University	Mouland, AJ (corresponding author), McGill Univ, Lady Davis Inst Med Res, Sir Mortimer B Davis Jewish Gen Hosp, 3755 Cote Ste Catherine Rd, Montreal, PQ H3T 1E2, Canada.	andrew.mouland@mcgill.ca	Lopez-Lastra, Marcelo/HHM-9832-2022	Lopez-Lastra, Marcelo/0000-0002-7936-8478	Chilean Fondo Nacional de Ciencia y Techologia [1090318, 7070200]; Canadian Foundation for Innovation [6848]; Canadian Institutes of Health Research (CIHR) [MOP-38111, MOP-56974]	Chilean Fondo Nacional de Ciencia y Techologia; Canadian Foundation for Innovation(Canada Foundation for Innovation); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Chilean Fondo Nacional de Ciencia y Techologia Grants 1090318 and 7070200 (to M. L. L.) and by the Canadian Foundation for Innovation (project # 6848) and Canadian Institutes of Health Research (CIHR) Grants MOP-38111 and MOP-56974 (to A. J. M.).	Ajamian L, 2008, RNA, V14, P914, DOI 10.1261/rna.829208; Bardina MV, 2009, J VIROL, V83, P3150, DOI 10.1128/JVI.01456-08; Barth W, 1999, BIOCHEM CELL BIOL, V77, P355, DOI 10.1139/bcb-77-4-355; Beriault V, 2004, J BIOL CHEM, V279, P44141, DOI 10.1074/jbc.M404691200; BIAMONTI G, 1993, J MOL BIOL, V230, P77, DOI 10.1006/jmbi.1993.1127; Bilodeau PS, 2001, J VIROL, V75, P8487, DOI 10.1128/JVI.75.18.8487-8497.2001; Black AC, 1996, VIRUS GENES, V12, P275, DOI 10.1007/BF00284648; Bonifaci N, 1997, P NATL ACAD SCI USA, V94, P5055, DOI 10.1073/pnas.94.10.5055; Bonnal S, 2005, J BIOL CHEM, V280, P4144, DOI 10.1074/jbc.M411492200; Bour S, 1996, J VIROL, V70, P8285, DOI 10.1128/JVI.70.12.8285-8300.1996; Brasey A, 2003, J VIROL, V77, P3939, DOI 10.1128/JVI.77.7.3939-3949.2003; Brooks S A, 2000, Nucleic Acids Res, V28, pE49, DOI 10.1093/nar/28.10.e49; BURD CG, 1994, EMBO J, V13, P1197, DOI 10.1002/j.1460-2075.1994.tb06369.x; Cammas A, 2007, MOL BIOL CELL, V18, P5048, DOI 10.1091/mbc.E07-06-0603; Caputi M, 1999, EMBO J, V18, P4060, DOI 10.1093/emboj/18.14.4060; Chatel-Chaix L, 2004, MOL CELL BIOL, V24, P2637, DOI 10.1128/MCB.24.7.2637-2648.2004; Cheunim T, 2008, VIRUS RES, V131, P189, DOI 10.1016/j.virusres.2007.09.006; Cochrane AW, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-18; Damgaard CK, 2002, RNA, V8, P1401, DOI 10.1017/S1355838202023075; Darshan MS, 2004, J VIROL, V78, P12179, DOI 10.1128/JVI.78.22.12179-12188.2004; Dowling D, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-18; Enokizono Yoshiaki, 2003, Nucleic Acids Res Suppl, P231; Fridell RA, 1997, J CELL SCI, V110, P1325; Friend LR, 2008, BBA-MOL CELL RES, V1783, P1972, DOI 10.1016/j.bbamcr.2008.05.021; Gordon-Alonso M, 2006, J IMMUNOL, V177, P5129, DOI 10.4049/jimmunol.177.8.5129; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Guil S, 2006, MOL CELL BIOL, V26, P5744, DOI 10.1128/MCB.00224-06; Gustin KE, 2002, J VIROL, V76, P8787, DOI 10.1128/JVI.76.17.8787-8796.2002; Gustin KE, 2001, EMBO J, V20, P240, DOI 10.1093/emboj/20.1.240; HAMILTON BJ, 1993, J BIOL CHEM, V268, P8881; Hamilton BJN, 1997, J BIOL CHEM, V272, P28732, DOI 10.1074/jbc.272.45.28732; Henriet S, 2009, MICROBIOL MOL BIOL R, V73, P211, DOI 10.1128/MMBR.00040-08; Hofmann W, 2001, J CELL BIOL, V152, P895, DOI 10.1083/jcb.152.5.895; Hubert T, 2009, TRAFFIC, V10, P1257, DOI 10.1111/j.1600-0854.2009.00940.x; Iervolino A, 2002, MOL CELL BIOL, V22, P2255, DOI 10.1128/MCB.22.7.2255-2266.2002; Jo OD, 2008, J BIOL CHEM, V283, P23274, DOI 10.1074/jbc.M801185200; Johannes G, 1999, P NATL ACAD SCI USA, V96, P13118, DOI 10.1073/pnas.96.23.13118; Jolly C, 2005, J VIROL, V79, P12088, DOI 10.1128/JVI.79.18.12088-12094.2005; Karlsson K, 1998, J BIOL CHEM, V273, P18966, DOI 10.1074/jbc.273.30.18966; Kim S, 1997, BIOCHEMISTRY-US, V36, P5185, DOI 10.1021/bi9625509; Kneller ELP, 2009, J VIROL, V83, P770, DOI 10.1128/JVI.01279-08; Kodiha M, 2004, CELL DEATH DIFFER, V11, P862, DOI 10.1038/sj.cdd.4401432; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Kotsopoulou E, 2000, J VIROL, V74, P4839, DOI 10.1128/JVI.74.10.4839-4852.2000; Lee SJ, 2005, NATURE, V435, P693, DOI 10.1038/nature03578; Lehmann M, 2009, J BIOL CHEM, V284, P14572, DOI 10.1074/jbc.M808531200; Levesque K, 2006, TRAFFIC, V7, P1177, DOI 10.1111/j.1600-0854.2006.00461.x; Lewis SM, 2007, MOL BIOL CELL, V18, P1302, DOI 10.1091/mbc.E06-06-0515; Li TW, 2004, P NATL ACAD SCI USA, V101, P8551, DOI 10.1073/pnas.0402889101; Lichtenstein M, 2001, TRAFFIC, V2, P261, DOI 10.1034/j.1600-0854.2001.1o002.x; MACAULAY C, 1995, J BIOL CHEM, V270, P254, DOI 10.1074/jbc.270.1.254; Mclaren M, 2004, RNA, V10, P1119, DOI 10.1261/rna.5263904; MICHAEL WM, 1995, CELL, V83, P415; Mouland AJ, 2001, MOL CELL BIOL, V21, P2133, DOI 10.1128/MCB.21.6.2133-2143.2001; MUNICIO MM, 1995, J BIOL CHEM, V270, P15884, DOI 10.1074/jbc.270.26.15884; Najera I, 1999, J MOL BIOL, V285, P1951, DOI 10.1006/jmbi.1998.2473; Nelson LM, 2003, VIROLOGY, V306, P162, DOI 10.1016/S0042-6822(02)00025-9; Nelson LM, 2002, J BIOL CHEM, V277, P23958, DOI 10.1074/jbc.M200724200; Nguyen DG, 2006, J VIROL, V80, P130, DOI 10.1128/JVI.80.1.130-137.2006; Patry C, 2004, MOL CANCER THER, V3, P1193; Patry C, 2003, CANCER RES, V63, P7679; Percipalle P, 1997, J MOL BIOL, V266, P722, DOI 10.1006/jmbi.1996.0801; PINOLROMA S, 1992, NATURE, V355, P730, DOI 10.1038/355730a0; Pollard VW, 1996, CELL, V86, P985, DOI 10.1016/S0092-8674(00)80173-7; Poon DTK, 2002, VIROLOGY, V293, P368, DOI 10.1006/viro.2001.1283; Porter FW, 2009, J VIROL, V83, P1941, DOI 10.1128/JVI.01752-08; SADAIE MR, 1988, SCIENCE, V239, P910, DOI 10.1126/science.3277284; Sakai K, 2006, P NATL ACAD SCI USA, V103, P3369, DOI 10.1073/pnas.0509417103; Sol-Foulon N, 2007, EMBO J, V26, P516, DOI 10.1038/sj.emboj.7601509; Svitkin YV, 1996, EMBO J, V15, P7147, DOI 10.1002/j.1460-2075.1996.tb01106.x; Swanson CM, 2006, TRAFFIC, V7, P1440, DOI 10.1111/j.1600-0854.2006.00488.x; Tange TO, 2001, EMBO J, V20, P5748; van Oordt WV, 2000, J CELL BIOL, V149, P307, DOI 10.1083/jcb.149.2.307; Visa N, 1996, CELL, V84, P253, DOI 10.1016/S0092-8674(00)80980-0; Wang XM, 1998, J BIOL CHEM, V273, P9373, DOI 10.1074/jbc.273.16.9373; YANG XM, 1994, P NATL ACAD SCI USA, V91, P6924, DOI 10.1073/pnas.91.15.6924; Zhang H, 2000, J VIROL, V74, P8252, DOI 10.1128/JVI.74.18.8252-8261.2000; Zhang Y, 2008, BIOCHEM BIOPH RES CO, V367, P54, DOI 10.1016/j.bbrc.2007.12.118; ZOLOTUKHIN AS, 1994, J VIROL, V68, P7944, DOI 10.1128/JVI.68.12.7944-7952.1994; Zolotukhin AS, 2003, MOL CELL BIOL, V23, P6618, DOI 10.1128/MCB.23.18.6618-6630.2003	80	70	71	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31350	31362		10.1074/jbc.M109.048736	http://dx.doi.org/10.1074/jbc.M109.048736			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19737937	Green Published, hybrid			2022-12-27	WOS:000271378400061
J	Clarke, BR; Greenfield, LK; Bouwman, C; Whitfield, C				Clarke, Bradley R.; Greenfield, Laura K.; Bouwman, Catrien; Whitfield, Chris			Coordination of Polymerization, Chain Termination, and Export in Assembly of the Escherichia coli Lipopolysaccharide O9a Antigen in an ATP-binding Cassette Transporter-dependent Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY STRUCTURE PREDICTION; GRAM-NEGATIVE BACTERIA; GENE-CLUSTER; CAPSULAR POLYSACCHARIDES; POLYACRYLAMIDE GELS; ABC TRANSPORTER; O-ANTIGENS; BIOSYNTHESIS; EXPRESSION; SYSTEM	The Escherichia coli O9a O-polysaccharide (O-PS) is a prototype for O-PS synthesis and export by the ATP-binding cassette transporter-dependent pathway. Comparable systems are widespread in Gram-negative bacteria. The polymannose O9a O-PS is assembled on a polyisoprenoid lipid intermediate by mannosyltransferases located at the cytoplasmic membrane, and the final polysaccharide chain length is determined by the chain terminating dual kinase/methyltransferase, WbdD. The WbdD protein is tethered to the membrane via a C-terminal region containing amphipathic helices located between residues 601 and 669. Here, we establish that the C-terminal domain of WbdD plays an additional pivotal role in assembly of the O-PS by forming a complex with the chain-extending mannosyltransferase, WbdA. Membrane preparations from a Delta wbdD mutant had severely diminished mannosyltransferase activity in vitro, and no significant amounts of the WbdA protein are targeted to the membrane fraction. Expression of a polypeptide comprising the WbdD C-terminal region was sufficient to restore both proper localization of WbdA and mannosyltransferase activity. In contrast to WbdA, the other required mannosyltransferases (WbdBC) are targeted to the membrane independent of WbdD. A bacterial two-hybrid system confirmed the interaction of WbdD and WbdA and identified two regions in the C terminus of WbdD that contributed to the interaction. Therefore, in the O9a assembly export system, the WbdD protein orchestrates the critical localization and coordination of activities involved in O-PS chain extension and termination at the cytoplasmic membrane.	[Clarke, Bradley R.; Greenfield, Laura K.; Bouwman, Catrien; Whitfield, Chris] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Whitfield, C (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, New Sci Complex, Guelph, ON N1G 2W1, Canada.	cwhitfie@uoguelph.ca			Natural Sciences and Engineering Research Council	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported in part the Natural Sciences and Engineering Research Council ( to C. W.).	ALEXANDER DC, 1994, J BACTERIOL, V176, P7079, DOI 10.1128/JB.176.22.7079-7084.1994; BRONNER D, 1993, J BACTERIOL, V175, P5984, DOI 10.1128/JB.175.18.5984-5992.1993; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Cieslewicz M, 1996, J BACTERIOL, V178, P3212, DOI 10.1128/jb.178.11.3212-3220.1996; Clarke BR, 2004, J BIOL CHEM, V279, P35709, DOI 10.1074/jbc.M404738200; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cuthbertson L, 2005, J BIOL CHEM, V280, P30310, DOI 10.1074/jbc.M504371200; Cuthbertson L, 2007, P NATL ACAD SCI USA, V104, P19529, DOI 10.1073/pnas.0705709104; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Datta S, 2006, GENE, V379, P109, DOI 10.1016/j.gene.2006.04.018; Feng L, 2004, J BACTERIOL, V186, P4510, DOI 10.1128/JB.186.14.4510-4519.2004; Fraenkel D., 1996, ESCHERICHIA COLI SAL, P189; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Heinrichs DE, 1998, J BIOL CHEM, V273, P29497, DOI 10.1074/jbc.273.45.29497; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Hudson T, 2009, J BACTERIOL, V191, P1716, DOI 10.1128/JB.01371-08; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kido N, 1998, MOL MICROBIOL, V27, P1213, DOI 10.1046/j.1365-2958.1998.00765.x; KIDO N, 1995, J BACTERIOL, V177, P2178, DOI 10.1128/jb.177.8.2178-2187.1995; Kos V, 2009, J BIOL CHEM, V284, P2947, DOI 10.1074/jbc.M807213200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lehrer J, 2007, J BACTERIOL, V189, P2618, DOI 10.1128/JB.01905-06; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; McNulty C, 2006, MOL MICROBIOL, V59, P907, DOI 10.1111/j.1365-2958.2005.05010.x; Miller J. H., 1972, EXPT MOL GENETICS, P432; Miller J. H, 1972, EXPT MOL GENETICS; Moutevelis E, 2009, J MOL BIOL, V385, P726, DOI 10.1016/j.jmb.2008.11.028; ORSKOV I, 1977, BACTERIOL REV, V41, P667, DOI 10.1128/MMBR.41.3.667-710.1977; Ouali M, 2000, PROTEIN SCI, V9, P1162, DOI 10.1110/ps.9.6.1162; Preston A, 2006, J BIOL CHEM, V281, P18135, DOI 10.1074/jbc.M513904200; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rahn A, 2003, MOL MICROBIOL, V47, P1045, DOI 10.1046/j.1365-2958.2003.03354.x; Rick P, 1996, ESCHERICHIA COLI SAL, P104; Rigg GP, 1998, MICROBIOL-SGM, V144, P2905, DOI 10.1099/00221287-144-10-2905; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Sambrook J., 1989, MOL CLONING LAB MANU; SCHWEIZER HP, 1993, BIOTECHNIQUES, V15, P831; Sperandeo P, 2009, BBA-MOL CELL BIOL L, V1791, P594, DOI 10.1016/j.bbalip.2009.01.011; STEENBERGEN SM, 1992, J BACTERIOL, V174, P1099, DOI 10.1128/jb.174.4.1099-1108.1992; Steenbergen SM, 2008, MOL MICROBIOL, V68, P1252, DOI 10.1111/j.1365-2958.2008.06231.x; Steiner K, 2008, J BIOL CHEM, V283, P21120, DOI 10.1074/jbc.M801833200; Stenutz R, 2006, FEMS MICROBIOL REV, V30, P382, DOI 10.1111/j.1574-6976.2006.00016.x; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Vinogradov E, 2002, J BIOL CHEM, V277, P25070, DOI 10.1074/jbc.M202683200; WHITFIELD C, 1989, J GEN MICROBIOL, V135, P2589; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Zhou GP, 2005, GLYCOBIOLOGY, V15, P347, DOI 10.1093/glycob/cwi016	47	37	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30662	30672		10.1074/jbc.M109.052878	http://dx.doi.org/10.1074/jbc.M109.052878			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19734145	hybrid, Green Published			2022-12-27	WOS:000271090000068
J	Collins, RF; Touret, N; Kuwata, H; Tandon, NN; Grinstein, S; Trimble, WS				Collins, Richard F.; Touret, Nicolas; Kuwata, Hirotaka; Tandon, Narendra N.; Grinstein, Sergio; Trimble, William S.			Uptake of Oxidized Low Density Lipoprotein by CD36 Occurs by an Actin-dependent Pathway Distinct from Macropinocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOAM CELL-FORMATION; CLASS-B; M-CSF; MACROPHAGES; RECEPTOR; PHAGOCYTOSIS; ENDOCYTOSIS; ERYTHROCYTES; PLATELETS	The class B scavenger receptor CD36 has numerous ligands that include modified forms of low density lipoprotein, fibrillar amyloid, apoptotic cells, and Plasmodium falciparum-infected red blood cells, linking this molecule to atherosclerosis, Alzheimer disease, malaria, and other diseases. We studied the signaling events that follow receptor engagement and lead to CD36 and ligand internalization. We show that oxidized low density lipoprotein or antibody-induced clustering of CD36 triggers macropinocytosis and internalization of the receptor-ligand complex. Remarkably, however, CD36 internalization is independent of macropinocytosis and occurs by a novel endocytic mechanism that depends on actin, but not dynamin. This actin-driven endocytosis requires the activation Src family kinases, JNK, and Rho family GTPases, but, unlike macropinocytosis, it is not affected by inhibitors of phosphatidylinositol 3-kinase or Na/H exchange. Manipulation of this unique mode of internalization may prove helpful in the prevention and management of the wide range of diseases in which CD36 is implicated.	[Collins, Richard F.; Kuwata, Hirotaka; Grinstein, Sergio; Trimble, William S.] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Touret, Nicolas] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Tandon, Narendra N.] Otsuka Maryland Med Labs, Thrombosis Res Lab, Rockville, MD 20850 USA; [Grinstein, Sergio; Trimble, William S.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Alberta; University of Toronto	Trimble, WS (corresponding author), Hosp Sick Children, Cell Biol Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	wtrimble@sickkids.ca	Kuwata, Hiro/N-2023-2019	Kuwata, Hiro/0000-0002-5023-1777	Canadian Institutes of Health [FRN68956]	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant FRN68956.	Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; Bamberger ME, 2003, J NEUROSCI, V23, P2665; Zhao B, 2006, J BIOL CHEM, V281, P15757, DOI 10.1074/jbc.M510714200; COUNILLON L, 1993, P NATL ACAD SCI USA, V90, P4508, DOI 10.1073/pnas.90.10.4508; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; Graf GA, 1999, J BIOL CHEM, V274, P12043, DOI 10.1074/jbc.274.17.12043; HERSKOVITS JS, 1993, J CELL BIOL, V122, P565, DOI 10.1083/jcb.122.3.565; HUANG MM, 1991, P NATL ACAD SCI USA, V88, P7844, DOI 10.1073/pnas.88.17.7844; Jones NL, 1999, ANAT REC, V255, P57; Koenigsknecht J, 2004, J NEUROSCI, V24, P9838, DOI 10.1523/JNEUROSCI.2557-04.2004; Kruth HS, 2005, J BIOL CHEM, V280, P2352, DOI 10.1074/jbc.M407167200; Kunjathoor VV, 2002, J BIOL CHEM, V277, P49982, DOI 10.1074/jbc.M209649200; McGilvray ID, 2000, BLOOD, V96, P3231, DOI 10.1182/blood.V96.9.3231; Miao WM, 2001, BLOOD, V97, P1689, DOI 10.1182/blood.V97.6.1689; NOZAKI S, 1995, J CLIN INVEST, V96, P1859, DOI 10.1172/JCI118231; Patel SN, 2004, J INFECT DIS, V189, P204, DOI 10.1086/380764; Pellinen T, 2006, J CELL SCI, V119, P3723, DOI 10.1242/jcs.03216; RACOOSIN EL, 1992, J CELL SCI, V102, P867; Rahaman SO, 2006, CELL METAB, V4, P211, DOI 10.1016/j.cmet.2006.06.007; Sun B, 2007, J LIPID RES, V48, P2560, DOI 10.1194/jlr.M700163-JLR200; Swanson JA, 2008, NAT REV MOL CELL BIO, V9, P639, DOI 10.1038/nrm2447; Thorne RF, 2007, FEBS LETT, V581, P1227, DOI 10.1016/j.febslet.2007.02.043; Zeng YC, 2003, J BIOL CHEM, V278, P45931, DOI 10.1074/jbc.M307722200	23	39	42	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30288	30297		10.1074/jbc.M109.045104	http://dx.doi.org/10.1074/jbc.M109.045104			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19740737	Green Published, hybrid			2022-12-27	WOS:000271090000032
J	Zhang, F; Wu, JX; Yu, XC				Zhang, Feng; Wu, Jiaxue; Yu, Xiaochun			Integrator3, a Partner of Single-stranded DNA-binding Protein 1, Participates in the DNA Damage Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOMIC STABILITY; HISTONE H2AX; REPAIR; CHECKPOINT; PHOSPHORYLATION; CHK1; ATR; COMPLEXES; PATHWAYS; RECOMBINATION	Single-stranded DNA-binding protein 1 (SSB1) plays an important role in the DNA damage response and maintenance of genomic stability. Here, by using protein affinity purification, we have identified Integrator3 (INT3) as a novel partner of SSB1. INT3 forms a complex with SSB1 by constitutively interacting with SSB1 regardless of DNA damage. However, following DNA damage, along with SSB1, INT3 relocates to the DNA damage sites and regulates the accumulation of TopBP1 and BRCA1 there. Moreover, INT3 controls DNA damage-induced Chk1 activation and G(2)/M checkpoint activation. In addition, INT3 is involved in homologous recombination repair by regulating Rad51 foci formation following DNA damage. Taken together, these results demonstrate that INT3 plays a key role in the DNA damage response.	[Zhang, Feng; Wu, Jiaxue; Yu, Xiaochun] Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Yu, XC (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet, 109 Zina Pitcher Pl,BSRB 1520, Ann Arbor, MI 48109 USA.	xiayu@umich.edu			National Institutes of Health [CA132755, CA130899]; NATIONAL CANCER INSTITUTE [R01CA130899, R01CA132755] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA132755 and CA130899 (to X. Y.).	Abraham RT, 2004, DNA REPAIR, V3, P883, DOI 10.1016/j.dnarep.2004.04.002; Baillat D, 2005, CELL, V123, P265, DOI 10.1016/j.cell.2005.08.019; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Fernandez-Capetillo O, 2004, J EXP MED, V199, P1671, DOI 10.1084/jem.20032247; Greenberger JS, 2006, EXP HEMATOL, V34, P46; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Huang J, 2009, MOL CELL, V35, P384, DOI 10.1016/j.molcel.2009.06.011; Khanna KK, 2001, CELL DEATH DIFFER, V8, P1052, DOI 10.1038/sj.cdd.4400874; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Li YJ, 2009, J BIOL CHEM, V284, P23525, DOI 10.1074/jbc.C109.039586; Lisby M, 2004, CURR OPIN CELL BIOL, V16, P328, DOI 10.1016/j.ceb.2004.03.011; Liu QH, 2000, GENE DEV, V14, P1448; Lopez-Girona A, 2001, P NATL ACAD SCI USA, V98, P11289, DOI 10.1073/pnas.191557598; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Richard DJ, 2008, NATURE, V453, P677, DOI 10.1038/nature06883; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rouse J, 2002, SCIENCE, V297, P547, DOI 10.1126/science.1074740; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Takeda S, 2007, MOL CELL, V28, P351, DOI 10.1016/j.molcel.2007.10.016; Ward IM, 2003, MOL CELL BIOL, V23, P2556, DOI 10.1128/MCB.23.7.2556-2563.2003; Weinstock DM, 2006, METHOD ENZYMOL, V409, P524, DOI 10.1016/S0076-6879(05)09031-2; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Yamane K, 2002, MOL CELL BIOL, V22, P555, DOI 10.1128/MCB.22.2.555-566.2002; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Zhang F, 2009, CURR BIOL, V19, P524, DOI 10.1016/j.cub.2009.02.018; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	32	34	35	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30408	30415		10.1074/jbc.M109.039404	http://dx.doi.org/10.1074/jbc.M109.039404			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19759019	hybrid, Green Published			2022-12-27	WOS:000271090000043
J	Sabourin, J; Lamiche, C; Vandebrouck, A; Magaud, C; Rivet, J; Cognard, C; Bourmeyster, N; Constantin, B				Sabourin, Jessica; Lamiche, Coralie; Vandebrouck, Aurelie; Magaud, Christophe; Rivet, Jerome; Cognard, Christian; Bourmeyster, Nicolas; Constantin, Bruno			Regulation of TRPC1 and TRPC4 Cation Channels Requires an alpha 1-Syntrophin-dependent Complex in Skeletal Mouse Myotubes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPERATED CA2+ ENTRY; NITRIC-OXIDE SYNTHASE; MUSCLE-CELLS; PDZ DOMAIN; MICE LACKING; DYSTROPHIN; SYNTROPHIN; ASSOCIATION; PROTEIN; EXPRESSION	The dystrophin-associated protein complex (DAPC) is essential for skeletal muscle, and the lack of dystrophin in Duchenne muscular dystrophy results in a reduction of DAPC components such as syntrophins and in fiber necrosis. By anchoring various molecules, the syntrophins may confer a role in cell signaling to the DAPC. Calcium disorders and abnormally elevated cation influx in dystrophic muscle cells have suggested that the DAPC regulates some sarcolemmal cationic channels. We demonstrated previously that mini-dystrophin and alpha 1-syntrophin restore normal cation entry in dystrophin-deficient myotubes and that sarcolemmal TRPC1 channels associate with dystrophin and the bound PDZ domain of alpha 1-syntrophin. This study shows that small interfering RNA (siRNA) silencing of alpha 1-syntrophin dysregulated cation influx in myotubes. Moreover, deletion of the PDZ-containing domain prevented restoration of normal cation entry by alpha 1-syntrophin transfection in dystrophin-deficient myotubes. TRPC1 and TRPC4 channels are expressed at the sarcolemma of muscle cells; forced expression or siRNA silencing showed that cation influx regulated by alpha 1-syntrophin is supported by TRPC1 and TRPC4. A molecular association was found between TRPC1 and TRPC4 channels and the alpha 1-syntrophin-dystrophin complex. TRPC1 and TRPC4 channels may form sarcolemmal channels anchored to the DAPC, and alpha 1-syntrophin is necessary to maintain the normal regulation of TRPC-supported cation entry in skeletal muscle. Cation channels with DAPC form a signaling complex that modulates cation entry and may be crucial for normal calcium homeostasis in skeletal muscles.	[Sabourin, Jessica; Lamiche, Coralie; Vandebrouck, Aurelie; Magaud, Christophe; Rivet, Jerome; Cognard, Christian; Bourmeyster, Nicolas; Constantin, Bruno] Univ Poitiers, CNRS, UMR 6187, Inst Physiol & Biol Cellulaires, F-86022 Poitiers, France	Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers	Constantin, B (corresponding author), Univ Poitiers, CNRS, UMR 6187, Inst Physiol & Biol Cellulaires, 40 Ave Recteur Pineau, F-86022 Poitiers, France.	bruno.constantin@univ-poitiers.fr	COGNARD, Christian/P-5305-2016; Constantin, Bruno/AAH-6463-2021	Sabourin, Jessica/0000-0002-2980-8455; Constantin, Bruno/0000-0003-1668-581X; Bourmeyster, Nicolas/0000-0002-9563-5142	CNRS; French Ministry of Research; Association Francaise contre les Myopathies	CNRS(Centre National de la Recherche Scientifique (CNRS)); French Ministry of Research(Ministry of Research, FranceEuropean Commission); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	This work was supported by the CNRS, the French Ministry of Research, and the Association Francaise contre les Myopathies.	ADAMS ME, 1993, NEURON, V11, P531, DOI 10.1016/0896-6273(93)90157-M; Alfonso S, 2008, CELL CALCIUM, V43, P375, DOI 10.1016/j.ceca.2007.07.004; Ambudkar IS, 2007, BIOCHEM SOC T, V35, P96, DOI 10.1042/BST0350096; Beech DJ, 2005, PFLUG ARCH EUR J PHY, V451, P53, DOI 10.1007/s00424-005-1441-3; Boittin FX, 2006, J CELL SCI, V119, P3733, DOI 10.1242/jcs.03184; BRENMAN JE, 1995, CELL, V82, P743, DOI 10.1016/0092-8674(95)90471-9; Chang WJ, 1996, P NATL ACAD SCI USA, V93, P9142, DOI 10.1073/pnas.93.17.9142; Cheng KT, 2008, J BIOL CHEM, V283, P12935, DOI 10.1074/jbc.C800008200; COGNARD C, 1986, P NATL ACAD SCI USA, V83, P517, DOI 10.1073/pnas.83.2.517; Compton AG, 2005, J NEUROPATH EXP NEUR, V64, P350, DOI 10.1093/jnen/64.4.350; Connors NC, 2004, J BIOL CHEM, V279, P28387, DOI 10.1074/jbc.M402604200; Ducret T, 2006, J PHYSIOL-LONDON, V575, P913, DOI 10.1113/jphysiol.2006.115154; Engelke M, 2002, FEBS LETT, V523, P193, DOI 10.1016/S0014-5793(02)02971-X; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Formigli L, 2009, J MOL CELL CARDIOL, V47, P335, DOI 10.1016/j.yjmcc.2009.05.008; FRANCO A, 1990, J PHYSIOL-LONDON, V427, P361, DOI 10.1113/jphysiol.1990.sp018176; Franco-Obregon A, 2002, J PHYSIOL-LONDON, V539, P391, DOI 10.1113/jphysiol.2001.013043; FRANCOOBREGON A, 1994, J PHYSIOL-LONDON, V481, P299, DOI 10.1113/jphysiol.1994.sp020440; Freichel M, 2001, NAT CELL BIOL, V3, P121, DOI 10.1038/35055019; FRIEDRICH O, 2004, J PHYSIOL-LONDON, V15, P251; Frigeri A, 1998, J CLIN INVEST, V102, P695, DOI 10.1172/JCI2545; Gee SH, 1998, J NEUROSCI, V18, P128; Gervasio OL, 2008, J CELL SCI, V121, P2246, DOI 10.1242/jcs.032003; Goel M, 2002, J BIOL CHEM, V277, P48303, DOI 10.1074/jbc.M207882200; Gottlieb P, 2008, PFLUG ARCH EUR J PHY, V455, P1097, DOI 10.1007/s00424-007-0359-3; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Hopf F. W., 2007, V45, P429; Hopf FW, 1996, J BIOL CHEM, V271, P22358, DOI 10.1074/jbc.271.37.22358; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Imbert N, 2001, J PHYSIOL-LONDON, V534, P343, DOI 10.1111/j.1469-7793.2001.00343.x; Imbert N, 1996, NEUROMUSCULAR DISORD, V6, P351, DOI 10.1016/0960-8966(96)00351-3; Kurebayashi N, 2001, J PHYSIOL-LONDON, V533, P185, DOI 10.1111/j.1469-7793.2001.0185b.x; Launikonis BS, 2007, J PHYSIOL-LONDON, V583, P81, DOI 10.1113/jphysiol.2007.135046; Liao Y, 2008, P NATL ACAD SCI USA, V105, P2895, DOI 10.1073/pnas.0712288105; Liao Y, 2007, P NATL ACAD SCI USA, V104, P4682, DOI 10.1073/pnas.0611692104; Liu XB, 2007, P NATL ACAD SCI USA, V104, P17542, DOI 10.1073/pnas.0701254104; Lockwich TP, 2000, J BIOL CHEM, V275, P11934, DOI 10.1074/jbc.275.16.11934; LYFENKO AD, 2008, J PHYSL, V15, P4815; Maroto R, 2005, NAT CELL BIOL, V7, P179, DOI 10.1038/ncb1218; Mery L, 2002, J CELL SCI, V115, P3497; Obukhov AG, 2004, J CELL PHYSIOL, V201, P227, DOI 10.1002/jcp.20057; Ou YJ, 2003, J BIOL CHEM, V278, P1915, DOI 10.1074/jbc.M209938200; Peters MF, 1997, J CELL BIOL, V138, P81, DOI 10.1083/jcb.138.1.81; Philipp S, 1996, EMBO J, V15, P6166, DOI 10.1002/j.1460-2075.1996.tb01004.x; RIVET M, 1990, CELL CALCIUM, V11, P507, DOI 10.1016/0143-4160(90)90026-Q; Stiber J, 2008, NAT CELL BIOL, V10, P688, DOI 10.1038/ncb1731; Stiber JA, 2008, MOL CELL BIOL, V28, P2637, DOI 10.1128/MCB.01601-07; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Tang Y, 2000, J BIOL CHEM, V275, P37559, DOI 10.1074/jbc.M006635200; Vandebrouck A, 2005, FASEB J, V19, P136, DOI 10.1096/fj.04-3633fje; Vandebrouck A, 2007, FASEB J, V21, P608, DOI 10.1096/fj.06-6683com; Vandebrouck C, 2002, J CELL BIOL, V158, P1089, DOI 10.1083/jcb.200203091; Vandebrouck C, 2001, NEUROMUSCULAR DISORD, V11, P72, DOI 10.1016/S0960-8966(00)00153-X; Varga-Szabo D, 2008, PFLUG ARCH EUR J PHY, V457, P377, DOI 10.1007/s00424-008-0531-4; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550; Wu MM, 2007, CELL CALCIUM, V42, P163, DOI 10.1016/j.ceca.2007.03.003; Yuan JP, 2007, NAT CELL BIOL, V9, P636, DOI 10.1038/ncb1590; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5; Zitt C, 1996, NEURON, V16, P1189, DOI 10.1016/S0896-6273(00)80145-2	60	62	62	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36248	36261		10.1074/jbc.M109.012872	http://dx.doi.org/10.1074/jbc.M109.012872			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19812031	hybrid, Green Published			2022-12-27	WOS:000272970500027
J	Wu, ZP; Gogonea, V; Lee, X; Wagner, MA; Li, XM; Huang, Y; Undurti, A; May, RP; Haertlein, M; Moulin, M; Gutsche, I; Zaccai, G; DiDonato, JA; Hazen, SL				Wu, Zhiping; Gogonea, Valentin; Lee, Xavier; Wagner, Matthew A.; Li, Xin-Min; Huang, Ying; Undurti, Arundhati; May, Roland P.; Haertlein, Michael; Moulin, Martine; Gutsche, Irina; Zaccai, Giuseppe; DiDonato, Joseph A.; Hazen, Stanley L.			Double Superhelix Model of High Density Lipoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-A-I; RANDOMIZED CONTROLLED-TRIAL; ESCHERICHIA-COLI RIBOSOMES; LIPID-BOUND CONFORMATION; ANGLE NEUTRON-SCATTERING; APOA-I; X-RAY; CORONARY ATHEROSCLEROSIS; MASS-SPECTROMETRY; HDL-CHOLESTEROL	High density lipoprotein (HDL), the carrier of so-called "good" cholesterol, serves as the major athero-protective lipoprotein and has emerged as a key therapeutic target for cardiovascular disease. We applied small angle neutron scattering (SANS) with contrast variation and selective isotopic deuteration to the study of nascent HDL to obtain the low resolution structure in solution of the overall time-averaged conformation of apolipoprotein AI (apoA-I) versus the lipid (acyl chain) core of the particle. Remarkably, apoA-I is observed to possess an open helical shape that wraps around a central ellipsoidal lipid phase. Using the low resolution SANS shapes of the protein and lipid core as scaffolding, an all-atom computational model for the protein and lipid components of nascent HDL was developed by integrating complementary structural data from hydrogen/deuterium exchange mass spectrometry and previously published constraints from multiple biophysical techniques. Both SANS data and the new computational model, the double superhelix model, suggest an unexpected structural arrangement of protein and lipids of nascent HDL, an anti-parallel double superhelix wrapped around an ellipsoidal lipid phase. The protein and lipid organization in nascent HDL envisages a potential generalized mechanism for lipoprotein biogenesis and remodeling, biological processes critical to sterol and lipid transport, organismal energy metabolism, and innate immunity.	[Wu, Zhiping; Gogonea, Valentin; Lee, Xavier; Wagner, Matthew A.; Li, Xin-Min; Huang, Ying; Undurti, Arundhati; DiDonato, Joseph A.; Hazen, Stanley L.] Cleveland Clin, Dept Cell Biol, Cleveland, OH 44195 USA; [Wu, Zhiping; Lee, Xavier; Wagner, Matthew A.; Li, Xin-Min; Huang, Ying; Undurti, Arundhati; DiDonato, Joseph A.; Hazen, Stanley L.] Cleveland Clin, Ctr Cardiovasc Diagnost & Prevent, Cleveland, OH 44195 USA; [Hazen, Stanley L.] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44195 USA; [Gogonea, Valentin] Cleveland State Univ, Dept Chem, Cleveland, OH 44115 USA; [May, Roland P.; Haertlein, Michael; Moulin, Martine; Zaccai, Giuseppe] Inst Max Von Laue Paul Langevin, F-38042 Grenoble 9, France; [Gutsche, Irina] Univ Grenoble 1, Unit Virus Host Interact, European Mol Biol Lab, CNRS,UMR 5233, F-38042 Grenoble 9, France; [Zaccai, Giuseppe] Univ Grenoble 1, Inst Biol Struct, Commissariat Energie Atom, CNRS, F-38027 Grenoble, France	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University System of Ohio; Cleveland State University; Institut Laue-Langevin (ILL); Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Hazen, SL (corresponding author), Cleveland Clin, Dept Cell Biol, 9500 Euclid Ave,NE-10, Cleveland, OH 44195 USA.	hazens@ccf.org	Hazen, Stanley L/ABD-5845-2021		National Institutes of Health [P01 HL076491-055328, P01 HL077107-050004, P01 HL087018-02001, 1R15 GM070469-01]; Case Western Reserve University/Cleveland Clinic Clinical and Translational Science Award [1KL2RR024990]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024990] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL087018, P50HL077107, P01HL076491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM070469, T32GM007250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Case Western Reserve University/Cleveland Clinic Clinical and Translational Science Award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 HL076491-055328, P01 HL077107-050004, P01 HL087018-02001, and 1R15 GM070469-01. This work was also supported by Case Western Reserve University/Cleveland Clinic Clinical and Translational Science Award 1KL2RR024990.	Ajees AA, 2006, P NATL ACAD SCI USA, V103, P2126, DOI 10.1073/pnas.0506877103; Alexander ET, 2005, BIOCHEMISTRY-US, V44, P5409, DOI 10.1021/bi047412v; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Artero JB, 2005, ACTA CRYSTALLOGR D, V61, P1541, DOI 10.1107/S0907444905028532; Assmann G, 2004, CIRCULATION, V109, P8, DOI 10.1161/01.CIR.0000131512.50667.46; Atkinson D, 1980, Ann N Y Acad Sci, V348, P284, DOI 10.1111/j.1749-6632.1980.tb21308.x; Baker PW, 2000, J LIPID RES, V41, P1261; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Barter PJ, 2006, CURR OPIN LIPIDOL, V17, P399, DOI 10.1097/01.mol.0000236365.40969.af; Bhat S, 2005, J BIOL CHEM, V280, P33015, DOI 10.1074/jbc.M505081200; Bhat S, 2007, BIOCHEMISTRY-US, V46, P7811, DOI 10.1021/bi700384t; BLACK SD, 1991, ANAL BIOCHEM, V193, P72, DOI 10.1016/0003-2697(91)90045-U; BOLTON AE, 1973, BIOCHEM J, V133, P529, DOI 10.1042/bj1330529; Borhani DW, 1997, P NATL ACAD SCI USA, V94, P12291, DOI 10.1073/pnas.94.23.12291; Catte A, 2006, BIOPHYS J, V90, P4345, DOI 10.1529/biophysj.105.071456; Chapman MJ, 2006, PHARMACOL THERAPEUT, V111, P893, DOI 10.1016/j.pharmthera.2006.02.003; Chung EW, 1997, PROTEIN SCI, V6, P1316, DOI 10.1002/pro.5560060620; Cowieson NP, 2008, CURR OPIN STRUC BIOL, V18, P617, DOI 10.1016/j.sbi.2008.07.004; Davidson WS, 2007, J BIOL CHEM, V282, P22249, DOI 10.1074/jbc.R700014200; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Duong PT, 2006, J LIPID RES, V47, P832, DOI 10.1194/jlr.M500531-JLR200; Fleishman SJ, 2006, TRENDS BIOCHEM SCI, V31, P106, DOI 10.1016/j.tibs.2005.12.005; Gingras AR, 2008, EMBO J, V27, P458, DOI 10.1038/sj.emboj.7601965; Gu XJ, 1998, J BIOL CHEM, V273, P35388, DOI 10.1074/jbc.273.41.26338; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guinier A., 1939, ANN PHYS-NEW YORK, V11, P161, DOI DOI 10.1051/ANPHYS/193911120161; Ibanez B, 2008, J AM COLL CARDIOL, V51, P1104, DOI 10.1016/j.jacc.2007.09.071; Imaizumi S, 2008, J AM COLL CARDIOL, V51, P1604, DOI 10.1016/j.jacc.2007.12.040; Jin LH, 1999, BIOCHEMISTRY-US, V38, P15659, DOI 10.1021/bi9916729; Johs A, 2006, J BIOL CHEM, V281, P19732, DOI 10.1074/jbc.M601688200; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Koppaka V, 1999, J BIOL CHEM, V274, P14541, DOI 10.1074/jbc.274.21.14541; Koukos G, 2007, BIOCHEM J, V406, P167, DOI 10.1042/BJ20070296; Li HH, 2002, J BIOL CHEM, V277, P39093, DOI 10.1074/jbc.M206770200; Li HH, 2001, J LIPID RES, V42, P2084; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Linsel-Nitschke P, 2005, NAT REV DRUG DISCOV, V4, P193, DOI 10.1038/nrd1658; Maiorano JN, 2004, BIOCHEMISTRY-US, V43, P11717, DOI 10.1021/bi0496642; Martin DDO, 2006, J BIOL CHEM, V281, P20418, DOI 10.1074/jbc.M602077200; MATZ CE, 1982, J BIOL CHEM, V257, P4535; MAY RP, 1992, EMBO J, V11, P373, DOI 10.1002/j.1460-2075.1992.tb05060.x; Meilleur F, 2004, BIOCHEMISTRY-US, V43, P8744, DOI 10.1021/bi049418q; Merzel F, 2002, ACTA CRYSTALLOGR D, V58, P242, DOI 10.1107/S0907444901019576; MIRANKER A, 1993, SCIENCE, V262, P896, DOI 10.1126/science.8235611; Navab M, 2004, CIRCULATION, V109, P3215, DOI 10.1161/01.CIR.0000134275.90823.87; Nicholls SJ, 2005, ARTERIOSCL THROM VAS, V25, P2416, DOI 10.1161/01.ATV.0000184760.95957.d6; Niemann HH, 2008, J MOL BIOL, V377, P489, DOI 10.1016/j.jmb.2008.01.027; Nissen SE, 2003, JAMA-J AM MED ASSOC, V290, P2292, DOI 10.1001/jama.290.17.2292; Nissen SE, 2007, NEW ENGL J MED, V356, P1304, DOI 10.1056/NEJMoa070635; PARDON JF, 1977, NUCLEIC ACIDS RES, V4, P3199, DOI 10.1093/nar/4.9.3199; Peng DQ, 2008, ARTERIOSCL THROM VAS, V28, P2063, DOI 10.1161/ATVBAHA.108.173815; Peng DQ, 2005, J BIOL CHEM, V280, P33775, DOI 10.1074/jbc.M504092200; Peters-Libeu CA, 2007, J LIPID RES, V48, P1035, DOI 10.1194/jlr.M600545-JLR200; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Phillips JC, 1997, BIOPHYS J, V73, P2337, DOI 10.1016/S0006-3495(97)78264-X; PLUMP AS, 1994, P NATL ACAD SCI USA, V91, P9607, DOI 10.1073/pnas.91.20.9607; Rader DJ, 2007, NAT CLIN PRACT CARD, V4, P102, DOI 10.1038/ncpcardio0768; RADFORD SE, 1992, NATURE, V358, P302, DOI 10.1038/358302a0; RAMAKRISHNAN V, 1986, SCIENCE, V231, P1562, DOI 10.1126/science.3513310; Rogers DP, 1998, BIOCHEMISTRY-US, V37, P945, DOI 10.1021/bi9713512; RYE KA, 1992, J LIPID RES, V33, P215; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Segrest JP, 1999, J BIOL CHEM, V274, P31755, DOI 10.1074/jbc.274.45.31755; SERDYUK IN, 2007, METHODS MOL BIOPHYSI, P776; Shah PK, 1998, CIRCULATION, V97, P780, DOI 10.1161/01.CIR.97.8.780; Shaw JA, 2008, CIRC RES, V103, P1084, DOI 10.1161/CIRCRESAHA.108.182063; Shih AY, 2008, BIOPHYS J, V94, pL87, DOI 10.1529/biophysj.108.131581; Shih AY, 2007, J PHYS CHEM B, V111, P11095, DOI 10.1021/jp072320b; Silva RAGD, 2005, BIOCHEMISTRY-US, V44, P8600, DOI 10.1021/bi050421z; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Svergun DI, 1998, P NATL ACAD SCI USA, V95, P2267, DOI 10.1073/pnas.95.5.2267; Tall AR, 2008, CELL METAB, V7, P365, DOI 10.1016/j.cmet.2008.03.001; Tall AR, 2007, NEW ENGL J MED, V356, P1364, DOI 10.1056/NEJMe078029; Tardif JC, 2007, JAMA-J AM MED ASSOC, V297, P1675, DOI 10.1001/jama.297.15.jpc70004; Thomas MJ, 2008, J LIPID RES, V49, P1875, DOI 10.1194/jlr.R800010-JLR200; Trigatti B, 2000, CURR OPIN LIPIDOL, V11, P123, DOI 10.1097/00041433-200004000-00004; Willumeit R, 2001, BBA-GENE STRUCT EXPR, V1520, P7, DOI 10.1016/S0167-4781(01)00245-7; Wu Z, 2007, NAT STRUCT MOL BIOL, V14, P861, DOI 10.1038/nsmb1284; ZACCAI G, 1983, ANNU REV BIOPHYS BIO, V12, P139, DOI 10.1146/annurev.bb.12.060183.001035; Zhu HL, 2004, BIOCHEMISTRY-US, V43, P13156, DOI 10.1021/bi0487894	81	77	78	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36605	36619		10.1074/jbc.M109.039537	http://dx.doi.org/10.1074/jbc.M109.039537			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19812036	Green Published, hybrid			2022-12-27	WOS:000272970500061
J	Kawano, MA; Xing, L; Tsukamoto, H; Inoue, T; Handa, H; Cheng, RH				Kawano, Masa-aki; Xing, Li; Tsukamoto, Hiroko; Inoue, Takamasa; Handa, Hiroshi; Cheng, R. Holland			Calcium Bridge Triggers Capsid Disassembly in the Cell Entry Process of Simian Virus 40	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BUSHY STUNT VIRUS; CLASS-I MOLECULES; ENDOPLASMIC-RETICULUM; MURINE POLYOMAVIRUS; SIMIAN VIRUS-40; CAVEOLAR ENDOCYTOSIS; PROTEIN VP1; BK VIRUS; INFECTION; BINDING	The calcium bridge between the pentamers of polyoma viruses maintains capsid metastability. It has been shown that viral infection is profoundly inhibited by the substitution of lysine for glutamate in one calcium-binding residue of the SV40 capsid protein, VP1. However, it is unclear how the calcium bridge affects SV40 infectivity. In this in vitro study, we analyzed the influence of host cell components on SV40 capsid stability. We used an SV40 mutant capsid (E330K) in which lysine had been substituted for glutamate 330 in protein VP1. The mutant capsid retained the ability to interact with the SV40 cellular receptor GM1, and the internalized mutant capsid accumulated in caveolin-1-mediated endocytic vesicles and was then translocated to the endoplasmic reticulum (ER) region. However, when placed in ER-rich microsome, the mutant capsid retained its spherical structure in contrast to the wild type, which disassembled. Structural analysis of the mutant capsid with cryo-electron microscopy and image reconstruction revealed altered pentamer coordination, possibly as a result of electrostatic interaction, although its overall structure resembled that of the wild type. These results indicate that the calcium ion serves as a trigger at the pentamer interface, which switches on capsid disassembly, and that the failure of the E330K mutant capsid to disassemble is attributable to an inadequate triggering system. Our data also indicate that calcium depletion-induced SV40 capsid disassembly may occur in the ER region and that this is essential for successful SV40 infection.	[Kawano, Masa-aki; Xing, Li; Cheng, R. Holland] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Tsukamoto, Hiroko; Inoue, Takamasa; Handa, Hiroshi] Tokyo Inst Technol, Fac Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268503, Japan	University of California System; University of California Davis; Tokyo Institute of Technology	Cheng, RH (corresponding author), Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA.	rhch@ucdavis.edu	Cheng, Holland/A-8973-2008	Kawano, Masaaki/0000-0001-8220-4717	STINT foundation; Uehara Memorial Foundation	STINT foundation; Uehara Memorial Foundation(Uehara Memorial Foundation)	This work was supported, in whole or in part, by National Institutes of Health, HIVRAD, grants. This work was also supported by grants from the Discovery Program, the Cancer Research Coordinating Committee, and the STINT foundation (to R. H. C.). This work was also supported in part by a postgraduate fellowship provided by the Uehara Memorial Foundation (to M. K.).	ANDERER FA, 1967, VIROLOGY, V32, P511, DOI 10.1016/0042-6822(67)90302-9; Anderson HA, 1996, MOL BIOL CELL, V7, P1825, DOI 10.1091/mbc.7.11.1825; Anderson HA, 1998, J GEN VIROL, V79, P1469, DOI 10.1099/0022-1317-79-6-1469; Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; Aramayo R, 2005, BBA-GEN SUBJECTS, V1724, P345, DOI 10.1016/j.bbagen.2005.05.020; ATWOOD WJ, 1989, J VIROL, V63, P4474, DOI 10.1128/JVI.63.10.4474-4477.1989; BAKER TS, 1989, BIOPHYS J, V55, P243, DOI 10.1016/S0006-3495(89)82799-7; Baker TS, 1996, J STRUCT BIOL, V116, P120, DOI 10.1006/jsbi.1996.0020; BAROUCH DH, 1994, J VIROL, V68, P3982, DOI 10.1128/JVI.68.6.3982-3989.1994; BECKER GL, 1980, J BIOL CHEM, V255, P9009; BRADY JN, 1980, J VIROL, V35, P371, DOI 10.1128/JVI.35.2.371-381.1980; BRADY JN, 1977, J VIROL, V23, P717, DOI 10.1128/JVI.23.3.717-724.1977; Butel JS, 1999, JNCI-J NATL CANCER I, V91, P119, DOI 10.1093/jnci/91.2.119; Chen XJS, 1998, EMBO J, V17, P3233, DOI 10.1093/emboj/17.12.3233; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; Eash S, 2004, J VIROL, V78, P11583, DOI 10.1128/JVI.78.21.11583-11590.2004; Gelebart P, 2005, INT J BIOCHEM CELL B, V37, P260, DOI 10.1016/j.biocel.2004.02.030; Gilbert J, 2004, J VIROL, V78, P12259, DOI 10.1128/JVI.78.22.12259-12267.2004; GRIFFITH JP, 1992, NATURE, V355, P652, DOI 10.1038/355652a0; Hajnoczky G, 2003, BIOCHEM BIOPH RES CO, V304, P445, DOI 10.1016/S0006-291X(03)00616-8; Hilleman MR, 1998, DEV BIOL STAND, V94, P183; Ji YC, 2006, J STRUCT BIOL, V154, P1, DOI 10.1016/j.jsb.2005.06.009; KARTENBECK J, 1989, J CELL BIOL, V109, P2721, DOI 10.1083/jcb.109.6.2721; KOCH MA, 1967, VIROLOGY, V32, P503, DOI 10.1016/0042-6822(67)90302-9; Li PP, 2007, J VIROL, V81, P6099, DOI 10.1128/JVI.02195-06; Li PP, 2005, J VIROL, V79, P3859, DOI 10.1128/JVI.79.6.3859-3864.2005; Li PP, 2003, J VIROL, V77, P7527, DOI 10.1128/JVI.77.13.7527-7538.2003; LIDDINGTON RC, 1991, NATURE, V354, P278, DOI 10.1038/354278a0; Lilley BN, 2006, J VIROL, V80, P8739, DOI 10.1128/JVI.00791-06; Low JA, 2006, J VIROL, V80, P1361, DOI 10.1128/JVI.80.3.1361-1366.2006; MACER DRJ, 1988, J CELL SCI, V91, P61; Magnuson B, 2005, MOL CELL, V20, P289, DOI 10.1016/j.molcel.2005.08.034; MOORE L, 1975, J BIOL CHEM, V250, P4562; Neu U, 2008, P NATL ACAD SCI USA, V105, P5219, DOI 10.1073/pnas.0710301105; Norkin LC, 2002, J VIROL, V76, P5156, DOI 10.1128/JVI.76.10.5156-5166.2002; Oliver JD, 1999, MOL BIOL CELL, V10, P2573, DOI 10.1091/mbc.10.8.2573; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Richterova Z, 2001, J VIROL, V75, P10880, DOI 10.1128/JVI.75.22.10880-10891.2001; ROBINSON IK, 1982, NATURE, V297, P563, DOI 10.1038/297563a0; Ruiz MC, 1997, J GEN VIROL, V78, P2883, DOI 10.1099/0022-1317-78-11-2883; SALUNKE DM, 1989, BIOPHYS J, V56, P887, DOI 10.1016/S0006-3495(89)82735-3; Schelhaas M, 2007, CELL, V131, P516, DOI 10.1016/j.cell.2007.09.038; Smith AE, 2003, FEBS LETT, V555, P199, DOI 10.1016/S0014-5793(03)01220-1; Stang E, 1997, MOL BIOL CELL, V8, P47, DOI 10.1091/mbc.8.1.47; Stehle T, 1996, STRUCTURE, V4, P165, DOI 10.1016/S0969-2126(96)00020-2; Stehle T, 1996, STRUCTURE, V4, P183, DOI 10.1016/S0969-2126(96)00021-4; Stehle T, 1997, EMBO J, V16, P5139, DOI 10.1093/emboj/16.16.5139; STEHLE T, 1994, NATURE, V369, P160, DOI 10.1038/369160a0; Sullivan CS, 2002, MICROBIOL MOL BIOL R, V66, P179, DOI 10.1128/MMBR.66.2.179-202.2002; Takahashi R, 2008, J BIOTECHNOL, V135, P385, DOI 10.1016/j.jbiotec.2008.05.012; Tsai B, 2003, EMBO J, V22, P4346, DOI 10.1093/emboj/cdg439	51	28	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34703	34712		10.1074/jbc.M109.015107	http://dx.doi.org/10.1074/jbc.M109.015107			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19822519	hybrid, Green Published			2022-12-27	WOS:000272439600026
J	Parolini, I; Federici, C; Raggi, C; Lugini, L; Palleschi, S; De Milito, A; Coscia, C; Iessi, E; Logozzi, M; Molinari, A; Colone, M; Tatti, M; Sargiacomo, M; Fais, S				Parolini, Isabella; Federici, Cristina; Raggi, Carla; Lugini, Luana; Palleschi, Simonetta; De Milito, Angelo; Coscia, Carolina; Iessi, Elisabetta; Logozzi, Mariantonia; Molinari, Agnese; Colone, Marisa; Tatti, Massimo; Sargiacomo, Massimo; Fais, Stefano			Microenvironmental pH Is a Key Factor for Exosome Traffic in Tumor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LAURDAN FLUORESCENCE; MEMBRANE-FUSION; PROTEOMIC ANALYSIS; INDUCE APOPTOSIS; PLASMA-MEMBRANE; MELANOMA-CELLS; T-LYMPHOCYTES; VESICLES; MICROVESICLES; CANCER	Exosomes secreted by normal and cancer cells carry and deliver a variety of molecules. To date, mechanisms referring to tumor exosome trafficking, including release and cell-cell transmission, have not been described. To gain insight into this, exosomes purified from metastatic melanoma cell medium were labeled with a lipid fluorescent probe, R18, and analyzed by spectrofluorometry and confocal microscopy. A low pH condition is a hallmark of tumor malignancy, potentially influencing exosome release and uptake by cancer cells. Using different pH conditions as a modifier of exosome traffic, we showed (i) an increased exosome release and uptake at low pH when compared with a buffered condition and (ii) exosome uptake by melanoma cells occurred by fusion. Membrane biophysical analysis, such as fluidity and lipid composition, indicated a high rigidity and sphingomyelin/ganglioside GM3 (N-acetylneuraminylgalactosylglucosylceramide) content in exosomes released at low pH. This was likely responsible for the increased fusion efficiency. Consistent with these results, pretreatment with proton pump inhibitors led to an inhibition of exosome uptake by melanoma cells. Fusion efficiency of tumor exosomes resulted in being higher in cells of metastatic origin than in those derived from primary tumors or normal cells. Furthermore, we found that caveolin-1, a protein involved in melanoma progression, is highly delivered through exosomes released in an acidic condition. The results of our study provide the evidence that exosomes may be used as a delivery system for paracrine diffusion of tumor malignancy, in turn supporting the importance of both exosomes and tumor pH as key targets for future anti-cancer strategies.	[Fais, Stefano] Ist Super Sanita, Dept Therapeut Res & Med Evaluat, Unit Antitumor Drugs, I-00161 Rome, Italy; [Coscia, Carolina; Tatti, Massimo] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy; [Molinari, Agnese; Colone, Marisa] Ist Super Sanita, Dept Technol & Hlth, I-00161 Rome, Italy	Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS)	Fais, S (corresponding author), Ist Super Sanita, Dept Therapeut Res & Med Evaluat, Unit Antitumor Drugs, Viale Regina Elena 299, I-00161 Rome, Italy.	stefano.fais@iss.it	Iessi, Elisabetta/O-2460-2017; Federici, Cristina/O-4676-2016; parolini, Isabella/J-9955-2016; Molinari, Agnese/E-7588-2015; tatti, Massimo/N-1382-2017; Lugini, Luana/J-8672-2016; Palleschi, Simonetta/G-8563-2011; COLONE, MARISA/E-9089-2015; Fais, Stefano/J-8638-2016; Molinari, Agnese/AAC-2918-2021	Iessi, Elisabetta/0000-0001-7221-9173; Federici, Cristina/0000-0001-6366-0231; parolini, Isabella/0000-0001-9863-1051; Molinari, Agnese/0000-0002-9592-5465; Lugini, Luana/0000-0002-8778-2601; Palleschi, Simonetta/0000-0002-2180-0168; COLONE, MARISA/0000-0002-7522-7483; Fais, Stefano/0000-0001-9060-2766; Molinari, Agnese/0000-0002-9592-5465; Sargiacomo, Massimo/0000-0003-4040-706X; De Milito, Angelo/0000-0003-2591-2914; Raggi, Carla/0000-0002-1317-1541	Italian Ministry for University and Research [RBNE03FMCJ-002]; Italy-to-China partnership; Chemores FP6 European; Italy-NIH partnership	Italian Ministry for University and Research(Ministry of Education, Universities and Research (MIUR)); Italy-to-China partnership; Chemores FP6 European; Italy-NIH partnership	This work was supported in part by a grant from Fondo per gli Investimenti della Ricerca di Base (FIRB) year 2003 (RBNE03FMCJ-002) of the Italian Ministry for University and Research (to M.S. and I. P.), by an Italy-to-China partnership project, by the Chemores FP6 European Project, and by a Italy-NIH partnership project supported by the Italian Ministry of Health.	Andre F, 2002, LANCET, V360, P295, DOI 10.1016/S0140-6736(02)09552-1; Andreola G, 2002, J EXP MED, V195, P1303, DOI 10.1084/jem.20011624; Bagatolli LA, 1998, BIOPHYS J, V75, P331, DOI 10.1016/S0006-3495(98)77517-4; Bard MP, 2004, AM J RESP CELL MOL, V31, P114, DOI 10.1165/rcmb.2003-0238OC; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Calzolari A, 2006, J CELL SCI, V119, P4486, DOI 10.1242/jcs.03228; Cevc G, 1999, ADV DRUG DELIVER REV, V38, P207, DOI 10.1016/S0169-409X(99)00030-7; Chu VC, 2006, J VIROL, V80, P3180, DOI 10.1128/JVI.80.7.3180-3188.2006; De Milito A, 2007, CANCER RES, V67, P5408, DOI 10.1158/0008-5472.CAN-06-4095; del Conde I, 2005, BLOOD, V106, P1604, DOI 10.1182/blood-2004-03-1095; Fais S, 2007, CANCER RES, V67, P10627, DOI 10.1158/0008-5472.CAN-07-1805; Felicetti F, 2009, INT J CANCER, V125, P1514, DOI 10.1002/ijc.24451; FOLCH J, 1957, J BIOL CHEM, V226, P497; Hakomori S, 2003, CURR OPIN HEMATOL, V10, P16, DOI 10.1097/00062752-200301000-00004; Harris FM, 2002, BBA-BIOMEMBRANES, V1565, P123, DOI 10.1016/S0005-2736(02)00514-X; HOEKSTRA D, 1984, BIOCHEMISTRY-US, V23, P5675, DOI 10.1021/bi00319a002; Holthuis JCM, 2001, PHYSIOL REV, V81, P1689, DOI 10.1152/physrev.2001.81.4.1689; Huber V, 2005, GASTROENTEROLOGY, V128, P1796, DOI 10.1053/j.gastro.2005.03.045; Kim JW, 2005, CLIN CANCER RES, V11, P1010; Lakkaraju A, 2008, TRENDS CELL BIOL, V18, P199, DOI 10.1016/j.tcb.2008.03.002; LARSSON H, 1985, SCAND J GASTROENTERO, V20, P23, DOI 10.3109/00365528509095817; Logozzi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005219; Lu YD, 2005, CANCER RES, V65, P6843, DOI 10.1158/0008-5472.CAN-04-3822; Luciani F, 2004, JNCI-J NATL CANCER I, V96, P1702, DOI 10.1093/jnci/djh305; Lugini L, 2006, CANCER RES, V66, P3629, DOI 10.1158/0008-5472.CAN-05-3204; MARTINEZZAGUILAN R, 1993, AM J PHYSIOL, V265, pC1015, DOI 10.1152/ajpcell.1993.265.4.C1015; Mears R, 2004, PROTEOMICS, V4, P4019, DOI 10.1002/pmic.200400876; Morelli AE, 2004, BLOOD, V104, P3257, DOI 10.1182/blood-2004-03-0824; Palleschi S, 1996, BBA-BIOMEMBRANES, V1279, P197, DOI 10.1016/0005-2736(95)00250-2; Parasassi T, 1998, J FLUORESC, V8, P365, DOI 10.1023/A:1020528716621; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Riteau B, 2003, HUM IMMUNOL, V64, P1064, DOI 10.1016/j.humimm.2003.08.344; Rogasevskaia T, 2006, J CELL SCI, V119, P2688, DOI 10.1242/jcs.03007; Sorice M, 1997, J LIPID RES, V38, P969; Taylor DD, 2002, GYNECOL ONCOL, V84, P443, DOI 10.1006/gyno.2001.6551; Teissier E, 2007, EUR BIOPHYS J BIOPHY, V36, P887, DOI 10.1007/s00249-007-0201-z; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Valenti R, 2006, CANCER RES, V66, P9290, DOI 10.1158/0008-5472.CAN-06-1819; VIDAL M, 1995, J BIOL CHEM, V270, P17823, DOI 10.1074/jbc.270.30.17823; Wubbolts R, 2003, J BIOL CHEM, V278, P10963, DOI 10.1074/jbc.M207550200	42	932	966	24	203	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34211	34222		10.1074/jbc.M109.041152	http://dx.doi.org/10.1074/jbc.M109.041152			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19801663	Green Published, hybrid			2022-12-27	WOS:000272165200053
J	Shen, W; Gao, L; Balakrishnan, M; Bambara, RA				Shen, Wen; Gao, Lu; Balakrishnan, Mini; Bambara, Robert A.			A Recombination Hot Spot in HIV-1 Contains Guanosine Runs That Can Form a G-quartet Structure and Promote Strand Transfer in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; COPY-CHOICE RECOMBINATION; MURINE SARCOMA-VIRUS; REVERSE-TRANSCRIPTASE; DNA-SYNTHESIS; RETROVIRAL RECOMBINATION; TELOMERIC DNA; GENOMIC RNA; INTERNAL REGIONS; G-QUADRUPLEXES	The co-packaged RNA genomes of human immunodeficiency virus-1 recombine at a high rate. Recombination can mix mutations to generate viruses that escape immune response. A cell-culture-based system was designed previously to map recombination events in a 459-bp region spanning the primer binding site through a portion of the gag protein coding region. Strikingly, a strong preferential site for recombination in vivo was identified within a 112-nucleotide-long region near the beginning of gag. Strand transfer assays in vitro revealed that three pause bands in the gag hot spot each corresponded to a run of guanosine (G) residues. Pausing of reverse transcriptase is known to promote recombination by strand transfer both in vivo and in vitro. To assess the significance of the G runs, we altered them by base substitutions. Disruption of the G runs eliminated both the associated pausing and strand transfer. Some G-rich sequences can develop G-quartet structures, which were first proposed to form in telomeric DNA. G-quartet structure formation is highly dependent on the presence of specific cations. Incubation in cations discouraging G-quartets altered gel mobility of the gag template consistent with breakdown of G-quartet structure. The same cations faded G-run pauses but did not affect pauses caused by hairpins, indicating that quartet structure causes pausing. Moreover, gel analysis with cations favoring G-quartet structure indicated no structure in mutated templates. Overall, results point to reverse transcriptase pausing at G runs that can form quartets as a unique feature of the gag recombination hot spot.	[Shen, Wen; Gao, Lu; Balakrishnan, Mini; Bambara, Robert A.] Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA	University of Rochester	Bambara, RA (corresponding author), Univ Rochester, Med Ctr, Dept Biochem & Biophys, 601 Elmwood Ave,Box 712, Rochester, NY 14642 USA.	robert_bambara@urmc.rochester.edu			National Institutes of Health [GM049573]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049573] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM049573 ( to R.A.B.).	Aguiar RS, 2008, VIRUS RES, V134, P74, DOI 10.1016/j.virusres.2007.12.022; AWANG G, 1993, BIOCHEMISTRY-US, V32, P11453, DOI 10.1021/bi00093a024; Balakrishnan M, 2003, J VIROL, V77, P4710, DOI 10.1128/JVI.77.8.4710-4721.2003; Balakrishnan M, 2001, J BIOL CHEM, V276, P36482, DOI 10.1074/jbc.M102860200; Balasubramanian S, 2009, CURR OPIN CHEM BIOL, V13, P345, DOI 10.1016/j.cbpa.2009.04.637; Basu VP, 2008, VIRUS RES, V134, P19, DOI 10.1016/j.virusres.2007.12.017; Berkhout B, 2004, AIDS, V18, P1861, DOI 10.1097/00002030-200409030-00022; Berkhout B, 2001, RNA, V7, P1097, DOI 10.1017/S1355838201002035; Bukrinskaya A, 2007, VIRUS RES, V124, P1, DOI 10.1016/j.virusres.2006.07.001; Chen JB, 2005, J VIROL, V79, P9337, DOI 10.1128/JVI.79.14.9337-9340.2005; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; DESTEFANO JJ, 1994, J BIOL CHEM, V269, P161; DESTEFANO JJ, 1991, J BIOL CHEM, V266, P7423; DESTEFANO JJ, 1992, J VIROL, V66, P6370, DOI 10.1128/JVI.66.11.6370-6378.1992; DUESBERG PH, 1968, P NATL ACAD SCI USA, V60, P1511, DOI 10.1073/pnas.60.4.1511; Dykes C, 2004, VIROLOGY, V326, P262, DOI 10.1016/j.virol.2004.02.033; EPSTEIN CJ, 1966, MEDICINE, V45, P177, DOI 10.1097/00005792-196605000-00001; Filler AG, 1997, AIDS RES HUM RETROV, V13, P291, DOI 10.1089/aid.1997.13.291; Freed EO, 1998, VIROLOGY, V251, P1, DOI 10.1006/viro.1998.9398; Galetto R, 2006, J BIOL CHEM, V281, P2711, DOI 10.1074/jbc.M505457200; Galetto R, 2004, J BIOL CHEM, V279, P36625, DOI 10.1074/jbc.M405476200; Gao L, 2008, J BIOL CHEM, V283, P9196, DOI 10.1074/jbc.M710148200; Gatanaga H, 2002, J BIOL CHEM, V277, P5952, DOI 10.1074/jbc.M108005200; GELLERT M, 1962, P NATL ACAD SCI USA, V48, P2013, DOI 10.1073/pnas.48.12.2013; GILBOA E, 1979, CELL, V18, P93, DOI 10.1016/0092-8674(79)90357-X; GOODENOW M, 1989, J ACQ IMMUN DEF SYND, V2, P344; GUSCHLBAUER W, 1990, J BIOMOL STRUCT DYN, V8, P491, DOI 10.1080/07391102.1990.10507825; Halder K, 2005, NUCLEIC ACIDS RES, V33, P4466, DOI 10.1093/nar/gki750; Han HY, 1999, NUCLEIC ACIDS RES, V27, P537, DOI 10.1093/nar/27.2.537; Hanson MN, 2005, J MOL BIOL, V353, P772, DOI 10.1016/j.jmb.2005.08.065; Hantson Anke, 2005, Antiviral Chemistry & Chemotherapy, V16, P253; HENDERSON E, 1987, CELL, V51, P899, DOI 10.1016/0092-8674(87)90577-0; HU WS, 1990, SCIENCE, V250, P1227, DOI 10.1126/science.1700865; HUBER HE, 1989, J BIOL CHEM, V264, P4669; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Jetzt AE, 2000, J VIROL, V74, P1234, DOI 10.1128/JVI.74.3.1234-1240.2000; JI JP, 1992, BIOCHEMISTRY-US, V31, P954, DOI 10.1021/bi00119a002; JI JP, 1994, NUCLEIC ACIDS RES, V22, P47, DOI 10.1093/nar/22.1.47; Kikin O, 2006, NUCLEIC ACIDS RES, V34, pW676, DOI 10.1093/nar/gkl253; KLARMANN GJ, 1993, J BIOL CHEM, V268, P9793; Lanciault C, 2006, J VIROL, V80, P2483, DOI 10.1128/JVI.80.5.2483-2494.2006; Lee R, 1998, BIOCHEMISTRY-US, V37, P900, DOI 10.1021/bi972197m; Levy DN, 2004, P NATL ACAD SCI USA, V101, P4204, DOI 10.1073/pnas.0306764101; Ly H, 1999, J VIROL, V73, P7255, DOI 10.1128/JVI.73.9.7255-7261.1999; Ly H, 2000, J VIROL, V74, P9937, DOI 10.1128/JVI.74.21.9937-9945.2000; Mani P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004399; MARQUET R, 1991, NUCLEIC ACIDS RES, V19, P2349, DOI 10.1093/nar/19.9.2349; Martin GM, 2000, NATURE, V408, P263, DOI 10.1038/35041705; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Mirkin EV, 2007, MICROBIOL MOL BIOL R, V71, P13, DOI 10.1128/MMBR.00030-06; Moumen A, 2003, J BIOL CHEM, V278, P15973, DOI 10.1074/jbc.M212306200; Moumen A, 2001, NUCLEIC ACIDS RES, V29, P3814, DOI 10.1093/nar/29.18.3814; Moutouh L, 1996, P NATL ACAD SCI USA, V93, P6106, DOI 10.1073/pnas.93.12.6106; Multani AS, 2007, J CELL SCI, V120, P713, DOI 10.1242/jcs.03397; Negroni M, 2000, P NATL ACAD SCI USA, V97, P6385, DOI 10.1073/pnas.120520497; Operario DJ, 2006, J BIOL CHEM, V281, P32113, DOI 10.1074/jbc.M604665200; Paillart JC, 2004, NAT REV MICROBIOL, V2, P461, DOI 10.1038/nrmicro903; Pandey VN, 1996, BIOCHEMISTRY-US, V35, P2168, DOI 10.1021/bi9516642; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; Roda RH, 2002, J BIOL CHEM, V277, P46900, DOI 10.1074/jbc.M208638200; Schaffitzel C, 2001, P NATL ACAD SCI USA, V98, P8572, DOI 10.1073/pnas.141229498; SEN D, 1990, NATURE, V344, P410, DOI 10.1038/344410a0; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; SKRIPKIN E, 1994, P NATL ACAD SCI USA, V91, P4945, DOI 10.1073/pnas.91.11.4945; SUNDQUIST WI, 1993, P NATL ACAD SCI USA, V90, P3393, DOI 10.1073/pnas.90.8.3393; WILLIAMSON JR, 1994, ANNU REV BIOPH BIOM, V23, P703, DOI 10.1146/annurev.bb.23.060194.003415; WILLIAMSON JR, 1989, CELL, V59, P871, DOI 10.1016/0092-8674(89)90610-7; Wooley DP, 1998, VIROLOGY, V243, P229, DOI 10.1006/viro.1998.9052; WU WM, 1995, J BIOL CHEM, V270, P325, DOI 10.1074/jbc.270.1.263; YONG WH, 1990, AIDS, V4, P199, DOI 10.1097/00002030-199003000-00004	70	30	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33883	33893		10.1074/jbc.M109.055368	http://dx.doi.org/10.1074/jbc.M109.055368			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19822521	hybrid, Green Published			2022-12-27	WOS:000272165200021
J	Hall, J; Karplus, PA; Barbar, E				Hall, Justin; Karplus, P. Andrew; Barbar, Elisar			Multivalency in the Assembly of Intrinsically Disordered Dynein Intermediate Chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOPLASMIC DYNEIN; LIGHT-CHAIN; FUNCTIONAL INTERACTION; DYNACTIN INTERACTION; BINDING; LC8; DIMERIZATION; PROCESSIVITY; COMPLEXES; PROTEINS	Dynein light chains are thought to increase binding efficiency of dynein intermediate chain to both dynein heavy chain and dynactin, but their exact role is not clear. Isothermal titration calorimetry and x-ray crystallography reported herein indicate that multivalency effects underlie efficient dynein assembly and regulation. For a ternary complex of a 60-amino acid segment of dynein intermediate chain (IC) bound to two homodimeric dynein light chains Tctex1 and LC8, there is a 50-fold affinity enhancement for the second light chain binding. For a designed IC construct containing two LC8 sites, observed the 1000-fold enhancement reflects a remarkably pure entropic chelate effect of a magnitude commensurate with theoretical predictions. The lower enhancement in wild-type IC is attributed to unfavorable free energy changes associated with incremental interactions of IC with Tctex1. Our results show assembled dynein IC as an elongated, flexible polybivalent duplex, and suggest that poly-bivalency is an important general mechanism for constructing stable yet reversible and functionally versatile complexes.	[Hall, Justin; Karplus, P. Andrew; Barbar, Elisar] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA	Oregon State University	Barbar, E (corresponding author), Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA.	barbare@science.oregonstate.edu		Barbar, Elisar/0000-0003-4892-5259; Karplus, Paul/0000-0001-8725-6292	National Science Foundation [MCB 0818896]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant MCB 0818896.	Barbar E, 2001, BIOCHEMISTRY-US, V40, P1596, DOI 10.1021/bi002278+; Barbar E, 2008, BIOCHEMISTRY-US, V47, P503, DOI 10.1021/bi701995m; Benison G, 2007, J MOL BIOL, V371, P457, DOI 10.1016/j.jmb.2007.05.046; Benison G, 2006, J MOL BIOL, V362, P1082, DOI 10.1016/j.jmb.2006.08.006; Bertozzi CR, 2001, SCIENCE, V291, P2357, DOI 10.1126/science.1059820; Boylan KLM, 2002, GENETICS, V162, P1211; Breslow R, 2000, PURE APPL CHEM, V72, P333, DOI 10.1351/pac200072030333; Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; Carter AP, 2008, SCIENCE, V322, P1691, DOI 10.1126/science.1164424; DeLano W.L, PYMOL MOL GRAPHICS S; Dhani SU, 2003, J BIOL CHEM, V278, P16262, DOI 10.1074/jbc.M209828200; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Dong AP, 2007, NAT METHODS, V4, P1019, DOI 10.1038/nmeth1118; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hall J, 2008, BIOCHEMISTRY-US, V47, P11940, DOI 10.1021/bi801093k; JENCKS WP, 1981, P NATL ACAD SCI-BIOL, V78, P4046, DOI 10.1073/pnas.78.7.4046; Kardon JR, 2009, P NATL ACAD SCI USA, V106, P5669, DOI 10.1073/pnas.0900976106; Kiessling LL, 2006, ANGEW CHEM INT EDIT, V45, P2348, DOI 10.1002/anie.200502794; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; King SJ, 2003, MOL BIOL CELL, V14, P5089, DOI 10.1091/mbc.E03-01-0025; LESLIE A, 1992, JOINT CCP4 ESF EAMCB, V6; Ligon LA, 2001, NAT CELL BIOL, V3, P913, DOI 10.1038/ncb1001-913; Ma S, 1999, J CELL BIOL, V147, P1261, DOI 10.1083/jcb.147.6.1261; Makokha M, 2002, BIOCHEMISTRY-US, V41, P4302, DOI 10.1021/bi011970h; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Murray CW, 2002, J COMPUT AID MOL DES, V16, P741, DOI 10.1023/A:1022446720849; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nyarko A, 2004, BIOCHEMISTRY-US, V43, P15595, DOI 10.1021/bi048451+; PAGE MI, 1971, P NATL ACAD SCI USA, V68, P1678, DOI 10.1073/pnas.68.8.1678; Pappu RV, 2002, PROTEIN SCI, V11, P2437, DOI 10.1110/ps.0217402; Pfister KK, 2006, PLOS GENET, V2, P11, DOI 10.1371/journal.pgen.0020001; Pfister KK, 2005, J CELL BIOL, V171, P411, DOI 10.1083/jcb.200508078; Rodriguez-Crespo I, 2001, FEBS LETT, V503, P135, DOI 10.1016/S0014-5793(01)02718-1; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; Stelter P, 2007, NAT CELL BIOL, V9, P788, DOI 10.1038/ncb1604; Talbott M, 2006, BIOCHEMISTRY-US, V45, P6793, DOI 10.1021/bi0600345; Tsodikov OV, 2002, J COMPUT CHEM, V23, P600, DOI 10.1002/jcc.10061; Turnbull WB, 2003, J AM CHEM SOC, V125, P14859, DOI 10.1021/ja036166s; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; Vaughan PS, 2001, J BIOL CHEM, V276, P26171, DOI 10.1074/jbc.M102649200; Wang L, 2004, BIOCHEMISTRY-US, V43, P4611, DOI 10.1021/bi036328x; Wilkins MR, 1999, METH MOL B, V112, P531; Williams JC, 2007, P NATL ACAD SCI USA, V104, P10028, DOI 10.1073/pnas.0703614104; Ye GJ, 2000, J VIROL, V74, P1355, DOI 10.1128/JVI.74.3.1355-1363.2000	45	53	54	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33115	33121		10.1074/jbc.M109.048587	http://dx.doi.org/10.1074/jbc.M109.048587			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19759397	Green Published, hybrid			2022-12-27	WOS:000272028500015
J	Koshikawa, N; Hayashi, JI; Nakagawara, A; Takenaga, K				Koshikawa, Nobuko; Hayashi, Jun-Ichi; Nakagawara, Akira; Takenaga, Keizo			Reactive Oxygen Species-generating Mitochondrial DNA Mutation Up-regulates Hypoxia-inducible Factor-1 alpha Gene Transcription via Phosphatidylinositol 3-Kinase-Akt/Protein Kinase C/Histone Deacetylase Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; FACTOR 1-ALPHA GENE; EXPRESSION; CANCER; CELLS; ACTIVATION; INDUCTION; MECHANISM; PROMOTER; TARGET	Lewis lung carcinoma-derived high metastatic A11 cells constitutively overexpress hypoxia-inducible factor (HIF)-1 alpha mRNA compared with low metastatic P29 cells. Because A11 cells exclusively possess a G13997A mutation in the mitochondrial NADH dehydrogenase subunit 6 (ND6) gene, we addressed here a causal relationship between the ND6 mutation and the activation of HIF-1 alpha transcription, and we investigated the potential mechanism. Using trans-mitochondrial cybrids between A11 and P29 cells, we found that the ND6 mutation was directly involved in HIF-1 alpha mRNA overexpression. Stimulation of HIF-1 alpha transcription by the ND6 mutation was mediated by overproduction of reactive oxygen species (ROS) and subsequent activation of phosphatidylinositol 3-kinase (PI3K)-Akt and protein kinase C (PKC) signaling pathways. The up-regulation of HIF-1 alpha transcription was abolished by mithramycin A, an Sp1 inhibitor, but luciferase reporter and chromatin immunoprecipitation assays indicated that Sp1 was necessary but not sufficient for HIF-1 alpha mRNA overexpression in A11 cells. On the other hand, trichostatin A, a histone deacetylase (HDAC) inhibitor, markedly suppressed HIF-1 alpha transcription in A11 cells. In accordance with this, HDAC activity was high in A11 cells but low in P29 cells and in A11 cells treated with the ROS scavenger ebselene, the PI3K inhibitor LY294002, and the PKC inhibitor Ro31-8220. These results suggest that the ROS-generating ND6 mutation increases HIF-1 alpha transcription via the PI3K-Akt/PKC/HDAC pathway, leading to HIF-1 alpha protein accumulation in hypoxic tumor cells.	[Koshikawa, Nobuko; Takenaga, Keizo] Chiba Canc Ctr, Res Inst, Lab Canc Metastasis, Chuoh Ku, Chiba 2608717, Japan; [Nakagawara, Akira] Chiba Canc Ctr, Res Inst, Div Biochem & Innovat Canc Therapeut, Chuoh Ku, Chiba 2608717, Japan; [Hayashi, Jun-Ichi] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Takenaga, Keizo] Shimane Univ, Fac Med, Div Life Sci, Lab Tumor Biol, Izumo, Shimane 6938501, Japan	Chiba Cancer Center; Chiba Cancer Center; University of Tsukuba; Shimane University	Nakagawara, A (corresponding author), 666-2 Nitona,Chuoh Ku, Chiba 2608717, Japan.	akiranak@chiba-cc.jp; biokeizo@med.shimaneu-u.ac.jp			Ministry of Health, Labor, and Welfare; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [21390317] Funding Source: KAKEN	Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for Third Term Comprehensive Control Research for Cancer from the Ministry of Health, Labor, and Welfare ( to K. T.) and by Grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan ( to N. K. and K. T.).	Adcock IM, 2007, BRIT J PHARMACOL, V150, P829, DOI 10.1038/sj.bjp.0707166; Bonello S, 2007, ARTERIOSCL THROM VAS, V27, P755, DOI 10.1161/01.ATV.0000258979.92828.bc; Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Das C, 2005, IUBMB LIFE, V57, P137, DOI 10.1080/15216540500090629; Dasgupta S, 2008, CANCER RES, V68, P700, DOI 10.1158/0008-5472.CAN-07-5532; Frede S, 2006, BIOCHEM J, V396, P517, DOI 10.1042/BJ20051839; Indo HP, 2007, MITOCHONDRION, V7, P106, DOI 10.1016/j.mito.2006.11.026; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Iyer NV, 1998, GENOMICS, V52, P159, DOI 10.1006/geno.1998.5416; Joseph J, 2004, ONCOGENE, V23, P6304, DOI 10.1038/sj.onc.1207852; Kim HY, 2007, EXP CELL RES, V313, P1866, DOI 10.1016/j.yexcr.2007.03.009; Klimova T, 2008, CELL DEATH DIFFER, V15, P660, DOI 10.1038/sj.cdd.4402307; Koshikawa N, 2006, ONCOGENE, V25, P917, DOI 10.1038/sj.onc.1209128; Koshikawa N, 2003, ONCOGENE, V22, P6717, DOI 10.1038/sj.onc.1206765; Leoni F, 2002, P NATL ACAD SCI USA, V99, P2995, DOI 10.1073/pnas.052702999; Luo G, 1997, GENE EXPRESSION, V6, P287; Mayerhofer M, 2002, BLOOD, V100, P3767, DOI 10.1182/blood-2002-01-0109; Minet E, 1999, BIOCHEM BIOPH RES CO, V261, P534, DOI 10.1006/bbrc.1999.0995; Noh H, 2009, AM J PHYSIOL-RENAL, V297, pF729, DOI 10.1152/ajprenal.00086.2009; Oh YT, 2008, NEUROSCI LETT, V431, P155, DOI 10.1016/j.neulet.2007.11.033; Page EL, 2002, J BIOL CHEM, V277, P48403, DOI 10.1074/jbc.M209114200; Park JS, 2009, HUM MOL GENET, V18, P1578, DOI 10.1093/hmg/ddp069; Pouyssegur J, 2006, BIOL CHEM, V387, P1337, DOI 10.1515/BC.2006.167; Quivy V, 2004, BIOCHEM PHARMACOL, V68, P1221, DOI 10.1016/j.bcp.2004.05.039; Saramaki OR, 2001, CANCER GENET CYTOGEN, V128, P31, DOI 10.1016/S0165-4608(01)00396-X; Secades P, 2009, GENE CHROMOSOME CANC, V48, P441, DOI 10.1002/gcc.20652; Semenza GL, 2008, IUBMB LIFE, V60, P591, DOI 10.1002/iub.93; Semenza GL, 2009, SEMIN CANCER BIOL, V19, P12, DOI 10.1016/j.semcancer.2008.11.009; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Yu ZT, 2002, J AM SOC NEPHROL, V13, P2009, DOI 10.1097/01.ASN.0000024253.59665.F1	32	109	117	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33185	33194		10.1074/jbc.M109.054221	http://dx.doi.org/10.1074/jbc.M109.054221			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801684	Green Published, hybrid			2022-12-27	WOS:000272028500023
J	Mathew, LK; Sengupta, S; Franzosa, JA; Perry, J; La Du, J; Andreasen, EA; Tanguay, RL				Mathew, Lijoy K.; Sengupta, Sumitra; Franzosa, Jill A.; Perry, Jessica; La Du, Jane; Andreasen, Eric A.; Tanguay, Robert L.			Comparative Expression Profiling Reveals an Essential Role for Raldh2 in Epimorphic Regeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZEBRAFISH FIN REGENERATION; RETINOIC ACID SYNTHESIS; CAUDAL FIN; LIMB REGENERATION; HEART REGENERATION; TISSUE REGENERATION; CELL-PROLIFERATION; POSITIONAL MEMORY; GENE; GROWTH	Zebrafish have the remarkable ability to regenerate body parts including the heart and fins by a process referred to as epimorphic regeneration. Recent studies have illustrated that similar to adult zebrafish, early life stage larvae also possess the ability to regenerate the caudal fin. A comparative microarray analysis was used to determine the degree of conservation in gene expression among the regenerating adult caudal fin, adult heart, and larval fin. Results indicate that these tissues respond to amputation/injury with strikingly similar genomic responses. Comparative analysis revealed raldh2, a rate-limiting enzyme for the synthesis of retinoic acid, as one of the most highly induced genes across the three regeneration platforms. In situ localization and functional studies indicate that raldh2 expression is critical for the formation of wound epithelium and blastema. Patterning during regenerative outgrowth was considered to be the primary function of retinoic acid signaling; however, our results suggest that it is also required for early stages of tissue regeneration. Expression of raldh2 is regulated by Wnt and fibroblast growth factor/ERK signaling.	[Mathew, Lijoy K.; Sengupta, Sumitra; Franzosa, Jill A.; Perry, Jessica; La Du, Jane; Andreasen, Eric A.; Tanguay, Robert L.] Oregon State Univ, Dept Environm & Mol Toxicol, Environm Hlth Sci Ctr, Corvallis, OR 97331 USA	Oregon State University	Tanguay, RL (corresponding author), 1007 ALS, Corvallis, OR 97331 USA.	robert.tanguay@oregonstate.edu	Sengupta, Sumitra/G-1814-2017	Sengupta, Sumitra/0000-0003-2861-5608	NIEHS [ES10820, ES00210, ES03850]; National Science Foundation [0641409]; Oregon Medical Research Foundation; American Heart Association; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR012546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210, R01ES010820, P30ES003850, P50ES003850] Funding Source: NIH RePORTER	NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Science Foundation(National Science Foundation (NSF)); Oregon Medical Research Foundation; American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES10820, ES00210, and ES03850 from the NIEHS, National Science Foundation Grant 0641409, a Oregon Medical Research Foundation grant, and a pre-doctoral fellowship from the American Heart Association (to L. K. M.).	Akimenko MA, 2003, DEV DYNAM, V226, P190, DOI 10.1002/dvdy.10248; Allen SP, 2002, DEV BIOL, V251, P409, DOI 10.1006/dbio.2002.0816; Andreasen EA, 2007, TOXICOL SCI, V95, P215, DOI 10.1093/toxsci/kfl119; Andreasen EA, 2006, TOXICOL SCI, V92, P254, DOI 10.1093/toxsci/kfj118; Begemann G, 2001, DEVELOPMENT, V128, P3081; Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181; BROCKES JP, 1994, TRENDS GENET, V10, P169, DOI 10.1016/0168-9525(94)90094-9; Brockes JP, 1996, BIOCHEM SOC SYMP, P137; BROCKES JP, 1990, J CELL SCI, P191; GERAUDIE J, 1995, INT J DEV BIOL, V39, P373; Geraudie J, 1997, INT J DEV BIOL, V41, P529; GERAUDIE J, 1993, PROG CLIN BIOL RES, V383, P803; Gibert Y, 2006, DEVELOPMENT, V133, P2649, DOI 10.1242/dev.02438; Jazwinska A, 2007, CURR BIOL, V17, P1390, DOI 10.1016/j.cub.2007.07.019; Kajihara M, 2001, J BIOCHEM-TOKYO, V129, P139, DOI 10.1093/oxfordjournals.jbchem.a002825; Kawakami A, 2004, DEV DYNAM, V231, P693, DOI 10.1002/dvdy.20181; Kawakami Y, 2006, GENE DEV, V20, P3232, DOI 10.1101/gad.1475106; KIM WS, 1986, DEV BIOL, V114, P170, DOI 10.1016/0012-1606(86)90393-3; Kizil C, 2009, DEV BIOL, V325, P329, DOI 10.1016/j.ydbio.2008.09.032; Krens SFG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-196; Lee Y, 2005, DEVELOPMENT, V132, P5173, DOI 10.1242/dev.02101; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Lien CL, 2006, PLOS BIOL, V4, P1386, DOI 10.1371/journal.pbio.0040260; Mathew LK, 2008, FASEB J, V22, P3087, DOI 10.1096/fj.08-109009; Mathew LK, 2007, J BIOL CHEM, V282, P35202, DOI 10.1074/jbc.M706640200; Mathew LK, 2006, MOL PHARMACOL, V69, P257, DOI 10.1124/mol.105.018044; Mey J, 2005, EUR J NEUROSCI, V21, P1555, DOI 10.1111/j.1460-9568.2005.03928.x; Mic FA, 2004, J BIOL CHEM, V279, P26698, DOI 10.1074/jbc.M401920200; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nechiporuk A, 2002, DEVELOPMENT, V129, P2607; Poleo G, 2001, DEV DYNAM, V221, P380, DOI 10.1002/dvdy.1152; Poss FD, 2000, DEV BIOL, V222, P347, DOI 10.1006/dbio.2000.9722; Quint E, 2002, P NATL ACAD SCI USA, V99, P8713, DOI 10.1073/pnas.122571799; Raya A, 2003, P NATL ACAD SCI USA, V100, P11889, DOI 10.1073/pnas.1834204100; Rinkevich Y, 2007, PLOS BIOL, V5, P900, DOI 10.1371/journal.pbio.0050071; Rojas-Munoz A, 2009, DEV BIOL, V327, P177, DOI 10.1016/j.ydbio.2008.12.012; Schebesta M, 2006, THESCIENTIFICWORLDJO, V6, P38, DOI 10.1100/tsw.2006.326; Schvarzstein M, 1999, MECH DEVELOP, V80, P223, DOI 10.1016/S0925-4773(98)00220-2; STOCUM DL, 1987, BIOCHEM CELL BIOL, V65, P750, DOI 10.1139/o87-098; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Viviano CM, 1996, INT J DEV BIOL, V40, P817; WHITE JA, 1994, DEVELOPMENT, V120, P1861; Whitehead GG, 2005, SCIENCE, V310, P1957, DOI 10.1126/science.1117637; Zodrow JM, 2003, TOXICOL SCI, V76, P151, DOI 10.1093/toxsci/kfg205	44	62	62	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33642	33653		10.1074/jbc.M109.011668	http://dx.doi.org/10.1074/jbc.M109.011668			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801676	hybrid, Green Published			2022-12-27	WOS:000272028500068
J	Akiyama, H; Gotoh, A; Shin, RW; Koga, T; Ohashi, T; Sakamoto, W; Harada, A; Arai, H; Sawa, A; Uchida, C; Uchida, T				Akiyama, Hirotada; Gotoh, Aina; Shin, Ryong-Woon; Koga, Tomoe; Ohashi, Tsubasa; Sakamoto, Wataru; Harada, Akihiro; Arai, Hiroyuki; Sawa, Akira; Uchida, Chiyoko; Uchida, Takafumi			A Novel Role for hGas7b in Microtubular Maintenance POSSIBLE IMPLICATION IN TAU-ASSOCIATED PATHOLOGY IN ALZHEIMER DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PC12 CELLS; PROTEIN; GAS7	Here, we report a novel role for hGas7b (human growth arrest specific protein 7b) in the regulation of microtubules. Using a bioinformatic approach, we studied the actin-binding protein hGas7b with a structural similarity to the WW domain of a peptidyl prolyl cis/trans isomerase, Pin1, that facilitates microtubule assembly. Thus, we have demonstrated that hGas7b binds Tau at the WW motif and that the hGas7b/Tau protein complex interacts with the microtubules, promoting tubulin polymerization. Tau, in turn, contributes to protein stability of hGas7b. Furthermore, we observed decreased levels of hGas7b in the brains from patients with Alzheimer disease. These results suggest an important role for hGas7b in microtubular maintenance and possible implication in Alzheimer disease.	[Akiyama, Hirotada; Gotoh, Aina; Koga, Tomoe; Ohashi, Tsubasa; Sakamoto, Wataru; Uchida, Takafumi] Tohoku Univ, Grad Sch Agr Sci, Dept Mol Enzymol, Sendai, Miyagi 9818555, Japan; [Shin, Ryong-Woon] Tohoku Univ, Grad Sch Med, Dept Neuropathol, Sendai, Miyagi 9818555, Japan; [Arai, Hiroyuki] Tohoku Univ, Inst Dev Aging & Canc, Sendai, Miyagi 9818555, Japan; [Harada, Akihiro] Gunma Univ, Inst Mol & Cellular Regulat, Gunma 3718511, Japan; [Uchida, Chiyoko] Ibaraki Univ, Univ Hlth Ctr, Mito, Ibaraki 3108512, Japan; [Sawa, Akira] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21287 USA; [Sawa, Akira] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21287 USA	Tohoku University; Tohoku University; Tohoku University; Gunma University; Ibaraki University; Johns Hopkins University; Johns Hopkins University	Uchida, T (corresponding author), 1-1 Amamiya, Sendai, Miyagi 9818555, Japan.	uchidat@biochem.tohoku.ac.jp		Uchida, Takafumi/0000-0003-3665-4906; Gotoh, Aina/0000-0002-0979-2265	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for scientific research on priority areas and a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Akiyama H, 2005, BIOCHEM BIOPH RES CO, V336, P521, DOI 10.1016/j.bbrc.2005.08.130; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Chao CCK, 2003, J NEUROSCI RES, V74, P248, DOI 10.1002/jnr.10763; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; Fujio K, 2007, NEUROREPORT, V18, P1049, DOI 10.1097/WNR.0b013e32818b2a0b; GREENBERG SG, 1992, J BIOL CHEM, V267, P564; Ju YT, 1998, P NATL ACAD SCI USA, V95, P11423, DOI 10.1073/pnas.95.19.11423; KARR TL, 1979, J BIOL CHEM, V254, P6107; LANG E, 1992, BIOCHEM BIOPH RES CO, V187, P783, DOI 10.1016/0006-291X(92)91264-Q; Lortie K, 2005, BRAIN RES, V1036, P27, DOI 10.1016/j.brainres.2004.12.024; Lu PJ, 1999, NATURE, V399, P784; Murayama H, 1999, AM J PATHOL, V155, P877, DOI 10.1016/S0002-9440(10)65187-5; MURPHY DB, 1991, METHODS ENZYMOL, V196, P235; Smet C, 2004, BIOCHEMISTRY-US, V43, P2032, DOI 10.1021/bi035479x; Uchida T, 2009, J MOL BIOL, V391, P849, DOI 10.1016/j.jmb.2009.06.081	15	22	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32695	32699		10.1074/jbc.M109.035998	http://dx.doi.org/10.1074/jbc.M109.035998			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19801671	Green Published, hybrid			2022-12-27	WOS:000272028400053
J	Imai, H; Hakkaku, N; Iwamoto, R; Suzuki, J; Suzuki, T; Tajima, Y; Konishi, K; Minami, S; Ichinose, S; Ishizaka, K; Shioda, S; Arata, S; Nishimura, M; Naito, S; Nakagawa, Y				Imai, Hirotaka; Hakkaku, Nao; Iwamoto, Ryo; Suzuki, Jyunko; Suzuki, Toshiyuki; Tajima, Yoko; Konishi, Kumiko; Minami, Shintaro; Ichinose, Shizuko; Ishizaka, Kazuhiro; Shioda, Seiji; Arata, Satoru; Nishimura, Masuhiro; Naito, Shinsaku; Nakagawa, Yasuhito			Depletion of Selenoprotein GPx4 in Spermatocytes Causes Male Infertility in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROPEROXIDE GLUTATHIONE-PEROXIDASE; SPERM DEVELOPMENT; MAMMALIAN-CELLS; BINDING-PROTEIN; PHGPX GENE; EXPRESSION; IDENTIFICATION; FERTILITY; TRANSCRIPTION; MITOCHONDRIA	Phospholipid hydroperoxide glutathione peroxidase (GPx4) is an intracellular antioxidant enzyme that directly reduces peroxidized phospholipids. GPx4 is strongly expressed in the mitochondria of testis and spermatozoa. We previously found a significant decrease in the expression of GPx4 in spermatozoa from 30% of infertile human males diagnosed with oligoasthenozoospermia (Imai, H., Suzuki, K., Ishizaka, K., Ichinose, S., Oshima, H., Okayasu, I., Emoto, K., Umeda, M., and Nakagawa, Y. (2001) Biol. Reprod. 64, 674-683). To clarify whether defective GPx4 in spermatocytes causes male infertility, we established spermatocyte-specific GPx4 knock-out mice using a CreloxP system. All the spermatocyte-specific GPx4 knock-out male mice were found to be infertile despite normal plug formation after mating and displayed a significant decrease in the number of spermatozoa. Isolated epididymal GPx4-null spermatozoa could not fertilize oocytes in vitro. These spermatozoa showed significant reductions of forward motility and the mitochondrial membrane potential. These impairments were accompanied by the structural abnormality, such as a hairpin-like flagella bend at the midpiece and swelling of mitochondria in the spermatozoa. These results demonstrate that the depletion of GPx4 in spermatocytes causes severe abnormalities in spermatozoa. This may be one of the causes of male infertility in mice and humans.	[Imai, Hirotaka; Minami, Shintaro] Kitasato Univ, Sch Pharmaceut Sci, Minato Ku, Tokyo 1088641, Japan; [Imai, Hirotaka] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Ichinose, Shizuko] Tokyo Med & Dent Univ, Sch Med, Instrumental Anal Res Ctr, Bunkyo Ku, Tokyo 1138510, Japan; [Ishizaka, Kazuhiro] Kanto Cent Hosp, Mutual Aid Assoc, Publ Sch Teachers, Dept Urol,Setagaya Ku, Tokyo 1588531, Japan; [Shioda, Seiji] Showa Univ, Ctr Biotechnol, Shinagawa Ku, Tokyo 1428555, Japan; [Arata, Satoru] Showa Univ, Dept Anat, Shinagawa Ku, Sch Med, Tokyo 1428555, Japan; [Nishimura, Masuhiro; Naito, Shinsaku] Otsuka Amer Pharmaceut Inc, Div Pharmacol Drug Safety & Metab, Tokushima 7728601, Japan	Kitasato University; Japan Science & Technology Agency (JST); Tokyo Medical & Dental University (TMDU); Showa University; Showa University	Imai, H (corresponding author), Kitasato Univ, Sch Pharmaceut Sci, Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan.	imaih@pharm.kitasato-u.ac.jp			Ministry of Education, Science and Culture of Japan [20590067]; Japan Science and Technology Agency; SHISEIDO	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); SHISEIDO	This work was supported by Grant-in-aid 20590067 from the Ministry of Education, Science and Culture of Japan, by PRESTO from the Japan Science and Technology Agency, and by a SHISEIDO grant for science research.	Andersen OM, 2003, J BIOL CHEM, V278, P23989, DOI 10.1074/jbc.M302157200; Arai M, 1999, J BIOL CHEM, V274, P4924, DOI 10.1074/jbc.274.8.4924; Arai M, 1996, BIOCHEM BIOPH RES CO, V227, P433, DOI 10.1006/bbrc.1996.1525; Boschan C, 2002, GENOMICS, V79, P387, DOI 10.1006/geno.2001.6715; Conrad M, 2005, MOL CELL BIOL, V25, P7637, DOI 10.1128/MCB.25.17.7637-7644.2005; Conrad M, 2007, BIOL CHEM, V388, P1019, DOI 10.1515/BC.2007.130; Diaconu M, 2006, ANDROLOGIA, V38, P152, DOI 10.1111/j.1439-0272.2006.00729.x; Ferramosca A, 2008, INT J ANDROL, V31, P337, DOI 10.1111/j.1365-2605.2007.00775.x; Flohe L, 2007, BIOL CHEM, V388, P987, DOI 10.1515/BC.2007.112; Foresta C, 2002, BIOL REPROD, V67, P967, DOI 10.1095/biolreprod.102.003822; Hattori H, 2007, BIOCHEM J, V408, P277, DOI 10.1042/BJ20070245; HULL MGR, 1985, BRIT MED J, V291, P1693, DOI 10.1136/bmj.291.6510.1693; Ikawa M, 1997, NATURE, V387, P607, DOI 10.1038/42484; Imai H, 2003, BIOCHEM J, V371, P799, DOI 10.1042/BJ20021342; Imai H, 1998, J BIOL CHEM, V273, P1990, DOI 10.1074/jbc.273.4.1990; Imai H, 2003, BIOCHEM BIOPH RES CO, V305, P278, DOI 10.1016/S0006-291X(03)00734-4; Imai H, 2003, FREE RADICAL BIO MED, V34, P145, DOI 10.1016/S0891-5849(02)01197-8; Imai H, 2001, BIOL REPROD, V64, P674, DOI 10.1095/biolreprod64.2.674; Imai H, 2006, J BIOCHEM, V140, P573, DOI 10.1093/jb/mvj186; Jeyaraj D Antony, 2003, Reprod Biol Endocrinol, V1, P48, DOI 10.1186/1477-7827-1-48; Kido T, 2005, DEV GROWTH DIFFER, V47, P15, DOI 10.1111/j.1440-169x.2004.00775.x; Lipschultz L.Y., 1983, INFERTILITY MALE, P187; Liu L, 2009, J AM ASSOC LAB ANIM, V48, P39; Nakamura T, 2003, BIOCHEM BIOPH RES CO, V311, P139, DOI 10.1016/j.bbrc.2003.09.183; Nishimune Y, 2006, J ANDROL, V27, P326, DOI 10.2164/jandrol.05162; Nomura K, 1999, J BIOL CHEM, V274, P29294, DOI 10.1074/jbc.274.41.29294; Olson GE, 2007, J BIOL CHEM, V282, P12290, DOI 10.1074/jbc.M611403200; Olson GE, 2005, BIOL REPROD, V73, P201, DOI 10.1095/biolreprod.105.040360; Pfeifer H, 2001, FASEB J, V15, P1236, DOI 10.1096/fj.00-0655fje; PUSHPAREKHA TR, 1995, J BIOL CHEM, V270, P26993, DOI 10.1074/jbc.270.45.26993; Schneider M, 2009, FASEB J, V23, P3233, DOI 10.1096/fj.09-132795; Sharma RK, 1996, UROLOGY, V48, P835, DOI 10.1016/S0090-4295(96)00313-5; Tramer F, 2004, BIOCHEM J, V383, P179, DOI 10.1042/BJ20040974; Ursini F, 1999, SCIENCE, V285, P1393, DOI 10.1126/science.285.5432.1393; Yamamoto T, 2008, MOL CELL BIOL, V28, P2758, DOI 10.1128/MCB.01704-07; Yant LJ, 2003, FREE RADICAL BIO MED, V34, P496, DOI 10.1016/S0891-5849(02)01360-6; Zhang CX, 2006, P NATL ACAD SCI USA, V103, P17718, DOI 10.1073/pnas.0608556103	37	126	134	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32522	32532		10.1074/jbc.M109.016139	http://dx.doi.org/10.1074/jbc.M109.016139			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19783653	hybrid, Green Published			2022-12-27	WOS:000272028400034
J	Levy, S; Beharier, O; Etzion, Y; Mor, M; Buzaglo, L; Shaltiel, L; Gheber, LA; Kahn, J; Muslin, AJ; Katz, A; Gitler, D; Moran, A				Levy, Shiri; Beharier, Ofer; Etzion, Yoram; Mor, Merav; Buzaglo, Liat; Shaltiel, Lior; Gheber, Levi A.; Kahn, Joy; Muslin, Anthony J.; Katz, Amos; Gitler, Daniel; Moran, Arie			Molecular Basis for Zinc Transporter 1 Action as an Endogenous Inhibitor of L-type Calcium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-INTERACTION DOMAIN; GATED CA2+ CHANNELS; BETA-SUBUNIT; TRANSCRIPTION FACTOR; FLUORESCENT PROTEIN; ZNT-1 EXPRESSION; FUNCTIONAL EXPRESSION; INTERNATIONAL-UNION; HEART-FAILURE; CELLS	The L-type calcium channel (LTCC) has a variety of physiological roles that are critical for the proper function of many cell types and organs. Recently, a member of the zinc-regulating family of proteins, ZnT-1, was recognized as an endogenous inhibitor of the LTCC, but its mechanism of action has not been elucidated. In the present study, using two-electrode voltage clamp recordings in Xenopus oocytes, we demonstrate that ZnT-1-mediated inhibition of the LTCC critically depends on the presence of the LTCC regulatory beta-subunit. Moreover, the ZnT-1-induced inhibition of the LTCC current is also abolished by excess levels of the beta-subunit. An interaction between ZnT-1 and the beta-subunit, as demonstrated by co-immunoprecipitation and by fluorescence resonance energy transfer, is consistent with this result. Using surface biotinylation and total internal reflection fluorescence microscopy in HEK293 cells, we show a ZnT-1-dependent decrease in the surface expression of the pore-forming alpha(1)-subunit of the LTCC. Similarly, a decrease in the surface expression of the alpha(1)-subunit is observed following up-regulation of the expression of endogenous ZnT-1 in rapidly paced cultured cardiomyocytes. We conclude that ZnT-1-mediated inhibition of the LTCC is mediated through a functional interaction of ZnT-1 with the LTCC beta-subunit and that it involves a decrease in the trafficking of the LTCC alpha(1)-subunit to the surface membrane.	[Gitler, Daniel; Moran, Arie] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol, IL-84101 Beer Sheva, Israel; [Gheber, Levi A.] Ben Gurion Univ Negev, Dept Biotechnol Engn, IL-84101 Beer Sheva, Israel; [Etzion, Yoram; Katz, Amos] Soroka Univ, Med Ctr, Cardiac Arrhythmia Res Lab, IL-84101 Beer Sheva, Israel; [Muslin, Anthony J.] Washington Univ, Sch Med, Cardiovasc Res Ctr, John Milliken Dept Med, St Louis, MO 63110 USA; [Katz, Amos] Barzilai Govt Hosp, Dept Cardiol, IL-78278 Ashqelon, Israel	Ben Gurion University; Ben Gurion University; Ben Gurion University; Soroka Medical Center; Washington University (WUSTL); Ben Gurion University; Barzilai Medical Center	Moran, A (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol, POB 653, IL-84101 Beer Sheva, Israel.	arie@bgu.ac.il	MORAN, ARIE/F-1210-2012; ETZION, YORAM/F-2065-2012; Gitler, Daniel/F-1304-2012; Katz, Amos/E-6261-2011; Beharier, Ofer/AAC-8016-2021; Gheber, Levi/D-4383-2011	ETZION, YORAM/0000-0002-9930-1035; Gitler, Daniel/0000-0001-9544-3610; Gheber, Levi/0000-0002-7909-100X; Katz, Amos/0000-0003-0422-934X	German Israeli Foundation [I-850-263.2/2004]; Israel Science Foundation [992/07, 452/06]; Marc Rich Foundation for education, culture, and welfare; Chief Scientist Office of the Ministry of Health, Israel; Deutsche Forschungsgemeinschaft [MO 1932/1-1]	German Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); Israel Science Foundation(Israel Science Foundation); Marc Rich Foundation for education, culture, and welfare; Chief Scientist Office of the Ministry of Health, Israel; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by German Israeli Foundation Grant I-850-263.2/2004 (to A. M., A. K., and Y.E.), by Israel Science Foundation Grants 992/07 (to A. M. and Y.E.) and 452/06 (to D. G.), by the Marc Rich Foundation for education, culture, and welfare (to D. G.), by the Chief Scientist Office of the Ministry of Health, Israel (to Y. E., A. K., and A. M.), and by Deutsche Forschungsgemeinschaft Grant MO 1932/1-1 (to A. M.).	Balijepalli RC, 2006, P NATL ACAD SCI USA, V103, P7500, DOI 10.1073/pnas.0503465103; Balijepalli RC, 2003, CARDIOVASC RES, V59, P67, DOI 10.1016/S0008-6363(03)00325-0; Bannister RA, 2007, J MUSCLE RES CELL M, V28, P275, DOI 10.1007/s10974-007-9118-5; Beguin P, 2006, J MOL BIOL, V355, P34, DOI 10.1016/j.jmb.2005.10.013; Beguin P, 2001, NATURE, V411, P701, DOI 10.1038/35079621; Beharier O, 2007, CELL CALCIUM, V42, P71, DOI 10.1016/j.ceca.2006.11.007; Bodi I, 2005, J CLIN INVEST, V115, P3306, DOI 10.1172/JCI27167; BRIK H, 1990, BASIC RES CARDIOL, V85, P237, DOI 10.1007/BF01907112; Catterall WA, 2003, PHARMACOL REV, V55, P579, DOI 10.1124/pr.55.4.8; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Chen NH, 2004, J BIOL CHEM, V279, P5508, DOI 10.1074/jbc.M306294200; Cousins RJ, 2003, J NUTR, V133, p1521S, DOI 10.1093/jn/133.5.1521S; Cousins RJ, 2006, J BIOL CHEM, V281, P24085, DOI 10.1074/jbc.R600011200; DEWAARD M, 1994, NEURON, V13, P495, DOI 10.1016/0896-6273(94)90363-8; Dufner-Beattie J, 2003, J BIOL CHEM, V278, P50142, DOI 10.1074/jbc.M304163200; Dulhunty AF, 2006, CLIN EXP PHARMACOL P, V33, P763, DOI 10.1111/j.1440-1681.2006.04441.x; Felix R, 1997, J NEUROSCI, V17, P6884; Finlin BS, 2003, P NATL ACAD SCI USA, V100, P14469, DOI 10.1073/pnas.2437756100; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; Green EM, 2007, NEURON, V55, P615, DOI 10.1016/j.neuron.2007.07.024; Hanlon MR, 1999, FEBS LETT, V445, P366, DOI 10.1016/S0014-5793(99)00156-8; He LL, 2007, BIOPHYS J, V93, P834, DOI 10.1529/biophysj.106.101691; Hidalgo P, 2006, J BIOL CHEM, V281, P24104, DOI 10.1074/jbc.M605930200; HULLIN R, 1992, EMBO J, V11, P885, DOI 10.1002/j.1460-2075.1992.tb05126.x; Jirakulaporn T, 2004, J BIOL CHEM, V279, P27807, DOI 10.1074/jbc.M401210200; Kambe T, 2004, CELL MOL LIFE SCI, V61, P49, DOI 10.1007/s00018-003-3148-y; Kanevsky N, 2006, J GEN PHYSIOL, V128, P15, DOI 10.1085/jgp.200609485; Kerfant EG, 2006, TRENDS CARDIOVAS MED, V16, P250, DOI 10.1016/j.tcm.2006.04.006; Kim AH, 2000, BRAIN RES, V886, P99, DOI 10.1016/S0006-8993(00)02944-9; Kobayashi T, 2007, J PHARMACOL SCI, V103, P347, DOI 10.1254/jphs.CR0070012; Langmade SJ, 2000, J BIOL CHEM, V275, P34803, DOI 10.1074/jbc.M007339200; Lavi Y, 2007, BIOPHYS J, V93, pL35, DOI 10.1529/biophysj.107.111567; Lazarczyk M, 2008, J EXP MED, V205, P35, DOI 10.1084/jem.20071311; Lee Tae-Seong, 2006, Journal of UOEH, V28, P277; Liuzzi JP, 2004, P NATL ACAD SCI USA, V101, P14355, DOI 10.1073/pnas.0406216101; Lubarski I, 2005, J BIOL CHEM, V280, P37717, DOI 10.1074/jbc.M506397200; Majumder S, 2003, J BIOL CHEM, V278, P26216, DOI 10.1074/jbc.M302887200; McKeown L, 2006, ACTA PHARMACOL SIN, V27, P799, DOI 10.1111/j.1745-7254.2006.00394.x; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; MOOSMANG S, 2007, HDB EXP PHARM, V178, P469; Mukherjee R, 1998, J MOL CELL CARDIOL, V30, P1899, DOI 10.1006/jmcc.1998.0755; Murata M, 2004, CIRC RES, V95, P398, DOI 10.1161/01.RES.0000138449.85324.c5; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nakayama H, 2007, J CLIN INVEST, V117, P2431, DOI 10.1172/JCI31060; Nattel S, 2002, NATURE, V415, P219, DOI 10.1038/415219a; Nattel S, 2008, CIRC-ARRHYTHMIA ELEC, V1, P62, DOI 10.1161/CIRCEP.107.754564; Nitzan YB, 2002, DEV BRAIN RES, V137, P149, DOI 10.1016/S0165-3806(02)00437-6; Nolte C, 2004, GLIA, V48, P145, DOI 10.1002/glia.20065; Ohana E, 2004, J BIOL CHEM, V279, P4278, DOI 10.1074/jbc.M309229200; Ohana E, 2006, J MOL MED-JMM, V84, P753, DOI 10.1007/s00109-006-0062-4; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; Opatowsky Y, 2003, J BIOL CHEM, V278, P52323, DOI 10.1074/jbc.M303564200; Palmiter RD, 2004, PFLUG ARCH EUR J PHY, V447, P744, DOI 10.1007/s00424-003-1070-7; PALMITER RD, 1995, EMBO J, V14, P639, DOI 10.1002/j.1460-2075.1995.tb07042.x; Piston DW, 2007, TRENDS BIOCHEM SCI, V32, P407, DOI 10.1016/j.tibs.2007.08.003; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Sasaki T, 2005, J BIOL CHEM, V280, P9308, DOI 10.1074/jbc.M413773200; Segal D, 2004, BIOCHEM BIOPH RES CO, V323, P1145, DOI 10.1016/j.bbrc.2004.08.211; SINGERLAHAT D, 1992, FEBS LETT, V306, P113, DOI 10.1016/0014-5793(92)80980-U; Sonkusare S, 2006, VASC PHARMACOL, V44, P131, DOI 10.1016/j.vph.2005.10.005; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Striessnig J, 1999, CELL PHYSIOL BIOCHEM, V9, P242, DOI 10.1159/000016320; Takanishi CL, 2006, BRAIN RES, V1091, P132, DOI 10.1016/j.brainres.2006.01.119; Tsuda M, 1997, J NEUROSCI, V17, P6678; Wang HG, 2007, J NEUROSCI, V27, P9086, DOI 10.1523/JNEUROSCI.1720-07.2007; Yamaguchi H, 1998, J BIOL CHEM, V273, P19348, DOI 10.1074/jbc.273.30.19348; Yang SN, 2006, ENDOCR REV, V27, P621, DOI 10.1210/er.2005-0888	68	47	48	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32434	32443		10.1074/jbc.M109.058842	http://dx.doi.org/10.1074/jbc.M109.058842			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19767393	Green Published, hybrid			2022-12-27	WOS:000272028400026
J	Ottolia, M; Nicoll, DA; Philipson, KD				Ottolia, Michela; Nicoll, Debora A.; Philipson, Kenneth D.			Roles of Two Ca2+-binding Domains in Regulation of the Cardiac Na+-Ca2+ Exchanger	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CALCIUM EXCHANGE; NA+/CA2+ EXCHANGER; MUTATIONAL ANALYSIS; CONFORMATIONAL-CHANGES; DYNAMIC PROPERTIES; CRYSTAL-STRUCTURE; CA2+ REGULATION; STEADY-STATE; NCX1; ISOFORMS	We expressed full-length Na+-Ca2+ exchangers (NCXs) with mutations in two Ca2+-binding domains (CBD1 and CBD2) to determine the roles of the CBDs in Ca2+-dependent regulation of NCX. CBD1 has four Ca2+-binding sites, and mutation of residues Asp(421) and Glu(451), which primarily coordinate Ca2+ at sites 1 and 2, had little effect on regulation of NCX by Ca2+. In contrast, mutations at residues Glu(385), Asp(446), Asp(447), and Asp(500), which coordinate Ca2+ at sites 3 and 4 of CBD1, resulted in a drastic decrease in the apparent affinity of peak exchange current for regulatory Ca2+. Another mutant, M7, with 7 key residues of CBD1 replaced, showed a further decrease in apparent Ca2+ affinity but retained regulation, confirming a contribution of CBD2 to Ca2+ regulation. Addition of the mutation K585E (located in CBD2) into the M7 background induced a marked increase in Ca2+ affinity for both steady-state and peak currents. Also, we have shown previously that the CBD2 mutations E516L and E683V have no Ca2+-dependent regulation. We now demonstrate that introduction of a positive charge at these locations rescues Ca2+-dependent regulation. Finally, our data demonstrate that deletion of the unstructured loops between beta-strands F and G of both CBDs does not alter the regulation of the exchanger by Ca2+, indicating that these segments are not important in regulation. Thus, CBD1 and CBD2 have distinct roles in Ca2+-dependent regulation of NCX. CBD1 determines the affinity of NCX for regulatory Ca2+, although CBD2 is also necessary for Ca2+-dependent regulation.	Univ Calif Los Angeles, Cardiovasc Res Labs, David Geffen Sch Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Ottolia, M (corresponding author), Univ Calif Los Angeles, Cardiovasc Res Lab MRL 3 645, David Geffen Sch Med, Los Angeles, CA 90095 USA.	mottolia@mednet.ucla.edu			National Institutes of Health [HL49101]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL49101.	Besserer GM, 2007, P NATL ACAD SCI USA, V104, P18467, DOI 10.1073/pnas.0707417104; Boyman L, 2009, J BIOL CHEM, V284, P6185, DOI 10.1074/jbc.M809012200; Chaptal V, 2009, J BIOL CHEM, V284, P14688, DOI 10.1074/jbc.C900037200; Dunn J, 2002, J BIOL CHEM, V277, P33957, DOI 10.1074/jbc.M206677200; Egger M, 1999, J MEMBRANE BIOL, V168, P107, DOI 10.1007/s002329900502; Hilge M, 2006, MOL CELL, V22, P15, DOI 10.1016/j.molcel.2006.03.008; Hilgemann DW, 1998, METHOD ENZYMOL, V293, P267; HILGEMANN DW, 1992, J GEN PHYSIOL, V100, P905, DOI 10.1085/jgp.100.6.905; HILGEMANN DW, 1992, J GEN PHYSIOL, V100, P933, DOI 10.1085/jgp.100.6.933; Hryshko LV, 1996, J GEN PHYSIOL, V108, P67, DOI 10.1085/jgp.108.1.67; Johnson E, 2008, J MOL BIOL, V377, P945, DOI 10.1016/j.jmb.2008.01.046; LEVITSKY DO, 1994, J BIOL CHEM, V269, P22847; MATSUOKA S, 1995, J GEN PHYSIOL, V105, P403, DOI 10.1085/jgp.105.3.403; Nicoll DA, 2002, ANN NY ACAD SCI, V976, P11; Nicoll DA, 2006, J BIOL CHEM, V281, P21577, DOI 10.1074/jbc.C600117200; Ottolia M, 2005, J BIOL CHEM, V280, P1061, DOI 10.1074/jbc.M411899200; Ottolia M, 2004, BIOPHYS J, V87, P899, DOI 10.1529/biophysj.104.043471; Patton C, 2004, CELL CALCIUM, V35, P427, DOI 10.1016/j.ceca.2003.10.006; Philipson KD, 2002, ANN NY ACAD SCI, V976, P1; Quednau BD, 1997, AM J PHYSIOL-CELL PH, V272, pC1250, DOI 10.1152/ajpcell.1997.272.4.C1250; Wu MS, 2009, J MOL BIOL, V387, P104, DOI 10.1016/j.jmb.2009.01.045; Xie Y, 2008, AM J PHYSIOL-CELL PH, V295, pC388, DOI 10.1152/ajpcell.00178.2008	22	58	58	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32735	32741		10.1074/jbc.M109.055434	http://dx.doi.org/10.1074/jbc.M109.055434			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19801651	Green Published, hybrid			2022-12-27	WOS:000272028400058
J	Tai, CC; Chen, CY; Lee, HS; Wang, YC; Li, TK; Mersamm, HJ; Ding, ST; Wang, PH				Tai, Chen C.; Chen, Ching Y.; Lee, Hsuan S.; Wang, Ya C.; Li, Tsai K.; Mersamm, Harry J.; Ding, Shih T.; Wang, Pei H.			Docosahexaenoic Acid Enhances Hepatic Serum Amyloid A Expression via Protein Kinase A-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYUNSATURATED FATTY-ACIDS; EICOSAPENTAENOIC ACID; ADIPOCYTE DETERMINATION; GENE-TRANSCRIPTION; SIGNALING PATHWAY; LIPOGENIC GENES; N-3; PHOSPHORYLATION; ACTIVATION; CELLS	Serum amyloid A (SAA) reduces fat deposition in adipocytes and hepatoma cells. Human SAA1 mRNA is increased by docosahexaenoic acid (DHA) treatment in human cells. These studies asked whether DHA decreases fat deposition through SAA1 and explored the mechanisms involved. We demonstrated that DHA increased human SAA1 and C/EBP beta mRNA expression in human hepatoma cells, SK-HEP-1. Utilizing a promoter deletion assay, we found that a CCAAT/enhancer-binding protein beta (C/EBP beta)-binding site in the SAA1 promoter region between -242 and -102 bp was critical for DHA-mediated SAA1 expression. Mutation of the putative C/EBP beta-binding site suppressed the DHA-induced SAA1 promoter activity. The addition of the protein kinase A inhibitor H89 negated the DHA-induced increase in C/EBP beta protein expression. The up-regulation of SAA1 mRNA and protein by DHA was also inhibited by H89. We also demonstrated that DHA increased protein kinase A (PKA) activities. These data suggest that C/EBP beta is involved in the DHA-regulated increase in SAA1 expression via PKA-dependent mechanisms. Furthermore, the suppressive effect of DHA on triacylglycerol accumulation was abolished by H89 in SK-HEP-1 cells and adipocytes, indicating that DHA also reduces lipid accumulation via PKA. The observation of increased SAA1 expression coupled with reduced fat accumulation mediated by DHA via PKA suggests that SAA1 is involved in DHA-induced triacylglycerol breakdown. These findings provide new insights into the complicated regulatory network in DHA-mediated lipid metabolism and are useful in developing new approaches to reduce body fat deposition and fatty liver.	[Tai, Chen C.; Chen, Ching Y.; Wang, Ya C.; Mersamm, Harry J.; Ding, Shih T.; Wang, Pei H.] Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei 106, Taiwan; [Lee, Hsuan S.; Ding, Shih T.] Natl Taiwan Univ, Inst Biotechnol, Taipei 106, Taiwan; [Li, Tsai K.] Natl Taiwan Univ, Inst Microbiol, Taipei 106, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University	Ding, ST (corresponding author), Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei 106, Taiwan.	sding@ntu.edu.tw; demonwang@ntu.edu.tw		LI, TSAI-KUN/0000-0003-0393-2340; Ding, Shih-Torng/0000-0002-9866-1776; LEE, HSUAN-SHU/0000-0002-8017-0434; Chen, Ching-Yi/0000-0002-5776-084X	National Science Council in Taiwan; National Taiwan University [97R0066-43]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University)	This work was supported in part by the National Science Council in Taiwan and National Taiwan University (Grant 97R0066-43).	Anthonsen MW, 1998, J BIOL CHEM, V273, P215, DOI 10.1074/jbc.273.1.215; BETTS JC, 1993, J BIOL CHEM, V268, P25624; Botolin D, 2006, J LIPID RES, V47, P181, DOI 10.1194/jlr.M500365-JLR200; Bousserouel S, 2003, J LIPID RES, V44, P601, DOI 10.1194/jlr.M200092-JLR200; BROWN ER, 1994, LIPIDS, V29, P825, DOI 10.1007/BF02536249; Bucher HC, 2002, AM J MED, V112, P298, DOI 10.1016/S0002-9343(01)01114-7; Capanni M, 2006, ALIMENT PHARM THER, V23, P1143, DOI 10.1111/j.1365-2036.2006.02885.x; Chang WC, 2007, ASIAN AUSTRAL J ANIM, V20, P768, DOI 10.5713/ajas.2007.768; Chen CH, 2008, J NUTR, V138, P674, DOI 10.1093/jn/138.4.674; Chinery R, 1997, J BIOL CHEM, V272, P30356, DOI 10.1074/jbc.272.48.30356; Dentin R, 2005, J CLIN INVEST, V115, P2843, DOI 10.1172/JCI25256; Ding ST, 2002, IN VITRO CELL DEV-AN, V38, P352; DUBOIS M, 1993, J CARDIOVASC PHARM, V21, P522, DOI 10.1097/00005344-199304000-00003; Fickova M, 1998, J NUTR, V128, P512, DOI 10.1093/jn/128.3.512; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Guo W, 2005, LIPIDS, V40, P815, DOI 10.1007/s11745-005-1443-8; Hershko DD, 2002, AM J PHYSIOL-REG I, V283, pR1140, DOI 10.1152/ajpregu.00161.2002; Jensen LE, 1997, J IMMUNOL, V158, P384; Jump DB, 2008, CHEM PHYS LIPIDS, V153, P3, DOI 10.1016/j.chemphyslip.2008.02.007; Kim HK, 2006, J NUTR, V136, P2965, DOI 10.1093/jn/136.12.2965; Kunesova M, 2006, PHYSIOL RES, V55, P63, DOI 10.33549/physiolres.930770; Leinonen E, 2003, ATHEROSCLEROSIS, V166, P387, DOI 10.1016/S0021-9150(02)00371-4; Liu BH, 2005, J ANIM SCI, V83, P1516; Marchioli R, 2002, CIRCULATION, V105, P1897, DOI 10.1161/01.CIR.0000014682.14181.F2; METZ R, 1991, GENE DEV, V5, P1754, DOI 10.1101/gad.5.10.1754; Mies F, 2004, AM J PHYSIOL-RENAL, V287, pF850, DOI 10.1152/ajprenal.00078.2004; Nakatani T, 2003, J LIPID RES, V44, P369, DOI 10.1194/jlr.M200289-JLR200; Niehof M, 1997, MOL CELL BIOL, V17, P3600, DOI 10.1128/MCB.17.7.3600; Osada S, 1996, J BIOL CHEM, V271, P3891; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Picq M, 1996, J MOL CELL CARDIOL, V28, P2151, DOI 10.1006/jmcc.1996.0207; Ray A, 2003, J BIOL CHEM, V278, P22586, DOI 10.1074/jbc.M300705200; Ray A, 2002, DNA CELL BIOL, V21, P31, DOI 10.1089/10445490252810294; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Ruzickova J, 2004, LIPIDS, V39, P1177, DOI 10.1007/s11745-004-1345-9; Szentandrassy N, 2007, J PHYSIOL-LONDON, V582, P349, DOI 10.1113/jphysiol.2007.132753; Tanaka N, 2008, J CLIN GASTROENTEROL, V42, P413, DOI 10.1097/MCG.0b013e31815591aa; Tansey JT, 2003, J BIOL CHEM, V278, P8401, DOI 10.1074/jbc.M211005200; Thorn CF, 2002, J IMMUNOL, V169, P399, DOI 10.4049/jimmunol.169.1.399; WANG YC, 2009, J NUTR BIOC IN PRESS; Wu A, 2008, NEUROSCIENCE, V155, P751, DOI 10.1016/j.neuroscience.2008.05.061; Xu J, 1999, J BIOL CHEM, V274, P23577, DOI 10.1074/jbc.274.33.23577; Yamamoto T, 2007, J BIOL CHEM, V282, P11687, DOI 10.1074/jbc.M611911200; Yang RZ, 2006, PLOS MED, V3, P884, DOI 10.1371/journal.pmed.0030287; Yang Y, 2004, EUR RESPIR J, V24, P360, DOI 10.1183/09031936.04.00089703	45	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32239	32247		10.1074/jbc.M109.024661	http://dx.doi.org/10.1074/jbc.M109.024661			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19755416	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000272028400004
J	Liu, HY; Han, JM; Cao, SY; Hong, T; Zhuo, DG; Shi, JB; Liu, ZQ; Cao, WH				Liu, Hui-Yu; Han, Jianmin; Cao, Sophia Y.; Hong, Tao; Zhuo, Degen; Shi, Jianbo; Liu, Zhenqi; Cao, Wenhong			Hepatic Autophagy Is Suppressed in the Presence of Insulin Resistance and Hyperinsulinemia INHIBITION OF FoxO1-DEPENDENT EXPRESSION OF KEY AUTOPHAGY GENES BY INSULIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; HIGH-FAT DIET; PRIMARY HEPATOCYTES; SIGNALING PATHWAY; OXIDATIVE STRESS; THERAPEUTIC IMPLICATIONS; ENDOPLASMIC-RETICULUM; ALZHEIMERS-DISEASE; MITOCHONDRIAL-DNA; CAPILLARY DENSITY	Autophagy is essential for maintaining both survival and health of cells. Autophagy is normally suppressed by amino acids and insulin. It is unclear what happens to the autophagy activity in the presence of insulin resistance and hyperinsulinemia. In this study, we examined the autophagy activity in the presence of insulin resistance and hyperinsulinemia and the associated mechanism. Insulin resistance and hyperinsulinemia were induced in mice by a high fat diet, followed by measurements of autophagy markers. Our results show that autophagy was suppressed in the livers of mice with insulin resistance and hyperinsulinemia. Transcript levels of some key autophagy genes were also suppressed in the presence of insulin resistance and hyperinsulinemia. Conversely, autophagy activity was increased in the livers of mice with streptozotocin-induced insulin deficiency. Levels of vps34, atg12, and gabarapl1 transcripts were elevated in the livers of mice with insulin deficiency. To study the mechanism, autophagy was induced by nutrient deprivation or glucagon in cultured hepatocytes in the presence or absence of insulin. Autophagy activity and transcript levels of vps34, atg12, and gabarapl1 genes were reduced by insulin. The effect of insulin was largely prevented by overexpression of the constitutive nuclear form of FoxO1. Importantly, autophagy of mitochondria (mitophagy) in cultured cells was suppressed by insulin in the presence of insulin resistance. Together, our results show that autophagy activity and expression of some key autophagy genes were suppressed in the presence of insulin resistance and hyperinsulinemia. Insulin suppression of autophagy involves FoxO1-mediated transcription of key autophagy genes.	[Liu, Hui-Yu; Han, Jianmin; Cao, Sophia Y.; Hong, Tao; Zhuo, Degen; Cao, Wenhong] Hamner Inst Hlth Sci, Durham, NC 27709 USA; [Han, Jianmin; Shi, Jianbo] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Otolaryngol & Head & Neck Surg, Guangzhou 510080, Guangdong, Peoples R China; [Liu, Zhenqi] Univ Virginia Hlth Syst, Dept Med Endocrinol, Charlottesville, VA 22908 USA; [Cao, Wenhong] Duke Univ Hlth Syst, Dept Internal Med Endocrinol, Durham, NC 27705 USA	The Hamner Institutes for Health Sciences; Sun Yat Sen University; University of Virginia; Duke University	Cao, WH (corresponding author), Hamner Inst Hlth Sci, Res Triangle Pk, NC 27709 USA.	wcao@thehamner.org			National Institutes of Health [R01DK076039]; The Hamner Institutes; American Heart Association [SDG-0530244N]; American Diabetes Association [7-09-BS-27]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076039] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Hamner Institutes; American Heart Association(American Heart Association); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK076039 (to W. C.). This work was also supported by the Investigator Development Fund from The Hamner Institutes for Health Sciences (to W. C.), American Heart Association Grant SDG-0530244N (to W. C.), and American Diabetes Association Grant 7-09-BS-27 (to W. C.).	Accili D, 2004, DIABETES, V53, P1633, DOI 10.2337/diabetes.53.7.1633; Al-Shawwa BA, 2007, J ASTHMA, V44, P469, DOI 10.1080/02770900701423597; Arsham AM, 2006, CURR OPIN CELL BIOL, V18, P589, DOI 10.1016/j.ceb.2006.09.005; Bertrand L, 2008, CARDIOVASC RES, V79, P238, DOI 10.1093/cvr/cvn093; Bogacka I, 2005, DIABETES, V54, P1392, DOI 10.2337/diabetes.54.5.1392; Bulic B, 2009, ANGEW CHEM INT EDIT, V48, P1741, DOI 10.1002/anie.200802621; Burns JM, 2007, NEUROLOGY, V69, P1094, DOI 10.1212/01.wnl.0000276952.91704.af; Cao WH, 2005, J BIOL CHEM, V280, P42731, DOI 10.1074/jbc.M506223200; Cole GM, 2007, EXP GERONTOL, V42, P10, DOI 10.1016/j.exger.2006.08.009; Collins QF, 2007, J BIOL CHEM, V282, P30143, DOI 10.1074/jbc.M702390200; Collins QF, 2006, J BIOL CHEM, V281, P24336, DOI 10.1074/jbc.M602177200; Crowell JA, 2007, MOL CANCER THER, V6, P2139, DOI 10.1158/1535-7163.MCT-07-0120; Droge W, 2008, ANTIOXID REDOX SIGN, V10, P661, DOI 10.1089/ars.2007.1953; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Kumashiro N, 2008, DIABETES, V57, P2083, DOI 10.2337/db08-0144; Lee S, 2008, AM J PHYSIOL-ENDOC M, V294, pE261, DOI 10.1152/ajpendo.00676.2007; LENK SE, 1992, AM J PHYSIOL, V263, pE856, DOI 10.1152/ajpendo.1992.263.5.E856; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; LILLIOJA S, 1987, J CLIN INVEST, V80, P415, DOI 10.1172/JCI113088; Liu HY, 2008, J BIOL CHEM, V283, P30642, DOI 10.1074/jbc.M803698200; Liu HY, 2008, J BIOL CHEM, V283, P12056, DOI 10.1074/jbc.M801033200; Liu HY, 2007, J BIOL CHEM, V282, P14205, DOI 10.1074/jbc.M609701200; Liu HY, 2009, J BIOL CHEM, V284, P27090, DOI 10.1074/jbc.M109.016675; Liu HY, 2009, AM J PHYSIOL-ENDOC M, V297, pE898, DOI 10.1152/ajpendo.00374.2009; Liu HY, 2009, J BIOL CHEM, V284, P14087, DOI 10.1074/jbc.M807992200; Maassen JA, 2004, DIABETES, V53, pS103, DOI 10.2337/diabetes.53.2007.S103; Maassen JA, 2007, CURR OPIN CLIN NUTR, V10, P693, DOI 10.1097/MCO.0b013e3282f0b774; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; MARIN P, 1994, DIABETES CARE, V17, P382, DOI 10.2337/diacare.17.5.382; Martinez-Vicente M, 2007, LANCET NEUROL, V6, P352, DOI 10.1016/S1474-4422(07)70076-5; Matsuzawa-Nagata N, 2008, METABOLISM, V57, P1071, DOI 10.1016/j.metabol.2008.03.010; Meijer AJ, 2007, AUTOPHAGY, V3, P523; Moreira PI, 2007, J NEUROL SCI, V257, P206, DOI 10.1016/j.jns.2007.01.017; Okazaki Ryo, 2008, Clin Calcium, V18, P638, DOI CliCa0805638643; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Popa C, 2007, J LIPID RES, V48, P751, DOI 10.1194/jlr.R600021-JLR200; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; Sterry W, 2007, BRIT J DERMATOL, V157, P649, DOI 10.1111/j.1365-2133.2007.08068.x; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; Thuesen BH, 2009, CLIN EXP ALLERGY, V39, P700, DOI 10.1111/j.1365-2222.2008.03197.x; Tsiotra PC, 2006, ANN NY ACAD SCI, V1083, P63, DOI 10.1196/annals.1367.007; van der Valk M, 2004, ANTIVIR THER, V9, P385; Williams A, 2006, CURR TOP DEV BIOL, V76, P89, DOI 10.1016/S0070-2153(06)76003-3; Xiong Y, 2007, J BIOL CHEM, V282, P4975, DOI 10.1074/jbc.M606742200; Yin XM, 2008, HEPATOLOGY, V47, P1773, DOI 10.1002/hep.22146; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	50	285	304	1	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31484	31492		10.1074/jbc.M109.033936	http://dx.doi.org/10.1074/jbc.M109.033936			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19758991	hybrid, Green Published			2022-12-27	WOS:000271378400073
J	Muller, B; Prante, C; Kleesiek, K; Gotting, C				Mueller, Benjamin; Prante, Christian; Kleesiek, Knut; Goetting, Christian			Identification and Characterization of the Human Xylosyltransferase I Gene Promoter Region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; TRANSCRIPTION FACTORS; SP1 BINDING; EXTRACELLULAR-MATRIX; BIGLYCAN GENE; SP-FAMILY; XT-II; EXPRESSION; CELLS; PROTEOGLYCANS	Human xylosyltransferase I catalyzes the initial and rate-limiting step in the biosynthesis of glycosaminoglycans and proteoglycans. Furthermore, this enzyme has been shown to play a major role in the physiological development of bone and cartilage as well as in pathophysiological processes such as systemic sclerosis, dilated cardiomyopathy, or fibrosis. Here, we report for the first time the identification and characterization of the XYLT1 gene promoter region and important transcription factors involved in its regulation. Members of the activator protein 1 (AP-1) and specificity protein 1 (Sp1) family of transcription factors are necessary for the transcriptional regulation of the XYLT1 gene, which was proven by curcumin, tanshinone IIA, mithramycin A, and short interference RNA treatment. A stepwise 5' and 3' deletion of the predicted GC-rich promoter region, which lacks a TATA and/or CAAT box, revealed that a 531-bp core promoter element is able to drive the transcription on a basal level. A binding site for transcription factors of the AP-1 family, which is essential for full promoter activity, was identified by site-directed mutagenesis located 730 bp 5' of the translation initiation site. The ability of this site to bind members of the AP-1 family was further verified by electrophoretic mobility shift assays. A promoter element containing this binding site was able to drive the transcription to about 79-fold above control in SW1353 chondrosarcoma cells. Our findings provide a first insight into the regulation of the XYLT1 gene and may contribute to understanding the processes taking place during extracellular matrix formation and remodeling in health and disease.	[Mueller, Benjamin; Prante, Christian; Kleesiek, Knut; Goetting, Christian] Ruhr Univ Bochum, Inst Lab & Transfus Med, Herz & Diabet Zentrum Nordrhein W Falen, Univ Klin, D-32545 Bad Oeynhausen, Germany	Ruhr University Bochum	Prante, C (corresponding author), Ruhr Univ Bochum, Inst Lab & Transfus Med, Herz & Diabet Zentrum Nordrhein W Falen, Univ Klin, Georgstr 11, D-32545 Bad Oeynhausen, Germany.	cprante@hdz-nrw.de			Forschungsforderung an der Medizinischen Fakultat der Ruhr-Universitat Bochum (FoRUM) [F609-2007]	Forschungsforderung an der Medizinischen Fakultat der Ruhr-Universitat Bochum (FoRUM)	This work was supported by Forschungsforderung an der Medizinischen Fakultat der Ruhr-Universitat Bochum (FoRUM) Grant F609-2007.	BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; Bontemps Y, 2003, J BIOL CHEM, V278, P21566, DOI 10.1074/jbc.M209366200; Bouwman P, 2002, MOL CELL ENDOCRINOL, V195, P27, DOI 10.1016/S0303-7207(02)00221-6; Butler JEF, 2002, GENE DEV, V16, P2583, DOI 10.1101/gad.1026202; Cook T, 1999, ANN NY ACAD SCI, V880, P94, DOI 10.1111/j.1749-6632.1999.tb09513.x; FISHER LW, 1991, J BIOL CHEM, V266, P14371; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gotting C, 2007, CELL MOL LIFE SCI, V64, P1498, DOI 10.1007/s00018-007-7069-z; Goto T, 2006, J BONE MINER RES, V21, P661, DOI 10.1359/JBMR.020605; Gotting C, 1999, J INVEST DERMATOL, V112, P919, DOI 10.1046/j.1523-1747.1999.00590.x; Gotting C, 2000, J MOL BIOL, V304, P517, DOI 10.1006/jmbi.2000.4261; Heegaard AM, 2004, J CELL BIOCHEM, V93, P463, DOI 10.1002/jcb.20189; Hergenhahn M, 2002, MOL CARCINOGEN, V33, P137, DOI 10.1002/mc.10029; HUANG TS, 1991, P NATL ACAD SCI USA, V88, P5292, DOI 10.1073/pnas.88.12.5292; Huber R, 1998, GENE, V214, P35, DOI 10.1016/S0378-1119(98)00233-9; Hurtado A, 2008, BRAIN, V131, P2596, DOI 10.1093/brain/awn206; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; Jin UH, 2008, J CELL BIOCHEM, V104, P15, DOI 10.1002/jcb.21599; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; KEARNS AE, 1991, BIOCHEMISTRY-US, V30, P7477, DOI 10.1021/bi00244a016; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Lania L, 1997, INT J BIOCHEM CELL B, V29, P1313, DOI 10.1016/S1357-2725(97)00094-0; Li HX, 2004, BBA-GENE STRUCT EXPR, V1679, P141, DOI 10.1016/j.bbaexp.2004.06.004; Li L, 2004, BIOCHEM CELL BIOL, V82, P460, DOI 10.1139/O04-045; Matsuo N, 2006, J BIOL CHEM, V281, P5445, DOI 10.1074/jbc.M509923200; Mauviel A, 1996, J BIOL CHEM, V271, P24824, DOI 10.1074/jbc.271.40.24824; Muller B, 2008, MATRIX BIOL, V27, P139, DOI 10.1016/j.matbio.2007.09.005; Park S, 1999, B KOR CHEM SOC, V20, P925; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PONTICOS M, 2009, NUCL ACIDS IN PRESS; Prante C, 2007, J BIOL CHEM, V282, P26441, DOI 10.1074/jbc.M702299200; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Schon S, 2006, J BIOL CHEM, V281, P14224, DOI 10.1074/jbc.M510690200; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Vatsyayan J, 2005, J BIOCHEM, V137, P703, DOI 10.1093/jb/mvi082; Venkatesan N, 2009, FASEB J, V23, P813, DOI 10.1096/fj.08-118166; Verrecchia F, 2001, J INVEST DERMATOL, V116, P755, DOI 10.1046/j.1523-1747.2001.01326.x; Weilke C, 1997, CLIN CHEM, V43, P45; Zhu J, 2008, TRENDS GENET, V24, P481, DOI 10.1016/j.tig.2008.08.004	39	18	18	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30775	30782		10.1074/jbc.M109.016592	http://dx.doi.org/10.1074/jbc.M109.016592			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19762916	hybrid, Green Published			2022-12-27	WOS:000271378400005
J	Chung, NPY; Breun, SKJ; Bashirova, A; Baumann, JG; Martin, TD; Karamchandani, JM; Rausch, JW; Le Grice, SFJ; Wu, L; Carrington, M; KewalRamani, VN				Chung, Nancy P. Y.; Breun, Sabine K. J.; Bashirova, Arman; Baumann, Joerg G.; Martin, Thomas D.; Karamchandani, Jaideep M.; Rausch, Jason W.; Le Grice, Stuart F. J.; Wu, Li; Carrington, Mary; KewalRamani, Vineet N.			HIV-1 Transmission by Dendritic Cell-specific ICAM-3-grabbing Nonintegrin (DC-SIGN) Is Regulated by Determinants in the Carbohydrate Recognition Domain That Are Absent in Liver/Lymph Node-SIGN (L-SIGN)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; C-TYPE LECTIN; RESPIRATORY SYNDROME CORONAVIRUS; T-CELLS; ENDOTHELIAL-CELLS; ADHESION RECEPTOR; STRUCTURAL BASIS; TRANS-INFECTION; BINDING-SITES; DENGUE VIRUS	In this study, we identify determinants in dendritic cell-specific ICAM-3-grabbing nonintegrin (DC-SIGN) necessary for human immunodeficiency virus, type 1 (HIV-1), transmission. Although human B cell lines expressing DC-SIGN efficiently capture and transmit HIV-1 to susceptible target cells, cells expressing the related molecule liver/lymph node-specific ICAM-3-grabbing nonintegrin (L-SIGN) do not. To understand the differences between DC-SIGN and L-SIGN that affect HIV-1 interactions, we developed Raji B cell lines expressing different DC-SIGN/L-SIGN chimeras. Testing of the chimeras demonstrated that replacement of the DC-SIGN carbohydrate-recognition domain (CRD) with that of L-SIGN was sufficient to impair virus binding and prevent transmission. Conversely, the ability to bind and transmit HIV-1 was conferred to L-SIGN chimeras containing the DC-SIGN CRD. We identified Trp-258 in the DC-SIGN CRD to be essential for HIV-1 transmission. Although introduction of a K270W mutation at the same position in L-SIGN was insufficient for HIV-1 binding, an L-SIGN mutant molecule with K270W and a C-terminal DC-SIGN CRD subdomain transmitted HIV-1. These data suggest that DC-SIGN structural elements distinct from the oligosaccharide-binding site are required for HIV-1 glycoprotein selectivity.	[Chung, Nancy P. Y.; Martin, Thomas D.; Karamchandani, Jaideep M.; Rausch, Jason W.; Le Grice, Stuart F. J.; KewalRamani, Vineet N.] NCI, HIV Drug Resistance Program, NIH, Frederick, MD 21702 USA; [Breun, Sabine K. J.; Baumann, Joerg G.] Fraunhofer Inst Cell Therapy & Immunol, D-04103 Leipzig, Germany; [Bashirova, Arman; Carrington, Mary] NCI, Canc & Inflammat Program, Expt Immunol Lab, SAIC Frederick,NIH, Frederick, MD 21702 USA; [Wu, Li] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Fraunhofer Gesellschaft; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Medical College of Wisconsin	KewalRamani, VN (corresponding author), NCI, HIV Drug Resistance Program, NIH, 1050 Boyles St, Frederick, MD 21702 USA.	vineet@mail.nih.gov	Wu, Li/E-4330-2011; KewalRamani, Vineet/V-5084-2019; Wu, Li/ABB-2813-2020	Wu, Li/0000-0002-5468-2487; Wu, Li/0000-0002-5468-2487; Martin, Thomas/0000-0002-7491-8274	National Institutes of Health [HHSN261200800001E]; NCI Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010791, ZIABC010485] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant HHSN261200800001E from NCI, NCI Intramural Research Program, and NCI Center for Cancer Research.	Alvarez CP, 2002, J VIROL, V76, P6841, DOI 10.1128/JVI.76.13.6841-6844.2002; Arrighi JF, 2004, J EXP MED, V200, P1279, DOI 10.1084/jem.20041356; Arrighi JF, 2004, J VIROL, V78, P10848, DOI 10.1128/JVI.78.20.10848-10855.2004; Bashirova AA, 2001, J EXP MED, V193, P671, DOI 10.1084/jem.193.6.671; Biggins JE, 2004, VIROLOGY, V324, P194, DOI 10.1016/j.virol.2004.03.026; Chan VSF, 2006, NAT GENET, V38, P38, DOI 10.1038/ng1698; CURTIS BM, 1992, P NATL ACAD SCI USA, V89, P8356, DOI 10.1073/pnas.89.17.8356; Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006; Engering A, 2002, J IMMUNOL, V168, P2118, DOI 10.4049/jimmunol.168.5.2118; Feinberg H, 2005, J BIOL CHEM, V280, P1327, DOI 10.1074/jbc.M409925200; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Figdor CG, 2002, NAT REV IMMUNOL, V2, P77, DOI 10.1038/nri723; Geijtenbeek TBH, 1999, BLOOD, V94, P754, DOI 10.1182/blood.V94.2.754.414k11_754_764; Geijtenbeek TBH, 2002, J BIOL CHEM, V277, P11314, DOI 10.1074/jbc.M111532200; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Granelli-Piperno A, 2005, J IMMUNOL, V175, P4265, DOI 10.4049/jimmunol.175.7.4265; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; Gurney KB, 2005, J VIROL, V79, P5762, DOI 10.1128/JVI.79.9.5762-5773.2005; Halary F, 2002, IMMUNITY, V17, P653, DOI 10.1016/S1074-7613(02)00447-8; He B, 2006, J IMMUNOL, V176, P3931, DOI 10.4049/jimmunol.176.7.3931; Hong PWP, 2002, J VIROL, V76, P12855, DOI 10.1128/JVI.76.24.12855-12865.2002; Jeffers SA, 2004, P NATL ACAD SCI USA, V101, P15748, DOI 10.1073/pnas.0403812101; Lee B, 2001, J VIROL, V75, P12028, DOI 10.1128/JVI.75.24.12028-12038.2001; Lin G, 2003, J VIROL, V77, P1337, DOI 10.1128/JVI.77.2.1337-1346.2003; Lozach PY, 2004, J BIOL CHEM, V279, P32035, DOI 10.1074/jbc.M402296200; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Mitchell DA, 2001, J BIOL CHEM, V276, P28939, DOI 10.1074/jbc.M104565200; Pohlmann S, 2001, TRENDS IMMUNOL, V22, P643, DOI 10.1016/S1471-4906(01)02081-6; Pohlmann S, 2001, J VIROL, V75, P10523, DOI 10.1128/JVI.75.21.10523-10526.2001; Pohlmann S, 2001, J VIROL, V75, P4664, DOI 10.1128/JVI.75.10.4664-4672.2001; Pohlmann S, 2001, P NATL ACAD SCI USA, V98, P2670, DOI 10.1073/pnas.051631398; Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042; Rappocciolo G, 2006, PLOS PATHOG, V2, P691, DOI 10.1371/journal.ppat.0020070; Sanders RW, 2002, J VIROL, V76, P7812, DOI 10.1128/JVI.76.15.7812-7821.2002; Schaefer M, 2008, J IMMUNOL, V180, P6836, DOI 10.4049/jimmunol.180.10.6836; Snyder GA, 2005, J VIROL, V79, P4589, DOI 10.1128/JVI.79.8.4589-4598.2005; Soilleux EJ, 2002, J LEUKOCYTE BIOL, V71, P445; Soilleux EJ, 2000, J IMMUNOL, V165, P2937, DOI 10.4049/jimmunol.165.6.2937; Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840; Trumpfheller C, 2003, INT IMMUNOL, V15, P289, DOI 10.1093/intimm/dxg030; Turville SG, 2001, BLOOD, V98, P2482, DOI 10.1182/blood.V98.8.2482; Turville SG, 2002, NAT IMMUNOL, V3, P975, DOI 10.1038/ni841; van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182; Wang JH, 2007, J VIROL, V81, P2497, DOI 10.1128/JVI.01970-06; Wu L, 2004, VIROLOGY, V318, P17, DOI 10.1016/j.virol.2003.09.028; Wu L, 2002, J VIROL, V76, P5905, DOI 10.1128/JVI.76.12.5905-5914.2002; Wu L, 2006, NAT REV IMMUNOL, V6, P859, DOI 10.1038/nri1960; Wu Li, 2004, Retrovirology, V1, P14, DOI 10.1186/1742-4690-1-14; Yang ZY, 2004, J VIROL, V78, P5642, DOI 10.1128/JVI.78.11.5642-5650.2004	50	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					2100	2112		10.1074/jbc.M109.030619	http://dx.doi.org/10.1074/jbc.M109.030619			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19833723	Green Published, hybrid			2022-12-27	WOS:000273429100054
J	Germer, F; Zebger, I; Saggu, M; Lendzian, F; Schulz, R; Appel, J				Germer, Frauke; Zebger, Ingo; Saggu, Miguel; Lendzian, Friedhelm; Schulz, Ruediger; Appel, Jens			Overexpression, Isolation, and Spectroscopic Characterization of the Bidirectional [NiFe] Hydrogenase from Synechocystis sp PCC 6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RALSTONIA-EUTROPHA H16; DESULFOVIBRIO-GIGAS HYDROGENASE; RAY-STRUCTURE ANALYSIS; VULGARIS MIYAZAKI-F; ACTIVE-SITE; ALLOCHROMATIUM-VINOSUM; CRYSTAL-STRUCTURE; SP PCC-6803; SPECTROELECTROCHEMICAL CHARACTERIZATION; CHROMATIUM-VINOSUM	The bidirectional [NiFe] hydrogenase of the cyanobacterium Synechocystis sp. PCC 6803 was purified to apparent homogeneity by a single affinity chromatography step using a Synechocystis mutant with a Strep-tag II fused to the C terminus of HoxF. To increase the yield of purified enzyme and to test its overexpression capacity in Synechocystis the psbAII promoter was inserted upstream of the hoxE gene. In addition, the accessory genes (hypF, C, D, E, A, and B) from Nostoc sp. PCC 7120 were expressed under control of the psbAII promoter. The respective strains show higher hydrogenase activities compared with the wild type. For the first time a Fourier transform infrared (FTIR) spectroscopic characterization of a [NiFe] hydrogenase from an oxygenic phototroph is presented, revealing that two cyanides and one carbon monoxide coordinate the iron of the active site. At least four different redox states of the active site were detected during the reversible activation/inactivation. Although these states appear similar to those observed in standard [NiFe] hydrogenases, no paramagnetic nickel state could be detected in the fully oxidized and reduced forms. Electron paramagnetic resonance spectroscopy confirms the presence of several iron-sulfur clusters after reductive activation. One [4Fe4S](+) and at least one [2Fe2S](+) cluster could be identified. Catalytic amounts of NADH or NADPH are sufficient to activate the reaction of this enzyme with hydrogen.	[Appel, Jens] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Germer, Frauke; Schulz, Ruediger] Univ Kiel, Inst Bot, D-24118 Kiel, Germany; [Zebger, Ingo; Saggu, Miguel; Lendzian, Friedhelm] Tech Univ Berlin, Max Volmer Lab, D-10623 Berlin, Germany	Arizona State University; Arizona State University-Tempe; University of Kiel; Technical University of Berlin	Appel, J (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	jens.appel@asu.edu	Saggu, Miguel/B-1224-2009	Appel, Jens/0000-0002-0658-7899	Linde AG; foundation of the Universitat Kiel; state of Schleswig-Holstein; DFG; SFB 498	Linde AG; foundation of the Universitat Kiel; state of Schleswig-Holstein; DFG(German Research Foundation (DFG)); SFB 498	This work was supported by grants from Linde AG, the foundation of the Universitat Kiel and state of Schleswig-Holstein (to F. G.). We also acknowledge the DFG for financial support within the CoE "UniCat" (F. L.) and SFB 498 (I. Z., M. S., F. L.).	Appel J, 2000, ARCH MICROBIOL, V173, P333, DOI 10.1007/s002030000139; Appel J, 1996, BBA-PROTEIN STRUCT M, V1298, P141, DOI 10.1016/S0167-4838(96)00176-8; Appel J, 1998, J PHOTOCH PHOTOBIO B, V47, P1, DOI 10.1016/S1011-1344(98)00179-1; Armstrong FA, 2008, SCIENCE, V321, P498, DOI 10.1126/science.1161326; ASSO M, 1992, BIOCHIM BIOPHYS ACTA, V1122, P50, DOI 10.1016/0167-4838(92)90126-X; Bleijlevens B, 2004, J BIOL INORG CHEM, V9, P743, DOI 10.1007/s00775-004-0570-z; Bock A, 2006, ADV MICROB PHYSIOL, V51, P1, DOI 10.1016/S0065-2911(06)51001-X; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRYANT FO, 1989, J BIOL CHEM, V264, P5070; Buhrke T, 2005, J BIOL CHEM, V280, P23791, DOI 10.1074/jbc.M503260200; Burgdorf T, 2005, J BACTERIOL, V187, P3122, DOI 10.1128/JB.187.9.3122-3132.2005; COREMANS JMCC, 1992, BIOCHIM BIOPHYS ACTA, V1119, P157, DOI 10.1016/0167-4838(92)90386-R; Cournac L, 2004, J BACTERIOL, V186, P1737, DOI 10.1128/JB.186.6.1737-1746.2003; Cournac L, 2002, INT J HYDROGEN ENERG, V27, P1229, DOI 10.1016/S0360-3199(02)00105-2; De Lacey AL, 2007, CHEM REV, V107, P4304, DOI 10.1021/cr0501947; deLacey AL, 1997, J AM CHEM SOC, V119, P7181, DOI 10.1021/ja963802w; DeLacey AL, 2002, J BIOL INORG CHEM, V7, P318, DOI 10.1007/s00775-001-0301-7; FERNANDEZ VM, 1985, BIOCHIM BIOPHYS ACTA, V832, P69, DOI 10.1016/0167-4838(85)90175-X; Fichtner C, 2006, BIOCHEMISTRY-US, V45, P9706, DOI 10.1021/bi0602462; Garcin E, 1999, STRUCT FOLD DES, V7, P557, DOI 10.1016/S0969-2126(99)80072-0; Guigliarelli B, 1999, ADV INORG CHEM, V47, P421, DOI 10.1016/S0898-8838(08)60084-7; GUIGLIARELLI B, 1995, BIOCHEMISTRY-US, V34, P4781, DOI 10.1021/bi00014a036; Gutekunst K, 2005, MOL MICROBIOL, V58, P810, DOI 10.1111/j.1365-2958.2005.04867.x; Gutthann F, 2007, BBA-BIOENERGETICS, V1767, P161, DOI 10.1016/j.bbabio.2006.12.003; Happe RP, 2000, FEBS LETT, V466, P259, DOI 10.1016/S0014-5793(99)01799-8; Happe RP, 1997, NATURE, V385, P126, DOI 10.1038/385126a0; Higuchi Y, 1999, STRUCT FOLD DES, V7, P549, DOI 10.1016/S0969-2126(99)80071-9; Higuchi Y, 1997, STRUCTURE, V5, P1671, DOI 10.1016/S0969-2126(97)00313-4; Hiromoto T, 2009, ANGEW CHEM INT EDIT, V48, P6457, DOI 10.1002/anie.200902695; Hoffmann D, 2006, FEBS J, V273, P4516, DOI 10.1111/j.1742-4658.2006.05460.x; Huyett JE, 1997, J AM CHEM SOC, V119, P9291, DOI 10.1021/ja9700919; Jones AK, 2004, BIOCHEMISTRY-US, V43, P13467, DOI 10.1021/bi048837k; Kurkin S, 2004, BIOCHEMISTRY-US, V43, P6820, DOI 10.1021/bi049854c; Lai CH, 1998, J AM CHEM SOC, V120, P10103, DOI 10.1021/ja982053a; Long MN, 2007, J BIOL INORG CHEM, V12, P62, DOI 10.1007/s00775-006-0162-1; Lubitz W, 2007, CHEM REV, V107, P4331, DOI 10.1021/cr050186q; Ludwig M, 2006, J MOL EVOL, V63, P758, DOI 10.1007/s00239-006-0001-6; Mate Z, 1998, J BIOL CHEM, V273, P17439, DOI 10.1074/jbc.273.28.17439; MUKAI K, 1973, BIOCHIM BIOPHYS ACTA, V295, P49, DOI 10.1016/0005-2795(73)90072-X; Ogata H, 2005, STRUCTURE, V13, P1635, DOI 10.1016/j.str.2005.07.018; Ogata H, 2002, J AM CHEM SOC, V124, P11628, DOI 10.1021/ja012645k; Ohnishi T, 1998, BBA-BIOENERGETICS, V1364, P186, DOI 10.1016/S0005-2728(98)00027-9; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Saggu M, 2009, J BIOL CHEM, V284, P16264, DOI 10.1074/jbc.M805690200; Sambrook J., 2001, MOL CLONING LAB MANU; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schmitz O, 2002, BBA-BIOENERGETICS, V1554, P66, DOI 10.1016/S0005-2728(02)00214-1; SCHMITZ O, 1995, EUR J BIOCHEM, V233, P266, DOI 10.1111/j.1432-1033.1995.266_1.x; Schmitz O, 2001, MOL MICROBIOL, V41, P1409, DOI 10.1046/j.1365-2958.2001.02612.x; SCHNEIDER K, 1984, EUR J BIOCHEM, V142, P75, DOI 10.1111/j.1432-1033.1984.tb08252.x; Schroder O, 2007, J BIOL INORG CHEM, V12, P212, DOI 10.1007/s00775-006-0185-7; Schumann S, 2008, J BIOL CHEM, V283, P16602, DOI 10.1074/jbc.M709894200; Serebryakova LT, 1996, FEBS LETT, V383, P79, DOI 10.1016/0014-5793(96)00228-1; STESMANS A, 1989, REV SCI INSTRUM, V60, P2949, DOI 10.1063/1.1140633; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; SURERUS KK, 1994, BIOCHEMISTRY-US, V33, P4980, DOI 10.1021/bi00182a029; Tamagnini P, 2007, FEMS MICROBIOL REV, V31, P692, DOI 10.1111/j.1574-6976.2007.00085.x; van der Linden E, 2006, J BIOL INORG CHEM, V11, P247, DOI 10.1007/s00775-005-0075-4; Van der Linden E, 2004, J BIOL INORG CHEM, V9, P616, DOI 10.1007/s00775-004-0555-y; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Vignais PM, 2001, FEMS MICROBIOL REV, V25, P455, DOI 10.1111/j.1574-6976.2001.tb00587.x; Volbeda A, 2005, J BIOL INORG CHEM, V10, P239, DOI 10.1007/s00775-005-0632-x; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0; Volbeda A, 1996, J AM CHEM SOC, V118, P12989, DOI 10.1021/ja962270g; WANG R, 1971, PLANT PHYSIOL, V48, P108, DOI 10.1104/pp.48.1.108	65	48	61	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36462	36472		10.1074/jbc.M109.028795	http://dx.doi.org/10.1074/jbc.M109.028795			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19801638	Green Published, hybrid			2022-12-27	WOS:000272970500048
J	Li, B; Xi, HK; Diehl, L; Lee, WP; Sturgeon, L; Chinn, J; DeForge, L; Kelley, RF; Wiesmann, C; Campagne, MV; Sidhu, SS				Li, Bing; Xi, Hongkang; Diehl, Lauri; Lee, Wyne P.; Sturgeon, Lizette; Chinn, Jason; DeForge, Laura; Kelley, Robert F.; Wiesmann, Christian; Campagne, Menno van Lookeren; Sidhu, Sachdev S.			Improving Therapeutic Efficacy of a Complement Receptor by Structure-based Affinity Maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALTERNATIVE PATHWAY; CONFORMATIONAL-CHANGES; 2 PARTS; IMMUNOLOGY; CONVERTASE; ACTIVATION; ARTHRITIS; SELECTION; INSIGHTS; DISEASES	CRIg is a recently discovered complement C3 receptor expressed on a subpopulation of tissue-resident macrophages. The extracellular IgV domain of CRIg (CRIg-ECD) holds considerable promise as a potential therapeutic because it selectively inhibits the alternative pathway of complement by binding to C3b and inhibiting proteolytic activation of C3 and C5. However, CRIg binds weakly to the convertase subunit C3b (K-D = 1.1 mu M), and thus a relatively high concentration of protein is required to reach nearly complete complement inhibition. To improve therapeutic efficacy while minimizing risk of immunogenicity, we devised a phage display strategy to evolve a high affinity CRIg-ECD variant with a minimal number of mutations. Using the crystal structure of CRIg in complex with C3b as a guide for library design, we isolated a CRIg-ECD double mutant (Q64R/M86Y, CRIg-v27) that showed increased binding affinity and improved complement inhibitory activity relative to CRIg-ECD. In a mouse model of arthritis, treatment with a Fc fusion of CRIg-v27 resulted in a significant reduction in clinical scores compared with treatment with an Fc fusion of CRIg-ECD. This study clearly illustrates how phage display technology and structural information can be combined to generate proteins with nearly natural sequences that act as potent complement inhibitors with greatly improved therapeutic efficacy.	[Xi, Hongkang; Lee, Wyne P.; Campagne, Menno van Lookeren] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; [Kelley, Robert F.] Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA; [Diehl, Lauri] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Sturgeon, Lizette; Chinn, Jason; DeForge, Laura] Genentech Inc, Dept Assay & Automat Technol, San Francisco, CA 94080 USA; [Wiesmann, Christian] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA; [Sidhu, Sachdev S.] Univ Toronto, Banting & Best Dept Med Res, Dept Mol Genet, Toronto, ON M5S 3E1, Canada	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; University of Toronto	Campagne, MV (corresponding author), Genentech Inc, Dept Immunol, 1 DNA Way, San Francisco, CA 94080 USA.	menno@gene.com; sachdev.sidhu@utoronto.ca		Wiesmann, Christian/0000-0002-4092-9880				Barthelemy PA, 2008, J BIOL CHEM, V283, P3639, DOI 10.1074/jbc.M708536200; Fellouse FAS, 2007, MAKING USING ANTIBOD, P157; Gotze O, 1976, Adv Immunol, V24, P1, DOI 10.1016/S0065-2776(08)60328-4; Gros P, 2008, NAT REV IMMUNOL, V8, P48, DOI 10.1038/nri2231; Helmy KY, 2006, CELL, V124, P915, DOI 10.1016/j.cell.2005.12.039; Holers VM, 2008, IMMUNOL REV, V223, P300, DOI 10.1111/j.1600-065X.2008.00641.x; Janssen BJC, 2007, J BIOL CHEM, V282, P29241, DOI 10.1074/jbc.M704587200; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; Jha P, 2007, MOL IMMUNOL, V44, P3901, DOI 10.1016/j.molimm.2007.06.145; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Katschke KJ, 2007, J EXP MED, V204, P1319, DOI 10.1084/jem.20070432; Katschke KJ, 2009, J BIOL CHEM, V284, P10473, DOI 10.1074/jbc.M809106200; Kim DD, 2006, CLIN IMMUNOL, V118, P127, DOI 10.1016/j.clim.2005.10.014; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Maccioni M, 2002, J EXP MED, V195, P1071, DOI 10.1084/jem.20011941; MULLEREBERHARD HJ, 1972, J EXP MED, V135, P1003, DOI 10.1084/jem.135.4.1003; Ricklin D, 2007, NAT BIOTECHNOL, V25, P1265, DOI 10.1038/nbt1342; Sidhu SS, 2000, METHOD ENZYMOL, V328, P333, DOI 10.1016/S0076-6879(00)28406-1; Torreira E, 2009, P NATL ACAD SCI USA, V106, P882, DOI 10.1073/pnas.0810860106; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Wiesmann C, 2006, NATURE, V444, P217, DOI 10.1038/nature05263	23	8	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35605	35611		10.1074/jbc.M109.035170	http://dx.doi.org/10.1074/jbc.M109.035170			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19833734	Green Published, hybrid			2022-12-27	WOS:000272645600038
J	Kirby, JM; Ahern, H; Roberts, AK; Kumar, V; Freeman, Z; Acharya, KR; Shone, CC				Kirby, Jonathan M.; Ahern, Helen; Roberts, April K.; Kumar, Vivek; Freeman, Zoe; Acharya, K. Ravi; Shone, Clifford C.			Cwp84, a Surface-associated Cysteine Protease, Plays a Role in the Maturation of the Surface Layer of Clostridium difficile	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-LAYER; TOXIN-B; PROTEINS; GENOME; INFECTION; EPIDEMIC; HAMSTERS; SEQUENCE; DISEASE; STRAIN	Clostridium difficile is a major and growing problem as a hospital-associated infection that can cause severe, recurrent diarrhea. The mechanism by which the bacterium colonizes the gut during infection is poorly understood but undoubtedly involves protein components within the surface layer (S-layer), which play a role in adhesion. In C. difficile, the S-layer is composed of two principal components, the high and low molecular weight S-layer proteins, which are formed from the post-translational cleavage of a single precursor, SlpA. In the present study, we demonstrate that a recently characterized cysteine protease, Cwp84 plays a role in maturation of SlpA. Using a gene knockout approach, we show that inactivation of the Cwp84 gene in C. difficile 630 Delta Erm results in a bacterial phenotype in which only immature, single chain SlpA comprises the S-layer. The Cwp84 knock-out mutants (CD Delta Cwp84) displayed significantly different colony morphology compared with the wild-type strain and grew more slowly in liquid medium. SlpA extracted from CD Delta Cwp84 was readily cleaved into its mature subunits by trypsin treatment. Addition of trypsin to the growth medium also cleaved SlpA on CD Delta Cwp84 and increased the growth rate of the bacterium in a dose-dependent manner. Using the hamster model for C. difficile infection, CD Delta Cwp84 was found to be competent at causing disease with a similar pathology to the wild-type strain. The data show that whereas Cwp84 plays a role in the cleavage of SlpA, it is not an essential virulence factor and that bacteria expressing immature SlpA are able to cause disease.	[Kirby, Jonathan M.; Ahern, Helen; Roberts, April K.; Kumar, Vivek; Shone, Clifford C.] Hlth Protect Agcy, Res Dept, Salisbury SP4 0JQ, Wilts, England; [Kirby, Jonathan M.; Freeman, Zoe; Acharya, K. Ravi] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	Health Protection Agency; University of Bath	Shone, CC (corresponding author), Hlth Protect Agcy, Res Dept, Salisbury SP4 0JQ, Wilts, England.	cliff.shone@hpa.org.uk	Roberts, April/AAD-7330-2019	Acharya, K. Ravi/0000-0002-3009-4058	Health Protection Agency studentship; United Kingdom Department of Health	Health Protection Agency studentship; United Kingdom Department of Health	This work was supported by a Health Protection Agency studentship ( to J. M. K.) and the United Kingdom Department of Health.	Babcock GJ, 2006, INFECT IMMUN, V74, P6339, DOI 10.1128/IAI.00982-06; Bartlett JG, 2006, ANN INTERN MED, V145, P758, DOI 10.7326/0003-4819-145-10-200611210-00008; Borriello SP, 1998, J ANTIMICROB CHEMOTH, V41, P13, DOI 10.1093/jac/41.suppl_3.13; Brazier JS, 2008, BRIT J BIOMED SCI, V65, P39, DOI 10.1080/09674845.2008.11732796; Calabi E, 2002, J BACTERIOL, V184, P3886, DOI 10.1128/JB.184.14.3886-3897.2002; Calabi E, 2001, MOL MICROBIOL, V40, P1187, DOI 10.1046/j.1365-2958.2001.02461.x; Carter GP, 2007, J BACTERIOL, V189, P7290, DOI 10.1128/JB.00731-07; Cerquetti M, 2000, MICROB PATHOGENESIS, V28, P363, DOI 10.1006/mpat.2000.0356; Davis Ian J., 2005, P37; Deneve C, 2008, J MED MICROBIOL, V57, P732, DOI 10.1099/jmm.0.47676-0; Desvaux M, 2006, FEMS MICROBIOL LETT, V256, P1, DOI 10.1111/j.1574-6968.2006.00122.x; Egerer M, 2009, J BIOL CHEM, V284, P3389, DOI 10.1074/jbc.M806002200; Emerson JE, 2009, MOL MICROBIOL, V74, P541, DOI 10.1111/j.1365-2958.2009.06812.x; Fagan RP, 2009, MOL MICROBIOL, V71, P1308, DOI 10.1111/j.1365-2958.2009.06603.x; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Hussain HA, 2005, J MED MICROBIOL, V54, P137, DOI 10.1099/jmm.0.45790-0; Janoir C, 2007, J BACTERIOL, V189, P7174, DOI 10.1128/JB.00578-07; Karjalainen T, 2002, J CLIN MICROBIOL, V40, P2452, DOI 10.1128/JCM.40.7.2452-2458.2002; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; Navaneethan U, 2008, Minerva Gastroenterol Dietol, V54, P451; Ni Eidhin D, 2006, J MED MICROBIOL, V55, P69, DOI 10.1099/jmm.0.46204-0; Purdy D, 2002, MOL MICROBIOL, V46, P439, DOI 10.1046/j.1365-2958.2002.03134.x; ROBERTS AK, 1992, ACTA PAEDIATR, V81, P119, DOI 10.1111/j.1651-2227.1992.tb12186.x; Sambol SP, 2001, J INFECT DIS, V183, P1760, DOI 10.1086/320736; Sara M, 2000, J BACTERIOL, V182, P859, DOI 10.1128/JB.182.4.859-868.2000; Savariau-Lacomme MP, 2003, J BACTERIOL, V185, P4461, DOI 10.1128/JB.185.15.4461-4470.2003; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Waligora AJ, 2001, INFECT IMMUN, V69, P2144, DOI 10.1128/IAI.69.4.2144-2153.2001; Wright A, 2005, PROTEOMICS, V5, P2443, DOI 10.1002/pmic.200401179; Wright A, 2008, J MED MICROBIOL, V57, P750, DOI 10.1099/jmm.0.47532-0	32	83	87	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34666	34673		10.1074/jbc.M109.051177	http://dx.doi.org/10.1074/jbc.M109.051177			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19808679	hybrid, Green Published			2022-12-27	WOS:000272439600022
J	Das, B; Heimeier, RA; Buchholz, DR; Shi, YB				Das, Biswajit; Heimeier, Rachel A.; Buchholz, Daniel R.; Shi, Yun-Bo			Identification of Direct Thyroid Hormone Response Genes Reveals the Earliest Gene Regulation Programs during Frog Metamorphosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOIC ACID RECEPTORS; BETA-A GENE; XENOPUS-LAEVIS; MATRIX-METALLOPROTEINASE; TRANSCRIPTIONAL ACTIVATION; EXPRESSION PROGRAM; DUAL FUNCTIONS; IN-VIVO; STROMELYSIN-3; ELEMENT	Thyroid hormone (T3) is essential for normal development and organ function throughout vertebrates. Its effects are mainly mediated through transcriptional regulation by T3 receptor (TR). The identification and characterization of the immediate early, direct target genes are thus of critical importance in understanding the molecular pathways induced by T3. Unfortunately, this has been hampered by the difficulty to study gene regulation by T3 in uterus-enclosed mammalian embryos. Here we used Xenopus metamorphosis as a model for vertebrate postembryonic development to identify direct T3 response genes in vivo. We took advantage of the ability to easily induce metamorphosis with physiological levels of T3 and to carry out microarray analysis in Xenopus laevis and genome-wide sequence analysis in Xenopus tropicalis. This allowed us to identify 188 up-regulated and 249 down-regulated genes by T3 in the absence of new protein synthesis in whole animals. We further provide evidence to show that these genes contain functional TREs that are bound by TR in tadpoles and that their promoters are regulated by TR in vivo. More importantly, gene ontology analysis showed that the direct up-regulated genes are enriched in categories important for transcriptional regulation and protein degradation-dependent signaling processes but not DNA replication. Our findings thus revealed the existence of interesting pathways induced by T3 at the earliest step of metamorphosis.	[Das, Biswajit; Heimeier, Rachel A.; Shi, Yun-Bo] Eunice Kennedy Shriver NICHD, Sect Mol Morphogenesis, Lab Gene Regulat & Dev, Program Cellular Regulat & Metab,NIH, Bethesda, MD 20892 USA; [Buchholz, Daniel R.] Univ Cincinnati, Dept Biol Sci, Cincinnati, OH 45221 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University System of Ohio; University of Cincinnati	Shi, YB (corresponding author), NICHD, Lab Gene Regulat & Dev, Program Cellular Regulat & Metab, NIH, Bldg 18T,Rm 106, Rockville, MD 20852 USA.	shi@helix.nih.gov		Shi, Yun-Bo/0000-0002-6330-0639	National Institutes of Health Intramural Research Program of NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001901] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program of NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of NICHD.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Amano T, 2002, DEV DYNAM, V223, P526, DOI 10.1002/dvdy.10075; [Anonymous], 1989, STORY IODINE DEFICIE; Anselmo J, 2004, JAMA-J AM MED ASSOC, V292, P691, DOI 10.1001/jama.292.6.691; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brown DD, 2007, DEV BIOL, V306, P20, DOI 10.1016/j.ydbio.2007.03.021; Buchholz DR, 2007, DEV BIOL, V303, P576, DOI 10.1016/j.ydbio.2006.11.037; Buchholz DR, 2004, GENE EXPR PATTERNS, V4, P321, DOI 10.1016/j.modgep.2003.10.005; Buchholz DR, 2006, GEN COMP ENDOCR, V145, P1, DOI 10.1016/j.ygcen.2005.07.009; Buchholz DR, 2005, J BIOL CHEM, V280, P41222, DOI 10.1074/jbc.M509593200; Buchholz DR, 2004, MOL CELL BIOL, V24, P9026, DOI 10.1128/MCB.24.20.9026-9037.2004; Cai LQ, 2007, DEV BIOL, V304, P260, DOI 10.1016/j.ydbio.2006.12.031; Das B, 2006, DEV BIOL, V291, P342, DOI 10.1016/j.ydbio.2005.12.032; Davis PJ, 1996, THYROID, V6, P497, DOI 10.1089/thy.1996.6.497; de Escobar GA, 2007, PUBLIC HEALTH NUTR, V10, P1554, DOI 10.1017/S1368980007360928; de Escobar GM, 2004, BEST PRACT RES CL EN, V18, P225, DOI 10.1016/j.beem.2004.03.012; Denver RJ, 1997, J BIOL CHEM, V272, P8179, DOI 10.1074/jbc.272.13.8179; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Franklyn JA, 1996, TRENDS ENDOCRIN MET, V7, P50, DOI 10.1016/1043-2760(95)00227-8; FREAKE HC, 1995, ANNU REV NUTR, V15, P263, DOI 10.1146/annurev.nu.15.070195.001403; Fu LZ, 2006, J BIOL CHEM, V281, P16870, DOI 10.1074/jbc.M603041200; Fu LZ, 2005, J BIOL CHEM, V280, P27856, DOI 10.1074/jbc.M413275200; Fu LZ, 2002, MOL REPROD DEV, V62, P470, DOI 10.1002/mrd.10137; Furlow JD, 2002, ENDOCRINOLOGY, V143, P3295, DOI 10.1210/en.2002-220126; Gilbert L.I., 1996, METAMORPHOSIS POSTEM; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Hasebe T, 2006, CELL TISSUE RES, V324, P105, DOI 10.1007/s00441-005-0099-7; Havis E, 2003, EMBO REP, V4, P883, DOI 10.1038/sj.embor.embor908; Howdeshell KL, 2002, ENVIRON HEALTH PERSP, V110, P337, DOI 10.1289/ehp.02110s3337; Hsu JH, 1998, TRENDS ENDOCRIN MET, V9, P103, DOI 10.1016/S1043-2760(98)00026-5; Ishizuya-Oka A, 2000, J CELL BIOL, V150, P1177, DOI 10.1083/jcb.150.5.1177; Ishizuya-Oka A, 2001, CELL TISSUE RES, V303, P187, DOI 10.1007/s004410000291; IshizuyaOka A, 1997, DEV GENET, V20, P329, DOI 10.1002/(SICI)1520-6408(1997)20:4<329::AID-DVG4>3.0.CO;2-9; KANAMORI A, 1992, J BIOL CHEM, V267, P739; KUROKAWA R, 1993, GENE DEV, V7, P1423, DOI 10.1101/gad.7.7b.1423; LAZAR MA, 1993, ENDOCR REV, V14, P184, DOI 10.1210/er.14.2.184; Mathew S, 2009, J BIOL CHEM, V284, P18545, DOI 10.1074/jbc.M109.017723; Matsuda H, 2009, MOL CELL BIOL, V29, P745, DOI 10.1128/MCB.00827-08; PATTERTON D, 1995, DEV BIOL, V167, P252, DOI 10.1006/dbio.1995.1021; Paul BD, 2005, J BIOL CHEM, V280, P27165, DOI 10.1074/jbc.M503999200; Paul BD, 2005, MOL CELL BIOL, V25, P5712, DOI 10.1128/MCB.25.13.5712-5724.2005; Paul BD, 2007, J BIOL CHEM, V282, P7472, DOI 10.1074/jbc.M607589200; PORTERFIELD SP, 1993, ENDOCR REV, V14, P94, DOI 10.1210/er.14.1.94; Puzianowska-Kuznicka M, 1996, J BIOL CHEM, V271, P6273, DOI 10.1074/jbc.271.11.6273; Puzianowska-Kuznicka M, 1997, MOL CELL BIOL, V17, P4738, DOI 10.1128/MCB.17.8.4738; RANJAN M, 1994, J BIOL CHEM, V269, P24699; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Ryu S, 2006, CELL CYCLE, V5, P1140, DOI 10.4161/cc.5.11.2779; Sachs LM, 2000, P NATL ACAD SCI USA, V97, P13138, DOI 10.1073/pnas.260141297; Sachs LM, 2000, COMP BIOCHEM PHYS B, V126, P199, DOI 10.1016/S0305-0491(00)00198-X; Sato Y, 2007, MECH DEVELOP, V124, P476, DOI 10.1016/j.mod.2007.03.006; Shi Y.-B., 1999, AMPHIBIAN METAMORPHO; Shi YB, 1996, BIOESSAYS, V18, P391, DOI 10.1002/bies.950180509; SHI YB, 1994, DEV BIOL, V161, P48, DOI 10.1006/dbio.1994.1006; SHI YB, 1993, J BIOL CHEM, V268, P20312; SHI YB, 1996, METAMORPHOSIS POSTEM; Shi YB, 2009, THYROID, V19, P987, DOI 10.1089/thy.2009.0041; Silva JE, 1995, THYROID, V5, P481, DOI 10.1089/thy.1995.5.481; TATA JR, 1968, DEV BIOL, V18, P415, DOI 10.1016/0012-1606(68)90050-X; TATA JR, 1993, BIOESSAYS, V15, P239, DOI 10.1002/bies.950150404; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; Walsh LA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001000; Wang XD, 2008, ENDOCRINOLOGY, V149, P5610, DOI 10.1210/en.2008-0751; WANG Z, 1993, J BIOL CHEM, V268, P16270; WONG JM, 1995, J BIOL CHEM, V270, P18479, DOI 10.1074/jbc.270.31.18479; WONG JM, 1995, GENE DEV, V9, P2696, DOI 10.1101/gad.9.21.2696; Wong JM, 1998, J BIOL CHEM, V273, P14186, DOI 10.1074/jbc.273.23.14186; YAOITA Y, 1990, GENE DEV, V4, P1917, DOI 10.1101/gad.4.11.1917; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28	72	74	74	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34167	34178		10.1074/jbc.M109.066084	http://dx.doi.org/10.1074/jbc.M109.066084			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19801647	hybrid, Green Published			2022-12-27	WOS:000272165200049
J	Du, YZ; Nomura, Y; Liu, ZQ; Huang, ZY; Dong, K				Du, Yuzhe; Nomura, Yoshiko; Liu, Zhiqi; Huang, Zachary Y.; Dong, Ke			Functional Expression of an Arachnid Sodium Channel Reveals Residues Responsible for Tetrodotoxin Resistance in Invertebrate Sodium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IONIC CURRENTS; POLYORCHIS-PENICILLATUS; CONFERS TETRODOTOXIN; HYDROZOAN JELLYFISH; GENE; DROSOPHILA; DIVERSITY; NEURONS; INSENSITIVITY; MECHANISMS	Tetrodotoxin (TTX) is a potent blocker of voltage-gated sodium channels, but not all sodium channels are equally sensitive to inhibition by TTX. The molecular basis of differential TTX sensitivity of mammalian sodium channels has been largely elucidated. In contrast, our knowledge about the sensitivity of invertebrate sodium channels to TTX remains poor, in part because of limited success in functional expression of these channels. In this study, we report the functional characterization in Xenopus oocytes of the first non-insect, invertebrate voltage-gated sodium channel from the varroa mite (Varroa destructor), an ecto-parasite of the honeybee. This arachnid sodium channel activates and inactivates rapidly with half-maximal activation at -18 mV and half-maximal fast inactivation at -29 mV. Interestingly, this arachnid channel showed surprising TTX resistance. TTX blocked this channel with an IC50 of 1 mu M. Subsequent site-directed mutagenesis revealed two residues, Thr-1674 and Ser-1967, in the pore-forming region of domains III and IV, respectively, which were responsible for the observed resistance to inhibition by TTX. Furthermore, sequence comparison and additional amino acid substitutions suggested that sequence polymorphisms at these two positions could be a widespread mechanism for modulating TTX sensitivity of sodium channels in diverse invertebrates.	[Dong, Ke] Michigan State Univ, Dept Entomol, Genet Program, E Lansing, MI 48824 USA; Michigan State Univ, Dept Entomol, Neurosci Program, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Dong, K (corresponding author), Michigan State Univ, Dept Entomol, Genet Program, E Lansing, MI 48824 USA.	dongk@msu.edu	Huang, Zachary/D-5485-2011	Huang, Zachary/0000-0001-5354-5547	National Institutes of Health [GM057440]; United States Department of Agriculture Cooperative State Research, Education and Extension Service [2004-35607-14866]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture Cooperative State Research, Education and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM057440 and National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education and Extension Service Grant 2004-35607-14866.	ANDERSON PAV, 1987, J EXP BIOL, V133, P231; BACKX PH, 1992, SCIENCE, V257, P248, DOI 10.1126/science.1321496; BLAIR KL, 1993, J EXP BIOL, V185, P267; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Dib-Hajj S, 2002, TRENDS NEUROSCI, V25, P253, DOI 10.1016/S0166-2236(02)02150-1; Dong Ke, 2007, Invertebrate Neuroscience, V7, P17, DOI 10.1007/s10158-006-0036-9; FENG GP, 1995, CELL, V82, P1001, DOI 10.1016/0092-8674(95)90279-1; Geffeney S, 2002, SCIENCE, V297, P1336, DOI 10.1126/science.1074310; Geffeney SL, 2005, NATURE, V434, P759, DOI 10.1038/nature03444; Goldin AL, 2002, J EXP BIOL, V205, P575; Goldin AL, 1999, ANN NY ACAD SCI, V868, P38, DOI 10.1111/j.1749-6632.1999.tb11272.x; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; HILLE B, 1992, IONIC CHANNELS EXCIT, P59; KLEINHAUS AL, 1995, J NEUROBIOL, V27, P419, DOI 10.1002/neu.480270313; Liu ZQ, 2004, P NATL ACAD SCI USA, V101, P11862, DOI 10.1073/pnas.0307695101; LOUGHNEY K, 1989, CELL, V58, P1143, DOI 10.1016/0092-8674(89)90512-6; MEECH RW, 1993, J NEUROPHYSIOL, V69, P884, DOI 10.1152/jn.1993.69.3.884; Nagahora H, 2000, BIOCHEM BIOPH RES CO, V275, P558, DOI 10.1006/bbrc.2000.3290; NARAHASHI T, 1964, J GEN PHYSIOL, V47, P965, DOI 10.1085/jgp.47.5.965; NODA M, 1989, FEBS LETT, V259, P213, DOI 10.1016/0014-5793(89)81531-5; Olson RO, 2008, INSECT BIOCHEM MOLEC, V38, P604, DOI 10.1016/j.ibmb.2008.01.003; SATIN J, 1992, SCIENCE, V256, P1202, DOI 10.1126/science.256.5060.1202; Schlief T, 1996, EUR BIOPHYS J BIOPHY, V25, P75, DOI 10.1007/s002490050020; Sivilotti L, 1997, FEBS LETT, V409, P49, DOI 10.1016/S0014-5793(97)00479-1; SODERLUND DM, 2006, SODIUM CHANNEL COMPR, V5, P1; Song WZ, 2004, J BIOL CHEM, V279, P32554, DOI 10.1074/jbc.M402392200; Soong TW, 2006, TRENDS GENET, V22, P621, DOI 10.1016/j.tig.2006.08.010; Spafford JD, 1996, J EXP BIOL, V199, P941; Spafford JD, 1998, BIOCHEM BIOPH RES CO, V244, P772, DOI 10.1006/bbrc.1998.8332; Tan J, 2002, INSECT BIOCHEM MOLEC, V32, P445, DOI 10.1016/S0965-1748(01)00122-9; Tan JG, 2005, MOL PHARMACOL, V67, P513, DOI 10.1124/mol.104.006205; Tan JG, 2002, J NEUROSCI, V22, P5300; TERLAU H, 1991, FEBS LETT, V293, P93, DOI 10.1016/0014-5793(91)81159-6; Venkatesh B, 2005, CURR BIOL, V15, P2069, DOI 10.1016/j.cub.2005.10.068; Wang RW, 2003, INSECT BIOCHEM MOLEC, V33, P733, DOI 10.1016/S0965-1748(03)00068-7; Zhou W, 2004, NEURON, V42, P101, DOI 10.1016/S0896-6273(04)00148-5	36	25	27	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33869	33875		10.1074/jbc.M109.045690	http://dx.doi.org/10.1074/jbc.M109.045690			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19828457	Green Published, hybrid			2022-12-27	WOS:000272165200019
J	Frizzell, KM; Gamble, MJ; Berrocal, JG; Zhang, T; Krishnakumar, R; Cen, Y; Sauve, AA; Kraus, WL				Frizzell, Kristine M.; Gamble, Matthew J.; Berrocal, Jhoanna G.; Zhang, Tong; Krishnakumar, Raga; Cen, Yana; Sauve, Anthony A.; Kraus, W. Lee			Global Analysis of Transcriptional Regulation by Poly(ADP-ribose) Polymerase-1 and Poly(ADP-ribose) Glycohydrolase in MCF-7 Human Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; ADP-RIBOSE POLYMERASE; GENE-EXPRESSION; CHROMATIN-STRUCTURE; DNA-BINDING; P-VALUE; PARP-1; ACTIVATION; CLONING	Poly(ADP-ribose) polymerase-1 (PARP-1) and poly(ADP-ribose) glycohydrolase (PARG) are enzymes that modify target proteins by the addition and removal, respectively, of ADP-ribose polymers. Although a role for PARP-1 in gene regulation has been well established, the role of PARG is less clear. To investigate how PARP-1 and PARG coordinately regulate global patterns of gene expression, we used short hairpin RNAs to stably knock down PARP-1 or PARG in MCF-7 cells followed by expression microarray analyses. Correlation analyses showed that the majority of genes affected by the knockdown of one factor were similarly affected by the knockdown of the other factor. The most robustly regulated common genes were enriched for stress-response and metabolic functions. In chromatin immunoprecipitation assays, PARP-1 and PARG localized to the promoters of positively and negatively regulated target genes. The levels of chromatin-bound PARG at a given promoter generally correlated with the levels of PARP-1 across the subset of promoters tested. For about half of the genes tested, the binding of PARP-1 at the promoter was dependent on the binding of PARG. Experiments using stable re-expression of short hairpin RNA-resistant catalytic mutants showed that PARP-1 and PARG enzymatic activities are required for some, but not all, target genes. Collectively, our results indicate that PARP-1 and PARG, nuclear enzymes with opposing enzymatic activities, localize to target promoters and act in a similar, rather than antagonistic, manner to regulate gene expression.	[Frizzell, Kristine M.; Gamble, Matthew J.; Berrocal, Jhoanna G.; Zhang, Tong; Krishnakumar, Raga; Kraus, W. Lee] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Frizzell, Kristine M.; Berrocal, Jhoanna G.; Krishnakumar, Raga; Kraus, W. Lee] Cornell Univ, Grad Field Biochem Mol & Cell Biol, Ithaca, NY 14853 USA; [Cen, Yana; Sauve, Anthony A.; Kraus, W. Lee] Cornell Univ, Dept Pharmacol, Weill Med Coll, New York, NY 10021 USA	Cornell University; Cornell University; Cornell University	Kraus, WL (corresponding author), Cornell Univ, Dept Mol Biol & Genet, 465 Biotechnol Bldg, Ithaca, NY 14853 USA.	wlk5@cornell.edu	Cen, Yana/F-4731-2014	Cen, Yana/0000-0001-6436-5744; Krishnakumar, Raga/0000-0002-2479-754X	National Institutes of Health [DK069710]; Endocrine Society; Cornell University Nanobiotechnology Center; National Science Foundation [ECS-9876771]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069710, R56DK069710] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Endocrine Society; Cornell University Nanobiotechnology Center; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK069710 throughout the NIDDK ( to W. L. K.). This work was also supported by a grant from the Endocrine Society ( to W. L. K.) and the Cornell University Nanobiotechnology Center, a Science and Technology Centers Program of the National Science Foundation (Agreement Number ECS-9876771).	Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Anderson MG, 2000, J VIROL, V74, P2169, DOI 10.1128/JVI.74.5.2169-2177.2000; Bonicalzi ME, 2003, BIOL CELL, V95, P635, DOI 10.1016/j.biolcel.2003.10.003; Butler AJ, 1999, MOL CELL BIOL, V19, P296; Cervellera MN, 2000, J BIOL CHEM, V275, P10692, DOI 10.1074/jbc.275.14.10692; Conde C, 2001, EMBO J, V20, P3535, DOI 10.1093/emboj/20.13.3535; Cortes U, 2004, MOL CELL BIOL, V24, P7163, DOI 10.1128/MCB.24.16.7163-7178.2004; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Davidovic L, 2001, EXP CELL RES, V268, P7, DOI 10.1006/excr.2001.5263; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; deSouza N, 2007, J CELL BIOL, V179, P923, DOI 10.1083/jcb.200708200; Dey BR, 1998, J BIOL CHEM, V273, P24095, DOI 10.1074/jbc.273.37.24095; Dow GS, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-4; Fisher AEO, 2007, MOL CELL BIOL, V27, P5597, DOI 10.1128/MCB.02248-06; Gagne JP, 2009, J PROTEOME RES, V8, P1014, DOI 10.1021/pr800810n; Gao H, 2007, EXP CELL RES, V313, P984, DOI 10.1016/j.yexcr.2006.12.025; Hanai S, 2004, P NATL ACAD SCI USA, V101, P82, DOI 10.1073/pnas.2237114100; Hassa PO, 1999, BIOL CHEM, V380, P953, DOI 10.1515/BC.1999.118; Hassa PO, 2001, J BIOL CHEM, V276, P45588, DOI 10.1074/jbc.M106528200; Hassa PO, 2002, CELL MOL LIFE SCI, V59, P1534, DOI 10.1007/s00018-002-8527-2; Hess A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-96; Inoue T, 1998, J NEUROSCI, V18, P5366, DOI 10.1523/JNEUROSCI.18-14-05366.1998; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Karras GI, 2005, EMBO J, V24, P1911, DOI 10.1038/sj.emboj.7600664; Kauppinen TM, 2006, P NATL ACAD SCI USA, V103, P7136, DOI 10.1073/pnas.0508606103; Keil C, 2006, J BIOL CHEM, V281, P34394, DOI 10.1074/jbc.M606470200; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Kininis M, 2007, MOL CELL BIOL, V27, P5090, DOI 10.1128/MCB.00083-07; Koh DW, 2004, P NATL ACAD SCI USA, V101, P17699, DOI 10.1073/pnas.0406182101; KOTHS K, 1993, J BIOL CHEM, V268, P14245; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Kun E, 2004, BIOCHEMISTRY-US, V43, P210, DOI 10.1021/bi0301791; Kun E, 2002, J BIOL CHEM, V277, P39066, DOI 10.1074/jbc.C200410200; Kustatscher G, 2005, NAT STRUCT MOL BIOL, V12, P624, DOI 10.1038/nsmb956; Leclerc D, 1996, HUM MOL GENET, V5, P1867, DOI 10.1093/hmg/5.12.1867; Li YN, 1996, HUM MOL GENET, V5, P1851, DOI 10.1093/hmg/5.12.1851; Lonskaya I, 2005, J BIOL CHEM, V280, P17076, DOI 10.1074/jbc.M413483200; Mabley JG, 2001, BRIT J PHARMACOL, V133, P909, DOI 10.1038/sj.bjp.0704156; MARSISCHKY GT, 1995, J BIOL CHEM, V270, P3247, DOI 10.1074/jbc.270.7.3247; Mathieu J, 2008, ONCOGENE, V27, P3361, DOI 10.1038/sj.onc.1210997; Meisterernst M, 1997, P NATL ACAD SCI USA, V94, P2261, DOI 10.1073/pnas.94.6.2261; Meyer-Ficca ML, 2005, INT J BIOCHEM CELL B, V37, P920, DOI 10.1016/j.biocel.2004.09.011; Meyer-Ficca ML, 2004, EXP CELL RES, V297, P521, DOI 10.1016/j.yexcr.2004.03.050; Minamoto S, 1997, BIOCHEM BIOPH RES CO, V237, P79, DOI 10.1006/bbrc.1997.7080; Miyamoto T, 1999, MOL CELL BIOL, V19, P2644; Morrison C, 1997, NAT GENET, V17, P479, DOI 10.1038/ng1297-479; Murphy D, 2002, ADV PHYSIOL EDUC, V26, P256, DOI 10.1152/advan.00043.2002; Nirodi C, 2001, J BIOL CHEM, V276, P9366, DOI 10.1074/jbc.M009897200; Oei SL, 2001, BIOCHEM BIOPH RES CO, V284, P450, DOI 10.1006/bbrc.2001.4985; OGATA N, 1981, J BIOL CHEM, V256, P4135; Ogino H, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-41; Ohashi S, 2003, BIOCHEM BIOPH RES CO, V307, P915, DOI 10.1016/S0006-291X(03)01272-5; Oliver FJ, 1999, EMBO J, V18, P4446, DOI 10.1093/emboj/18.16.4446; Pavri R, 2005, MOL CELL, V18, P83, DOI 10.1016/j.molcel.2005.02.034; Potaman VN, 2005, J MOL BIOL, V348, P609, DOI 10.1016/j.jmb.2005.03.010; Rapizzi E, 2004, MOL PHARMACOL, V66, P890, DOI 10.1124/mol.104.000968; Rolli V, 1997, BIOCHEMISTRY-US, V36, P12147, DOI 10.1021/bi971055p; Rolli V., 2000, DNA DAMAGE STRESS SI, P35; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Shah RG, 2005, BIOCHEM BIOPH RES CO, V331, P167, DOI 10.1016/j.bbrc.2005.03.135; Shimokawa T, 1999, J BIOCHEM-TOKYO, V126, P748, DOI 10.1093/oxfordjournals.jbchem.a022512; Simbulan-Rosenthal CM, 2000, P NATL ACAD SCI USA, V97, P11274, DOI 10.1073/pnas.200285797; Simbulan-Rosenthal CM, 1999, MOL CELL BIOCHEM, V193, P137, DOI 10.1023/A:1006988832729; St-Laurent JF, 2007, DNA REPAIR, V6, P329, DOI 10.1016/j.dnarep.2006.10.027; Tinari N, 2001, INT J CANCER, V91, P167, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1022>3.3.CO;2-Q; Tong WM, 2001, MOL CELL BIOL, V21, P4046, DOI 10.1128/MCB.21.12.4046-4054.2001; Tulin A, 2003, SCIENCE, V299, P560, DOI 10.1126/science.1078764; Tulin A, 2006, GENETICS, V172, P363, DOI 10.1534/genetics.105.049239; Tulin A, 2002, GENE DEV, V16, P2108, DOI 10.1101/gad.1003902; Tulin A, 2003, CURR TOP DEV BIOL, V56, P55, DOI 10.1016/S0070-2153(03)01007-X; Wacker David A, 2007, Subcell Biochem, V41, P45; Wacker DA, 2007, MOL CELL BIOL, V27, P7475, DOI 10.1128/MCB.01314-07; Wang ZQ, 1997, GENE DEV, V11, P2347, DOI 10.1101/gad.11.18.2347; WANG ZQ, 1995, GENE DEV, V9, P509, DOI 10.1101/gad.9.5.509; WATKINS D, 1989, AM J MED GENET, V34, P427, DOI 10.1002/ajmg.1320340320; YAMADA N, 1994, BIOCHEM J, V302, P781, DOI 10.1042/bj3020781; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yang TL, 2006, AAPS J, V8, pE632, DOI 10.1208/aapsj080472; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zhang T, 2009, J BIOL CHEM, V284, P20408, DOI 10.1074/jbc.M109.016469; Zingarelli B, 2003, MOL MED, V9, P143, DOI 10.1007/BF03402179; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904	87	94	100	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33926	33938		10.1074/jbc.M109.023879	http://dx.doi.org/10.1074/jbc.M109.023879			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19812418	Green Published, hybrid			2022-12-27	WOS:000272165200025
J	Han, YY; Eppinger, E; Schuster, IG; Weigand, LU; Liang, XL; Kremmer, E; Peschel, C; Krackhardt, AM				Han, Yanyan; Eppinger, Elfriede; Schuster, Ingrid G.; Weigand, Luise U.; Liang, Xiaoling; Kremmer, Elisabeth; Peschel, Christian; Krackhardt, Angela M.			Formin-like 1 (FMNL1) Is Regulated by N-terminal Myristoylation and Induces Polarized Membrane Blebbing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIAPHANOUS-RELATED FORMIN; AUTOREGULATORY DOMAIN; ACTIN-FILAMENTS; CELL MOTILITY; MOUSE FORMIN; FRL-ALPHA; PROTEIN; MDIA1; RHO; IDENTIFICATION	The formin protein formin-like 1 (FMNL1) is highly restrictedly expressed in hematopoietic lineage-derived cells and has been previously identified as a tumor-associated antigen. However, function and regulation of FMNL1 are not well defined. We have identified a novel splice variant (FMNL1 gamma) containing an intron retention at the C terminus affecting the diaphanous autoinhibitory domain (DAD). FMNL1 gamma is specifically located at the cell membrane and cortex in diverse cell lines. Similar localization of FMNL1 was observed for a mutant lacking the DAD domain (FMNL1 Delta DAD), indicating that deregulation of autoinhibition is effective in FMNL1 gamma. Expression of both FMNL1 gamma and FMNL1 Delta DAD induces polarized nonapoptotic blebbing that is dependent on N-terminal myristoylation of FMNL1 but independent of Src and ROCK activity. Thus, our results describe N-myristoylation as a regulative mechanism of FMNL1 responsible for membrane trafficking potentially involved in a diversity of polarized processes of hematopoietic lineage-derived cells.	[Han, Yanyan; Eppinger, Elfriede; Schuster, Ingrid G.; Weigand, Luise U.; Liang, Xiaoling; Kremmer, Elisabeth; Krackhardt, Angela M.] Helmholtz Zentrum Munchen, Natl Res Ctr Environm & Hlth, Inst Mol Immunol, D-81377 Munich, Germany; [Peschel, Christian; Krackhardt, Angela M.] Tech Univ Munich, Klinikum Rechts Isar, Med Klin 3, D-81675 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Technical University of Munich	Krackhardt, AM (corresponding author), Helmholtz Zentrum Munchen, Natl Res Ctr Environm & Hlth, Inst Mol Immunol, Marchioninistr 25, D-81377 Munich, Germany.	HTUangela.krackhardt@helmholtz-muenchen.deUTH		Liang, Xiaoling/0000-0002-0572-5188	Deutsche Forschungsgemeinschaft [KR2305/3-1]; Helmholtz Zentrum Munchen; Life Science Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Helmholtz Zentrum Munchen(Helmholtz Association); Life Science Stiftung	This work was supported by Deutsche Forschungsgemeinschaft Grant KR2305/3-1, the Helmholtz Zentrum Munchen, and the Life Science Stiftung.	Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Copeland SJ, 2007, J BIOL CHEM, V282, P30120, DOI 10.1074/jbc.M703834200; CROSS FR, 1984, MOL CELL BIOL, V4, P1834, DOI 10.1128/MCB.4.9.1834; Eisenmann KM, 2007, CURR BIOL, V17, P579, DOI 10.1016/j.cub.2007.03.024; Evangelista M, 1997, SCIENCE, V276, P118, DOI 10.1126/science.276.5309.118; Faix J, 2006, DEV CELL, V10, P693, DOI 10.1016/j.devcel.2006.05.001; Gasman S, 2003, NAT CELL BIOL, V5, P195, DOI 10.1038/ncb935; Gomez TS, 2007, IMMUNITY, V26, P177, DOI 10.1016/j.immuni.2007.01.008; Hannemann S, 2008, J BIOL CHEM, V283, P27891, DOI 10.1074/jbc.M801800200; Harris ES, 2004, J BIOL CHEM, V279, P20076, DOI 10.1074/jbc.M312718200; Higgs HN, 2005, MOL BIOL CELL, V16, P1, DOI 10.1091/mbc.E04-07-0565; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; KAMPS MP, 1985, P NATL ACAD SCI USA, V82, P4625, DOI 10.1073/pnas.82.14.4625; Kitzing TM, 2007, GENE DEV, V21, P1478, DOI 10.1101/gad.424807; Krackhardt AM, 2002, BLOOD, V100, P2123, DOI 10.1182/blood-2002-02-0513; Lammers M, 2008, J BIOL CHEM, V283, P35236, DOI 10.1074/jbc.M805634200; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nezami AG, 2006, STRUCTURE, V14, P257, DOI 10.1016/j.str.2005.12.003; Otomo T, 2005, MOL CELL, V18, P273, DOI 10.1016/j.molcel.2005.04.002; PAIGE LA, 1990, BIOCHEMISTRY-US, V29, P10566, DOI 10.1021/bi00498a021; Rose R, 2005, NATURE, V435, P513, DOI 10.1038/nature03604; Schuster IG, 2007, BLOOD, V110, P2931, DOI 10.1182/blood-2006-11-058750; Seth A, 2006, J CELL BIOL, V174, P701, DOI 10.1083/jcb.200605006; Seykora JT, 1996, J BIOL CHEM, V271, P18797, DOI 10.1074/jbc.271.31.18797; Tournaviti S, 2007, J CELL SCI, V120, P3820, DOI 10.1242/jcs.011130; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Watanabe N, 2004, EXP CELL RES, V301, P16, DOI 10.1016/j.yexcr.2004.08.020; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Yayoshi-Yamamoto S, 2000, MOL CELL BIOL, V20, P6872, DOI 10.1128/MCB.20.18.6872-6881.2000; Zigmond SH, 2004, CURR OPIN CELL BIOL, V16, P99, DOI 10.1016/j.ceb.2003.10.019	33	47	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33409	33417		10.1074/jbc.M109.060699	http://dx.doi.org/10.1074/jbc.M109.060699			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19815554	Green Published, hybrid			2022-12-27	WOS:000272028500047
J	Lonne, GK; Masoumi, KC; Lennartsson, J; Larsson, C				Lonne, Gry Kalstad; Masoumi, Katarzyna Chmielarska; Lennartsson, Johan; Larsson, Christer			Protein Kinase C delta Supports Survival of MDA-MB-231 Breast Cancer Cells by Suppressing the ERK1/2 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY-TUMOR CELLS; PROTEOLYTIC ACTIVATION; PKC-EPSILON; INDUCED APOPTOSIS; REGULATORY DOMAIN; ONCOGENIC RAS; MCF-7 CELLS; DEATH; PHOSPHORYLATION; NEUROBLASTOMA	Mechanisms that mediate apoptosis resistance are attractive therapeutic targets for cancer. Protein kinase C delta (PKC delta) is considered a pro-apoptotic factor in many cell types. In breast cancer, however, it has shown both pro-survival and pro-apoptotic effects. Here, we report for the first time that down-regulation of PKC delta per se leads to apoptosis of MDA-MB-231 cells. Inhibition of MEK1/2 by either PD98059 or U0126 suppressed the induction of apoptosis of PKC delta-depleted MDA-MB-231 cells but did not support survival of MCF-7 or MDA-MB-468 cells. Basal ERK1/2 phosphorylation was substantially higher in MDA-MB-231 cells than in the other cell lines. PKC delta depletion led to even higher ERK1/2 phosphorylation levels and also to lower expression levels of the ERK1/2 phosphatase MKP3. Depletion of MKP3 led to apoptosis and higher levels of ERK1/2 phosphorylation, suggesting that this may be a mechanism mediating the effect of PKC delta down-regulation. However, PKC delta silencing also induced increased MEK1/2 phosphorylation, indicating that PKC delta regulates ERK1/2 phosphorylation both upstream and downstream. Moreover, PKC delta silencing led to increased levels of the E3 ubiquitin ligase Nedd4, which is a potential regulator of MKP3, because down-regulation led to increased MKP3 levels. Our results highlight PKC delta as a potential target for therapy of breast cancers with high activity of the ERK1/2 pathway.	[Larsson, Christer] Lund Univ, Malmo Univ Hosp, Dept Lab Med, Ctr Mol Pathol, SE-20502 Malmo, Sweden; [Lonne, Gry Kalstad; Masoumi, Katarzyna Chmielarska; Larsson, Christer] Lund Univ, Dept Lab Med, Ctr Mol Pathol, SE-20502 Malmo, Sweden; [Lennartsson, Johan] Uppsala Univ, Ludwig Inst Canc Res, SE-75124 Uppsala, Sweden	Lund University; Skane University Hospital; Lund University; Ludwig Institute for Cancer Research; Uppsala University	Larsson, C (corresponding author), Lund Univ, Malmo Univ Hosp, Dept Lab Med, Ctr Mol Pathol, Entrance 78,3rd Floor, SE-20502 Malmo, Sweden.	christer.larsson@med.lu.se		Masoumi, Katarzyna/0000-0002-9277-6505	Swedish Cancer Society; Swedish Research Council; Children's Cancer Foundation of Sweden; Malmo University Hospital Research Funds; Kock Foundation; Crafoord Foundation; Ollie and Elof Ericsson Foundation; Gunnar Nilsson Foundation	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Children's Cancer Foundation of Sweden(Swedish Cancer Society); Malmo University Hospital Research Funds; Kock Foundation; Crafoord Foundation; Ollie and Elof Ericsson Foundation(Ericsson); Gunnar Nilsson Foundation	This work was supported by grants from The Swedish Cancer Society, The Swedish Research Council, The Children's Cancer Foundation of Sweden, Malmo University Hospital Research Funds, and the Kock, Crafoord, Ollie and Elof Ericsson, and Gunnar Nilsson Foundations.	Alonso-Escolano D, 2006, J PHARMACOL EXP THER, V318, P373, DOI 10.1124/jpet.106.103358; Basu A, 2002, J BIOL CHEM, V277, P41850, DOI 10.1074/jbc.M205997200; Basu A, 1999, BIOCHEMISTRY-US, V38, P4245, DOI 10.1021/bi982854q; Basu A, 2001, BIOCHEM BIOPH RES CO, V280, P883, DOI 10.1006/bbrc.2000.4209; Blass M, 2002, MOL CELL BIOL, V22, P182, DOI 10.1128/MCB.22.1.182-195.2002; Brodie C, 2003, APOPTOSIS, V8, P19, DOI 10.1023/A:1021640817208; Chen C, 2007, CANCER METAST REV, V26, P587, DOI 10.1007/s10555-007-9091-x; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Emoto Y, 1995, EMBO J, V14, P6148, DOI 10.1002/j.1460-2075.1995.tb00305.x; Ghayur T, 1996, J EXP MED, V184, P2399, DOI 10.1084/jem.184.6.2399; Grossoni VC, 2007, MOL CARCINOGEN, V46, P381, DOI 10.1002/mc.20287; Hoppe J, 2001, EXP CELL RES, V266, P64, DOI 10.1006/excr.2001.5211; Jurek A, 2009, J BIOL CHEM, V284, P4626, DOI 10.1074/jbc.M808490200; Keyse SM, 2008, CANCER METAST REV, V27, P253, DOI 10.1007/s10555-008-9123-1; Kiley SC, 1999, ONCOGENE, V18, P6748, DOI 10.1038/sj.onc.1203101; Kiley SC, 1999, CANCER RES, V59, P3230; Koriyama H, 1999, CELL SIGNAL, V11, P831, DOI 10.1016/S0898-6568(99)00055-8; KOZMA SC, 1987, NUCLEIC ACIDS RES, V15, P5963; Lee YJ, 2003, BBA-MOL CELL RES, V1593, P219, DOI 10.1016/S0167-4889(02)00392-0; Lu DM, 2007, APOPTOSIS, V12, P1893, DOI 10.1007/s10495-007-0111-7; Marchetti S, 2005, MOL CELL BIOL, V25, P854, DOI 10.1128/MCB.25.2.854-864.2005; Mayo MW, 1997, SCIENCE, V278, P1812, DOI 10.1126/science.278.5344.1812; McCracken MA, 2003, MOL CANCER THER, V2, P273; Mirzoeva OK, 2009, CANCER RES, V69, P565, DOI 10.1158/0008-5472.CAN-08-3389; Mooi WJ, 2006, NEW ENGL J MED, V355, P1037, DOI 10.1056/NEJMra062285; Nabha SM, 2005, ONCOGENE, V24, P3166, DOI 10.1038/sj.onc.1208502; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; Okhrimenko H, 2005, CANCER RES, V65, P7301, DOI 10.1158/0008-5472.CAN-05-1064; Pan Q, 2005, CANCER RES, V65, P8366, DOI 10.1158/0008-5472.CAN-05-0553; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Pedram A, 2006, MOL BIOL CELL, V17, P2125, DOI 10.1091/mbc.E05-11-1013; Pettersson F, 2004, ONCOGENE, V23, P7053, DOI 10.1038/sj.onc.1207956; Reyland ME, 2007, BIOCHEM SOC T, V35, P1001, DOI 10.1042/BST0351001; Schmitt CA, 2003, NAT REV CANCER, V3, P286, DOI 10.1038/nrc1044; Schultz A, 2003, CELL DEATH DIFFER, V10, P662, DOI 10.1038/sj.cdd.4401235; Sivaprasad U, 2007, CELL DEATH DIFFER, V14, P851, DOI 10.1038/sj.cdd.4402077; Tang DM, 2002, J BIOL CHEM, V277, P12710, DOI 10.1074/jbc.M111598200; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Wang XT, 2000, J BIOL CHEM, V275, P39435, DOI 10.1074/jbc.M004583200; Warmka JK, 2004, J BIOL CHEM, V279, P33085, DOI 10.1074/jbc.M403120200; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Xia SH, 2007, J BIOL CHEM, V282, P13199, DOI 10.1074/jbc.M610225200; Yonekawa H, 2008, FEBS J, V275, P4005, DOI 10.1111/j.1742-4658.2008.06558.x; Zeidan YH, 2008, FASEB J, V22, P183, DOI 10.1096/fj.07-8967com; Zeidman R, 1999, J CELL BIOL, V145, P713, DOI 10.1083/jcb.145.4.713; Zhang JD, 2005, J CELL BIOCHEM, V96, P522, DOI 10.1002/jcb.20535	46	41	42	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33456	33465		10.1074/jbc.M109.036186	http://dx.doi.org/10.1074/jbc.M109.036186			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19833733	Green Published, hybrid			2022-12-27	WOS:000272028500052
J	Praporski, S; Ng, SM; Nguyen, AD; Corbin, CJ; Mechler, A; Zheng, J; Conley, AJ; Martin, LL				Praporski, Slavica; Ng, Su May; Nguyen, Ann D.; Corbin, C. Jo; Mechler, Adam; Zheng, Jie; Conley, Alan J.; Martin, Lisandra L.			Organization of Cytochrome P450 Enzymes Involved in Sex Steroid Synthesis PROTEIN-PROTEIN INTERACTIONS IN LIPID MEMBRANES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUARTZ-CRYSTAL MICROBALANCE; ATOMIC-FORCE MICROSCOPY; MOLECULE HEIGHT MEASUREMENTS; PHOSPHOLIPID-BILAYER DISKS; ESTROGEN SYNTHESIS; P450 REDUCTASE; AROMATASE CYTOCHROME-P450; MAMMALIAN AROMATASES; COMPLEX-FORMATION; ESCHERICHIA-COLI	Mounting evidence underscores the importance of protein-protein interactions in the functional regulation of drug-metabolizing P450s, but few studies have been conducted in membrane environments, and none have examined P450s catalyzing sex steroid synthesis. Here we report specific protein-protein interactions for full-length, human, wild type steroidogenic cytochrome P450 (P450, CYP) enzymes: 17 alpha-hydroxylase/17,20-lyase (P450c17, CYP17) and aromatase (P450arom, CYP19), as well as their electron donor NADPH-cytochrome P450 oxidoreductase (CPR). Fluorescence resonance energy transfer (FRET) 3 in live cells, coupled with quartz crystal microbalance (QCM), and atomic force microscopy (AFM) studies on phosphatidyl choline +/- cholesterol (mammalian) biomimetic membranes were used to investigate steroidogenic P450 interactions. The FRET results in living cells demonstrated that both P450c17 and P450arom homodimerize but do not heterodimerize, although they each heterodimerize with CPR. The lack of heteroassociation between P450c17 and P450arom was confirmed by QCM, wherein neither enzyme bound a membrane saturated with the other. In contrast, the CPR bound readily to either P450c17- or P450arom-saturated surfaces. Interestingly, N-terminally modified P450arom was stably incorporated and gave similar results to the wild type, although saturation was achieved with much less protein, suggesting that the putative transmembrane domain is not required for membrane association but for orientation. In fact, all of the proteins were remarkably stable in the membrane, such that high resolution AFM images were obtained, further supporting the formation of P450c17, P450arom, and CPR homodimers and oligomers in lipid bilayers. This unique combination of in vivo and in vitro studies has provided strong evidence for homodimerization and perhaps some higher order interactions for both P450c17 and P450arom.	[Nguyen, Ann D.; Corbin, C. Jo; Conley, Alan J.] Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA; [Praporski, Slavica; Ng, Su May; Mechler, Adam; Martin, Lisandra L.] Monash Univ, Sch Chem, Clayton, Vic 3800, Australia; [Zheng, Jie] Univ Calif Davis, Sch Med, Dept Physiol, Davis, CA 95616 USA	University of California System; University of California Davis; Monash University; University of California System; University of California Davis	Conley, AJ (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA.	ajconley@ucdavis.edu; Lisa.Martin@sci.monash.edu.au	Martin, Lisandra L/E-4482-2010; Mechler, Adam/C-5777-2009; Praporski, Slavica/ABA-6323-2020	Martin, Lisandra L/0000-0003-0486-5813; Mechler, Adam/0000-0002-6428-6760; Conley, Alan/0000-0003-3798-7390; Praporski, Slavica/0000-0003-1891-759X	Australian Research Council; National Health & Medical Research Council; National Institutes of Health [HD-048797]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD048797] Funding Source: NIH RePORTER	Australian Research Council(Australian Research Council); National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by funds from the Australian Research Council (to L. L. M. and A. M.), the National Health & Medical Research Council (to L. L. M.), and National Institutes of Health Grant HD-048797 (to A.J.C.).	Asakura N, 2003, ANAL BIOCHEM, V314, P153, DOI 10.1016/S0003-2697(02)00642-5; Backes WL, 2003, PHARMACOL THERAPEUT, V98, P221, DOI 10.1016/S0163-7258(03)00031-7; BARNES HJ, 1991, P NATL ACAD SCI USA, V88, P5597, DOI 10.1073/pnas.88.13.5597; Bayburt TH, 1998, J STRUCT BIOL, V123, P37, DOI 10.1006/jsbi.1998.4007; Bayburt TH, 2000, LANGMUIR, V16, P5993, DOI 10.1021/la991449c; Bayburt TH, 2002, P NATL ACAD SCI USA, V99, P6725, DOI 10.1073/pnas.062565599; Caruso F, 1997, J COLLOID INTERF SCI, V186, P129, DOI 10.1006/jcis.1996.4625; Civjan NR, 2003, BIOTECHNIQUES, V35, P556, DOI 10.2144/03353rr02; Conley A, 2001, REPRODUCTION, V121, P685, DOI 10.1530/rep.0.1210685; CONLEY AJ, 1990, BAILLIERE CLIN ENDOC, V4, P249, DOI 10.1016/S0950-351X(05)80050-3; Corbin CJ, 2003, MOL CELL ENDOCRINOL, V206, P147, DOI 10.1016/S0303-7207(02)00422-7; Corbin CJ, 2003, BIOL REPROD, V69, P390, DOI 10.1095/biolreprod.103.015578; Davydov DR, 2008, EXPERT OPIN DRUG MET, V4, P1523, DOI 10.1517/17425250802500028 ; Denisov IG, 2009, PHARMACOL THERAPEUT, V124, P151, DOI 10.1016/j.pharmthera.2009.05.011; DICZFALUSY E, 1984, J STEROID BIOCHEM, V20, P945, DOI 10.1016/0022-4731(84)90002-5; ENGEL LL, 1973, HDB PHYSL, P467; Estavillo C, 2003, BIOPHYS CHEM, V104, P291, DOI 10.1016/S0301-4622(02)00383-6; Fleming BD, 2008, LANGMUIR, V24, P323, DOI 10.1021/la702511w; Fredriksson C, 1998, LANGMUIR, V14, P248, DOI 10.1021/la971005l; Ghosh D, 2009, NATURE, V457, P219, DOI 10.1038/nature07614; Glasmastar K, 2002, J COLLOID INTERF SCI, V246, P40, DOI 10.1006/jcis.2001.8060; GRAHAMLORENCE S, 1995, PROTEIN SCI, V4, P1065, DOI 10.1002/pro.5560040605; GUENGERICH FP, 2003, 12 N AM ISSX M; GUT J, 1983, J BIOL CHEM, V258, P8588; HILLIER SG, 1994, MOL CELL ENDOCRINOL, V100, P51, DOI 10.1016/0303-7207(94)90278-X; Hlavica P, 2003, J INORG BIOCHEM, V96, P279, DOI 10.1016/S0162-0134(03)00152-1; Hook F, 2001, ANAL CHEM, V73, P5796, DOI 10.1021/ac0106501; Hook F, 1998, J COLLOID INTERF SCI, V208, P63, DOI 10.1006/jcis.1998.5774; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; Johnson DL, 2006, J MOL ENDOCRINOL, V36, P349, DOI 10.1677/jme.1.01971; Johnson DL, 2005, J AM CHEM SOC, V127, P2018, DOI 10.1021/ja045084g; Kagawa N, 2004, STEROIDS, V69, P235, DOI 10.1016/j.steroids.2004.01.002; Kaufman ED, 2007, LANGMUIR, V23, P6053, DOI 10.1021/la063725a; KAWATO S, 1982, J BIOL CHEM, V257, P7023; Kiselyova OI, 1999, ARCH BIOCHEM BIOPHYS, V371, P1, DOI 10.1006/abbi.1999.1412; Kuznetsov VY, 2004, PROTEOMICS, V4, P2390, DOI 10.1002/pmic.200300751; Mechler A, 2007, BIOPHYS J, V93, P3907, DOI 10.1529/biophysj.107.116525; Mechler A, 2009, BIOMATERIALS, V30, P682, DOI 10.1016/j.biomaterials.2008.10.016; Moran FM, 2002, ENDOCRINOLOGY, V143, P3361, DOI 10.1210/en.2002-220329; Muguruma H, 2006, J PHYS CHEM B, V110, P26033, DOI 10.1021/jp063755m; MYASOEDOVA KN, 1990, FEBS LETT, V275, P235, DOI 10.1016/0014-5793(90)81479-8; NAKAJIN S, 1981, J STEROID BIOCHEM, V14, P1249, DOI 10.1016/0022-4731(81)90328-9; Nath A, 2007, BIOCHEMISTRY-US, V46, P2059, DOI 10.1021/bi602371n; Ozalp C, 2005, DRUG METAB DISPOS, V33, P1382, DOI 10.1124/dmd.105.005538; Schenkman JB, 2001, ARCH BIOCHEM BIOPHYS, V385, P78, DOI 10.1006/abbi.2000.2140; Schuler G, 2006, REPRODUCTION, V131, P669, DOI 10.1530/rep.1.01033; Shen ZH, 2007, ANAL CHEM, V79, P1283, DOI 10.1021/ac061211a; Szczesna-Skorupa E, 2003, J BIOL CHEM, V278, P31269, DOI 10.1074/jbc.M301489200; Takanishi CL, 2006, BRAIN RES, V1091, P132, DOI 10.1016/j.brainres.2006.01.119; TAMURA T, 1992, J ENDOCRINOL, V135, P589, DOI 10.1677/joe.0.1350589; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; Yamazaki T, 1998, BIOCHEMISTRY-US, V37, P2800, DOI 10.1021/bi9715066	52	44	46	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33224	33232		10.1074/jbc.M109.006064	http://dx.doi.org/10.1074/jbc.M109.006064			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19805543	hybrid, Green Published			2022-12-27	WOS:000272028500027
J	Tsiang, M; Jones, GS; Hung, M; Mukund, S; Han, B; Liu, XH; Babaoglu, K; Lansdon, E; Chen, X; Todd, J; Cai, T; Pagratis, N; Sakowicz, R; Geleziunas, R				Tsiang, Manuel; Jones, Gregg S.; Hung, Magdeleine; Mukund, Susmith; Han, Bin; Liu, Xiaohong; Babaoglu, Kerim; Lansdon, Eric; Chen, Xiaowu; Todd, Jacob; Cai, Terrence; Pagratis, Nikos; Sakowicz, Roman; Geleziunas, Romas			Affinities between the Binding Partners of the HIV-1 Integrase Dimer-Lens Epithelium-derived Growth Factor (IN Dimer-LEDGF) Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REVERSE-TRANSCRIPTASE; PROTEIN; DOMAIN; DNA; DIMERIZATION; INHIBITORS; IDENTIFICATION; INTERFACE; KINETICS; MUTANTS	The interaction between lens epithelium-derived growth factor/transcriptional co-activator p75 (LEDGF) and human immunodeficiency virus type 1 (HIV-1) integrase (IN) is essential for HIV-1 replication. Homogeneous time-resolved fluorescence resonance energy transfer assays were developed to characterize HIV-1 integrase dimerization and the interaction between LEDGF and IN dimers. Using these assays in an equilibrium end point dose-response format with mathematical modeling, we determined the dissociation constants of IN dimers (K-dimer = 67.8 pM) and of LEDGF from IN dimers (K-d = 10.9 nM). When used in a kinetic format, the assays allowed the determination of the on-and off-rate constants for these same interactions. Integrase dimerization had a k(on) of 0.1247 nM(-1).min(-1) and a k(off) of 0.0080 min(-1) resulting in a K-dimer of 64.5 pM. LEDGF binding to IN dimers had a k(on) of 0.0285 nM(-1).min(-1) and a k(off) of 0.2340 min(-1) resulting in a K-d of 8.2 nM. These binding assays can also be used in an equilibrium end point competition format. In this format, the IN catalytic core domain produced a K-i of 15.2 nM while competing for integrase dimerization, confirming the very tight interaction of IN with itself. In the same format, LEDGF produced a K-i value of 35 nM when competing for LEDGF binding to IN dimers. In summary, this study describes a methodology combining homogeneous time-resolved fluorescence resonance energy transfer and mathematical modeling to derive the affinities between IN monomers and between LEDGF and IN dimers. This study revealed the significantly tighter nature of the IN-IN dimer compared with the IN-LEDGF interaction.	[Tsiang, Manuel; Jones, Gregg S.; Hung, Magdeleine; Mukund, Susmith; Han, Bin; Liu, Xiaohong; Babaoglu, Kerim; Lansdon, Eric; Chen, Xiaowu; Todd, Jacob; Cai, Terrence; Pagratis, Nikos; Sakowicz, Roman; Geleziunas, Romas] Gilead Sci Inc, Foster City, CA 94404 USA	Gilead Sciences	Tsiang, M (corresponding author), Gilead Sci Inc, 333 Lakeside Dr, Foster City, CA 94404 USA.	MTsiang@gilead.com						Al-Mawsawi LQ, 2008, FEBS LETT, V582, P1425, DOI 10.1016/j.febslet.2008.02.076; Botbol YR, 2008, NUCLEIC ACIDS RES, V36, P1237, DOI 10.1093/nar/gkm1127; Chen X, 2008, J MOL BIOL, V380, P504, DOI 10.1016/j.jmb.2008.04.054; Cherepanov P, 2005, P NATL ACAD SCI USA, V102, P17308, DOI 10.1073/pnas.0506924102; Cherepanov P, 2005, NAT STRUCT MOL BIOL, V12, P526, DOI 10.1038/nsmb937; Cherepanov P, 2004, J BIOL CHEM, V279, P48883, DOI 10.1074/jbc.M406307200; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329; COLEMAN RA, 1995, J BIOL CHEM, V270, P13842, DOI 10.1074/jbc.270.23.13842; De Rijck J, 2006, J VIROL, V80, P11498, DOI 10.1128/JVI.00801-06; DEBYSER Z, 2009, 16 C RETR OPP INF MO, P91; DIVITA G, 1993, FEBS LETT, V324, P153, DOI 10.1016/0014-5793(93)81383-B; DIVITA G, 1995, J MOL BIOL, V245, P508, DOI 10.1006/jmbi.1994.0042; Emiliani S, 2005, J BIOL CHEM, V280, P25517, DOI 10.1074/jbc.M501378200; Espeseth AS, 2000, P NATL ACAD SCI USA, V97, P11244, DOI 10.1073/pnas.200139397; Hare S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000515; Hare S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000259; Hayouka Z, 2007, P NATL ACAD SCI USA, V104, P8316, DOI 10.1073/pnas.0700781104; Hombrouck A, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030047; Hou Y, 2008, J BIOMOL SCREEN, V13, P406, DOI 10.1177/1087057108317060; Jenkins TM, 1996, J BIOL CHEM, V271, P7712, DOI 10.1074/jbc.271.13.7712; Laurence JS, 2000, BIOCHEMISTRY-US, V39, P3401, DOI 10.1021/bi9923196; Llano M, 2004, J BIOL CHEM, V279, P55570, DOI 10.1074/jbc.M408508200; Llano M, 2004, J VIROL, V78, P9524, DOI 10.1128/JVI.78.17.9524-9537.2004; Llano M, 2006, SCIENCE, V314, P461, DOI 10.1126/science.1132319; Lu R, 2004, J VIROL, V78, P12735, DOI 10.1128/JVI.78.23.12735-12746.2004; MacKenzie CR, 1996, J BIOL CHEM, V271, P1527, DOI 10.1074/jbc.271.3.1527; Maertens G, 2005, FASEB J, V19, P1039, DOI 10.1096/fj.04-3373fje; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; Maroun RG, 2001, BIOCHEMISTRY-US, V40, P13840, DOI 10.1021/bi011328n; Mckee CJ, 2008, J BIOL CHEM, V283, P31802, DOI 10.1074/jbc.M805843200; Molteni V, 2001, ACTA CRYSTALLOGR D, V57, P536, DOI 10.1107/S0907444901001652; Rahman S, 2007, VIROLOGY, V357, P79, DOI 10.1016/j.virol.2006.08.011; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Vandegraaff N, 2006, VIROLOGY, V346, P415, DOI 10.1016/j.virol.2005.11.022; Vandekerckhove L, 2006, J VIROL, V80, P1886, DOI 10.1128/JVI.80.4.1886-1896.2006; Yu F, 2007, BIOCHEMISTRY-US, V46, P2899, DOI 10.1021/bi602387u; ZHANG ZY, 1991, J BIOL CHEM, V266, P15591	38	34	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33580	33599		10.1074/jbc.M109.040121	http://dx.doi.org/10.1074/jbc.M109.040121			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801648	Green Published, hybrid			2022-12-27	WOS:000272028500063
J	Bunpo, P; Dudley, A; Cundiff, JK; Cavener, DR; Wek, RC; Anthony, TG				Bunpo, Piyawan; Dudley, Allison; Cundiff, Judy K.; Cavener, Douglas R.; Wek, Ronald C.; Anthony, Tracy G.			GCN2 Protein Kinase Is Required to Activate Amino Acid Deprivation Responses in Mice Treated with the Anti-cancer Agent L-Asparaginase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; EIF2-ALPHA KINASE; MAMMALIAN TARGET; STRESS RESPONSES; RAPAMYCIN; INDUCTION; LEUKEMIA; GROWTH; PHOSPHORYLATION; TRANSLATION	Asparaginase depletes circulating asparagine and glutamine, activating amino acid deprivation responses (AADR) such as phosphorylation of eukaryotic initiation factor 2 (p-eIF2) leading to increased mRNA levels of asparagine synthetase and CCAAT/enhancer-binding protein beta homologous protein (CHOP) and decreased mammalian target of rapamycin complex 1 (mTORC1) signaling. The objectives of this study were to assess the role of the eIF2 kinases and protein kinase R-like endoplasmic reticulum resident kinase (PERK) in controlling AADR to asparaginase and to compare the effects of asparaginase on mTORC1 to that of rapamycin. In experiment 1, asparaginase increased hepatic p-eIF2 in wild-type mice and mice with a liver-specific PERK deletion but not in GCN2 null mice nor in GCN2-PERK double null livers. In experiment 2, wild-type and GCN2 null mice were treated with asparaginase (3 IU per g of body weight), rapamycin (2 mg per kg of body weight), or both. In wild-type mice, asparaginase but not rapamycin increased p-eIF2, p-ERK1/2, p-Akt, and mRNA levels of asparagine synthetase and CHOP in liver. Asparaginase and rapamycin each inhibited mTORC1 signaling in liver and pancreas but maximally together. In GCN2 null livers, all responses to asparaginase were precluded except CHOP mRNA expression, which remained partially elevated. Interestingly, rapamycin blocked CHOP induction by asparaginase in both wild-type and GCN2 null livers. These results indicate that GCN2 is required for activation of AADR to asparaginase in liver. Rapamycin modifies the hepatic AADR to asparaginase by preventing CHOP induction while maximizing inhibition of mTORC1.	[Bunpo, Piyawan; Dudley, Allison; Cundiff, Judy K.; Anthony, Tracy G.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Evansville, IN 47712 USA; [Cavener, Douglas R.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Wek, Ronald C.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Indiana University System; Indiana University-Purdue University Indianapolis	Anthony, TG (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, 8600 Univ Blvd, Evansville, IN 47712 USA.	tganthon@iupui.edu	Cavener, Douglas R/E-3524-2010; Anthony, Tracy/K-7951-2017	Anthony, Tracy/0000-0002-8586-5884; Lyle, Allison/0000-0002-5169-5792	National Institutes of Health [GM49164]; American Institute for Cancer Research; Indiana University School of Medicine; American Cancer Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049164, R29GM049164] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Institute for Cancer Research; Indiana University School of Medicine; American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM49164 (to R. C. W.), the American Institute for Cancer Research (to T. G. A.), a research enhancement grant from the Indiana University School of Medicine (to T. G. A.), and an American Cancer Society institutional grant (to T. G. A.).	Anthony TG, 2004, J BIOL CHEM, V279, P36553, DOI 10.1074/jbc.M404559200; Anthony TG, 2001, AM J PHYSIOL-ENDOC M, V281, pE430, DOI 10.1152/ajpendo.2001.281.3.E430; Aoki H, 2007, MOL PHARMACOL, V72, P29, DOI 10.1124/mol.106.033167; Bobrovnikova-Marjon E, 2008, P NATL ACAD SCI USA, V105, P16314, DOI 10.1073/pnas.0808517105; Bunpo P, 2008, J NUTR, V138, P338, DOI 10.1093/jn/138.2.338; Deval C, 2009, FEBS J, V276, P707, DOI 10.1111/j.1742-4658.2008.06818.x; DISTASIO JA, 1976, J BIOL CHEM, V251, P6929; Do AND, 2009, PHYSIOL GENOMICS, V38, P328, DOI 10.1152/physiolgenomics.90396.2008; Entingh AJ, 2001, ENDOCRINOLOGY, V142, P221, DOI 10.1210/en.142.1.221; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Han EKH, 2007, ONCOGENE, V26, P5655, DOI 10.1038/sj.onc.1210343; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hernandez-Espinosa D, 2006, AM J PATHOL, V169, P142, DOI 10.2353/ajpath.2006.051238; HILL JM, 1967, J AMER MED ASSOC, V202, P882, DOI 10.1001/jama.202.9.882; Holcenberg J, 2004, J PEDIAT HEMATOL ONC, V26, P273, DOI 10.1097/00043426-200405000-00001; Huang QH, 1999, BIOCHEM J, V341, P225, DOI 10.1042/0264-6021:3410225; Janus A, 2009, ANTI-CANCER DRUG, V20, P693, DOI 10.1097/CAD.0b013e32832e89b4; Kimball SR, 2008, J BIOL CHEM, V283, P3465, DOI 10.1074/jbc.M706643200; Kimball Sr, 2004, TOP CURR GENET, V7, P113; Lawless MW, 2004, J IMMUNOL, V172, P5722, DOI 10.4049/jimmunol.172.9.5722; OLLENSCHLAGER G, 1988, EUR J CLIN INVEST, V18, P512, DOI 10.1111/j.1365-2362.1988.tb01049.x; Peng T, 2002, MOL CELL BIOL, V22, P5575, DOI 10.1128/MCB.22.15.5575-5584.2002; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Reinert RB, 2006, J BIOL CHEM, V281, P31222, DOI 10.1074/jbc.M604511200; Shah OJ, 2000, AM J PHYSIOL-ENDOC M, V279, pE715, DOI 10.1152/ajpendo.2000.279.4.E715; Smolewski P, 2006, EXPERT OPIN INV DRUG, V15, P1201, DOI 10.1517/13543784.15.10.1201; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Sood R, 2000, BIOCHEM J, V346, P281, DOI 10.1042/0264-6021:3460281; Su N, 2008, PEDIATR BLOOD CANCER, V50, P274, DOI 10.1002/pbc.21213; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; Thiaville MM, 2008, J BIOL CHEM, V283, P10848, DOI 10.1074/jbc.M708320200; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Whitney ML, 2009, BIOCHEM BIOPH RES CO, V379, P451, DOI 10.1016/j.bbrc.2008.12.079; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002	36	88	90	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32742	32749		10.1074/jbc.M109.047910	http://dx.doi.org/10.1074/jbc.M109.047910			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19783659	hybrid, Green Published			2022-12-27	WOS:000272028400059
J	Cap, M; Vachova, L; Palkova, Z				Cap, Michal; Vachova, Libuse; Palkova, Zdena			Yeast Colony Survival Depends on Metabolic Adaptation and Cell Differentiation Rather Than on Stress Defense	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM SURVIVAL; SACCHAROMYCES-CEREVISIAE; SUPEROXIDE-DISMUTASE; HYDROGEN-PEROXIDE; OXIDATIVE DAMAGE; LIFE-SPAN; CATALASE; AMMONIA; PROTEIN; OXYGEN	Enzymes scavenging reactive oxygen species (ROS) are important for cell protection during stress and aging. A deficiency in these enzymes leads to ROS imbalance, causing various disorders in many organisms, including yeast. In contrast to liquid cultures, where fitness of the yeast population depends on its ROS scavenging capability, the present study suggests that Saccharomyces cerevisiae cells growing in colonies capable of ammonia signaling use a broader protective strategy. Instead of maintaining high levels of antioxidant enzymes for ROS detoxification, colonies activate an alternative metabolism that prevents ROS production. Colonies of the strain deficient in cytosolic superoxide dismutase Sod1p thus developed the same way as wild type colonies. They produced comparable levels of ammonia and underwent similar developmental changes (expression of genes of alternative metabolism and center margin differentiation in ROS production, cell death occurrence, and activities of stress defense enzymes) and did not accumulate stress-resistant suppressants. An absence of cytosolic catalase Ctt1p, however, brought colonies developmental problems, which were even more prominent in the absence of mitochondrial Sod2p. sod2 Delta and ctt1 Delta colonies failed in ammonia production and sufficient activation of the alternative metabolism and were incapable of center margin differentiation, but they did not increase ROS levels. These new data indicate that colony disorders are not accompanied by ROS burst but could be a consequence of metabolic defects, which, however, could be elicited by imbalance in ROS produced in early developmental phases. Sod2p and homeostasis of ROS may participate in regulatory events leading to ammonia signaling.	[Palkova, Zdena] Charles Univ Prague, Dept Genet & Microbiol, Fac Sci, CR-12844 Prague 2, Czech Republic; [Vachova, Libuse] ASCR, VVI, Inst Microbiol, Prague 14220 4, Czech Republic	Charles University Prague; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Palkova, Z (corresponding author), Charles Univ Prague, Dept Genet & Microbiol, Fac Sci, Vinicna 5, CR-12844 Prague 2, Czech Republic.	zdenap@natur.cuni.cz	Cap, Michal/HGB-8892-2022; Vachova, Libuse/H-7620-2014; Čáp, Michal/Q-6496-2017; Palkova, Zdena/M-8692-2014	Vachova, Libuse/0000-0002-8143-6054; Palkova, Zdena/0000-0002-0864-8042; Cap, Michal/0000-0002-2327-371X	Grant Agency of the Czech Republic [525/05/0297, 204/08/0718]; Ministry of Education [LC531, MSM0021620858, AV0Z50200510]; Howard Hughes Medical Institute [55005623]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Education; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by Grant Agency of the Czech Republic Grants 525/05/0297 and 204/08/0718; by Ministry of Education Grants LC531, MSM0021620858, and AV0Z50200510; and by Howard Hughes Medical Institute International Research Award 55005623 (to Z. P.).	BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Bonatto D, 2007, FREE RADICAL BIO MED, V43, P557, DOI 10.1016/j.freeradbiomed.2007.05.013; Buhler M, 2009, EMBO J, V28, P2149, DOI 10.1038/emboj.2009.185; CLARE DA, 1984, ANAL BIOCHEM, V140, P532, DOI 10.1016/0003-2697(84)90204-5; Davidson JF, 1996, P NATL ACAD SCI USA, V93, P5116, DOI 10.1073/pnas.93.10.5116; Eberhardt M.K., 2001, REACTIVE OXYGEN META, P303; Fabrizio P, 2004, J CELL BIOL, V166, P1055, DOI 10.1083/jcb.200404002; GRALLA EB, 1991, J BACTERIOL, V173, P5918, DOI 10.1128/jb.173.18.5918-5920.1991; Guaragnella N, 2008, FEBS LETT, V582, P210, DOI 10.1016/j.febslet.2007.12.007; Izawa S, 1996, BIOCHEM J, V320, P61, DOI 10.1042/bj3200061; KIM KW, 1988, J BIOL CHEM, V263, P4704; LAPINSKAS PJ, 1995, MOL CELL BIOL, V15, P1382; Longo VD, 1996, J BIOL CHEM, V271, P12275, DOI 10.1074/jbc.271.21.12275; Nadell CD, 2009, FEMS MICROBIOL REV, V33, P206, DOI 10.1111/j.1574-6976.2008.00150.x; Netto LES, 1996, J BIOL CHEM, V271, P15315, DOI 10.1074/jbc.271.26.15315; O'Brien KM, 2004, J BIOL CHEM, V279, P51817, DOI 10.1074/jbc.M405958200; Palkova Z, 2002, MOL BIOL CELL, V13, P3901, DOI 10.1091/mbc.E01-12-0149; Palkova Z, 1997, NATURE, V390, P532, DOI 10.1038/37398; Palkova Z, 2006, FEMS MICROBIOL REV, V30, P806, DOI 10.1111/j.1574-6976.2006.00034.x; Palkova Z, 2009, MOL MEMBR BIOL, V26, P228, DOI 10.1080/09687680902893130; Perrone GG, 2008, BBA-MOL CELL RES, V1783, P1354, DOI 10.1016/j.bbamcr.2008.01.023; SCHULLER C, 1994, EMBO J, V13, P4382, DOI 10.1002/j.1460-2075.1994.tb06758.x; Strain J, 1998, J BIOL CHEM, V273, P31138, DOI 10.1074/jbc.273.47.31138; Vachova L, 2005, J CELL BIOL, V169, P711, DOI 10.1083/jcb.200410064; Vachova L, 2004, J BIOL CHEM, V279, P37973, DOI 10.1074/jbc.M404594200; Vachova L, 2009, ENVIRON MICROBIOL, V11, P494, DOI 10.1111/j.1462-2920.2008.01789.x; Van Zandyeke SM, 2002, MECH AGEING DEV, V123, P365, DOI 10.1016/S0047-6374(01)00382-7; Wawryn J, 1999, ACTA BIOCHIM POL, V46, P249, DOI 10.18388/abp.1999_4158; WESTERBEEKMARRES CAM, 1988, EUR J BIOCHEM, V174, P611, DOI 10.1111/j.1432-1033.1988.tb14142.x	29	38	38	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32572	32581		10.1074/jbc.M109.022871	http://dx.doi.org/10.1074/jbc.M109.022871			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19801643	Green Published, hybrid			2022-12-27	WOS:000272028400039
J	Eggers, CT; Schafer, JC; Goldenring, JR; Taylor, SS				Eggers, Christopher T.; Schafer, Jenny C.; Goldenring, James R.; Taylor, Susan S.			D-AKAP2 Interacts with Rab4 and Rab11 through Its RGS Domains and Regulates Transferrin Receptor Recycling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEINS; KINASE BINDING DOMAIN; A ANCHORING PROTEIN; CANINE KIDNEY-CELLS; STRUCTURAL BASIS; MYOCARDIAL-INFARCTION; GENE POLYMORPHISMS; COUPLING PROTEIN; MEMBRANE DOMAINS; EARLY ENDOSOMES	Dual-specific A-kinase-anchoring protein 2 (D-AKAP2/AKAP10), which interacts at its carboxyl terminus with protein kinase A and PDZ domain proteins, contains two tandem regulator of G-protein signaling (RGS) domains for which the binding partners have remained unknown. We show here that these RGS domains interact with Rab11 and GTP-bound Rab4, the first demonstration of RGS domains binding small GTPases. Rab4 and Rab11 help regulate membrane trafficking through the endocytic recycling pathways by recruiting effector proteins to specific membrane domains. Although D-AKAP2 is primarily cytosolic in HeLa cells, a fraction of the protein localizes to endosomes and can be recruited there to a greater extent by overexpression of Rab4 or Rab11. D-AKAP2 also regulates the morphology of the Rab11-containing compartment, with co-expression causing accumulation of both proteins on enlarged endosomes. Knockdown of D-AKAP2 by RNA interference caused a redistribution of both Rab11 and the constitutively recycling transferrin receptor to the periphery of cells. Knockdown also caused an increase in the rate of transferrin recycling, suggesting that D-AKAP2 promotes accumulation of recycling proteins in the Rab4/Rab11-positive endocytic recycling compartment.	[Taylor, Susan S.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Taylor, Susan S.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Taylor, Susan S.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Schafer, Jenny C.; Goldenring, James R.] Vanderbilt Univ, Sch Med, Dept Surg, Nashville, TN 37232 USA; [Schafer, Jenny C.; Goldenring, James R.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Schafer, Jenny C.; Goldenring, James R.] Nashville Vet Affairs Med Ctr, Nashville, TN 37232 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; Vanderbilt University; Vanderbilt University	Taylor, SS (corresponding author), Univ Calif San Diego, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	staylor@ucsd.edu			National Institutes of Health [DK054441]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK070856, R01DK048370, P01DK054441, R01DK070856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM082146] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant DK054441.	Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Casanova JE, 1999, MOL BIOL CELL, V10, P47, DOI 10.1091/mbc.10.1.47; Deneka M, 2003, EMBO J, V22, P2645, DOI 10.1093/emboj/cdg257; Eathiraj S, 2005, NATURE, V436, P415, DOI 10.1038/nature03798; Fukuda M, 2008, MOL CELL PROTEOMICS, V7, P1031, DOI 10.1074/mcp.M700569-MCP200; Fushimi K, 1997, J BIOL CHEM, V272, P14800, DOI 10.1074/jbc.272.23.14800; Gage RM, 2001, J BIOL CHEM, V276, P44712, DOI 10.1074/jbc.M107417200; Gisler SM, 2003, KIDNEY INT, V64, P1746, DOI 10.1046/j.1523-1755.2003.00267.x; Hamuro Y, 2002, J MOL BIOL, V321, P703, DOI 10.1016/S0022-2836(02)00419-9; Huang LJS, 1997, P NATL ACAD SCI USA, V94, P11184, DOI 10.1073/pnas.94.21.11184; Kammerer S, 2003, P NATL ACAD SCI USA, V100, P4066, DOI 10.1073/pnas.2628028100; Lapierre LA, 2007, AM J PHYSIOL-GASTR L, V292, pG1249, DOI 10.1152/ajpgi.00505.2006; Lindsay AJ, 2004, FEBS LETT, V571, P86, DOI 10.1016/j.febslet.2004.06.068; Lindsay AJ, 2002, J BIOL CHEM, V277, P12190, DOI 10.1074/jbc.M108665200; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Nagelkerken B, 2000, BIOCHEM J, V346, P593, DOI 10.1042/0264-6021:3460593; Nakamura T, 2005, P NATL ACAD SCI USA, V102, P13404, DOI 10.1073/pnas.0506679102; Neubig RR, 2002, NAT REV DRUG DISCOV, V1, P187, DOI 10.1038/nrd747; Nishihama K, 2007, INT J MOL MED, V19, P129; Ostermeier C, 1999, CELL, V96, P363, DOI 10.1016/S0092-8674(00)80549-8; Pagano A, 2004, MOL BIOL CELL, V15, P4990, DOI 10.1091/mbc.E04-04-0355; Peden AA, 2004, MOL BIOL CELL, V15, P3530, DOI 10.1091/mbc.E03-12-0918; Pfeffer S, 2003, CELL, V112, P507, DOI 10.1016/S0092-8674(03)00118-1; Ren MD, 1998, P NATL ACAD SCI USA, V95, P6187, DOI 10.1073/pnas.95.11.6187; Segev N, 2001, CURR OPIN CELL BIOL, V13, P500, DOI 10.1016/S0955-0674(00)00242-8; Sheff DR, 1999, J CELL BIOL, V145, P123, DOI 10.1083/jcb.145.1.123; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Tingley WG, 2007, P NATL ACAD SCI USA, V104, P8461, DOI 10.1073/pnas.0610393104; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; URBE S, 1993, FEBS LETT, V334, P175, DOI 10.1016/0014-5793(93)81707-7; VANDERSLUIJS P, 1992, CELL, V70, P729, DOI 10.1016/0092-8674(92)90307-X; Wang L, 2001, P NATL ACAD SCI USA, V98, P3220, DOI 10.1073/pnas.051633398; Wang XY, 2000, J BIOL CHEM, V275, P29138, DOI 10.1074/jbc.M004410200; Watson N, 1996, NATURE, V383, P172, DOI 10.1038/383172a0; Wilcke M, 2000, J CELL BIOL, V151, P1207, DOI 10.1083/jcb.151.6.1207; Wirtenberger M, 2007, CARCINOGENESIS, V28, P423, DOI 10.1093/carcin/bgl164; Yoshida T, 2007, INT J MOL MED, V20, P581; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zheng B, 1999, TRENDS BIOCHEM SCI, V24, P411, DOI 10.1016/S0968-0004(99)01474-7; Zhu GY, 2004, NAT STRUCT MOL BIOL, V11, P975, DOI 10.1038/nsmb832	42	51	52	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32869	32880		10.1074/jbc.M109.022582	http://dx.doi.org/10.1074/jbc.M109.022582			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19797056	hybrid, Green Published			2022-12-27	WOS:000272028400071
J	Fujita, N; Saitoh, T; Kageyama, S; Akira, S; Noda, T; Yoshimori, T				Fujita, Naonobu; Saitoh, Tatsuya; Kageyama, Shun; Akira, Shizuo; Noda, Takeshi; Yoshimori, Tamotsu			Differential Involvement of Atg16L1 in Crohn Disease and Canonical Autophagy ANALYSIS OF THE ORGANIZATION OF THE Atg16L1 COMPLEX IN FIBROBLASTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOME-WIDE ASSOCIATION; MEMBRANE BIOGENESIS; PROTEIN; LC3; LIPIDATION; MOUSE; CELLS; PATHOGENESIS; CONJUGATE; VARIANT	A single nucleotide polymorphism in Atg16L1, an autophagy-related gene (ATG), is a risk factor for Crohn disease, a major form of chronic inflammatory bowel disease. However, it is still unknown how the Atg16L1 variant contributes to disease development. The Atg16L1 protein possesses a C-terminal WD repeat domain whose function is entirely unknown, and the Crohn disease-associated mutation (T300A) is within this domain. To elucidate the function of the WD repeat domain, we established an experimental system in which a WD repeat domain mutant of Atg16L1 is stably expressed in Atg16L1-deficient mouse embryonic fibroblasts. Using the system, we show that the Atg16L1 complex forms a dimeric complex and that the total Atg16L1 protein level is strictly maintained, possibly by the ubiquitin proteasome system. Furthermore, we show that an Atg16L1 WD repeat domain deletion and the T300A mutant have little impact on canonical autophagy and autophagy against Salmonella enterica serovar Typhimurium. Therefore, we propose that Atg16L1 T300A is differentially involved in Crohn disease and canonical autophagy.	[Fujita, Naonobu; Kageyama, Shun; Noda, Takeshi; Yoshimori, Tamotsu] Osaka Univ, Dept Cellular Regulat, Suita, Osaka 5650871, Japan; [Saitoh, Tatsuya; Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 5650871, Japan; [Saitoh, Tatsuya; Akira, Shizuo] Osaka Univ, World Premier Int Immunol Frontier Res Ctr, Host Def Lab, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Osaka University	Yoshimori, T (corresponding author), Osaka Univ, Dept Cellular Regulat, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	tamyoshi@biken.osaka-u.ac.jp	Fujita, Naonobu/A-1218-2010; Akira, Shizuo/C-3134-2009; Noda, Takeshi/B-7240-2008	Noda, Takeshi/0000-0003-3581-7961; Fujita, Naonobu/0000-0003-1914-8438	Ministry of Education, Culture, Sports, Science, and Technology; Japan Society for the Promotion of Science; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by the Ministry of Education, Culture, Sports, Science, and Technology (to T. Y. and T. N.), the Japan Society for the Promotion of Science (to N. F.), and the Takeda Science Foundation (to T. Y.).	Birmingham CL, 2006, J BIOL CHEM, V281, P11374, DOI 10.1074/jbc.M509157200; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Hosokawa N, 2007, FEBS LETT, V581, P2623, DOI 10.1016/j.febslet.2006.04.008; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kimura S, 2009, METHOD ENZYMOL, V452, P1, DOI 10.1016/S0076-6879(08)03601-X; Kuballa P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003391; Matsushita M, 2007, J BIOL CHEM, V282, P6763, DOI 10.1074/jbc.M609876200; McClellan AJ, 2005, CELL, V121, P739, DOI 10.1016/j.cell.2005.03.024; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2003, J CELL SCI, V116, P1679, DOI 10.1242/jcs.00381; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Saitoh T, 2003, J BIOL CHEM, V278, P36005, DOI 10.1074/jbc.M304266200; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Sou Y, 2006, J BIOL CHEM, V281, P3017, DOI 10.1074/jbc.M505888200; Virgin HW, 2009, NAT IMMUNOL, V10, P461, DOI 10.1038/ni.1726; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yoshimori T, 2008, CURR OPIN CELL BIOL, V20, P401, DOI 10.1016/j.ceb.2008.03.010	27	95	97	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32602	32609		10.1074/jbc.M109.037671	http://dx.doi.org/10.1074/jbc.M109.037671			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19783656	hybrid, Green Published			2022-12-27	WOS:000272028400042
J	Domazet, I; Martin, SS; Holleran, BJ; Morin, ME; Lacasse, P; Lavigne, P; Escher, E; Leduc, R; Guillemette, G				Domazet, Ivana; Martin, Stephane S.; Holleran, Brian J.; Morin, Marie-Eve; Lacasse, Patrick; Lavigne, Pierre; Escher, Emanuel; Leduc, Richard; Guillemette, Gaetan			The Fifth Transmembrane Domain of Angiotensin II Type 1 Receptor Participates in the Formation of the Ligand-binding Pocket and Undergoes a Counterclockwise Rotation upon Receptor Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; CYSTEINE ACCESSIBILITY METHOD; MEMBRANE-SPANNING SEGMENT; HUMAN AT(1) RECEPTOR; CRYSTAL-STRUCTURE; CONSTITUTIVE ACTIVATION; CONFORMATIONAL-CHANGES; CONTACT POINTS; SITE CREVICE; RHODOPSIN	The octapeptide hormone angiotensin II exerts a wide variety of cardiovascular effects through the activation of the angiotensin II Type 1 (AT(1)) receptor, which belongs to the G protein-coupled receptor superfamily. Like other G protein-coupled receptors, the AT(1) receptor possesses seven transmembrane domains that provide structural support for the formation of the ligand-binding pocket. The role of the fifth transmembrane domain (TMD5) was investigated using the substituted cysteine accessibility method. All of the residues within Thr-190 to Leu-217 region were mutated one at a time to cysteine, and after expression in COS-7 cells, the mutant receptors were treated with the sulfhydryl-specific alkylating agent methanethiosulfonate-ethylammonium (MTSEA). MTSEA reacts selectively with water-accessible, free sulfhydryl groups of endogenous or introduced point mutation cysteines. If a cysteine is found in the binding pocket, the covalent modification will affect the binding kinetics of the ligand. MTSEA substantially decreased the binding affinity of L197C-AT(1), N200C-AT(1), I201C-AT(1), G203C-AT(1), and F204C-AT(1) mutant receptors, which suggests that these residues orient themselves within the water-accessible binding pocket of the AT(1) receptor. Interestingly, this pattern of acquired MTSEA sensitivity was altered for TMD5 reporter cysteines engineered in a constitutively active N111G-AT(1) receptor background. Indeed, mutant I201C-N111G-AT(1) became more sensitive to MTSEA, whereas mutant G203C-N111G-AT(1) lost some sensitivity. Our results suggest that constitutive activation of AT(1) receptor causes an apparent counterclockwise rotation of TMD5 as viewed from the extracellular side.	[Domazet, Ivana; Martin, Stephane S.; Holleran, Brian J.; Morin, Marie-Eve; Lacasse, Patrick; Lavigne, Pierre; Escher, Emanuel; Leduc, Richard; Guillemette, Gaetan] Univ Sherbrooke, Dept Pharmacol, Fac Med & Hlth Sci, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke	Guillemette, G (corresponding author), Univ Sherbrooke, Dept Pharmacol, Fac Med & Hlth Sci, 3001 12th Ave N, Sherbrooke, PQ J1H 5N4, Canada.	Gaetan.Guillemette@USherbrooke.ca	Lacasse, Pierre/B-5084-2013	Escher, Emanuel/0000-0001-6601-987X	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research.	Ahuja S, 2009, J BIOL CHEM, V284, P10190, DOI 10.1074/jbc.M805725200; Ahuja S, 2009, NAT STRUCT MOL BIOL, V16, P168, DOI 10.1038/nsmb.1549; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; BALLA T, 1986, P NATL ACAD SCI USA, V83, P9323, DOI 10.1073/pnas.83.24.9323; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Balmforth AJ, 1997, J BIOL CHEM, V272, P4245, DOI 10.1074/jbc.272.7.4245; Boucard AA, 2000, BIOCHEMISTRY-US, V39, P9662, DOI 10.1021/bi000597v; Boucard AA, 2003, J BIOL CHEM, V278, P36628, DOI 10.1074/jbc.M305952200; Burnier M, 2001, CIRCULATION, V103, P904, DOI 10.1161/01.CIR.103.6.904; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Clement M, 2009, J BIOL CHEM, V284, P26603, DOI 10.1074/jbc.M109.012922; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; de Gasparo M, 2000, PHARMACOL REV, V52, P415; Domazet I, 2009, J BIOL CHEM, V284, P11922, DOI 10.1074/jbc.M808113200; Dunham TD, 1999, J BIOL CHEM, V274, P1683, DOI 10.1074/jbc.274.3.1683; Feng YH, 1998, BIOCHEMISTRY-US, V37, P15791, DOI 10.1021/bi980863t; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; Gether U, 1998, J BIOL CHEM, V273, P17979, DOI 10.1074/jbc.273.29.17979; Ghanouni P, 2001, P NATL ACAD SCI USA, V98, P5997, DOI 10.1073/pnas.101126198; Groblewski T, 1997, J BIOL CHEM, V272, P1822, DOI 10.1074/jbc.272.3.1822; GUILLEMETTE G, 1983, BIOCHEMISTRY-US, V22, P5591, DOI 10.1021/bi00293a021; Hildebrand PW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004382; Inoue Y, 1997, J HYPERTENS, V15, P703, DOI 10.1097/00004872-199715070-00001; Javitch JA, 2002, METHOD ENZYMOL, V343, P137; Javitch JA, 1995, BIOCHEMISTRY-US, V34, P16433, DOI 10.1021/bi00050a026; JAVITCH JA, 1994, P NATL ACAD SCI USA, V91, P10355, DOI 10.1073/pnas.91.22.10355; JOSEPH MP, 1995, J PROTEIN CHEM, V14, P381, DOI 10.1007/BF01886795; KOJIMA I, 1984, J BIOL CHEM, V259, P4448; Lanctot PM, 1999, BIOCHEMISTRY-US, V38, P8621, DOI 10.1021/bi9830516; Laporte SA, 1999, MOL ENDOCRINOL, V13, P578, DOI 10.1210/me.13.4.578; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Martin SS, 2004, J BIOL CHEM, V279, P51415, DOI 10.1074/jbc.M407965200; Martin SS, 2007, MOL PHARMACOL, V72, P182, DOI 10.1124/mol.106.033670; Matthews EE, 2006, CELL, V127, P447, DOI 10.1016/j.cell.2006.10.016; Miura S, 2003, HYPERTENS RES, V26, P937, DOI 10.1291/hypres.26.937; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Patel AB, 2004, P NATL ACAD SCI USA, V101, P10048, DOI 10.1073/pnas.0402848101; Perodin J, 2002, BIOCHEMISTRY-US, V41, P14348, DOI 10.1021/bi0258602; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; Vogel R, 2008, J MOL BIOL, V380, P648, DOI 10.1016/j.jmb.2008.05.022; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101	45	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31953	31961		10.1074/jbc.M109.051839	http://dx.doi.org/10.1074/jbc.M109.051839			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19773549	Green Published, hybrid			2022-12-27	WOS:000271572700051
J	Fuchsova, B; Fernandez, ME; Alfonso, J; Frasch, AC				Fuchsova, Beata; Fernandez, Maria E.; Alfonso, Julieta; Frasch, Alberto C.			Cysteine Residues in the Large Extracellular Loop (EC2) Are Essential for the Function of the Stress-regulated Glycoprotein M6a	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIPPOCAMPAL CA3C NEURONS; TETRASPANIN PROTEINS; NEURITE EXTENSION; APICAL DENDRITES; RAT HIPPOCAMPUS; INDUCED ATROPHY; CROSS-LINKING; GROWTH-FACTOR; GENE FAMILY; EXPRESSION	Gpm6a was identified as a stress-responsive gene in the hippocampal formation. This gene is down-regulated in the hippocampus of both socially and physically stressed animals, and this effect can be reversed by antidepressant treatment. Previously we showed that the stress-regulated protein M6a is a key modulator for neurite outgrowth and filopodium/spine formation. In the present work, mutational analysis was used to characterize the action of M6a at the molecular level. We show that four cysteines 162, 174, 192, and 202 within EC2 are functionally crucial sites. The presence of cysteines 162 and 202 is essential for the efficient cell surface expression of the M6a protein. In contrast, cysteines 174 and 192, which form a disulfide bridge as shown by biochemical analysis, are not required for the efficient surface expression of M6a. Their mutation to alanine does not interfere with the localization of M6a to filopodial protrusions in primary hippocampal neurons. The neurons expressing C174A and/or C192A mutants display decreased filopodia number. In non-permeabilized cells, these mutant proteins are not recognized by a function-blocking monoclonal antibody directed to M6a. Moreover, neurons in contact with axons expressing C174A/C192A mutant display significantly lower density of presynaptic clusters over their dendrites. Taken together, this study demonstrates that cysteines in the EC2 domain are critical for the role of M6a in filopodium outgrowth and synaptogenesis.	[Frasch, Alberto C.] Consejo Nacl Invest Cient & Tecn, Natl Res Council, RA-1033 Buenos Aires, DF, Argentina; [Fuchsova, Beata; Fernandez, Maria E.; Alfonso, Julieta; Frasch, Alberto C.] Univ Nacl San Martin, Consejo Nacl Invest Cient & Tecn, Inst Invest Biotecnol INTECH, RA-1650 San Martin, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Fuchsova, B (corresponding author), Univ Nacl San Martin, INTI, Inst Invest Biotecnol, Edificio 24,Av Gen Paz 5445, RA-1650 San Martin, Buenos Aires, Argentina.	beata@iib.unsam.edu.ar		Frasch, Alberto Carlos/0000-0001-7532-653X	Howard Hughes Medical Institute; Agencia Nacional de Promocion Cientifica y Tecnologica	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT)	This work was supported in part by an international Research Scholars grant from the Howard Hughes Medical Institute (to A. C. F.) and the Agencia Nacional de Promocion Cientifica y Tecnologica.	Alfonso J, 2006, BIOL PSYCHIAT, V59, P244, DOI 10.1016/j.biopsych.2005.06.036; Alfonso J, 2005, P NATL ACAD SCI USA, V102, P17196, DOI 10.1073/pnas.0504262102; Alfonso J, 2004, EUR J NEUROSCI, V19, P659, DOI 10.1111/j.1460-9568.2004.03178.x; Berditchevski F, 2001, J CELL SCI, V114, P4143; Boks MPM, 2008, AM J MED GENET B, V147B, P707, DOI 10.1002/ajmg.b.30667; Brocco M, 2003, J NEUROSCI RES, V74, P744, DOI 10.1002/jnr.10781; Cohen-Cory S, 2002, SCIENCE, V298, P770, DOI 10.1126/science.1075510; Cooper B, 2008, BRAIN RES, V1197, P1, DOI 10.1016/j.brainres.2007.11.066; DAVIDSON FF, 1994, P NATL ACAD SCI USA, V91, P4029, DOI 10.1073/pnas.91.9.4029; Donohue HS, 2006, NEUROSCIENCE, V140, P597, DOI 10.1016/j.neuroscience.2006.02.072; FLETCHER TL, 1991, J NEUROSCI, V11, P1617; Gudz TI, 2002, J NEUROSCI, V22, P7398; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Higginbottom A, 2000, J VIROL, V74, P3642, DOI 10.1128/JVI.74.8.3642-3649.2000; IWAMOTO R, 1994, EMBO J, V13, P2322, DOI 10.1002/j.1460-2075.1994.tb06516.x; Kazarov AR, 2002, J CELL BIOL, V158, P1299, DOI 10.1083/jcb.200204056; Kitadokoro K, 2001, EMBO J, V20, P12, DOI 10.1093/emboj/20.1.12; Kohl S, 1998, ACTA ANAT, V162, P75; Kovalenko OV, 2007, MOL CELL PROTEOMICS, V6, P1855, DOI 10.1074/mcp.M700183-MCP200; Kovalenko OV, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-11; Kovalenko OV, 2004, BIOCHEM J, V377, P407, DOI 10.1042/BJ20031037; LAGENAUR C, 1992, J NEUROBIOL, V23, P71, DOI 10.1002/neu.480230108; Latysheva N, 2006, MOL CELL BIOL, V26, P7707, DOI 10.1128/MCB.00849-06; Levy S, 2005, PHYSIOLOGY, V20, P218, DOI 10.1152/physiol.00015.2005; Levy S, 2005, NAT REV IMMUNOL, V5, P136, DOI 10.1038/nri1548; Magarinos AM, 1997, P NATL ACAD SCI USA, V94, P14002, DOI 10.1073/pnas.94.25.14002; MAGARINOS AM, 1995, NEUROSCIENCE, V69, P89, DOI 10.1016/0306-4522(95)00259-L; MAGARINOS AM, 1995, NEUROSCIENCE, V69, P83, DOI 10.1016/0306-4522(95)00256-I; Masciopinto F, 2001, VIRUS RES, V80, P1, DOI 10.1016/S0168-1702(01)00245-3; Michibata H, 2008, STEM CELLS DEV, V17, P641, DOI 10.1089/scd.2008.0088; Mukobata S, 2002, BIOCHEM BIOPH RES CO, V297, P722, DOI 10.1016/S0006-291X(02)02284-2; Nishiuchi R, 2005, P NATL ACAD SCI USA, V102, P1939, DOI 10.1073/pnas.0409493102; Roussel G, 1998, J NEUROCYTOL, V27, P695, DOI 10.1023/A:1006924400768; Sandi C, 2003, EUR J NEUROSCI, V17, P2447, DOI 10.1046/j.1460-9568.2003.02675.x; Seigneuret M, 2001, J BIOL CHEM, V276, P40055, DOI 10.1074/jbc.M105557200; Serru V, 1999, BIOCHEM J, V340, P103, DOI 10.1042/0264-6021:3400103; Sousa N, 2000, NEUROSCIENCE, V97, P253, DOI 10.1016/S0306-4522(00)00050-6; Stipp CS, 2003, TRENDS BIOCHEM SCI, V28, P106, DOI 10.1016/S0968-0004(02)00014-2; Stipp CS, 2001, J BIOL CHEM, V276, P40545, DOI 10.1074/jbc.M107338200; Stipp CS, 2001, J BIOL CHEM, V276, P4853, DOI 10.1074/jbc.M009859200; Tarone G, 2000, INT J DEV BIOL, V44, P725; Tarrant JM, 2003, TRENDS IMMUNOL, V24, P610, DOI 10.1016/j.it.2003.09.011; WEIMBS T, 1992, BIOCHEMISTRY-US, V31, P12289, DOI 10.1021/bi00164a002; Werner H, 2001, MOL CELL NEUROSCI, V18, P593, DOI 10.1006/mcne.2001.1044; Wu DF, 2007, J BIOL CHEM, V282, P22239, DOI 10.1074/jbc.M700941200; YAN YM, 1993, NEURON, V11, P423, DOI 10.1016/0896-6273(93)90147-J; Yan YM, 1996, J COMP NEUROL, V370, P465, DOI 10.1002/(SICI)1096-9861(19960708)370:4<465::AID-CNE4>3.0.CO;2-2; Yauch RL, 2000, BIOCHEM J, V351, P629, DOI 10.1042/0264-6021:3510629; Zemni R, 2000, NAT GENET, V24, P167, DOI 10.1038/72829; Zhang XA, 2001, J BIOL CHEM, V276, P25005, DOI 10.1074/jbc.M102156200; Zhao J, 2008, MOL VIS, V14, P1623	51	24	26	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					32075	32088		10.1074/jbc.M109.012377	http://dx.doi.org/10.1074/jbc.M109.012377			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19737934	hybrid, Green Published			2022-12-27	WOS:000271572700062
J	Zhao, M; Wan, ZL; Whittaker, L; Xu, B; Phillips, NB; Katsoyannis, PG; Ismail-Beigi, F; Whittaker, J; Weiss, MA				Zhao, Ming; Wan, Zhu-li; Whittaker, Linda; Xu, Bin; Phillips, Nelson B.; Katsoyannis, Panayotis G.; Ismail-Beigi, Faramarz; Whittaker, Jonathan; Weiss, Michael A.			Design of an Insulin Analog with Enhanced Receptor Binding Selectivity RATIONALE, STRUCTURE, AND THERAPEUTIC IMPLICATIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; TYPE-2 DIABETES-MELLITUS; PHOTO-CROSS-LINKING; ALANINE SCANNING MUTAGENESIS; CANCER-RELATED MORTALITY; COLORECTAL-CANCER; CRYSTAL-STRUCTURE; A-CHAIN; RISK; PROTEIN	Insulin binds with high affinity to the insulin receptor (IR) and with low affinity to the type 1 insulin-like growth factor (IGF) receptor (IGFR). Such cross-binding, which reflects homologies within the insulin-IGF signaling system, is of clinical interest in relation to the association between hyperinsulinemia and colorectal cancer. Here, we employ nonstandard mutagenesis to design an insulin analog with enhanced affinity for the IR but reduced affinity for the IGFR. Unnatural amino acids were introduced by chemical synthesis at the N- and C-capping positions of a recognition alpha-helix (residues A1 and A8). These sites adjoin the hormone-receptor interface as indicated by photocross-linking studies. Specificity is enhanced more than 3-fold on the following: (i) substitution of Gly(A1) by D-Ala or D-Leu, and (ii) substitution of Thr(A8) by diaminobutyric acid (Dab). The crystal structure of [D-Ala(A1), Dab(A8)] insulin, as determined within a T-6 zinc hexamer to a resolution of 1.35 angstrom, is essentially identical to that of human insulin. The nonstandard side chains project into solvent at the edge of a conserved receptor-binding surface shared by insulin and IGF-I. Our results demonstrate that modifications at this edge discriminate between IR and IGFR. Because hyperinsulinemia is typically characterized by a 3-fold increase in integrated postprandial insulin concentrations, we envisage that such insulin analogs may facilitate studies of the initiation and progression of cancer in animal models. Future development of clinical analogs lacking significant IGFR cross-binding may enhance the safety of insulin replacement therapy in patients with type 2 diabetes mellitus at increased risk of colorectal cancer.	[Zhao, Ming; Wan, Zhu-li; Whittaker, Linda; Xu, Bin; Phillips, Nelson B.; Whittaker, Jonathan; Weiss, Michael A.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Ismail-Beigi, Faramarz; Weiss, Michael A.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Katsoyannis, Panayotis G.] NYU, Mt Sinai Sch Med, Dept Pharmacol & Biol Chem, New York, NY 10029 USA	Case Western Reserve University; Case Western Reserve University; Icahn School of Medicine at Mount Sinai; New York University	Weiss, MA (corresponding author), Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA.	michael.weiss@case.edu		Xu, Bin/0000-0002-0490-9540	National Institutes of Health [DK065890, DK40949, DK074176]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040949, R01DK065890, R01DK074176] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK065890 (to J.W.) and DK40949 and DK074176 (to M. A. W.). This article is a contribution from the Cleveland Center for Structural Biology.	Adams TE, 2000, CELL MOL LIFE SCI, V57, P1050, DOI 10.1007/PL00000744; Amos A F, 1997, Diabet Med, V14 Suppl 5, pS1; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; Berster Jutta M., 2008, Archives of Physiology and Biochemistry, V114, P84, DOI [10.1080/13813450802008455, 10.1080/13813450802008455 ]; Berti L, 1998, HORM METAB RES, V30, P123, DOI 10.1055/s-2007-978849; Bowker SL, 2006, DIABETES CARE, V29, P254, DOI 10.2337/diacare.29.02.06.dc05-1558; Brange J, 1999, ADV DRUG DELIVER REV, V35, P307, DOI 10.1016/S0169-409X(98)00079-9; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brzozowski AM, 2002, BIOCHEMISTRY-US, V41, P9389, DOI 10.1021/bi020084j; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Chung YW, 2008, DIS COLON RECTUM, V51, P593, DOI 10.1007/s10350-007-9184-1; Clemmons DR, 2007, NAT REV DRUG DISCOV, V6, P821, DOI 10.1038/nrd2359; COSMATOS A, 1978, J BIOL CHEM, V253, P6586; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; DEMEYTS P, 1990, MOL ENDOCRINOL, V4, P409, DOI 10.1210/mend-4-3-409; Denley A, 2005, MOL ENDOCRINOL, V19, P711, DOI 10.1210/me.2004-0409; Donovan EA, 2008, CRIT REV ONCOL HEMAT, V66, P91, DOI 10.1016/j.critrevonc.2007.09.003; DULL TJ, 1984, NATURE, V310, P777, DOI 10.1038/310777a0; Gauguin L, 2008, J BIOL CHEM, V283, P20821, DOI 10.1074/jbc.M802620200; Gauguin L, 2008, J BIOL CHEM, V283, P2604, DOI 10.1074/jbc.M709220200; GEIGER R, 1975, H-S Z PHYSIOL CHEM, V356, P1635, DOI 10.1515/bchm2.1975.356.2.1635; GEIGER R, 1982, H-S Z PHYSIOL CHEM, V363, P1231, DOI 10.1515/bchm2.1982.363.2.1231; GIOVANNUCCI E, 1995, CANCER CAUSE CONTROL, V6, P164, DOI 10.1007/BF00052777; Giovannucci E, 2001, J NUTR, V131, p3109S, DOI 10.1093/jn/131.11.3109S; Heald A, 2006, DIABETIC MED, V23, P19, DOI 10.1111/j.1464-5491.2006.01833f.x; Hemkens LG, 2009, DIABETOLOGIA, V52, P1732, DOI 10.1007/s00125-009-1418-4; Huang K, 2007, J BIOL CHEM, V282, P35337, DOI 10.1074/jbc.M705996200; HUANG Z, 1994, J CLIN INVEST, V94, P1289, DOI 10.1172/JCI117447; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAARSHOLM NC, 1993, BIOCHEMISTRY-US, V32, P10773, DOI 10.1021/bi00091a031; KATSOYAN.PG, 1972, BIOCHEMISTRY-US, V11, P1128, DOI 10.1021/bi00757a002; KATSOYANNIS PG, 1966, SCIENCE, V154, P1509, DOI 10.1126/science.154.3756.1509; Kochendoerfer GG, 1999, CURR OPIN CHEM BIOL, V3, P665, DOI 10.1016/S1367-5931(99)00024-1; Kohn WD, 2007, PEPTIDES, V28, P935, DOI 10.1016/j.peptides.2007.01.012; KRAIL G, 1975, H-S Z PHYSIOL CHEM, V356, P981, DOI 10.1515/bchm2.1975.356.s1.981; Kristensen C, 1997, J BIOL CHEM, V272, P12978, DOI 10.1074/jbc.272.20.12978; KUROSE T, 1994, J BIOL CHEM, V269, P29190; LASKOWSKI RA, 1995, J MOL GRAPHICS, V13, P323, DOI 10.1016/0263-7855(95)00073-9; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LeRoith D, 2008, EXP CLIN ENDOCR DIAB, V116, pS4, DOI 10.1055/s-2008-1081488; Lou MZ, 2006, P NATL ACAD SCI USA, V103, P12429, DOI 10.1073/pnas.0605395103; Milazzo G, 1997, MOL CARCINOGEN, V18, P19, DOI 10.1002/(SICI)1098-2744(199701)18:1<19::AID-MC3>3.0.CO;2-M; Monami M, 2008, EXP CLIN ENDOCR DIAB, V116, P184, DOI 10.1055/s-2007-992157; NAKAGAWA SH, 1991, J BIOL CHEM, V266, P11502; Nanjo K, 1986, Trans Assoc Am Physicians, V99, P132; Pocock SJ, 2009, LANCET, V374, P511, DOI 10.1016/S0140-6736(09)61307-6; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Pollak M, 2008, BEST PRACT RES CL EN, V22, P625, DOI 10.1016/j.beem.2008.08.004; Renehan AG, 2006, TRENDS ENDOCRIN MET, V17, P328, DOI 10.1016/j.tem.2006.08.006; ROTWEIN P, 1986, J BIOL CHEM, V261, P4828; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Sandhu MS, 2002, J NATL CANCER I, V94, P972; Saydah SH, 2003, AM J EPIDEMIOL, V157, P1092, DOI 10.1093/aje/kwg100; SCHWARTZ GP, 1987, P NATL ACAD SCI USA, V84, P6408, DOI 10.1073/pnas.84.18.6408; SHOELSON SE, 1993, J BIOL CHEM, V268, P4085; Sosnick TR, 2000, METHOD ENZYMOL, V317, P393; Sun J, 2008, CELL SIGNAL, V20, P219, DOI 10.1016/j.cellsig.2007.10.010; Tran TT, 2006, ENDOCRINOLOGY, V147, P1830, DOI 10.1210/en.2005-1012; WAN Z, 1988, SCI CHINA SER B, V31, P1426; Wan ZL, 2005, BIOCHEMISTRY-US, V44, P5000, DOI 10.1021/bi047585k; Wan ZL, 2004, BIOCHEMISTRY-US, V43, P16119, DOI 10.1021/bi048223f; Wang L, 2006, ANNU REV BIOPH BIOM, V35, P225, DOI 10.1146/annurev.biophys.35.101105.121507; Weiss MA, 2002, J MOL BIOL, V315, P103, DOI 10.1006/jmbi.2001.5224; Weiss MA, 2000, BIOCHEMISTRY-US, V39, P15429, DOI 10.1021/bi001905s; Weroha S, 2008, J MAMMARY GLAND BIOL, V13, P471, DOI 10.1007/s10911-008-9104-6; Whittaker J, 2005, J BIOL CHEM, V280, P20932, DOI 10.1074/jbc.M411320200; Whittaker J, 2001, J BIOL CHEM, V276, P43980, DOI 10.1074/jbc.M102863200; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Xu B, 2004, BIOCHEMISTRY-US, V43, P8356, DOI 10.1021/bi0497796; Xu B, 2009, J BIOL CHEM, V284, P14597, DOI 10.1074/jbc.M900087200; Yang YX, 2004, GASTROENTEROLOGY, V127, P1044, DOI 10.1053/j.gastro.2004.07.011	72	8	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					32178	32187		10.1074/jbc.M109.028399	http://dx.doi.org/10.1074/jbc.M109.028399			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19773552	hybrid, Green Published			2022-12-27	WOS:000271572700072
J	Heyno, E; Gross, CM; Laureau, C; Culcasi, M; Pietri, S; Krieger-Liszkay, A				Heyno, Eiri; Gross, Christine M.; Laureau, Constance; Culcasi, Marcel; Pietri, Sylvia; Krieger-Liszkay, Anja			Plastid Alternative Oxidase (PTOX) Promotes Oxidative Stress When Overexpressed in Tobacco	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYNTHETIC ELECTRON-TRANSPORT; TERMINAL OXIDASE; PHOTOSYSTEM-II; IN-VITRO; SUPEROXIDE-DISMUTASE; PROTEIN-DEGRADATION; PLASTOQUINONE-POOL; ARABIDOPSIS; IMMUTANS; LIGHT	Photoinhibition and production of reactive oxygen species were studied in tobacco plants overexpressing the plastid terminal oxidase (PTOX). In high light, these plants was more susceptible to photoinhibition than wild-type plants. Also oxygen-evolving activity of isolated thylakoid membranes from the PTOX-overexpressing plants was more strongly inhibited in high light than in thylakoids from wild-type plants. In contrast in low light, in the PTOX overexpressor, the thylakoids were protected against photoinhibition while in wild type they were significantly damaged. The production of superoxide and hydroxyl radicals was shown by EPR spin-trapping techniques in the different samples. Superoxide and hydroxyl radical production was stimulated in the overexpressor. Two-thirds of the superoxide production was maintained in the presence of DNPINT, an inhibitor of the cytochrome b(6)f complex. No increase of the SOD content was observed in the overexpressor compared with the wild type. We propose that superoxide is produced by PTOX in a side reaction and that PTOX can only act as a safety valve under stress conditions when the generated superoxide is detoxified by an efficient antioxidant system.	CEA, iBiTecS, Serv Bioenerget Biol Struct & Mecanisme, CNRS,URA 2096, F-91191 Gif Sur Yvette, France; [Laureau, Constance] Univ Paris 11, Lab Ecol Systemat & Evolut, CNRS, UMR 8079,IFR 87, F-91405 Orsay, France; [Culcasi, Marcel; Pietri, Sylvia] CNRS, Sondes Mol Biol Lab Chim Prov, UMR 6264, F-13397 Marseille 20, France	CEA; Centre National de la Recherche Scientifique (CNRS); AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS)	Krieger-Liszkay, A (corresponding author), CEA Saclay, iBiTec S, Bat 532, F-91191 Gif Sur Yvette, France.	anja.krieger-liszkay@cea.fr		Krieger-Liszkay, Anja/0000-0001-7141-4129; PIETRI, SYLVIA/0000-0002-9207-0780; Heyno, Eiri/0000-0003-2172-0341				Affourtit C, 2002, FEBS LETT, V510, P121, DOI 10.1016/S0014-5793(01)03261-6; Aluru MR, 2004, PHYSIOL PLANTARUM, V120, P4, DOI 10.1111/j.0031-9317.2004.0217.x; ANANYEV G, 1994, PHOTOSYNTH RES, V41, P327, DOI 10.1007/BF00019410; Andersson ME, 1999, FEBS LETT, V449, P17, DOI 10.1016/S0014-5793(99)00376-2; Arato A, 2004, BBA-BIOENERGETICS, V1608, P171, DOI 10.1016/j.bbabio.2003.12.003; Berliner LJ, 2001, FREE RADICAL BIO MED, V30, P489, DOI 10.1016/S0891-5849(00)00491-3; Berthold DA, 2000, BBA-BIOENERGETICS, V1460, P241, DOI 10.1016/S0005-2728(00)00149-3; Berthold DA, 2003, ANNU REV PLANT BIOL, V54, P497, DOI 10.1146/annurev.arplant.54.031902.134915; BJORKMAN O, 1987, PLANTA, V170, P489, DOI 10.1007/BF00402983; Carol P, 1999, PLANT CELL, V11, P57, DOI 10.1105/tpc.11.1.57; Carol P, 2001, TRENDS PLANT SCI, V6, P31, DOI 10.1016/S1360-1385(00)01811-2; Cournac L, 2000, PHILOS T ROY SOC B, V355, P1447, DOI 10.1098/rstb.2000.0705; Culcasi M, 2006, FREE RADICAL BIO MED, V40, P1524, DOI 10.1016/j.freeradbiomed.2005.12.029; Diaz M, 2007, PLANT CELL ENVIRON, V30, P1578, DOI 10.1111/j.1365-3040.2007.01735.x; Dutilleul C, 2003, PLANT CELL, V15, P1212, DOI 10.1105/tpc.009464; FREJAVILLE C, 1995, J MED CHEM, V38, P258, DOI 10.1021/jm00002a007; Fu AG, 2005, J BIOL CHEM, V280, P42489, DOI 10.1074/jbc.M508940200; Ivanov B, 2007, FEBS LETT, V581, P1342, DOI 10.1016/j.febslet.2007.02.044; Joet T, 2002, J BIOL CHEM, V277, P31623, DOI 10.1074/jbc.M203538200; Josse EM, 2003, EUR J BIOCHEM, V270, P3787, DOI 10.1046/j.1432-1033.2003.03766.x; Karoui H, 2002, CHEM COMMUN, P3030, DOI 10.1039/b209787g; Keren N, 1997, P NATL ACAD SCI USA, V94, P1579, DOI 10.1073/pnas.94.4.1579; KEREN N, 1995, J BIOL CHEM, V270, P806, DOI 10.1074/jbc.270.2.806; Kliebenstein DJ, 1998, PLANT PHYSIOL, V118, P637, DOI 10.1104/pp.118.2.637; Krieger-Liszkay A, 2005, J EXP BOT, V56, P337, DOI 10.1093/jxb/erh237; Kruk J, 2001, J BIOL CHEM, V276, P86, DOI 10.1074/jbc.M003602200; Kruk J, 1999, PHOTOSYNTH RES, V62, P273, DOI 10.1023/A:1006374319191; Kuntz M, 2004, PLANTA, V218, P896, DOI 10.1007/s00425-004-1217-6; LAASCH H, 1987, PLANTA, V171, P220, DOI 10.1007/BF00391097; Lennon AM, 2003, PLANTA, V218, P254, DOI 10.1007/s00425-003-1111-7; Nixon Peter J., 2006, V23, P237; Niyogi KK, 2000, CURR OPIN PLANT BIOL, V3, P455, DOI 10.1016/S1369-5266(00)00113-8; Peltier G, 2002, ANNU REV PLANT BIOL, V53, P523, DOI 10.1146/annurev.arplant.53.100301.135242; Pospisil P, 2004, BIOCHEMISTRY-US, V43, P6783, DOI 10.1021/bi036219i; Quiles MJ, 2006, PLANT CELL ENVIRON, V29, P1463, DOI 10.1111/j.1365-3040.2006.01510.x; RAMOS CL, 1992, J BIOL CHEM, V267, P8307; Rosso D, 2006, PLANT PHYSIOL, V142, P574, DOI 10.1104/pp.106.085886; Rumeau D, 2007, PLANT CELL ENVIRON, V30, P1041, DOI 10.1111/j.1365-3040.2007.01675.x; Shahbazi M, 2007, PLANT PHYSIOL, V145, P691, DOI 10.1104/pp.107.106336; Stepien P, 2009, PLANT PHYSIOL, V149, P1154, DOI 10.1104/pp.108.132407; Streb P, 2005, PLANT CELL ENVIRON, V28, P1123, DOI 10.1111/j.1365-3040.2005.01350.x; TREBST A, 1978, Z NATURFORSCH C, V33, P919; WETZEL CM, 1994, PLANT J, V6, P161, DOI 10.1046/j.1365-313X.1994.6020161.x; Wu DY, 1999, PLANT CELL, V11, P43, DOI 10.1105/tpc.11.1.43	44	61	62	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31174	31180		10.1074/jbc.M109.021667	http://dx.doi.org/10.1074/jbc.M109.021667			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19740740	Green Published, hybrid			2022-12-27	WOS:000271378400045
J	Ingaramo, M; Beckett, D				Ingaramo, Maria; Beckett, Dorothy			Distinct Amino Termini of Two Human HCS Isoforms Influence Biotin Acceptor Substrate Recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOLOCARBOXYLASE SYNTHETASE DEFICIENCY; MULTIPLE CARBOXYLASE DEFICIENCY; ESCHERICHIA-COLI; COA CARBOXYLASE; BIOTINYLATION; EXPRESSION; SEQUENCE; PROTEIN; GENE; IDENTIFICATION	The human holocarboxylase synthetase (HCS) catalyzes transfer of biotin to biotin-dependent carboxylases, and the enzyme is therefore of fundamental importance for many physiological processes, including fatty acid synthesis, gluconeogenesis, and amino acid catabolism. In addition, the enzyme functions in regulating transcription initiation at several genes that code for proteins involved in biotin metabolism. Two major forms of HCS exist in humans, which differ at the amino terminus by 57 amino acids. In this work, the two proteins were expressed in Escherichia coli, purified, and subjected to biochemical characterization. Equilibrium sedimentation indicates that the two proteins are monomers both in their apo-forms and when bound to the enzymatic intermediate biotinyl 5'-AMP. Steady state kinetic analyses as a function of biotin, ATP, or a minimal biotin-accepting substrate concentration indicate similar behaviors for both isoforms. However, pre-steady state analysis of biotin transfer reveals that the full-length HCS associates with the minimal biotin acceptor substrate with a rate twice as fast as that of the truncated isoform. These results are consistent with a role for the HCS amino terminus in biotin acceptor substrate recognition.	[Ingaramo, Maria; Beckett, Dorothy] Univ Maryland, Dept Chem & Biochem, Ctr Biol Struct & Org, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Beckett, D (corresponding author), Univ Maryland, Dept Chem & Biochem, Ctr Biol Struct & Org, College Pk, MD 20742 USA.	dbeckett@umd.edu			National Institutes of Health [R01-GM46511, S10-RR15899]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR015899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046511] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-GM46511 and S10-RR15899.	ABBOTT J, 1993, BIOCHEMISTRY-US, V32, P9649, DOI 10.1021/bi00088a017; Aoki Y, 1997, PEDIATR RES, V42, P849, DOI 10.1203/00006450-199712000-00021; BAKER H, 1962, ANAL BIOCHEM, V3, P31, DOI 10.1016/0003-2697(62)90041-6; BURRI BJ, 1985, AM J HUM GENET, V37, P326; BURRI BJ, 1981, J CLIN INVEST, V68, P1491, DOI 10.1172/JCI110402; Campeau E, 2001, J BIOL CHEM, V276, P12310, DOI 10.1074/jbc.M009717200; CHAUHAN J, 1991, J BIOL CHEM, V266, P10035; DAKSHINAMURTI K, 1968, ARCH BIOCHEM BIOPHYS, V127, P17, DOI 10.1016/0003-9861(68)90195-1; Eisenstein E, 1999, BIOCHEMISTRY-US, V38, P13077, DOI 10.1021/bi991241q; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Healy S, 2009, PROTEIN SCI, V18, P314, DOI 10.1002/pro.37; Hiratsuka M, 1998, BBA-PROTEIN STRUCT M, V1385, P165, DOI 10.1016/S0167-4838(98)00032-6; JOHNSON ML, 1981, BIOPHYS J, V36, P575, DOI 10.1016/S0006-3495(81)84753-4; LANE MD, 1964, J BIOL CHEM, V239, P2865; LEONDELRIO A, 1995, P NATL ACAD SCI USA, V92, P4626, DOI 10.1073/pnas.92.10.4626; LEONDELRIO A, 1994, J BIOL CHEM, V269, P22964; Marblestone JG, 2006, PROTEIN SCI, V15, P182, DOI 10.1110/ps.051812706; MOCK DM, 1981, NEW ENGL J MED, V304, P820, DOI 10.1056/NEJM198104023041405; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Narang MA, 2004, HUM MOL GENET, V13, P15, DOI 10.1093/hmg/ddh006; Nenortas E, 1996, J BIOL CHEM, V271, P7559, DOI 10.1074/jbc.271.13.7559; ROARK DE, 1976, BIOPHYS CHEM, V5, P185, DOI 10.1016/0301-4622(76)80034-8; Sakamoto O, 1999, PEDIATR RES, V46, P671, DOI 10.1203/00006450-199912000-00006; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P379; SHERWOOD WG, 1982, J PEDIATR-US, V101, P546, DOI 10.1016/S0022-3476(82)80697-5; Solorzano-Vargas RS, 2002, P NATL ACAD SCI USA, V99, P5325, DOI 10.1073/pnas.082097699; SUZUKI Y, 1994, NAT GENET, V8, P122, DOI 10.1038/ng1094-122; SWEETMAN L, 1985, ANN NY ACAD SCI, V447, P288, DOI 10.1111/j.1749-6632.1985.tb18446.x; Tissot G, 1998, EUR J BIOCHEM, V258, P586, DOI 10.1046/j.1432-1327.1998.2580586.x; Yang X, 2001, HUM GENET, V109, P526, DOI 10.1007/s004390100603; Zempleni J, 2005, ANNU REV NUTR, V25, P175, DOI 10.1146/annurev.nutr.25.121304.131724	31	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30862	30870		10.1074/jbc.M109.046201	http://dx.doi.org/10.1074/jbc.M109.046201			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19740736	hybrid, Green Published			2022-12-27	WOS:000271378400014
J	Lung, M; Shulga, YV; Ivanova, PT; Myers, DS; Milne, SB; Brown, HA; Topham, MK; Epand, RM				Lung, Michael; Shulga, Yulia V.; Ivanova, Pavlina T.; Myers, David S.; Milne, Stephen B.; Brown, H. Alex; Topham, Matthew K.; Epand, Richard M.			Diacylglycerol Kinase epsilon Is Selective for Both Acyl Chains of Phosphatidic Acid or Diacylglycerol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; DICTYOSTELIUM-DISCOIDEUM; ARABIDOPSIS-THALIANA; HYDROPHOBIC SEGMENT; GENE-EXPRESSION; BINDING DOMAINS; NERVOUS-SYSTEM; IN-VITRO; PROTEIN; ISOFORMS	The phosphatidylinositol ( PI) cycle mediates many cellular events by controlling the metabolism of many lipid second messengers. Diacylglycerol kinase epsilon (DGK epsilon) has an important role in this cycle. DGK epsilon is the only DGK isoform to show inhibition by its product phosphatidic acid (PA) as well as substrate specificity for sn-2 arachidonoyl-diacylglycerol (DAG). Here, we show that this inhibition and substrate specificity are both determined by selectivity for a combination of the sn-1 and sn-2 acyl chains of PA or DAG, respectively, preferring the most prevalent acyl chain composition of lipids involved specifically in the PI cycle, 1-stearoyl-2-arachidonoyl. Although the difference in rate for closely related lipid species is small, there is a significant enrichment of 1-stearoyl-2-arachidonoyl PI because of the cyclical nature of PI turnover. Wealso show that the inhibition of DGK epsilon by PA is competitive and that the deletion of the hydrophobic segment and cationic cluster of DGK epsilon does not affect its selectivity for the acyl chains of PA or DAG. Thus, this active site not only recognizes the lipid headgroup but also a combination of the two acyl chains in PA or DAG. We propose a mechanism of DGK epsilon regulation where its dual acyl chain selectivity is used to negatively regulate its enzymatic activity in a manner that ensures DGK epsilon remains committed to the PI turnover cycle. This novel mechanism of enzyme regulation within a signaling pathway could serve as a template for the regulation of enzymes in other pathways in the cell.	[Epand, Richard M.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Ivanova, Pavlina T.; Myers, David S.; Milne, Stephen B.; Brown, H. Alex] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Topham, Matthew K.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA	McMaster University; Vanderbilt University; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Epand, RM (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, 1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	epand@mcmaster.ca	, Richard/R-2316-2019; Ivanova, Pavlina/K-8307-2012	, Richard/0000-0002-9602-9558; 	National Institutes of Health [R01-CA95463, U54 GM069338]; Natural Sciences and Engineering Research Council of Canada [9848]; NATIONAL CANCER INSTITUTE [R01CA095463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-CA95463 (to M.K.T.) and by National Institutes of Health Large Scale Collaborative Initiative LIPID MAPS Grant U54 GM069338 (to H.A.B.). This work was also supported by Natural Sciences and Engineering Research Council of Canada Grant 9848 (to R.M.E.).	Ames B.N., 1966, METHOD ENZYMOL, V8, P115, DOI [10.1016/0076-6879(66)08014-5, DOI 10.1016/0076-6879(66)08014-5]; Caloca MJ, 1999, P NATL ACAD SCI USA, V96, P11854, DOI 10.1073/pnas.96.21.11854; CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; Carrasco S, 2007, TRENDS BIOCHEM SCI, V32, P27, DOI 10.1016/j.tibs.2006.11.004; Cipres A, 2003, J BIOL CHEM, V278, P35629, DOI 10.1074/jbc.M305635200; de la Roche MA, 2002, BIOCHEM J, V368, P809, DOI 10.1042/BJ20021027; de Turco EBR, 2001, P NATL ACAD SCI USA, V98, P4740, DOI 10.1073/pnas.081536298; Decaffmeyer M, 2008, J MOL BIOL, V383, P797, DOI 10.1016/j.jmb.2008.08.076; Deems RA, 2000, ANAL BIOCHEM, V287, P1, DOI 10.1006/abio.2000.4766; Delon C, 2004, J BIOL CHEM, V279, P44763, DOI 10.1074/jbc.M405771200; Dicu AO, 2007, BIOCHEMISTRY-US, V46, P6109, DOI 10.1021/bi6024726; Epand RM, 2007, BIOCHEMISTRY-US, V46, P14225, DOI 10.1021/bi701584v; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Ghosh S, 1996, J BIOL CHEM, V271, P8472, DOI 10.1074/jbc.271.14.8472; Gomez-Merino FC, 2005, J BIOL CHEM, V280, P34888, DOI 10.1074/jbc.M506859200; Gomez-Merino FC, 2004, J BIOL CHEM, V279, P8230, DOI 10.1074/jbc.M312187200; Goto K, 1999, CHEM PHYS LIPIDS, V98, P109, DOI 10.1016/S0009-3084(99)00023-7; Gotoh A, 2008, ARTHROPOD STRUCT DEV, V37, P199, DOI 10.1016/j.asd.2007.11.001; Han GS, 2008, J BIOL CHEM, V283, P20443, DOI 10.1074/jbc.M802866200; Han GS, 2008, J BIOL CHEM, V283, P20433, DOI 10.1074/jbc.M802903200; HARDEN N, 1993, BIOCHEM J, V289, P439, DOI 10.1042/bj2890439; Holub B J, 1978, Adv Lipid Res, V16, P1; Ivanova PT, 2007, METHOD ENZYMOL, V432, P21, DOI 10.1016/S0076-6879(07)32002-8; JENKINS GH, 1994, J BIOL CHEM, V269, P11547; JONES GA, 1993, J BIOL CHEM, V268, P20845; Jones JA, 2002, J BIOL CHEM, V277, P15530, DOI 10.1074/jbc.M111555200; KAI M, 1994, J BIOL CHEM, V269, P18492; Kanoh H, 2002, J BIOCHEM, V131, P629, DOI 10.1093/oxfordjournals.jbchem.a003144; Katagiri T, 1996, PLANT MOL BIOL, V30, P647, DOI 10.1007/BF00049339; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; LIMATOLA C, 1994, BIOCHEM J, V304, P1001, DOI 10.1042/bj3041001; Lucas P, 2003, NEURON, V40, P551, DOI 10.1016/S0896-6273(03)00675-5; MASAI I, 1993, P NATL ACAD SCI USA, V90, P11157, DOI 10.1073/pnas.90.23.11157; MASAI I, 1992, P NATL ACAD SCI USA, V89, P6030, DOI 10.1073/pnas.89.13.6030; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; Miller KG, 1999, NEURON, V24, P323, DOI 10.1016/S0896-6273(00)80847-8; Milne SB, 2008, BIOCHEMISTRY-US, V47, P9372, DOI 10.1021/bi800492c; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; Ostroski M, 2005, BIOCHEMISTRY-US, V44, P10199, DOI 10.1021/bi0507276; Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496; Pettitt TR, 1999, J BIOL CHEM, V274, P36181, DOI 10.1074/jbc.274.51.36181; Postle AD, 2004, BIOCHEM SOC T, V32, P1057, DOI 10.1042/BST0321057; Ron D, 1999, FASEB J, V13, P1658, DOI 10.1096/fasebj.13.13.1658; SAKANE F, 1991, J BIOL CHEM, V266, P7096; Sakane F, 2007, BBA-MOL CELL BIOL L, V1771, P793, DOI 10.1016/j.bbalip.2007.04.006; Siddhanta A, 1998, J BIOL CHEM, V273, P17995, DOI 10.1074/jbc.273.29.17995; TANG Q, 1996, J BIOL CHEM, V271, P10237; Thirugnanam S, 2001, BIOCHEMISTRY-US, V40, P10607, DOI 10.1021/bi010609s; Toker A, 2002, CELL MOL LIFE SCI, V59, P761, DOI 10.1007/s00018-002-8465-z; Toker A., 1998, FRONT BIOSCI-LANDMRK, V3, P1134, DOI 10.2741/A350; Topham MK, 2009, BBA-GEN SUBJECTS, V1790, P416, DOI 10.1016/j.bbagen.2009.01.010; Topham MK, 2006, J CELL BIOCHEM, V97, P474, DOI 10.1002/jcb.20704; Tu-Sekine B, 2007, BIOCHEMISTRY-US, V46, P924, DOI 10.1021/bi061170c; van Blitterswijk WJ, 2000, CELL SIGNAL, V12, P595, DOI 10.1016/S0898-6568(00)00113-3; VANCORVEN EJ, 1992, BIOCHEM J, V281, P163, DOI 10.1042/bj2810163; Wakelam MJO, 1998, BBA-MOL CELL BIOL L, V1436, P117, DOI 10.1016/S0005-2760(98)00123-4; WALSH JP, 1994, J BIOL CHEM, V269, P21155; WALSH JP, 1995, J BIOL CHEM, V270, P28647, DOI 10.1074/jbc.270.48.28647	58	50	51	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31062	31073		10.1074/jbc.M109.050617	http://dx.doi.org/10.1074/jbc.M109.050617			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19744926	Green Published, hybrid			2022-12-27	WOS:000271378400035
J	Faa, V; Incani, F; Meloni, A; Corda, D; Masala, M; Baffico, AM; Seia, M; Cao, A; Rosatelli, MC				Faa, Valeria; Incani, Federica; Meloni, Alessandra; Corda, Denise; Masala, Maddalena; Baffico, A. Maria; Seia, Manuela; Cao, Antonio; Rosatelli, M. Cristina			Characterization of a Disease-associated Mutation Affecting a Putative Splicing Regulatory Element in Intron 6b of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MESSENGER-RNA; VAS-DEFERENS; DISSEMINATED BRONCHIECTASIS; CONGENITAL ABSENCE; EXON; PROTEINS; COMPLEX; PANCREATITIS; SPLICEOSOME	Cystic fibrosis (CF) is a common recessive disorder caused by > 1600 mutations in the CF transmembrane conductance regulator (CFTR) gene. About 13% of CFTR mutations are classified as "splicing mutations," but for almost 40% of these, their role in affecting the pre-mRNA splicing of the gene is not yet defined. In this work, we describe a new splicing mutation detected in three unrelated Italian CF patients. By DNA analyses and mRNA studies, we identified the c.1002-1110_1113delTAAG mutation localized in intron 6b of the CFTR gene. At the mRNA level, this mutation creates an aberrant inclusion of a sequence of 101 nucleotides between exons 6b and 7. This sequence corresponds to a portion of intron 6b and resembles a cryptic exon because it is characterized by an upstream ag and a downstream gt sequence, which are most probably recognized as 5'- and 3'-splice sites by the spliceosome. Through functional analysis of this splicing defect, we show that this mutation abolishes the interaction of the splicing regulatory protein heterogeneous nuclear ribonucleoprotein A2/B1 with an intronic splicing regulatory element and creates a new recognition motif for the SRp75 splicing factor, causing activation of the cryptic exon. Our results show that the c.1002-1110_1113delTAAG mutation creates a new intronic splicing regulatory element in intron 6b of the CFTR gene exclusively recognized by SRp75.	[Incani, Federica; Corda, Denise; Masala, Maddalena; Rosatelli, M. Cristina] Univ Cagliari, Dipt Sci Biomed & Biotecnol, I-09121 Cagliari, Italy; [Faa, Valeria; Meloni, Alessandra; Cao, Antonio] CNR, Ist Neurogenet & Neurofarmacol, I-09042 Cagliari, Italy; [Baffico, A. Maria] Ente Osped Galliera, I-16128 Genoa, Italy; [Seia, Manuela] Fdn Policlin Mangiagalli & Regina Elena, I-20122 Milan, Italy	University of Cagliari; Consiglio Nazionale delle Ricerche (CNR); Ente Ospedaliero Ospedali Galliera; IRCCS Ca Granda Ospedale Maggiore Policlinico	Rosatelli, MC (corresponding author), Univ Cagliari, Dipt Sci Biomed & Biotecnol, Via Jenner, I-09121 Cagliari, Italy.	rosatelli@mcweb.unica.it		MASALA, MADDALENA/0000-0003-1222-2885; Faa, Valeria/0000-0001-9783-7904; ROSATELLI, MARIA CRISTINA/0000-0001-6821-3190; incani, federica/0000-0003-2699-8035	Italian Cystic Fibrosis Research Foundation [FFC24/2006]	Italian Cystic Fibrosis Research Foundation(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation)	This work was supported by an Italian Cystic Fibrosis Research Foundation grant (to M. C. R.), Project FFC24/2006, adopted by Silvana Ratti (Pesaro, Italy).	AMENDT BA, 1995, MOL CELL BIOL, V15, P4606; Ars E, 2000, HUM MOL GENET, V9, P237, DOI 10.1093/hmg/9.2.237; Caputi M, 1999, EMBO J, V18, P4060, DOI 10.1093/emboj/18.14.4060; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Chiba-Falek O, 1998, GENOMICS, V53, P276, DOI 10.1006/geno.1998.5517; Chiba-Falek O, 1999, AM J RESP CRIT CARE, V159, P1998, DOI 10.1164/ajrccm.159.6.9808012; CHILLON M, 1995, AM J HUM GENET, V56, P623; CHILLON M, 1995, NEW ENGL J MED, V332, P1475, DOI 10.1056/NEJM199506013322204; Cohn JA, 1998, NEW ENGL J MED, V339, P653, DOI 10.1056/NEJM199809033391002; COSTES B, 1995, EUR J HUM GENET, V3, P285; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Estivill X, 1997, HUM MUTAT, V10, P135, DOI 10.1002/(SICI)1098-1004(1997)10:2<135::AID-HUMU6>3.3.CO;2-P; Faa V, 2006, J MOL DIAGN, V8, P499, DOI 10.2353/jmoldx.2006.050146; Fairbrother WG, 2000, MOL CELL BIOL, V20, P6816, DOI 10.1128/MCB.20.18.6816-6825.2000; Girodon E, 1997, EUR J HUM GENET, V5, P149, DOI 10.1159/000484750; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; Groman JD, 2002, NEW ENGL J MED, V347, P401, DOI 10.1056/NEJMoa011899; HIGHSMITH WE, 1994, NEW ENGL J MED, V331, P974, DOI 10.1056/NEJM199410133311503; Ishii S, 2002, AM J HUM GENET, V70, P994, DOI 10.1086/339431; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Nilsen TW, 2003, BIOESSAYS, V25, P1147, DOI 10.1002/bies.10394; Nissim-Rafinia M, 2000, HUM MOL GENET, V9, P1771, DOI 10.1093/hmg/9.12.1771; Pagani F, 2000, J BIOL CHEM, V275, P21041, DOI 10.1074/jbc.M910165199; Pagani F, 2002, NAT GENET, V30, P426, DOI 10.1038/ng858; PIGNATTI PF, 1995, HUM MOL GENET, V4, P635, DOI 10.1093/hmg/4.4.635; Sharer N, 1998, NEW ENGL J MED, V339, P645, DOI 10.1056/NEJM199809033391001; Sironi M, 2004, NUCLEIC ACIDS RES, V32, P1783, DOI 10.1093/nar/gkh341; STAFFA A, 1995, MOL CELL BIOL, V15, P4597; Sun HZ, 2000, MOL CELL BIOL, V20, P6414, DOI 10.1128/MCB.20.17.6414-6425.2000; Vervoort R, 1998, HUM GENET, V103, P686, DOI 10.1007/PL00008709; Wang M, 1997, BREAST CANCER RES TR, V44, P145, DOI 10.1023/A:1005753117205; Welsh MJ, 1995, CYSTIC FIBROSIS META, P3799; Yeakley JM, 1996, P NATL ACAD SCI USA, V93, P7582, DOI 10.1073/pnas.93.15.7582; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031; ZIELENSKI J, 1995, AM J HUM GENET, V57, P958	36	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30024	30031		10.1074/jbc.M109.032623	http://dx.doi.org/10.1074/jbc.M109.032623			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19759008	Green Published, hybrid			2022-12-27	WOS:000271090000004
J	Sette, M; Spurio, R; Trotta, E; Brandizi, C; Brandi, A; Pon, CL; Barbato, G; Boelens, R; Gualerzi, CO				Sette, Marco; Spurio, Roberto; Trotta, Edoardo; Brandizi, Cinzia; Brandi, Anna; Pon, Cynthia L.; Barbato, Gaetano; Boelens, Rolf; Gualerzi, Claudio O.			Sequence-specific Recognition of DNA by the C-terminal Domain of Nucleoid-associated Protein H-NS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CURVED DNA; TRANSCRIPTIONAL CONTROL; STRUCTURAL BASIS; BINDING PROTEIN; VIRF PROMOTER; GENE; SHIGELLA; EXPRESSION; OLIGOMERIZATION	The molecular determinants necessary and sufficient for recognition of its specific DNA target are contained in the C-terminal domain (H-NSctd) of nucleoid-associated protein H-NS. H-NSctd protects from DNaseI cleavage a few short DNA segments of the H-NS-sensitive hns promoter whose sequences closely match the recently identified H-NS consensus motif (tCG(t/a)T(a/t)AATT) and, alone or fused to the protein oligomerization domain of phage lambda CI repressor, inhibits transcription from the hns promoter in vitro and in vivo. The importance of H-NS oligomerization is indicated by the fact that with an extended hns promoter construct (400 bp), which allows protein oligomerization, DNA binding and transcriptional repression are highly and almost equally efficient with native H-NS and H-NSctd::lambda CI and much less effective with the monomeric H-NSctd. With a shorter (110 bp) construct, which does not sustain extensive protein oligomerization, transcriptional repression is less effective, but native H-NS, H-NSctd::lambda CI, and monomeric H-NSctd have comparable activity on this construct. The specific H-NS-DNA interaction was investigated by NMR spectroscopy using monomeric H-NSctd and short DNA duplexes encompassing the H-NS target sequence of hns (TCCTTACATT) with the best fit (8 of 10 residues) to the H-NS-binding motif. H-NSctd binds specifically and with high affinity to the chosen duplexes via an overall electropositive surface involving four residues (Thr(109), Arg(113), Thr(114), and Ala(116)) belonging to the same protein loop and Glu(101). The DNA target is recognized by virtue of its sequence and of a TpA step that confers a structural irregularity to the B-DNA duplex.	[Spurio, Roberto; Brandizi, Cinzia; Brandi, Anna; Pon, Cynthia L.; Gualerzi, Claudio O.] Univ Camerino, Genet Lab, Dept Biol, I-62032 Camerino, MC, Italy; [Trotta, Edoardo] CNR, Inst Neurobiol & Mol Med, I-00133 Rome, Italy; [Sette, Marco] Univ Roma Tor Vergata, Dept Chem Sci & Technol, I-00133 Rome, Italy; [Barbato, Gaetano] Merck Ist Ric Biol Mol P Angeletti, I-00040 Pomezia, Italy; [Boelens, Rolf] Univ Utrecht, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands	University of Camerino; Consiglio Nazionale delle Ricerche (CNR); University of Rome Tor Vergata; Merck & Company; Utrecht University	Gualerzi, CO (corresponding author), Univ Camerino, Genet Lab, Dept Biol MCA, I-62032 Camerino, MC, Italy.	claudio.gualerzi@unicam.it	Trotta, Edoardo/AAW-4697-2020; Barbato, Gaetano/G-4904-2011; Boelens, Rolf/B-4702-2009	Trotta, Edoardo/0000-0002-1417-9238; Barbato, Gaetano/0000-0001-9840-6858; Boelens, Rolf/0000-0002-6939-8913; Spurio, Roberto/0000-0002-7611-4341	Programmi di Ricerca di Rilevante Interesse Nazionale [PRIN 2003, PRIN 2005]; Ministero dell'Istruzione; dell'Universita e della Ricerca; European Commission [RII3-026145]	Programmi di Ricerca di Rilevante Interesse Nazionale(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Ministero dell'Istruzione(Ministry of Education, Universities and Research (MIUR)); dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by Programmi di Ricerca di Rilevante Interesse Nazionale Grants PRIN 2003 (to C. L. P. and M. S.) and PRIN 2005 ( to C. L. P. and R. S.) from the Ministero dell'Istruzione, dell'Universita e della Ricerca and by Contract RII3-026145 from the European Commission 6th Framework for Access to Research Infrastructures.	Badaut C, 2002, J BIOL CHEM, V277, P41657, DOI 10.1074/jbc.M206037200; BAIN DL, 1994, BIOCHEMISTRY-US, V33, P14679, DOI 10.1021/bi00253a005; Bloch V, 2003, NAT STRUCT BIOL, V10, P212, DOI 10.1038/nsb904; Bouffartigues E, 2007, NAT STRUCT MOL BIOL, V14, P441, DOI 10.1038/nsmb1233; BRACCO L, 1989, EMBO J, V8, P4289, DOI 10.1002/j.1460-2075.1989.tb08615.x; Brandi A, 1999, EMBO J, V18, P1653, DOI 10.1093/emboj/18.6.1653; Dame RT, 2005, MOL MICROBIOL, V56, P858, DOI 10.1111/j.1365-2958.2005.04598.x; Dame RT, 2002, J BIOL CHEM, V277, P2146, DOI 10.1074/jbc.C100603200; Dame RT, 2001, BIOCHIMIE, V83, P231; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DERSCH P, 1993, MOL MICROBIOL, V8, P875, DOI 10.1111/j.1365-2958.1993.tb01634.x; Dorman CJ, 2004, NAT REV MICROBIOL, V2, P391, DOI 10.1038/nrmicro883; FALCONI M, 1993, MOL MICROBIOL, V10, P273, DOI 10.1111/j.1365-2958.1993.tb01953.x; Falconi M, 1998, EMBO J, V17, P7033, DOI 10.1093/emboj/17.23.7033; Falconi M, 1996, MOL MICROBIOL, V19, P965, DOI 10.1046/j.1365-2958.1996.436961.x; Falconi M, 2001, MOL MICROBIOL, V42, P439, DOI 10.1046/j.1365-2958.2001.02646.x; Goldenberg D, 1997, MOL GEN GENET, V256, P282, DOI 10.1007/s004380050571; Hardy CD, 2005, MOL MICROBIOL, V57, P1636, DOI 10.1111/j.1365-2958.2005.04799.x; Hommais F, 2001, MOL MICROBIOL, V40, P20, DOI 10.1046/j.1365-2958.2001.02358.x; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Lang B, 2007, NUCLEIC ACIDS RES, V35, P6330, DOI 10.1093/nar/gkm712; LATEANA A, 1991, P NATL ACAD SCI USA, V88, P10907, DOI 10.1073/pnas.88.23.10907; Leonard PG, 2009, MOL MICROBIOL, V73, P165, DOI 10.1111/j.1365-2958.2009.06754.x; Lingbeck J, 1996, BIOCHEMISTRY-US, V35, P719, DOI 10.1021/bi951364k; Luijsterburg MS, 2006, J STRUCT BIOL, V156, P262, DOI 10.1016/j.jsb.2006.05.006; Madrid C, 2002, J BACTERIOL, V184, P5058, DOI 10.1128/JB.184.18.5058-5066.2002; Pon CL, 2005, MOL B INT U, P52; Prosseda G, 2004, MOL MICROBIOL, V51, P523, DOI 10.1046/j.1365-2958.2003.03848.x; Protozanova E, 2004, J MOL BIOL, V342, P775, DOI 10.1016/j.jmb.2004.07.075; RIMSKY S, 1990, BIOCHEMISTRY-US, V29, P3765, DOI 10.1021/bi00467a024; Rimsky S, 2004, CURR OPIN MICROBIOL, V7, P109, DOI 10.1016/j.mib.2004.02.001; Rimsky S, 2001, MOL MICROBIOL, V42, P1311, DOI 10.1046/j.1365-2958.2001.02706.x; SHINDO H, 1995, FEBS LETT, V360, P125, DOI 10.1016/0014-5793(95)00079-O; Shindo H, 1999, FEBS LETT, V455, P63, DOI 10.1016/S0014-5793(99)00862-5; Spurio R, 1997, EMBO J, V16, P1795, DOI 10.1093/emboj/16.7.1795; Stella S, 2005, EMBO J, V24, P2896, DOI 10.1038/sj.emboj.7600754; TIPPNER D, 1995, J BIOL CHEM, V270, P22243, DOI 10.1074/jbc.270.38.22243; TOBE T, 1993, J BACTERIOL, V175, P6142, DOI 10.1128/JB.175.19.6142-6149.1993; USSERY DW, 1994, BIOCHIMIE, V76, P968, DOI 10.1016/0300-9084(94)90022-1; WIJMENGA SS, 1993, NMR MACROMOLECULES P, P216; YAMADA H, 1990, J BIOCHEM-TOKYO, V108, P420, DOI 10.1093/oxfordjournals.jbchem.a123216; YAMADA H, 1991, MOL GEN GENET, V230, P332, DOI 10.1007/BF00290685; YASUZAWA K, 1992, GENE, V122, P9; ZUBER F, 1994, MOL MICROBIOL, V12, P231, DOI 10.1111/j.1365-2958.1994.tb01012.x	44	36	36	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30453	30462		10.1074/jbc.M109.044313	http://dx.doi.org/10.1074/jbc.M109.044313			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19740756	Green Published, hybrid			2022-12-27	WOS:000271090000048
J	Wen, KK; Rubenstein, PA; DeMali, KA				Wen, Kuo-Kuang; Rubenstein, Peter A.; DeMali, Kris A.			Vinculin Nucleates Actin Polymerization and Modifies Actin Filament Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE THIN-FILAMENTS; COUPLING MEMBRANE PROTRUSION; F-ACTIN; ALPHA-ACTININ; ARP2/3 COMPLEX; 3-DIMENSIONAL RECONSTRUCTION; INTRAMOLECULAR ASSOCIATION; CYTOSKELETAL PROTEIN; MYOSIN SUBFRAGMENT-1; SKELETAL-MUSCLE	Vinculin links integrins to the actin cytoskeleton by binding F-actin. Little is known with respect to how this interaction occurs or affects actin dynamics. Here we assess the consequence of the vinculin tail (VT) on actin dynamics by examining its binding to monomeric and filamentous yeast actins. VT causes pyrene-labeled G-actin to polymerize in low ionic strength buffer (G-buffer), conditions that normally do not promote actin polymerization. Analysis by electron microscopy shows that, under these conditions, the filaments form small bundles at low VT concentrations, which gradually increase in size until saturation occurs at a ratio of 2 VT:1 actin. Addition of VT to pyrene-labeled mutant yeast G-actin (S265C) produced a fluorescence excimer band, which requires a relatively normal filament geometry. In higher ionic strength polymerization-promoting F-buffer, substoichiometric amounts of VT accelerate the polymerization of pyrene-labeled WT actin. However, the amplitude of the pyrene fluorescence caused by actin polymerization is quenched as the VT concentration increases without an effect on net actin polymerization as determined by centrifugation assays. Finally, addition of VT to preformed pyrene-labeled S265C F-actin causes a concentration-dependent decrease in the maximum amplitude of the pyrene fluorescence band demonstrating the ability of VT to remodel the conformation of the actin filament. These observations support the idea that vinculin can link adhesion plaques to the cytoskeleton by initiating the formation of bundled actin filaments or by remodeling existing filaments.	[Wen, Kuo-Kuang; Rubenstein, Peter A.; DeMali, Kris A.] Univ Iowa, Dept Biochem, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa	DeMali, KA (corresponding author), Univ Iowa, Dept Biochem, Roy J & Lucille A Carver Coll Med, 51 Newton Rd,4-470 BSB, Iowa City, IA 52242 USA.	kris-demali@uiowa.edu		DeMali, Kris/0000-0003-0906-1371; Rubenstein, Peter/0000-0003-1225-4414	National Institutes of Health [1K01CA111818, GM33689]; American Cancer Society [115274]; NATIONAL CANCER INSTITUTE [K01CA111818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033689] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1K01CA111818 (to K. A. D.) and GM33689 (to P. A. R.). This work was also supported by American Cancer Society Research Scholar Grant 115274 (to K. A. D.).	Bakolitsa C, 1999, CELL, V99, P603, DOI 10.1016/S0092-8674(00)81549-4; Bamburg JR, 1999, TRENDS CELL BIOL, V9, P364, DOI 10.1016/S0962-8924(99)01619-0; Bobkov AA, 2004, J MOL BIOL, V337, P93, DOI 10.1016/j.jmb.2004.01.014; BRETSCHER A, 1981, P NATL ACAD SCI-BIOL, V78, P6849, DOI 10.1073/pnas.78.11.6849; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Chen H, 2006, J BIOL CHEM, V281, P40389, DOI 10.1074/jbc.M607324200; Cohen DM, 2005, J BIOL CHEM, V280, P17109, DOI 10.1074/jbc.M414704200; COOK RK, 1993, J BIOL CHEM, V268, P2410; DeMali KA, 2003, J CELL SCI, V116, P2389, DOI 10.1242/jcs.00605; DeMali KA, 2002, J CELL BIOL, V159, P881, DOI 10.1083/jcb.200206043; DETMERS P, 1981, J BIOL CHEM, V256, P99; Esue O, 2008, J MOL BIOL, V384, P324, DOI 10.1016/j.jmb.2008.09.043; Feng L, 1997, J BIOL CHEM, V272, P16829, DOI 10.1074/jbc.272.27.16829; Galbraith CG, 2007, SCIENCE, V315, P992, DOI 10.1126/science.1137904; Goldmann WH, 1998, EUR J BIOCHEM, V254, P413, DOI 10.1046/j.1432-1327.1998.2540413.x; GRAZI E, 1980, FEBS LETT, V112, P67, DOI 10.1016/0014-5793(80)80129-3; Hodgkinson JL, 1997, J MOL BIOL, V273, P150, DOI 10.1006/jmbi.1997.1307; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Huttelmaier S, 1997, EUR J BIOCHEM, V247, P1136, DOI 10.1111/j.1432-1033.1997.01136.x; Janssen MEW, 2006, MOL CELL, V21, P271, DOI 10.1016/j.molcel.2005.11.020; JOCKUSCH BM, 1981, P NATL ACAD SCI-BIOL, V78, P3005, DOI 10.1073/pnas.78.5.3005; Johnson RP, 2000, J BIOL CHEM, V275, P95, DOI 10.1074/jbc.275.1.95; JOHNSON RP, 1995, NATURE, V373, P261, DOI 10.1038/373261a0; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; LEHMAN W, 1994, NATURE, V368, P65, DOI 10.1038/368065a0; LEHMAN W, 1995, J MOL BIOL, V251, P191, DOI 10.1006/jmbi.1995.0425; MCGOUGH A, 1994, J CELL BIOL, V126, P433, DOI 10.1083/jcb.126.2.433; MENKEL AR, 1994, J CELL BIOL, V126, P1231, DOI 10.1083/jcb.126.5.1231; MILLER L, 1988, J BIOL CHEM, V263, P1996; Moese S, 2007, CELL MICROBIOL, V9, P1148, DOI 10.1111/j.1462-5822.2006.00856.x; Mullins RD, 1997, J CELL BIOL, V136, P331, DOI 10.1083/jcb.136.2.331; Nolz JC, 2007, MOL CELL BIOL, V27, P5986, DOI 10.1128/MCB.00136-07; ORIOLAUDIT C, 1978, EUR J BIOCHEM, V87, P371, DOI 10.1111/j.1432-1033.1978.tb12386.x; OTTO JJ, 1986, CELL MOTIL CYTOSKEL, V6, P48, DOI 10.1002/cm.970060107; PARDO JV, 1983, P NATL ACAD SCI-BIOL, V80, P1008, DOI 10.1073/pnas.80.4.1008; PARDO JV, 1983, J CELL BIOL, V97, P1081, DOI 10.1083/jcb.97.4.1081; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; ROSENFELD GC, 1985, J CELL BIOL, V100, P669, DOI 10.1083/jcb.100.3.669; Schindeler A, 2005, EXP CELL RES, V307, P367, DOI 10.1016/j.yexcr.2005.04.006; SCHRODER RR, 1993, NATURE, V364, P171, DOI 10.1038/364171a0; Serrels B, 2007, NAT CELL BIOL, V9, P1046, DOI 10.1038/ncb1626; Sowa GZ, 2006, J PHYS CHEM B, V110, P22279, DOI 10.1021/jp063371w; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Steimle PA, 1999, J BIOL CHEM, V274, P18414, DOI 10.1074/jbc.274.26.18414; Tseng Y, 2004, J BIOL CHEM, V279, P1819, DOI 10.1074/jbc.M306090200; Tseng Y, 2001, J MOL BIOL, V310, P351, DOI 10.1006/jmbi.2001.4716; VIBERT P, 1993, J CELL BIOL, V123, P313, DOI 10.1083/jcb.123.2.313; Vicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564; Weekes J, 1996, BIOCHEM J, V314, P827, DOI 10.1042/bj3140827; Wen KK, 2008, J BIOL CHEM, V283, P9444, DOI 10.1074/jbc.M709806200; Wen KK, 2009, J BIOL CHEM, V284, P16776, DOI 10.1074/jbc.M109.006981; WILKINS JA, 1982, CELL, V28, P83, DOI 10.1016/0092-8674(82)90377-4; WILKINS JA, 1986, J CELL BIOL, V102, P1085, DOI 10.1083/jcb.102.3.1085; Xu JY, 2000, J BIOL CHEM, V275, P35886, DOI 10.1074/jbc.M002377200; Zimerman B, 2004, CELL MOTIL CYTOSKEL, V58, P143, DOI 10.1002/cm.20005	55	56	56	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30463	30473		10.1074/jbc.M109.021295	http://dx.doi.org/10.1074/jbc.M109.021295			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19736312	Green Published, hybrid			2022-12-27	WOS:000271090000049
J	Ballal, RD; Saha, T; Fan, SJ; Haddad, BR; Rosen, EM				Ballal, Rahul D.; Saha, Tapas; Fan, Saijun; Haddad, Bassam R.; Rosen, Eliot M.			BRCA1 Localization to the Telomere and Its Loss from the Telomere in Response to DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUSCEPTIBILITY GENE BRCA1; BREAST-CANCER; CELL-LINES; CATALYTIC SUBUNIT; LENGTH CONTROL; COMPLEX; ASSOCIATION; INHIBITION; DISRUPTION; EXPRESSION	BRCA1, a tumor suppressor, participates in DNA damage signaling and repair. Previously, we showed that BRCA1 overexpression caused inhibition of telomerase activity and telomere shortening in breast and prostate cancer cells. We now report that BRCA1 knockdown causes increased telomerase reverse transcriptase expression, telomerase activity, and telomere length; but studies utilizing a combination of BRCA1 and telomerase reverse transcriptase small interfering RNAs suggest that BRCA1 also regulates telomere length independently of telomerase. Using telomeric chromatin immunoprecipitation assays, we detected BRCA1 at the telomere and demonstrated time-dependent loss of BRCA1 from the telomere following DNA damage. Further studies suggest that BRCA1 interacts with TRF1 and TRF2 in a DNA-dependent manner and that some of the nuclear BRCA1 colocalizes with TRF1/2. Our findings further suggest that Rad50 is required to localize BRCA1 at the telomere and that the association of BRCA1 with Rad50 does not require DNA. Finally, we found that BRCA1 regulates the length of the 3' G-rich overhang in a manner that is dependent upon Rad50. Our findings suggest that BRCA1 is recruited to the telomere in a Rad50-dependent manner and that BRCA1 may regulate telomere length and stability, in part through its presence at the telomere.	[Rosen, Eliot M.] Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Sch Med, Washington, DC 20057 USA; [Ballal, Rahul D.; Rosen, Eliot M.] Georgetown Univ, Sch Med, Dept Biochem & Mol & Cellular Biol, Washington, DC 20057 USA	Georgetown University; Georgetown University	Rosen, EM (corresponding author), Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Sch Med, 3970 Reservoir Rd NW, Washington, DC 20057 USA.	emr36@georgetown.edu			National Institutes of Health United States Public Health Service [RO1-CA80000, RO1-CA82599, RO1-CA104546]; American Federation for Aging Research; Cosmos Scholars Foundation; NATIONAL CANCER INSTITUTE [R01CA104546, R01CA080000, R01CA082599] Funding Source: NIH RePORTER	National Institutes of Health United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); American Federation for Aging Research; Cosmos Scholars Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health United States Public Health Service Grants RO1-CA80000, RO1-CA82599, and RO1-CA104546 (to E.M.R.). This work was also supported by a predoctoral award from the American Federation for Aging Research (to R.D.B.) and the Cosmos Scholars Foundation Henry H. Work Science Award (to R.D.B.).	Al-Wahiby S, 2005, CYTOGENET GENOME RES, V109, P491, DOI 10.1159/000084208; ALLEY MC, 1988, CANCER RES, V48, P589; Bae I, 2005, CELL CYCLE, V4, P1641, DOI 10.4161/cc.4.11.2152; Blackburn EH, 1997, BIOCHEMISTRY-MOSCOW+, V62, P1196; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Chai WH, 2006, EMBO REP, V7, P225, DOI 10.1038/sj.embor.7400600; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; Counter CM, 1997, P NATL ACAD SCI USA, V94, P9202, DOI 10.1073/pnas.94.17.9202; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Fan SJ, 2001, ONCOGENE, V20, P4827, DOI 10.1038/sj.onc.1204666; Fan SJ, 1998, ONCOGENE, V16, P3069, DOI 10.1038/sj.onc.1202116; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; French JD, 2006, GENE CHROMOSOME CANC, V45, P277, DOI 10.1002/gcc.20290; Greider CW, 1999, CELL, V97, P419, DOI 10.1016/S0092-8674(00)80750-3; Hahn WC, 1999, NAT MED, V5, P1164, DOI 10.1038/13495; Igbavboa U, 2003, J BIOL CHEM, V278, P17150, DOI 10.1074/jbc.M301150200; Jiang L, 2004, BIOL REPROD, V70, P1589, DOI 10.1095/biolreprod.103.022616; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Ma YX, 2006, MOL ENDOCRINOL, V20, P14, DOI 10.1210/me.2004-0488; McEachern MJ, 2000, ANNU REV GENET, V34, P331, DOI 10.1146/annurev.genet.34.1.331; McPherson JP, 2006, HUM MOL GENET, V15, P831, DOI 10.1093/hmg/ddl002; Meeker AK, 2002, AM J PATHOL, V160, P1259, DOI 10.1016/S0002-9440(10)62553-9; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Monteiro ANA, 1996, P NATL ACAD SCI USA, V93, P13595, DOI 10.1073/pnas.93.24.13595; MORIN GB, 1989, CELL, V59, P521, DOI 10.1016/0092-8674(89)90035-4; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Rosen EM, 2006, CANCER LETT, V236, P175, DOI 10.1016/j.canlet.2005.04.037; Rosen EM, 2003, J CELL PHYSIOL, V196, P19, DOI 10.1002/jcp.10257; Staff S, 2003, CANCER RES, V63, P4978; Tahara H, 2005, NAT METHODS, V2, P829, DOI 10.1038/NMETH797; Wang X, 2007, CELL DEATH DIFFER, V14, P924, DOI 10.1038/sj.cdd.4402105; Weisberg TF, 1996, MOL CELL PROBE, V10, P139, DOI 10.1006/mcpr.1996.0019; Wilson CA, 1999, NAT GENET, V21, P236, DOI 10.1038/6029; Wu GK, 2003, CANCER RES, V63, P2589; Wu Y, 2007, NAT STRUCT MOL BIOL, V14, P832, DOI 10.1038/nsmb1286; Xiong JB, 2003, MOL CELL BIOL, V23, P8668, DOI 10.1128/MCB.23.23.8668-8690.2003; Zhao Y, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1063; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747; Zhu XD, 2000, NAT GENET, V25, P347, DOI 10.1038/77139	40	45	50	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36083	36098		10.1074/jbc.M109.025825	http://dx.doi.org/10.1074/jbc.M109.025825			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19797051	Green Published, hybrid			2022-12-27	WOS:000272970500010
J	Beckham, SA; Boyd, SE; Reynolds, S; Willis, C; Johnstone, M; Mika, A; Simerska, P; Wijeyewickrema, LC; Smith, AI; Kemp, DJ; Pike, RN; Fischer, K				Beckham, Simone A.; Boyd, Sarah E.; Reynolds, Simone; Willis, Charlene; Johnstone, Masego; Mika, Angela; Simerska, Pavla; Wijeyewickrema, Lakshmi C.; Smith, A. Ian; Kemp, David J.; Pike, Robert N.; Fischer, Katja			Characterization of a Serine Protease Homologous to House Dust Mite Group 3 Allergens from the Scabies Mite Sarcoptes scabiei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-III ALLERGEN; DERMATOPHAGOIDES-PTERONYSSINUS; SUBSTRATE-SPECIFICITY; IN-VIVO; DISEASE; SKIN; RESISTANCE; BEHAVIOR; ENZYME; PHAGE	The scabies mite, Sarcoptes scabiei var. hominis, infests human skin, causing allergic reactions and facilitating bacterial infection by Streptococcus sp., with serious consequences such as rheumatic fever and rheumatic heart disease. To identify a possible drug target or vaccine candidate protein, we searched for homologues of the group 3 allergen of house dust mites, which we subsequently identified in a cDNA library. The native protein, designated Sar s 3, was shown to be present in the mite gut and excreted in fecal pellets into mite burrows within the upper epidermis. The substrate specificity of proteolytically active recombinant rSar s 3 was elucidated by screening a bacteriophage library. A preference for substrates containing a RS(G/A) sequence at the P1-P2' positions was revealed. A series of peptides synthesized as internally quenched fluorescent substrates validated the phage display data and high performance liquid chromatography/mass spectrometry analysis of the preferred cleaved substrate and confirmed the predicted cleavage site. Searches of the human proteome using sequence data from the phage display allowed the in silico prediction of putative physiological substrates. Among these were numerous epidermal proteins, with filaggrin being a particularly likely candidate substrate. We showed that recombinant rSar s 3 cleaves human filaggrin in vitro and obtained immunohistological evidence that the filaggrin protein is ingested by the mite. This is the first report elucidating the substrate specificity of Sar s 3 and its potential role in scabies mite biology.	[Beckham, Simone A.; Reynolds, Simone; Willis, Charlene; Johnstone, Masego; Mika, Angela; Kemp, David J.; Fischer, Katja] Queensland Inst Med Res, Div Infect Dis & Immunol, Herston, Qld 4029, Australia; [Boyd, Sarah E.] Monash Univ, Clayton Sch Informat Technol, Fac Informat Technol, Clayton, Vic 3800, Australia; [Beckham, Simone A.; Wijeyewickrema, Lakshmi C.; Smith, A. Ian; Pike, Robert N.] Monash Univ, Dept Biochem & Mol Biol, Sch Biomed Sci, Fac Med, Clayton, Vic 3800, Australia; [Simerska, Pavla] Univ Queensland, Sch Mol & Microbial Sci, St Lucia, Qld 4072, Australia; [Reynolds, Simone] Univ Queensland, Sch Vet Sci, St Lucia, Qld 4072, Australia	QIMR Berghofer Medical Research Institute; Monash University; Monash University; University of Queensland; University of Queensland	Fischer, K (corresponding author), PO Royal Brisbane Hosp, Brisbane, Qld 4029, Australia.	Katja.Fischer@qimr.edu.au	Fischer, Katja/H-4989-2014; Willis, Charlene/U-1344-2017; Boyd, Sarah E/I-9047-2012; Wijeyewickrema, Lakshmi/A-9676-2015	Fischer, Katja/0000-0003-3408-3337; Wijeyewickrema, Lakshmi/0000-0001-6084-4887; , Simone/0000-0002-4902-2003; Smith, Ian/0000-0002-4143-2892; Pike, Robert/0000-0002-2083-0269; Boyd, Sarah/0000-0002-7264-8602	Australian National Health and Medical Research Council [496600]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a Australian National Health and Medical Research Council fellowship and Program Grant 496600 (to D.J.K.).	BEYNON R, 2001, PROTEOLYTIC ENZYMES, P109; Boyd Sarah E., 2005, Journal of Bioinformatics and Computational Biology, V3, P551, DOI 10.1142/S021972000500117X; BROOK I, 1995, J CLIN MICROBIOL, V33, P2139, DOI 10.1128/JCM.33.8.2139-2140.1995; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; CHUA KY, 1988, J EXP MED, V167, P175, DOI 10.1084/jem.167.1.175; Currie B J, 2000, Australas J Dermatol, V41, P139, DOI 10.1046/j.1440-0960.2000.00417.x; Currie BJ, 2004, CLIN INFECT DIS, V39, pE8, DOI 10.1086/421776; CWIRLA SE, 1990, P NATL ACAD SCI USA, V87, P6378, DOI 10.1073/pnas.87.16.6378; Fimiani M, 1997, J SUBMICR CYTOL PATH, V29, P105; HALL PK, 1978, BIOCHEM J, V173, P27, DOI 10.1042/bj1730027; Hanquier J, 2003, APPL ENVIRON MICROB, V69, P1108, DOI 10.1128/AEM.69.2.1108-1113.2003; Holt DC, 2003, J INVEST DERMATOL, V121, P1419, DOI 10.1046/j.1523-1747.2003.12621.x; Hwang SR, 2008, FEBS LETT, V582, P2527, DOI 10.1016/j.febslet.2008.06.017; JOHN RA, 2002, ENZYME ASSAYS, P75; Kerr FK, 2005, J BIOL CHEM, V280, P39510, DOI 10.1074/jbc.M506131200; List K, 2003, J CELL BIOL, V163, P901, DOI 10.1083/jcb.200304161; MATTHEWS DJ, 1994, PROTEIN SCI, V3, P1197, DOI 10.1002/pro.5560030805; McGrath JA, 2008, TRENDS MOL MED, V14, P20, DOI 10.1016/j.molmed.2007.10.006; Mounsey KE, 2008, FUTURE MICROBIOL, V3, P57, DOI 10.2217/17460913.3.1.57; Nomura T, 2008, J INVEST DERMATOL, V128, P1436, DOI 10.1038/sj.jid.5701205; Perry DK, 1997, J BIOL CHEM, V272, P18530, DOI 10.1074/jbc.272.30.18530; Platts-Mills TAE, 1998, J ALLERGY CLIN IMMUN, V101, pS364, DOI 10.1016/S0091-6749(98)70221-0; Prins C, 2004, DERMATOLOGY, V208, P241, DOI 10.1159/000077310; Rapp CM, 2006, J MED ENTOMOL, V43, P539, DOI 10.1603/0022-2585(2006)43[539:POHIIT]2.0.CO;2; RAWLINGS ND, 1994, METHOD ENZYMOL, V244, P19; Scott FL, 2008, J BIOL CHEM, V283, P19499, DOI 10.1074/jbc.M800331200; SMITH WA, 1994, CLIN EXP ALLERGY, V24, P220, DOI 10.1111/j.1365-2222.1994.tb00223.x; STEWART GA, 1992, IMMUNOLOGY, V75, P29; STEWART GA, 1994, ALLERGY, V49, P553, DOI 10.1111/j.1398-9995.1994.tb01128.x; Thomas WR, 1999, CLIN EXP ALLERGY, V29, P1583, DOI 10.1046/j.1365-2222.1999.00670.x; VANNESTE D, 1985, DERMATOLOGICA, V171, P343, DOI 10.1159/000249449; Walton SF, 2004, INT J PARASITOL, V34, P839, DOI 10.1016/j.ijpara.2004.04.002; Walton SF, 2007, CLIN MICROBIOL REV, V20, P268, DOI 10.1128/CMR.00042-06; Wan H, 1999, J CLIN INVEST, V104, P123, DOI 10.1172/JCI5844; WELLS CM, 1992, BIOCHEMISTRY-US, V31, P11721, DOI 10.1021/bi00162a008; Willis C, 2006, AM J TROP MED HYG, V75, P683, DOI 10.4269/ajtmh.2006.75.683	36	36	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34413	34422		10.1074/jbc.M109.061911	http://dx.doi.org/10.1074/jbc.M109.061911			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19812030	Green Published, hybrid			2022-12-27	WOS:000272165200071
J	Bouvier, D; Spagnol, G; Chenavas, S; Kieken, F; Vitrac, H; Brownell, S; Kellezi, A; Forge, V; Sorgen, PL				Bouvier, Denis; Spagnol, Gaelle; Chenavas, Sylvie; Kieken, Fabien; Vitrac, Heidi; Brownell, Sarah; Kellezi, Admir; Forge, Vincent; Sorgen, Paul L.			Characterization of the Structure and Intermolecular Interactions between the Connexin40 and Connexin43 Carboxyl-terminal and Cytoplasmic Loop Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION CHANNELS; DICHROISM SPECTROSCOPIC DATA; C-SRC; ZONULA OCCLUDENS-1; EXPRESSION RATIO; PH REGULATION; PROTEIN; CX43; CELLS; NMR	Gap junctions are intercellular channels that allow the passage of ions, small molecules, and second messengers that are essential for the coordination of cellular function. They are formed by two hemichannels, each constituted by the oligomerization of six connexins (Cx). Among the 21 different human Cx isoforms, studies have suggested that in the heart, Cx40 and Cx43 can oligomerize to form heteromeric hemichannels. The mechanism of heteromeric channel regulation has not been clearly defined. Tissue ischemia leads to intracellular acidification and closure of Cx43 and Cx40 homomeric channels. However, coexpression of Cx40 and Cx43 in Xenopus oocytes enhances the pH sensitivity of the channel. This phenomenon requires the carboxyl-terminal (CT) part of both connexins. In this study we used different biophysical methods to determine the structure of the Cx40CT and characterize the Cx40CT/Cx43CT interaction. Our results revealed that the Cx40CT is an intrinsically disordered protein similar to the Cx43CT and that the Cx40CT and Cx43CT can interact. Additionally, we have identified an interaction between the Cx40CT and the cytoplasmic loop of Cx40 as well as between the Cx40CT and the cytoplasmic loop of Cx43 ( and vice versa). Our studies support the "particle-receptor" model for pH gating of Cx40 and Cx43 gap junction channels and suggest that interactions between cytoplasmic regulatory domains (both homo- and hetero-connexin) could be important for the regulation of heteromeric channels.	[Bouvier, Denis; Spagnol, Gaelle; Chenavas, Sylvie; Kieken, Fabien; Brownell, Sarah; Sorgen, Paul L.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Kellezi, Admir] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Vitrac, Heidi; Forge, Vincent] Commissariat Energie Atom, Lab Chim & Biol Metaux, UMR 5249, F-38054 Grenoble, France	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Sorgen, PL (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.	psorgen@unmc.edu	Vitrac, Heidi/R-7117-2018	Vitrac, Heidi/0000-0002-8858-4914; Spagnol, Gaelle/0000-0002-3201-4840	National Institutes of Health [GM072631, HL039707]; American Heart Association [0560050Z]; Nebraska Research Initiative [P30CA036727]; NATIONAL CANCER INSTITUTE [P30CA036727] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL039707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072631] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Nebraska Research Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM072631 and HL039707 (USPHS). This work was also supported by American Heart Association Grant 0560050Z, the Nebraska Research Initiative funding for the Nebraska Center for Structural Biology, and Eppley Cancer Center Support Grant P30CA036727.	Anumonwo JMB, 2001, CIRC RES, V88, P666, DOI 10.1161/hh0701.088833; Baxter NJ, 1997, J BIOMOL NMR, V9, P359, DOI 10.1023/A:1018334207887; Bernstein SA, 2006, ADV CARDIOL, V42, P71, DOI 10.1159/000092563; Bouvier D, 2007, BIOMOL NMR ASSIGM, V1, P155, DOI 10.1007/s12104-007-9044-x; Bouvier D, 2008, CELL COMMUN ADHES, V15, P107, DOI 10.1080/15419060802014347; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bukauskas FF, 2001, BIOPHYS J, V81, P137, DOI 10.1016/S0006-3495(01)75687-1; Burt JM, 2001, AM J PHYSIOL-CELL PH, V280, pC500, DOI 10.1152/ajpcell.2001.280.3.C500; Cottrell GT, 2002, AM J PHYSIOL-CELL PH, V282, pC1469, DOI 10.1152/ajpcell.00484.2001; Cottrell GT, 2001, AM J PHYSIOL-CELL PH, V281, pC1559, DOI 10.1152/ajpcell.2001.281.5.C1559; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dhein S, 2006, ADV CARDIOL, V42, P198, DOI 10.1159/000092570; Duffy HS, 2004, CIRC RES, V94, P215, DOI 10.1161/01.RES.0000113924.06926.11; Duffy HS, 2002, J BIOL CHEM, V277, P36706, DOI 10.1074/jbc.M207016200; Dunker AK, 2001, NAT BIOTECHNOL, V19, P805, DOI 10.1038/nbt0901-805; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; EkVitorin JF, 1996, BIOPHYS J, V71, P1273, DOI 10.1016/S0006-3495(96)79328-1; Elenes S, 1999, J CARDIOVASC ELECTR, V10, P990, DOI 10.1111/j.1540-8167.1999.tb01270.x; Francis D, 1999, DEV GENET, V24, P123, DOI 10.1002/(SICI)1520-6408(1999)24:1/2<123::AID-DVG12>3.0.CO;2-H; Gu H, 2000, CIRC RES, V86, pE98, DOI 10.1161/01.RES.86.10.e98; He DS, 1999, P NATL ACAD SCI USA, V96, P6495, DOI 10.1073/pnas.96.11.6495; Herve JC, 2006, ADV CARDIOL, V42, P107, DOI 10.1159/000092565; Hirst-Jensen BJ, 2007, J BIOL CHEM, V282, P5801, DOI 10.1074/jbc.M605233200; Hoh JH, 1998, PROTEINS, V32, P223, DOI 10.1002/(SICI)1097-0134(19980801)32:2<223::AID-PROT8>3.0.CO;2-L; HOSSAIN MZ, 1994, J NEUROCHEM, V62, P2394; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kellezi A, 2008, PROTEIN EXPRES PURIF, V59, P215, DOI 10.1016/j.pep.2008.01.023; Koval M, 2006, TRENDS CELL BIOL, V16, P159, DOI 10.1016/j.tcb.2006.01.006; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lees JG, 2004, ANAL BIOCHEM, V332, P285, DOI 10.1016/j.ab.2004.06.002; Matesic D, 2003, CELL BIOL INT, V27, P89, DOI 10.1016/S1065-6995(02)00281-0; Minezaki Y, 2007, J MOL BIOL, V368, P902, DOI 10.1016/j.jmb.2007.02.033; Morley GE, 1996, BIOPHYS J, V70, P1294, DOI 10.1016/S0006-3495(96)79686-8; Peters NS, 1997, CIRCULATION, V95, P988; Roger C, 2004, J PATHOL, V202, P241, DOI 10.1002/path.1509; Saffitz JE, 2000, CARDIOVASC RES, V45, P807, DOI 10.1016/S0008-6363(99)00421-6; Seki A, 2004, CIRC RES, V95, P22, DOI 10.1161/01.RES.0000140737.62245.c5; Sorgen PL, 2004, J BIOL CHEM, V279, P54695, DOI 10.1074/jbc.M409552200; Sorgen PL, 2004, BIOPHYS J, V87, P574, DOI 10.1529/biophysj.103.039230; SPRAY DC, 1985, ANNU REV PHYSIOL, V47, P281, DOI 10.1146/annurev.ph.47.030185.001433; Stergiopoulos K, 1999, CIRC RES, V84, P1144, DOI 10.1161/01.RES.84.10.1144; Toyofuku T, 2001, J BIOL CHEM, V276, P1780, DOI 10.1074/jbc.M005826200; Unger VM, 1999, SCIENCE, V283, P1176, DOI 10.1126/science.283.5405.1176; Valiunas V, 2000, CIRC RES, V86, pE42, DOI 10.1161/01.RES.86.2.e42; Valiunas V, 2001, AM J PHYSIOL-HEART C, V281, pH1675, DOI 10.1152/ajpheart.2001.281.4.H1675; van Veen TAB, 2006, ADV CARDIOL, V42, P18, DOI 10.1159/000092560; VanSlyke JK, 2000, METHODS, V20, P156, DOI 10.1006/meth.1999.0933; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371	50	40	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34257	34271		10.1074/jbc.M109.039594	http://dx.doi.org/10.1074/jbc.M109.039594			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19808665	Green Published, hybrid			2022-12-27	WOS:000272165200057
J	Rostovtseva, TK; Boukari, H; Antignani, A; Shiu, B; Banerjee, S; Neutzner, A; Youle, RJ				Rostovtseva, Tatiana K.; Boukari, Hacene; Antignani, Antonella; Shiu, Brian; Banerjee, Soojay; Neutzner, Albert; Youle, Richard J.			Bax Activates Endophilin B1 Oligomerization and Lipid Membrane Vesiculation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; GIANT PHOSPHOLIPID-VESICLES; FLUCTUATION SPECTROSCOPY; PROTEIN FAMILY; DOMAIN; CURVATURE; MECHANISM; DYNAMICS; FISSION; BIF-1	Endophilins participate in membrane scission events that occur during endocytosis and intracellular organelle biogenesis through the combined activity of an N-terminal BAR domain that interacts with membranes and a C-terminal SH3 domain that mediates protein binding. Endophilin B1 (Endo B1) was identified to bind Bax, a Bcl-2 family member that promotes apoptosis, through yeast two-hybrid protein screens. Although Endo B1 does not bind Bax in healthy cells, during apoptosis, Endo B1 interacts transiently with Bax and promotes cytochrome c release from mitochondria. To explore the molecular mechanism of action of Endo B1, we have analyzed its interaction with Bax in cell-free systems. Purified recombinant Endo B1 in solution displays a Stokes radius indicating a tetrameric quarternary structure. However, when incubated with purified Bax, it assembles into oligomersmore than 4-fold greater in molecular weight. Although Endo B1 oligomerization is induced by Bax, Bax does not stably associate with the high molecular weight Endo B1 complex. Endo B1 oligomerization requires its C-terminal Src homology 3 domain and is not induced by Bcl-xL. Endo B1 combined with Bax reduces the size and changes the morphology of giant unilamellar vesicles by inducing massive vesiculation of liposomes. This activity of purified Bax protein to induce cell-free assembly of Endo B1 may reflect its activity in cells that regulates apoptosis and/or mitochondrial fusion.	[Antignani, Antonella; Shiu, Brian; Banerjee, Soojay; Youle, Richard J.] NINDS, Biochem Sect, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA; Eunice Kennedy Shriver NICHD, Lab Phys & Struct Biol, Bethesda, MD 20892 USA; [Boukari, Hacene] Eunice Kennedy Shriver NICHD, Lab Integrat & Med Biophys, Program Phys Biol, Bethesda, MD 20892 USA; [Neutzner, Albert] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Basel	Youle, RJ (corresponding author), NINDS, Biochem Sect, Surg Neurol Branch, NIH, 35 Convent Dr,2C-917, Bethesda, MD 20892 USA.	youler@ninds.nih.gov	Neutzner, Albert/ABC-4368-2020	Neutzner, Albert/0000-0001-9254-5558	Eunice Kennedy Shriver NICHD; NINDS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002859] Funding Source: NIH RePORTER	Eunice Kennedy Shriver NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Programs of the Eunice Kennedy Shriver NICHD (to T.K.R., H.B., and B.S.) and NINDS (to A.A., S.B., and R.J.Y.).	Angelova MI, 1999, EUR BIOPHYS J BIOPHY, V28, P142, DOI 10.1007/s002490050193; Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Bagatolli LA, 2000, CHEM PHYS LIPIDS, V105, P135, DOI 10.1016/S0009-3084(00)00118-3; Basanez G, 2002, J BIOL CHEM, V277, P49360, DOI 10.1074/jbc.M206069200; Basanez G, 1999, P NATL ACAD SCI USA, V96, P5492, DOI 10.1073/pnas.96.10.5492; Bernard AL, 2002, BBA-BIOMEMBRANES, V1567, P1, DOI 10.1016/S0005-2736(02)00617-X; BOROSKE E, 1981, BIOPHYS J, V34, P95, DOI 10.1016/S0006-3495(81)84839-4; Boukari H, 2003, BIOCHEMISTRY-US, V42, P1292, DOI 10.1021/bi026751q; Boukari H, 2008, METHOD CELL BIOL, V84, P659, DOI 10.1016/S0091-679X(07)84021-0; Chen Y, 1999, METHODS, V19, P234, DOI 10.1006/meth.1999.0854; Chen Y, 2002, BIOPHYS J, V82, P133, DOI 10.1016/S0006-3495(02)75380-0; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Cuddeback SM, 2001, J BIOL CHEM, V276, P20559, DOI 10.1074/jbc.M101527200; Delivani P, 2006, MOL CELL, V21, P761, DOI 10.1016/j.molcel.2006.01.034; Etxebarria A, 2009, J BIOL CHEM, V284, P4200, DOI 10.1074/jbc.M808050200; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Karbowski M, 2004, J CELL BIOL, V166, P1027, DOI 10.1083/jcb.200407046; Karbowski M, 2006, NATURE, V443, P658, DOI 10.1038/nature05111; Khalifat N, 2008, BIOPHYS J, V95, P4924, DOI 10.1529/biophysj.108.136077; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; Mathivet L, 1996, BIOPHYS J, V70, P1112, DOI 10.1016/S0006-3495(96)79693-5; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; Pierrat B, 2001, GENOMICS, V71, P222, DOI 10.1006/geno.2000.6378; Ringstad N, 2001, J BIOL CHEM, V276, P40424, DOI 10.1074/jbc.M106338200; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; Roucou X, 2002, BIOCHEM J, V363, P547, DOI 10.1042/0264-6021:3630547; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Sinha S, 2008, AUTOPHAGY, V4, P989, DOI 10.4161/auto.6803; Staneva G, 2005, CHEM PHYS LIPIDS, V136, P55, DOI 10.1016/j.chemphyslip.2005.03.007; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Takahashi Y, 2005, MOL CELL BIOL, V25, P9369, DOI 10.1128/MCB.25.21.9369-9382.2005; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Tamba Y, 2007, BIOPHYS J, V92, P3178, DOI 10.1529/biophysj.106.097105; Tanaka T, 2004, LANGMUIR, V20, P9526, DOI 10.1021/la049481g; Tareste D, 2008, P NATL ACAD SCI USA, V105, P2380, DOI 10.1073/pnas.0712125105; Webb WW, 2001, APPL OPTICS, V40, P3969, DOI 10.1364/AO.40.003969; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Youle RJ, 2007, SCIENCE, V315, P776, DOI 10.1126/science.1138870	42	36	38	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34390	34399		10.1074/jbc.M109.021873	http://dx.doi.org/10.1074/jbc.M109.021873			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19805544	Green Published, hybrid			2022-12-27	WOS:000272165200069
J	Polanska, UM; Duchesne, L; Harries, JC; Fernig, DG; Kinnunen, TK				Polanska, Urszula M.; Duchesne, Laurence; Harries, Janet C.; Fernig, David G.; Kinnunen, Tarja K.			N-Glycosylation Regulates Fibroblast Growth Factor Receptor/EGL-15 Activity in Caenorhabditis elegans in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FGF RECEPTOR; C-ELEGANS; SIGNALING PATHWAY; FACTOR FAMILY; MUTATIONS; LIGAND; ACTIVATION; ENCODES; DIFFERENTIATION; TRANSMEMBRANE	The regulation of cell function by fibroblast growth factors (FGFs) classically occurs through a dual receptor system of a tyrosine kinase receptor (FGFR) and a heparan sulfate proteoglycan co-receptor. Mutations in some consensus N-glycosylation sites in human FGFR result in skeletal disorders and craniosynostosis syndromes, and biophysical studies in vitro suggest that N-glycosylation of FGFR alters ligand and heparan sulfate binding properties. The evolutionarily conserved FGFR signaling system of Caenorhabditis elegans has been used to assess the role of N-glycosylation in the regulation of FGFR signaling in vivo. The C. elegans FGF receptor, EGL-15, is N-glycosylated in vivo, and genetic substitution of specific consensus N-glycosylation sites leads to defects in the maintenance of fluid homeostasis and differentiation of sex muscles, both of which are phenotypes previously associated with hyperactive EGL-15 signaling. These phenotypes are suppressed by hypoactive mutations in EGL-15 downstream signaling components or activating mutations in the phosphatidylinositol 3-kinase pathway, respectively. The results show that N-glycans negatively regulate FGFR activity in vivo supporting the notion that mutation of N-glycosylation sites in human FGFR may lead to inappropriate activation of the receptor.	[Polanska, Urszula M.; Duchesne, Laurence; Harries, Janet C.; Fernig, David G.; Kinnunen, Tarja K.] Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England	University of Liverpool	Kinnunen, TK (corresponding author), Univ Liverpool, Sch Biol Sci, Biosci Bldg,Crown St, Liverpool L69 7ZB, Merseyside, England.	T.K.Kinnunen@liverpool.ac.uk	Fernig, David G/A-3590-2008	Fernig, David G/0000-0003-4875-4293; Duchesne, Laurence/0000-0003-1985-6266; Kinnunen, Dr Tarja K/0000-0001-5630-2233	European Union Marie Curie Early Stage Training Programme; NorthWest Cancer Research Fund; Cancer and Polio Research Fund; Human Frontiers Science Programme; Medical Research Council; MRC [G0601549] Funding Source: UKRI; Medical Research Council [G0601549] Funding Source: researchfish	European Union Marie Curie Early Stage Training Programme(European Commission); NorthWest Cancer Research Fund; Cancer and Polio Research Fund; Human Frontiers Science Programme(Human Frontier Science Program); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by European Union Marie Curie Early Stage Training Programme ( to U. M. P.), NorthWest Cancer Research Fund, Cancer and Polio Research Fund ( to D. G. F. and J. C. H.), Human Frontiers Science Programme ( to L. D.), and by the Medical Research Council ( to T. K.).	Altmann F, 2001, BIOCHIMIE, V83, P703, DOI 10.1016/S0300-9084(01)01297-4; Anderson J, 1998, HUM MOL GENET, V7, P1475, DOI 10.1093/hmg/7.9.1475; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Birnbaum D, 2005, DEV DYNAM, V232, P247, DOI 10.1002/dvdy.20219; Borland CZ, 2001, BIOESSAYS, V23, P1120, DOI 10.1002/bies.10007; BRENNER S, 1974, GENETICS, V77, P71; Bulow HE, 2004, NEURON, V42, P367, DOI 10.1016/S0896-6273(04)00246-6; Burdine RD, 1997, P NATL ACAD SCI USA, V94, P2433, DOI 10.1073/pnas.94.6.2433; Chen SH, 1999, J BIOL CHEM, V274, P288, DOI 10.1074/jbc.274.1.288; DEVORE DL, 1995, CELL, V83, P611, DOI 10.1016/0092-8674(95)90101-9; Dode C, 2003, NAT GENET, V33, P463, DOI 10.1038/ng1122; Duchesne L, 2006, J BIOL CHEM, V281, P27178, DOI 10.1074/jbc.M601248200; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; Freeze HH, 2006, NAT REV GENET, V7, P537, DOI 10.1038/nrg1894; Goodman SJ, 2003, DEVELOPMENT, V130, P3757, DOI 10.1242/dev.00604; Guimond SE, 1999, CURR BIOL, V9, P1343, DOI 10.1016/S0960-9822(00)80060-3; Haslam SM, 2003, BIOCHIMIE, V85, P25, DOI 10.1016/S0300-9084(03)00041-5; Haslam SM, 2002, BIOCHEM SOC SYMP, V69, P117; Heuertz S, 2006, EUR J HUM GENET, V14, P1240, DOI 10.1038/sj.ejhg.5201700; Huang P, 2004, DEVELOPMENT, V131, P2595, DOI 10.1242/dev.01135; Ibrahimi OA, 2001, P NATL ACAD SCI USA, V98, P7182, DOI 10.1073/pnas.121183798; Johnson D, 2008, PFLUG ARCH EUR J PHY, V456, P393, DOI 10.1007/s00424-007-0378-0; Kaliman P, 1996, J BIOL CHEM, V271, P19146, DOI 10.1074/jbc.271.32.19146; Kinnunen T, 2005, P NATL ACAD SCI USA, V102, P1507, DOI 10.1073/pnas.0401591102; Kokel M, 1998, GENE DEV, V12, P1425, DOI 10.1101/gad.12.10.1425; Kuro-o M, 2006, CURR OPIN NEPHROL HY, V15, P437, DOI 10.1097/01.mnh.0000232885.81142.83; Lee W, 2005, BIOCHEM BIOPH RES CO, V338, P1018, DOI 10.1016/j.bbrc.2005.10.041; Li Y, 1997, ONCOGENE, V14, P1397, DOI 10.1038/sj.onc.1200983; Lo TW, 2008, DEV BIOL, V318, P268, DOI 10.1016/j.ydbio.2008.03.026; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Neilson KM, 1996, J BIOL CHEM, V271, P25049, DOI 10.1074/jbc.271.40.25049; Ornitz DM, 2001, GENOME BIOL, V2; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Paschinger K, 2008, CARBOHYD RES, V343, P2041, DOI 10.1016/j.carres.2007.12.018; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Plotnikov AN, 2000, CELL, V101, P413, DOI 10.1016/S0092-8674(00)80851-X; Polanska UM, 2009, DEV DYNAM, V238, P277, DOI 10.1002/dvdy.21757; Razzaque MS, 2007, J ENDOCRINOL, V194, P1, DOI 10.1677/JOE-07-0095; Roubin R, 1999, ONCOGENE, V18, P6741, DOI 10.1038/sj.onc.1203074; Saremba S, 2008, FEBS J, V275, P172, DOI 10.1111/j.1742-4658.2007.06187.x; Sasson IE, 2004, DEVELOPMENT, V131, P5381, DOI 10.1242/dev.01423; Schachter H, 2002, BIOCHEM SOC SYMP, V69, P1; Selfors LM, 1998, P NATL ACAD SCI USA, V95, P6903, DOI 10.1073/pnas.95.12.6903; SODERQUIST AM, 1984, J BIOL CHEM, V259, P2586; Steinberger D, 1996, HUM MUTAT, V8, P386, DOI 10.1002/(SICI)1098-1004(1996)8:4<386::AID-HUMU18>3.3.CO;2-A; White KE, 2005, AM J HUM GENET, V76, P361, DOI 10.1086/427956; Wilkie AOM, 2005, CYTOKINE GROWTH F R, V16, P187, DOI 10.1016/j.cytogfr.2005.03.001; Winterpacht A, 2000, PHYSIOL GENOMICS, V2, P9, DOI 10.1152/physiolgenomics.2000.2.1.9; Yu C, 2000, J NEUROIMMUNOL, V108, P2, DOI 10.1016/S0165-5728(99)00278-7; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200; Zhu SX, 2004, BIOCHEM J, V382, P995, DOI 10.1042/BJ20040793	53	15	19	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33030	33039		10.1074/jbc.M109.058925	http://dx.doi.org/10.1074/jbc.M109.058925			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801543	Green Published, hybrid			2022-12-27	WOS:000272028500005
J	Sarhan, MF; Van Petegem, F; Ahern, CA				Sarhan, Maen F.; Van Petegem, Filip; Ahern, Christopher A.			A Double Tyrosine Motif in the Cardiac Sodium Channel Domain III-IV Linker Couples Calcium-dependent Calmodulin Binding to Inactivation Gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; NA+ CHANNELS; MODULATION; KINASE; CA2+; EXCITABILITY; FACILITATION; DYSFUNCTION; ACTIVATION; UNDERLIE	Voltage-gated sodium channels maintain the electrical cadence and stability of neurons and muscle cells by selectively controlling the transmembrane passage of their namesake ion. The degree to which these channels contribute to cellular excitability can be managed therapeutically or fine-tuned by endogenous ligands. Intracellular calcium, for instance, modulates sodium channel inactivation, the process by which sodium conductance is negatively regulated. We explored the molecular basis for this effect by investigating the interaction between the ubiquitous calcium binding protein calmodulin (CaM) and the putative sodium channel inactivation gate composed of the cytosolic linker between homologous channel domains III and IV (DIII-IV). Experiments using isothermal titration calorimetry show that CaM binds to a novel double tyrosine motif in the center of the DIII-IV linker in a calcium- dependent manner, N-terminal to a region previously reported to be a CaM binding site. An alanine scan of aromatic residues in recombinant DIII-DIV linker peptides shows that whereas multiple side chains contribute to CaM binding, two tyrosines (Tyr(1494) and Tyr(1495)) play a crucial role in binding the CaM C-lobe. The functional relevance of these observations was then ascertained through electrophysiological measurement of sodium channel inactivation gating in the presence and absence of calcium. Experiments on patch-clamped transfected tsA201 cells show that only the Y1494A mutation of the five sites tested renders sodium channel steady-state inactivation insensitive to cytosolic calcium. The results demonstrate that calcium- dependent calmodulin binding to the sodium channel inactivation gate double tyrosine motif is required for calcium regulation of the cardiac sodium channel.	[Sarhan, Maen F.; Ahern, Christopher A.] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V6T 1Z3, Canada; [Sarhan, Maen F.; Ahern, Christopher A.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada; [Van Petegem, Filip] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Ahern, CA (corresponding author), Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	cahern@interchange.ubc.ca	Van Petegem, Filip/M-6061-2016	Van Petegem, Filip/0000-0003-2728-8537; Ahern, Christopher/0000-0002-7975-2744	Canadian Institutes of Health Research [56858]; Heart and Stroke Foundation of Canada; Michael Smith Foundation for Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	Supported by Canadian Institutes of Health Research Grant 56858, the Heart and Stroke Foundation of Canada, and the Michael Smith Foundation for Health Research.	Ahern CA, 2005, CIRC RES, V96, P991, DOI 10.1161/01.RES.0000166324.00524.dd; Bankston JR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001258; Biswas S, 2009, CIRC RES, V104, P870, DOI 10.1161/CIRCRESAHA.108.193565; Chaudhuri D, 2007, J GEN PHYSIOL, V129, P385, DOI 10.1085/jgp.200709749; Deschenes I, 2002, CIRC RES, V90, pE49, DOI 10.1161/01.RES.0000012502.92751.E6; Dick IE, 2008, NATURE, V451, P830, DOI 10.1038/nature06529; DUNITZ JD, 1995, CHEM BIOL, V2, P709, DOI 10.1016/1074-5521(95)90097-7; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Fallon JL, 2009, P NATL ACAD SCI USA, V106, P5135, DOI 10.1073/pnas.0807487106; Fallon JL, 2005, STRUCTURE, V13, P1881, DOI 10.1016/j.str.2005.09.021; GELLENS ME, 1992, P NATL ACAD SCI USA, V89, P554, DOI 10.1073/pnas.89.2.554; George AL, 2005, J CLIN INVEST, V115, P1990, DOI 10.1172/JCI25505; Grieco TM, 2005, NEURON, V45, P233, DOI 10.1016/j.neuron.2004.12.035; HORN R, 1981, NATURE, V291, P426, DOI 10.1038/291426a0; JOSEPH D, 1990, SCIENCE, V249, P1425, DOI 10.1126/science.2402636; Kass Robert S, 2006, J Cardiovasc Electrophysiol, V17 Suppl 1, pS21, DOI 10.1111/j.1540-8167.2006.00381.x; Kim EY, 2008, STRUCTURE, V16, P1455, DOI 10.1016/j.str.2008.07.010; Kim J, 2004, J BIOL CHEM, V279, P45004, DOI 10.1074/jbc.M407286200; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Maltsev VA, 2008, AM J PHYSIOL-HEART C, V294, pH1597, DOI 10.1152/ajpheart.00484.2007; McPhee JC, 1998, J BIOL CHEM, V273, P1121, DOI 10.1074/jbc.273.2.1121; Melillo G, 1996, CIRCULATION, V93, P1447, DOI 10.1161/01.CIR.93.7.1447; Mori M, 2000, BIOCHEMISTRY-US, V39, P1316, DOI 10.1021/bi9912600; Motoike HK, 2004, J GEN PHYSIOL, V123, P155, DOI 10.1085/jgp.200308929; OLEARY ME, 1995, J GEN PHYSIOL, V106, P641, DOI 10.1085/jgp.106.4.641; Potet F, 2009, J BIOL CHEM, V284, P8846, DOI 10.1074/jbc.M806871200; Rohl CA, 1999, BIOCHEMISTRY-US, V38, P855, DOI 10.1021/bi9823380; Smith MR, 1997, BIOPHYS J, V73, P1885, DOI 10.1016/S0006-3495(97)78219-5; Tan HL, 2002, NATURE, V415, P442, DOI 10.1038/415442a; Van Petegem F, 2005, NAT STRUCT MOL BIOL, V12, P1108, DOI 10.1038/nsmb1027; Viswanathan PC, 2004, TRENDS CARDIOVAS MED, V14, P28, DOI 10.1016/j.tcm.2003.10.001; Wagner S, 2006, J CLIN INVEST, V116, P3127, DOI 10.1172/JCI26620; WEST JW, 1991, SCIENCE, V254, P866, DOI 10.1126/science.1658937; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; Wingo TL, 2004, NAT STRUCT MOL BIOL, V11, P219, DOI 10.1038/nsmb737; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Young KA, 2005, J PHYSIOL-LONDON, V565, P349, DOI 10.1113/jphysiol.2004.081422	37	42	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33265	33274		10.1074/jbc.M109.052910	http://dx.doi.org/10.1074/jbc.M109.052910			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19808664	Green Published, hybrid			2022-12-27	WOS:000272028500031
J	Anquetil, V; Le Sommer, C; Mereau, A; Hamon, S; Lerivray, H; Hardy, S				Anquetil, Vincent; Le Sommer, Caroline; Mereau, Agnes; Hamon, Sandra; Lerivray, Hubert; Hardy, Serge			Polypyrimidine Tract Binding Protein Prevents Activity of an Intronic Regulatory Element That Promotes Usage of a Composite 3 '-Terminal Exon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; ALTERNATIVE POLYADENYLATION; SR FAMILY; IMMUNOGLOBULIN; XENOPUS; RECOGNITION; EFFICIENCY; CONTRIBUTE; MOUSE; GENE	Alternative splicing of 3'-terminal exons plays a critical role in gene expression by producing mRNA with distinct 3'-untranslated regions that regulate their fate and their expression. The Xenopus alpha-tropomyosin pre-mRNA possesses a composite internal/3'-terminal exon (exon 9A9') that is differentially processed depending on the embryonic tissue. Exon 9A9' is repressed in non-muscle tissue by the polypyrimidine tract binding protein, whereas it is selected as a 3'-terminal or internal exon in myotomal cells and adult striated muscles, respectively. We report here the identification of an intronic regulatory element, designated the upstream terminal exon enhancer (UTE), that is required for the specific usage of exon 9A9' as a 3'-terminal exon in the myotome. We demonstrate that polypyrimidine tract binding protein prevents the activity of UTE in non-muscle cells, whereas a subclass of serine/arginine rich (SR) proteins promotes the selection of exon 9A9' in a UTE-dependent way. Morpholino-targeted blocking of UTE in the embryo strongly reduced the inclusion of exon 9A9' as a 3'-terminal exon in the endogenous mRNA, demonstrating the function of UTE under physiological circumstances. This strategy allowed us to reveal a splicing pathway that generates a mRNA with no in frame stop codon and whose steady-state level is translation-dependent. This result suggests that a non-stop decay mechanism participates in the strict control of the 3'- end processing of the alpha-tropomyosin pre-mRNA.	[Anquetil, Vincent; Le Sommer, Caroline; Mereau, Agnes; Hamon, Sandra; Lerivray, Hubert; Hardy, Serge] Univ Rennes 1, CNRS, Inst Genet & Dev Rennes, Fac Med,UMR 6061,IFR 140,CS 34317, F-35043 Rennes, France	Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	Hardy, S (corresponding author), Univ Rennes 1, CNRS, Inst Genet & Dev Rennes, Fac Med,UMR 6061,IFR 140,CS 34317, F-35043 Rennes, France.	serge.hardy@univ-rennes1.fr	anquetil, vincent/K-9865-2019	anquetil, vincent/0000-0002-6912-9908; MEREAU, AGNES/0000-0002-5603-757X	Association Francaise contre les Myopathies	Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	This work was supported by grants from the Association Francaise contre les Myopathies (to S. H.).	Awasthi S, 2003, RNA, V9, P1400, DOI 10.1261/rna.5104603; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bruno IG, 2004, HUM MOL GENET, V13, P2409, DOI 10.1093/hmg/ddh272; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Castelo-Branco P, 2004, MOL CELL BIOL, V24, P4174, DOI 10.1128/MCB.24.10.4174-4183.2004; Charlet-B N, 2002, MOL CELL, V9, P649, DOI 10.1016/S1097-2765(02)00479-3; EDWALDSGILBERT G, 1995, MOL CELL BIOL, V15, P6420; EdwaldsGilbert G, 1997, NUCLEIC ACIDS RES, V25, P2547, DOI 10.1093/nar/25.13.2547; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Gawande B, 2006, EMBO J, V25, P1263, DOI 10.1038/sj.emboj.7601022; Gromak N, 2003, RNA, V9, P443, DOI 10.1261/rna.2191903; Hamon S, 2004, J BIOL CHEM, V279, P22166, DOI 10.1074/jbc.M313809200; Hardy S, 1999, MECH DEVELOP, V87, P199, DOI 10.1016/S0925-4773(99)00148-3; HARDY S, 1991, EUR J BIOCHEM, V202, P431, DOI 10.1111/j.1432-1033.1991.tb16392.x; Hua YM, 2008, AM J HUM GENET, V82, P834, DOI 10.1016/j.ajhg.2008.01.014; KOHTZ JD, 1994, NATURE, V368, P119, DOI 10.1038/368119a0; Kole R, 1998, APPLIED ANTISENSE OLIGONUCLEOTIDE TECHNOLOGY, P451; Kyburz A, 2006, MOL CELL, V23, P195, DOI 10.1016/j.molcel.2006.05.037; Le Sommer C, 2005, MOL CELL BIOL, V25, P9595, DOI 10.1128/MCB.25.21.9595-9607.2005; LEESMILLER JP, 1990, MOL CELL BIOL, V10, P1729, DOI 10.1128/MCB.10.4.1729; Longman D, 2001, CURR BIOL, V11, P1923, DOI 10.1016/S0960-9822(01)00589-9; Lou H, 1998, MOL CELL BIOL, V18, P4977, DOI 10.1128/MCB.18.9.4977; Maciolek NL, 2007, J VIROL, V81, P11208, DOI 10.1128/JVI.00919-07; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; McCracken S, 2002, MOL CELL BIOL, V22, P148, DOI 10.1128/MCB.22.1.148-160.2002; McGlincy NJ, 2008, TRENDS BIOCHEM SCI, V33, P385, DOI 10.1016/j.tibs.2008.06.001; Mereau A, 2007, BIOL CELL, V99, P55, DOI 10.1042/BC20060073; Millevoi S, 2006, EMBO J, V25, P4854, DOI 10.1038/sj.emboj.7601331; NESIC D, 1994, GENE DEV, V8, P363, DOI 10.1101/gad.8.3.363; NIEUWKOOP P, 1956, NORMAL TABLE X LAEVI; NIWA M, 1991, GENE DEV, V5, P2086, DOI 10.1101/gad.5.11.2086; Peterson ML, 2007, IMMUNOL RES, V37, P33, DOI 10.1007/BF02686094; Peterson ML, 2006, MOL CELL BIOL, V26, P6762, DOI 10.1128/MCB.00889-06; PETERSON ML, 1994, MOL CELL BIOL, V14, P7891, DOI 10.1128/MCB.14.12.7891; PETERSON ML, 1991, MOL CELL BIOL, V11, P2324, DOI 10.1128/MCB.11.4.2324; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Sauliere J, 2006, MOL CELL BIOL, V26, P8755, DOI 10.1128/MCB.00893-06; Sazani P, 2003, J CLIN INVEST, V112, P481, DOI 10.1172/JCI200319547; SCREATON GR, 1995, EMBO J, V14, P4336, DOI 10.1002/j.1460-2075.1995.tb00108.x; Seipelt RL, 1998, MOL CELL BIOL, V18, P1042, DOI 10.1128/MCB.18.2.1042; Sharma S, 2008, NAT STRUCT MOL BIOL, V15, P183, DOI 10.1038/nsmb.1375; Takagaki Y, 1996, CELL, V87, P941, DOI 10.1016/S0092-8674(00)82000-0; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Tian B, 2007, GENOME RES, V17, P156, DOI 10.1101/gr.5532707; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272; Yan J, 2005, GENOME RES, V15, P369, DOI 10.1101/gr.3109605	46	6	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32370	32383		10.1074/jbc.M109.029314	http://dx.doi.org/10.1074/jbc.M109.029314			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19762469	Green Published, hybrid			2022-12-27	WOS:000272028400020
J	Dierker, T; Dreier, R; Migone, M; Hamer, S; Grobe, K				Dierker, Tabea; Dreier, Rita; Migone, Manuel; Hamer, Sabine; Grobe, Kay			Heparan Sulfate and Transglutaminase Activity Are Required for the Formation of Covalently Cross-linked Hedgehog Oligomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID BETA-A4 PEPTIDE; GLYPICAN DALLY-LIKE; UP-REGULATED GENES; SONIC-HEDGEHOG; TISSUE TRANSGLUTAMINASE; TERMINAL DIFFERENTIATION; CHONDROCYTE HYPERTROPHY; FACTOR-XIIIA; DISEASE; LINKING	Sonic hedgehog (Shh) signaling plays major roles in embryonic development and has also been associated with the progression of certain cancers. Here, Shh family members act directly as long range morphogens, and their ability to do so has been linked to the formation of freely diffusible multimers from the lipidated, cell-tethered monomer (ShhNp). In this work we demonstrate that the multimeric morphogen secreted from endogenous sources, such as mouse embryos and primary chick chondrocytes, consists of oligomeric substructures that are "undisruptable" by boiling, denaturants, and reducing agents. Undisruptable (UD) morphogen oligomers vary in molecular weight and possess elevated biological activity if compared with recombinant Sonic hedgehog (ShhN). However, ShhN can also undergo UD oligomerization via a heparan sulfate (HS)-dependent mechanism in vitro, and HS isolated from different sources differs in its ability to mediate UD oligomer formation. Moreover, site-directed mutagenesis of conserved ShhN glutamine residues abolishes UD oligomerization, and inhibitors directed against transglutaminase (TG) activity strongly decrease the amount of chondrocyte-secreted UD oligomers. These findings reveal an unsuspected ability of the N-terminal hedgehog (Hh) signaling domain to form biologically active, covalently crosslinked oligomers and a novel HS function in this TG-catalyzed process. We suggest that in hypertrophic chondrocytes, HS-assisted, TG-mediated Hh oligomerization modulates signaling via enhanced protein signaling activity.	[Dierker, Tabea; Migone, Manuel; Hamer, Sabine; Grobe, Kay] Univ Munster, Dept Gen Zool & Genet, D-48149 Munster, Germany; [Dierker, Tabea; Dreier, Rita; Migone, Manuel; Grobe, Kay] Univ Munster, Inst Physiol Chem & Pathobiochem, D-48149 Munster, Germany	University of Munster; University of Munster	Grobe, K (corresponding author), Waldeyerstr 15, D-48149 Munster, Germany.	kgrobe@uni-muenster.de	Grobe, Kay/F-2399-2011	Dierker, Tabea/0000-0003-1991-2723	Deutsche Forschungsgemeinschaft (German Research Council) [SFB 492-B15, SFB 492-B18]	Deutsche Forschungsgemeinschaft (German Research Council)(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (German Research Council) Grants SFB 492-B15 (to K. G.) and SFB 492-B18 (to R. D.). The on-line version of this article (available at http://www.jbc.org) contains Supplements 1-5.	AESCHLIMANN D, 1993, J CELL BIOL, V120, P1461, DOI 10.1083/jcb.120.6.1461; Bellaiche Y, 1998, NATURE, V394, P85, DOI 10.1038/27932; Buglino JA, 2008, J BIOL CHEM, V283, P22076, DOI 10.1074/jbc.M803901200; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Desbordes SC, 2003, DEVELOPMENT, V130, P6245, DOI 10.1242/dev.00874; Dierker T, 2009, J BIOL CHEM, V284, P8013, DOI 10.1074/jbc.M806838200; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Esposito C, 2005, FEBS J, V272, P615, DOI 10.1111/j.1742-4658.2004.04476.x; Feng J, 2004, DEVELOPMENT, V131, P4357, DOI 10.1242/dev.01301; Fuse N, 1999, P NATL ACAD SCI USA, V96, P10992, DOI 10.1073/pnas.96.20.10992; Gallet A, 2008, DEV CELL, V14, P712, DOI 10.1016/j.devcel.2008.03.001; Gambetti S, 2005, BIOCHIMIE, V87, P551, DOI 10.1016/j.biochi.2005.01.012; Goetz JA, 2006, J BIOL CHEM, V281, P4087, DOI 10.1074/jbc.M511427200; GROENEN PJTA, 1994, EUR J BIOCHEM, V220, P795, DOI 10.1111/j.1432-1033.1994.tb18681.x; HALL TMT, 1995, NATURE, V378, P212, DOI 10.1038/378212a0; Incardona JP, 1998, DEVELOPMENT, V125, P3553; Jacob L, 2007, SCIENCE, V318, P66, DOI 10.1126/science.1147314; JENSEN PH, 1995, BIOCHEM J, V310, P91, DOI 10.1042/bj3100091; Johnson K, 2001, AM J PATHOL, V159, P149, DOI 10.1016/S0002-9440(10)61682-3; Johnson KA, 2008, J CELL SCI, V121, P2256, DOI 10.1242/jcs.011262; Kim SY, 2002, NEUROCHEM INT, V40, P85, DOI 10.1016/S0197-0186(01)00064-X; Kirsch T, 2000, OSTEOARTHR CARTILAGE, V8, P294, DOI 10.1053/joca.1999.0304; Leteux C, 2001, J BIOL CHEM, V276, P12539, DOI 10.1074/jbc.M010291200; LORAND L, 1963, ARCH BIOCHEM BIOPHYS, V102, P171, DOI 10.1016/0003-9861(63)90168-1; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Ma Y, 2002, CELL, V111, P63, DOI 10.1016/S0092-8674(02)00977-7; Murthy SNP, 1998, J NEUROCHEM, V71, P2607; Nakamura T, 1997, BIOCHEM BIOPH RES CO, V237, P465, DOI 10.1006/bbrc.1997.7156; Nurminskaya M, 1996, DEV DYNAM, V206, P260, DOI 10.1002/(SICI)1097-0177(199607)206:3<260::AID-AJA4>3.0.CO;2-G; Nurminskaya M, 1996, ANN NY ACAD SCI, V785, P309, DOI 10.1111/j.1749-6632.1996.tb56293.x; Pastor MT, 1999, FEBS LETT, V451, P231, DOI 10.1016/S0014-5793(99)00572-4; RASMUSSEN LK, 1994, FEBS LETT, V338, P161, DOI 10.1016/0014-5793(94)80356-0; Rietveld A, 1999, J BIOL CHEM, V274, P12049, DOI 10.1074/jbc.274.17.12049; Rosenthal AK, 2003, OSTEOARTHR CARTILAGE, V11, P463, DOI 10.1016/S1063-4584(03)00074-8; Rubin JB, 2002, DEVELOPMENT, V129, P2223; Vader LW, 2002, J EXP MED, V195, P643, DOI 10.1084/jem.20012028; Vyas N, 2008, CELL, V133, P1214, DOI 10.1016/j.cell.2008.05.026; WILLIAMS.HG, 1972, P NATL ACAD SCI USA, V69, P2322, DOI 10.1073/pnas.69.8.2322; Zeng X, 2001, NATURE, V411, P716, DOI 10.1038/35079648; Zhang FM, 2007, BIOCHEMISTRY-US, V46, P3933, DOI 10.1021/bi6025424	41	32	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32562	32571		10.1074/jbc.M109.044867	http://dx.doi.org/10.1074/jbc.M109.044867			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19801637	hybrid, Green Published			2022-12-27	WOS:000272028400038
J	Waidmann, O; Pleli, T; Dvorak, K; Baehr, C; Mondorf, U; Plotz, G; Biondi, RM; Zeuzem, S; Piiper, A				Waidmann, Oliver; Pleli, Thomas; Dvorak, Karel; Baehr, Christina; Mondorf, Ulrich; Plotz, Guido; Biondi, Ricardo M.; Zeuzem, Stefan; Piiper, Albrecht			Inhibition of the Equilibrative Nucleoside Transporter 1 and Activation of A(2A) Adenosine Receptors by 8-(4-Chlorophenylthio)-modified cAMP Analogs and Their Hydrolytic Products	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; PROTEIN-KINASE-C; SIGNALING PATHWAYS; DOWN-REGULATION; PC12 CELLS; EPAC; APOPTOSIS	Cyclic AMP analogs containing hydrophobic modification of C-8 at the adenine ring such as 8-(4-chlorophenylthio)-cAMP (8-pCPT-cAMP) and 8-(4-chlorophenylthio)-2'-O-methyl-cAMP (8-pCPT-2'-O-methyl-cAMP) can penetrate membranes due to their high lipophilicity and directly activate intracellular cAMP effectors. Therefore, these cAMP analogs have been used in numerous studies, assuming that their effects reflect the consequences of direct activation of cAMP effectors. The present study provides evidence that 8-pCPT-modified cAMP analogs and their corresponding putative hydrolysis products (8-(4-chlorophenylthio)-adenosine (8-pCPT-ado) and 8-(4-chlorophenylthio)-2'-O-methyl-adenosine (8-pCPT-2'-O-methylado)) inhibit the equilibrative nucleoside transporter 1 (ENT1). In PC12 cells, in which nucleoside transport strongly depended on ENT1, 8- pCPT-ado, 8- pCPT-2'-O-methyl-ado, and, to a smaller extent, 8- pCPT-2'-O-methyl-cAMP caused an increase of protein kinase A substrate motif phosphorylation and antiapoptotic effect by an A(2A) adenosine receptor (A(2A)R)-dependent mechanism. In contrast, the effects of 8-pCPT-cAMP were mainly A(2A)R-independent. In HEK 293 showing little endogenous ENT1-dependent nucleoside transport, transfection of ENT1 conferred A(2A)R-dependent increase in protein kinase A substrate motif phosphorylation. Together, the data of the present study indicate that inhibition of ENT1 and activation of adenosine receptors have to be considered when interpreting the effects of 8-pCPT-substituted cAMP/adenosine analogs.	[Waidmann, Oliver; Pleli, Thomas; Dvorak, Karel; Baehr, Christina; Plotz, Guido; Biondi, Ricardo M.; Zeuzem, Stefan; Piiper, Albrecht] Univ Hosp Frankfurt, Dept Med, D-60590 Frankfurt, Germany; [Mondorf, Ulrich] Univ Hosp Frankfurt, Dept Med 3, D-60590 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Piiper, A (corresponding author), Univ Hosp Frankfurt, Dept Med, D-60590 Frankfurt, Germany.	piiper@med.uni-frankfurt.de	Zeuzem, Stefan/AAE-7435-2019; Dvorak, Karel/AAD-8111-2020	Biondi, Ricardo/0000-0002-8873-7167; Plotz, Guido/0000-0001-5314-9739	Deutsche Forschungsgemeinschaft [Pi 258/7-4]; University of Saarland (HOMFOR); Wilhelm Sander foundation [2003.119.2]; Marie Christine Held and Erika Hecker foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Saarland (HOMFOR); Wilhelm Sander foundation; Marie Christine Held and Erika Hecker foundation	This work was supported by grants from the Deutsche Forschungsgemeinschaft (Grant Pi 258/7-4) and in part by grants from the University of Saarland (HOMFOR), the Wilhelm Sander foundation (Grant 2003.119.2), and the Marie Christine Held and Erika Hecker foundation.	Arslan G, 1999, N-S ARCH PHARMACOL, V359, P28, DOI 10.1007/PL00005319; Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; CAMPAGNE MMV, 1991, CANCER RES, V51, P1600; Carrier EJ, 2006, P NATL ACAD SCI USA, V103, P7895, DOI 10.1073/pnas.0511232103; Dremier S, 2007, ENDOCRINOLOGY, V148, P4612, DOI 10.1210/en.2007-0540; Dumaz N, 2005, FEBS J, V272, P3491, DOI 10.1111/j.1742-4658.2005.04763.x; Dunwiddie TV, 2000, NEUROSCIENCE, V95, P81; Enyeart JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006088; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Haag S, 2008, N-S ARCH PHARMACOL, V378, P617, DOI 10.1007/s00210-008-0334-3; Holz GG, 2008, CELL SIGNAL, V20, P10, DOI 10.1016/j.cellsig.2007.07.009; Huang M, 2003, J PHARMACOL EXP THER, V304, P753, DOI 10.1124/jpet.102.044214; Huang M, 2002, J BIOL CHEM, V277, P28364, DOI 10.1074/jbc.C200321200; Huang NK, 2001, J BIOL CHEM, V276, P13838, DOI 10.1074/jbc.M008589200; Kiermayer S, 2005, MOL BIOL CELL, V16, P5639, DOI 10.1091/mbc.E05-05-0432; Laxman S, 2006, P NATL ACAD SCI USA, V103, P19194, DOI 10.1073/pnas.0608971103; Loffler M, 2007, ARTERIOSCL THROM VAS, V27, P1004, DOI 10.1161/ATVBAHA.106.126714; MARTINEK RG, 1963, CLIN CHEM, V9, P620; Mondorf UF, 2000, FEBS LETT, V472, P129, DOI 10.1016/S0014-5793(00)01433-2; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Noji T, 2002, J PHARMACOL EXP THER, V300, P200, DOI 10.1124/jpet.300.1.200; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Piiper A, 2003, J BIOL CHEM, V278, P7065, DOI 10.1074/jbc.M211234200; Piiper A, 2002, J BIOL CHEM, V277, P43623, DOI 10.1074/jbc.M203926200; Poppe H, 2008, NAT METHODS, V5, P277, DOI 10.1038/nmeth0408-277; Ralevic V, 1998, PHARMACOL REV, V50, P413; van Noesel MM, 2002, CANCER RES, V62, P2157; VINTERMYR OK, 1995, ENDOCRINOLOGY, V136, P2513, DOI 10.1210/en.136.6.2513; Zimmerman EI, 2009, FEBS LETT, V583, P425, DOI 10.1016/j.febslet.2008.12.041	31	11	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32256	32263		10.1074/jbc.M109.056622	http://dx.doi.org/10.1074/jbc.M109.056622			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19801629	hybrid, Green Published			2022-12-27	WOS:000272028400006
J	Clayton, CC; Xu, M; Chavkin, C				Clayton, Cecilea C.; Xu, Mei; Chavkin, Charles			Tyrosine Phosphorylation of K(ir)3 following kappa-Opioid Receptor Activation of p38 MAPK Causes Heterologous Desensitization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED POTASSIUM CHANNELS; CHRONIC NEUROPATHIC PAIN; SIGNAL-REGULATED KINASE; PROTEIN-KINASE; SPINAL-CORD; BETA-ARRESTINS; NERVE INJURY; K+ CHANNELS; STRESS; INHIBITION	Prior studies showed that tyrosine 12 phosphorylation in the N-terminal, cytoplasmic domain of the G-protein-gated inwardly rectifying potassium channel, K(ir)3.1 facilitates channel deactivation by increasing intrinsic GTPase activity of the channel. Using a phosphoselective antibody directed against this residue (pY12), we now report that partial sciatic nerve ligation increased pY12-K(ir)3.1-immunoreactivity (ir) in the ipsilateral dorsal horn of wildtype mice, but not in mice lacking the kappa-opioid receptor (KOR) or lacking the G-protein receptor kinase 3 (GRK3) genes. Treatment of AtT-20 cells stably expressing KOR-GFP with the selective KOR agonist U50,488 increased both phospho-p38-ir and pY12-K(ir)3.1-ir. The U50,488-induced increase in pY12-K(ir)3.1-ir was blocked by the p38 inhibitor SB203580. Cells expressing KOR(S369A)-GFP did not increase either phospho-p38-ir or pY12-K(ir)3.1-ir following U50,488 treatment. Whole cell voltage clamp of AtT-20 cells expressing KOR-GFP demonstrated that p38 activation by U50,488 reduced somatostatin-evoked K(ir)3 currents. This heterologous desensitization was blocked by SB203580 and was not evident in cells expressing KOR(S369A)-GFP. Tyrosine phosphorylation of K(ir)3.1 was likely mediated by p38 MAPK activation of Src kinase. U50,488 also increased (pY418)Src-ir; this increase was blocked by SB203580 and not evident in KOR(S369A)-GFP expressing AtT20 cells; the Src inhibitor PP2 blocked the U50,488-induced increase in pY12-K(ir)3.1-ir; and the heterologous desensitization of K(ir)3 currents was blocked by PP2. These results suggest that KOR causes phosphorylation of Y12-K(ir)3.1 and channel inhibition through a GRK3-, p38 MAPK- and Src-dependent mechanism. Reduced inward potassium current following nerve ligation would increase dorsal horn neuronal excitability and may contribute to the neuropathic pain response.	[Clayton, Cecilea C.; Xu, Mei; Chavkin, Charles] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Chavkin, C (corresponding author), Univ Washington, Dept Pharmacol, Box 357280,1959 Pacific Ave NE, Seattle, WA 98195 USA.	cchavkin@u.washington.edu	Chavkin, Charles/G-2797-2010		National Institutes of Health USPHS [R37-DA11672]; NIDA [K05 DA20570]; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA011672, K05DA020570] Funding Source: NIH RePORTER	National Institutes of Health USPHS(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health USPHS Grants R37-DA11672 and K05 DA20570 from NIDA.	Belcheva MM, 2001, J BIOL CHEM, V276, P33847, DOI 10.1074/jbc.M101535200; Belcheva MM, 2005, J BIOL CHEM, V280, P27662, DOI 10.1074/jbc.M502593200; Bhat NR, 1998, J NEUROSCI, V18, P1633; Bruchas MR, 2008, NEUROREPORT, V19, P1417, DOI 10.1097/WNR.0b013e32830dd655; Bruchas MR, 2007, J NEUROSCI, V27, P11614, DOI 10.1523/JNEUROSCI.3769-07.2007; Bruchas MR, 2006, J BIOL CHEM, V281, P18081, DOI 10.1074/jbc.M513640200; Carr GV, 2008, J NEUROSCI, V28, P2299, DOI 10.1523/JNEUROSCI.5679-07.2008; Chen L, 2009, INT J BIOCHEM CELL B, V41, P1284, DOI 10.1016/j.biocel.2008.10.029; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Gallagher TF, 1997, BIOORGAN MED CHEM, V5, P49, DOI 10.1016/S0968-0896(96)00212-X; Gardell LR, 2004, NEUROSCIENCE, V123, P43, DOI 10.1016/j.neuroscience.2003.08.021; Ippolito DL, 2005, J BIOL CHEM, V280, P41683, DOI 10.1074/jbc.M507069200; Ippolito DL, 2002, J BIOL CHEM, V277, P32692, DOI 10.1074/jbc.M204407200; Kam AYF, 2004, J PHARMACOL EXP THER, V310, P301, DOI 10.1124/jpet.104.065078; Koyrakh L, 2005, J NEUROSCI, V25, P11468, DOI 10.1523/JNEUROSCI.3484-05.2005; Kuzhikandathil EV, 1998, MOL CELL NEUROSCI, V12, P390, DOI 10.1006/mcne.1998.0722; Lai J, 2001, Mol Interv, V1, P160; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Luttrell LM, 2002, J CELL SCI, V115, P455; Mace T, 2005, EMBO J, V24, P3235, DOI 10.1038/sj.emboj.7600799; Mao JZ, 2004, P NATL ACAD SCI USA, V101, P1087, DOI 10.1073/pnas.0304827101; Marker CL, 2006, J NEUROSCI, V26, P12251, DOI 10.1523/JNEUROSCI.3693-06.2006; Marker CL, 2005, J NEUROSCI, V25, P3551, DOI 10.1523/JNEUROSCI.4899-04.2005; Marker CL, 2004, J NEUROSCI, V24, P2806, DOI 10.1523/JNEUROSCI.5251-03.2004; Maudsley S, 2005, J PHARMACOL EXP THER, V314, P485, DOI 10.1124/jpet.105.083121; McLaughlin JP, 2003, J BIOL CHEM, V278, P34631, DOI 10.1074/jbc.M304022200; Mora SI, 2005, FEBS LETT, V579, P3019, DOI 10.1016/j.febslet.2005.04.056; PATEL YC, 1994, J BIOL CHEM, V269, P1506; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pierce KL, 2001, NAT REV NEUROSCI, V2, P727, DOI 10.1038/35094577; Pravetoni M, 2008, GENES BRAIN BEHAV, V7, P523, DOI 10.1111/j.1601-183X.2008.00388.x; Redman PT, 2007, P NATL ACAD SCI USA, V104, P3568, DOI 10.1073/pnas.0610159104; Rogalski SL, 2000, J BIOL CHEM, V275, P25082, DOI 10.1074/jbc.M000183200; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Sadja R, 2003, NEURON, V39, P9, DOI 10.1016/S0896-6273(03)00402-1; SELTZER Z, 1990, PAIN, V43, P205, DOI 10.1016/0304-3959(90)91074-S; Shenoy Sudha K, 2005, Sci STKE, V2005, pcm10, DOI 10.1126/stke.2005/308/cm10; Signorini S, 1997, P NATL ACAD SCI USA, V94, P923, DOI 10.1073/pnas.94.3.923; Thakali K, 2007, J PHARMACOL EXP THER, V320, P236, DOI 10.1124/jpet.106.110650; Vit JP, 2008, J NEUROSCI, V28, P4161, DOI 10.1523/JNEUROSCI.5053-07.2008; Wang ZJ, 2001, J NEUROSCI, V21, P1779, DOI 10.1523/JNEUROSCI.21-05-01779.2001; WICKMAN K, 1995, PHYSIOL REV, V75, P865, DOI 10.1152/physrev.1995.75.4.865; Wittmann W, 2009, NEUROPSYCHOPHARMACOL, V34, P775, DOI 10.1038/npp.2008.142; Xu M, 2004, J NEUROSCI, V24, P4576, DOI 10.1523/JNEUROSCI.5552-03.2004; Xu M, 2007, J NEUROSCI, V27, P2570, DOI 10.1523/JNEUROSCI.3728-06.2007; Young PR, 1997, J BIOL CHEM, V272, P12116, DOI 10.1074/jbc.272.18.12116; Zhu CB, 2005, J BIOL CHEM, V280, P15649, DOI 10.1074/jbc.M410858200	48	27	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31872	31881		10.1074/jbc.M109.053793	http://dx.doi.org/10.1074/jbc.M109.053793			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19773548	hybrid, Green Published			2022-12-27	WOS:000271572700042
J	Musayev, FN; Di Salvo, ML; Saavedra, MA; Contestabile, R; Ghatge, MS; Haynes, A; Schirch, V; Safo, MK				Musayev, Faik N.; Di Salvo, Martino L.; Saavedra, Mario A.; Contestabile, Roberto; Ghatge, Mohini S.; Haynes, Alexina; Schirch, Verne; Safo, Martin K.			Molecular Basis of Reduced Pyridoxine 5 '-Phosphate Oxidase Catalytic Activity in Neonatal Epileptic Encephalopathy Disorder	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI PYRIDOXINE-5'-PHOSPHATE OXIDASE; X-RAY-STRUCTURE; PYRIDOXINE-5-PHOSPHATE OXIDASE; ANGSTROM RESOLUTION; PNPO DEFICIENCY; PHOSPHATE; KINASE; SCHIZOPHRENIA; CHILDREN; ENZYMES	Mutations in pyridoxine 5'-phosphate oxidase are known to cause neonatal epileptic encephalopathy. This disorder has no cure or effective treatment and is often fatal. Pyridoxine 5'-phosphate oxidase catalyzes the oxidation of pyridoxine 5'-phosphate to pyridoxal 5'-phosphate, the active cofactor form of vitamin B-6 required by more than 140 different catalytic activities, including enzymes involved in amino acid metabolism and biosynthesis of neurotransmitters. Our aim is to elucidate the mechanism by which a homozygous missense mutation (R229W) in the oxidase, linked to neonatal epileptic encephalopathy, leads to reduced oxidase activity. The R229W variant is similar to 850-fold less efficient than the wild-type enzyme due to an similar to 192-fold decrease in pyridoxine 5'-phosphate affinity and an similar to 4.5-fold decrease in catalytic activity. There is also an similar to 50-fold reduction in the affinity of the R229W variant for the FMN cofactor. A 2.5 angstrom crystal structure of the R229W variant shows that the substitution of Arg-229 at the FMN binding site has led to a loss of hydrogen-bond and/or salt-bridge interactions between FMN and Arg-229 and Ser-175. Additionally, the mutation has led to an alteration of the configuration of a beta-strand-loop-beta-strand structure at the active site, resulting in loss of two critical hydrogen-bond interactions involving residues His-227 and Arg-225, which are important for substrate binding and orientation for catalysis. These results provide a molecular basis for the phenotype associated with the R229W mutation, as well as providing a foundation for understanding the pathophysiological consequences of pyridoxine 5'-phosphate oxidase mutations.	[Musayev, Faik N.; Saavedra, Mario A.; Ghatge, Mohini S.; Schirch, Verne; Safo, Martin K.] Virginia Commonwealth Univ, Inst Struct Biol & Drug Discovery, Richmond, VA 23219 USA; [Musayev, Faik N.; Saavedra, Mario A.; Ghatge, Mohini S.; Schirch, Verne; Safo, Martin K.] Virginia Commonwealth Univ, Dept Med Chem, Sch Pharm, Richmond, VA 23219 USA; [Di Salvo, Martino L.; Contestabile, Roberto] Univ Roma La Sapienza, Dipartimento Sci Biochim, Ist Pasteur, Fdn Cenci Bolognetti, I-00185 Rome, Italy; [Haynes, Alexina] Virginia Union Univ, Dept Nat Sci, Richmond, VA 23220 USA	Virginia Commonwealth University; Virginia Commonwealth University; Fondazione Cenci Bolognetti; Sapienza University Rome; Virginia Union University	Safo, MK (corresponding author), Virginia Commonwealth Univ, Inst Struct Biol & Drug Discovery, 800 E Leigh St,Ste 212, Richmond, VA 23219 USA.	msafo@vcu.edu	Safo, Martin/AAJ-9833-2020; Ghatge, Mohini/AAY-3381-2020; Musayev, Faik/AAY-2010-2020; Contestabile, Roberto/J-3467-2019	Contestabile, Roberto/0000-0002-5235-9993; di Salvo, Martino Luigi/0000-0003-1233-9338	Jeffress Research; Istituto Pasteur - Fondazione Cenci Bolognetti [PRIN2007]	Jeffress Research; Istituto Pasteur - Fondazione Cenci Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti)	The work was supported by a grant from the AD Williams Fund (to M. K. S.), the Jeffress Research Grant Award (to M. K. S.) and grants from PRIN2007 and Istituto Pasteur - Fondazione Cenci Bolognetti (to M. L. D. S. and R. C.).	AALTONEN J, 1994, NAT GENET, V8, P83, DOI 10.1038/ng0994-83; Adams JB, 2006, J ALTERN COMPLEM MED, V12, P59, DOI 10.1089/acm.2006.12.59; Adams JB, 2004, J ALTERN COMPLEM MED, V10, P1033, DOI 10.1089/acm.2004.10.1033; Bagci S, 2008, ARCH DIS CHILD-FETAL, V93, pF151, DOI 10.1136/adc.2006.115162; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHOI SY, 1987, J BIOL CHEM, V262, P12013; Clayton PT, 2006, J INHERIT METAB DIS, V29, P317, DOI 10.1007/s10545-005-0243-2; Clayton PT, 2003, LANCET, V361, P1614, DOI 10.1016/S0140-6736(03)13312-0; COBURN SP, 1991, J MENT DEFIC RES, V35, P543; DeLano W.L, PYMOL MOL GRAPHICS S; DELPORT R, 1993, RES COMMUN CHEM PATH, V79, P325; di Salvo ML, 2002, J MOL BIOL, V315, P385, DOI 10.1006/jmbi.2001.5254; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hoffmann GF, 2007, J INHERIT METAB DIS, V30, P96, DOI 10.1007/s10545-006-0508-4; HORIIKE K, 1979, J BIOL CHEM, V254, P6638; Jansonius JN, 1998, CURR OPIN STRUC BIOL, V8, P759, DOI 10.1016/S0959-440X(98)80096-1; JOHN RA, 1995, BBA-PROTEIN STRUCT M, V1248, P81, DOI 10.1016/0167-4838(95)00025-P; KAZARINOFF MN, 1973, BIOCHEM BIOPH RES CO, V52, P440, DOI 10.1016/0006-291X(73)90731-6; Khayat M, 2008, MOL GENET METAB, V94, P431, DOI 10.1016/j.ymgme.2008.04.008; Kuwahara Hiroya, 2008, Rinsho Shinkeigaku, V48, P125; KWON O, 1991, J BIOL CHEM, V266, P22136; LaineCessac P, 1997, BIOCHEM PHARMACOL, V54, P863, DOI 10.1016/S0006-2952(97)00252-9; Leklem J.E., 1991, HDB VITAMINS, P341; McCormick Donald B., 1996, P396; Mills PB, 2005, HUM MOL GENET, V14, P1077, DOI 10.1093/hmg/ddi120; Miodownik C, 2007, CLIN NEUROPHARMACOL, V30, P13, DOI 10.1097/01.WNF.0000236770.38903.AF; Mousain-Bosc M, 2006, MAGNESIUM RES, V19, P53; Musayev FN, 2003, PROTEIN SCI, V12, P1455, DOI 10.1110/ps.0356203; Nakagawa E, 1997, NEUROLOGY, V48, P1468, DOI 10.1212/WNL.48.5.1468; Nogovitsina O. R., 2006, Eksperimental'naya i Klinicheskaya Farmakologiya, V69, P74; Pedelacq JD, 2006, PROTEINS, V62, P563, DOI 10.1002/prot.20824; Rajesh R, 2003, Indian Pediatr, V40, P633; Reif A, 2003, J NEURAL TRANSM, V110, P1401, DOI 10.1007/s00702-003-0061-3; Ruiz A, 2008, MOL GENET METAB, V93, P216, DOI 10.1016/j.ymgme.2007.10.003; Safo MK, 2000, STRUCTURE, V8, P751, DOI 10.1016/S0969-2126(00)00162-3; Safo MK, 2005, ACTA CRYSTALLOGR D, V61, P599, DOI 10.1107/S0907444905005512; Safo MK, 2001, J MOL BIOL, V310, P817, DOI 10.1006/jmbi.2001.4734; SANDYK R, 1990, INT J NEUROSCI, V52, P225, DOI 10.3109/00207459009000524; SETO T, 2000, TO HATTATSU, V32, P295; Song H, 2007, SCHIZOPHR RES, V97, P264, DOI 10.1016/j.schres.2007.08.004; Steichen O, 2006, REV MAL RESPIR, V23, P157, DOI 10.1016/S0761-8425(06)71480-2; Takuma Y, 1998, EPILEPSIA, V39, P42, DOI 10.1111/j.1528-1157.1998.tb05149.x; UBBINK JB, 1990, J NUTR, V120, P1352, DOI 10.1093/jn/120.11.1352; Yang ES, 2000, ARCH BIOCHEM BIOPHYS, V377, P109, DOI 10.1006/abbi.2000.1737	45	32	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30949	30956		10.1074/jbc.M109.038372	http://dx.doi.org/10.1074/jbc.M109.038372			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19759001	Green Published, hybrid			2022-12-27	WOS:000271378400024
J	Patsouris, D; Neels, JG; Fan, WQ; Li, PP; Nguyen, MTA; Olefsky, JM				Patsouris, David; Neels, Jaap G.; Fan, WuQiang; Li, Ping-Ping; Nguyen, M. T. Audrey; Olefsky, Jerrold M.			Glucocorticoids and Thiazolidinediones Interfere with Adipocyte-mediated Macrophage Chemotaxis and Recruitment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; DEHYDROGENASE TYPE-1 EXPRESSION; INDUCED INSULIN-RESISTANCE; ADIPOSE-TISSUE; UP-REGULATION; PPAR-DELTA; T-CELLS; KAPPA-B; OBESITY; FAT	The link between intra-abdominal adiposity and type II diabetes has been known for decades, and adipose tissue macrophage (ATM)-associated inflammation has recently been linked to insulin resistance. However, the mechanisms associated with ATM recruitment remain ill defined. Herein, we describe in vitro chemotaxis studies, in which adipocyte conditioned medium was used to stimulate macrophage migration. We demonstrate that tumor necrosis factor alpha and free fatty acids, key inflammatory stimuli involved in obesity-associated autocrine/paracrine inflammatory signaling, stimulate adipocyte expression and secretion of macrophage chemoattractants. Pharmacological studies showed that peroxisome proliferator-activated receptor gamma agonists and glucocorticoids potently inhibit adipocyte- induced recruitment of macrophages. This latter effect was mediated by the glucocorticoid receptor, which led to decreased chemokine secretion and expression. In vivo results were quite comparable; treatment of high fat diet-fed mice with dexamethasone prevented ATM accumulation in epididymal fat. This decrease in ATM was most pronounced for the proinflammatory F4/80(+), CD11b(+), CD11c(+) M-1-like ATM subset. Overall, our results elucidate a beneficial function of peroxisome proliferator-activated receptor gamma activation and glucocorticoid receptor/glucocorticoids in adipose tissue and indicate that pharmacologic prevention of ATM accumulation could be beneficial.	[Patsouris, David; Neels, Jaap G.; Fan, WuQiang; Li, Ping-Ping; Nguyen, M. T. Audrey; Olefsky, Jerrold M.] Univ Calif San Diego, Dept Med, Div Endocrinol Metab, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Olefsky, JM (corresponding author), Univ Calif San Diego, Dept Med 0673, 9500 Gilman Dr, La Jolla, CA 92093 USA.	jolefsky@ucsd.edu	Neels, Jaap G/F-5534-2010; Li, Pingping/F-1109-2019	Neels, Jaap G/0000-0002-5900-8395; Li, Pingping/0000-0003-0679-270X	National Institutes of Health [DK033651, DK074868, T32 DK007494]; Eunice Kennedy Shriver NICHD/National Institutes of Health [U54 HD 012303-25]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD012303, P50HD012303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK074868, T32DK007494, R37DK033651, R01DK033651] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver NICHD/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK033651, DK074868, and T32 DK007494 and by the Eunice Kennedy Shriver NICHD/National Institutes of Health through cooperative agreement U54 HD 012303-25 as part of the specialized Cooperative Centers Program in Reproduction and Infertility Research.	Andrews RC, 1999, CLIN SCI, V96, P513, DOI 10.1042/cs0960513; Barish GD, 2006, J CLIN INVEST, V116, P590, DOI 10.1172/JCI27955; Berger J, 2001, J BIOL CHEM, V276, P12629, DOI 10.1074/jbc.M003592200; Bujalska IJ, 2008, ENDOCRINOLOGY, V149, P2584, DOI 10.1210/en.2007-1705; Caprio M, 2007, FASEB J, V21, P2185, DOI 10.1096/fj.06-7970com; Chavey C, 2009, CELL METAB, V9, P339, DOI 10.1016/j.cmet.2009.03.002; de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; Gevrey JC, 2005, J IMMUNOL, V175, P3737, DOI 10.4049/jimmunol.175.6.3737; Glass CK, 2006, NAT REV IMMUNOL, V6, P44, DOI 10.1038/nri1748; Gunin AG, 2003, EUR J OBSTET GYN R B, V107, P62, DOI 10.1016/S0301-2115(02)00375-5; Harman-Boehm I, 2007, J CLIN ENDOCR METAB, V92, P2240, DOI 10.1210/jc.2006-1811; Hundal RS, 2002, J CLIN INVEST, V109, P1321, DOI 10.1172/JCI200214955; Inouye KE, 2007, DIABETES, V56, P2242, DOI 10.2337/db07-0425; Jiao P, 2009, DIABETES, V58, P104, DOI 10.2337/db07-1344; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kassel O, 2001, EMBO J, V20, P7108, DOI 10.1093/emboj/20.24.7108; Kharroubi I, 2006, DIABETOLOGIA, V49, P2350, DOI 10.1007/s00125-006-0366-5; Kim JK, 2001, J CLIN INVEST, V108, P437, DOI 10.1172/JCI11559; Kirk EA, 2008, DIABETES, V57, P1254, DOI 10.2337/db07-1061; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Lehrke M, 2005, GENE DEV, V19, P1737, DOI 10.1101/gad.1341005; Liao W, 2007, AM J PHYSIOL-ENDOC M, V293, pE219, DOI 10.1152/ajpendo.00695.2006; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Macfarlane DP, 2008, J ENDOCRINOL, V197, P189, DOI 10.1677/JOE-08-0054; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Neels JG, 2009, J BIOL CHEM, V284, P20692, DOI 10.1074/jbc.M109.018556; Neels JG, 2006, J CLIN INVEST, V116, P33, DOI 10.1172/JCI27280; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Nguyen MTA, 2005, J BIOL CHEM, V280, P35361, DOI 10.1074/jbc.M504611200; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Reynolds RM, 2003, DIABETES OBES METAB, V5, P5, DOI 10.1046/j.1463-1326.2003.00221.x; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Stulnig TM, 2002, DIABETES, V51, P2426, DOI 10.2337/diabetes.51.8.2426; Syed AA, 2005, OBES RES, V13, P1131, DOI 10.1038/oby.2005.132; Takahashi K, 2008, AM J PHYSIOL-ENDOC M, V294, pE898, DOI 10.1152/ajpendo.00131.2007; Takaishi H, 2003, BIOCHEM BIOPH RES CO, V305, P122, DOI 10.1016/S0006-291X(03)00712-5; Wallerath T, 2004, NITRIC OXIDE-BIOL CH, V10, P36, DOI 10.1016/j.niox.2004.01.008; Weiss-Haljiti C, 2004, J BIOL CHEM, V279, P43273, DOI 10.1074/jbc.M402924200; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wu HZ, 2007, CIRCULATION, V115, P1029, DOI 10.1161/CIRCULATIONAHA.106.638379; Yoshizaki T, 2009, MOL CELL BIOL, V29, P1363, DOI 10.1128/MCB.00705-08; Yu RN, 2006, OBESITY, V14, P1353, DOI 10.1038/oby.2006.153; Zhang BG, 2009, EUR J IMMUNOL, V39, P894, DOI 10.1002/eji.200838809	50	65	65	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31223	31235		10.1074/jbc.M109.041665	http://dx.doi.org/10.1074/jbc.M109.041665			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19740750	Green Published, hybrid			2022-12-27	WOS:000271378400050
J	Vollmuth, F; Blankenfeldt, W; Geyer, M				Vollmuth, Friederike; Blankenfeldt, Wulf; Geyer, Matthias			Structures of the Dual Bromodomains of the P-TEFb-activating Protein Brd4 at Atomic Resolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT TRANSCRIPTIONAL ELONGATION; ACETYLATED HISTONE H4; T-BINDING DOMAIN; CRYSTAL-STRUCTURE; 7SK SNRNP; HIV-1 TAT; RECOGNITION; DROSOPHILA; COMPONENT; COMPLEX	Brd4 is a member of the bromodomains and extra terminal domain (BET) family of proteins that recognize acetylated chromatin structures through their bromodomains and act as transcriptional activators. Brd4 functions as an associated factor and positive regulator of P-TEFb, a Cdk9-cyclin T heterodimer that stimulates transcriptional elongation by RNA polymerase II. Here, the crystal structures of the two bromodomains of Brd4 (BD1 and BD2) were determined at 1.5 and 1.2 angstrom resolution, respectively. Complex formation of BD1 with a histone H3 tail polypeptide encompassing residues 12 - 19 showed binding of the N zeta-acetylated lysine 14 to the conserved asparagine 140 of Brd4. In contrast, in BD2 the N-terminal linker sequence was found to interact with the binding site for acetylated lysines of the adjacent molecule to form continuous strings in the crystal lattice. This assembly shows for the first time a different binding ligand than acetylated lysine indicating that also other sequence compositions may be able to form similar interaction networks. Isothermal titration calorimetry revealed best binding of BD1 to H3 and of BD2 to H4 acetylated lysine sequences, suggesting alternating histone recognition specificities. Intriguingly, an acetylated lysine motif from cyclin T1 bound similarly well to BD2. Whereas the structure of Brd2 BD1 suggested its dimer formation, both Brd4 bromodomains appeared monomeric in solution as shown by size exclusion chromatography and mutational analyses.	[Geyer, Matthias] Max Planck Inst Mol Physiol, Dept Phys Biochem, Abt Phys Biochem, D-44227 Dortmund, Germany	Max Planck Society	Geyer, M (corresponding author), Max Planck Inst Mol Physiol, Dept Phys Biochem, Abt Phys Biochem, Otto Hahn Str 11, D-44227 Dortmund, Germany.	matthias.geyer@mpi-dortmund.mpg.de	Blankenfeldt, Wulf/F-8877-2010	Blankenfeldt, Wulf/0000-0001-9886-9668; Geyer, Matthias/0000-0002-7718-5002	Deutsche Forschungsgemeinschaft [GE-976/5]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Grant GE-976/5 from the Deutsche Forschungsgemeinschaft (to M. G.).	Abbate EA, 2006, MOL CELL, V24, P877, DOI 10.1016/j.molcel.2006.11.002; Anand K, 2008, NAT STRUCT MOL BIOL, V15, P1287, DOI 10.1038/nsmb.1513; Barboric M, 2007, NUCLEIC ACIDS RES, V35, P2003, DOI 10.1093/nar/gkm063; Baumli S, 2008, EMBO J, V27, P1907, DOI 10.1038/emboj.2008.121; Beck S, 1992, DNA Seq, V2, P203, DOI 10.3109/10425179209020804; Bisgrovet DA, 2007, P NATL ACAD SCI USA, V104, P13690, DOI 10.1073/pnas.0705053104; Cho SY, 2009, EMBO J, V28, P1407, DOI 10.1038/emboj.2009.99; CHUA P, 1995, MOL CELL BIOL, V15, P3685; Crawford NPS, 2008, P NATL ACAD SCI USA, V105, P6380, DOI 10.1073/pnas.0710331105; Dames SA, 2007, P NATL ACAD SCI USA, V104, P14312, DOI 10.1073/pnas.0701848104; Denis GV, 1996, GENE DEV, V10, P261, DOI 10.1101/gad.10.3.261; Dey A, 2000, MOL CELL BIOL, V20, P6537, DOI 10.1128/MCB.20.17.6537-6549.2000; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Farina A, 2004, MOL CELL BIOL, V24, P9059, DOI 10.1128/MCB.24.20.9059-9069.2004; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; HAYNES SR, 1992, NUCLEIC ACIDS RES, V20, P2603, DOI 10.1093/nar/20.10.2603; He N, 2008, MOL CELL, V29, P588, DOI 10.1016/j.molcel.2008.01.003; Huang B, 2009, MOL CELL BIOL, V29, P1375, DOI 10.1128/MCB.01365-08; Hudson BP, 2000, J MOL BIOL, V304, P355, DOI 10.1006/jmbi.2000.4207; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jones MH, 1997, GENOMICS, V45, P529, DOI 10.1006/geno.1997.5000; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kanno T, 2004, MOL CELL, V13, P33, DOI 10.1016/S1097-2765(03)00482-9; Krueger BJ, 2008, NUCLEIC ACIDS RES, V36, P2219, DOI 10.1093/nar/gkn061; Lin YJ, 2008, PROTEIN SCI, V17, P2174, DOI 10.1110/ps.037580.108; Liu Y, 2008, BIOCHEMISTRY-US, V47, P6403, DOI 10.1021/bi8001659; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Markert A, 2008, EMBO REP, V9, P569, DOI 10.1038/embor.2008.72; Maruyama T, 2002, MOL CELL BIOL, V22, P6509, DOI 10.1128/MCB.22.18.6509-6520.2002; Mujtaba S, 2007, ONCOGENE, V26, P5521, DOI 10.1038/sj.onc.1210618; Mujtaba S, 2004, MOL CELL, V13, P251, DOI 10.1016/S1097-2765(03)00528-8; Mujtaba S, 2002, MOL CELL, V9, P575, DOI 10.1016/S1097-2765(02)00483-5; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura Y, 2007, J BIOL CHEM, V282, P4193, DOI 10.1074/jbc.M605971200; Owen DJ, 2000, EMBO J, V19, P6141, DOI 10.1093/emboj/19.22.6141; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Schonichen A, 2006, J BIOL CHEM, V281, P5084, DOI 10.1074/jbc.M509226200; Schulte A, 2005, J BIOL CHEM, V280, P24968, DOI 10.1074/jbc.M501431200; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; TAMKUN JW, 1992, CELL, V68, P561, DOI 10.1016/0092-8674(92)90191-E; Thorpe KL, 1997, GENE, V200, P177, DOI 10.1016/S0378-1119(97)00415-0; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VanDemark AP, 2007, MOL CELL, V27, P817, DOI 10.1016/j.molcel.2007.08.018; Wu SY, 2007, J BIOL CHEM, V282, P13141, DOI 10.1074/jbc.R700001200; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Zeng L, 2008, STRUCTURE, V16, P643, DOI 10.1016/j.str.2008.01.010; Zippo A, 2009, CELL, V138, P1122, DOI 10.1016/j.cell.2009.07.031	51	94	115	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36547	36556		10.1074/jbc.M109.033712	http://dx.doi.org/10.1074/jbc.M109.033712			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19828451	Green Published, hybrid			2022-12-27	WOS:000272970500056
J	Pantoja-Uceda, D; Arolas, JL; Aviles, FX; Santoro, J; Ventura, S; Sommerhoff, CP				Pantoja-Uceda, David; Arolas, Joan L.; Aviles, Francesc X.; Santoro, Jorge; Ventura, Salvador; Sommerhoff, Christian P.			Deciphering the Structural Basis That Guides the Oxidative Folding of Leech-derived Tryptase Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAST-CELL TRYPTASE; TORSION ANGLE DYNAMICS; KAZAL-TYPE INHIBITOR; CARBOXYPEPTIDASE INHIBITOR; PROTEIN STRUCTURES; TRYPSIN-INHIBITOR; NMR; PROGRAM; PATHWAY; INTERMEDIATE	Protein folding mechanisms have remained elusive mainly because of the transient nature of intermediates. Leech-derived tryptase inhibitor (LDTI) is a Kazal-type serine proteinase inhibitor that is emerging as an attractive model for folding studies. It comprises 46 amino acid residues with three disulfide bonds, with one located inside a small triple-stranded antiparallel beta-sheet and with two involved in a cystine-stabilized alpha-helix, a motif that is widely distributed in bioactive peptides. Here, we analyzed the oxidative folding and reductive unfolding of LDTI by chromatographic and disulfide analyses of acid-trapped intermediates. It folds and unfolds, respectively, via sequential oxidation and reduction of the cysteine residues that give rise to a few 1- and 2-disulfide intermediates. Species containing two native disulfide bonds predominate during LDTI folding (IIa and IIc) and unfolding (IIa and IIb). Stop/go folding experiments demonstrate that only intermediate IIa is productive and oxidizes directly into the native form. The NMR structures of acid-trapped and further isolated IIa, IIb, and IIc reveal global folds similar to that of the native protein, including a native-like canonical inhibitory loop. Enzyme kinetics shows that both IIa and IIc are inhibitory-active, which may substantially reduce proteolysis of LDTI during its folding process. The results reported show that the kinetics of the folding reaction is modulated by the specific structural properties of the intermediates and together provide insights into the interdependence of conformational folding and the assembly of native disulfides during oxidative folding.	[Pantoja-Uceda, David; Arolas, Joan L.; Santoro, Jorge] CSIC, Inst Quim Fis Rocasolano, Dept Espectroscopia & Estructura Mol, E-28006 Madrid, Spain; [Aviles, Francesc X.; Ventura, Salvador] Univ Autonoma Barcelona, Fac Ciencies, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain; [Aviles, Francesc X.; Ventura, Salvador] Univ Autonoma Barcelona, Fac Ciencies, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain; [Sommerhoff, Christian P.] Univ Munich, Klinikumsstandort Innenstadt, Klin Chem & Klin Biochem Abt, D-80336 Munich, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Autonomous University of Barcelona; Autonomous University of Barcelona; University of Munich	Santoro, J (corresponding author), CSIC, Inst Quim Fis Rocasolano, Dept Espectroscopia & Estructura Mol, Serrano 119, E-28006 Madrid, Spain.	jsantoro@iqfr.csic.es; salvador.ventura@uab.es	Ventura, Salvador/C-7021-2008; Avilés, Francesc Xavier/A-2664-2015; Ventura, Salvador/AAY-3170-2021; Aviles, Francesc Xavier/F-3482-2019; Pantoja-Uceda, David/J-8097-2014	Ventura, Salvador/0000-0002-9652-6351; Avilés, Francesc Xavier/0000-0002-1399-6789; Ventura, Salvador/0000-0002-9652-6351; Aviles, Francesc Xavier/0000-0002-1399-6789; Lopez Arolas, Joan/0000-0002-4198-5016; Pantoja-Uceda, David/0000-0003-4390-6972	Spanish Ministry for Science and Innovation [BIO2007-68046, BFU2005-01855]; Deutsche Forschungsgemeinschaft [SO 249/1-1]	Spanish Ministry for Science and Innovation(Spanish Government); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Spanish Ministry for Science and Innovation Grants BIO2007-68046 and BFU2005-01855 and Deutsche Forschungsgemeinschaft Grant SO 249/1-1.	Arolas JL, 2005, STRUCTURE, V13, P1193, DOI 10.1016/j.str.2005.05.008; Arolas JL, 2008, J BIOL CHEM, V283, P27110, DOI 10.1074/jbc.M803978200; Arolas JL, 2008, ANTIOXID REDOX SIGN, V10, P77, DOI 10.1089/ars.2007.1850; Arolas JL, 2006, TRENDS BIOCHEM SCI, V31, P292, DOI 10.1016/j.tibs.2006.03.005; AUERSWALD EA, 1994, BIOL CHEM H-S, V375, P695, DOI 10.1515/bchm3.1994.375.10.695; Cemazar M, 2008, STRUCTURE, V16, P842, DOI 10.1016/j.str.2008.02.023; Chang JY, 2008, ANTIOXID REDOX SIGN, V10, P171, DOI 10.1089/ars.2007.1873; Chang JY, 2004, BIOCHEMISTRY-US, V43, P4522, DOI 10.1021/bi0360354; Creighton TE, 1997, BIOL CHEM, V378, P731; Darby N, 1995, Methods Mol Biol, V40, P219; DARBY NJ, 1995, J MOL BIOL, V249, P463, DOI 10.1006/jmbi.1995.0309; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DiMarco S, 1997, STRUCTURE, V5, P1465; Gahl RF, 2009, BIOCHEMISTRY-US, V48, P2740, DOI 10.1021/bi802327j; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; GUNTERT P, 1991, J MOL BIOL, V217, P517, DOI 10.1016/0022-2836(91)90754-T; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hallgren J, 2006, FEBS J, V273, P1871, DOI 10.1111/j.1742-4658.2006.05211.x; Hemmi H, 2005, BIOCHEMISTRY-US, V44, P9626, DOI 10.1021/bi0472806; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LASKOWSKI M, 1953, J BIOL CHEM, V204, P797; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Magert HJ, 1999, J BIOL CHEM, V274, P21499, DOI 10.1074/jbc.274.31.21499; MORRISON JF, 1982, TRENDS BIOCHEM SCI, V7, P102, DOI 10.1016/0968-0004(82)90157-8; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; MUHLHAHN P, 1994, FEBS LETT, V355, P290, DOI 10.1016/0014-5793(94)01225-3; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Narayan M, 2000, ACCOUNTS CHEM RES, V33, P805, DOI 10.1021/ar000063m; Pantoja-Uceda D, 2005, PROTEIN SCI, V14, P224, DOI 10.1110/ps.041138705; Pohlig G, 1996, EUR J BIOCHEM, V241, P619, DOI 10.1111/j.1432-1033.1996.00619.x; Schirra HJ, 1998, BIOCHEMISTRY-US, V37, P6263, DOI 10.1021/bi980136y; SEALOCK RW, 1973, BIOCHEMISTRY-US, V12, P3139, DOI 10.1021/bi00741a001; Sommerhoff CP, 2007, CURR PHARM DESIGN, V13, P313, DOI 10.2174/138161207779313579; SOMMERHOFF CP, 1994, BIOL CHEM H-S, V375, P685, DOI 10.1515/bchm3.1994.375.10.685; Sommerhoff CP, 2001, AM J RESP CRIT CARE, V164, pS52, DOI 10.1164/ajrccm.164.supplement_2.2106058; Stubbs MT, 1997, J BIOL CHEM, V272, P19931, DOI 10.1074/jbc.272.32.19931; Thannhauser TW, 1997, BIOCHEMISTRY-US, V36, P2154, DOI 10.1021/bi962340w; TSCHESCHE H, 1974, ANGEW CHEM INT EDIT, V13, P10, DOI 10.1002/anie.197400101; van den Berg P, 1999, EMBO J, V18, P4794, DOI 10.1093/emboj/18.17.4794; WEISSMAN JS, 1991, SCIENCE, V253, P1386, DOI 10.1126/science.1716783; Welker E, 2001, P NATL ACAD SCI USA, V98, P2312, DOI 10.1073/pnas.041615798; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wuthrich K, 1986, NMR PROTEINS NUCL AC	45	14	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35612	35620		10.1074/jbc.M109.061077	http://dx.doi.org/10.1074/jbc.M109.061077			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19820233	Green Published, hybrid			2022-12-27	WOS:000272645600039
J	Fasanaro, P; Greco, S; Lorenzi, M; Pescatori, M; Brioschi, M; Kulshreshtha, R; Banfi, C; Stubbs, A; Calin, GA; Ivan, M; Capogrossi, MC; Martelli, F				Fasanaro, Pasquale; Greco, Simona; Lorenzi, Maria; Pescatori, Mario; Brioschi, Maura; Kulshreshtha, Ritu; Banfi, Cristina; Stubbs, Andrew; Calin, George A.; Ivan, Mircea; Capogrossi, Maurizio C.; Martelli, Fabio			An Integrated Approach for Experimental Target Identification of Hypoxia-induced miR-210	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3' UNTRANSLATED REGIONS; MESSENGER-RNAS; GENE-EXPRESSION; BREAST-CANCER; BRUGADA-SYNDROME; IN-VIVO; MICRORNA TARGETS; HEART-FAILURE; MIRNAS; CELLS	miR-210 is a key player of cell response to hypoxia, modulating cell survival, VEGF-driven endothelial cell migration, and the ability of endothelial cells to form capillary-like structures. A crucial step in understanding microRNA (miRNA) function is the identification of their targets. However, only few miR-210 targets have been identified to date. Here, we describe an integrated strategy for large-scale identification of new miR-210 targets by combining transcriptomics and proteomics with bioinformatic approaches. To experimentally validate candidate targets, the RNA-induced silencing complex (RISC) loaded with miR-210 was purified by immunoprecipitation along with its mRNA targets. The complex was significantly enriched in mRNAs of 31 candidate targets, such as BDNF, GPD1L, ISCU, NCAM, and the non-coding RNA Xist. A subset of the newly identified targets was further confirmed by 3'-untranslated region (UTR) reporter assays, and hypoxia induced down-modulation of their expression was rescued blocking miR-210, providing support for the approach validity. In the case of 9 targets, such as PTPN1 and P4HB, miR-210 seed-pairing sequences localized in the coding sequence or in the 5'-UTR, in line with recent data extending miRNA targeting beyond the "classic" 3'-UTR recognition. Finally, Gene Ontology analysis of the targets highlights known miR-210 impact on cell cycle regulation and differentiation, and predicts a new role of this miRNA in RNA processing, DNA binding, development, membrane trafficking, and amino acid catabolism. Given the complexity of miRNA actions, we view such a multiprong approach as useful to adequately describe the multiple pathways regulated by miR-210 during physiopathological processes.	[Martelli, Fabio] IRCCS Ist Dermopat Immacolata, Lab Patol Vasc, I-00167 Rome, Italy; [Fasanaro, Pasquale; Greco, Simona] IRCCS Policlin San Donato, I-20097 San Donato Milanese, Italy; [Lorenzi, Maria] Ist Nazl Riposa & Cura Anziani, I-60121 Ancona, Italy; [Pescatori, Mario; Stubbs, Andrew] Erasmus MC, NL-3015 Rotterdam, Netherlands; [Brioschi, Maura; Banfi, Cristina] Ctr Cardiol Monzino IRCCS, I-20138 Milan, Italy; [Kulshreshtha, Ritu] Tufts Univ New England Med Ctr, Boston, MA 02111 USA; [Calin, George A.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Ivan, Mircea] Indiana Univ, Indianapolis, IN 46202 USA	IRCCS Istituto Dermopatico dell'Immacolata (IDI); IRCCS Policlinico San Donato; IRCCS INRCA; Erasmus University Rotterdam; Erasmus MC; IRCCS Centro Cardiologico Monzino; Tufts Medical Center; University of Texas System; UTMD Anderson Cancer Center; Indiana University System; Indiana University-Purdue University Indianapolis	Martelli, F (corresponding author), IRCCS Ist Dermopat Immacolata, Lab Patol Vasc, I-00167 Rome, Italy.	f.martelli@idi.it	Calin, George/E-9390-2011; Banfi, Cristina/G-6362-2018; Brioschi, Marcos/AAA-7034-2022; Brioschi, Maura/G-5687-2018; greco, simona/J-5374-2016; Martelli, Fabio/AAL-3788-2020; greco, simona/AAD-3211-2021; Ivan, Mircea/A-8109-2012; Brioschi, Maura/AAB-4860-2019	Banfi, Cristina/0000-0003-3346-9879; Brioschi, Marcos/0000-0003-4822-8314; Brioschi, Maura/0000-0003-4706-4418; greco, simona/0000-0002-0275-7221; Martelli, Fabio/0000-0002-8624-7738; greco, simona/0000-0002-0275-7221; Brioschi, Maura/0000-0003-4706-4418; Calin, George/0000-0001-6704-5615; Ivan, Mircea/0000-0003-3424-6642	Ministero della Salute [RF06-conv.29/07-1, RF07-conv-85.1, RBLA035a4X-001, RF05-conv.66-1, RF07-55.1, RF07-strat]	Ministero della Salute(Ministry of Health, Italy)	This work was supported in part by Ministero della Salute Grants RF06-conv.29/07-1, RF07-conv-85.1, RBLA035a4X-001, RF05-conv.66-1, RF07-55.1, and RF07-strat.	Al-Shahrour F, 2008, NUCLEIC ACIDS RES, V36, pW341, DOI 10.1093/nar/gkn318; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benito B, 2008, PROG CARDIOVASC DIS, V51, P1, DOI 10.1016/j.pcad.2008.05.002; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; Bianchi N, 2009, BMB REP, V42, P493, DOI 10.5483/BMBRep.2009.42.8.493; Blewitt ME, 2008, NAT GENET, V40, P663, DOI 10.1038/ng.142; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Crosby ME, 2009, CANCER RES, V69, P1221, DOI 10.1158/0008-5472.CAN-08-2516; Di Diego JM, 2005, J ELECTROCARDIOL, V38, P14, DOI 10.1016/j.jelectrocard.2005.06.003; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Foekens JA, 2008, P NATL ACAD SCI USA, V105, P13021, DOI 10.1073/pnas.0803304105; Giannakakis A, 2008, CANCER BIOL THER, V7, P255, DOI 10.4161/cbt.7.2.5297; GREITHER T, 2009, INT J CANC IN PRESS; Gross C, 2008, ONCOGENE, V27, P1333, DOI 10.1038/sj.onc.1210736; Hagele S, 2009, BIOCHEM J, V417, P235, DOI 10.1042/BJ20081353; Hendrickson DG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002126; Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006; Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235; Iorns E, 2008, CANCER CELL, V13, P91, DOI 10.1016/j.ccr.2008.01.001; Ivan M, 2008, J CELL MOL MED, V12, P1426, DOI 10.1111/j.1582-4934.2008.00398.x; Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106; Karginov FV, 2007, P NATL ACAD SCI USA, V104, P19291, DOI 10.1073/pnas.0709971104; Kataoka H, 2000, AM J CARDIOL, V86, P1056, DOI 10.1016/S0002-9149(00)01351-5; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; KIM HW, 2009, J BIOL CHEM IN PRESS; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kirino Y, 2008, RNA, V14, P2254, DOI 10.1261/rna.1133808; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Lee I, 2009, GENOME RES, V19, P1175, DOI 10.1101/gr.089367.108; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Lodes MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006229; London B, 2007, CIRCULATION, V116, P2260, DOI 10.1161/CIRCULATIONAHA.107.703330; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Mili S, 2004, RNA, V10, P1692, DOI 10.1261/rna.7151404; Mizuno Y, 2009, FEBS LETT, V583, P2263, DOI 10.1016/j.febslet.2009.06.006; Nakamura Y, 2008, CIRC RES, V102, P1182, DOI 10.1161/CIRCRESAHA.107.167080; Ng K, 2007, EMBO REP, V8, P34, DOI 10.1038/sj.embor.7400871; Nicolas FE, 2008, RNA, V14, P2513, DOI 10.1261/rna.1221108; OMICHI C, 2009, INT J CARDI IN PRESS; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Pulkkinen K, 2008, FEBS LETT, V582, P2397, DOI 10.1016/j.febslet.2008.05.048; Rigoutsos I, 2009, CANCER RES, V69, P3245, DOI 10.1158/0008-5472.CAN-09-0352; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Sirchia SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005559; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; TSAI NP, 2009, BIOCH J IN PRESS; Tsuchiya S, 2009, NUCLEIC ACIDS RES, V37, P3821, DOI 10.1093/nar/gkp255; Van Norstrand DW, 2007, CIRCULATION, V116, P2253, DOI 10.1161/CIRCULATIONAHA.107.704627; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Yoshida T, 2002, KIDNEY INT, V61, P1646, DOI 10.1046/j.1523-1755.2002.00341.x; Zhang Z, 2009, CELL CYCLE, V8, P2756, DOI 10.4161/cc.8.17.9387; Zhdanov VP, 2009, MOL BIOSYST, V5, P638, DOI 10.1039/b808095j; Zhou X, 2009, GENETICA, V137, P159, DOI 10.1007/s10709-009-9378-7	64	230	238	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					35134	35143		10.1074/jbc.M109.052779	http://dx.doi.org/10.1074/jbc.M109.052779			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19826008	hybrid, Green Published			2022-12-27	WOS:000272439600067
J	Ithychanda, SS; Hsu, D; Li, HH; Yan, LD; Liu, DW; Das, M; Plow, EF; Qin, J				Ithychanda, Sujay Subbayya; Hsu, Dennis; Li, Hanhan; Yan, Linda; Liu, Darwen; Das, Mitali; Plow, Edward F.; Qin, Jun			Identification and Characterization of Multiple Similar Ligand-binding Repeats in Filamin IMPLICATION ON FILAMIN-MEDIATED RECEPTOR CLUSTERING AND CROSS-TALK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; MOLECULAR-BASIS; PHOSPHORYLATION; CYTOSKELETON; COMPETITION; MIGFILIN	The actin-binding protein filamin links membrane receptors to the underlying cytoskeleton. The cytoplasmic domains of these membrane receptors have been shown to bind to various filamin immunoglobulin repeats. Notably, among 24 human filamin repeats, repeat 17 was reported to specifically bind to platelet receptor glycoprotein Ib alpha and repeat 21 to integrins. However, a complete sequence alignment of all 24 human filamin repeats reveals that repeats 17 and 21 actually belong to a distinct filamin repeat subgroup ( containing repeats 4, 9, 12, 17, 19, 21, and 23) that shares a conserved ligand-binding site. Using isothermal calorimetry and NMR analyses, we show that all repeats in this subgroup can actually bind glycoprotein Ib alpha, integrins, and a cytoskeleton regulator migfilin in similar manners. These data provide a new view on the ligand specificity of the filamin repeats. They also suggest a multiple ligand binding mechanism where similar repeats within a filamin monomer may promote receptor clustering or receptor cross-talking for regulation of the cytoskeleton organization and diverse filamin-mediated cellular activities.	[Ithychanda, Sujay Subbayya; Yan, Linda; Liu, Darwen; Das, Mitali; Plow, Edward F.; Qin, Jun] Cleveland Clin, Dept Mol Cardiol, Lerner Res Inst, Cleveland, OH 44195 USA; [Hsu, Dennis; Li, Hanhan; Qin, Jun] Cleveland Clin, Lerner Coll Med, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Qin, J (corresponding author), Cleveland Clin, Dept Mol Cardiol, Lerner Res Inst, NB20,9500 Euclid Ave, Cleveland, OH 44195 USA.	qinj@ccf.org	Ithychanda, Sujay Subbayya/C-7792-2011; Qin, Jun/D-5559-2009	Ithychanda, Sujay Subbayya/0000-0001-8979-246X; Yan, Linda/0000-0003-4270-9045; Qin, Jun/0000-0002-2647-9270	National Institutes of Health [R01 GM62823, P01 HL073311]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL073311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062823] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM62823 and P01 HL073311 (to J.Q. and E.F.P.).	Calderwood DA, 2001, NAT CELL BIOL, V3, P1060, DOI 10.1038/ncb1201-1060; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Feng SJ, 2005, J BIOL CHEM, V280, P6709, DOI 10.1074/jbc.M413590200; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Goldmann WH, 2000, BIOCHEM BIOPH RES CO, V271, P553, DOI 10.1006/bbrc.2000.2653; Gravante B, 2004, J BIOL CHEM, V279, P43847, DOI 10.1074/jbc.M401598200; Ithychanda SS, 2009, J BIOL CHEM, V284, P4713, DOI 10.1074/jbc.M807719200; Jimenez-Baranda S, 2007, NAT CELL BIOL, V9, P838, DOI 10.1038/ncb1610; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Lad Y, 2007, EMBO J, V26, P3993, DOI 10.1038/sj.emboj.7601827; Lad Y, 2008, J BIOL CHEM, V283, P35154, DOI 10.1074/jbc.M802592200; LARKIN MA, 2007, CLUSTALW CLUSTALX VE, V23, P947; Nakamura F, 2006, BLOOD, V107, P1925, DOI 10.1182/blood-2005-10-3964; Nakamura F, 2007, J CELL BIOL, V179, P1011, DOI 10.1083/jcb.200707073; Nakamura F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004928; Popowicz GM, 2006, TRENDS BIOCHEM SCI, V31, P411, DOI 10.1016/j.tibs.2006.05.006; Pudas R, 2005, STRUCTURE, V13, P111, DOI 10.1016/j.str.2004.10.014; Robertson SP, 2005, CURR OPIN GENET DEV, V15, P301, DOI 10.1016/j.gde.2005.04.001; SHARMA CP, 1995, J IMMUNOL, V154, P3461; Takafuta T, 2003, J BIOL CHEM, V278, P12175, DOI 10.1074/jbc.M209339200; Takala H, 2008, BLOOD, V112, P1853, DOI 10.1182/blood-2007-12-127795; Travis MA, 2004, FEBS LETT, V569, P185, DOI 10.1016/j.febslet.2004.04.099; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; van der Flier A, 2002, J CELL BIOL, V156, P361, DOI 10.1083/jcb.200103037; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6	25	59	63	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					35113	35121		10.1074/jbc.M109.060954	http://dx.doi.org/10.1074/jbc.M109.060954			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19828450	hybrid, Green Published			2022-12-27	WOS:000272439600065
J	Cho, JH; Jung, DK; Lee, K; Rhee, S				Cho, Jang-Hee; Jung, Du-Kyo; Lee, Kyoung; Rhee, Sangkee			Crystal Structure and Functional Analysis of the Extradiol Dioxygenase LapB from a Long-chain Alkylphenol Degradation Pathway in Pseudomonas	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATECHOL 2,3-DIOXYGENASE; DEPENDENT DIOXYGENASES; OXYGEN ACTIVATION; RING-CLEAVAGE; MECHANISM; 1,2-DIOXYGENASE; CATALYSIS; BINDING	LapB is a non-heme Fe(II)-dependent 2,3-dioxygenase that catalyzes the second step of a long-chain alkylphenol (lap) degradation pathway in Pseudomonas sp. KL28 and belongs to the superfamily of type I extradiol dioxygenases. In this study, the crystal structures of substrate-free LapB and its complexes with a substrate or product were determined, along with a functional analysis of the active site residues. Structural features of the homotetramer are similar to those of other type I extradiol dioxygenases. In particular, the active site is located in the C-domain of each monomer, with a 2-His-1-carboxylate motif as the first coordination shell to iron ion. A comparison of three different structures in the catalytic cycle indicated catalysis-related local conformational changes in the active site. Specifically, the active site loop containing His-248 exhibits positional changes upon binding of the substrate and establishes a hydrogen-bonding network with Tyr-257, which is near the hydroxyl group of the substrate. Kinetic analysis of the mutant enzymes H248A, H248N, and Y257F showed that these three mutant enzymes are inactive, suggesting that this hydrogen-bonding network plays a crucial role in catalysis by deprotonating the incoming substrate and leaving it in a monoanionic state. Additional functional analysis of His-201, by using H201A and H201N mutants, near the dioxygen-binding site also supports its role as base and acid catalyst in the late stage of catalysis. We also noticed a disordered-to-ordered structural transition in the C-terminal region, resulting in the opening or closing of the active site. These results provide detailed insights into the structural and functional features of an extradiol dioxygenase that can accommodate a wide range of alkylcatechols.	[Rhee, Sangkee] Seoul Natl Univ, Coll Agr & Life Sci, Dept Agr Biotechnol, Seoul 151921, South Korea; [Rhee, Sangkee] Seoul Natl Univ, Ctr Agr Biomat, Seoul 151921, South Korea; [Rhee, Sangkee] Seoul Natl Univ, Ctr Fugal Pathogenesis, Seoul 151921, South Korea; [Lee, Kyoung] Changwon Natl Univ, Dept Microbiol, Kyongnam 641773, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Changwon National University	Rhee, S (corresponding author), Seoul Natl Univ, Coll Agr & Life Sci, Dept Agr Biotechnol, Rm 7117 Bldg 200, Seoul 151921, South Korea.	srheesnu@snu.ac.kr			Korea Science and Engineering Foundation (KOSEF) [R01-2007-000-21067-0, R11-2008-062-01002-0]; Ministry of Science and Technology, Republic of Korea	Korea Science and Engineering Foundation (KOSEF)(Korea Science and Engineering Foundation); Ministry of Science and Technology, Republic of Korea(Ministry of Science & Technology (MOST), Republic of Korea)	This work was supported by Korea Science and Engineering Foundation (KOSEF) Grants R01-2007-000-21067-0 and R11-2008-062-01002-0 and by a grant from Crop Functional Genomics Center of the 21st Century Frontier Research Program funded by the Ministry of Science and Technology, Republic of Korea.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bugg TDH, 2008, CURR OPIN CHEM BIOL, V12, P134, DOI 10.1016/j.cbpa.2007.12.007; DeLano W.L, PYMOL MOL GRAPHICS S; Emerson JP, 2008, P NATL ACAD SCI USA, V105, P7347, DOI 10.1073/pnas.0711179105; GIGER W, 1984, SCIENCE, V225, P623, DOI 10.1126/science.6740328; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Groce SL, 2005, BIOCHEMISTRY-US, V44, P7175, DOI 10.1021/bi050180v; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; Jeong JJ, 2003, MICROBIOL-SGM, V149, P3265, DOI 10.1099/mic.0.26628-0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kita A, 1999, STRUCTURE, V7, P25, DOI 10.1016/S0969-2126(99)80006-9; Kovaleva EG, 2007, ACCOUNTS CHEM RES, V40, P475, DOI 10.1021/ar700052v; Kovaleva EG, 2008, BIOCHEMISTRY-US, V47, P11168, DOI 10.1021/bi801459q; Kovaleva EG, 2008, NAT CHEM BIOL, V4, P186, DOI 10.1038/nchembio.71; Kovaleva EG, 2007, SCIENCE, V316, P453, DOI 10.1126/science.1134697; Lipscomb JD, 2008, CURR OPIN STRUC BIOL, V18, P644, DOI 10.1016/j.sbi.2008.11.001; Mendel S, 2004, BIOCHEMISTRY-US, V43, P13390, DOI 10.1021/bi048518t; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sharpe RM, 1995, ENVIRON HEALTH PERSP, V103, P1136, DOI 10.2307/3432610; Siegbahn PEM, 2004, J AM CHEM SOC, V126, P8919, DOI 10.1021/ja0493805; Takeo M, 2007, J BIOSCI BIOENG, V104, P309, DOI 10.1263/jbb.104.309; Vaillancourt FH, 2002, J AM CHEM SOC, V124, P2485, DOI 10.1021/ja0174682; Vaillancourt FH, 2006, CRIT REV BIOCHEM MOL, V41, P241, DOI 10.1080/10409230600817422; Vetting MW, 2004, J BACTERIOL, V186, P1945, DOI 10.1128/JB.186.7.1945-1958.2004; Viggiani A, 2004, J BIOL CHEM, V279, P48630, DOI 10.1074/jbc.M406243200; Weisel M, 2007, CHEM CENT J, V1, DOI 10.1186/1752-153X-1-7	27	19	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34321	34330		10.1074/jbc.M109.031054	http://dx.doi.org/10.1074/jbc.M109.031054			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19828456	Green Published, hybrid			2022-12-27	WOS:000272165200062
J	Fuentealba, RA; Liu, Q; Kanekiyo, T; Zhang, J; Bu, GJ				Fuentealba, Rodrigo A.; Liu, Qiang; Kanekiyo, Takahisa; Zhang, Juan; Bu, Guojun			Low Density Lipoprotein Receptor-related Protein 1 Promotes Anti-apoptotic Signaling in Neurons by Activating Akt Survival Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REDUCES TAU PHOSPHORYLATION; AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; GROWTH-FACTOR; INSULIN-RECEPTOR; APOLIPOPROTEIN-E; CELL-DEATH; A-BETA; PHOSPHATIDYLINOSITOL 3-KINASE; TYROSINE PHOSPHORYLATION	The low density lipoprotein receptor-related protein 1 (LRP1) is a multi-ligand receptor abundantly expressed in neurons. Previous work has shown that brain LRP1 levels are decreased during aging and in Alzheimer disease. Although mounting evidence has demonstrated a role for LRP1 in the metabolism of apolipoprotein E/lipoprotein and amyloid-beta peptide, whether LRP1 also plays a direct role in neuronal survival is not clear. Here, we show that LRP1 expression is critical for the survival of primary neurons under stress conditions including trophic withdrawal, the presence of apoptosis inducers, or amyloid-beta-induced neurotoxicity. Using lentiviral short hairpin RNA to knock down endogenous LRP1 expression, we showed that a depletion of LRP1 leads to an activation of caspase-3 and increased neuronal apoptosis, an effect that was rescued by a caspase-3 inhibitor. A correlation between decreased Akt phosphorylation and the activation of caspase-3 was demonstrated in LRP1 knocked down neurons. Notably, LRP1 knockdown decreased insulin receptor levels in primary neurons, suggesting that decreased neuronal survival might be a consequence of an impaired insulin receptor signaling pathway. Correspondingly, both insulin receptor and phospho-Akt levels were decreased in LRP1 forebrain knock-out mice. These results demonstrate that LRP1 mediates anti-apoptotic function in neurons by regulating insulin receptor and the Akt survival pathway and suggest that restoring LRP1 expression in Alzheimer disease brain might be beneficial to inhibiting neurodegeneration.	[Bu, Guojun] Washington Univ, Sch Med, Dept Pediat, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA; Washington Univ, Sch Med, Hope Ctr Neurol Disorders, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Bu, GJ (corresponding author), Washington Univ, Sch Med, Dept Pediat, Hope Ctr Neurol Disorders, 660 S Euclid Ave,Campus Box 8208, St Louis, MO 63110 USA.	bu@wustl.edu	Liu, Qiang/E-9245-2011	Fuentealba, Rodrigo/0000-0001-8724-091X	National Institutes of Health [R01 AG027924, R01 AG031784]; Alzheimer's Association; NATIONAL INSTITUTE ON AGING [R01AG035355, R01AG031784, R01AG027924, P01AG030128] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AG027924 and R01 AG031784. This work was also supported by a Zenith Fellows Award from the Alzheimer's Association (to G.B.).	Arguello PA, 2006, NEURON, V52, P179, DOI 10.1016/j.neuron.2006.09.023; Baki L, 2008, J NEUROSCI, V28, P483, DOI 10.1523/JNEUROSCI.4067-07.2008; Beffert U, 2006, J NEUROSCI, V26, P2041, DOI 10.1523/JNEUROSCI.4566-05.2006; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Boucher P, 2002, J BIOL CHEM, V277, P15507, DOI 10.1074/jbc.M200428200; Brown MD, 1997, BRAIN RES, V747, P313, DOI 10.1016/S0006-8993(96)01321-2; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; BU GJ, 1994, J BIOL CHEM, V269, P18521; Bu GJ, 2001, INT REV CYTOL, V209, P79; Bu GJ, 2006, ANN NY ACAD SCI, V1086, P35, DOI 10.1196/annals.1377.005; Caccamo A, 2007, AM J PATHOL, V170, P1669, DOI 10.2353/ajpath.2007.061178; CARPENTIER JL, 1989, DIABETOLOGIA, V32, P627; Cole GM, 2007, EXP GERONTOL, V42, P10, DOI 10.1016/j.exger.2006.08.009; Dhandapani KM, 2003, J BIOL CHEM, V278, P43329, DOI 10.1074/jbc.M305835200; Galvan V, 2006, P NATL ACAD SCI USA, V103, P7130, DOI 10.1073/pnas.0509695103; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; Gauthier A, 2003, J BIOL CHEM, V278, P11945, DOI 10.1074/jbc.M212989200; Griffin RJ, 2005, J NEUROCHEM, V93, P105, DOI 10.1111/j.1471-4159.2004.02949.x; Hayashi H, 2007, J NEUROSCI, V27, P1933, DOI 10.1523/JNEUROSCI.5471-06.2007; HERZ J, 1992, CELL, V71, P411, DOI 10.1016/0092-8674(92)90511-A; Hong M, 1997, J BIOL CHEM, V272, P25326, DOI 10.1074/jbc.272.40.25326; Howell BW, 1999, MOL CELL BIOL, V19, P5179; Kang DE, 2000, J CLIN INVEST, V106, P1159, DOI 10.1172/JCI11013; Kihara T, 2001, J BIOL CHEM, V276, P13541, DOI 10.1074/jbc.M008035200; Ko KWS, 2001, BIOCHEMISTRY-US, V40, P752, DOI 10.1021/bi001797+; LaFerla FM, 1997, J CLIN INVEST, V100, P310, DOI 10.1172/JCI119536; Lasserre R, 2008, NAT CHEM BIOL, V4, P538, DOI 10.1038/nchembio.103; LeBlanc Andrea C., 2005, Current Alzheimer Research, V2, P389, DOI 10.2174/156720505774330573; Lesne S, 2005, J BIOL CHEM, V280, P24941, DOI 10.1074/jbc.M413495200; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Lillis AP, 2005, J THROMB HAEMOST, V3, P1884, DOI 10.1111/j.1538-7836.2005.01371.x; Liu Q, 2007, NEURON, V56, P66, DOI 10.1016/j.neuron.2007.08.008; Loukinova E, 2002, J BIOL CHEM, V277, P15499, DOI 10.1074/jbc.M200427200; Magrane J, 2005, J NEUROSCI, V25, P10960, DOI 10.1523/JNEUROSCI.1723-05.2005; Mantuano E, 2008, J BIOL CHEM, V283, P19904, DOI 10.1074/jbc.M801762200; Narita M, 1997, J NEUROCHEM, V68, P587; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Pei JJ, 2003, ACTA NEUROPATHOL, V105, P381, DOI 10.1007/s00401-002-0657-y; Rickle A, 2004, NEUROREPORT, V15, P955, DOI 10.1097/00001756-200404290-00005; Rissman RA, 2004, J CLIN INVEST, V114, P121, DOI 10.1172/JCI200420640; Rohlmann A, 1998, J CLIN INVEST, V101, P689, DOI 10.1172/JCI1240; Rohn TT, 2001, AM J PATHOL, V158, P189, DOI 10.1016/S0002-9440(10)63957-0; Saito A, 2004, J NEUROSCI, V24, P1584, DOI 10.1523/JNEUROSCI.5209-03.2004; SHEARMAN MS, 1995, J NEUROCHEM, V65, P218, DOI 10.1046/j.1471-4159.1995.65010218.x; Simakova O, 2007, J NEUROSCI, V27, P13719, DOI 10.1523/JNEUROSCI.3006-07.2007; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Tamaki C, 2007, MOL PHARMACOL, V72, P850, DOI 10.1124/mol.107.036913; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Tong LQ, 2004, J NEUROSCI, V24, P6799, DOI 10.1523/JNEUROSCI.5463-03.2004; TOOYAMA I, 1995, BRAIN RES, V691, P235, DOI 10.1016/0006-8993(95)00735-9; Townsend M, 2007, J BIOL CHEM, V282, P33305, DOI 10.1074/jbc.M610390200; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; Vainio S, 2002, EMBO REP, V3, P95, DOI 10.1093/embo-reports/kvf010; van der Heide LP, 2006, PROG NEUROBIOL, V79, P205, DOI 10.1016/j.pneurobio.2006.06.003; Van Uden E, 2002, J NEUROSCI, V22, P9298; Wei WL, 2002, J BIOL CHEM, V277, P17649, DOI 10.1074/jbc.M111704200; Weihl CC, 1999, J NEUROSCI, V19, P5360; Wogulis M, 2005, J NEUROSCI, V25, P1071, DOI 10.1523/JNEUROSCI.2381-04.2005; WOLF BB, 1992, AM J PATHOL, V141, P37; Yamada K, 2008, J BIOL CHEM, V283, P34554, DOI 10.1074/jbc.M801487200; Zerbinatti CV, 2006, J BIOL CHEM, V281, P36180, DOI 10.1074/jbc.M604436200; Zhang Y, 2000, J NEUROSCI, V20, P8384, DOI 10.1523/JNEUROSCI.20-22-08384.2000; Zhao LX, 2004, J NEUROSCI, V24, P11120, DOI 10.1523/JNEUROSCI.2860-04.2004; Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com	65	76	81	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34045	34053		10.1074/jbc.M109.021030	http://dx.doi.org/10.1074/jbc.M109.021030			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19815552	Green Published, hybrid			2022-12-27	WOS:000272165200037
J	Geiben-Lynn, R; Greenland, JR; Frimpong-Boateng, K; Letvin, NL				Geiben-Lynn, Ralf; Greenland, John R.; Frimpong-Boateng, Kwesi; Letvin, Norman L.			Non-classical Natural Killer T Cells Modulate Plasmid DNA Vaccine Antigen Expression and Vaccine-elicited Immune Responses by MCP-1 Secretion after Interaction with a beta 2-Microglobulin-independent CD1d	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GATA-3; V-ALPHA-14 NKT CELLS; IN-VIVO; TUMOR-IMMUNITY; ULCERATIVE-COLITIS; MOUSE MODEL; MICE; DISTINCT; ACTIVATION; INDUCTION	The magnitude and durability of a plasmid DNA vaccine-induced immune response is shaped by immune effector molecules at the site of vaccination. In the present study, we show that antigen expression is modified by type II NKT cells, after interaction with a beta 2-microglobulin-independent CD1d receptor. After activation, during the first days following plasmid DNA vaccination, NKT cells release IL-5 and MCP-1, leading to a T helper 0 (T(H)0) cytokine/chemokine profile and a stronger CD8(+)/CD4(+) T cell immune response. Our data indicate that this phenomenon was induced through the strong T(H)1 chemokine MCP-1 during the early phases of plasmid DNA vaccination because injecting the type II NKT cell-associated MCP-1 during the first 5 days led to 2-3-fold increases in vaccine-elicited T cell responses. This study demonstrates a critical role for NKT cells in plasmid DNA vaccine-induced immune responses. Manipulation of NKT cell function or co-administration of MCP-1 may represent novel methods for enhancing immune responses to plasmid DNA vaccines.	[Geiben-Lynn, Ralf] Harvard Univ, Sch Med, Div Viral Pathogenesis, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Geiben-Lynn, R (corresponding author), Harvard Univ, Sch Med, Div Viral Pathogenesis, Beth Israel Deaconess Med Ctr, 3 Blackfan Circle E CLS,Rm 1028, Boston, MA 02215 USA.	rgeibenl@bidmc.harvard.edu	Greenland, John R/AAR-6030-2021	Greenland, John R/0000-0003-1422-8367	National Institutes of Health [AI067854]; NIAID Center for HIV/AIDS Vaccine Immunology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067854, U01AI067854] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID Center for HIV/AIDS Vaccine Immunology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI067854 ( to N.L.L.) from the NIAID Center for HIV/AIDS Vaccine Immunology.	Amano M, 1998, J IMMUNOL, V161, P1710; Baron JL, 2002, IMMUNITY, V16, P583, DOI 10.1016/S1074-7613(02)00305-9; Barouch DH, 2004, J IMMUNOL, V172, P6290, DOI 10.4049/jimmunol.172.10.6290; BECKMAN EM, 1995, IMMUNOL TODAY, V16, P349, DOI 10.1016/0167-5699(95)80154-5; BERNABEU C, 1984, NATURE, V308, P642, DOI 10.1038/308642a0; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Bottino C, 2000, HUM IMMUNOL, V61, P1, DOI 10.1016/S0198-8859(99)00162-7; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Brutkiewicz RR, 2002, CRIT REV ONCOL HEMAT, V41, P287, DOI 10.1016/S1040-8428(01)00198-6; CARDELL S, 1995, J EXP MED, V182, P993, DOI 10.1084/jem.182.4.993; Chang DH, 2008, BLOOD, V112, P1308, DOI 10.1182/blood-2008-04-149831; Chang YJ, 2007, P NATL ACAD SCI USA, V104, P10299, DOI 10.1073/pnas.0703824104; Chargui J, 2001, TRANSPLANT P, V33, P3833, DOI 10.1016/S0041-1345(01)02623-9; Crowe NY, 2003, J IMMUNOL, V171, P4020, DOI 10.4049/jimmunol.171.8.4020; Di Santo JP, 2008, EUR J IMMUNOL, V38, P2948, DOI 10.1002/eji.200838830; Duarte N, 2004, J IMMUNOL, V173, P3112, DOI 10.4049/jimmunol.173.5.3112; Fuss IJ, 2008, MUCOSAL IMMUNOL, V1, pS31, DOI 10.1038/mi.2008.40; Fuss IJ, 2004, J CLIN INVEST, V113, P1490, DOI 10.1172/JCI200419836; GALLIN JI, 1974, BLOOD, V43, P201, DOI 10.1182/blood.V43.2.201.201; Geiben-Lynn R, 2008, CLIN VACCINE IMMUNOL, V15, P691, DOI 10.1128/CVI.00418-07; Geiben-Lynn R, 2008, BLOOD, V112, P4585, DOI 10.1182/blood-2008-06-165803; Greenland JR, 2007, J IMMUNOL, V178, P5652, DOI 10.4049/jimmunol.178.9.5652; Greenland JR, 2005, MOL THER, V12, P164, DOI 10.1016/j.ymthe.2005.01.021; Gumperz JE, 2002, J EXP MED, V195, P625, DOI 10.1084/jem.20011786; Hovav AH, 2007, J VIROL, V81, P74, DOI 10.1128/JVI.01269-06; Ikehara Y, 2000, J CLIN INVEST, V105, P1761, DOI 10.1172/JCI8922; Ito K, 2000, P NATL ACAD SCI USA, V97, P740, DOI 10.1073/pnas.97.2.740; Jahng A, 2004, J EXP MED, V199, P947, DOI 10.1084/jem.20031389; Johnson TR, 2003, J IMMUNOL, V170, P2037, DOI 10.4049/jimmunol.170.4.2037; Kakimi K, 2000, J EXP MED, V192, P921, DOI 10.1084/jem.192.7.921; Kawakami K, 2001, J IMMUNOL, V167, P6525, DOI 10.4049/jimmunol.167.11.6525; Kim HS, 1999, J BIOL CHEM, V274, P9289, DOI 10.1074/jbc.274.14.9289; Koh YI, 2008, J IMMUNOL, V181, P4560, DOI 10.4049/jimmunol.181.7.4560; Kronenberg M, 2002, NAT REV IMMUNOL, V2, P557, DOI 10.1038/nri854; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Lee PT, 2002, J EXP MED, V195, P637, DOI 10.1084/jem.20011908; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Matsuda JL, 2003, P NATL ACAD SCI USA, V100, P8395, DOI 10.1073/pnas.1332805100; Miyamoto K, 2001, NATURE, V413, P531, DOI 10.1038/35097097; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Norris PJ, 2002, J MOL MED, V80, P397, DOI 10.1007/s00109-002-0337-3; Orlans FB, 1997, ETHICS BEHAV, V7, P163, DOI 10.1207/s15327019eb0702_7; Ortaldo JR, 2004, J IMMUNOL, V172, P943, DOI 10.4049/jimmunol.172.2.943; Park SH, 1998, J IMMUNOL, V160, P3128; Perou CM, 1996, NAT GENET, V13, P303, DOI 10.1038/ng0796-303; RODER J, 1979, NATURE, V278, P451, DOI 10.1038/278451a0; Sada-Ovalle I, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000239; Seino K, 2001, P NATL ACAD SCI USA, V98, P2577, DOI 10.1073/pnas.041608298; Seino K, 2005, J EXP MED, V202, P1623, DOI 10.1084/jem.20051600; SHIRAHATA T, 1994, J VET MED SCI, V56, P293, DOI 10.1292/jvms.56.293; Smiley ST, 1997, SCIENCE, V275, P977, DOI 10.1126/science.275.5302.977; Smyth MJ, 2002, CURR OPIN IMMUNOL, V14, P165, DOI 10.1016/S0952-7915(02)00316-3; Smyth MJ, 2000, NAT IMMUNOL, V1, P459, DOI 10.1038/82698; Sonoda KH, 2001, J IMMUNOL, V166, P42, DOI 10.4049/jimmunol.166.1.42; Stan AC, 2001, EUR J IMMUNOL, V31, P301, DOI 10.1002/1521-4141(200101)31:1<301::AID-IMMU301>3.0.CO;2-K; Terabe M, 2000, NAT IMMUNOL, V1, P515, DOI 10.1038/82771; Van Rhijn I, 2004, P NATL ACAD SCI USA, V101, P13578, DOI 10.1073/pnas.0402838101; Wang ZY, 2006, J IMMUNOL, V176, P880, DOI 10.4049/jimmunol.176.2.880; Wilson SB, 2003, NAT REV IMMUNOL, V3, P211, DOI 10.1038/nri1028; Zeng DF, 1999, J EXP MED, V189, P1073, DOI 10.1084/jem.189.7.1073; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	62	5	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33800	33806		10.1074/jbc.M109.019638	http://dx.doi.org/10.1074/jbc.M109.019638			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19833737	Green Published, hybrid			2022-12-27	WOS:000272165200011
J	Kwon, MC; Koo, BK; Kim, YY; Lee, SH; Kim, NS; Kim, JH; Kong, YY				Kwon, Min-chul; Koo, Bon-Kyoung; Kim, Yoon-Young; Lee, Sang-Hee; Kim, Nam-Shik; Kim, Jae-Hwan; Kong, Young-Yun			Essential Role of CR6-interacting Factor 1 (Crif1) in E74-like Factor 3 (ELF3)-mediated Intestinal Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; EPITHELIAL-CELLS; STEM-CELLS; CANCER; DIFFERENTIATION; PROTEINS; RECEPTOR; IDENTIFICATION; EXPRESSION; STAT3	Although terminal differentiation of intestinal epithelium is essential for the efficient digestion and absorption of nutrients, little is known about the molecular mechanisms underlying this process. Recent studies have shown that Elf3 (E74-like factor 3), a member of the ETS transcription factor family, has an essential role in the terminal differentiation of absorptive enterocytes and mucus-secreting goblet cells. Here, we demonstrated that Crif1 (CR6-interacting factor 1) functions as transcriptional coactivator of Elf3 in intestinal epithelium differentiation. The intestinal epithelium-specific Crif1-deficient mice died soon after birth and displayed severe alterations of tissue architecture in the small intestine, including poor microvillus formation and abnormal differentiation of absorptive enterocytes. Strikingly, these phenotypes are largely similar to that of Elf3-deficient mice, suggesting that Elf3 signaling in the intestinal epithelium depends on the Crif1 expression. We dissected this relationship further and found that Crif1 indeed interacted with Elf3 through its ETS DNA binding domain and enhanced the transcriptional activity of Elf3 by regulating the DNA binding activity. Knockdown of Crif1 by RNA interference conversely attenuated the transcriptional activity of Elf3. Consistently, the expression level of Tgf-beta RII (transforming growth factor beta type II receptor), a critical target gene of Elf3, was dramatically reduced in the Crif1-deficient mice. Our results reveal that Crif1 is a novel and essential transcriptional coactivator of Elf3 for the terminal differentiation of absorptive enterocytes.	[Kwon, Min-chul; Koo, Bon-Kyoung; Kong, Young-Yun] Seoul Natl Univ, Coll Nat Sci, Dept Biol Sci, Seoul 151747, South Korea; [Kwon, Min-chul; Koo, Bon-Kyoung; Kim, Yoon-Young; Kim, Nam-Shik] Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, Kyungbuk, South Korea; [Lee, Sang-Hee] Korea Basic Sci Inst, Div Electron Microscop Res, Taejon 305333, South Korea; [Kim, Jae-Hwan] Pochon CHA Univ, Grad Sch Life Sci & Biotechnol, CHA Stem Cell Inst, Seoul 135907, South Korea	Seoul National University (SNU); Pohang University of Science & Technology (POSTECH); Korea Basic Science Institute (KBSI); Pochon Cha University	Kong, YY (corresponding author), Seoul Natl Univ, Coll Nat Sci, Dept Biol Sci, San 56-1, Seoul 151747, South Korea.	ykong@snu.ac.kr	Koo, Bon-Kyoung/V-5219-2017	Koo, Bon-Kyoung/0000-0002-4134-8033	Center for Biological Modulators of the 21C Frontier RD Program [CBM32-A2300-01-00-01]; Korea Science and Engineering Foundation [2009-0062800]; Ministry of Science and Technology of Korea [FG06-42-1]; National Research Foundation of Korea [2009-0079371]	Center for Biological Modulators of the 21C Frontier RD Program(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Ministry of Science and Technology of Korea(Ministry of Science & Technology (MOST), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by Center for Biological Modulators of the 21C Frontier R&D Program Grant CBM32-A2300-01-00-01, Korea Science and Engineering Foundation Grant 2009-0062800, 21C Frontier Functional Human Genome Project Grant FG06-42-1 from the Ministry of Science and Technology of Korea, and Basic Science Research Program Grant 2009-0079371 through the National Research Foundation of Korea.	Alonzi T, 2004, CYTOKINE, V26, P45, DOI 10.1016/j.cyto.2003.12.002; Bach SP, 2000, CARCINOGENESIS, V21, P469, DOI 10.1093/carcin/21.3.469; Bararia D, 2008, LEUKEMIA, V22, P800, DOI 10.1038/sj.leu.2405101; Choi SG, 1998, J BIOL CHEM, V273, P110, DOI 10.1074/jbc.273.1.110; Chung HK, 2003, J BIOL CHEM, V278, P28079, DOI 10.1074/jbc.M212835200; Do HJ, 2006, FEBS LETT, V580, P1865, DOI 10.1016/j.febslet.2006.02.049; Flentjar N, 2007, GASTROENTEROLOGY, V132, P1410, DOI 10.1053/j.gastro.2007.02.054; Gornemann J, 2002, VIROLOGY, V303, P69, DOI 10.1006/viro.2002.1670; Grady WM, 2002, ANNU REV GENOM HUM G, V3, P101, DOI 10.1146/annurev.genom.3.022502.103043; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; Hsu T, 2004, J CELL BIOCHEM, V91, P896, DOI 10.1002/jcb.20012; Katz JP, 2002, DEVELOPMENT, V129, P2619; Khurana S, 2008, FEBS LETT, V582, P2128, DOI 10.1016/j.febslet.2008.02.040; Kim JH, 2002, J BIOL CHEM, V277, P17520, DOI 10.1074/jbc.M110434200; Koo BK, 2005, DEVELOPMENT, V132, P3459, DOI 10.1242/dev.01922; Kwon MC, 2008, EMBO J, V27, P642, DOI 10.1038/sj.emboj.7601986; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Li RZ, 2000, ONCOGENE, V19, P6514, DOI 10.1038/sj.onc.1204035; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Mills JC, 2001, P NATL ACAD SCI USA, V98, P12334, DOI 10.1073/pnas.231487198; Mori-Akiyama Y, 2007, GASTROENTEROLOGY, V133, P539, DOI 10.1053/j.gastro.2007.05.020; Ng AYN, 2002, GASTROENTEROLOGY, V122, P1455, DOI 10.1053/gast.2002.32990; Park KC, 2005, MOL ENDOCRINOL, V19, P12, DOI 10.1210/me.2004-0107; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Sancho E, 2004, ANNU REV CELL DEV BI, V20, P695, DOI 10.1146/annurev.cellbio.20.010403.092805; Schedin PJ, 2004, ONCOGENE, V23, P1766, DOI 10.1038/sj.onc.1207391; Schonhoff SE, 2004, ENDOCRINOLOGY, V145, P2639, DOI 10.1210/en.2004-0051; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Shroyer NF, 2005, GENE DEV, V19, P2412, DOI 10.1101/gad.1353905; Suh JH, 2008, MOL ENDOCRINOL, V22, P33, DOI 10.1210/me.2007-0194; Tymms MJ, 1997, ONCOGENE, V15, P2449, DOI 10.1038/sj.onc.1201427; Verger A, 2002, BIOESSAYS, V24, P362, DOI 10.1002/bies.10068; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718	34	20	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33634	33641		10.1074/jbc.M109.059840	http://dx.doi.org/10.1074/jbc.M109.059840			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801644	Green Published, hybrid			2022-12-27	WOS:000272028500067
J	Wang, PS; Wang, J; Xiao, ZC; Pallen, CJ				Wang, Pei-Shan; Wang, Jing; Xiao, Zhi-Cheng; Pallen, Catherine J.			Protein-tyrosine Phosphatase alpha Acts as an Upstream Regulator of Fyn Signaling to Promote Oligodendrocyte Differentiation and Myelination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; CILIARY NEUROTROPHIC FACTOR; SRC FAMILY KINASES; CNS MYELINATION; MORPHOLOGICAL-DIFFERENTIATION; PROCESS OUTGROWTH; PROGENITOR CELLS; PRECURSOR CELLS; RPTP-ALPHA; PTP-ALPHA	The tyrosine kinase Fyn plays a key role in oligodendrocyte differentiation and myelination in the central nervous system, but the molecules responsible for regulating Fyn activation in these processes remain poorly defined. Here we show that receptor-like protein-tyrosine phosphatase alpha (PTP alpha) is an important positive regulator of Fyn activation and signaling that is required for the differentiation of oligodendrocyte progenitor cells (OPCs). PTP alpha is expressed in OPCs and is up-regulated during differentiation. We used two model systems to investigate the role of PTP alpha in OPC differentiation: the rat CG4 cell line where PTP alpha expression was silenced by small interfering RNA, and oligosphere-derived primary OPCs isolated from wild-type and PTP alpha-null mouse embryos. In both cell systems, the ablation of PTP alpha inhibited differentiation and morphological changes that accompany this process. Although Fyn was activated upon induction of differentiation, the level of activation was severely reduced in cells lacking PTP alpha, as was the activation of Fyn effector molecules focal adhesion kinase, Rac1, and Cdc42, and inactivation of Rho. Interestingly, another downstream effector of Fyn, p190RhoGAP, which is responsible for Rho inactivation during differentiation, was not affected by PTP alpha ablation. In vivo studies revealed defective myelination in the PTP alpha(-/-) mouse brain. Together, our findings demonstrate that PTP alpha is a critical regulator of Fyn activation and of specific Fyn signaling events during differentiation, and is essential for promoting OPC differentiation and central nervous system myelination.	[Wang, Pei-Shan; Pallen, Catherine J.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 4H4, Canada; [Wang, Jing; Pallen, Catherine J.] Univ British Columbia, Dept Pediat, Vancouver, BC V5Z 4H4, Canada; [Wang, Pei-Shan; Wang, Jing; Pallen, Catherine J.] Univ British Columbia, Child & Family Res Inst, Vancouver, BC V5Z 4H4, Canada; [Xiao, Zhi-Cheng] Kunming Med Coll, Inst Mol & Clin Med, Kunming 650031, Peoples R China; [Xiao, Zhi-Cheng] GlaxoSmithKline Inc, R&D China, Shanghai 201203, Peoples R China	University of British Columbia; University of British Columbia; Child & Family Research Institute; University of British Columbia; Kunming Medical University; GlaxoSmithKline	Pallen, CJ (corresponding author), 3102-950 W 28th Ave, Vancouver, BC V5Z 4H4, Canada.	cpallen@interchange.ubc.ca	xiao, zhicheng/A-1529-2011	Pallen, Catherine/0000-0002-3576-5295; xiao, zhicheng/0000-0001-5172-762X	Canadian Institutes of Health Research [MOP-62759]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Canadian Institutes of Health Research Grant MOP-62759.	AvellanaAdalid V, 1996, J NEUROSCI RES, V45, P558, DOI 10.1002/(SICI)1097-4547(19960901)45:5<558::AID-JNR6>3.0.CO;2-B; Baer AS, 2009, BRAIN, V132, P465, DOI 10.1093/brain/awn334; BARRES BA, 1994, DEVELOPMENT, V120, P1097; Biffiger K, 2000, J NEUROSCI, V20, P7430; Bodrikov V, 2005, J CELL BIOL, V168, P127, DOI 10.1083/jcb.200405073; BRAUNINGER A, 1992, GENE, V110, P205, DOI 10.1016/0378-1119(92)90649-A; BRYANT SS, 1995, J BIOL CHEM, V270, P17947, DOI 10.1074/jbc.270.30.17947; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Chen M, 2006, J BIOL CHEM, V281, P11972, DOI 10.1074/jbc.M600561200; Chen Y, 2007, NAT PROTOC, V2, P1044, DOI 10.1038/nprot.2007.149; Colognato H, 2004, J CELL BIOL, V167, P365, DOI 10.1083/jcb.200404076; Cui QL, 2005, J BIOL CHEM, V280, P8918, DOI 10.1074/jbc.M414267200; Deng WB, 2003, NEUROTOXICOLOGY, V24, P161, DOI 10.1016/S0161-813X(02)00196-1; Dubois-Dalcq M, 2005, NEURON, V48, P9, DOI 10.1016/j.neuron.2005.09.004; FANARRAGA ML, 1995, GLIA, V15, P95, DOI 10.1002/glia.440150202; Forrest AD, 2009, J NEUROSCI RES, V87, P3456, DOI 10.1002/jnr.22022; Granot-Attas S, 2004, EXP CELL RES, V294, P236, DOI 10.1016/j.yexcr.2003.11.003; Harroch S, 2000, MOL CELL BIOL, V20, P7706, DOI 10.1128/MCB.20.20.7706-7715.2000; Harroch S, 2002, NAT GENET, V32, P411, DOI 10.1038/ng1004; Hoshina N, 2007, GENES CELLS, V12, P1245, DOI 10.1111/j.1365-2443.2007.01130.x; Hsieh J, 2004, J CELL BIOL, V164, P111, DOI 10.1083/jcb.200308101; Hu QD, 2003, CELL, V115, P163, DOI 10.1016/S0092-8674(03)00810-9; HUGHES SM, 1988, NATURE, V335, P70, DOI 10.1038/335070a0; Klein C, 2002, J NEUROSCI, V22, P698, DOI 10.1523/JNEUROSCI.22-03-00698.2002; Laursen LS, 2009, J NEUROSCI, V29, P9174, DOI 10.1523/JNEUROSCI.5942-08.2009; Liang XQ, 2004, J NEUROSCI, V24, P7140, DOI 10.1523/JNEUROSCI.5319-03.2004; LOUIS JC, 1992, J NEUROSCI RES, V31, P193, DOI 10.1002/jnr.490310125; Lu ZF, 2005, J BIOL CHEM, V280, P389, DOI 10.1074/jbc.M405973200; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Massa PT, 2004, J NEUROSCI RES, V77, P15, DOI 10.1002/jnr.20155; MAYER M, 1994, P NATL ACAD SCI USA, V91, P7496, DOI 10.1073/pnas.91.16.7496; MAYER M, 1994, DEVELOPMENT, V120, P143; McDonald JW, 2006, J NEUROTRAUM, V23, P345, DOI 10.1089/neu.2006.23.345; MCMORRIS FA, 1988, J NEUROSCI RES, V21, P199, DOI 10.1002/jnr.490210212; Mi S, 2005, NAT NEUROSCI, V8, P745, DOI 10.1038/nn1460; Miller RH, 2002, PROG NEUROBIOL, V67, P451, DOI 10.1016/S0301-0082(02)00058-8; Miyamoto Y, 2007, J CELL SCI, V120, P4355, DOI 10.1242/jcs.018218; Nakahara J, 2003, DEV CELL, V4, P841, DOI 10.1016/S1534-5807(03)00155-2; Nakahara J, 2005, NEUROSCI LETT, V379, P116, DOI 10.1016/j.neulet.2004.12.066; Osterhout DJ, 1999, J CELL BIOL, V145, P1209, DOI 10.1083/jcb.145.6.1209; Pallen CJ, 2003, CURR TOP MED CHEM, V3, P821, DOI 10.2174/1568026033452320; Pedraza CE, 2008, GLIA, V56, P1339, DOI 10.1002/glia.20702; Peretz A, 2000, EMBO J, V19, P4036, DOI 10.1093/emboj/19.15.4036; Rajasekharan S, 2009, DEVELOPMENT, V136, P415, DOI 10.1242/dev.018234; Ranjan M, 1996, MOL CELL NEUROSCI, V7, P404, DOI 10.1006/mcne.1996.0029; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; Samayawardhena LA, 2008, J BIOL CHEM, V283, P29175, DOI 10.1074/jbc.M804077200; Sperber BR, 2001, J NEUROSCI RES, V63, P303, DOI 10.1002/1097-4547(20010215)63:4<303::AID-JNR1024>3.0.CO;2-A; Sperber BR, 2001, J NEUROSCI, V21, P2039, DOI 10.1523/JNEUROSCI.21-06-02039.2001; Taniguchi S, 2003, BIOCHEM BIOPH RES CO, V306, P151, DOI 10.1016/S0006-291X(03)00923-9; Thurnherr T, 2006, J NEUROSCI, V26, P10110, DOI 10.1523/JNEUROSCI.2158-06.2006; Tiran Z, 2006, MOL BIOL CELL, V17, P4330, DOI 10.1091/mbc.E06-02-0151; UMEMORI H, 1994, NATURE, V367, P572, DOI 10.1038/367572a0; Umemori H, 1999, J NEUROSCI, V19, P1393; Vitry S, 1999, J NEUROSCI RES, V58, P735; von Wichert G, 2003, J CELL BIOL, V161, P143, DOI 10.1083/jcb.200211061; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; Wolf RM, 2001, J NEUROBIOL, V49, P62, DOI 10.1002/neu.1066; Zawadzka M, 2007, CURR OPIN NEUROL, V20, P294, DOI 10.1097/WCO.0b013e32813aee7f; Zeng L, 1999, J CELL BIOL, V147, P707, DOI 10.1083/jcb.147.4.707; Zhang SC, 1998, J NEUROCYTOL, V27, P475, DOI 10.1023/A:1006953023845; Zhang SC, 1998, J NEUROSCI RES, V54, P181, DOI 10.1002/(SICI)1097-4547(19981015)54:2<181::AID-JNR6>3.0.CO;2-A	62	35	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33692	33702		10.1074/jbc.M109.061770	http://dx.doi.org/10.1074/jbc.M109.061770			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19812040	Green Published, hybrid			2022-12-27	WOS:000272028500073
J	Westrop, GD; Georg, I; Coombs, GH				Westrop, Gareth D.; Georg, Ina; Coombs, Graham H.			The Mercaptopyruvate Sulfurtransferase of Trichomonas vaginalis Links Cysteine Catabolism to the Production of Thioredoxin Persulfide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; AMINO-ACID-METABOLISM; SULFANE SULFUR; 3-MERCAPTOPYRUVATE SULFURTRANSFERASE; INTRACELLULAR CYSTEINE; ENTAMOEBA-HISTOLYTICA; ENZYMATIC ACTIVATION; PROTOZOAN PARASITES; CRYSTAL-STRUCTURE; HYDROGEN-SULFIDE	Trichomonas vaginalis is a protozoan parasite of humans that is able to synthesize cysteine de novo using cysteine synthase but does not produce glutathione. In this study, high pressure liquid chromatography analysis confirmed that cysteine is the major intracellular redox buffer by showing that T. vaginalis contains high levels of cysteine (similar to 600 mu M) comprising more than 70% of the total thiols detected. To investigate possible mechanisms for the regulation of cysteine levels in T. vaginalis, we have characterized enzymes of the mercaptopyruvate pathway. This consists of an aspartate aminotransferase (TvAspAT1), which transaminates cysteine to form 3-mercaptopyruvate (3-MP), and mercaptopyruvate sulfurtransferase (TvMST), which transfers the sulfur of 3-MP to a nucleophilic acceptor, generating pyruvate. TvMST has high activity with 3-MP as a sulfur donor and can use several thiol compounds as sulfur acceptor substrates. Our analysis indicated that TvMST has a k(cat)/K-m for reduced thioredoxin of 6.2 x 10(7) M-1 s(-1), more than 100-fold higher than that observed for beta-mercaptoethanol and cysteine, suggesting that thioredoxin is a preferred substrate for TvMST. Thiol trapping and mass spectrometry provided direct evidence for the formation of thioredoxin persulfide as a product of this reaction. The thioredoxin persulfide could serve a biological function such as the transfer of the persulfide to a target protein or the sequestered release of sulfide for biosynthesis. Changes in MST activity of T. vaginalis in response to variation in the supply of exogenous cysteine are suggestive of a role for the mercaptopyruvate pathway in the removal of excess intracellular cysteine, redox homeostasis, and antioxidant defense.	[Westrop, Gareth D.; Georg, Ina; Coombs, Graham H.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow G4 0NR, Lanark, Scotland	University of Strathclyde	Westrop, GD (corresponding author), Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow G4 0NR, Lanark, Scotland.	gareth.westrop@strath.ac.uk	Georg, Ina/L-5018-2014	Georg, Ina/0000-0002-1256-5805; Westrop, Gareth/0000-0002-8011-6219	Medical Research Council [G9722968] Funding Source: Medline; MRC [G9722968] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		AKAGI R, 1982, ACTA MED OKAYAMA, V36, P187; Ali V, 2007, CLIN MICROBIOL REV, V20, P164, DOI 10.1128/CMR.00019-06; Alphey MS, 2003, J BIOL CHEM, V278, P48219, DOI 10.1074/jbc.M307187200; Ariyanayagam MR, 1999, MOL BIOCHEM PARASIT, V103, P61, DOI 10.1016/S0166-6851(99)00118-8; Beinert H, 2000, EUR J BIOCHEM, V267, P5657, DOI 10.1046/j.1432-1327.2000.01637.x; Billaut-Laden I, 2006, TOXICOL LETT, V165, P101, DOI 10.1016/j.toxlet.2006.02.002; BROWN DM, 1993, MOL BIOCHEM PARASIT, V61, P155, DOI 10.1016/0166-6851(93)90169-X; Coombs GH, 2004, J BIOL CHEM, V279, P5249, DOI 10.1074/jbc.M304359200; Cotch MF, 1997, SEX TRANSM DIS, V24, P353, DOI 10.1097/00007435-199707000-00008; Dominy JE, 2007, AM J PHYSIOL-ENDOC M, V293, pE62, DOI 10.1152/ajpendo.00053.2007; DRAKE MR, 1987, BIOCHEM J, V244, P279, DOI 10.1042/bj2440279; Dunne RL, 2003, CELL RES, V13, P239, DOI 10.1038/sj.cr.7290169; ELLIS JE, 1994, MICROBIOL-SGM, V140, P2489, DOI 10.1099/13500872-140-9-2489; FAHEY RC, 1984, SCIENCE, V224, P70, DOI 10.1126/science.6322306; Iciek M, 2001, POL J PHARMACOL, V53, P215; Iciek M, 2007, EUR J PHARMACOL, V569, P1, DOI 10.1016/j.ejphar.2007.04.055; Ishigami M, 2009, ANTIOXID REDOX SIGN, V11, P205, DOI [10.1089/ars.2008.2132, 10.1089/ARS.2008.2132]; Jensen RA, 1996, J BACTERIOL, V178, P2161, DOI 10.1128/jb.178.8.2161-2171.1996; Kessler D, 2006, FEMS MICROBIOL REV, V30, P825, DOI 10.1111/j.1574-6976.2006.00036.x; Kissinger P, 2009, SEX TRANSM DIS, V36, P11, DOI 10.1097/OLQ.0b013e318186decf; KNODLER LA, 1994, EXP PARASITOL, V79, P117, DOI 10.1006/expr.1994.1071; Kumar A, 2006, BIOCHEM J, V396, P61, DOI 10.1042/BJ20051411; LINSTEAD DJ, 1988, MOL BIOCHEM PARASIT, V27, P125, DOI 10.1016/0166-6851(88)90032-1; LOWE PN, 1986, MOL BIOCHEM PARASIT, V21, P65, DOI 10.1016/0166-6851(86)90080-0; McClelland RS, 2007, J INFECT DIS, V195, P698, DOI 10.1086/511278; McKie AE, 1998, J BIOL CHEM, V273, P5549, DOI 10.1074/jbc.273.10.5549; Meyer AJ, 2005, PHOTOSYNTH RES, V86, P435, DOI 10.1007/s11120-005-8425-1; MIKAMI H, 1984, ACTA MED OKAYAMA, V38, P415; Mueller EG, 2006, NAT CHEM BIOL, V2, P185, DOI 10.1038/nchembio779; Muller S, 2003, TRENDS PARASITOL, V19, P320, DOI 10.1016/S1471-4922(03)00141-7; Nagahara N, 2005, J BIOL CHEM, V280, P34569, DOI 10.1074/jbc.M505643200; NAGAHARA N, 1995, J BIOL CHEM, V270, P16230, DOI 10.1074/jbc.270.27.16230; Nagahara N, 2007, J BIOL CHEM, V282, P1561, DOI 10.1074/jbc.M605931200; Nandi DL, 2000, INT J BIOCHEM CELL B, V32, P465, DOI 10.1016/S1357-2725(99)00035-7; Nandi DL, 1998, INT J BIOCHEM CELL B, V30, P973, DOI 10.1016/S1357-2725(98)00050-8; Park S, 2003, J BACTERIOL, V185, P1942, DOI 10.1128/JB.185.6.1942-1950.2003; Schwebke JR, 2004, CLIN MICROBIOL REV, V17, P794, DOI 10.1128/CMR.17.4.794-803.2004; Shafir SC, 2009, CLIN MICROBIOL REV, V22, P37, DOI 10.1128/CMR.00002-08; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; Sorvillo F, 2001, EMERG INFECT DIS, V7, P927, DOI 10.3201/eid0706.010603; Spallarossa A, 2004, J MOL BIOL, V335, P583, DOI 10.1016/j.jmb.2003.10.072; Stipanuk MH, 2006, J NUTR, V136, p1652S, DOI 10.1093/jn/136.6.1652S; Sutak R, 2004, P NATL ACAD SCI USA, V101, P10368, DOI 10.1073/pnas.0401319101; TERKUILE BH, 1993, FEMS MICROBIOL LETT, V110, P27, DOI 10.1111/j.1574-6968.1993.tb06290.x; TOOHEY JI, 1989, BIOCHEM J, V264, P625, DOI 10.1042/bj2640625; Van Der Pol B, 2008, J INFECT DIS, V197, P548, DOI 10.1086/526496; VINA J, 1983, BIOCHEM J, V212, P39, DOI 10.1042/bj2120039; Walker J, 1997, INT J PARASITOL, V27, P883, DOI 10.1016/S0020-7519(97)00039-8; WESTLEY J, 1983, FUND APPL TOXICOL, V3, P377, DOI 10.1016/S0272-0590(83)80008-6; Westrop GD, 2006, J BIOL CHEM, V281, P25062, DOI 10.1074/jbc.M600688200; Williams RAM, 2003, J BIOL CHEM, V278, P1480, DOI 10.1074/jbc.M209395200; Wright CM, 2006, CHEM COMMUN, P3104, DOI 10.1039/b604040c	52	42	43	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33485	33494		10.1074/jbc.M109.054320	http://dx.doi.org/10.1074/jbc.M109.054320			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19762467	Green Published, hybrid			2022-12-27	WOS:000272028500055
J	Saliba, RS; Gu, ZL; Yan, Z; Moss, SJ				Saliba, Richard S.; Gu, Zhenglin; Yan, Zhen; Moss, Stephen J.			Blocking L-type Voltage-gated Ca2+ Channels with Dihydropyridines Reduces gamma-Aminobutyric Acid Type A Receptor Expression and Synaptic Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GABA(A) RECEPTORS; HIPPOCAMPAL-NEURONS; NEUROTROPHIC FACTOR; NMDA RECEPTORS; PROTEIN-KINASE; TRAFFICKING; SYNAPSES; PHOSPHORYLATION; MODULATION; AMPLITUDE	gamma-Aminobutyric acid type A receptors (GABA(A)Rs) are the major sites of fast inhibitory neurotransmission in the brain, and the numbers of these receptors at the cell surface can determine the strength of GABAergic neurotransmission. Chronic changes in neuronal activity lead to an adaptive modulation in the efficacy of GABAergic synaptic inhibition, brought about in part by changes in the number of synaptic GABA(A)Rs, a mechanism known as homeostatic synaptic plasticity. Reduction in the number of GABA(A) Rs in response to prolonged neuronal activity blockade is dependent on the ubiquitin-proteasome system. The underlying biochemical pathways linking chronic activity blockade to proteasome-dependent degradation of GABA(A)Rs are unknown. Here, we show that chronic blockade of L-type voltage-gated calcium channels (VGCCs) with nifedipine decreases the number of GABA(A) Rs at synaptic sites but not the overall number of inhibitory synapses. In parallel, blockade of L-type VGCCs decreases the amplitude but not the frequency of miniature inhibitory postsynaptic currents or expression of the glutamic acid decarboxylase GAD65. We further reveal that the activation of L-type VGCCs regulates the turnover of newly translated GABA(A)R subunits in a mechanism dependent upon the activity of the proteasome and thus regulates GABA(A)R insertion into the plasma membrane. Together, these observations suggest that activation of L-type VGCCs can regulate the abundance of synaptic GABA(A)Rs and the efficacy of synaptic inhibition, revealing a potential mechanism underlying the homeostatic adaptation of fast GABAergic inhibition to prolonged changes in activity.	[Saliba, Richard S.; Moss, Stephen J.] Tufts Univ, Dept Neurosci, Boston, MA 02111 USA; [Gu, Zhenglin; Yan, Zhen] SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14214 USA; [Moss, Stephen J.] UCL, Dept Neurosci, London WC1E 6BT, England; [Moss, Stephen J.] UCL, Dept Physiol, London WC1E 6BT, England; [Moss, Stephen J.] UCL, Dept Pharmacol, London WC1E 6BT, England	Tufts University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of London; University College London; University of London; University College London; University of London; University College London	Moss, SJ (corresponding author), Tufts Univ, Dept Neurosci, 136 Harrison Ave, Boston, MA 02111 USA.	stephen.moss@tufts.edu			National Institutes of Health [NS047478, NS048045, NS051195, NS056359, NS054900]; NINDS; American Society for Epilepsy; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051195, R01NS056359, R01NS048045, P01NS054900, R01NS047478] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Society for Epilepsy; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS047478, NS048045, NS051195, NS056359, and NS054900 from NINDS ( to S. J. M.) and by a fellowship from the American Society for Epilepsy (to R. S. S.).	Bogdanov Y, 2006, EMBO J, V25, P4381, DOI 10.1038/sj.emboj.7601309; Brandon NJ, 2003, MOL CELL NEUROSCI, V22, P87, DOI 10.1016/S1044-7431(02)00017-9; Brandon NJ, 2000, J BIOL CHEM, V275, P38856, DOI 10.1074/jbc.M004910200; Burrone J, 2003, CURR OPIN NEUROBIOL, V13, P560, DOI 10.1016/j.conb.2003.09.007; De Gois S, 2005, J NEUROSCI, V25, P7121, DOI 10.1523/JNEUROSCI.5221-04.2005; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Goldberg JH, 2003, J PHYSIOL-LONDON, V551, P67, DOI 10.1113/jphysiol.2003.042598; Gorrie GH, 1997, J NEUROSCI, V17, P6587; GROVER LM, 1990, NATURE, V347, P477, DOI 10.1038/347477a0; Hartman KN, 2006, NAT NEUROSCI, V9, P642, DOI 10.1038/nn1677; Ibata K, 2008, NEURON, V57, P819, DOI 10.1016/j.neuron.2008.02.031; Jacob TC, 2005, J NEUROSCI, V25, P10469, DOI 10.1523/JNEUROSCI.2267-05.2005; Jacob TC, 2008, NAT REV NEUROSCI, V9, P331, DOI 10.1038/nrn2370; Jovanovic JN, 2004, J NEUROSCI, V24, P522, DOI 10.1523/JNEUROSCI.3606-03.2004; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Kinney JW, 2006, J NEUROSCI, V26, P1604, DOI 10.1523/JNEUROSCI.4722-05.2006; Kittler JT, 2003, CURR OPIN NEUROBIOL, V13, P341, DOI 10.1016/S0959-4388(03)00064-3; Kittler JT, 2004, P NATL ACAD SCI USA, V101, P12736, DOI 10.1073/pnas.0401860101; Kittler JT, 2000, J NEUROSCI, V20, P7972; Luscher B, 2004, PHARMACOL THERAPEUT, V102, P195, DOI 10.1016/j.pharmthera.2004.04.003; Moss SJ, 2001, NAT REV NEUROSCI, V2, P240, DOI 10.1038/35067500; Nusser Z, 1997, NEURON, V19, P697, DOI 10.1016/S0896-6273(00)80382-7; Nusser Z, 1998, NATURE, V395, P172, DOI 10.1038/25999; PEDERSEN SE, 1990, P NATL ACAD SCI USA, V87, P2785, DOI 10.1073/pnas.87.7.2785; Rudolph U, 2004, ANNU REV PHARMACOL, V44, P475, DOI 10.1146/annurev.pharmtox.44.101802.121429; Rudolph U, 2006, CURR OPIN PHARMACOL, V6, P18, DOI 10.1016/j.coph.2005.10.003; Saliba RS, 2008, J BIOL CHEM, V283, P18538, DOI 10.1074/jbc.M802077200; Saliba RS, 2007, J NEUROSCI, V27, P13341, DOI 10.1523/JNEUROSCI.3277-07.2007; Sekine-Aizawa Y, 2004, P NATL ACAD SCI USA, V101, P17114, DOI 10.1073/pnas.0407563101; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Swanwick CC, 2006, MOL CELL NEUROSCI, V31, P481, DOI 10.1016/j.mcn.2005.11.002; Thiagarajan TC, 2005, NEURON, V47, P725, DOI 10.1016/j.neuron.2005.06.037; TSIEN RW, 1990, ANNU REV CELL BIOL, V6, P715, DOI 10.1146/annurev.cb.06.110190.003435; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987	39	40	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32544	32550		10.1074/jbc.M109.040071	http://dx.doi.org/10.1074/jbc.M109.040071			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19778903	hybrid, Green Published			2022-12-27	WOS:000272028400036
J	Choi, HJ; Gross, JC; Pokutta, S; Weis, WI				Choi, Hee-Jung; Gross, Julia C.; Pokutta, Sabine; Weis, William I.			Interactions of Plakoglobin and beta-Catenin with Desmosomal Cadherins BASIS OF SELECTIVE EXCLUSION OF alpha-AND beta-CATENIN FROM DESMOSOMES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERMEDIATE-FILAMENT ANCHORAGE; CELL-CELL ADHESION; ADHERENS JUNCTIONS; INTERCELLULAR-ADHESION; CLASSICAL CADHERINS; CYTOPLASMIC DOMAIN; CRYSTAL-STRUCTURE; TERMINAL TAILS; BINDING-SITES; FULL-LENGTH	Plakoglobin and beta-catenin are homologous armadillo repeat proteins found in adherens junctions, where they interact with the cytoplasmic domain of classical cadherins and with beta-catenin. Plakoglobin, but normally not beta-catenin, is also a structural constituent of desmosomes, where it binds to the cytoplasmic domains of the desmosomal cadherins, desmogleins and desmocollins. Here, we report structural, biophysical, and biochemical studies aimed at understanding the molecular basis of selective exclusion of beta-catenin and beta-catenin from desmosomes. The crystal structure of the plakoglobin armadillo domain bound to phosphorylated E-cadherin shows virtually identical interactions to those observed between beta-catenin and E-cadherin. Trypsin sensitivity experiments indicate that the plakoglobin arm domain by itself is more flexible than that of beta-catenin. Binding of plakoglobin and beta-catenin to the intracellular regions of E-cadherin, desmoglein1, and desmocollin1 was measured by isothermal titration calorimetry. Plakoglobin and beta-catenin bind strongly and with similar thermodynamic parameters to E-cadherin. In contrast, beta-catenin binds to desmoglein-1 more weakly than does plakoglobin. beta-Catenin and plakoglobin bind with similar weak affinities to desmocollin-1. Full affinity binding of desmoglein-1 requires sequences C-terminal to the region homologous to the catenin-binding domain of classical cadherins. Although pulldown assays suggest that the presence of N- and C-terminal beta-catenin "tails" that flank the armadillo repeat region reduces the affinity for desmosomal cadherins, calorimetric measurements show no significant effects of the tails on binding to the cadherins. Using purified proteins, we show that desmosomal cadherins and beta-catenin compete directly for binding to plakoglobin, consistent with the absence of beta-catenin in desmosomes.	[Weis, William I.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA	Stanford University; Stanford University	Weis, WI (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, 299 Campus Dr W, Stanford, CA 94305 USA.	bill.weis@stanford.edu	Weis, William I/G-1437-2011; Gross, Julia Christina/AAN-5730-2020	Weis, William I/0000-0002-5583-6150; Gross, Julia Christina/0000-0002-8939-5664; Choi, Hee-Jung/0000-0002-1167-1526	National Institutes of Health [R01 GM56169]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056169] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM56169.	Acehan D, 2008, J INVEST DERMATOL, V128, P2665, DOI 10.1038/jid.2008.141; Adams CL, 1996, J CELL BIOL, V135, P1899, DOI 10.1083/jcb.135.6.1899; Bierkamp C, 1999, DEVELOPMENT, V126, P371; Chitaev NA, 1996, J CELL BIOL, V133, P359, DOI 10.1083/jcb.133.2.359; Chitaev NA, 1998, J CELL SCI, V111, P1941; Choi HJ, 2006, J BIOL CHEM, V281, P1027, DOI 10.1074/jbc.M511338200; Daniels DL, 2002, MOL CELL, V10, P573, DOI 10.1016/S1097-2765(02)00631-7; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Garrod DR, 2002, CURR OPIN CELL BIOL, V14, P537, DOI 10.1016/S0955-0674(02)00366-6; Gaudry CA, 2001, J BIOL CHEM, V276, P24871, DOI 10.1074/jbc.M102731200; Graham TA, 2002, MOL CELL, V10, P563, DOI 10.1016/S1097-2765(02)00637-8; Green KJ, 2007, J INVEST DERMATOL, V127, P2499, DOI 10.1038/sj.jid.5701015; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Huber AH, 2001, J BIOL CHEM, V276, P12301, DOI 10.1074/jbc.M010377200; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; Kami K, 2009, J MOL BIOL, V386, P531, DOI 10.1016/j.jmb.2008.12.054; KOUKLIS PD, 1994, J CELL BIOL, V127, P1049, DOI 10.1083/jcb.127.4.1049; Kowalczyk AP, 1999, INT REV CYTOL, V185, P237; Kowalczyk AP, 1997, J CELL BIOL, V139, P773, DOI 10.1083/jcb.139.3.773; Lewis JE, 1997, J CELL BIOL, V136, P919, DOI 10.1083/jcb.136.4.919; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Lorch JH, 2004, J BIOL CHEM, V279, P37191, DOI 10.1074/jbc.M405123200; MATHUR M, 1994, J BIOL CHEM, V269, P14075; Miravet S, 2003, MOL CELL BIOL, V23, P7391, DOI 10.1128/MCB.23.20.7391-7402.2003; Norvell SM, 1998, J CELL SCI, V111, P1305; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; PLOTT RT, 1994, J INVEST DERMATOL, V103, P168, DOI 10.1111/1523-1747.ep12392642; Pokutta S, 2000, MOL CELL, V5, P533, DOI 10.1016/S1097-2765(00)80447-5; Pokutta S, 2007, ANNU REV CELL DEV BI, V23, P237, DOI 10.1146/annurev.cellbio.22.010305.104241; Solanas G, 2004, J BIOL CHEM, V279, P49849, DOI 10.1074/jbc.M408685200; STAPPENBECK TS, 1992, J CELL BIOL, V116, P1197, DOI 10.1083/jcb.116.5.1197; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Tago K, 2000, GENE DEV, V14, P1741; Troyanovsky RB, 1996, J CELL SCI, V109, P3069; TROYANOVSKY SM, 1994, J CELL BIOL, V127, P151, DOI 10.1083/jcb.127.1.151; TROYANOVSKY SM, 1993, CELL, V72, P561, DOI 10.1016/0092-8674(93)90075-2; TROYANOVSKY SM, 1994, P NATL ACAD SCI USA, V91, P10790, DOI 10.1073/pnas.91.23.10790; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Wahl JK, 2000, J CELL SCI, V113, P1737; Wahl JK, 1996, J CELL SCI, V109, P1143; Witcher LL, 1996, J BIOL CHEM, V271, P10904, DOI 10.1074/jbc.271.18.10904; Xing Y, 2008, STRUCTURE, V16, P478, DOI 10.1016/j.str.2007.12.021; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119; Yin TF, 2005, P NATL ACAD SCI USA, V102, P5420, DOI 10.1073/pnas.0501676102; Zhurinsky J, 2000, MOL CELL BIOL, V20, P4238, DOI 10.1128/MCB.20.12.4238-4252.2000	49	51	56	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31776	31788		10.1074/jbc.M109.047928	http://dx.doi.org/10.1074/jbc.M109.047928			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19759396	hybrid, Green Published			2022-12-27	WOS:000271572700032
J	Jung, SY; Kim, JM; Kang, HK; Jang, DH; Min, BM				Jung, Sung Youn; Kim, Jin-Man; Kang, Hyun Ki; Jang, Da Hyun; Min, Byung-Moo			A Biologically Active Sequence of the Laminin alpha 2 Large Globular 1 Domain Promotes Cell Adhesion through Syndecan-1 by Inducing Phosphorylation and Membrane Localization of Protein Kinase C delta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNTHETIC PEPTIDE; HEPARAN-SULFATE; BINDING-SITE; A-CHAIN; PERIPHERAL-NERVE; SCHWANN-CELLS; LG4 MODULE; PKC-ALPHA; IDENTIFICATION; DYSTROGLYCAN	Laminin-2 promotes basement membrane assembly and peripheral myelinogenesis; however, a receptor-binding motif within laminin-2 and the downstream signaling pathways for motif-mediated cell adhesion have not been fully established. The human laminin-2 alpha 2 chain cDNAs cloned from human keratinocytes and fibroblasts correspond to the laminin alpha 2 chain variant sequence from the human brain. Individually expressed recombinant large globular (LG) 1 protein promotes cell adhesion and has heparin binding activities. Studies with synthetic peptides delineate the DLTIDDSYWYRI motif (Ln2-P3) within the LG1 as a major site for both heparin and cell binding. Cell adhesion to LG1 and Ln2-P3 is inhibited by treatment of heparitinase I and chondroitinase ABC. Syndecan-1 from PC12 cells binds to LG1 and Ln2-P3 and colocalizes with both molecules. Suppression of syndecan-1 with RNA interference inhibits cell adhesion to LG1 and Ln2-P3. The binding of syndecan-1 with LG1 and Ln2-P3 induces the recruitment of protein kinase C delta (PKC delta) into the membrane and stimulates its tyrosine phosphorylation. A decrease in PKC delta activity significantly reduces cell adhesion to LG1 and Ln2-P3. Taken together, these results indicate that the Ln2-P3 motif and LG1 domain, containing the motif, within the human laminin-2 alpha 2 chain are major ligands for syndecan-1, which mediates cell adhesion through the PKC delta signaling pathway.	Intellectual Biointerface Engn Ctr, Dent Res Inst, Dept Oral Biochem, Seoul 110749, South Korea; Intellectual Biointerface Engn Ctr, Dent Res Inst, Program Craniomaxillofacial Reconstruct Sci, Seoul 110749, South Korea; Seoul Natl Univ, Sch Dent, CLS BK21, Seoul 110749, South Korea	Seoul National University (SNU)	Min, BM (corresponding author), 28 Yeonkun Dong, Seoul 110749, South Korea.	bmmin@snu.ac.kr	Min, Byung-Moo/F-2854-2012		Korea Science and Engineering Foundation through the Intellectual Biointerface Engineering Center at Seoul National University	Korea Science and Engineering Foundation through the Intellectual Biointerface Engineering Center at Seoul National University(Korea Science and Engineering Foundation)	This work was supported by grants from the Korea Science and Engineering Foundation through the Intellectual Biointerface Engineering Center at Seoul National University ( to B.- M. M.).	Benes C, 2001, AM J PHYSIOL-CELL PH, V280, pC1498, DOI 10.1152/ajpcell.2001.280.6.C1498; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; Calzada MJ, 2003, J BIOL CHEM, V278, P40679, DOI 10.1074/jbc.M302014200; Carey DJ, 1997, BIOCHEM J, V327, P1; CHARONIS AS, 1988, J CELL BIOL, V107, P1253, DOI 10.1083/jcb.107.3.1253; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; Couchman JR, 1999, J CELL SCI, V112, P3415; Edwards JP, 1998, BRAIN RES, V788, P262, DOI 10.1016/S0006-8993(98)00010-9; Ekblom M, 1998, ANN NY ACAD SCI, V857, P194, DOI 10.1111/j.1749-6632.1998.tb10117.x; Feltri ML, 2005, J PERIPHER NERV SYST, V10, P128, DOI 10.1111/j.1085-9489.2005.0010204.x; GEHLSEN KR, 1992, J CELL BIOL, V117, P449, DOI 10.1083/jcb.117.2.449; Hall H, 2003, MOL CELL NEUROSCI, V24, P1062, DOI 10.1016/j.mcn.2003.08.007; Hoffman MP, 1998, J BIOL CHEM, V273, P28633, DOI 10.1074/jbc.273.44.28633; Hozumi K, 2006, J BIOL CHEM, V281, P32929, DOI 10.1074/jbc.M605708200; Keum E, 2004, BIOCHEM J, V378, P1007, DOI 10.1042/BJ20031734; Kim JM, 2005, EXP CELL RES, V304, P317, DOI 10.1016/j.yexcr.2004.11.009; LEIVO I, 1988, P NATL ACAD SCI USA, V85, P1544, DOI 10.1073/pnas.85.5.1544; Lim ST, 2003, J BIOL CHEM, V278, P13795, DOI 10.1074/jbc.M208300200; Lundin L, 2000, J BIOL CHEM, V275, P24653, DOI 10.1074/jbc.M908930199; Lyon M, 2000, J BIOL CHEM, V275, P4599, DOI 10.1074/jbc.275.7.4599; Maccarana M, 1996, J BIOL CHEM, V271, P17804, DOI 10.1074/jbc.271.30.17804; Malave C, 2003, BRAIN RES, V983, P74, DOI 10.1016/S0006-8993(03)03031-2; Masaki T, 2000, ACTA NEUROPATHOL, V99, P289, DOI 10.1007/PL00007440; Matsumura K, 1997, NEUROMUSCULAR DISORD, V7, P7, DOI 10.1016/S0960-8966(96)00402-6; Nielsen PK, 2000, J BIOL CHEM, V275, P14517, DOI 10.1074/jbc.275.19.14517; Nomizu M, 1996, FEBS LETT, V396, P37, DOI 10.1016/0014-5793(96)01060-5; Okamoto O, 2003, J BIOL CHEM, V278, P44168, DOI 10.1074/jbc.M300726200; Okazaki I, 2002, J BIOL CHEM, V277, P37070, DOI 10.1074/jbc.M201672200; Quittau-Prevostel C, 2004, J CELL SCI, V117, P63, DOI 10.1242/jcs.00832; Richard BL, 1996, EXP CELL RES, V228, P98, DOI 10.1006/excr.1996.0304; Salmivirta M, 1996, FASEB J, V10, P1270, DOI 10.1096/fasebj.10.11.8836040; Sewry CA, 1997, NEUROPEDIATRICS, V28, P217, DOI 10.1055/s-2007-973703; Smirnov SP, 2002, J BIOL CHEM, V277, P18928, DOI 10.1074/jbc.M201880200; STANLEY MJ, 1995, J BIOL CHEM, V270, P5077, DOI 10.1074/jbc.270.10.5077; Steinberg SF, 2004, BIOCHEM J, V384, P449, DOI 10.1042/BJ20040704; Suzuki N, 2005, CONNECT TISSUE RES, V46, P142, DOI 10.1080/03008200591008527; Suzuki N, 2003, J BIOL CHEM, V278, P45697, DOI 10.1074/jbc.M304667200; Talts JF, 1999, FEBS LETT, V458, P319, DOI 10.1016/S0014-5793(99)01180-1; Talts JF, 1998, FEBS LETT, V426, P71, DOI 10.1016/S0014-5793(98)00312-3; TASHIRO K, 1994, BIOCHEM J, V302, P73, DOI 10.1042/bj3020073; Tisi D, 2000, EMBO J, V19, P1432, DOI 10.1093/emboj/19.7.1432; Utani A, 2001, J BIOL CHEM, V276, P28779, DOI 10.1074/jbc.M101420200; Vossmeyer D, 2002, J BIOL CHEM, V277, P4636, DOI 10.1074/jbc.M105415200; VUOLTEENAHO R, 1994, J CELL BIOL, V124, P381, DOI 10.1083/jcb.124.3.381; Wizemann H, 2003, J MOL BIOL, V332, P635, DOI 10.1016/S0022-2836(03)00848-9; Yamaguchi H, 2000, J BIOL CHEM, V275, P29458, DOI 10.1074/jbc.M003103200; Yamashita H, 2004, BIOCHEM J, V382, P933, DOI 10.1042/BJ20040558; Yeo IS, 2008, BIOMACROMOLECULES, V9, P1106, DOI 10.1021/bm700875a; Yoshida I, 1999, J CELL PHYSIOL, V179, P18, DOI 10.1002/(SICI)1097-4652(199904)179:1<18::AID-JCP3>3.0.CO;2-K	49	19	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31764	31775		10.1074/jbc.M109.038547	http://dx.doi.org/10.1074/jbc.M109.038547			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19762914	Green Published, hybrid			2022-12-27	WOS:000271572700031
J	Ascenzi, P; di Masi, A; Coletta, M; Ciaccio, C; Fanali, G; Nicoletti, FP; Smulevich, G; Fasano, M				Ascenzi, Paolo; di Masi, Alessandra; Coletta, Massimo; Ciaccio, Chiara; Fanali, Gabriella; Nicoletti, Francesco P.; Smulevich, Giulietta; Fasano, Mauro			Ibuprofen Impairs Allosterically Peroxynitrite Isomerization by Ferric Human Serum Heme-Albumin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID-BINDING; ANTI-HIV DRUGS; CRYSTAL-STRUCTURE; LIGAND-BINDING; NITRIC-OXIDE; CRYSTALLOGRAPHIC ANALYSIS; ENZYMATIC-PROPERTIES; MEDIATED OXIDATION; WARFARIN-BINDING; HUMAN HEMALBUMIN	Human serum albumin (HSA) participates in heme scavenging; in turn, heme endows HSA with myoglobin-like reactivity and spectroscopic properties. Here, the allosteric effect of ibuprofen on peroxynitrite isomerization to NO3- catalyzed by ferric human serum heme-albumin (HSA-heme-Fe(III)) is reported. Data were obtained at 22.0 C. HSA-heme-Fe(III) catalyzes peroxynitrite isomerization in the absence and presence of CO2; the values of the second order catalytic rate constant (k(on)) are 4.1 x 10(5) and 4.5 x 10(5) M-1 s(-1), respectively. Moreover, HSA-heme-Fe( III) prevents peroxynitrite-mediated nitration of free added L-tyrosine. The pH dependence of k(on) (p(Ka) = 6.9) suggests that peroxynitrous acid reacts preferentially with the heme-Fe(III) atom, in the absence and presence of CO2. The HSA-heme-Fe(III)-catalyzed isomerization of peroxynitrite has been ascribed to the reactive pentacoordinated heme-Fe(III) atom. In the absence and presence of CO2, ibuprofen impairs dose-dependently peroxynitrite isomerization by HSA-heme-Fe(III) and facilitates the nitration of free added L-tyrosine; the value of the dissociation equilibrium constant for ibuprofen binding to HSA-heme-Fe(III) (L) ranges between 7.7 x 10(-4) and 9.7 x 10(-4)M. Underconditionswhere[ibuprofen] is >> L, the kinetics of HSA-heme-Fe(III)-catalyzed isomerization of peroxynitrite is superimposable to that obtained in the absence of HSA-heme-Fe(III) or in the presence of non-catalytic HSA-heme-Fe(III)-cyanide complex and HSA. Ibuprofen binding impairs allosterically peroxynitrite isomerization by HSA-heme-Fe(III), inducing the hexacoordination of the heme-Fe(III) atom. These results represent the first evidence for peroxynitrite isomerization by HSA-heme-Fe(III), highlighting the allosteric modulation of HSA-heme-Fe(III) reactivity by heterotropic interaction(s), and outlining the role of drugs in modulating HSA functions. The present results could be relevant for the drug-dependent protective role of HSA-heme-Fe(III) in vivo.	[Ascenzi, Paolo] Univ Roma Tre, Dept Biol, I-00146 Rome, Italy; Univ Roma Tre, Interdepartmental Lab Electron Microscopy, I-00146 Rome, Italy; [Ascenzi, Paolo] IRCCS Lazzaro Spallanzani, Natl Inst Infect Dis, I-00149 Rome, Italy; [Coletta, Massimo; Ciaccio, Chiara] Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, I-00133 Rome, Italy; [Coletta, Massimo; Smulevich, Giulietta] Interuniv Consortium Res Chem Met Biol Syst, I-70126 Bari, Italy; [Fanali, Gabriella; Fasano, Mauro] Univ Insubria, Dept Struct & Funct Biol, I-21052 Busto Arsizio, VA, Italy; [Fanali, Gabriella; Fasano, Mauro] Univ Insubria, Ctr Neurosci, I-21052 Busto Arsizio, VA, Italy; [Nicoletti, Francesco P.; Smulevich, Giulietta] Univ Florence, Dept Chem, I-50019 Sesto Fiorentino, FI, Italy	Roma Tre University; Roma Tre University; IRCCS Lazzaro Spallanzani; University of Rome Tor Vergata; University of Insubria; University of Insubria; University of Florence	Ascenzi, P (corresponding author), Univ Roma Tre, Dept Biol, Viale Guglielmo Marconi 446, I-00146 Rome, Italy.	ascenzi@uniroma3.it	smulevich, giulietta/A-6510-2008; Fasano, Mauro/A-7100-2008; di Masi, Alessandra/K-2300-2018; Coletta, Massimo/N-9049-2015; Coletta, Massimiliano/GSN-5927-2022	Fasano, Mauro/0000-0003-0628-5871; COLETTA, Massimiliano/0000-0002-5489-9467; Smulevich, Giulietta/0000-0003-3021-8919	Ministry for Health of Italy; Italian Ministry of University and Research [COFIN 2007SFZXZ7002]	Ministry for Health of Italy(Ministry of Health, Italy); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR))	This work was supported in part by grants from the Ministry for Health of Italy (National Institute for Infectious Diseases I. R. C. C. S. "Lazzaro Spallanzani," Roma, Italy, Ricerca Corrente 2008) (to P. A.) and the Italian Ministry of University and Research (COFIN 2007SFZXZ7002) (to M. C.).	Alvarez B, 2003, AMINO ACIDS, V25, P295, DOI 10.1007/s00726-003-0018-8; Antonini E., 1971, HEMOGLOBIN MYOGLOBIN; Ascenzi P, 2006, MINI-REV MED CHEM, V6, P483, DOI 10.2174/138955706776361448; Ascenzi P, 2005, IUBMB LIFE, V57, P749, DOI 10.1080/15216540500380871; Ascenzi P, 2006, BIOCHEM BIOPH RES CO, V339, P450, DOI 10.1016/j.bbrc.2005.11.031; Ascenzi P, 2005, BIOCHEM MOL BIOL EDU, V33, P169, DOI 10.1002/bmb.2005.494033032470; Ascenzi P, 2005, BIOCHEM BIOPH RES CO, V334, P481, DOI 10.1016/j.bbrc.2005.06.127; Ascenzi P, 2008, BIOCHEM BIOPH RES CO, V369, P686, DOI 10.1016/j.bbrc.2008.02.077; Ascenzi P, 2008, METHOD ENZYMOL, V436, P317, DOI 10.1016/S0076-6879(08)36018-2; Ascenzi P, 2007, BIOCHEM BIOPH RES CO, V353, P469, DOI 10.1016/j.bbrc.2006.12.041; Ascenzi P, 2006, IUBMB LIFE, V58, P611, DOI 10.1080/15216540600746344; Ascenzi P, 2009, BIOCHEM BIOPH RES CO, V387, P83, DOI 10.1016/j.bbrc.2009.06.117; Baroni S, 2001, EUR J BIOCHEM, V268, P6214, DOI 10.1046/j.0014-2956.2001.02569.x; Baroni S, 2009, BIOCHEM BIOPH RES CO, V385, P385, DOI 10.1016/j.bbrc.2009.05.075; Bertucci C, 2002, CURR MED CHEM, V9, P1463, DOI 10.2174/0929867023369673; Bhattacharya AA, 2000, J MOL BIOL, V303, P721, DOI 10.1006/jmbi.2000.4158; Bhattacharya AA, 2000, J BIOL CHEM, V275, P38731, DOI 10.1074/jbc.M005460200; Bocedi A, 2005, FEBS J, V272, P6287, DOI 10.1111/j.1742-4658.2005.05015.x; Bocedi A, 2004, IUBMB LIFE, V56, P609, DOI 10.1080/15216540400016286; Boffi A, 1999, BIOPHYS J, V77, P1143, DOI 10.1016/S0006-3495(99)76965-1; Bohle DS, 1996, METHOD ENZYMOL, V269, P302; BROWN RD, 1992, J CLIN PHARMACOL, V32, P231, DOI 10.1002/j.1552-4604.1992.tb03831.x; Cabrera-Crespo J, 2000, BIOTECHNOL APPL BIOC, V31, P101, DOI 10.1042/BA19990095; CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153; CARTER DC, 1999, Patent No. 5948609; Chuang VTG, 2002, PHARMACEUT RES, V19, P1458, DOI 10.1023/A:1020496314081; Curry S, 2002, VOX SANG, V83, P315, DOI 10.1111/j.1423-0410.2002.tb05326.x; Curry S, 1998, NAT STRUCT BIOL, V5, P827, DOI 10.1038/1869; DIANA FJ, 1989, J PHARM SCI-US, V78, P195, DOI 10.1002/jps.2600780304; DILL KA, 1989, BIOCHEMISTRY-US, V28, P5439, DOI 10.1021/bi00439a019; Dockal M, 2000, PROTEIN SCI, V9, P1455, DOI 10.1110/ps.9.8.1455; Fanali G, 2005, FEBS J, V272, P4672, DOI 10.1111/j.1742-4658.2005.04883.x; Fanali G, 2007, FEBS J, V274, P4491, DOI 10.1111/j.1742-4658.2007.05978.x; Fanali G, 2009, FEBS J, V276, P2241, DOI 10.1111/j.1742-4658.2009.06952.x; Fanali G, 2009, J BIOL INORG CHEM, V14, P209, DOI 10.1007/s00775-008-0439-7; Fasano M, 2005, IUBMB LIFE, V57, P787, DOI 10.1080/15216540500404093; Fasano M, 2004, J BIOL INORG CHEM, V9, P800, DOI 10.1007/s00775-004-0598-0; Fasano M, 2002, J INORG BIOCHEM, V91, P487, DOI 10.1016/S0162-0134(02)00473-7; Fasano M, 2001, J BIOL INORG CHEM, V6, P650, DOI 10.1007/s007750100242; FASANO M, 2008, HUMAN SERUM HAEME AL, P121; Fasano M, 2007, IUBMB LIFE, V59, P436, DOI 10.1080/15216540701474523; Ghuman J, 2005, J MOL BIOL, V353, P38, DOI 10.1016/j.jmb.2005.07.075; Goldstein S, 2005, CHEM REV, V105, P2457, DOI 10.1021/cr0307087; Goldstein S, 2008, METHOD ENZYMOL, V436, P49, DOI 10.1016/S0076-6879(08)36004-2; Groves JT, 1999, CURR OPIN CHEM BIOL, V3, P226, DOI 10.1016/S1367-5931(99)80036-2; HAMILTON JA, 1984, P NATL ACAD SCI-BIOL, V81, P3718, DOI 10.1073/pnas.81.12.3718; Hamilton JA, 2004, PROG LIPID RES, V43, P177, DOI 10.1016/j.plipres.2003.09.002; HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0; Herold S, 2005, COMP BIOCHEM PHYS A, V142, P124, DOI 10.1016/j.cbpb.2005.06.009; Herold S, 2004, J AM CHEM SOC, V126, P6945, DOI 10.1021/ja0493300; Herold S, 2003, BIOCHEMISTRY-US, V42, P14036, DOI 10.1021/bi0350349; Herold S, 2003, CHEM RES TOXICOL, V16, P390, DOI 10.1021/tx025595l; Herold S, 2001, J AM CHEM SOC, V123, P4085, DOI 10.1021/ja010111d; Kamal JKA, 2002, J BIOL INORG CHEM, V7, P273, DOI 10.1007/s007750100294; Kharitonov VG, 1997, BIOCHEMISTRY-US, V36, P6814, DOI 10.1021/bi970201o; Kissner R, 2002, J AM CHEM SOC, V124, P234, DOI 10.1021/ja010497s; Komatsu T, 2005, J AM CHEM SOC, V127, P15933, DOI 10.1021/ja054819u; Komatsu T, 2004, J AM CHEM SOC, V126, P14304, DOI 10.1021/ja046022t; Komatsu T, 2000, BIOCONJUGATE CHEM, V11, P772, DOI 10.1021/bc000016e; Koppenol WH, 1996, METHOD ENZYMOL, V269, P296; Kragh-Hansen U, 2002, BIOL PHARM BULL, V25, P695, DOI 10.1248/bpb.25.695; Kragh-Hansen U, 2006, J MOL BIOL, V363, P702, DOI 10.1016/j.jmb.2006.08.056; Ma XL, 2000, J PHARMACOL EXP THER, V292, P912; MARTIN W, 1990, BIOPHARM DRUG DISPOS, V11, P265, DOI 10.1002/bdd.2510110311; Mattu M, 2001, J INORG BIOCHEM, V84, P293, DOI 10.1016/S0162-0134(01)00185-4; Miller YI, 1999, BBA-MOL BASIS DIS, V1454, P153, DOI 10.1016/S0925-4439(99)00027-7; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Monzani E, 2002, BIOPHYS J, V83, P2248, DOI 10.1016/S0006-3495(02)73985-4; Monzani E, 2001, BBA-PROTEIN STRUCT M, V1547, P302, DOI 10.1016/S0167-4838(01)00192-3; MULLEREBERHARD U, 1968, BLOOD, V32, P811, DOI 10.1182/blood.V32.5.811.811; Nicoletti FP, 2008, J AM CHEM SOC, V130, P11677, DOI 10.1021/ja800966t; Peters T., 1996, ALL ALBUMIN BIOCH GE; Petitpas I, 2003, P NATL ACAD SCI USA, V100, P6440, DOI 10.1073/pnas.1137188100; Petitpas I, 2001, J BIOL CHEM, V276, P22804, DOI 10.1074/jbc.M100575200; Pfeiffer S, 1997, J BIOL CHEM, V272, P3465, DOI 10.1074/jbc.272.6.3465; REGAZZI BM, 1986, INT J CLIN PHARM RES, V6, P469; Sakurai Y, 2004, PHARM RES-DORDR, V21, P285, DOI 10.1023/B:PHAM.0000016241.84630.06; Schulz R, 1997, AM J PHYSIOL-HEART C, V272, pH1212, DOI 10.1152/ajpheart.1997.272.3.H1212; Shimanovich R, 2001, ARCH BIOCHEM BIOPHYS, V387, P307, DOI 10.1006/abbi.2000.2247; Simard JR, 2006, J MOL BIOL, V361, P336, DOI 10.1016/j.jmb.2006.06.028; Simard JR, 2005, P NATL ACAD SCI USA, V102, P17958, DOI 10.1073/pnas.0506440102; SPECTOR AA, 1975, J LIPID RES, V16, P165; Squadrito GL, 2002, CHEM RES TOXICOL, V15, P885, DOI 10.1021/tx020004c; SUDLOW G, 1976, MOL PHARMACOL, V12, P1052; SUDLOW G, 1975, MOL PHARMACOL, V11, P824; Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439; Sulkowska A, 2004, BIOPOLYMERS, V74, P256, DOI 10.1002/bip.20031; Wardell M, 2002, BIOCHEM BIOPH RES CO, V291, P813, DOI 10.1006/bbrc.2002.6540; Yamasaki K, 1999, BBA-PROTEIN STRUCT M, V1432, P313, DOI 10.1016/S0167-4838(99)00098-9; Zunszain PA, 2008, J MOL BIOL, V381, P394, DOI 10.1016/j.jmb.2008.06.016; Zunszain Patricia A, 2003, BMC Struct Biol, V3, P6, DOI 10.1186/1472-6807-3-6	91	41	41	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31006	31017		10.1074/jbc.M109.010736	http://dx.doi.org/10.1074/jbc.M109.010736			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19734142	Green Published, hybrid			2022-12-27	WOS:000271378400030
J	Peck, GR; Chavez, JA; Roach, WG; Budnik, BA; Lane, WS; Karlsson, HKR; Zierath, JR; Lienhard, GE				Peck, Grantley R.; Chavez, Jose A.; Roach, William G.; Budnik, Bogdan A.; Lane, William S.; Karlsson, Hakan K. R.; Zierath, Juleen R.; Lienhard, Gustav E.			Insulin-stimulated Phosphorylation of the Rab GTPase-activating Protein TBC1D1 Regulates GLUT4 Translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; GLUCOSE-TRANSPORT; 3T3-L1 ADIPOCYTES; KINASE; CONTRACTION; INHIBITION; OBESITY; AS160	Insulin stimulates the translocation of the glucose transporter GLUT4 from intracellular locations to the plasma membrane in adipose and muscle cells. Prior studies have shown that Akt phosphorylation of the Rab GTPase-activating protein, AS160 (160-kDa Akt substrate; also known as TBC1D4), triggers GLUT4 translocation, most likely by suppressing its Rab GTPase-activating protein activity. However, the regulation of a very similar protein, TBC1D1 (TBC domain family, member 1), which is mainly found in muscle, in insulin-stimulated GLUT4 translocation has been unclear. In the present study, we have identified likely Akt sites of insulin-stimulated phosphorylation of TBC1D1 in C2C12 myotubes. We show that a mutant of TBC1D1, in which several Akt sites have been converted to alanine, is considerably more inhibitory to insulin-stimulated GLUT4 translocation than wild-type TBC1D1. This result thus indicates that similar to AS160, Akt phosphorylation of TBC1D1 enables GLUT4 translocation. We also show that in addition to Akt activation, activation of the AMP-dependent protein kinase partially relieves the inhibition of GLUT4 translocation by TBC1D1. Finally, we show that the R125W variant of TBC1D1, which has been genetically associated with obesity, is equally inhibitory to insulin-stimulated GLUT4 translocation, as is wild-type TBC1D1, and that healthy and type 2 diabetic individuals express approximately the same level of TBC1D1 in biopsies of vastus lateralis muscle. In conclusion, phosphorylation of TBC1D1 is required for GLUT4 translocation. Thus, the regulation of TBC1D1 resembles that of its paralog, AS160.	[Peck, Grantley R.; Chavez, Jose A.; Roach, William G.; Lienhard, Gustav E.] Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA; [Budnik, Bogdan A.; Lane, William S.] Harvard Univ, Ctr Syst Biol, Mass Spectrometry & Prote Resource Lab, Cambridge, MA 02318 USA; [Karlsson, Hakan K. R.; Zierath, Juleen R.] Karolinska Inst, Dept Mol Med & Surg, S-17177 Stockholm, Sweden	Dartmouth College; Harvard University; Karolinska Institutet	Lienhard, GE (corresponding author), Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA.	gustav.e.lienhard@dartmouth.edu	Budnik, Bogdan/AGG-8824-2022; Budnik, Bogdan/AAH-9987-2019; Peck, Grantley/H-2318-2013	Budnik, Bogdan/0000-0003-3622-2003; Zierath, Juleen/0000-0001-6891-7497; Karlsson, Hakan/0000-0003-0818-5460	National Institutes of Health [DK25336, DK42816]; European Research Council; Swedish Research Council; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK042816, R01DK042816, R56DK025336, R01DK025336, R55DK025336] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council(European Research Council (ERC)European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK25336 and DK42816 (to G. E. L.). This work was also supported by grants from the European Research Council and the Swedish Research Council (to J. R. Z.).	Ariga M, 2008, J BIOL CHEM, V283, P10208, DOI 10.1074/jbc.M710604200; Chadt A, 2008, NAT GENET, V40, P1354, DOI 10.1038/ng.244; Chavez JA, 2003, J BIOL CHEM, V278, P10297, DOI 10.1074/jbc.M212307200; Chavez JA, 2008, J BIOL CHEM, V283, P9187, DOI 10.1074/jbc.M708934200; Chen SA, 2008, BIOCHEM J, V409, P449, DOI 10.1042/BJ20071114; FROST SC, 1985, J BIOL CHEM, V260, P2646; Fujii N, 2006, AM J PHYSIOL-ENDOC M, V291, pE867, DOI 10.1152/ajpendo.00207.2006; Funai K, 2009, DIABETES, V58, P1096, DOI 10.2337/db08-1477; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Karlsson HKR, 2009, DIABETES, V58, P847, DOI 10.2337/db08-1539; Lyons PD, 2009, BIOSCIENCE REP, V29, P229, DOI 10.1042/BSR20080162; Meyre D, 2008, HUM MOL GENET, V17, P1798, DOI 10.1093/hmg/ddn070; Miinea CP, 2005, BIOCHEM J, V391, P87, DOI 10.1042/BJ20050887; Nickerson JG, 2007, APPL PHYSIOL NUTR ME, V32, P865, DOI 10.1139/H07-084; Obata T, 2000, J BIOL CHEM, V275, P36108, DOI 10.1074/jbc.M005497200; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Roach WG, 2007, BIOCHEM J, V403, P353, DOI 10.1042/BJ20061798; Ryder JW, 2000, DIABETES, V49, P647, DOI 10.2337/diabetes.49.4.647; Sakamoto K, 2008, AM J PHYSIOL-ENDOC M, V295, pE29, DOI 10.1152/ajpendo.90331.2008; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Stone S, 2006, HUM MOL GENET, V15, P2709, DOI 10.1093/hmg/ddl204; TANNER LI, 1987, J BIOL CHEM, V262, P8975; Taylor EB, 2008, J BIOL CHEM, V283, P9787, DOI 10.1074/jbc.M708839200; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Zaid H, 2008, BIOCHEM J, V413, P201, DOI 10.1042/BJ20080723; Zeigerer A, 2004, MOL BIOL CELL, V15, P4406, DOI 10.1091/mbc.e04-04-0333	26	67	70	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30016	30023		10.1074/jbc.M109.035568	http://dx.doi.org/10.1074/jbc.M109.035568			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19740738	hybrid, Green Published			2022-12-27	WOS:000271090000003
J	Zhao, Q; Wang, QE; Ray, A; Wani, G; Han, CH; Milum, K; Wani, AA				Zhao, Qun; Wang, Qi-En; Ray, Alo; Wani, Gulzar; Han, Chunhua; Milum, Keisha; Wani, Altaf A.			Modulation of Nucleotide Excision Repair by Mammalian SWI/SNF Chromatin-remodeling Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; DNA-BINDING-PROTEIN; GROUP-C PROTEIN; DAMAGED-DNA; HUMAN-CELLS; PYRIMIDINE DIMERS; HUMAN-FIBROBLASTS; UV-IRRADIATION; XPC; RECRUITMENT	Accessibility within chromatin is an important factor in the prompt removal of UV-induced DNA damage by nucleotide excision repair (NER). Chromatin remodeling by the SWI/SNF complex has been shown to play an important modulating role in NER in vitro and yeast in vivo. Nevertheless, the molecular basis of cross-talk between SWI/SNF and NER in mammalian cells is not fully understood. Here, we show that knockdown of Brg1, the ATPase subunit of SWI/SNF, negatively affects the elimination of cyclobutane pyrimidine dimers (CPD), but not of pyrimidine (6, 4) pyrimidone photoproducts (6-4PP) following UV irradiation of mammalian cells. Brg1-deficient cells exhibit a lower chromatin relaxation as well as impaired recruitment of downstream NER factors, XPG and PCNA, to UV lesions. However, the assembly of upstream NER factors, DDB2 and XPC, at the damage site was unaffected by Brg1 knockdown. Interestingly, Brg1 interacts with XPC within chromatin and is recruited to UV-damaged sites in a DDB2- and XPC-dependent manner. Also, postirradiation decrease of XPC levels occurred more rapidly in Brg1-deficient than normal cells. Conversely, XPC transcription remained unaltered upon Brg1 knockdown indicating that Brg1 affects the stability of XPC protein following irradiation. Thus, Brg1 facilitates different stages of NER by initially modulating UV-induced chromatin relaxation and stabilizing XPC at the damage sites, and subsequently stimulating the recruitment of XPG and PCNA to successfully culminate the repair.	[Zhao, Qun; Wang, Qi-En; Ray, Alo; Wani, Gulzar; Han, Chunhua; Milum, Keisha; Wani, Altaf A.] Ohio State Univ, Dept Radiol, Columbus, OH 43210 USA; [Wani, Altaf A.] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Wani, Altaf A.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Wang, QE (corresponding author), Ohio State Univ, Dept Radiol, Columbus, OH 43210 USA.	wang.771@osu.edu; wani.2@osu.edu			National Institutes of Health [ES2388, ES12991, CA93413]; NATIONAL CANCER INSTITUTE [R01CA093413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012991, R01ES002388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by Public Health Service National Institutes of Health Grants ES2388, ES12991, and CA93413 (to A. A. W.).	ABOUSSEKHRA A, 1995, EXP CELL RES, V221, P326, DOI 10.1006/excr.1995.1382; Bao YH, 2007, CURR OPIN GENET DEV, V17, P126, DOI 10.1016/j.gde.2007.02.010; Baxter BK, 1998, J BIOL CHEM, V273, P17517, DOI 10.1074/jbc.273.28.17517; Chai B, 2005, GENE DEV, V19, P1656, DOI 10.1101/gad.1273105; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; Dinant C, 2008, EPIGENET CHROMATIN, V1, DOI 10.1186/1756-8935-1-9; Downs JA, 2004, MOL CELL, V16, P979, DOI 10.1016/j.molcel.2004.12.003; Fitch ME, 2003, J BIOL CHEM, V278, P46906, DOI 10.1074/jbc.M307254200; Gong F, 2008, CELL CYCLE, V7, P1067, DOI 10.4161/cc.7.8.5647; Gong F, 2006, NAT STRUCT MOL BIOL, V13, P902, DOI 10.1038/nsmb1152; Green CM, 2002, EMBO REP, V3, P28, DOI 10.1093/embo-reports/kvf005; Hanawalt PC, 2002, ONCOGENE, V21, P8949, DOI 10.1038/sj.onc.1206096; Hara R, 2003, MOL CELL BIOL, V23, P4121, DOI 10.1128/MCB.23.12.4121-4125.2003; Hara R, 2002, MOL CELL BIOL, V22, P6779, DOI 10.1128/MCB.22.19.6779-6787.2002; Hara R, 2000, MOL CELL BIOL, V20, P9173, DOI 10.1128/MCB.20.24.9173-9181.2000; Hwang BJ, 1998, MOL CELL BIOL, V18, P4391, DOI 10.1128/MCB.18.7.4391; Li JY, 2006, CANCER RES, V66, P8590, DOI 10.1158/0008-5472.CAN-06-1115; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Mocquet V, 2008, EMBO J, V27, P155, DOI 10.1038/sj.emboj.7601948; Morrison AJ, 2004, CELL, V119, P767, DOI 10.1016/j.cell.2004.11.037; Moser J, 2005, DNA REPAIR, V4, P571, DOI 10.1016/j.dnarep.2005.01.001; Nakanishi S, 2007, NUCLEIC ACIDS RES, V35, P4313, DOI 10.1093/nar/gkm436; Park JH, 2006, EMBO J, V25, P3986, DOI 10.1038/sj.emboj.7601291; RAMANATHAN B, 1989, J BIOL CHEM, V264, P11026; RAMANATHAN B, 1986, CARCINOGENESIS, V7, P1087, DOI 10.1093/carcin/7.7.1087; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Riedl T, 2003, EMBO J, V22, P5293, DOI 10.1093/emboj/cdg489; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; SMERDON MJ, 1990, CELL, V61, P675, DOI 10.1016/0092-8674(90)90479-X; SMERDON MJ, 1982, J BIOL CHEM, V257, P13441; Staresincic L, 2009, EMBO J, V28, P1111, DOI 10.1038/emboj.2009.49; Sugasawa K, 1998, MOL CELL, V2, P223, DOI 10.1016/S1097-2765(00)80132-X; Sugasawa K, 2006, J MOL HISTOL, V37, P189, DOI 10.1007/s10735-006-9044-7; Tang JY, 2000, MOL CELL, V5, P737, DOI 10.1016/S1097-2765(00)80252-X; Ura K, 2001, EMBO J, V20, P2004, DOI 10.1093/emboj/20.8.2004; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; VENKATACHALAM S, 1995, CARCINOGENESIS, V16, P2029, DOI 10.1093/carcin/16.9.2029; Wang QE, 2005, NUCLEIC ACIDS RES, V33, P4023, DOI 10.1093/nar/gki684; Wang QE, 2004, CARCINOGENESIS, V25, P1033, DOI 10.1093/carcin/bgh085; Wang QE, 2003, DNA REPAIR, V2, P483, DOI 10.1016/S1568-7864(03)00002-8; Wang QE, 2007, NUCLEIC ACIDS RES, V35, P5338, DOI 10.1093/nar/gkm550; WANG ZG, 1991, J BIOL CHEM, V266, P22472; WANI AA, 1987, PHOTOCHEM PHOTOBIOL, V46, P477, DOI 10.1111/j.1751-1097.1987.tb04798.x; Wellinger RE, 1997, EMBO J, V16, P5046, DOI 10.1093/emboj/16.16.5046; Zhang L, 2009, BIOCHEM CELL BIOL, V87, P265, DOI 10.1139/O08-101; Zhao Q, 2008, J BIOL CHEM, V283, P32553, DOI 10.1074/jbc.M803963200	46	76	77	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30424	30432		10.1074/jbc.M109.044982	http://dx.doi.org/10.1074/jbc.M109.044982			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19740755	Green Published, hybrid			2022-12-27	WOS:000271090000045
J	Molloy, SA; Kaplan, JH				Molloy, Shannon A.; Kaplan, Jack H.			Copper-dependent Recycling of hCTR1, the Human High Affinity Copper Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; BIOCHEMICAL-CHARACTERIZATION; STIMULATED ENDOCYTOSIS; MUTATIONAL ANALYSIS; HUMAN CTR1; YEAST; GENE; COMPLEMENTATION; TRAFFICKING; MECHANISMS	Copper is an essential co-factor in many important physiological processes, but at elevated levels it is toxic to cells. Thus at both the organism and cellular level mechanisms have evolved to finely tune copper homeostasis. The protein responsible for copper entry from the circulation in most human cells is hCTR1, a small protein (190 amino acid residues) that functions as a trimer in the plasma membrane. In the present work we employ cell surface biotinylation and isotopic copper uptake studies of overexpressed hCTR1 in HEK293 cells to examine the acute (minutes) response of hCTR1 to changes in extracellular copper. We show that within 10 min of exposure to copper at 2.5 mu M or higher, plasma membrane hCTR1 levels are reduced (by similar to 40%), with a concomitant reduction in copper uptake rates. We are unable to detect any degradation of internalized hCTR1 in the presence of cycloheximide after up to 2 h of exposure to 0-100 mu M copper. Using a reversible biotinylation assay, we quantified internalized hCTR1, which increased upon the addition of copper and corresponded to the hCTR1 lost from the surface. In addition, when extracellular copper is then removed, internalized hCTR1 is promptly (within 30 min) recycled to the plasma membrane. We have shown that in the absence of added extracellular copper, there is a small but detectable amount of internalized hCTR1 that is increased in the presence of copper. Similar studies on endogenous hCTR1 show a cell-specific response to elevated extracellular copper. Copper-dependent internalization and recycling of hCTR1 provides an acute and reversible mechanism for the regulation of cellular copper entry.	[Molloy, Shannon A.; Kaplan, Jack H.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Kaplan, JH (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, 900 S Ashland Ave, Chicago, IL 60607 USA.	kaplanj@uic.edu		Kaplan, Jack/0000-0002-7048-6574	National Institutes of Health [PO1 GM 067166]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM067166] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant PO1 GM 067166, Project 1 (to J. H. K.).	Aller SG, 2006, P NATL ACAD SCI USA, V103, P3627, DOI 10.1073/pnas.0509929103; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DANCIS A, 1994, J BIOL CHEM, V269, P25660; De Feo CJ, 2009, P NATL ACAD SCI USA, V106, P4237, DOI 10.1073/pnas.0810286106; Dumay QC, 2006, J MOL MICROB BIOTECH, V11, P10, DOI 10.1159/000092815; Eisses JF, 2005, J BIOL CHEM, V280, P37159, DOI 10.1074/jbc.M508822200; Eisses JF, 2005, J BIOL CHEM, V280, P9635, DOI 10.1074/jbc.M500116200; Eisses JF, 2002, J BIOL CHEM, V277, P29162, DOI 10.1074/jbc.M203652200; Ford ES, 2000, AM J EPIDEMIOL, V151, P1182, DOI 10.1093/oxfordjournals.aje.a010168; Garza LA, 2000, J BIOL CHEM, V275, P2560, DOI 10.1074/jbc.275.4.2560; GOTTARDI CJ, 1995, AM J PHYSIOL-RENAL, V268, pF285, DOI 10.1152/ajprenal.1995.268.2.F285; Guo Y, 2004, J BIOL CHEM, V279, P17428, DOI 10.1074/jbc.M401493200; Harris ED, 2000, ANNU REV NUTR, V20, P291, DOI 10.1146/annurev.nutr.20.1.291; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Klomp AEM, 2003, BIOCHEM J, V370, P881, DOI 10.1042/BJ20021128; Klomp AEM, 2002, BIOCHEM J, V364, P497, DOI 10.1042/BJ20011803; Knight SAB, 1996, GENE DEV, V10, P1917, DOI 10.1101/gad.10.15.1917; Kuo YM, 2001, P NATL ACAD SCI USA, V98, P6836, DOI 10.1073/pnas.111057298; Laughery MD, 2003, J BIOL CHEM, V278, P34794, DOI 10.1074/jbc.M302899200; Lee J, 2002, J BIOL CHEM, V277, P4380, DOI 10.1074/jbc.M104728200; Lee J, 2000, GENE, V254, P87, DOI 10.1016/S0378-1119(00)00287-0; Linder Maria C., 1996, American Journal of Clinical Nutrition, V63, p797S; Linder MC, 1998, AM J CLIN NUTR, V67, p965S, DOI 10.1093/ajcn/67.5.965S; Lutsenko S, 2003, J MEMBRANE BIOL, V191, P1, DOI 10.1007/s00232-002-1040-6; Maryon EB, 2007, BIOMETALS, V20, P355, DOI 10.1007/s10534-006-9066-3; Maryon EB, 2007, J BIOL CHEM, V282, P20376, DOI 10.1074/jbc.M701806200; Pase L, 2004, BIOCHEM J, V378, P1031, DOI 10.1042/BJ20031181; Petris MJ, 2003, J BIOL CHEM, V278, P9639, DOI 10.1074/jbc.M209455200; Puig S, 2002, CURR OPIN CHEM BIOL, V6, P171, DOI 10.1016/S1367-5931(02)00298-3; Puig S, 2002, J BIOL CHEM, V277, P26021, DOI 10.1074/jbc.M202547200; Zhou B, 1997, P NATL ACAD SCI USA, V94, P7481, DOI 10.1073/pnas.94.14.7481; Zimnicka AM, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702653200	32	73	76	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29704	29713		10.1074/jbc.M109.000166	http://dx.doi.org/10.1074/jbc.M109.000166			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19740744	hybrid, Green Published			2022-12-27	WOS:000270896800052
J	Acharya, M; Lingenfelter, DJ; Huang, LJ; Gage, PJ; Walter, MA				Acharya, Moulinath; Lingenfelter, David J.; Huang, LiJia; Gage, Philip J.; Walter, Michael A.			Human PRKC Apoptosis WT1 Regulator Is a Novel PITX2-interacting Protein That Regulates PITX2 Transcriptional Activity in Ocular Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AXENFELD-RIEGER MALFORMATIONS; AMYLOID-BETA; FACTOR GENE; PAR-4; MUTATIONS; FOXC1; HINDLIMB; ISOFORMS; CLONING; KINASE	Mutations in the homeobox transcription factor PITX2 result in Axenfeld-Rieger syndrome (ARS), which is associated with anterior segment dysgenesis and an increased risk of glaucoma. To understand the pathogenesis of the defects resulting from PITX2 mutations, it is essential to know the normal functions of PITX2 and its interaction with the network of proteins in the eye. Yeast two-hybrid screening was performed using a cDNA library from a human trabecular meshwork primary cell line to detect novel PITX2-interacting proteins and study their role in ARS pathogenesis. After screening of similar to 1 x 10(6) clones, one putative interacting protein was identified named PRKC apoptosis WT1 regulator (PAWR). This interaction was further confirmed by retransformation assay in yeast cells as well as co-immunoprecipitation in ocular cells and nickel pulldown assay in vitro. PAWR is reportedly a proapoptotic protein capable of selectively inducing apoptosis primarily in cancer cells. Our analysis indicates that the homeodomain and the adjacent inhibitory domain in PITX2 interact with the C-terminal leucine zipper domain of PAWR. Endogenous PAWR and PITX2 were found to be located in the nucleus of ocular cells and to co-localize in the mesenchyme of the iridocorneal angle of the developing mouse eye, consistent with a role in the development of the anterior segment of the eye. PAWR was also found to inhibit PITX2 transcriptional activity in ocular cells. These data suggest PAWR is a novel PITX2-interacting protein that regulates PITX2 activity in ocular cells. This information sheds new light in understanding ARS and associated glaucoma pathogenesis.	[Acharya, Moulinath; Huang, LiJia; Walter, Michael A.] Univ Alberta, Dept Med Genet, Edmonton, AB T6G 2H7, Canada; [Walter, Michael A.] Univ Alberta, Dept Ophthalmol, Edmonton, AB T6G 2H7, Canada; [Lingenfelter, David J.; Gage, Philip J.] Univ Michigan, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA	University of Alberta; University of Alberta; University of Michigan System; University of Michigan	Walter, MA (corresponding author), Univ Alberta, Dept Med Genet, 8-32 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	mwalter@ualberta.ca		Acharya, Moulinath/0000-0001-8013-7426; Gage, Philip/0000-0001-5536-6702	Canadian Institute of Health Research [CIHRMOP77782]; National Institutes of Health [EY014126, EY007003]; NATIONAL EYE INSTITUTE [P30EY007003, R01EY014126, F31EY007003] Funding Source: NIH RePORTER	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by Operating Grant CIHRMOP77782 from the Canadian Institute of Health Research (to M. A. W.). This work was also supported by National Institutes of Health Grants EY014126 and EY007003 from the NEI (to P. J. G.).	ACHARYA M, 2010, ENCY EYE IN PRESS; Alward WLM, 1998, AM J OPHTHALMOL, V125, P98, DOI 10.1016/S0002-9394(99)80242-6; Amendt BA, 1999, MOL CELL BIOL, V19, P7001; Arakawa H, 1998, P NATL ACAD SCI USA, V95, P4573, DOI 10.1073/pnas.95.8.4573; Axenfeld TH, 1920, KLIN MONATSBL AUGENH, V65, P381; Berry FB, 2006, HUM MOL GENET, V15, P905, DOI 10.1093/hmg/ddl008; Cox CJ, 2002, J BIOL CHEM, V277, P25001, DOI 10.1074/jbc.M201737200; Cunningham ET, 1998, ARCH OPHTHALMOL-CHIC, V116, P78, DOI 10.1001/archopht.116.1.78; DiazMeco MT, 1996, CELL, V86, P777, DOI 10.1016/S0092-8674(00)80152-X; Doward W, 1999, J MED GENET, V36, P152; El-Guendy N, 2003, EXP CELL RES, V283, P51, DOI 10.1016/S0014-4827(02)00016-2; Footz T, 2009, INVEST OPHTH VIS SCI, V50, P2599, DOI 10.1167/iovs.08-3251; Gage PJ, 1999, DEVELOPMENT, V126, P4643; Gage PJ, 1997, HUM MOL GENET, V6, P457, DOI 10.1093/hmg/6.3.457; Guo L, 2007, P NATL ACAD SCI USA, V104, P13444, DOI 10.1073/pnas.0703707104; Guo Q, 2004, J BIOL CHEM, V279, P4596, DOI 10.1074/jbc.M309811200; Hjalt TA, 2000, DEV DYNAM, V218, P195, DOI 10.1002/(SICI)1097-0177(200005)218:1<195::AID-DVDY17>3.0.CO;2-C; Hjalt Tord A., 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405010082; Huang LJ, 2008, INVEST OPHTH VIS SCI, V49, P5243, DOI 10.1167/iovs.07-1625; Johnstone RW, 1998, GENOMICS, V53, P241, DOI 10.1006/geno.1998.5494; Johnstone RW, 1996, MOL CELL BIOL, V16, P6945; Kogel D, 1998, ONCOGENE, V17, P2645, DOI 10.1038/sj.onc.1202204; Kozlowski K, 2000, HUM MOL GENET, V9, P2131, DOI 10.1093/hmg/9.14.2131; Kulak SC, 1998, HUM MOL GENET, V7, P1113, DOI 10.1093/hmg/7.7.1113; Lines MA, 2004, INVEST OPHTH VIS SCI, V45, P828, DOI 10.1167/iovs.03-0309; Lines MA, 2002, HUM MOL GENET, V11, P1177, DOI 10.1093/hmg/11.10.1177; Marcil A, 2003, DEVELOPMENT, V130, P45, DOI 10.1242/dev.00192; Mears AJ, 1998, AM J HUM GENET, V63, P1316, DOI 10.1086/302109; Nishimura DY, 1998, NAT GENET, V19, P140, DOI 10.1038/493; Ranganathan P, 2005, ANN NY ACAD SCI, V1059, P76, DOI 10.1196/annals.1339.046; RIEGER H, 1935, GRAEFE ARCH OPHTHALM, V133, P602; Roussigne M, 2003, ONCOGENE, V22, P2432, DOI 10.1038/sj.onc.1206271; Saleem RA, 2001, AM J HUM GENET, V68, P627, DOI 10.1086/318792; SELLS SF, 1994, CELL GROWTH DIFFER, V5, P457; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; Shields M B, 1983, Trans Am Ophthalmol Soc, V81, P736; Smidt MP, 2004, DEVELOPMENT, V131, P1145, DOI 10.1242/dev.01022; Szeto DP, 1999, GENE DEV, V13, P484, DOI 10.1101/gad.13.4.484; Xie J, 2005, J BIOL CHEM, V280, P13824, DOI 10.1074/jbc.M411933200	39	19	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34829	34838		10.1074/jbc.M109.006684	http://dx.doi.org/10.1074/jbc.M109.006684			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19801652	Green Published, hybrid			2022-12-27	WOS:000272439600038
J	Cameron, PH; Chevet, E; Pluquet, O; Thomas, DY; Bergeron, JJM				Cameron, Pamela H.; Chevet, Eric; Pluquet, Olivier; Thomas, David Y.; Bergeron, John J. M.			Calnexin Phosphorylation Attenuates the Release of Partially Misfolded alpha 1-Antitrypsin to the Secretory Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; IN-VIVO; GLYCOPROTEIN; ALPHA(1)-ANTITRYPSIN; SIGNAL; PHOSPHOPROTEOME; ASSOCIATION; CELLS	Calnexin is a type I integral membrane phosphoprotein resident of the endoplasmic reticulum. Its intraluminal domain has been deduced to function as a lectin chaperone coordinating the timing of folding of newly synthesized N-linked glycoproteins of the secretory pathway. Its C-terminal cytosolic oriented extension has an ERK1 phosphorylation site at Ser(563) affecting calnexin association with the translocon. Here we find an additional function for calnexin phosphorylation at Ser563 in endoplasmic reticulum quality control. A low dose of the mis-folding agent L-azetidine 2-carboxylic acid slows glycoprotein maturation and diminishes the extent and rate of secretion of newly synthesized secretory alpha 1-antitrypsin. Under these conditions the phosphorylation of calnexin is enhanced at Ser563. Inhibition of this phosphorylation by the MEK1 inhibitor PD98059 enhanced the extent and rate of alpha 1-antitrypsin secretion comparable with that achieved by inhibiting alpha-mannosidase activity with kifunensine. This is the first report in which the phosphorylation of calnexin is linked to the efficiency of secretion of a cargo glycoprotein.	[Cameron, Pamela H.; Thomas, David Y.; Bergeron, John J. M.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada; [Thomas, David Y.] McGill Univ, Dept Biochem, Montreal, PQ H3A 2B2, Canada; [Chevet, Eric; Pluquet, Olivier] Univ Bordeaux 2, INSERM, U889, F-33076 Bordeaux, France	McGill University; McGill University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Bergeron, JJM (corresponding author), McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada.	john.bergeron@mcgill.ca	Bergeron, John/AAW-1893-2021; chevet, eric/E-4992-2016; Thomas, David/M-7661-2017	chevet, eric/0000-0001-5855-4522; Thomas, David/0000-0002-8854-762X	Canadian Institutes of Health Research; Avenir Program	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Avenir Program	This work was supported by grants from the Canadian Institutes of Health Research ( to D.Y.T. and J. J. M. B.) and from the Avenir Program ( to E. C.).	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cabral CM, 2002, MOL BIOL CELL, V13, P2639, DOI 10.1091/mbc.E02-02-0068; Cabral CM, 2001, TRENDS BIOCHEM SCI, V26, P619, DOI 10.1016/S0968-0004(01)01942-9; Caramelo JJ, 2008, J BIOL CHEM, V283, P10221, DOI 10.1074/jbc.R700048200; Chevet E, 1999, EMBO J, V18, P3655, DOI 10.1093/emboj/18.13.3655; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Clerc S, 2009, J CELL BIOL, V184, P159, DOI 10.1083/jcb.200809198; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hosokawa N, 2003, J BIOL CHEM, V278, P26287, DOI 10.1074/jbc.M303395200; Kim JE, 2005, J PROTEOME RES, V4, P1339, DOI 10.1021/pr050048h; Lederkremer GZ, 2009, CURR OPIN STRUC BIOL, V19, P515, DOI 10.1016/j.sbi.2009.06.004; Liu Y, 1999, J BIOL CHEM, V274, P5861, DOI 10.1074/jbc.274.9.5861; Liu Y, 1997, J BIOL CHEM, V272, P7946, DOI 10.1074/jbc.272.12.7946; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Molinari M, 2003, SCIENCE, V299, P1397, DOI 10.1126/science.1079474; Nguyen DT, 2004, MOL BIOL CELL, V15, P4248, DOI 10.1091/mbc.E03-11-0851; Nyfeler B, 2008, J CELL BIOL, V180, P705, DOI 10.1083/jcb.200709100; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; Olivari S, 2006, BIOCHEM BIOPH RES CO, V349, P1278, DOI 10.1016/j.bbrc.2006.08.186; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; OU WJ, 1995, J BIOL CHEM, V270, P18051, DOI 10.1074/jbc.270.30.18051; OU WJ, 1993, NATURE, V364, P771, DOI 10.1038/364771a0; Quan EM, 2008, MOL CELL, V32, P870, DOI 10.1016/j.molcel.2008.11.017; Ruddock LW, 2006, J CELL SCI, V119, P4373, DOI 10.1242/jcs.03225; Schrag JD, 2003, TRENDS BIOCHEM SCI, V28, P49, DOI 10.1016/S0968-0004(02)00004-X; Sekijima Y, 2005, CELL, V121, P73, DOI 10.1016/j.cell.2005.01.018; Trombetta ES, 1998, CURR OPIN STRUC BIOL, V8, P587, DOI 10.1016/S0959-440X(98)80148-6; Wong HN, 1998, J BIOL CHEM, V273, P17227, DOI 10.1074/jbc.273.27.17227; Yang F, 2006, J PROTEOME RES, V5, P1252, DOI 10.1021/pr060028v	29	32	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34570	34579		10.1074/jbc.M109.053165	http://dx.doi.org/10.1074/jbc.M109.053165			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19815548	Green Published, hybrid			2022-12-27	WOS:000272439600012
J	Doyle, PJ; Saeed, H; Hermans, A; Gleddie, SC; Hussack, G; Arbabi-Ghahroudi, M; Seguin, C; Savard, ME; MacKenzie, CR; Hall, JC				Doyle, Patrick J.; Saeed, Hanaa; Hermans, Anne; Gleddie, Steve C.; Hussack, Greg; Arbabi-Ghahroudi, Mehdi; Seguin, Charles; Savard, Marc E.; MacKenzie, C. Roger; Hall, J. Christopher			Intracellular Expression of a Single Domain Antibody Reduces Cytotoxicity of 15-Acetyldeoxynivalenol in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUSARIUM-GRAMINEARUM; MYCOTOXIN DEOXYNIVALENOL; TRICHOTHECENE MYCOTOXINS; ARABIDOPSIS-THALIANA; RESISTANCE; GROWTH; GENE; TOXIN; CELLS; WHEAT	15-Acetyldeoxynivalenol (15-AcDON) is a low molecular weight sesquiterpenoid trichothecene mycotoxin associated with Fusarium ear rot of maize and Fusarium head blight of small grain cereals. The accumulation of mycotoxins such as deoxynivalenol (DON) and 15-AcDON within harvested grain is subject to stringent regulation as both toxins pose dietary health risks to humans and animals. These toxins inhibit peptidyltransferase activity, which in turn limits eukaryotic protein synthesis. To assess the ability of intracellular antibodies (intrabodies) to modulate mycotoxin-specific cytotoxocity, a gene encoding a camelid single domain antibody fragment (VHH) with specificity and affinity for 15-AcDON was expressed in the methylotropic yeast Pichia pastoris. Cytotoxicity and VHH immunomodulation were assessed by continuous measurement of cellular growth. At equivalent doses, 15-AcDON was significantly more toxic to wild-type P. pastoris than was DON. In turn, DON was orders of magnitude more toxic than 3-acetyldeoxynivalenol. Intracellular expression of a mycotoxin-specific VHH within P. pastoris conveyed significant (p = 0.01) resistance to 15-AcDON cytotoxicity at doses ranging from 20 to 100 mu g.ml(-1). We also documented a biochemical transformation of DON to 15-AcDON to account for the attenuation of DON cytotoxicity at 100 and 200 mu g.ml(-1). The proof of concept established within this eukaryotic system suggests that in planta VHH expression may lead to enhanced tolerance to mycotoxins and thereby limit Fusarium infection of commercial agricultural crops.	[Doyle, Patrick J.; Hall, J. Christopher] Univ Guelph, Dept Environm Biol, Guelph, ON N1G 2W1, Canada; [Saeed, Hanaa; Hermans, Anne; Gleddie, Steve C.; Seguin, Charles; Savard, Marc E.] Agr & Agri Food Canada, Eastern Cereal & Oilseed Res Ctr, Ottawa, ON K1A 0C6, Canada; [Hussack, Greg; Arbabi-Ghahroudi, Mehdi; MacKenzie, C. Roger] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada	University of Guelph; Agriculture & Agri Food Canada; National Research Council Canada	Hall, JC (corresponding author), Univ Guelph, Dept Environm Biol, Guelph, ON N1G 2W1, Canada.	jchall@uoguelph.ca			Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs Program; Ontario Ministry of Agriculture, Food, and Rural Affairs	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs Program(Canada Research Chairs); Ontario Ministry of Agriculture, Food, and Rural Affairs	This work was supported by grants from the Natural Sciences and Engineering Research Council of Canada, the Canada Research Chairs Program, and the Ontario Ministry of Agriculture, Food, and Rural Affairs (to J.C.H.).	Abolinaal S, 2008, J MICROBIOL METH, V72, P306, DOI 10.1016/j.mimet.2007.12.013; Alexander NJ, 2008, WORLD MYCOTOXIN J, V1, P31, DOI 10.3920/WMJ2008.x004; Alexander NJ, 1999, MOL GEN GENET, V261, P977, DOI 10.1007/s004380051046; Almquist KC, 2004, PLANT BIOTECHNOL J, V2, P189, DOI 10.1111/j.1467-7652.2004.00060.x; BETINA V, 1989, CHEM-BIOL INTERACT, V71, P105, DOI 10.1016/0009-2797(89)90030-6; Binder J, 1999, NAT TOXINS, V7, P401, DOI 10.1002/1522-7189(199911/12)7:6<401::AID-NT77>3.0.CO;2-A; Binder J, 1997, CEREAL RES COMMUN, V25, P343; Biswas SK, 2003, J ELECTRON MICROSC, V52, P133, DOI 10.1093/jmicro/52.2.133; Cereghino JL, 2000, FEMS MICROBIOL REV, V24, P45, DOI 10.1111/j.1574-6976.2000.tb00532.x; CHRISTOPHER J, 1977, BIOCHEM J, V166, P399; Copeland RA, 2006, NAT REV DRUG DISCOV, V5, P730, DOI 10.1038/nrd2082; D'Mello JPF, 1999, ANIM FEED SCI TECH, V80, P183, DOI 10.1016/S0377-8401(99)00059-0; Del Ponte EM, 2007, J PHYTOPATHOL, V155, P577, DOI 10.1111/j.1439-0434.2007.01281.x; Desjardins, 2006, FUSARIUM MYCOTOXINS, P13; Desjardins AE, 2007, J AGR FOOD CHEM, V55, P6487, DOI 10.1021/jf0709193; Doyle PJ, 2008, MOL IMMUNOL, V45, P3703, DOI 10.1016/j.molimm.2008.06.005; EHRLICH KC, 1987, BIOCHIM BIOPHYS ACTA, V923, P206, DOI 10.1016/0304-4165(87)90005-5; Ellgaard L, 2004, BIOCHEM SOC T, V32, P663, DOI 10.1042/BST0320663; Goswami RS, 2004, MOL PLANT PATHOL, V5, P515, DOI 10.1111/J.1364-3703.2004.00252.X; Gurkan C, 2004, BIOTECHNOL APPL BIOC, V39, P115, DOI 10.1042/BA20030096; Harris LJ, 1999, PLANT DIS, V83, P954, DOI 10.1094/PDIS.1999.83.10.954; Harris LJ, 2001, PHYSIOL MOL PLANT P, V58, P173, DOI 10.1006/pmpp.2001.0326; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Jobling SA, 2003, NAT BIOTECHNOL, V21, P77, DOI 10.1038/nbt772; Johnson DD, 2003, FUSARIUM HEAD BLIGHT OF WHEAT & BARLEY, P461; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Kimura M, 1998, J BIOL CHEM, V273, P1654, DOI 10.1074/jbc.273.3.1654; Kimura M, 2006, PESTIC BIOCHEM PHYS, V86, P117, DOI 10.1016/j.pestbp.2006.02.008; Maynard J, 2000, ANNU REV BIOMED ENG, V2, P339, DOI 10.1146/annurev.bioeng.2.1.339; McCormick SP, 1996, APPL ENVIRON MICROB, V62, P353, DOI 10.1128/AEM.62.2.353-359.1996; Mesterhazy A, 2002, EUR J PLANT PATHOL, V108, P675, DOI 10.1023/A:1020631114063; Mitterbauer R, 2004, PLANT BIOTECHNOL J, V2, P329, DOI 10.1111/j.1467-7652.2004.00075.x; Mitterbauer R, 2002, EUR J PLANT PATHOL, V108, P699, DOI 10.1023/A:1020666627267; Moss MO, 2004, TOXICOL LETT, V153, P23, DOI 10.1016/j.toxlet.2004.04.021; Mudge AM, 2006, PHYSIOL MOL PLANT P, V69, P73, DOI 10.1016/j.pmpp.2007.01.003; Omidfar K, 2007, BIOTECHNOL APPL BIOC, V46, P41, DOI 10.1042/BA20060104; Pestka JJ, 2008, FOOD ADDIT CONTAM A, V25, P1128, DOI 10.1080/02652030802056626; Poppenberger B, 2003, J BIOL CHEM, V278, P47905, DOI 10.1074/jbc.M307552200; Rahbarizadeh F, 2006, MOL IMMUNOL, V43, P426, DOI 10.1016/j.molimm.2005.03.003; Rocha O, 2005, FOOD ADDIT CONTAM A, V22, P369, DOI 10.1080/02652030500058403; Rotter BA, 1996, J TOXICOL ENV HEALTH, V48, P1, DOI 10.1080/009841096161447; Saerens D, 2008, CURR OPIN PHARMACOL, V8, P600, DOI 10.1016/j.coph.2008.07.006; SCHWADORF K, 1991, CHROMATOGRAPHIA, V32, P137, DOI 10.1007/BF02325016; SHERMAN F, 2000, METHOD ENZYMOL, V350, P3; Snijders CHA, 2004, TOXICOL LETT, V153, P37, DOI 10.1016/j.toxlet.2004.04.044; Tamaki H, 2005, GENES CELLS, V10, P193, DOI 10.1111/j.1365-2443.2005.00828.x; TYSON CB, 1979, J BACTERIOL, V138, P92, DOI 10.1128/JB.138.1.92-98.1979; UENO Y, 1984, FUND APPL TOXICOL, V4, pS124, DOI 10.1016/0272-0590(84)90144-1	48	14	17	4	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					35029	35039		10.1074/jbc.M109.045047	http://dx.doi.org/10.1074/jbc.M109.045047			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19783651	Green Published, hybrid			2022-12-27	WOS:000272439600057
J	Lin, JC; Tarn, WY				Lin, Jung-Chun; Tarn, Woan-Yuh			RNA-binding Motif Protein 4 Translocates to Cytoplasmic Granules and Suppresses Translation via Argonaute2 during Muscle Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; MICRORNAS; MODULATION; REGULATOR; PATHWAY; RBM4	The RNA-binding motif protein 4 (RBM4) plays multiple roles in mRNA metabolism, including translation control. RBM4 suppresses cap-dependent translation but activates internal ribosome entry site-mediated translation. Because of its high expression level in muscle and heart, we investigated the function of RBM4 in myoblast cells. Here, we demonstrate that RBM4 is phosphorylated and translocates to the cytoplasm in mouse C2C12 cells upon cell differentiation. Notably, RBM4 is transiently deposited into cytoplasmic granules containing microtubule assembly factors as well as poly(A)(+) RNAs. Moreover, RBM4 colocalizes with the components of micro-ribonucleoproteins, including the Argonaute2 (Ago2) protein, during muscle cell differentiation. RBM4 interacts directly with Ago2 and may recruit Ago2 to suppress translation of target mRNAs. Furthermore, RBM4 selectively associates with muscle cell-specific microRNAs and potentiates their translation repression activity by promoting micro-ribonucleoprotein association with target mRNAs. Altogether, our results suggest that RBM4 translocates to the cytoplasm and participates in translation suppression during muscle cell differentiation.	[Lin, Jung-Chun; Tarn, Woan-Yuh] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan	Academia Sinica - Taiwan	Tarn, WY (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan.	wtarn@ibms.sinica.edu.tw	Tarn, Woan-Yuh/N-8464-2018		National Science Council [NSC 96-2628-B001-013]	National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by National Science Council Grant NSC 96-2628-B001-013.	Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Bugnard E, 2005, CELL MOTIL CYTOSKEL, V60, P1, DOI 10.1002/cm.20042; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Hammell CM, 2008, RNA BIOL, V5, P123, DOI 10.4161/rna.5.3.6570; Hock J, 2007, EMBO REP, V8, P1052, DOI 10.1038/sj.embor.7401088; Iwasaki S, 2009, MOL CELL, V34, P58, DOI 10.1016/j.molcel.2009.02.010; JACKSON RJ, 2007, SCI STKE, V367, pRE1, DOI DOI 10.1126/STKE.3672007RE1; Kedde M, 2008, CELL CYCLE, V7, P899, DOI 10.4161/cc.7.7.5644; Keren A, 2006, MOL CELL ENDOCRINOL, V252, P224, DOI 10.1016/j.mce.2006.03.017; Kiriakidou M, 2007, CELL, V129, P1141, DOI 10.1016/j.cell.2007.05.016; Kotaja N, 2007, NAT REV MOL CELL BIO, V8, P85, DOI 10.1038/nrm2081; Lai MC, 2003, EMBO J, V22, P1359, DOI 10.1093/emboj/cdg126; Li C, 2003, MOL CELL BIOL, V23, P7363, DOI 10.1128/MCB.23.20.7363-7376.2003; Lin JC, 2005, MOL CELL BIOL, V25, P10111, DOI 10.1128/MCB.25.22.10111-10121.2005; Lin JC, 2007, P NATL ACAD SCI USA, V104, P2235, DOI 10.1073/pnas.0611015104; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Srsen V, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-28; TARN WY, 1995, P NATL ACAD SCI USA, V92, P2504, DOI 10.1073/pnas.92.7.2504; van Rooij E, 2008, TRENDS GENET, V24, P159, DOI 10.1016/j.tig.2008.01.007	21	29	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34658	34665		10.1074/jbc.M109.032946	http://dx.doi.org/10.1074/jbc.M109.032946			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19801630	Green Published, hybrid			2022-12-27	WOS:000272439600021
J	Herget, M; Kreissig, N; Kolbe, C; Scholz, C; Tampe, R; Abele, R				Herget, Meike; Kreissig, Nina; Kolbe, Christian; Schoelz, Christian; Tampe, Robert; Abele, Rupert			Purification and Reconstitution of the Antigen Transport Complex TAP A PREREQUISITE FOR DETERMINATION OF PEPTIDE STOICHIOMETRY AND ATP HYDROLYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; ABC TRANSPORTER; PROCESSING TAP; DISTINCT FUNCTIONS; BINDING; MECHANISM; PROTEINS; MACHINERY; TRANSLOCATION; TRANSMISSION	The transporter associated with antigen processing (TAP) is an essential machine of the adaptive immune system that translocates antigenic peptides from the cytosol into the endoplasmic reticulum lumen for loading of major histocompatibility class I molecules. To examine this ABC transport complex in mechanistic detail, we have established, after extensive screening and optimization, the solubilization, purification, and reconstitution for TAP to preserve its function in each step. This allowed us to determine the substrate-binding stoichiometry of the TAP complex by fluorescence cross-correlation spectroscopy. In addition, the TAP complex shows strict coupling between peptide binding and ATP hydrolysis, revealing no basal ATPase activity in the absence of peptides. These results represent an optimal starting point for detailed mechanistic studies of the transport cycle of TAP by single molecule experiments to analyze single steps of peptide translocation and the stoichiometry between peptide transport and ATP hydrolysis.	[Herget, Meike; Kreissig, Nina; Kolbe, Christian; Schoelz, Christian; Tampe, Robert; Abele, Rupert] Goethe Univ Frankfurt, Inst Biochem, Bioctr, D-60438 Frankfurt, Germany	Goethe University Frankfurt	Tampe, R (corresponding author), Goethe Univ Frankfurt, Inst Biochem, Bioctr, Max von Laue Str 9, D-60438 Frankfurt, Germany.	tampe@em.uni-frankfurt.de; abele@em.uni-frankfurt.de	Schölz, Christian/K-2855-2014; Tampé, Robert/H-2953-2015; Schölz, Christian/F-1261-2010	Schölz, Christian/0000-0002-1633-2072; Tampé, Robert/0000-0002-0403-2160; 	German Research Foundation [SFB 807, AB149/1-1]	German Research Foundation(German Research Foundation (DFG))	This work was supported by German Research Foundation Grant SFB 807 ( to R. T.) and Grant AB149/1-1 ( to R. A.).	ABACIOGLU YH, 1994, AIDS RES HUM RETROV, V10, P371, DOI 10.1089/aid.1994.10.371; Aisenbrey C, 2006, J BIOL CHEM, V281, P30365, DOI 10.1074/jbc.M603000200; Bamber L, 2006, P NATL ACAD SCI USA, V103, P16224, DOI 10.1073/pnas.0607640103; Cantor RS, 1997, J PHYS CHEM B, V101, P1723, DOI 10.1021/jp963911x; Chen M, 2003, J BIOL CHEM, V278, P29686, DOI 10.1074/jbc.M302757200; Chen M, 2004, J BIOL CHEM, V279, P46073, DOI 10.1074/jbc.M404042200; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Doeven MK, 2004, J BIOL CHEM, V279, P32301, DOI 10.1074/jbc.M404343200; Gorbulev S, 2001, P NATL ACAD SCI USA, V98, P3732, DOI 10.1073/pnas.061467898; Groothuis TAM, 2005, IMMUNOL REV, V207, P60, DOI 10.1111/j.0105-2896.2005.00305.x; HEEMELS MT, 1993, SCIENCE, V262, P2059, DOI 10.1126/science.8266106; HENKEL RD, 1988, ANAL BIOCHEM, V169, P312, DOI 10.1016/0003-2697(88)90290-4; Herget M, 2007, J BIOL CHEM, V282, P3871, DOI 10.1074/jbc.M608480200; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; Karttunen JT, 2001, P NATL ACAD SCI USA, V98, P7431, DOI 10.1073/pnas.121180198; Koch J, 2004, J BIOL CHEM, V279, P10142, DOI 10.1074/jbc.M312816200; Lapinski PE, 2001, J BIOL CHEM, V276, P7526, DOI 10.1074/jbc.M009448200; Loman A, 2008, CHEM PHYS LETT, V459, P18, DOI 10.1016/j.cplett.2008.05.018; Marsh D, 2007, BIOPHYS J, V93, P3884, DOI 10.1529/biophysj.107.107938; MOMBURG F, 1994, NATURE, V367, P648, DOI 10.1038/367648a0; Neumann L, 2002, J MOL BIOL, V324, P965, DOI 10.1016/S0022-2836(02)01148-8; Neumann L, 1999, J MOL BIOL, V294, P1203, DOI 10.1006/jmbi.1999.3329; Nijenhuis M, 1996, J IMMUNOL, V157, P5467; Nitsche JM, 2004, BIOPHYS J, V86, P2058, DOI 10.1016/S0006-3495(04)74267-8; Oancea G, 2009, P NATL ACAD SCI USA, V106, P5551, DOI 10.1073/pnas.0811260106; Ravaud S, 2006, BIOCHEM J, V395, P345, DOI 10.1042/BJ20051719; RUSS G, 1995, J BIOL CHEM, V270, P21312, DOI 10.1074/jbc.270.36.21312; Saveanu L, 2001, J BIOL CHEM, V276, P22107, DOI 10.1074/jbc.M011221200; Schmitt L, 2002, CURR OPIN STRUC BIOL, V12, P754, DOI 10.1016/S0959-440X(02)00399-8; Scholz C, 2005, J BIOENERG BIOMEMBR, V37, P509, DOI 10.1007/s10863-005-9500-1; Sherman E, 2008, BIOPHYS J, V94, P4819, DOI 10.1529/biophysj.107.120220; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Uebel S, 1997, P NATL ACAD SCI USA, V94, P8976, DOI 10.1073/pnas.94.17.8976; VANENDERT PM, 1994, IMMUNITY, V1, P491, DOI 10.1016/1074-7613(94)90091-4; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Zaitseva J, 2005, EMBO J, V24, P1901, DOI 10.1038/sj.emboj.7600657; Zhao CG, 2008, J BIOL CHEM, V283, P17083, DOI 10.1074/jbc.M801794200	39	38	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33740	33749		10.1074/jbc.M109.047779	http://dx.doi.org/10.1074/jbc.M109.047779			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19808685	hybrid, Green Published			2022-12-27	WOS:000272165200004
J	Machida, YJ; Machida, Y; Vashisht, AA; Wohlschlegel, JA; Dutta, A				Machida, Yuichi J.; Machida, Yuka; Vashisht, Ajay A.; Wohlschlegel, James A.; Dutta, Anindya			The Deubiquitinating Enzyme BAP1 Regulates Cell Growth via Interaction with HCF-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN IDENTIFICATION TECHNOLOGY; BRCA1-ASSOCIATED PROTEIN-1; SHOTGUN PROTEOMICS; MASS-SPECTROMETRY; UBIQUITIN HYDROLASE; ACTIVATION DOMAIN; RNA INTERFERENCE; ASSOCIATION; COMPLEX; CYCLE	The deubiquitinating enzyme BRCA1-associated protein 1 (BAP1) possesses growth inhibitory activity and functions as a tumor suppressor. In this study we report that BAP1 also plays positive roles in cell proliferation. BAP1 depletion by RNAi inhibits cell proliferation as does overexpression of a dominant negative mutant of BAP1. Mass spectrometry analyses of copurified proteins revealed that BAP1 is associated with factors involved in chromatin modulation and transcriptional regulation. We show that the interaction with host cell factor-1 (HCF-1), a cell-cycle regulator composed of HCF-1N and HCF-1C, is critical for the BAP1-mediated growth regulation. We found that HCF-1N is modified with Lys-48-linked polyubiquitin chains on its Kelch domain. The HCF-1 binding motif of BAP1 is required for interaction with HCF-1N and mediates deubiquitination of HCF-1N by BAP1. The importance of the BAP1-HCF-1 interaction is underscored by the fact that growth suppression by the dominant negative BAP1 mutant is entirely dependent on the HCF-1 binding motif. These results suggest that BAP1 regulates cell proliferation by deubiquitinating HCF-1.	[Machida, Yuichi J.; Machida, Yuka] Mayo Clin, Mayo Coll Med, Div Oncol Res, Rochester, MN 55905 USA; [Vashisht, Ajay A.; Wohlschlegel, James A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Machida, Yuichi J.; Machida, Yuka; Dutta, Anindya] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22901 USA	Mayo Clinic; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Virginia	Machida, YJ (corresponding author), 200 1st St Sw, Rochester, MN 55905 USA.	machida.yuichi@mayo.edu	Machida, Yuichi/AAO-3533-2021	Machida, Yuichi/0000-0003-1414-0568; Dutta, Anindya/0000-0002-4319-0073	National Institutes of Health [R01 CA60499]; Minnesota Partnership for Biotechnology and Medical Genomics; UCLA Jonsson Cancer Center; NATIONAL CANCER INSTITUTE [R01CA060499] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Minnesota Partnership for Biotechnology and Medical Genomics; UCLA Jonsson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA60499 (to A. D.). This work was also supported by the Minnesota Partnership for Biotechnology and Medical Genomics (to Y. J. M.) and the UCLA Jonsson Cancer Center (to J. A. W.).	Adams J, 2000, TRENDS CELL BIOL, V10, P17, DOI 10.1016/S0962-8924(99)01673-6; Baker LA, 2008, MUTAT RES-FUND MOL M, V647, P3, DOI 10.1016/j.mrfmmm.2008.07.004; BUCHHAGEN DL, 1994, INT J CANCER, V57, P473, DOI 10.1002/ijc.2910570406; Clague MJ, 2006, TRENDS CELL BIOL, V16, P551, DOI 10.1016/j.tcb.2006.09.002; Cohn MA, 2008, MOL CELL, V32, P306, DOI 10.1016/j.molcel.2008.10.009; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Florens L, 2006, METHODS, V40, P303, DOI 10.1016/j.ymeth.2006.07.028; Freiman RN, 1997, GENE DEV, V11, P3122, DOI 10.1101/gad.11.23.3122; Goto H, 1997, GENE DEV, V11, P726, DOI 10.1101/gad.11.6.726; Govers R, 1997, EMBO J, V16, P4851, DOI 10.1093/emboj/16.16.4851; Hussain S, 2009, CELL CYCLE, V8, P1688, DOI 10.4161/cc.8.11.8739; Jensen DE, 1998, ONCOGENE, V16, P1097, DOI 10.1038/sj.onc.1201861; Julien E, 2003, EMBO J, V22, P2360, DOI 10.1093/emboj/cdg242; Karytinos A, 2009, J BIOL CHEM, V284, P17775, DOI 10.1074/jbc.M109.003087; Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659; KRISTIE TM, 1995, J BIOL CHEM, V270, P4387, DOI 10.1074/jbc.270.9.4387; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Lu R, 1997, MOL CELL BIOL, V17, P5117, DOI 10.1128/MCB.17.9.5117; Luciano RL, 2000, P NATL ACAD SCI USA, V97, P10757, DOI 10.1073/pnas.190062797; Luciano RL, 2003, J BIOL CHEM, V278, P51116, DOI 10.1074/jbc.M303470200; Luciano RL, 2002, P NATL ACAD SCI USA, V99, P13403, DOI 10.1073/pnas.202200399; Machida YJ, 2006, MOL BIOL CELL, V17, P4837, DOI 10.1091/mbc.E06-04-0340; Mallery DL, 2002, EMBO J, V21, P6755, DOI 10.1093/emboj/cdf691; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Misaghi S, 2009, MOL CELL BIOL, V29, P2181, DOI 10.1128/MCB.01517-08; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Narayanan A, 2007, P NATL ACAD SCI USA, V104, P10835, DOI 10.1073/pnas.0704351104; Nielsen ML, 2008, NAT METHODS, V5, P459, DOI 10.1038/nmeth0608-459; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Nishikawa H, 2009, CANCER RES, V69, P111, DOI 10.1158/0008-5472.CAN-08-3355; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Smith ER, 2005, MOL CELL BIOL, V25, P9175, DOI 10.1128/MCB.25.21.9175-9188.2005; Song L, 2008, CURR OPIN CELL BIOL, V20, P156, DOI 10.1016/j.ceb.2008.01.012; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tyagi S, 2007, MOL CELL, V27, P107, DOI 10.1016/j.molcel.2007.05.030; Ventii KH, 2008, CANCER RES, V68, P6953, DOI 10.1158/0008-5472.CAN-08-0365; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; WILSON AC, 1995, GENE DEV, V9, P2445, DOI 10.1101/gad.9.20.2445; Wilson AC, 1997, MOL CELL BIOL, V17, P6139, DOI 10.1128/MCB.17.10.6139; WILSON AC, 1993, CELL, V74, P115, DOI 10.1016/0092-8674(93)90299-6; Wohlschlegel James A., 2009, V497, P33, DOI 10.1007/978-1-59745-566-4_3; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Wysocka J, 2001, MOL CELL BIOL, V21, P3820, DOI 10.1128/MCB.21.11.3820-3829.2001; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Zhang Y, 2003, GENE DEV, V17, P2733, DOI 10.1101/gad.1156403	52	188	198	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34179	34188		10.1074/jbc.M109.046755	http://dx.doi.org/10.1074/jbc.M109.046755			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19815555	Green Published, hybrid			2022-12-27	WOS:000272165200050
J	Duterme, C; Mertens-Strijthagen, J; Tammi, M; Flamion, B				Duterme, Cecile; Mertens-Strijthagen, Jeannine; Tammi, Markku; Flamion, Bruno			Two Novel Functions of Hyaluronidase-2 (Hyal2) Are Formation of the Glycocalyx and Control of CD44-ERM Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RICH PERICELLULAR MATRIX; JAAGSIEKTE SHEEP RETROVIRUS; MARROW ENDOTHELIAL-CELLS; ERM PROTEINS; HYALURONAN-BINDING; MUCOPOLYSACCHARIDOSIS-IX; EPITHELIAL-CELLS; BREAST-CANCER; TUMOR-CELLS; IN-VITRO	It has long been predicted that the members of the hyaluronidase enzyme family have important non-enzymatic functions. However, their nature remains a mystery. The metabolism of hyaluronan (HA), their major enzymatic substrate, is also enigmatic. To examine the function of Hyal2, a glycosylphosphatidylinositol-anchored hyaluronidase with intrinsically weak enzymatic activity, we have compared stably transfected rat fibroblastic BB16 cell lines with various levels of expression of Hyal2. These cell lines continue to express exclusively the standard form (CD44s) of the main HA receptor, CD44. Hyal2, CD44, and one of its main intracellular partners, ezrin-radixin-moesin (ERM), were found to co-immunoprecipitate. Functionally, Hyal2 overexpression was linked to loss of the glycocalyx, the HA-rich pericellular coat. This effect could be mimicked by exposure of BB16 cells either to Streptomyces hyaluronidase, to HA synthesis inhibitors, or to HA oligosaccharides. This led to shedding of CD44, separation of CD44 from ERM, reduction in baseline level of ERM activation, and markedly decreased cell motility (50% reduction in a wound healing assay). The effects of Hyal2 on the pericellular coat and on CD44-ERM interactions were inhibited by treatment with the Na+/H+ exchanger-1 inhibitor ethyl-N-isopropylamiloride. We surmise that Hyal2, through direct interactions with CD44 and possibly some pericellular hyaluronidase activity requiring acidic foci, suppresses the formation or the stability of the glycocalyx, modulates ERM-related cytoskeletal interactions, and diminishes cell motility. These effects may be relevant to the purported in vivo tumor-suppressive activity of Hyal2.	[Duterme, Cecile; Mertens-Strijthagen, Jeannine; Flamion, Bruno] Univ Namur, URPhyM, B-5000 Namur, Belgium; [Tammi, Markku] Univ Kuopio, Dept Anat, Inst Biomed, FIN-70211 Kuopio, Finland	University of Namur; University of Eastern Finland	Flamion, B (corresponding author), Univ Namur, URPhyM, 61 Rue Bruxelles, B-5000 Namur, Belgium.	Bruno.Flamion@fundp.ac.be	Tammi, Markku/AAQ-7878-2021		Academy of Finland; Sigrid Juselius Foundation; Kuopio University Hospital	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Kuopio University Hospital	This work was supported by The Academy of Finland, the Sigrid Juselius Foundation, and the EVO Funds of Kuopio University Hospital.	Andre F, 1999, GASTROENTEROLOGY, V116, P64, DOI 10.1016/S0016-5085(99)70230-1; Atmuri V, 2008, MATRIX BIOL, V27, P653, DOI 10.1016/j.matbio.2008.07.006; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; Brown KL, 2005, EXP CELL RES, V303, P400, DOI 10.1016/j.yexcr.2004.10.002; Chang NS, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-8; Chow G, 2006, OSTEOARTHR CARTILAGE, V14, P849, DOI 10.1016/j.joca.2006.02.009; Cichy J, 2000, J BIOL CHEM, V275, P18061, DOI 10.1074/jbc.M907962199; CLARRIS BJ, 1968, EXP CELL RES, V49, P181, DOI 10.1016/0014-4827(68)90530-2; Conn EM, 2008, J BIOL CHEM, V283, P26518, DOI 10.1074/jbc.M803337200; Csoka AB, 1999, GENOMICS, V60, P356, DOI 10.1006/geno.1999.5876; Csoka AB, 2001, MATRIX BIOL, V20, P499, DOI 10.1016/S0945-053X(01)00172-X; CULTY M, 1992, J CELL BIOL, V116, P1055, DOI 10.1083/jcb.116.4.1055; DEBELDER AN, 1975, CARBOHYD RES, V44, P251, DOI 10.1016/S0008-6215(00)84168-3; Draffin JE, 2004, CANCER RES, V64, P5702, DOI 10.1158/0008-5472.CAN-04-0389; Evanko SP, 1999, ARTERIOSCL THROM VAS, V19, P1004, DOI 10.1161/01.ATV.19.4.1004; Evanko SP, 2007, ADV DRUG DELIVER REV, V59, P1351, DOI 10.1016/j.addr.2007.08.008; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; GOLDBERG RL, 1984, EXP CELL RES, V151, P258, DOI 10.1016/0014-4827(84)90374-4; Harada H, 2007, J BIOL CHEM, V282, P5597, DOI 10.1074/jbc.M608358200; Hosono K, 2007, AM J PATHOL, V171, P274, DOI 10.2353/ajpath.2007.060828; Hsu LJ, 2009, J BIOL CHEM, V284, P16049, DOI 10.1074/jbc.M806688200; Jadin L, 2008, FASEB J, V22, P4316, DOI 10.1096/fj.08-111997; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; KNUDSON CB, 1993, FASEB J, V7, P1233, DOI 10.1096/fasebj.7.13.7691670; KNUDSON W, 1993, P NATL ACAD SCI USA, V90, P4003, DOI 10.1073/pnas.90.9.4003; KREIL G, 1995, PROTEIN SCI, V4, P1666, DOI 10.1002/pro.5560040902; LEE HG, 1994, ANAL BIOCHEM, V219, P278, DOI 10.1006/abio.1994.1267; Lee JH, 2004, J CELL BIOL, V167, P327, DOI 10.1083/jcb.200403091; Lepperdinger G, 1998, J BIOL CHEM, V273, P22466, DOI 10.1074/jbc.273.35.22466; LESLEY J, 1993, EUR J IMMUNOL, V23, P1902, DOI 10.1002/eji.1830230826; Liu Dacai, 1998, Frontiers in Bioscience, V3, pD631; Lokeshwar VB, 2002, J BIOL CHEM, V277, P33654, DOI 10.1074/jbc.M203821200; LOKESHWAR VB, 1991, J BIOL CHEM, V266, P17983; Maiti A, 1998, SCIENCE, V282, P941, DOI 10.1126/science.282.5390.941; Martin DC, 2008, HUM MOL GENET, V17, P1904, DOI 10.1093/hmg/ddn088; Miranda M, 2004, J BIOL CHEM, V279, P30760, DOI 10.1074/jbc.M312774200; Monz K, 2008, J CELL BIOCHEM, V105, P1260, DOI 10.1002/jcb.21925; Mori T, 2008, J BIOL CHEM, V283, P29602, DOI 10.1074/jbc.M803606200; Nagano O, 2004, CANCER SCI, V95, P930, DOI 10.1111/j.1349-7006.2004.tb03179.x; Novak U, 1999, CANCER RES, V59, P6246; Okamoto I, 1999, ONCOGENE, V18, P1435, DOI 10.1038/sj.onc.1202447; Platek A, 2004, J CELL SCI, V117, P4849, DOI 10.1242/jcs.01359; QIN Y, 1992, DEV DYNAM, V193, P145, DOI 10.1002/aja.1001930206; Rai SK, 2001, P NATL ACAD SCI USA, V98, P4443, DOI 10.1073/pnas.071572898; Ricciardelli C, 2007, J BIOL CHEM, V282, P10814, DOI 10.1074/jbc.M606991200; Selbi W, 2006, J AM SOC NEPHROL, V17, P1553, DOI 10.1681/ASN.2005080879; Shi M, 2001, J IMMUNOL, V167, P123, DOI 10.4049/jimmunol.167.1.123; Simpson MA, 2002, J BIOL CHEM, V277, P10050, DOI 10.1074/jbc.M110069200; Skelton TP, 1998, J CELL BIOL, V140, P431, DOI 10.1083/jcb.140.2.431; Sleeman J, 1996, J CELL BIOL, V135, P1139, DOI 10.1083/jcb.135.4.1139; Stern R, 2003, GLYCOBIOLOGY, V13, p105R, DOI 10.1093/glycob/cwg112; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Sugahara KN, 2003, J BIOL CHEM, V278, P32259, DOI 10.1074/jbc.M300347200; Tsuda M, 2004, J BIOL CHEM, V279, P46843, DOI 10.1074/jbc.M401476200; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391; Udabage L, 2005, EXP CELL RES, V310, P205, DOI 10.1016/j.yexcr.2005.07.026; UNDERHILL CB, 1983, J BIOL CHEM, V258, P8086; Veithen A, 1996, J CELL SCI, V109, P2005; Vigdorovich V, 2007, J VIROL, V81, P3124, DOI 10.1128/JVI.02177-06; Wang FL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003031; Webber J, 2009, J BIOL CHEM, V284, P9083, DOI 10.1074/jbc.M806989200; Yonemura S, 1999, J CELL BIOL, V145, P1497, DOI 10.1083/jcb.145.7.1497	62	61	62	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33495	33508		10.1074/jbc.M109.044362	http://dx.doi.org/10.1074/jbc.M109.044362			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19783662	hybrid, Green Published			2022-12-27	WOS:000272028500056
J	Kale, S; Jordan, F				Kale, Sachin; Jordan, Frank			Conformational Ensemble Modulates Cooperativity in the Rate-determining Catalytic Step in the E1 Component of the Escherichia coli Pyruvate Dehydrogenase Multienzyme Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE-CENTER COMMUNICATION; REDUCTIVE ACETYLATION; REACTION INTERMEDIATE; DEPENDENT ENZYMES; SUBUNIT INTERFACE; THIAMINE ENZYMES; PLAUSIBLE MODEL; SITES; BINDING; SUBSTRATE	Cooperativity is extensively used by enzymes, particularly those acting at key metabolic branch points, to "fine tune" catalysis. Thus, cooperativity and enzyme catalysis are intimately linked, yet their linkage is poorly understood. Here we show that negative cooperativity in the rate-determining step in the E1 component of the Escherichia coli pyruvate dehydrogenase multienzyme complex is an outcome of redistribution of a "rate-promoting" conformational pre-equilibrium. An array of biophysical and biochemical studies indicates that non-catalytic but conserved residues directly regulate the redistribution. Furthermore, factors such as ligands and temperature, individually or in concert, also strongly influence the redistribution. As a consequence, these factors also exert their influence on catalysis by profoundly influencing the pre-equilibrium facilitated dynamics of communication between multienzyme components. Our observations suggest a mode of cooperativity in the E1 component that is consistent with the dynamical hypothesis shown to satisfactorily explain cooperativity in many well studied enzymes. The results point to the likely existence of multiple modes of communication between subunits when the entire class of thiamin diphosphate-dependent enzymes is considered.	[Kale, Sachin; Jordan, Frank] Rutgers State Univ, Dept Chem, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick	Jordan, F (corresponding author), Rutgers State Univ, Dept Chem, Newark, NJ 07102 USA.	frjordan@rutgers.edu			National Institutes of Health [GM 50380]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant GM 50380.	Agarwal PK, 2002, P NATL ACAD SCI USA, V99, P2794, DOI 10.1073/pnas.052005999; Arjunan P, 2002, BIOCHEMISTRY-US, V41, P5213, DOI 10.1021/bi0118557; Arjunan P, 2006, J BIOL CHEM, V281, P15296, DOI 10.1074/jbc.M600656200; Ciszak EM, 2003, J BIOL CHEM, V278, P21240, DOI 10.1074/jbc.M300339200; COOPER A, 1984, EUR BIOPHYS J BIOPHY, V11, P103, DOI 10.1007/BF00276625; Fenton AW, 2008, TRENDS BIOCHEM SCI, V33, P420, DOI 10.1016/j.tibs.2008.05.009; Fersht A., 1998, STRUCTURE MECH PROTE, P147; Frank RAW, 2004, SCIENCE, V306, P872, DOI 10.1126/science.1101030; Gunasekaran K, 2004, PROTEINS, V57, P433, DOI 10.1002/prot.20232; Hilser VJ, 2007, P NATL ACAD SCI USA, V104, P8311, DOI 10.1073/pnas.0700329104; Jones DD, 2001, J MOL BIOL, V305, P49, DOI 10.1006/jmbi.2000.4257; Jordan F, 2005, ACCOUNTS CHEM RES, V38, P755, DOI 10.1021/ar040244e; Jordan F, 2004, SCIENCE, V306, P818, DOI 10.1126/science.1105457; Kale S, 2008, P NATL ACAD SCI USA, V105, P1158, DOI 10.1073/pnas.0709328105; Kale S, 2007, J BIOL CHEM, V282, P28106, DOI 10.1074/jbc.M704326200; KLUGER R, 1977, J AM CHEM SOC, V99, P4504, DOI 10.1021/ja00455a052; Kolodziej AF, 1996, BIOCHEMISTRY-US, V35, P14782, DOI 10.1021/bi961481v; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Kovina MV, 1998, FEBS LETT, V440, P81, DOI 10.1016/S0014-5793(98)01423-9; Kumar S, 2000, PROTEIN SCI, V9, P10; Li J, 2004, J BIOL CHEM, V279, P32968, DOI 10.1074/jbc.M403611200; Li J, 2007, J BIOL CHEM, V282, P11904, DOI 10.1074/jbc.M610843200; MASSEY V, 1966, J BIOL CHEM, V241, P2347; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Nakai T, 2004, J MOL BIOL, V337, P1011, DOI 10.1016/j.jmb.2004.02.011; Nemeria N, 2005, J BIOL CHEM, V280, P21473, DOI 10.1074/jbc.M502691200; Nemeria N, 2002, BIOCHEMISTRY-US, V41, P15459, DOI 10.1021/bi0205909; Nemeria N, 1998, BIOCHEMISTRY-US, V37, P911, DOI 10.1021/bi9722251; Nemeria N, 2001, J BIOL CHEM, V276, P45969, DOI 10.1074/jbc.M104116200; Pan H, 2000, P NATL ACAD SCI USA, V97, P12020, DOI 10.1073/pnas.220240297; Park YH, 2004, BIOCHEMISTRY-US, V43, P14037, DOI 10.1021/bi049027b; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; Rajagopalan PTR, 2002, BIOCHEMISTRY-US, V41, P12618, DOI 10.1021/bi026369d; SCRUTTON NS, 1992, SCIENCE, V258, P1140, DOI 10.1126/science.1439821; Seifert F, 2006, BIOCHEMISTRY-US, V45, P12775, DOI 10.1021/bi061582l; Sergienko EA, 2000, BIOCHEMISTRY-US, V39, P13862, DOI 10.1021/bi001214w; Sergienko EA, 2002, BIOCHEMISTRY-US, V41, P3952, DOI 10.1021/bi011860a; Stetefeld J, 2006, P NATL ACAD SCI USA, V103, P13688, DOI 10.1073/pnas.0600306103; SUNDSTROM M, 1992, FEBS LETT, V313, P229, DOI 10.1016/0014-5793(92)81197-T; Tousignant A, 2004, CHEM BIOL, V11, P1037, DOI 10.1016/j.chembiol.2004.06.007; Truhlar DG, 2001, P NATL ACAD SCI USA, V98, P848, DOI 10.1073/pnas.98.3.848; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429; Wynn RM, 2004, STRUCTURE, V12, P2185, DOI 10.1016/j.str.2004.09.013; Yi JZ, 1996, J BIOL CHEM, V271, P33192, DOI 10.1074/jbc.271.52.33192	44	13	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33122	33129		10.1074/jbc.M109.065508	http://dx.doi.org/10.1074/jbc.M109.065508			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801660	Green Published, hybrid			2022-12-27	WOS:000272028500016
J	Khazaei, MR; Puschel, AW				Khazaei, Mohammad R.; Pueschel, Andreas W.			Phosphorylation of the Par Polarity Complex Protein Par3 at Serine 962 Is Mediated by Aurora A and Regulates Its Function in Neuronal Polarity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN LIGASE SMURF2; MAMMALIAN-CELLS; SELF-RENEWAL; ESTABLISHMENT; ACTIVATION; APKC; LOCALIZATION; MECHANISMS; MATURATION; GSK-3-BETA	The Aurora kinases are a family of serine/threonine protein kinases that perform important functions during the cell cycle. Recently, it was shown that Drosophila Aurora A also regulates the asymmetric localization of Numb to the basal and the partitioning-defective (Par) complex to the apical cortex of neuroblasts by phosphorylating Par6. Here, we show that Aurora A is required for neuronal polarity. Suppression of Aurora A by RNA interference results in the loss of neuronal polarity. Aurora A interacts directly with the atypical protein kinase C binding domain of Par3 and phosphorylates it at serine 962. The phosphorylation of Par3 at serine 962 contributes to its function in the establishment of neuronal polarity.	[Khazaei, Mohammad R.; Pueschel, Andreas W.] Univ Munster, Inst Allgemeine Zool & Genet, Mol Biol Abt, D-48149 Munster, Germany	University of Munster	Puschel, AW (corresponding author), Univ Munster, Inst Allgemeine Zool & Genet, Mol Biol Abt, Schlosspl 5, D-48149 Munster, Germany.	apuschel@uni-muenster.de			Deutsche Forschungsgemeinschaft [SFB 629, GRK 1050]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB 629 and GRK 1050 (to A. W. P.).	Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Benton R, 2003, CELL, V115, P691, DOI 10.1016/S0092-8674(03)00938-3; Berdnik D, 2002, CURR BIOL, V12, P640, DOI 10.1016/S0960-9822(02)00766-2; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Chen XY, 2006, J CELL BIOL, V172, P671, DOI 10.1083/jcb.200510061; Chen XY, 2005, NAT CELL BIOL, V7, P262, DOI 10.1038/ncb1226; Chen YM, 2006, P NATL ACAD SCI USA, V103, P8534, DOI 10.1073/pnas.0509955103; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Eyers PA, 2003, CURR BIOL, V13, P691, DOI 10.1016/S0960-9822(03)00166-0; Ferrari S, 2005, BIOCHEM J, V390, P293, DOI 10.1042/BJ20050343; Frank CL, 2009, NEURON, V62, P312, DOI 10.1016/j.neuron.2009.03.029; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Honda R, 2003, MOL BIOL CELL, V14, P3325, DOI 10.1091/mbc.E02-11-0769; Huang YS, 2002, EMBO J, V21, P2139, DOI 10.1093/emboj/21.9.2139; Hutterer A, 2006, DEV CELL, V11, P147, DOI 10.1016/j.devcel.2006.06.002; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Lee CY, 2006, GENE DEV, V20, P3464, DOI 10.1101/gad.1489406; Mandell JW, 1996, J NEUROSCI, V16, P5727; Nagai-Tamai Y, 2002, GENES CELLS, V7, P1161, DOI 10.1046/j.1365-2443.2002.00590.x; Nakayama M, 2008, DEV CELL, V14, P205, DOI 10.1016/j.devcel.2007.11.021; Nishimura T, 2005, NAT CELL BIOL, V7, P270, DOI 10.1038/ncb1227; Nishimura T, 2004, NAT CELL BIOL, V6, P328, DOI 10.1038/ncb1118; Nishimura T, 2007, DEV CELL, V13, P15, DOI 10.1016/j.devcel.2007.05.003; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Paddison PJ, 2002, P NATL ACAD SCI USA, V99, P1443, DOI 10.1073/pnas.032652399; Schwamborn JC, 2006, METHOD ENZYMOL, V406, P715, DOI 10.1016/S0076-6879(06)06056-3; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Schwamborn JC, 2007, J BIOL CHEM, V282, P35259, DOI 10.1074/jbc.M703438200; Schwamborn JC, 2007, EMBO J, V26, P1410, DOI 10.1038/sj.emboj.7601580; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Traweger A, 2008, P NATL ACAD SCI USA, V105, P10402, DOI 10.1073/pnas.0804102105; Tsai MY, 2003, NAT CELL BIOL, V5, P242, DOI 10.1038/ncb936; Walter AO, 2000, ONCOGENE, V19, P4906, DOI 10.1038/sj.onc.1203847; Wang H, 2006, GENE DEV, V20, P3453, DOI 10.1101/gad.1487506; Wang YG, 2006, EMBO J, V25, P5058, DOI 10.1038/sj.emboj.7601384; Wirtz-Peitz F, 2008, CELL, V135, P161, DOI 10.1016/j.cell.2008.07.049; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zhang HY, 2006, NAT CELL BIOL, V8, P227, DOI 10.1038/ncb1368	41	32	35	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33571	33579		10.1074/jbc.M109.055897	http://dx.doi.org/10.1074/jbc.M109.055897			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19812038	Green Published, hybrid			2022-12-27	WOS:000272028500062
J	Oakley, FD; Smith, RL; Engelhardt, JF				Oakley, Fredrick D.; Smith, Rachel L.; Engelhardt, John F.			Lipid Rafts and Caveolin-1 Coordinate Interleukin-1 beta (IL-1 beta)-dependent Activation of NF kappa B by Controlling Endocytosis of Nox2 and IL-1 beta Receptor 1 from the Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHAGOCYTE NADPH OXIDASE; SMOOTH-MUSCLE-CELLS; SIGNALING PATHWAYS; TYPE-1 RECEPTOR; VAV PROTEINS; MICRODOMAINS; RAC1; TRAFFICKING; DOMAIN; CHOLESTEROL	Recent evidence suggests that signaling by the proinflammatory cytokine interleukin-1 beta (IL-1 beta) is dependent on reactive oxygen species derived from NADPH oxidase. Redox signaling in response to IL-1 beta is known to require endocytosis of its cognate receptor (IL-1R1) following ligand binding and the formation of redox-active signaling endosomes that contain Nox2 (also called redoxosomes). The consequent generation of reactive oxygen species by redoxosomes is responsible for the downstream recruitment of IL-1R1 effectors (IRAK, TRAF6, and I kappa B kinase kinases) and ultimately for activation of the transcription factor NF kappa B. Despite this knowledge of the signaling events that occur downstream of redoxosome formation, an understanding of the mechanisms that coordinate the genesis of redoxosomes following IL-1 beta stimulation has been lacking. Here, we demonstrate that lipid rafts play an important role in this process. We show that Nox2 and IL-1R1 localize to plasma membrane lipid rafts in the unstimulated state and that IL-1 beta signals caveolin-1-dependent endocytosis of both proteins into the redoxosome. We also show that inhibiting lipid raft-mediated endocytosis prevents NF kappa B activation. Finally, we demonstrate that Vav1, a Rac1 guanine exchange factor and activator of Nox2, is recruited to lipid rafts following IL-1 beta stimulation and that it is required for NF kappa B activation. Our results fill in an important mechanistic gap in the understanding of early IL-1R1 and Nox2 signaling events that control NF kappa B activation, a redox-dependent process important in inflammation.	[Oakley, Fredrick D.; Smith, Rachel L.; Engelhardt, John F.] Univ Iowa, Carver Coll Med, Dept Anat & Cell Biol, Iowa City, IA 52242 USA; [Engelhardt, John F.] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Oakley, Fredrick D.; Engelhardt, John F.] Univ Iowa, Carver Coll Med, Med Scientist Training Program, Iowa City, IA 52242 USA; [Engelhardt, John F.] Univ Iowa, Carver Coll Med, Ctr Gene Therapy, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa	Engelhardt, JF (corresponding author), Univ Iowa, Carver Coll Med, Dept Anat & Cell Biol, Rm 1-111 BSB,51 Newton Rd, Iowa City, IA 52242 USA.	john-engelhardt@uiowa.edu		Engelhardt, John/0000-0003-2389-9277	National Institutes of Health [R01 DK067928, R01 DK051315]; NIDDK [R01 DK051315]; NIEHS [F30 ES015950]; Center for Gene Therapy; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067928, R01DK051315, P30DK054759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F30ES015950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Center for Gene Therapy(Ohio State University); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK067928 and R01 DK051315 from NIDDK and Grant F30 ES015950 from NIEHS. This work was also supported by the University of Iowa Gene Transfer Vector Core, which is funded through the Center for Gene Therapy (National Institutes of Health Grant P30 DK54759), and by the Roy J. Carver Chair in Molecular Medicine.	ALCAMI A, 1992, CELL, V71, P153, DOI 10.1016/0092-8674(92)90274-G; Arnalich F, 2000, INFECT IMMUN, V68, P1942, DOI 10.1128/IAI.68.4.1942-1945.2000; BORISH L, 1992, J IMMUNOL, V149, P3078; Brissoni B, 2006, CURR BIOL, V16, P2265, DOI 10.1016/j.cub.2006.09.062; Burns K, 2000, NAT CELL BIOL, V2, P346, DOI 10.1038/35014038; Carter GC, 2009, VIROLOGY, V386, P192, DOI 10.1016/j.virol.2008.12.031; Charvet C, 2002, J BIOL CHEM, V277, P15376, DOI 10.1074/jbc.M111627200; Chen YK, 2005, BRIT J ORAL MAX SURG, V43, P185, DOI 10.1016/j.bjoms.2004.02.026; Choudhury A, 2006, NAT CELL BIOL, V8, P317, DOI 10.1038/ncb1380; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; DUNNE A, 2003, SCI STKE, pRE3, DOI DOI 10.1126/STKE.2003.171.RE3; Fan HK, 2006, FRONT BIOSCI-LANDMRK, V11, P2264, DOI 10.2741/1969; Han C H, 2000, J Vet Sci, V1, P19; Han CH, 2001, J BIOCHEM-TOKYO, V129, P513, DOI 10.1093/oxfordjournals.jbchem.a002885; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Hebeis B, 2005, BLOOD, V106, P635, DOI 10.1182/blood-2004-10-3919; Kabe Y, 2005, ANTIOXID REDOX SIGN, V7, P395, DOI 10.1089/ars.2005.7.395; Kreuzer J, 2002, FASEB J, V16, P38, DOI 10.1096/fj.01-1036fje; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lassegue B, 2001, CIRC RES, V88, P888, DOI 10.1161/hh0901.090299; LeClerc PC, 2002, ENDOCRINOLOGY, V143, P4702, DOI 10.1210/en.2002-220679; Legler DF, 2003, IMMUNITY, V18, P655, DOI 10.1016/S1074-7613(03)00092-X; Li Q, 2001, ANTIOXID REDOX SIGN, V3, P415, DOI 10.1089/15230860152409068; Li QA, 2006, MOL CELL BIOL, V26, P140, DOI 10.1128/MCB.26.1.140-154.2006; Li Q, 2009, ANTIOXID REDOX SIGN, V11, P1249, DOI 10.1089/ARS.2008.2407; Lin HW, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-15; Martin MU, 2002, BBA-MOL CELL RES, V1592, P265, DOI 10.1016/S0167-4889(02)00320-8; Miletic AV, 2007, BLOOD, V109, P3360, DOI 10.1182/blood-2006-07-033662; Miller FJ, 2007, CIRC RES, V101, P663, DOI 10.1161/CIRCRESAHA.107.151076; Mizrahi A, 2005, J BIOL CHEM, V280, P3802, DOI 10.1074/jbc.M410257200; Mumbengegwi DR, 2008, MOL CELL BIOL, V28, P3700, DOI 10.1128/MCB.02038-07; Nakahira K, 2006, J EXP MED, V203, P2377, DOI 10.1084/jem.20060845; Oakley FD, 2009, ANTIOXID REDOX SIGN, V11, P1313, DOI 10.1089/ARS.2008.2363; Park HS, 2004, MOL CELL BIOL, V24, P4384, DOI 10.1128/MCB.24.10.4384-4394.2004; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; Puri C, 2005, MOL BIOL CELL, V16, P2704, DOI 10.1091/mbc.e04-07-0596; Roepstorff K, 2008, J BIOL CHEM, V283, P7983, DOI 10.1074/jbc.M708281200; Ros-Baro A, 2001, P NATL ACAD SCI USA, V98, P12050, DOI 10.1073/pnas.211341698; Shao DM, 2003, FEBS LETT, V550, P101, DOI 10.1016/S0014-5793(03)00845-7; Smart EJ, 2002, METHOD ENZYMOL, V353, P131; Smith RM, 1998, CELL SIGNAL, V10, P355, DOI 10.1016/S0898-6568(97)00170-8; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Sverdlov M, 2007, J CELL MOL MED, V11, P1239, DOI 10.1111/j.1582-4934.2007.00127.x; Teixeira A, 1999, J NEUROCHEM, V72, P120, DOI 10.1046/j.1471-4159.1999.0720120.x; Verstrepen L, 2008, CELL MOL LIFE SCI, V65, P2964, DOI 10.1007/s00018-008-8064-8; Vilhardt F, 2004, EMBO J, V23, P739, DOI 10.1038/sj.emboj.7600066; Villalba M, 2001, J CELL BIOL, V155, P331, DOI 10.1083/jcb.200107080; von Bernuth H, 2005, CLIN INFECT DIS, V41, pS436, DOI 10.1086/431994; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; WILSON CA, 1990, J IMMUNOL, V144, P3784; Yamada J, 2003, EXP EYE RES, V76, P161, DOI 10.1016/S0014-4835(02)00293-2; Zhang AY, 2006, HYPERTENSION, V47, P74, DOI 10.1161/01.HYP.0000196727.53300.62; Zuo L, 2005, ARTERIOSCL THROM VAS, V25, P1824, DOI 10.1161/01.ATV.0000175295.09607.18	53	89	90	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33255	33264		10.1074/jbc.M109.042127	http://dx.doi.org/10.1074/jbc.M109.042127			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801678	hybrid, Green Published			2022-12-27	WOS:000272028500030
J	Diani, L; Colombelli, C; Nachimuthu, BT; Donnianni, R; Plevani, P; Muzi-Falconi, M; Pellicioli, A				Diani, Laura; Colombelli, Claudia; Nachimuthu, Benjamin Tamilselvan; Donnianni, Roberto; Plevani, Paolo; Muzi-Falconi, Marco; Pellicioli, Achille			Saccharomyces CDK1 Phosphorylates Rad53 Kinase in Metaphase, Influencing Cellular Morphogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHECKPOINT ACTIVATION; PROTEIN-INTERACTION; BUDDING YEAST; DNA-DAMAGE; CEREVISIAE; GROWTH; DOMAIN; PHASE; CYCLE	Rad53 is an essential protein kinase governing DNA damage and replication stress checkpoints in budding yeast. It also appears to be involved in cellular morphogenesis processes. Mass spectrometry analyses revealed that Rad53 is phosphorylated at multiple SQ/TQ and at SP/TP residues, which are typical consensus sites for phosphatidylinositol 3-kinase-related kinases and CDKs, respectively. Here we show that Clb-CDK1 phosphorylates Rad53 at Ser(774) in metaphase. This phosphorylation event does not influence the DNA damage and replication checkpoint roles of Rad53, and it is independent of the spindle assembly checkpoint network. Moreover, the Ser-to-Asp mutation, mimicking a constitutive phosphorylation state at site 774, causes sensitivity to calcofluor, supporting a functional linkage between Rad53 and cellular morphogenesis.	[Diani, Laura; Colombelli, Claudia; Nachimuthu, Benjamin Tamilselvan; Donnianni, Roberto; Plevani, Paolo; Muzi-Falconi, Marco; Pellicioli, Achille] Univ Milan, Dipartimento Sci Biomol & Biotecnol, I-20133 Milan, Italy	University of Milan	Pellicioli, A (corresponding author), Univ Milan, Dipartimento Sci Biomol & Biotecnol, Via Celoria 26, I-20133 Milan, Italy.	achille.pellicioli@unimi.it	Nachimuthu, Benjamin Tamilselvan/AAE-6473-2019; Muzi-Falconi, Marco/A-6035-2012; Pellicioli, Achille/B-8765-2017	Muzi-Falconi, Marco/0000-0001-7046-6090; Pellicioli, Achille/0000-0002-1528-9009; PLEVANI, PAOLO/0000-0003-1869-2626	Associazione Italiana Ricerca sul Cancro; Fondazione Cariplo; European Union; Ministero dell'Istruzione; dell'Universita' d della Ricerca	Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Fondazione Cariplo(Fondazione Cariplo); European Union(European Commission); Ministero dell'Istruzione(Ministry of Education, Universities and Research (MIUR)); dell'Universita' d della Ricerca(Ministry of Education, Universities and Research (MIUR))	This work was supported by grants from Associazione Italiana Ricerca sul Cancro, Fondazione Cariplo, the European Union FP6 Integrated Project DNA Repair, and Ministero dell'Istruzione, dell'Universita' d della Ricerca (to A. P., M. M.- F., and P. P.).	Bartek J, 2001, NAT REV MOL CELL BIO, V2, P877, DOI 10.1038/35103059; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Clemenson C, 2006, MOL CELL BIOL, V26, P9149, DOI 10.1128/MCB.00310-06; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Enserink JM, 2006, J CELL BIOL, V175, P729, DOI 10.1083/jcb.200605080; Enserink JM, 2009, J CELL BIOL, V185, P423, DOI 10.1083/jcb.200811083; Fay DS, 1997, CURR GENET, V31, P97, DOI 10.1007/s002940050181; Fiorani S, 2008, CELL CYCLE, V7, P493, DOI 10.4161/cc.7.4.5323; Hammet A, 2003, IUBMB LIFE, V55, P23, DOI 10.1080/1521654031000070636; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Lew DJ, 2003, CURR OPIN CELL BIOL, V15, P648, DOI 10.1016/j.ceb.2003.09.001; Lew DJ, 2003, ANNU REV GENET, V37, P251, DOI 10.1146/annurev.genet.37.042203.120656; Lim HH, 1998, CURR BIOL, V8, P231, DOI 10.1016/S0960-9822(98)70088-0; Nasmyth K, 1996, TRENDS GENET, V12, P405, DOI 10.1016/0168-9525(96)10041-X; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; Pellicioli A, 2005, CURR BIOL, V15, pR769, DOI 10.1016/j.cub.2005.08.057; Smolka MB, 2006, J CELL BIOL, V175, P743, DOI 10.1083/jcb.200605081; Smolka MB, 2005, MOL CELL PROTEOMICS, V4, P1358, DOI 10.1074/mcp.M500115-MCP200; STRACKER TH, 2009, DNA REPAIR AMST; Stracker TH, 2009, DNA REPAIR, V8, P1047, DOI 10.1016/j.dnarep.2009.04.012; Sweeney FD, 2005, CURR BIOL, V15, P1364, DOI 10.1016/j.cub.2005.06.063; Tercero JA, 2003, MOL CELL, V11, P1323, DOI 10.1016/S1097-2765(03)00169-2; ZHENG P, 1993, MOL CELL BIOL, V13, P5829, DOI 10.1128/MCB.13.9.5829	25	11	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32627	32634		10.1074/jbc.M109.048157	http://dx.doi.org/10.1074/jbc.M109.048157			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19801655	hybrid, Green Published			2022-12-27	WOS:000272028400045
J	Marechal, A; Kido, Y; Kita, K; Moore, AL; Rich, PR				Marechal, Amandine; Kido, Yasutoshi; Kita, Kiyoshi; Moore, Anthony L.; Rich, Peter R.			Three Redox States of Trypanosoma brucei Alternative Oxidase Identified by Infrared Spectroscopy and Electrochemistry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARASITE CRYPTOSPORIDIUM-PARVUM; CYTOCHROME BC(1) COMPLEX; ACTIVE-SITE; RIBONUCLEOTIDE REDUCTASE; PARTIAL-PURIFICATION; ARUM-MACULATUM; PHOTOSYSTEM-II; IRON; PROTEIN; RESPIRATION	Electrochemistry coupled with Fourier transform infrared (IR) spectroscopy was used to investigate the redox properties of recombinant alternative ubiquinol oxidase from Trypanosoma brucei, the organism responsible for African sleeping sickness. Stepwise reduction of the fully oxidized resting state of recombinant alternative ubiquinol oxidase revealed two distinct IR redox difference spectra. The first of these, signal 1, titrates in the reductive direction as an n = 2 Nernstian component with an apparent midpoint potential of 80 mV at pH 7.0. However, reoxidation of signal 1 in the same potential range under anaerobic conditions did not occur and only began with potentials in excess of 500 mV. Reoxidation by introduction of oxygen was also unsuccessful. Signal 1 contained clear features that can be assigned to protonation of at least one carboxylate group, further perturbations of carboxylic and histidine residues, bound ubiquinone, and a negative band at 1554 cm(-1) that might arise from a radical in the fully oxidized protein. A second distinct IR redox difference spectrum, signal 2, appeared more slowly once signal 1 had been reduced. This component could be reoxidized with potentials above 100 mV. In addition, when both signals 1 and 2 were reduced, introduction of oxygen caused rapid oxidation of both components. These data are interpreted in terms of the possible active site structure and mechanism of oxygen reduction to water.	[Marechal, Amandine; Rich, Peter R.] UCL, Inst Struct & Mol Biol, Glynn Lab Bioenerget, London WC1E 6BT, England; [Kido, Yasutoshi; Kita, Kiyoshi] Univ Tokyo, Dept Biomed Chem, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; [Moore, Anthony L.] Univ Sussex, Sch Life Sci, Dept Biochem & Biomed Sci, Brighton BN1 9QG, E Sussex, England	University of London; Birkbeck University London; University College London; University of Tokyo; University of Sussex	Rich, PR (corresponding author), UCL, Inst Struct & Mol Biol, Glynn Lab Bioenerget, Gower St, London WC1E 6BT, England.	prr@ucl.ac.uk	MARECHAL, Amandine/AAF-7931-2020; Kido, Yasutoshi/AAW-3688-2021	MARECHAL, Amandine/0000-0003-3460-3806; Kido, Yasutoshi/0000-0003-3615-2631; Kita, Kiyoshi/0000-0002-0426-4308	Wellcome Trust; Japanese Society for the Promotion of Science [18GS0314, 18073004]; Japanese Ministry of Education, Science, Culture, Sports and Technology; Biotechnology and Biological Sciences Research Council; Prime Minister's Initiative 2 ( Connect) fund for collaborative twinning with KK; Biotechnology and Biological Sciences Research Council Research [BB/H000097/1];  [21790402]; Biotechnology and Biological Sciences Research Council [BB/H000097/1, BB/C50747X/1, BB/E015328/1] Funding Source: researchfish; BBSRC [BB/H000097/1, BB/E015328/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Ministry of Education, Science, Culture, Sports and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Prime Minister's Initiative 2 ( Connect) fund for collaborative twinning with KK; Biotechnology and Biological Sciences Research Council Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Supported by a Wellcome Trust ViP award.; 2 Supported in part by Grant-in-aid for Young Scientists ( B) 21790402.; 3 Supported by Creative Scientific Research Grant 18GS0314, Grant-in-aid for Scientific Research on Priority Areas 18073004 from the Japanese Society for the Promotion of Science, and a Targeted Proteins Research Program from the Japanese Ministry of Education, Science, Culture, Sports and Technology.; 4 Supported by the Biotechnology and Biological Sciences Research Council and the Prime Minister's Initiative 2 ( Connect) fund for collaborative twinning with KK.; 5 Supported by Biotechnology and Biological Sciences Research Council Research Grant BB/H000097/1. To whom correspondence should be addressed. Tel.: 44-20-7679-7746; Fax: 44-20-7679-7096; E-mail: prr@ucl.ac.uk.	Affourtit C, 2004, BBA-BIOENERGETICS, V1608, P181, DOI 10.1016/j.bbabio.2003.12.002; Affourtit C, 2002, FEBS LETT, V510, P121, DOI 10.1016/S0014-5793(01)03261-6; Ajayi WU, 2002, J BIOL CHEM, V277, P8187, DOI 10.1074/jbc.M111477200; Albury MS, 2002, J BIOL CHEM, V277, P1190, DOI 10.1074/jbc.M109853200; Andersson ME, 1999, FEBS LETT, V449, P17, DOI 10.1016/S0014-5793(99)00376-2; Arrondo JLR, 1999, PROG BIOPHYS MOL BIO, V72, P367, DOI 10.1016/S0079-6107(99)00007-3; ARRONDO JLR, 1993, PROG BIOPHYS MOL BIO, V59, P23, DOI 10.1016/0079-6107(93)90006-6; ATKIN CL, 1973, J BIOL CHEM, V248, P7464; Barth A, 2000, PROG BIOPHYS MOL BIO, V74, P141, DOI 10.1016/S0079-6107(00)00021-3; Berthold DA, 2000, BBA-BIOENERGETICS, V1460, P241, DOI 10.1016/S0005-2728(00)00149-3; BERTHOLD DA, 1993, PLANT PHYSIOL, V101, P113, DOI 10.1104/pp.101.1.113; Berthold DA, 2003, ANNU REV PLANT BIOL, V54, P497, DOI 10.1146/annurev.arplant.54.031902.134915; Berthold DA, 2002, J BIOL CHEM, V277, P43608, DOI 10.1074/jbc.M206724200; Berthomieu C, 1998, BBA-BIOENERGETICS, V1365, P112, DOI 10.1016/S0005-2728(98)00056-5; Berthomieu C, 2005, BBA-BIOENERGETICS, V1707, P51, DOI 10.1016/j.bbabio.2004.03.011; Berthomieu C, 1998, BIOCHEMISTRY-US, V37, P10547, DOI 10.1021/bi980788m; Breton J, 1996, BBA-BIOENERGETICS, V1275, P84, DOI 10.1016/0005-2728(96)00054-0; Chaudhuri M, 2006, TRENDS PARASITOL, V22, P484, DOI 10.1016/j.pt.2006.08.007; CLARKSON AB, 1989, J BIOL CHEM, V264, P17770; Finnegan PM, 2004, ADV PHOTO RESPIRAT, V17, P163; Frisch MJ., 2005, GAUSSIAN 03; GLASOE PK, 1960, J PHYS CHEM-US, V64, P188, DOI 10.1021/j100830a521; Heimburg T, 1996, BIOCHEMISTRY-US, V35, P1375, DOI 10.1021/bi9515883; Iwaki M, 2005, BIOCHEMISTRY-US, V44, P4230, DOI 10.1021/bi047533v; Iwaki M, 2004, J AM CHEM SOC, V126, P2386, DOI 10.1021/ja039320j; Iwaki M, 2003, BIOCHEMISTRY-US, V42, P11109, DOI 10.1021/bi0343020; Koppenhofer A, 2000, BIOCHEMISTRY-US, V39, P4243, DOI 10.1021/bi000192a; McDonald AE, 2004, IUBMB LIFE, V56, P333, DOI 10.1080/1521-6540400000876; McDonald AE, 2006, COMP BIOCHEM PHYS D, V1, P357, DOI 10.1016/j.cbd.2006.08.001; MINAGAWA N, 1990, FEBS LETT, V267, P114, DOI 10.1016/0014-5793(90)80302-Y; Minagawa N, 1997, MOL BIOCHEM PARASIT, V84, P271, DOI 10.1016/S0166-6851(96)02797-1; Moore AL, 2002, TRENDS PLANT SCI, V7, P478, DOI 10.1016/S1360-1385(02)02366-X; Moore AL, 2008, BIOCHEM SOC T, V36, P1022, DOI 10.1042/BST0361022; Moore AL, 2008, BBA-BIOENERGETICS, V1777, P327, DOI 10.1016/j.bbabio.2008.01.004; Nakamura K, 2005, BIOCHEM BIOPH RES CO, V334, P593, DOI 10.1016/j.bbrc.2005.06.131; Nihei C, 2003, FEBS LETT, V538, P35, DOI 10.1016/S0014-5793(03)00120-0; Nihei C, 2002, BBA-MOL BASIS DIS, V1587, P234, DOI 10.1016/S0925-4439(02)00086-8; Noguchi T, 1999, BIOCHEMISTRY-US, V38, P10187, DOI 10.1021/bi990631+; Reisdorf WC, 1996, BIOCHEMISTRY-US, V35, P1383, DOI 10.1021/bi951589v; Rich PR, 2007, MOL BIOSYST, V3, P398, DOI 10.1039/b702328f; Rich PR, 2005, RSC BIOMOLEC SCI, P314; RICH PR, 1978, FEBS LETT, V96, P252, DOI 10.1016/0014-5793(78)80412-8; Rich PR, 2004, BBA-BIOENERGETICS, V1658, P165, DOI 10.1016/j.bbabio.2004.04.021; Roberts CW, 2004, INT J PARASITOL, V34, P297, DOI 10.1016/j.ijpara.2003.11.002; Solomon EI, 2000, CHEM REV, V100, P235, DOI 10.1021/cr9900275; Suzuki T, 2004, BIOCHEM BIOPH RES CO, V313, P1044, DOI 10.1016/j.bbrc.2003.12.038; Voevodskaya N, 2006, P NATL ACAD SCI USA, V103, P9850, DOI 10.1073/pnas.0600603103; Walden SE, 1996, J CHEM SOC PERK T 2, P2663, DOI 10.1039/p29960002663; Yabu Y, 2003, PARASITOL INT, V52, P155, DOI 10.1016/S1383-5769(03)00012-6	49	24	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31827	31833		10.1074/jbc.M109.059980	http://dx.doi.org/10.1074/jbc.M109.059980			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19767647	Green Published, hybrid			2022-12-27	WOS:000271572700037
J	Zou, K; Maeda, T; Watanabe, A; Liu, JJ; Liu, SY; Oba, R; Satoh, Y; Komano, H; Michikawa, M				Zou, Kun; Maeda, Tomoji; Watanabe, Atsushi; Liu, Junjun; Liu, Shuyu; Oba, Ryutaro; Satoh, Yoh-ichi; Komano, Hiroto; Michikawa, Makoto			A beta 42-to-A beta 40-and Angiotensin-converting Activities in Different Domains of Angiotensin-converting Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID BETA-PROTEIN; TERMINAL CATALYTIC DOMAIN; ALZHEIMERS-DISEASE; A-BETA; ACE; INHIBITION; DEPOSITION; PEPTIDE; MICE; A-BETA(1-42)	Amyloid beta-protein 1-42 (A beta 42) is believed to play a causative role in the development of Alzheimer disease (AD), although it is a minor part of A beta. In contrast, A beta 40 is the predominant secreted form of A beta and recent studies have suggested that A beta 40 has neuroprotective effects and inhibits amyloid deposition. We have reported that angiotensin-converting enzyme (ACE) converts A beta 42 to A beta 40, and its inhibition enhances brain A beta 42 deposition (Zou, K., Yamaguchi, H., Akatsu, H., Sakamoto, T., Ko, M., Mizoguchi, K., Gong, J. S., Yu, W., Yamamoto, T., Kosaka, K., Yanagisawa, K., and Michikawa, M. (2007) J. Neurosci. 27, 8628-8635). ACE has two homologous domains, each having a functional active site. In the present study, we identified the domain of ACE, which is responsible for converting A beta 42 to A beta 40. Interestingly, A beta 42-to-A beta 40-converting activity is solely found in the N-domain of ACE and the angiotensin-converting activity is found predominantly in the C-domain of ACE. We also found that the N-linked glycosylation is essential for both A beta 42-to-A beta 40- and angiotensin-converting activities and that unglycosylated ACE rapidly degraded. The domain-specific converting activity of ACE suggests that ACE inhibitors could be designed to specifically target the angiotensin-converting C-domain, without inhibiting the A beta 42-to-A beta 40-converting activity of ACE or increasing neurotoxic A beta 42.	[Komano, Hiroto] Iwate Med Univ, Sch Pharm, Dept Neurosci, Yahaba, Iwate 0283694, Japan; [Satoh, Yoh-ichi] Iwate Med Univ, Sch Med, Dept Anat, Yahaba, Iwate 0283694, Japan; [Oba, Ryutaro] BML Inc, Dept Adv Med & Dev, Kawagoe, Saitama 3501101, Japan; [Watanabe, Atsushi] Natl Ctr Geriatr & Gerontol, Dept Vasc Dementia Res, Natl Inst Longev Sci, Aichi 4748522, Japan; [Michikawa, Makoto] Natl Ctr Geriatr & Gerontol, Dept Alzheimer Dis Res, Natl Inst Longev Sci, Aichi 4748522, Japan	Iwate Medical University; Iwate Medical University; BML, Inc.; National Center for Geriatrics & Gerontology; National Center for Geriatrics & Gerontology		kunzou@iwate-med.ac.jp; hkomano@iwate-med.ac.jp; michi@nils.go.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [19800040, 19300138]; Ministry of Health, Labor and Welfare of Japan ( Comprehensive Research on Aging and Health) [H20-007]; National Institute of Biomedical Innovation ( NIBIO); Takeda Science Foundation; Kato Memorial Bioscience Foundation; The Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan ( Comprehensive Research on Aging and Health)(Ministry of Health, Labour and Welfare, Japan); National Institute of Biomedical Innovation ( NIBIO)(National Institute of Biomedical Innovation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Kato Memorial Bioscience Foundation; The Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan, Grant-in-Aid for Young Scientists ( Start-up) ( 19800040), and Scientific Research ( B) ( 19300138), the Ministry of Health, Labor and Welfare of Japan ( Comprehensive Research on Aging and Health) (H20-007), the Program for Promotion of Fundamental Studies in Health of the National Institute of Biomedical Innovation ( NIBIO), Takeda Science Foundation, Kato Memorial Bioscience Foundation, and The Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care.	Elkins JS, 2004, NEUROLOGY, V62, P363, DOI 10.1212/01.WNL.0000106823.72493.FF; Fuchs S, 2004, J BIOL CHEM, V279, P15946, DOI 10.1074/jbc.M400149200; Fuchs S, 2008, HYPERTENSION, V51, P267, DOI 10.1161/HYPERTENSIONAHA.107.097865; Hemming ML, 2005, J BIOL CHEM, V280, P37644, DOI 10.1074/jbc.M508460200; Hu JG, 2001, J BIOL CHEM, V276, P47863, DOI 10.1074/jbc.M104068200; Kehoe PG, 2007, LANCET NEUROL, V6, P373, DOI 10.1016/S1474-4422(07)70077-7; Kehoe PG, 1999, NAT GENET, V21, P71, DOI 10.1038/5009; Khachaturian AS, 2006, ARCH NEUROL-CHICAGO, V63, P686, DOI 10.1001/archneur.63.5.noc60013; Kim HJ, 2007, LIVER INT, V27, P633, DOI 10.1111/j.1478-3231.2007.01481.x; Lehmann DJ, 2005, AM J EPIDEMIOL, V162, P305, DOI 10.1093/aje/kwi202; McGowan E, 2005, NEURON, V47, P191, DOI 10.1016/j.neuron.2005.06.030; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Oba R, 2005, EUR J NEUROSCI, V21, P733, DOI 10.1111/j.1460-9568.2005.03912.x; ROUSSEAU A, 1995, J BIOL CHEM, V270, P3656, DOI 10.1074/jbc.270.8.3656; Sadhukhan R, 1996, J BIOL CHEM, V271, P6429, DOI 10.1074/jbc.271.11.6429; Sink KM, 2009, ARCH INTERN MED, V169, P1195, DOI 10.1001/archinternmed.2009.175; Skoog I, 1996, LANCET, V347, P1141, DOI 10.1016/S0140-6736(96)90608-X; SOUBRIER F, 1988, P NATL ACAD SCI USA, V85, P9386, DOI 10.1073/pnas.85.24.9386; Turner AJ, 2002, TRENDS PHARMACOL SCI, V23, P177, DOI 10.1016/S0165-6147(00)01994-5; Zou K, 2003, J NEUROCHEM, V87, P609, DOI 10.1046/j.1471-4159.2003.02018.x; Zou K, 2002, J NEUROSCI, V22, P4833, DOI 10.1523/JNEUROSCI.22-12-04833.2002; Zou K, 2008, BIOCHEMISTRY-US, V47, P3370, DOI 10.1021/bi7014508; Zou K, 2007, J NEUROSCI, V27, P8628, DOI 10.1523/JNEUROSCI.1549-07.2007; Zou K, 2008, REV NEUROSCIENCE, V19, P203	24	50	51	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31914	31920		10.1074/jbc.M109.011437	http://dx.doi.org/10.1074/jbc.M109.011437			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19773553	Green Published, hybrid			2022-12-27	WOS:000271572700046
J	Bu, SY; Mashek, MT; Mashek, DG				Bu, So Young; Mashek, Mara T.; Mashek, Douglas G.			Suppression of Long Chain Acyl-CoA Synthetase 3 Decreases Hepatic de Novo Fatty Acid Synthesis through Decreased Transcriptional Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN; INSULIN-RESISTANCE; GENE-EXPRESSION; LIPID DROPLETS; PPAR-ALPHA; LIVER; RECEPTOR; SREBP-1C; LIPOGENESIS; INHIBITION	Long chain acyl-CoA synthetases (ACSL) and fatty acid transport proteins (FATP) activate fatty acids to acyl-CoAs in the initial step of fatty acid metabolism. Numerous isoforms of ACSL and FATP exist with different tissue distribution patterns, intracellular locations, and substrate preferences, suggesting that each isoform has distinct functions in channeling fatty acids into different metabolic pathways. Because fatty acids, acyl-CoAs, and downstream lipid metabolites regulate various transcription factors that control hepatic energy metabolism, we hypothesized that ACSL or FATP isoforms differentially regulate hepatic gene expression. Using small interference RNA (siRNA), we knocked down each liver-specific ACSL and FATP isoform in rat primary hepatocyte cultures and subsequently analyzed reporter gene activity of numerous transcription factors and performed quantitative mRNA analysis of their target genes. Compared with control cells, which were transfected with control siRNA, knockdown of acyl-CoA synthetase 3 (ACSL3) significantly decreased reporter gene activity of several lipogenic transcription factors such as peroxisome proliferator activation receptor-gamma, carbohydrate-responsive element-binding protein, sterol regulatory element-binding protein-1c, and liver X receptor-alpha and the expression of their target genes. These findings were further supported by metabolic labeling studies that showed [1-C-14] acetate incorporation into lipid extracts was decreased in cells treated with ACSL3 siRNAs and that ACSL3 expression is up-regulated in ob/ob mice and mice fed a high sucrose diet. ACSL3 knockdown decreased total acyl-CoA synthetase activity without substantially altering the expression of other ACSL isoforms. In summary, these results identify a novel role for ACSL3 in mediating transcriptional control of hepatic lipogenesis.	[Bu, So Young; Mashek, Mara T.; Mashek, Douglas G.] Univ Minnesota, Dept Food Sci & Nutr, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Mashek, DG (corresponding author), Univ Minnesota, Dept Food Sci & Nutr, 1334 Eckles Ave, St Paul, MN 55108 USA.	dmashek@umn.edu	Mashek, Douglas/ABD-6844-2021	Mashek, Douglas/0000-0001-7033-3386	American Diabetes Association [07-07-JF-43]; Minnesota Obesity Center	American Diabetes Association(American Diabetes Association); Minnesota Obesity Center	This work was supported by American Diabetes Association Grant 07-07-JF-43 (to D. G. M.) and the Minnesota Obesity Center.	BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Chakravarthy MV, 2005, CELL METAB, V1, P309, DOI 10.1016/j.cmet.2005.04.002; Cohen P, 2002, SCIENCE, V297, P240, DOI 10.1126/science.1071527; Dentin R, 2005, J CLIN INVEST, V115, P2843, DOI 10.1172/JCI25256; Dentin R, 2006, DIABETES, V55, P2159, DOI 10.2337/db06-0200; Diraison F, 2002, AM J PHYSIOL-ENDOC M, V282, pE46, DOI 10.1152/ajpendo.2002.282.1.E46; Doege H, 2006, GASTROENTEROLOGY, V130, P1245, DOI 10.1053/j.gastro.2006.02.006; Forsythe CE, 2008, LIPIDS, V43, P65, DOI 10.1007/s11745-007-3132-7; Fujimoto Y, 2007, J LIPID RES, V48, P1280, DOI 10.1194/jlr.M700050-JLR200; Fujino T, 1996, J BIOL CHEM, V271, P16748, DOI 10.1074/jbc.271.28.16748; Gauthier MS, 2008, J BIOL CHEM, V283, P16514, DOI 10.1074/jbc.M708177200; GIBBONS GF, 1992, BIOCHEM J, V287, P749, DOI 10.1042/bj2870749; He ZB, 2004, AM J PHYSIOL-ENDOC M, V287, pE424, DOI 10.1152/ajpendo.00568.2003; Hernandez C, 2009, CELL METAB, V9, P215, DOI 10.1016/j.cmet.2009.02.001; Higuchi N, 2008, HEPATOL RES, V38, P1122, DOI 10.1111/j.1872-034X.2008.00382.x; Ide T, 2004, NAT CELL BIOL, V6, P351, DOI 10.1038/ncb1111; Innis SM, 2003, J PEDIATR-US, V143, pS1, DOI 10.1067/S0022-3476(03)00396-2; Jump DB, 2005, J NUTR, V135, P2503, DOI 10.1093/jn/135.11.2503; Kawaguchi T, 2002, J BIOL CHEM, V277, P3829, DOI 10.1074/jbc.M107895200; Li LO, 2006, J BIOL CHEM, V281, P37246, DOI 10.1074/jbc.M604427200; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Lorente-Cebrian S, 2006, J PHYSIOL BIOCHEM, V62, P61, DOI 10.1007/BF03174067; Mashek DG, 2006, J BIOL CHEM, V281, P945, DOI 10.1074/jbc.M507646200; Mashek DG, 2007, FUTURE LIPIDOL, V2, P465, DOI 10.2217/17460875.2.4.465; Mashek DG, 2006, J LIPID RES, V47, P2004, DOI 10.1194/jlr.M600150-JLR200; Mashek DG, 2006, CURR OPIN LIPIDOL, V17, P274, DOI 10.1097/01.mol.0000226119.20307.2b; MCGARRY JD, 1978, J BIOL CHEM, V253, P4128; Muoio DM, 2000, AM J PHYSIOL-ENDOC M, V279, pE1366, DOI 10.1152/ajpendo.2000.279.6.E1366; Nakamura MT, 2004, LIPIDS, V39, P1077, DOI 10.1007/s11745-004-1333-0; Pawar A, 2003, J BIOL CHEM, V278, P35931, DOI 10.1074/jbc.M306238200; Pawar A, 2002, J BIOL CHEM, V277, P39243, DOI 10.1074/jbc.M206170200; Pinent M, 2008, GENOMICS, V92, P26, DOI 10.1016/j.ygeno.2008.03.010; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Sapiro JM, 2009, J LIPID RES, V50, P1621, DOI 10.1194/jlr.M800614-JLR200; Schadinger SE, 2005, AM J PHYSIOL-ENDOC M, V288, pE1195, DOI 10.1152/ajpendo.00513.2004; Schroeder F, 2008, LIPIDS, V43, P1, DOI 10.1007/s11745-007-3111-z; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Stoeckman AK, 2004, J BIOL CHEM, V279, P15662, DOI 10.1074/jbc.M311301200; Stoeckman AK, 2002, J BIOL CHEM, V277, P27029, DOI 10.1074/jbc.M202638200; Tobe K, 2001, J BIOL CHEM, V276, P38337, DOI 10.1074/jbc.C100160200; Umlauf E, 2004, J BIOL CHEM, V279, P23699, DOI 10.1074/jbc.M310546200; Van Horn CG, 2005, BIOCHEMISTRY-US, V44, P1635, DOI 10.1021/bi047721l; Vedala A, 2006, J LIPID RES, V47, P2562, DOI 10.1194/jlr.M600200-JLR200; Watkins PA, 2008, J BIOL CHEM, V283, P1773, DOI 10.1074/jbc.R700037200; Westerbacka J, 2007, DIABETES, V56, P2759, DOI 10.2337/db07-0156; Winder WW, 1999, AM J PHYSIOL-ENDOC M, V277, pE1, DOI 10.1152/ajpendo.1999.277.1.E1; Xu J, 2001, J BIOL CHEM, V276, P9800, DOI 10.1074/jbc.M008973200; Yao HB, 2008, J BIOL CHEM, V283, P849, DOI 10.1074/jbc.M706160200; Zhang YL, 2006, J BIOL CHEM, V281, P37603, DOI 10.1074/jbc.M604709200	52	72	76	1	19	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30474	30483		10.1074/jbc.M109.036665	http://dx.doi.org/10.1074/jbc.M109.036665			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19737935	Green Published, hybrid			2022-12-27	WOS:000271090000050
J	Masuoka, HC; Mott, J; Bronk, SF; Werneburg, NW; Akazawa, Y; Kaufmann, SH; Gores, GJ				Masuoka, Howard C.; Mott, Justin; Bronk, Steven F.; Werneburg, Nathan W.; Akazawa, Yuko; Kaufmann, Scott H.; Gores, Gregory J.			Mcl-1 Degradation during Hepatocyte Lipoapoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY LIVER-DISEASE; PROTEIN-KINASE-C; HUMAN NONALCOHOLIC STEATOHEPATITIS; ENDOPLASMIC-RETICULUM STRESS; INDUCED INSULIN-RESISTANCE; HEPATIC STEATOSIS; BCL-2 FAMILY; APOPTOSIS; ACIDS; THETA	The mechanisms of free fatty acid-induced lipoapoptosis are incompletely understood. Here we demonstrate that Mcl-1, an anti-apoptotic member of the Bcl-2 family, was rapidly degraded in hepatocytes in response to palmitate and stearate by a proteasome-dependent pathway. Overexpression of a ubiquitin-resistant Mcl-1 mutant in Huh-7 cells attenuated palmitate-mediated Mcl-1 loss and lipoapoptosis; conversely, short hairpin RNA-targeted knockdown of Mcl-1 sensitized these cells to lipoapoptosis. Palmitate-induced Mcl-1 degradation was attenuated by the novel protein kinase C (PKC) inhibitor rottlerin. Of the two human novel PKC isozymes, PKC delta and PKC theta, only activation of PKC theta was observed by phospho-immunoblot analysis. As compared with Jurkat cells, a smaller PKC theta polypeptide and mRNA were expressed in hepatocytes consistent with an alternative splice variant. Short hairpin RNA-mediated knockdown of PKC theta reduced Mcl-1 degradation and lipoapoptosis. Likewise, genetic deletion of Pkc theta also attenuated Mcl-1 degradation and cytotoxicity by palmitate in primary hepatocytes. During treatment with palmitate, rottlerin inhibited phosphorylation of Mcl-1 at Ser(159), a phosphorylation site previously implicated in Mcl-1 turnover. Consistent with these results, an Mcl-1 S159A mutant was resistant to degradation and improved cell survival during palmitate treatment. Collectively, these results implicate PKC theta-dependent destabilization of Mcl-1 as a mechanism contributing to hepatocyte lipoapoptosis.	[Masuoka, Howard C.; Mott, Justin; Bronk, Steven F.; Werneburg, Nathan W.; Akazawa, Yuko; Gores, Gregory J.] Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA; [Kaufmann, Scott H.] Mayo Clin, Coll Med, Div Oncol Res, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Gores, GJ (corresponding author), Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, 200 1st St SW, Rochester, MN 55905 USA.	gores.gregory@mayo.edu		Mott, Justin/0000-0002-2927-6962; Kaufmann, Scott/0000-0002-4900-7145	National Institutes of Health [R01 DK41876, T32 07198, K01 DK79875, R01 CA69008]; Mayo Foundation;  [P309K 84567]; NATIONAL CANCER INSTITUTE [R01CA069008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK079875, P30DK084567, R01DK041876] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK41876 (to G. J. G.), T32 07198 (to H. C. M.), K01 DK79875 (to J. L. M.), R01 CA69008 (to S. H. K.), and the optical microscopy core of P309K 84567. This work was also supported by the Mayo Foundation.	Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Araya J, 2004, CLIN SCI, V106, P635, DOI 10.1042/CS20030326; Barreyro FJ, 2007, J BIOL CHEM, V282, P27141, DOI 10.1074/jbc.M704391200; Belfort R, 2006, NEW ENGL J MED, V355, P2297, DOI 10.1056/NEJMoa060326; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Chavez-Tapia NC, 2006, ANN INTERN MED, V144, P379, DOI 10.7326/0003-4819-144-5-200603070-00021; Cuconati A, 2003, GENE DEV, V17, P2922, DOI 10.1101/gad.1156903; Datta R, 1997, J BIOL CHEM, V272, P20317, DOI 10.1074/jbc.272.33.20317; De Almeida IT, 2002, CLIN NUTR, V21, P219, DOI 10.1054/clnu.2001.0529; Ding QQ, 2007, MOL CELL BIOL, V27, P4006, DOI 10.1128/MCB.00620-06; Doege H, 2008, J BIOL CHEM, V283, P22186, DOI 10.1074/jbc.M803510200; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Faubion WA, 1999, J CLIN INVEST, V103, P137, DOI 10.1172/JCI4765; Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Gentile CL, 2008, J NUTR BIOCHEM, V19, P567, DOI 10.1016/j.jnutbio.2007.10.001; Hamasaki A, 1998, J EXP MED, V188, P1985, DOI 10.1084/jem.188.11.1985; Han J, 2004, J BIOL CHEM, V279, P22020, DOI 10.1074/jbc.M313234200; Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005; Kahraman A, 2009, DIGEST DIS SCI, V54, P1908, DOI 10.1007/s10620-008-0583-5; Kim JK, 2004, J CLIN INVEST, V114, P823, DOI 10.1172/JCI200422230; Kobayashi S, 2007, J BIOL CHEM, V282, P18407, DOI 10.1074/jbc.M610010200; Kodama Y, 2009, GASTROENTEROLOGY, V136, P1423, DOI 10.1053/j.gastro.2008.12.064; Larter CZ, 2008, J HEPATOL, V48, P638, DOI 10.1016/j.jhep.2007.12.011; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Liu Y, 2002, BIOCHEM J, V361, P255, DOI 10.1042/bj3610255; Malhi H, 2006, J BIOL CHEM, V281, P12093, DOI 10.1074/jbc.M510660200; Malhi H, 2007, GUT, V56, P1124, DOI 10.1136/gut.2006.118059; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Meng XW, 2007, J BIOL CHEM, V282, P29831, DOI 10.1074/jbc.M706110200; Nehra V, 2001, DIGEST DIS SCI, V46, P2347, DOI 10.1023/A:1012338828418; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Parekh S, 2007, GASTROENTEROLOGY, V132, P2191, DOI 10.1053/j.gastro.2007.03.055; Print CG, 1998, P NATL ACAD SCI USA, V95, P12424, DOI 10.1073/pnas.95.21.12424; Puri P, 2007, HEPATOLOGY, V46, P1081, DOI 10.1002/hep.21763; Ratziu V, 2006, HEPATOLOGY, V44, P802, DOI 10.1002/hep.21391; RICHIERI GV, 1995, J LIPID RES, V36, P229; Ross AJ, 1998, NAT GENET, V18, P251, DOI 10.1038/ng0398-251; Sakaki K, 2008, J BIOL CHEM, V283, P15370, DOI 10.1074/jbc.M710209200; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Schultz A, 2003, CELL DEATH DIFFER, V10, P662, DOI 10.1038/sj.cdd.4401235; Schulze-Bergkamen H, 2004, HEPATOLOGY, V39, P645, DOI 10.1002/hep.20138; Solinas G, 2006, P NATL ACAD SCI USA, V103, P16454, DOI 10.1073/pnas.0607626103; Takehara T, 2004, GASTROENTEROLOGY, V127, P1189, DOI 10.1053/j.gastro.2004.07.019; Taniai M, 2004, CANCER RES, V64, P3517, DOI 10.1158/0008-5472.CAN-03-2770; Timmers S, 2008, PHYSIOL BEHAV, V94, P242, DOI 10.1016/j.physbeh.2007.12.002; Tzung SP, 1997, AM J PATHOL, V150, P1985; Vick B, 2009, HEPATOLOGY, V49, P627, DOI 10.1002/hep.22664; Wang D, 2006, ENDOCRINOLOGY, V147, P943, DOI 10.1210/en.2005-0570; Warr MR, 2008, CURR MOL MED, V8, P138; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Wieckowska A, 2006, HEPATOLOGY, V44, P27, DOI 10.1002/hep.21223; Yamaguchi K, 2007, HEPATOLOGY, V45, P1366, DOI 10.1002/hep.21655; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Zhao Y, 2007, MOL CELL BIOL, V27, P4328, DOI 10.1128/MCB.00153-07; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009; Zhou J, 2008, GASTROENTEROLOGY, V134, P556, DOI 10.1053/j.gastro.2007.11.037	62	35	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30039	30048		10.1074/jbc.M109.039545	http://dx.doi.org/10.1074/jbc.M109.039545			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19734538	Green Published, hybrid			2022-12-27	WOS:000271090000006
J	Liang, J; Lei, TH; Song, YT; Yanes, N; Qi, YF; Fu, MG				Liang, Jian; Lei, Tianhua; Song, Yuting; Yanes, Natalie; Qi, Yongfen; Fu, Mingui			RNA-destabilizing Factor Tristetraprolin Negatively Regulates NF-kappa B Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEINS; MESSENGER-RNA; MACROPHAGE ACTIVATION; INFLAMMATORY DISEASES; GENE-EXPRESSION; TNF-ALPHA; FAMILY; PATHWAY; LOCALIZATION; TRANSDUCTION	Tristetraprolin (TTP) is a CCCH zinc finger-containing protein that destabilizes mRNA by binding to an AU-rich element. Mice deficient in TTP develop a severe inflammatory syndrome mainly because of overproduction of tumor necrosis factor alpha. We report here that TTP also negatively regulates NF-kappa B signaling at the transcriptional corepressor level, by which it may repress inflammatory gene transcription. TTP expression inhibited NF-kappa B-dependent transcription. However, overexpression of TTP did not affect reporter mRNA stability. Instead, TTP functioned as a corepressor of p65/NF-kappa B. In support of this concept, we found that TTP physically interacted with the p65 subunit of NF-kappa B and was also associated with HDAC1, -3, and -7 in vivo. Treatment with histone deacetylase inhibitors or small interfering RNA induced HDAC1 or HDAC3 knockdown completely or partly abolished the inhibitory activity of TTP on NF-kappa B reporter activation. Consistently, chromatin immuno-precipitation showed decreased recruitment of HDAC1 and increased recruitment of CREB-binding protein on the Mcp-1 promoter in TTP-/- cells compared with wild-type cells. Moreover, overexpression of TTP blocked CREB-binding protein-induced acetylation of p65/NF-kappa B. Taken together, these data suggest that TTP may also function in vivo as a modulator in suppressing the transcriptional activity of NF-kappa B.	[Liang, Jian; Lei, Tianhua; Song, Yuting; Yanes, Natalie; Qi, Yongfen; Fu, Mingui] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida	Fu, MG (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, 4000 Cent Florida Blvd, Orlando, FL 32816 USA.	mfu@mail.ucf.edu			James and Esther King New Investigator research grant; American Heart Association	James and Esther King New Investigator research grant; American Heart Association(American Heart Association)	This work was supported by a James and Esther King New Investigator research grant and an American Heart Association beginning grant-in-aid (to M. F.).	Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Batchelder C, 1999, GENE DEV, V13, P202, DOI 10.1101/gad.13.2.202; Cao HP, 2004, J BIOL CHEM, V279, P21489, DOI 10.1074/jbc.M400900200; Carballo E, 2000, BLOOD, V95, P1891, DOI 10.1182/blood.V95.6.1891; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Carballo E, 2001, J BIOL CHEM, V276, P42580, DOI 10.1074/jbc.M104953200; Carrick DM, 2004, ARTHRITIS RES THER, V6, P248, DOI 10.1186/ar1441; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Fairhurst AM, 2003, ARTHRITIS RES THER, V5, pR214, DOI 10.1186/ar778; Goler-Baron V, 2008, GENE DEV, V22, P2022, DOI 10.1101/gad.473608; Harkin DP, 1999, CELL, V97, P575, DOI 10.1016/S0092-8674(00)80769-2; Ishmael FT, 2008, J IMMUNOL, V180, P8342, DOI 10.4049/jimmunol.180.12.8342; Johnson BA, 2000, ONCOGENE, V19, P1657, DOI 10.1038/sj.onc.1203474; Johnson BA, 2002, J BIOL CHEM, V277, P18029, DOI 10.1074/jbc.M110465200; Johnson BA, 2002, ONCOGENE, V21, P4237, DOI 10.1038/sj.onc.1205526; KANOH J, 1995, MOL BIOL CELL, V6, P1185, DOI 10.1091/mbc.6.9.1185; Kuprash DV, 1999, J IMMUNOL, V162, P4045; Lai WS, 2002, J BIOL CHEM, V277, P9606, DOI 10.1074/jbc.M110395200; Liang J, 2008, J BIOL CHEM, V283, P6337, DOI 10.1074/jbc.M707861200; Liang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002880; Natoli G, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.11pe1; O'Neill LAJ, 2006, NAT REV DRUG DISCOV, V5, P549, DOI 10.1038/nrd2070; Ogawa S, 2004, P NATL ACAD SCI USA, V101, P14461, DOI 10.1073/pnas.0405786101; Ogilvie RL, 2005, J IMMUNOL, V174, P953, DOI 10.4049/jimmunol.174.2.953; Pfitzner E, 2004, CURR PHARM DESIGN, V10, P2839; Phillips RS, 2002, J BIOL CHEM, V277, P11606, DOI 10.1074/jbc.M111457200; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Thompson MJ, 1996, GENE, V174, P225, DOI 10.1016/0378-1119(96)00084-4; Twizere JC, 2003, J NATL CANCER I, V95, P1846, DOI 10.1093/jnci/djg118; WARBRICK E, 1994, GENE, V151, P243, DOI 10.1016/0378-1119(94)90664-5; Wormald S, 2004, J BIOL CHEM, V279, P821, DOI 10.1074/jbc.R300030200; Zhu W, 2001, AM J PHYSIOL-LUNG C, V281, pL499, DOI 10.1152/ajplung.2001.281.2.L499	32	72	72	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29383	29390		10.1074/jbc.M109.024745	http://dx.doi.org/10.1074/jbc.M109.024745			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19738286	Green Published, hybrid			2022-12-27	WOS:000270896800019
J	Murayama, K; Nakayama, S; Kato-Murayama, M; Akasaka, R; Ohbayashi, N; Kamewari-Hayami, Y; Terada, T; Shirouzu, M; Tsurumi, T; Yokoyama, S				Murayama, Kazutaka; Nakayama, Sanae; Kato-Murayama, Miyuki; Akasaka, Ryogo; Ohbayashi, Naomi; Kamewari-Hayami, Yuki; Terada, Takaho; Shirouzu, Mikako; Tsurumi, Tatsuya; Yokoyama, Shigeyuki			Crystal Structure of Epstein-Barr Virus DNA Polymerase Processivity Factor BMRF1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC SUBUNIT; ACCESSORY PROTEIN; SLIDING CLAMP; C-TERMINUS; FUNCTIONAL INTERACTION; BINDING ACTIVITY; REPLICATION; UL42; PURIFICATION; SPECIFICITY	The DNA polymerase processivity factor of the Epstein-Barr virus, BMRF1, associates with the polymerase catalytic subunit, BALF5, to enhance the polymerase processivity and exonuclease activities of the holoenzyme. In this study, the crystal structure of C-terminally truncated BMRF1 (BMRF1-Delta C) was solved in an oligomeric state. The molecular structure of BMRF1-Delta C shares structural similarity with other processivity factors, such as herpes simplex virus UL42, cytomegalovirus UL44, and human proliferating cell nuclear antigen. However, the oligomerization architectures of these proteins range from a monomer to a trimer. PAGE and mutational analyses indicated that BMRF1-Delta C, like UL44, forms a C-shaped head-to-head dimer. DNA binding assays suggested that basic amino acid residues on the concave surface of the C-shaped dimer play an important role in interactions with DNA. The C95E mutant, which disrupts dimer formation, lacked DNA binding activity, indicating that dimer formation is required for DNA binding. These characteristics are similar to those of another dimeric viral processivity factor, UL44. Although the R87E and H141F mutants of BMRF1-Delta C exhibited dramatically reduced polymerase processivity, they were still able to bind DNA and to dimerize. These amino acid residues are located near the dimer interface, suggesting that BMRF1-Delta C associates with the catalytic subunit BALF5 around the dimer interface. Consequently, the monomeric form of BMRF1-Delta C probably binds to BALF5, because the steric consequences would prevent the maintenance of the dimeric form. A distinctive feature of BMRF1-Delta C is that the dimeric and monomeric forms might be utilized for the DNA binding and replication processes, respectively.	[Nakayama, Sanae; Tsurumi, Tatsuya] Aichi Canc Ctr, Div Virol, Res Inst, Chikusa Ku, Nagoya, Aichi 4648681, Japan; Tohoku Univ, Grad Sch Biomed Engn, Div Biomed Measurements & Diagnost, Sendai, Miyagi 9808575, Japan; [Murayama, Kazutaka; Kato-Murayama, Miyuki; Akasaka, Ryogo; Ohbayashi, Naomi; Kamewari-Hayami, Yuki; Terada, Takaho; Shirouzu, Mikako; Yokoyama, Shigeyuki] RIKEN, Syst Struct Biol Ctr, Yokohama, Kanagawa 2300045, Japan; [Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130033, Japan	Aichi Cancer Center; Tohoku University; RIKEN; University of Tokyo	Tsurumi, T (corresponding author), Aichi Canc Ctr, Div Virol, Res Inst, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.	ttsurumi@aichi-cc.jp; yokoyama@biochem.s.u-tokyo.ac.jp	Shirouzu, Mikako/A-6521-2016; Yokoyama, Shigeyuki/N-6911-2015	Yokoyama, Shigeyuki/0000-0003-3133-7338	Special Coordination Funds for Promoting Science and Technology; RIKEN; Ministry of Education, Culture, Sports, Science, and Technology	Special Coordination Funds for Promoting Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN; Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Special Coordination Funds for Promoting Science and Technology and the RIKEN Structure Genomics/Proteomics Initiative in the National Project on Protein Structural and Functional Analyses, Ministry of Education, Culture, Sports, Science, and Technology.	Appleton BA, 2006, J BIOL CHEM, V281, P5224, DOI 10.1074/jbc.M506900200; Appleton BA, 2004, MOL CELL, V15, P233, DOI 10.1016/j.molcel.2004.06.018; Argiriadi MA, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-2; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bruck I, 2001, GENOME BIOL, V2; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burnouf DY, 2004, J MOL BIOL, V335, P1187, DOI 10.1016/j.jmb.2003.11.049; Chapados BR, 2004, CELL, V116, P39, DOI 10.1016/S0092-8674(03)01036-5; Chen XL, 2004, J BIOL CHEM, V279, P28375, DOI 10.1074/jbc.M400032200; CHOW CS, 1995, J VIROL, V69, P6965, DOI 10.1128/JVI.69.11.6965-6971.1995; Daikoku T, 2005, J VIROL, V79, P3409, DOI 10.1128/JVI.79.6.3409-3418.2005; DeLano W.L, PYMOL MOL GRAPHICS S; DIGARD P, 1993, J VIROL, V67, P398, DOI 10.1128/JVI.67.1.398-406.1993; FIXMAN ED, 1995, J VIROL, V69, P2998, DOI 10.1128/JVI.69.5.2998-3006.1995; Georgescu RE, 2008, CELL, V132, P43, DOI 10.1016/j.cell.2007.11.045; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kawabata T, 2003, NUCLEIC ACIDS RES, V31, P3367, DOI 10.1093/nar/gkg581; Kigawa Takanori, 2002, Journal of Structural and Functional Genomics, V2, P29, DOI 10.1023/A:1013203532303; Komazin-Meredith G, 2008, STRUCTURE, V16, P1214, DOI 10.1016/j.str.2008.05.008; Komazin-Meredith G, 2008, J BIOL CHEM, V283, P6154, DOI 10.1074/jbc.M708691200; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Loregian A, 2004, J VIROL, V78, P158, DOI 10.1128/JVI.78.1.158-167.2004; Loregian A, 2007, NUCLEIC ACIDS RES, V35, P4779, DOI 10.1093/nar/gkm506; Makhov AM, 2004, J BIOL CHEM, V279, P40358, DOI 10.1074/jbc.M408733200; Matsumiya S, 2003, PROTEIN SCI, V12, P823, DOI 10.1110/ps.0234503; MCENTEE K, 1980, P NATL ACAD SCI-BIOL, V77, P857, DOI 10.1073/pnas.77.2.857; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Moarefi I, 2000, J MOL BIOL, V296, P1215, DOI 10.1006/jmbi.1999.3511; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Randell JCW, 2005, J VIROL, V79, P12025, DOI 10.1128/JVI.79.18.12025-12034.2005; Randell JCW, 2004, J MOL BIOL, V335, P409, DOI 10.1016/j.jmb.2003.10.064; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shamoo Y, 1999, CELL, V99, P155, DOI 10.1016/S0092-8674(00)81647-5; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tsurumi T, 2005, REV MED VIROL, V15, P3, DOI 10.1002/rmv.441; Tsurumi T, 1996, VIROLOGY, V222, P352, DOI 10.1006/viro.1996.0432; TSURUMI T, 1993, J VIROL, V67, P1681, DOI 10.1128/JVI.67.3.1681-1687.1993; TSURUMI T, 1991, BIOCHEM J, V280, P703, DOI 10.1042/bj2800703; TSURUMI T, 1994, J VIROL, V68, P3354, DOI 10.1128/JVI.68.5.3354-3363.1994; TSURUMI T, 1993, J VIROL, V67, P7648, DOI 10.1128/JVI.67.12.7648-7653.1993; TSURUMI T, 1991, VIROLOGY, V182, P376, DOI 10.1016/0042-6822(91)90685-5; Tsurumi T, 2001, CURR TOP MICROBIOL, V258, P65; VILLANI G, 1981, J BIOL CHEM, V256, P8202; Weisshart K, 1999, J VIROL, V73, P55, DOI 10.1128/JVI.73.1.55-66.1999; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Zuccola HJ, 2000, MOL CELL, V5, P267, DOI 10.1016/S1097-2765(00)80422-0	48	31	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35896	35905		10.1074/jbc.M109.051581	http://dx.doi.org/10.1074/jbc.M109.051581			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19801550	hybrid, Green Published			2022-12-27	WOS:000272645600065
J	Hall, EH; Daugherty, AE; Choi, CK; Horwitz, AF; Brautigan, DL				Hall, Emily H.; Daugherty, Abbi E.; Choi, Colin K.; Horwitz, Alan F.; Brautigan, David L.			Tensin1 Requires Protein Phosphatase-1 alpha in Addition to RhoGAP DLC-1 to Control Cell Polarization, Migration, and Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; FOCAL ADHESIONS; MATRIX ADHESIONS; TUMOR-SUPPRESSOR; LIVER; DROSOPHILA; DYNAMICS; INTEGRIN; DOMAIN; SWITCH	Tensin is a family of multidomain scaffold proteins that bind the cytoplasmic tail of beta-integrins and localize to adhesions that anchor stress fibers in cells. Tensin expression is suppressed in cancer, especially metastatic cancer. The N-terminal domain of tensin1 associates with protein phosphatase-1 alpha (PP1 alpha) and mediates PP1 alpha localization to adhesions. Here, we show F302A mutation in aKVXF motif of tensin1 abrogates binding to PP1 alpha. The SH2 domain in tensin family member c-ten requires R474 to bind a RhoGAP called DLC-1 (deleted in liver cancer). We mutated the corresponding residue in tensin1, R1488A, and showed this reduces association with DLC-1. Unexpectedly, tensin1 F302A also had reduced association with DLC-1. Expression of tensin1 F302A or R1488A showed similar dominant phenotypes, with reduced cell polarization, lowered MLC20 phosphorylation and reduced levels of RhoA(GTP) compared with cells expressing tensin1 WT. However, migration and invasion of metastatic MDA MB 231 breast cancer cells were differentially affected by tensin1 mutated at F302A or R1488A. Cancer cells stably expressing F302A tensin1 showed increased migration and invasion compared with cells stably expressing either R1488A tensin1 or WT tensin1. This suggests that PP1 alpha bound to tensin1 has additional effects in reducing migration and invasion that are not mediated through DLC-1. Our results show the importance of PP1 alpha binding to tensin1 for the regulation of cell polarization, migration, and invasion.	[Hall, Emily H.; Daugherty, Abbi E.] Univ Virginia, Sch Med, Ctr Cell Signaling, Charlottesville, VA 22908 USA; [Hall, Emily H.; Daugherty, Abbi E.; Brautigan, David L.] Univ Virginia, Sch Med, Dept Microbiol, Charlottesville, VA 22908 USA; [Choi, Colin K.] Univ Virginia, Sch Med, Dept Biomed Engn, Charlottesville, VA 22908 USA; [Horwitz, Alan F.] Univ Virginia, Sch Med, Dept Cell Biol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia	Brautigan, DL (corresponding author), Univ Virginia, Sch Med, Ctr Cell Signaling, POB 800577, Charlottesville, VA 22908 USA.	db8g@virginia.edu			National Institutes of Health [CA40042, GM23244, T32 CA009109]; NATIONAL CANCER INSTITUTE [P01CA040042, T32CA009109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023244, R37GM023244] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA40042, GM23244, and T32 CA009109.	Chen HY, 2000, BIOCHEM J, V351, P403, DOI 10.1042/0264-6021:3510403; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Durkin ME, 2007, J CELL MOL MED, V11, P1185, DOI 10.1111/j.1582-4934.2007.00098.x; Eto M, 2007, J BIOL CHEM, V282, P17806, DOI 10.1074/jbc.M700944200; Hendrickx A, 2009, CHEM BIOL, V16, P365, DOI 10.1016/j.chembiol.2009.02.012; Hers I, 2006, J BIOL CHEM, V281, P4762, DOI 10.1074/jbc.M511008200; Katz BZ, 2000, MOL BIOL CELL, V11, P1047, DOI 10.1091/mbc.11.3.1047; Katz M, 2007, NAT CELL BIOL, V9, P961, DOI 10.1038/ncb1622; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee SB, 2003, DEVELOPMENT, V130, P4001, DOI 10.1242/dev.00595; Liao YC, 2008, INT J BIOCHEM CELL B, V40, P843, DOI 10.1016/j.biocel.2007.04.008; Liao YC, 2007, J CELL BIOL, V176, P43, DOI 10.1083/jcb.200608015; Lo SH, 2004, INT J BIOCHEM CELL B, V36, P31, DOI 10.1016/S1357-2725(03)00171-7; Lo SH, 1997, J CELL BIOL, V136, P1349, DOI 10.1083/jcb.136.6.1349; Mouneimne G, 2007, DEV CELL, V13, P317, DOI 10.1016/j.devcel.2007.08.010; Petit V, 2000, BIOL CELL, V92, P477, DOI 10.1016/S0248-4900(00)01101-1; Pylayeva Y, 2007, NAT CELL BIOL, V9, P877, DOI 10.1038/ncb0807-877; Qian XL, 2007, P NATL ACAD SCI USA, V104, P9012, DOI 10.1073/pnas.0703033104; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Romer LH, 2006, CIRC RES, V98, P606, DOI 10.1161/01.RES.0000207408.31270.db; Torgler CN, 2004, DEV CELL, V6, P357, DOI 10.1016/S1534-5807(04)00055-3; Vicente-Manzanares M, 2008, J CELL BIOL, V183, P543, DOI 10.1083/jcb.200806030; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Yam JWP, 2006, CANCER RES, V66, P8367, DOI 10.1158/0008-5472.CAN-05-2850; Zamir E, 2001, J CELL SCI, V114, P3583; Zamir E, 1999, J CELL SCI, V112, P1655	26	39	42	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34713	34722		10.1074/jbc.M109.059592	http://dx.doi.org/10.1074/jbc.M109.059592			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19826001	Green Published, hybrid			2022-12-27	WOS:000272439600027
J	Singleton, PA; Pendyala, S; Gorshkova, IA; Mambetsariev, N; Moitra, J; Garcia, JGN; Natarajan, V				Singleton, Patrick A.; Pendyala, Srikanth; Gorshkova, Irina A.; Mambetsariev, Nurbek; Moitra, Jaideep; Garcia, Joe G. N.; Natarajan, Viswanathan			Dynamin 2 and c-Abl Are Novel Regulators of Hyperoxia-mediated NADPH Oxidase Activation and Reactive Oxygen Species Production in Caveolin-enriched Microdomains of the Endothelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR SMOOTH-MUSCLE; TYROSINE KINASE; NAD(P)H OXIDASE; ANGIOTENSIN-II; LIPID RAFTS; PHOSPHORYLATION; RECEPTOR; SRC; GENERATION; TRANSACTIVATION	Reactive oxygen species (ROS) generation, particularly by the endothelial NADPH oxidase family of proteins, plays a major role in the pathophysiology associated with lung inflammation, ischemia/reperfusion injury, sepsis, hyperoxia, and ventilator-associated lung injury. We examined potential regulators of ROS production and discovered that hyperoxia treatment of human pulmonary artery endothelial cells induced recruitment of the vesicular regulator, dynamin 2, the non-receptor tyrosine kinase, c-Abl, and the NADPH oxidase subunit, p47(phox), to caveolin-enriched microdomains (CEMs). Silencing caveolin-1 (which blocks CEM formation) and/or c-Abl expression with small interference RNA inhibited hyperoxia-mediated tyrosine phosphorylation and association of dynamin 2 with p47(phox) and ROS production. In addition, treatment of human pulmonary artery endothelial cells with dynamin 2 small interfering RNA or the dynamin GTPase inhibitor, Dynasore, attenuated hyperoxia-mediated ROS production and p47(phox) recruitment to CEMs. Using purified recombinant proteins, we observed that c-Abl tyrosine-phosphorylated dynamin 2, and this phosphorylation increased p47(phox)/dynamin 2 association (change in the dissociation constant (K-d) from 85.8 to 6.9 nM). Furthermore, exposure of mice to hyperoxia increased ROS production, c-Abl activation, dynamin 2 association with p47(phox), and pulmonary leak, events that were attenuated in the caveolin-1 knock-out mouse confirming a role for CEMs in ROS generation. These results suggest that hyperoxia induces c-Abl-mediated dynamin 2 phosphorylation required for recruitment of p47(phox) to CEMs and subsequent ROS production in lung endothelium.	[Singleton, Patrick A.] Univ Chicago, Dept Med, Sect Pulm & Crit Care Med, Pritzker Sch Med, Chicago, IL 60637 USA	University of Chicago	Singleton, PA (corresponding author), Univ Chicago, Dept Med, Sect Pulm & Crit Care Med, Pritzker Sch Med, GCIS Bldg,Suite W403E,929 E 57th St, Chicago, IL 60637 USA.	psinglet@medicine.bsd.uchicago.edu	Garcia, Joe GN/E-8862-2010		National Institutes of Health [RO1-HL 095723, RO1 HL 085553, PO1-HL 58064]; American Heart Association [0730277N]; American Lung Association [RG-75229-N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL058064, R01HL095723, R01HL085553] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Lung Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-HL 095723 (to P.A.S.), RO1 HL 085553 (to V.N.), and PO1-HL 58064 (to J.G.N., V.N., and P.A.S.). This work was also supported by American Heart Association National Scientist Development Grant 0730277N (to P.A.S.) and by American Lung Association National Biomedical Research Grant RG-75229-N (to P.A.S.).	Cadwallader KA, 2002, J IMMUNOL, V169, P3336, DOI 10.4049/jimmunol.169.6.3336; Cave AC, 2006, ANTIOXID REDOX SIGN, V8, P691, DOI 10.1089/ars.2006.8.691; Chowdhury AK, 2005, J BIOL CHEM, V280, P20700, DOI 10.1074/jbc.M411722200; El-Benna J, 2009, EXP MOL MED, V41, P217, DOI 10.3858/emm.2009.41.4.058; Frank PG, 2007, CURR PHARM DESIGN, V13, P1761, DOI 10.2174/138161207780831202; Furstoss O, 2002, EMBO J, V21, P514, DOI 10.1093/emboj/21.4.514; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Hantschel O, 2004, NAT REV MOL CELL BIO, V5, P33, DOI 10.1038/nrm1280; Hu GC, 2008, AM J PHYSIOL-LUNG C, V294, pL178, DOI 10.1152/ajplung.00263.2007; Jin Y, 2008, AM J RESP CELL MOL, V39, P171, DOI 10.1165/rcmb.2007-0323OC; Kruchten AE, 2006, J CELL SCI, V119, P1683, DOI 10.1242/jcs.02963; Lau ATY, 2008, J CELL BIOCHEM, V104, P657, DOI 10.1002/jcb.21655; Lee CS, 2006, NAT CELL BIOL, V8, P477, DOI 10.1038/ncb1401; Li XA, 2005, TRENDS CARDIOVAS MED, V15, P92, DOI 10.1016/j.tcm.2005.04.001; Lin J, 2008, ONCOGENE, V27, P4385, DOI 10.1038/onc.2008.86; Murata T, 2007, J EXP MED, V204, P2373, DOI 10.1084/jem.20062340; Parinandi NL, 2003, AM J PHYSIOL-LUNG C, V284, pL26, DOI 10.1152/ajplung.00123.2002; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Pendyala S, 2009, ANTIOXID REDOX SIGN, V11, P841, DOI [10.1089/ars.2008.2231, 10.1089/ARS.2008.2231]; Pendyala S, 2009, ANTIOXID REDOX SIGN, V11, P747, DOI [10.1089/ars.2008.2203, 10.1089/ARS.2008.2203]; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Pries A. R., 2006, V176, P1; Ray R, 2005, CLIN SCI, V109, P217, DOI 10.1042/CS20050067; Robinson JM, 2008, HISTOCHEM CELL BIOL, V130, P281, DOI 10.1007/s00418-008-0461-4; Sanguinetti AR, 2003, CELL SIGNAL, V15, P289, DOI 10.1016/S0898-6568(02)00090-6; Schafer DA, 2004, TRAFFIC, V5, P463, DOI 10.1111/j.1600-0854.2004.00199.x; Schlunck G, 2004, MOL BIOL CELL, V15, P256, DOI 10.1091/mbc.E03-01-0019; Selemidis S, 2008, PHARMACOL THERAPEUT, V120, P254, DOI 10.1016/j.pharmthera.2008.08.005; Shajahan AN, 2004, J BIOL CHEM, V279, P20392, DOI 10.1074/jbc.M308710200; Singleton PA, 2004, EXP CELL RES, V295, P102, DOI 10.1016/j.yexcr.2003.12.025; Singleton PA, 2007, J BIOL CHEM, V282, P30643, DOI 10.1074/jbc.M702573200; Singleton PA, 2006, J BIOL CHEM, V281, P34381, DOI 10.1074/jbc.M603680200; Singleton PA, 2009, CIRC RES, V104, P978, DOI 10.1161/CIRCRESAHA.108.193367; Sirvent A, 2008, BIOL CELL, V100, P617, DOI 10.1042/BC20080020; Sun XG, 2000, J BIOL CHEM, V275, P17237, DOI 10.1074/jbc.C000099200; Touyz RM, 2003, ARTERIOSCL THROM VAS, V23, P981, DOI 10.1161/01.ATV.0000069236.27911.68; Usatyuk PV, 2007, J BIOL CHEM, V282, P23284, DOI 10.1074/jbc.M700535200; Usatyuk PV, 2009, J BIOL CHEM, V284, P15339, DOI 10.1074/jbc.M109.005439; Ushio-Fukai M, 2005, CIRC RES, V97, P829, DOI 10.1161/01.RES.0000185322.46009.F5; Ushio-Fukai M, 2006, SCI STKE, V2006, pre8, DOI DOI 10.1126/STKE.3492006RE8; Utomo A, 2006, J IMMUNOL, V177, P6388, DOI 10.4049/jimmunol.177.9.6388; Williams TM, 2004, ANN MED, V36, P584, DOI 10.1080/07853890410018899; Wunderlich C, 2008, J MOL CELL CARDIOL, V44, P938, DOI 10.1016/j.yjmcc.2008.02.275; Yao Q, 2005, J MOL BIOL, V348, P491, DOI 10.1016/j.jmb.2005.02.003; Yung Lai Ming, 2006, Cardiovascular & Hematological Disorders - Drug Targets, V6, P1; Zhang DX, 2007, AM J PHYSIOL-HEART C, V292, pH2023, DOI 10.1152/ajpheart.01283.2006; Zuo L, 2005, ARTERIOSCL THROM VAS, V25, P1824, DOI 10.1161/01.ATV.0000175295.09607.18	47	30	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34964	34975		10.1074/jbc.M109.013771	http://dx.doi.org/10.1074/jbc.M109.013771			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19833721	Green Published, hybrid			2022-12-27	WOS:000272439600052
J	Bando, M; Katou, Y; Komata, M; Tanaka, H; Itoh, T; Sutani, T; Shirahige, K				Bando, Masashige; Katou, Yuki; Komata, Makiko; Tanaka, Hirokazu; Itoh, Takehiko; Sutani, Takashi; Shirahige, Katsuhiko			Csm3, Tof1, and Mrc1 Form a Heterotrimeric Mediator Complex That Associates with DNA Replication Forks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-PHASE CHECKPOINT; SACCHAROMYCES-CEREVISIAE; EUKARYOTIC DNA; PROGRESSION; HELICASE; STRESS; RAD53; MCM; COMPONENTS; RESPONSES	Mrc1(mediator of replication checkpoint), Tof1 (topoisomerase I interacting factor), and Csm3 (chromosome segregation in meiosis) are checkpoint-mediator proteins that function during DNA replication and activate the effector kinase Rad53. We reported previously that Mrc1 and Tof1 are constituents of the replication machinery and that both proteins are required for the proper arrest and stabilization of replication forks in the presence of hydroxyurea. In our current study, we show that Csm3 is a component of moving replication forks and that both Tof1 and Csm3 are specifically required for the association of Mrc1 with these structures. In contrast, the deletion of mrc1 did not affect the association of Tof1 and Csm3 with the replication fork complex. In agreement with previous observations in yeast cells, the results of a baculovirus coexpression system showed that these three proteins interact directly with each other to form a mediator complex in the absence of replication forks.	[Bando, Masashige; Katou, Yuki; Komata, Makiko; Tanaka, Hirokazu; Itoh, Takehiko; Sutani, Takashi; Shirahige, Katsuhiko] Tokyo Inst Technol, Dept Biol Sci, Lab Chromosome Struct & Funct, Grad Sch Biosci & Biotechnol,Midori Ku, Yokohama, Kanagawa 2268501, Japan	Tokyo Institute of Technology	Shirahige, K (corresponding author), Tokyo Inst Technol, Dept Biol Sci, Lab Chromosome Struct & Funct, Grad Sch Biosci & Biotechnol,Midori Ku, B-20,4259 Nagatsuta, Yokohama, Kanagawa 2268501, Japan.	kshirahi@bio.titech.ac.jp	Itoh, Takehiko/E-8873-2014	Itoh, Takehiko/0000-0002-6113-557X; Shirahige, Katsuhiko/0000-0002-7862-1144; Sutani, Takashi/0000-0002-9959-9513	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Supported in part by Grants-in-aid on priority areas from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. To whom correspondence should be addressed. Tel.: 81-45-924-5812; Fax: 81-45-924-5814; E-mail: kshirahi@bio.titech.ac.jp.	Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Branzei D, 2005, CURR OPIN CELL BIOL, V17, P568, DOI 10.1016/j.ceb.2005.09.003; Branzei D, 2006, EXP CELL RES, V312, P2654, DOI 10.1016/j.yexcr.2006.06.012; Calzada A, 2005, GENE DEV, V19, P1905, DOI 10.1101/gad.337205; De Antoni A, 2000, GENE, V246, P179, DOI 10.1016/S0378-1119(00)00083-4; Foss EJ, 2001, GENETICS, V157, P567; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gottifredi V, 2005, SEMIN CELL DEV BIOL, V16, P355, DOI 10.1016/j.semcdb.2005.02.011; Hodgson B, 2007, MOL BIOL CELL, V18, P3894, DOI 10.1091/mbc.E07-05-0500; Hori Y, 1996, MOL BIOL CELL, V7, P409, DOI 10.1091/mbc.7.3.409; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Katou Y, 2006, METHOD ENZYMOL, V409, P389, DOI 10.1016/S0076-6879(05)09023-3; Komata M, 2009, MOL CELL BIOL, V29, P5008, DOI 10.1128/MCB.01934-08; Labib K, 2007, EMBO REP, V8, P346, DOI 10.1038/sj.embor.7400940; Lambert S, 2005, BIOCHIMIE, V87, P591, DOI 10.1016/j.biochi.2004.10.020; Lou HQ, 2008, MOL CELL, V32, P106, DOI 10.1016/j.molcel.2008.08.020; Mayer ML, 2004, MOL BIOL CELL, V15, P1736, DOI 10.1091/mbc.E03-08-0619; Mohanty BK, 2006, P NATL ACAD SCI USA, V103, P897, DOI 10.1073/pnas.0506540103; Nedelcheva MN, 2005, J MOL BIOL, V347, P509, DOI 10.1016/j.jmb.2005.01.041; Noguchi E, 2004, MOL CELL BIOL, V24, P8342, DOI 10.1128/MCB.24.19.8342-8355.2004; Noguchi E, 2003, MOL CELL BIOL, V23, P7861, DOI 10.1128/MCB.23.21.7861-7874.2003; Osborn AJ, 2003, GENE DEV, V17, P1755, DOI 10.1101/gad.1098303; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Szyjka SJ, 2005, MOL CELL, V19, P691, DOI 10.1016/j.molcel.2005.06.037; Tanaka H, 2009, GENES CELLS, V14, P807, DOI 10.1111/j.1365-2443.2009.01310.x; Tanaka K, 2001, NAT CELL BIOL, V3, P966, DOI 10.1038/ncb1101-966; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tourriere H, 2005, MOL CELL, V19, P699, DOI 10.1016/j.molcel.2005.07.028; Tourriere H, 2007, DNA REPAIR, V6, P900, DOI 10.1016/j.dnarep.2007.02.004	30	98	99	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34355	34365		10.1074/jbc.M109.065730	http://dx.doi.org/10.1074/jbc.M109.065730			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19819872	Green Published, hybrid			2022-12-27	WOS:000272165200065
J	Kim, SC; Kang, L; Nagaraj, S; Blancaflor, EB; Mysore, KS; Chapman, KD				Kim, Sang-Chul; Kang, Li; Nagaraj, Satish; Blancaflor, Elison B.; Mysore, Kirankumar S.; Chapman, Kent D.			Mutations in Arabidopsis Fatty Acid Amide Hydrolase Reveal That Catalytic Activity Influences Growth but Not Sensitivity to Abscisic Acid or Pathogens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-ACYLETHANOLAMINES; SIGNATURE FAMILY; ANANDAMIDE AMIDOHYDROLASE; ENDOCANNABINOID SYSTEM; THALIANA SEEDLINGS; ENZYME; LIPIDS; PLANTS; 2-ARACHIDONOYLGLYCEROL; IDENTIFICATION	Fatty acid amide hydrolase (FAAH) terminates the endocannabinoid signaling pathway that regulates numerous neurobehavioral processes in animals by hydrolyzing N-acylethanolamines (NAEs). Recently, an Arabidopsis FAAH homologue (AtFAAH) was identified, and several studies, especially those using AtFAAH overexpressing and knock-out lines, have suggested an in vivo role for FAAH in the catabolism of NAEs in plants. We previously reported that overexpression of AtFAAH in Arabidopsis resulted in accelerated seedling growth, and in seedlings that were insensitive to exogenous NAEs but hypersensitive to abscisic acid (ABA) and hypersusceptible to nonhost pathogens. Here we show that whereas the enhanced growth and NAE tolerance of the AtFAAH overexpressing seedlings depend on the catalytic activity of AtFAAH, hypersensitivity to ABA and hypersusceptibility to nonhost pathogens are independent of its enzymatic activity. Five amino acids known to be critical for rat FAAH activity are also conserved in AtFAAH (Lys-205, Ser-281, Ser-282, Ser-305, and Arg-307). Site-directed mutation of each of these conserved residues in AtFAAH abolished its hydrolytic activity when expressed in Escherichia coli, supporting a common catalytic mechanism in animal and plant FAAH enzymes. Overexpression of these inactive AtFAAH mutants in Arabidopsis showed no growth enhancement and no NAE tolerance, but still rendered the seedlings hypersensitive to ABA and hypersusceptible to nonhost pathogens to a degree similar to the overexpression of the native AtFAAH. Taken together, our findings suggest that the AtFAAH influences plant growth and interacts with ABA signaling and plant defense through distinctly different mechanisms.	[Kang, Li; Nagaraj, Satish; Blancaflor, Elison B.; Mysore, Kirankumar S.] Samuel Roberts Noble Fdn Inc, Div Plant Biol, Ardmore, OK 73402 USA; [Kim, Sang-Chul; Blancaflor, Elison B.; Chapman, Kent D.] Univ N Texas, Ctr Plant Lipid Res, Dept Biol Sci, Denton, TX 76203 USA	Noble Research Institute; University of North Texas System; University of North Texas Denton	Mysore, KS (corresponding author), 2510 Sam Noble Pkwy, Ardmore, OK 73401 USA.	ksmysore@noble.org; chapman@unt.edu	Mysore, Kirankumar/AAG-7112-2020	Mysore, Kirankumar/0000-0002-9805-5741; Chapman, Kent/0000-0003-0489-3072; Blancaflor, Elison/0000-0001-6115-9670	Samuel Roberts Noble Foundation; United States Department of Energy Office of Science (BES) [DE-FG02-05ER15647]	Samuel Roberts Noble Foundation; United States Department of Energy Office of Science (BES)(United States Department of Energy (DOE))	This work was supported by the Samuel Roberts Noble Foundation and a grant from the United States Department of Energy Office of Science (BES) agreement number DE-FG02-05ER15647 (to E. B. B. and K. D. C.).	Blancaflor EB, 2003, PLANTA, V217, P206, DOI 10.1007/s00425-003-0985-8; Bracey MH, 2002, SCIENCE, V298, P1793, DOI 10.1126/science.1076535; Cai G, 2005, FEMS MICROBIOL LETT, V249, P15, DOI 10.1016/j.femsle.2005.05.038; Chapman KD, 2004, PROG LIPID RES, V43, P302, DOI 10.1016/j.plipres.2004.03.002; Chapman KD, 1998, PLANT PHYSIOL, V116, P1163, DOI 10.1104/pp.116.3.1163; Chebrou H, 1996, BBA-PROTEIN STRUCT M, V1298, P285, DOI 10.1016/S0167-4838(96)00145-8; Clement AB, 2003, J NEUROSCI, V23, P3916; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; Cravatt BF, 2004, P NATL ACAD SCI USA, V101, P10821, DOI 10.1073/pnas.0401292101; CRAVATT BF, 1995, SCIENCE, V268, P1506, DOI 10.1126/science.7770779; DESARNAUD F, 1995, J BIOL CHEM, V270, P6030, DOI 10.1074/jbc.270.11.6030; DEUTSCH DG, 1993, BIOCHEM PHARMACOL, V46, P791, DOI 10.1016/0006-2952(93)90486-G; Fezza Filomena, 2008, V49, P101, DOI 10.1007/978-1-4020-8831-5_4; Fowler CJ, 2006, FUND CLIN PHARMACOL, V20, P549, DOI 10.1111/j.1472-8206.2006.00442.x; Fowler CJ, 2001, BIOCHEM PHARMACOL, V62, P517, DOI 10.1016/S0006-2952(01)00712-2; Gertsch J, 2008, PLANTA MED, V74, P638, DOI 10.1055/s-2008-1034302; Ghafouri N, 2004, BRIT J PHARMACOL, V143, P774, DOI 10.1038/sj.bjp.0705948; Gopalakrishna KN, 2004, BIOCHEMISTRY-US, V43, P7725, DOI 10.1021/bi049907q; Kang L, 2008, PLANT J, V56, P336, DOI 10.1111/j.1365-313X.2008.03603.x; Kilaru A, 2007, CHEM BIODIVERS, V4, P1933, DOI 10.1002/cbdv.200790161; Labahn J, 2002, J MOL BIOL, V322, P1053, DOI 10.1016/S0022-2836(02)00886-0; Labar G, 2007, CHEM BIODIVERS, V4, P1882, DOI 10.1002/cbdv.200790157; Lichtman AH, 2004, PAIN, V109, P319, DOI 10.1016/j.pain.2004.01.022; Maurelli S, 1995, FEBS LETT, V377, P82, DOI 10.1016/0014-5793(95)01311-3; McKinney MK, 2005, ANNU REV BIOCHEM, V74, P411, DOI 10.1146/annurev.biochem.74.082803.133450; McKinney MK, 2003, J BIOL CHEM, V278, P37393, DOI 10.1074/jbc.M303922200; Neu D, 2007, FEBS J, V274, P3440, DOI 10.1111/j.1742-4658.2007.05876.x; Patricelli MP, 2000, J BIOL CHEM, V275, P19177, DOI 10.1074/jbc.M001607200; Patricelli MP, 1999, BIOCHEMISTRY-US, V38, P14125, DOI 10.1021/bi991876p; Patricelli MP, 1999, BIOCHEMISTRY-US, V38, P9804, DOI 10.1021/bi990637z; SCHMID PC, 1985, J BIOL CHEM, V260, P4145; Shrestha R, 2003, J BIOL CHEM, V278, P34990, DOI 10.1074/jbc.M305613200; Shrestha R, 2002, PLANT PHYSIOL, V130, P391, DOI 10.1104/pp.004689; Shrestha R, 2006, BBA-MOL CELL BIOL L, V1761, P324, DOI 10.1016/j.bbalip.2006.03.004; Teaster ND, 2007, PLANT CELL, V19, P2454, DOI 10.1105/tpc.106.048702; UEDA N, 1995, J BIOL CHEM, V270, P23823, DOI 10.1074/jbc.270.40.23823; Wang YS, 2006, P NATL ACAD SCI USA, V103, P12197, DOI 10.1073/pnas.0603571103; Yates ML, 2007, FASEB J, V21, pA1177	40	18	20	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34065	34074		10.1074/jbc.M109.059022	http://dx.doi.org/10.1074/jbc.M109.059022			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19801664	Green Published, hybrid			2022-12-27	WOS:000272165200039
J	de Alba, E				de Alba, Eva			Structure and Interdomain Dynamics of Apoptosis-associated Speck-like Protein Containing a CARD (ASC)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASPASE RECRUITMENT DOMAIN; N-15 NMR RELAXATION; PYRIN DOMAIN; CHEMICAL-SHIFTS; ROTATIONAL DIFFUSION; ACTIVATING ADAPTER; BACKBONE DYNAMICS; ONLY PROTEIN; CELL-DEATH; KAPPA-B	The human protein ASC is a key mediator in apoptosis and inflammation. Through its two death domains (pyrin and CARD) ASC interacts with cell death executioners, acts as an essential adapter for inflammasome integrity, and oligomerizes into functional supramolecular assemblies. However, these functions are not understood at the structural-dynamic level. This study reports the solution structure and interdomain dynamics of full-length ASC. The pyrin and CARD domains are structurally independent six-helix bundle motifs connected by a 23-residue linker. The CARD structure reveals two distinctive characteristics; helix 1 is not fragmented as in all other known CARDs, and its electrostatic surface shows a uniform distribution of positive and negative charges, whereas these are commonly separated into two areas in other death domains. The linker adopts residual structure resulting in a back-to-back orientation of the domains, which avoids steric interference of each domain with the binding site of the other. NMR relaxation experiments show that the linker is flexible despite the residual structure. This flexibility could help expand the relative volume occupied by each domain, thus increasing the capture radius for effectors. Based on the ASC structure, a tentative model is proposed to illustrate how ASC oligomerizes via CARD and pyrin homophilic interactions. Moreover, ASC oligomers have been analyzed by atomic force microscopy, showing a predominant species of disk-like particles of similar to 12-nm diameter and similar to 1-nm height. Taken together, these results provide structural insight into the behavior of ASC as an adapter molecule.	CSIC, Ctr Invest Biol, Madrid 28040, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	de Alba, E (corresponding author), CSIC, Ctr Invest Biol, Ramiro de Maeztu 9, Madrid 28040, Spain.	dealbae@cib.csic.es			European Commission Marie Curie International Reintegration [IRG-046412]; Spanish Ministerio de Ciencia e Innovacion through the Programa Ramo n y Cajal; Plan Nacional I+D+I [BFU2008-03278]; Comunidad de Madrid and Agencia CSIC [CCG08CSIC/SAL-3777]	European Commission Marie Curie International Reintegration(European Commission); Spanish Ministerio de Ciencia e Innovacion through the Programa Ramo n y Cajal(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Plan Nacional I+D+I; Comunidad de Madrid and Agencia CSIC	This work was supported by the European Commission Marie Curie International Reintegration Grant IRG-046412 (to E.d.A.), by the Spanish Ministerio de Ciencia e Innovacion through the Programa Ramo n y Cajal (to E.d.A.), by Plan Nacional I+D+I Grant BFU2008-03278 (to E.d.A.), and by Comunidad de Madrid and Agencia CSIC through the IV PRICIT CCG08CSIC/SAL-3777 (to E.d.A.).	Baber JL, 2001, J AM CHEM SOC, V123, P3953, DOI 10.1021/ja0041876; BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; BRUSCHWEILER R, 1995, SCIENCE, V268, P886, DOI 10.1126/science.7754375; Carrington PE, 2006, MOL CELL, V22, P599, DOI 10.1016/j.molcel.2006.04.018; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Chou JJ, 1998, CELL, V94, P171, DOI 10.1016/S0092-8674(00)81417-8; Clore GM, 1998, J AM CHEM SOC, V120, P10571, DOI 10.1021/ja982592f; Conway KE, 2000, CANCER RES, V60, P6236; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Daragan VA, 1997, PROG NUCL MAG RES SP, V31, P63, DOI 10.1016/S0079-6565(97)00006-X; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Day CL, 1999, CELL DEATH DIFFER, V6, P1125, DOI 10.1038/sj.cdd.4400584; de Alba E, 2007, BIOMOL NMR ASSIGM, V1, P135, DOI 10.1007/s12104-007-9036-x; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fernandes-Alnemri T, 2008, METHOD ENZYMOL, V442, P251, DOI [10.1016/S0076-6S79(08)01413-4, 10.1016/S0076-6879(08)01413-4]; Fushman D, 2004, PROG NUCL MAG RES SP, V44, P189, DOI 10.1016/j.pnmrs.2004.02.001; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; George RA, 2002, PROTEIN ENG, V15, P871, DOI 10.1093/protein/15.11.871; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176; Hasegawa M, 2007, ONCOGENE, V26, P1748, DOI 10.1038/sj.onc.1209965; Hiller S, 2003, STRUCTURE, V11, P1199, DOI 10.1016/j.str.2003.08.009; Humke EW, 2000, CELL, V103, P99, DOI 10.1016/S0092-8674(00)00108-2; Ishima R, 2000, NAT STRUCT BIOL, V7, P740, DOI 10.1038/78963; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Liepinsh E, 2003, J MOL BIOL, V332, P1155, DOI 10.1016/j.jmb.2003.07.007; Manon F, 2007, J MOL BIOL, V365, P160, DOI 10.1016/j.jmb.2006.09.067; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2007, MICROBES INFECT, V9, P664, DOI 10.1016/j.micinf.2007.01.017; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Masumoto J, 1999, J BIOL CHEM, V274, P33835, DOI 10.1074/jbc.274.48.33835; Masumoto J, 2003, BIOCHEM BIOPH RES CO, V303, P69, DOI 10.1016/S0006-291X(03)00309-7; McConnell BB, 2000, CANCER RES, V60, P6243; McConnell BB, 2004, APOPTOSIS, V9, P5, DOI 10.1023/B:APPT.0000012117.32430.0c; Moriya M, 2005, BIOCHEMISTRY-US, V44, P575, DOI 10.1021/bi048374i; Natarajan A, 2006, J BIOL CHEM, V281, P31863, DOI 10.1074/jbc.M605458200; NILGES M, 1993, PROTEINS, V17, P297, DOI 10.1002/prot.340170307; Ogura Y, 2006, CELL, V126, P659, DOI 10.1016/j.cell.2006.08.002; Ohtsuka T, 2004, NAT CELL BIOL, V6, P121, DOI 10.1038/ncb1087; Palmer AG, 1996, J PHYS CHEM-US, V100, P13293, DOI 10.1021/jp9606117; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Petrilli V, 2007, JOINT BONE SPINE, V74, P571, DOI 10.1016/j.jbspin.2007.04.004; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Schanda P, 2005, J AM CHEM SOC, V127, P8014, DOI 10.1021/ja051306e; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; Stehlik C, 2003, J IMMUNOL, V171, P6154, DOI 10.4049/jimmunol.171.11.6154; Stehlik C, 2003, BIOCHEM J, V373, P101, DOI 10.1042/BJ20030304; Taniguchi S, 2007, SEMIN IMMUNOPATHOL, V29, P231, DOI 10.1007/s00281-007-0082-3; Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111; Tjandra N, 1996, J BIOMOL NMR, V8, P273, DOI 10.1007/BF00410326; Tjandra N, 1995, J AM CHEM SOC, V117, P12562, DOI 10.1021/ja00155a020; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; WAGNER G, 1993, J BIOMOL NMR, V3, P375; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Yang JK, 2005, MOL CELL, V20, P939, DOI 10.1016/j.molcel.2005.10.023; Yu XC, 2005, STRUCTURE, V13, P1725, DOI 10.1016/j.str.2005.09.006; Zhou P, 1999, P NATL ACAD SCI USA, V96, P11265, DOI 10.1073/pnas.96.20.11265	68	98	100	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32932	32941		10.1074/jbc.M109.024273	http://dx.doi.org/10.1074/jbc.M109.024273			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19759015	Green Published, hybrid			2022-12-27	WOS:000272028400076
J	Ge, CX; Xiao, GZ; Jiang, D; Yang, Q; Hatch, NE; Roca, H; Franceschi, RT				Ge, Chunxi; Xiao, Guozhi; Jiang, Di; Yang, Qian; Hatch, Nan E.; Roca, Hernan; Franceschi, Renny T.			Identification and Functional Characterization of ERK/MAPK Phosphorylation Sites in the Runx2 Transcription Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN-2; MYELOID-LEUKEMIA GENE; GROWTH-FACTOR; OSTEOBLAST DIFFERENTIATION; CELL-DIFFERENTIATION; MAMMALIAN-CELLS; ASCORBIC-ACID; IN-VITRO; KINASE; EXPRESSION	The Runx2 transcription factor is required for commitment of mesenchymal cells to bone lineages and is a major regulator of osteoblast-specific gene expression. Runx2 is subject to a number of post-transcriptional controls including selective proteolysis and phosphorylation. We previously reported that Runx2 is phosphorylated and activated by the ERK/MAPK pathway (Xiao, G., Jiang, D., Thomas, P., Benson, M. D., Guan, K., Karsenty, G., and Franceschi, R. T. (2000) J. Biol. Chem. 275, 4453-4459). In this study, we used a combination of in vitro and in vivo phosphorylation analysis, mass spectroscopy, and functional assays to identify two sites at Ser(301) and Ser(319) within the proline/serine/threonine domain of Runx2 that are required for this regulation. These sites are phosphorylated by activated ERK1 in vitro and in cell culture. In addition to confirming ERK-dependent phosphorylation at Ser(319), mass spectroscopy identified two other ERK-phosphorylated sites at Ser(43) and Ser(510). Furthermore, introduction of S301A, S319A mutations rendered Runx2 resistant to MAPK-dependent activation and reduced its ability to stimulate osteoblast-specific gene expression and differentiation after transfection into Runx2-null calvarial cells and mesenchymal cells. In contrast, S301E, S319E Runx2 mutants had enhanced transcriptional activity that was minimally dependent on MAPK signaling, consistent with the addition of a negative charge mimicking serine phosphorylation. These results emphasize the important role played by Runx2 phosphorylation in the control of osteoblast gene expression and provide a mechanism to explain how physiological signals acting on bone through the ERK/MAPK pathway can stimulate osteoblast-specific gene expression.	[Franceschi, Renny T.] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA; [Franceschi, Renny T.] Univ Michigan, Dept Biol Chem, Sch Med, Ann Arbor, MI 48109 USA; [Xiao, Guozhi] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15240 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Franceschi, RT (corresponding author), Univ Michigan, Sch Dent, Dept Periodont & Oral Med, 1101 N Univ Ave, Ann Arbor, MI 48109 USA.	rennyf@umich.edu	Hatch, Nan/ABC-9177-2020; Hatch, Nan/AAQ-8465-2020	Hatch, Nan/0000-0002-2632-0841	National Institutes of Health; Department of Defense [W81XWH-07-1-0160];  [DE11723];  [DE12211];  [DK072230]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE011723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R56DE011723, R01DE012211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072230] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); ; ; ; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Runx2 phosphorylation and skeletal maturation. Furthermore, Grants DE11723 and DE12211 (to R. T. F.) and Grant DK072230 and Department of Defense Grant W81XWH-07-1-0160 (to G. X.).	Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; Afzal F, 2005, J CELL PHYSIOL, V204, P63, DOI 10.1002/jcp.20258; Akella R, 2008, BBA-PROTEINS PROTEOM, V1784, P48, DOI 10.1016/j.bbapap.2007.09.016; Bae JS, 2007, J CELL BIOCHEM, V100, P434, DOI 10.1002/jcb.21039; Barnes GL, 2004, CANCER RES, V64, P4506, DOI 10.1158/0008-5472.CAN-03-3851; Celil AB, 2005, J BIOL CHEM, V280, P31353, DOI 10.1074/jbc.M503845200; Celil AB, 2005, J CELL BIOCHEM, V95, P518, DOI 10.1002/jcb.20429; COBB MH, 1991, CELL REGUL, V2, P965, DOI 10.1091/mbc.2.12.965; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025; Franceschi RT, 2007, ANN NY ACAD SCI, V1116, P196, DOI 10.1196/annals.1402.081; Franceschi RT, 2003, J CELL BIOCHEM, V88, P446, DOI 10.1002/jcb.10369; FRANCESCHI RT, 1992, J BONE MINER RES, V7, P235; FRANCESCHI RT, 1994, J BONE MINER RES, V9, P843; Fujita T, 2004, J CELL BIOL, V166, P85, DOI 10.1083/jcb.200401138; Ge CX, 2007, J CELL BIOL, V176, P709, DOI 10.1083/jcb.200610046; Hardy S, 1997, J VIROL, V71, P1842, DOI 10.1128/JVI.71.3.1842-1849.1997; Imai Y, 2004, MOL CELL BIOL, V24, P1033, DOI 10.1128/MCB.24.3.1033-1043.2004; Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645; Jeon EJ, 2006, J BIOL CHEM, V281, P16502, DOI 10.1074/jbc.M512494200; Jikko A, 1999, J BONE MINER RES, V14, P1075, DOI 10.1359/jbmr.1999.14.7.1075; Kao SC, 2001, J BIOL CHEM, V276, P18169, DOI 10.1074/jbc.M008870200; Kim BG, 2006, PROTEOMICS, V6, P1166, DOI 10.1002/pmic.200500289; Kousteni S, 2003, J CLIN INVEST, V111, P1651, DOI 10.1172/JCI200317261; Kugimiya F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000837; Lai CF, 2001, J BIOL CHEM, V276, P14443, DOI 10.1074/jbc.M010021200; Lecanda F, 2000, J CELL BIOL, V151, P931, DOI 10.1083/jcb.151.4.931; LI Y, 2009, J BONE MINE IN PRESS; Lian JB, 2004, CRIT REV EUKAR GENE, V14, P1; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Moalli MR, 2001, J APPL PHYSIOL, V91, P912, DOI 10.1152/jappl.2001.91.2.912; Murakami S, 2000, P NATL ACAD SCI USA, V97, P1113, DOI 10.1073/pnas.97.3.1113; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Pavalko FM, 1998, AM J PHYSIOL-CELL PH, V275, pC1591; Pratap J, 2006, CANCER METAST REV, V25, P589, DOI 10.1007/s10555-006-9032-0; Qiao M, 2006, J BIOL CHEM, V281, P7118, DOI 10.1074/jbc.M508162200; Qiao M, 2004, J BIOL CHEM, V279, P42709, DOI 10.1074/jbc.M404480200; Schmidt C, 1998, J BIOL CHEM, V273, P5081, DOI 10.1074/jbc.273.9.5081; Selvamurugan N, 2000, J BIOL CHEM, V275, P5037, DOI 10.1074/jbc.275.7.5037; Shen R, 2006, J BIOL CHEM, V281, P16347, DOI 10.1074/jbc.M603439200; Shui CX, 2003, J BONE MINER RES, V18, P213, DOI 10.1359/jbmr.2003.18.2.213; Takeuchi Y, 1997, J BIOL CHEM, V272, P29309, DOI 10.1074/jbc.272.46.29309; Takeuchi Y, 1996, J BIOL CHEM, V271, P3938; TANAKA T, 1995, EMBO J, V14, P341, DOI 10.1002/j.1460-2075.1995.tb07008.x; Tanaka T, 1996, MOL CELL BIOL, V16, P3967; Thirunavukkarasu K, 1998, MOL CELL BIOL, V18, P4197, DOI 10.1128/MCB.18.7.4197; Tou LQ, 2003, MOL CELL ENDOCRINOL, V205, P121, DOI 10.1016/S0303-7207(03)00151-5; Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893; Xiao GZ, 1998, J BIOL CHEM, V273, P32988, DOI 10.1074/jbc.273.49.32988; Xiao GZ, 1997, MOL ENDOCRINOL, V11, P1103, DOI 10.1210/me.11.8.1103; Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453; Xiao GZ, 2002, J BIOL CHEM, V277, P36181, DOI 10.1074/JBC.m206057200; Xiao GZ, 2002, J BONE MINER RES, V17, P101, DOI 10.1359/jbmr.2002.17.1.101; Yang SY, 2003, J BONE MINER RES, V18, P705, DOI 10.1359/jbmr.2003.18.4.705; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Yao Y, 2003, P NATL ACAD SCI USA, V100, P12759, DOI 10.1073/pnas.2134254100; Zayzafoon M, 2004, J BIOL CHEM, V279, P3662, DOI 10.1074/jbc.M308158200; Zetser A, 2001, DEV BIOL, V240, P168, DOI 10.1006/dbio.2001.0465; Zhang YH, 2004, J BIOL CHEM, V279, P53116, DOI 10.1074/jbc.M405502200; ZHENG CF, 1993, J BIOL CHEM, V268, P23933; Zimmerman D, 2000, DEV BIOL, V220, P2, DOI 10.1006/dbio.2000.9633; Ziros PG, 2002, J BIOL CHEM, V277, P23934, DOI 10.1074/jbc.M109881200	64	170	173	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32533	32543		10.1074/jbc.M109.040980	http://dx.doi.org/10.1074/jbc.M109.040980			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19801668	Green Published, hybrid			2022-12-27	WOS:000272028400035
J	Wittrup, A; Zhang, SH; ten Dam, GB; van Kuppevelt, TH; Bengtson, P; Johansson, M; Welch, J; Morgelin, M; Belting, M				Wittrup, Anders; Zhang, Si-He; ten Dam, Gerdy B.; van Kuppevelt, Toin H.; Bengtson, Per; Johansson, Maria; Welch, Johanna; Morgelin, Matthias; Belting, Mattias			ScFv Antibody-induced Translocation of Cell-surface Heparan Sulfate Proteoglycan to Endocytic Vesicles EVIDENCE FOR HEPARAN SULFATE EPITOPE SPECIFICITY AND ROLE OF BOTH SYNDECAN AND GLYPICAN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR DEGRADATIVE PATHWAYS; PHAGE DISPLAY ANTIBODIES; ARGININE-RICH PEPTIDES; MEDIATED GENE-TRANSFER; MAMMALIAN-CELLS; MACROPINOCYTOSIS; INTERNALIZATION; 2-O-SULFATION; PROTEINS; DOMAINS	Cellular uptake of several viruses and polybasic macromolecules requires the expression of cell-surface heparan sulfate proteoglycan (HSPG) through as yet ill defined mechanisms. We unexpectedly found that among several cell-surface-binding single chain variable fragment (scFv) anti-HS antibody (alpha HS) clones, only one, AO4B08, efficiently translocated macromolecular cargo to intracellular vesicles through induction of HSPG endocytosis. Interestingly, AO4B08-induced PG internalization was strictly dependent on HS 2-O-sulfation and appeared independent of intact N-sulfation. AO4B08 and human immunodeficiency virus (HIV)-Tat, i.e. a well known cell-penetrating peptide, were shown to compete for the internalizing PG population. To obtain a more detailed characterization of this pathway, we have developed a procedure for the isolation of endocytic vesicles by conjugating AO4B08 with superparamagnetic nanoparticles. [S-35] sulfate-labeled HSPG was found to accumulate in isolated, AO4B08-containing vesicles, providing the first biochemical evidence for intact HSPG co-internalization with its ligand. Further analysis revealed the existence of both syndecan, i.e. a transmembrane HSPG, and glycosyl-phosphatidyl-inositol-anchored glypican in purified vesicles. Importantly, internalized syndecan and glypican were found to colocalize in AO4B08-containing vesicles. Our data establish HSPGs as true internalizing receptors of macromolecular cargo and indicate that the sorting of cell-surface HSPG to endocytic vesicles is determined by a specific HS epitope that can be carried by both syndecan and glypican core protein.	[Wittrup, Anders; Zhang, Si-He; Bengtson, Per; Johansson, Maria; Welch, Johanna; Belting, Mattias] Lund Univ, Sect Oncol, Dept Clin Sci, SE-22185 Lund, Sweden; [Morgelin, Matthias] Lund Univ, Sect Clin & Expt Infect Med, Dept Clin Sci, SE-22185 Lund, Sweden; [ten Dam, Gerdy B.; van Kuppevelt, Toin H.] Nijmegen Ctr Mol Life Sci, Dept Biochem, NL-6500 HB Nijmegen, Netherlands	Lund University; Lund University; Radboud University Nijmegen	Wittrup, A (corresponding author), Lund Univ, Sect Oncol, Dept Clin Sci, Barngatan 2-1, SE-22185 Lund, Sweden.	anders.wittrup@med.lu.se; mattias.belting@med.lu.se	Zhang, Si-he/AAV-9442-2021; van Kuppevelt, A.H.M.S.M./L-4463-2015	Zhang, Si-he/0000-0002-8923-1993; Belting, Mattias/0000-0003-1585-5434; Wittrup, Anders/0000-0003-4918-0500	Swedish Cancer Fund; Swedish Research Council; Swedish Foundation for Strategic Research (FLAK); Swedish Society of Medicine; Physiographic Society, Lund; Crafoordska, Gunnar Nilsson, and Kamprad Foundations; Lund University Hospital (ALF)	Swedish Cancer Fund; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research (FLAK)(Swedish Foundation for Strategic Research); Swedish Society of Medicine; Physiographic Society, Lund; Crafoordska, Gunnar Nilsson, and Kamprad Foundations; Lund University Hospital (ALF)	This work was supported by grants from the Swedish Cancer Fund; the Swedish Research Council; the Swedish Foundation for Strategic Research (FLAK); the Swedish Society of Medicine; the Physiographic Society, Lund; the Crafoordska, Gunnar Nilsson, and Kamprad Foundations; and the Lund University Hospital (ALF).	Bai X, 2001, Methods Mol Biol, V171, P309; Bai XM, 1997, J BIOL CHEM, V272, P23172, DOI 10.1074/jbc.272.37.23172; Bai XM, 1996, J BIOL CHEM, V271, P17711, DOI 10.1074/jbc.271.30.17711; BAME KJ, 1994, BIOCHEM J, V303, P81, DOI 10.1042/bj3030081; Beauvais DeannaLee M, 2004, Reprod Biol Endocrinol, V2, P3, DOI 10.1186/1477-7827-2-3; Belting M, 1999, BIOCHEM J, V338, P317, DOI 10.1042/0264-6021:3380317; Belting M, 2003, TRENDS BIOCHEM SCI, V28, P145, DOI 10.1016/S0968-0004(03)00031-8; Belting M, 1999, J BIOL CHEM, V274, P19375, DOI 10.1074/jbc.274.27.19375; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; Couchman JR, 2003, NAT REV MOL CELL BIO, V4, P926, DOI 10.1038/nrm1257; Dennissen MABA, 2002, J BIOL CHEM, V277, P10982, DOI 10.1074/jbc.M104852200; Duenas-Gonzalez A, 1998, J CELL BIOL, V141, P1407, DOI 10.1083/jcb.141.6.1407; ENGEL J, 1987, METHOD ENZYMOL, V145, P3; Filmus J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-224; Fransson LA, 2004, CELL MOL LIFE SCI, V61, P1016, DOI 10.1007/s00018-004-3445-0; Fuki IV, 2000, BIOCHEM J, V351, P607, DOI 10.1042/0264-6021:3510607; Fuki IV, 1997, J CLIN INVEST, V100, P1611, DOI 10.1172/JCI119685; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Kurup S, 2007, J BIOL CHEM, V282, P21032, DOI 10.1074/jbc.M702073200; Landgraf P, 2008, J BIOL CHEM, V283, P25036, DOI 10.1074/jbc.M800963200; Mislick KA, 1996, P NATL ACAD SCI USA, V93, P12349, DOI 10.1073/pnas.93.22.12349; Nakase I, 2004, MOL THER, V10, P1011, DOI 10.1016/j.ymthe.2004.08.010; Nakase I, 2007, BIOCHEMISTRY-US, V46, P492, DOI 10.1021/bi0612824; Payne CK, 2007, TRAFFIC, V8, P389, DOI 10.1111/j.1600-0854.2007.00540.x; Powell AK, 2004, GLYCOBIOLOGY, V14, p17R, DOI 10.1093/glycob/cwh051; Sandgren S, 2002, J BIOL CHEM, V277, P38877, DOI 10.1074/jbc.M205395200; Sandgren S, 2004, J BIOL CHEM, V279, P17951, DOI 10.1074/jbc.M311440200; Smits NC, 2004, AM J RESP CELL MOL, V30, P166, DOI 10.1165/rcmb.2003-0198OC; Spillmann D, 2001, BIOCHIMIE, V83, P811, DOI 10.1016/S0300-9084(01)01290-1; ten Dam GB, 2003, J HISTOCHEM CYTOCHEM, V51, P727; Tkachenko E, 2004, J CELL SCI, V117, P3189, DOI 10.1242/jcs.01190; Wittrup A, 2007, J BIOL CHEM, V282, P27897, DOI 10.1074/jbc.M701611200; YANAGISHITA M, 1992, J BIOL CHEM, V267, P9505; YANAGISHITA M, 1984, J BIOL CHEM, V259, P270	36	50	52	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32959	32967		10.1074/jbc.M109.036129	http://dx.doi.org/10.1074/jbc.M109.036129			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19783663	Green Published, hybrid			2022-12-27	WOS:000272028400079
J	Sabouri, N; Johansson, E				Sabouri, Nasim; Johansson, Erik			Translesion Synthesis of Abasic Sites by Yeast DNA Polymerase epsilon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; REPLICATION FORK; SULFOLOBUS-SOLFATARICUS; LESION BYPASS; SPECIFICITY; ETA; EXONUCLEASE; MECHANISMS; EFFICIENCY; PROTEINS	Studies of replicative DNA polymerases have led to the generalization that abasic sites are strong blocks to DNA replication. Here we show that yeast replicative DNA polymerase epsilon bypasses a model abasic site with comparable efficiency to Pol eta and Dpo4, two translesion polymerases. DNA polymerase epsilon also exhibited high bypass efficiency with a natural abasic site on the template. Translesion synthesis primarily resulted in deletions. In cases where only a single nucleotide was inserted, dATP was the preferred nucleotide opposite the natural abasic site. In contrast to translesion polymerases, DNA polymerase epsilon with 3'-5' proofreading exonuclease activity bypasses only the model abasic site during processive synthesis and cannot reinitiate DNA synthesis. This characteristic may allow other pathways to rescue leading strand synthesis when stalled at an abasic site.	[Sabouri, Nasim; Johansson, Erik] Umea Univ, Dept Med Biochem & Biophys, SE-90187 Umea, Sweden	Umea University	Johansson, E (corresponding author), Umea Univ, Dept Med Biochem & Biophys, SE-90187 Umea, Sweden.	erik.johansson@medchem.umu.se	Sabouri, Nasim/AFP-6927-2022	Sabouri, Nasim/0000-0002-4541-7702; Johansson, Erik/0000-0002-8526-6224	Swedish Research Council; The Swedish Cancer Society; Fund for Basic Science-oriented Biotechnology; Medical Faculty at Umea University; Smartafonden; Ake Wibergs stiftelse; Magnus Bergwalls stiftelse; Kempe Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); The Swedish Cancer Society(Swedish Cancer Society); Fund for Basic Science-oriented Biotechnology; Medical Faculty at Umea University; Smartafonden; Ake Wibergs stiftelse; Magnus Bergwalls stiftelse; Kempe Foundation	This work was supported by the Swedish Research Council, The Swedish Cancer Society, the Fund for Basic Science-oriented Biotechnology, and the Medical Faculty at Umea University, Smartafonden, Ake Wibergs stiftelse, and Magnus Bergwalls stiftelse (to E. J.) and in part by a grant from the Kempe Foundation (to N. S.).	Asturias FJ, 2006, NAT STRUCT MOL BIOL, V13, P35, DOI 10.1038/nsmb1040; Auerbach P, 2005, P NATL ACAD SCI USA, V102, P17711, DOI 10.1073/pnas.0504643102; Blanca G, 2007, BIOCHEM J, V402, P321, DOI 10.1042/BJ20060898; BONNER CA, 1988, J BIOL CHEM, V263, P18946; Branzei D, 2007, DNA REPAIR, V6, P994, DOI 10.1016/j.dnarep.2007.02.018; Budzowska M, 2009, CELL BIOCHEM BIOPHYS, V53, P17, DOI 10.1007/s12013-008-9039-y; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Chilkova O, 2003, J BIOL CHEM, V278, P14082, DOI 10.1074/jbc.M211818200; Chilkova O, 2007, NUCLEIC ACIDS RES, V35, P6588, DOI 10.1093/nar/gkm741; Eckert KA, 1999, MUTAT RES-FUND MOL M, V424, P221, DOI 10.1016/S0027-5107(99)00021-4; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Garg P, 2005, J BIOL CHEM, V280, P23446, DOI 10.1074/jbc.C500173200; Gibbs PEM, 2005, GENETICS, V169, P575, DOI 10.1534/genetics.104.034611; Gruz P, 2003, NUCLEIC ACIDS RES, V31, P4024, DOI 10.1093/nar/gkg447; Haracska L, 2001, GENE DEV, V15, P945, DOI 10.1101/gad.882301; Heller RC, 2006, NATURE, V439, P557, DOI 10.1038/nature04329; Johansson E, 2004, J BIOL CHEM, V279, P1907, DOI 10.1074/jbc.M310362200; Kokoska RJ, 2003, J BIOL CHEM, V278, P50537, DOI 10.1074/jbc.M308515200; Le Gac NT, 2004, J MOL BIOL, V336, P1023, DOI 10.1016/j.jmb.2004.01.005; Lehmann AR, 2006, DNA REPAIR, V5, P1495, DOI 10.1016/j.dnarep.2006.07.002; Ling H, 2004, MOL CELL, V13, P751, DOI 10.1016/S1097-2765(04)00101-7; Lopes M, 2006, MOL CELL, V21, P15, DOI 10.1016/j.molcel.2005.11.015; McCulloch SD, 2006, DNA REPAIR, V5, P1373, DOI 10.1016/j.dnarep.2006.06.003; McCulloch SD, 2009, NUCLEIC ACIDS RES, V37, P2830, DOI 10.1093/nar/gkp103; McCulloch SD, 2004, NUCLEIC ACIDS RES, V32, P4665, DOI 10.1093/nar/gkh777; McCulloch SD, 2004, NATURE, V428, P97, DOI 10.1038/nature02352; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; MEZZINA M, 1988, J VIROL, V62, P4249, DOI 10.1128/JVI.62.11.4249-4258.1988; Pages V, 2008, P NATL ACAD SCI USA, V105, P1170, DOI 10.1073/pnas.0711227105; Pursell ZF, 2007, SCIENCE, V317, P127, DOI 10.1126/science.1144067; Sabouri N, 2008, NUCLEIC ACIDS RES, V36, P5660, DOI 10.1093/nar/gkn555; Shcherbakova PV, 2003, J BIOL CHEM, V278, P43770, DOI 10.1074/jbc.M306893200; Zhang YB, 2002, DNA REPAIR, V1, P559, DOI 10.1016/S1568-7864(02)00055-1	33	21	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31555	31563		10.1074/jbc.M109.043927	http://dx.doi.org/10.1074/jbc.M109.043927			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19776424	Green Published, hybrid			2022-12-27	WOS:000271572700009
J	Horler, RSP; Muller, A; Williamson, DC; Potts, JR; Wilson, KS; Thomas, GH				Horler, Richard S. P.; Mueller, Axel; Williamson, David C.; Potts, Jennifer R.; Wilson, Keith S.; Thomas, Gavin H.			Furanose-specific Sugar Transport CHARACTERIZATION OF A BACTERIAL GALACTOFURANOSE-BINDING PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY STRUCTURES; ESCHERICHIA-COLI; HAEMOPHILUS-INFLUENZAE; SALMONELLA-TYPHIMURIUM; LIGAND SPECIFICITY; ACTIVE-TRANSPORT; GALACTOSE; GLUCOSE; CHEMOTAXIS; RECEPTOR	The widespread utilization of sugars by microbes is reflected in the diversity and multiplicity of cellular transporters used to acquire these compounds from the environment. The model bacterium Escherichia coli has numerous transporters that allow it to take up hexoses and pentoses, which recognize the more abundant pyranose forms of these sugars. Here we report the biochemical and structural characterization of a transporter protein YtfQ from E. coli that forms part of an uncharacterized ABC transporter system. Remarkably the crystal structure of this protein, solved to 1.2 angstrom using x-ray crystallography, revealed that YtfQ binds a single molecule of galactofuranose in its ligand binding pocket. Selective binding of galactofuranose over galactopyranose was also observed using NMR methods that determined the form of the sugar released from the protein. The pattern of expression of the ytfQRTyjfF operon encoding this transporter mirrors that of the high affinity galactopyranose transporter of E. coli, suggesting that this bacterium has evolved complementary transporters that enable it to use all the available galactose present during carbon limiting conditions.	[Horler, Richard S. P.; Mueller, Axel; Potts, Jennifer R.; Thomas, Gavin H.] Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England; [Mueller, Axel; Wilson, Keith S.] Univ York, York Struct Biol Lab, York YO10 5YW, N Yorkshire, England; [Williamson, David C.; Potts, Jennifer R.] Univ York, Dept Chem, York YO10 5YW, N Yorkshire, England	University of York - UK; University of York - UK; University of York - UK	Thomas, GH (corresponding author), Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England.	ght2@york.ac.uk	Thomas, Gavin H/E-5753-2011	Thomas, Gavin H/0000-0002-9763-1313; Horler, Richard/0000-0002-9908-2469; Wilson, Keith/0000-0002-3581-2194	Biotechnology and Biological Sciences Research Council (BBSRC)	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Biotechnology and Biological Sciences Research Council (BBSRC) (to G.H.T.) and a BBSRC quota studentship (to R.S.P.H.).	Barlow JN, 2000, CARBOHYD RES, V328, P473, DOI 10.1016/S0008-6215(00)00135-X; BJORKMAN AJ, 1994, J BIOL CHEM, V269, P30206; Bulyk ML, 2004, GENOME RES, V14, P201, DOI 10.1101/gr.1448004; Chaudhuri BN, 1999, J MOL BIOL, V286, P1519, DOI 10.1006/jmbi.1999.2571; Collins P. C., 1995, MONOSACCHARIDES THEI; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fabich AJ, 2008, INFECT IMMUN, V76, P1143, DOI 10.1128/IAI.01386-07; Franchini AG, 2006, MICROBIOL-SGM, V152, P2111, DOI 10.1099/mic.0.28939-0; FRANKS F, 1987, PURE APPL CHEM, V59, P1189, DOI 10.1351/pac198759091189; Fukami-Kobayashi K, 2003, MOL BIOL EVOL, V20, P267, DOI 10.1093/molbev/msg038; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; HENDERSON PJF, 1977, BIOCHEM J, V162, P309, DOI 10.1042/bj1620309; Hobley P, 1996, MAGN RESON CHEM, V34, P755; Holm Liisa, 2006, Curr Protoc Bioinformatics, VChapter 5, DOI 10.1002/0471250953.bi0505s14; Ingraham JL., 1987, Escherichia coli and Salmonella typhimurium: cellular and molecular biology; Jahreis K, 2008, FEMS MICROBIOL REV, V32, P891, DOI 10.1111/j.1574-6976.2008.00125.x; JASEJA M, 1990, MAGN RESON CHEM, V28, P283, DOI 10.1002/mrc.1260280402; Liu MZ, 2005, J BIOL CHEM, V280, P15921, DOI 10.1074/jbc.M414050200; Magnusson U, 2004, J BIOL CHEM, V279, P8747, DOI 10.1074/jbc.M311890200; Mauchline TH, 2006, P NATL ACAD SCI USA, V103, P17933, DOI 10.1073/pnas.0606673103; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MILLER DM, 1980, J BIOL CHEM, V255, P2465; MILLER DM, 1983, J BIOL CHEM, V258, P3665; Misra RV, 2005, NUCLEIC ACIDS RES, V33, pD329, DOI 10.1093/nar/gki028; MOWBRAY SL, 1992, J MOL BIOL, V225, P155, DOI 10.1016/0022-2836(92)91033-L; Muller A, 2005, MOL MICROBIOL, V57, P143, DOI 10.1111/j.1365-2958.2005.04691.x; Muller A, 2006, J BIOL CHEM, V281, P22212, DOI 10.1074/jbc.M603463200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Newman J, 2005, ACTA CRYSTALLOGR D, V61, P1426, DOI [10.1107/S0907444905024984, 10.1107/S090744905024984]; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; QUIOCHO FA, 1990, PHILOS T R SOC B, V326, P341, DOI 10.1098/rstb.1990.0016; QUIOCHO FA, 1977, J SUPRAMOL STR CELL, V6, P502; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; QUIOCHO FA, 1984, NATURE, V310, P381, DOI 10.1038/310381a0; Raman B, 2005, BIOTECHNOL BIOENG, V92, P384, DOI 10.1002/bit.20570; SACK JS, 1989, J MOL BIOL, V206, P171, DOI 10.1016/0022-2836(89)90531-7; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Savery NJ, 1998, EMBO J, V17, P3439, DOI 10.1093/emboj/17.12.3439; Severi E, 2005, MOL MICROBIOL, V58, P1173, DOI 10.1111/j.1365-2958.2005.04901.x; Siebold C, 2001, FEBS LETT, V504, P104, DOI 10.1016/S0014-5793(01)02705-3; Thomas GH, 2006, MICROBIOL-SGM, V152, P187, DOI 10.1099/MIC.0.28334-0; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vertommen D, 2008, MOL MICROBIOL, V67, P336, DOI 10.1111/j.1365-2958.2007.06030.x; Wilkinson T., 2003, ABC PROTEINS BACTERI, P187; WILSON DB, 1974, J BIOL CHEM, V249, P553; WITHOLT B, 1976, ANAL BIOCHEM, V74, P160, DOI 10.1016/0003-2697(76)90320-1; Zheng DL, 2004, NUCLEIC ACIDS RES, V32, P5874, DOI 10.1093/nar/gkh908; ZOU JY, 1993, J MOL BIOL, V233, P739, DOI 10.1006/jmbi.1993.1549; ZUKIN RS, 1977, BIOCHEMISTRY-US, V16, P381, DOI 10.1021/bi00622a007	52	22	23	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31156	31163		10.1074/jbc.M109.054296	http://dx.doi.org/10.1074/jbc.M109.054296			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19744923	hybrid, Green Published			2022-12-27	WOS:000271378400043
J	Potula, HSK; Wang, D; Van Quyen, D; Singh, NK; Kundumani-Sridharan, V; Karpurapu, M; Park, EA; Glasgow, WC; Rao, GN				Potula, Harihara S. K.; Wang, Dong; Van Quyen, Dong; Singh, Nikhlesh K.; Kundumani-Sridharan, Venkatesh; Karpurapu, Manjula; Park, Edwards A.; Glasgow, Wayne C.; Rao, Gadiparthi N.			Src-dependent STAT-3-mediated Expression of Monocyte Chemoattractant Protein-1 Is Required for 15(S)-Hydroxyeicosatetraenoic Acid-induced Vascular Smooth Muscle Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED NEOINTIMA FORMATION; LOW-DENSITY-LIPOPROTEIN; E-KNOCKOUT MICE; ARACHIDONIC-ACID; ARTERIAL INJURY; BALLOON INJURY; VESSEL WALL; HUMAN 15-LIPOXYGENASE; INTIMAL HYPERPLASIA; DEFICIENT MICE	To understand the role of human 15-lipoxygenase 1 (15-LOX1) in vascular wall remodeling, we have studied the effect of the major 15-LOX1 metabolite of arachidonic acid, 15(S)-hydroxyeicosatetraenoic acid (15(S)-HETE), on vascular smooth muscle cell (VSMC) migration both in vitro and in vivo. Among 5(S)-HETE, 12(S)-HETE, and 15(S)-HETE, 15(S)-HETE potentially stimulated more vascular smooth muscle cell ( VSMC) migration. In addition, 15(S)-HETE-induced VSMC migration was dependent on Src-mediated activation of signal transducer and activator of transcription-3 (STAT-3). 15(S)-HETE also induced monocyte chemoattractant protein-1 (MCP-1) expression via Src-STAT-3 signaling, and neutralizing anti-MCP-1 antibodies completely negated 15(S)-HETE-induced VSMC migration. Cloning and characterization of a 2.6-kb MCP-1 promoter revealed the presence of four putative STAT-binding sites, and the site that is proximal to the transcription start site was found to be essential for 15(S)-HETE-induced Src-STAT-3-mediated MCP-1 expression. Rat carotid arteries that were subjected to balloon injury and transduced with Ad-15-LOX1 upon exposure to [H-3] arachidonic acid ex vivo produced 15-HETE as a major eicosanoid and enhanced balloon injury-induced expression of MCP-1 in smooth muscle cells in Src and STAT-3-dependent manner in vivo. Adenovirus-mediated delivery of 15-LOX1 into rat carotid artery also led to recruitment and homing of macrophages to medial region in response to injury. In addition, transduction of Ad-15-LOX1 into arteries enhanced balloon injury-induced smooth muscle cell migration from media to intima and neointima formation. These results show for the first time that 15-LOX1-15(S)-HETE axis plays a major role in vascular wall remodeling after balloon angioplasty.	[Potula, Harihara S. K.; Wang, Dong; Van Quyen, Dong; Singh, Nikhlesh K.; Kundumani-Sridharan, Venkatesh; Karpurapu, Manjula; Rao, Gadiparthi N.] Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Memphis, TN 38163 USA; [Park, Edwards A.] Univ Tennessee, Hlth Sci Ctr, Dept Pharmacol, Memphis, TN 38163 USA; [Glasgow, Wayne C.] Mercer Univ, Sch Med, Div Basic Med Sci, Macon, GA 31207 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Mercer University	Rao, GN (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Physiol, 894 Union Ave, Memphis, TN 38163 USA.	grao@physio1.utmem.edu	Kundumani-Sridharan, Venkatesh/I-4799-2016; Kundumani-Sridharan, Venkatesh/ABD-9613-2021; Singh, Nikhlesh/AAA-4253-2020; Kundumani-Sridharan, Venkatesh/AAB-4535-2020	Kundumani-Sridharan, Venkatesh/0000-0002-6134-4371; Kundumani-Sridharan, Venkatesh/0000-0002-6134-4371; Singh, Nikhlesh/0000-0002-3665-6023; Quyen, Dong Van/0000-0003-1002-7517	National Institutes of Health [HL064165]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064165] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL064165 (NHLBI; to G.N.R.).	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Bajpai AK, 2007, INVEST OPHTH VIS SCI, V48, P4930, DOI 10.1167/iovs.07-0617; BENDECK MP, 1994, CIRC RES, V75, P539, DOI 10.1161/01.RES.75.3.539; BERKNER KL, 1988, BIOTECHNIQUES, V6, P616; Brash AR, 1997, P NATL ACAD SCI USA, V94, P6148, DOI 10.1073/pnas.94.12.6148; BRYANT RW, 1982, J BIOL CHEM, V257, P6050; Burysek L, 2002, J BIOL CHEM, V277, P33509, DOI 10.1074/jbc.M201941200; Cao HQ, 2006, CIRC RES, V98, P913, DOI 10.1161/01.RES.0000216954.55724.a2; Chang MS, 2005, INVEST OPHTH VIS SCI, V46, P849, DOI 10.1167/iovs.04-1166; Chava KR, 2009, ARTERIOSCL THROM VAS, V29, P809, DOI 10.1161/ATVBAHA.109.185777; Cheranov SY, 2008, BLOOD, V111, P5581, DOI 10.1182/blood-2007-11-126680; Cheranov SY, 2009, BLOOD, V113, P6023, DOI 10.1182/blood-2008-10-183210; Cyrus T, 1999, J CLIN INVEST, V103, P1597, DOI 10.1172/JCI5897; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Dronadula N, 2006, J LIPID RES, V47, P767, DOI 10.1194/jlr.M500369-JLR200; Gerthoffer WT, 2007, CIRC RES, V100, P607, DOI 10.1161/01.RES.0000258492.96097.47; Gu JL, 2001, CIRCULATION, V103, P1446, DOI 10.1161/01.CIR.103.10.1446; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; Harats D, 2000, ARTERIOSCL THROM VAS, V20, P2100, DOI 10.1161/01.ATV.20.9.2100; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; HENRIKSSON P, 1985, BIOCHIM BIOPHYS ACTA, V834, P272, DOI 10.1016/0005-2760(85)90166-3; Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551; Hou SX, 2002, DEV CELL, V3, P765, DOI 10.1016/S1534-5807(02)00376-3; HUGOU I, 1995, ATHEROSCLEROSIS, V113, P189, DOI 10.1016/0021-9150(94)05446-P; Inoue S, 2002, CIRCULATION, V106, P2700, DOI 10.1161/01.CIR.0000038140.80105.AD; Kelavkar UP, 2001, CARCINOGENESIS, V22, P1765, DOI 10.1093/carcin/22.11.1765; Kilty I, 1999, EUR J BIOCHEM, V266, P83, DOI 10.1046/j.1432-1327.1999.00818.x; Kotecha N, 2008, CANCER CELL, V14, P335, DOI 10.1016/j.ccr.2008.08.014; Krymskaya VP, 2004, FASEB J, V18, P428, DOI 10.1096/fj.04-2869fje; Kuhn H, 2006, PROG LIPID RES, V45, P334, DOI 10.1016/j.plipres.2006.02.003; Kuhn H, 2007, J CARDIOVASC PHARM, V50, P609, DOI 10.1097/FJC.0b013e318159f177; Kuhn Hartmut, 2005, Expert Rev Cardiovasc Ther, V3, P1099, DOI 10.1586/14779072.3.6.1099; Kundumani-Sridharan V, 2007, AM J PATHOL, V171, P1381, DOI 10.2353/ajpath.2007.061258; Levine RL, 2008, BLOOD, V112, P2190, DOI 10.1182/blood-2008-03-077966; LIN L, 1994, CIRC RES, V74, P197, DOI 10.1161/01.RES.74.2.197; Liu ZM, 2005, J BIOL CHEM, V280, P14700, DOI 10.1074/jbc.M500322200; Natarajan R, 1999, CARDIOVASC RES, V41, P489, DOI 10.1016/S0008-6363(98)00312-5; Neeli I, 2004, J BIOL CHEM, V279, P46122, DOI 10.1074/jbc.M406922200; Newby AC, 2000, J PATHOL, V190, P300, DOI 10.1002/(SICI)1096-9896(200002)190:3<300::AID-PATH596>3.0.CO;2-I; Ni WH, 2001, CIRCULATION, V103, P2096; Nony PA, 2005, J BIOL CHEM, V280, P31413, DOI 10.1074/jbc.M500418200; Raines EW, 2005, J LIPID RES, V46, P1081, DOI 10.1194/jlr.R500004-JLR200; RAO GN, 1994, J BIOL CHEM, V269, P32586; Reape TJ, 1999, ATHEROSCLEROSIS, V147, P213, DOI 10.1016/S0021-9150(99)00346-9; Sampath P, 2003, MOL CELL BIOL, V23, P1509, DOI 10.1128/MCB.23.5.1509-1519.2003; Schepers A, 2006, ARTERIOSCL THROM VAS, V26, P2063, DOI 10.1161/01.ATV.0000235694.69719.e2; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Schober A, 2004, CIRC RES, V95, P1125, DOI 10.1161/01.RES.0000149518.86865.3e; Schober A, 2008, ARTERIOSCL THROM VAS, V28, P1950, DOI 10.1161/ATVBAHA.107.161224; SCHWARTZ SM, 1995, CIRC RES, V77, P445, DOI 10.1161/01.RES.77.3.445; SIGAL E, 1988, BIOCHEM BIOPH RES CO, V157, P457, DOI 10.1016/S0006-291X(88)80271-7; Silva CM, 2004, ONCOGENE, V23, P8017, DOI 10.1038/sj.onc.1208159; SIMON TC, 1989, ATHEROSCLEROSIS, V75, P31, DOI 10.1016/0021-9150(89)90204-9; Srivastava K, 2007, CANCER RES, V67, P4328, DOI 10.1158/0008-5472.CAN-06-3594; Sun P, 2009, ONCOGENE, V28, P1339, DOI 10.1038/onc.2008.480; Tang X, 2006, ARTERIOSCL THROM VAS, V26, P78, DOI 10.1161/01.ATV.0000191640.73313.ad; Verma S, 2002, CIRCULATION, V105, P1890, DOI 10.1161/01.CIR.0000015126.83143.B4; Wang D, 2007, CIRC RES, V100, P807, DOI 10.1161/01.RES.0000261350.61711.9e; YLAHERTTUALA S, 1990, P NATL ACAD SCI USA, V87, P6959, DOI 10.1073/pnas.87.18.6959; Zhao L, 2004, TRENDS CARDIOVAS MED, V14, P191, DOI 10.1016/j.tcm.2004.04.003; Zhu DL, 2003, CIRC RES, V92, P992, DOI 10.1161/01.RES.0000070881.65194.8F; Zhu H, 2003, J BIOL CHEM, V278, P13350, DOI 10.1074/jbc.M212104200	62	52	56	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31142	31155		10.1074/jbc.M109.012526	http://dx.doi.org/10.1074/jbc.M109.012526			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19736311	hybrid, Green Published			2022-12-27	WOS:000271378400042
J	Ahn, YH; Kurie, JM				Ahn, Young-Ho; Kurie, Jonathan M.			MKK4/SEK1 Is Negatively Regulated through a Feedback Loop Involving the E3 Ubiquitin Ligase Itch	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-JUN; MEDIATES UBIQUITINATION; DIFFERENTIAL REGULATION; PROTEIN LIGASE; KINASE 1; DEGRADATION; PHOSPHORYLATION; ACTIVATION; ACTS; SCAFFOLD	Cells exposed to environmental stress rapidly activate the MAPK cascade (MKKK/MKK/MAPK). The transient nature of stress signaling is a consequence of negative feedback signals that lead to kinase dephosphorylation, degradation, and sequestration, which have not been fully elucidated for MKK family members. Here, we investigated the signals that negatively regulate MKK4/SEK1, an upstream activator of the MAPKs JNK and p38/HOG1. Following exposure of cells to sorbitol, MKK4 underwent ubiquitination and degradation in a proteasome-dependent manner. MKK4 ubiquitination required JNK kinase activity. The JNK substrate Itch (a HECT domain-containing Nedd4-like ubiquitin protein ligase) bound to MKK4, ubiquitinated lysines 140 and 143, and promoted MKK4 degradation. Other E3 ligases within the MAPK modular complex did not ubiquitinate MKK4. These data suggest that MKK4 is negatively regulated through a feedback loop involving the E3 ubiquitin ligase Itch, which has a fundamental role in the mechanism that controls MKK4 protein levels.	[Kurie, Jonathan M.] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Unit 432, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Kurie, JM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Unit 432, 1515 Holcombe Blvd, Houston, TX 77030 USA.	jkurie@mdanderson.org			National Institutes of Health, NCI [R01 CA105155]; NATIONAL CANCER INSTITUTE [R01CA105155, P50CA070907] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA105155 from NCI.	Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen W, 2002, J BIOL CHEM, V277, P49105, DOI 10.1074/jbc.M204934200; Deacon K, 1997, J BIOL CHEM, V272, P14489, DOI 10.1074/jbc.272.22.14489; Gallagher E, 2006, P NATL ACAD SCI USA, V103, P1717, DOI 10.1073/pnas.0510664103; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Johnson GL, 2005, CURR OPIN CHEM BIOL, V9, P325, DOI 10.1016/j.cbpa.2005.04.004; Kuo WL, 2004, J BIOL CHEM, V279, P23073, DOI 10.1074/jbc.M313696200; Laine Aaron, 2005, Sci STKE, V2005, pre5, DOI 10.1126/stke.2812005re5; Liu WH, 2005, MOL CELL BIOL, V25, P1367, DOI 10.1128/MCB.25.4.1367-1378.2005; Lu ZM, 2009, ANNU REV BIOCHEM, V78, P435, DOI 10.1146/annurev.biochem.013008.092711; Lu ZM, 2002, MOL CELL, V9, P945, DOI 10.1016/S1097-2765(02)00519-1; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Matsuzawa A, 2008, SCIENCE, V321, P663, DOI 10.1126/science.1157340; Melino G, 2008, CELL DEATH DIFFER, V15, P1103, DOI 10.1038/cdd.2008.60; Meza R, 1996, FEMS MICROBIOL LETT, V145, P333, DOI 10.1111/j.1574-6968.1996.tb08597.x; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Perry WL, 1998, NAT GENET, V18, P143, DOI 10.1038/ng0298-143; Qiu L, 2000, J BIOL CHEM, V275, P35734, DOI 10.1074/jbc.M007300200; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Rossi M, 2005, EMBO J, V24, P836, DOI 10.1038/sj.emboj.7600444; Rossi M, 2006, P NATL ACAD SCI USA, V103, P12753, DOI 10.1073/pnas.0603449103; Sobko A, 2002, DEV CELL, V2, P745, DOI 10.1016/S1534-5807(02)00186-7; Sundvall M, 2008, P NATL ACAD SCI USA, V105, P4162, DOI 10.1073/pnas.0708333105; Wang YQ, 2003, J BIOL CHEM, V278, P22284, DOI 10.1074/jbc.M301272200; Xia Y, 1998, GENE DEV, V12, P3369, DOI 10.1101/gad.12.21.3369; Xia Y, 2007, MOL CELL BIOL, V27, P510, DOI 10.1128/MCB.01355-06; Xu ZH, 2003, EMBO J, V22, P252, DOI 10.1093/emboj/cdg021; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Yujiri T, 2000, P NATL ACAD SCI USA, V97, P7272, DOI 10.1073/pnas.130176697; Zheng CJ, 1999, J BIOL CHEM, V274, P28966, DOI 10.1074/jbc.274.41.28966	35	14	15	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29399	29404		10.1074/jbc.M109.044958	http://dx.doi.org/10.1074/jbc.M109.044958			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19737936	Green Published, hybrid			2022-12-27	WOS:000270896800021
J	Rickman, C; Duncan, RR				Rickman, Colin; Duncan, Rory R.			Munc18/Syntaxin Interaction Kinetics Control Secretory Vesicle Dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; NEURONAL SNARE COMPLEX; PROTEIN-KINASE-C; MEMBRANE-FUSION; SEC1/MUNC18 PROTEINS; DISTINCT MODES; BINDING MODE; MUNC18-1; SYNTAXIN; EXOCYTOSIS	In neuronal and hormonal release, regulated exocytosis requires an essential set of proteins: the soluble N-ethylmaleimide sensitive-factor attachment receptor proteins (SNAREs) syntaxin 1, SNAP-25, VAMP, and their regulator, Munc18. Recently, it was found that Munc18-1 can interact with syntaxin 1 through distinct mechanisms: an inhibitory mode enveloping syntaxin (mode 1), sequestering it from SNARE protein interactions, and direct binding to an evolutionarily conserved N-terminal peptide of syntaxin (mode 2/3). The latter interaction has been proposed to control "priming" of the fusion reaction, defined using electrophysiology, but it is unknown how this interaction is regulated, and any dynamic effect at the molecular or vesicular level in cells remains undiscovered. We now show that a phosphorylation site in syntaxin 1 (Ser14) regulates the N-terminal interaction with Munc18-1. Probing syntaxin 1 association with Munc18-1, in real-time and in living cells, we found that modification of Ser14 modulated the dynamics of this interaction, specifically at the plasma membrane. Destabilization of this dynamic interaction enhanced vesicle immobilization at the plasma membrane with a resulting inhibition of exocytosis.	[Rickman, Colin; Duncan, Rory R.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland	University of Edinburgh	Duncan, RR (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland.	rory.duncan@ed.ac.uk		Rickman, Colin/0000-0001-8938-524X; Duncan, Rory/0000-0003-0693-910X	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a project grant from the Wellcome Trust (to R. R. D.).	Arunachalam L, 2008, MOL BIOL CELL, V19, P722, DOI 10.1091/mbc.E07-07-0662; Barclay JW, 2003, J BIOL CHEM, V278, P10538, DOI 10.1074/jbc.M211114200; Becherer U, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000505; BENNETT MK, 1993, J NEUROSCI, V13, P1701; Bracher A, 2002, EMBO J, V21, P6114, DOI 10.1093/emboj/cdf608; Burgoyne RD, 2007, CURR BIOL, V17, pR255, DOI 10.1016/j.cub.2007.02.006; Burkhardt P, 2008, EMBO J, V27, P923, DOI 10.1038/emboj.2008.37; Carpp LN, 2006, J CELL BIOL, V173, P927, DOI 10.1083/jcb.200512024; Connell E, 2007, EMBO REP, V8, P414, DOI 10.1038/sj.embor.7400935; de Wit H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000126; Deak F, 2009, J CELL BIOL, V184, P751, DOI 10.1083/jcb.200812026; Degtyar VE, 2007, P NATL ACAD SCI USA, V104, P15929, DOI 10.1073/pnas.0705406104; DeLano W.L, PYMOL MOL GRAPHICS S; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Duncan RR, 2004, J MICROSC-OXFORD, V215, P1, DOI 10.1111/j.0022-2720.2004.01343.x; Li F, 2007, NAT STRUCT MOL BIOL, V14, P890, DOI 10.1038/nsmb1310; Foletti DL, 2000, J NEUROSCI, V20, P4535, DOI 10.1523/JNEUROSCI.20-12-04535.2000; Fujita Y, 1996, J BIOL CHEM, V271, P7265, DOI 10.1074/jbc.271.13.7265; Ganesan S, 2006, P NATL ACAD SCI USA, V103, P4089, DOI 10.1073/pnas.0509922103; Hu K, 2002, NATURE, V415, P646, DOI 10.1038/415646a; Hu SH, 2007, P NATL ACAD SCI USA, V104, P8773, DOI 10.1073/pnas.0701124104; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Lam AD, 2008, MOL BIOL CELL, V19, P485, DOI 10.1091/mbc.E07-02-0148; Latham CF, 2006, TRAFFIC, V7, P1408, DOI 10.1111/j.1600-0854.2006.00474.x; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Liu J, 2004, J BIOL CHEM, V279, P55924, DOI 10.1074/jbc.M410024200; MARIN O, 1986, EUR J BIOCHEM, V160, P239, DOI 10.1111/j.1432-1033.1986.tb09962.x; McNew JA, 2000, J CELL BIOL, V150, P105, DOI 10.1083/jcb.150.1.105; Medine CN, 2007, J CELL SCI, V120, P4407, DOI 10.1242/jcs.020230; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Nofal S, 2007, J NEUROSCI, V27, P1386, DOI 10.1523/JNEUROSCI.4714-06.2007; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; QIAN H, 1990, P NATL ACAD SCI USA, V87, P5479, DOI 10.1073/pnas.87.14.5479; Rickman C, 2005, CHEM BIOL, V12, P545, DOI 10.1016/j.chembiol.2005.03.004; Rickman C, 2007, J BIOL CHEM, V282, P12097, DOI 10.1074/jbc.M700227200; Risinger C, 1999, J NEUROCHEM, V72, P614, DOI 10.1046/j.1471-4159.1999.0720614.x; Rizo J, 2002, NAT REV NEUROSCI, V3, P641, DOI 10.1038/nrn898; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Togneri J, 2006, P NATL ACAD SCI USA, V103, P17730, DOI 10.1073/pnas.0605448103; Toonen RFG, 2003, TRENDS CELL BIOL, V13, P177, DOI 10.1016/S0962-8924(03)00031-X; Tsuboi T, 2003, CURR BIOL, V13, P563, DOI 10.1016/S0960-9822(03)00176-3; Voets T, 2001, NEURON, V31, P581, DOI 10.1016/S0896-6273(01)00391-9; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Yang B, 2000, J CELL BIOL, V148, P247, DOI 10.1083/jcb.148.2.247	46	36	36	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3965	3972		10.1074/jbc.M109.040402	http://dx.doi.org/10.1074/jbc.M109.040402			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19748891	Green Published, hybrid			2022-12-27	WOS:000275254000050
J	Duc, C; Cellier, F; Lobreaux, S; Briat, JF; Gaymard, F				Duc, Celine; Cellier, Francoise; Lobreaux, Stephane; Briat, Jean-Francois; Gaymard, Frederic			Regulation of Iron Homeostasis in Arabidopsis thaliana by the Clock Regulator Time for Coffee	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISRUPTS CIRCADIAN-RHYTHMS; GENE-EXPRESSION; FERRITIN GENE; OXIDATIVE STRESS; SOUTHERN-OCEAN; PLANT-GROWTH; PROTEIN; TRANSCRIPTION; LIGHT; DEGRADATION	In plants, iron homeostasis is tightly regulated to supply sufficient amounts of this metal for an optimal growth while preventing excess accumulation to avoid oxidative stress. To identify new regulators of iron homeostasis, a luciferase-based genetic screen using the Arabidopsis AtFer1 ferritin promoter as a target was developed. This screen identified TIME FOR COFFEE(TIC) as a regulator of AtFer1 gene expression. TIC was previously described as a nuclear regulator of the circadian clock. Mutants in the TIC gene exhibited a chlorotic phenotype rescued by exogenous iron addition and are hypersensitive to iron during the early stages of development. We showed that iron overload-responsive genes are regulated by TIC and by the central oscillator of the circadian clock. TIC represses their expression under low iron conditions, and its activity requires light and light/dark cycles. Regarding AtFer1, this repression is independent of the previously characterized cis-acting element iron-dependent regulatory sequence, known to be involved in AtFer1 repression. These results showed that the regulation of iron homeostasis in plants is a major output of the TIC-and central oscillator-dependent signaling pathways.	[Duc, Celine; Cellier, Francoise; Briat, Jean-Francois; Gaymard, Frederic] Univ Montpellier 2, Inst Natl Rech Agron, CNRS, Lab Biochim & Physiol Mol Plantes,UMR 5004, F-34060 Montpellier 1, France; [Lobreaux, Stephane] Univ Grenoble 1, Ctr Rech Macromol Organisees, Lab Plastes & Differenciat Cellulaire, F-38041 Grenoble 9, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Institut Agro; Montpellier SupAgro; Universite de Montpellier; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Gaymard, F (corresponding author), 2 Pl Viala, F-34060 Montpellier 1, France.	gaymard@supagro.inra.fr	duc, celine/F-1372-2015	duc, celine/0000-0001-7426-4541	Institut National de la Recherche Agronomique; CNRS; Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche [BCMS166]	Institut National de la Recherche Agronomique; CNRS(Centre National de la Recherche Scientifique (CNRS)); Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche	This work was supported by the Institut National de la Recherche Agronomique, the CNRS, and Action Concertee Incitative "Biologie Cellulaire Moleculaire et Structurale" Grant BCMS166 from the Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche.	Andrews NC, 2000, NAT REV GENET, V1, P208, DOI 10.1038/35042073; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Arnaud N, 2006, J BIOL CHEM, V281, P23579, DOI 10.1074/jbc.M602135200; Baena-Gonzalez E, 2008, TRENDS PLANT SCI, V13, P474, DOI 10.1016/j.tplants.2008.06.006; Baena-Gonzalez E, 2007, NATURE, V448, P938, DOI 10.1038/nature06069; Baruah A, 2009, PLANT J, V60, P22, DOI 10.1111/j.1365-313X.2009.03935.x; Baruah A, 2009, PLANT MOL BIOL, V70, P547, DOI 10.1007/s11103-009-9491-0; Beinert H, 1978, Methods Enzymol, V54, P435; Bhalerao RP, 1999, P NATL ACAD SCI USA, V96, P5322, DOI 10.1073/pnas.96.9.5322; Blain S, 2007, NATURE, V446, P1070, DOI 10.1038/nature05700; Blasing OE, 2005, PLANT CELL, V17, P3257, DOI 10.1105/tpc.105.035261; BRIAT J, 2005, IRON NUTR PLANTS RHI; Briat JF, 2007, CURR OPIN PLANT BIOL, V10, P276, DOI 10.1016/j.pbi.2007.04.003; Briat JF, 2010, ANN BOT-LONDON, V105, P811, DOI 10.1093/aob/mcp128; Briat JF, 1995, BIOL CELL, V84, P69, DOI 10.1016/0248-4900(96)81320-7; CADENAS E, 1989, ANNU REV BIOCHEM, V58, P79, DOI 10.1146/annurev.bi.58.070189.000455; Carre IA, 2002, J EXP BOT, V53, P1551, DOI 10.1093/jxb/erf027; Cassar N, 2007, SCIENCE, V317, P1067, DOI 10.1126/science.1144602; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Covington MF, 2001, PLANT CELL, V13, P1305, DOI 10.1105/tpc.13.6.1305; Curie C, 2003, ANNU REV PLANT BIOL, V54, P183, DOI 10.1146/annurev.arplant.54.031902.135018; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Dellagi A, 2005, PLANT J, V43, P262, DOI 10.1111/j.1365-313X.2005.02451.x; Ding Z, 2007, PLANT CELL, V19, P1522, DOI 10.1105/tpc.106.047241; Doyle MR, 2002, NATURE, V419, P74, DOI 10.1038/nature00954; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Farras R, 2001, EMBO J, V20, P2742, DOI 10.1093/emboj/20.11.2742; Fourcroy P, 2004, PLANT PHYSIOL, V134, P605, DOI 10.1104/pp.103.029876; GUERINOT ML, 1994, PLANT PHYSIOL, V104, P815, DOI 10.1104/pp.104.3.815; Hall A, 2003, PLANT CELL, V15, P2719, DOI 10.1105/tpc.013730; Kim SA, 2007, FEBS LETT, V581, P2273, DOI 10.1016/j.febslet.2007.04.043; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu XL, 2001, PLANT CELL, V13, P1293, DOI 10.1105/tpc.13.6.1293; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; LOBREAUX S, 1991, BIOCHEM J, V274, P601, DOI 10.1042/bj2740601; LOBREAUX S, 1995, PLANT J, V8, P443, DOI 10.1046/j.1365-313X.1995.08030443.x; MacKinney G, 1941, J BIOL CHEM, V140, P315; Mas P, 2005, INT J DEV BIOL, V49, P491, DOI 10.1387/ijdb.041968pm; Mas P, 2008, TRENDS CELL BIOL, V18, P273, DOI 10.1016/j.tcb.2008.03.005; McWatters HG, 2007, PLANT PHYSIOL, V144, P391, DOI 10.1104/pp.107.096206; McWatters HG, 2000, NATURE, V408, P716, DOI 10.1038/35047079; Moore B, 2003, SCIENCE, V300, P332, DOI 10.1126/science.1080585; Patton EE, 1998, TRENDS GENET, V14, P236, DOI 10.1016/S0168-9525(98)01473-5; Petit JM, 2001, J BIOL CHEM, V276, P5584, DOI 10.1074/jbc.M005903200; Petit JM, 2001, BIOCHEM J, V359, P575, DOI 10.1042/0264-6021:3590575; Pilon M, 2009, CURR OPIN PLANT BIOL, V12, P347, DOI 10.1016/j.pbi.2009.04.011; Ravet K, 2009, MOL PLANT, V2, P1095, DOI 10.1093/mp/ssp041; Ravet K, 2009, PLANT J, V57, P400, DOI 10.1111/j.1365-313X.2008.03698.x; Robinson NJ, 1999, NATURE, V397, P694, DOI 10.1038/17800; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Smith AM, 2007, PLANT CELL ENVIRON, V30, P1126, DOI 10.1111/j.1365-3040.2007.01708.x; Somers DE, 1998, DEVELOPMENT, V125, P485; Tarantino D, 2003, PLANTA, V217, P709, DOI 10.1007/s00425-003-1038-z; Van Wuytswinkel O, 1999, PLANT J, V17, P93, DOI 10.1046/j.1365-313X.1999.00349.x; Vert G, 2002, PLANT CELL, V14, P1223, DOI 10.1105/tpc.001388; VILLARREAL AS, 2009, 20 INT C AR RES ED U; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6	58	59	63	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36271	36281		10.1074/jbc.M109.059873	http://dx.doi.org/10.1074/jbc.M109.059873			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19828447	hybrid, Green Published			2022-12-27	WOS:000272970500029
J	Mizwicki, MT; Bula, CM; Mahinthichaichan, P; Henry, HL; Ishizuka, S; Norman, AW				Mizwicki, Mathew T.; Bula, Craig M.; Mahinthichaichan, Paween; Henry, Helen L.; Ishizuka, Seiichi; Norman, Anthony W.			On the Mechanism Underlying (23S)-25-Dehydro-1 alpha(OH)-vitamin D-3-26,23-lactone Antagonism of hVDRwt Gene Activation and Its Switch to a Superagonist	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-D-RECEPTOR; CONFORMATIONAL ENSEMBLE MODEL; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; CRYSTAL-STRUCTURES; NUCLEAR RECEPTOR; STRUCTURAL BASIS; PAGETS-DISEASE; LIGAND; VDR; ANALOGS	(23S)-25-Dehydro-1 alpha(OH)-vitamin D-3-26,23-lactone (MK) is an antagonist of the 1 alpha,25(OH)(2)-vitamin D-3 (1,25D)/human nuclear vitamin D receptor (hVDR) transcription initiation complex, where the activation helix (i.e. helix-12) is closed. To study the mode of antagonism of MK an hVDR mutant library was designed to alter the free molecular volume in the region of the hVDR ligand binding pocket occupied by the ligand side-chain atoms (i.e. proximal to helix-12). The 1,25D-hVDR structure-function studies demonstrate that 1) van der Waals contacts between helix-12 residues Leu-414 and Val-418 and 1,25D enhance the stability of the closed helix-12 conformer and 2) removal of the side-chain H-bonds to His-305(F) and/or His-397(F) have no effect on 1,25D transactivation, even though they reduce the binding affinity of 1,25D. The MK structure-function results demonstrate that the His-305, Leu-404, Leu-414, and Val-418 mutations, which increase the free volume of the hVDR ligand binding pocket, significantly enhance MK antagonist potency. Surprisingly, the H305F and H305F/H397F mutations turn MK into a VDR superagonist (EC50 similar to 0.05 nM) but do not concomitantly alter MK binding affinity. Molecular modeling studies demonstrate that MK antagonism stems from its side chain energetically preferring a pose in the VDR ligand binding pocket where its terminal C26-methylene atom is far removed from helix-12. MK superagonism results from an energetically favored increase in interaction between Leu-404/Val-418 and C26, resulting in an increase in the stability and population of the closed, helix-12 conformer. Finally, the results/model generated, coupled with application of a VDR ensemble allosterics model, provide an understanding for the species specificity of MK.	[Mizwicki, Mathew T.; Bula, Craig M.; Mahinthichaichan, Paween; Henry, Helen L.; Norman, Anthony W.] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA; [Ishizuka, Seiichi] Teijin Inst Biomed Res, Dept Bone & Calcium Metab, Tokyo 1918512, Japan	University of California System; University of California Riverside	Mizwicki, MT (corresponding author), Univ Calif Riverside, Dept Biochem, 5470 Boyce Hall, Riverside, CA 92521 USA.	mathew.mizwicki@ucr.edu		Mahinthichaichan, Paween/0000-0002-2216-4482				Barletta F, 2002, MOL ENDOCRINOL, V16, P301, DOI 10.1210/me.16.2.301; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Bula CM, 2000, MOL ENDOCRINOL, V14, P1788, DOI 10.1210/me.14.11.1788; Bula CM, 2005, ENDOCRINOLOGY, V146, P5581, DOI 10.1210/en.2005-0806; CHESKIS B, 1994, MOL CELL BIOL, V14, P3329, DOI 10.1128/MCB.14.5.3329; Choi MW, 2001, BIOORGAN MED CHEM, V9, P1721, DOI 10.1016/S0968-0896(01)00060-8; Ciesielski F, 2004, J STEROID BIOCHEM, V89-90, P55, DOI 10.1016/j.jsbmb.2004.03.109; Egea PF, 2000, FEBS LETT, V476, P62, DOI 10.1016/S0014-5793(00)01672-0; Im WP, 2003, J COMPUT CHEM, V24, P1691, DOI 10.1002/jcc.10321; Ishizuka S, 2005, ENDOCRINOLOGY, V146, P2023, DOI 10.1210/en.2004-1140; Ishizuka S, 2001, STEROIDS, V66, P227, DOI 10.1016/S0039-128X(00)00146-X; Kurihara N, 2004, J STEROID BIOCHEM, V89-90, P321, DOI 10.1016/j.jsbmb.2004.03.023; Miura D, 1999, FEBS LETT, V460, P297, DOI 10.1016/S0014-5793(99)01347-2; Miura D, 1999, J BIOL CHEM, V274, P16392, DOI 10.1074/jbc.274.23.16392; Mizwicki MT, 2007, J STEROID BIOCHEM, V103, P243, DOI 10.1016/j.jsbmb.2006.12.004; Mizwicki MT, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.275re4; Mizwicki MT, 2004, P NATL ACAD SCI USA, V101, P12876, DOI 10.1073/pnas.0403606101; Norman AW, 2004, NAT REV DRUG DISCOV, V3, P27, DOI 10.1038/nrd1283; Ochiai E, 2005, MOL ENDOCRINOL, V19, P1147, DOI 10.1210/me.2004-0234; PELEG S, 1995, J BIOL CHEM, V270, P10551, DOI 10.1074/jbc.270.18.10551; PELEG S, 1994, VITAMIN D, P237; Perakyla M, 2004, CHEM BIOL, V11, P1147, DOI 10.1016/j.chembiol.2004.05.023; Rachez C, 2000, GENE, V246, P9, DOI 10.1016/S0378-1119(00)00052-4; Rochel N, 2000, MOL CELL, V5, P173, DOI 10.1016/S1097-2765(00)80413-X; Siu-Caldera ML, 1999, J STEROID BIOCHEM, V71, P111, DOI 10.1016/S0960-0760(99)00130-2; Sutton ALM, 2003, MOL ENDOCRINOL, V17, P777, DOI 10.1210/me.2002-0363; Takenouchi K, 2004, J STEROID BIOCHEM, V89-90, P31, DOI 10.1016/j.jsbmb.2004.03.046; Tocchini-Valentini G, 2004, J MED CHEM, V47, P1956, DOI 10.1021/jm0310582; Tocchini-Valentini G, 2001, P NATL ACAD SCI USA, V98, P5491, DOI 10.1073/pnas.091018698; Toell A, 2001, MOL PHARMACOL, V59, P1478, DOI 10.1124/mol.59.6.1478; Vaisanen S, 2002, MOL PHARMACOL, V62, P788, DOI 10.1124/mol.62.4.788; WECKSLER WR, 1979, ANAL BIOCHEM, V92, P314, DOI 10.1016/0003-2697(79)90664-X; Zoete V, 2005, PROTEINS, V61, P79, DOI 10.1002/prot.20528	33	21	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36292	36301		10.1074/jbc.M109.042069	http://dx.doi.org/10.1074/jbc.M109.042069			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19801650	hybrid, Green Published			2022-12-27	WOS:000272970500031
J	Deriy, LV; Gomez, EA; Zhang, GP; Beacham, DW; Hopson, JA; Gallan, AJ; Shevchenko, PD; Bindokas, VP; Nelson, DJ				Deriy, Ludmila V.; Gomez, Erwin A.; Zhang, Guangping; Beacham, Daniel W.; Hopson, Jessika A.; Gallan, Alexander J.; Shevchenko, Pavel D.; Bindokas, Vytautas P.; Nelson, Deborah J.			Disease-causing Mutations in the Cystic Fibrosis Transmembrane Conductance Regulator Determine the Functional Responses of Alveolar Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLORIDE CHANNELS; MAST-CELLS; PHAGOSOMAL ACIDIFICATION; PSEUDOMONAS-AERUGINOSA; HUMAN-NEUTROPHILS; NECROTIC CELLS; MICE; CFTR; EXOCYTOSIS; G551D	Alveolar macrophages (AMs) play a major role in host defense against microbial infections in the lung. To perform this function, these cells must ingest and destroy pathogens, generally in phagosomes, as well as secrete a number of products that signal other immune cells to respond. Recently, we demonstrated that murine alveolar macrophages employ the cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channel as a determinant in lysosomal acidification (Di, A., Brown, M. E., Deriy, L. V., Li, C., Szeto, F. L., Chen, Y., Huang, P., Tong, J., Naren, A. P., Bindokas, V., Palfrey, H. C., and Nelson, D. J. (2006) Nat. Cell Biol. 8, 933-944). Lysosomes and phagosomes in murine cftr(-/-) AMs failed to acidify, and the cells were deficient in bacterial killing compared with wild type controls. Cystic fibrosis is caused by mutations in CFTR and is characterized by chronic lung infections. The information about relationships between the CFTR genotype and the disease phenotype is scarce both on the organismal and cellular level. The most common disease-causing mutation, Delta F508, is found in 70% of patients with cystic fibrosis. The mutant protein fails to fold properly and is targeted for proteosomal degradation. G551D, the second most common mutation, causes loss of function of the protein at the plasma membrane. In this study, we have investigated the impact of CFTR Delta F508 and G551D on a set of core intracellular functions, including organellar acidification, granule secretion, and microbicidal activity in the AM. Utilizing primary AMs from wild type, cftr(-/-), as well as mutant mice, we show a tight correlation between CFTR genotype and levels of lysosomal acidification, bacterial killing, and agonist-induced secretory responses, all of which would be expected to contribute to a significant impact on microbial clearance in the lung.	[Deriy, Ludmila V.; Gomez, Erwin A.; Zhang, Guangping; Hopson, Jessika A.; Gallan, Alexander J.; Shevchenko, Pavel D.; Bindokas, Vytautas P.; Nelson, Deborah J.] Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA; [Beacham, Daniel W.] Mol Probes Invitrogen Labeling & Detect Technol, Eugene, OR 97402 USA	University of Chicago	Nelson, DJ (corresponding author), Univ Chicago, Dept Neurobiol Pharmacol & Physiol, 947 E 58th St,AB 500 MC 0926, Chicago, IL 60637 USA.	nelson@uchicago.edu	Zhang, Guang-Ping/C-8300-2011; Zhang, Guang-Ping/T-2664-2019	Zhang, Guang-Ping/0000-0002-1620-0221; Zhang, Guang-Ping/0000-0002-1620-0221; Ralph, Jessika/0000-0001-8065-8993	National Institutes of Health; NIGMS [RO1 GM36823]; Cystic Fibrosis Foundation [O6PO]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK027651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036823] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by a National Institutes of Health grant and Grant RO1 GM36823 from NIGMS. This work was also supported by Cystic Fibrosis Foundation Grant O6PO (to D. J. N.).	BARASCH J, 1991, NATURE, V352, P70, DOI 10.1038/352070a0; Barg S, 2001, J CELL SCI, V114, P2145; Barriere H, 2009, MOL BIOL CELL, V20, P3125, DOI 10.1091/mbc.E09-01-0061; Blott EJ, 2002, NAT REV MOL CELL BIO, V3, P122, DOI 10.1038/nrm732; Bompadre SG, 2008, J BIOL CHEM, V283, P5364, DOI 10.1074/jbc.M709417200; Bompadre SG, 2007, J GEN PHYSIOL, V129, P285, DOI 10.1085/jgp.200609667; Bruscia EM, 2009, AM J RESP CELL MOL, V40, P295, DOI 10.1165/rcmb.2008-0170OC; BUTOR C, 1995, J CELL SCI, V108, P2213; Delaney SJ, 1996, EMBO J, V15, P955, DOI 10.1002/j.1460-2075.1996.tb00432.x; Demaurex N, 2002, NEWS PHYSIOL SCI, V17, P1; Di A, 2002, NAT CELL BIOL, V4, P279, DOI 10.1038/ncb771; Di AK, 2003, MOL BIOL CELL, V14, P2016, DOI 10.1091/mbc.e02-09-0626; Di AK, 2001, J BIOL CHEM, V276, P37124, DOI 10.1074/jbc.M105038200; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; Downey GP, 1999, J BIOL CHEM, V274, P28436, DOI 10.1074/jbc.274.40.28436; FERNANDEZ JM, 1984, NATURE, V312, P453, DOI 10.1038/312453a0; Grabe M, 2001, J GEN PHYSIOL, V117, P329, DOI 10.1085/jgp.117.4.329; GREENBERG S, 1991, J CELL BIOL, V113, P757, DOI 10.1083/jcb.113.4.757; Haas A, 2007, TRAFFIC, V8, P311, DOI 10.1111/j.1600-0854.2006.00531.x; Haggie PM, 2007, J BIOL CHEM, V282, P31422, DOI 10.1074/jbc.M705296200; Hara-Chikuma M, 2005, J BIOL CHEM, V280, P1241, DOI 10.1074/jbc.M407030200; Henson Peter M, 2006, Proc Am Thorac Soc, V3, P512; Jentsch TJ, 2008, CRIT REV BIOCHEM MOL, V43, P3, DOI [10.1080/10409230701829110, 10.1080/10409230701829110 ]; Jentsch TJ, 2007, J PHYSIOL-LONDON, V578, P633, DOI 10.1113/jphysiol.2006.124719; Krysko DV, 2006, CELL DEATH DIFFER, V13, P2011, DOI 10.1038/sj.cdd.4401900; Krysko DV, 2006, APOPTOSIS, V11, P1709, DOI 10.1007/s10495-006-9527-8; Lamothe J, 2008, MICROBIOL-SGM, V154, P3825, DOI 10.1099/mic.0.2008/023200-0; Li JN, 2007, J LEUKOCYTE BIOL, V81, P328, DOI 10.1189/jlb.0206124; LINDAU M, 1986, NATURE, V319, P150, DOI 10.1038/319150a0; Mani M, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.003.2009; MATTHEWS G, 1989, J PHYSIOL-LONDON, V418, P105, DOI 10.1113/jphysiol.1989.sp017830; McMorran BJ, 2001, AM J PHYSIOL-LUNG C, V281, pL740, DOI 10.1152/ajplung.2001.281.3.L740; Moreland JG, 2006, J BIOL CHEM, V281, P12277, DOI 10.1074/jbc.M511030200; Morris MR, 2005, CLIN EXP IMMUNOL, V142, P68, DOI [10.1111/j.1365-2249.2005.02893.x, 10.1111/j.1365-2249.2005.02893.X]; NUSSE O, 1988, J CELL BIOL, V107, P2117, DOI 10.1083/jcb.107.6.2117; ORCI L, 1987, CELL, V49, P865, DOI 10.1016/0092-8674(87)90624-6; Painter RG, 2006, BIOCHEMISTRY-US, V45, P10260, DOI 10.1021/bi060490t; Plans V, 2009, PFLUG ARCH EUR J PHY, V458, P23, DOI 10.1007/s00424-008-0597-z; Poschet J, 2002, TRENDS MOL MED, V8, P512, DOI 10.1016/S1471-4914(02)02414-0; Poschet JF, 2001, P NATL ACAD SCI USA, V98, P13972, DOI 10.1073/pnas.241182598; Russell DG, 2009, NAT REV IMMUNOL, V9, P594, DOI 10.1038/nri2591; Steinberg BE, 2007, P NATL ACAD SCI USA, V104, P9523, DOI 10.1073/pnas.0700783104; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; Sun-Wada GH, 2009, J CELL SCI, V122, P2504, DOI 10.1242/jcs.050443; Teichgraber V, 2008, NAT MED, V14, P382, DOI 10.1038/nm1748; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thomas GR, 2000, J IMMUNOL, V164, P3870, DOI 10.4049/jimmunol.164.7.3870; van Heeckeren AM, 2004, AM J PHYSIOL-LUNG C, V287, pL944, DOI 10.1152/ajplung.00387.2003; Wang F, 2000, J PHYSIOL-LONDON, V524, P637, DOI 10.1111/j.1469-7793.2000.00637.x; Weisz OA, 2003, TRAFFIC, V4, P57, DOI 10.1034/j.1600-0854.2003.40201.x; Wu LC, 2004, GASTROENTEROLOGY, V126, P488, DOI 10.1053/j.gastro.2003.11.011; Yates RM, 2007, TRAFFIC, V8, P241, DOI 10.1111/j.1600-0854.2006.00528.x	53	93	94	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35926	35938		10.1074/jbc.M109.057372	http://dx.doi.org/10.1074/jbc.M109.057372			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19837664	Green Published, hybrid			2022-12-27	WOS:000272645600068
J	Franz, H; Mosch, K; Soeroes, S; Urlaub, H; Fischle, W				Franz, Henriette; Mosch, Kerstin; Soeroes, Szabolcs; Urlaub, Henning; Fischle, Wolfgang			Multimerization and H3K9me3 Binding Are Required for CDYL1b Heterochromatin Association	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE LYSINE METHYLATION; STRUCTURAL BASIS; CHROMATIN FIBER; GENE FAMILY; PROTEINS; CHROMODOMAIN; H3; NUCLEOSOME; METHYLTRANSFERASES; HYDRATASE	Proteins containing defined recognition modules mediate readout and translation of histone modifications. These factors are thought to initiate downstream signaling events regulating chromatin structure and function. We identified CDYL1 as an interaction partner of histone H3 trimethylated on lysine 9 (H3K9me3). CDYL1 belongs to a family of chromodomain factors found in vertebrates. We show that three different splicing variants of CDYL1, a, b, and c, are differentially expressed in various tissues with CDYL1b being the most abundant variant. Although all three splicing variants share a common C-terminal enoyl-CoA hydratase-like domain, only CDYL1b contains a functional chromodomain implicated in H3K9me3 binding. A splicing event introducing an N-terminal extension right at the beginning of the chromodomain of CDYL1a inactivates its chromodomain. CDYL1c does not contain a chromodomain at all. Although CDYL1b displays binding affinity to methyl-lysine residues in different sequence context similar to chromodomains in other chromatin factors, we demonstrate that the CDYL1b chromodomain/H3K9me3 interaction is necessary but not sufficient for association of the factor with heterochromatin. Indeed, multimerization of the protein via the enoyl-CoA hydratase-like domain is essential for H3K9me3 chromatin binding in vitro and heterochromatin localization in vivo. In agreement, overexpression of CDYL1c that can multimerize, but does not interact with H3K9me3 can displace CDYL1b from heterochromatin. Our results imply that multimeric binding to H3K9me3 by CDYL1b homomeric complexes is essential for efficient chromatin targeting. We suggest that similar multivalent binding stably anchors other histone modification binding factors on their target chromatin regions.	[Franz, Henriette; Mosch, Kerstin; Soeroes, Szabolcs; Fischle, Wolfgang] Max Planck Inst Biophys Chem, Lab Chromatin Biochem, D-37077 Gottingen, Germany; [Urlaub, Henning] Max Planck Inst Biophys Chem, Bioanalyt Mass Spectrometry Grp, D-37077 Gottingen, Germany	Max Planck Society; Max Planck Society	Fischle, W (corresponding author), Max Planck Inst Biophys Chem, Lab Chromatin Biochem, D-37077 Gottingen, Germany.	wfischl@gwdg.de		Franz, Henriette/0000-0001-9358-7442	Max Planck Society; European Union [FP6]	Max Planck Society(Max Planck SocietyFoundation CELLEX); European Union(European Commission)	This work was supported in whole or in part by the Max Planck Society and the European Union FP6, Network of Excellence, "The Epigenome."	Bhowmick BK, 2006, GENET MOL RES, V5, P696; Caron C, 2003, EMBO REP, V4, P877, DOI 10.1038/sj.embor.embor917; Daniel JA, 2005, CELL CYCLE, V4, P919, DOI 10.4161/cc.4.7.1824; Dorus S, 2003, HUM MOL GENET, V12, P1643, DOI 10.1093/hmg/ddg185; Elgin SCR, 2003, CURR BIOL, V13, pR895, DOI 10.1016/j.cub.2003.11.006; Engel CK, 1996, EMBO J, V15, P5135, DOI 10.1002/j.1460-2075.1996.tb00897.x; Eskeland R, 2007, MOL CELL BIOL, V27, P453, DOI 10.1128/MCB.01576-06; Fischle W, 2003, NATURE, V425, P475, DOI 10.1038/nature02017; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Fischle W, 2008, J BIOL CHEM, V283, P19626, DOI 10.1074/jbc.M802655200; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Hamed RB, 2008, CELL MOL LIFE SCI, V65, P2507, DOI 10.1007/s00018-008-8082-6; Hirota T, 2005, NATURE, V438, P1176, DOI 10.1038/nature04254; Huynh VAT, 2005, J MOL BIOL, V345, P957, DOI 10.1016/j.jmb.2004.10.075; Jacobs SA, 2004, METHOD ENZYMOL, V376, P131; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Kim JJP, 2002, CURR OPIN STRUC BIOL, V12, P721, DOI 10.1016/S0959-440X(02)00390-1; Kuppuswamy M, 2008, MOL CELL BIOL, V28, P269, DOI 10.1128/MCB.01077-07; Lachner M, 2004, COLD SPRING HARB SYM, V69, P209, DOI 10.1101/sqb.2004.69.209; Lahn BT, 1997, SCIENCE, V278, P675, DOI 10.1126/science.278.5338.675; Lahn BT, 2002, P NATL ACAD SCI USA, V99, P8707, DOI 10.1073/pnas.082248899; Lahn BT, 1999, NAT GENET, V21, P429, DOI 10.1038/7771; Lakowski B, 2006, J MOL NEUROSCI, V29, P227, DOI 10.1385/JMN:29:3:227; Leuba SH, 1999, METH MOL B, V119, P143; Li X, 2007, TRENDS GENET, V23, P427, DOI 10.1016/j.tig.2007.06.001; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 2005, CURR OPIN STRUC BIOL, V15, P188, DOI 10.1016/j.sbi.2005.03.006; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; Mateos-Langerak J, 2007, MOL BIOL CELL, V18, P1464, DOI 10.1091/mbc.E06-01-0025; McBryant SJ, 2006, CHROMOSOME RES, V14, P39, DOI 10.1007/s10577-006-1025-x; Mulligan P, 2008, MOL CELL, V32, P718, DOI 10.1016/j.molcel.2008.10.025; Muralidharan V, 2006, NAT METHODS, V3, P429, DOI 10.1038/NMETH886; PALOSAARI PM, 1991, J BIOL CHEM, V266, P10750; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Rathert P, 2008, NAT CHEM BIOL, V4, P344, DOI 10.1038/nchembio.88; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Sampath SC, 2007, MOL CELL, V27, P596, DOI 10.1016/j.molcel.2007.06.026; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shogren-Knaak MA, 2004, METHOD ENZYMOL, V375, P62; Shogren-Knaak M, 2006, CELL CYCLE, V5, P1361, DOI 10.4161/cc.5.13.2891; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Sims RJ, 2008, NAT REV MOL CELL BIO, V9, P815, DOI 10.1038/nrm2502; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Thiru A, 2004, EMBO J, V23, P489, DOI 10.1038/sj.emboj.7600088; Vagnarelli P, 2004, CHROMOSOMA, V113, P211, DOI 10.1007/s00412-004-0307-3; Volkel P, 2007, BIOCHIMIE, V89, P1, DOI 10.1016/j.biochi.2006.07.009; Wu H, 2009, PROTEINS, V76, P1054, DOI 10.1002/prot.22472	52	40	42	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					35049	35059		10.1074/jbc.M109.052332	http://dx.doi.org/10.1074/jbc.M109.052332			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19808672	Green Published, hybrid			2022-12-27	WOS:000272439600059
J	Ikeda, Y; DeMartino, GN; Brown, MS; Lee, JN; Goldstein, JL; Ye, J				Ikeda, Yukio; DeMartino, George N.; Brown, Michael S.; Lee, Joon No; Goldstein, Joseph L.; Ye, Jin			Regulated Endoplasmic Reticulum-associated Degradation of a Polytopic Protein p97 RECRUITS PROTEASOMES TO Insig-1 BEFORE EXTRACTION FROM MEMBRANES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASOME-ASSOCIATED PROTEINS; CLEAVAGE-ACTIVATING PROTEIN; ELEMENT-BINDING PROTEINS; HAMSTER OVARY CELLS; 26S PROTEASOME; INSIG-1; CHOLESTEROL; MEMBRANE; SREBPS; REDUCTASE	Polytopic membrane proteins subjected to endoplasmic reticulum (ER)-associated degradation are extracted from membranes and targeted to proteasomes for destruction. The extraction mechanism is poorly understood. One polytopic ER protein subjected to ER-associated degradation is Insig-1, a negative regulator of cholesterol synthesis. Insig-1 is rapidly degraded by proteasomes when cells are depleted of cholesterol, and its degradation is inhibited when sterols accumulate in cells. Insig-2, a functional homologue of Insig-1, is degraded slowly, and its degradation is not regulated by sterols. Here, we report that a single amino acid substitution in Insig-2, Insig-2(L210A), causes Insig-2 to be degraded in an accelerated and sterol-regulated manner similar to Insig-1. In seeking an explanation for the accelerated degradation, we found that proteasomes bind to wild type Insig-1 and mutant Insig-2(L210A) but not to wild type Insig-2, whereas the proteins are still embedded in cell membranes. This binding depends on at least two factors, ubiquitination of Insig and association with the ATPase p97/VCP complex. These data suggest that p97 recruits proteasomes to polytopic ER proteins even before they are extracted from membranes.	[Ikeda, Yukio; Brown, Michael S.; Lee, Joon No; Goldstein, Joseph L.; Ye, Jin] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [DeMartino, George N.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Brown, MS (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Genet, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	mike.brown@utsouthwestern.edu; joe.goldstein@utsouthwestern.edu			National Institutes of Health [2PO1HL20948, RO1DK46181]; Perot Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046181] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Perot Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants 2PO1HL20948 and RO1DK46181. This work was also supported by the Perot Family Foundation.	Adams CM, 2004, J BIOL CHEM, V279, P52772, DOI 10.1074/jbc.M410302200; Besche HC, 2009, BIOCHEMISTRY-US, V48, P2538, DOI 10.1021/bi802198q; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; BROWN MS, 1978, J BIOL CHEM, V253, P1121; DeMartino GN, 2007, CELL, V129, P659, DOI 10.1016/j.cell.2007.05.007; Feramisco JD, 2004, J BIOL CHEM, V279, P8487, DOI 10.1074/jbc.M312623200; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Flierman D, 2003, J BIOL CHEM, V278, P34774, DOI 10.1074/jbc.M303360200; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Gong Y, 2006, CELL METAB, V3, P15, DOI 10.1016/j.cmet.2005.11.014; Halawani D, 2006, MOL CELL, V22, P713, DOI 10.1016/j.molcel.2006.06.003; Hampton RY, 2009, CHEM REV, V109, P1561, DOI 10.1021/cr800544v; Hannah VC, 2001, J BIOL CHEM, V276, P4365, DOI 10.1074/jbc.M007273200; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Hua XX, 1996, CELL, V87, P415, DOI 10.1016/S0092-8674(00)81362-8; Koulich E, 2008, MOL BIOL CELL, V19, P1072, DOI 10.1091/mbc.E07-10-1040; Lee JN, 2004, J BIOL CHEM, V279, P45257, DOI 10.1074/jbc.M408235200; Lee JN, 2006, P NATL ACAD SCI USA, V103, P4958, DOI 10.1073/pnas.0600422103; Lee JN, 2008, J BIOL CHEM, V283, P33772, DOI 10.1074/jbc.M806108200; Lee JN, 2006, J BIOL CHEM, V281, P39308, DOI 10.1074/jbc.M608999200; Lee PCW, 2005, J BIOL CHEM, V280, P25242, DOI 10.1074/jbc.M502989200; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; Matiuhin Y, 2008, MOL CELL, V32, P415, DOI 10.1016/j.molcel.2008.10.011; Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579; Ploegh HL, 2007, NATURE, V448, P435, DOI 10.1038/nature06004; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Rawson RB, 1999, J BIOL CHEM, V274, P28549, DOI 10.1074/jbc.274.40.28549; Reeves PJ, 1996, P NATL ACAD SCI USA, V93, P11487, DOI 10.1073/pnas.93.21.11487; Schmidt M, 2005, BIOL CHEM, V386, P725, DOI 10.1515/BC.2005.085; Sever N, 2004, J BIOL CHEM, V279, P43136, DOI 10.1074/jbc.M406406200; Sever N, 2003, J BIOL CHEM, V278, P52479, DOI 10.1074/jbc.M310053200; Sever N, 2003, MOL CELL, V11, P25, DOI 10.1016/S1097-2765(02)00822-5; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wojcik C, 2002, J BIOL CHEM, V277, P6188, DOI 10.1074/jbc.M109996200; Yabe D, 2002, P NATL ACAD SCI USA, V99, P12753, DOI 10.1073/pnas.162488899; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3	40	27	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34889	34900		10.1074/jbc.M109.044875	http://dx.doi.org/10.1074/jbc.M109.044875			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19815544	Green Published, hybrid			2022-12-27	WOS:000272439600044
J	Alonso, H; Blayney, MJ; Beck, JL; Whitney, SM				Alonso, Hernan; Blayney, Michelle J.; Beck, Jennifer L.; Whitney, Spencer M.			Substrate-induced Assembly of Methanococcoides burtonii D-Ribulose-1,5-bisphosphate Carboxylase/Oxygenase Dimers into Decamers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBULOSE-BISPHOSPHATE CARBOXYLASE; RIBULOSEBISPHOSPHATE CARBOXYLASE; TOBACCO CHLOROPLASTS; LARGE SUBUNITS; RUBISCO; CHAPERONIN; CATALYSIS; PROTEINS; RIBULOSE-1,5-BISPHOSPHATE; PHOTOSYNTHESIS	Like many enzymes, the biogenesis of the multi-subunit CO2-fixing enzyme ribulose-1,5-bisphosphate (RuBP) carboxylase/oxygenase (Rubisco) in different organisms requires molecular chaperones. When expressed in Escherichia coli, the large (L) subunits of the Rubisco from the archaeabacterium Methanococcoides burtonii assemble into functional dimers (L-2). However, further assembly into pentamers of L-2 (L-10) occurs when expressed in tobacco chloroplasts or E. coli producing RuBP. In vitro analyses indicate that the sequential assembly of L-2 into L-10 (via detectable L-4 and L-6 intermediates) occurs without chaperone involvement and is stimulated by protein rearrangements associated with either the binding of substrate RuBP, the tight binding transition state analog carboxyarabinitol-1,5-bisphosphate, or inhibitory divalent metal ions within the active site. The catalytic properties of L-2 and L10 M. burtonii Rubisco (MbR) were indistinguishable. At 25 C they both shared a low specificity for CO2 over O-2 (1.1 mol.mol(-1)) and RuBP carboxylation rates that were distinctively enhanced at low pH (similar to 4 s(-1) at pH6, relative to 0.8 s(-1) at pH 8) with a temperature optimum of 55 degrees C. Like other archaeal Rubiscos, MbR also has a high O-2 affinity (K-m(O-2) = similar to 2.5 mu M). The catalytic and structural similarities of MbR to other archaeal Rubiscos contrast with its closer sequence homology to bacterial L-2 Rubisco, complicating its classification within the Rubisco superfamily.	[Alonso, Hernan; Whitney, Spencer M.] Australian Natl Univ, Res Sch Biol, Canberra, ACT 2601, Australia; [Blayney, Michelle J.; Beck, Jennifer L.] Univ Wollongong, Sch Chem, Wollongong, NSW 2522, Australia	Australian National University; University of Wollongong	Whitney, SM (corresponding author), Australian Natl Univ, Res Sch Biol, POB 475, Canberra, ACT 2601, Australia.	spencer.whitney@anu.edu.au	Whitney, Spencer M/C-9266-2009; Beck, Jennifer L/B-6151-2016	Whitney, Spencer M/0000-0003-2954-2359; Beck, Jennifer L/0000-0001-6058-4886	Australian Research Council Discovery [DP0450564]	Australian Research Council Discovery(Australian Research Council)	This work was supported by Australian Research Council Discovery Grant DP0450564 ( to S. M. W.).	Andersson I, 2008, PLANT PHYSIOL BIOCH, V46, P275, DOI 10.1016/j.plaphy.2008.01.001; ANDREWS TJ, 1988, J BIOL CHEM, V263, P12213; Baker RT, 2005, METHOD ENZYMOL, V398, P540, DOI 10.1016/S0076-6879(05)98044-0; Brinker A, 2001, CELL, V107, P223, DOI 10.1016/S0092-8674(01)00517-7; Brutnell TP, 1999, PLANT CELL, V11, P849, DOI 10.1105/tpc.11.5.849; Cleland WW, 1998, CHEM REV, V98, P549, DOI 10.1021/cr970010r; Duff AP, 2000, J MOL BIOL, V298, P903, DOI 10.1006/jmbi.2000.3724; Emlyn-Jones D, 2006, PLANT CELL PHYSIOL, V47, P1630, DOI 10.1093/pcp/pcl028; Finn MW, 2004, J BACTERIOL, V186, P6360, DOI 10.1128/JB.186.19.6360-6366.2004; Finn MW, 2003, J BACTERIOL, V185, P3049, DOI 10.1128/JB.185.10.3049-3059.2003; FRANZMANN PD, 1992, SYST APPL MICROBIOL, V15, P573, DOI 10.1016/S0723-2020(11)80117-7; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; Jiang JS, 2008, P NATL ACAD SCI USA, V105, P11939, DOI 10.1073/pnas.0805464105; Kane HJ, 1998, PLANT PHYSIOL, V117, P1059, DOI 10.1104/pp.117.3.1059; Kannappan B, 2008, J AM CHEM SOC, V130, P15063, DOI 10.1021/ja803464a; Karkehabadi S, 2003, J MOL BIOL, V334, P65, DOI 10.1016/j.jmb.2003.09.025; Kitano K, 2001, STRUCTURE, V9, P473, DOI 10.1016/S0969-2126(01)00608-6; Kreel NE, 2007, J BIOL CHEM, V282, P1341, DOI 10.1074/jbc.M609399200; Mueller-Cajar O, 2007, BIOCHEMISTRY-US, V46, P14067, DOI 10.1021/bi700820a; Mueller-Cajar O, 2007, BIOESSAYS, V29, P722, DOI 10.1002/bies.20616; Mueller-Cajar O, 2008, PHOTOSYNTH RES, V98, P667, DOI 10.1007/s11120-008-9324-z; Parry MAJ, 2007, J AGR SCI-CAMBRIDGE, V145, P31, DOI 10.1017/S0021859606006666; PAUL K, 1991, BIOCHEMISTRY-US, V30, P10019, DOI 10.1021/bi00105a029; PIERCE J, 1980, BIOCHEMISTRY-US, V19, P934, DOI 10.1021/bi00546a018; Raunser S, 2009, P NATL ACAD SCI USA, V106, P3160, DOI 10.1073/pnas.0810563106; ROBISON PD, 1979, BIOCHEMISTRY-US, V18, P4453, DOI 10.1021/bi00588a001; Saschenbrecker S, 2007, CELL, V129, P1189, DOI 10.1016/j.cell.2007.04.025; Sato T, 2007, SCIENCE, V315, P1003, DOI 10.1126/science.1135999; Saunders NFW, 2005, J PROTEOME RES, V4, P464, DOI 10.1021/pr049797+; Sharwood RE, 2008, PLANT PHYSIOL, V146, P83, DOI 10.1104/pp.107.109058; Tabita FR, 2008, PHILOS T R SOC B, V363, P2629, DOI 10.1098/rstb.2008.0023; Tcherkez GGB, 2006, P NATL ACAD SCI USA, V103, P7246, DOI 10.1073/pnas.0600605103; VIITANEN PV, 1990, BIOCHEMISTRY-US, V29, P5665, DOI 10.1021/bi00476a003; Whitney SM, 2001, P NATL ACAD SCI USA, V98, P14738, DOI 10.1073/pnas.261417298; Whitney SM, 2001, PLANT J, V26, P535, DOI 10.1046/j.1365-313x.2001.01056.x; Whitney SM, 2008, J EXP BOT, V59, P1909, DOI 10.1093/jxb/erm311; Wostrikoff K, 2007, P NATL ACAD SCI USA, V104, P6466, DOI 10.1073/pnas.0610586104; Yoshida S, 2007, APPL ENVIRON MICROB, V73, P6254, DOI 10.1128/AEM.00044-07; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492	39	38	39	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33876	33882		10.1074/jbc.M109.050989	http://dx.doi.org/10.1074/jbc.M109.050989			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19837658	Green Published, hybrid			2022-12-27	WOS:000272165200020
J	De Arcangelis, V; Liu, R; Soto, D; Xiang, Y				De Arcangelis, Vania; Liu, Ruijie; Soto, Dagoberto; Xiang, Yang			Differential Association of Phosphodiesterase 4D Isoforms with beta(2)-Adrenoceptor in Cardiac Myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; RECEPTOR; CAMP; PHOSPHORYLATION; CONTRACTION; MODULATION; HEART; PDE4	cAMP and protein kinase A (PKA) activation represents a key signaling mechanism upon beta-adrenergic stimulation under stress. Both beta(1)- and beta(2)-adrenoreceptor (ARs) subtypes induce cAMP accumulation, yet play distinct roles in cardiac contraction and myocyte apoptosis. Differences in controlling cAMP/PKA activities through the assembly of complexes between the receptors and cAMP-specific phosphodiesterases contribute to the distinct biological outcomes. Here, we demonstrate that beta(2)ARs form signaling complexes with a set of PDE4D isoforms expressed in cardiac myocytes. PDE4D9 and PDE4D8 bind to the beta(2)AR at resting conditions; however, agonist stimulation induces dissociation of PDE4D9 from the receptor but recruitment of PDE4D8 to the receptor. Agonist stimulation also induces recruitment of PDE4D5 to the beta(2)AR. Moreover, the receptor-associated PDE4D isoforms play distinct roles in controlling cAMP activities and regulating the PKA phosphorylation of the receptor and myocyte contraction rate responses. Knockdown of PDE4D9 with short hairpin RNA enhances the beta(2)AR-induced cAMP signaling, whereas knockdown of PDE4D8 only slightly prolongs the receptor-induced cAMP signaling in myocytes. Inhibition of PDE4D9 and PDE4D5 enhances the base-line levels of contraction rates, whereas inhibition of PDE4D9 and PDE4D8 enhances the maximal contraction rate increases upon activation of beta(2)AR. Our data underscore the complex regulation of intracellular cAMP by beta(2)AR-associated phosphodiesterase enzymes to enforce the specificity of the receptor signaling for physiological responses.	[Xiang, Yang] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [Xiang, Yang] Univ Illinois, Neurosci Program, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Xiang, Y (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, 523 Burrill Hall,407 S Goodwin Ave, Urbana, IL 61801 USA.	kevinyx@illinois.edu	Soto, Dagoberto I/N-6817-2014	Soto, Dagoberto I/0000-0002-7350-1530; liu, ruijie/0000-0002-2468-0579	National Institutes of Health [HL082846]; American Heart Association [0635331N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082846] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL082846 ( to Y.X.). This work was also supported by American Heart Association 0635331N ( to Y.X.).	Allen MD, 2006, ACS CHEM BIOL, V1, P371, DOI 10.1021/cb600202f; Baillie GS, 2003, P NATL ACAD SCI USA, V100, P940, DOI 10.1073/pnas.262787199; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; Lehnart SE, 2005, CELL, V123, P25, DOI 10.1016/j.cell.2005.07.030; Perry SJ, 2002, SCIENCE, V298, P834, DOI 10.1126/science.1074683; Richter W, 2005, BIOCHEM J, V388, P803, DOI 10.1042/BJ20050030; Richter W, 2008, EMBO J, V27, P384, DOI 10.1038/sj.emboj.7601968; Soto D, 2009, CIRC RES, V104, P770, DOI 10.1161/CIRCRESAHA.108.187880; Tran TM, 2004, MOL PHARMACOL, V65, P196, DOI 10.1124/mol.65.1.196; Wang Y, 2008, J BIOL CHEM, V283, P1799, DOI 10.1074/jbc.M705747200; Xiang Y, 2005, P NATL ACAD SCI USA, V102, P909, DOI 10.1073/pnas.0405263102; Xiang Y, 2002, J BIOL CHEM, V277, P34280, DOI 10.1074/jbc.M201644200; Xiao RP, 2006, TRENDS PHARMACOL SCI, V27, P330, DOI 10.1016/j.tips.2006.04.009; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zhou YY, 1997, AM J PHYSIOL-HEART C, V273, pH1611, DOI 10.1152/ajpheart.1997.273.3.H1611; Zhu WZ, 2005, CIRC RES, V97, P244, DOI 10.1161/01.RES.0000176764.38934.86	18	46	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33824	33832		10.1074/jbc.M109.020388	http://dx.doi.org/10.1074/jbc.M109.020388			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19801680	hybrid, Green Published			2022-12-27	WOS:000272165200014
J	Zhao, J; Connorton, JM; Guo, YQ; Li, XK; Shigaki, T; Hirschi, KD; Pittman, JK				Zhao, Jian; Connorton, James M.; Guo, YingQing; Li, Xiangkai; Shigaki, Toshiro; Hirschi, Kendal D.; Pittman, Jon K.			Functional Studies of Split Arabidopsis Ca2+/H+ Exchangers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIMOLECULAR FLUORESCENCE COMPLEMENTATION; PROTEIN-PROTEIN INTERACTIONS; SACCHAROMYCES-CEREVISIAE; SUCROSE TRANSPORTERS; H+/CA2+ ANTIPORTER; ABC TRANSPORTER; CROSS-TALK; CAX1; YEAST; IDENTIFICATION	In plants, high capacity tonoplast cation/H+ antiport is mediated in part by a family of cation exchanger (CAX) transporters. Functional association between CAX1 and CAX3 has previously been shown. In this study we further examine the interactions between CAX protein domains through the use of nonfunctional halves of CAX transporters. We demonstrate that a protein coding for an N-terminal half of an activated variant of CAX1(sCAX1) can associate with the C-terminal half of either CAX1 or CAX3 to form a functional transporter that may exhibit unique transport properties. Using yeast split ubiquitin, in planta bimolecular fluorescence complementation, and gel shift experiments, we demonstrate a physical interaction among the half proteins. Moreover, the half-proteins both independently localized to the same yeast endomembrane. Co-expressing variants of N- and C-terminal halves of CAX1 and CAX3 in yeast suggested that the N-terminal region mediates Ca2+ transport, whereas the C-terminal half defines salt tolerance phenotypes. Furthermore, in yeast assays, auto-inhibited CAX1 could be differentially activated by CAX split proteins. The N-terminal half of CAX1 when co-expressed with CAX1 activated Ca2+ transport, whereas co-expressing C-terminal halves of CAX variants with CAX1 conferred salt tolerance but no apparent Ca2+ transport. These findings demonstrate plasticity through hetero-CAX complex formation as well as a novel means to engineer CAX transport.	[Zhao, Jian; Guo, YingQing; Li, Xiangkai; Shigaki, Toshiro; Hirschi, Kendal D.] Baylor Coll Med, Childrens Nutr Res Ctr, USDA ARS, Houston, TX 77030 USA; [Connorton, James M.; Pittman, Jon K.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Hirschi, Kendal D.] Texas A&M Univ, Vegetable & Fruit Improvement Ctr, College Stn, TX 77845 USA	Baylor College of Medicine; United States Department of Agriculture (USDA); University of Manchester; Texas A&M University System; Texas A&M University College Station	Hirschi, KD (corresponding author), Baylor Coll Med, Childrens Nutr Res Ctr, USDA ARS, 1100 Bates St,Suite 9018,Campus Mail Stop BCM 320, Houston, TX 77030 USA.	kendalh@bcm.edu	hirschi, kendal/GNP-0351-2022; Zhao, Jian/Q-8591-2019; li, xiang/GWM-6319-2022	Zhao, Jian/0000-0002-4416-7334; Pittman, Jon/0000-0001-7197-1494; Connorton, James/0000-0002-9379-5599; Guo, Yingqing/0000-0002-9527-6119	United States Department of Agriculture/Agricultural Research Service [58-6250-6001]; National Science Foundation [90344350]; United States Department of Agriculture Cooperative State Research, Education, & Extension Service [2005-34402-17121]; Designing Foods for Health grant; Biotechnology and Biological Sciences Research Council [BB/B502152/1]	United States Department of Agriculture/Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture Cooperative State Research, Education, & Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Designing Foods for Health grant; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by funding from the United States Department of Agriculture/Agricultural Research Service under Cooperative Agreement 58-6250-6001, National Science Foundation Grant 90344350, United States Department of Agriculture Cooperative State Research, Education, & Extension Service Grant 2005-34402-17121, a Designing Foods for Health grant (to K. D. H.), and by Biotechnology and Biological Sciences Research Council Grant BB/B502152/1 (to J. K. P.).	Amtmann A, 2009, NEW PHYTOL, V181, P35, DOI 10.1111/j.1469-8137.2008.02666.x; Bracha-Drori K, 2004, PLANT J, V40, P419, DOI 10.1111/j.1365-313X.2004.02206.x; Carter C, 2004, PLANT CELL, V16, P3285, DOI 10.1105/tpc.104.027078; Cheng NH, 2005, PLANT PHYSIOL, V138, P2048, DOI 10.1104/pp.105.061218; Cheng NH, 2003, J BIOL CHEM, V278, P6503, DOI 10.1074/jbc.M210883200; Cunningham KW, 1996, MOL CELL BIOL, V16, P2226; Eide DJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r77; Hirschi KD, 1996, P NATL ACAD SCI USA, V93, P8782, DOI 10.1073/pnas.93.16.8782; Hirschi KD, 2004, PLANT PHYSIOL, V136, P2438, DOI 10.1104/pp.104.046490; Hull G, 1996, PLANT SCI, V120, P153, DOI 10.1016/S0168-9452(96)04496-2; Lahner B, 2003, NAT BIOTECHNOL, V21, P1215, DOI 10.1038/nbt865; Liang F, 1997, P NATL ACAD SCI USA, V94, P8579, DOI 10.1073/pnas.94.16.8579; Loque D, 2007, NATURE, V446, P195, DOI 10.1038/nature05579; Ludewig U, 2003, J BIOL CHEM, V278, P45603, DOI 10.1074/jbc.M307424200; Marini AM, 2000, MOL MICROBIOL, V35, P378, DOI 10.1046/j.1365-2958.2000.01704.x; Marty F, 1999, PLANT CELL, V11, P587, DOI 10.1105/tpc.11.4.587; McAinsh MR, 2009, NEW PHYTOL, V181, P275, DOI 10.1111/j.1469-8137.2008.02682.x; Mitsui K, 2005, BBA-BIOMEMBRANES, V1720, P125, DOI 10.1016/j.bbamem.2005.11.005; Nathan DF, 1999, P NATL ACAD SCI USA, V96, P1409, DOI 10.1073/pnas.96.4.1409; Neuhauser B, 2007, PLANT PHYSIOL, V143, P1651, DOI 10.1104/pp.106.094243; Obrdlik P, 2004, P NATL ACAD SCI USA, V101, P12242, DOI 10.1073/pnas.0404467101; Ottolia M, 2001, J BIOL CHEM, V276, P19603, DOI 10.1074/jbc.M101489200; Pandey S, 2004, PLANT CELL, V16, P1616, DOI 10.1105/tpc.020321; Pighin JA, 2004, SCIENCE, V306, P702, DOI 10.1126/science.1102331; Pittman JK, 2002, PLANT PHYSIOL, V130, P1054, DOI 10.1104/pp.008193; Pittman JK, 2001, PLANT PHYSIOL, V127, P1020, DOI 10.1104/pp.010409; Reinders A, 2002, PLANT CELL, V14, P1567, DOI 10.1105/tpc.002428; Reinders A, 2002, STRUCTURE, V10, P763, DOI 10.1016/S0969-2126(02)00773-6; Sanders D, 2002, PLANT CELL, V14, pS401, DOI 10.1105/tpc.002899; Schulz B, 2004, SCIENCE, V306, P622, DOI 10.1126/science.1105227; SCHUMAKER KS, 1986, J BIOL CHEM, V261, P2172; Shigaki T, 2006, J MOL EVOL, V63, P815, DOI 10.1007/s00239-006-0048-4; Shigaki T, 2006, PLANT BIOLOGY, V8, P419, DOI 10.1055/s-2006-923950; Shigaki T, 2005, J BIOL CHEM, V280, P30136, DOI 10.1074/jbc.M503610200; Shigaki T, 2003, J BIOL CHEM, V278, P6610, DOI 10.1074/jbc.M209952200; Shigaki T, 2001, J BIOL CHEM, V276, P43152, DOI 10.1074/jbc.M106637200; Shigaki T, 2001, ANAL BIOCHEM, V298, P118, DOI 10.1006/abio.2001.5341; Shigaki T, 2000, GENE, V257, P291, DOI 10.1016/S0378-1119(00)00390-5; Sze H, 2000, ANNU REV PLANT PHYS, V51, P433, DOI 10.1146/annurev.arplant.51.1.433; Ueoka-Nakanishi H, 2000, EUR J BIOCHEM, V267, P3090, DOI 10.1046/j.1432-1033.2000.01343.x; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Zhao J, 2008, PLANTA, V227, P659, DOI 10.1007/s00425-007-0648-2; Zhao J, 2009, J BIOL CHEM, V284, P4605, DOI 10.1074/jbc.M804462200; ZOTTOLA RJ, 1995, BIOCHEMISTRY-US, V34, P9734, DOI 10.1021/bi00030a011	44	38	42	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34075	34083		10.1074/jbc.M109.070235	http://dx.doi.org/10.1074/jbc.M109.070235			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19819871	Green Published, hybrid			2022-12-27	WOS:000272165200040
J	Ferrera, L; Caputo, A; Ubby, I; Bussani, E; Zegarra-Moran, O; Ravazzolo, R; Pagani, F; Galietta, LJV				Ferrera, Loretta; Caputo, Antonella; Ubby, Ifeoma; Bussani, Erica; Zegarra-Moran, Olga; Ravazzolo, Roberto; Pagani, Franco; Galietta, Luis J. V.			Regulation of TMEM16A Chloride Channel Properties by Alternative Splicing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; CA2+-ACTIVATED CL-CURRENTS; COLLECTING DUCT CELLS; SMOOTH-MUSCLE-CELLS; INOSITOL 3,4,5,6-TETRAKISPHOSPHATE; BINDING-PROTEIN; CALCIUM; CONDUCTANCE; ACTIVATION; MECHANISM	Expression of TMEM16A protein is associated with the activity of Ca2+-activated Cl- channels. TMEM16A primary transcript undergoes alternative splicing. thus resulting in the generation of multiple isoforms. We have determined the pattern of splicing and assessed the functional properties of the corresponding TMEM16A variants. We found three alternative exons, 6b, 13, and 15, coding for segments of 22, 4, and 26 amino acids, respectively, which are differently spliced in human organs. By patch clamp experiments on transfected cells, we found that skipping of exon 6b changes the Ca2+ sensitivity by nearly 4-fold, resulting in Cl- currents requiring lower Ca2+ concentrations to be activated. At the membrane potential of 80 mV, the apparent half-effective concentration decreases from 350 to 90 nM when the segment corresponding to exon 6b is excluded. Skipping of exon 13 instead strongly reduces the characteristic time-dependent activation observed for Ca2+-activated Cl- channels at positive membrane potentials. This effect was also obtained by deleting only the second pair of amino acids corresponding to exon 13. Alternative splicing appears as an important mechanism to regulate the voltage and Ca2+ dependence of the TMEM16A-dependent Cl- channels in a tissue-specific manner.	[Ferrera, Loretta; Caputo, Antonella; Zegarra-Moran, Olga; Ravazzolo, Roberto; Galietta, Luis J. V.] Ist Giannina Gaslini, Genet Mol Lab, I-16147 Genoa, Italy; [Ubby, Ifeoma; Bussani, Erica; Pagani, Franco] Int Ctr Genet Engn & Biotechnol, I-34149 Trieste, Italy; [Ravazzolo, Roberto] Univ Genoa, Dept Pediat, I-16132 Genoa, Italy; [Ravazzolo, Roberto] Univ Genoa, Ctr Excellence Biomed Res, I-16132 Genoa, Italy	University of Genoa; IRCCS Istituto Giannina Gaslini; International Center for Genetic Engineering & Biotechnology (ICGEB); University of Genoa; University of Genoa	Galietta, LJV (corresponding author), Ist Giannina Gaslini, Genet Mol Lab, Largo G Gaslini 5, I-16147 Genoa, Italy.	galietta@unige.it	Galietta, Luis JV/HCG-8692-2022; Pillay, Nischalan/F-9536-2012; Ferrera, Loretta/AAA-7641-2020; Ferrera, Loretta/AGJ-3063-2022	Ferrera, Loretta/0000-0003-0528-1158; Galietta, Luis/0000-0001-8686-3461; Pagani, Franco/0000-0002-2678-3459	National Institutes of Health [P30 DK072517]; Cystic Fibrosis Foundation; Fondazione Italiana per la Ricerca sulla Fibrosi Cistica; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072517] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Fondazione Italiana per la Ricerca sulla Fibrosi Cistica(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant P30 DK072517 and by the Cystic Fibrosis Foundation (to L.J.V.G) and the Fondazione Italiana per la Ricerca sulla Fibrosi Cistica (to L.J.V.G. and F.P.).	Angermann JE, 2006, J GEN PHYSIOL, V128, P73, DOI 10.1085/jgp.200609507; Arreola J, 1996, J GEN PHYSIOL, V108, P35, DOI 10.1085/jgp.108.1.35; Boese SH, 2004, AM J PHYSIOL-RENAL, V286, pF682, DOI 10.1152/ajprenal.00123.2003; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Eggermont Jan, 2004, Proc Am Thorac Soc, V1, P22, DOI 10.1513/pats.2306010; EVANS MG, 1986, J PHYSIOL-LONDON, V378, P437, DOI 10.1113/jphysiol.1986.sp016229; Fededa JP, 2005, MOL CELL, V19, P393, DOI 10.1016/j.molcel.2005.06.035; Frings S, 2000, PROG NEUROBIOL, V60, P247, DOI 10.1016/S0301-0082(99)00027-1; GomezHernandez JM, 1997, J PHYSIOL-LONDON, V502, P569, DOI 10.1111/j.1469-7793.1997.569bj.x; Greenwood IA, 2001, J PHYSIOL-LONDON, V534, P395, DOI 10.1111/j.1469-7793.2001.00395.x; Hallani M, 1998, J MEMBRANE BIOL, V161, P163, DOI 10.1007/s002329900323; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Ho MWY, 2001, J BIOL CHEM, V276, P18673, DOI 10.1074/jbc.M101128200; Jensen KB, 2000, NEURON, V25, P359, DOI 10.1016/S0896-6273(00)80900-9; Jin Y, 2003, EMBO J, V22, P905, DOI 10.1093/emboj/cdg089; Kaneko H, 2006, J GEN PHYSIOL, V127, P737, DOI 10.1085/jgp.200609497; Kidd JF, 2000, ANNU REV PHYSIOL, V62, P493, DOI 10.1146/annurev.physiol.62.1.493; KLEENE SJ, 1991, J NEUROSCI, V11, P3624; Kuruma A, 2000, J GEN PHYSIOL, V115, P59, DOI 10.1085/jgp.115.1.59; Ladd AN, 2001, MOL CELL BIOL, V21, P1285, DOI 10.1128/MCB.21.4.1285-1296.2001; Markovtsov V, 2000, MOL CELL BIOL, V20, P7463, DOI 10.1128/MCB.20.20.7463-7479.2000; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; Nilius B, 1997, J PHYSIOL-LONDON, V498, P381, DOI 10.1113/jphysiol.1997.sp021865; Pifferi S, 2009, PFLUG ARCH EUR J PHY, V458, P1023, DOI 10.1007/s00424-009-0684-9; Qu ZQ, 2003, AM J PHYSIOL-RENAL, V285, pF326, DOI 10.1152/ajprenal.00034.2003; Rock JR, 2009, J BIOL CHEM, V284, P14875, DOI 10.1074/jbc.C109.000869; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; SCOTT RH, 1995, PHARMACOL THERAPEUT, V66, P535, DOI 10.1016/0163-7258(95)00018-C; Stohr H, 2009, J NEUROSCI, V29, P6809, DOI 10.1523/JNEUROSCI.5546-08.2009; TALEB O, 1988, PFLUG ARCH EUR J PHY, V412, P641, DOI 10.1007/BF00583766; Tarran R, 2002, J GEN PHYSIOL, V120, P407, DOI 10.1085/jgp.20028599; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; Wang YX, 1997, P NATL ACAD SCI USA, V94, P14918, DOI 10.1073/pnas.94.26.14918; Xie WW, 1996, J BIOL CHEM, V271, P14092, DOI 10.1074/jbc.271.24.14092; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313	35	170	178	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33360	33368		10.1074/jbc.M109.046607	http://dx.doi.org/10.1074/jbc.M109.046607			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19819874	hybrid, Green Published			2022-12-27	WOS:000272028500041
J	Jimenez, N; Vilches, S; Lacasta, A; Regue, M; Merino, S; Tomas, JM				Jimenez, Natalia; Vilches, Silvia; Lacasta, Anna; Regue, Miguel; Merino, Susana; Tomas, Juan M.			A Bifunctional Enzyme in a Single Gene Catalyzes the Incorporation of GlcN into the Aeromonas Core Lipopolysaccharide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-MANNO-HEPTOSE; ESCHERICHIA-COLI; VIBRIO-CHOLERAE; 3-DEOXY-D-MANNO-OCTULOSONIC ACID; SALMONICIDA LIPOPOLYSACCHARIDE; HYDROPHILA STRAINS; LIPID-A; BIOSYNTHESIS; VIRULENCE; SEQUENCE	The core lipopolysaccharide (LPS) of Aeromonas hydrophila AH-3 and Aeromonas salmonicida A450 is characterized by the presence of the pentasaccharide alpha-D-GlcN-(1 -> 7)-L-alpha-D-Hep-(1 -> 2)-L-alpha-D-Hep-(1 -> 3)-L- alpha-D-Hep-(1 -> 5)-alpha-Kdo. Previously it has been suggested that the WahA protein is involved in the incorporation of GlcN residue to outer core LPS. The WahA protein contains two domains: a glycosyltransferase and a carbohydrate esterase. In this work we demonstrate that the independent expression of the WahA glycosyltransferase domain catalyzes the incorporation of GlcNAc from UDP-GlcNAc to the outer core LPS. Independent expression of the carbohydrate esterase domain leads to the deacetylation of the GlcNAc residue to GlcN. Thus, the WahA is the first described bifunctional glycosyltransferase enzyme involved in the biosynthesis of core LPS. By contrast in Enterobacteriaceae containing GlcN in their outer core LPS the two reactions are performed by two different enzymes.	[Jimenez, Natalia; Vilches, Silvia; Lacasta, Anna; Merino, Susana; Tomas, Juan M.] Univ Barcelona, Fac Biol, Dept Microbiol, E-08071 Barcelona, Spain; [Regue, Miguel] Univ Barcelona, Fac Farm, Dept Microbiol & Parasitol Sanitarias, E-08028 Barcelona, Spain	University of Barcelona; University of Barcelona	Tomas, JM (corresponding author), Univ Barcelona, Fac Biol, Dept Microbiol, Diagonal 645, E-08071 Barcelona, Spain.	jtomas@ub.edu	Tomas, Juan M/L-1398-2015; Merino, Susana/D-4342-2014; Lacasta, Anna/P-2278-2017	Tomas, Juan M/0000-0002-3575-7113; Merino, Susana/0000-0001-6040-4259; Jimenez, Natalia/0000-0002-7057-0426; Lacasta, Anna/0000-0001-8381-9844	Ministerio de Educacion, Ciencia y Deporte; Ministerio de Sanidad, Spain; Generalitat de Catalunya	Ministerio de Educacion, Ciencia y Deporte(Spanish Government); Ministerio de Sanidad, Spain(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya)	This work was supported by Plan Nacional de I + D and Fondo de Investigaciones Sanitarias grants from Ministerio de Educacion, Ciencia y Deporte, and Ministerio de Sanidad, Spain and the Generalitat de Catalunya ( Centre de Referencia en Biotecnologia).	Aguilar A, 1997, INFECT IMMUN, V65, P1245, DOI 10.1128/IAI.65.4.1245-1250.1997; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BELUNIS CJ, 1992, J BIOL CHEM, V267, P9988; BOYER HW, 1969, J MOL BIOL, V41, P459, DOI 10.1016/0022-2836(69)90288-5; BROZEK KA, 1989, J BIOL CHEM, V264, P6956; BURKE V, 1984, APPL ENVIRON MICROB, V48, P361, DOI 10.1128/AEM.48.2.361-366.1984; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; DARVEAU RP, 1983, J BACTERIOL, V155, P831, DOI 10.1128/JB.155.2.831-838.1983; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; James CL, 2002, BIOCHEMISTRY-US, V41, P3720, DOI 10.1021/bi015909o; Jimenez N, 2008, J BACTERIOL, V190, P3176, DOI 10.1128/JB.01874-07; Jimenez N, 2009, J BACTERIOL, V191, P2228, DOI 10.1128/JB.01395-08; Knirel YA, 2004, CARBOHYD RES, V339, P787, DOI 10.1016/j.carres.2003.12.008; Knirel YA, 1997, EUR J BIOCHEM, V247, P402, DOI 10.1111/j.1432-1033.1997.00402.x; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; McArthur F, 2005, J BACTERIOL, V187, P5292, DOI 10.1128/JB.187.15.5292-5300.2005; Merino S, 1996, FEMS MICROBIOL LETT, V139, P97, DOI 10.1016/0378-1097(96)00068-7; MERINO S, 1992, INFECT IMMUN, V60, P4343, DOI 10.1128/IAI.60.10.4343-4349.1992; MERINO S, 1991, J GEN MICROBIOL, V137, P1583, DOI 10.1099/00221287-137-7-1583; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; NASSIF X, 1989, INFECT IMMUN, V57, P546, DOI 10.1128/IAI.57.2.546-552.1989; Regue M, 2005, J BIOL CHEM, V280, P36648, DOI 10.1074/jbc.M506278200; Reith ME, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-427; Rubires X, 1997, J BACTERIOL, V179, P7581, DOI 10.1128/jb.179.23.7581-7586.1997; SCOTT M, 1968, J GEN MICROBIOL, V50, P321, DOI 10.1099/00221287-50-2-321; Seshadri R, 2006, J BACTERIOL, V188, P8272, DOI 10.1128/JB.00621-06; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thornley JP, 1997, REV MED MICROBIOL, V8, P61; Valvano MA, 2000, J BACTERIOL, V182, P488, DOI 10.1128/JB.182.2.488-497.2000; Valvano MA, 2002, MICROBIOL-SGM, V148, P1979, DOI 10.1099/00221287-148-7-1979; VINOGRADOV EV, 1995, EUR J BIOCHEM, V233, P152, DOI 10.1111/j.1432-1033.1995.152_1.x; Wang Z, 2006, CARBOHYD RES, V341, P109, DOI 10.1016/j.carres.2005.10.017; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83	38	10	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					32995	33005		10.1074/jbc.M109.038828	http://dx.doi.org/10.1074/jbc.M109.038828			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19805547	hybrid, Green Published			2022-12-27	WOS:000272028500002
J	Kronenberg, D; Vadon-Le Goff, S; Bourhis, JM; Font, B; Eichenberger, D; Hulmes, DJS; Moali, C				Kronenberg, Daniel; Vadon-Le Goff, Sandrine; Bourhis, Jean-Marie; Font, Bernard; Eichenberger, Denise; Hulmes, David J. S.; Moali, Catherine			Strong Cooperativity and Loose Geometry between CUB Domains Are the Basis for Procollagen C-Proteinase Enhancer Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MORPHOGENETIC PROTEIN-1; BINDING; METALLOPROTEINASES; GLYCOPROTEIN; INHIBITORS; INSIGHTS; ROLES	Procollagen C-proteinase enhancers (PCPE-1 and -2) specifically activate bone morphogenetic protein-1 (BMP-1) and other members of the tolloid proteinase family during C-terminal processing of fibrillar collagen precursors. PCPEs consist of two CUB domains (CUB1 and CUB2) and one NTR domain separated by one short and one long linker. It was previously shown that PCPEs can strongly interact with procollagen molecules, but the exact mechanism by which they enhance BMP-1 activity remains largely unknown. Here, we used a series of deletion mutants of PCPE-1 and two chimeric constructs with repetitions of the same CUB domain to study the role of each domain and linker. Out of all the forms tested, only those containing both CUB1 and CUB2 were capable of enhancing BMP-1 activity and binding to a mini-procollagen substrate with nanomolar affinity. Both these properties were lost by individual CUB domains, which had dissociation constants at least three orders of magnitude higher. In addition, none of the constructs tested could inhibit PCPE activity, although CUB2CUB2NTR was found to modulate BMP-1 activity through direct complex formation with the enzyme, resulting in a decreased rate of substrate processing. Finally, increasing the length of the short linker between CUB1 and CUB2 was without detrimental effect on both activity and substrate binding. These data support the conclusion that CUB1 and CUB2 bind to the procollagen substrate in a cooperative manner, involving the short linker that provides a flexible tether linking the two binding regions.	[Kronenberg, Daniel; Vadon-Le Goff, Sandrine; Bourhis, Jean-Marie; Font, Bernard; Eichenberger, Denise; Hulmes, David J. S.; Moali, Catherine] Univ Lyon, CNRS, UMR 5086, Inst Biol & Chim Prot,Biosci Gerland Lyon Sud IFR, F-69367 Lyon 7, France; [Kronenberg, Daniel] Johannes Gutenberg Univ Mainz, Inst Zool Cell & Matrix Biol, D-55128 Mainz, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Johannes Gutenberg University of Mainz	Moali, C (corresponding author), Univ Lyon, CNRS, UMR 5086, Inst Biol & Chim Prot,Biosci Gerland Lyon Sud IFR, 7 Passage Vercors, F-69367 Lyon 7, France.	c.moali@ibcp.fr	le goff, sandrine/AAE-1990-2019; Kronenberg, Daniel/ABA-9255-2020	Kronenberg, Daniel/0000-0001-6807-7328; Hulmes, David/0000-0002-0651-1317; vadon-le goff, sandrine/0000-0002-4582-2273; MOALI, Catherine/0000-0003-2479-4290	Region Rhone-Alpes; European Commission [NMP2-CT-2003-504017]; Agence Nationale de la Recherche; CNRS; Universite Claude Bernard Lyon 1	Region Rhone-Alpes(Region Auvergne-Rhone-Alpes); European Commission(European CommissionEuropean Commission Joint Research Centre); Agence Nationale de la Recherche(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Claude Bernard Lyon 1	This work was supported by the Region Rhone-Alpes, the European Commission (contract NMP2-CT-2003-504017), the Agence Nationale de la Recherche, the CNRS, and the Universite Claude Bernard Lyon 1.	ADAR R, 1986, COLLAGEN REL RES, V6, P267; Appleton BA, 2007, EMBO J, V26, P4902, DOI 10.1038/sj.emboj.7601906; BAICI A, 1981, EUR J BIOCHEM, V119, P9, DOI 10.1111/j.1432-1033.1981.tb05570.x; Bernocco S, 2003, J BIOL CHEM, V278, P7199, DOI 10.1074/jbc.M210857200; Blanc G, 2007, J BIOL CHEM, V282, P16924, DOI 10.1074/jbc.M701610200; Bradford D, 2009, INT J BIOCHEM CELL B, V41, P487, DOI 10.1016/j.biocel.2008.03.014; Cornish-Bowden A, 2012, FUNDAMENTALS ENZYME, V4th; Ge Gaoxiang, 2006, Birth Defects Research, V78, P47, DOI 10.1002/bdrc.20060; Ge GX, 2006, J BIOL CHEM, V281, P10786, DOI 10.1074/jbc.M511111200; Hopkins DR, 2007, MATRIX BIOL, V26, P508, DOI 10.1016/j.matbio.2007.05.004; Hulmes D. J. S., 2008, P15, DOI 10.1007/978-0-387-73906-9_2; Hulmes DJS, 1997, MATRIX BIOL, V16, P41, DOI 10.1016/S0945-053X(97)90115-3; Inomata H, 2008, CELL, V134, P854, DOI 10.1016/j.cell.2008.07.008; KESSLER E, 1989, EUR J BIOCHEM, V186, P115, DOI 10.1111/j.1432-1033.1989.tb15184.x; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Kobayashi K, 2009, NAT CELL BIOL, V11, P46, DOI 10.1038/ncb1811; Lee HX, 2006, CELL, V124, P147, DOI 10.1016/j.cell.2005.12.018; Liepinsh E, 2003, J BIOL CHEM, V278, P25982, DOI 10.1074/jbc.M302734200; Moali C, 2005, J BIOL CHEM, V280, P24188, DOI 10.1074/jbc.M501486200; MOALI C, 2009, EUR J DERMA IN PRESS, V19; Ricard-Blum S, 2002, J BIOL CHEM, V277, P33864, DOI 10.1074/jbc.M205018200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scott IC, 2001, NATURE, V410, P475, DOI 10.1038/35068572; Steiglitz BM, 2002, J BIOL CHEM, V277, P49820, DOI 10.1074/jbc.M209891200	24	23	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33437	33446		10.1074/jbc.M109.046128	http://dx.doi.org/10.1074/jbc.M109.046128			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801683	Green Published, hybrid			2022-12-27	WOS:000272028500050
J	Lee, Y; Ha, J; Kim, HJ; Kim, YS; Chang, EJ; Song, WJ; Kim, HH				Lee, Youngkyun; Ha, Jeongim; Kim, Hyung Joon; Kim, Yeun-Soo; Chang, Eun-Ju; Song, Woo-Joo; Kim, Hong-Hee			Negative Feedback Inhibition of NFATc1 by DYRK1A Regulates Bone Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-KAPPA-B; DOWN-SYNDROME; DUAL-SPECIFICITY; TRANSGENIC MICE; OSTEOCLAST DIFFERENTIATION; MENTAL-RETARDATION; RECEPTOR ACTIVATOR; FUNCTIONAL-LINK; PROTEIN-KINASES; YOUNG MEN	DYRK1A is a serine/threonine kinase that has been linked to mental retardation associated with Down syndrome. In the present report, we describe a previously unknown role for DYRK1A in bone homeostasis. The protein expression of DYRK1A increased during osteoclast differentiation. In vitro studies in osteoclasts revealed that DYRK1A inhibited osteoclastogenesis. Whereas DYRK1A phosphorylated and inhibited the osteoclastogenic transcription factor NFATc1, forced expression of NFATc1 induced DYRK1A expression, suggesting a negative feedback loop. Transgenic mice overexpressing DYRK1A by the extent of the increased gene dosage in Down syndrome exhibited significantly reduced bone mass despite the decreased osteoclastogenesis, which is reminiscent of osteoporotic bone phenotype in Down syndrome patients. In these mice, attenuated osteoblast differentiation and function in the presence of extra DYRK1A overrode the effect of impaired osteoclastogenesis. However, impeded osteoclastogenesis in DYRK1A transgenic mice was proven to be beneficial in protecting bone loss induced by inflammation or estrogen deficiency. These results provide novel insight into the role for DYRK1A in bone homeostasis as well as in bone destructive diseases, in which modulation of DYRK1A might be used as a strategy to treat unregulated bone resorption.	[Kim, Yeun-Soo; Song, Woo-Joo] Inje Univ, Inst Brain Sci & Technol, Grad Program Neurosci, Pusan 614735, South Korea; [Lee, Youngkyun; Ha, Jeongim; Kim, Hyung Joon; Chang, Eun-Ju; Kim, Hong-Hee] Seoul Natl Univ, Dept Cell & Dev Biol, BK21 Program, Seoul 110749, South Korea; [Lee, Youngkyun; Ha, Jeongim; Kim, Hyung Joon; Chang, Eun-Ju; Kim, Hong-Hee] Seoul Natl Univ, DRI, Seoul 110749, South Korea	Inje University; Seoul National University (SNU); Seoul National University (SNU)	Song, WJ (corresponding author), Inje Univ, Inst Brain Sci & Technol, Grad Program Neurosci, Kaegum 2 Dong, Pusan 614735, South Korea.	wjsong@inje.ac.kr; hhbkim@snu.ac.kr	Kim, Hyung-Joon/ABD-3143-2020; Kim, Hyung Joon/D-6123-2012; Lee, Youngkyun/D-2667-2011	Kim, Hyung-Joon/0000-0002-2962-9553; 	Korea Science and Engineering Foundation [R01-2007-000-11910-0]; Korea Research Foundation [KRF-2008-314-E00180, KRF-2008-313-E00439]; Korean Government; 21C Frontier Functional Proteomics Project [FPR08B1-170]; Science Research Center [2009-0063269]	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Korea Research Foundation(National Research Foundation of Korea); Korean Government(Korean Government); 21C Frontier Functional Proteomics Project(Ministry of Education, Science & Technology (MEST), Republic of Korea); Science Research Center	This work was supported by Korea Science and Engineering Foundation Grant R01-2007-000-11910-0 (to W.-J.S.), Korea Research Foundation Grants KRF-2008-314-E00180 (to W.-J.S.) and KRF-2008-313-E00439 (to Y.L.) funded by the Korean Government, and 21C Frontier Functional Proteomics Project Grant FPR08B1-170 and Science Research Center Grant 2009-0063269 (to H.-H. K.).	Ahn KJ, 2006, NEUROBIOL DIS, V22, P463, DOI 10.1016/j.nbd.2005.12.006; Altafaj X, 2001, HUM MOL GENET, V10, P1915, DOI 10.1093/hmg/10.18.1915; Angelopoulou N, 2000, CALCIFIED TISSUE INT, V66, P176, DOI 10.1007/s002230010035; Arai F, 1999, J EXP MED, V190, P1741, DOI 10.1084/jem.190.12.1741; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Baptista F, 2005, OSTEOPOROSIS INT, V16, P380, DOI 10.1007/s00198-004-1687-1; Becker W, 1999, PROG NUCLEIC ACID RE, V62, P1; Becker W, 1998, J BIOL CHEM, V273, P25893, DOI 10.1074/jbc.273.40.25893; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Center J, 1998, AM J MENT RETARD, V103, P19, DOI 10.1352/0895-8017(1998)103<0019:PWMRHA>2.0.CO;2; Chang EJ, 2008, NAT MED, V14, P966, DOI 10.1038/nm.1860; Chuvpilo S, 2002, IMMUNITY, V16, P881, DOI 10.1016/S1074-7613(02)00329-1; Delabar Jean-Maurice, 1993, European Journal of Human Genetics, V1, P114; Fotaki V, 2002, MOL CELL BIOL, V22, P6636, DOI 10.1128/MCB.22.18.6636-6647.2002; Grimwood JS, 2000, HISTOPATHOLOGY, V36, P279; Guijarro M, 2008, J INTELL DISABIL RES, V52, P182, DOI 10.1111/j.1365-2788.2007.00992.x; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Kentrup H, 1996, J BIOL CHEM, V271, P3488; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; Lee Y, 2008, BLOOD, V111, P885, DOI 10.1182/blood-2007-03-082941; Lee ZH, 2003, BIOCHEM BIOPH RES CO, V305, P211, DOI 10.1016/S0006-291X(03)00695-8; Olson LE, 2004, SCIENCE, V306, P687, DOI 10.1126/science.1098992; Richtsmeier JT, 2002, AM J MED GENET, V107, P317, DOI 10.1002/ajmg.10175; Richtsmeier JT, 2000, DEV DYNAM, V217, P137, DOI 10.1002/(SICI)1097-0177(200002)217:2<137::AID-DVDY1>3.0.CO;2-N; Ryoo SR, 2008, J NEUROCHEM, V104, P1333, DOI 10.1111/j.1471-4159.2007.05075.x; Ryoo SR, 2007, J BIOL CHEM, V282, P34850, DOI 10.1074/jbc.M707358200; Ryu J, 2006, EMBO J, V25, P5840, DOI 10.1038/sj.emboj.7601430; Sakadamis A, 2002, EUR J OBSTET GYN R B, V100, P208, DOI 10.1016/S0301-2115(01)00478-X; Smith DJ, 1997, NAT GENET, V16, P28, DOI 10.1038/ng0597-28; Sumarsono SH, 1996, NATURE, V379, P534, DOI 10.1038/379534a0; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Theill LE, 2002, ANNU REV IMMUNOL, V20, P795, DOI 10.1146/annurev.immunol.20.100301.064753; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Winslow MM, 2006, DEV CELL, V10, P771, DOI 10.1016/j.devcel.2006.04.006	37	44	44	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33343	33351		10.1074/jbc.M109.042234	http://dx.doi.org/10.1074/jbc.M109.042234			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801542	Green Published, hybrid			2022-12-27	WOS:000272028500039
J	Zou, YX; Mi, J; Cui, JP; Lu, DF; Zhang, XY; Guo, CH; Gao, GM; Liu, QJ; Chen, BX; Shao, CS; Gong, YQ				Zou, Yongxin; Mi, Jun; Cui, Jinpeng; Lu, Defen; Zhang, Xiyu; Guo, Chenhong; Gao, Guimin; Liu, Qiji; Chen, Bingxi; Shao, Changshun; Gong, Yaoqin			Characterization of Nuclear Localization Signal in the N Terminus of CUL4B and Its Essential Role in Cyclin E Degradation and Cell Cycle Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED MENTAL-RETARDATION; UBIQUITIN LIGASE COMPLEX; CHROMOSOME INSTABILITY; IMPORTIN-ALPHA; HUMAN HOMOLOG; DNA-DAMAGE; S-PHASE; PROTEIN; TARGETS; CDT1	CUL4A and CUL4B, which are derived from the same ancestor, CUL4, encode scaffold proteins that organize cullin-RING ubiquitin ligase (E3) complexes. Recent genetic studies have shown that germ line mutation in CUL4B can cause mental retardation, short stature, and other abnormalities in humans. CUL4A was observed to be overexpressed in breast and hepatocellular cancers, although no germ line mutation in human CUL4A has been reported. Although CUL4A has been known to be involved in a number of cellular processes, including DNA repair and cell cycle regulation, little is known about whether CUL4B has similar functions. In this report, we tested the functional importance of CUL4B in cell proliferation and characterized the nuclear localization signal (NLS) that is essential for its function. We found that RNA interference silencing of CUL4B led to an inhibition of cell proliferation and a prolonged S phase, due to the overaccumulation of cyclin E, a substrate targeted by CUL4B for ubiquitination. We showed that, unlike CUL4A and other cullins that carry their NLS in their C termini, NLS in CUL4B is located in its N terminus, between amino acid 37 and 40, KKRK. This NLS could bind to importin alpha 1, alpha 3, and alpha 5. NLS-deleted CUL4B was distributed in cytoplasm and failed to promote cell proliferation. Therefore, the nuclear localization of CUL4B mediated by NLS is critical for its normal function in cell proliferation.	[Zou, Yongxin; Mi, Jun; Cui, Jinpeng; Lu, Defen; Zhang, Xiyu; Guo, Chenhong; Gao, Guimin; Liu, Qiji; Chen, Bingxi; Shao, Changshun; Gong, Yaoqin] Shandong Univ, Sch Med, Inst Mol Med & Genet, Minist Educ,Key Lab Expt Teratol, Jinan 250012, Shandong, Peoples R China; [Shao, Changshun] Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA	Shandong University; Rutgers State University New Brunswick	Shao, CS (corresponding author), Shandong Univ, Sch Med, Inst Mol Med & Genet, Minist Educ,Key Lab Expt Teratol, 44 Wen Hua Xi Lu, Jinan 250012, Shandong, Peoples R China.	shao@biology.rutgers.edu; yxg8@sdu.edu.cn	Shao, Changshun/AAD-8977-2022	Shao, Changshun/0000-0003-2618-9342	National Science Foundation Research [30830065]; National Basic Research Program of China [2007CB512001]; National High-tech Research and Development Program of China [2006AA02A406]	National Science Foundation Research(National Science Foundation (NSF)); National Basic Research Program of China(National Basic Research Program of China); National High-tech Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by National Science Foundation Research Grant 30830065, National Basic Research Program of China grant 2007CB512001, and National High-tech Research and Development Program of China Grant 2006AA02A406.	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Banks D, 2006, CELL CYCLE, V5, P1719, DOI 10.4161/cc.5.15.3150; Bosu DR, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-7; Chen LC, 1998, CANCER RES, V58, P3677; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; Cyert MS, 2001, J BIOL CHEM, V276, P20805, DOI 10.1074/jbc.R100012200; Doronkin S, 2003, DEV CELL, V4, P699, DOI 10.1016/S1534-5807(03)00121-7; Fagerlund R, 2005, J BIOL CHEM, V280, P15942, DOI 10.1074/jbc.M500814200; Furukawa M, 2000, MOL CELL BIOL, V20, P8185, DOI 10.1128/MCB.20.21.8185-8197.2000; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Grundt K, 2007, BBA-MOL CELL RES, V1773, P1398, DOI 10.1016/j.bbamcr.2007.05.013; Guerrero-Santoro J, 2008, CANCER RES, V68, P5014, DOI 10.1158/0008-5472.CAN-07-6162; He YZJ, 2006, GENE DEV, V20, P2949, DOI 10.1101/gad.1483206; Higa LA, 2006, CELL CYCLE, V5, P71, DOI 10.4161/cc.5.1.2266; Higa LAA, 2003, NAT CELL BIOL, V5, P1008, DOI 10.1038/ncb1061; Higa LA, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-5; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hu J, 2004, NAT CELL BIOL, V6, P1003, DOI 10.1038/ncb1172; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Kim Y, 2008, GENE DEV, V22, P2507, DOI 10.1101/gad.1703708; Kopanja D, 2009, ONCOGENE, V28, P2456, DOI 10.1038/onc.2009.86; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Leung-Pineda V, 2009, CANCER RES, V69, P2630, DOI 10.1158/0008-5472.CAN-08-3382; Li BH, 2002, MOL CELL BIOL, V22, P4997, DOI 10.1128/MCB.22.14.4997-5005.2002; Li BH, 2006, BLOOD, V107, P4291, DOI 10.1182/blood-2005-08-3349; Li KY, 2003, CANCER RES, V63, P3593; Lischka P, 2003, J VIROL, V77, P3734, DOI 10.1128/JVI.77.6.3734-3748.2003; Liu LR, 2009, MOL CELL, V34, P451, DOI 10.1016/j.molcel.2009.04.020; Liu ZJ, 2009, MUTAT RES-FUND MOL M, V662, P75, DOI 10.1016/j.mrfmmm.2008.12.009; Miranda-Carboni GA, 2008, GENE DEV, V22, P3121, DOI 10.1101/gad.1692808; Moroy T, 2004, INT J BIOCHEM CELL B, V36, P1424, DOI 10.1016/S1357-2725(03)00432-1; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nag A, 2004, CANCER RES, V64, P8152, DOI 10.1158/0008-5472.CAN-04-2598; Nishitani H, 2008, J BIOL CHEM, V283, P29045, DOI 10.1074/jbc.M806045200; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Schindl M, 2007, ANTICANCER RES, V27, P949; Senga T, 2006, J BIOL CHEM, V281, P6246, DOI 10.1074/jbc.M512705200; Simone C, 2002, J CLIN PATHOL-MOL PA, V55, P200, DOI 10.1136/mp.55.3.200; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Suntharalingam M, 2003, DEV CELL, V4, P775, DOI 10.1016/S1534-5807(03)00162-X; Tarpey PS, 2007, AM J HUM GENET, V80, P345, DOI 10.1086/511134; Waning DL, 2008, BLOOD, V112, P320, DOI 10.1182/blood-2007-11-126300; Xia Y, 2008, BIOCHEM BIOPH RES CO, V368, P438, DOI 10.1016/j.bbrc.2008.01.111; Yasui K, 2002, HEPATOLOGY, V35, P1476, DOI 10.1053/jhep.2002.33683; Yoneda Y, 2000, GENES CELLS, V5, P777, DOI 10.1046/j.1365-2443.2000.00366.x; Zou YX, 2007, AM J HUM GENET, V80, P561, DOI 10.1086/512489	49	85	89	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33320	33332		10.1074/jbc.M109.050427	http://dx.doi.org/10.1074/jbc.M109.050427			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801544	hybrid, Green Published			2022-12-27	WOS:000272028500037
J	Han, XB; Kitamoto, S; Lian, QY; Boisvert, WA				Han, Xinbing; Kitamoto, Shiro; Lian, Qingyu; Boisvert, William A.			Interleukin-10 Facilitates Both Cholesterol Uptake and Efflux in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIINFLAMMATORY CYTOKINE INTERLEUKIN-10; LOW-DENSITY-LIPOPROTEIN; E-DEFICIENT MICE; SCAVENGER RECEPTOR; FOAM CELL; INHIBITS ATHEROSCLEROSIS; TANGIER-DISEASE; TRANSGENIC MICE; SERUM-LEVELS; EXPRESSION	Foam cell formation is a hallmark event during atherosclerosis. The current paradigm is that lipid uptake by scavenger receptor in macrophages initiates the chronic proinflammatory cascade and necrosis core formation that characterize atherosclerosis. We report here that a cytokine considered to be antiatherogenic, interleukin-10 (IL10), promotes cholesterol uptake from modified lipoproteins in macrophages and its transformation into foam cells by increasing the expression of scavenger receptor CD36 and scavenger receptor A. Although uptake of modified lipoproteins is considered proatherogenic, we found that IL10 also increases cholesterol efflux from macrophages to protect against toxicity of free cholesterol accumulation in the cell. This process was PPAR gamma-dependent and was mediated through up-regulation of ABCA1 (ATP-binding cassette transporter A1) protein expression. Importantly, expression of inflammatory molecules, such as tumor necrosis factor-alpha, intercellular adhesion molecule-1, and MMP9 as well as apoptosis were dramatically suppressed in lipid-laden foam cells treated with IL10. The notion that IL10 can mediate both the uptake of cholesterol from modified lipoproteins and the efflux of stored cholesterol suggests that the process of foam cell formation is not necessarily detrimental as long as mechanisms of cholesterol efflux and transfer to an exogenous acceptor are functioning robustly. Our results present a comprehensive antiatherogenic role of IL10 in macrophages, including enhanced disposal of harmful lipoproteins, inhibition of inflammatory molecules, and reduced apoptosis.	[Han, Xinbing; Kitamoto, Shiro; Lian, Qingyu; Boisvert, William A.] Harvard Univ, Sch Med, Brigham Womens Hosp, Vasc Med Res Unit, Cambridge, MA 02139 USA	Harvard University; Brigham & Women's Hospital	Boisvert, WA (corresponding author), Harvard Univ, Sch Med, Brigham Womens Hosp, Vasc Med Res Unit, Cambridge, MA 02139 USA.	wab@hawaii.edu			National Institutes of Health [HL075677]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075677] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL075677 (to W.A.B.).	ACTON SL, 1994, J BIOL CHEM, V269, P21003; Akiyama TE, 2002, MOL CELL BIOL, V22, P2607, DOI 10.1128/MCB.22.8.2607-2619.2002; Anguera I, 2002, AM HEART J, V144, P811, DOI 10.1067/mhj.2002.124831; Attie AD, 2001, J LIPID RES, V42, P1717; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Cavelier LB, 2001, J BIOL CHEM, V276, P18046, DOI 10.1074/jbc.M100565200; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Chinetti G, 2001, NAT MED, V7, P53, DOI 10.1038/83348; Clee SM, 2000, J CLIN INVEST, V106, P1263, DOI 10.1172/JCI10727; Costet P, 2000, J BIOL CHEM, V275, P28240; de Winther MPJ, 2000, J CLIN INVEST, V105, P1039, DOI 10.1172/JCI9919; Fazio S, 1997, P NATL ACAD SCI USA, V94, P4647, DOI 10.1073/pnas.94.9.4647; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; GOCZE PM, 1994, CYTOMETRY, V17, P151, DOI 10.1002/cyto.990170207; Halvorsen B, 2005, J LIPID RES, V46, P211, DOI 10.1194/jlr.M400324-JLR200; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Kolodgie FD, 2000, AM J PATHOL, V157, P1259, DOI 10.1016/S0002-9440(10)64641-X; Kunjathoor VV, 2002, J BIOL CHEM, V277, P49982, DOI 10.1074/jbc.M209649200; Lang R, 2002, J IMMUNOL, V168, P3402, DOI 10.4049/jimmunol.168.7.3402; Lee CH, 2003, SCIENCE, V302, P453, DOI 10.1126/science.1087344; Li AC, 2002, NAT MED, V8, P1235, DOI 10.1038/nm1102-1235; Liao HS, 2000, ARTERIOSCL THROM VAS, V20, P1968, DOI 10.1161/01.ATV.20.8.1968; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Mallat Z, 1999, CIRC RES, V85, pE17, DOI 10.1161/01.RES.85.8.e17; Mallat Z, 1999, ARTERIOSCL THROM VAS, V19, P611, DOI 10.1161/01.ATV.19.3.611; Mei CL, 2007, CELL BIOL INT, V31, P1456, DOI 10.1016/j.cellbi.2007.06.009; Mitchinson MJ, 1996, CURR OPIN LIPIDOL, V7, P324, DOI 10.1097/00041433-199610000-00011; Moore KJ, 2005, J CLIN INVEST, V115, P2192, DOI 10.1172/JCI24061; Oslund LJP, 1999, ARTERIOSCL THROM VAS, V19, P2847, DOI 10.1161/01.ATV.19.12.2847; Pinderski LJ, 2002, CIRC RES, V90, P1064, DOI 10.1161/01.RES.0000018941.10726.FA; ROSS R, 1995, ANNU REV PHYSIOL, V57, P791, DOI 10.1146/annurev.ph.57.030195.004043; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rubic T, 2006, CARDIOVASC RES, V69, P527, DOI 10.1016/j.cardiores.2005.10.018; Singaraja RR, 2002, J CLIN INVEST, V110, P35, DOI 10.1172/JCI200215748; Smith DA, 2001, CIRCULATION, V104, P746, DOI 10.1161/hc3201.094973; Tabas I, 1996, J BIOL CHEM, V271, P22773, DOI 10.1074/jbc.271.37.22773; Tall AR, 2000, J CLIN INVEST, V106, P1205, DOI 10.1172/JCI11538; Teupser D, 1999, ARTERIOSCL THROM VAS, V19, P1299, DOI 10.1161/01.ATV.19.5.1299; Trogan E, 2002, P NATL ACAD SCI USA, V99, P2234, DOI 10.1073/pnas.042683999; van Dam MJ, 2002, LANCET, V359, P37, DOI 10.1016/S0140-6736(02)07277-X; Van Eck M, 2000, ARTERIOSCL THROM VAS, V20, P2600, DOI 10.1161/01.ATV.20.12.2600; WANG P, 1995, J BIOL CHEM, V270, P9558, DOI 10.1074/jbc.270.16.9558; WARNER GJ, 1995, J BIOL CHEM, V270, P5772, DOI 10.1074/jbc.270.11.5772; Whitman SC, 2002, J LIPID RES, V43, P1201, DOI 10.1194/jlr.M200116-JLR200; Yoshioka T, 2004, GENE THER, V11, P1772, DOI 10.1038/sj.gt.3302348	46	63	63	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32950	32958		10.1074/jbc.M109.040899	http://dx.doi.org/10.1074/jbc.M109.040899			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19776020	Green Published, hybrid			2022-12-27	WOS:000272028400078
J	Marin, M; Heinz, DW; Pieper, DH; Klink, BU				Marin, Macarena; Heinz, Dirk W.; Pieper, Dietmar H.; Klink, Bjoern U.			Crystal Structure and Catalytic Mechanism of 4-Methylmuconolactone Methylisomerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODIFIED 3-OXOADIPATE PATHWAY; SP STRAIN MT1; GENE-CLUSTER; PROTEIN; PSEUDOMONAS; 4-METHYLCATECHOL; PURIFICATION; DEGRADATION; REFINEMENT; METABOLISM	When methyl-substituted aromatic compounds are degraded via ortho (intradiol)-cleavage of 4-methylcatechol, the dead-end metabolite 4-methylmuconolactone (4-ML) is formed. Degradation of 4-ML has only been described in few bacterial species, including Pseudomonas reinekei MT1. The isomerization of 4-ML to 3-methylmuconolactone (3-ML) is the first step required for the mineralization of 4-ML and is catalyzed by an enzyme termed 4-methylmuconolactone methylisomerase (MLMI). We identified the gene encoding MLMI in P. reinekei MT1 and solved the crystal structures of MLMI in complex with 3-ML at 1.4-angstrom resolution, with 4-ML at 1.9-angstrom resolution and with a MES buffer molecule at 1.45-angstrom resolution. MLMI exhibits a ferredoxin-like fold and assembles as a tight functional homodimeric complex. We were able to assign the active site clefts of MLMI from P. reinekei MT1 and of the homologous MLMI from Cupriavidus necator JMP134, which has previously been crystallized in a structural genomics project. Kinetic and structural analysis of wild-type MLMI and variants created by site-directed mutagenesis indicate Tyr-39 and His-26 to be the most probable catalytic residues. The previously proposed involvement of Cys-67 in covalent catalysis can now be excluded. Residue His-52 was found to be important for substrate affinity, with only marginal effect on catalytic activity. Based on these results, a novel catalytic mechanism for the isomerization of 4-ML to 3-ML by MLMI, involving a bislactonic intermediate, is proposed. This broadens the knowledge about the diverse group of proteins exhibiting a ferredoxin-like fold.	Helmholtz Ctr Infect Res, Dept Microbial Pathogenesis, D-38124 Braunschweig, Germany; [Heinz, Dirk W.; Klink, Bjoern U.] Helmholtz Ctr Infect Res, Div Struct Biol, D-38124 Braunschweig, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research		dpi@helmholtz-hzi.de	Marin, Macarena/H-8742-2013	Marin, Macarena/0000-0002-6966-2446	Deutsche Forschungsgemeinschaft-International Research	Deutsche Forschungsgemeinschaft-International Research(German Research Foundation (DFG))	This work was funded by Deutsche Forschungsgemeinschaft-International Research Training Group 653.	Adams MA, 2005, J BIOL CHEM, V280, P8358, DOI 10.1074/jbc.M412637200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUCE NC, 1989, BIOCHEM J, V262, P303, DOI 10.1042/bj2620303; CAIN RB, 1989, J CHEM SOC PERK T 1, P202, DOI 10.1039/p19890000202; Camara B, 2007, J BACTERIOL, V189, P1664, DOI 10.1128/JB.01192-06; CATELANI D, 1971, BIOCHEM J, V121, P89, DOI 10.1042/bj1210089; CHARI RVJ, 1987, J AM CHEM SOC, V109, P5520, DOI 10.1021/ja00252a035; Dgany O, 2004, J BIOL CHEM, V279, P51516, DOI 10.1074/jbc.M409952200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erb RW, 1998, GENE, V206, P53, DOI 10.1016/S0378-1119(97)00565-9; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P67, DOI 10.1107/S0021889887009737; Kleywegt GJ, 2004, ACTA CRYSTALLOGR D, V60, P2240, DOI 10.1107/S0907444904013253; KNACKMUSS HJ, 1976, EUR J APPL MICROBIOL, V2, P267, DOI 10.1007/BF01278610; Lytle BL, 2004, J BIOMOL NMR, V28, P397, DOI 10.1023/B:JNMR.0000015385.54050.19; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nikodem P, 2003, J BACTERIOL, V185, P6790, DOI 10.1128/JB.185.23.6790-6800.2003; ORENGO CA, 1994, NATURE, V372, P631, DOI 10.1038/372631a0; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; PIEPER DH, 1990, BIOCHEM J, V271, P529, DOI 10.1042/bj2710529; Russell RB, 1998, J MOL BIOL, V282, P903, DOI 10.1006/jmbi.1998.2043; SANDER C, 1991, PROTEINS, V9, P56, DOI 10.1002/prot.340090107; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sciara G, 2003, EMBO J, V22, P205, DOI 10.1093/emboj/cdg031; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766	24	5	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32709	32716		10.1074/jbc.M109.024604	http://dx.doi.org/10.1074/jbc.M109.024604			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19801657	hybrid, Green Published			2022-12-27	WOS:000272028400055
J	Yellaturu, CR; Deng, X; Park, EA; Raghow, R; Elam, MB				Yellaturu, Chandrahasa R.; Deng, Xiong; Park, Edwards A.; Raghow, Rajendra; Elam, Marshall B.			Insulin Enhances the Biogenesis of Nuclear Sterol Regulatory Element-binding Protein (SREBP)-1c by Posttranscriptional Down-regulation of Insig-2A and Its Dissociation from SREBP Cleavage-activating Protein (SCAP).SREBP-1c Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; GENE-EXPRESSION; TRANSCRIPTION FACTORS; LIPID HOMEOSTASIS; RAT HEPATOCYTES; COPII VESICLES; MESSENGER-RNA; SCAP; CHOLESTEROL; TRANSPORT	The regulation of lipid homeostasis by insulin is mediated in part by the enhanced transcription of the gene encoding sterol regulatory element-binding protein-1c (SREBP-1c). The nascent SREBP-1c is embedded in the endoplasmic reticulum (ER) and must be transported to the Golgi where two sequential cleavages generate its NH2-terminal fragment, nSREBP-1c. We have shown recently that in primary cultures of rat hepatocytes, insulin rapidly and selectively stimulates proteolytic processing of the nascent SREBP-1c by enhancing the affinity of the SREBP cleavage-activating protein (SCAP).SREBP-1c complex for coatomer protein complex II (COPII) vesicles. The SCAP.SREBP complex is retained in the ER by Insig proteins. We report here that insulin persistently stimulates controlled proteolysis of the nascent SREBP-1c by selectively reducing the level of Insig-2a protein via accelerated degradation of its cognate mRNA. Insulin enhanced the rate of turnover of Insig-2a mRNA via its 3'-untranslated region. Insulin-induced depletion of Insig-2a promotes association of the SCAP.SREBP-1c complex with COPII vesicles and subsequent migration to the Golgi where site-1 and site-2 proteases process the nascent SREBP-1c. Consistent with this mechanism, experimental knockdown of Insig-2a expression with small interfering RNA mimicked insulin-induced proteolysis of the nascent SREBP-1c, whereas exogenous expression of Insig-2a in hepatocytes led to reduced intramembrane proteolysis of the newly synthesized SREBP-1c. The action of insulin on the processing of the nascent SREBP-1c via Insig-2a was highly selective, as proteolysis of the newly synthesized SREBP-2 remained unchanged under identical conditions. On the basis of these data, we propose that the stimulation of SREBP-1c processing by insulin is mediated by a selective depletion of Insig-2a protein by promoting decay of its cognate mRNA. Thus, insulin-induced reduction in Insig-2a protein leads to an enhanced export of the SCAP.SREBP-1c complex from ER to the Golgi.	[Yellaturu, Chandrahasa R.; Deng, Xiong; Park, Edwards A.; Raghow, Rajendra; Elam, Marshall B.] Univ Tennessee, Hlth Sci Ctr, Dept Pharmacol, Memphis, TN 38163 USA; [Elam, Marshall B.] Univ Tennessee, Hlth Sci Ctr, Dept Med, Memphis, TN 38163 USA; [Deng, Xiong; Raghow, Rajendra; Elam, Marshall B.] Dept Vet Affairs Med Ctr, Memphis, TN 38104 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center	Yellaturu, CR (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Pharmacol, 874 Union Ave, Memphis, TN 38163 USA.	cyellatu@utmem.edu			National Institutes of Health [RO1 DK075504]; NIDDK [RO1 DK059368]; American Heart Association; American Heart Association, Southeastern Affiliate; Office of Research and Development, Department of Veterans Affairs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059368, R01DK075504] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Heart Association(American Heart Association); American Heart Association, Southeastern Affiliate(American Heart Association); Office of Research and Development, Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK075504 ( to M. B. E., R. R., and C. R. Y.) and RO1 DK059368 ( to E. A. P.) from the NIDDK. This work was also supported by a postdoctoral fellowship grant from the American Heart Association ( to C. R. Y.), a grantin- aid from the American Heart Association, Southeastern Affiliate ( to M. B. E. and C. R. Y.), and the Office of Research and Development, Department of Veterans Affairs ( to M. B. E.).	Azzout-Marniche D, 2000, BIOCHEM J, V350, P389, DOI 10.1042/0264-6021:3500389; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Cagen LM, 2005, BIOCHEM J, V385, P207, DOI 10.1042/BJ20040162; Deng X, 2007, J BIOL CHEM, V282, P17517, DOI 10.1074/jbc.M702228200; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Edwards PA, 2000, BBA-MOL CELL BIOL L, V1529, P103, DOI 10.1016/S1388-1981(00)00140-2; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315; Espenshade PJ, 2006, J CELL SCI, V119, P973, DOI 10.1242/jcs02866; Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737; Foretz M, 1999, MOL CELL BIOL, V19, P3760; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; HUA XX, 1995, GENOMICS, V25, P667, DOI 10.1016/0888-7543(95)80009-B; McPherson R, 2004, BIOCHEM CELL BIOL, V82, P201, DOI 10.1139/o03-090; OBrien RM, 1996, PHYSIOL REV, V76, P1109, DOI 10.1152/physrev.1996.76.4.1109; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Raghow R, 2008, TRENDS ENDOCRIN MET, V19, P65, DOI 10.1016/j.tem.2007.10.009; Rowe T, 1996, J CELL BIOL, V135, P895, DOI 10.1083/jcb.135.4.895; Shimomura I, 1999, J BIOL CHEM, V274, P30028, DOI 10.1074/jbc.274.42.30028; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; Sun LP, 2007, P NATL ACAD SCI USA, V104, P6519, DOI 10.1073/pnas.0700907104; Sun LP, 2005, J BIOL CHEM, V280, P26483, DOI 10.1074/jbc.M504041200; THORNGATE FE, 1994, P NATL ACAD SCI USA, V91, P5392, DOI 10.1073/pnas.91.12.5392; Roretz C, 2008, J CELL BIOL, V181, P189, DOI 10.1083/jcb.200712054; Yabe D, 2003, P NATL ACAD SCI USA, V100, P3155, DOI 10.1073/pnas.0130116100; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Yellaturu CR, 2009, J BIOL CHEM, V284, P7518, DOI 10.1074/jbc.M805746200; Yellaturu CR, 2005, BIOCHEM BIOPH RES CO, V332, P174, DOI 10.1016/j.bbrc.2005.04.112	31	79	82	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31726	31734		10.1074/jbc.M109.050914	http://dx.doi.org/10.1074/jbc.M109.050914			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19759400	Green Published, hybrid			2022-12-27	WOS:000271572700027
J	Reddy, MCM; Palaninathan, SK; Bruning, JB; Thurman, C; Smith, D; Sacchettini, JC				Reddy, Manchi C. M.; Palaninathan, Satheesh K.; Bruning, John B.; Thurman, Cory; Smith, Danielle; Sacchettini, James C.			Structural Insights into the Mechanism of the Allosteric Transitions of Mycobacterium tuberculosis cAMP Receptor Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATABOLITE ACTIVATOR PROTEIN; CYCLIC-NUCLEOTIDE BINDING; CAP-DNA COMPLEX; ESCHERICHIA-COLI; TRANSCRIPTION REGULATORS; STRUCTURE VALIDATION; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; ELECTRON-DENSITY; GENE-EXPRESSION	The cAMP receptor protein (CRP) from Mycobacterium tuberculosis is a cAMP-responsive global transcriptional regulator, responsible for the regulation of a multitude of diverse proteins. We have determined the crystal structures of the CRP.cAMP and CRP.N-6-cAMP derivative-bound forms of the enzyme to 2.2- and 2.3 angstrom-resolution, respectively, to investigate cAMP-mediated conformational and structural changes. The allosteric switch from the open, inactive conformation to the closed, active conformation begins with a number of changes in the ligand-binding cavity upon cAMP binding. These subtle structural changes and numerous non-bonding interactions between cAMP, the N-domain residues, and the C-domain helices demonstrate that the N-domain hairpin loop acts as a structural mediator of the allosteric switch. Based on the CRP.N-6-cAMP crystal structure, binding of N-6-cAMP with a bulkier methylphenylethyl extension from the N6 atom stabilizes the cAMP-binding domain, N-domain hairpin, and C-terminal domain in a similar manner as that of the CRP.cAMP structure, maintaining structural integrity within the subunits. However, the bulkier N6 extension of N-6-cAMP (in R conformation) is accommodated only in subunit A with minor changes, whereas in subunit B, the N-6 extension is in the S conformation hindering the hinge region of the central helix. As a result, the entire N-domain and the C-domain of subunit B integrated by the cAMP portion of this ligand, together tilt away (similar to 7 degrees tilt) from central helix C, positioning the helix-turn-helix motif in an unfavorable position for the DNA substrate, asymmetrically. Together, these crystal structures demonstrate the mechanism of action of the cAMP molecule and its role in integrating the active CRP structure.	[Reddy, Manchi C. M.; Palaninathan, Satheesh K.; Bruning, John B.; Thurman, Cory; Smith, Danielle; Sacchettini, James C.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Sacchettini, JC (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, 103 Biochem Biophys Bldg, College Stn, TX 77843 USA.	sacchett@tamu.edu	Bruning, John/AAW-8567-2020	Bruning, John/0000-0002-6919-1824	Structural Genomics of Persistence Targets from Mycobacterium tuberculosis [PO1AI068135]; Wolfe-Welch Foundation Chair in Science [8-0015]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI068135] Funding Source: NIH RePORTER	Structural Genomics of Persistence Targets from Mycobacterium tuberculosis; Wolfe-Welch Foundation Chair in Science; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Structural Genomics of Persistence Targets from Mycobacterium tuberculosis (Grant PO1AI068135) and by the R. J. Wolfe-Welch Foundation Chair in Science (Grant 8-0015).	Agari Y, 2008, MOL MICROBIOL, V70, P60, DOI 10.1111/j.1365-2958.2008.06388.x; ANDERSON WB, 1972, J BIOL CHEM, V247, P2717; Bai GC, 2005, J BACTERIOL, V187, P7795, DOI 10.1128/JB.187.22.7795-7804.2005; BOTSFORD JL, 1992, MICROBIOL REV, V56, P100, DOI 10.1128/MMBR.56.1.100-122.1992; Chen R, 2003, J BIOL CHEM, V278, P13235, DOI 10.1074/jbc.M211551200; CHENG XD, 1995, BIOCHEMISTRY-US, V34, P10816, DOI 10.1021/bi00034a014; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; EBRIGHT RH, 1985, J MOL BIOL, V182, P91, DOI 10.1016/0022-2836(85)90030-0; Gallagher DT, 2009, J BIOL CHEM, V284, P8228, DOI 10.1074/jbc.C800215200; GARGES S, 1985, CELL, V41, P745, DOI 10.1016/S0092-8674(85)80055-6; Gorshkova EV, 2005, BIOCHEMISTRY-MOSCOW+, V70, P1180, DOI 10.1007/s10541-005-0244-7; Gosset G, 2004, J BACTERIOL, V186, P3516, DOI 10.1128/JB.186.11.3516-3524.2004; Green J, 2001, ADV MICROB PHYSIOL, V44, P1, DOI 10.1016/S0065-2911(01)44010-0; Harman JG, 2001, BBA-PROTEIN STRUCT M, V1547, P1, DOI 10.1016/S0167-4838(01)00187-X; Hobson RJ, 2002, MICROBIOL-SGM, V148, P1571, DOI 10.1099/00221287-148-5-1571; KOLB A, 1993, NUCLEIC ACIDS RES, V21, P319, DOI 10.1093/nar/21.2.319; Korner H, 2003, FEMS MICROBIOL REV, V27, P559, DOI 10.1016/S0168-6445(03)00066-4; Lawson CL, 2004, CURR OPIN STRUC BIOL, V14, P10, DOI 10.1016/j.sbi.2004.01.012; Lee TW, 2001, J BIOCHEM-TOKYO, V130, P57, DOI 10.1093/oxfordjournals.jbchem.a002962; Malecki J, 2000, J BIOL CHEM, V275, P8480, DOI 10.1074/jbc.275.12.8480; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Parkinson G, 1996, J MOL BIOL, V260, P395, DOI 10.1006/jmbi.1996.0409; Passner JM, 2000, J MOL BIOL, V304, P847, DOI 10.1006/jmbi.2000.4231; Popovych N, 2009, P NATL ACAD SCI USA, V106, P6927, DOI 10.1073/pnas.0900595106; Reddy V, 2003, ACTA CRYSTALLOGR D, V59, P2200, DOI 10.1107/S0907444903020316; Rickman L, 2005, MOL MICROBIOL, V56, P1274, DOI 10.1111/j.1365-2958.2005.04609.x; RYU S, 1993, P NATL ACAD SCI USA, V90, P75, DOI 10.1073/pnas.90.1.75; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; SCHULTZ SC, 1991, SCIENCE, V253, P1001, DOI 10.1126/science.1653449; Spreadbury CL, 2005, MICROBIOL-SGM, V151, P547, DOI 10.1099/mic.0.27444-0; Tutar Y, 2008, CELL BIOCHEM FUNCT, V26, P399, DOI 10.1002/cbf.1462; Ulrichs T, 2006, J PATHOL, V208, P261, DOI 10.1002/path.1906; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wang JW, 2004, ACTA CRYSTALLOGR D, V60, P1244, DOI 10.1107/S0907444904010674; WAYNE LG, 1994, EUR J CLIN MICROBIOL, V13, P908, DOI 10.1007/BF02111491; WEBER IT, 1982, P NATL ACAD SCI-BIOL, V79, P7679, DOI 10.1073/pnas.79.24.7679; Won HS, 2002, J BIOL CHEM, V277, P11450, DOI 10.1074/jbc.M112411200; Won HS, 2008, J BIOCHEM, V143, P163, DOI 10.1093/jb/mvm238; Won HS, 2009, BBA-PROTEINS PROTEOM, V1794, P1299, DOI 10.1016/j.bbapap.2009.04.015; Yu SN, 2004, BIOCHEMISTRY-US, V43, P4662, DOI 10.1021/bi0362166	41	28	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36581	36591		10.1074/jbc.M109.041343	http://dx.doi.org/10.1074/jbc.M109.041343			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19740754	Green Published, hybrid			2022-12-27	WOS:000272970500059
J	Pope, AJ; Karrupiah, K; Kearns, PN; Xia, Y; Cardounel, AJ				Pope, Arthur J.; Karrupiah, Kanchana; Kearns, Patrick N.; Xia, Yong; Cardounel, Arturo J.			Role of Dimethylarginine Dimethylaminohydrolases in the Regulation of Endothelial Nitric Oxide Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORONARY-ARTERY-DISEASE; ASYMMETRIC DIMETHYLARGININE; ENDOGENOUS METHYLARGININES; MEDIATED INHIBITION; ARGININE ADMA; DYSFUNCTION; OVEREXPRESSION; EXPRESSION; SYNTHASE; PATHWAY	Reduced NO is a hallmark of endothelial dysfunction, and among the mechanisms for impaired NO synthesis is the accumulation of the endogenous nitric-oxide synthase inhibitor asymmetric dimethylarginine (ADMA). Free ADMA is actively metabolized by the intracellular enzyme dimethylarginine dimethylaminohydrolase (DDAH), which catalyzes the conversion of ADMA to citrulline. Decreased DDAH expression/activity is evident in disease states associated with endothelial dysfunction and is believed to be the mechanism responsible for increased methylarginines and sub-sequent ADMA-mediated endothelial nitric-oxide synthase impairment. Two isoforms of DDAH have been identified; however, it is presently unclear which is responsible for endothelial ADMA metabolism and NO regulation. The current study investigated the effects of both DDAH-1 and DDAH-2 in the regulation of methylarginines and endothelial NO generation. Results demonstrated that overexpression of DDAH-1 and DDAH-2 increased endothelial NO by 24 and 18%,respectively. Moreover, small interfering RNA-mediated down-regulation of DDAH-1 and DDAH-2 reduced NO bioavailability by 27 and 57%, respectively. The reduction in NO production following DDAH-1 gene silencing was associated with a 48% reduction in L-Arg/ADMA and was partially restored with L-Arg supplementation. In contrast, L-Arg/ADMA was unchanged in the DDAH-2-silenced cells, and L-Arg supplementation had no effect on NO. These results clearly demonstrate that DDAH-1 and DDAH-2 manifest their effects through different mechanisms, the former of which is largely ADMA-dependent and the latter ADMA-independent. Overall, the present study demonstrates an important regulatory role for DDAH in the maintenance of endothelial function and identifies this pathway as a potential target for treating diseases associated with decreased NO bioavailability.	[Cardounel, Arturo J.] Univ Florida, Dept Physiol & Funct Genom, Coll Med, Gainesville, FL 32607 USA; [Xia, Yong] Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA	State University System of Florida; University of Florida; University System of Ohio; Ohio State University	Cardounel, AJ (corresponding author), Univ Florida, Dept Physiol & Funct Genom, Coll Med, 1600 SW Archer Rd,M552, Gainesville, FL 32607 USA.	cardounel.1@ufl.edu			National Institutes of Health [HL081734, F31H90027]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081734] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL081734 and F31H90027.	Achan V, 2003, ARTERIOSCL THROM VAS, V23, P1455, DOI 10.1161/01.ATV.0000081742.92006.59; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Birdsey GM, 2000, ACTA PHYSIOL SCAND, V168, P73; Boger GI, 2007, J AM COLL CARDIOL, V49, P2274, DOI 10.1016/j.jacc.2007.02.051; Boger RH, 2001, CLIN SCI, V100, P161, DOI 10.1042/CS20000173; Boger RH, 2000, ARTERIOSCL THROM VAS, V20, P1557, DOI 10.1161/01.ATV.20.6.1557; Boulanger MC, 2005, J VIROL, V79, P124, DOI 10.1128/JVI.79.1.124-131.2005; Cardounel AJ, 2007, J BIOL CHEM, V282, P879, DOI 10.1074/jbc.M603606200; Cooke JP, 2000, ARTERIOSCL THROM VAS, V20, P2032, DOI 10.1161/01.ATV.20.9.2032; Dayal S, 2008, AM J PHYSIOL-HEART C, V295, pH816, DOI 10.1152/ajpheart.01348.2007; Dayoub H, 2008, STROKE, V39, P180, DOI 10.1161/STROKEAHA.107.490631; Forbes SP, 2008, BIOCHEMISTRY-US, V47, P1819, DOI 10.1021/bi701659n; GRAY GA, 2009, ACTA HISTOC IN PRESS; GRIFFITH TM, 1984, NATURE, V308, P645, DOI 10.1038/308645a0; Hong L, 2007, J BIOL CHEM, V282, P34684, DOI 10.1074/jbc.M707231200; Ito A, 1999, CIRCULATION, V99, P3092, DOI 10.1161/01.CIR.99.24.3092; Jacobi J, 2005, CIRCULATION, V111, P1431, DOI 10.1161/01.CIR.0000158487.80483.09; Leiper J, 1999, CARDIOVASC RES, V43, P542, DOI 10.1016/S0008-6363(99)00162-5; Leiper J, 2007, NAT MED, V13, P198, DOI 10.1038/nm1543; Leiper JM, 1999, BIOCHEM J, V343, P209, DOI 10.1042/0264-6021:3430209; Lin KY, 2002, CIRCULATION, V106, P987, DOI 10.1161/01.CIR.0000027109.14149.67; Maas R, 2007, CRIT CARE MED, V35, P1876, DOI 10.1097/01.CCM.0000277038.11630.71; Maas R, 2007, CLIN CHEM, V53, P693, DOI 10.1373/clinchem.2006.081893; Maas R, 2007, ATHEROSCLEROSIS, V191, P211, DOI 10.1016/j.atherosclerosis.2006.03.024; Onozato ML, 2008, DIABETES, V57, P172, DOI 10.2337/db06-1772; Palm F, 2007, AM J PHYSIOL-HEART C, V293, pH3227, DOI 10.1152/ajpheart.00998.2007; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Pope AJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1679, DOI 10.1152/ajpcell.00224.2007; Potena L, 2008, TRANSPLANTATION, V85, P827, DOI 10.1097/TP.0b013e318166a3a4; Schulze F, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.06.005; Simon A, 2003, CIRC RES, V93, P813, DOI 10.1161/01.RES.0000097761.19223.0D; Smith CL, 2003, BIOCHEM BIOPH RES CO, V308, P984, DOI 10.1016/S0006-291X(03)01507-9; Stuhlinger MC, 2007, CARDIOVASC RES, V75, P417, DOI 10.1016/j.cardiores.2007.04.030; Sydow K, 2008, ARTERIOSCL THROM VAS, V28, P692, DOI 10.1161/ATVBAHA.108.162073; Tanaka M, 2005, CIRCULATION, V112, P1549, DOI 10.1161/CIRCULATIONAHA.105.537670; Tran CTL, 2003, ATHEROSCLEROSIS SUPP, V4, P33, DOI 10.1016/S1567-5688(03)00032-1; Vallance P, 2004, ARTERIOSCL THROM VAS, V24, P1023, DOI 10.1161/01.ATV.0000128897.54893.26; Vallance P, 2005, J AM SOC NEPHROL, V16, P2254, DOI 10.1681/ASN.2005050539; Volti GL, 2008, ANESTHESIOLOGY, V109, P1054, DOI 10.1097/ALN.0b013e31818d8a77; Wang D, 2007, CIRC RES, V101, P627, DOI 10.1161/CIRCRESAHA.107.158915; Wojciak-Stothard B, 2007, J CELL SCI, V120, P929, DOI 10.1242/jcs.002212; Zakrzewicz Dariusz, 2009, BMC Pulm Med, V9, P5, DOI 10.1186/1471-2466-9-5; Zoccali C, 2007, NEPHROL DIAL TRANSPL, V22, P801, DOI 10.1093/ndt/gfl719	43	66	68	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35338	35347		10.1074/jbc.M109.037036	http://dx.doi.org/10.1074/jbc.M109.037036			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19820234	Green Published, hybrid			2022-12-27	WOS:000272645600010
J	Tomar, A; George, SP; Mathew, S; Khurana, S				Tomar, Alok; George, Sundeep P.; Mathew, Sijo; Khurana, Seema			Differential Effects of Lysophosphatidic Acid and Phosphatidylinositol 4,5-Bisphosphate on Actin Dynamics by Direct Association with the Actin-binding Protein Villin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-CELL MIGRATION; PHOSPHOLIPASE C-GAMMA(1); PHOSPHATIDIC-ACID; PPAR-GAMMA; GELSOLIN; LPA; LYSOPHOSPHOLIPIDS; IDENTIFICATION; ACTIVATION; MOTILITY	We have previously reported that the epithelial cell-specific actin-binding protein villin directly associates with phosphatidylinositol 4,5-bisphosphate (PIP2) through three binding sites that overlap with actin-binding sites in villin. As a result, association of villin with PIP2 inhibits actin depolymerization and enhances actin cross-linking by villin. In this study, we demonstrate that these three PIP2-binding sites also bind the more hydrophilic phospholipid, lysophosphatidic acid (LPA) but with a higher affinity than PIP2 (dissociation constant (K-d) of 22 mu M versus 39.5 mu M for PIP2). More interestingly, unlike PIP2, the association of villin with LPA inhibits all actin regulatory functions of villin. In addition, unlike PIP2, LPA dramatically stimulates the tyrosine phosphorylation of villin by c-Src kinase. These studies suggest that in cells, selective interaction of villin with either PIP2 or LPA could have dramatically different outcomes on actin reorganization as well as phospholipid-regulated cell signaling. These studies provide a novel regulatory mechanism for phospholipid-induced changes in the microfilament structure and cell function and suggest that LPA could be an intracellular regulator of the actin cytoskeleton.	[Tomar, Alok; George, Sundeep P.; Mathew, Sijo; Khurana, Seema] Univ Tennessee, Dept Physiol, Hlth Sci Ctr, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Khurana, S (corresponding author), Univ Tennessee, Dept Physiol, Hlth Sci Ctr, Nash 402,894 Union Ave, Memphis, TN 38163 USA.	skhurana@utmem.edu		Khurana, Seema/0000-0002-6884-810X	NIDDK [DK-65006, DK-54755, DK-81408]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054755, R01DK065006, R01DK081408] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-65006, DK-54755, and DK-81408 (to S. K.) through the NIDDK.	AHMED S, 1993, J BIOL CHEM, V268, P10709; Aoki J, 2004, SEMIN CELL DEV BIOL, V15, P477, DOI 10.1016/j.semcdb.2004.05.001; Chemin J, 2005, J BIOL CHEM, V280, P4415, DOI 10.1074/jbc.M408246200; CHETTIBI S, 1994, FEMS IMMUNOL MED MIC, V8, P271, DOI 10.1016/0928-8244(94)90059-0; DeCorte V, 1997, FEBS LETT, V401, P191, DOI 10.1016/S0014-5793(96)01471-8; Dubuquoy L, 2006, GUT, V55, P1341, DOI 10.1136/gut.2006.093484; George SP, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703617200; Gilmore AP, 1996, NATURE, V381, P531, DOI 10.1038/381531a0; Harris ES, 2006, J BIOL CHEM, V281, P14383, DOI 10.1074/jbc.M510923200; Kalari S, 2009, AM J PHYSIOL-LUNG C, V296, pL328, DOI 10.1152/ajplung.90431.2008; Khurana S, 2008, FEBS LETT, V582, P2128, DOI 10.1016/j.febslet.2008.02.040; Kooijman EE, 2005, BIOCHEMISTRY-US, V44, P2097, DOI 10.1021/bi0478502; Kranenburg O, 1999, MOL BIOL CELL, V10, P1851, DOI 10.1091/mbc.10.6.1851; Kumar N, 2004, J BIOL CHEM, V279, P24915, DOI 10.1074/jbc.C400110200; Kumar N, 2004, J BIOL CHEM, V279, P3096, DOI 10.1074/jbc.M308878200; LAUENER R, 1995, BIOCHEM BIOPH RES CO, V215, P8, DOI 10.1006/bbrc.1995.2427; Louvard RAD, 2003, MOL BIOL CELL, V14, P4641, DOI 10.1091/mbc.E03-02-0091; McIntyre TM, 2003, P NATL ACAD SCI USA, V100, P131, DOI 10.1073/pnas.0135855100; Meerschaert K, 1998, EMBO J, V17, P5923, DOI 10.1093/emboj/17.20.5923; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Mintzer E, 2006, BBA-BIOMEMBRANES, V1758, P85, DOI 10.1016/j.bbamem.2005.12.009; Murph M, 2006, CLIN CANCER RES, V12, P6598, DOI 10.1158/1078-0432.CCR-06-1721; Nam JO, 2005, CANCER RES, V65, P4153, DOI 10.1158/0008-5472.CAN-04-2705; Niggli V, 2006, ADV MOL CEL, V37, P221, DOI 10.1016/S1569-2558(06)37011-7; Panebra A, 2001, AM J PHYSIOL-CELL PH, V281, pC1046, DOI 10.1152/ajpcell.2001.281.3.C1046; Rivera R, 2008, REV PHYSIOL BIOCH P, V160, P25, DOI 10.1007/112_0507; Sakisaka T, 1997, MOL CELL BIOL, V17, P3841, DOI 10.1128/MCB.17.7.3841; Sando JJ, 1996, BIOCHEM J, V317, P583, DOI 10.1042/bj3170583; Sengupta S, 2004, SEMIN CELL DEV BIOL, V15, P503, DOI 10.1016/j.semcdb.2004.05.003; Tomar A, 2004, MOL BIOL CELL, V15, P4807, DOI 10.1091/mbc.E04-05-0431; Tomar A, 2006, J BIOL CHEM, V281, P31972, DOI 10.1074/jbc.M604323200; Wang YH, 2007, AM J PHYSIOL-CELL PH, V292, pC1775, DOI 10.1152/ajpcell.00420.2006; Waters CM, 2006, BIOCHEM J, V398, P55, DOI 10.1042/BJ20060155; WATSON SP, 1985, BIOCHEM J, V232, P61, DOI 10.1042/bj2320061	34	16	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35278	35282		10.1074/jbc.C109.060830	http://dx.doi.org/10.1074/jbc.C109.060830			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19808673	Green Published, hybrid			2022-12-27	WOS:000272645600003
J	Rosen, D; Lewis, AM; Mizote, A; Thomas, JM; Aley, PK; Vasudevan, SR; Parkesh, R; Galione, A; Izumi, M; Ganesan, A; Churchill, GC				Rosen, Daniel; Lewis, Alexander M.; Mizote, Akiko; Thomas, Justyn M.; Aley, Parvinder K.; Vasudevan, Sridhar R.; Parkesh, Raman; Galione, Antony; Izumi, Minoru; Ganesan, A.; Churchill, Grant C.			Analogues of the Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP) Antagonist Ned-19 Indicate Two Binding Sites on the NAADP Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ RELEASE; MOBILIZES CALCIUM; INACTIVATION; COORDINATION; METABOLITE; ORGANELLES; CHANNEL; CELLS; CA-2+	Nicotinic acid adenine dinucleotide phosphate (NAADP) is a Ca2+-releasing messenger. Biological data suggest that its receptor has two binding sites: one high-affinity locking site and one low-affinity opening site. To directly address the presence and function of these putative binding sites, we synthesized and tested analogues of the NAADP antagonist Ned-19. Ned-19 itself inhibits both NAADP-mediated Ca2+ release and NAADP binding. A fluorometry bioassay was used to assess NAADP-mediated Ca2+ release, whereas a radioreceptor assay was used to assess binding to the NAAD Preceptor (only at the high-affinity site). In Ned-20, the fluorine is para rather than ortho as in Ned-19. Ned-20 does not inhibit NAADP-mediated Ca2+ release but inhibits NAADP binding. Conversely, Ned-19.4 (a methyl ester of Ned-19) inhibits NAADP-mediated Ca2+ release but cannot inhibit NAADP binding. Furthermore, Ned-20 prevents the self-desensitization response characteristic of NAADP in sea urchin eggs, confirming that this response is mediated by a high-affinity allosteric site to which NAADP binds in the radioreceptor assay. Collectively, these data provide the first direct evidence for two binding sites (one high-and one low affinity) on the NAADP receptor.	[Rosen, Daniel; Lewis, Alexander M.; Thomas, Justyn M.; Aley, Parvinder K.; Vasudevan, Sridhar R.; Parkesh, Raman; Galione, Antony; Churchill, Grant C.] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; [Ganesan, A.] Univ Southampton, Dept Chem, Southampton SO17 1BJ, Hants, England; [Mizote, Akiko; Izumi, Minoru] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan	University of Oxford; University of Southampton; Okayama University	Churchill, GC (corresponding author), Univ Oxford, Dept Pharmacol, Mansfield Rd, Oxford OX1 3QT, England.	grant.churchill@pharm.ox.ac.uk	Ganesan, A/F-6698-2011; Galione, Antony/E-5884-2011; Vasudevan, Sridhar/B-1841-2015	Vasudevan, Sridhar/0000-0003-0516-2984; Ganesan, A/0000-0003-4862-7999; Aley, Parvinder/0000-0002-0749-8329; Galione, Antony/0000-0002-4132-7646	Biotechnology and Biological Sciences Research Council [BB/G008523/1]; BBSRC [BB/G008523/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grant BB/G008523/1.	Aarhus R, 1996, J BIOL CHEM, V271, P8513, DOI 10.1074/jbc.271.15.8513; Aarhus R, 1995, J BIOL CHEM, V270, P30327, DOI 10.1074/jbc.270.51.30327; Berg I, 2000, J CELL BIOL, V150, P581, DOI 10.1083/jcb.150.3.581; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Billington RA, 2000, BIOCHEM BIOPH RES CO, V276, P112, DOI 10.1006/bbrc.2000.3444; Billington RA, 2005, CELL CALCIUM, V37, P81, DOI 10.1016/j.ceca.2004.06.009; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cancela JM, 1999, NATURE, V398, P74, DOI 10.1038/18032; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; Churamani D, 2006, BIOCHEM J, V397, P313, DOI 10.1042/BJ20060179; Churchill GC, 2001, J BIOL CHEM, V276, P11223, DOI 10.1074/jbc.M009335200; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; CLAPPER DL, 1987, J BIOL CHEM, V262, P9561; Dammermann W, 2009, P NATL ACAD SCI USA, V106, P10678, DOI 10.1073/pnas.0809997106; DARGIE PJ, 1990, CELL REGUL, V1, P279, DOI 10.1091/mbc.1.3.279; Galione A, 2006, BIOCHEM SOC T, V34, P922, DOI 10.1042/BST0340922; Galione A, 2004, BRIT J PHARMACOL, V142, P1203, DOI 10.1038/sj.bjp.0705888; Galione A, 2002, CELL CALCIUM, V32, P343, DOI 10.1016/S0143416002001902; Galione A, 2005, CELL CALCIUM, V38, P273, DOI 10.1016/j.ceca.2005.06.031; Genazzani AA, 1997, J BIOL CHEM, V272, P7669, DOI 10.1074/jbc.272.12.7669; Genazzani AA, 1996, J BIOL CHEM, V271, P11599, DOI 10.1074/jbc.271.20.11599; Guse AH, 2009, CURR BIOL, V19, pR521, DOI 10.1016/j.cub.2009.05.045; Guse AH, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.144re10; Hohenegger M, 2002, BIOCHEM J, V367, P423, DOI 10.1042/BJ20020584; Kenakin T, 2003, TRENDS PHARMACOL SCI, V24, P346, DOI 10.1016/S0165-6147(03)00167-6; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; Lee HC, 2000, J CELL SCI, V113, P4413; LEE HC, 1989, J BIOL CHEM, V264, P1608; Lee HC, 2005, J BIOL CHEM, V280, P33693, DOI 10.1074/jbc.R500012200; Lewis AM, 2007, ANAL BIOCHEM, V371, P26, DOI 10.1016/j.ab.2007.08.030; MORGAN AJ, 2006, CALCIUM SIGNALING, P265; Naylor E, 2009, NAT CHEM BIOL, V5, P220, DOI 10.1038/nchembio.150; Parkesh R, 2008, CELL CALCIUM, V43, P531, DOI 10.1016/j.ceca.2007.08.006; Patel S, 2001, TRENDS BIOCHEM SCI, V26, P482, DOI 10.1016/S0968-0004(01)01896-5; Patel S, 2000, BIOCHEM J, V352, P725, DOI 10.1042/0264-6021:3520725; STREB H, 1983, NATURE, V306, P67, DOI 10.1038/306067a0; Watson C, 2005, MOL PHARMACOL, V67, P1268, DOI 10.1124/mol.104.008565; Zhang F, 2007, J BIOL CHEM, V282, P25259, DOI 10.1074/jbc.M701614200; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	40	34	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34930	34934		10.1074/jbc.M109.016519	http://dx.doi.org/10.1074/jbc.M109.016519			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19826006	Green Published, hybrid			2022-12-27	WOS:000272439600048
J	Song, XZ; Lasanajak, Y; Olson, LJ; Boonen, M; Dahms, NM; Kornfeld, S; Cummings, RD; Smith, DF				Song, Xuezheng; Lasanajak, Yi; Olson, Linda J.; Boonen, Marielle; Dahms, Nancy M.; Kornfeld, Stuart; Cummings, Richard D.; Smith, David F.			Glycan Microarray Analysis of P-type Lectins Reveals Distinct Phosphomannose Glycan Recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANNOSE 6-PHOSPHATE RECEPTOR; ACETYLGLUCOSAMINELYSOSOMAL-ENZYME N-ACETYLGLUCOSAMINE-1-PHOSPHOTRANSFERASE; ALPHA-N-ACETYLGLUCOSAMINIDASE; RICINUS-COMMUNIS AGGLUTININ; PANCREATIC RIBONUCLEASE-B; LYSOSOMAL-ENZYMES; CARBOHYDRATE-RECOGNITION; CONCANAVALIN-A; STRUCTURAL DETERMINANTS; LIGAND INTERACTIONS	The specificity of the cation-independent and -dependent mannose 6-phosphate receptors (CI-MPR and CD-MPR) for high mannose-type N-glycans of defined structure containing zero, one, or two Man-P-GlcNAc phosphodiester or Man-6-P phosphomonoester residues was determined by analysis on a phosphorylated glycan microarray. Amine-activated glycans were covalently printed on N-hydroxysuccinimide-activated glass slides and interrogated with different concentrations of recombinant CD-MPR or soluble CI-MPR. Neither receptor bound to non-phosphorylated glycans. The CD-MPR bound weakly or undetectably to the phosphodiester derivatives, but strongly to the phosphomonoester-containing glycans with the exception of a single Man7GlcNAc2-R isomer that contained a single Man-6-P residue. By contrast, the CI-MPR bound with high affinity to glycans containing either phospho-mono- or -diesters although, like the CD-MPR, it differentially recognized isomers of phosphorylated Man7GlcNAc2-R. This differential recognition of phosphorylated glycans by the CI- and CD-MPRs has implications for understanding the biosynthesis and targeting of lysosomal hydrolases.	[Smith, David F.] Emory Univ, Dept Biochem, Sch Med, O Wayne Rollins Res Ctr, Atlanta, GA 30322 USA; [Olson, Linda J.; Dahms, Nancy M.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Boonen, Marielle; Kornfeld, Stuart] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA	Emory University; Medical College of Wisconsin; Washington University (WUSTL)	Smith, DF (corresponding author), Emory Univ, Dept Biochem, Sch Med, O Wayne Rollins Res Ctr, 1510 Clifton Rd,Rm 4035, Atlanta, GA 30322 USA.	dfsmith@emory.edu			National Institutes of Health [R01DK42667, CA08759, GM085448]; NATIONAL CANCER INSTITUTE [R37CA008759, R01CA008759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042667] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK42667 (to N.M.D.), CA08759 (to S.K.), and GM085448 (to D.F.S.).	BAENZIGER JU, 1979, J BIOL CHEM, V254, P2400; BAENZIGER JU, 1979, J BIOL CHEM, V254, P9795; Bao M, 1996, J BIOL CHEM, V271, P31437, DOI 10.1074/jbc.271.49.31437; Bao M, 1996, J BIOL CHEM, V271, P31446, DOI 10.1074/jbc.271.49.31446; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Bohnsack RN, 2009, J BIOL CHEM, V284, P35215, DOI 10.1074/jbc.M109.056184; Boonen M, 2009, MOL BIOL CELL, V20, P4381, DOI 10.1091/mbc.E09-05-0398; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; BRENCKLE R, 1980, ARCH BIOCHEM BIOPHYS, V201, P160, DOI 10.1016/0003-9861(80)90499-3; BREWER CF, 1986, J BIOL CHEM, V261, P7306; Chavez CA, 2007, BIOCHEMISTRY-US, V46, P12604, DOI 10.1021/bi7011806; Dahms NM, 2008, GLYCOBIOLOGY, V18, P664, DOI 10.1093/glycob/cwn061; Dahms NM, 2002, BBA-GEN SUBJECTS, V1572, P317, DOI 10.1016/S0304-4165(02)00317-3; DORLAND L, 1981, J BIOL CHEM, V256, P7708; Feizi T, 2003, CURR OPIN STRUC BIOL, V13, P637, DOI 10.1016/j.sbi.2003.09.002; Gary-Bobo M, 2007, CURR MED CHEM, V14, P2945, DOI 10.2174/092986707782794005; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; GORDON JA, 1972, FEBS LETT, V24, P193, DOI 10.1016/0014-5793(72)80765-8; Hancock MK, 2002, J BIOL CHEM, V277, P47205, DOI 10.1074/jbc.M208534200; HILLEREHFELD A, 1995, BBA-REV BIOMEMBRANES, V1241, P177, DOI 10.1016/0304-4157(95)00004-B; Hosokawa N, 2009, J BIOL CHEM, V284, P17061, DOI 10.1074/jbc.M809725200; Kornfeld R, 1998, J BIOL CHEM, V273, P23203, DOI 10.1074/jbc.273.36.23203; Kornfeld R, 1999, J BIOL CHEM, V274, P32778, DOI 10.1074/jbc.274.46.32778; KORNFELD S, 1986, J CLIN INVEST, V77, P1, DOI 10.1172/JCI112262; KORNFELD S, 1987, FASEB J, V1, P462, DOI 10.1096/fasebj.1.6.3315809; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; LIANG CJ, 1980, J BIOCHEM-TOKYO, V88, P51; Liang PH, 2008, CURR OPIN CHEM BIOL, V12, P86, DOI 10.1016/j.cbpa.2008.01.031; Munro S, 2001, CURR BIOL, V11, pR499, DOI 10.1016/S0960-9822(01)00302-5; NARASIMHAN S, 1986, CARBOHYD RES, V149, P65, DOI 10.1016/S0008-6215(00)90370-7; NATOWICZ M, 1982, J BIOL CHEM, V257, P4412; Olson LJ, 2004, J BIOL CHEM, V279, P34000, DOI 10.1074/jbc.M404588200; PLUMMER TH, 1968, J BIOL CHEM, V243, P5158; PLUMMER TH, 1964, J BIOL CHEM, V239, P2530; Prien JM, 2009, J AM SOC MASS SPECTR, V20, P539, DOI 10.1016/j.jasms.2008.11.012; Qian MQ, 2008, MOL CELL PROTEOMICS, V7, P58, DOI 10.1074/mcp.M700217-MCP200; Reddy ST, 2004, J BIOL CHEM, V279, P38658, DOI 10.1074/jbc.M407474200; REITMAN ML, 1981, J BIOL CHEM, V256, P4275; Roberts DL, 1998, CELL, V93, P639, DOI 10.1016/S0092-8674(00)81192-7; Schimanski LM, 2009, BLOOD CELL MOL DIS, V43, P180, DOI 10.1016/j.bcmd.2009.03.010; Song XZ, 2009, CHEM BIOL, V16, P36, DOI 10.1016/j.chembiol.2008.11.004; STEIN M, 1987, EMBO J, V6, P2677, DOI 10.1002/j.1460-2075.1987.tb02559.x; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; Sun GJ, 2005, GLYCOBIOLOGY, V15, P1136, DOI 10.1093/glycob/cwi098; TABAS I, 1980, J BIOL CHEM, V255, P6633; TONG PY, 1989, J BIOL CHEM, V264, P7962; TONG PY, 1989, J BIOL CHEM, V264, P7970; VARKI A, 1983, J BIOL CHEM, V258, P2808; VARKI A, 1980, J BIOL CHEM, V255, P847; von Figura K, 1991, Curr Opin Cell Biol, V3, P642, DOI 10.1016/0955-0674(91)90035-W; Wang DN, 2003, PROTEOMICS, V3, P2167, DOI 10.1002/pmic.200300601; Zhao KW, 1997, J BIOL CHEM, V272, P22758, DOI 10.1074/jbc.272.36.22758	52	51	56	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					35201	35214		10.1074/jbc.M109.056119	http://dx.doi.org/10.1074/jbc.M109.056119			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19801653	Green Published, hybrid			2022-12-27	WOS:000272439600073
J	Li, Y; Trojer, P; Xu, CF; Cheung, P; Kuo, A; Drury, WJ; Qiao, Q; Neubert, TA; Xu, RM; Gozani, O; Reinberg, D				Li, Yan; Trojer, Patrick; Xu, Chong-Feng; Cheung, Peggie; Kuo, Alex; Drury, William J., III; Qiao, Qi; Neubert, Thomas A.; Xu, Rui-Ming; Gozani, Or; Reinberg, Danny			The Target of the NSD Family of Histone Lysine Methyltransferases Depends on the Nature of the Substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; WOLF-HIRSCHHORN-SYNDROME; NUCLEOSOME CORE PARTICLE; SYNDROME CRITICAL REGION; ACUTE MYELOID-LEUKEMIA; DOMAIN-CONTAINING GENE; H3K36 METHYLATION; MULTIPLE-MYELOMA; TRANSCRIPTIONAL ELONGATION; RECOMBINANT HISTONES	The NSD (nuclear receptor SET domain-containing) family of histone lysine methyltransferases is a critical participant in chromatin integrity as evidenced by the number of human diseases associated with the aberrant expression of its family members. Yet, the specific targets of these enzymes are not clear, with marked discrepancies being reported in the literature. We demonstrate that NSD2 can exhibit disparate target preferences based on the nature of the substrate provided. The NSD2 complex purified from human cells and recombinant NSD2 both exhibit specific targeting of histone H3 lysine 36 (H3K36) when provided with nucleosome substrates, but histone H4 lysine 44 is the primary target in the case of octamer substrates, irrespective of the histones being native or recombinant. This disparity is negated when NSD2 is presented with octamer targets in conjunction with short single- or double-stranded DNA. Although the octamers cannot form nucleosomes, the target is nonetheless nucleosome-specific as is the product, dimethylated H3K36. This study clarifies in part the previous discrepancies reported with respect to NSD targets. We propose that DNA acts as an allosteric effector of NSD2 such that H3K36 becomes the preferred target.	[Drury, William J., III; Reinberg, Danny] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; [Reinberg, Danny] NYU, Sch Med, Dept Biochem, New York, NY 10016 USA; [Xu, Chong-Feng; Neubert, Thomas A.; Xu, Rui-Ming] NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY 10016 USA; [Xu, Chong-Feng; Neubert, Thomas A.] NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA; [Cheung, Peggie; Kuo, Alex; Gozani, Or] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Xu, Rui-Ming] Chinese Acad Sci, Inst Biophys, State Key Lab Biomacromol, Beijing 100101, Peoples R China	Howard Hughes Medical Institute; New York University; New York University; New York University; New York University; Stanford University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Reinberg, D (corresponding author), 522 1st Ave,2nd Floor,Rm 211, New York, NY 10016 USA.	reinbd01@nyumc.org	Kuo, Alex/AAL-2845-2020; Gozani, Or P/I-6157-2013; xu, rui/GRX-5734-2022	Gozani, Or/0000-0002-1365-4463; Reinberg, Danny/0000-0003-4288-2016	National Institutes of Health [4R37GM037120-24, S10 RR017990, P30 NS050276, P30CA016087, GM063716]; Howard Hughes Medical Institute; Basic Research Program of China [2009CB825501]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063716, R37GM037120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS050276] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Basic Research Program of China(National Basic Research Program of China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants 4R37GM037120-24 (to D.R.), S10 RR017990, P30 NS050276, and P30CA016087 (to T.A.N.) and GM063716 (to R.M.X.). This work was also supported by a grant from the Howard Hughes Medical Institute (to D.R.) and Basic Research Program of China Grant 2009CB825501 (to R.M.X.).	Angrand PO, 2001, GENOMICS, V74, P79, DOI 10.1006/geno.2001.6524; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bell O, 2007, EMBO J, V26, P4974, DOI 10.1038/sj.emboj.7601926; Bender LB, 2006, DEVELOPMENT, V133, P3907, DOI 10.1242/dev.02584; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chesi M, 1998, BLOOD, V92, P3025, DOI 10.1182/blood.V92.9.3025.421k53_3025_3034; Dilworth FJ, 1999, P NATL ACAD SCI USA, V96, P1995, DOI 10.1073/pnas.96.5.1995; Douglas J, 2003, AM J HUM GENET, V72, P132, DOI 10.1086/345647; Du HN, 2008, GENE DEV, V22, P2786, DOI 10.1101/gad.1700008; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; Fang J, 2002, CURR BIOL, V12, P1086, DOI 10.1016/S0960-9822(02)00924-7; Gregory GD, 2007, MOL CELL BIOL, V27, P8466, DOI 10.1128/MCB.00993-07; Huang NW, 1998, EMBO J, V17, P3398, DOI 10.1093/emboj/17.12.3398; Jaju RJ, 2001, BLOOD, V98, P1264, DOI 10.1182/blood.V98.4.1264; Kang HB, 2009, FEBS LETT, V583, P1880, DOI 10.1016/j.febslet.2009.05.038; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kim JY, 2008, MOL CELL BIOL, V28, P2023, DOI 10.1128/MCB.02130-07; Kim SM, 2006, BIOCHEM BIOPH RES CO, V345, P318, DOI 10.1016/j.bbrc.2006.04.095; Kim T, 2009, CELL, V137, P259, DOI 10.1016/j.cell.2009.02.045; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; Krajewski WA, 2005, MOL CELL BIOL, V25, P1891, DOI 10.1128/MCB.25.5.1891-1899.2005; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Kurotaki N, 2002, NAT GENET, V30, P365, DOI 10.1038/ng863; Li B, 2009, J BIOL CHEM, V284, P7970, DOI 10.1074/jbc.M808220200; Li JX, 2002, J BIOL CHEM, V277, P49383, DOI 10.1074/jbc.M209294200; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1998, CURR OPIN STRUC BIOL, V8, P33, DOI 10.1016/S0959-440X(98)80007-9; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Marango J, 2008, BLOOD, V111, P3145, DOI 10.1182/blood-2007-06-092122; Nimura K, 2009, NATURE, V460, P287, DOI 10.1038/nature08086; Oda H, 2009, MOL CELL BIOL, V29, P2278, DOI 10.1128/MCB.01768-08; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Rosati R, 2002, BLOOD, V99, P3857, DOI 10.1182/blood.V99.10.3857; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Stec I, 1998, HUM MOL GENET, V7, P1071, DOI 10.1093/hmg/7.7.1071; Todoerti K, 2005, BRIT J HAEMATOL, V131, P214, DOI 10.1111/j.1365-2141.2005.05741.x; Wang GG, 2007, NAT CELL BIOL, V9, P804, DOI 10.1038/ncb1608; Wang X, 2001, J BIOL CHEM, V276, P40417, DOI 10.1074/jbc.M104765200; Wright TJ, 1997, HUM MOL GENET, V6, P317, DOI 10.1093/hmg/6.2.317; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; Youdell ML, 2008, MOL CELL BIOL, V28, P4915, DOI 10.1128/MCB.00001-08; Yuan W, 2009, J BIOL CHEM, V284, P15701, DOI 10.1074/jbc.M808431200; Zhang LW, 2004, INT J MASS SPECTROM, V234, P213, DOI 10.1016/j.ijms.2004.02.012	44	196	206	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34283	34295		10.1074/jbc.M109.034462	http://dx.doi.org/10.1074/jbc.M109.034462			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19808676	hybrid, Green Published			2022-12-27	WOS:000272165200059
J	Tuli, A; Sharma, M; Capek, HL; Naslavsky, N; Caplan, S; Solheim, JC				Tuli, Amit; Sharma, Mahak; Capek, Haley L.; Naslavsky, Naava; Caplan, Steve; Solheim, Joyce C.			Mechanism for Amyloid Precursor-like Protein 2 Enhancement of Major Histocompatibility Complex Class I Molecule Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SORTING SIGNALS; COATED PITS; ENDOCYTOSIS; PEPTIDE; EXPRESSION; CLATHRIN; APP; TRAFFICKING; ANTIGENS; APLP2	Earlier studies have demonstrated interaction of the murine major histocompatibility complex (MHC) class I molecule K-d with amyloid precursor-like protein 2 (APLP2), a ubiquitously expressed member of the amyloid precursor protein family. Our current findings indicate that APLP2 is internalized in a clathrin-dependent manner, as shown by utilization of inhibitors of the clathrin pathway. Furthermore, we demonstrated that APLP2 and K-d bind at the cell surface and are internalized together. The APLP2 cytoplasmic tail contains two overlapping consensus motifs for binding to the adaptor protein-2 complex, and mutation of a tyrosine shared by both motifs severely impaired APLP2 internalization and ability to promote K-d endocytosis. Upon increased expression of wild type APLP2, K-d molecules were predominantly directed to the lysosomes rather than recycled to the plasma membrane. These findings suggest a model in which APLP2 binds K-d at the plasma membrane, facilitates uptake of K-d in a clathrin-dependent manner, and routes the endocytosed K-d to the lysosomal degradation pathway. Thus, APLP2 has a multistep trafficking function that influences the expression of major histocompatibility complex class I molecules at the plasma membrane.	[Tuli, Amit; Capek, Haley L.; Solheim, Joyce C.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Tuli, Amit; Sharma, Mahak; Naslavsky, Naava; Caplan, Steve; Solheim, Joyce C.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Solheim, Joyce C.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Solheim, JC (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, 986805 Nebraska Med Ctr, Omaha, NE 68198 USA.	jsolheim@unmc.edu		Sharma, Mahak/0000-0002-4117-4790; Tuli, Amit/0000-0001-5476-4127	National Institutes of Health [GM57428, GM74876]; Nebraska Cancer and Smoking Disease Research; Eppley Cancer Center Pediatric Cancer Research; NATIONAL CANCER INSTITUTE [P30CA036727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074876, R01GM057428] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nebraska Cancer and Smoking Disease Research; Eppley Cancer Center Pediatric Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM57428 (to J.C.S.) and GM74876 (to S.C.), a Nebraska Cancer and Smoking Disease Research Program grant, and an Eppley Cancer Center Pediatric Cancer Research grant (to J.C.S.).	Abba MC, 2004, BREAST CANCER RES, V6, pR499, DOI 10.1186/bcr899; Boll W, 2002, TRAFFIC, V3, P590, DOI 10.1034/j.1600-0854.2002.30808.x; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Caplan S, 2002, EMBO J, V21, P2557, DOI 10.1093/emboj/21.11.2557; Cappai R, 1999, FEBS LETT, V442, P95, DOI 10.1016/S0014-5793(98)01635-4; CAPPS GG, 1989, J CELL BIOL, V108, P1317, DOI 10.1083/jcb.108.4.1317; Chiu I, 1999, P NATL ACAD SCI USA, V96, P13944, DOI 10.1073/pnas.96.24.13944; Covell DG, 2003, MOL CANCER THER, V2, P317; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; DASGUPTA JD, 1988, J IMMUNOL, V141, P2577; DESTROOPER B, 1993, J CELL BIOL, V121, P295, DOI 10.1083/jcb.121.2.295; FEUERBACH D, 1993, EMBO J, V12, P3153, DOI 10.1002/j.1460-2075.1993.tb05984.x; Gromme M, 1999, P NATL ACAD SCI USA, V96, P10326, DOI 10.1073/pnas.96.18.10326; Guo J, 1998, INVEST OPHTH VIS SCI, V39, P292; HAASS C, 1993, J BIOL CHEM, V268, P3021; Harris MR, 2001, INT IMMUNOL, V13, P1275, DOI 10.1093/intimm/13.10.1275; HOCHMAN JH, 1991, J IMMUNOL, V146, P1862; HUET C, 1980, CELL, V21, P429, DOI 10.1016/0092-8674(80)90479-1; JACOBSEN JS, 1994, J BIOL CHEM, V269, P8376; Kaether C, 2006, TRAFFIC, V7, P408, DOI 10.1111/j.1600-0854.2006.00396.x; Keyel PA, 2006, MOL BIOL CELL, V17, P4300, DOI 10.1091/mbc.E06-05-0421; LAI A, 1995, J BIOL CHEM, V270, P3565, DOI 10.1074/jbc.270.8.3565; Lai A, 1998, J BIOL CHEM, V273, P3732, DOI 10.1074/jbc.273.6.3732; Li XF, 1999, J BIOL CHEM, V274, P27249, DOI 10.1074/jbc.274.38.27249; LO ACY, 1995, J BIOL CHEM, V270, P12641, DOI 10.1074/jbc.270.21.12641; Lybarger L, 2001, J IMMUNOL, V167, P2097, DOI 10.4049/jimmunol.167.4.2097; MACHY P, 1982, P NATL ACAD SCI-BIOL, V79, P4148, DOI 10.1073/pnas.79.13.4148; MACHY P, 1987, NATURE, V328, P724, DOI 10.1038/328724a0; Maurer ME, 2006, J CELL SCI, V119, P4235, DOI 10.1242/jcs.03217; Morris CR, 2003, J BIOL CHEM, V278, P12618, DOI 10.1074/jbc.M208203200; Myers NB, 2000, J IMMUNOL, V165, P5656, DOI 10.4049/jimmunol.165.10.5656; Naslavsky N, 2004, MOL BIOL CELL, V15, P2410, DOI 10.1091/mbc.E03-10-0733; OZATO K, 1983, P NATL ACAD SCI-BIOL, V80, P2040, DOI 10.1073/pnas.80.7.2040; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Rassoulzadegan M, 1998, EMBO J, V17, P4647, DOI 10.1093/emboj/17.16.4647; REID PA, 1990, NATURE, V346, P655, DOI 10.1038/346655a0; Santos SG, 2006, J IMMUNOL, V176, P2942, DOI 10.4049/jimmunol.176.5.2942; Scheinfeld MH, 2002, J BIOL CHEM, V277, P44195, DOI 10.1074/jbc.M208110200; Sester M, 2000, J BIOL CHEM, V275, P3645, DOI 10.1074/jbc.275.5.3645; Sharma M, 2008, TRAFFIC, V9, P995, DOI 10.1111/j.1600-0854.2008.00732.x; SLUNT HH, 1994, J BIOL CHEM, V269, P2637; SMITH JD, 1993, J EXP MED, V178, P2035, DOI 10.1084/jem.178.6.2035; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; THINAKARAN G, 1995, J NEUROSCI, V15, P6314; Traub LM, 2003, J CELL BIOL, V163, P203, DOI 10.1083/jcb.200309175; TSE DB, 1984, J EXP MED, V159, P193, DOI 10.1084/jem.159.1.193; Tuli A, 2008, IMMUNOGENETICS, V60, P303, DOI 10.1007/s00251-008-0296-0; Tuli A, 2008, J IMMUNOL, V181, P1978, DOI 10.4049/jimmunol.181.3.1978; Tuli A, 2009, CANCER IMMUNOL IMMUN, V58, P1419, DOI 10.1007/s00262-009-0657-z; Turnquist HR, 2000, METH MOL B, V156, P165; VEGA MA, 1989, P NATL ACAD SCI USA, V86, P2688, DOI 10.1073/pnas.86.8.2688; Walsh DM, 2003, BIOCHEMISTRY-US, V42, P6664, DOI 10.1021/bi027375c; Wang B, 2007, P NATL ACAD SCI USA, V104, P14140, DOI 10.1073/pnas.0704070104; Wolfe MS, 2007, J CELL SCI, V120, P3157, DOI 10.1242/jcs.03481; Yu YYL, 1999, INT IMMUNOL, V11, P1897, DOI 10.1093/intimm/11.12.1897; Zhao XH, 2001, J CELL SCI, V114, P353; Zheng H, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-5	59	19	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34296	34307		10.1074/jbc.M109.039727	http://dx.doi.org/10.1074/jbc.M109.039727			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19808674	hybrid, Green Published			2022-12-27	WOS:000272165200060
J	Lee, JW; Park, E; Jeong, MS; Jeon, YJ; Eom, SH; Seol, JH; Chung, CH				Lee, Jung Wook; Park, Eunyong; Jeong, Min Sun; Jeon, Young Joo; Eom, Soo Hyun; Seol, Jae Hong; Chung, Chin Ha			HslVU ATP-dependent Protease Utilizes Maximally Six among Twelve Threonine Active Sites during Proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI HOMOLOG; CRYSTAL-STRUCTURE; 20S PROTEASOME; HSLUV PROTEASE; COMPLEX; CELL; MECHANISM; HSIU; HYDROLYSIS; ACTIVATION	HslVU is a bacterial ATP-dependent protease distantly related to eukaryotic proteasomes consisting of hexameric HslU ATPase and dodecameric HslV protease. As a homolog of the 20 S proteasome beta-subunits, HslV also uses the N-terminal threonine as the active site residue. However, unlike the proteasome that has only 6 active sites among the 14 beta-subunits, HslV has 12 active sites that could potentially contribute to proteolytic activity. Here, by using a series of HslV dodecamers containing different numbers of active sites, we demonstrate that like the proteasome, HslV with only similar to 6 active sites is sufficient to support full catalytic activity. However, a further reduction of the number of active sites leads to a proportional decrease in activity. Using proteasome inhibitors, we also demonstrate that substrate-mediated stabilization of the HslV-HslU interaction remains unchanged until the number of the active sites is decreased to similar to 6 but is gradually compromised upon further reduction. These results with a mathematical model suggest HslVU utilizes no more than 6 active sites at any given time, presumably because of the action of HslU. These results also suggest that each ATP-bound HslU subunit activates one HslV subunit and that substrate bound to the HslV active site stimulates the HslU ATPase activity by stabilizing the HslV-HslU interaction. We propose this mechanism plays an important role in supporting complete degradation of substrates while preventing wasteful ATP hydrolysis in the resting state by controlling the interaction between HslV and HslU through the catalytic engagement of the proteolytic active sites.	[Lee, Jung Wook; Park, Eunyong; Jeong, Min Sun; Jeon, Young Joo; Seol, Jae Hong; Chung, Chin Ha] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; [Eom, Soo Hyun] Gwangju Inst Sci & Technol, Dept Life Sci, Kwangju 500712, South Korea	Seoul National University (SNU); Gwangju Institute of Science & Technology (GIST)	Chung, CH (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea.	chchung@snu.ac.kr		Jeon, Young Joo/0000-0003-1004-5336	Korean Research Foundation [KRF-2005-084-C00025]; Korea Science and Engineering Foundation [M10533010001-05-N3301]	Korean Research Foundation(National Research Foundation of Korea); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation)	This work was supported by Korean Research Foundation Grant KRF-2005-084-C00025 and Korea Science and Engineering Foundation Grant M10533010001-05-N3301.	Bochtler M, 2000, NATURE, V403, P800, DOI 10.1038/35001629; Bochtler M, 1997, P NATL ACAD SCI USA, V94, P6070, DOI 10.1073/pnas.94.12.6070; Bogyo M, 1997, P NATL ACAD SCI USA, V94, P6629, DOI 10.1073/pnas.94.13.6629; BROWN BM, 1993, BIOCHEMISTRY-US, V32, P1354, DOI 10.1021/bi00056a022; Burton RE, 2005, NAT STRUCT MOL BIOL, V12, P245, DOI 10.1038/nsmb898; CREAMER LK, 1981, ARCH BIOCHEM BIOPHYS, V211, P689, DOI 10.1016/0003-9861(81)90505-1; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Huang HC, 1997, J BIOL CHEM, V272, P21364, DOI 10.1074/jbc.272.34.21364; HUISMAN O, 1984, P NATL ACAD SCI-BIOL, V81, P4490, DOI 10.1073/pnas.81.14.4490; HUISMAN O, 1981, NATURE, V290, P797, DOI 10.1038/290797a0; Ishikawa T, 2000, NATURE, V408, P667, DOI 10.1038/35047165; Kessel M, 1996, FEBS LETT, V398, P274, DOI 10.1016/S0014-5793(96)01261-6; Kleijnen MF, 2007, NAT STRUCT MOL BIOL, V14, P1180, DOI 10.1038/nsmb1335; KOZAK M, 1983, MICROBIOL REV, V47, P1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Maupin-Furlow JA, 2001, ADV APPL MICROBIOL, V50, P279, DOI 10.1016/S0065-2164(01)50008-8; MILLA ME, 1995, BIOCHEMISTRY-US, V34, P3344, DOI 10.1021/bi00010a025; Neuwald AF, 1999, GENOME RES, V9, P27; NORBY JG, 1988, METHOD ENZYMOL, V156, P116; Park E, 2008, J BIOL CHEM, V283, P33258, DOI 10.1074/jbc.M805411200; Ramachandran R, 2002, P NATL ACAD SCI USA, V99, P7396, DOI 10.1073/pnas.102188799; REDDY P, 1985, P NATL ACAD SCI USA, V82, P5656, DOI 10.1073/pnas.82.17.5656; Rohrwild M, 1996, P NATL ACAD SCI USA, V93, P5808, DOI 10.1073/pnas.93.12.5808; Rohrwild M, 1997, NAT STRUCT BIOL, V4, P133, DOI 10.1038/nsb0297-133; RUBIN DM, 1995, CURR BIOL, V5, P854, DOI 10.1016/S0960-9822(95)00172-2; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P379; SEEMULLER E, 1995, SCIENCE, V268, P579, DOI 10.1126/science.7725107; Seemuller E, 1996, NATURE, V382, P468, DOI 10.1038/382468a0; Seol JH, 1997, EUR J BIOCHEM, V247, P1143, DOI 10.1111/j.1432-1033.1997.01143.x; Seong IS, 1999, FEBS LETT, V456, P211, DOI 10.1016/S0014-5793(99)00935-7; Seong IS, 2002, J BIOL CHEM, V277, P25976, DOI 10.1074/jbc.M202793200; Sousa MC, 2000, CELL, V103, P633, DOI 10.1016/S0092-8674(00)00166-5; Sousa MC, 2002, J MOL BIOL, V318, P779, DOI 10.1016/S0022-2836(02)00145-6; Szyk A, 2006, J STRUCT BIOL, V156, P165, DOI 10.1016/j.jsb.2006.03.013; Wang J, 2001, STRUCTURE, V9, P177, DOI 10.1016/S0969-2126(01)00570-6; Wang J, 2001, STRUCTURE, V9, P1107, DOI 10.1016/S0969-2126(01)00670-0; Yakamavich JA, 2008, J MOL BIOL, V380, P946, DOI 10.1016/j.jmb.2008.05.070; Yoo SJ, 1997, FEBS LETT, V412, P57, DOI 10.1016/S0014-5793(97)00742-4; Yoo SJ, 1997, BIOCHEM BIOPH RES CO, V238, P581, DOI 10.1006/bbrc.1997.7341; Yoo SJ, 1996, J BIOL CHEM, V271, P14035, DOI 10.1074/jbc.271.24.14035	42	10	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33475	33484		10.1074/jbc.M109.045807	http://dx.doi.org/10.1074/jbc.M109.045807			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801685	hybrid, Green Published			2022-12-27	WOS:000272028500054
J	Lindsey-Boltz, LA; Sercin, O; Choi, JH; Sancar, A				Lindsey-Boltz, Laura A.; Sercin, Oezdemirhan; Choi, Jun-Hyuk; Sancar, Aziz			Reconstitution of Human Claspin-mediated Phosphorylation of Chk1 by the ATR (Ataxia Telangiectasia-mutated and Rad3-related) Checkpoint Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE CHECKPOINT; REPEATED PHOSPHOPEPTIDE MOTIFS; RAD53 ACTIVATION; PROTEIN; BINDING; TOPBP1; DOMAIN; MEC1; COMPLEX; ADAPTER	ATR (ATM and Rad3-related) initiates a DNA damage signaling pathway in human cells upon DNA damage induced by UV and UV-mimetic agents and in response to inhibition of DNA replication. Genetic data with human cells and in vitro data with Xenopus egg extracts have led to the conclusion that the kinase activity of ATR toward the signal-transducing kinase Chk1 depends on the mediator protein Claspin. Here we have reconstituted a Claspin-mediated checkpoint system with purified human proteins. We find that the ATR-dependent phosphorylation of Chk1, but not p53, is strongly stimulated by Claspin. Similarly, DNA containing bulky base adducts stimulates ATR kinase activity, and Claspin acts synergistically with damaged DNA to increase phosphorylation of Chk1 by ATR. Mutations in putative phosphorylation sites in the Chk1-binding domain of Claspin abolish its ability to mediate ATR phosphorylation of Chk1. We also find that a fragment of Claspin containing the Chk1-binding domain together with a domain conserved in the yeast Mrc1 orthologs of Claspin is sufficient for its mediator activity. This in vitro system recapitulates essential components of the genetically defined ATR-signaling pathway.	[Lindsey-Boltz, Laura A.; Sercin, Oezdemirhan; Choi, Jun-Hyuk; Sancar, Aziz] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Sancar, A (corresponding author), Univ N Carolina, Sch Med, Dept Biochem & Biophys, CB 7260, Chapel Hill, NC 27599 USA.	Aziz_Sancar@med.unc.edu	Lindsey-Boltz, Laura/A-3121-2010	Lindsey-Boltz, Laura/0000-0001-6493-8194; Sercin, Ozdemirhan/0000-0002-4893-9135	National Institutes of Health [GM32833]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032833] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM32833 ( to A. S.).	Bennett LN, 2008, BIOCHEM BIOPH RES CO, V369, P973, DOI 10.1016/j.bbrc.2008.02.154; Bennett LN, 2006, FEBS LETT, V580, P4176, DOI 10.1016/j.febslet.2006.06.071; Chen SH, 2009, J BIOL CHEM, V284, P18593, DOI 10.1074/jbc.M109.018242; Chini CCS, 2006, J BIOL CHEM, V281, P33276, DOI 10.1074/jbc.M604373200; Choi JH, 2007, P NATL ACAD SCI USA, V104, P13301, DOI 10.1073/pnas.0706013104; Choi JH, 2009, METHODS, V48, P3, DOI 10.1016/j.ymeth.2009.02.006; Choi JH, 2009, NUCLEIC ACIDS RES, V37, P1501, DOI 10.1093/nar/gkn1075; Christiano C, 2003, J BIOL CHEM, V278, P30057, DOI 10.1074/jbc.M301136200; Clarke CAL, 2005, BIOCHEM J, V388, P705, DOI 10.1042/BJ20041966; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Hashimoto Y, 2006, GENES CELLS, V11, P993, DOI 10.1111/j.1365-2443.2006.00998.x; Jeong SY, 2003, J BIOL CHEM, V278, P46782, DOI 10.1074/jbc.M304551200; Kumagai A, 2000, MOL CELL, V6, P839, DOI 10.1016/S1097-2765(00)00082-4; Kumagai A, 2003, NAT CELL BIOL, V5, P161, DOI 10.1038/ncb921; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Kumagai A, 2004, J BIOL CHEM, V279, P49599, DOI 10.1074/jbc.M408353200; Lin SY, 2004, P NATL ACAD SCI USA, V101, P6484, DOI 10.1073/pnas.0401847101; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; Liu QH, 2000, GENE DEV, V14, P1448; Liu S, 2006, MOL CELL BIOL, V26, P6056, DOI 10.1128/MCB.00492-06; Majka J, 2006, MOL CELL, V24, P891, DOI 10.1016/j.molcel.2006.11.027; Mordes DA, 2008, P NATL ACAD SCI USA, V105, P18730, DOI 10.1073/pnas.0806621105; Navadgi-Patil VM, 2008, J BIOL CHEM, V283, P35853, DOI 10.1074/jbc.M807435200; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sar F, 2004, J BIOL CHEM, V279, P39289, DOI 10.1074/jbc.M405793200; Shiotani B, 2009, MOL CELL, V33, P547, DOI 10.1016/j.molcel.2009.01.024; Sweeney FD, 2005, CURR BIOL, V15, P1364, DOI 10.1016/j.cub.2005.06.063; Yan S, 2006, J CELL BIOL, V173, P181, DOI 10.1083/jcb.200601076; Yoo HY, 2006, GENE DEV, V20, P772, DOI 10.1101/gad.1398806; Yoshioka K, 2006, MOL CELL, V22, P501, DOI 10.1016/j.molcel.2006.04.023; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001	31	39	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33107	33114		10.1074/jbc.M109.064485	http://dx.doi.org/10.1074/jbc.M109.064485			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19828454	hybrid, Green Published			2022-12-27	WOS:000272028500014
J	Oberholzer, AE; Schneider, P; Siebold, C; Baumann, U; Erni, B				Oberholzer, Anselm E.; Schneider, Philipp; Siebold, Christian; Baumann, Ulrich; Erni, Bernhard			Crystal Structure of Enzyme I of the Phosphoenolpyruvate Sugar Phosphotransferase System in the Dephosphorylated State	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRUVATE PHOSPHATE DIKINASE; N-TERMINAL DOMAIN; ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; ACETATE KINASE; BACTERIAL PHOSPHOENOLPYRUVATE; CARBOHYDRATE TRANSPORTERS; PHOSPHOCARRIER PROTEIN; LACTOCOCCUS-LACTIS; DIFFRACTION DATA	The bacterial phosphoenolpyruvate (PEP) sugar phosphotransferase system mediates sugar uptake and controls the carbon metabolism in response to carbohydrate availability. Enzyme I (EI), the first component of the phosphotransferase system, consists of an N-terminal protein binding domain (EIN) and a C-terminal PEP binding domain (EIC). EI transfers phosphate from PEP by double displacement via a histidine residue on EIN to the general phosphoryl carrier protein HPr. Here we report the 2.4 angstrom crystal structure of the homodimeric EI from Staphylococcus aureus. EIN consists of the helical hairpin HPr binding subdomain and the phosphorylatable beta alpha phospho-histidine (P-His) domain. EIC folds into an (beta alpha)(8) barrel. The dimer interface of EIC buries 1833 angstrom(2) of accessible surface per monomer and contains two Ca2+ binding sites per dimer. The structures of the S. aureus and Escherichia coli EI domains (Teplyakov, A., Lim, K., Zhu, P. P., Kapadia, G., Chen, C. C., Schwartz, J., Howard, A., Reddy, P. T., Peterkofsky, A., and Herzberg, O. (2006) Proc. Natl. Acad. Sci. U. S. A. 103, 16218-16223) are very similar. The orientation of the domains relative to each other, however, is different. In the present structure the P-His domain is docked to the HPr binding domain in an orientation appropriate for in-line transfer of the phosphate to the active site histidine of the acceptor HPr. In the E. coli structure the phospho-His of the P-His domain projects into the PEP binding site of EIC. In the S. aureus structure the crystallographic temperature factors are lower for the HPr binding domain in contact with the P-His domain and higher for EIC. In the E. coli structure it is the reverse.	[Oberholzer, Anselm E.; Schneider, Philipp; Siebold, Christian; Baumann, Ulrich; Erni, Bernhard] Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland	University of Bern	Baumann, U (corresponding author), Univ Bern, Dept Chem & Biochem, Freiestr 3, CH-3012 Bern, Switzerland.	ulrich.baumann@ibc.unibe.ch; erni@ibc.unibe.ch	Baumann, Ulrich/B-1220-2013	Siebold, Christian/0000-0002-6635-3621	Swiss National Science Foundation [3100A0-105247]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation Grant 3100A0-105247.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Barabote RD, 2005, MICROBIOL MOL BIOL R, V69, P608, DOI 10.1128/MMBR.69.4.608-634.2005; Bolhuis H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-169; Christen S, 2006, J BIOL CHEM, V281, P23129, DOI 10.1074/jbc.M603486200; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FOX DK, 1986, J BIOL CHEM, V261, P3487; FOX DK, 1986, J BIOL CHEM, V261, P3498; Garcia-Alles LF, 2003, BIOCHEMISTRY-US, V42, P4744, DOI 10.1021/bi034007f; Garcia-Alles LF, 2002, J BIOL CHEM, V277, P6934, DOI 10.1074/jbc.M110067200; Garrett DS, 1997, BIOCHEMISTRY-US, V36, P4393, DOI 10.1021/bi970221q; Garrett DS, 1999, NAT STRUCT BIOL, V6, P166; Ginsburg A, 2002, ARCH BIOCHEM BIOPHYS, V397, P273, DOI 10.1006/abbi.2001.2603; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Gorrell A, 2005, J BIOL CHEM, V280, P10731, DOI 10.1074/jbc.M412118200; Herzberg O, 1996, P NATL ACAD SCI USA, V93, P2652, DOI 10.1073/pnas.93.7.2652; Herzberg O, 2002, BIOCHEMISTRY-US, V41, P780, DOI 10.1021/bi011799+; Hesterkamp Thomas, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P309; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Klein AH, 2007, J BACTERIOL, V189, P5574, DOI 10.1128/JB.00564-07; Lahiri SD, 2003, SCIENCE, V299, P2067, DOI 10.1126/science.1082710; Liao DI, 1996, STRUCTURE, V4, P861, DOI 10.1016/S0969-2126(96)00092-5; LICALSI C, 1991, J BIOL CHEM, V266, P19519; Lim K, 2007, BIOCHEMISTRY-US, V46, P14845, DOI 10.1021/bi701848w; LUKAT GS, 1992, P NATL ACAD SCI USA, V89, P718, DOI 10.1073/pnas.89.2.718; Marquez JA, 2006, J BIOL CHEM, V281, P32508, DOI 10.1074/jbc.M513721200; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Nunn RS, 1996, J MOL BIOL, V259, P502, DOI 10.1006/jmbi.1996.0335; Oberholzer AE, 2005, J MOL BIOL, V346, P521, DOI 10.1016/j.jmb.2004.11.077; Patel HV, 2006, J BIOL CHEM, V281, P17579, DOI 10.1074/jbc.M508966200; Patel HV, 2006, J BIOL CHEM, V281, P17570, DOI 10.1074/jbc.M508965200; Peterkofsky A, 2001, J MOL MICROB BIOTECH, V3, P347; Robillard GT, 1999, BBA-REV BIOMEMBRANES, V1422, P73, DOI 10.1016/S0304-4157(99)00002-7; Saier MH, 2005, BIOCHEM SOC T, V33, P220, DOI 10.1042/BST0330220; Seok YJ, 1996, P NATL ACAD SCI USA, V93, P347, DOI 10.1073/pnas.93.1.347; Seok YJ, 1996, BIOCHEMISTRY-US, V35, P236, DOI 10.1021/bi952052k; Siebold C, 2001, FEBS LETT, V504, P104, DOI 10.1016/S0014-5793(01)02705-3; SIEBOLD C, 2002, THESIS U BERN; Suh JY, 2008, J BIOL CHEM, V283, P18980, DOI 10.1074/jbc.M802211200; Suh JY, 2006, J BIOL CHEM, V281, P8939, DOI 10.1074/jbc.M513466200; Teplyakov A, 2006, P NATL ACAD SCI USA, V103, P16218, DOI 10.1073/pnas.0607587103; Wei M, 2000, J BIOL CHEM, V275, P41156, DOI 10.1074/jbc.M006149200; WEIGEL N, 1982, J BIOL CHEM, V257, P4477; XU Y, 1995, BIOCHEMISTRY-US, V34, P2181, DOI 10.1021/bi00007a011; Xue YF, 2001, INT J SYST EVOL MICR, V51, P1335, DOI 10.1099/00207713-51-4-1335; Zurbriggen A, 2008, J BIOL CHEM, V283, P35789, DOI 10.1074/jbc.M804893200	47	18	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33169	33176		10.1074/jbc.M109.057612	http://dx.doi.org/10.1074/jbc.M109.057612			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801641	Green Published, hybrid			2022-12-27	WOS:000272028500021
J	Cesaro, E; De Cegli, R; Medugno, L; Florio, F; Grosso, M; Lupo, A; Izzo, P; Costanzo, P				Cesaro, Elena; De Cegli, Rossella; Medugno, Lina; Florio, Francesca; Grosso, Michela; Lupo, Angelo; Izzo, Paola; Costanzo, Paola			The Kruppel-like Zinc Finger Protein ZNF224 Recruits the Arginine Methyltransferase PRMT5 on the Transcriptional Repressor Complex of the Aldolase A Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEGATIVE REGULATION; SM PROTEINS; METHYLATION; EXPRESSION; COREPRESSOR; BINDING; FAMILY; DOMAIN; KAP-1; INTERACTS	Gene transcription in eukaryotes is modulated by the coordinated recruitment of specific transcription factors and chromatin-modulating proteins. Indeed, gene activation and/or repression is/are regulated by histone methylation status at specific arginine or lysine residues. In this work, by co-immunoprecipitation experiments, we demonstrate that PRMT5, a type II protein arginine methyltransferase that monomethylates and symmetrically dimethylates arginine residues, is physically associated with the Kruppel-like associated box-zinc finger protein ZNF224, the aldolase A gene repressor. Moreover, chromatin immunoprecipitation assays show that PRMT5 is recruited to the L-type aldolase A promoter and that methylation of the nucleosomes that surround the L-type promoter region occurs in vivo on the arginine 3 of histone H4. Consistent with its association to the ZNF224 repressor complex, the decrease of PRMT5 expression produced by RNA interference positively affects L-type aldolase A promoter transcription. Finally, the alternating occupancy of the L-type aldolase A promoter by the ZNF224-PRMT5 repression complex in proliferating and growth-arrested cells suggests that these regulatory proteins play a significant role during the cell cycle modulation of human aldolase A gene expression. Our data represent the first experimental evidence that protein arginine methylation plays a role in ZNF224-mediated transcriptional repression and provide novel insight into the chromatin modifications required for repression of gene transcription by Kruppel-like associated box-zinc finger proteins.	[Cesaro, Elena; De Cegli, Rossella; Medugno, Lina; Florio, Francesca; Grosso, Michela; Lupo, Angelo; Izzo, Paola; Costanzo, Paola] Univ Naples Federico 2, Dipartimento Biochim & Biotecnol Med, I-80131 Naples, Italy; [Lupo, Angelo] Univ Sannio, Fac Sci, Dipartimento Sci Biol & Ambientali, I-82100 Benevento, Italy	University of Naples Federico II; University of Sannio	Costanzo, P (corresponding author), Univ Naples Federico 2, Dipartimento Biochim & Biotecnol Med, Via S Pansini 5, I-80131 Naples, Italy.	costanzo@dbbm.unina.it	De Cegli, Rossella/ABA-4372-2020; Florio, Francesca/K-6509-2018	Florio, Francesca/0000-0001-6687-9183; CESARO, Elena/0000-0003-3931-7956; COSTANZO, Paola/0000-0002-0267-379X; De Cegli, Rossella/0000-0002-8526-8692; Izzo, Paola/0000-0003-1549-0615; Grosso, Michela/0000-0003-1664-1657	Ministero dell'Istruzione dell'Universita e della Ricerca [PRIN2004, PRIN2007]; Regione Campania	Ministero dell'Istruzione dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Regione Campania(Regione Campania)	This work was supported by the Ministero dell'Istruzione dell'Universita e della Ricerca (Grants PRIN2004 and PRIN2007) and by Regione Campania.	Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Branscombe TL, 2001, J BIOL CHEM, V276, P32971, DOI 10.1074/jbc.M105412200; Chakrabarti SK, 2002, J BIOL CHEM, V277, P13286, DOI 10.1074/jbc.M111857200; Costanzo P, 1999, FEBS LETT, V454, P61, DOI 10.1016/S0014-5793(99)00775-9; Dacwag CS, 2007, MOL CELL BIOL, V27, P384, DOI 10.1128/MCB.01528-06; Fabbrizio E, 2002, EMBO REP, V3, P641, DOI 10.1093/embo-reports/kvf136; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Hake SB, 2004, BRIT J CANCER, V90, P761, DOI 10.1038/sj.bjc.6601575; Huntley S, 2006, GENOME RES, V16, P669, DOI 10.1101/gr.4842106; Jansson M, 2008, NAT CELL BIOL, V10, P1431, DOI 10.1038/ncb1802; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kim SS, 1996, P NATL ACAD SCI USA, V93, P15299, DOI 10.1073/pnas.93.26.15299; Krebs CJ, 2005, GENOMICS, V85, P752, DOI 10.1016/j.ygeno.2005.03.004; LE DB, 1996, EMBO J, V15, P6701; Lechner MS, 2000, MOL CELL BIOL, V20, P6449, DOI 10.1128/MCB.20.17.6449-6465.2000; Lupo A, 1997, J BIOL CHEM, V272, P31641, DOI 10.1074/jbc.272.50.31641; MARGOLIN JF, 1994, P NATL ACAD SCI USA, V91, P4509, DOI 10.1073/pnas.91.10.4509; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Medugno L, 2005, GENE, V359, P35, DOI 10.1016/j.gene.2005.06.021; Medugno L, 2003, FEBS LETT, V534, P93, DOI 10.1016/S0014-5793(02)03783-3; Medugno L, 2007, GENE, V403, P125, DOI 10.1016/j.gene.2007.07.036; Meister G, 2001, CURR BIOL, V11, P1990, DOI 10.1016/S0960-9822(01)00592-9; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Pal S, 2003, MOL CELL BIOL, V23, P7475, DOI 10.1128/MCB.23.21.7475-7487.2003; Pollack BP, 1999, J BIOL CHEM, V274, P31531, DOI 10.1074/jbc.274.44.31531; Richard S, 2005, BIOCHEM J, V388, P379, DOI 10.1042/BJ20040373; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Shannon M, 2003, GENOME RES, V13, P1097, DOI 10.1101/gr.963903; Sripathy SP, 2006, MOL CELL BIOL, V26, P8623, DOI 10.1128/MCB.00487-06; Stallcup MR, 2001, ONCOGENE, V20, P3014, DOI 10.1038/sj.onc.1204325; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; WIESCHAUS E, 1984, DEV BIOL, V104, P172, DOI 10.1016/0012-1606(84)90046-0; WITZGALL R, 1994, P NATL ACAD SCI USA, V91, P4514, DOI 10.1073/pnas.91.10.4514; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	37	29	30	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32321	32330		10.1074/jbc.M109.043349	http://dx.doi.org/10.1074/jbc.M109.043349			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19741270	Green Published, hybrid			2022-12-27	WOS:000272028400014
J	Damsma, GE; Cramer, P				Damsma, Gerke E.; Cramer, Patrick			Molecular Basis of Transcriptional Mutagenesis at 8-Oxoguanine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; FIDELITY DNA-POLYMERASE; STRUCTURAL BASIS; DAMAGED DNA; ELONGATION; BYPASS; LESION; TRANSLOCATION; REPLICATION; COMPLEXES	Structure-function analysis has revealed the mechanism of yeast RNA polymerase II transcription at 8-oxoguanine (8-oxoG), the major DNA lesion resulting from oxidative stress. When polymerase II encounters 8-oxoG in the DNA template strand, it can misincorporate adenine, which forms a Hoogsteen bp with 8-oxoG at the active center. This requires rotation of the 8-oxoG base from the standard anti- to an uncommon syn-conformation, which likely occurs during 8-oxoG loading into the active site. The misincorporated adenine escapes intrinsic proofreading, resulting in transcriptional mutagenesis that is observed directly by mass spectrometric RNA analysis.	[Cramer, Patrick] Univ Munich, Dept Chem & Biochem, Gene Ctr, D-81377 Munich, Germany; Univ Munich, Dept Chem & Biochem, CIPSM, D-81377 Munich, Germany	University of Munich; University of Munich	Cramer, P (corresponding author), Univ Munich, Dept Chem & Biochem, Gene Ctr, Feodor Lynen Str 25, D-81377 Munich, Germany.	cramer@LMB.uni-muenchen.de			Deutsche Forschungsgemeinschaft; Sonderforschungsbereich [SFB646]; Transregio 5	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Sonderforschungsbereich(German Research Foundation (DFG)); Transregio 5	This work was supported in part by grants from the Deutsche Forschungsgemeinschaft, Sonderforschungsbereich SFB646, and Transregio 5. Part of this work was performed at the Swiss Light Source at the Paul Scherrer Institut (Villigen, Switzerland).	Armache KJ, 2005, J BIOL CHEM, V280, P7131, DOI 10.1074/jbc.M413038200; Brieba LG, 2004, EMBO J, V23, P3452, DOI 10.1038/sj.emboj.7600354; Broennimann C, 2006, J SYNCHROTRON RADIAT, V13, P120, DOI 10.1107/S0909049505038665; Broyde S, 2008, TRENDS BIOCHEM SCI, V33, P209, DOI 10.1016/j.tibs.2008.02.004; Brueckner F, 2008, NAT STRUCT MOL BIOL, V15, P811, DOI 10.1038/nsmb.1458; Brueckner F, 2007, SCIENCE, V315, P859, DOI 10.1126/science.1135400; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Charlet-Berguerand N, 2006, EMBO J, V25, P5481, DOI 10.1038/sj.emboj.7601403; CHEN YH, 1993, J BIOL CHEM, V268, P5849; Damsma GE, 2007, NAT STRUCT MOL BIOL, V14, P1127, DOI 10.1038/nsmb1314; Dengl S, 2009, J BIOL CHEM, V284, P21270, DOI 10.1074/jbc.M109.013847; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Freisinger E, 2004, EMBO J, V23, P1494, DOI 10.1038/sj.emboj.7600158; Hsu GW, 2004, NATURE, V431, P217, DOI 10.1038/nature02908; IZBAN MG, 1993, J BIOL CHEM, V268, P12864; Jeon C, 1996, P NATL ACAD SCI USA, V93, P13677, DOI 10.1073/pnas.93.24.13677; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kashkina E, 2006, MOL CELL, V24, P257, DOI 10.1016/j.molcel.2006.10.001; Kathe SD, 2004, J BIOL CHEM, V279, P18511, DOI 10.1074/jbc.M313598200; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Komissarova N, 2003, METHOD ENZYMOL, V371, P233; Koyama H, 2003, GENES CELLS, V8, P779, DOI 10.1046/j.1365-2443.2003.00677.x; Koyama H, 2007, GENES CELLS, V12, P547, DOI 10.1111/j.1365-2443.2007.01072.x; Krahn JM, 2003, STRUCTURE, V11, P121, DOI 10.1016/S0969-2126(02)00930-9; Kuraoka I, 2003, J BIOL CHEM, V278, P7294, DOI 10.1074/jbc.M208102200; Kuraoka I, 2007, DNA REPAIR, V6, P841, DOI 10.1016/j.dnarep.2007.01.014; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Maga G, 2007, NATURE, V447, P606, DOI 10.1038/nature05843; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Rechkoblit O, 2006, PLOS BIOL, V4, P25, DOI 10.1371/journal.pbio.0040011; Silvia TA, 2004, DNA REPAIR, V3, P483, DOI 10.1016/j.dnarep.2004.01.003; Sydow JF, 2009, MOL CELL, V34, P710, DOI 10.1016/j.molcel.2009.06.002; Thomas MJ, 1998, CELL, V93, P627, DOI 10.1016/S0092-8674(00)81191-5; Viswanathan A, 1998, J BIOL CHEM, V273, P21276, DOI 10.1074/jbc.273.33.21276; Yamaguchi Y, 2007, GENES CELLS, V12, P863, DOI 10.1111/j.1365-2443.2007.01094.x	35	54	54	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31658	31663		10.1074/jbc.M109.022764	http://dx.doi.org/10.1074/jbc.M109.022764			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19758983	Green Published, hybrid			2022-12-27	WOS:000271572700020
J	Rajavel, M; Mitra, A; Gopal, B				Rajavel, Malligarjunan; Mitra, Ashima; Gopal, Balasubramanian			Role of Bacillus subtilis BacB in the Synthesis of Bacilysin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOSYNTHESIS; DIFFRACTION; ENZYME; ACID	Bacilysin is a non-ribosomally synthesized dipeptide antibiotic that is active against a wide range of bacteria and some fungi. Synthesis of bacilysin (L-alanine-[2,3-epoxycyclohexano-4]-L-alanine) is achieved by proteins in the bac operon, also referred to as the bacABCDE (ywfBCDEF) gene cluster in B. subtilis. Extensive genetic analysis from several strains of B. subtilis suggests that the bacABC gene cluster encodes all the proteins that synthesize the epoxyhexanone ring of L-anticapsin. These data, however, were not consistent with the putative functional annotation for these proteins whereby BacA, a prephenate dehydratase along with a potential isomerase/guanylyl transferase, BacB and an oxidoreductase, BacC, could synthesize L-anticapsin. Here we demonstrate that BacA is a decarboxylase that acts on prephenate. Further, based on the biochemical characterization and the crystal structure of BacB, we show that BacB is an oxidase that catalyzes the synthesis of 2-oxo-3-(4-oxocyclohexa-2,5-dienyl)propanoic acid, a precursor to L-anticapsin. This protein is a bi-cupin, with two putative active sites each containing a bound metal ion. Additional electron density at the active site of the C-terminal domain of BacB could be interpreted as a bound phenylpyruvic acid. A significant decrease in the catalytic activity of a point variant of BacB with a mutation at the N-terminal domain suggests that the N-terminal cupin domain is involved in catalysis.	[Rajavel, Malligarjunan; Mitra, Ashima; Gopal, Balasubramanian] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Gopal, B (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	bgopal@mbu.iisc.ernet.in	Gopal, Balasubramanian/ABG-3754-2021; Gopal, Balasubramanian/K-4566-2012		Department of Science and Technology; Department of Biotechnology; Council for Scientific and Industrial Research, India	Department of Science and Technology(Department of Science & Technology (India)); Department of Biotechnology; Council for Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported in part by grants from the Department of Science and Technology, Department of Biotechnology, and the Council for Scientific and Industrial Research, India.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Agarwal G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005736; ANNATHARAMAN V, 2003, CURR OPIN CHEM BIOL, V7, P12; Anthon GE, 2003, J SCI FOOD AGR, V83, P1210, DOI 10.1002/jsfa.1525; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Dimitropoulos D., 2006, CURRENT PROTOCOLS BI, P141311; Dunwell JM, 2004, PHYTOCHEMISTRY, V65, P7, DOI 10.1016/j.phytochem.2003.08.016; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Finking R, 2004, ANNU REV MICROBIOL, V58, P453, DOI 10.1146/annurev.micro.58.030603.123615; Gopal B, 2005, BIOCHEMISTRY-US, V44, P193, DOI 10.1021/bi0484421; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Inaoka T, 2003, J BIOL CHEM, V278, P2169, DOI 10.1074/jbc.M208722200; KENIG M, 1976, J GEN MICROBIOL, V94, P37, DOI 10.1099/00221287-94-1-37; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Leslie AGW, 1999, ACTA CRYSTALLOGR D, V55, P1696, DOI 10.1107/S090744499900846X; Marahiel MA, 1997, CHEM REV, V97, P2651, DOI 10.1021/cr960029e; Rajavel M, 2006, ACTA CRYSTALLOGR F, V62, P1259, DOI 10.1107/S1744309106047087; ROSCOE J, 1966, BIOCHEM J, V99, P793, DOI 10.1042/bj0990793; SAKAJOH M, 1987, J IND MICROBIOL, V2, P201, DOI 10.1007/BF01569541; Steinborn G, 2005, ARCH MICROBIOL, V183, P71, DOI 10.1007/s00203-004-0743-8; Tabata K, 2005, J BACTERIOL, V187, P5195, DOI 10.1128/JB.187.15.5195-5202.2005; Walsh CT, 2004, SCIENCE, V303, P1805, DOI 10.1126/science.1094318; Williams A, 2003, PROTEIN ENG, V16, P913, DOI 10.1093/protein/gzg116	23	46	47	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31882	31892		10.1074/jbc.M109.014522	http://dx.doi.org/10.1074/jbc.M109.014522			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19776011	Green Published, hybrid			2022-12-27	WOS:000271572700043
J	Yuan, JS; Chen, JJ				Yuan, Jingsong; Chen, Junjie			N Terminus of CtIP Is Critical for Homologous Recombination-mediated Double-strand Break Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION PROTEIN-A; DNA-DAMAGE RESPONSE; S-PHASE CHECKPOINT; MRE11 COMPLEX; MEIOTIC RECOMBINATION; END RESECTION; BRCA1; PHOSPHORYLATION; BINDING; PATHWAY	DNA double-strand breaks (DSBs) represent one of the most lethal types of DNA damage cells encounter. CtIP (also known as RBBP8) acts together with the MRN (MRE11-RAD50-NBS1) complex to promote DNA end resection and the generation of single-stranded DNA, which is critically important for homologous recombination repair. However, it is not yet clear exactly how CtIP participates in this process. Here, we demonstrate that besides the known conserved C terminus, the N terminus of CtIP protein is also required in DSB end resection and DNA damage-induced G(2)/M checkpoint control. We further show that both termini of CtIP can interact with the MRN complex and that the N terminus of CtIP, especially residues 22-45, binds to MRN and plays a critical role in targeting CtIP to sites of DNA breaks. Collectively, our results highlight the importance of the N terminus of CtIP in directing its localization and function in DSB repair.	[Yuan, Jingsong; Chen, Junjie] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Chen, JJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA.	jchen8@mdanderson.org	Yuan, Jingsong/G-4527-2011		National Institutes of Health [CA089239, CA092312, CA100109]; United States Department of Defense; NATIONAL CANCER INSTITUTE [R01CA092312, R01CA089239, R01CA100109] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA089239, CA092312, and CA100109 (to J. C.).; Recipient of an Era of Hope Scholar Award from the United States Department of Defense and member of the Mayo Clinic Breast SPORE Program.	Anantha RW, 2008, P NATL ACAD SCI USA, V105, P12903, DOI 10.1073/pnas.0803001105; Aylon Y, 2004, DNA REPAIR, V3, P797, DOI 10.1016/j.dnarep.2004.04.013; Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Borde V, 2007, CHROMOSOME RES, V15, P551, DOI 10.1007/s10577-007-1147-9; Carson CT, 2003, EMBO J, V22, P6610, DOI 10.1093/emboj/cdg630; Chen JJ, 1998, MOL CELL, V2, P317, DOI 10.1016/S1097-2765(00)80276-2; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; Clerici M, 2005, J BIOL CHEM, V280, P38631, DOI 10.1074/jbc.M508339200; Falck J, 2002, NAT GENET, V30, P290, DOI 10.1038/ng845; Fusco C, 1998, GENOMICS, V51, P351, DOI 10.1006/geno.1998.5368; Greenberger JS, 2006, EXP HEMATOL, V34, P46; Huertas P, 2009, J BIOL CHEM, V284, P9558, DOI 10.1074/jbc.M808906200; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Lavin MF, 2004, DNA REPAIR, V3, P1515, DOI 10.1016/j.dnarep.2004.07.001; Li S, 1999, J BIOL CHEM, V274, P11334, DOI 10.1074/jbc.274.16.11334; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; Lou ZK, 2003, J BIOL CHEM, V278, P13599, DOI 10.1074/jbc.C300060200; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Olson E, 2007, MOL CELL BIOL, V27, P6053, DOI 10.1128/MCB.00532-07; Penkner A, 2007, EMBO J, V26, P5071, DOI 10.1038/sj.emboj.7601916; Petrini JHJ, 2003, TRENDS CELL BIOL, V13, P458, DOI 10.1016/S0962-8924(03)00170-3; Pierce AJ, 2001, TRENDS CELL BIOL, V11, pS52, DOI 10.1016/S0962-8924(01)02149-3; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Schaeper U, 1998, J BIOL CHEM, V273, P8549, DOI 10.1074/jbc.273.15.8549; Sugiyama T, 2006, EMBO J, V25, P5539, DOI 10.1038/sj.emboj.7601412; Takeda S, 2007, MOL CELL, V28, P351, DOI 10.1016/j.molcel.2007.10.016; Uanschou C, 2007, EMBO J, V26, P5061, DOI 10.1038/sj.emboj.7601913; Weinstock DM, 2006, METHOD ENZYMOL, V409, P524, DOI 10.1016/S0076-6879(05)09031-2; Yu X, 1998, J BIOL CHEM, V273, P25388, DOI 10.1074/jbc.273.39.25388; Yu XC, 2004, MOL CELL BIOL, V24, P9478, DOI 10.1128/MCB.24.21.9478-9486.2004; Yu XC, 2006, GENE DEV, V20, P1721, DOI 10.1101/gad.1431006; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	33	55	57	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31746	31752		10.1074/jbc.M109.023424	http://dx.doi.org/10.1074/jbc.M109.023424			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19759395	Green Published, hybrid			2022-12-27	WOS:000271572700029
J	Skinner, JR; Shew, TM; Schwartz, DM; Tzekov, A; Lepus, CM; Abumrad, NA; Wolins, NE				Skinner, James R.; Shew, Trevor M.; Schwartz, Danielle M.; Tzekov, Anatoly; Lepus, Christin M.; Abumrad, Nada A.; Wolins, Nathan E.			Diacylglycerol Enrichment of Endoplasmic Reticulum or Lipid Droplets Recruits Perilipin 3/TIP47 during Lipid Storage and Mobilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ACYL-COA; ADIPOCYTE LIPOLYSIS; PROTEIN-KINASE; MEMBRANE; CELL; DROSOPHILA; BINDING; TRIACYLGLYCEROL; STABILIZATION; BIOSYNTHESIS	Fatty acid-induced triacylglycerol synthesis produces triacylglycerol droplets with a protein coat that includes perilipin 3/TIP47 and perilipin 4/S3-12. This study addresses the following two questions. Where do lipid droplets emerge, and how are their coat proteins recruited? We show that perilipin 3- and perilipin 4-coated lipid droplets emerge along the endoplasmic reticulum (ER). Blocking membrane trafficking with AlF4- during fatty acid-induced triacylglycerol synthesis drove perilipin 3 to the tubular ER. Forskolin, which like AlF4- activates adenylate cyclase, did not redistribute perilipin 3, but when added together with AlF4- perilipin 3 was recruited to lipid droplets rather than the ER. Thus inhibiting trafficking with AlF4- redistributed perilipin 3 differently under conditions of triacylglycerol synthesis (fatty acid addition) versus hydrolysis (forskolin) suggesting a shared acylglycerol-mediated mechanism. We tested whether diacylglycerol (DG), the immediate precursor of triacylglycerol and its first hydrolytic product, affects the distribution of perilipin 3. Stabilizing DG with the DG lipase inhibitor RHC80267 enhanced the perilipin 3 recruited to lipid droplets and raised DG levels in this fraction. Treating cells with a membrane-permeable DG recruited perilipin 3 to the ER. Stabilizing DG, by blocking its hydrolysis with RHC80267 or its acylation with triacsin C, enhanced recruitment of perilipin 3 to the ER. Expressing the ER enzyme DGAT1, which removes DG by converting it to triacylglycerol, attenuated perilipin 3 DG-induced ER recruitment. Membrane-permeable DG also drove perilipin 4 and 5 onto the ER. Together the data suggest that these lipid droplet proteins are recruited to DG-enriched membranes thereby linking lipid coat proteins to the metabolic state of the cell.	[Wolins, Nathan E.] Washington Univ, Sch Med, Dept Med, Ctr Human Nutr, St Louis, MO 63110 USA; [Tzekov, Anatoly] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Abumrad, Nada A.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Wolins, NE (corresponding author), Washington Univ, Sch Med, Dept Med, Ctr Human Nutr, Campus Box 8031, St Louis, MO 63110 USA.	nwolins@wustl.edu			National Institutes of Health [R01DK 33301]; American Diabetes Association [7-06-JF-69]; Clinical Nutrition Research Unit [DK56351]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033301, P30DK056341] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Clinical Nutrition Research Unit; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK 33301 (to N.A.A.). This work was supported by American Diabetes Association Grant 7-06-JF-69 (to N.E.W.) and by Clinical Nutrition Research Unit Grant DK56351 through a pilot and feasibility grant (to N.E.W.) for use of the Adipocyte Biology Core facility.	Abell BM, 2004, PLANT J, V37, P461, DOI 10.1111/j.1365-313X.2003.01988.x; Beller M, 2006, MOL CELL PROTEOMICS, V5, P1082, DOI 10.1074/mcp.M600011-MCP200; Beller M, 2008, PLOS BIOL, V6, P2530, DOI 10.1371/journal.pbio.0060292; BLANCHETTEMACKIE EJ, 1995, J LIPID RES, V36, P1211; Bonifacino JS, 2003, NAT REV MOL CELL BIO, V4, P409, DOI 10.1038/nrm1099; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Brasaemle DL, 1997, J BIOL CHEM, V272, P9378; Carey GB, 1998, ADV EXP MED BIOL, V441, P157; Carrasco S, 2007, TRENDS BIOCHEM SCI, V32, P27, DOI 10.1016/j.tibs.2006.11.004; Cheng D, 2001, BIOCHEM J, V359, P707, DOI 10.1042/0264-6021:3590707; Colon-Gonzalez F, 2006, BBA-MOL CELL BIOL L, V1761, P827, DOI 10.1016/j.bbalip.2006.05.001; CUSHMAN SW, 1970, J CELL BIOL, V46, P326, DOI 10.1083/jcb.46.2.326; FINAZZI D, 1994, J BIOL CHEM, V269, P13325; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Joyce CW, 2000, MOL BIOL CELL, V11, P3675, DOI 10.1091/mbc.11.11.3675; Kazanietz MG, 2002, MOL PHARMACOL, V61, P759, DOI 10.1124/mol.61.4.759; KIMMEL AR, 2009, J LIPID RES IN PRESS; Kuerschner L, 2008, TRAFFIC, V9, P338, DOI 10.1111/j.1600-0854.2007.00689.x; Lewin TM, 2001, J BIOL CHEM, V276, P24674, DOI 10.1074/jbc.M102036200; Lin S, 1999, J BIOL CHEM, V274, P23276, DOI 10.1074/jbc.274.33.23276; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Lundmark R, 2008, BIOCHEM J, V414, P189, DOI 10.1042/BJ20081237; Miura S, 2002, J BIOL CHEM, V277, P32253, DOI 10.1074/jbc.M204410200; Murphy DJ, 1999, TRENDS BIOCHEM SCI, V24, P109, DOI 10.1016/S0968-0004(98)01349-8; Nakamura N, 2005, BIOCHEM BIOPH RES CO, V335, P117, DOI 10.1016/j.bbrc.2005.07.050; Nakamura N, 2004, BIOCHEM BIOPH RES CO, V322, P957, DOI 10.1016/j.bbrc.2004.08.010; Nie ZZ, 2006, J CELL SCI, V119, P1203, DOI 10.1242/jcs.02924; Ohsaki Y, 2008, J CELL SCI, V121, P2415, DOI 10.1242/jcs.025452; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; ROBENEK H, 2008, BIOCH BIOPH IN PRESS; Sato S, 2006, J BIOCHEM, V139, P921, DOI 10.1093/jb/mvj104; Schwartz DM, 2007, J LIPID RES, V48, P2514, DOI 10.1194/jlr.D700017-JLR200; Shockey JM, 2006, PLANT CELL, V18, P2294, DOI 10.1105/tpc.106.043695; Snapp EL, 2004, MOL BIOL CELL, V15, P4512, DOI 10.1091/mbc.E04-06-0475; Soni KG, 2009, J CELL SCI, V122, P1834, DOI 10.1242/jcs.045849; STERNWEIS PC, 1982, P NATL ACAD SCI-BIOL, V79, P4888, DOI 10.1073/pnas.79.16.4888; Stone SJ, 2009, J BIOL CHEM, V284, P5352, DOI 10.1074/jbc.M805768200; SUTHERLAND CA, 1982, J BIOL CHEM, V257, P4006; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; Tansey JT, 2004, IUBMB LIFE, V56, P379, DOI 10.1080/15216540400009968; Turro S, 2006, TRAFFIC, V7, P1254, DOI 10.1111/j.1600-0854.2006.00465.x; Wang RX, 1998, J IMMUNOL, V161, P2201; Wolins N, 1997, J CELL BIOL, V139, P1735, DOI 10.1083/jcb.139.7.1735; Wolins NE, 2006, DIABETES, V55, P3418, DOI 10.2337/db06-0399; Wolins NE, 2006, FEBS LETT, V580, P5484, DOI 10.1016/j.febslet.2006.08.040; Wolins NE, 2006, J LIPID RES, V47, P450, DOI 10.1194/jlr.D500037-JLR200; Wolins NE, 2005, J BIOL CHEM, V280, P19146, DOI 10.1074/jbc.M500978200; Wolins NE, 2001, J BIOL CHEM, V276, P5101, DOI 10.1074/jbc.M006775200; Wolins NE, 2003, J BIOL CHEM, V278, P37713, DOI 10.1074/jbc.M304025200	50	102	106	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30941	30948		10.1074/jbc.M109.013995	http://dx.doi.org/10.1074/jbc.M109.013995			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19748893	hybrid, Green Published			2022-12-27	WOS:000271378400023
J	Chen, YJ; Dominguez-Brauer, C; Wang, ZB; Asara, JM; Costa, RH; Tyner, AL; Lau, LF; Raychaudhuri, P				Chen, Yi-Ju; Dominguez-Brauer, Carmen; Wang, Zebin; Asara, John M.; Costa, Robert H.; Tyner, Angela L.; Lau, Lester F.; Raychaudhuri, Pradip			A Conserved Phosphorylation Site within the Forkhead Domain of FoxM1B Is Required for Its Activation by Cyclin-CDK1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							M1 TRANSCRIPTION FACTOR; GENE-EXPRESSION PROFILES; CELL-CYCLE PROGRESSION; PROTEIN-KINASE CK2; MITOTIC PROGRESSION; BINDING DOMAIN; SOMATIC WEE1; CANCER; MITOSIS; PHASE	The Forkhead box M1 (FoxM1) transcription factor is critical for expression of the genes essential for G1/S transition and mitotic progression. To explore the cell cycle regulation of FoxM1, we examined the phosphorylation profile of FoxM1. Here, we show that the phosphorylated status and the activity of FoxM1 increase as cells progress from S to G2/M phases. Moreover, dephosphorylation of FoxM1 coincides with exit from mitosis. Using mass spectrometry, we have identified a new conserved phosphorylation site (Ser-251) within the forkhead domain of FoxM1. Disruption of Ser-251 inhibits phosphorylation of FoxM1 and dramatically decreases its transcriptional activity. Wedemonstrate that the Ser-251 residue is required for CDK1-dependent phosphorylation of FoxM1 as well as its interaction with the coactivator CREB-binding protein (CBP). Interestingly, the transcriptional activity of the S251A mutant protein remains responsive to activation by overexpressed Polo-like kinase 1 (PLK1). Cells expressing the S251A mutant exhibit reduced expression of the G2/M phase genes and impaired mitotic progression. Our results demonstrate that the transcriptional activity of FoxM1 is controlled in a cell cycle-dependent fashion by temporally regulated phosphorylation and dephosphorylation events, and that the phosphorylation at Ser-251 is critical for the activation of FoxM1.	[Chen, Yi-Ju; Dominguez-Brauer, Carmen; Wang, Zebin; Costa, Robert H.; Tyner, Angela L.; Lau, Lester F.; Raychaudhuri, Pradip] Univ Illinois, Coll Med, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Asara, John M.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA; [Asara, John M.] Harvard Univ, Dept Pathol, Sch Med, Boston, MA 02115 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Raychaudhuri, P (corresponding author), Univ Illinois, Coll Med, Dept Biochem & Mol Genet, M-C 669,900 S Ashland Ave,MBRB Rm 2302, Chicago, IL 60607 USA.	pradip@uic.edu		Lau, Lester/0000-0002-4364-2914; Tyner, Angela/0000-0001-7448-8625	National Institutes of Health [CA 124488, CA 77637, AG021842, DK44525, DK068503]; United States Public Health Service; NATIONAL CANCER INSTITUTE [R01CA077637, R01CA124488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R55DK044525, R01DK044525, R01DK068503, R01DK054687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021842] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants CA 124488 and CA 77637 ( to P. R.) from the United States Public Health Service, and NIH Grants AG021842 ( to L. F. L.), DK44525, and DK068503 ( to A. L. T.).	ARIAS J, 1994, NATURE, V370, P226, DOI 10.1038/370226a0; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Barz T, 2003, J CELL SCI, V116, P1563, DOI 10.1242/jcs.00352; Bektas N, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-42; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; Costa RH, 2005, NAT CELL BIOL, V7, P108, DOI 10.1038/ncb0205-108; Dai B, 2007, ONCOGENE, V26, P6212, DOI 10.1038/sj.onc.1210443; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Fu Z, 2008, NAT CELL BIOL, V10, P1076, DOI 10.1038/ncb1767; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Kaestner KH, 2000, GENE DEV, V14, P142; Kalin TV, 2006, CANCER RES, V66, P1712, DOI 10.1158/0008-5472.CAN-05-3138; Kalinichenko VV, 2004, GENE DEV, V18, P830, DOI 10.1101/gad.1200704; Kim IM, 2006, CANCER RES, V66, P2153, DOI 10.1158/0008-5472.CAN-05-3003; Korver W, 1997, GENOMICS, V46, P435, DOI 10.1006/geno.1997.5065; Korver W, 1997, NUCLEIC ACIDS RES, V25, P1715, DOI 10.1093/nar/25.9.1715; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Laoukili J, 2008, CELL CYCLE, V7, P2720, DOI 10.4161/cc.7.17.6580; Laoukili J, 2008, MOL CELL BIOL, V28, P3076, DOI 10.1128/MCB.01710-07; Leung TWC, 2001, FEBS LETT, V507, P59, DOI 10.1016/S0014-5793(01)02915-5; Li Q, 2009, CANCER RES, V69, P3501, DOI 10.1158/0008-5472.CAN-08-3045; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Luscher-Firzlaff JM, 2006, FEBS LETT, V580, P1716, DOI 10.1016/j.febslet.2006.02.021; Luscher-Firzlaff JM, 1999, ONCOGENE, V18, P5620, DOI 10.1038/sj.onc.1202967; Major ML, 2004, MOL CELL BIOL, V24, P2649, DOI 10.1128/MCB.24.7.2649-2661.2004; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Park HJ, 2008, ONCOGENE, V27, P1696, DOI 10.1038/sj.onc.1210814; Park HJ, 2008, MOL CELL BIOL, V28, P5162, DOI 10.1128/MCB.00387-08; Petrovic V, 2008, J BIOL CHEM, V283, P453, DOI 10.1074/jbc.M705792200; Pilarsky C, 2004, NEOPLASIA, V6, P744, DOI 10.1593/neo.04277; Pines J, 1999, NAT CELL BIOL, V1, pE73, DOI 10.1038/11041; Poole A, 2005, MOL CELL BIOCHEM, V274, P163, DOI 10.1007/s11010-005-2945-z; Takaki T, 2008, CURR OPIN CELL BIOL, V20, P650, DOI 10.1016/j.ceb.2008.10.005; van den Boom J, 2003, AM J PATHOL, V163, P1033, DOI 10.1016/S0002-9440(10)63463-3; van Vugt MATM, 2005, ONCOGENE, V24, P2844, DOI 10.1038/sj.onc.1208617; Wang IC, 2008, ONCOGENE, V27, P4137, DOI 10.1038/onc.2008.60; Wang IC, 2008, J BIOL CHEM, V283, P20770, DOI 10.1074/jbc.M709892200; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Wang ZW, 2007, CANCER RES, V67, P8293, DOI 10.1158/0008-5472.CAN-07-1265; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Watanabe N, 2005, P NATL ACAD SCI USA, V102, P11663, DOI 10.1073/pnas.0500410102; WESTENDORF JM, 1994, P NATL ACAD SCI USA, V91, P714, DOI 10.1073/pnas.91.2.714; Whitmarsh AJ, 2000, CELL MOL LIFE SCI, V57, P1172, DOI 10.1007/PL00000757; Wierstra I, 2006, BIOL CHEM, V387, P963, DOI 10.1515/BC.2006.120; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059; Yao KM, 1997, J BIOL CHEM, V272, P19827, DOI 10.1074/jbc.272.32.19827; Yde CW, 2008, ONCOGENE, V27, P4986, DOI 10.1038/onc.2008.146; Ye HG, 1997, MOL CELL BIOL, V17, P1626, DOI 10.1128/MCB.17.3.1626; Yoshida Y, 2007, GASTROENTEROLOGY, V132, P1420, DOI 10.1053/j.gastro.2007.01.036	55	66	67	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30695	30707		10.1074/jbc.M109.007997	http://dx.doi.org/10.1074/jbc.M109.007997			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19737929	hybrid, Green Published			2022-12-27	WOS:000271090000071
J	Taylor, WA; Hatch, GM				Taylor, William A.; Hatch, Grant M.			Identification of the Human Mitochondrial Linoleoyl-coenzyme A Monolysocardiolipin Acyltransferase (MLCL AT-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MITOCHONDRIA; BARTH-SYNDROME PATIENTS; CARDIOLIPIN METABOLISM; ENDOTHELIAL LINEAGES; RESPIRATORY-CHAIN; DE-NOVO; BIOSYNTHESIS; HEART; MEMBRANE; MOUSE	Here we report the identification of a previously uncharacterized human protein as the human monolysocardiolipin acyltransferase-1 (MLCL AT-1). Pig liver mitochondria were treated with n-butyl alcohol followed by Q-Sepharose chromatography, preparative gel electrophoresis, cytidine diphosphate-1,2-diacyl-sn-glycerol-Sepharose chromatography, and finally monolysocardiolipin-adriamycin-agarose affinity chromatography. Elution with either monolysocardiolipin or linoleoyl coenzyme A revealed a major band at 74 kDa with high specific activity (2,300 pmol/min/mg) for the acylation of monolysocardiolipin to cardiolipin using [1-C-14]linoleoyl coenzyme A as substrate. Matrix-assisted laser desorption ionization time-of-flight-mass spectrometry analysis followed by search of the Mascot protein data base revealed peptide matches consistent with a 59-kDa protein identified as unknown human protein (GenBank (TM) protein accession number AAX93141; nucleotide accession number AC011742.3). The purified human recombinant MLCL AT-1 protein utilized linoleoyl coenzyme A> oleoyl coenzyme A> palmitoyl coenzyme A for the specific acylation of monolysocardiolipin to cardiolipin. Expression of MLCL AT-1 in HeLa cells increased mitochondrial monolysocardiolipin acyltransferase activity and [1-C-14]linoleic acid incorporated into cardiolipin, whereas RNA interference knockdown of MLCL AT-1 in HeLa cells resulted in reduction in enzyme activity and [1-C-14]linoleic acid incorporated into cardiolipin. In contrast, expression of MLCL AT-1 in HeLa cells did not alter [1-C-14]oleic or [1-C-14]palmitate incorporation into cardiolipin indicating in vivo specificity for the remodeling of cardiolipin with linoleate. Finally, expression of MLCL AT-1 in Barth syndrome lymphoblasts, which exhibit cardiolipin levels 20% that of normal lymphoblasts, increased mitochondrial monolysocardiolipin acyltransferase activity, [1-C-14]linoleic acid incorporation into cardiolipin, cardiolipin mass, and succinate dehydrogenase (mitochondrial complex II) activity compared with mock-transfected Barth syndrome lymphoblasts. The results identify MLCL AT-1 as a human mitochondrial monolysocardiolipin acyltransferase involved in the remodeling of cardiolipin.	[Hatch, Grant M.] Univ Manitoba, Dept Pharmacol & Therapeut, Fac Med, Winnipeg, MB R3E 0W3, Canada; [Hatch, Grant M.] Univ Manitoba, Dept Biochem, Winnipeg, MB R3E 0W3, Canada; [Hatch, Grant M.] Univ Manitoba, Dept Med Genet, Winnipeg, MB R3E 0W3, Canada; [Hatch, Grant M.] Univ Manitoba, Dept Internal Med, Winnipeg, MB R3E 0W3, Canada; [Hatch, Grant M.] Univ Manitoba, Ctr Res & Treatment Atherosclerosis, Winnipeg, MB R3E 0W3, Canada	University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba	Hatch, GM (corresponding author), Univ Manitoba, Dept Pharmacol & Therapeut, Fac Med, 753 McDermot Ave, Winnipeg, MB R3E 0W3, Canada.	hatchgm@ms.umanitoba.ca			Canadian Institutes of Health Research; Manitoba Health Research Council; Barth Syndrome Foundation of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Manitoba Health Research Council; Barth Syndrome Foundation of Canada	This work was supported by grants from the Canadian Institutes of Health Research, the Manitoba Health Research Council, and the Barth Syndrome Foundation of Canada.	Athea Y, 2007, DIABETES, V56, P786, DOI 10.2337/db06-0187; Beigneux AP, 2006, J LIPID RES, V47, P734, DOI 10.1194/jlr.M500556-JLR200; Cao JS, 2009, AM J PHYSIOL-ENDOC M, V296, pE647, DOI 10.1152/ajpendo.90761.2008; Cao JS, 2004, J BIOL CHEM, V279, P31727, DOI 10.1074/jbc.M402930200; Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, pC33, DOI 10.1152/ajpcell.00243.2006; Colby TD, 1999, P NATL ACAD SCI USA, V96, P3531, DOI 10.1073/pnas.96.7.3531; Danos M, 2008, BIOCHEM CELL BIOL, V86, P11, DOI [10.1139/O07-156, 10.1139/o07-156]; Dowhan W, 1997, ANNU REV BIOCHEM, V66, P199, DOI 10.1146/annurev.biochem.66.1.199; EICHBERG J, 1974, J BIOL CHEM, V249, P3423; Han XL, 2007, BIOCHEMISTRY-US, V46, P6417, DOI 10.1021/bi7004015; Hatch GM, 1998, INT J MOL MED, V1, P33; Hatch GM, 1996, J BIOL CHEM, V271, P25810, DOI 10.1074/jbc.271.42.25810; Hatch GM, 2004, BIOCHEM CELL BIOL, V82, P99, DOI 10.1139/o03-074; Hauff KD, 2006, PROG LIPID RES, V45, P91, DOI 10.1016/j.plipres.2005.12.001; Hauff K, 2009, BIOCHEM J, V417, P573, DOI 10.1042/BJ20080650; HOCH FL, 1992, BIOCHIM BIOPHYS ACTA, V1113, P71, DOI 10.1016/0304-4157(92)90035-9; Hostetler K. Y., 1982, PHOSPHOLIPIDS, V4, P215; HOSTETLER KY, 1975, BIOCHIM BIOPHYS ACTA, V380, P382, DOI 10.1016/0005-2760(75)90106-X; Houtkooper RH, 2008, CELL MOL LIFE SCI, V65, P2493, DOI 10.1007/s00018-008-8030-5; KELLEY M, 1992, BIOCHEM J, V288, P315, DOI 10.1042/bj2880315; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma BJ, 1999, J LIPID RES, V40, P1837; McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057; MORTON RK, 1955, METHOD ENZYMOL, V1, P26; Ott M, 2007, CELL DEATH DIFFER, V14, P1243, DOI 10.1038/sj.cdd.4402135; RUSINOL AE, 1994, J BIOL CHEM, V269, P27494; RUSTOW B, 1989, BIOCHIM BIOPHYS ACTA, V1002, P261, DOI 10.1016/0005-2760(89)90296-8; Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9; Schlame M, 2005, CHEM PHYS LIPIDS, V138, P38, DOI 10.1016/j.chemphyslip.2005.08.002; SCHLAME M, 1990, BIOCHEM J, V272, P589, DOI 10.1042/bj2720589; Schlame M, 2008, J LIPID RES, V49, P1607, DOI 10.1194/jlr.R700018-JLR200; Schlame M, 2006, FEBS LETT, V580, P5450, DOI 10.1016/j.febslet.2006.07.022; Singer T P, 1974, Methods Biochem Anal, V22, P123, DOI 10.1002/9780470110423.ch3; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Taylor WA, 2003, J BIOL CHEM, V278, P12716, DOI 10.1074/jbc.M210329200; Valianpour F, 2002, CLIN CHEM, V48, P1390; Van QY, 2007, BIOCHEM J, V401, P103, DOI 10.1042/BJ20060373; Volchenboum SL, 2000, J BIOL CHEM, V275, P7958, DOI 10.1074/jbc.275.11.7958; Wang CY, 2007, BLOOD, V110, P3601, DOI 10.1182/blood-2007-04-086827; Xiong JW, 2008, CIRC RES, V102, P1057, DOI 10.1161/CIRCRESAHA.107.163907; Xu Y, 2003, J BIOL CHEM, V278, P51380, DOI 10.1074/jbc.M307382200; Xu Y, 2006, J BIOL CHEM, V281, P39217, DOI 10.1074/jbc.M606100200; YANG SY, 1995, BIOCHEMISTRY-US, V34, P6441, DOI 10.1021/bi00019a025; Yao KW, 1996, J BIOL CHEM, V271, P17816, DOI 10.1074/jbc.271.30.17816; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200; Zhao Y, 2009, J LIPID RES, V50, P945, DOI 10.1194/jlr.M800567-JLR200	46	76	77	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30360	30371		10.1074/jbc.M109.048322	http://dx.doi.org/10.1074/jbc.M109.048322			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19737925	hybrid, Green Published			2022-12-27	WOS:000271090000039
J	Ikeda, Y; Sato, K; Pimentel, DR; Sam, F; Shaw, RJ; Dyck, JRB; Walsh, K				Ikeda, Yasumasa; Sato, Kaori; Pimentel, David R.; Sam, Flora; Shaw, Reuben J.; Dyck, Jason R. B.; Walsh, Kenneth			Cardiac-specific Deletion of LKB1 Leads to Hypertrophy and Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; PEUTZ-JEGHERS-SYNDROME; SKELETAL-MUSCLE; TRANSGENIC MICE; CONTRACTILE DYSFUNCTION; GLUCOSE-HOMEOSTASIS; INSULIN SENSITIVITY; ATRIAL-FIBRILLATION; PRESSURE-OVERLOAD; EXPRESSION	LKB1 encodes a serine/threonine kinase, which functions upstream of the AMP-activated protein kinase (AMPK) superfamily. To clarify the role of LKB1 in heart, we generated and characterized cardiac myocyte-specific LKB1 knock-out (KO) mice using alpha-myosin heavy chain-Cre deletor strain. LKB1-KO mice displayed biatrial enlargement with atrial fibrillation and cardiac dysfunction at 4 weeks of age. Left ventricular hypertrophy was observed in LKB1-KO mice at 12 weeks but not 4 weeks of age. Collagen I and III mRNA expression was elevated in atria at 4 weeks, and atrial fibrosis was seen at 12 weeks. LKB1-KO mice displayed cardiac dysfunction and atrial fibrillation and died within 6 months of age. Indicative of a prohypertrophic environment, the phosphorylation of AMPK and eEF2 was reduced, whereas mammalian target of rapamycin (mTOR) phosphorylation and p70S6 kinase phosphorylation were increased in both the atria and ventricles of LKB1-deficient mice. Consistent with vascular endothelial growth factor mRNA and protein levels being significantly reduced in LKB1-KO mice, these mice also exhibited a reduction in capillary density of both atria and ventricles. In cultured cardiac myocytes, LKB1 silencing induced hypertrophy, which was ameliorated by the expression of a constitutively active form AMPK or by treatment with the inhibitor of mTOR, rapamycin. These findings indicate that LKB1 signaling in cardiac myocytes is essential for normal development of the atria and ventricles. Cardiac hypertrophy and dysfunction in LKB1-deficient hearts are associated with alterations in AMPK and mTOR/p70S6 kinase/eEF2 signaling and with a reduction in vascular endothelial growth factor expression and vessel rarefaction.	[Walsh, Kenneth] Boston Univ, Mol Cardiol Whitaker Cardiovasc Inst, Sch Med, Boston, MA 02118 USA; [Pimentel, David R.] Boston Univ, Med Ctr, Dept Med, Cardiovasc Med Sect, Boston, MA 02118 USA; [Pimentel, David R.] Boston Univ, Myocardial Biol Unit, Sch Med, Boston, MA 02118 USA; [Sam, Flora] Boston Univ, Cardiac Remodeling Lab, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Shaw, Reuben J.] Salk Inst Biol Studies, Mol & Cell Biol Lab, San Diego, CA 92186 USA; [Dyck, Jason R. B.] Univ Alberta, Cardiovasc Res Ctr, Edmonton, AB T6G 2S2, Canada	Boston University; Boston University; Boston University; Boston University; Salk Institute; University of Alberta	Walsh, K (corresponding author), Boston Univ, Mol Cardiol Whitaker Cardiovasc Inst, Sch Med, Med Campus,715 Albany St,Rm W611, Boston, MA 02118 USA.	kxwalsh@bu.edu		Walsh, Kenneth/0000-0001-7580-2276; Sam, Flora/0000-0001-8442-9362; Ikeda, Yasumasa/0000-0003-4318-7349; Dyck, Jason/0000-0002-7045-2884; Pimentel, David/0000-0002-0537-7195	Japan Health Sciences Foundation; National Institutes of Health [HL079099, HL68758, HL77774, HL86785, AG15052]; Canadian Institutes of Health [MOP53088]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL095891, R01HL079099] Funding Source: NIH RePORTER	Japan Health Sciences Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by the Japan Health Sciences Foundation.; Supported by National Institutes of Health Grant HL079099.; Alberta Heritage Foundation for Medical Research Senior Scholar and a Canada Research Chair in Molecular Biology of Heart Disease and Metabolism and supported by Canadian Institutes of Health Research Grant MOP53088.; Supported by National Institutes of Health Grants HL68758, HL77774, HL86785, and AG15052.	Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Brundel BJJM, 2002, CARDIOVASC RES, V54, P315, DOI 10.1016/S0008-6363(02)00222-5; CARLBERG U, 1990, EUR J BIOCHEM, V191, P639, DOI 10.1111/j.1432-1033.1990.tb19169.x; Chan AYM, 2008, J BIOL CHEM, V283, P24194, DOI 10.1074/jbc.M802869200; Chan AYM, 2004, J BIOL CHEM, V279, P32771, DOI 10.1074/jbc.M403528200; Chan AYM, 2005, CAN J PHYSIOL PHARM, V83, P24, DOI 10.1139/Y04-107; Dolinsky VW, 2006, AM J PHYSIOL-HEART C, V291, pH2557, DOI 10.1152/ajpheart.00329.2006; Dolinsky VW, 2009, CIRCULATION, V119, P1643, DOI 10.1161/CIRCULATIONAHA.108.787440; Dyck JRB, 2006, J PHYSIOL-LONDON, V574, P95, DOI 10.1113/jphysiol.2006.109389; El-Armouche A, 2006, CIRCULATION, V114, P670, DOI 10.1161/CIRCULATIONAHA.106.636845; Fentzke RC, 1998, J CLIN INVEST, V101, P2415, DOI 10.1172/JCI2950; Giordano FJ, 2001, P NATL ACAD SCI USA, V98, P5780, DOI 10.1073/pnas.091415198; Gulick James, 2009, Methods Mol Biol, V561, P91, DOI 10.1007/978-1-60327-019-9_6; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Ikeda Y, 2005, J BIOL CHEM, V280, P29661, DOI 10.1074/jbc.M411694200; Ikeda Y, 2008, FEBS LETT, V582, P1147, DOI 10.1016/j.febslet.2008.03.002; Izumiya Y, 2006, HYPERTENSION, V47, P887, DOI 10.1161/01.HYP.0000215207.54689.31; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; JOHNSON JE, 1989, MOL CELL BIOL, V9, P3393, DOI 10.1128/MCB.9.8.3393; Jorgensen SB, 2004, J BIOL CHEM, V279, P1070, DOI 10.1074/jbc.M306205200; Karuman P, 2001, MOL CELL, V7, P1307, DOI 10.1016/S1097-2765(01)00258-1; Koh HJ, 2006, MOL CELL BIOL, V26, P8217, DOI 10.1128/MCB.00979-06; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Marignani PA, 2005, J CLIN PATHOL, V58, P15, DOI 10.1136/jcp.2003.015255; Marignani PA, 2001, J BIOL CHEM, V276, P32415, DOI 10.1074/jbc.C100207200; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Muller FU, 2005, J BIOL CHEM, V280, P6906, DOI 10.1074/jbc.M407864200; Noga AA, 2007, AM J PHYSIOL-HEART C, V292, pH1460, DOI 10.1152/ajpheart.01133.2006; Ohashi K, 2006, HYPERTENSION, V47, P1108, DOI 10.1161/01.HYP.0000222368.43759.a1; Okamoto Y, 2001, AM J PATHOL, V159, P639, DOI 10.1016/S0002-9440(10)61735-X; Ouchi N, 2005, CIRC RES, V96, P838, DOI 10.1161/01.RES.0000163633.10240.3b; Pimentel DR, 2006, J MOL CELL CARDIOL, V41, P613, DOI 10.1016/j.yjmcc.2006.05.009; Saba S, 2005, AM J PHYSIOL-HEART C, V289, pH1456, DOI 10.1152/ajpheart.00733.2004; Sakamoto K, 2006, AM J PHYSIOL-ENDOC M, V290, pE780, DOI 10.1152/ajpendo.00443.2005; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Severs NJ, 2008, CARDIOVASC RES, V80, P9, DOI 10.1093/cvr/cvn133; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Shield MA, 1996, MOL CELL BIOL, V16, P5058; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Shiojima I, 2002, J BIOL CHEM, V277, P37670, DOI 10.1074/jbc.M204572200; Smith DP, 2001, HUM MOL GENET, V10, P2869, DOI 10.1093/hmg/10.25.2869; Thomson DM, 2008, J APPL PHYSIOL, V104, P429, DOI 10.1152/japplphysiol.00900.2007; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Witczak CA, 2008, CELL MOL LIFE SCI, V65, P3737, DOI 10.1007/s00018-008-8244-6; Xiao HD, 2004, AM J PATHOL, V165, P1019, DOI 10.1016/S0002-9440(10)63363-9; Xie M, 2006, P NATL ACAD SCI USA, V103, P17378, DOI 10.1073/pnas.0604708103; Xing YQ, 2003, J BIOL CHEM, V278, P28372, DOI 10.1074/jbc.M303521200; Ylikorkala A, 2001, SCIENCE, V293, P1323, DOI 10.1126/science.1062074; Zang MW, 2004, J BIOL CHEM, V279, P47898, DOI 10.1074/jbc.M408149200; Zhang P, 2008, HYPERTENSION, V52, P918, DOI 10.1161/HYPERTENSIONAHA.108.114702; Zhu Wei, 2003, J Cardiovasc Electrophysiol, V14, P982, DOI 10.1046/j.1540-8167.2003.02002.x	54	121	125	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35839	35849		10.1074/jbc.M109.057273	http://dx.doi.org/10.1074/jbc.M109.057273			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19828446	hybrid, Green Published			2022-12-27	WOS:000272645600060
J	Das, K; Bandwar, RP; White, KL; Feng, JY; Sarafianos, SG; Tuske, S; Tu, XY; Clark, AD; Boyer, PL; Hou, XR; Gaffney, BL; Jones, RA; Miller, MD; Hughes, SH; Arnold, E				Das, Kalyan; Bandwar, Rajiv P.; White, Kirsten L.; Feng, Joy Y.; Sarafianos, Stefan G.; Tuske, Steven; Tu, Xiongying; Clark, Arthur D., Jr.; Boyer, Paul L.; Hou, Xiaorong; Gaffney, Barbara L.; Jones, Roger A.; Miller, Michael D.; Hughes, Stephen H.; Arnold, Eddy			Structural Basis for the Role of the K65R Mutation in HIV-1 Reverse Transcriptase Polymerization, Excision Antagonism, and Tenofovir Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; THYMIDINE ANALOG MUTATIONS; IN-VITRO SELECTION; MOLECULAR-MECHANISMS; PRIMER UNBLOCKING; NUCLEOSIDE ANALOG; COMBINATION THERAPY; DRUG-RESISTANCE; AZT RESISTANCE; DNA	K65R is a primary reverse transcriptase (RT) mutation selected in human immunodeficiency virus type 1-infected patients taking antiretroviral regimens containing tenofovir disoproxil fumarate or other nucleoside analog RT drugs. We determined the crystal structures of K65R mutant RT crosslinked to double-stranded DNA and in complexes with tenofovir diphosphate (TFV-DP) or dATP. The crystals permit substitution of TFV-DP with dATP at the dNTP-binding site. The guanidinium planes of the arginines K65R and Arg72 were stacked to form a molecular platform that restricts the conformational adaptability of both of the residues, which explains the negative effects of the K65R mutation on nucleotide incorporation and on excision. Furthermore, the guanidinium planes of K65R and Arg72 were stacked in two different rotameric conformations in TFV-DP- and dATP-bound structures that may help explain how K65R RT discriminates the drug from substrates. These K65R-mediated effects on RT structure and function help us to visualize the complex interaction with other key nucleotide RT drug resistance mutations, such as M184V, L74V, and thymidine analog resistance mutations.	[Das, Kalyan; Bandwar, Rajiv P.; Sarafianos, Stefan G.; Tuske, Steven; Tu, Xiongying; Clark, Arthur D., Jr.; Arnold, Eddy] Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Das, Kalyan; Bandwar, Rajiv P.; Sarafianos, Stefan G.; Tuske, Steven; Tu, Xiongying; Clark, Arthur D., Jr.; Hou, Xiaorong; Gaffney, Barbara L.; Jones, Roger A.; Arnold, Eddy] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA; [White, Kirsten L.; Feng, Joy Y.; Miller, Michael D.] Gilead Sci Inc, Foster City, CA 94404 USA; [Boyer, Paul L.; Hughes, Stephen H.] NCI, HIV Drug Resistance Program, NIH, Frederick, MD 21702 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Gilead Sciences; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Arnold, E (corresponding author), Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA.	arnold@cabm.rutgers.edu	Tu, Xiongying/H-7983-2012; Das, Kalyan/B-2967-2018; Das, Kalyan/O-9224-2019; Jones, Roger A./GRY-0637-2022	Das, Kalyan/0000-0002-8897-324X; Das, Kalyan/0000-0002-8897-324X; Bandwar, Rajiv/0000-0002-8081-8958; Sarafianos, Stefan G/0000-0002-5840-154X; Jones, Roger A./0000-0002-6835-6615	National Institutes of Health [AI 27690]; NCI; Center for Cancer Research; NIGMS;  [P01 GM066671]; NATIONAL CANCER INSTITUTE [ZIABC010481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI027690, R01AI027690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM066671] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health MERIT Award AI 27690 and Grant P01 GM066671 (to E.A.) for support of RT structural studies and by the Intramural Research Program of the National Institutes of Health, NCI, Center for Cancer Research, and NIGMS (to S.H.H.).	Arnold E, 1996, Drug Des Discov, V13, P29; Bazmi HZ, 2000, ANTIMICROB AGENTS CH, V44, P1783, DOI 10.1128/AAC.44.7.1783-1788.2000; Boyer PL, 2002, J VIROL, V76, P9143, DOI 10.1128/JVI.76.18.9143-9151.2002; Boyer PL, 2001, J VIROL, V75, P4832, DOI 10.1128/JVI.75.10.4832-4842.2001; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Catucci M, 1999, J ACQ IMMUN DEF SYND, V21, P203, DOI 10.1097/00126334-199907010-00004; Coutsinos D, 2009, J VIROL, V83, P2029, DOI 10.1128/JVI.01349-08; Das K, 2007, J MOL BIOL, V365, P77, DOI 10.1016/j.jmb.2006.08.097; Deval J, 2004, J BIOL CHEM, V279, P25489, DOI 10.1074/jbc.M313534200; Deval J, 2004, J BIOL CHEM, V279, P509, DOI 10.1074/jbc.M308806200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FARAJ A, 1994, ANTIMICROB AGENTS CH, V38, P2300, DOI 10.1128/AAC.38.10.2300; Feng JY, 1999, FASEB J, V13, P1511, DOI 10.1096/fasebj.13.12.1511; Feng JY, 1999, BIOCHEMISTRY-US, V38, P55, DOI 10.1021/bi982340r; Garforth SJ, 2007, J MOL BIOL, V365, P38, DOI 10.1016/j.jmb.2006.09.057; GU ZX, 1995, P NATL ACAD SCI USA, V92, P2760, DOI 10.1073/pnas.92.7.2760; Harrigan PR, 2000, J INFECT DIS, V181, P912, DOI 10.1086/315317; HSIEH JC, 1993, J BIOL CHEM, V268, P24607; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Kagan RM, 2007, ANTIVIR RES, V75, P210, DOI 10.1016/j.antiviral.2007.03.006; KATI WM, 1992, J BIOL CHEM, V267, P25988; LARDER BA, 1989, SCIENCE, V246, P1155, DOI 10.1126/science.2479983; Marchand B, 2003, J BIOL CHEM, V278, P35362, DOI 10.1074/jbc.M304262200; Margot NA, 2006, HIV MED, V7, P442, DOI 10.1111/j.1468-1293.2006.00404.x; Mas A, 2000, EMBO J, V19, P5752, DOI 10.1093/emboj/19.21.5752; Mason PE, 2003, P NATL ACAD SCI USA, V100, P4557, DOI 10.1073/pnas.0735920100; Masquelier B, 1999, ANTIVIR THER, V4, P69; McColl DJ, 2008, ANTIVIR THER, V13, P189; Meyer PR, 2003, J VIROL, V77, P3871, DOI 10.1128/JVI.77.6.3871-3877.2003; Meyer PR, 1999, MOL CELL, V4, P35, DOI 10.1016/S1097-2765(00)80185-9; Meyer PR, 2003, J VIROL, V77, P6127, DOI 10.1128/JVI.77.11.6127-6137.2003; Meyer PR, 1998, P NATL ACAD SCI USA, V95, P13471, DOI 10.1073/pnas.95.23.13471; MIZRAHI V, 1985, BIOCHEMISTRY-US, V24, P4010, DOI 10.1021/bi00336a031; Parikh UM, 2007, AIDS, V21, P1405, DOI 10.1097/QAD.0b013e3281ac229b; Parikh UM, 2006, J VIROL, V80, P4971, DOI 10.1128/JVI.80.10.4971-4977.2006; Potterton E, 2002, ACTA CRYSTALLOGR D, V58, P1955, DOI 10.1107/S0907444902015391; Radzio J, 2005, PROTEIN SCI, V14, P1929, DOI 10.1110/ps.051445605; REARDON JE, 1992, BIOCHEMISTRY-US, V31, P4473, DOI 10.1021/bi00133a013; Sarafianos SG, 1999, P NATL ACAD SCI USA, V96, P10027, DOI 10.1073/pnas.96.18.10027; Sarafianos SG, 2003, J BIOL CHEM, V278, P16280, DOI 10.1074/jbc.M212911200; Selmi B, 2001, J BIOL CHEM, V276, P48466, DOI 10.1074/jbc.M107003200; Shahs FS, 2000, J BIOL CHEM, V275, P27037; Sharma PL, 2004, VIROLOGY, V321, P222, DOI 10.1016/j.virol.2003.11.013; Sluis-Cremer N, 2000, BIOCHEM J, V348, P77, DOI 10.1042/0264-6021:3480077; Sluis-Cremer N, 2007, ANTIMICROB AGENTS CH, V51, P48, DOI 10.1128/AAC.00683-06; Svarovskaia ES, 2008, JAIDS-J ACQ IMM DEF, V48, P428, DOI 10.1097/QAI.0b013e31817bbe93; TISDALE M, 1993, P NATL ACAD SCI USA, V90, P5653, DOI 10.1073/pnas.90.12.5653; Tuske S, 2004, NAT STRUCT MOL BIOL, V11, P469, DOI 10.1038/nsmb760; Whitcomb JM, 2003, J INFECT DIS, V188, P992, DOI 10.1086/378281; White KL, 2006, ANTIVIR THER, V11, P155; White KL, 2005, AIDS, V19, P1751, DOI 10.1097/01.aids.0000189851.21441.f1; White KL, 2004, ANTIMICROB AGENTS CH, V48, P992, DOI 10.1128/AAC.48.3.992-1003.2004; White KL, 2002, ANTIMICROB AGENTS CH, V46, P3437, DOI 10.1128/AAC.46.11.3437-3446.2002; Winters MA, 1997, ANTIMICROB AGENTS CH, V41, P757, DOI 10.1128/AAC.41.4.757	54	67	68	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					35092	35100		10.1074/jbc.M109.022525	http://dx.doi.org/10.1074/jbc.M109.022525			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19812032	hybrid, Green Published			2022-12-27	WOS:000272439600063
J	daCosta, CJB; Medaglia, SA; Lavigne, N; Wang, SZ; Carswell, CL; Baenziger, JE				daCosta, Corrie J. B.; Medaglia, Sarah A.; Lavigne, Nadine; Wang, Shuzhi; Carswell, Casey L.; Baenziger, John E.			Anionic Lipids Allosterically Modulate Multiple Nicotinic Acetylcholine Receptor Conformational Equilibria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFRARED DIFFERENCE SPECTROSCOPY; PHOSPHATIDIC-ACID; PROTEIN INTERACTIONS; RECONSTITUTED MEMBRANES; SPONTANEOUS CURVATURE; TORPEDO-CALIFORNICA; AGONIST BINDING; ION-CHANNEL; CHOLESTEROL; LIGAND	Anionic lipids influence the ability of the nicotinic acetylcholine receptor to gate open in response to neurotransmitter binding, but the underlying mechanisms are poorly understood. We show here that anionic lipids with relatively small headgroups, and thus the greatest ability to influence lipid packing/bilayer physical properties, are the most effective at stabilizing an agonist-activatable receptor. The differing abilities of anionic lipids to stabilize an activatable receptor stem from differing abilities to preferentially favor resting over both uncoupled and desensitized conformations. Anionic lipids thus modulate multiple acetylcholine receptor conformational equilibria. Our data suggest that both lipids and membrane physical properties act as classic allosteric modulators influencing function by interacting with and thus preferentially stabilizing different native acetylcholine receptor conformational states.	[daCosta, Corrie J. B.; Medaglia, Sarah A.; Lavigne, Nadine; Wang, Shuzhi; Carswell, Casey L.; Baenziger, John E.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada	University of Ottawa	Baenziger, JE (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	John.Baenziger@uottawa.ca		Baenziger, John/0000-0002-2888-5328	Canadian Institutes of Health Research; Canadian Institutes of Health Research Canadian Graduate Scholarship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research Canadian Graduate Scholarship(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Institutes of Health Research (to J.E.B.) and a Canadian Institutes of Health Research Canadian Graduate Scholarship (to C.J.B.D.).	Alley SH, 2008, CHEM PHYS LIPIDS, V154, P64, DOI 10.1016/j.chemphyslip.2008.03.007; Baenziger JE, 1999, BIOCHEMISTRY-US, V38, P4905, DOI 10.1021/bi990181l; Baenziger JE, 2000, J BIOL CHEM, V275, P777, DOI 10.1074/jbc.275.2.777; BAENZIGER JE, 1992, BIOPHYS J, V61, P983, DOI 10.1016/S0006-3495(92)81905-7; BAENZIGER JE, 1993, BIOCHEMISTRY-US, V32, P5448, DOI 10.1021/bi00071a022; Baenziger JE, 2008, MOL PHARMACOL, V73, P880, DOI 10.1124/mol.107.039008; Barrantes FJ, 2004, BRAIN RES REV, V47, P71, DOI 10.1016/j.brainresrev.2004.06.008; BHUSHAN A, 1993, BIOPHYS J, V64, P716, DOI 10.1016/S0006-3495(93)81431-0; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; BOYD ND, 1980, BIOCHEMISTRY-US, V19, P5344, DOI 10.1021/bi00564a031; Brannigan G, 2008, P NATL ACAD SCI USA, V105, P14418, DOI 10.1073/pnas.0803029105; Bruses JL, 2001, J NEUROSCI, V21, P504, DOI 10.1523/JNEUROSCI.21-02-00504.2001; CRIADO M, 1984, BIOCHIM BIOPHYS ACTA, V798, P374, DOI 10.1016/0304-4165(84)90112-0; CRIADO M, 1984, J BIOL CHEM, V259, P9188; daCosta CJB, 2004, J BIOL CHEM, V279, P14967, DOI 10.1074/jbc.M310037200; daCosta CJB, 2003, ACTA CRYSTALLOGR D, V59, P77, DOI 10.1107/S0907444902019236; daCosta CJB, 2002, J BIOL CHEM, V277, P201, DOI 10.1074/jbc.M108341200; daCosta CJB, 2009, J BIOL CHEM, V284, P17819, DOI 10.1074/jbc.M900030200; Dickey A, 2008, BIOPHYS J, V95, P2636, DOI 10.1529/biophysj.107.128074; ELLENA JF, 1983, BIOCHEMISTRY-US, V22, P5523, DOI 10.1021/bi00293a012; Elmore DE, 2006, FEBS LETT, V580, P144, DOI 10.1016/j.febslet.2005.11.064; Engel AG, 2002, MOL NEUROBIOL, V26, P347, DOI 10.1385/MN:26:2-3:347; FERNANDEZBALLESTER G, 1994, BIOCHEMISTRY-US, V33, P4065, DOI 10.1021/bi00179a035; FONG TM, 1987, BIOCHEMISTRY-US, V26, P3871, DOI 10.1021/bi00387a020; FONG TM, 1986, BIOCHEMISTRY-US, V25, P830, DOI 10.1021/bi00352a015; Hamouda AK, 2006, BIOCHEMISTRY-US, V45, P4327, DOI 10.1021/bi052281z; HEIDMANN T, 1979, EUR J BIOCHEM, V94, P281, DOI 10.1111/j.1432-1033.1979.tb12894.x; HERZ JM, 1987, J BIOL CHEM, V262, P7238; Kooijman EE, 2005, BIOCHEMISTRY-US, V44, P2097, DOI 10.1021/bi0478502; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Mantipragada SB, 2003, BIOCHEMISTRY-US, V42, P9167, DOI 10.1021/bi034485q; Marchand S, 2002, J NEUROSCI, V22, P8891; MCCARTHY MP, 1992, J BIOL CHEM, V267, P7655; METHOT N, 1995, BIOCHEMISTRY-US, V34, P15142, DOI 10.1021/bi00046a021; Rankin SE, 1997, BIOPHYS J, V73, P2446, DOI 10.1016/S0006-3495(97)78273-0; Reid SE, 1996, SPECTROCHIM ACTA A, V52, P1347, DOI 10.1016/0584-8539(96)01718-7; Ryan SE, 2002, J BIOL CHEM, V277, P10420, DOI 10.1074/jbc.M107412200; Ryan SE, 1996, J BIOL CHEM, V271, P24590, DOI 10.1074/jbc.271.40.24590; Shen XM, 2006, ANN NEUROL, V60, P128, DOI 10.1002/ana.20861; Shen XM, 2003, J CLIN INVEST, V111, P497, DOI 10.1172/JC1200316997; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; SUNSHINE C, 1992, BIOCHIM BIOPHYS ACTA, V1108, P240, DOI 10.1016/0005-2736(92)90031-G; SUNSHINE C, 1994, BBA-BIOMEMBRANES, V1191, P59, DOI 10.1016/0005-2736(94)90233-X; Vance D., 1996, BIOCH LIPIDS LIPOPRO, V31, P1	45	44	44	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33841	33849		10.1074/jbc.M109.048280	http://dx.doi.org/10.1074/jbc.M109.048280			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19815550	Green Published, hybrid			2022-12-27	WOS:000272165200016
J	Oosterveer, MH; Grefhorst, A; van Dijk, TH; Havinga, R; Staels, B; Kuipers, F; Groen, AK; Reijngoud, DJ				Oosterveer, Maaike H.; Grefhorst, Aldo; van Dijk, Theo H.; Havinga, Rick; Staels, Bart; Kuipers, Folkert; Groen, Albert K.; Reijngoud, Dirk-Jan			Fenofibrate Simultaneously Induces Hepatic Fatty Acid Oxidation, Synthesis, and Elongation in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED-RECEPTOR-ALPHA; PPAR-ALPHA; GENE-EXPRESSION; LIVER-DISEASE; IN-VIVO; ADAPTIVE RESPONSE; FASTING RESPONSE; METABOLISM; DEFICIENCY; RAT	A growing body of evidence indicates that peroxisome proliferator-activated receptor alpha (PPAR alpha) not merely serves as a transcriptional regulator of fatty acid catabolism but also exerts a much broader role in hepatic lipid metabolism. We determined adaptations in hepatic lipid metabolism and related aspects of carbohydrate metabolism upon treatment of C57Bl/6 mice with the PPAR alpha agonist fenofibrate. Stable isotope procedures were applied to assess hepatic fatty acid synthesis, fatty acid elongation, and carbohydrate metabolism. Fenofibrate treatment strongly induced hepatic de novo lipogenesis and chain elongation (+/- 300, 150, and 600% for C16:0, C18:0, and C18:1 synthesis, respectively) in parallel with an increased expression of lipogenic genes. The lipogenic induction in fenofibrate-treated mice was found to depend on sterol regulatory element-binding protein 1c (SREBP-1c) but not carbohydrate response element-binding protein (ChREBP). Fenofibrate treatment resulted in a reduced contribution of glycolysis to acetylCoA production, whereas the cycling of glucose 6-phosphate through the pentose phosphate pathway presumably was enhanced. Altogether, our data indicate that beta-oxidation and lipogenesis are induced simultaneously upon fenofibrate treatment. These observations may reflect a physiological mechanism by which PPAR beta and SREBP-1c collectively ensure proper handling of fatty acids to protect the liver against cytotoxic damage.	[Oosterveer, Maaike H.] Univ Groningen, Univ Med Ctr Groningen, Ctr Liver Digest & Metab Dis, Pediat Lab,Dept Pediat, NL-9700 RB Groningen, Netherlands; [van Dijk, Theo H.; Kuipers, Folkert; Groen, Albert K.; Reijngoud, Dirk-Jan] Univ Groningen, Univ Med Ctr Groningen, Ctr Liver Digest & Metab Dis, Dept Lab Med, NL-9700 RB Groningen, Netherlands; [Staels, Bart] Univ Lille Nord France, Inst Pasteur Lille, INSERM, U545, F-59019 Lille, France	University of Groningen; University of Groningen; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille	Oosterveer, MH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Liver Digest & Metab Dis, Pediat Lab,Dept Pediat, POB 30-001, NL-9700 RB Groningen, Netherlands.	M.H.Oosterveer@med.umcg.nl	Staels, Bart/N-9497-2016; oosterveer, maaike h/C-3374-2013	Staels, Bart/0000-0002-3784-1503; Reijngoud, Dirk-Jan/0000-0003-1157-4491; Kuipers, Folkert/0000-0003-2518-737X	Dutch Diabetes Foundation [2002.00.041]; EU [018734]	Dutch Diabetes Foundation; EU(European Commission)	This work was supported by Dutch Diabetes Foundation Grant 2002.00.041 and by EU Grant Hepadip 018734.	Andrews ZB, 2009, AM J PHYSIOL-ENDOC M, V296, pE621, DOI 10.1152/ajpendo.90903.2008; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CASTELEIN H, 1994, J BIOL CHEM, V269, P26754; Chakravarthy MV, 2005, CELL METAB, V1, P309, DOI 10.1016/j.cmet.2005.04.002; Cheung C, 2004, CANCER RES, V64, P3849, DOI 10.1158/0008-5472.CAN-04-0322; Dalen KT, 2006, J LIPID RES, V47, P931, DOI 10.1194/jlr.M500459-JLR200; Derks TGJ, 2008, HEPATOLOGY, V47, P1032, DOI 10.1002/hep.22101; Devchand PR, 1996, NATURE, V384, P39, DOI 10.1038/384039a0; Gueraud F, 1999, J LIPID RES, V40, P152; Hebbachi AM, 2008, J BIOL CHEM, V283, P4866, DOI 10.1074/jbc.M709471200; HOHORST HJ, 1970, METHODEN ENZYMATISCH, P1200; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Inoue I, 1998, LIFE SCI, V63, P135, DOI 10.1016/S0024-3205(98)00249-5; Kabashima T, 2003, P NATL ACAD SCI USA, V100, P5107, DOI 10.1073/pnas.0730817100; Kelly LJ, 1998, ENDOCRINOLOGY, V139, P4920, DOI 10.1210/en.139.12.4920; KEPPLER D, 1970, METHODEN ENZYMATISCH, P1089; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Knight BL, 2005, BIOCHEM J, V389, P413, DOI 10.1042/BJ20041896; Konig B, 2009, EUR J PHARMACOL, V605, P23, DOI 10.1016/j.ejphar.2009.01.009; KUIPERS F, 1985, GASTROENTEROLOGY, V88, P403, DOI 10.1016/0016-5085(85)90499-8; LEE WNP, 1991, BIOL MASS SPECTROM, V20, P451, DOI 10.1002/bms.1200200804; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Li ZZ, 2009, J BIOL CHEM, V284, P5637, DOI 10.1074/jbc.M807616200; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lundasen T, 2007, BIOCHEM BIOPH RES CO, V360, P437, DOI 10.1016/j.bbrc.2007.06.068; Malhi H, 2008, SEMIN LIVER DIS, V28, P360, DOI 10.1055/s-0028-1091980; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; Martin PGP, 2007, HEPATOLOGY, V45, P767, DOI 10.1002/hep.21510; Miller CW, 1996, P NATL ACAD SCI USA, V93, P9443, DOI 10.1073/pnas.93.18.9443; MUSKIET FAJ, 1983, J CHROMATOGR, V278, P231, DOI 10.1016/S0378-4347(00)84782-9; Ogata M, 2009, ATHEROSCLEROSIS, V205, P413, DOI 10.1016/j.atherosclerosis.2009.01.008; Oosterveer MH, 2008, J BIOL CHEM, V283, P25437, DOI 10.1074/jbc.M801922200; Oosterveer MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006066; Patsouris D, 2006, ENDOCRINOLOGY, V147, P1508, DOI 10.1210/en.2005-1132; Patsouris D, 2004, J CLIN INVEST, V114, P94, DOI 10.1172/JC1200420468; Reszko AE, 2004, J BIOL CHEM, V279, P19574, DOI 10.1074/jbc.M400162200; Sampath H, 2007, J BIOL CHEM, V282, P2483, DOI 10.1074/jbc.M610158200; Schrader M, 2006, BBA-MOL CELL RES, V1763, P1755, DOI 10.1016/j.bbamcr.2006.09.006; Schrauwen P, 2004, P NUTR SOC, V63, P287, DOI 10.1079/PNS2003336; Seo YS, 2008, J GASTROEN HEPATOL, V23, P102, DOI 10.1111/j.1440-1746.2006.04819.x; Shiri-Sverdlov R, 2006, J HEPATOL, V44, P732, DOI 10.1016/j.jhep.2005.10.033; Spolarics Z, 1998, J LEUKOCYTE BIOL, V63, P534, DOI 10.1002/jlb.63.5.534; Sriram G, 2008, MOL GENET METAB, V93, P145, DOI 10.1016/j.ymgme.2007.09.008; Staels B, 2008, NAT CLIN PRACT CARD, V5, P542, DOI 10.1038/ncpcardio1278; Stienstra R, 2007, ENDOCRINOLOGY, V148, P2753, DOI 10.1210/en.2007-0014; Sugden MC, 2003, AM J PHYSIOL-ENDOC M, V284, pE855, DOI 10.1152/ajpendo.00526.2002; Toyama T, 2004, BIOCHEM BIOPH RES CO, V324, P697, DOI 10.1016/j.bbrc.2004.09.110; van der Veen JN, 2007, J LIPID RES, V48, P337, DOI 10.1194/jlr.M600170-JLR200; van Dijk TH, 2003, ANAL BIOCHEM, V322, P1, DOI 10.1016/j.ab.2003.07.008; Wong DA, 2004, J BIOL CHEM, V279, P41302, DOI 10.1074/jbc.M406766200; Xu J, 2004, ENDOCRINOLOGY, V145, P1087, DOI 10.1210/en.2003-1173; Yeon JE, 2004, J GASTROEN HEPATOL, V19, P799, DOI 10.1111/j.1440-1746.2004.03349.x	55	114	116	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34036	34044		10.1074/jbc.M109.051052	http://dx.doi.org/10.1074/jbc.M109.051052			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19801551	Green Published, hybrid			2022-12-27	WOS:000272165200036
J	Agrawal, S; van Dooren, GG; Beatty, WL; Striepen, B				Agrawal, Swati; van Dooren, Giel G.; Beatty, Wandy L.; Striepen, Boris			Genetic Evidence that an Endosymbiont-derived Endoplasmic Reticulum-associated Protein Degradation (ERAD) System Functions in Import of Apicoplast Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOXOPLASMA-GONDII; APICOMPLEXAN PARASITES; PLASMODIUM-FALCIPARUM; ESCHERICHIA-COLI; ENCODED PROTEINS; DRUG TARGET; COMPLEX; TRANSLOCATION; EVOLUTION; TRANSPORT	Most apicomplexan parasites harbor a relict chloroplast, the apicoplast, that is critical for their survival. Whereas the apicoplast maintains a small genome, the bulk of its proteins are nuclear encoded and imported into the organelle. Several models have been proposed to explain how proteins might cross the four membranes that surround the apicoplast; however, experimental data discriminating these models are largely missing. Here we present genetic evidence that apicoplast protein import depends on elements derived from the ER-associated protein degradation (ERAD) system of the endosymbiont. We identified two sets of ERAD components in Toxoplasma gondii, one associated with the ER and cytoplasm and one localized to the membranes of the apicoplast. We engineered a conditional null mutant in apicoplast Der1, the putative pore of the apicoplast ERAD complex, and found that loss of Der1(Ap) results in loss of apicoplast protein import and subsequent death of the parasite.	[Agrawal, Swati; Striepen, Boris] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [van Dooren, Giel G.; Striepen, Boris] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Beatty, Wandy L.] Washington Univ, Dept Mol Microbiol, St Louis, MO 63110 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Washington University (WUSTL)	Striepen, B (corresponding author), 500 W Brooks Dr, Athens, GA 30602 USA.	striepen@cb.uga.edu	van Dooren, Giel G/A-8896-2012	van Dooren, Giel G/0000-0003-2455-9821; Striepen, Boris/0000-0002-7426-432X; Agrawal, Swati/0000-0001-6295-6954	National Institutes of Health [AI64671]; American Heart Association; Australian National Health and Medical Research Council [400489]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064671] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI64671 (to B. S.).; Supported by a predoctoral fellowship from the American Heart Association.; Recipient of a C. J. Martin Overseas Fellowship (400489) from the Australian National Health and Medical Research Council. Current address: Plant Cell Biology Research Centre, School of Botany, University of Melbourne, Parkville, Vic, Australia.	Brossier F, 2008, EUKARYOT CELL, V7, P664, DOI 10.1128/EC.00331-07; Brydges SD, 2008, BIOL CELL, V100, P253, DOI 10.1042/BC20070076; Carey KL, 2000, MOL BIOCHEM PARASIT, V105, P25, DOI 10.1016/S0166-6851(99)00160-7; Cavalier-Smith T, 2002, INT J SYST EVOL MICR, V52, P297, DOI 10.1099/00207713-52-2-297; DeRocher A, 2005, J CELL SCI, V118, P565, DOI 10.1242/jcs.01627; Fichera ME, 1997, NATURE, V390, P407, DOI 10.1038/37132; Flierman D, 2003, J BIOL CHEM, V278, P34774, DOI 10.1074/jbc.M303360200; Gabaldon T, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-8; Gissot M, 2007, PLOS PATHOG, V3, P709, DOI 10.1371/journal.ppat.0030077; Goodman CD, 2007, CURR DRUG TARGETS, V8, P15, DOI 10.2174/138945007779315579; Gould SB, 2008, ANNU REV PLANT BIOL, V59, P491, DOI 10.1146/annurev.arplant.59.032607.092915; Gubbels MJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040036; Hager KM, 1999, J CELL SCI, V112, P2631; Hempel F, 2009, MOL BIOL EVOL, V26, P1781, DOI 10.1093/molbev/msp079; Jarvis P, 2008, NEW PHYTOL, V179, P257, DOI 10.1111/j.1469-8137.2008.02452.x; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; Kalanon M, 2009, EUKARYOT CELL, V8, P1146, DOI 10.1128/EC.00061-09; Karnataki A, 2007, MOL MICROBIOL, V63, P1653, DOI 10.1111/j.1365-2958.2007.05619.x; Keeling PJ, 2009, J EUKARYOT MICROBIOL, V56, P1, DOI 10.1111/j.1550-7408.2008.00371.x; Kleine T, 2009, ANNU REV PLANT BIOL, V60, P115, DOI 10.1146/annurev.arplant.043008.092119; Kohler S, 1997, SCIENCE, V275, P1485, DOI 10.1126/science.275.5305.1485; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Mazumdar J, 2006, P NATL ACAD SCI USA, V103, P13192, DOI 10.1073/pnas.0603391103; Meissner M, 2002, SCIENCE, V298, P837, DOI 10.1126/science.1074553; Meissner M, 2002, J CELL SCI, V115, P563; MESSINA M, 1995, GENE, V165, P213, DOI 10.1016/0378-1119(95)00548-K; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Moore RB, 2008, NATURE, V451, P959, DOI 10.1038/nature06635; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Poteete AR, 2006, BIOTECHNIQUES, V41, P261, DOI 10.2144/000112242; Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843; Sommer MS, 2007, MOL BIOL EVOL, V24, P918, DOI 10.1093/molbev/msm008; Spork S, 2009, EUKARYOT CELL, V8, P1134, DOI 10.1128/EC.00083-09; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Striepen B., 2007, P391, DOI 10.1016/B978-012369542-0/50017-9; Striepen B, 2000, J CELL BIOL, V151, P1423, DOI 10.1083/jcb.151.7.1423; Thomsen-Zieger N, 2003, FEBS LETT, V547, P80, DOI 10.1016/S0014-5793(03)00673-2; Tonkin CJ, 2008, TRAFFIC, V9, P166, DOI 10.1111/j.1600-0854.2007.00660.x; Tonkin CJ, 2006, MOL MICROBIOL, V61, P614, DOI 10.1111/j.1365-2958.2006.05244.x; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; van Dooren GG, 2002, J BIOL CHEM, V277, P23612, DOI 10.1074/jbc.M201748200; van Dooren GG, 2008, P NATL ACAD SCI USA, V105, P13574, DOI 10.1073/pnas.0803862105; van Dooren GG, 2009, CURR BIOL, V19, P267, DOI 10.1016/j.cub.2008.12.048; Waller RF, 1998, P NATL ACAD SCI USA, V95, P12352, DOI 10.1073/pnas.95.21.12352; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656	46	138	138	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33683	33691		10.1074/jbc.M109.044024	http://dx.doi.org/10.1074/jbc.M109.044024			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19808683	hybrid, Green Published			2022-12-27	WOS:000272028500072
J	Hawse, WF; Wolberger, C				Hawse, William F.; Wolberger, Cynthia			Structure-based Mechanism of ADP-ribosylation by Sirtuins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIR2 PROTEIN; DEACETYLASE ACTIVITY; SIR2-LIKE PROTEINS; TRYPANOSOMA-BRUCEI; RIBOSYLTRANSFERASE; ACETYLATION; FAMILY; YEAST; GENE; CRYSTALLOGRAPHY	Sirtuins comprise a family of enzymes found in all organisms, where they play a role in diverse processes including transcriptional silencing, aging, regulation of transcription, and metabolism. The predominant reaction catalyzed by these enzymes is NAD(+)-dependent lysine deacetylation, although some sirtuins exhibit a weaker ADP-ribosyltransferase activity. Although the Sir2 deacetylation mechanism is well established, much less is known about the Sir2 ADP-ribosylation reaction. We have studied the ADP-ribosylation activity of a bacterial sirtuin, Sir2Tm, and show that acetylated peptides containing arginine or lysine 2 residues C-terminal to the acetyl lysine, the +2 position, are preferentially ADP-ribosylated at the +2 residue. A structure of Sir2Tm bound to the acetylated +2 arginine peptide shows how this arginine could enter the active site and react with a deacetylation reaction intermediate to yield an ADP-ribosylated peptide. The new biochemical and structural studies presented here provide mechanistic insights into the Sir2 ADP-ribosylation reaction and will aid in identifying substrates of this reaction.	[Hawse, William F.; Wolberger, Cynthia] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Wolberger, Cynthia] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Wolberger, C (corresponding author), 725 N Wolfe St, Baltimore, MD 21205 USA.	cwolberg@jhmi.edu		Wolberger, Cynthia/0000-0001-8578-2969	National Science Foundation [MCB-0615815]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant MCB-0615815.	Avalos JL, 2004, MOL CELL, V13, P639, DOI 10.1016/S1097-2765(04)00082-6; Avalos JL, 2002, MOL CELL, V10, P523, DOI 10.1016/S1097-2765(02)00628-7; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Cosgrove MS, 2006, BIOCHEMISTRY-US, V45, P7511, DOI 10.1021/bi0526332; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Garcia-Salcedo JA, 2003, EMBO J, V22, P5851, DOI 10.1093/emboj/cdg553; Garrity J, 2007, J BIOL CHEM, V282, P30239, DOI 10.1074/jbc.M704409200; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Hawse WF, 2008, STRUCTURE, V16, P1368, DOI 10.1016/j.str.2008.05.015; Hoff KG, 2006, STRUCTURE, V14, P1231, DOI 10.1016/j.str.2006.06.006; Jackson AD, 2002, J BIOL CHEM, V277, P18535, DOI 10.1074/jbc.M200671200; Jackson MD, 2003, J BIOL CHEM, V278, P50985, DOI 10.1074/jbc.M306552200; JOHNSON LM, 1990, P NATL ACAD SCI USA, V87, P6286, DOI 10.1073/pnas.87.16.6286; Kowieski TM, 2008, J BIOL CHEM, V283, P5317, DOI 10.1074/jbc.M707613200; LENO GH, 1990, FEBS LETT, V276, P29, DOI 10.1016/0014-5793(90)80499-9; Liszt G, 2005, J BIOL CHEM, V280, P21313, DOI 10.1074/jbc.M413296200; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sauve AA, 2003, BIOCHEMISTRY-US, V42, P9249, DOI 10.1021/bi034959l; Sauve AA, 2001, BIOCHEMISTRY-US, V40, P15456, DOI 10.1021/bi011858j; Smith BC, 2006, BIOCHEMISTRY-US, V45, P272, DOI 10.1021/bi052014t; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Smith JS, 2002, METHOD ENZYMOL, V353, P282; Tanny JC, 1999, CELL, V99, P735, DOI 10.1016/S0092-8674(00)81671-2; Tsang AW, 1998, J BIOL CHEM, V273, P31788, DOI 10.1074/jbc.273.48.31788	35	46	47	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33654	33661		10.1074/jbc.M109.024521	http://dx.doi.org/10.1074/jbc.M109.024521			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801667	Green Published, hybrid			2022-12-27	WOS:000272028500069
J	Kim, J; Hannibal, L; Gherasim, C; Jacobsen, DW; Banerjee, R				Kim, Jihoe; Hannibal, Luciana; Gherasim, Carmen; Jacobsen, Donald W.; Banerjee, Ruma			A Human Vitamin B-12 Trafficking Protein Uses Glutathione Transferase Activity for Processing Alkylcobalamins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYLMALONYL-COA MUTASE; GENETIC COMPLEMENTATION; HUMAN-FIBROBLASTS; COBALAMIN; HYDROXOCOBALAMIN; METHYLCOBALAMIN; HOMOCYSTINURIA; IDENTIFICATION; METABOLISM; ACIDEMIA	Pathways for tailoring and processing vitamins into active cofactor forms exist in mammals that are unable to synthesize these cofactors de novo. A prerequisite for intracellular tailoring of alkylcobalamins entering from the circulation is removal of the alkyl group to generate an intermediate that can subsequently be converted into the active cofactor forms. MMACHC, a cytosolic cobalamin trafficking chaperone, has been shown recently to catalyze a reductive decyanation reaction when it encounters cyanocobalamin. In this study, we demonstrate that this versatile protein catalyzes an entirely different chemical reaction with alkylcobalamins using the thiolate of glutathione for nucleophilic displacement to generate cob( I) alamin and the corresponding glutathione thioether. Biologically relevant thiols, e. g. cysteine and homocysteine, cannot substitute for glutathione. The catalytic turnover numbers for the dealkylation of methylcobalamin and 5'-deoxyadenosylcobalamin by MMACHC are 11.7 +/- 0.2 and 0.174 +/- 0.006 h(-1) at 20 degrees C, respectively. This glutathione transferase activity of MMACHC is reminiscent of the methyltransferase chemistry catalyzed by the vitamin B-12-dependent methionine synthase and is impaired in the cblC group of inborn errors of cobalamin disorders.	[Kim, Jihoe; Gherasim, Carmen; Banerjee, Ruma] Univ Michigan, Dept Biol Chem, Med Ctr, Ann Arbor, MI 48109 USA; [Hannibal, Luciana; Jacobsen, Donald W.] Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA; [Hannibal, Luciana; Jacobsen, Donald W.] Kent State Univ, Sch Biomed Sci, Kent, OH 44242 USA; [Jacobsen, Donald W.] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Dept Mol Med, Cleveland, OH 44106 USA	University of Michigan System; University of Michigan; Cleveland Clinic Foundation; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Case Western Reserve University; Cleveland Clinic Foundation	Banerjee, R (corresponding author), Univ Michigan, Dept Biol Chem, Med Ctr, 3320B MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu	Hannibal, Luciana/AAY-7689-2021	Hannibal, Luciana/0000-0002-0911-5758	National Institutes of Health [DK45776, HL71907]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045776, R29DK045776] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK45776 (to R.B.) and HL71907 (to D.W.J.).	AMAGASAKI T, 1990, BLOOD, V76, P1380; Andersson HC, 1998, J PEDIATR-US, V132, P121, DOI 10.1016/S0022-3476(98)70496-2; Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; Babbitt PC, 2000, P NATL ACAD SCI USA, V97, P10298, DOI 10.1073/pnas.97.19.10298; Banerjee R, 2006, ACS CHEM BIOL, V1, P149, DOI 10.1021/cb6001174; Banerjee R, 2009, CURR OPIN CHEM BIOL, V13, P484, DOI 10.1016/j.cbpa.2009.07.007; BANERJEE RV, 1990, FASEB J, V4, P1450, DOI 10.1096/fasebj.4.5.2407589; BARTHOLOMEW DW, 1988, J PEDIATR-US, V112, P32, DOI 10.1016/S0022-3476(88)80114-8; CHU RC, 1993, METABOLISM, V42, P315, DOI 10.1016/0026-0495(93)90080-8; GIMSING P, 1983, ANAL BIOCHEM, V129, P296, DOI 10.1016/0003-2697(83)90553-5; GRAVEL RA, 1975, P NATL ACAD SCI USA, V72, P3181, DOI 10.1073/pnas.72.8.3181; Gupta Y, 2008, CRIT REV THER DRUG, V25, P347, DOI 10.1615/CritRevTherDrugCarrierSyst.v25.i4.20; Hannibal L, 2009, MOL GENET METAB, V97, P260, DOI 10.1016/j.ymgme.2009.04.005; HOGENKAMP HPC, 1987, BIOCHEMISTRY-US, V26, P4723, DOI 10.1021/bi00389a019; HOGENKAMP HPC, 1985, BIOCHEMISTRY-US, V24, P6428, DOI 10.1021/bi00344a018; Kim J, 2008, P NATL ACAD SCI USA, V105, P14551, DOI 10.1073/pnas.0805989105; KOLHOUSE JF, 1977, P NATL ACAD SCI USA, V74, P921, DOI 10.1073/pnas.74.3.921; Lerner-Ellis JP, 2006, NAT GENET, V38, P93, DOI 10.1038/ng1683; LEXA D, 1983, ACCOUNTS CHEM RES, V16, P235, DOI 10.1021/ar00091a001; MARTIN BD, 1992, J AM CHEM SOC, V114, P585, DOI 10.1021/ja00028a027; Matthews RG, 2001, ACCOUNTS CHEM RES, V34, P681, DOI 10.1021/ar0000051; MELLMAN I, 1979, J BIOL CHEM, V254, P1847; MELLMAN IS, 1977, P NATL ACAD SCI USA, V74, P916, DOI 10.1073/pnas.74.3.916; Mosharov E, 2000, BIOCHEMISTRY-US, V39, P13005, DOI 10.1021/bi001088w; Olteanu H, 2001, J BIOL CHEM, V276, P35558, DOI 10.1074/jbc.M103707200; Padovani D, 2006, BIOCHEMISTRY-US, V45, P2951, DOI 10.1021/bi051742d; Paine MJI, 2000, J BIOL CHEM, V275, P1471, DOI 10.1074/jbc.275.2.1471; Rosenblatt D. S., 2001, METABOLIC MOL BASES, V8th, P3897; SHEVELL MI, 1992, CAN J NEUROL SCI, V19, P472, DOI 10.1017/S0317167100041676; WILLARD HF, 1978, AM J HUM GENET, V30, P1	30	84	87	5	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33418	33424		10.1074/jbc.M109.057877	http://dx.doi.org/10.1074/jbc.M109.057877			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801555	hybrid, Green Published			2022-12-27	WOS:000272028500048
J	Noorwez, SM; Sama, RRK; Kaushal, S				Noorwez, Syed M.; Sama, Reddy Ranjith K.; Kaushal, Shalesh			Calnexin Improves the Folding Efficiency of Mutant Rhodopsin in the Presence of Pharmacological Chaperone 11-cis-Retinal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMINANT RETINITIS-PIGMENTOSA; ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; MOLECULAR CHAPERONES; CELL-SURFACE; WILD-TYPE; EXPRESSION; RECEPTOR; PROTEIN; DISEASES	The lectin chaperone calnexin (Cnx) is important for quality control of glycoproteins, and the chances of correct folding of a protein increase the longer the protein interacts with Cnx. Mutations in glycoproteins increase their association with Cnx, and these mutant proteins are retained in the endoplasmic reticulum. However, until now, the increased interaction with Cnx was not known to increase the folding of mutant glycoproteins. Because many human diseases result from glycoprotein misfolding, a Cnx-assisted folding of mutant glycoproteins could be beneficial. Mutations of rhodopsin, the glycoprotein pigment of rod photoreceptors, cause misfolding resulting in retinitis pigmentosa. Despite the critical role of Cnx in glycoprotein folding, surprisingly little is known about its interaction with rhodopsin or whether this interaction could be modulated to increase the folding of mutant rhodopsin. Here, we demonstrate that Cnx preferentially associates with misfolded mutant opsins associated with retinitis pigmentosa. Furthermore, the overexpression of Cnx leads to an increased accumulation of misfolded P23H opsin but not the correctly folded protein. Finally, we demonstrate that increased levels of Cnx in the presence of the pharmacological chaperone 11-cis-retinal increase the folding efficiency and result in an increase in correct folding of mutant rhodopsin. These results demonstrate that misfolded rather than correctly folded rhodopsin is a substrate for Cnx and that the interaction between Cnx and mutant, misfolded rhodopsin, can be targeted to increase the yield of folded mutant protein.	[Noorwez, Syed M.; Sama, Reddy Ranjith K.; Kaushal, Shalesh] Univ Massachusetts, Sch Med, Dept Ophthalmol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester		shalesh.kaushal@umassmemorial.org			Research to Prevent Blindness; Charlie Mack Overstreet Retinal Diseases Fund	Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Charlie Mack Overstreet Retinal Diseases Fund	This work was supported by Research to Prevent Blindness (unrestricted grant) and Charlie Mack Overstreet Retinal Diseases Fund.	Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Barral JM, 2004, SEMIN CELL DEV BIOL, V15, P17, DOI 10.1016/j.semcdb.2003.12.010; Bradley CA, 2008, J BIOL CHEM, V283, P22043, DOI 10.1074/jbc.M801708200; Brothers SP, 2006, J MOL ENDOCRINOL, V37, P479, DOI 10.1677/jme.1.02142; Butz JA, 2003, BIOTECHNOL BIOENG, V84, P292, DOI 10.1002/bit.10771; Deretic D, 2006, VISION RES, V46, P4427, DOI 10.1016/j.visres.2006.07.028; Dickson KM, 2002, P NATL ACAD SCI USA, V99, P9852, DOI 10.1073/pnas.152621799; Ellgaard L, 2003, CELL BIOCHEM BIOPHYS, V39, P223, DOI 10.1385/CBB:39:3:223; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Esapa CT, 2005, HUM MOL GENET, V14, P295, DOI 10.1093/hmg/ddi026; Farinha CA, 2005, MOL CELL BIOL, V25, P5242, DOI 10.1128/MCB.25.12.5242-5252.2005; Frederick JM, 2001, INVEST OPHTH VIS SCI, V42, P826; Gong QM, 2006, J BIOL CHEM, V281, P4069, DOI 10.1074/jbc.M511765200; Higgins MK, 2003, BBA-BIOMEMBRANES, V1610, P124, DOI 10.1016/S0005-2736(02)00715-0; Illing ME, 2002, J BIOL CHEM, V277, P34150, DOI 10.1074/jbc.M204955200; Katanosaka K, 1998, FEBS LETT, V424, P149, DOI 10.1016/S0014-5793(98)00160-4; KAUSHAL S, 1994, BIOCHEMISTRY-US, V33, P6121, DOI 10.1021/bi00186a011; Kim PS, 2008, MOL ENDOCRINOL, V22, P477, DOI 10.1210/me.2007-0183; Klabunde J, 2007, FEMS YEAST RES, V7, P1168, DOI 10.1111/j.1567-1364.2007.00271.x; Kosmaoglou M, 2008, MOL VIS, V14, P2466; Krebs MP, 2009, INVEST OPHTH VIS SCI, V50, P2956, DOI 10.1167/iovs.08-3116; LE AQ, 1994, J BIOL CHEM, V269, P7514; Leskela TT, 2007, J BIOL CHEM, V282, P23171, DOI 10.1074/jbc.M610896200; Markkanen PMH, 2008, J BIOL CHEM, V283, P29086, DOI 10.1074/jbc.M801880200; Morello JP, 2001, BIOCHEMISTRY-US, V40, P6766, DOI 10.1021/bi002699r; Mu TW, 2008, CELL, V134, P769, DOI 10.1016/j.cell.2008.06.037; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Noorwez SM, 2004, J BIOL CHEM, V279, P16278, DOI 10.1074/jbc.M312101200; Noorwez SM, 2003, J BIOL CHEM, V278, P14442, DOI 10.1074/jbc.M300087200; Noorwez SM, 2008, INVEST OPHTH VIS SCI, V49, P3224, DOI 10.1167/iovs.07-1539; Okada T, 2001, CURR OPIN STRUC BIOL, V11, P420, DOI 10.1016/S0959-440X(00)00227-X; Okiyoneda T, 2008, BBA-MOL CELL RES, V1783, P1585, DOI 10.1016/j.bbamcr.2008.04.002; Paulsson K, 2003, BBA-MOL CELL RES, V1641, P1, DOI 10.1016/S0167-4889(03)00048-X; Prasad SA, 1998, EUR J IMMUNOL, V28, P907, DOI 10.1002/(SICI)1521-4141(199803)28:03<907::AID-IMMU907>3.3.CO;2-W; Rattner A, 1999, ANNU REV GENET, V33, P89, DOI 10.1146/annurev.genet.33.1.89; Robert J, 2005, J BIOL CHEM, V280, P42198, DOI 10.1074/jbc.M510180200; Rosenbaum EE, 2006, NEURON, V49, P229, DOI 10.1016/j.neuron.2005.12.011; Saliba RS, 2002, J CELL SCI, V115, P2907; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P8840, DOI 10.1073/pnas.88.19.8840; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532	40	35	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33333	33342		10.1074/jbc.M109.043364	http://dx.doi.org/10.1074/jbc.M109.043364			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801547	Green Published, hybrid			2022-12-27	WOS:000272028500038
J	Huart, AS; MacLaine, NJ; Meek, DW; Hupp, TR				Huart, Anne-Sophie; MacLaine, Nicola J.; Meek, David W.; Hupp, Ted R.			CK1 alpha Plays a Central Role in Mediating MDM2 Control of p53 and E2F-1 Protein Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTORS; IN-VITRO; PHOSPHORYLATION; DOMAIN; CASEIN-KINASE-1; UBIQUITINATION; STABILIZATION; INHIBITION; PATHWAY; BINDING	The ubiquitin ligase murine double minute clone 2 (MDM2) mediates ubiquitination and degradation of the tumor suppressor p53. The activation and stabilization of p53 by contrast is maintained by enzymes catalyzing p53 phosphorylation and acetylation. Casein kinase 1 (CK1) is one such enzyme; it stimulates p53 after transforming growth factor-beta treatment, irradiation, or DNA virus infection. We analyzed whether CK1 regulates p53 protein stability in unstressed conditions. Depletion of CK1 using small interfering RNA or inhibition of CK1 using the kinase inhibitor (D4476) activated p53 and destabilized E2F-1, indicating that steady-state levels of these proteins are controlled by CK1. Co-immunoprecipitation of endogenous CK1 with MDM2 occurred in undamaged cells, indicating the existence of a stable multiprotein complex, and as such, we evaluated whether the MDM2 Nutlin had similar pharmacological properties to the CK1 inhibitor D4476. Indeed, D4476 or Nutlin treatments resulted in the same p53 and E2F-1 steady-state protein level changes, indicating that the MDM2 center dot CK1 complex is both a negative regulator of p53 and a positive regulator of E2F-1 in undamaged cells. Although the treatment of cells with D4476 resulted in a partial p53-dependent growth arrest, the induction of p53-independent apoptosis by D4476 suggested a critical role for the MDM2 center dot CK1 complex in maintaining E2F-1 anti-apoptotic signaling. These data highlighting a pharmacological similarity between MDM2 and CK1 small molecule inhibitors and the fact that CK1 and MDM2 form a stable complex suggest that the MDM2 center dot CK1 complex is a component of a genetic pathway that co-regulates the stability of the p53 and E2F-1 transcription factors.	[Huart, Anne-Sophie; MacLaine, Nicola J.; Hupp, Ted R.] Univ Edinburgh, Inst Genet & Mol Med, Div Canc Biol, CRUK Signal Transduct Grp P53, Edinburgh EH4 2XR, Midlothian, Scotland; [Meek, David W.] Univ Dundee, Sch Med, Dundee DD1 9SY, Scotland; [Meek, David W.] Ninewells Hosp, Biomed Res Ctr, Dundee DD1 9SY, Scotland	University of Edinburgh; University of Dundee; University of Dundee	Hupp, TR (corresponding author), Univ Edinburgh, Inst Genet & Mol Med, Div Canc Biol, CRUK Signal Transduct Grp P53, Crewe Rd S, Edinburgh EH4 2XR, Midlothian, Scotland.	ted.hupp@ed.ac.uk		Huart, Anne-Sophie/0000-0003-0913-1501	Cancer Research UK [C483/A10706]	Cancer Research UK(Cancer Research UK)	Supported by a Ph.D. studentship from the Cancer Research UK (C483/A10706).	Ambrosini G, 2007, ONCOGENE, V26, P3473, DOI 10.1038/sj.onc.1210136; Blattner C, 2002, MOL CELL BIOL, V22, P6170, DOI 10.1128/MCB.22.17.6170-6182.2002; Bouska A, 2009, TRENDS BIOCHEM SCI, V34, P279, DOI 10.1016/j.tibs.2009.02.006; Chen LH, 2005, MOL CELL BIOL, V25, P6509, DOI 10.1128/MCB.25.15.6509-6520.2005; Harms K, 2004, CELL MOL LIFE SCI, V61, P822, DOI 10.1007/s00018-003-3304-4; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Iwakuma T, 2003, MOL CANCER RES, V1, P993; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; Knippschild U, 1997, ONCOGENE, V15, P1727, DOI 10.1038/sj.onc.1201541; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Loughran O, 2000, MOL CELL BIOL, V20, P2186, DOI 10.1128/MCB.20.6.2186-2197.2000; MacLaine NJ, 2008, J BIOL CHEM, V283, P28563, DOI 10.1074/jbc.M804433200; Marine JC, 2006, CELL DEATH DIFFER, V13, P927, DOI 10.1038/sj.cdd.4401912; MARTIN K, 1995, NATURE, V375, P691, DOI 10.1038/375691a0; MITTNACHT S, 1991, CELL, V65, P381, DOI 10.1016/0092-8674(91)90456-9; Pettersson S, 2009, BIOCHEM J, V418, P575, DOI 10.1042/BJ20082087; Popowicz GM, 2007, CELL CYCLE, V6, P2386, DOI 10.4161/cc.6.19.4740; Rena G, 2004, EMBO REP, V5, P60, DOI 10.1038/sj.embor.7400048; Sakaguchi K, 2000, J BIOL CHEM, V275, P9278, DOI 10.1074/jbc.275.13.9278; Stevens C, 2008, FEBS J, V275, P4875, DOI 10.1111/j.1742-4658.2008.06627.x; Tabe Y, 2009, CLIN CANCER RES, V15, P933, DOI 10.1158/1078-0432.CCR-08-0399; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Wallace M, 2006, MOL CELL, V23, P251, DOI 10.1016/j.molcel.2006.05.029; Winter M, 2004, BIOCHEMISTRY-US, V43, P16356, DOI 10.1021/bi0489255; Worrall Erin G, 2009, J Chem Biol, V2, P113, DOI 10.1007/s12154-009-0019-5; Zhang Z, 2005, ONCOGENE, V24, P7238, DOI 10.1038/sj.onc.1208814	26	69	79	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32384	32394		10.1074/jbc.M109.052647	http://dx.doi.org/10.1074/jbc.M109.052647			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19759023	hybrid, Green Published			2022-12-27	WOS:000272028400021
J	Shim, MS; Kim, JY; Jung, HK; Lee, KH; Xu, XM; Carlson, BA; Kim, KW; Kim, IY; Hatfield, DL; Lee, BJ				Shim, Myoung Sup; Kim, Jin Young; Jung, Hee Kyoung; Lee, Kwang Hee; Xu, Xue-Ming; Carlson, Bradley A.; Kim, Ki Woo; Kim, Ick Young; Hatfield, Dolph L.; Lee, Byeong Jae			Elevation of Glutamine Level by Selenophosphate Synthetase 1 Knockdown Induces Megamitochondrial Formation in Drosophila Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELENOPROTEIN SYNTHESIS; SELENOCYSTEINE TRANSFER; INDUCED APOPTOSIS; ESCHERICHIA-COLI; IN-VITRO; SELENIUM; GENE; HOMOLOG; VIVO; IDENTIFICATION	Although selenophosphate synthetase 1 (SPS1/SelD) is an essential gene in Drosophila, its function has not been determined. To elucidate its intracellular role, we targeted the removal of SPS1/SelD mRNA in Drosophila SL2 cells using RNA interference technology that led to the formation of vacuole-like globular structures. Surprisingly, these structures were identified as megamitochondria, and only depolarized mitochondria developed into megamitochondria. The mRNA levels of l(2) 01810 and glutamine synthetase 1 (GS1) were increased by SPS1/SelD knockdown. Blocking the expression of GS1 and l(2) 01810 completely inhibited the formation of megamitochondria induced by loss of SPS1/SelD activity and decreased the intracellular levels of glutamine to those of control cells suggesting that the elevated level of glutamine is responsible for megamitochondrial formation. Overexpression of GS1 and l(2) 01810 had a synergistic effect on the induction of megamitochondrial formation and on the synthesis of glutamine suggesting that l(2) 01810 is involved in glutamine synthesis presumably by activating GS1. Our results indicate that, in Drosophila, SPS1/SelD regulates the intracellular glutamine by inhibiting GS1 and l(2) 01810 expression and that elevated levels of glutamine lead to a nutritional stress that provides a signal for megamitochondrial formation.	[Shim, Myoung Sup; Kim, Jin Young; Jung, Hee Kyoung; Lee, Kwang Hee; Lee, Byeong Jae] Seoul Natl Univ, Sch Biol Sci, Inst Mol Biol & Genet, Lab Mol Genet & Genom, Seoul 151742, South Korea; [Xu, Xue-Ming; Carlson, Bradley A.; Hatfield, Dolph L.] NCI, Lab Canc Prevent, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Kim, Ki Woo] Seoul Natl Univ, Coll Agr & Life Sci, Natl Instrumentat Ctr Environm Management, Seoul 151742, South Korea; [Kim, Ick Young] Korea Univ, Sch Life Sci & Biotechnol, Lab Cellular & Mol Biochem, Seoul 136701, South Korea	Seoul National University (SNU); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Seoul National University (SNU); Korea University	Lee, BJ (corresponding author), Seoul Natl Univ, Sch Biol Sci, Inst Mol Biol & Genet, Lab Mol Genet & Genom, Bldg 504,Rm 523, Seoul 151742, South Korea.	imbglmg@snu.ac.kr	Kim, Ki Woo/AAC-5623-2022	Kim, Ki Woo/0000-0002-7010-0336	Korean Government [KRF-2005-070-C00086, KRF-2008-005-J00201]; NCI, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010767, ZIABC005317] Funding Source: NIH RePORTER	Korean Government(Korean Government); NCI, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Korea Research Foundation Grants KRF-2005-070-C00086 and KRF-2008-005-J00201 funded by the Korean Government (Ministry of Education, Science, and Technology) (to B. J. L.). This work was also supported in part by a National Institutes of Health Intramural Research Program grant from NCI, Center for Cancer Research.	ALBERTS B, 2001, MOL BIOL CELL, P769; Allmang C, 2009, BBA-GEN SUBJECTS, V1790, P1415, DOI 10.1016/j.bbagen.2009.03.003; Alsina B, 1998, MOL GEN GENET, V257, P113, DOI 10.1007/s004380050630; BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; Boosalis MG, 2008, NUTR CLIN PRACT, V23, P152, DOI 10.1177/0884533608314532; Brigelius-Flohe R, 2008, CHEM BIODIVERS, V5, P389, DOI 10.1002/cbdv.200890039; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; CAIZZI R, 1990, J MOL BIOL, V212, P17, DOI 10.1016/0022-2836(90)90301-2; Carlson BA, 2005, J BIOL CHEM, V280, P5542, DOI 10.1074/jbc.M411725200; Chen CL, 2006, BIOCHEM BIOPH RES CO, V348, P1296, DOI 10.1016/j.bbrc.2006.07.203; CLAUDE A, 1946, J EXP MED, V84, P61, DOI 10.1084/jem.84.1.61; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; EHRENREICH A, 1992, EUR J BIOCHEM, V206, P767, DOI 10.1111/j.1432-1033.1992.tb16983.x; Flohe L, 2007, BIOL CHEM, V388, P987, DOI 10.1515/BC.2007.112; Gao WH, 2001, J CELL SCI, V114, P2855; GLASS RS, 1993, BIOCHEMISTRY-US, V32, P12555, DOI 10.1021/bi00210a001; Guimaraes MJ, 1996, P NATL ACAD SCI USA, V93, P15086, DOI 10.1073/pnas.93.26.15086; HALESTRAP AP, 1989, BIOCHIM BIOPHYS ACTA, V973, P355, DOI 10.1016/S0005-2728(89)80378-0; Han KH, 1996, NUCLEIC ACIDS RES, V24, P4362, DOI 10.1093/nar/24.21.4362; Hatfield D.L., 2002, SELENIUM ITS MOL BIO, V36, P235, DOI 10.1080/10715760290006394; Hatfield DL, 2002, MOL CELL BIOL, V22, P3565, DOI 10.1128/MCB.22.11.3565-3576.2002; Hoffmann PR, 2008, MOL NUTR FOOD RES, V52, P1273, DOI 10.1002/mnfr.200700330; Jin JS, 2004, NUCLEIC ACIDS RES, V32, P2482, DOI 10.1093/nar/gkh569; Kaasik A, 2007, AM J PHYSIOL-CELL PH, V292, pC157, DOI 10.1152/ajpcell.00272.2006; Karbowski M, 1999, FREE RADICAL BIO MED, V26, P396, DOI 10.1016/S0891-5849(98)00209-3; Kim M, 2003, BIOCHEM BIOPH RES CO, V306, P1106, DOI 10.1016/S0006-291X(03)01069-6; Kim SK, 2003, PEPTIDES, V24, P945, DOI 10.1016/S0196-9781(03)00194-3; LAMAR C, 1965, BIOCHEM PHARMACOL, V14, P489, DOI 10.1016/0006-2952(65)90222-4; LEE BJ, 1990, MOL CELL BIOL, V10, P1940, DOI 10.1128/MCB.10.5.1940; LEE BJ, 1989, J BIOL CHEM, V264, P9724; LEINFELDER W, 1990, P NATL ACAD SCI USA, V87, P543, DOI 10.1073/pnas.87.2.543; LEINFELDER W, 1989, J BIOL CHEM, V264, P9720; Lim KHH, 2002, J PHYSIOL-LONDON, V545, P961, DOI 10.1113/jphysiol.2002.031484; Lobanov AV, 2008, PROTEIN SCI, V17, P176, DOI 10.1110/ps.073261508; Longtin R, 2004, J NATL CANCER I, V96, P504, DOI 10.1093/jnci/96.7.504; LOW SC, 1995, J BIOL CHEM, V270, P21659, DOI 10.1074/jbc.270.37.21659; Lu J, 2009, J BIOL CHEM, V284, P723, DOI 10.1074/jbc.R800045200; Lund P, 1986, METHOD ENZYMAT AN, P357; Morey M, 2003, J CELL SCI, V116, P4597, DOI 10.1242/jcs.00783; Morey M, 2001, DEV BIOL, V238, P145, DOI 10.1006/dbio.2001.0389; PALADE GE, 1952, ANAT RECORD, V114, P427, DOI 10.1002/ar.1091140304; Peng TI, 2004, ANN NY ACAD SCI, V1011, P112, DOI 10.1196/annals.1293.012; Poot M, 1996, J HISTOCHEM CYTOCHEM, V44, P1363, DOI 10.1177/44.12.8985128; Rao KVR, 2003, NEUROCHEM INT, V43, P517, DOI 10.1016/S0197-0186(03)00042-1; Rayman MP, 2009, BBA-GEN SUBJECTS, V1790, P1533, DOI 10.1016/j.bbagen.2009.03.014; Senoo-Matsuda N, 2005, EMBO J, V24, P2700, DOI 10.1038/sj.emboj.7600721; SMILEY ST, 1991, P NATL ACAD SCI USA, V88, P3671, DOI 10.1073/pnas.88.9.3671; Squires JE, 2008, IUBMB LIFE, V60, P232, DOI 10.1002/iub.38; Stadtman ER, 2001, J BIOL CHEM, V276, P44357, DOI 10.1074/jbc.R100055200; TANDLER B, 1986, ANN NY ACAD SCI, V488, P65; TANDLER B, 1968, AM J PATHOL, V52, P69; Teranishi M, 1999, J ELECTRON MICROSC, V48, P637, DOI 10.1093/oxfordjournals.jmicro.a023730; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; Wakabayashi T, 2002, J CELL MOL MED, V6, P497, DOI 10.1111/j.1582-4934.2002.tb00452.x; Xu XM, 2007, PLOS BIOL, V5, P96, DOI 10.1371/journal.pbio.0050004; Xu XM, 2007, BIOCHEM J, V404, P115, DOI 10.1042/BJ20070165; ZARAGOZA R, 1987, ARCH BIOCHEM BIOPHYS, V258, P426, DOI 10.1016/0003-9861(87)90364-X	57	26	28	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32881	32894		10.1074/jbc.M109.026492	http://dx.doi.org/10.1074/jbc.M109.026492			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19755423	Green Published, hybrid			2022-12-27	WOS:000272028400072
J	Cekic, C; Casella, CR; Eaves, CA; Matsuzawa, A; Ichijo, H; Mitchell, TC				Cekic, Caglar; Casella, Carolyn R.; Eaves, Chelsea A.; Matsuzawa, Atsushi; Ichijo, Hidenori; Mitchell, Thomas C.			Selective Activation of the p38 MAPK Pathway by Synthetic Monophosphoryl Lipid A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IFN-REGULATORY FACTOR-3; PROTEIN-KINASES; GENE-EXPRESSION; HELICOBACTER-PYLORI; SIGNALING PATHWAYS; ADAPTIVE IMMUNITY; DENDRITIC CELLS; CUTTING EDGE; LIPOPOLYSACCHARIDE; ADJUVANT	TLR4 stimulation by lipopolysaccharide can cause both MAL/MyD88- and TRAM/TRIF (Toll IL-1 receptor domain-containing adaptor-inducing IFN beta)-dependent signaling events. Monophosphoryl lipid A (MPLA), a low toxicity derivative of endotoxic lipopolysaccharide, enhances antibody responses, T cell expansion, and recall responses against antigens without causing excessive inflammatory side effects. Previously, we proposed that TRIF-biased activation of TLR4 by MPLA is responsible for its reduced toxicity while retaining potent adjuvant effects. However, some TRIF-associated genes, such as MCP-1, are only weakly expressed, and some MyD88-associated inflammatory and anti-inflammatory cytokines, such as tumor necrosis factor alpha and interleukin-10, are strongly activated after MPLA stimulation despite weak NF-kappa B but strong IRF3 activation. We now report that synthetic derivatives of MPLA retained TRIF bias as compared with synthetic diphosphoryl lipid A, indicating a change in a single phosphoryl group is sufficient for TRIF-biased TLR4 stimulation. We extend our previous observations by showing that sMLA induces strong p38 MAPK but weak JNK activation, resulting in high IP-10 (interferon-inducible protein 10), tumor necrosis factor alpha, and interleukin-10 but low MCP-1 transcript levels. Results of this study identify a novel biochemical mechanism for regulation of sMLA-induced gene expression.	[Cekic, Caglar; Casella, Carolyn R.; Eaves, Chelsea A.; Mitchell, Thomas C.] Univ Louisville, Inst Cellular Therapeut, Sch Med, Donald Baxter Res Bldg,570 S Preston St,Rm 410, Louisville, KY 40202 USA; Univ Louisville, Dept Microbiol & Immunol, Sch Med, Louisville, KY 40202 USA; [Matsuzawa, Atsushi; Ichijo, Hidenori] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Cell Signaling, Tokyo 1130033, Japan	University of Louisville; University of Louisville; University of Tokyo	Mitchell, TC (corresponding author), Univ Louisville, Inst Cellular Therapeut, Sch Med, Donald Baxter Res Bldg,570 S Preston St,Rm 410, Louisville, KY 40202 USA.	tom.mitchell@louisville.edu	Mitchell, Thomas C/B-4193-2013; Matsuzawa, Atsushi/GLU-1387-2022	Matsuzawa, Atsushi/0000-0001-8303-3905; Cekic, Caglar/0000-0001-8081-508X; Ichijo, Hidenori/0000-0002-5005-6438	National Institutes of Health [AI071047, AI059023]; American Heart Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071047, K02AI059023] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI071047 and AI059023 (to T. C. M.). This work was also supported by an American Heart Association Predoctoral fellowship (to C. C.).	Alderson MR, 2006, J ENDOTOXIN RES, V12, P313, DOI 10.1179/096805106X118753; Arndt PG, 2004, J BIOL CHEM, V279, P10883, DOI 10.1074/jbc.M309901200; Basak C, 2005, J BIOL CHEM, V280, P4279, DOI 10.1074/jbc.M412820200; Bohnenkamp HR, 2007, CELL IMMUNOL, V247, P72, DOI 10.1016/j.cellimm.2007.07.008; Chiang E, 2006, J IMMUNOL, V176, P5720, DOI 10.4049/jimmunol.176.10.5720; Cohen P, 2009, CURR OPIN CELL BIOL, V21, P317, DOI 10.1016/j.ceb.2009.01.015; Dang O, 2004, J IMMUNOL, V172, P747, DOI 10.4049/jimmunol.172.2.747; Del Corno M, 2009, BLOOD, V114, P796, DOI 10.1182/blood-2009-01-199406; Dixon DR, 2005, J DENT RES, V84, P584, DOI 10.1177/154405910508400702; Evans Jay T, 2003, Expert Rev Vaccines, V2, P219, DOI 10.1586/14760584.2.2.219; Foey AD, 1998, J IMMUNOL, V160, P920; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Horwood NJ, 2006, J IMMUNOL, V176, P3635, DOI 10.4049/jimmunol.176.6.3635; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Lasa M, 2000, MOL CELL BIOL, V20, P4265, DOI 10.1128/MCB.20.12.4265-4274.2000; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Martin M, 2003, INFECT IMMUN, V71, P2498, DOI 10.1128/IAI.71.5.2498-2507.2003; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; Mestre JR, 2001, J BIOL CHEM, V276, P3977, DOI 10.1074/jbc.M005077200; Navarro L, 1999, J BIOL CHEM, V274, P35535, DOI 10.1074/jbc.274.50.35535; Okemoto K, 2006, J IMMUNOL, V176, P1203, DOI 10.4049/jimmunol.176.2.1203; Park SM, 2008, J IMMUNOL, V181, P6447, DOI 10.4049/jimmunol.181.9.6447; Rincon M, 2009, IMMUNOL REV, V228, P212, DOI 10.1111/j.1600-065X.2008.00744.x; Salkowski CA, 1997, INFECT IMMUN, V65, P3239, DOI 10.1128/IAI.65.8.3239-3247.1997; Salmon RA, 2001, EUR J IMMUNOL, V31, P3218, DOI 10.1002/1521-4141(200111)31:11<3218::AID-IMMU3218>3.0.CO;2-9; Spiller S, 2007, J BIOL CHEM, V282, P13190, DOI 10.1074/jbc.M610340200; Sukhumavasi W, 2008, J IMMUNOL, V181, P3464, DOI 10.4049/jimmunol.181.5.3464; Thompson BS, 2005, J LEUKOCYTE BIOL, V78, P1273, DOI 10.1189/jlb.0305172; Thornton TM, 2008, SCIENCE, V320, P667, DOI 10.1126/science.1156037; Tran AX, 2006, J BACTERIOL, V188, P4531, DOI 10.1128/JB.00146-06; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wheeler AW, 2001, INT ARCH ALLERGY IMM, V126, P135, DOI 10.1159/000049504; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986	40	67	69	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31982	31991		10.1074/jbc.M109.046383	http://dx.doi.org/10.1074/jbc.M109.046383			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19759006	hybrid, Green Published			2022-12-27	WOS:000271572700054
J	Szwagierczak, A; Antonenka, U; Popowicz, GM; Sitar, T; Holak, TA; Rakin, A				Szwagierczak, Aleksandra; Antonenka, Uladzimir; Popowicz, Grzegorz M.; Sitar, Tomasz; Holak, Tad A.; Rakin, Alexander			Structures of the Arm-type Binding Domains of HPI and HAI7 Integrases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LAMBDA-INTEGRASE; NMR STRUCTURE; TRANSFER-RNA; DNA; PROTEIN; RECOMBINATION; RECOGNITION; REFINEMENT; ISLANDS; COMPLEX	The structures of the N-terminal domains of two integrases of closely related but not identical asn tDNA-associated genomic islands, Yersinia HPI (high pathogenicity island; encoding siderophore yersiniabactin biosynthesis and transport) and an Erwinia carotovora genomic island with yet unknown function, HAI7, have been resolved. Both integrases utilize a novel four-stranded beta-sheet DNA-binding motif, in contrast to the known proteins that bind their DNA targets by means of three-stranded beta-sheets. Moreover, the beta-sheets in Int(HPI) and Int(HAI7) are longer than those in other integrases, and the structured helical N terminus is positioned perpendicularly to the large C-terminal helix. These differences strongly support the proposal that the integrases of the genomic islands make up a distinct evolutionary branch of the site-specific recombinases that utilize a unique DNA-binding mechanism.	[Antonenka, Uladzimir; Rakin, Alexander] Univ Munich, Max Von Pettenkofer Inst, D-80336 Munich, Germany; Max Planck Inst Biochem, D-82152 Martinsried, Germany	University of Munich; Max Planck Society	Rakin, A (corresponding author), Univ Munich, Max Von Pettenkofer Inst, Pettenkoferstr 9A, D-80336 Munich, Germany.	rakin@mvp.uni-muenchen.de	Popowicz, Grzegorz/G-4769-2017	Popowicz, Grzegorz/0000-0003-2818-7498	Deutsche Forschungsgemeinschaft [RA 991/1-2, RA 991/1-3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was supported by Deutsche Forschungsgemeinschaft Grants RA 991/1-2 and RA 991/1-3.	Allen MD, 1998, EMBO J, V17, P5484, DOI 10.1093/emboj/17.18.5484; Antonenka U, 2006, INT J MED MICROBIOL, V296, P341, DOI 10.1016/j.ijmm.2006.02.021; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balding C, 2005, ENVIRON MICROBIOL, V7, P1558, DOI 10.1111/j.1462-2920.2005.00845.x; Bell KS, 2004, P NATL ACAD SCI USA, V101, P11105, DOI 10.1073/pnas.0402424101; Biswas T, 2005, NATURE, V435, P1059, DOI 10.1038/nature03657; Boyd EF, 2009, TRENDS MICROBIOL, V17, P47, DOI 10.1016/j.tim.2008.11.003; Connolly KM, 1998, NAT STRUCT BIOL, V5, P546, DOI 10.1038/799; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; Fadeev EA, 2009, J MOL BIOL, V388, P682, DOI 10.1016/j.jmb.2009.03.041; Hacker J, 1997, MOL MICROBIOL, V23, P1089, DOI 10.1046/j.1365-2958.1997.3101672.x; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Nougayrede JP, 2006, SCIENCE, V313, P848, DOI 10.1126/science.1127059; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Rakin A, 2001, MOL MICROBIOL, V39, P407, DOI 10.1046/j.1365-2958.2001.02227.x; RAKIN A, 1999, HIGH PATHOGENICITY I; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Williams KP, 2002, NUCLEIC ACIDS RES, V30, P866, DOI 10.1093/nar/30.4.866; Wojciak JM, 1999, NAT STRUCT BIOL, V6, P366; Wojciak JM, 2002, P NATL ACAD SCI USA, V99, P3434, DOI 10.1073/pnas.052017999	23	2	2	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31664	31671		10.1074/jbc.M109.059261	http://dx.doi.org/10.1074/jbc.M109.059261			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19737930	hybrid, Green Published			2022-12-27	WOS:000271572700021
J	Yuan, Q; McHenry, CS				Yuan, Quan; McHenry, Charles S.			Strand Displacement by DNA Polymerase III Occurs through a tau-psi-chi Link to Single-stranded DNA-binding Protein Coating the Lagging Strand Template	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI REPLICATION PROTEINS; CLAMP-LOADER COMPLEX; ESCHERICHIA-COLI; DISTINCT DOMAINS; BETA-SUBUNIT; GAMMA-SUBUNIT; CRYSTAL-STRUCTURE; ALPHA-SUBUNIT; DELTA-DELTA'; SSB PROTEIN	In addition to the well characterized processive replication reaction catalyzed by the DNA polymerase III holoenzyme on single-stranded DNA templates, the enzyme possesses an intrinsic strand displacement activity on flapped templates. The strand displacement activity is distinguished from the single-stranded DNA-templated reaction by a high dependence upon single-stranded DNA binding protein and an inability of gamma-complex to support the reaction in the absence of tau. However, if gamma-complex is present to load beta(2), a truncated tau protein containing only domains III-V will suffice. This truncated protein is sufficient to bind both the alpha subunit of DNA polymerase (Pol) III and chi psi. This is reminiscent of the minimal requirements for Pol III to replicate short single-stranded DNA-binding protein (SSB)-coated templates where tau is only required to serve as a scaffold to hold Pol III and chi in the same complex (Glover, B., and McHenry, C. (1998) J. Biol. Chem. 273, 23476-23484). We propose a model in which strand displacement by DNA polymerase III holoenzyme depends upon a Pol III-tau-psi-chi-SSB binding network, where SSB is bound to the displaced strand, stabilizing the Pol III-template interaction. The same interaction network is probably important for stabilizing the leading strand polymerase interactions with authentic replication forks. The specificity constant (k(cat)/K-m) for the strand displacement reaction is similar to 300-fold less favorable than reactions on single-stranded templates and proceeds with a slower rate (150 nucleotides/s) and only moderate processivity (similar to 300 nucleotides). PriA, the initiator of replication restart on collapsed or misassembled replication forks, blocks the strand displacement reaction, even if added to an ongoing reaction.	[Yuan, Quan; McHenry, Charles S.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	McHenry, CS (corresponding author), Univ Colorado, Dept Chem & Biochem, Campus Box 215, Boulder, CO 80309 USA.	charles.mchenry@colorado.edu	yuan, quan/GZM-5597-2022		National Institutes of Health [R01 GM035695, T32 GM-065103]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065103, R01GM035695] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM035695 and T32 GM-065103 (Molecular Biophysics Training Grant to Q. Y.).	BLINKOWA AL, 1990, NUCLEIC ACIDS RES, V18, P1725, DOI 10.1093/nar/18.7.1725; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Canceill D, 1996, P NATL ACAD SCI USA, V93, P6647, DOI 10.1073/pnas.93.13.6647; Clover BP, 2001, CELL, V105, P925, DOI 10.1016/S0092-8674(01)00400-7; DALLMANN HG, 1995, J BIOL CHEM, V270, P29563, DOI 10.1074/jbc.270.49.29563; Dohrmann PR, 2005, J MOL BIOL, V350, P228, DOI 10.1016/j.jmb.2005.04.065; FLOWER AM, 1990, P NATL ACAD SCI USA, V87, P3713, DOI 10.1073/pnas.87.10.3713; Gao DX, 2001, J BIOL CHEM, V276, P4447, DOI 10.1074/jbc.M009827200; Gao DX, 2001, J BIOL CHEM, V276, P4441, DOI 10.1074/jbc.M009830200; Gao DX, 2001, J BIOL CHEM, V276, P4433, DOI 10.1074/jbc.M009828200; Glover BP, 2000, J BIOL CHEM, V275, P3017, DOI 10.1074/jbc.275.5.3017; Glover BP, 2001, J BIOL CHEM, V276, P35842, DOI 10.1074/jbc.M103719200; Glover BP, 1998, J BIOL CHEM, V273, P23476, DOI 10.1074/jbc.273.36.23476; GRIEP MA, 1989, J BIOL CHEM, V264, P11294; Gulbis JM, 2004, EUR J BIOCHEM, V271, P439, DOI 10.1046/j.1432-1033.2003.03944.x; Hobbs MD, 2007, J BIOL CHEM, V282, P11058, DOI 10.1074/jbc.M611007200; Jeruzalmi D, 2001, CELL, V106, P429, DOI 10.1016/S0092-8674(01)00463-9; JOHANSON KO, 1982, J BIOL CHEM, V257, P2310; JOHANSON KO, 1986, J BIOL CHEM, V261, P1460; Jones CE, 2004, J BIOL CHEM, V279, P25721, DOI 10.1074/jbc.M402128200; Kelman Z, 1998, EMBO J, V17, P2436, DOI 10.1093/emboj/17.8.2436; KELMAN Z, 1995, ANNU REV BIOCHEM, V64, P171, DOI 10.1146/annurev.bi.64.070195.001131; Kim DR, 1996, J BIOL CHEM, V271, P20681, DOI 10.1074/jbc.271.34.20681; Kim DR, 1996, J BIOL CHEM, V271, P20690, DOI 10.1074/jbc.271.34.20690; Kim S, 1996, J BIOL CHEM, V271, P21406, DOI 10.1074/jbc.271.35.21406; Kim SS, 1996, CELL, V84, P643, DOI 10.1016/S0092-8674(00)81039-9; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; LADUCA RJ, 1986, J BIOL CHEM, V261, P7550; McHenry CS, 2003, MOL MICROBIOL, V49, P1157, DOI 10.1046/j.1365-2958.2003.03645.x; MCHENRY CS, 1979, J BIOL CHEM, V254, P1748; ODONNELL ME, 1985, J BIOL CHEM, V260, P2884; OLSON MW, 1995, J BIOL CHEM, V270, P29570, DOI 10.1074/jbc.270.49.29570; Pritchard AE, 2000, EMBO J, V19, P6536, DOI 10.1093/emboj/19.23.6536; Pritchard AE, 2001, J BIOL CHEM, V276, P35217, DOI 10.1074/jbc.M102735200; Roy R, 2007, J MOL BIOL, V369, P1244, DOI 10.1016/j.jmb.2007.03.079; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; Simonetta KR, 2009, CELL, V137, P659, DOI 10.1016/j.cell.2009.03.044; Stephens KM, 1997, J BIOL CHEM, V272, P28800, DOI 10.1074/jbc.272.45.28800; TSUCHIHASHI Z, 1990, P NATL ACAD SCI USA, V87, P2516, DOI 10.1073/pnas.87.7.2516; Witte G, 2003, NUCLEIC ACIDS RES, V31, P4434, DOI 10.1093/nar/gkg498; Xi J, 2005, BIOCHEMISTRY-US, V44, P2305, DOI 10.1021/bi0479508; Xu LW, 2003, MOL CELL, V11, P817, DOI 10.1016/S1097-2765(03)00061-3; Yao N, 2000, J BIOL CHEM, V275, P1421, DOI 10.1074/jbc.275.2.1421	43	35	36	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31672	31679		10.1074/jbc.M109.050740	http://dx.doi.org/10.1074/jbc.M109.050740			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19749191	hybrid, Green Published			2022-12-27	WOS:000271572700022
J	Lee, JH; Wang, F; Schnell, DJ				Lee, Jeonghwa; Wang, Fei; Schnell, Danny J.			Toc Receptor Dimerization Participates in the Initiation of Membrane Translocation during Protein Import into Chloroplasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; ATTOC159 PREPROTEIN RECEPTOR; PRECURSOR PROTEINS; GTP-BINDING; OUTER ENVELOPE; FLORAL-DIP; RECOGNITION; APPARATUS; COMPONENT; MUTANT	The post-translational import of nucleus-encoded preproteins into chloroplasts occurs through multimeric translocons in the outer (Toc) and inner (Tic) membranes. The high fidelity of the protein import process is maintained by specific recognition of the transit peptide of preproteins by the coordinate activities of two homologous GTPase Toc receptors, Toc34 and Toc159. Structural and biochemical studies suggest that dimerization of the Toc receptors functions as a component of the mechanism to control access of preproteins to the membrane translocation channel of the translocon. We show that specific mutations that disrupted receptor dimerization in vitro reduced the rate of protein import in transgenic Arabidopsis compared with the wild type receptor. The mutations did not affect the GTPase activities of the receptors. Interestingly, these mutations did not decrease the initial preprotein binding at the receptors, but they reduced the efficiency of the transition from preprotein binding to membrane translocation. These data indicate that dimerization of receptors has a direct role in protein import and support a hypothesis in which receptor-receptor interactions participate in the initiation of membrane translocation of chloroplast preproteins as part of the molecular mechanism of GTP-regulated protein import.	[Lee, Jeonghwa; Schnell, Danny J.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Lee, Jeonghwa; Schnell, Danny J.] Univ Massachusetts, Program Plant Biol, Amherst, MA 01003 USA; [Wang, Fei] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; Harvard University	Schnell, DJ (corresponding author), Univ Massachusetts, Dept Biochem & Mol Biol, 710 N Pleasant St,913 Lederle GRC, Amherst, MA 01003 USA.	dschnell@biochem.umass.edu			National Institutes of Health [GM61893]; Gilgut; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061893] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gilgut; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM61893 (to D.J.S.). This work was also supported by a Gilgut Fellowship in Plant Biology (to J.L.).	Agne B, 2009, J BIOL CHEM, V284, P8661, DOI 10.1074/jbc.M804235200; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Bauer J, 2000, NATURE, V403, P203, DOI 10.1038/35003214; Bauer J, 2002, J CELL BIOL, V159, P845, DOI 10.1083/jcb.200208018; Becker T, 2004, EMBO J, V23, P520, DOI 10.1038/sj.emboj.7600089; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen DD, 1997, J BIOL CHEM, V272, P6614, DOI 10.1074/jbc.272.10.6614; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Constan D, 2004, PLANT J, V38, P93, DOI 10.1111/j.1365-313X.2004.02024.x; Dabney-Smith C, 1999, J BIOL CHEM, V274, P32351, DOI 10.1074/jbc.274.45.32351; Desfeux C, 2000, PLANT PHYSIOL, V123, P895, DOI 10.1104/pp.123.3.895; Fisher CL, 1997, BIOTECHNIQUES, V23, P570, DOI 10.2144/97234bm01; Gutensohn M, 2000, PLANT J, V23, P771, DOI 10.1046/j.1365-313x.2000.00849.x; Gutensohn M, 2004, MOL GENET GENOMICS, V272, P379, DOI 10.1007/s00438-004-1068-7; Haas AK, 2005, NAT CELL BIOL, V7, P887, DOI 10.1038/ncb1290; Hiltbrunner A, 2001, J CELL BIOL, V154, P309, DOI 10.1083/jcb.200104022; Hinnah SC, 1997, EMBO J, V16, P7351, DOI 10.1093/emboj/16.24.7351; Hinnah SC, 2002, BIOPHYS J, V83, P899, DOI 10.1016/S0006-3495(02)75216-8; Inaba T, 2008, BIOCHEM J, V413, P15, DOI 10.1042/BJ20080490; INOUE H, 2008, PLANT PHYSIOL BIOCH, V72, P2926; Inoue H, 2008, J BIOL CHEM, V283, P7491, DOI 10.1074/jbc.M709571200; Ivanova Y, 2004, MOL BIOL CELL, V15, P3379, DOI 10.1091/mbc.E03-12-0923; Jarvis P, 1998, SCIENCE, V282, P100, DOI 10.1126/science.282.5386.100; Jarvis P, 2008, NEW PHYTOL, V179, P257, DOI 10.1111/j.1469-8137.2008.02452.x; Jelic M, 2003, BIOCHEMISTRY-US, V42, P5906, DOI 10.1021/bi034001q; Jelic M, 2002, BIOL CHEM, V383, P1875, DOI 10.1515/BC.2002.211; Kessler F, 2002, NAT STRUCT BIOL, V9, P81, DOI 10.1038/nsb0202-81; KOBASHI K, 1968, BIOCHIM BIOPHYS ACTA, V158, P239, DOI 10.1016/0304-4165(68)90136-0; Koenig P, 2008, J BIOL CHEM, V283, P23104, DOI 10.1074/jbc.M710576200; Koenig P, 2008, STRUCTURE, V16, P585, DOI 10.1016/j.str.2008.01.008; Kouranov A, 1997, J CELL BIOL, V139, P1677, DOI 10.1083/jcb.139.7.1677; Kubis S, 2004, PLANT CELL, V16, P2059, DOI 10.1105/tpc.104.023309; Kubis S, 2003, PLANT CELL, V15, P1859, DOI 10.1105/tpc.012955; Li HM, 2007, J BIOMED SCI, V14, P505, DOI 10.1007/s11373-007-9166-2; Ma YK, 1996, J CELL BIOL, V134, P315, DOI 10.1083/jcb.134.2.315; OLSEN LJ, 1992, J BIOL CHEM, V267, P433; OLSEN LJ, 1989, J BIOL CHEM, V264, P6724; Rahim G, 2009, J EXP BOT, V60, P257, DOI 10.1093/jxb/ern283; Reddick LE, 2007, J BIOL CHEM, V282, P11410, DOI 10.1074/jbc.M609491200; ROUNDS C, 2007, ENZYMES MOL MACHINES, V25, P407; Schleiff E, 2003, J CELL BIOL, V160, P541, DOI 10.1083/jcb.200210060; Schleiff E, 2002, BIOCHEMISTRY-US, V41, P1934, DOI 10.1021/bi011361+; SCHNELL DJ, 1993, J CELL BIOL, V120, P103, DOI 10.1083/jcb.120.1.103; Smith MD, 2002, J CELL BIOL, V159, P833, DOI 10.1083/jcb.200208017; Sun YJ, 2002, NAT STRUCT BIOL, V9, P95, DOI 10.1038/nsb744; THEG SM, 1989, J BIOL CHEM, V264, P6730; Wallas TR, 2003, J BIOL CHEM, V278, P44289, DOI 10.1074/jbc.M307873200; Wang F, 2008, J CELL BIOL, V183, P87, DOI 10.1083/jcb.200803034; Weibel P, 2003, J BIOL CHEM, V278, P37321, DOI 10.1074/jbc.M305946200; Wittinghofer A, 2000, BIOL CHEM, V381, P355, DOI 10.1515/BC.2000.047; Yeh YH, 2007, J BIOL CHEM, V282, P13845, DOI 10.1074/jbc.M608385200; Young ME, 1999, PLANT PHYSIOL, V121, P237, DOI 10.1104/pp.121.1.237	53	26	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31130	31141		10.1074/jbc.M109.053751	http://dx.doi.org/10.1074/jbc.M109.053751			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19744928	Green Published, hybrid			2022-12-27	WOS:000271378400041
J	Liang, HY; Yoo, SE; Na, R; Walter, CA; Richardson, A; Ran, QT				Liang, Hanyu; Yoo, Si-Eun; Na, Ren; Walter, Christi A.; Richardson, Arlan; Ran, Qitao			Short Form Glutathione Peroxidase 4 Is the Essential Isoform Required for Survival and Somatic Mitochondrial Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE DAMAGE; LIPID-PEROXIDATION; CELLS; EXPRESSION; PHGPX; GPX4; GLUTATHIONE-PEROXIDASE-4; APOPTOSIS; PROTECTS; SEQUENCE	Glutathione peroxidase 4 (Gpx4) is an essential antioxidant enzyme having multiple functions. A long form Gpx4 protein and a short form Gpx4 protein, which are distinguishable by the presence or lack of a mitochondrial signal peptide at the N terminus, are generated from the Gpx4 gene. In this study, we generated transgenic mice using mutated GPX4 genes encoding either the long form Gpx4 (lPX4 gene) or the short form Gpx4 (sGPX4 gene). Our results showed that transgenic mice with the sGPX4 gene had increased Gpx4 protein in all tissues and were protected against diquat-induced apoptosis in liver. Moreover, the sGPX4 gene was able to rescue the lethal phenotype of the mouse Gpx4-null mutation. In contrast, transgenic mice with the lGPX4 gene had increased Gpx4 protein only in the testes, and the lGPX4 gene failed to rescue the lethal phenotype of the mouse Gpx4-null mutation. In Gpx4-null mice rescued by the sGPX4 gene, the Gpx4 protein was present in mitochondria isolated from somatic tissues, and the submitochondrial distribution pattern of the Gpx4 protein in these mice was identical to that in wild-type mice. Interestingly, the male Gpx4-null mice rescued by the sGPX4 gene were infertile and exhibited sperm malformation. Together, our results demonstrated for the first time that the short form Gpx4 protein is present in somatic tissue mitochondria and is essential for survival and protection against apoptosis in mice, whereas the long form Gpx4 protein is important for male fertility.	Univ Texas Hlth Sci Ctr San Antonio, Sam & Ann Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA; [Yoo, Si-Eun] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Walter, Christi A.; Richardson, Arlan; Ran, Qitao] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Walter, Christi A.; Richardson, Arlan; Ran, Qitao] S Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Ran, QT (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Sam & Ann Barshop Inst Longev & Aging Studies, 15355 Lambda Dr, San Antonio, TX 78245 USA.	ran@uthscsa.edu	Liang, Hanyu/A-1066-2010		National Institutes of Health [P01AG19316, R37 AG026557, AG021163]; San Antonio Nathan Shock Aging Center [1P30-AG13319]; Veterans Affairs Merit; NATIONAL INSTITUTE ON AGING [P01AG019316, P30AG013319, R37AG026557, R01AG021163] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); San Antonio Nathan Shock Aging Center; Veterans Affairs Merit(US Department of Veterans Affairs); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants P01AG19316, R37 AG026557, and AG021163, San Antonio Nathan Shock Aging Center Grant 1P30-AG13319, and Veterans Affairs Merit grants (to A. R. and Q. R.).	Arai M, 1999, J BIOL CHEM, V274, P4924, DOI 10.1074/jbc.274.8.4924; Arai M, 1996, BIOCHEM BIOPH RES CO, V227, P433, DOI 10.1006/bbrc.1996.1525; Aral F, 2008, RES VET SCI, V84, P95, DOI 10.1016/j.rvsc.2007.04.007; Borchert A, 2006, J BIOL CHEM, V281, P19655, DOI 10.1074/jbc.M601195200; Brigelius-Flohe R, 1999, FREE RADICAL BIO MED, V27, P951, DOI 10.1016/S0891-5849(99)00173-2; Chen LJ, 2008, J NEUROCHEM, V107, P197, DOI 10.1111/j.1471-4159.2008.05603.x; Conrad M, 2005, MOL CELL BIOL, V25, P7637, DOI 10.1128/MCB.25.17.7637-7644.2005; Flohe L, 2007, BIOL CHEM, V388, P987, DOI 10.1515/BC.2007.112; Imai H, 1998, J BIOL CHEM, V273, P1990, DOI 10.1074/jbc.273.4.1990; Imai H, 2003, BIOCHEM BIOPH RES CO, V305, P278, DOI 10.1016/S0006-291X(03)00734-4; Imai H, 2003, FREE RADICAL BIO MED, V34, P145, DOI 10.1016/S0891-5849(02)01197-8; Knopp EA, 1999, MAMM GENOME, V10, P601, DOI 10.1007/s003359901053; Legault J, 2000, BIOCHEM BIOPH RES CO, V272, P416, DOI 10.1006/bbrc.2000.2800; Liang HY, 2007, BIOCHEM BIOPH RES CO, V356, P893, DOI 10.1016/j.bbrc.2007.03.045; Liang HY, 2009, FREE RADICAL BIO MED, V47, P312, DOI 10.1016/j.freeradbiomed.2009.05.012; Nomura K, 1999, J BIOL CHEM, V274, P29294, DOI 10.1074/jbc.274.41.29294; Okado-Matsumoto A, 2001, J BIOL CHEM, V276, P38388, DOI 10.1074/jbc.M105395200; PUSHPAREKHA TR, 1995, J BIOL CHEM, V270, P26993, DOI 10.1074/jbc.270.45.26993; Ran QT, 2004, J BIOL CHEM, V279, P55137, DOI 10.1074/jbc.M410387200; Schneider M, 2006, GENE EXPR PATTERNS, V6, P489, DOI 10.1016/j.modgep.2005.11.002; Schneider M, 2009, FASEB J, V23, P3233, DOI 10.1096/fj.09-132795; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; Tanaka M, 2004, BLOOD, V104, P3789, DOI 10.1182/blood-2004-02-0666; THOMAS JP, 1990, J BIOL CHEM, V265, P454; Ursini F, 1999, SCIENCE, V285, P1393, DOI 10.1126/science.285.5432.1393; Yant LJ, 2003, FREE RADICAL BIO MED, V34, P496, DOI 10.1016/S0891-5849(02)01360-6	26	93	95	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30836	30844		10.1074/jbc.M109.032839	http://dx.doi.org/10.1074/jbc.M109.032839			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19744930	hybrid, Green Published			2022-12-27	WOS:000271378400011
J	Zhang, YL; Reynolds, JM; Chang, SH; Martin-Orozco, N; Chung, Y; Nurieva, RI; Dong, C				Zhang, Yongliang; Reynolds, Joseph M.; Chang, Seon Hee; Martin-Orozco, Natalia; Chung, Yeonseok; Nurieva, Roza I.; Dong, Chen			MKP-1 Is Necessary for T Cell Activation and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNE-RESPONSES; PROTEIN-TYROSINE-PHOSPHATASE; MAP KINASE PHOSPHATASE-1; IMMEDIATE-EARLY GENE; VIRUS-INFECTION; SHOCK; DIFFERENTIATION; INFLAMMATION; STRESS; GROWTH	MAPKs are evolutionarily conserved immune regulators. MAPK phosphatases (MKPs) that negatively regulate MAPK activities have recently emerged as critical players in both innate and adaptive immune responses. MKP-1, also known as DUSP1, was previously shown to negatively regulate innate immunity by inhibiting pro-inflammatory cytokine production. Here, we found that MKP-1 is necessary in T cell activation and function. MKP-1 deficiency in T cells impaired the activation, proliferation, and function of T cells in vitro, associated with enhanced activation of JNK and reduced NFATc1 translocation into the nucleus. Consistently, MKP-1(-/-) mice were defective in anti-influenza immunity in vivo and resistant to experimental autoimmune encephalomyelitis. Our results thus demonstrate that MKP-1 is a critical positive regulator of T cell activation and function and may be targeted in treatment of autoimmune diseases.	[Zhang, Yongliang; Reynolds, Joseph M.; Chang, Seon Hee; Martin-Orozco, Natalia; Chung, Yeonseok; Nurieva, Roza I.; Dong, Chen] MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Dong, C (corresponding author), MD Anderson Canc Ctr, Dept Immunol, 7455 Fannin,Unit 902, Houston, TX 77030 USA.	cdong@mdanderson.org	Chang, Seon Hee/AAQ-9521-2020; Martin Orozco, Natalia/E-4794-2010; dong, chen/B-3181-2009	Chang, Seon Hee/0000-0002-9389-508X; dong, chen/0000-0002-0084-9130; Chung, Yeonseok/0000-0001-5780-4841	National Institutes of Health [AI050761]; Center for Targeted Therapy of the M. D. Anderson Cancer Center; NCI training; American Heart Association scientist developmen; Leukemia and Lymphoma Society scholar; Trust fellowship; Anderson Cancer Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083761, R56AI050761, R01AI050761] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Targeted Therapy of the M. D. Anderson Cancer Center; NCI training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Heart Association scientist developmen(American Heart Association); Leukemia and Lymphoma Society scholar(Leukemia and Lymphoma Society); Trust fellowship; Anderson Cancer Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI050761 (to C. D. and R.I.N.). This work was also supported by grants from the Center for Targeted Therapy of the M. D. Anderson Cancer Center (to C. D.), an NCI training grant (to J.R.), an American Heart Association scientist development grant (to R.I.N.), and a Leukemia and Lymphoma Society scholar award and a Trust fellowship from the M. D. Anderson Cancer Center (to C. D.).	Angkasekwinai P, 2007, J EXP MED, V204, P1509, DOI 10.1084/jem.20061675; Belz GT, 2000, J VIROL, V74, P3486, DOI 10.1128/JVI.74.8.3486-3493.2000; Bruder D, 2006, VIRAL IMMUNOL, V19, P147, DOI 10.1089/vim.2006.19.147; CHARLES CH, 1992, ONCOGENE, V7, P187; Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103; Chow CW, 2000, MOL CELL BIOL, V20, P5227, DOI 10.1128/MCB.20.14.5227-5234.2000; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Dong C, 2000, NATURE, V405, P91, DOI 10.1038/35011091; Dorfman K, 1996, ONCOGENE, V13, P925; EICHELBERGER M, 1991, J EXP MED, V174, P875, DOI 10.1084/jem.174.4.875; Fischer AM, 2005, IMMUNITY, V23, P431, DOI 10.1016/j.immuni.2005.08.013; Hammer M, 2006, J EXP MED, V203, P15, DOI 10.1084/jem.20051753; Hussell T, 1996, J GEN VIROL, V77, P2447, DOI 10.1099/0022-1317-77-10-2447; Jeffrey KL, 2006, NAT IMMUNOL, V7, P274, DOI 10.1038/ni1310; KEYSE SM, 1992, NATURE, V359, P644, DOI 10.1038/359644a0; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; NOGUCHI T, 1993, MOL CELL BIOL, V13, P5195, DOI 10.1128/MCB.13.9.5195; Nurieva RI, 2003, IMMUNITY, V18, P801, DOI 10.1016/S1074-7613(03)00144-4; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Ranger AM, 1998, IMMUNITY, V8, P125, DOI 10.1016/S1074-7613(00)80465-3; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Salojin KV, 2006, J IMMUNOL, V176, P1899, DOI 10.4049/jimmunol.176.3.1899; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; Wiley JA, 2001, J IMMUNOL, V167, P3293, DOI 10.4049/jimmunol.167.6.3293; Willoughby EA, 2003, J BIOL CHEM, V278, P10731, DOI 10.1074/jbc.M207324200; Wu JJ, 2005, J BIOL CHEM, V280, P16461, DOI 10.1074/jbc.M501762200; Yoshida H, 1998, IMMUNITY, V8, P115, DOI 10.1016/S1074-7613(00)80464-1; Zhang YL, 2004, NATURE, V430, P793, DOI 10.1038/nature02764; Zhang Y, 2006, P NATL ACAD SCI USA, V103, P11695, DOI 10.1073/pnas.0601347103; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794	35	50	50	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30815	30824		10.1074/jbc.M109.052472	http://dx.doi.org/10.1074/jbc.M109.052472			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19748894	Green Published, hybrid			2022-12-27	WOS:000271378400009
J	Kresge, N; Simoni, RD; Hill, RL				Kresge, Nicole; Simoni, Robert D.; Hill, Robert L.			The Mechanism of Amino Acid Activation: the Work of Mahlon Hoagland	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material																		HOAGLAND MB, 1958, J BIOL CHEM, V231, P241; LIPMANN F, 1945, J BIOL CHEM, V160, P173; ZAMECNIK PC, 1954, J BIOL CHEM, V209, P337	3	0	0	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25							e7					2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19785094	hybrid, Green Published			2022-12-27	WOS:000266962400001
J	Becker, CE; Creagh, EM; O'Neill, LAJ				Becker, Christine E.; Creagh, Emma M.; O'Neill, Luke A. J.			Rab39a Binds Caspase-1 and Is Required for Caspase-1-dependent Interleukin-1 beta Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IL-1-BETA SECRETION; INFLAMMASOME; ACTIVATION; MACROPHAGES; IDENTIFICATION; RELEASE; GENE	Interleukin-1 beta (IL-1 beta) is an important pro-inflammatory cytokine that is secreted by unconventional means in a caspase-1-dependent manner. Using a one-step immunoprecipitation approach to isolate endogenous caspase-1 from the monocytic THP1 cell line, we identified previously undescribed binding partners using mass spectrometry. One of the proteins identified was Rab39a, a member of the Rab GTPase family, agroup of proteins that have important roles in protein trafficking and secretion. We confirmed by co-immunoprecipitation that Rab39a binds caspase-1. Knock down of Rab39a with small interfering RNA resulted in diminished levels of secreted IL-1 beta but had no effect on induction of pro-IL-1 beta mRNA by lipopolysaccharide. Rab39a contains a highly conserved caspase-1 cleavage site and was cleaved in the presence of recombinant caspase-1 or lipopolysaccharide. Finally, overexpression of Rab39a results in an increase in IL-1 beta secretion, and furthermore, overexpression of a Rab39a construct lacking the caspase-1 cleavage site leads to an additional increase in IL-1 beta secretion. Altogether, our findings show that Rab39a interacts with caspase-1 and suggest that Rab39a functions as a trafficking adaptor linking caspase-1 to IL-1 beta secretion.	[Becker, Christine E.; Creagh, Emma M.; O'Neill, Luke A. J.] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland	Trinity College Dublin	O'Neill, LAJ (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland.	laoneill@tcd.ie	Creagh, Emma/AAX-1064-2021	Creagh, Emma/0000-0001-7631-4370; O'Neill, Luke/0000-0002-4333-2748	Health Research Board Science Foundation Ireland; Wellcome Trust	Health Research Board Science Foundation Ireland(Science Foundation Ireland); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by grants from the Health Research Board Science Foundation Ireland and the Wellcome Trust.	Andrei C, 2004, P NATL ACAD SCI USA, V101, P9745, DOI 10.1073/pnas.0308558101; Andrei C, 1999, MOL BIOL CELL, V10, P1463, DOI 10.1091/mbc.10.5.1463; Cheng H, 2002, CYTOGENET GENOME RES, V97, P72, DOI 10.1159/000064047; Creagh EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005055; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Eder C, 2009, IMMUNOBIOLOGY, V214, P543, DOI 10.1016/j.imbio.2008.11.007; Feldmeyer L, 2007, CURR BIOL, V17, P1140, DOI 10.1016/j.cub.2007.05.074; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Miggin SM, 2007, P NATL ACAD SCI USA, V104, P3372, DOI 10.1073/pnas.0608100104; Pelegrin P, 2008, J IMMUNOL, V180, P7147, DOI 10.4049/jimmunol.180.11.7147; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Stankovic T, 1997, GENOMICS, V40, P267, DOI 10.1006/geno.1996.4595; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Wang YZ, 2007, BLOOD, V110, P962, DOI 10.1182/blood-2007-01-066027; Yao M, 2009, J IMMUNOL, V183, P1751, DOI 10.4049/jimmunol.0900249; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	21	42	45	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34531	34537		10.1074/jbc.M109.046102	http://dx.doi.org/10.1074/jbc.M109.046102			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19833722	hybrid, Green Published			2022-12-27	WOS:000272439600007
J	Silva, FD; Rezende, CA; Rossi, DCP; Esteves, E; Dyszy, FH; Schreier, S; Gueiros-Filho, F; Campos, CB; Pires, JR; Daffre, S				Silva, Fernanda D.; Rezende, Carlos A.; Rossi, Diego C. P.; Esteves, Eliane; Dyszy, Fabio H.; Schreier, Shirley; Gueiros-Filho, Frederico; Campos, Claudia B.; Pires, Jose R.; Daffre, Sirlei			Structure and Mode of Action of Microplusin, a Copper II-chelating Antimicrobial Peptide from the Cattle Tick Rhipicephalus (Boophilus) microplus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PASTEURELLA-HAEMOLYTICA; PSEUDOMONAS-AERUGINOSA; BINDING PROPERTIES; BACILLUS-SUBTILIS; HUMAN LACTOFERRIN; PROTEIN; HEPCIDIN; GOMESIN; MICROORGANISMS; IDENTIFICATION	Microplusin, a Rhipicephalus (Boophilus) microplus antimicrobial peptide (AMP) is the first fully characterized member of a new family of cysteine-rich AMPs with histidine-rich regions at the N and C termini. In the tick, microplusin belongs to the arsenal of innate defense molecules active against bacteria and fungi. Here we describe the NMR solution structure of microplusin and demonstrate that the protein binds copper II and iron II. Structured as a single alpha-helical globular domain, microplusin consists of five alpha-helices: alpha 1 (residues Gly-9 to Arg-21), alpha 2 (residues Glu-27 to Asn-40), alpha 3 (residues Arg-44 to Thr-54), alpha 4 (residues Leu-57 to Tyr-64), and alpha 5 (residues Asn-67 to Cys-80). The N and C termini are disordered. This structure is unlike any other AMP structures described to date. We also used NMR spectroscopy to map the copper binding region on microplusin. Finally, using the Gram-positive bacteria Micrococcus luteus as a model, we studied of mode of action of microplusin. Microplusin has a bacteriostatic effect and does not permeabilize the bacterial membrane. Because microplusin binds metals, we tested whether this was related to its antimicrobial activity. We found that the bacteriostatic effect of microplusin was fully reversed by supplementation of culture media with copper II but not iron II. We also demonstrated that microplusin affects M. luteus respiration, a copper-dependent process. Thus, we conclude that the antibacterial effect of microplusin is due to its ability to bind and sequester copper II.	[Silva, Fernanda D.; Rossi, Diego C. P.; Esteves, Eliane; Daffre, Sirlei] Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, BR-05508900 Sao Paulo, Brazil; [Rezende, Carlos A.; Pires, Jose R.] Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Bioquim Med, BR-21941590 Rio De Janeiro, Brazil; [Dyszy, Fabio H.; Schreier, Shirley; Gueiros-Filho, Frederico] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05508000 Sao Paulo, Brazil; [Campos, Claudia B.] Univ Vale Paraiba, Inst Pesquisa & Desenvolvimento, BR-12244000 Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo; Universidade do Vale do Paraiba	Daffre, S (corresponding author), Ave Prof Lineu Prestes 1374, BR-05508900 Sao Paulo, Brazil.	sidaffre@icb.usp.br	Schreier, Shirley/F-7001-2014; Esteves, Eliane/H-9508-2013; Gueiros-Filho, Frederico J./D-2160-2013; Daffre, Sirlei/M-4233-2013; Silva, Fernanda D./F-2723-2012; Pires, Jose/C-2226-2013; Campos, Claudia B.L./I-4802-2018; Dyszy, Fábio/F-6782-2012; Esteves, Eliane/H-1037-2015; Rossi, Diego/J-1456-2018	Gueiros-Filho, Frederico J./0000-0001-5425-2439; Daffre, Sirlei/0000-0002-9966-0433; Silva, Fernanda D./0000-0002-3508-6241; Esteves, Eliane/0000-0002-4347-798X; Rossi, Diego/0000-0003-1385-1501; Pires, Jose Ricardo/0000-0001-6610-8530	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil, the Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil.	Aguila A, 2001, FEMS IMMUNOL MED MIC, V31, P145, DOI 10.1111/j.1574-695X.2001.tb00511.x; Arnesano F, 2005, Q REV BIOPHYS, V38, P167, DOI 10.1017/S0033583506004161; ARNOLD RR, 1982, INFECT IMMUN, V35, P792, DOI 10.1128/IAI.35.3.792-799.1982; Azarkina N, 1999, J BIOL CHEM, V274, P32810, DOI 10.1074/jbc.274.46.32810; Benoff B, 2002, SCIENCE, V297, P1562, DOI 10.1126/science.1076376; Brewer D, 2000, RAPID COMMUN MASS SP, V14, P1736, DOI 10.1002/1097-0231(20001015)14:19<1736::AID-RCM86>3.0.CO;2-2; Brogden KA, 1996, P NATL ACAD SCI USA, V93, P412, DOI 10.1073/pnas.93.1.412; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Brown KL, 2006, CURR OPIN IMMUNOL, V18, P24, DOI 10.1016/j.coi.2005.11.004; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; Cavanagh J., 1996, PROTEIN NMR SPECTROS; CLORE GM, 1990, J AM CHEM SOC, V112, P4989, DOI 10.1021/ja00168a070; Comolli JC, 2004, MOL MICROBIOL, V51, P1193, DOI 10.1046/j.1365-2958.2003.03904.x; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; Dar AC, 2005, CELL, V122, P887, DOI 10.1016/j.cell.2005.06.044; Das SK, 2006, NAT CLIN PRACT NEURO, V2, P482, DOI 10.1038/ncpneuro0291; DEGIER JWL, 1994, MOL MICROBIOL, V13, P183, DOI 10.1111/j.1365-2958.1994.tb00414.x; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; Dur n RV, 2004, J BIOL CHEM, V279, P7229, DOI 10.1074/jbc.M311565200; Esteves E, 2009, DEV COMP IMMUNOL, V33, P913, DOI 10.1016/j.dci.2009.02.009; Esteves E, 2008, INSECT BIOCHEM MOLEC, V38, P568, DOI 10.1016/j.ibmb.2008.01.006; Falzacappa MVV, 2005, GENE, V364, P37, DOI 10.1016/j.gene.2005.07.020; Farnaud S, 2008, BIOCHEM J, V413, P553, DOI 10.1042/BJ20080406; Fazio MA, 2006, BIOPOLYMERS, V84, P205, DOI 10.1002/bip.20396; Fazio MA, 2007, BIOPOLYMERS, V88, P386, DOI 10.1002/bip.20660; Fogaca AC, 2006, PEPTIDES, V27, P667, DOI 10.1016/j.peptides.2005.07.013; Fogaca AC, 1999, J BIOL CHEM, V274, P25330, DOI 10.1074/jbc.274.36.25330; Fogaca AC, 2004, DEV COMP IMMUNOL, V28, P191, DOI 10.1016/j.dci.2003.08.001; Frangipani E, 2008, J BACTERIOL, V190, P6706, DOI 10.1128/JB.00450-08; Ganz T, 2006, CURR TOP MICROBIOL, V306, P183; Ganz T, 2005, COMB CHEM HIGH T SCR, V8, P209, DOI 10.2174/1386207053764594; Goumon Y, 1996, EUR J BIOCHEM, V235, P516, DOI 10.1111/j.1432-1033.1996.t01-1-00516.x; Grogan J, 2001, FEBS LETT, V491, P76, DOI 10.1016/S0014-5793(01)02157-3; Gusman H, 2001, BBA-PROTEIN STRUCT M, V1545, P86, DOI 10.1016/S0167-4838(00)00265-X; Harwood C., 1990, MOL BIOL METHODS BAC, P1; Heidari M, 2002, INT J ANTIMICROB AG, V20, P69, DOI 10.1016/S0924-8579(02)00048-1; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; Horn D, 2008, IUBMB LIFE, V60, P421, DOI 10.1002/iub.50; Hsu CH, 2005, NUCLEIC ACIDS RES, V33, P4053, DOI 10.1093/nar/gki725; Kavanagh K, 2004, J PHARM PHARMACOL, V56, P285, DOI 10.1211/0022357022971; Kay LE, 1995, PROG BIOPHYS MOL BIO, V63, P277, DOI 10.1016/0079-6107(95)00007-0; Kragol G, 2001, BIOCHEMISTRY-US, V40, P3016, DOI 10.1021/bi002656a; Lai R, 2004, FASEB J, V18, P1447, DOI 10.1096/fj.03-1154fje; Lai R, 2002, BIOCHEM BIOPH RES CO, V295, P796, DOI 10.1016/S0006-291X(02)00762-3; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; Lulloff SJ, 2004, J LAB CLIN MED, V144, P208, DOI 10.1016/j.lab.2004.07.007; Mans BJ, 2008, INSECT BIOCHEM MOLEC, V38, P42, DOI 10.1016/j.ibmb.2007.09.003; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Nilges M, 1998, PROG NUCL MAG RES SP, V32, P107, DOI 10.1016/S0079-6565(97)00025-3; Nishikawa M, 2004, ANTIMICROB AGENTS CH, V48, P229, DOI 10.1128/AAC.48.1.229-235.2004; Otvos L, 2005, J PEPT SCI, V11, P697, DOI 10.1002/psc.698; Park CB, 1998, BIOCHEM BIOPH RES CO, V244, P253, DOI 10.1006/bbrc.1998.8159; Rezende CA, 2009, BIOMOL NMR ASSIGN, V3, P187, DOI 10.1007/s12104-009-9171-7; RODRIGUES DG, 2005, THESIS U SAO PAULO; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schittek B, 2001, NAT IMMUNOL, V2, P1133, DOI 10.1038/ni732; Sforca ML, 2005, BIOCHEMISTRY-US, V44, P6440, DOI 10.1021/bi0475323; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; Silva FR, 2008, THESIS U SAO PAULO; Silva PI, 2000, J BIOL CHEM, V275, P33464, DOI 10.1074/jbc.M001491200; Sohnle PG, 2001, J LAB CLIN MED, V137, P284, DOI 10.1067/mlc.2001.113577; Sonenshine DE., 1991, BIOL TICKS; Steffen H, 2006, ANTIMICROB AGENTS CH, V50, P2608, DOI 10.1128/AAC.00181-06; STERN AS, 1981, P NATL ACAD SCI-BIOL, V78, P1962, DOI 10.1073/pnas.78.3.1962; Stone Kathryn L., 1996, P415, DOI 10.1007/978-1-60327-259-9_71; Ulvatne H, 2004, FEMS MICROBIOL LETT, V237, P377, DOI 10.1016/j.femsle.2004.07.001; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Yount NY, 2006, BIOPOLYMERS, V84, P435, DOI 10.1002/bip.20543	69	64	65	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34735	34746		10.1074/jbc.M109.016410	http://dx.doi.org/10.1074/jbc.M109.016410			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19828445	Green Published, hybrid			2022-12-27	WOS:000272439600029
J	Durazo, A; Shaw, BF; Chattopadhyay, M; Faull, KF; Nersissian, AM; Valentine, JS; Whitelegge, JP				Durazo, Armando; Shaw, Bryan F.; Chattopadhyay, Madhuri; Faull, Kym F.; Nersissian, Aram M.; Valentine, Joan Selverstone; Whitelegge, Julian P.			Metal-free Superoxide Dismutase-1 and Three Different Amyotrophic Lateral Sclerosis Variants Share a Similar Partially Unfolded beta-Barrel at Physiological Temperature	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMIDE HYDROGEN-EXCHANGE; PANCREATIC TRYPSIN-INHIBITOR; MOLECULAR-WEIGHT COMPLEXES; NUCLEAR MAGNETIC-RESONANCE; MASS-SPECTROMETRY; CU,ZN-SUPEROXIDE DISMUTASE; PROTON-EXCHANGE; PROTEIN; MUTATIONS; DISEASE	The structure and unfolding of metal-free (apo) human wildtype SOD1 and three pathogenic variants of SOD1 (A4V, G93R, and H48Q) that cause familial amyotrophic lateral sclerosis have been studied with amide hydrogen/deuterium exchange and mass spectrometry. The results indicate that a significant proportion of each of these proteins exists in solution in a conformation in which some strands of the beta-barrel (i.e. beta 2) are well protected from exchange at physiological temperature (37 degrees C), whereas other strands (i.e. beta 3 and beta 4) appear to be unprotected from hydrogen/deuterium exchange. Moreover, the thermal unfolding of these proteins does not result in the uniform incorporation of deuterium throughout the polypeptide but involves the local unfolding of different residues at different temperatures. Some regions of the proteins (i.e. the "Greek key" loop, residues 104-116) unfold at a significantly higher temperature than other regions (i.e. beta 3 and beta 4, residues 21-53). Together, these results show that human wild-type apo-SOD1 and variants have a partially unfolded beta-barrel at physiological temperature and unfold non-cooperatively.	[Durazo, Armando; Chattopadhyay, Madhuri; Valentine, Joan Selverstone] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Faull, Kym F.; Whitelegge, Julian P.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Shaw, Bryan F.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Nersissian, Aram M.] Occidental Coll, Dept Chem, Los Angeles, CA 90041 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Harvard University; Occidental College	Whitelegge, JP (corresponding author), Univ Calif Los Angeles, Pasarow Mass Spectrometry Lab, NPI Semel Inst, POB 42,760 Westwood Plaza, Los Angeles, CA 90024 USA.	jpw@chem.ucla.edu	Shaw, Bryan/A-7001-2008		National Institutes of Health [NS-049134, DK46828, GM28222]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS049134] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS-049134, DK46828, and GM28222.	Anderson JS, 2008, BIOCHEMISTRY-US, V47, P6178, DOI 10.1021/bi800284y; Anderson JS, 2006, BIOPHYS J, V91, pL93, DOI 10.1529/biophysj.106.094219; Arnesano F, 2004, J BIOL CHEM, V279, P47998, DOI 10.1074/jbc.M406021200; Assfalg M, 2003, J MOL BIOL, V330, P145, DOI 10.1016/S0022-2836(03)00533-3; Banci L, 2003, BIOCHEMISTRY-US, V42, P9543, DOI 10.1021/bi034324m; Bieler S, 2004, CURR DRUG TARGETS, V5, P553; Chattopadhyay M, 2008, P NATL ACAD SCI USA, V105, P18663, DOI 10.1073/pnas.0807058105; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Dumoulin M, 2005, J MOL BIOL, V346, P773, DOI 10.1016/j.jmb.2004.11.020; Durer ZAO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005004; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hayward LJ, 2002, J BIOL CHEM, V277, P15923, DOI 10.1074/jbc.M112087200; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Krishna MMG, 2004, METHODS, V34, P51, DOI 10.1016/j.ymeth.2004.03.005; KRISHNA NR, 1979, BIOPHYS J, V26, P345, DOI 10.1016/S0006-3495(79)85258-3; KRISHNA NR, 1980, BIOPOLYMERS, V19, P2003, DOI 10.1002/bip.1980.360191106; Lee VMY, 2002, NEUROBIOL AGING, V23, P1039, DOI 10.1016/S0197-4580(02)00121-5; Molnar KS, 2009, J BIOL CHEM, V284, P30965, DOI 10.1074/jbc.M109.023945; Ray SS, 2005, P NATL ACAD SCI USA, V102, P3639, DOI 10.1073/pnas.0408277102; Rodriguez JA, 2005, P NATL ACAD SCI USA, V102, P10516, DOI 10.1073/pnas.0502515102; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Shaw BF, 2008, J BIOL CHEM, V283, P8340, DOI 10.1074/jbc.M707751200; Shaw BF, 2007, TRENDS BIOCHEM SCI, V32, P78, DOI 10.1016/j.tibs.2006.12.005; Shaw BF, 2006, J BIOL CHEM, V281, P18167, DOI 10.1074/jbc.M600623200; Smith DL, 1997, J MASS SPECTROM, V32, P135, DOI 10.1002/(SICI)1096-9888(199702)32:2<135::AID-JMS486>3.0.CO;2-M; Strange RW, 2003, J MOL BIOL, V328, P877, DOI 10.1016/S0022-2836(03)00355-3; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; WAGNER G, 1979, J MOL BIOL, V134, P75, DOI 10.1016/0022-2836(79)90414-5; WAGNER G, 1978, NATURE, V275, P247, DOI 10.1038/275247a0; WAGNER G, 1982, J MOL BIOL, V160, P343, DOI 10.1016/0022-2836(82)90180-2; Wang J, 2002, NEUROBIOL DIS, V9, P139, DOI 10.1006/nbdi.2001.0471; Zhang ZQ, 1996, BIOCHEMISTRY-US, V35, P779, DOI 10.1021/bi952227q	32	35	35	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34382	34389		10.1074/jbc.M109.052076	http://dx.doi.org/10.1074/jbc.M109.052076			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19805550	Green Published, hybrid			2022-12-27	WOS:000272165200068
J	Sharda, S; Koay, MST; Kim, YJ; Engelhard, M; Gartner, W				Sharda, Shivani; Koay, Melissa S. T.; Kim, Young-Jun; Engelhard, Martin; Gaertner, Wolfgang			A Non-hydrolyzable ATP Derivative Generates a Stable Complex in a Light-inducible Two-component System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION; FILAMENTOUS CYANOBACTERIUM; PHYTOCHROME; CHROMOPHORE; BACTERIOPHYTOCHROME; DIMERIZATION; BILIVERDIN; PROTEINS; REVEALS	Isothermal calorimetry (ITC) measurements yielded the binding constants during complex formation of light-inducible histidine kinases (HK) and their cognate CheY-type response regulators (RR). HK-RR interactions represent the core function of the bacterial two-component system, which is also present in many bacterial phytochromes. Here, we have studied the recombinant forms of phytochromes CphA and CphB from the cyanobacterium Tolypothrix PCC7601 and their cognate RRs RcpA and RcpB. The interaction between the two reaction partners (HK and RR) was studied in the presence and absence of ATP. A complex formation was observable in the presence of ATP, but specific interactions were only found when a non-hydrolyzable ATP derivative was added to the mixture. Also, the incubation of the HK domain alone (expressed as a recombinant protein) with the RR did not yield specific interactions, indicating that the HK domain is only active as a component of the full-length phytochrome. Considering also previous studies on the same proteins (Hubschmann, T., Jorissen, H. J. M. M., Borner, T., Gartner, W., and de Marsac, N. (2001) Eur. J. Biochem. 268, 3383-3389) we now conclude that the HK domains of these phytochromes are active only when the chromophore domain is in its Pr form. The formerly documented phosphate transfer between the HK domain and the RR takes place via a transiently formed protein-protein complex, which becomes detectable by ITC in the presence of a non-hydrolyzable ATP derivative. This finding is of interest also in relation to the function of some (blue light-sensitive) photoreceptors that carry the HK domain and the RR fused together in one single protein.	[Kim, Young-Jun; Engelhard, Martin] Max Planck Inst Mol Physiol, D-44227 Dortmund, Germany; [Sharda, Shivani; Koay, Melissa S. T.; Gaertner, Wolfgang] Max Planck Inst Bioinorgan Chem, D-45413 Mulheim, Germany	Max Planck Society; Max Planck Society	Engelhard, M (corresponding author), Max Planck Inst Mol Physiol, D-44227 Dortmund, Germany.	martin.engelhard@mpi-dortmund.mpg.de; gaertner@mpi-muelheim.mpg.de	Sharda, Shivani/ABI-5086-2020; Koay, Melissa/E-9915-2012	Sharda, Shivani/0000-0002-8838-0823; Gartner, Wolfgang/0000-0002-6898-7011	Helmholtz-Society [VIBS VH-VI-157]; International Max Planck Research School Chemical Biology	Helmholtz-Society(Helmholtz Association); International Max Planck Research School Chemical Biology	This work was supported in part by the Helmholtz-Society (VIBS VH-VI-157, to M. E. and W. G.) and the International Max Planck Research School Chemical Biology (to Y. J. K.).	Benda C, 2004, BIOPHYS J, V87, P476, DOI 10.1529/biophysj.103.033696; Bhoo SH, 2001, NATURE, V414, P776, DOI 10.1038/414776a; Cao Z, 2008, BIOPHYS J, V94, P897, DOI 10.1529/biophysj.107.108977; Esteban B, 2005, BIOCHEMISTRY-US, V44, P450, DOI 10.1021/bi0484365; Evans K, 2006, J MOL BIOL, V364, P655, DOI 10.1016/j.jmb.2006.09.045; Giraud E, 2002, NATURE, V417, P202, DOI 10.1038/417202a; Hubschmann T, 2001, EUR J BIOCHEM, V268, P3383, DOI 10.1046/j.1432-1327.2001.02229.x; Hubschmann T, 2001, EUR J BIOCHEM, V268, P2055, DOI 10.1046/j.1432-1327.2001.02083.x; Hughes J, 1997, NATURE, V386, P663, DOI 10.1038/386663a0; Jorissen HJMM, 2002, EUR J BIOCHEM, V269, P2662, DOI 10.1046/j.1432-1033.2002.02928.x; Karniol B, 2005, BIOCHEM J, V392, P103, DOI 10.1042/BJ20050826; Otto H, 2003, BIOPHYS J, V84, p291A; Pathak GP, 2009, ENVIRON MICROBIOL, V11, P2388, DOI 10.1111/j.1462-2920.2009.01967.x; Quest B, 2004, EUR J BIOCHEM, V271, P1117, DOI 10.1111/j.1432-1033.2004.04015.x; Quest B, 2007, FEBS J, V274, P2088, DOI 10.1111/j.1742-4658.2007.05751.x; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Szurmant H, 2007, CURR OPIN STRUC BIOL, V17, P706, DOI 10.1016/j.sbi.2007.08.019; Yeh KC, 1997, SCIENCE, V277, P1505, DOI 10.1126/science.277.5331.1505	19	5	5	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33999	34004		10.1074/jbc.M109.017772	http://dx.doi.org/10.1074/jbc.M109.017772			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19808667	Green Published, hybrid			2022-12-27	WOS:000272165200032
J	Wendt, MK; Smith, JA; Schiemann, WP				Wendt, Michael K.; Smith, Jason A.; Schiemann, William P.			p130Cas Is Required for Mammary Tumor Growth and Transforming Growth Factor-beta-mediated Metastasis through Regulation of Smad2/3 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-CANCER PROGRESSION; TGF-BETA; CELL-PROLIFERATION; GLAND DEVELOPMENT; TUMORIGENESIS; RECEPTOR; MODEL; MECHANISMS; RESISTANCE	During breast cancer progression, transforming growth factor-beta (TGF-beta) switches from tumor suppressor to a prometastatic molecule. Several recent studies suggest that this conversion in TGF-beta function depends upon fundamental changes in the TGF-beta signaling system. We show here that these changes in TGF-beta signaling are concomitant with aberrant expression of the focal adhesion protein, p130Cas. Indeed, elevating expression of either the full-length (FL) or just the carboxyl terminus (CT) of p130Cas in mammary epithelial cells (MECs) diminished the ability of TGF-beta 1 to activate Smad2/3, but increased its coupling to p38 MAPK. This shift in TGF-beta signaling evoked (i) resistance to TGF-beta-induced growth arrest, and (ii) acinar filling upon three-dimensional organotypic cultures of p130Cas-FL or -CT expressing MECs. Furthermore, rendering metastatic MECs deficient in p130Cas enhanced TGF-beta-stimulated Smad2/3 activity, which restored TGF-beta-induced growth inhibition both in vitro and in mammary tumors produced in mice. Additionally, whereas elevating T beta R-II expression in metastatic MECs had no affect on their phosphorylation of Smad2/3, this event markedly enhanced their activation of p38 MAPK, leading to increased MEC invasion and metastasis. Importantly, depleting p130Cas expression in T beta R-II-expressing metastatic MECs significantly increased their activation of Smad2/3, which (i) reestablished the physiologic balance between canonical and noncanonical TGF-beta signaling, and (ii) reversed cellular invasion and early mammary tumor cell dissemination stimulated by TGF-beta. Collectively, our findings identify p130Cas as a molecular rheostat that regulatesthedelicatebalancebetweencanonicalandnoncanonical TGF-beta signaling, a balance that is critical to maintaining the tumor suppressor function of TGF-beta during breast cancer progression.	[Wendt, Michael K.; Smith, Jason A.; Schiemann, William P.] Univ Colorado, Dept Pharmacol, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Schiemann, WP (corresponding author), Univ Colorado Denver, Anschutz Med Campus,RC1 S Tower,Rm L18-6110,1280, Aurora, CO 80045 USA.	Bill.Schiemann@ucdenver.edu		Wendt, Mike/0000-0002-3665-7413	National Institutes of Health [CA129359]; Komen Foundation [BCTR0706967]; Department of Defense [BC084651]; American Cancer Society [PF-09-120-01-CSM]; NATIONAL CANCER INSTITUTE [R01CA129359] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Komen Foundation(Susan G. Komen Breast Cancer Foundation); Department of Defense(United States Department of Defense); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA129359, Komen Foundation Grant BCTR0706967, Department of Defense Grant BC084651 (to W. P. S.), and American Cancer Society Grant PF-09-120-01-CSM (to M. K. W.).	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Benson JR, 2004, LANCET ONCOL, V5, P229, DOI 10.1016/S1470-2045(04)01426-3; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Brabek J, 2004, ONCOGENE, V23, P7406, DOI 10.1038/sj.onc.1207965; Brown KA, 2007, J CELL BIOCHEM, V101, P9, DOI 10.1002/jcb.21255; Buck MB, 2006, ANN NY ACAD SCI, V1089, P119, DOI 10.1196/annals.1386.024; Cabodi S, 2006, CANCER RES, V66, P4672, DOI 10.1158/0008-5472.CAN-05-2909; Chen RH, 1997, CELL GROWTH DIFFER, V8, P821; Dawson PJ, 1996, AM J PATHOL, V148, P313; Galliher Amy J, 2006, Future Oncol, V2, P743, DOI 10.2217/14796694.2.6.743; Galliher AJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1524; Galliher AJ, 2007, CANCER RES, V67, P3752, DOI 10.1158/0008-5472.CAN-06-3851; Galliher-Beckley AJ, 2008, CARCINOGENESIS, V29, P244, DOI 10.1093/carcin/bgm245; Geiger B, 2006, CELL, V127, P879, DOI 10.1016/j.cell.2006.11.020; Gomis RR, 2006, CANCER CELL, V10, P203, DOI 10.1016/j.ccr.2006.07.019; Honda H, 1998, NAT GENET, V19, P361, DOI 10.1038/1246; Ingman WV, 2008, BIOL REPROD, V79, P711, DOI 10.1095/biolreprod.107.067272; Jin W, 2007, ONCOGENE, V26, P7684, DOI 10.1038/sj.onc.1210571; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kim W, 2008, MOL BIOL CELL, V19, P2135, DOI 10.1091/mbc.E07-10-0991; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; Liu XD, 1997, P NATL ACAD SCI USA, V94, P10669, DOI 10.1073/pnas.94.20.10669; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Muraoka RS, 2002, J CLIN INVEST, V109, P1551, DOI 10.1172/JCI200215234; Nam JS, 2008, CANCER RES, V68, P3835, DOI 10.1158/0008-5472.CAN-08-0215; Neil JR, 2008, CARCINOGENESIS, V29, P2227, DOI 10.1093/carcin/bgn202; Nelson CM, 2006, SCIENCE, V314, P298, DOI 10.1126/science.1131000; Santner SJ, 2001, BREAST CANCER RES TR, V65, P101, DOI 10.1023/A:1006461422273; Schiemann WP, 2007, EXPERT REV ANTICANC, V7, P609, DOI 10.1586/14737140.7.5.609; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; SILBERSTEIN GB, 1987, SCIENCE, V237, P291, DOI 10.1126/science.3474783; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Ta HQ, 2008, CANCER RES, V68, P8796, DOI 10.1158/0008-5472.CAN-08-2426; Tang BW, 2003, J CLIN INVEST, V112, P1116, DOI 10.1172/JCI200318899; Tian M, 2009, FUTURE ONCOL, V5, P259, DOI 10.2217/14796694.5.2.259; van der Flier S, 2000, INT J CANCER, V89, P465, DOI 10.1002/1097-0215(20000920)89:5<465::AID-IJC11>3.0.CO;2-O; Wakefield LM, 2001, J MAMMARY GLAND BIOL, V6, P67, DOI 10.1023/A:1009568532177; Weaver VM, 1996, BIOCHEM CELL BIOL, V74, P833, DOI 10.1139/o96-089; Wendt MK, 2008, ONCOGENE, V27, P1461, DOI 10.1038/sj.onc.1210751; Wendt MK, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2360; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Yoshida BA, 2000, JNCI-J NATL CANCER I, V92, P1717, DOI 10.1093/jnci/92.21.1717	44	48	50	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34145	34156		10.1074/jbc.M109.023614	http://dx.doi.org/10.1074/jbc.M109.023614			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19822523	Green Published, hybrid			2022-12-27	WOS:000272165200047
J	Long, X; Tharp, DL; Georger, MA; Slivano, OJ; Lee, MY; Wamhoff, BR; Bowles, DK; Miano, JM				Long, Xiaochun; Tharp, Darla L.; Georger, Mary A.; Slivano, Orazio J.; Lee, Monica Y.; Wamhoff, Brian R.; Bowles, Douglas K.; Miano, Joseph M.			The Smooth Muscle Cell-restricted KCNMB1 Ion Channel Subunit Is a Direct Transcriptional Target of Serum Response Factor and Myocardin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED POTASSIUM CHANNEL; CA2+-ACTIVATED K+ CHANNEL; GENE-EXPRESSION; MAXIK CHANNEL; LARGE-CONDUCTANCE; PHENOTYPIC MODULATION; FORCED EXPRESSION; BETA-1 SUBUNIT; CALPONIN GENE; UP-REGULATION	Large conductance calcium-activated potassium (MaxiK) channels play a pivotal role in maintaining normal arterial tone by regulating the excitation-contraction coupling process. MaxiK channels comprise alpha and beta subunits encoded by Kcnma and the cell-restricted Kcnmb genes, respectively. Although the functionality of MaxiK channel subunits has been well studied, the molecular regulation of their transcription and modulation in smooth muscle cells (SMCs) is incomplete. Using several model systems, we demonstrate down-regulation of Kcnmb1 mRNA upon SMC phenotypic modulation in vitro and in vivo. As part of a broad effort to define all functional CArG elements in the genome (i.e. the CArGome), we discovered two conserved CArG boxes located in the proximal promoter and first intron of the human KCNMB1 gene. Gel shift and chromatin immunoprecipitation assays confirmed serum response factor (SRF) binding to both CArG elements. A luciferase assay showed myocardin (MYOCD)-mediated transactivation of the KCNMB1 promoter in a CArG element-dependent manner. In vivo analysis of the human KCNMB1 promoter disclosed activity in embryonic heart and aortic SMCs; mutation of both conserved CArG elements completely abolished in vivo promoter activity. Forced expression of MYOCD increased Kcnmb1 expression in a variety of rodent and human non-SMC lines with no effect on expression of the Kcnma1 subunit. Conversely, knockdown of Srf resulted in decreases of endogenous Kcnmb1. Functional studies demonstrated MYOCD-induced, iberiotoxin-sensitive potassium currents in porcine coronary SMCs. These results reveal the first ion channel subunit as a direct target of SRF-MYOCD transactivation, providing further insight into the role of MYOCD as a master regulator of the SMC contractile phenotype.	[Miano, Joseph M.] Univ Rochester, Sch Med & Dent, Dept Med, Aab Cardiovasc Res Inst, Rochester, NY 14642 USA; [Tharp, Darla L.; Bowles, Douglas K.] Univ Missouri, Dept Biomed Sci, Columbia, MO 65211 USA; [Lee, Monica Y.; Wamhoff, Brian R.] Univ Virginia, Dept Med, Div Cardiovasc, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA	University of Rochester; University of Missouri System; University of Missouri Columbia; University of Virginia	Miano, JM (corresponding author), Univ Rochester, Sch Med & Dent, Dept Med, Aab Cardiovasc Res Inst, Box CVRI,601 Elmwood Ave, Rochester, NY 14642 USA.	j.m.miano@rochester.edu	; Miano, Joseph/L-5634-2018	Bowles, Doug/0000-0003-2043-7368; Miano, Joseph/0000-0001-7522-3207; Long, Xiaochun/0000-0001-9714-0023	National Institutes of Health [HL62572, HL091168, HL52490, HL079934, HL081682]; American Heart Association [0535002N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091168, R01HL062572, K02HL079934, R01HL081682, P01HL052490] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL62572 and HL091168 (to J. M. M.), HL52490 and HL079934 (to D. K. B.), and HL081682 (to B. R. W.). This work was also supported by American Heart Association Scientist Development Grant 0535002N (to B. R. W.).	Amberg GC, 2003, J CLIN INVEST, V112, P717, DOI 10.1172/JC1200318684; Baker DL, 1998, NUCLEIC ACIDS RES, V26, P1092, DOI 10.1093/nar/26.4.1092; Barlow CA, 2006, J PHYSIOL-LONDON, V570, P59, DOI 10.1113/jphysiol.2005.098426; Behrens R, 2000, FEBS LETT, V474, P99, DOI 10.1016/S0014-5793(00)01584-2; Belaguli NS, 1997, J BIOL CHEM, V272, P18222, DOI 10.1074/jbc.272.29.18222; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; CAMPBELL GR, 1985, EXP MOL PATHOL, V42, P139, DOI 10.1016/0014-4800(85)90023-1; Cao DS, 2005, MOL CELL BIOL, V25, P364, DOI 10.1128/MCB.25.1.364-376.2005; Chang WM, 2000, J BIOL CHEM, V275, P3991, DOI 10.1074/jbc.275.6.3991; Chen JY, 2002, J MOL CELL CARDIOL, V34, P1345, DOI 10.1006/jmcc.2002.2086; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Chow N, 2007, P NATL ACAD SCI USA, V104, P823, DOI 10.1073/pnas.0608251104; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dhulipala PDK, 1999, BBA-GENE STRUCT EXPR, V1444, P254, DOI 10.1016/S0167-4781(98)00276-0; Fan QI, 2002, BBA-GENE STRUCT EXPR, V1577, P401, DOI 10.1016/S0167-4781(02)00441-4; FERNS GAA, 1991, SCIENCE, V253, P1129, DOI 10.1126/science.1653454; Ghatta S, 2006, PHARMACOL THERAPEUT, V110, P103, DOI 10.1016/j.pharmthera.2005.10.007; Gollasch M, 1998, FASEB J, V12, P593, DOI 10.1096/fasebj.12.7.593; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Hendrix JA, 2005, J CLIN INVEST, V115, P418, DOI 10.1172/JCI200522648; HOLYCROSS BJ, 1992, CIRC RES, V71, P1525, DOI 10.1161/01.RES.71.6.1525; Huang JH, 2008, J CLIN INVEST, V118, P515, DOI [10.1172/JC133304, 10.1172/JCI33304]; Jiang Z, 1999, GENOMICS, V55, P57, DOI 10.1006/geno.1998.5627; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kohler R, 2003, CIRCULATION, V108, P1119, DOI 10.1161/01.CIR.0000086464.04719.DD; Kraner SD, 1999, J BIOL CHEM, V274, P8129, DOI 10.1074/jbc.274.12.8129; Kumar A, 1997, ARTERIOSCL THROM VAS, V17, P2238, DOI 10.1161/01.ATV.17.10.2238; Kundu P, 2007, J BIOL CHEM, V282, P27478, DOI 10.1074/jbc.M704777200; Kuratomi S, 2009, CARDIOVASC RES, V83, P682, DOI 10.1093/cvr/cvp171; Larsson E, 2008, MOL GENET GENOMICS, V280, P127, DOI 10.1007/s00438-008-0349-y; Li L, 1996, J CELL BIOL, V132, P849, DOI 10.1083/jcb.132.5.849; Li SJ, 2003, P NATL ACAD SCI USA, V100, P9366, DOI 10.1073/pnas.1233635100; Long XC, 2008, ARTERIOSCL THROM VAS, V28, P1505, DOI 10.1161/ATVBAHA.108.166066; Long XC, 2007, P NATL ACAD SCI USA, V104, P16570, DOI 10.1073/pnas.0708253104; Mack CP, 1999, CIRC RES, V84, P852; McGahon Mary K, 2007, Channels (Austin), V1, P141; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Miano JM, 2004, CIRC RES, V95, P340, DOI 10.1161/01.RES.0000140893.16465.2d; Miano JM, 2001, MAMM GENOME, V12, P187, DOI 10.1007/s003350010266; Miano JM, 2000, J BIOL CHEM, V275, P9814, DOI 10.1074/jbc.275.13.9814; MIANO JM, 1994, CIRC RES, V75, P803, DOI 10.1161/01.RES.75.5.803; Neylon CB, 1999, CIRC RES, V85, pE33, DOI 10.1161/01.RES.85.9.e33; Nishimaru K, 2004, J PHYSIOL-LONDON, V559, P849, DOI 10.1113/jphysiol.2004.068676; Niu Z, 2008, P NATL ACAD SCI USA, V105, P17824, DOI 10.1073/pnas.0805491105; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; PALLANCK L, 1994, HUM MOL GENET, V3, P1239, DOI 10.1093/hmg/3.8.1239; Pruunsild P, 2005, GENOMICS, V86, P581, DOI 10.1016/j.ygeno.2005.07.001; Quignard JF, 2001, CARDIOVASC RES, V49, P177, DOI 10.1016/S0008-6363(00)00210-8; Rene C, 2005, NUCLEIC ACIDS RES, V33, P5271, DOI 10.1093/nar/gki837; Saada N, 2003, BIOCHEM BIOPH RES CO, V302, P23, DOI 10.1016/S0006-291X(03)00097-4; Si H, 2006, BRIT J PHARMACOL, V148, P909, DOI 10.1038/sj.bjp.0706793; Streb JW, 2005, J BIOL CHEM, V280, P4125, DOI 10.1074/jbc.M412466200; Sun Q, 2006, GENOME RES, V16, P197, DOI 10.1101/gr.4108706; Tanaka Y, 2004, J PHARMACOL SCI, V94, P339, DOI 10.1254/jphs.94.339; Tharp DL, 2008, ARTERIOSCL THROM VAS, V28, P1084, DOI 10.1161/ATVBAHA.107.155796; Tharp DL, 2006, AM J PHYSIOL-HEART C, V291, pH2493, DOI 10.1152/ajpheart.01254.2005; Thorneloe KS, 2005, CAN J PHYSIOL PHARM, V83, P215, DOI 10.1139/Y05-016; van Tuyn J, 2005, CARDIOVASC RES, V67, P245, DOI 10.1016/j.cardiores.2005.04.013; Wamhoff BR, 2004, CIRC RES, V95, P406, DOI 10.1161/01.RES.0000138582.36921.9e; Wamhoff BR, 2006, CIRC RES, V98, P868, DOI 10.1161/01.RES.0000216596.73005.3c; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Woodman L, 2008, J IMMUNOL, V181, P5001, DOI 10.4049/jimmunol.181.7.5001; Yin F, 2006, AM J PHYSIOL-CELL PH, V290, pC1599, DOI 10.1152/ajpcell.00289.2005; Yoshida T, 2004, ARTERIOSCL THROM VAS, V24, P1596, DOI 10.1161/01.ATV.0000137190.63214.c5; Zhang XY, 2009, GENE, V438, P33, DOI 10.1016/j.gene.2009.03.001; Zhou JL, 2005, J BIOL CHEM, V280, P10861, DOI 10.1074/jbc.M411586200	69	51	52	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33671	33682		10.1074/jbc.M109.050419	http://dx.doi.org/10.1074/jbc.M109.050419			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801679	Green Published, hybrid			2022-12-27	WOS:000272028500071
J	Araki, K; Shimura, T; Yajima, T; Tsutsumi, S; Suzuki, H; Okada, K; Kobayashi, T; Raz, A; Kuwano, H				Araki, Kenichiro; Shimura, Tatsuo; Yajima, Toshiki; Tsutsumi, Soichi; Suzuki, Hideki; Okada, Kohji; Kobayashi, Tsutomu; Raz, Avraham; Kuwano, Hiroyuki			Phosphoglucose Isomerase/Autocrine Motility Factor Promotes Melanoma Cell Migration through ERK Activation Dependent on Autocrine Production of Interleukin-8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; MESSENGER-RNA EXPRESSION; PROTEIN-KINASE; GENE-EXPRESSION; DOWN-REGULATION; CANCER CELLS; NUDE-MICE; IN-VITRO; IL-8; INDUCTION	It is well known that phosphoglucose isomerase/autocrine motility factor (AMF) promotes cell migration in an autocrine manner in various tumor cells. However, it remains unclear whether certain cytokines modulate the effects of AMF on tumor cell migration. Because interleukin (IL)-8, a proinflammatory cytokine, is produced by melanoma cells and has been correlated with melanoma migration, the migratory ability of melanoma cells induced by AMF may also involve induction of IL-8 expression. In the present study, we assessed whether AMF promotes melanoma cell migration through autocrine production of IL-8. We found that AMF stimulation increased IL-8 production through up-regulation of IL-8 mRNA transcription, especially in biologically early stage melanoma cells. AMF-induced migration of these cells was inhibited by a specific neutralizing antibody against IL-8. The IL-8 production induced by AMF was mediated by the ERK1/2 pathways. These findings suggest that melanoma migration induced by AMF is mediated by autocrine production of IL-8 as a novel downstream modulator of the AMF signaling pathway.	[Araki, Kenichiro; Shimura, Tatsuo; Yajima, Toshiki; Tsutsumi, Soichi; Suzuki, Hideki; Okada, Kohji; Kobayashi, Tsutomu; Kuwano, Hiroyuki] Gunma Univ, Grad Sch Med, Dept Gen Surg Sci Surg 1, Gunma, Japan; [Raz, Avraham] Wayne State Univ, Karmanos Canc Inst, Dept Tumor Progress & Metastasis, Detroit, MI 48201 USA	Gunma University; Barbara Ann Karmanos Cancer Institute; Wayne State University	Araki, K (corresponding author), Gunma Univ, Grad Sch Med, Dept Gen Surg Sci Surg 1, 3-39-22 Showa Machi, Gunma, Japan.	karaki@showa.gunma-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT); NATIONAL CANCER INSTITUTE [R01CA051714] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) and the Support Program for Improving Graduate School Education from MEXT.	Abdel-Malak NA, 2008, BLOOD, V111, P4145, DOI 10.1182/blood-2007-08-110338; ACHARI A, 1981, PHILOS T ROY SOC B, V293, P145, DOI 10.1098/rstb.1981.0068; Aihara M, 1997, INFECT IMMUN, V65, P3218, DOI 10.1128/IAI.65.8.3218-3224.1997; BAGGIOLINI M, 1992, FEBS LETT, V307, P97, DOI 10.1016/0014-5793(92)80909-Z; Brat DJ, 2005, NEURO-ONCOLOGY, V7, P122, DOI 10.1215/S1152851704001061; COLOMBO MP, 1992, MELANOMA RES, V2, P181, DOI 10.1097/00008390-199209000-00006; DEFORGE LE, 1993, J BIOL CHEM, V268, P25568; Freund A, 2003, ONCOGENE, V22, P256, DOI 10.1038/sj.onc.1206113; Funasaka T, 2002, INT J CANCER, V101, P217, DOI 10.1002/ijc.10617; Funasaka T, 2007, CANCER RES, V67, P4236, DOI 10.1158/0008-5472.CAN-06-3935; Furuya M, 2004, J PATHOL, V203, P551, DOI 10.1002/path.1543; Haga A, 2003, INT J CANCER, V107, P707, DOI 10.1002/ijc.11449; Haga A, 2000, BBA-PROTEIN STRUCT M, V1480, P235, DOI 10.1016/S0167-4838(00)00075-3; HERLYN M, 1985, CANCER RES, V45, P5670; Hobbie S, 1997, J IMMUNOL, V159, P5550; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; JUHASZ I, 1993, AM J PATHOL, V143, P528; KASAHARA T, 1991, IMMUNOLOGY, V74, P60; KOHN EC, 1990, BIOCHEM BIOPH RES CO, V166, P757, DOI 10.1016/0006-291X(90)90874-M; LIOTTA LA, 1986, P NATL ACAD SCI USA, V83, P3302, DOI 10.1073/pnas.83.10.3302; LUSCINSKAS FW, 1992, J IMMUNOL, V149, P2163; Neudauer CL, 2003, EXP CELL RES, V286, P128, DOI 10.1016/S0014-4827(03)00049-1; Norgauer J, 1996, J IMMUNOL, V156, P1132; Satyamoorthy K, 1997, MELANOMA RES, V7, pS35; Satyamoorthy K, 2002, CELL GROWTH DIFFER, V13, P87; SCHADENDORF D, 1993, J IMMUNOL, V151, P2667; Schaider H, 2003, INT J CANCER, V103, P335, DOI 10.1002/ijc.10775; Shimizu K, 1999, FEBS LETT, V456, P295, DOI 10.1016/S0014-5793(99)00966-7; Shimoda K, 1998, HEPATOLOGY, V28, P108, DOI 10.1002/hep.510280116; SILLETTI S, 1991, CANCER RES, V51, P3507; SINGH RK, 1994, CANCER RES, V54, P3242; Sonoda Y, 1997, J BIOL CHEM, V272, P15366, DOI 10.1074/jbc.272.24.15366; STRACKE ML, 1989, J BIOL CHEM, V264, P21544; STRACKE ML, 1988, BIOCHEM BIOPH RES CO, V153, P1076, DOI 10.1016/S0006-291X(88)81338-X; Tikhonov I, 2001, CLIN EXP IMMUNOL, V125, P414, DOI 10.1046/j.1365-2249.2001.01626.x; Timar J, 1996, CANCER RES, V56, P1902; Tsutsumi S, 2004, CLIN CANCER RES, V10, P7775, DOI 10.1158/1078-0432.CCR-04-1015; Tsutsumi S, 2003, J BIOL CHEM, V278, P32165, DOI 10.1074/jbc.M304537200; Tsutsumi S, 2002, CANCER RES, V62, P4484; Venkatakrishnan G, 2000, J BIOL CHEM, V275, P6868, DOI 10.1074/jbc.275.10.6868; VERSCHRAEGEN CF, 1991, ANTICANCER RES, V11, P529; WANG JM, 1990, BIOCHEM BIOPH RES CO, V169, P165, DOI 10.1016/0006-291X(90)91449-3; Watanabe H, 1996, CANCER RES, V56, P2960; Wigmore SJ, 1997, AM J PHYSIOL-ENDOC M, V273, pE720, DOI 10.1152/ajpendo.1997.273.4.E720	44	21	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32305	32311		10.1074/jbc.M109.008250	http://dx.doi.org/10.1074/jbc.M109.008250			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19801670	Green Published, hybrid			2022-12-27	WOS:000272028400012
J	Jagannathan, I; Ichikawa, HT; Kruger, T; Fay, PJ				Jagannathan, Indu; Ichikawa, H. Travis; Kruger, Tricia; Fay, Philip J.			Identification of Residues in the 558-Loop of Factor VIIIa A2 Subunit That Interact with Factor IXa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Proceedings Paper	22nd Congress of the International-Society-on-Thrombosis-and-Haemostasis	JUL 11-17, 2009	Boston, MA	Int Soc Thrombosis & Haemostasis			PORCINE FACTOR-VIII; ACTIVATED PROTEIN-C; A1/A3-C1-C2 DIMER; FACTOR XASE; FACTOR-X; BINDING-SITE; RECONSTITUTION; PROTEOLYSIS; A2-SUBUNIT; CLEAVAGE	Factor VIIIa is comprised of A1, A2, and A3C1C2 subunits. Several lines of evidence have identified the A2 558-loop as interacting with factor IXa. The contributions of individual residues within this region to inter-protein affinity and cofactor activity were assessed following alanine scanning mutagenesis of residues 555-571 that border or are contained within the loop. Variants were expressed as isolated A2 domains in Sf9 cells using a baculovirus construct and purified to >90%. Two reconstitution assays were employed to determine affinity and activity parameters. The first assay reconstituted factor Xase using varying concentrations of A2 mutant and fixed levels of A1/A3C1C2 dimer purified from wild type (WT), baby hamster kidney cell-expressed factor VIII, factor IXa, and phospholipid vesicles to determine the inter-molecular K-d for A2. The second assay determined the K-d for A2 in factor VIIIa by reconstituting various A2 and fixed levels of A1/A3C1C2. Parameter values were determined by factor Xa generation assays. WT A2 expressed in insect cells yielded similar K-d and k(cat) values following reconstitution as WT A2 purified from baby hamster kidney cell-expressed factor VIII. All A2 variants exhibited modest if any increases in K-d values for factor VIIIa assembly. However, variants S558A, V559A, D560A, G563A, and I566A showed >9-fold increases in K-d for factor Xase assembly, implicating these residues in stabilizing A2 association with factor IXa. Furthermore, variants Y555A, V559A, D560A, G563A, I566A, and D569A showed >80% reduction in k(cat) for factor Xa generation. These results identify residues in the 558-loop critical to interaction with factor IXa in Xase.	[Fay, Philip J.] Univ Rochester, Med Ctr, Dept Biochem & Biophys, Sch Med, Rochester, NY 14642 USA	University of Rochester	Fay, PJ (corresponding author), Univ Rochester, Med Ctr, Dept Biochem & Biophys, Sch Med, POB 712,601 Elmwood Ave, Rochester, NY 14642 USA.	Philip_Fay@urmc.rochester.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076213, R01HL038199] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL38199, R01 HL076213, HL76213, R01 HL038199] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bajaj SP, 2001, J BIOL CHEM, V276, P16302, DOI 10.1074/jbc.M011680200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DUFFY EJ, 1992, J BIOL CHEM, V267, P7821; Fay PJ, 1998, J BIOL CHEM, V273, P19049, DOI 10.1074/jbc.273.30.19049; Fay PJ, 2005, BLOOD REV, V19, P15, DOI 10.1016/j.blre.2004.02.003; FAY PJ, 1994, J BIOL CHEM, V269, P20522; Fay PJ, 1996, J BIOL CHEM, V271, P6027, DOI 10.1074/jbc.271.11.6027; FAY PJ, 1991, J BIOL CHEM, V266, P20139; FAY PJ, 1992, J BIOL CHEM, V267, P13246; FAY PJ, 1991, J BIOL CHEM, V266, P8957; Fay PJ, 2004, BLOOD REV, V18, P1, DOI 10.1016/S0268-960X(03)00025-0; Jenkins PV, 2004, BIOCHEMISTRY-US, V43, P5094, DOI 10.1021/bi036289p; Jenkins PV, 2002, BLOOD, V100, P501, DOI 10.1182/blood-2001-12-0361; Kemball-Cook G, 1998, NUCLEIC ACIDS RES, V26, P216, DOI 10.1093/nar/26.1.216; LAMPHEAR BJ, 1992, J BIOL CHEM, V267, P3725; Lapan KA, 1997, J BIOL CHEM, V272, P2082; Lenting PJ, 1996, J BIOL CHEM, V271, P1935, DOI 10.1074/jbc.271.4.1935; LENTING PJ, 1994, J BIOL CHEM, V269, P7150; LOLLAR P, 1990, J BIOL CHEM, V265, P1688; LOLLAR P, 1984, BLOOD, V63, P1303; LOLLAR P, 1989, BIOCHEMISTRY-US, V28, P666, DOI 10.1021/bi00428a038; LOLLAR P, 1991, J BIOL CHEM, V266, P12481; MIMMS LT, 1981, BIOCHEMISTRY-US, V20, P833, DOI 10.1021/bi00507a028; MUTUCUMARANA VP, 1992, J BIOL CHEM, V267, P17012; Newell JL, 2009, J BIOL CHEM, V284, P11080, DOI 10.1074/jbc.M900234200; Ngo JCK, 2008, STRUCTURE, V16, P597, DOI 10.1016/j.str.2008.03.001; REGAN LM, 1994, J BIOL CHEM, V269, P9445; Sarafanov AG, 2006, BIOCHEMISTRY-US, V45, P1829, DOI 10.1021/bi0520380; VANDIEIJEN G, 1981, J BIOL CHEM, V256, P3433; VEHAR GA, 1984, NATURE, V312, P337, DOI 10.1038/312337a0	30	10	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32248	32255		10.1074/jbc.M109.050781	http://dx.doi.org/10.1074/jbc.M109.050781			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology	522VR	19801661	Green Published, hybrid			2022-12-27	WOS:000272028400005
J	Liu, YT; Matte, SL; Corbin, JD; Francis, SH; Cote, RH				Liu, Yu-Ting; Matte, Suzanne L.; Corbin, Jackie D.; Francis, Sharron H.; Cote, Rick H.			Probing the Catalytic Sites and Activation Mechanism of Photoreceptor Phosphodiesterase Using Radiolabeled Phosphodiesterase Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-GMP PHOSPHODIESTERASE; ROD CGMP PHOSPHODIESTERASE; DEPENDENT CONFORMATIONAL-CHANGE; GAMMA-SUBUNIT; BINDING-SITES; OUTER SEGMENTS; G-PROTEIN; GAF DOMAINS; TRANSDUCIN; BOVINE	Retinal photoreceptor phosphodiesterase (PDE6) is unique among the phosphodiesterase enzyme family not only for its catalytic heterodimer but also for its regulatory gamma-subunits (P gamma) whose inhibitory action is released upon binding to the G-protein transducin. It is generally assumed that during visual excitation both catalytic sites are relieved of P gamma inhibition upon binding of two activated transducin molecules. Because PDE6 shares structural and pharmacological similarities with PDE5, we utilized radiolabeled PDE5 inhibitors to probe the catalytic sites of PDE6. The membrane filtration assay we used to quantify [H-3] vardenafil binding to PDE6 required histone II-AS to stabilize drug binding to the active site. Under these conditions, [H-3] vardenafil binds stoichiometrically to both the alpha- and beta-subunits of the activated PDE6 heterodimer. [H-3] vardenafil fails to bind to either the PDE6 holoenzyme or the PDE6 catalytic dimer reconstituted with P gamma, consistent with P gamma blocking access to the drug-binding sites. Following transducin activation of membrane-associated PDE6 holoenzyme, [H-3] vardenafil binding increases in proportion to the extent of PDE6 activation. Both [H-3] vardenafil binding and hydrolytic activity of transducin-activated PDE6 fail to exceed 50% of the value for the PDE6 catalytic dimer. However, adding a 1000-fold excess of activated transducin can stimulate the hydrolytic activity of PDE6 to its maximum extent. These results demonstrate that both subunits of the PDE6 heterodimer are able to bind ligands to the enzyme active site. Furthermore, transducin relieves P gamma inhibition of PDE6 in a biphasic manner, with only one-half of the maximum PDE6 activity efficiently attained during visual excitation.	[Liu, Yu-Ting; Matte, Suzanne L.; Cote, Rick H.] Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA; [Corbin, Jackie D.; Francis, Sharron H.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	University System Of New Hampshire; University of New Hampshire; Vanderbilt University	Cote, RH (corresponding author), Univ New Hampshire, Dept Mol Cellular & Biomed Sci, 46 Coll Rd, Durham, NH 03824 USA.	rick.cote@unh.edu	Cote, Rick H/G-3363-2013	Cote, Rick H/0000-0002-1573-6526	National Institutes of Health [EY-05798, DK-40029]; NATIONAL EYE INSTITUTE [R01EY005798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040029] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants EY-05798 and DK-40029. This is Scientific Contribution Number 2392 from the New Hampshire Agricultural Experiment Station.	ARSHAVSKY VY, 1992, J BIOL CHEM, V267, P24501; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Artemyev NO, 1996, P NATL ACAD SCI USA, V93, P5407, DOI 10.1073/pnas.93.11.5407; Artemyev NO, 1998, METHODS, V14, P93, DOI 10.1006/meth.1997.0568; BEAVO JA, 2006, CYCLIC NUCL PHOSPHOD; BELTMAN J, 1995, MOL PHARMACOL, V47, P330; Blount MA, 2004, MOL PHARMACOL, V66, P144, DOI 10.1124/mol.66.1.144; BOWNDS D, 1971, J GEN PHYSIOL, V58, P225, DOI 10.1085/jgp.58.3.225; BRUCKERT F, 1994, BIOCHEMISTRY-US, V33, P12625, DOI 10.1021/bi00208a013; Burns ME, 2005, NEURON, V48, P387, DOI 10.1016/j.neuron.2005.10.014; Cote RH, 2004, INT J IMPOT RES, V16, pS28, DOI 10.1038/sj.ijir.3901212; Cote RH, 2000, METHOD ENZYMOL, V315, P646; COTE RH, 2006, CYCLIC NUCL PHOSPHOD; COTE RH, 2008, VISUAL TRANSDUCTION; Cote Rick H., 2005, V307, P141; D'Amours MR, 1999, MOL PHARMACOL, V55, P508; Fink TL, 1999, J BIOL CHEM, V274, P34613, DOI 10.1074/jbc.274.49.34613; FRANCIS SH, 2006, CYCLIC NUCL PHOSPHOD; FUNG BKK, 1989, BIOCHEMISTRY-US, V28, P3133, DOI 10.1021/bi00434a003; FUNG BKK, 1990, BIOCHEMISTRY-US, V29, P2657, DOI 10.1021/bi00463a006; GILLESPIE PG, 1988, J BIOL CHEM, V263, P8133; GILLESPIE PG, 1989, MOL PHARMACOL, V36, P773; GILLESPIE PG, 1990, CYCLIC NUCL PHOSPHOD; Granovsky AE, 2000, J BIOL CHEM, V275, P41258, DOI 10.1074/jbc.M008094200; Guo LW, 2006, J BIOL CHEM, V281, P15412, DOI 10.1074/jbc.M600595200; Guo LW, 2008, CURR PROTEIN PEPT SC, V9, P611, DOI 10.2174/138920308786733930; Hebert MC, 1998, J BIOL CHEM, V273, P5557, DOI 10.1074/jbc.273.10.5557; Heikaus CC, 2008, J BIOL CHEM, V283, P22749, DOI 10.1074/jbc.M801577200; Huang DM, 2004, J BIOL CHEM, V279, P48143, DOI 10.1074/jbc.M404338200; HURLEY JB, 1982, J BIOL CHEM, V257, P1094; HURWITZ RL, 1984, J BIOL CHEM, V259, P8612; KLEUSS C, 1987, J CHROMATOGR, V407, P281, DOI 10.1016/S0021-9673(01)92625-1; Leskov IB, 2000, NEURON, V27, P525, DOI 10.1016/S0896-6273(00)00063-5; Martinez SE, 2008, J BIOL CHEM, V283, P25913, DOI 10.1074/jbc.M802891200; MCALLISTERLUCAS LM, 1993, J BIOL CHEM, V268, P22863; Melia TJ, 2000, J BIOL CHEM, V275, P3535, DOI 10.1074/jbc.275.5.3535; MIKI N, 1975, J BIOL CHEM, V250, P6320; Mou HM, 1999, J BIOL CHEM, V274, P18813, DOI 10.1074/jbc.274.26.18813; Mou HM, 2001, J BIOL CHEM, V276, P27527, DOI 10.1074/jbc.M103316200; Norton AW, 2000, J BIOL CHEM, V275, P38611, DOI 10.1074/jbc.M004606200; OTTOBRUC A, 1993, BIOCHEMISTRY-US, V32, P8636, DOI 10.1021/bi00084a035; Pentia Dana C., 2005, V307, P125; PLEISS U, 2007, SYNTHESIS 3H VARDENA; PUGH EN, 2000, MOL MECH VISUAL TRAN; SLEPAK VZ, 1995, J BIOL CHEM, V270, P14319, DOI 10.1074/jbc.270.24.14319; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Tcheudji JFK, 2001, J MOL BIOL, V310, P781, DOI 10.1006/jmbi.2001.4813; Tsang SH, 1998, SCIENCE, V282, P117, DOI 10.1126/science.282.5386.117; WENSEL T G, 1986, Proteins Structure Function and Genetics, V1, P90, DOI 10.1002/prot.340010114; WENSEL TG, 1990, BIOCHEMISTRY-US, V29, P2155, DOI 10.1021/bi00460a028; WENSEL TG, 1988, ENZYME DYNAMICS REGU; Wensel Theodore G., 2005, V307, P289; WHALEN MM, 1990, BIOCHEM J, V265, P655, DOI 10.1042/bj2650655; YAMAZAKI A, 1990, J BIOL CHEM, V265, P11539; Yamazaki M, 2002, J BIOL CHEM, V277, P40675, DOI 10.1074/jbc.M203469200; Zhang XJ, 2005, INVEST OPHTH VIS SCI, V46, P3060, DOI 10.1167/iovs.05-0257	56	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31541	31547		10.1074/jbc.M109.018606	http://dx.doi.org/10.1074/jbc.M109.018606			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19758990	Green Published, hybrid			2022-12-27	WOS:000271572700007
J	Perez-Oliva, AB; Olivares, C; Jimenez-Cervantes, C; Garcia-Borron, JC				Perez-Oliva, Ana B.; Olivares, Concepcion; Jimenez-Cervantes, Celia; Garcia-Borron, Jose C.			Mahogunin Ring Finger-1 (MGRN1) E3 Ubiquitin Ligase Inhibits Signaling from Melanocortin Receptor by Competition with G alpha(s)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ARRESTIN; MUTANT MICE; PROTEIN; MUTATIONS; SYSTEM; EXPRESSION; NEURODEGENERATION; PIGMENTATION; TRAFFICKING; ATTRACTIN	Mahogunin ring finger-1 (MGRN1) is a RING domain-containing ubiquitin ligase mutated in mahoganoid, a mouse mutation causing coat color darkening, congenital heart defects, high embryonic lethality, and spongiform neurodegeneration. The melanocortin hormones regulate pigmentation, cortisol production, food intake, and body weight by signaling through five G protein-coupled receptors positively coupled to the cAMP pathway (MC1R-MC5R). Genetic analysis has shown that mouse Mgrn1 is an accessory protein for melanocortin signaling that may inhibit MC1R and MC4R by unknown mechanisms. These melanocortin receptors (MCRs) regulate pigmentation and body weight, respectively. We show that human melanoma cells express 4 MGRN1 isoforms differing in the C-terminal exon 17 and in usage of exon 12. This exon contains nuclear localization signals. MGRN1 isoforms decreased MC1R and MC4R signaling to cAMP, without effect on beta(2)-adrenergic receptor. Inhibition was independent on receptor plasma membrane expression, ubiquitylation, internalization, or stability and occurred upstream of G alpha(s) binding to/activation of adenylyl cyclase. MGRN1 co-immunoprecipitated with MCRs, suggesting a physical interaction of the proteins. Significantly, overexpression of G alpha(s) abolished the inhibitory effect of MGRN1 and decreased co-immunoprecipitation with MCRs, suggesting competition between MGRN1 and G alpha(s) for binding to MCRs. Although all MGRN1s were located in the cytosol in the absence of MCRs, exon 12-containing isoforms accumulated in the nuclei upon co-expression with the receptors. Therefore, MGRN1 inhibits MCR signaling by a new mechanism involving displacement of G alpha(s), thus accounting for key features of the mahoganoid phenotype. Moreover, MGRN1 might provide a novel pathway for melanocortin signaling from the cell surface to the nucleus.	[Perez-Oliva, Ana B.; Olivares, Concepcion; Jimenez-Cervantes, Celia; Garcia-Borron, Jose C.] Univ Murcia, Dept Biochem & Mol Biol, Sch Med, E-30100 Murcia, Spain	University of Murcia	Garcia-Borron, JC (corresponding author), Univ Murcia, Espinardo 30100, Spain.	gborron@um.es	Olivares, Conchi/H-2794-2015; Perez-Oliva, Ana Belen/GNW-3708-2022; Jimenez-Cervantes, Celia/H-1953-2015; Perez-Oliva, Ana B/K-2674-2017; Garcia-Borron, Jose Carlos/H-2247-2015	Olivares, Conchi/0000-0001-7518-3858; Jimenez-Cervantes, Celia/0000-0002-5821-9510; Perez-Oliva, Ana B/0000-0002-2596-0871; Garcia-Borron, Jose Carlos/0000-0002-9192-588X	Comision Interministerial de Ciencia y Tecnolog a (CICYT), Spain [SAF2006-11206]; Fondo Europeo de Desarrollo Regional funds ( European Community); Comunidad Autonoma Region de Murcia [464/2008]; Plan de Ciencia y Tecnologia [2007/10]; Ministerio de Educacion y Ciencia	Comision Interministerial de Ciencia y Tecnolog a (CICYT), Spain(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Fondo Europeo de Desarrollo Regional funds ( European Community)(European Commission); Comunidad Autonoma Region de Murcia; Plan de Ciencia y Tecnologia; Ministerio de Educacion y Ciencia(Spanish Government)	This work was supported in part by Comision Interministerial de Ciencia y Tecnolog a (CICYT), Spain, Grant SAF2006-11206, Fondo Europeo de Desarrollo Regional funds ( European Community), Comunidad Autonoma Region de Murcia Grant 464/2008, and the Plan de Ciencia y Tecnologia 2007/10.; The nucleotide sequence(s) reported in this paper has been submitted to the GenBank (TM)/EBI Data Bank with accession number( s) ABO69623 and ABO69624. 1 Fellow of the Formacion de Personal Investigador program of the Ministerio de Educacion y Ciencia.	Adan RAH, 2003, TRENDS PHARMACOL SCI, V24, P315, DOI 10.1016/S0165-6147(03)00130-5; Bagher P, 2006, PIGM CELL RES, V19, P635, DOI 10.1111/j.1600-0749.2006.00340.x; Barsh GS, 2002, J RECEPT SIGNAL TR R, V22, P63, DOI 10.1081/RRS-120014588; Barsh GS, 2006, PIGMENTARY SYSTEM, P395, DOI DOI 10.1002/9780470987100.CH19; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; BULTMAN SJ, 1992, CELL, V71, P1195, DOI 10.1016/S0092-8674(05)80067-4; Cabrera-Vera TM, 2003, ENDOCR REV, V24, P765, DOI 10.1210/er.2000-0026; Cota CD, 2006, DEV DYNAM, V235, P3438, DOI 10.1002/dvdy.20992; Cui RT, 2007, CELL, V128, P853, DOI 10.1016/j.cell.2006.12.045; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gantz I, 2003, AM J PHYSIOL-ENDOC M, V284, pE468, DOI 10.1152/ajpendo.00434.2002; Garcia-Borron JC, 2005, PIGM CELL RES, V18, P393, DOI 10.1111/j.1600-0749.2005.00278.x; GESCHWIND II, 1966, ENDOCRINOLOGY, V79, P1165, DOI 10.1210/endo-79-6-1165; He L, 2003, ANN NY ACAD SCI, V994, P288, DOI 10.1111/j.1749-6632.2003.tb03192.x; He L, 2003, SCIENCE, V299, P710, DOI 10.1126/science.1079694; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Jiao J, 2009, GENESIS, V47, P524, DOI 10.1002/dvg.20529; Jimenez-Cervantes C, 2001, FEBS LETT, V508, P44, DOI 10.1016/S0014-5793(01)03025-3; Kim BY, 2007, MOL BIOL CELL, V18, P1129, DOI 10.1091/mbc.E06-09-0787; Kraehn GM, 2001, BRIT J CANCER, V84, P72, DOI 10.1054/bjoc.2000.1535; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; Luttrell LM, 2002, J CELL SCI, V115, P455; Martin NP, 2003, J BIOL CHEM, V278, P45954, DOI 10.1074/jbc.M308285200; Mas JS, 2003, PIGM CELL RES, V16, P540, DOI 10.1034/j.1600-0749.2003.00073.x; Miller KA, 1997, GENETICS, V146, P1407; MILLER MW, 1993, GENE DEV, V7, P454, DOI 10.1101/gad.7.3.454; Miyamura Y, 2007, PIGM CELL RES, V20, P2, DOI 10.1111/j.1600-0749.2006.00358.x; Mountjoy KG, 2003, ENDOCRINOLOGY, V144, P5488, DOI 10.1210/en.2003-0570; MUCA C, 1994, ONCOGENE, V9, P3647; Murakami H, 2005, PIGM CELL RES, V18, P265, DOI 10.1111/j.1600-0749.2005.00234.x; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Oliva ABP, 2009, HUM MUTAT, V30, P811, DOI 10.1002/humu.20971; Phan LK, 2002, J CLIN INVEST, V110, P1449, DOI 10.1172/JC1200216131; Rees JL, 2004, AM J HUM GENET, V75, P739, DOI 10.1086/425285; ROBBINS LS, 1993, CELL, V72, P827, DOI 10.1016/0092-8674(93)90572-8; Sanchez-Laorden BL, 2007, J BIOL CHEM, V282, P3241, DOI 10.1074/jbc.M606865200; Sanchez-Laorden BL, 2006, J INVEST DERMATOL, V126, P172, DOI 10.1038/sj.jid.5700036; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2007, J BIOL CHEM, V282, P29549, DOI 10.1074/jbc.M700852200; Starowicz K, 2003, LIFE SCI, V73, P823, DOI 10.1016/S0024-3205(03)00349-7; Sun K, 2007, NEUROBIOL AGING, V28, P1840, DOI 10.1016/j.neurobiolaging.2007.07.012; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Wojcikiewicz RJH, 2004, TRENDS PHARMACOL SCI, V25, P35, DOI 10.1016/j.tips.2003.11.008	44	40	44	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31714	31725		10.1074/jbc.M109.028100	http://dx.doi.org/10.1074/jbc.M109.028100			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19737927	hybrid, Green Published			2022-12-27	WOS:000271572700026
J	Ghosh, A; Rossi, ML; Aulds, J; Croteau, D; Bohr, VA				Ghosh, Avik; Rossi, Marie L.; Aulds, Jason; Croteau, Deborah; Bohr, Vilhelm A.			Telomeric D-loops Containing 8-Oxo-2 '-deoxyguanosine Are Preferred Substrates for Werner and Bloom Syndrome Helicases and Are Bound by POT1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; RECQ HELICASES; OXIDATIVE STRESS; SYNDROME PROTEIN; WRN PROTEIN; BINDING; SITE; END; TELOMESTATIN; 8-OXOGUANINE	8-Oxo-2'-deoxyguanosine (8-oxodG) is one of the most important oxidative DNA lesions, and G-rich telomeric DNA is especially susceptible to oxidative DNA damage. RecQ helicases WRN and BLM and telomere- binding protein POT1 are thought to play roles in telomere maintenance. This study examines the ability of WRN, BLM, and RecQ5 to unwind and POT1 to bind telomeric D-loops containing 8-oxodG. The results demonstrate that WRN and BLM preferentially unwind telomeric D-loops containing 8-oxodG and that POT1 binds with higher affinity to telomeric D-loops with 8-oxodG but shows no preference for telomeric single-stranded DNA with 8-oxodG. We speculate that telomeric D-loops with 8-oxodG may have a greater tendency to form G-quadruplex DNA structures than telomeric DNA lacking 8-oxodG.	[Bohr, Vilhelm A.] NIA, Lab Mol Gerontol, NIH, Biomed Res Ctr, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Bohr, VA (corresponding author), NIA, Lab Mol Gerontol, NIH, Biomed Res Ctr, 251 Bayview Blvd, Baltimore, MD 21224 USA.	BohrV@.nih.gov	Croteau, Deb/AAP-5933-2020; Bohr, Vilhelm/AAP-5931-2020	Croteau, Deborah/0000-0002-6094-4084	National Institute on Aging; NATIONAL INSTITUTE ON AGING [ZIAAG000727, ZIAAG000726, ZIAAG000721] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Program of the National Institute on Aging.	Aldaye FA, 2006, ANGEW CHEM INT EDIT, V45, P2204, DOI 10.1002/anie.200502481; Bianchi A, 1999, EMBO J, V18, P5735, DOI 10.1093/emboj/18.20.5735; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Bohr VA, 2008, TRENDS BIOCHEM SCI, V33, P609, DOI 10.1016/j.tibs.2008.09.003; Brosh RM, 2000, NUCLEIC ACIDS RES, V28, P2420, DOI 10.1093/nar/28.12.2420; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; Castro L, 2001, NUTRITION, V17, P161, DOI 10.1016/S0899-9007(00)00570-0; Chang S, 2004, NAT GENET, V36, P877, DOI 10.1038/ng1389; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; Du XB, 2004, MOL CELL BIOL, V24, P8437, DOI 10.1128/MCB.24.19.8437-8446.2004; Gomez D, 2006, CANCER RES, V66, P6908, DOI 10.1158/0008-5472.CAN-06-1581; Greider CW, 1996, SCI AM, V274, P92, DOI 10.1038/scientificamerican0296-92; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; GROLLMAN AP, 1993, TRENDS GENET, V9, P246, DOI 10.1016/0168-9525(93)90089-Z; Gros J, 2007, NUCLEIC ACIDS RES, V35, P3064, DOI 10.1093/nar/gkm111; Han HY, 2001, J AM CHEM SOC, V123, P8902, DOI 10.1021/ja002179j; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Henle ES, 1999, J BIOL CHEM, V274, P962, DOI 10.1074/jbc.274.2.962; Henson JD, 2002, ONCOGENE, V21, P598, DOI 10.1038/sj.onc.1205058; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Izumikawa K, 2008, BIOCHEM J, V413, P505, DOI 10.1042/BJ20071392; Kanvah S, 2005, NUCLEIC ACIDS RES, V33, P5133, DOI 10.1093/nar/gki801; Karow JK, 1999, CURR BIOL, V9, P597, DOI 10.1016/S0960-9822(99)80264-4; Kawanishi S, 1999, BIOCHEMISTRY-US, V38, P16733, DOI 10.1021/bi990890z; Lei M, 2004, NAT STRUCT MOL BIOL, V11, P1223, DOI 10.1038/nsmb867; Lei M, 2003, NATURE, V426, P198, DOI 10.1038/nature02092; Li JL, 2001, BIOCHEMISTRY-US, V40, P15194, DOI 10.1021/bi011067h; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LIPSCOMB LA, 1995, P NATL ACAD SCI USA, V92, P719, DOI 10.1073/pnas.92.3.719; Machwe A, 2000, NUCLEIC ACIDS RES, V28, P2762, DOI 10.1093/nar/28.14.2762; MICHAELS ML, 1992, J BACTERIOL, V174, P6321, DOI 10.1128/JB.174.20.6321-6325.1992; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; Oikawa S, 1999, FEBS LETT, V453, P365, DOI 10.1016/S0014-5793(99)00748-6; Opresko PL, 2008, MECH AGEING DEV, V129, P79, DOI 10.1016/j.mad.2007.10.007; Opresko PL, 2004, MOL CELL, V14, P763, DOI 10.1016/j.molcel.2004.05.023; Opresko PL, 2005, J BIOL CHEM, V280, P32069, DOI 10.1074/jbc.M505211200; Opresko PL, 2002, J BIOL CHEM, V277, P41110, DOI 10.1074/jbc.M205396200; Orren DK, 1999, NUCLEIC ACIDS RES, V27, P3557, DOI 10.1093/nar/27.17.3557; Parkinson GN, 2002, NATURE, V417, P876, DOI 10.1038/nature755; Peakman LJ, 2003, J MOL BIOL, V333, P321, DOI 10.1016/j.jmb.2003.08.042; Shen JC, 2000, TRENDS GENET, V16, P213, DOI 10.1016/S0168-9525(99)01970-8; Shin-ya K, 2001, J AM CHEM SOC, V123, P1262, DOI 10.1021/ja005780q; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Sowd G, 2008, NUCLEIC ACIDS RES, V36, P4242, DOI 10.1093/nar/gkn385; Szalai VA, 2002, J AM CHEM SOC, V124, P1625, DOI 10.1021/ja0119651; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Walpita D, 1999, P NATL ACAD SCI USA, V96, P5622, DOI 10.1073/pnas.96.10.5622; WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258; Zaug AJ, 2005, P NATL ACAD SCI USA, V102, P10864, DOI 10.1073/pnas.0504744102	51	42	42	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31074	31084		10.1074/jbc.M109.027532	http://dx.doi.org/10.1074/jbc.M109.027532			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19734539	Green Published, hybrid			2022-12-27	WOS:000271378400036
J	Park, MS; O'Donnell, M				Park, Mee Sook; O'Donnell, Mike			The Clamp Loader Assembles the beta Clamp onto Either a 3 ' or 5 ' Primer Terminus THE UNDERLYING BASIS FAVORING 3 ' LOADING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-III; CHROMOSOMAL REPLICATION MACHINE; ONE HOLOENZYME PARTICLE; ESCHERICHIA-COLI; SLIDING CLAMP; GAMMA COMPLEX; ATP HYDROLYSIS; DELTA-SUBUNIT; RECA PROTEIN; MECHANISM	Clamp loaders assemble sliding clamps onto 3' primed sites for DNA polymerases. Clamp loaders are thought to be specific for a 3' primed site, and unable to bind a 5' site. We demonstrate here that the Escherichia coli gamma complex clamp loader can load the beta clamp onto a 5' primed site, although with at least 20-fold reduced efficiency relative to loading at a 3' primed site. Preferential clamp loading at a 3' site does not appear to be due to DNA binding, as the clamp loader forms an avid complex with beta at a 5' site. Preferential loading at a 3' versus a 5' site occurs at the ATP hydrolysis step, needed to close the ring around DNA. We also address DNA structural features that are recognized for preferential loading at a 3' site. Although the single-stranded template strand extends in opposite directions from 3' and 5' primed sites, thus making it a favorite candidate for distinguishing between 3' and 5' sites, the single-strand polarity at a primed template junction does not determine 3' site selection for clamp loading. Instead, we find that clamp loader recognition of a 3' site lies in the duplex portion of the primed site, not the single-strand portion. We present evidence that the beta clamp facilitates its own loading specificity for a 3' primed site. Implications to eukaryotic clamp loader complexes are proposed.	[Park, Mee Sook; O'Donnell, Mike] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	O'Donnell, M (corresponding author), 1230 York Ave,Box 228, New York, NY 10065 USA.	odonnel@mail.rockefeller.edu		O'Donnell, Michael/0000-0001-9002-4214	National Institutes of Health [GM3883]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant GM3883.	Ason B, 2000, J BIOL CHEM, V275, P3006, DOI 10.1074/jbc.275.4.3006; Bermudez VP, 2003, P NATL ACAD SCI USA, V100, P1633, DOI 10.1073/pnas.0437927100; Bertram JG, 2000, J BIOL CHEM, V275, P28413, DOI 10.1074/jbc.M910441199; Bork JM, 2001, EMBO J, V20, P7313, DOI 10.1093/emboj/20.24.7313; Bowman GD, 2005, FEBS LETT, V579, P863, DOI 10.1016/j.febslet.2004.11.038; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; Breier AM, 2005, P NATL ACAD SCI USA, V102, P3942, DOI 10.1073/pnas.0500812102; Clover BP, 2001, CELL, V105, P925, DOI 10.1016/S0092-8674(01)00400-7; de Saro FJL, 2003, EMBO J, V22, P6408, DOI 10.1093/emboj/cdg603; de Saro FJL, 2001, P NATL ACAD SCI USA, V98, P8376, DOI 10.1073/pnas.121009498; Ellison V, 2003, PLOS BIOL, V1, P231, DOI 10.1371/journal.pbio.0000033; FLOWER AM, 1990, P NATL ACAD SCI USA, V87, P3713, DOI 10.1073/pnas.87.10.3713; Gao DX, 2001, J BIOL CHEM, V276, P4441, DOI 10.1074/jbc.M009830200; Georgescu RE, 2008, CELL, V132, P43, DOI 10.1016/j.cell.2007.11.045; Hingorani MM, 1999, EMBO J, V18, P5131, DOI 10.1093/emboj/18.18.5131; Hingorani MM, 1998, J BIOL CHEM, V273, P24550, DOI 10.1074/jbc.273.38.24550; Jeruzalmi D, 2001, CELL, V106, P429, DOI 10.1016/S0092-8674(01)00463-9; Jeruzalmi D, 2001, CELL, V106, P417, DOI 10.1016/S0092-8674(01)00462-7; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kazmirski SL, 2005, P NATL ACAD SCI USA, V102, P13801, DOI 10.1073/pnas.0506430102; Kelman Z, 1995, METHOD ENZYMOL, V262, P430; Leu FP, 2000, J BIOL CHEM, V275, P34609, DOI 10.1074/jbc.M005495200; Leu FP, 2003, MOL CELL, V11, P315, DOI 10.1016/S1097-2765(03)00042-X; Majka J, 2003, P NATL ACAD SCI USA, V100, P2249, DOI 10.1073/pnas.0437148100; McInerney P, 2007, MOL CELL, V27, P527, DOI 10.1016/j.molcel.2007.06.019; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; Naktinis V, 1996, CELL, V84, P137, DOI 10.1016/S0092-8674(00)81000-4; ODONNELL M, 1990, J BIOL CHEM, V265, P1179; ONRUST R, 1991, J BIOL CHEM, V266, P21681; ONRUST R, 1995, J BIOL CHEM, V270, P13366, DOI 10.1074/jbc.270.22.13366; ONRUST R, 1995, J BIOL CHEM, V270, P13348, DOI 10.1074/jbc.270.22.13348; SCHEUERMANN RH, 1984, P NATL ACAD SCI-BIOL, V81, P7747, DOI 10.1073/pnas.81.24.7747; Simonetta KR, 2009, CELL, V137, P659, DOI 10.1016/j.cell.2009.03.044; Turner J, 1999, EMBO J, V18, P771, DOI 10.1093/emboj/18.3.771; Yao N, 2000, J BIOL CHEM, V275, P11440, DOI 10.1074/jbc.275.15.11440	35	12	12	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31473	31483		10.1074/jbc.M109.050310	http://dx.doi.org/10.1074/jbc.M109.050310			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19759020	Green Published, hybrid			2022-12-27	WOS:000271378400072
J	Veesler, D; Dreier, B; Blangy, S; Lichiere, J; Tremblay, D; Moineau, S; Spinelli, S; Tegoni, M; Pluckthun, A; Campanacci, V; Cambillau, C				Veesler, David; Dreier, Birgit; Blangy, Stephanie; Lichiere, Julie; Tremblay, Denise; Moineau, Sylvain; Spinelli, Silvia; Tegoni, Mariella; Plueckthun, Andreas; Campanacci, Valerie; Cambillau, Christian			Crystal Structure and Function of a DARPin Neutralizing Inhibitor of Lactococcal Phage TP901-1 COMPARISON OF DARPin AND CAMELID VHH BINDING MODE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANKYRIN REPEAT PROTEIN; CHAIN ANTIBODY FRAGMENT; IN-VITRO; RIBOSOME DISPLAY; LACTIS PHAGES; IDENTIFICATION; DOMAIN; LLAMA; CRYSTALLIZATION; BACTERIOPHAGES	Combinatorial libraries of designed ankyrin repeat proteins (DARPins) have been proven to be a valuable source of specific binding proteins, as they can be expressed at very high levels and are very stable. We report here the selection of DARPins directed against a macromolecular multiprotein complex, the baseplate BppU.BppL complex of the lactococcal phage TP901-1. Using ribosome display, we selected several DARPins that bound specifically to the tip of the receptor-binding protein (RBP, the BppL trimer). The three selected DARPins display high specificity and affinity in the low nanomolar range and bind with a stoichiometry of one DARPin per BppL trimer. The crystal structure of a DARPin complexed with the RBP was solved at 2.1 angstrom resolution. The DARPin.RBP interface is of the concave (DARPin)-convex (RBP) type, typical of other DARPin protein complexes and different from what is observed with a camelid VHH domain, which penetrates the phage p2 RBP inter-monomer interface. Finally, phage infection assays demonstrated that TP901-1 infection of Lactococcus lactis cells was inhibited by each of the three selected DARPins. This study provides proof of concept for the possible use of DARPins to circumvent viral infection. It also provides support for the use of DARPins in co-crystallization, due to their rigidity and their ability to provide multiple crystal contacts.	[Veesler, David; Blangy, Stephanie; Lichiere, Julie; Spinelli, Silvia; Tegoni, Mariella; Campanacci, Valerie; Cambillau, Christian] AFMB, CNRS, UMR 6098, F-13288 Marseille 09, France; [Veesler, David; Blangy, Stephanie; Lichiere, Julie; Spinelli, Silvia; Tegoni, Mariella; Campanacci, Valerie; Cambillau, Christian] Univ Aix Marseille 1, F-13288 Marseille 09, France; [Veesler, David; Blangy, Stephanie; Lichiere, Julie; Spinelli, Silvia; Tegoni, Mariella; Campanacci, Valerie; Cambillau, Christian] Univ Aix Marseille 2, F-13288 Marseille 09, France; [Dreier, Birgit; Plueckthun, Andreas] Univ Zurich, Inst Biochem, CH-8057 Zurich, Switzerland; [Tremblay, Denise] Univ Laval, Grp Rech Ecol Buccale, Felix Herelle Reference Ctr Bacterial Viruses, Fac Med Dent, Quebec City, PQ G1V 0A6, Canada; [Moineau, Sylvain] Univ Laval, Dept Biochim & Microbiol, Fac Sci & Genie, Quebec City, PQ G1V 0A6, Canada	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; University of Zurich; Laval University; Laval University	Campanacci, V (corresponding author), AFMB, CNRS, UMR 6098, 163 Av Luminy,Case 932,Campus Luminy, F-13288 Marseille 09, France.	valerie.campanacci@afmb.univ-mrs.fr; cambillau@afmb.univ-mrs.fr	Veesler, David/HCH-3986-2022; Moineau, Sylvain/I-7231-2019; Moineau, Sylvain/N-3578-2013; Plückthun, Andreas/C-2746-2009	Moineau, Sylvain/0000-0002-2832-5101; Plückthun, Andreas/0000-0003-4191-5306; Campanacci, Valerie/0000-0001-6407-6395	Marseille-Nice Geno-pole; CNRS; Natural Sciences and Engineering Research Council of Canada through its strategic grogram; Agence Nationale de la Recherche [ANR-07-BLAN-0095]	Marseille-Nice Geno-pole; CNRS(Centre National de la Recherche Scientifique (CNRS)); Natural Sciences and Engineering Research Council of Canada through its strategic grogram(Natural Sciences and Engineering Research Council of Canada (NSERC)); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported, in part, by grants from the Marseille-Nice Geno-pole ( to J.L.), the CNRS, the Natural Sciences and Engineering Research Council of Canada through its strategic grogram ( to S. M.), and by Agence Nationale de la Recherche (ANR-07-BLAN-0095).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bandeiras TM, 2008, ACTA CRYSTALLOGR D, V64, P339, DOI 10.1107/S0907444907068217; Binz HK, 2004, NAT BIOTECHNOL, V22, P575, DOI 10.1038/nbt962; Binz HK, 2003, J MOL BIOL, V332, P489, DOI 10.1016/S0022-2836(03)00896-9; Bissonnette F, 2000, J DAIRY SCI, V83, P620, DOI 10.3168/jds.S0022-0302(00)74921-6; BORK P, 1993, PROTEINS, V17, P363, DOI 10.1002/prot.340170405; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; De Haard HJW, 2005, J BACTERIOL, V187, P4531, DOI 10.1128/JB.187.13.4531-4541.2005; Deveau H, 2006, APPL ENVIRON MICROB, V72, P4338, DOI 10.1128/AEM.02517-05; Dupont K, 2004, APPL ENVIRON MICROB, V70, P5818, DOI 10.1128/AEM.70.10.5818-5824.2004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ewert S, 2002, BIOCHEMISTRY-US, V41, P3628, DOI 10.1021/bi011239a; Geller BL, 2005, J DAIRY SCI, V88, P900, DOI 10.3168/jds.S0022-0302(05)72756-9; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Hanes J, 1997, P NATL ACAD SCI USA, V94, P4937, DOI 10.1073/pnas.94.10.4937; Hultberg A, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-58; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kohl A, 2005, STRUCTURE, V13, P1131, DOI 10.1016/j.str.2005.04.020; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Labrie SJ, 2008, APPL ENVIRON MICROB, V74, P4636, DOI 10.1128/AEM.00118-08; Labrie SJ, 2007, J BACTERIOL, V189, P1482, DOI 10.1128/JB.01111-06; Ledeboer AM, 2002, J DAIRY SCI, V85, P1376, DOI 10.3168/jds.S0022-0302(02)74204-5; MOINEAU S, 1993, APPL ENVIRON MICROB, V59, P197, DOI 10.1128/AEM.59.1.197-202.1993; Moineau S, 1999, ANTON LEEUW INT J G, V76, P377, DOI 10.1023/A:1002045701064; Muyldermans S, 2001, TRENDS BIOCHEM SCI, V26, P230, DOI 10.1016/S0968-0004(01)01790-X; NAVAZA J, 1993, ACTA CRYSTALLOGR D, V49, P588, DOI 10.1107/S0907444993005141; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Reynolds C, 2009, BIOINFORMATICS, V25, P413, DOI 10.1093/bioinformatics/btn584; Ricagno S, 2006, J VIROL, V80, P9331, DOI 10.1128/JVI.01160-06; Schweizer A, 2007, STRUCTURE, V15, P625, DOI 10.1016/j.str.2007.03.014; Sennhauser G, 2008, STRUCTURE, V16, P1443, DOI 10.1016/j.str.2008.08.010; Sennhauser G, 2007, PLOS BIOL, V5, P106, DOI 10.1371/journal.pbio.0050007; Siponen M, 2009, J BACTERIOL, V191, P3220, DOI 10.1128/JB.01637-08; Spinelli S, 2006, NAT STRUCT MOL BIOL, V13, P85, DOI 10.1038/nsmb1029; Spinelli S, 2006, J BIOL CHEM, V281, P14256, DOI 10.1074/jbc.M600666200; Steiner D, 2008, J MOL BIOL, V382, P1211, DOI 10.1016/j.jmb.2008.07.085; Sturino JM, 2006, NAT REV MICROBIOL, V4, P395, DOI 10.1038/nrmicro1393; Sulzenbacher G, 2002, ACTA CRYSTALLOGR D, V58, P2109, DOI 10.1107/S0907444902013938; Tremblay DM, 2006, J BACTERIOL, V188, P2400, DOI 10.1128/JB.188.7.2400-2410.2006; Veesler D, 2009, ANAL BIOCHEM, V388, P115, DOI 10.1016/j.ab.2009.02.018; Vegge CS, 2006, J BACTERIOL, V188, P55, DOI 10.1128/JB.188.1.55-63.2006; Vincentelli R, 2003, ACCOUNTS CHEM RES, V36, P165, DOI 10.1021/ar010130s; Zahnd C, 2004, J BIOL CHEM, V279, P18870, DOI 10.1074/jbc.M309169200; Zahnd C, 2007, NAT METHODS, V4, P269, DOI 10.1038/NMETH1003	44	53	57	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30718	30726		10.1074/jbc.M109.037812	http://dx.doi.org/10.1074/jbc.M109.037812			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19740746	Green Published, hybrid			2022-12-27	WOS:000271090000073
